Citrus Sinensis ID: 006739
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 633 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SKB2 | 641 | Leucine-rich repeat recep | yes | no | 0.988 | 0.976 | 0.662 | 0.0 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.808 | 0.505 | 0.343 | 3e-68 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.830 | 0.421 | 0.322 | 6e-68 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.819 | 0.521 | 0.342 | 1e-66 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.744 | 0.452 | 0.332 | 3e-66 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.829 | 0.476 | 0.338 | 5e-66 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.808 | 0.470 | 0.337 | 5e-66 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.862 | 0.458 | 0.315 | 1e-65 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.750 | 0.393 | 0.313 | 1e-65 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.750 | 0.393 | 0.313 | 1e-65 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/635 (66%), Positives = 501/635 (78%), Gaps = 9/635 (1%)
Query: 3 LSPAKLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLG-GQQLFIPSD--PCSTPG 59
L P L + F LLS S L++D SD KAL VI +LG Q SD PC G
Sbjct: 12 LRPLILAVLSFLLLSSFVSSVEWLDIDSSDLKALQVIETELGVNSQRSSASDVNPCGRRG 71
Query: 60 VFCERRLS-DNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQI 118
VFCERR S YVL++T+LV+ R LTG +SP IG LSEL+EL+L+NN LV+ +P I
Sbjct: 72 VFCERRHSATTGEYVLRVTRLVYRSRSLTGTISPVIGMLSELKELTLSNNQLVNAVPVDI 131
Query: 119 VDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAK 178
+ CK+LE+L+++ N+FSG IP + SSL RLR+LDLS N SGNL FLK NLE+LS+A
Sbjct: 132 LSCKQLEVLDLRKNRFSGQIPGNFSSLSRLRILDLSSNKLSGNLNFLKNLRNLENLSVAN 191
Query: 179 NLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRS 238
NLF+GK+P I +F NL+FFDFSGN LEGP PVM + + R++LAET T+ +
Sbjct: 192 NLFSGKIPEQIVSFHNLRFFDFSGNRYLEGPAPVMSSIKLQTSPHQTRHILAETPTSSPT 251
Query: 239 NGPSPAAAPNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFS 298
N P+ NS+T + AP P K KKSK KK A WILGF+ GA+ GTISGFVFS
Sbjct: 252 NKPN-----NSTTSKAPKGAPKPGKLKKKKKKSKKKKVAAWILGFVVGAIGGTISGFVFS 306
Query: 299 VLFKLILAAVRGGGRDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAEL 358
VLFKLI+ A+RG + GP+IFSPLIKKAEDLAFLE E+ LASLE IG GGCGEV+KAEL
Sbjct: 307 VLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAEL 366
Query: 359 PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418
PGSNGK+IA+KKVIQPPKDA ELT+EDSK LNKKMRQIRSEINTVG IRHRNLLPLLAH+
Sbjct: 367 PGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHV 426
Query: 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRII 478
+RP+CH LVYE+M+ GSLQDIL DV G +EL W ARHKIALG+A GLEYLH+ HNPRII
Sbjct: 427 SRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRII 486
Query: 479 HRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDK 538
HRDLKPANVLLDDDMEARI+DFGLAKAMPDA THITTS+VAGTVGYIAPE++QT KFTDK
Sbjct: 487 HRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDK 546
Query: 539 CDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEE 598
CDIYSFGV+L +LV+G+LPSD+FFQHT+EMSL+KWMRN++TSENP+ AID KL++ G++E
Sbjct: 547 CDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDE 606
Query: 599 QMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
QMLLVLKIAC+CT+D P++RPNSKDVR MLSQI+H
Sbjct: 607 QMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 260 bits (664), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 193/562 (34%), Positives = 294/562 (52%), Gaps = 50/562 (8%)
Query: 81 FVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPS 140
F ++ L +I + L+ +A+N + +P Q DC L L++ +N +GTIPS
Sbjct: 459 FSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPS 518
Query: 141 DLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFD 199
++S +L L+L N+ +G + + L L L+ N TG +P SI T L+ +
Sbjct: 519 SIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLN 578
Query: 200 FSGNSLLEGPIPV---MRRVGPSGFQYPKRYVLAETTTNGRSNGPSPAAAPNSSTRSSGA 256
S N L GP+P+ ++ + P + +G G P P S +
Sbjct: 579 VSYNKL-TGPVPINGFLKTINPDDLR----------GNSGLCGGVLP---PCSKFQR--- 621
Query: 257 EAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSVLFKLILAAVRGGGRDSG 316
A S H H K + AGW++G IA +A I V L+K + G +
Sbjct: 622 ---ATSSHSSLHGK---RIVAGWLIG-IASVLALGILTIVTRTLYKKWYSNGFCGDETAS 674
Query: 317 PAIFSPLIKKAEDLAFLEKEDGLASLEK---IGSGGCGEVYKAELPGSNGKMIAIKKVIQ 373
+ + L F D LA +++ IG G G VYKAE+ S+ ++A+KK+ +
Sbjct: 675 KGEWPWRLMAFHRLGF-TASDILACIKESNMIGMGATGIVYKAEMSRSS-TVLAVKKLWR 732
Query: 374 PPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKN 433
D + T D E+N +G++RHRN++ LL + ++VYEFM N
Sbjct: 733 SAADIEDGTTGD----------FVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLN 782
Query: 434 GSLQD-ILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492
G+L D I + GR +DW++R+ IALGVA GL YLH +P +IHRD+K N+LLD +
Sbjct: 783 GNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDAN 842
Query: 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV 552
++ARIADFGLA+ M A+ T S VAG+ GYIAPEY TLK +K DIYS+GV+L L+
Sbjct: 843 LDARIADFGLARMM--ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELL 900
Query: 553 MGRLPSDDFFQHTEEMSLVKWM-RNVMTSENPTRAIDAKLLENGY-EEQMLLVLKIACFC 610
GR P + F E + +V+W+ R + + + A+D + Y +E+MLLVL+IA C
Sbjct: 901 TGRRPLEPEFG--ESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLC 958
Query: 611 TVDSPRERPNSKDVRCMLSQIR 632
T P++RP+ +DV ML + +
Sbjct: 959 TTKLPKDRPSMRDVISMLGEAK 980
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (661), Expect = 6e-68, Method: Compositional matrix adjust.
Identities = 195/604 (32%), Positives = 303/604 (50%), Gaps = 78/604 (12%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
K+T + L+G + P +G+LS+L EL L++N V+ LP ++ +C KL +L++ N
Sbjct: 648 KLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSL 707
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNL----GFLKYFPNL------------------- 171
+G+IP ++ +L L VL+L N FSG+L G L L
Sbjct: 708 NGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQ 767
Query: 172 ---EHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL---LEGPIPVMRRVGPSGFQYPK 225
L L+ N FTG +P++I T L+ D S N L + G + M+ +G +
Sbjct: 768 DLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNN 827
Query: 226 RYVLAETTTNGRSNGPSPAAAPNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIA 285
L S P+ + N+ S ++K + + I+ I+
Sbjct: 828 ---LGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVV--IISAIS 882
Query: 286 GAVAGTISGFVFSVLFKLILAAVRGGGRDSGP---------AIFSPLIKKAEDLAFLEKE 336
A + V ++ FK + G S A PL + + + E
Sbjct: 883 ALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWE 942
Query: 337 DGLASLEK------IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLN 390
D + + IGSGG G+VYKAEL NG+ +A+KK++ +D + N
Sbjct: 943 DIMEATHNLSEEFMIGSGGSGKVYKAEL--ENGETVAVKKILW----------KDDLMSN 990
Query: 391 KKMRQIRSEINTVGQIRHRNLLPLLAHMARPD--CHLLVYEFMKNGSLQDILND----VS 444
K + E+ T+G+IRHR+L+ L+ + + +LL+YE+MKNGS+ D L++ +
Sbjct: 991 KSFSR---EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLE 1047
Query: 445 QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504
+ ++ LDW AR +IA+G+A G+EYLH P I+HRD+K +NVLLD +MEA + DFGLAK
Sbjct: 1048 KKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAK 1107
Query: 505 AMPDAQTHITTSNV--AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562
+ + T SN A + GYIAPEY +LK T+K D+YS G++L +V G++P+D F
Sbjct: 1108 VLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVF 1167
Query: 563 QHTEEMSLVKWMRNVMTSENPTR--AIDAKL--LENGYEEQMLLVLKIACFCTVDSPRER 618
EM +V+W+ + R ID KL L E+ VL+IA CT SP+ER
Sbjct: 1168 --GAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQER 1225
Query: 619 PNSK 622
P+S+
Sbjct: 1226 PSSR 1229
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 198/578 (34%), Positives = 280/578 (48%), Gaps = 59/578 (10%)
Query: 76 ITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFS 135
+ L V +G +S SIG S L L L+NN LP +I L L+ N+FS
Sbjct: 422 VNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFS 481
Query: 136 GTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN 194
G++P L SL L LDL GN FSG L +K + L L+LA N FTGK+P I +
Sbjct: 482 GSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSV 541
Query: 195 LQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRSNGPSPAAAPNSSTRSS 254
L + D SGN + G IPV Q K L S R S
Sbjct: 542 LNYLDLSGN-MFSGKIPV-------SLQSLKLNQLNL-----------------SYNRLS 576
Query: 255 GAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSVLFKLILAAVRGGGRD 314
G P+ + +K+ G I G G+V+ + +LAA+
Sbjct: 577 GDLPPSLAKDMYKNSFIGNPGLCGDIKGLCGSENEAKKRGYVWLLRSIFVLAAMV---LL 633
Query: 315 SGPAIFS---PLIKKA-------------EDLAFLEKEDGLASLEK---IGSGGCGEVYK 355
+G A F KKA L F E E L SL++ IG+G G+VYK
Sbjct: 634 AGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEI-LESLDEDNVIGAGASGKVYK 692
Query: 356 AELPGSNGKMIAIKKVIQPP-KDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414
L +NG+ +A+K++ K+ + E + +E+ T+G+IRH+N++ L
Sbjct: 693 VVL--TNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKL 750
Query: 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHN 474
+ DC LLVYE+M NGSL D+L+ G L W R KI L A GL YLH
Sbjct: 751 WCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGM--LGWQTRFKIILDAAEGLSYLHHDSV 808
Query: 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMP-DAQTHITTSNVAGTVGYIAPEYHQTL 533
P I+HRD+K N+L+D D AR+ADFG+AKA+ + + S +AG+ GYIAPEY TL
Sbjct: 809 PPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTL 868
Query: 534 KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLE 593
+ +K DIYSFGV++ +V + P D E LVKW+ + + + ID K L+
Sbjct: 869 RVNEKSDIYSFGVVILEIVTRKRPVD---PELGEKDLVKWVCSTLDQKGIEHVIDPK-LD 924
Query: 594 NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
+ ++E++ +L + CT P RP+ + V ML +I
Sbjct: 925 SCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQEI 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (646), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 180/542 (33%), Positives = 279/542 (51%), Gaps = 71/542 (13%)
Query: 116 PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGF-LKYFPNLEHL 174
P V CK + +Q N +GTIP D+ +L L+LS N +G + + + P++ +
Sbjct: 506 PNYVGCKSFYRIELQGNSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADV 565
Query: 175 SLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPV--MRRVGPSGFQYPKRYVLAET 232
L+ NL TG +P+ + + + F+ S N L+ GPIP + PS F +
Sbjct: 566 DLSHNLLTGTIPSDFGSSKTITTFNVSYNQLI-GPIPSGSFAHLNPSFF----------S 614
Query: 233 TTNGRSNGPSPAAAPNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTI 292
+ G P +S R + A HK+ + KK AG I+ +A A+
Sbjct: 615 SNEGLCG--DLVGKPCNSDRFNAGNADIDG----HHKEERPKKTAGAIVWILAAAIG--- 665
Query: 293 SGFVFSVLFKLILAAVRGGGRDSGPAI-----------------FSPLIKKAEDLA-FLE 334
V F +++AA R + G + F L A+D+ L
Sbjct: 666 ------VGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQRLNFTADDVVECLS 719
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
K D + +G G G VYKAE+P NG++IA+KK+ K+ ++ S +L
Sbjct: 720 KTDNI-----LGMGSTGTVYKAEMP--NGEIIAVKKLWGKNKENGKIRRRKSGVL----- 767
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRREL-DWL 453
+E++ +G +RHRN++ LL DC +L+YE+M NGSL D+L+ + +W
Sbjct: 768 ---AEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWT 824
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
A ++IA+GVA G+ YLH +P I+HRDLKP+N+LLD D EAR+ADFG+AK + QT
Sbjct: 825 ALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI---QTDE 881
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573
+ S VAG+ GYIAPEY TL+ K DIYS+GV+L ++ G+ + F E S+V W
Sbjct: 882 SMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEF--GEGNSIVDW 939
Query: 574 MRNVM-TSENPTRAIDAKLLENG--YEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630
+R+ + T E+ +D + + E+M +L+IA CT SP +RP +DV +L +
Sbjct: 940 VRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQE 999
Query: 631 IR 632
+
Sbjct: 1000 AK 1001
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (645), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 203/600 (33%), Positives = 291/600 (48%), Gaps = 75/600 (12%)
Query: 76 ITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFS 135
+ +L TG L IG LS+L L++++N L +P +I +CK L+ L++ N FS
Sbjct: 507 LQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFS 566
Query: 136 GTIPSDLSSLIRLRVLDLSGNSFSGNLGF-LKYFPNLEHLSLAKNLFTGKVPTSIRTFRN 194
GT+PS++ SL +L +L LS N+ SG + L L L + NLF G +P + +
Sbjct: 567 GTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTG 626
Query: 195 LQF-FDFSGNSLLEGPIP------VMRRVG-----------PSGFQYPKRYVLAETTTNG 236
LQ + S N L G IP VM PS F + + N
Sbjct: 627 LQIALNLSYNKL-TGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNS 685
Query: 237 RSNGPSPAAAPNSSTRSSGAEAPAPSPHHH-----------KHKKSKGKKAAGWILGFIA 285
+ GP P S + G E P + K G +++ I I
Sbjct: 686 LT-GPIPLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIA--IT 742
Query: 286 GAVAGTISGFVFSVLFKLILAAVR---GGGRDSGPAIFSPLIKKAEDLAFLEKE-----D 337
AV G +S + +++ L+ VR +D P+ + + D+ F KE D
Sbjct: 743 AAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPS------EMSLDIYFPPKEGFTFQD 796
Query: 338 GLASLEK------IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK 391
+A+ + +G G CG VYKA LP G +A+KK+ + ++S
Sbjct: 797 LVAATDNFDESFVVGRGACGTVYKAVLPA--GYTLAVKKLASNHEGGNNNNVDNS----- 849
Query: 392 KMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD 451
R+EI T+G IRHRN++ L +LL+YE+M GSL +IL+D S LD
Sbjct: 850 ----FRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC---NLD 902
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
W R KIALG A GL YLH PRI HRD+K N+LLDD EA + DFGLAK + D
Sbjct: 903 WSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPH 961
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571
+ S +AG+ GYIAPEY T+K T+K DIYS+GV+L L+ G+ P Q + +V
Sbjct: 962 SKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGD---VV 1018
Query: 572 KWMRNVMTSENPTRAI-DAKLL--ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628
W+R+ + + + + DA+L + ML VLKIA CT SP RP+ + V ML
Sbjct: 1019 NWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 196/580 (33%), Positives = 292/580 (50%), Gaps = 68/580 (11%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
+LTG++ P +G L L L+L++N L LP Q+ C +L +V +N +G+IPS S
Sbjct: 518 KLTGLIPPELGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRS 577
Query: 145 LIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQF-FDFSG 202
L L LS N+F G + FL L L +A+N F GK+P+S+ ++L++ D S
Sbjct: 578 WKSLSTLVLSDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSA 637
Query: 203 NSLLEGPIPVM---------------RRVGP-SGFQYPKRYVLAETTTNGRSNGPSPAAA 246
N + G IP + GP S Q K + + N + GP P
Sbjct: 638 N-VFTGEIPTTLGALINLERLNISNNKLTGPLSVLQSLKSLNQVDVSYN-QFTGPIPVNL 695
Query: 247 PNSSTRSSG-------AEAPAPSPHHHKHKKSKGK-KAAGWILGFIAGAVAGTISGFVFS 298
++S++ SG A + + K KG+ K + W + IA ++S
Sbjct: 696 LSNSSKFSGNPDLCIQASYSVSAIIRKEFKSCKGQVKLSTWKIALIAAG--SSLSVLALL 753
Query: 299 VLFKLILAAVRGGGRDSGPAIF-----SPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEV 353
L+L + G + I S L+ K L D L IG G G V
Sbjct: 754 FALFLVLCRCKRGTKTEDANILAEEGLSLLLNKV-----LAATDNLDDKYIIGRGAHGVV 808
Query: 354 YKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413
Y+A L +G+ A+KK+I A N+ M++ EI T+G +RHRNL+
Sbjct: 809 YRASL--GSGEEYAVKKLIFAEHIRA----------NQNMKR---EIETIGLVRHRNLIR 853
Query: 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISH 473
L R + L++Y++M NGSL D+L+ +QG LDW AR IALG++ GL YLH
Sbjct: 854 LERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHGLAYLHHDC 913
Query: 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL 533
+P IIHRD+KP N+L+D DME I DFGLA+ + D+ ++T+ V GT GYIAPE
Sbjct: 914 HPPIIHRDIKPENILMDSDMEPHIGDFGLARILDDST--VSTATVTGTTGYIAPENAYKT 971
Query: 534 KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS---ENPTRA--ID 588
+ + D+YS+GV+L LV G+ D F E++++V W+R+V++S E+ T +D
Sbjct: 972 VRSKESDVYSYGVVLLELVTGKRALDRSF--PEDINIVSWVRSVLSSYEDEDDTAGPIVD 1029
Query: 589 AK----LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
K LL+ EQ + V +A CT P RP+ +DV
Sbjct: 1030 PKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRDV 1069
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 194/614 (31%), Positives = 289/614 (47%), Gaps = 68/614 (11%)
Query: 60 VFCERRLSDNN---------TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSL 110
V E LS+N+ + + +T L LTG + +G +L+ L+LANN L
Sbjct: 605 VLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQL 664
Query: 111 VDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGF-LKYFP 169
+P L LN+ N+ G +P+ L +L L +DLS N+ SG L L
Sbjct: 665 NGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTME 724
Query: 170 NLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQY---PKR 226
L L + +N FTG++P+ + L++ D S N LL G IP + G ++ K
Sbjct: 725 KLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSEN-LLSGEIPT-KICGLPNLEFLNLAKN 782
Query: 227 YVLAETTTNGRSNGPSPAAAPNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAG 286
+ E ++G PS A + K + + G AG +LGF
Sbjct: 783 NLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWG--IAGLMLGFTI- 839
Query: 287 AVAGTISGFVFSVLFKLILAAVR------------------------GGGRDSGP----- 317
+ FVFS+ + V+ G R P
Sbjct: 840 ----IVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINI 895
Query: 318 AIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKD 377
A+F + K +E D + IG GG G VYKA LPG K +A+KK+
Sbjct: 896 AMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGE--KTVAVKKL------ 947
Query: 378 AAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQ 437
S+ + R+ +E+ T+G+++H NL+ LL + + + LLVYE+M NGSL
Sbjct: 948 --------SEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLD 999
Query: 438 DILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497
L + + LDW R KIA+G A GL +LH P IIHRD+K +N+LLD D E ++
Sbjct: 1000 HWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKV 1059
Query: 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
ADFGLA+ + ++H++T +AGT GYI PEY Q+ + T K D+YSFGV+L LV G+ P
Sbjct: 1060 ADFGLARLISACESHVSTV-IAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEP 1118
Query: 558 SDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE 617
+ F+ +E +LV W + ID L+ + L +L+IA C ++P +
Sbjct: 1119 TGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAK 1178
Query: 618 RPNSKDVRCMLSQI 631
RPN DV L +I
Sbjct: 1179 RPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 185/590 (31%), Positives = 287/590 (48%), Gaps = 115/590 (19%)
Query: 84 RELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS 143
R G+ P+ + L L+ N L +P ++ L ILN+ +N SG IP L
Sbjct: 649 RVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLG 708
Query: 144 SLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSG 202
L + +LDLS N F+G + L L + L+ N +G +P S F + F+
Sbjct: 709 GLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPES-APFDTFPDYRFAN 767
Query: 203 NSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRSNGPSPAAAPNSSTRSSGAEAPAPS 262
NSL P+P+ P SS P
Sbjct: 768 NSLCGYPLPI----------------------------------PCSS---------GPK 784
Query: 263 PHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSV--LFKLILAAVRGGGRDSGP--- 317
++H+KS ++A+ +AG+VA G +FS+ +F LI+ A+ R
Sbjct: 785 SDANQHQKSHRRQAS------LAGSVA---MGLLFSLFCIFGLIIVAIETKKRRRKKEAA 835
Query: 318 -------------------------------AIFSPLIKKAEDLAFLEKEDGLASLEKIG 346
A F ++K LE +G + +G
Sbjct: 836 LEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVG 895
Query: 347 SGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI 406
SGG G+VYKA+L +G ++AIKK+I + + R+ +E+ T+G+I
Sbjct: 896 SGGFGDVYKAQL--KDGSVVAIKKLIH--------------VSGQGDREFTAEMETIGKI 939
Query: 407 RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGL 466
+HRNL+PLL + + LLVYE+MK GSL+D+L+D + +L+W AR KIA+G A GL
Sbjct: 940 KHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGL 999
Query: 467 EYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIA 526
+LH + P IIHRD+K +NVLLD+++EAR++DFG+A+ M TH++ S +AGT GY+
Sbjct: 1000 AFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1059
Query: 527 PEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD--DFFQHTEEMSLVKWMRNVMTSENPT 584
PEY+Q+ + + K D+YS+GV+L L+ G+ P+D DF + +LV W++ + T
Sbjct: 1060 PEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADF----GDNNLVGWVK-LHAKGKIT 1114
Query: 585 RAIDAKLLEN--GYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
D +LL+ E ++L LK+AC C D +RP V M +I+
Sbjct: 1115 DVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKEIQ 1164
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (642), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 185/590 (31%), Positives = 287/590 (48%), Gaps = 115/590 (19%)
Query: 84 RELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS 143
R G+ P+ + L L+ N L +P ++ L ILN+ +N SG IP L
Sbjct: 649 RVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLG 708
Query: 144 SLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSG 202
L + +LDLS N F+G + L L + L+ N +G +P S F + F+
Sbjct: 709 GLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPES-APFDTFPDYRFAN 767
Query: 203 NSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRSNGPSPAAAPNSSTRSSGAEAPAPS 262
NSL P+P+ P SS P
Sbjct: 768 NSLCGYPLPL----------------------------------PCSS---------GPK 784
Query: 263 PHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSV--LFKLILAAVRGGGRDSGP--- 317
++H+KS ++A+ +AG+VA G +FS+ +F LI+ A+ R
Sbjct: 785 SDANQHQKSHRRQAS------LAGSVA---MGLLFSLFCIFGLIIVAIETKKRRRKKEAA 835
Query: 318 -------------------------------AIFSPLIKKAEDLAFLEKEDGLASLEKIG 346
A F ++K LE +G + +G
Sbjct: 836 LEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFHNDSLVG 895
Query: 347 SGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI 406
SGG G+VYKA+L +G ++AIKK+I + + R+ +E+ T+G+I
Sbjct: 896 SGGFGDVYKAQL--KDGSVVAIKKLIH--------------VSGQGDREFTAEMETIGKI 939
Query: 407 RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGL 466
+HRNL+PLL + + LLVYE+MK GSL+D+L+D + +L+W AR KIA+G A GL
Sbjct: 940 KHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARGL 999
Query: 467 EYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIA 526
+LH + P IIHRD+K +NVLLD+++EAR++DFG+A+ M TH++ S +AGT GY+
Sbjct: 1000 AFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVP 1059
Query: 527 PEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD--DFFQHTEEMSLVKWMRNVMTSENPT 584
PEY+Q+ + + K D+YS+GV+L L+ G+ P+D DF + +LV W++ + T
Sbjct: 1060 PEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADF----GDNNLVGWVK-LHAKGKIT 1114
Query: 585 RAIDAKLLEN--GYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
D +LL+ E ++L LK+AC C D +RP V M +I+
Sbjct: 1115 DVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKEIQ 1164
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 633 | ||||||
| 255540437 | 633 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.992 | 0.992 | 0.746 | 0.0 | |
| 224119518 | 627 | predicted protein [Populus trichocarpa] | 0.988 | 0.998 | 0.744 | 0.0 | |
| 224133744 | 630 | predicted protein [Populus trichocarpa] | 0.958 | 0.963 | 0.755 | 0.0 | |
| 449440606 | 643 | PREDICTED: leucine-rich repeat receptor- | 0.971 | 0.956 | 0.687 | 0.0 | |
| 356508750 | 636 | PREDICTED: leucine-rich repeat receptor- | 0.951 | 0.946 | 0.700 | 0.0 | |
| 225456834 | 632 | PREDICTED: leucine-rich repeat receptor- | 0.954 | 0.955 | 0.730 | 0.0 | |
| 24421095 | 633 | receptor-like protein kinase [Nicotiana | 0.979 | 0.979 | 0.651 | 0.0 | |
| 356516603 | 631 | PREDICTED: leucine-rich repeat receptor- | 0.957 | 0.960 | 0.688 | 0.0 | |
| 15225153 | 641 | putative leucine-rich repeat transmembra | 0.988 | 0.976 | 0.662 | 0.0 | |
| 16648755 | 641 | At2g31880/F20M17.8 [Arabidopsis thaliana | 0.988 | 0.976 | 0.659 | 0.0 |
| >gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 972 bits (2512), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 476/638 (74%), Positives = 542/638 (84%), Gaps = 10/638 (1%)
Query: 1 MALSPAKLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLGGQQLFIPS-DPCSTPG 59
MA +P LS+ LLS++ L+ AR+NLD D A SVI RDLG IPS PC
Sbjct: 1 MAFTPHSPFLSILILLSVVSLTSARVNLDNIDLNAFSVIHRDLGINSQRIPSATPCDNSA 60
Query: 60 VFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIV 119
VFCERRLS NNTY+LKI++L+F + L G LSP+IGRLSEL+ELS+ NN LVD LP QIV
Sbjct: 61 VFCERRLSKNNTYILKISRLIFKSQRLDGFLSPAIGRLSELKELSVPNNQLVDQLPSQIV 120
Query: 120 DCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKN 179
DCKKLEIL++ NN+FSG IPS+LS L+RLRVLDLS N F GNL FLK FPNLEHL+LA N
Sbjct: 121 DCKKLEILDLGNNEFSGQIPSELSKLLRLRVLDLSNNKFFGNLSFLKQFPNLEHLNLANN 180
Query: 180 LFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRSN 239
LF+G VP SIR+FRNLQFFDFSGN LEG +P+M + SG QYPKRYVLAE+ SN
Sbjct: 181 LFSGTVPKSIRSFRNLQFFDFSGNGFLEGRMPLMSKAEASGSQYPKRYVLAES-----SN 235
Query: 240 GPSPAAAPNSSTRS--SGAEAPAPSPHHHKHKKSKGK-KAAGWILGFIAGAVAGTISGFV 296
+ A N ++ + A+AP+PS + HKK GK K +GWILGF+AGAVAG++SGFV
Sbjct: 236 KSTTAINKNVTSVEGPTSAQAPSPSTGNAPHKKKSGKRKLSGWILGFLAGAVAGSMSGFV 295
Query: 297 FSVLFKLILAAVRGGGRDSGPAIFSP-LIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYK 355
FSV+FKLILA +RGGG+DSGPAIFSP LIKKAE+LAFLEKEDGL++LE IG GGCGEVYK
Sbjct: 296 FSVMFKLILATIRGGGKDSGPAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGGCGEVYK 355
Query: 356 AELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415
AELPGSNGKMIAIKK++QPP+DAAELTEED+KLLNKKMRQIRSEINTVGQIRHRNLLPLL
Sbjct: 356 AELPGSNGKMIAIKKIVQPPRDAAELTEEDTKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415
Query: 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNP 475
AH++RPDCH LVYEFMKNGSLQDIL+DV QG+RELDWLARH+IA+GVA GLEYLH SH+P
Sbjct: 416 AHVSRPDCHCLVYEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLEYLHTSHSP 475
Query: 476 RIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF 535
RIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA TH+TTSNVAGTVGYIAPEYHQTLKF
Sbjct: 476 RIIHRDLKPANVLLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAPEYHQTLKF 535
Query: 536 TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENG 595
TDKCDIYSFGVLL VLVMG+LPSD+FFQ T EMSLVKWMRN+MTSENP++AID K+ NG
Sbjct: 536 TDKCDIYSFGVLLGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAIDPKMNGNG 595
Query: 596 YEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
+EEQMLLVLKIACFCT+D PR+RPNSKD+RCMLSQI+H
Sbjct: 596 FEEQMLLVLKIACFCTLDDPRQRPNSKDIRCMLSQIKH 633
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 960 bits (2481), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/634 (74%), Positives = 543/634 (85%), Gaps = 8/634 (1%)
Query: 1 MALSPAKLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLG-GQQLFIPSDPCSTPG 59
MA+ K +LS+F LLS+L L+ ARLNLD SD KA S I +DLG Q S PC+TPG
Sbjct: 1 MAVLHHKHHLSIFVLLSVLLLADARLNLDHSDLKAFSTIQKDLGISSQRSSSSTPCNTPG 60
Query: 60 VFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIV 119
VFCERRLS N+T+VLKIT+LVF + L G LSP+IGRLSEL+ELSL NN LVD +P QIV
Sbjct: 61 VFCERRLSPNSTFVLKITRLVFKSQRLAGFLSPAIGRLSELKELSLTNNQLVDQVPAQIV 120
Query: 120 DCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKN 179
CKKLEIL + NNQFSG IPS+LSSL+RLRVLDLS N FSGNL FLK+FPNLE LSLA N
Sbjct: 121 KCKKLEILELANNQFSGEIPSELSSLVRLRVLDLSSNEFSGNLSFLKHFPNLESLSLANN 180
Query: 180 LFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRSN 239
LFTGKVP SIR+FRNLQFFDFSGNS LEGP+PV+ + S QYPKRY+L E TT+ S
Sbjct: 181 LFTGKVPKSIRSFRNLQFFDFSGNSFLEGPVPVIGKGESSRPQYPKRYILKENTTSTGSK 240
Query: 240 GPSPAAAPNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSV 299
S S + A + + HKHK SK +K AGW+LGF+AG+VAG++SGFVFS+
Sbjct: 241 NKS------SGLAPAPAPSSSAPSAPHKHKNSK-RKLAGWLLGFLAGSVAGSLSGFVFSL 293
Query: 300 LFKLILAAVRGGGRDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELP 359
LFK++LAAV+GGGRD GPAIFSPLIKKAEDLAFLEK++GLA+LE IG GGCGEV+KAELP
Sbjct: 294 LFKIVLAAVKGGGRDVGPAIFSPLIKKAEDLAFLEKDEGLANLEIIGRGGCGEVFKAELP 353
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419
GSNGKMIA+KK+IQPPKDAAEL+EEDSK+LNKKMRQI+SEINTVG IRHRNLLPLLAH++
Sbjct: 354 GSNGKMIAVKKIIQPPKDAAELSEEDSKVLNKKMRQIQSEINTVGHIRHRNLLPLLAHVS 413
Query: 420 RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIH 479
RPDCH LVYEFMKNGSLQD+LN V++G+RELDWLARHKIA+GVA GLEYLH+SH+P+IIH
Sbjct: 414 RPDCHYLVYEFMKNGSLQDVLNQVTEGKRELDWLARHKIAVGVASGLEYLHLSHSPQIIH 473
Query: 480 RDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKC 539
RDLKPANVLLDDDMEARIADFGLAKAMPDA+THITTSNVAGTVGYIAPEYHQTLKFT+KC
Sbjct: 474 RDLKPANVLLDDDMEARIADFGLAKAMPDAKTHITTSNVAGTVGYIAPEYHQTLKFTEKC 533
Query: 540 DIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQ 599
DIYSFGV+L VLVMG+LPSD FFQ T E+SLVKWMRN+M SENP++AID KL+ +G EEQ
Sbjct: 534 DIYSFGVVLGVLVMGKLPSDAFFQSTRELSLVKWMRNIMISENPSQAIDPKLIGHGLEEQ 593
Query: 600 MLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
MLLVLKIACFCT+D P++RP+SKDVRCMLSQI+H
Sbjct: 594 MLLVLKIACFCTIDDPKQRPSSKDVRCMLSQIKH 627
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2457), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/613 (75%), Positives = 527/613 (85%), Gaps = 6/613 (0%)
Query: 22 SHARLNLDRSDYKALSVILRDLG-GQQLFIPSDPCSTPGVFCERRLSDNNTYVLKITKLV 80
++ARLNLD SD KA S+I +DLG Q S PC+TPGVFCERRLS N TYVLKIT+LV
Sbjct: 23 TYARLNLDHSDLKAFSIIQKDLGINGQRSSSSTPCNTPGVFCERRLSPNGTYVLKITRLV 82
Query: 81 FVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPS 140
F + LTG LSP+IGRLSEL+ELSL NN LVD LP QIV+CKKL+IL + NN+FSG +PS
Sbjct: 83 FKSQRLTGFLSPAIGRLSELKELSLTNNQLVDHLPVQIVNCKKLDILELGNNKFSGEVPS 142
Query: 141 DLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200
+LSS++ LRVLDLS N FSGNL FLK+FPNLE+LSLA NLFTGKVP SIR+FRNLQ FDF
Sbjct: 143 ELSSIVSLRVLDLSRNLFSGNLSFLKHFPNLENLSLANNLFTGKVPKSIRSFRNLQSFDF 202
Query: 201 SGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRSNGPSPAAAPNSSTRSSGAEAPA 260
SGNS LEGP+PV+R+ S QYPKRY+LAE T++ +S S + T +
Sbjct: 203 SGNSFLEGPVPVIRKGESSRPQYPKRYILAENTSSTKSRNTSSG----NKTYNLAPAPGP 258
Query: 261 PSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSVLFKLILAAVRGGGRDSGPAIF 320
+ HKHK K +K AGW+ GF+AG+VAG +SG VFS+LFK++LAAV+GGGRD GPAIF
Sbjct: 259 SAAAPHKHKNGK-RKLAGWLFGFLAGSVAGCLSGLVFSLLFKIVLAAVKGGGRDGGPAIF 317
Query: 321 SPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAE 380
SPLIK+AEDLAFLEK+DGLA+LE IG GGCGEVYKAELPGSNGKMIAIKK+IQPPKDAAE
Sbjct: 318 SPLIKRAEDLAFLEKDDGLANLEVIGKGGCGEVYKAELPGSNGKMIAIKKIIQPPKDAAE 377
Query: 381 LTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL 440
LTEEDSKLL+KKMRQI+SEINTVG IRHRNLLPLLAH++RPDCH LVYE MKNGSLQD L
Sbjct: 378 LTEEDSKLLHKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPDCHYLVYELMKNGSLQDAL 437
Query: 441 NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500
N V++GRRELDWLARH+IA+GVA GLEYLH+SH+PRIIHRDLKPANVLLDD MEARIADF
Sbjct: 438 NHVTEGRRELDWLARHRIAVGVASGLEYLHLSHSPRIIHRDLKPANVLLDDSMEARIADF 497
Query: 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGV+L VLVMG+LPSD+
Sbjct: 498 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVVLGVLVMGKLPSDE 557
Query: 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620
FFQ+T EMSLVKWMRN+MTSENP +AID KL+ NG EEQMLLVLKIACFCT+D P++RPN
Sbjct: 558 FFQNTREMSLVKWMRNIMTSENPRQAIDPKLMGNGLEEQMLLVLKIACFCTIDDPKQRPN 617
Query: 621 SKDVRCMLSQIRH 633
SKDVRCMLSQI+H
Sbjct: 618 SKDVRCMLSQIKH 630
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2312), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/628 (68%), Positives = 523/628 (83%), Gaps = 13/628 (2%)
Query: 10 LSLFALLSLLFLSHARLNLDRSDYKALSVILRDLG--GQQLFIPSDPCSTPGVFCERRLS 67
L A LS++ HA LNLD SD +A S+I DLG GQ + S PC GVFCERRLS
Sbjct: 15 LPFLAFLSIVLHVHAGLNLDPSDLRAFSIIKNDLGIDGQ---LSSSPCHNAGVFCERRLS 71
Query: 68 DNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEIL 127
+N TYVL+IT+L+F + L+G LSP+IGRL+EL+EL+++NN LVD +P QIVDC+KLEIL
Sbjct: 72 NNGTYVLRITRLIFNSKGLSGSLSPAIGRLTELKELTVSNNHLVDQVPYQIVDCQKLEIL 131
Query: 128 NVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPT 187
++QNNQFSG +PS LS+LIRLRV+DLS N FSG+L FLKYFPNLE LS+A N FTGK+P
Sbjct: 132 DLQNNQFSGEVPSGLSTLIRLRVIDLSSNKFSGSLDFLKYFPNLESLSIANNYFTGKIPA 191
Query: 188 SIRTFRNLQFFDFSGNSLLEGPIPVMRRVG-PSGFQYPKRYVLAE-TTTNGRSNGPSPAA 245
SIR+FRNL+ F+FSGN LLE +++ V S + PKRY+LAE ++TNG+ +PA
Sbjct: 192 SIRSFRNLRVFNFSGNRLLESSTSILKDVEFYSATEVPKRYMLAENSSTNGKQRATAPAT 251
Query: 246 APNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSVLFKLIL 305
+P SS A+AP +P H K++K+K KK A WILGFIAGA+AG++SGF+FS+LFKL++
Sbjct: 252 SPTSS-----AQAPNAAPVH-KNRKNKAKKIASWILGFIAGAIAGSLSGFIFSLLFKLVI 305
Query: 306 AAVRGGGRDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKM 365
AA++GG ++SGP+IF+P + K +DLAFLE+++ LASL+ IG GGCGEVYKAELP +GKM
Sbjct: 306 AAIKGGSKNSGPSIFAPKLIKRDDLAFLERDNALASLQLIGKGGCGEVYKAELPEKSGKM 365
Query: 366 IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHL 425
AIKK+ QPPKDAAEL EE+S+ ++KKMRQI+SEI TVG+IRHRNLLPL+AH+ RPDCH
Sbjct: 366 FAIKKITQPPKDAAELIEEESRHMSKKMRQIKSEIRTVGEIRHRNLLPLVAHVPRPDCHY 425
Query: 426 LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485
LVYE MKNGSLQD+LN VS G +ELDWL RH IALGVA GLEYLH++H PRIIHRDLKPA
Sbjct: 426 LVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYLHMNHTPRIIHRDLKPA 485
Query: 486 NVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFG 545
NVLLDD MEARIADFGLAKAMPDAQTH+T SNVAGTVGYIAPEYHQTLKFTDKCDIY FG
Sbjct: 486 NVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEYHQTLKFTDKCDIYGFG 545
Query: 546 VLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLK 605
VLL VLV+G+LPSD+FFQ+T+EMSLVKWM+NVMTS+NP AID KLL NG+EEQMLL LK
Sbjct: 546 VLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDPKLLGNGWEEQMLLALK 605
Query: 606 IACFCTVDSPRERPNSKDVRCMLSQIRH 633
IACFCT+D+P+ERPNSKDVRCMLSQI+H
Sbjct: 606 IACFCTMDNPKERPNSKDVRCMLSQIKH 633
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 876 bits (2264), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/621 (70%), Positives = 508/621 (81%), Gaps = 19/621 (3%)
Query: 23 HARLNLDRSDYKALSVILRDLG-GQQLFIPSDPCSTPGVFCERR-LSDNNTYVLKITKLV 80
+A+L+L SDYKAL + +DL QL ++ C T GV CERR LS TY L+IT+LV
Sbjct: 25 NAKLDLYPSDYKALLTLQKDLRVNGQLAAATEACETEGVLCERRRLSGKETYALRITRLV 84
Query: 81 FVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPS 140
F L GVLSPSIGRL+EL+ELSL++N LVD +PPQIVDC+KLEIL++ NN FSG +PS
Sbjct: 85 FKSNNLNGVLSPSIGRLTELKELSLSDNQLVDRVPPQIVDCRKLEILDLANNIFSGEVPS 144
Query: 141 DLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200
+LSSL RLRVLDLS N SGNL FLKYFPNLE LS+A NLFTG+VP S+R+FRNL+ F+F
Sbjct: 145 ELSSLTRLRVLDLSTNRLSGNLNFLKYFPNLETLSVADNLFTGRVPPSVRSFRNLRHFNF 204
Query: 201 SGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRSNGPSPAAAPN--------SSTR 252
SGN L+ P ++ P R L+E +G + P+PA APN +ST
Sbjct: 205 SGNRFLD---PSLQSSSPDTIL--SRRFLSE---DGDGDVPAPAPAPNNSQKKKSNASTH 256
Query: 253 SSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSVLFKLILAAVRGGG 312
++ A H +KHK SK +K GWILGF+AGA+ GT+SGFVFS++FKL LA ++G G
Sbjct: 257 AAAAAPGPAPNHTNKHKHSK-RKLLGWILGFVAGALGGTLSGFVFSLMFKLALALIKGRG 315
Query: 313 RDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVI 372
R +GP I+SPLIKKAEDLAFLEKE+G+ASLE IG GGCGEVYKAELPGSNGKMIAIKK++
Sbjct: 316 RKAGPDIYSPLIKKAEDLAFLEKEEGIASLEIIGRGGCGEVYKAELPGSNGKMIAIKKIV 375
Query: 373 QPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMK 432
QPPKD AEL EEDSK+LNKKMRQIRSEINTVGQIRHRNLLPLLAH++RP+CH LVYEFMK
Sbjct: 376 QPPKDGAELAEEDSKVLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPECHYLVYEFMK 435
Query: 433 NGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492
NGSLQD L+ V +G ELDWL+RHKI+LGVA GLEYLH++HNPRIIHRDLKPAN+LLDDD
Sbjct: 436 NGSLQDTLSKVERGESELDWLSRHKISLGVAAGLEYLHMNHNPRIIHRDLKPANILLDDD 495
Query: 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV 552
MEARIADFGLAKAMPD +THITTSNVAGTVGYIAPEYHQ LKFTDKCDIYS+GV+L VLV
Sbjct: 496 MEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSYGVILGVLV 555
Query: 553 MGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTV 612
+G+LPSDDFFQHTEEMSLVKWMR ++SENP AI++KLL NGYEEQMLLVLKIACFCT+
Sbjct: 556 IGKLPSDDFFQHTEEMSLVKWMRKTLSSENPKEAINSKLLGNGYEEQMLLVLKIACFCTM 615
Query: 613 DSPRERPNSKDVRCMLSQIRH 633
D P+ERPNSKDVRCMLSQI+H
Sbjct: 616 DDPKERPNSKDVRCMLSQIKH 636
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456834|ref|XP_002276125.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 876 bits (2264), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/615 (73%), Positives = 517/615 (84%), Gaps = 11/615 (1%)
Query: 23 HARLNLDRSDYKALSVILRDLG--GQQLFIPSDPCSTPGVFCERRLSDNNTYVLKITKLV 80
HA L+L SDY AL +I + LG GQ+ P +PC+TPGVFCERR+SDN T VL++T+LV
Sbjct: 25 HATLHLHPSDYDALLLIQKHLGINGQRRSSP-NPCNTPGVFCERRVSDNAT-VLRVTRLV 82
Query: 81 FVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPS 140
F + L+G LSP IGRLS+L+ELSL +N L+D +P QIVDC+KLEIL+++NN+FSG IP
Sbjct: 83 FKSQRLSGFLSPQIGRLSQLKELSLPDNYLLDRIPSQIVDCRKLEILDLRNNRFSGEIPP 142
Query: 141 DLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200
+LSSL+RLR+LDLS N FSGNL FL++FPNLE LSLA+NLF+GKVP S+R+FRNL+ F+
Sbjct: 143 ELSSLVRLRILDLSSNKFSGNLNFLRFFPNLEKLSLAENLFSGKVPVSVRSFRNLRVFNL 202
Query: 201 SGNSLLEGPIPVMRRVGPSGFQ--YPKRYVLAETTTNGRSNGPSPAAAPNSSTRSSGAEA 258
SGNS LEGP+P MR V P+RYV AE T G SN A AP+ S+ G EA
Sbjct: 203 SGNSFLEGPVPGMREVEVESLASALPRRYVFAENLTRGSSN--HSAVAPSGSSGYYG-EA 259
Query: 259 PAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSVLFKLILAAVRGGGRDSGPA 318
PAPSP HK K KK + WILGFIAGAVAG ISG VFSVLFK +L VRGGG++SGPA
Sbjct: 260 PAPSPSAPPHKHRKNKKLSAWILGFIAGAVAGCISGLVFSVLFKALLVLVRGGGKESGPA 319
Query: 319 IFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDA 378
IFSPLIKKAEDLAFLEK+DGLASLE IG GGCGEVY+AELPG GK+IAIKK++QPPKDA
Sbjct: 320 IFSPLIKKAEDLAFLEKDDGLASLEIIGKGGCGEVYRAELPG--GKLIAIKKIVQPPKDA 377
Query: 379 AELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD 438
AEL EEDSKLLNKKMRQIRSEI TVG IRHRNLLPLLAH++RP+CH LVYEFMKNGSLQD
Sbjct: 378 AELAEEDSKLLNKKMRQIRSEIQTVGNIRHRNLLPLLAHVSRPNCHYLVYEFMKNGSLQD 437
Query: 439 ILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498
+L VS+G RELDWLARH++ALGVA GLEYLH+SH+PRIIHRDLKP N+LLDDDMEARIA
Sbjct: 438 MLTQVSEGTRELDWLARHRVALGVAAGLEYLHMSHSPRIIHRDLKPGNILLDDDMEARIA 497
Query: 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPS 558
DFGLAKA+PDA TH+TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL VLV+G+LPS
Sbjct: 498 DFGLAKAVPDANTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLGVLVVGKLPS 557
Query: 559 DDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRER 618
DDFFQHT EMSLVKWM N+ TS++P+RAID KL+ NG+EEQMLLVLKIACFCTVD + R
Sbjct: 558 DDFFQHTAEMSLVKWMANIRTSDDPSRAIDRKLMGNGFEEQMLLVLKIACFCTVDDAKIR 617
Query: 619 PNSKDVRCMLSQIRH 633
PNSKDVR MLSQI+H
Sbjct: 618 PNSKDVRTMLSQIKH 632
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/646 (65%), Positives = 515/646 (79%), Gaps = 26/646 (4%)
Query: 1 MALSPAKLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLG--GQQLFIPSDPCSTP 58
MA + ++++ +L +LL + A+LNL D+ AL ++ +DLG GQ++ + C++
Sbjct: 1 MAFTASQIHFFFISLFALLLIVQAKLNLYPPDHAALLLVQKDLGIQGQRIAL----CNSV 56
Query: 59 GVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQI 118
V CERR + N T +L++T++ F L+G LSP+IG+LSEL+ELSL NN L D +P QI
Sbjct: 57 AVSCERRKA-NRTQLLRVTRIDFRSNGLSGTLSPAIGKLSELKELSLPNNRLFDQIPVQI 115
Query: 119 VDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAK 178
+DC+KLEIL++ NN FSG + S+LSSL+RLR+LDLS N SGNL FLKYFPNLE LSLA
Sbjct: 116 LDCRKLEILDLGNNLFSGKVTSELSSLVRLRILDLSSNELSGNLNFLKYFPNLEKLSLAD 175
Query: 179 NLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRV-------GPSGFQYPKRYVLAE 231
N+FTGK+P S+++FRNL+F + SGNS LEGP+PVM +V + F PKRY+LAE
Sbjct: 176 NMFTGKIPPSLKSFRNLRFLNISGNSFLEGPVPVMSQVEHLSADLDRNNF-VPKRYILAE 234
Query: 232 TTTNGRSNGPSPAAAPNSSTRSSGAEAPAPSPHHH----KHKKSKGKKAAGWILGFIAGA 287
+T RSN S A APNS++ APAP+P H+ + K +K W LGF AG+
Sbjct: 235 NST--RSNQIS-ALAPNSNS----GNAPAPAPSHNVAPVHKRNKKKRKVRAWFLGFFAGS 287
Query: 288 VAGTISGFVFSVLFKLILAAVRGGGRDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGS 347
AG IS + SVLFKL++ VR G D I+SPLIKKAEDLAFLEKEDG+ASLE IG
Sbjct: 288 FAGAISAVLLSVLFKLVMFFVRKGKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGK 347
Query: 348 GGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR 407
GGCGEVY+AELPGSNGK+IAIKK++QPP DAAEL EED+K LNKKMRQ++SEI +GQIR
Sbjct: 348 GGCGEVYRAELPGSNGKIIAIKKILQPPMDAAELAEEDTKALNKKMRQVKSEIQILGQIR 407
Query: 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLE 467
HRNLLPLLAHM RPDCH LVYE+MKNGSLQDIL V++G RELDWL RH+IA+G+A GLE
Sbjct: 408 HRNLLPLLAHMPRPDCHYLVYEYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLE 467
Query: 468 YLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAP 527
YLHI+H+ IIHRDLKPANVLLDDDMEARIADFGLAKA+PDA TH+TTSNVAGTVGYIAP
Sbjct: 468 YLHINHSQCIIHRDLKPANVLLDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAP 527
Query: 528 EYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAI 587
EYHQTLKFTDKCDIYSFGV+LAVLV+G+LPSD+FFQHT EMSLVKW+RNVMTSE+P RAI
Sbjct: 528 EYHQTLKFTDKCDIYSFGVVLAVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAI 587
Query: 588 DAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
D KL+ +G+EEQMLLVLKIACFCT+++P+ERPNSKDVRCML+QI+H
Sbjct: 588 DPKLIGSGFEEQMLLVLKIACFCTLENPKERPNSKDVRCMLTQIKH 633
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2161), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/616 (68%), Positives = 495/616 (80%), Gaps = 10/616 (1%)
Query: 23 HARLNLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFCERR-LSDNNTYVLKITKLVF 81
+A+L+L SDYKAL + +DLG + C T GVFCERR LS TY L+IT+LVF
Sbjct: 21 NAKLDLYPSDYKALLTLQKDLGVNGQVSATLACETEGVFCERRKLSGKETYALRITRLVF 80
Query: 82 VPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD 141
L GVLSPSIGRL+EL+ELSL++N+L LPPQI DC+KL+IL++ NN FSG +P +
Sbjct: 81 KSNNLNGVLSPSIGRLTELKELSLSDNNLFGRLPPQIFDCRKLQILDLANNLFSGPVPPE 140
Query: 142 LSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201
LSSL RLRVLD+S N SGNL FLKYFPNLE LS+A NLFTG+VP S+R+FRNL+ F+FS
Sbjct: 141 LSSLTRLRVLDISTNRLSGNLNFLKYFPNLETLSVADNLFTGRVPPSVRSFRNLRQFNFS 200
Query: 202 GNSLLEGPIPVMRRVGPSGFQYPKRYVLAE----TTTNGRSNGPSPAAAPNSSTRSSGAE 257
GN LE P ++ P +R++L + S+ S A
Sbjct: 201 GNRFLE---PSLQSSSPETI-LSRRFLLDGDGDVPAPAPAPAPNNSNKKKKSNASSGAAA 256
Query: 258 APAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSVLFKLILAAVRGGGRDSGP 317
AP P+P++HKHKKS+ +K GWILGF+AGAVAG ++GFVFS++FKL LA ++G GR +GP
Sbjct: 257 APGPAPNNHKHKKSR-RKLLGWILGFVAGAVAGILAGFVFSLMFKLALALIKGRGRKAGP 315
Query: 318 AIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKD 377
I+SPLIKKAEDLAFLEKE+G+ASLE IG GGCGEVYKAELPGSNGKMIAIKK+IQPPK+
Sbjct: 316 DIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEVYKAELPGSNGKMIAIKKIIQPPKE 375
Query: 378 AAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQ 437
AEL EEDSK+LNKKMRQIRSEI TVGQIRHRNLLPLLAH++RP CH LVYEFMKNGSL
Sbjct: 376 GAELAEEDSKVLNKKMRQIRSEITTVGQIRHRNLLPLLAHVSRPGCHYLVYEFMKNGSLH 435
Query: 438 DILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497
D L+ V G ELDWL+RHKIALGVA GLEYLH++HNPRIIHRDLKPAN+LLDDDMEARI
Sbjct: 436 DTLSKVEVGEFELDWLSRHKIALGVAAGLEYLHLNHNPRIIHRDLKPANILLDDDMEARI 495
Query: 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
ADFGLAKAMPD +THITTSNVAGTVGYIAPEYHQ LKFTDKCDIYSFGV+L VLV+G+LP
Sbjct: 496 ADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSFGVILGVLVIGKLP 555
Query: 558 SDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE 617
S +FFQHTEEMSLVKWMR +++SENP AID KLL NGYE+QMLLVLKIACFCT+D P+E
Sbjct: 556 SHEFFQHTEEMSLVKWMRKILSSENPKEAIDTKLLGNGYEDQMLLVLKIACFCTMDDPKE 615
Query: 618 RPNSKDVRCMLSQIRH 633
RPNSKDV CMLSQI+H
Sbjct: 616 RPNSKDVWCMLSQIKH 631
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2153), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/635 (66%), Positives = 501/635 (78%), Gaps = 9/635 (1%)
Query: 3 LSPAKLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLG-GQQLFIPSD--PCSTPG 59
L P L + F LLS S L++D SD KAL VI +LG Q SD PC G
Sbjct: 12 LRPLILAVLSFLLLSSFVSSVEWLDIDSSDLKALQVIETELGVNSQRSSASDVNPCGRRG 71
Query: 60 VFCERRLS-DNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQI 118
VFCERR S YVL++T+LV+ R LTG +SP IG LSEL+EL+L+NN LV+ +P I
Sbjct: 72 VFCERRHSATTGEYVLRVTRLVYRSRSLTGTISPVIGMLSELKELTLSNNQLVNAVPVDI 131
Query: 119 VDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAK 178
+ CK+LE+L+++ N+FSG IP + SSL RLR+LDLS N SGNL FLK NLE+LS+A
Sbjct: 132 LSCKQLEVLDLRKNRFSGQIPGNFSSLSRLRILDLSSNKLSGNLNFLKNLRNLENLSVAN 191
Query: 179 NLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRS 238
NLF+GK+P I +F NL+FFDFSGN LEGP PVM + + R++LAET T+ +
Sbjct: 192 NLFSGKIPEQIVSFHNLRFFDFSGNRYLEGPAPVMSSIKLQTSPHQTRHILAETPTSSPT 251
Query: 239 NGPSPAAAPNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFS 298
N P+ NS+T + AP P K KKSK KK A WILGF+ GA+ GTISGFVFS
Sbjct: 252 NKPN-----NSTTSKAPKGAPKPGKLKKKKKKSKKKKVAAWILGFVVGAIGGTISGFVFS 306
Query: 299 VLFKLILAAVRGGGRDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAEL 358
VLFKLI+ A+RG + GP+IFSPLIKKAEDLAFLE E+ LASLE IG GGCGEV+KAEL
Sbjct: 307 VLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAEL 366
Query: 359 PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418
PGSNGK+IA+KKVIQPPKDA ELT+EDSK LNKKMRQIRSEINTVG IRHRNLLPLLAH+
Sbjct: 367 PGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHV 426
Query: 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRII 478
+RP+CH LVYE+M+ GSLQDIL DV G +EL W ARHKIALG+A GLEYLH+ HNPRII
Sbjct: 427 SRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRII 486
Query: 479 HRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDK 538
HRDLKPANVLLDDDMEARI+DFGLAKAMPDA THITTS+VAGTVGYIAPE++QT KFTDK
Sbjct: 487 HRDLKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDK 546
Query: 539 CDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEE 598
CDIYSFGV+L +LV+G+LPSD+FFQHT+EMSL+KWMRN++TSENP+ AID KL++ G++E
Sbjct: 547 CDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDE 606
Query: 599 QMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
QMLLVLKIAC+CT+D P++RPNSKDVR MLSQI+H
Sbjct: 607 QMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|16648755|gb|AAL25569.1| At2g31880/F20M17.8 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2139), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/635 (65%), Positives = 499/635 (78%), Gaps = 9/635 (1%)
Query: 3 LSPAKLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLG-GQQLFIPSD--PCSTPG 59
L P L + F LLS S L++D SD KAL VI +LG Q SD PC G
Sbjct: 12 LRPLILAVLSFLLLSSFVSSVEWLDIDSSDLKALQVIETELGVNSQRSSASDVNPCGRRG 71
Query: 60 VFCERRLS-DNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQI 118
VFCERR S YVL++T+LV+ R LTG +SP IG LS L+EL+L+NN LV+ +P I
Sbjct: 72 VFCERRHSATTGEYVLRVTRLVYRSRSLTGTISPVIGMLSVLKELTLSNNQLVNAVPVDI 131
Query: 119 VDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAK 178
+ CK+LE+L+++ N+FSG IP + SSL RLR+LDLS N SGNL FLK NLE+LS+A
Sbjct: 132 LSCKQLEVLDLRKNRFSGQIPGNFSSLSRLRILDLSSNKLSGNLNFLKNLRNLENLSVAN 191
Query: 179 NLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRS 238
NLF+GK+P I +F NL+FFDFSGN LEGP PVM + + R++LAET T+ +
Sbjct: 192 NLFSGKIPEQIVSFHNLRFFDFSGNRYLEGPAPVMSSIKLQTSPHQTRHILAETPTSSPT 251
Query: 239 NGPSPAAAPNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFS 298
N P+ NS+T + AP P K KKSK KK A WILGF+ GA+ GTISGFVFS
Sbjct: 252 NKPN-----NSTTSKAPKGAPKPGKLKKKKKKSKKKKVAAWILGFVVGAIGGTISGFVFS 306
Query: 299 VLFKLILAAVRGGGRDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAEL 358
VLFKLI+ A+RG + GP+IFSPLIKKAEDLAFLE E+ LASLE IG GGCGEV+KAEL
Sbjct: 307 VLFKLIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAEL 366
Query: 359 PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418
PGSNGK+IA+KKVIQPPKDA ELT+EDSK LNKKMRQIRSEINTVG IRHRNLLPLLAH+
Sbjct: 367 PGSNGKIIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHV 426
Query: 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRII 478
+RP+CH LVYE+M+ GSLQDIL DV G +EL W ARHKIALG+A GLEYLH+ HNPRII
Sbjct: 427 SRPECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRII 486
Query: 479 HRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDK 538
HRD KPANVLLDDDMEARI+DFGLAKAMPDA THITTS+VAGTVGYIAPE++QT KFTDK
Sbjct: 487 HRDSKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDK 546
Query: 539 CDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEE 598
CDIYSFGV+L +LV+G+LPSD+FFQHT+EMSL+KWMRN++TSENP+ AID KL++ G++E
Sbjct: 547 CDIYSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDE 606
Query: 599 QMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
QMLLVLKIAC+CT+D P++RPNSKDVR MLSQI+H
Sbjct: 607 QMLLVLKIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 633 | ||||||
| TAIR|locus:2045228 | 641 | SOBIR1 "SUPPRESSOR OF BIR1 1" | 0.947 | 0.936 | 0.658 | 2.6e-212 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.421 | 0.242 | 0.430 | 9.7e-70 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.445 | 0.251 | 0.410 | 1.4e-69 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.532 | 0.332 | 0.383 | 2.4e-69 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.442 | 0.249 | 0.412 | 4.4e-69 | |
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.462 | 0.303 | 0.398 | 2.4e-68 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.516 | 0.296 | 0.390 | 3.6e-68 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.462 | 0.294 | 0.384 | 7.3e-68 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.436 | 0.220 | 0.410 | 1.3e-67 | |
| TAIR|locus:2041150 | 1143 | BRL2 "BRI1-like 2" [Arabidopsi | 0.469 | 0.259 | 0.379 | 1.7e-67 |
| TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2052 (727.4 bits), Expect = 2.6e-212, P = 2.6e-212
Identities = 401/609 (65%), Positives = 477/609 (78%)
Query: 29 DRSDYKALSVILRDLG-GQQLFIPSD--PCSTPGVFCERRLS-DNNTYVLKITKLVFVPR 84
D SD KAL VI +LG Q SD PC GVFCERR S YVL++T+LV+ R
Sbjct: 38 DSSDLKALQVIETELGVNSQRSSASDVNPCGRRGVFCERRHSATTGEYVLRVTRLVYRSR 97
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
LTG +SP IG LSEL+EL+L+NN LV+ +P I+ CK+LE+L+++ N+FSG IP + SS
Sbjct: 98 SLTGTISPVIGMLSELKELTLSNNQLVNAVPVDILSCKQLEVLDLRKNRFSGQIPGNFSS 157
Query: 145 LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L RLR+LDLS N SGNL FLK NLE+LS+A NLF+GK+P I +F NL+FFDFSGN
Sbjct: 158 LSRLRILDLSSNKLSGNLNFLKNLRNLENLSVANNLFSGKIPEQIVSFHNLRFFDFSGNR 217
Query: 205 LLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRSNGPSPAAAPNSSTRXXXXXXXXXXXX 264
LEGP PVM + + R++LAET T+ +N P+ NS+T
Sbjct: 218 YLEGPAPVMSSIKLQTSPHQTRHILAETPTSSPTNKPN-----NSTTSKAPKGAPKPGKL 272
Query: 265 XXXXXXXXXXXXXXWILGFIAGAVAGTISGFVFSVLFKLILAAVRGGGRDSGPAIFSPLI 324
WILGF+ GA+ GTISGFVFSVLFKLI+ A+RG + GP+IFSPLI
Sbjct: 273 KKKKKKSKKKKVAAWILGFVVGAIGGTISGFVFSVLFKLIIQAIRGSEKPPGPSIFSPLI 332
Query: 325 KKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEE 384
KKAEDLAFLE E+ LASLE IG GGCGEV+KAELPGSNGK+IA+KKVIQPPKDA ELT+E
Sbjct: 333 KKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPPKDADELTDE 392
Query: 385 DSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVS 444
DSK LNKKMRQIRSEINTVG IRHRNLLPLLAH++RP+CH LVYE+M+ GSLQDIL DV
Sbjct: 393 DSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQDILTDVQ 452
Query: 445 QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504
G +EL W ARHKIALG+A GLEYLH+ HNPRIIHRDLKPANVLLDDDMEARI+DFGLAK
Sbjct: 453 AGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARISDFGLAK 512
Query: 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564
AMPDA THITTS+VAGTVGYIAPE++QT KFTDKCDIYSFGV+L +LV+G+LPSD+FFQH
Sbjct: 513 AMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLPSDEFFQH 572
Query: 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
T+EMSL+KWMRN++TSENP+ AID KL++ G++EQMLLVLKIAC+CT+D P++RPNSKDV
Sbjct: 573 TDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQRPNSKDV 632
Query: 625 RCMLSQIRH 633
R MLSQI+H
Sbjct: 633 RTMLSQIKH 641
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 9.7e-70, Sum P(2) = 9.7e-70
Identities = 126/293 (43%), Positives = 175/293 (59%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G CG VYKAE+ G G++IA+KK+ E D+ R+EI+T+G
Sbjct: 805 LGRGACGTVYKAEMSG--GEVIAVKKL----NSRGEGASSDNSF--------RAEISTLG 850
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE--LDWLARHKIALGV 462
+IRHRN++ L + +LL+YE+M GSL + L +G + LDW AR++IALG
Sbjct: 851 KIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQ---RGEKNCLLDWNARYRIALGA 907
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
A GL YLH P+I+HRD+K N+LLD+ +A + DFGLAK + D + S VAG+
Sbjct: 908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI-DLSYSKSMSAVAGSY 966
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN 582
GYIAPEY T+K T+KCDIYSFGV+L L+ G+ P Q + LV W+R + +
Sbjct: 967 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD---LVNWVRRSIRNMI 1023
Query: 583 PT-RAIDAKLLENGYE--EQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
PT DA+L N +M LVLKIA FCT +SP RP ++V M+++ R
Sbjct: 1024 PTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 1.4e-69, Sum P(2) = 1.4e-69
Identities = 124/302 (41%), Positives = 188/302 (62%)
Query: 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK 392
+E +G +IGSGG G+VYKA+L +GK++AIKK+I + +
Sbjct: 801 VEATNGFHIACQIGSGGFGDVYKAQL--KDGKVVAIKKLIH--------------VSGQG 844
Query: 393 MRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDW 452
R+ +E+ T+G+I+HRNL+PLL + + LLVY++MK GSL+D+L+D + ++L+W
Sbjct: 845 DREFTAEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNW 904
Query: 453 LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
AR KIA+G A GL +LH + P IIHRD+K +NVL+D+ +EAR++DFG+A+ M TH
Sbjct: 905 EARRKIAVGAARGLAFLHHNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTH 964
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572
++ S +AGT GY+ PEY+Q+ + T K D+YS+GV+L L+ G+ P+D E+ +LV
Sbjct: 965 LSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLELLTGKPPTDSA-DFGEDNNLVG 1023
Query: 573 WMRNVMTSENPTRAIDAKLLEN--GYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630
W++ T T D +LL+ E ++L LKIAC C D P RP V M +
Sbjct: 1024 WVKQ-HTKLKITDVFDPELLKEDPSVELELLEHLKIACACLDDRPSRRPTMLKVMAMFKE 1082
Query: 631 IR 632
I+
Sbjct: 1083 IQ 1084
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 2.4e-69, Sum P(2) = 2.4e-69
Identities = 138/360 (38%), Positives = 207/360 (57%)
Query: 279 WILGFIAGAVAGTISGFVFSVLFKLILAAVRGGGRDSGPAIFSPLIKKAEDLAFLEKEDG 338
W++G IA +A I V L+K + G + + + L F D
Sbjct: 638 WLIG-IASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTAS-DI 695
Query: 339 LASLEK---IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
LA +++ IG G G VYKAE+ S+ ++A+KK+ + D + T D
Sbjct: 696 LACIKESNMIGMGATGIVYKAEMSRSS-TVLAVKKLWRSAADIEDGTTGD---------- 744
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-GRRELDWLA 454
E+N +G++RHRN++ LL + ++VYEFM NG+L D ++ + GR +DW++
Sbjct: 745 FVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVS 804
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
R+ IALGVA GL YLH +P +IHRD+K N+LLD +++ARIADFGLA+ M A+ T
Sbjct: 805 RYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKKET 862
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
S VAG+ GYIAPEY TLK +K DIYS+GV+L L+ GR P + F E + +V+W+
Sbjct: 863 VSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFG--ESVDIVEWV 920
Query: 575 RN-VMTSENPTRAIDAKLLENGY-EEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
R + + + A+D + Y +E+MLLVL+IA CT P++RP+ +DV ML + +
Sbjct: 921 RRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAK 980
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 4.4e-69, Sum P(2) = 4.4e-69
Identities = 125/303 (41%), Positives = 170/303 (56%)
Query: 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK 392
LE G +G G CG VYKA +P +GK IA+KK+ + E +S N
Sbjct: 813 LEATKGFHDSYIVGRGACGTVYKAVMP--SGKTIAVKKL----ESNREGNNNNS---NNT 863
Query: 393 MRQIRSEINTVGQIRHRNLLPLLA---HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE 449
R+EI T+G+IRHRN++ L + H + +LL+YE+M GSL ++L+
Sbjct: 864 DNSFRAEILTLGKIRHRNIVRLYSFCYHQGS-NSNLLLYEYMSRGSLGELLHGGKS--HS 920
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA 509
+DW R IALG A GL YLH PRIIHRD+K N+L+D++ EA + DFGLAK + D
Sbjct: 921 MDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI-DM 979
Query: 510 QTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569
+ S VAG+ GYIAPEY T+K T+KCDIYSFGV+L L+ G+ P Q +
Sbjct: 980 PLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGD--- 1036
Query: 570 LVKWMRNVMTSENPTRAI-D---AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625
L W RN + + T I D K+ ++ M+ V KIA CT SP +RP ++V
Sbjct: 1037 LATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVV 1096
Query: 626 CML 628
ML
Sbjct: 1097 LML 1099
|
|
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 2.4e-68, Sum P(2) = 2.4e-68
Identities = 124/311 (39%), Positives = 189/311 (60%)
Query: 318 AIFSPLIKKAEDLAFLEKE--DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQP 374
+ FS +K ++F ++E + L +G GG G VY+ EL +G+++A+KK+ Q
Sbjct: 633 SFFSYDVKSFHRISFDQREILESLVDKNIVGHGGSGTVYRVEL--KSGEVVAVKKLWSQS 690
Query: 375 PKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNG 434
KD+A ED LNK ++++E+ T+G IRH+N++ L ++ + DC LLVYE+M NG
Sbjct: 691 NKDSAS---EDKMHLNK---ELKTEVETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMPNG 744
Query: 435 SLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494
+L D L+ +G L+W RH+IA+GVA GL YLH +P IIHRD+K N+LLD + +
Sbjct: 745 NLWDALH---KGFVHLEWRTRHQIAVGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQ 801
Query: 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMG 554
++ADFG+AK + TT+ +AGT GY+APEY + K T KCD+YSFGV+L L+ G
Sbjct: 802 PKVADFGIAKVLQARGKDSTTTVMAGTYGYLAPEYAYSSKATIKCDVYSFGVVLMELITG 861
Query: 555 RLPSDDFFQHTEEMSLVKWMRN-VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVD 613
+ P D F E ++V W+ + T E +D +L E+ + M+ L++A CT
Sbjct: 862 KKPVDSCFG--ENKNIVNWVSTKIDTKEGLIETLDKRLSESS-KADMINALRVAIRCTSR 918
Query: 614 SPRERPNSKDV 624
+P RP +V
Sbjct: 919 TPTIRPTMNEV 929
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 500 (181.1 bits), Expect = 3.6e-68, Sum P(2) = 3.6e-68
Identities = 139/356 (39%), Positives = 190/356 (53%)
Query: 284 IAGAVAGTISGFVFSVLFKLILAAVR---GGGRDSGPAIFSPLI--KKAEDLAFLEKEDG 338
I AV G +S + +++ L+ VR +D P+ S I E F +
Sbjct: 741 ITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAA 800
Query: 339 LASLEK---IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
+ ++ +G G CG VYKA LP G +A+KK+ A E + N
Sbjct: 801 TDNFDESFVVGRGACGTVYKAVLPA--GYTLAVKKL-------ASNHEGGNN--NNVDNS 849
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
R+EI T+G IRHRN++ L +LL+YE+M GSL +IL+D S LDW R
Sbjct: 850 FRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCN---LDWSKR 906
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
KIALG A GL YLH PRI HRD+K N+LLDD EA + DFGLAK + D +
Sbjct: 907 FKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPHSKSM 965
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575
S +AG+ GYIAPEY T+K T+K DIYS+GV+L L+ G+ P Q + +V W+R
Sbjct: 966 SAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGD---VVNWVR 1022
Query: 576 NVMTSENPTRAI-DAKL-LENG-YEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628
+ + + + + DA+L LE+ ML VLKIA CT SP RP+ + V ML
Sbjct: 1023 SYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 492 (178.3 bits), Expect = 7.3e-68, Sum P(2) = 7.3e-68
Identities = 118/307 (38%), Positives = 174/307 (56%)
Query: 330 LAFLEKEDGLASLEK---IGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEED 385
L F E E L SL++ IG+G G+VYK L +NG+ +A+K++ K+ + E
Sbjct: 665 LGFSEHEI-LESLDEDNVIGAGASGKVYKVVL--TNGETVAVKRLWTGSVKETGDCDPEK 721
Query: 386 SKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ 445
+ +E+ T+G+IRH+N++ L + DC LLVYE+M NGSL D+L+
Sbjct: 722 GYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKG 781
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
G L W R KI L A GL YLH P I+HRD+K N+L+D D AR+ADFG+AKA
Sbjct: 782 GM--LGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKA 839
Query: 506 MP-DAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564
+ + + S +AG+ GYIAPEY TL+ +K DIYSFGV++ +V + P D
Sbjct: 840 VDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDP---E 896
Query: 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
E LVKW+ + + + ID KL ++ ++E++ +L + CT P RP+ + V
Sbjct: 897 LGEKDLVKWVCSTLDQKGIEHVIDPKL-DSCFKEEISKILNVGLLCTSPLPINRPSMRRV 955
Query: 625 RCMLSQI 631
ML +I
Sbjct: 956 VKMLQEI 962
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 514 (186.0 bits), Expect = 1.3e-67, Sum P(2) = 1.3e-67
Identities = 126/307 (41%), Positives = 186/307 (60%)
Query: 328 EDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSK 387
ED+ +E L+ IGSGG G+VYKAEL NG+ +A+KK++ +D
Sbjct: 942 EDI--MEATHNLSEEFMIGSGGSGKVYKAEL--ENGETVAVKKILW----------KDDL 987
Query: 388 LLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD--CHLLVYEFMKNGSLQDILND--- 442
+ NK + E+ T+G+IRHR+L+ L+ + + +LL+YE+MKNGS+ D L++
Sbjct: 988 MSNKSFSR---EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKP 1044
Query: 443 -VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501
+ + ++ LDW AR +IA+G+A G+EYLH P I+HRD+K +NVLLD +MEA + DFG
Sbjct: 1045 VLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFG 1104
Query: 502 LAKAMPDAQTHITTSNV--AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559
LAK + + T SN A + GYIAPEY +LK T+K D+YS G++L +V G++P+D
Sbjct: 1105 LAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTD 1164
Query: 560 DFFQHTEEMSLVKWMRNVMTSENPTR--AIDAKL--LENGYEEQMLLVLKIACFCTVDSP 615
F EM +V+W+ + R ID KL L E+ VL+IA CT SP
Sbjct: 1165 SVFG--AEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSP 1222
Query: 616 RERPNSK 622
+ERP+S+
Sbjct: 1223 QERPSSR 1229
|
|
| TAIR|locus:2041150 BRL2 "BRI1-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 1.7e-67, Sum P(2) = 1.7e-67
Identities = 126/332 (37%), Positives = 186/332 (56%)
Query: 318 AIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKD 377
A F ++K + +E +G ++ IG GG GEV+KA L +G +AIKK+I
Sbjct: 817 ATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATL--KDGSSVAIKKLI----- 869
Query: 378 AAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQ 437
+L + R+ +E+ T+G+I+HRNL+PLL + + LLVYEFM+ GSL+
Sbjct: 870 ---------RLSCQGDREFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLE 920
Query: 438 DILNDVSQG--RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495
++L+ G RR L W R KIA G A GL +LH + P IIHRD+K +NVLLD DMEA
Sbjct: 921 EVLHGPRTGEKRRILGWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEA 980
Query: 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
R++DFG+A+ + TH++ S +AGT GY+ PEY+Q+ + T K D+YS GV++ ++ G+
Sbjct: 981 RVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGK 1040
Query: 556 LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEE---------------QM 600
P+D + + +LV W + ID LL+ G E +M
Sbjct: 1041 RPTDK--EEFGDTNLVGWSKMKAREGKHMEVIDEDLLKEGSSESLNEKEGFEGGVIVKEM 1098
Query: 601 LLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
L L+IA C D P +RPN V L ++R
Sbjct: 1099 LRYLEIALRCVDDFPSKRPNMLQVVASLRELR 1130
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SKB2 | SBIR1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6629 | 0.9889 | 0.9765 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 633 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-20 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-20 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 5e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 6e-49
Identities = 76/235 (32%), Positives = 112/235 (47%), Gaps = 27/235 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEK+G G G+VY A + GK++AIK + K + K +I EI
Sbjct: 4 LEKLGEGSFGKVYLARDKKT-GKLVAIKVI-------------KKKKIKKDRERILREIK 49
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +++H N++ L D LV E+ + G L D+L +GR D
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR--FYLRQ 105
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ LEYLH S I+HRDLKP N+LLD+D ++ADFGLA+ + + T GT
Sbjct: 106 ILSALEYLH-SKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGT 159
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
Y+APE + DI+S GV+L L+ G+ P F + + L K +
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGK 211
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 93/286 (32%), Positives = 141/286 (49%), Gaps = 34/286 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L K+GSG G VYKA+ G+ GK++A+K + + E SK + R EI
Sbjct: 4 LRKLGSGSFGTVYKAKHKGT-GKIVAVKIL--------KKRSEKSKKD----QTARREIR 50
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H N++ L+ D LV E+ + G L D L+ L KIAL
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQ 106
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ GLEYLH S+ IIHRDLKP N+LLD++ +IADFGLAK + + + +TT GT
Sbjct: 107 ILRGLEYLH-SNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGT 161
Query: 522 VGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580
Y+APE + K D++S GV+L L+ G+ P F + ++ +R ++
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP----FSGENILDQLQLIRRILGP 217
Query: 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626
D +G EE L+ K D P +RP ++++
Sbjct: 218 PLE---FDEPKWSSGSEEAKDLIKKC---LNKD-PSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 68/209 (32%), Positives = 105/209 (50%), Gaps = 24/209 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G GG G VY A GK +AIK + + + + ++ EI +
Sbjct: 1 LGEGGFGTVYLARDKK-TGKKVAIKII-------------KKEDSSSLLEELLREIEILK 46
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
++ H N++ L + LV E+ + GSL+D+L + +L +I L +
Sbjct: 47 KLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILE 103
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
GLEYLH S+ IIHRDLKP N+LLD D+ + ++ADFGL+K + + GT
Sbjct: 104 GLEYLH-SNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPA 158
Query: 524 YIAPE-YHQTLKFTDKCDIYSFGVLLAVL 551
Y+APE +++K DI+S GV+L L
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK---MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
+K+G G GEVYK +L G GK +A+K ++ ++ E
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT-LKEDASEQQIEE------------FLR 50
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E + ++ H N++ LL + +V E+M+ G L L R +L
Sbjct: 51 EARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSF 107
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
AL +A G+EYL S N IHRDL N L+ +++ +I+DFGL++ + D +
Sbjct: 108 ALQIARGMEYLE-SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-RKRGG 163
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ ++APE + KFT K D++SFGVLL
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 342 LEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
+K+G G GEVYK L +A+K ++ ++ E
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKT-LKEDASEQQIEE------------FLR 50
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E + ++ H N++ LL + ++V E+M G L D L +EL
Sbjct: 51 EARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSF 108
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
AL +A G+EYL S N IHRDL N L+ +++ +I+DFGL++ + D
Sbjct: 109 ALQIARGMEYLE-SKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGG 164
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ ++APE + KFT K D++SFGVLL
Sbjct: 165 KLPIRWMAPESLKEGKFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+K+G G GEVYK +L G +GK A+K + K+ A ++ + E
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL----KEDAS---------EEERKDFLKEA 47
Query: 401 NTVGQIRHRNLLPLL--AHMARPDCHLLVYEFMKNGSLQDIL-----NDVSQGRRELDWL 453
+ ++ H N++ LL P LV E+M+ G L D L S + L
Sbjct: 48 RVMKKLGHPNVVRLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
A+ +A G+EYL + + +HRDL N L+ +D+ +I+DFGL++ + D +
Sbjct: 106 DLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR 162
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + ++APE + FT K D++SFGVLL
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 8e-36
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 342 LEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
+K+G G GEVYK L +A+K L E S+ ++ +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT----------LKEGASEEEREEFLE--- 50
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E + + ++ H N++ LL + + +V E+M G L D L + +L ++
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQM 107
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
AL +A G+EYL S N +HRDL N L+ +++ +I+DFGL++ + + +
Sbjct: 108 ALQIAKGMEYLE-SKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGG 164
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ ++APE + KFT K D++SFGVLL
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 75/222 (33%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEKIG GG GEVYKA GK +AIK I+ +K +I +EI
Sbjct: 5 LEKIGKGGFGEVYKA-RHKRTGKEVAIKV-IKLESK-------------EKKEKIINEIQ 49
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL------LVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ + +H N++ +L +V EF GSL+D+L +Q E +A
Sbjct: 50 ILKKCKHPNIVKYY------GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTE-SQIA- 101
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+ + GLEYLH S+ IIHRD+K AN+LL D E ++ DFGL+ + D + T
Sbjct: 102 -YVCKELLKGLEYLH-SNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT ++APE + K DI+S G+ L G+ P
Sbjct: 158 ---VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E +G G G VY A G+++A+K V E S +++ + EI
Sbjct: 6 ELLGRGSFGSVYLALD-KDTGELMAVKSV------------ELSGDSEEELEALEREIRI 52
Query: 403 VGQIRHRNLLPLLAHM-ARPDCHLLVY-EFMKNGSLQDILNDVSQGR-RELDWLARHKIA 459
+ ++H N++ L ++ E++ GSL +L G+ E + R K
Sbjct: 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEP--VIR-KYT 107
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ GL YLH S+ I+HRD+K AN+L+D D ++ADFG AK + D +T T +V
Sbjct: 108 RQILEGLAYLH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
GT ++APE + ++ DI+S G + + G+ P + + M+ + + +
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP---WSELGNPMAAL--YKIGSS 219
Query: 580 SENPTRAIDAKLLENGYEEQMLLVLKIACF---CTVDSPRERPN 620
E P I L E + F C P++RP
Sbjct: 220 GEPP--EIPEHLSEEAKD-----------FLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-33
Identities = 140/605 (23%), Positives = 241/605 (39%), Gaps = 98/605 (16%)
Query: 76 ITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIV---------------- 119
+ KL+ L G + S+G LR + L +NS LP +
Sbjct: 382 LFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ 441
Query: 120 --------DCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL--GFLKYFP 169
D L++L++ N+F G +P D RL LDLS N FSG +
Sbjct: 442 GRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGS-LS 499
Query: 170 NLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGF-QYPKRYV 228
L L L++N +G++P + + + L D S N L G I P+ F + P V
Sbjct: 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL-SGQI-------PASFSEMP---V 548
Query: 229 LAETTTNGRSNGPSPAAAPNSSTRSSGAEAPAPSPHHHKHKKSKGKKAAGWILGFIAGAV 288
L++ + N S N S + H H S G L A AV
Sbjct: 549 LSQLDLS--QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA-----FLAINASAV 601
Query: 289 AGTI--------SG---------------FVFSVLFKLILAAVRGGGRDSGPAIFSPLIK 325
AG I SG ++ L ++ A+ +
Sbjct: 602 AGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLAL------VAFGFVFIRGR 655
Query: 326 KAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEED 385
+L +E EDG L+ S + ++ S + I + + + +
Sbjct: 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNG 715
Query: 386 SKLLNKKMRQIRS----EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILN 441
+ + K++ + S EI +G+++H N++ L+ L++E+++ +L ++L
Sbjct: 716 MQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775
Query: 442 DVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501
++S W R KIA+G+A L +LH +P ++ +L P +++D E +
Sbjct: 776 NLS-------WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
L + +S Y+APE +T T+K DIY FG++L L+ G+ P+D
Sbjct: 828 LPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881
Query: 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENG--YEEQMLLVLKIACFCTVDSPRERP 619
F S+V+W R + + ID + + + +++ V+ +A CT P RP
Sbjct: 882 FGVHG--SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
Query: 620 NSKDV 624
+ DV
Sbjct: 940 CANDV 944
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 7e-30
Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 33/291 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L K+G G GEVY A K++A+K + + + +K++ + EI
Sbjct: 5 LRKLGEGSFGEVYLARDR----KLVALKVLAKKLESK-----------SKEVERFLREIQ 49
Query: 402 TVGQIRH-RNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ + H N++ L LV E++ GSL+D+L + + + A I
Sbjct: 50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF-ILA 108
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTH----ITT 515
+ LEYLH IIHRD+KP N+LLD D ++ DFGLAK +PD +
Sbjct: 109 QILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165
Query: 516 SNVAGTVGYIAPEYHQTLKF---TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572
S GT GY+APE L + DI+S G+ L L+ G P + + +K
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225
Query: 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
+ + T + E + L+ K P+ R +S
Sbjct: 226 IILELPTPSLA-SPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 47/282 (16%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
+G G G VYK + GK+ A+KK I D +Q+ E+ T+
Sbjct: 8 VLGQGSSGVVYKVRHKPT-GKIYALKK-IHVDGDEE------------FRKQLLRELKTL 53
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDW----LARHKIA 459
++ + +V E+M GSL D+L ++ LA IA
Sbjct: 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL------KKVGKIPEPVLA--YIA 105
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ GL+YLH IIHRD+KP+N+L++ E +IADFG++K + + + V
Sbjct: 106 RQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFV- 161
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
GTV Y++PE Q ++ DI+S G+ L +G+ P F + S + M+ +
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP----FLPPGQPSFFELMQAICD 217
Query: 580 SENPTRAIDAKLLENGYEEQMLLVLK--IACFCTVDSPRERP 619
P L + + + I+ C P++RP
Sbjct: 218 GPPP------SLPAEEFSPEF----RDFISA-CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 70/236 (29%), Positives = 99/236 (41%), Gaps = 48/236 (20%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+V + GK+ A+K L KK R E+
Sbjct: 1 LGKGSFGKVLLVRKKDT-GKLYAMKV------------------LKKKKIIKRKEVEHT- 40
Query: 405 QIRHRNLLPLLAHMARP-----------DCHL-LVYEFMKNGSLQDILNDVSQGRRELDW 452
+ RN+L + H P + L LV E+ G L L+ +GR +
Sbjct: 41 -LTERNILSRINH---PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS--KEGRFSEER 94
Query: 453 LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
AR A + LEYLH S II+RDLKP N+LLD D ++ DFGLAK + +
Sbjct: 95 -ARFYAA-EIVLALEYLH-SLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
T GT Y+APE + D +S GVLL ++ G+ P F+ +
Sbjct: 150 TNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP---FYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
IG G G+V + G+ +A+K + KD + T + L E +
Sbjct: 12 ATIGKGEFGDVMLGDY---RGQKVAVKCL----KD--DSTAAQAFLA---------EASV 53
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ +RH NL+ LL + + + +V E+M GSL D L S+GR + + AL V
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDV 111
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
G+EYL +HRDL NVL+ +D+ A+++DFGLAK +A + + V
Sbjct: 112 CEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLP--V 163
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ APE + KF+ K D++SFG+LL + GR+P
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 62/248 (25%), Positives = 112/248 (45%), Gaps = 37/248 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+++IG G G+VY S+GK+ +K++ D + ++E++ + +E+
Sbjct: 5 IKQIGKGSFGKVYLVR-RKSDGKLYVLKEI-----DLSNMSEKERE-------DALNEVK 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR--RE---LDWLAR 455
+ ++ H N++ +V E+ G L I +G+ E LDW
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV- 110
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
++ L L+YLH S +I+HRD+KP N+ L + ++ DFG++K + T
Sbjct: 111 -QLCLA----LKYLH-SR--KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT 162
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575
V GT Y++PE Q + K DI+S G +L L + P F+ + L
Sbjct: 163 --VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGENLLEL---AL 213
Query: 576 NVMTSENP 583
++ + P
Sbjct: 214 KILKGQYP 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ IG G G VYK L G +AIK++ K+ + ++ I EI+
Sbjct: 6 DLIGRGAFGVVYKG-LNLETGDFVAIKQI------------SLEKIKEEALKSIMQEIDL 52
Query: 403 VGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++H N++ + L ++ E+ +NGSL+ I+ G +A+
Sbjct: 53 LKNLKHPNIVKYIGS-IETSDSLYIILEYAENGSLRQIIK--KFGP-----FPESLVAVY 104
Query: 462 VA---CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
V GL YL H +IHRD+K AN+L D ++ADFG+A + D ++V
Sbjct: 105 VYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASV 159
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT ++APE + + DI+S G + L+ G P
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEK+G G G VYKA + G+++AIK V EED + + K EI+
Sbjct: 8 LEKLGEGSYGSVYKA-IHKETGQVVAIKVV---------PVEEDLQEIIK-------EIS 50
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL- 460
+ Q ++ + +V E+ GS+ DI+ + L +IA
Sbjct: 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKT----LTEEEIAAI 104
Query: 461 --GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
GLEYLH + + IHRD+K N+LL+++ +A++ADFG++ + D T V
Sbjct: 105 LYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--V 159
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGV 546
GT ++APE Q + + +K DI+S G+
Sbjct: 160 IGTPFWMAPEVIQEIGYNNKADIWSLGI 187
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 79/297 (26%), Positives = 130/297 (43%), Gaps = 34/297 (11%)
Query: 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQI 396
A LE +GSG G VYK + ++A+K++ + P + E D K + I
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERD-----KSIGDI 55
Query: 397 RSEINTVG-QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
SE+ + Q+RH N++ D +V + ++ L + N + + ++
Sbjct: 56 VSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
I + + L YLH RI+HRDL P N++L +D + I DFGLAK Q
Sbjct: 116 WNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKL 170
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575
++V GT+ Y PE + + +K D+++FG +L + + P F T +SL
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----FYSTNMLSLA---- 222
Query: 576 NVMTSENPTRAIDAK---LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629
T+ ++A L E Y E + V+ C RP+ V M+S
Sbjct: 223 --------TKIVEAVYEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 74/293 (25%), Positives = 132/293 (45%), Gaps = 50/293 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LE IG G G V K S+GK++ K++ D +TE K+ +Q+ SE+N
Sbjct: 5 LETIGKGSFGTVRKVRRK-SDGKILVWKEI-----DYGNMTE-------KEKQQLVSEVN 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLL--VYEFMKNGSLQDILNDVSQGRRELDWLARH--- 456
+ +++H N++ + L V E+ + G L + + + ++E ++
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQL---IQKCKKERKYIEEEFIW 108
Query: 457 KIALGVACGLEYLH--ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD----AQ 510
+I + L H ++HRDLKPAN+ LD + ++ DFGLAK + A+
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168
Query: 511 THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570
T++ GT Y++PE + + +K DI+S G L+ L P F ++ L
Sbjct: 169 TYV------GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP----FTARNQLQL 218
Query: 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
++ P R Y ++ V+K + VD P +RP++++
Sbjct: 219 ASKIKEGKFRRIPYR----------YSSELNEVIK-SML-NVD-PDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 46/230 (20%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
+LEKIG G GEVYKA + ++ AIKK+ +L + I +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEV-AIKKM---------------RLRKQNKELIIN 64
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHL------LVYEFMKNGSLQDIL--NDVSQGRREL 450
EI + +H N++ D +L +V E+M GSL DI+ N V
Sbjct: 65 EILIMKDCKHPNIVDYY------DSYLVGDELWVVMEYMDGGSLTDIITQNFVR------ 112
Query: 451 DWLARHKIA---LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
+ +IA V GLEYLH + +IHRD+K N+LL D ++ADFG A +
Sbjct: 113 --MNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167
Query: 508 DAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
++ + V GT ++APE + + K DI+S G++ + G P
Sbjct: 168 KEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/236 (25%), Positives = 93/236 (39%), Gaps = 42/236 (17%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK--KMRQIRSEI 400
+ IG G V A+ K AIK + D + L K K++ ++ E
Sbjct: 7 KIIGEGSFSTVVLAKEK-ETNKEYAIKIL-------------DKRQLIKEKKVKYVKIEK 52
Query: 401 NTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ ++ H ++ L + V E+ NG L + G + R A
Sbjct: 53 EVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAA 109
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD----------- 508
+ LEYLH S IIHRDLKP N+LLD DM +I DFG AK +
Sbjct: 110 E-ILLALEYLH-SKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 509 -------AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ ++ GT Y++PE D+++ G ++ ++ G+ P
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 72/223 (32%), Positives = 111/223 (49%), Gaps = 19/223 (8%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E IG G G VY A L + G+M+A+K+V P A ++ +RSEI T
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIA----GRHDSRQKDMVKALRSEIET 61
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ + H N++ L + + E++ GS+ L + GR E L R V
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQ-LVRF-FTEQV 117
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
GL YLH + I+HRDLK N+L+D D +I+DFG++K D + ++ G+V
Sbjct: 118 LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 523 GYIAPE----YHQTLKFTDKCDIYSFGVLLAVLVMGRLP-SDD 560
++APE Y Q ++ K DI+S G ++ + GR P SD+
Sbjct: 175 FWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 74/228 (32%), Positives = 107/228 (46%), Gaps = 37/228 (16%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
D L L ++G+G G V K + I K I+ E+ E K QI
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTG--KIMAVKTIR-----LEINEAIQK-------QI 46
Query: 397 RSEINTVGQIRHRNLLPLL-----AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD 451
E+ I H+ P + A D + + E+M GSL IL QGR
Sbjct: 47 LREL----DILHKCNSPYIVGFYGAFYNNGDISICM-EYMDGGSLDKIL-KEVQGRIPER 100
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD--A 509
L KIA+ V GL YLH H IIHRD+KP+N+L++ + ++ DFG++ + + A
Sbjct: 101 ILG--KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156
Query: 510 QTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+T + TS+ Y+APE Q ++ K DI+S G+ L L GR P
Sbjct: 157 KTFVGTSS------YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 75/297 (25%), Positives = 120/297 (40%), Gaps = 61/297 (20%)
Query: 342 LEKIGSGGCGEVYKAE-LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+E IG G VY A LP N + +AIK++ D + + ++R E+
Sbjct: 6 IEVIGVGATAVVYAAICLP--NNEKVAIKRI-------------DLEKCQTSVDELRKEV 50
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ Q H N++ D LV ++ GSL DI+ +
Sbjct: 51 QAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIM--------------KSSYPR 96
Query: 461 GV------AC-------GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
G A GLEYLH S+ IHRD+K N+LL +D +IADFG++ ++
Sbjct: 97 GGLDEAIIATVLKEVLKGLEYLH-SN--GQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153
Query: 508 DA--QTHITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564
D +T GT ++APE Q + K DI+SFG+ L G P +
Sbjct: 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP- 212
Query: 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621
+K + + ++ P+ A + + ++ L C P +RP +
Sbjct: 213 ------MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISL-----CLQKDPSKRPTA 258
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 71/233 (30%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM--------RQI 396
+G GG GEV ++ + GKM A KK+ D K L K+ ++I
Sbjct: 1 LGKGGFGEVCACQVKAT-GKMYACKKL-------------DKKRLKKRKGEQMALNEKKI 46
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
++++ R ++ L D LV M G L+ + +V G
Sbjct: 47 LEKVSS------RFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAI 98
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
A + CGLE+LH RI++RDLKP NVLLDD RI+D GLA + +
Sbjct: 99 FYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569
AGT GY+APE Q + D ++ G L ++ GR P F Q E++
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP---FRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-23
Identities = 74/291 (25%), Positives = 129/291 (44%), Gaps = 41/291 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
K+GSG GEV++ N +AIK + + D L K + + E+
Sbjct: 11 ERKLGSGYFGEVWEGLW--KNRVRVAIK-----------ILKSDDLL---KQQDFQKEVQ 54
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++RH++L+ L A + + ++ E M+ GSL L +G+ L + +A
Sbjct: 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ-VLPVASLIDMACQ 112
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
VA G+ YL + IHRDL N+L+ +D+ ++ADFGLA+ + + +S+
Sbjct: 113 VAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE--DVYLSSDKKIP 167
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580
+ APE F+ K D++SFG+LL + G++P H + R +
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA 227
Query: 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
+ P Q + + + C+ P +RP+ K +R L I
Sbjct: 228 KCP---------------QEIYKIMLECWAA--EPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L KIG G G VYKA G+++AIKK+ +S+ + K +R EI
Sbjct: 4 LGKIGEGTYGVVYKAR-DKLTGEIVAIKKIKLR---------FESEGIPK--TALR-EIK 50
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H N++ LL LV+EFM D+ + +R L
Sbjct: 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ GL + H SH I+HRDLKP N+L++ + ++ADFGLA++ + T V T
Sbjct: 107 LLQGLAFCH-SHG--ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVV-T 161
Query: 522 VGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGR--LPSDD 560
Y APE K + DI+S G + A L+ R P
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E +GSG G VY+ L +G A+K+V +D + + ++Q+ EI
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEV---------SLADDGQTGQEAVKQLEQEIAL 55
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVY-EFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +++H N++ L R + +L ++ E + GSL +L + L +I LG
Sbjct: 56 LSKLQHPNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG 114
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
LEYLH + +HRD+K AN+L+D + ++ADFG+AK + + G+
Sbjct: 115 ----LEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGS 164
Query: 522 VGYIAPEY-HQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563
++APE Q + DI+S G + + G+ P
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 69/237 (29%), Positives = 105/237 (44%), Gaps = 52/237 (21%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ------ 395
+K+G G VYKA G+++AIKK+ KL +K +
Sbjct: 5 GKKLGEGTYAVVYKAR-DKETGRIVAIKKI---------------KLGERKEAKDGINFT 48
Query: 396 -IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+R EI + +++H N++ LL LV+EFM+ L+ ++ D + +
Sbjct: 49 ALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKD-----KSIVLTP 101
Query: 455 RHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
L GLEYLH S+ I+HRDLKP N+L+ D ++ADFGLA++
Sbjct: 102 ADIKSYMLMTLRGLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158
Query: 513 ITTSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR--LPSDD 560
+T V T Y APE Y D++S G + A L++ LP D
Sbjct: 159 MTHQVV--TRWYRAPELLFGARHYGVG------VDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L K+G+G GEV+ G+ +A+K + +E
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQE-------------- 51
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ ++RH L+ L A + + +V E+M GSL D L + L L +
Sbjct: 52 -AQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV--DM 108
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
A +A G+ YL + IHRDL N+L+ +++ +IADFGLA+ + D + +
Sbjct: 109 AAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YTAREGA 164
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLP 557
+ + APE +FT K D++SFG+LL +V GR+P
Sbjct: 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIK-KVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+K+G G G V + E S GK+I + K ++ K L+ M E
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK------------LSDIMDDFLKEAA 48
Query: 402 TVGQIRHRNLLPL----LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+ + H NL+ L L H ++V E GSL D L + G + L
Sbjct: 49 IMHSLDHENLIRLYGVVLTHPL-----MMVTELAPLGSLLDRLRKDALGHFLISTL--CD 101
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH-ITTS 516
A+ +A G+ YL R IHRDL N+LL D + +I DFGL +A+P + H +
Sbjct: 102 YAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
++ + APE +T F+ D++ FGV L
Sbjct: 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 72/213 (33%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G GG GEV ++ + GKM A KK+ K + + +S LN+K QI ++N+
Sbjct: 8 LGKGGFGEVCACQVRAT-GKMYACKKL---EKKRIKKRKGESMALNEK--QILEKVNS-- 59
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
R ++ L D LV M G L+ + + + E + A + C
Sbjct: 60 ----RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY--AAEICC 113
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGY 524
GLE LH RI++RDLKP N+LLDD RI+D GLA +P+ Q T GTVGY
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGY 167
Query: 525 IAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+APE + ++T D ++ G LL ++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 76/298 (25%), Positives = 123/298 (41%), Gaps = 38/298 (12%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ + L ++G G G V K L N MI K I T+ + L +QI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLK--NTGMIFALKTI--------TTDPNPDL----QKQI 46
Query: 397 RSEINTVGQIRHRNLLPLL-AHMARPDCHL-LVYEFMKNGSLQDILNDV-SQGRRELDWL 453
E+ + ++ A + + + E+ + GSL I V +G R + +
Sbjct: 47 LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
KIA V GL YLH + +IIHRD+KP+N+LL + ++ DFG++ + ++
Sbjct: 107 L-GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT 162
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL--V 571
T GT Y+APE Q ++ D++S G+ L + R P F E L +
Sbjct: 163 FT----GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPI 214
Query: 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629
+ + ++ NP D + E+ + C P RP D ML
Sbjct: 215 ELLSYIVNMPNP-ELKDEPGNGIKWSEEFKDFI---KQCLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 30/220 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L K+G+G GEV++ + +A+K + D + E QI
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAE---------AQI----- 54
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++RH L+ L A + +V E MK GSL + L + +L L +A
Sbjct: 55 -MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQ 111
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
VA G+ YL + N IHRDL NVL+ ++ ++ADFGLA+ + + I + G
Sbjct: 112 VASGMAYLE-AQN--YIHRDLAARNVLVGENNICKVADFGLARVIKE---DIYEARE-GA 164
Query: 522 ---VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLP 557
+ + APE +F+ K D++SFG+LL +V GR+P
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 51/301 (16%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
+ + L ++ +G+G G V K + + M KKV+ S + +
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA--KKVV--------HIGAKSSV----RK 48
Query: 395 QIRSEINTVGQIRHRNLLPLL-----AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE 449
QI E+ QI H P + A + + + EFM GSL I G
Sbjct: 49 QILREL----QIMHECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSLDRIYKKG--GPIP 101
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD- 508
++ L KIA+ V GL YL+ H RI+HRD+KP+N+L++ + ++ DFG++ + +
Sbjct: 102 VEILG--KIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157
Query: 509 -AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP----SDDFFQ 563
A T + TS Y++PE Q K+T K D++S G+ + L +G+ P + D
Sbjct: 158 IADTFVGTST------YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
+ M ++ ++ ++ P +L + + E + + C + P ERP +
Sbjct: 212 QDDPMGILDLLQQIVQEPPP------RLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQ 262
Query: 624 V 624
+
Sbjct: 263 L 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-21
Identities = 66/289 (22%), Positives = 129/289 (44%), Gaps = 55/289 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR--SE 399
L KIG G G V+K + ++ ++ A+K++ +L++ + + + + + R ++
Sbjct: 5 LNKIGKGSFGVVFKV-VRKADKRVYAMKQI--------DLSKMNRREREEAIDEARVLAK 55
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHL------LVYEFMKNGSLQDILNDVSQGRRELDWL 453
+++ IR+ + L +V E+ +NG L +L Q R L
Sbjct: 56 LDSSYIIRYY------------ESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPED 101
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
+ + + GL +LH + +I+HRD+K N+ LD +I D G+AK + D
Sbjct: 102 QVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV-K 572
T + GT Y++PE + + +K D+++ GV+L G+ P F + +L+ K
Sbjct: 159 NT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP----FDANNQGALILK 212
Query: 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621
+R V + Y +Q+ ++ C R+RP++
Sbjct: 213 IIRGVF-----------PPVSQMYSQQLAQLIDQ---CLTKDYRQRPDT 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E IG G G V + E G+ +A+K I+ A EE + +
Sbjct: 12 EIIGEGEFGAVLQGEY---TGQKVAVK-NIKCDVTAQAFLEETAVMTK------------ 55
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ H+NL+ LL + ++ V E M G+L + L ++GR + + + +L V
Sbjct: 56 ---LHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDV 109
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
A G+EYL + +++HRDL N+L+ +D A+++DFGLA+ N V
Sbjct: 110 AEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPV 161
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ APE + KF+ K D++S+GVLL V GR P
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 68/216 (31%), Positives = 105/216 (48%), Gaps = 42/216 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+++IGSG G+VYKA + G+++AIK + P D E I+ EI+
Sbjct: 8 IQRIGSGTYGDVYKARDIAT-GELVAIKVIKLEPGDDFE--------------IIQQEIS 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + RH N++ R D +V E+ GSLQDI R L L +IA
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLSEL---QIAY- 105
Query: 462 VAC----GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA----KAMPDAQTHI 513
V GL YLH + IHRD+K AN+LL +D + ++ADFG++ + ++ I
Sbjct: 106 VCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI 162
Query: 514 TTSNVAGTVGYIAPEYHQTLK---FTDKCDIYSFGV 546
GT ++APE + + KCDI++ G+
Sbjct: 163 ------GTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 28/221 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LE++G G G+VYK EL G N ++ A I+ K+ AE + + R E
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---------EFRQEAE 60
Query: 402 TVGQIRHRNLLPLLAHMAR--PDCHLLVYEFMKNGSLQDIL------------NDVSQGR 447
+ ++H N++ LL + P C L +E++ +G L + L + +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
LD IA+ +A G+EYL SH+ +HRDL N L+ + + +I+DFGL++ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS-SHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 508 DAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
A + S V ++ PE KFT + DI+SFGV+L
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 66/245 (26%), Positives = 117/245 (47%), Gaps = 56/245 (22%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM----RQIR 397
+ +IG G G+VYKA G+++A+KK+ ++ N+K IR
Sbjct: 4 IAQIGEGTYGQVYKAR-NKKTGELVALKKI---------------RMENEKEGFPITAIR 47
Query: 398 SEINTVGQIRHRNLLPLLAHM---ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
EI + ++RH N++ L + + + +V+E+M + L +L+
Sbjct: 48 -EIKLLQKLRHPNIVRLKEIVTSKGKGSIY-MVFEYMDH-DLTGLLDSPE---------- 94
Query: 455 RHKIALG-VAC-------GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM 506
K + C GL+YLH + I+HRD+K +N+L+++D ++ADFGLA+
Sbjct: 95 -VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY 150
Query: 507 PDAQTHITTSNVAGTVGYIAPE--YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564
+ T+ V T+ Y PE T ++ + D++S G +LA L +G+ P FQ
Sbjct: 151 TKRNSADYTNRVI-TLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK-P---IFQG 204
Query: 565 TEEMS 569
+ E+
Sbjct: 205 STELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
K+G G GEVY+ + +A+K + +ED+ + + ++ E +
Sbjct: 13 KLGGGQYGEVYEG-VWKKYSLTVAVKTL-----------KEDTMEVEEFLK----EAAVM 56
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+I+H NL+ LL R ++ EFM G+L D L + R+E++ + +A ++
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQIS 114
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
+EYL + IHRDL N L+ ++ ++ADFGL++ M T+ + +
Sbjct: 115 SAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIK 170
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLL 548
+ APE KF+ K D+++FGVLL
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 65/224 (29%), Positives = 112/224 (50%), Gaps = 23/224 (10%)
Query: 345 IGSGGCGEVYKA--ELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
IG+G GEV++ ++PG +AIK + TE K+ + SE +
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL------KPGYTE-------KQRQDFLSEASI 59
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+GQ H N++ L + + +++ E+M+NG+L L D G E + G+
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDG--EFSSYQLVGMLRGI 116
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD-AQTHITTSNVAGT 521
A G++YL + +HRDL N+L++ ++E +++DFGL++ + D + TTS
Sbjct: 117 AAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQH 564
+ + APE KFT D++SFG+++ V+ G P D H
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 88/299 (29%), Positives = 141/299 (47%), Gaps = 40/299 (13%)
Query: 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK-KMRQIRSE 399
+L +G G G V K + + G+++AIKK ++ ED K++ K MR+IR
Sbjct: 5 NLGLVGEGSYGMVMKCKHKET-GQIVAIKKFLE---------SEDDKMVKKIAMREIR-- 52
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ Q+RH NL+ L+ R LV+EF+ + +L+D+ + LD K
Sbjct: 53 --MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYL 106
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ G+E+ H SHN IIHRD+KP N+L+ ++ DFG A+ + A + T VA
Sbjct: 107 FQILRGIEFCH-SHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYTDYVA 162
Query: 520 GTVGYIAPEYH-QTLKFTDKCDIYSFGVLLAVLVMGR--LPSD---DFFQHTEEM--SLV 571
T Y APE K+ DI++ G L+ ++ G P D D H + +L+
Sbjct: 163 -TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI 221
Query: 572 KWMRNVMTSENPTRAI-------DAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
+ + +NP A + + LE + + LVL +A C P +RP+S
Sbjct: 222 PRHQEIF-QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 71/223 (31%), Positives = 113/223 (50%), Gaps = 27/223 (12%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ L ++K+G+G GEV+ NG K ++P + E E+++++ K
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTW---NGNTKVAVKTLKPGTMSPESFLEEAQIMKK----- 57
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRR-ELDWLAR 455
+RH L+ L A ++ ++ V E+M GSL D L D +GR +L L
Sbjct: 58 ---------LRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLV- 105
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+A VA G+ Y+ IHRDL+ AN+L+ D + +IADFGLA+ + D + +
Sbjct: 106 -DMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTAR 160
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLP 557
+ + APE +FT K D++SFG+LL LV GR+P
Sbjct: 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 75/226 (33%), Positives = 123/226 (54%), Gaps = 23/226 (10%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM-RQIRSEINTV 403
IGSG G VY + S+G+++A+K+V P A SK + M + EI +
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSA------SSKDRKRSMLDALAREIALL 60
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVY-EFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+++H N++ L D HL ++ E++ GS+ +LN+ G E + L R+ + +
Sbjct: 61 KELQHENIVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNY--GAFE-ETLVRNFVR-QI 115
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA--- 519
GL YLH N IIHRD+K AN+L+D+ +I+DFG++K + +A + T +N A
Sbjct: 116 LKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPS 171
Query: 520 --GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563
G+V ++APE + +T K DI+S G L+ ++ G+ P D Q
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 46/285 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LE IG G GEVYKA +N +++AIK + E E++ + + + EI
Sbjct: 6 LECIGKGSFGEVYKAIDKRTN-QVVAIKVI------DLEEAEDEIEDIQQ-------EIQ 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ Q R + + L ++ E+ GS D+L +LD I
Sbjct: 52 FLSQCRSPYITKYYGSFLK-GSKLWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILR 105
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
V GLEYLH IHRD+K AN+LL ++ + ++ADFG++ + + T G
Sbjct: 106 EVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVG 160
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580
T ++APE + + +K DI+S G+ L G P D + ++ + + +
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-------LHPMRVLFLIPKN 213
Query: 581 ENPTRAIDAKLLENGYEEQMLLVLK--IACFCTVDSPRERPNSKD 623
P+ L N + + K ++ C P+ERP++K+
Sbjct: 214 NPPS------LEGNKFSKP----FKDFVSL-CLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 74/233 (31%), Positives = 113/233 (48%), Gaps = 34/233 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G GG GEV ++ + GKM A KK+ K + + ++ LN+K QI ++N+
Sbjct: 8 LGKGGFGEVCACQVRAT-GKMYACKKL---EKKRIKKRKGEAMALNEK--QILEKVNS-- 59
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG----RRELDWLARHKIAL 460
R ++ L D LV M G L+ + ++ R + + A
Sbjct: 60 ----RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE----- 110
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ CGLE LH RI++RDLKP N+LLDD RI+D GLA +P+ + T G
Sbjct: 111 -ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVG 163
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573
TVGY+APE + ++T D + G L+ ++ G+ P F Q E+ VK
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP---FRQRKEK---VKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 73/229 (31%), Positives = 108/229 (47%), Gaps = 26/229 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G GG GEV ++ + GKM A KK+ K + + ++ LN+K +I ++N+
Sbjct: 8 LGKGGFGEVCACQVRAT-GKMYACKKL---EKKRIKKRKGEAMALNEK--RILEKVNS-- 59
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
R ++ L D LV M G L+ + + G D A + C
Sbjct: 60 ----RFVVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYAAELCC 113
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGY 524
GLE L RI++RDLKP N+LLDD RI+D GLA +P+ + T GTVGY
Sbjct: 114 GLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGY 167
Query: 525 IAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573
+APE K+T D + G L+ ++ G+ P F + E VK
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP---FRKRKER---VKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 22/218 (10%)
Query: 343 EKIGSGGCGEVYKA--ELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+ IG G GEV + +LPG +AIK + K + +K+ +E
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL----KAGSS---------DKQRLDFLTEA 56
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ +GQ H N++ L + + +++ E+M+NGSL L + + +
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLR 113
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
G+A G++YL N +HRDL N+L++ ++ +++DFGL++ + D++ TT
Sbjct: 114 GIASGMKYLS-EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + APE KFT D++SFG+++ V+ G P
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 59/162 (36%), Positives = 87/162 (53%), Gaps = 12/162 (7%)
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
+E + + Q+RH NL+ LL + L +V E+M GSL D L S+GR L
Sbjct: 48 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLL 105
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
K +L V +EYL ++ +HRDL NVL+ +D A+++DFGL K Q T
Sbjct: 106 KFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTG 159
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ V + APE + KF+ K D++SFG+LL + GR+P
Sbjct: 160 KLP--VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
KIG G G+VY A + G+++A+K++ IQ +++I E+
Sbjct: 5 GNKIGGGTFGKVYTA-VNLDTGELMAVKEIRIQDNDPKT-------------IKEIADEM 50
Query: 401 NTVGQIRHRNLLPLLA---HMARPDCHLLVYEFMK---NGSLQDILNDVSQGRRELDWLA 454
+ ++H NL+ H + VY FM+ G+L+++L + R LD
Sbjct: 51 KVLELLKHPNLVKYYGVEVHREK------VYIFMEYCSGGTLEELL----EHGRILDEHV 100
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
L + GL YLH SH I+HRD+KPAN+ LD + ++ DFG A + + T +
Sbjct: 101 IRVYTLQLLEGLAYLH-SH--GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157
Query: 515 TS--NVAGTVGYIAPEYHQTLKFTDK---CDIYSFGVLLAVLVMGRLP 557
++AGT Y+APE K DI+S G ++ + G+ P
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 27/220 (12%)
Query: 336 EDGLASLEKIGSGGCGEVYKA--ELPGSN-GKMIAIKKVIQPPKDAAELTEEDSKLLNKK 392
+ L ++++G G G+V + G N G+ +A+K + E +
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS----LNHSGE---------EQH 49
Query: 393 MRQIRSEINTVGQIRHRNLLPL--LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRREL 450
EI + + H N++ + L+ E++ +GSL+D L Q R+
Sbjct: 50 RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQ 105
Query: 451 DWLARH-KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA 509
L R + + G++YL + R IHRDL N+L++ + +I+DFGLAK +P+
Sbjct: 106 INLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
Query: 510 QTHITTSNVAGT-VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + + + + APE +T KF+ D++SFGV L
Sbjct: 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 59/255 (23%), Positives = 110/255 (43%), Gaps = 48/255 (18%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLN 390
+ D + ++G G G+V+ E P ++ +++A+K + K+ A N
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETAS---------N 49
Query: 391 KKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD----------IL 440
+ E + +H N++ D ++V+E+M++G L L
Sbjct: 50 DARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFL 109
Query: 441 NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500
EL +IA+ +A G+ YL H +HRDL N L+ D+ +I DF
Sbjct: 110 KSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDF 166
Query: 501 GLAKAMPDAQTHITTSN---VAGT----VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLV 552
G+++ + T++ V G + ++ PE KFT + D++SFGV+L +
Sbjct: 167 GMSR-------DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
Query: 553 MGRLPSDDFFQHTEE 567
G+ P ++ + E
Sbjct: 220 YGKQP---WYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG G G+V + KM A+K + ++ + +R + +E +
Sbjct: 8 IGKGAFGKVCIVQK-RDTKKMFAMK----------YMNKQKC-VEKGSVRNVLNERRILQ 55
Query: 405 QIRHRNLLPLLAHM-----ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
++ H P L ++ + +L+V + + G L+ L SQ + + + I
Sbjct: 56 ELNH----PFLVNLWYSFQDEENMYLVV-DLLLGGDLRYHL---SQKVKFSEEQVKFWIC 107
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ LEYLH + IIHRD+KP N+LLD+ I DF +A + T T+ +
Sbjct: 108 -EIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-DTLTTS--TS 160
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT GY+APE ++ D +S GV + G+ P
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 22/218 (10%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G GG GEV ++ + GKM A KK+ + K + + E LL K++ + + V
Sbjct: 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDK--KRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 405 QIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
LA+ HL LV M G L+ + +V + E++ + + +
Sbjct: 58 ----------LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ--IT 105
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
CG+ LH+ H+ I++RD+KP NVLLDD R++D GLA + D + T + AGT G
Sbjct: 106 CGI--LHL-HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNG 159
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
Y+APE + ++ D ++ G + +V GR P D
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
K+G G GEV+ G+ I K ++P E ++++++ K
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAI---KTLKPGTMMPEAFLQEAQIMKK------------ 57
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+RH L+PL A ++ ++ V EFM GSL D L + +L L +A +A
Sbjct: 58 --LRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIA 112
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
G+ Y+ IHRDL+ AN+L+ D++ +IADFGLA+ + D + + +
Sbjct: 113 DGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIK 168
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLP 557
+ APE +FT K D++SFG+LL LV GR+P
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 68/223 (30%), Positives = 112/223 (50%), Gaps = 29/223 (13%)
Query: 343 EKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
E IG+G GEV + L PG +AIK + + TE K+ R SE
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL------KSGYTE-------KQRRDFLSEA 56
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL--NDVSQGRRELDWLARHKI 458
+ +GQ H N++ L + + +++ EFM+NG+L L ND +L + R
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR--- 113
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-TSN 517
G+A G++YL +HRDL N+L++ ++ +++DFGL++ + D + T TS+
Sbjct: 114 --GIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 518 VAGT--VGYIAPEYHQTLKFTDKCDIYSFG-VLLAVLVMGRLP 557
+ G + + APE KFT D++S+G V+ V+ G P
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G GG GEV ++ + GKM A K++ K + + +S LN+K QI ++N+
Sbjct: 8 LGKGGFGEVCACQVRAT-GKMYACKRL---EKKRIKKRKGESMALNEK--QILEKVNS-- 59
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQ-DILNDVSQGRRELDWLARHKIALGVA 463
+ ++ L D LV M G L+ I N + G E L A +
Sbjct: 60 ----QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF---YAAEIL 112
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
CGLE LH ++RDLKP N+LLDD RI+D GLA +P+ + + GTVG
Sbjct: 113 CGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVG 166
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
Y+APE ++T D + G L+ ++ G+ P
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
E L +IG G G VY A +++AIKK+ K + E K +
Sbjct: 14 EKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNE-----------KWQD 61
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
I E+ + Q+RH N + R LV E+ GS DIL + +E++ A
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA- 119
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
I G GL YLH SH IHRD+K N+LL + ++ADFG A + A + +
Sbjct: 120 --ICHGALQGLAYLH-SHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-- 172
Query: 516 SNVAGTVGYIAPEYHQTL---KFTDKCDIYSFGV 546
GT ++APE + ++ K D++S G+
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ-IRSEI 400
L+K+G G G VYK + S+ + A+K+V D +++K R+ +EI
Sbjct: 5 LKKLGKGSYGSVYKVKRL-SDNQFYALKEV-------------DLGSMSQKEREDAVNEI 50
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLL--VYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ + H N++ A D + L V E+ G L ++ + R+ + +I
Sbjct: 51 RILASVNHPNIISY--KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD--AQTHITTS 516
+ + GL+ LH +I+HRDLK AN+LL + +I D G++K + A+T I
Sbjct: 109 FIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--- 162
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT Y+APE + ++ K DI+S G LL + P
Sbjct: 163 ---GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 24/222 (10%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ + ++K+G+G GEV+ +N +A+K ++P + + E++ L+
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYY--NNSTKVAVK-TLKPGTMSVQAFLEEANLMKT----- 57
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
++H L+ L A + + + ++ E+M GSL D L G+ L L
Sbjct: 58 ---------LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-- 106
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
+ +A G+ Y+ IHRDL+ ANVL+ + + +IADFGLA+ + D + +
Sbjct: 107 DFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTARE 162
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + APE FT K D++SFG+LL ++ G++P
Sbjct: 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G GG G V ++ N + A+K V + + + I SE +
Sbjct: 1 LGVGGFGRVELVKVKSKN-RTFALKCVKK-----------RHIVETGQQEHIFSEKEILE 48
Query: 405 QIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+ H ++ L + ++ ++ E+ G L IL D G + ++ AR IA V
Sbjct: 49 ECNHPFIVKLYRTF-KDKKYIYMLMEYCLGGELWTILRDR--GLFD-EYTARFYIA-CVV 103
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
EYLH + II+RDLKP N+LLD + ++ DFG AK + Q T GT
Sbjct: 104 LAFEYLH-NRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
Y+APE + D +S G+LL L+ GR P
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 30/216 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+E IGSG G V A + +GK +AIKK+ P T K R +R E+
Sbjct: 10 IENIGSGAYGVVCSA-IDTRSGKKVAIKKI---PHAFDVPT-------LAK-RTLR-ELK 56
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL----LVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+ +H N++ + + P +V + M++ L I++ S + R+
Sbjct: 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEE-HIRY- 111
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM---PDAQTHIT 514
+ GL+Y+H S N +IHRDLKP+N+L+++D E RI DFG+A+ + P +
Sbjct: 112 FLYQLLRGLKYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 515 TSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLA 549
T VA T Y APE +L ++T D++S G + A
Sbjct: 169 TEYVA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFA 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 61/230 (26%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 335 KEDGLASLEKIGSGGCGEVYKA--ELPGSNGKM-IAIKKVIQPPKDAAELTEEDSKLLNK 391
KE L ++ +GSG G VYK G K+ +AIK L EE S NK
Sbjct: 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIK----------VLREETSPKANK 54
Query: 392 KMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD 451
+I E + + H +++ LL + L+ + M G L L+ V + +
Sbjct: 55 ---EILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCL---LDYVRNHKDNIG 107
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
+ +A G+ YL R++HRDL NVL+ +I DFGLAK + +
Sbjct: 108 SQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDD 560
+ ++A E +T K D++S+GV + ++ G P +
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ L ++K+G+G GEV+ + +AIK + + + L
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYY--NGHTKVAIKSL-------KQGSMSPEAFL------- 49
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
+E N + Q++H L+ L A + + ++ + E+M+NGSL D L + ++ L
Sbjct: 50 -AEANLMKQLQHPRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIKLTINKLI-- 105
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
+A +A G+ ++ + IHRDL+ AN+L+ + + +IADFGLA+ + D + +
Sbjct: 106 DMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTARE 161
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575
+ + APE FT K D++SFG+LL +V GR+P M
Sbjct: 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG-------------MT 208
Query: 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628
N +N R +N EE L+ C + P ERP + +R +L
Sbjct: 209 NPEVIQNLERGYRMPRPDNCPEELYELMRL----CWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 73/229 (31%), Positives = 111/229 (48%), Gaps = 35/229 (15%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEE-DSKLLNKKMRQIRSEINTV 403
+G G G+V AEL G G+ A+K + KD + ++ + ++ K++ + E
Sbjct: 3 LGKGSFGKVLLAELKGK-GEYFAVKAL---KKDVVLIDDDVECTMVEKRVLALAWEN--- 55
Query: 404 GQIRHRNLLPLLAHM----ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
P L H+ + V EF+ G L + D +GR +L + A
Sbjct: 56 ---------PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFY--A 102
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ CGL++LH + II+RDLK NV+LD D +IADFG+ K +T
Sbjct: 103 AEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FC 157
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP-----SDDFFQ 563
GT YIAPE Q LK+T D +SFGVLL +++G+ P D+ F+
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 71/228 (31%), Positives = 112/228 (49%), Gaps = 49/228 (21%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK-------MR 394
LEK+G G G VYKA G+++A+KK+ +L N++ +R
Sbjct: 4 LEKLGEGTYGVVYKARDK-KTGEIVALKKI---------------RLDNEEEGIPSTALR 47
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
EI+ + +++H N++ LL + LV+E+ L+ L D G + +
Sbjct: 48 ----EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIK 101
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MPDAQTH 512
I + GL Y H SH RI+HRDLKP N+L++ D ++ADFGLA+A +P +T+
Sbjct: 102 S--IMYQLLRGLAYCH-SH--RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTY 155
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTDKC-----DIYSFGVLLAVLVMGR 555
T V T+ Y APE + K DI+S G + A ++ G+
Sbjct: 156 --THEVV-TLWYRAPE----ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 30/218 (13%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAA-ELTEEDSKLLNKKMRQIRSEINTV 403
+G G G+V AEL G+N + AIK + KD E + + ++ +++ + E
Sbjct: 3 LGKGSFGKVMLAELKGTN-EFFAIKAL---KKDVVLEDDDVECTMVERRVLALAWE---- 54
Query: 404 GQIRHRNLLPLLAHMA---RPDCHLL-VYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
P L H+ + HL V E++ G D++ + R + AR A
Sbjct: 55 --------HPFLTHLFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARF-YA 102
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ CGL++LH II+RDLK NVLLD D +IADFG+ K + + S
Sbjct: 103 AEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFC 157
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT YIAPE + K+ + D +SFGVLL +++G+ P
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
IG G G VY L S+G+ I A+K + + EE + L + + I +
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-----NRITDLEEVEQFLKEGI--IMKDF 53
Query: 401 NTVGQIRHRNLLPLLAHMARPD-CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ H N+L LL + L+V +MK+G L++ + + D +
Sbjct: 54 S------HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FG 104
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
L VA G+EYL + + +HRDL N +LD+ ++ADFGLA+ + D + + ++
Sbjct: 105 LQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG 161
Query: 520 GT--VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
V ++A E QT KFT K D++SFGVLL
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 35/222 (15%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS------ 398
+G GG GEV ++ + GK+ A KK LNKK + R
Sbjct: 1 LGKGGFGEVSACQMRAT-GKLYACKK------------------LNKKRLKKRKGYEGAM 41
Query: 399 -EINTVGQIRHRNLLPL-LAHMARPD-CHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
E + ++ R ++ L A + D C LV M G L+ + +V +
Sbjct: 42 VEKRILAKVHSRFIVSLAYAFQTKTDLC--LVMTIMNGGDLRYHIYNVDEENPGFPEPRA 99
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+ GLE+LH RII+RDLKP NVLLD+D RI+D GLA + D Q+ T
Sbjct: 100 CFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT 154
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
AGT G++APE Q ++ D ++ GV L ++ R P
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM 393
+ E+ LE+IG G GEVYK + +++AIK + D E +E +
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKII-----DLEEAEDE--------I 46
Query: 394 RQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWL 453
I+ EI + Q + + ++ E++ GS D+L G E ++
Sbjct: 47 EDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK---PGPLEETYI 103
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
A I + GL+YLH + R IHRD+K ANVLL + + ++ADFG+A + D Q I
Sbjct: 104 A--TILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
+ GT ++APE + + K DI+S G+ L G P+ D
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 77/291 (26%), Positives = 127/291 (43%), Gaps = 41/291 (14%)
Query: 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM 393
+ E+ LEKIG G GEV+K + K++AIK + D E +E +
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-----DLEEAEDE--------I 46
Query: 394 RQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWL 453
I+ EI + Q + + ++ E++ GS D+L ++ +
Sbjct: 47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI 106
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
R + GL+YLH + + IHRD+K ANVLL + E ++ADFG+A + D Q I
Sbjct: 107 LREILK-----GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 156
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573
+ GT ++APE + + K DI+S G+ L G P E+ +K
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH-------SELHPMKV 209
Query: 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ + + PT LE Y + + ++ C P RP +K++
Sbjct: 210 LFLIPKNNPPT-------LEGNYSKPLKEFVEA---CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
K+G G GEV+ G+ +AIK ++P + E ++++++ K
Sbjct: 13 KLGQGCFGEVWMGTWNGTT--RVAIK-TLKPGTMSPEAFLQEAQVMKK------------ 57
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+RH L+ L A ++ ++ V E+M GSL D L L L +A +A
Sbjct: 58 --LRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIA 112
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
G+ Y+ +HRDL+ AN+L+ +++ ++ADFGLA+ + D + + +
Sbjct: 113 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIK 168
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLP 557
+ APE +FT K D++SFG+LL L GR+P
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +IG G G V+KA G+ +A+KKV L + + N+ +R EI
Sbjct: 5 LGRIGEGAHGIVFKA-KDRETGETVALKKV--------ALRRLEGGIPNQALR----EIK 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +H ++ LL +LV E+M L ++L D R L
Sbjct: 52 ALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDE---ERPLPEAQVKSYMRM 107
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ G+ Y+H I+HRDLKPAN+L+ D +IADFGLA+ + + + + VA T
Sbjct: 108 LLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-T 163
Query: 522 VGYIAPE--YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
Y APE Y K+ D+++ G + A L+ G
Sbjct: 164 RWYRAPELLYGAR-KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 77/248 (31%), Positives = 119/248 (47%), Gaps = 51/248 (20%)
Query: 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+L +GSG G+V A + K +AIKK+ +P + A +K R R E+
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRK-VAIKKLSRPFQSA-----IHAK------RTYR-EL 65
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRRELDWL 453
+ + H N++ LL + P L LV M D LN++ + ++ D
Sbjct: 66 RLLKHMDHENVIGLL-DVFTPASSLEDFQDVYLVTHLMG----AD-LNNIVKCQKLSDDH 119
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
+ + + GL+Y+H + IIHRDLKP+N+ +++D E +I DFGLA+ D +
Sbjct: 120 IQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDE--- 171
Query: 514 TTSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR--LPSDDFF-Q 563
T VA T Y APE Y+QT+ DI+S G ++A L+ G+ P D Q
Sbjct: 172 MTGYVA-TRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGKTLFPGSDHIDQ 224
Query: 564 HTEEMSLV 571
M+LV
Sbjct: 225 LKRIMNLV 232
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 59/186 (31%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 387 KLLNK----KMRQ---IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDI 439
K+L+K K++Q + +E + IRH L+ L LV E++ G L
Sbjct: 32 KILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH 91
Query: 440 LNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIAD 499
L GR AR A V LEYLH + I++RDLKP N+LLD D +I D
Sbjct: 92 LRKS--GRFPEPV-ARFYAA-QVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITD 144
Query: 500 FGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559
FG AK + T + GT Y+APE + + D ++ G+L+ ++ G P
Sbjct: 145 FGFAKRVKG-----RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP-- 197
Query: 560 DFFQHT 565
FF
Sbjct: 198 -FFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 70/237 (29%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM-RQIRSEINTV 403
I G G V+ A+ S G + AIK + K ++ K Q+ +E + +
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIKVI---KKA---------DMIRKNQVDQVLTERDIL 47
Query: 404 GQIRHRNLLPLLAHM---ARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
Q + P + + + +L LV E++ G L +L +V G + D AR IA
Sbjct: 48 SQAQS----PYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDV-ARIYIA 100
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--------MPDAQT 511
V LEYLH S+ IIHRDLKP N+L+D + ++ DFGL+K + D +
Sbjct: 101 EIVLA-LEYLH-SNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
+ GT YIAPE + D +S G +L ++G P F T E
Sbjct: 157 EDKR--IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP---FHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 5e-17
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKM-IAIK--KVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
EKIG G G+VYK L G +A+K + PP + +E L
Sbjct: 1 EKIGKGNFGDVYKGVL---KGNTEVAVKTCRSTLPPDLKRKFLQEAEILK---------- 47
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI- 458
Q H N++ L+ + +V E + GSL L R++ + L K+
Sbjct: 48 -----QYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLL 96
Query: 459 --ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
+L A G+EYL S N IHRDL N L+ ++ +I+DFG+++ ++
Sbjct: 97 QMSLDAAAGMEYLE-SKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + APE ++T + D++S+G+LL
Sbjct: 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILL 185
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 69/249 (27%), Positives = 115/249 (46%), Gaps = 43/249 (17%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+VYKA+ + A K+IQ + EL ED + EI+ +
Sbjct: 13 LGDGAFGKVYKAQ--HKETGLFAAAKIIQI-ESEEEL--EDFMV----------EIDILS 57
Query: 405 QIRHRNLLPLL-AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE--LDWLARHKIALG 461
+ +H N++ L A+ +L+ EF G+L I+ ++ +G E + ++ R
Sbjct: 58 ECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQ----- 111
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL-AKAMPDAQTHITTSNVAG 520
+ L +LH + ++IHRDLK N+LL D + ++ADFG+ AK Q G
Sbjct: 112 MLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIG 165
Query: 521 TVGYIAPEYHQTLKFTD-----KCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575
T ++APE F D K DI+S G+ L L P + ++ ++ +
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE-------LNPMRVLL 218
Query: 576 NVMTSENPT 584
++ SE PT
Sbjct: 219 KILKSEPPT 227
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 71/242 (29%), Positives = 113/242 (46%), Gaps = 39/242 (16%)
Query: 327 AEDLAFLEKEDGLASLEKIGSGGCGEVYKAE---LPGSNGKM-IAIKKVIQPPKDAAELT 382
D + D L + +G G G+V KAE L N +A+K + KD A T
Sbjct: 2 PLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDA--T 55
Query: 383 EEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILND 442
E+D L +M ++ +G+ H+N++ LL + +V E+ +G+L+D L
Sbjct: 56 EKDLSDLVSEMEMMK----MIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-- 107
Query: 443 VSQGRR--------ELDWLARHKI--------ALGVACGLEYLHISHNPRIIHRDLKPAN 486
+ RR + + A VA G+E+L + + IHRDL N
Sbjct: 108 --RARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARN 162
Query: 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGV 546
VL+ +D +IADFGLA+ + + T+N V ++APE +T + D++SFGV
Sbjct: 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 222
Query: 547 LL 548
LL
Sbjct: 223 LL 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 24/227 (10%)
Query: 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM 393
+ E+ LE+IG G GEV+K + +++AIK + D E +E +
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKII-----DLEEAEDE--------I 46
Query: 394 RQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWL 453
I+ EI + Q + + ++ E++ GS D+L ++ +
Sbjct: 47 EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATM 106
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
+ + GL+YLH + + IHRD+K ANVLL + + ++ADFG+A + D Q I
Sbjct: 107 LKEILK-----GLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
+ GT ++APE Q + K DI+S G+ L G P+ D
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +G G G V K + G+++AIKK K++ E+D + +R E+
Sbjct: 6 LGVVGEGAYGVVLKCRNKAT-GEIVAIKKF----KES----EDDEDVKKTALR----EVK 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q+RH N++ L R LV+E+++ + +L + L A
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIWQ 108
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ + Y H SHN IIHRD+KP N+L+ + ++ DFG A+A+ T VA T
Sbjct: 109 LLQAIAYCH-SHN--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-T 164
Query: 522 VGYIAPEYHQTLKFTDK-----CDIYSFGVLLAVLVMGR 555
Y APE L D D+++ G ++A L+ G
Sbjct: 165 RWYRAPE----LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G VY G+ +A+K+V + DS K++ + EI +
Sbjct: 10 LGQGAFGRVYLC-YDVDTGRELAVKQV---------PFDPDSPETKKEVNALECEIQLLK 59
Query: 405 QIRHRNLLPLLAHMARPDCHLLVY-EFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
++H ++ + R D L ++ E+M GS++D L + + R K +
Sbjct: 60 NLQHERIVQYYGCL-RDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTR-KYTRQIL 114
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-TSNVAGTV 522
G+EYLH + I+HRD+K AN+L D ++ DFG +K + + T +V GT
Sbjct: 115 EGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
+++PE + K D++S G + ++ + P +F
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 50/233 (21%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L + +IGSG G VYK + G++ A+K + +D RQI
Sbjct: 76 LERVNRIGSGAGGTVYKV-IHRPTGRLYALKVIYGNHEDTVR-------------RQICR 121
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCH---------LLVYEFMKNGSLQDILNDVSQGRRE 449
EI + + H N++ CH ++ EFM GSL+ G
Sbjct: 122 EIEILRDVNHPNVV---------KCHDMFDHNGEIQVLLEFMDGGSLE--------GTHI 164
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA 509
D +A + G+ YLH H I+HRD+KP+N+L++ +IADFG+++ + A
Sbjct: 165 ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL--A 219
Query: 510 QTHITTSNVAGTVGYIAPEYHQT---LKFTDKC--DIYSFGVLLAVLVMGRLP 557
QT ++ GT+ Y++PE T D DI+S GV + +GR P
Sbjct: 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 28/224 (12%)
Query: 341 SLEK-IGSGGCGEVY--KAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+EK IG+G GEV + +LPG +AIK + A TE K+ R
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL------KAGYTE-------KQRRDFL 53
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL--NDVSQGRRELDWLAR 455
SE + +GQ H N++ L + + ++V E+M+NGSL L +D +L + R
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP-DAQTHIT 514
G+A G++YL + +HRDL N+L++ ++ +++DFGL++ + D + T
Sbjct: 114 -----GIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
T + + APE KFT D++S+G+++ V+ G P
Sbjct: 166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 44/226 (19%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IGSG G V A + G+ +AIKK+ D D+K R +R EI +
Sbjct: 8 IGSGAYGVVCSA-VDKRTGRKVAIKKISNVFDD-----LIDAK------RILR-EIKLLR 54
Query: 405 QIRHRN---LLPLLAHMARPDCH--LLVYEFMKNGSLQDILNDVSQGRRELDWLARHK-I 458
+RH N LL +L + D + +V E M + L+ V + + L +
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYF 108
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM--PDAQTHITTS 516
+ GL+YLH ++ +IHRDLKP+N+L++ + + +I DFGLA+ + + + T
Sbjct: 109 LYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 517 NVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
V T Y APE Y + + DI+S G + A L+ +
Sbjct: 166 YVV-TRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 70/229 (30%), Positives = 114/229 (49%), Gaps = 35/229 (15%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L L+++GSG G V+ + G +AIK + ++ A ++E+D
Sbjct: 6 LTFLKELGSGQFGVVHLGKWRGK--IDVAIKMI----REGA-MSEDD----------FIE 48
Query: 399 EINTVGQIRHRNLLPL--LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
E + ++ H NL+ L + RP +V E+M NG L + L + +G+ +WL
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIF--IVTEYMANGCLLNYLRE-RKGKLGTEWLL-- 103
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
+ V +EYL S+ IHRDL N L+ +D +++DFGLA+ + D Q TS
Sbjct: 104 DMCSDVCEAMEYLE-SNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTS 157
Query: 517 NVAGT---VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDF 561
+ GT V + PE +F+ K D++SFGVL+ V G++P + F
Sbjct: 158 SQ-GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 68/238 (28%), Positives = 110/238 (46%), Gaps = 29/238 (12%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+V AEL G++ ++ A+K + KD ++ + +K ++ +
Sbjct: 3 LGKGSFGKVLLAELKGTD-ELYAVKVL---KKDVILQDDDVECTMTEK--RVLALAG--- 53
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
+H L L + D V E++ G D++ + + R + AR A +
Sbjct: 54 --KHPFLTQLHSCFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARF-YAAEIVL 107
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAGTVG 523
GL++LH II+RDLK NVLLD + +IADFG+ K + TTS GT
Sbjct: 108 GLQFLH-ERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCGTPD 161
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP-----SDDFFQHTEEMSLV--KWM 574
YIAPE + D ++ GVLL ++ G+ P D+ FQ E + +W+
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 35/295 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
++IG+G G+V E + M + V++ + +A E+ L E+
Sbjct: 1 DEIGNGWFGKVLLGEA---HRGMSKARVVVKELRASATPDEQLLFL---------QEVQP 48
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRREL-DWLARHKIALG 461
++ H N+L L +LLV EF G L++ L ++ ++A
Sbjct: 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE 108
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
VA GL +LH + IH DL N L D+ +I D+GLA +IT A
Sbjct: 109 VASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP 165
Query: 522 VGYIAPE----YHQTL---KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
+ ++APE Q L T K +I+S GV + + + ++E L + +
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM--WELFTAADQPYPDLSDEQVLKQVV 223
Query: 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629
R + P +D K + YE FC +D P RP +++V +L+
Sbjct: 224 REQDI-KLPKPQLDLKYSDRWYEVMQ--------FCWLD-PETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 24/241 (9%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ-IRSEINT 402
KIG G VYKA +G+++A+KKV ++ E +++ K RQ EI+
Sbjct: 9 KIGKGQFSVVYKAICL-LDGRVVALKKV--------QIFE----MMDAKARQDCLKEIDL 55
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ Q+ H N++ LA + +V E G L ++ + +R + K + +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
LE++H S RI+HRD+KPANV + ++ D GL + ++T S V GT
Sbjct: 116 CSALEHMH-SK--RIMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTP 170
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN 582
Y++PE + K DI+S G LL + + P F+ ++M+L + + +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYG--DKMNLYSLCKKIEKCDY 225
Query: 583 P 583
P
Sbjct: 226 P 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 5e-16
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 43/225 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS--E 399
++++G G G VY A G+++AIKK+ + E +R+++S +
Sbjct: 4 IKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECM---------NLREVKSLRK 53
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+N H N++ L + R + L V+E+M G+L ++ D R+ + I
Sbjct: 54 LN-----EHPNIVKLK-EVFRENDELYFVFEYM-EGNLYQLMKD-----RKGKPFSESVI 101
Query: 459 A---LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK---AMPDAQTH 512
+ GL ++H H HRDLKP N+L+ +IADFGLA+ + P +
Sbjct: 102 RSIIYQILQGLAHIH-KHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158
Query: 513 ITTSNVAGTVGYIAPE--YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
++T Y APE T ++ DI++ G ++A L R
Sbjct: 159 VSTR------WYRAPEILLRST-SYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 53/222 (23%), Positives = 106/222 (47%), Gaps = 27/222 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+++G+G Y+A + G ++A+K+V ++E + + +R EI
Sbjct: 6 QQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQ--------EEVVEALRKEIRL 56
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVY-EFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H +++ +L D H ++ E+M GS+ +L+ + + ++ G
Sbjct: 57 MARLNHPHIIRMLG-ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRG 115
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDD-MEARIADFGLAKAMPDAQTHITTSN--- 517
++ YLH +IIHRD+K AN+L+D RIADFG A + T +
Sbjct: 116 LS----YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQ 165
Query: 518 --VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ GT+ ++APE + ++ CD++S G ++ + + P
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 71/231 (30%), Positives = 105/231 (45%), Gaps = 39/231 (16%)
Query: 345 IGSGGCGEVYKAELPGSNG--KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+G G G+V+ AEL G+N + A+KK + D E T + ++L+
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH------- 55
Query: 403 VGQIRHRNLLPLLAHM----ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
P L H+ + V E++ G L + Q + D
Sbjct: 56 ----------PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFY 101
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MPDAQTHITTS 516
A + CGL++LH + I++RDLK N+LLD D +IADFG+ K + DA+ T
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----TC 154
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT YIAPE K+ D +SFGVLL +++G+ P F H EE
Sbjct: 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP---FHGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+E IG G G+VYKA G+++AIK I + EE I+ E N
Sbjct: 11 VEVIGEGTYGKVYKARHK-KTGQLVAIK--IMDII--EDEEEE-----------IKEEYN 54
Query: 402 TVGQI-RHRNLLP------LLAHMARPDCHLLVYEFMKNGSLQDILNDV-SQGRR-ELDW 452
+ + H N+ D LV E GS+ D++ + +G+R + +W
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 453 LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
+A I GL YLH + +IHRD+K N+LL + E ++ DFG++ A D+
Sbjct: 115 IAY--ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS-AQLDSTLG 168
Query: 513 ITTSNVAGTVGYIAPE-----YHQTLKFTDKCDIYSFGV 546
+ + GT ++APE + + D++S G+
Sbjct: 169 RRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-15
Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 69 NNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILN 128
NN VL ++ LTG + + L +L L +NSL +P + C+ L +
Sbjct: 356 NNLTVLDLST-----NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410
Query: 129 VQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKY-FPNLEHLSLAKNLFTGKVPT 187
+Q+N FSG +PS+ + L + LD+S N+ G + K+ P+L+ LSLA+N F G +P
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470
Query: 188 SIRTFRNLQFFDFSGNSLLEGPIP 211
S + + L+ D S N G +P
Sbjct: 471 SFGS-KRLENLDLSRN-QFSGAVP 492
|
Length = 968 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 79/254 (31%), Positives = 117/254 (46%), Gaps = 51/254 (20%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG GG GEVY GKM A+K + D K + KM+Q G
Sbjct: 2 IGRGGFGEVYGCR-KADTGKMYAMKCL-------------DKKRI--KMKQ--------G 37
Query: 405 QIRHRNLLPLLAHMARPDCHLLV---YEFMKNGSLQDILNDVSQGRRELDW-LARHKI-- 458
+ N +L+ ++ DC +V Y F L IL+ ++ G +L + L++H +
Sbjct: 38 ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFS 95
Query: 459 -------ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
A + GLE++H N +++RDLKPAN+LLD+ RI+D GLA +
Sbjct: 96 EAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152
Query: 512 HITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH-TEEMS 569
H + GT GY+APE Q + + D +S G +L L+ G P F QH T++
Sbjct: 153 HASV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKH 205
Query: 570 LVKWMRNVMTSENP 583
+ M M E P
Sbjct: 206 EIDRMTLTMAVELP 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 71/224 (31%), Positives = 108/224 (48%), Gaps = 32/224 (14%)
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419
GS GK+ ++K+ DA +L K+L K ++R + T + R++L A +
Sbjct: 7 GSFGKVFLVRKIT--GPDAGQLYA--MKVLKKATLKVRDRVRTKME---RDIL---AEVN 56
Query: 420 RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH--------KIALG-VACGLEYLH 470
P L Y F G L IL D +G L++ K L +A L++LH
Sbjct: 57 HPFIVKLHYAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 471 ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH 530
+ II+RDLKP N+LLD++ ++ DFGL+K D + + GTV Y+APE
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVV 170
Query: 531 QTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ---HTEEMSLV 571
T D +SFGVL+ ++ G LP FQ E M+++
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+EKIG G G VYKA G+++A+KK+ L E + + +R EI+
Sbjct: 5 VEKIGEGTYGVVYKAR-NKLTGEVVALKKI--------RLDTETEGVPSTAIR----EIS 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H N++ LL + + LV+EF+ + L+ ++ L + + L
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL- 109
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
GL + H SH R++HRDLKP N+L++ + ++ADFGLA+A T V T
Sbjct: 110 -LQGLAFCH-SH--RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--T 163
Query: 522 VGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGR--LPSD 559
+ Y APE K+ + DI+S G + A +V R P D
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
EKIG G G VY A + + G+ +AIK++ L ++ K L I +EI
Sbjct: 24 FEKIGQGASGTVYTA-IDVATGQEVAIKQM--------NLQQQPKKEL------IINEIL 68
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + +H N++ L D +V E++ GSL D++ + ++ + R
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE----- 123
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
LE+LH + +IHRD+K N+LL D ++ DFG + Q+ +T + GT
Sbjct: 124 CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
++APE + K DI+S G++ +V G P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 52 SDPCSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLV 111
+D C G+ C NN+ ++ + + ++G +S +I RL ++ ++L+NN L
Sbjct: 55 ADVCLWQGITC------NNSS--RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106
Query: 112 DLLPPQIVD-CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFP 169
+P I L LN+ NN F+G+IP S+ L LDLS N SG + + F
Sbjct: 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFS 164
Query: 170 NLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212
+L+ L L N+ GK+P S+ +L+F + N L+ G IP
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLV-GQIPR 206
|
Length = 968 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 53/229 (23%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
L + +G G G+V +N G+M+A+K L E + ++
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKT----------LKRECGQQNTSGWKK 55
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCH-------LLVYEFMKNGSLQDILNDVSQGRR 448
EIN + + H N++ + C L+ E++ GSL
Sbjct: 56 ---EINILKTLYHENIVKY-----KGCCSEQGGKGLQLIMEYVPLGSL------------ 95
Query: 449 ELDWLARHKIALG--------VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500
D+L +HK+ L + G+ YLH H IHRDL NVLLD+D +I DF
Sbjct: 96 -RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDF 151
Query: 501 GLAKAMPDAQTHITTS-NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
GLAKA+P+ + + V + A E + KF+ D++SFGV L
Sbjct: 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+K+G+G GEV+ A N K ++P + E ++ ++
Sbjct: 12 KKLGAGQFGEVWMATY---NKHTKVAVKTMKPGSMSVEAFLAEANVMK------------ 56
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
++H L+ L A + + +++ EFM GSL D L ++ L L + +
Sbjct: 57 --TLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQI 111
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
A G+ ++ IHRDL+ AN+L+ + +IADFGLA+ + D + + +
Sbjct: 112 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPI 167
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLA-VLVMGRLP 557
+ APE FT K D++SFG+LL ++ GR+P
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+++G G G V K +GK + A+K T + + K ++ E
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVK------------TLKQEHIAAGK-KEFLREA 47
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ + Q+ H ++ L+ + + + +LV E G L L + RRE+ ++A
Sbjct: 48 SVMAQLDHPCIVRLIG-VCKGEPLMLVMELAPLGPLLKYL----KKRREIPVSDLKELAH 102
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM-PDAQTHITTSNVA 519
VA G+ YL H +HRDL NVLL + +A+I+DFG+++A+ + + T+
Sbjct: 103 QVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGR 159
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + APE KF+ K D++S+GV L
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 78/254 (30%), Positives = 116/254 (45%), Gaps = 51/254 (20%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG GG GEVY GKM A+K + D K + KM+Q G
Sbjct: 2 IGRGGFGEVYGCR-KADTGKMYAMKCL-------------DKKRI--KMKQ--------G 37
Query: 405 QIRHRNLLPLLAHMARPDCHLLV---YEFMKNGSLQDILNDVSQGRRELDW-LARHKI-- 458
+ N +L+ ++ DC +V Y F L IL+ ++ G +L + L++H +
Sbjct: 38 ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFS 95
Query: 459 -------ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
A + GLE++H N +++RDLKPAN+LLD+ RI+D GLA +
Sbjct: 96 EKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152
Query: 512 HITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH-TEEMS 569
H + GT GY+APE Q + D +S G +L L+ G P F QH T++
Sbjct: 153 HASV----GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP---FRQHKTKDKH 205
Query: 570 LVKWMRNVMTSENP 583
+ M + E P
Sbjct: 206 EIDRMTLTVNVELP 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +IG G G VYKA G+ +A+KKV P L+EE + +R EI
Sbjct: 4 LAEIGEGAYGTVYKARDLN-TGRFVALKKVRVP------LSEE-----GIPLSTLR-EIA 50
Query: 402 TVGQIR---HRNLLPLLAHMARPDCH-----LLVYEFMKNGSLQDILNDVSQ---GRREL 450
+ Q+ H N++ LL P LV+E + L L+ + +
Sbjct: 51 LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETI 109
Query: 451 DWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ 510
L R + G+++LH SH RI+HRDLKP N+L+ D + +IADFGLA+ +
Sbjct: 110 KDLMRQLLR-----GVDFLH-SH--RIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFE 160
Query: 511 THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVL 551
+T+ V T+ Y APE + D++S G + A L
Sbjct: 161 MALTS--VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 38/238 (15%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKV--IQPPKDAAELTEEDSKLLNKKMRQIR----S 398
+G G G+V KA GK++AIKKV I+ D + + M I
Sbjct: 17 LGEGTYGKVEKAY-DTLTGKIVAIKKVKIIEISNDVTKDRQ------LVGMCGIHFTTLR 69
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E+ + +I+H N++ L+ D LV + M L+ +++ + L I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR----KIRLTESQVKCI 124
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA-------------KA 505
L + GL LH + +HRDL PAN+ ++ +IADFGLA K
Sbjct: 125 LLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 506 MPDAQTHITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR--LPSDD 560
+ TS V T+ Y APE K+ D++S G + A L+ G+ P ++
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 47/129 (36%), Positives = 73/129 (56%), Gaps = 10/129 (7%)
Query: 429 EFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488
E M GSL +L GR + L KI++ V GL YL H +I+HRD+KP+N+L
Sbjct: 79 EHMDGGSLDQVLKKA--GRIPENILG--KISIAVLRGLTYLREKH--KIMHRDVKPSNIL 132
Query: 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
++ E ++ DFG++ + D+ + S V GT Y++PE Q +T + DI+S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDS---MANSFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 549 AVLVMGRLP 557
+ +GR P
Sbjct: 189 VEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 54/130 (41%), Positives = 74/130 (56%), Gaps = 8/130 (6%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L+G + PSI L +L L L++NSL +P ++ + LEIL++ +N F+G IP L+SL
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 146 IRLRVLDLSGNSFSG----NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201
RL+VL L N FSG NLG NL L L+ N TG++P + + NL
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHN---NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILF 388
Query: 202 GNSLLEGPIP 211
NS LEG IP
Sbjct: 389 SNS-LEGEIP 397
|
Length = 968 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 74/305 (24%), Positives = 133/305 (43%), Gaps = 52/305 (17%)
Query: 342 LEKIGSGGCGEVYKAEL--PG-SNGKMIAIK--KVIQPPKDAAELTEEDSKLLNKKMRQI 396
+E++G G++YK L PG + +++AIK K I P+ E +E S +
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLM-------- 61
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------NDVSQGRRE- 449
++ H N++ LL + + +++E++ G L + L +DV E
Sbjct: 62 -------AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 450 ------LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA 503
LD IA+ +A G+EYL SH +H+DL N+L+ + + +I+D GL+
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLS-SH--FFVHKDLAARNILIGEQLHVKISDLGLS 171
Query: 504 KAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563
+ + A + + ++ PE KF+ DI+SFGV+L + L F
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231
Query: 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
+ E + +V+ + + SE+ + + + E C + P RP KD
Sbjct: 232 NQEVIEMVRKRQLLPCSEDCPPRMYSLMTE----------------CWQEGPSRRPRFKD 275
Query: 624 VRCML 628
+ L
Sbjct: 276 IHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 37/232 (15%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
D + L+++G G G VYK L G +A+K++ L ++SK QI
Sbjct: 1 DEIEVLDELGKGNYGSVYKV-LHRPTGVTMAMKEI--------RLELDESKF-----NQI 46
Query: 397 RSEINTVGQIRHRNLLPLLAHM----ARPDCHLLVYEFMKNGSLQDILND-VSQGRRELD 451
E++ I H+ + P + + E+M GSL + V+ D
Sbjct: 47 IMELD----ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPED 102
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
L R I V GL++L HN IIHRD+KP NVL++ + + ++ DFG++ +
Sbjct: 103 VLRR--ITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VA 155
Query: 512 HITTSNVAGTVGYIAPEY------HQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ +N+ G Y+APE +Q +T + D++S G+ + + +GR P
Sbjct: 156 SLAKTNI-GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 42/225 (18%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+EKIG G G VYKA G+++A+KK+ L ED + + +R EI+
Sbjct: 4 VEKIGEGTYGVVYKA-RDKLTGEIVALKKI--------RLETEDEGVPSTAIR----EIS 50
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR--HKIA 459
+ ++ H N++ LL + + LV+EF+ + L+ ++ + + +++
Sbjct: 51 LLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MP-DAQTHITTS 516
G+A Y H SH R++HRDLKP N+L+D + ++ADFGLA+A +P TH
Sbjct: 110 QGIA----YCH-SH--RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV- 161
Query: 517 NVAGTVGYIAPE------YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
T+ Y APE + T DI+S G + A +V R
Sbjct: 162 ----TLWYRAPEILLGSRQYST-----PVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 329 DLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSK 387
DL+ ++ +++IGSG G+VYKA + G++ AIK + ++P +D A
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKAR-NVNTGELAAIKVIKLEPGEDFA-------- 51
Query: 388 LLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR 447
++ EI + +H N++ R D + EF GSLQDI +
Sbjct: 52 -------VVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP-- 102
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
L+ +IA L+ L+ H+ +HRD+K AN+LL D+ ++ADFG++ +
Sbjct: 103 -----LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI- 156
Query: 508 DAQTHITTSNVAGTVGYIAPEYHQTLK---FTDKCDIYSFGV 546
T + GT ++APE + + CDI++ G+
Sbjct: 157 -TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 37/232 (15%)
Query: 344 KIGSGGCGEVYKAE----LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
++G G G+V+ AE LP + ++A+K + K+A+E +D Q +E
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL----KEASESARQDF--------QREAE 59
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL-------------NDVSQG 446
+ TV ++H++++ L+V+E+M++G L L DV+ G
Sbjct: 60 LLTV--LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG 117
Query: 447 RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM 506
+ L + IA +A G+ YL H +HRDL N L+ + +I DFG+++ +
Sbjct: 118 QLTLGQML--AIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172
Query: 507 PDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + ++ PE KFT + DI+SFGV+L + G+ P
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 80/308 (25%), Positives = 136/308 (44%), Gaps = 47/308 (15%)
Query: 323 LIKKAEDLAFLEKEDG---LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAA 379
++K E K+D L +IG G G VY A +N +++A+KK+
Sbjct: 4 VVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTN-EVVAVKKM-------- 54
Query: 380 ELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDI 439
K N+K + I E+ + Q++H N + + LV E+ GS D+
Sbjct: 55 ---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDL 110
Query: 440 LNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIAD 499
L + +E++ A I G GL YLH SHN +IHRD+K N+LL + + ++AD
Sbjct: 111 LEVHKKPLQEVEIAA---ITHGALQGLAYLH-SHN--MIHRDIKAGNILLTEPGQVKLAD 164
Query: 500 FGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL---KFTDKCDIYSFGVLLAVLVMGRL 556
FG A A + + GT ++APE + ++ K D++S G+ L +
Sbjct: 165 FGSASKSSPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218
Query: 557 PSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPR 616
P F M+ + + ++ +++PT L N + + +C P+
Sbjct: 219 P---LFN----MNAMSALYHIAQNDSPT------LQSNEWTDSF---RGFVDYCLQKIPQ 262
Query: 617 ERPNSKDV 624
ERP S ++
Sbjct: 263 ERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-14
Identities = 49/134 (36%), Positives = 69/134 (51%), Gaps = 2/134 (1%)
Query: 79 LVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTI 138
L V LTG + S+G L L+ L L N L +PP I +KL L++ +N SG I
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 139 PSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQF 197
P + L L +L L N+F+G + L P L+ L L N F+G++P ++ NL
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360
Query: 198 FDFSGNSLLEGPIP 211
D S N+ L G IP
Sbjct: 361 LDLSTNN-LTGEIP 373
|
Length = 968 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 29/226 (12%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L L+++G+G G V + G +AIK + + E EE ++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMK-------- 55
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ H L+ L + +V E+M NG L LN + + + ++
Sbjct: 56 -------LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL---LNYLREHGKRFQPSQLLEM 105
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
V G+ YL S + IHRDL N L+DD +++DFGL++ + D + TS+V
Sbjct: 106 CKDVCEGMAYLE-SK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSV 159
Query: 519 AGT--VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDF 561
V + PE KF+ K D+++FGVL+ V +G++P + F
Sbjct: 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 25/225 (11%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
L +++IGSG G V+ + +AIK + + ++EED
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYW--LEKRKVAIKTIRE-----GAMSEEDFI--------- 47
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
E + ++ H L+ L LV+EFM++G L D L +Q R +
Sbjct: 48 -EEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR--AQ-RGKFSQETLL 103
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
+ L V G+ YL S+ +IHRDL N L+ ++ +++DFG+ + + D Q + +++
Sbjct: 104 GMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSST 159
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDD 560
V + +PE K++ K D++SFGVL+ V G+ P ++
Sbjct: 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK 391
+E L ++++G G G V L + G+++A+KK +Q +
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKK-LQHSTA-------------E 47
Query: 392 KMRQIRSEINTVGQIRHRNLLP---LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRR 448
+R EI + ++H N++ + R + L V E++ GSL+D L + R
Sbjct: 48 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL-VMEYLPYGSLRDYL---QKHRE 103
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP- 507
LD A + G+EYL R +HRDL N+L++ + +I DFGL K +P
Sbjct: 104 RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160
Query: 508 DAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
D + + + + APE KF+ D++SFGV+L
Sbjct: 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 72/248 (29%), Positives = 113/248 (45%), Gaps = 39/248 (15%)
Query: 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM 393
E D L+++GSG G V A L G +AIKK+ +P + S+L K+
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQ---------SELFAKRA 61
Query: 394 RQIRSEINTVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQG 446
+ E+ + ++H N++ LL + PD L LV FM L ++
Sbjct: 62 YR---ELRLLKHMKHENVIGLL-DVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLS 116
Query: 447 RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM 506
+ +L + GL+Y+H + IIHRDLKP N+ +++D E +I DFGLA+
Sbjct: 117 EDRIQFLVYQMLK-----GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-- 166
Query: 507 PDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRL---PSDDFF 562
QT + T Y APE + +T DI+S G ++A ++ G+ D
Sbjct: 167 ---QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223
Query: 563 QHTEEMSL 570
Q E M +
Sbjct: 224 QLMEIMKV 231
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
EKIG G G VY A + + G+ +AIK++ L ++ K L I +EI
Sbjct: 24 FEKIGQGASGTVYTA-IDIATGQEVAIKQM--------NLQQQPKKEL------IINEIL 68
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + ++ N++ L D +V E++ GSL D++ + ++ + R
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE----- 123
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
C L+ L H+ ++IHRD+K N+LL D ++ DFG + Q+ +T + GT
Sbjct: 124 --C-LQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
++APE + K DI+S G++ +V G P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 23/217 (10%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+V +AE G I + Q A ++ ++++ +K + + SE+ +
Sbjct: 20 LGEGCFGQVVRAEAYG-----IDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMK 72
Query: 405 QI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILN-----------DVSQGRRE-LD 451
I +H+N++ LL + ++ E+ G+L++ L D+++ E L
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
+ A VA G+EYL + R IHRDL NVL+ +D +IADFGLA+ + D
Sbjct: 133 FKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY 189
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ TSN V ++APE +T + D++SFG+L+
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILM 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-14
Identities = 47/127 (37%), Positives = 65/127 (51%), Gaps = 2/127 (1%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L+G + IG L+ L L L N+L +P + + K L+ L + N+ SG IP + SL
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 146 IRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
+L LDLS NS SG + + NLE L L N FTGK+P ++ + LQ N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 205 LLEGPIP 211
G IP
Sbjct: 344 -FSGEIP 349
|
Length = 968 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 48/153 (31%), Positives = 66/153 (43%), Gaps = 35/153 (22%)
Query: 424 HL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482
HL LV E+M G L ++L + + AR IA V L H IHRD+
Sbjct: 75 HLYLVMEYMPGGDLMNLLIR--KDVFPEET-ARFYIAELVLA----LDSVHKLGFIHRDI 127
Query: 483 KPANVLLDDDMEARIADFGLAKAMPDA---------------------------QTHITT 515
KP N+L+D D ++ADFGL K M A Q +
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
++ GT YIAPE + + +CD +S GV+L
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 39/231 (16%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIK-----KVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+G G G+V AEL G++ ++ AIK ++Q +TE+ L K
Sbjct: 3 LGKGSFGKVMLAELKGTD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK------- 54
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
H L L D V E++ G D++ + + R+ + +R A
Sbjct: 55 --------HPFLTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRF-YA 102
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MPDAQTHITTSN 517
V L +LH H +I+RDLK N+LLD + ++ADFG+ K + +TT+
Sbjct: 103 AEVTLALMFLH-RHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTT 155
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP-----SDDFFQ 563
GT YIAPE Q L++ D ++ GVL+ ++ G+ P DD F+
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 62/220 (28%), Positives = 113/220 (51%), Gaps = 31/220 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+EKIG G G VYK G+++A+KK+ L E+ + + +R EI+
Sbjct: 5 IEKIGEGTYGVVYKGR-NKKTGQIVAMKKI--------RLESEEEGVPSTAIR----EIS 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR---RELDWLARHKI 458
+ +++H N++ L + + L++EF+ + L+ L+ + +G+ EL ++I
Sbjct: 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQI 110
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MPDAQTHITTS 516
G+ H+ R++HRDLKP N+L+D+ ++ADFGLA+A +P + T
Sbjct: 111 LQGIL-------FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VRVYTH 160
Query: 517 NVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
V T+ Y APE + +++ DI+S G + A + +
Sbjct: 161 EVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 66/279 (23%), Positives = 121/279 (43%), Gaps = 33/279 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ-IRSEIN 401
+KIG G EVY+A K +A+KKV + ++++ K RQ EI+
Sbjct: 8 KKIGRGQFSEVYRATCLLDR-KPVALKKV------------QIFEMMDAKARQDCVKEID 54
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q+ H N++ L + +V E G L ++ + +R + K +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ +E++H + R++HRD+KPANV + ++ D GL + T ++ GT
Sbjct: 115 LCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGT 169
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
Y++PE + K DI+S G LL + + P + ++M+L + + +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLFSLCQKIEQCD 224
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620
P L Y E++ ++ C P +RP+
Sbjct: 225 YP------PLPTEHYSEKL---RELVSMCIYPDPDQRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 345 IGSGGCGEVYKAE----LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
IG G G V++A LP M+A+K L EE S + ++ E
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM----------LKEEASADMQADFQR---EA 59
Query: 401 NTVGQIRHRNLLPLLAHMA--RPDCHLLVYEFMKNGSLQDILNDVS-------------- 444
+ + H N++ LL A +P C L++E+M G L + L S
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 445 ----QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500
L + IA VA G+ YL +HRDL N L+ ++M +IADF
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 174
Query: 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
GL++ + A + + N A + ++ PE ++T + D++++GV+L
Sbjct: 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+V AE + G++ AIK + + D E +S + K++ T
Sbjct: 7 LGRGHFGKVLLAEYKKT-GELYAIKALKK--GDIIARDEVESLMCEKRI------FETAN 57
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQ-DILNDVSQGRRELDWLARHKIALGVA 463
RH L+ L A D V E+ G L I DV R + + A V
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC------VV 111
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAGTV 522
GL+YLH + I++RDLK N+LLD + +IADFGL K M TS GT
Sbjct: 112 LGLQYLH-ENK--IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTP 165
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR--LPSDD 560
++APE +T D + GVL+ +++G P DD
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L KIG G G V+K G+++AIKK ++ +E+D + +R+IR
Sbjct: 6 LSKIGEGSYGVVFKCR-NRETGQIVAIKKFVE--------SEDDPVIKKIALREIR---- 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q++H NL+ L+ R LV+E+ + +LN++ + R + KI
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM--PDAQTHITTSNVA 519
+ + H HN IHRD+KP N+L+ + ++ DFG A+ + P T VA
Sbjct: 109 TLQAVNFCH-KHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVA 162
Query: 520 GTVGYIAPEYH-QTLKFTDKCDIYSFGVLLAVLVMG 554
T Y APE ++ D+++ G + A L+ G
Sbjct: 163 -TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 69/238 (28%), Positives = 114/238 (47%), Gaps = 63/238 (26%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV---IQPPKDAAELTEEDSKLLNKKMRQIRS 398
L+K+G G G V+KA + +++A+KK+ + DA R R
Sbjct: 12 LQKLGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDA--------------QRTFR- 55
Query: 399 EINTVGQIR-HRNLLPLLA-HMARPDCHL-LVYEFM--------KNGSLQDILNDVSQGR 447
EI + ++ H N++ LL A D + LV+E+M + L+D+
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDV-------- 107
Query: 448 RELDWLARHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
HK I + L+Y+H S N +IHRDLKP+N+LL+ D ++ADFGLA++
Sbjct: 108 --------HKRYIMYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARS 156
Query: 506 M----PDAQTHITTSNVAGTVGYIAPEYHQTL----KFTDKCDIYSFGVLLAVLVMGR 555
+ + + + T VA T Y APE L ++T D++S G +L +++G+
Sbjct: 157 LSELEENPENPVLTDYVA-TRWYRAPE---ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 65/232 (28%), Positives = 99/232 (42%), Gaps = 27/232 (11%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIK-KVIQPPKDAAELTEEDSKLLNKKMRQ 395
D + L +G G GEVY+ G +G + ++ V P+ +E E D L
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD--FLM----- 58
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL--NDVSQGR----RE 449
E + + H+N++ L+ ++ E M G L+ L N R
Sbjct: 59 ---EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD---DMEARIADFGLAKAM 506
D L A VA G +YL +H IHRD+ N LL A+IADFG+A+ +
Sbjct: 116 KDLL---FCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169
Query: 507 PDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
A + + ++ PE FT K D++SFGVLL + +G +P
Sbjct: 170 YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 29/219 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
L +IG G G VY+A S G+++A+KKV + +D ++ +R EI
Sbjct: 12 LNRIGEGTYGIVYRARDTTS-GEIVALKKVRMDNERDGIPIS------------SLR-EI 57
Query: 401 NTVGQIRHRNLLPLLAHMA--RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK- 457
+ +RH N++ L + D LV E+ + L +L+++ E ++ K
Sbjct: 58 TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSE----SQVKC 112
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+ L + GL+YLH + IIHRDLK +N+LL D +IADFGLA+ +T
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 518 VAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
V T+ Y APE +T D+++ G +LA L+ +
Sbjct: 170 V--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
EKIG G G V+ A + G+ +AIK++ + EL I +EI
Sbjct: 25 EKIGQGASGTVFTAI-DVATGQEVAIKQINLQKQPKKEL--------------IINEILV 69
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ ++++ N++ L D +V E++ GSL D++ + ++ + R +
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ--- 126
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
LE+LH + ++IHRD+K NVLL D ++ DFG + Q+ +T + GT
Sbjct: 127 --ALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTP 179
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
++APE + K DI+S G++ +V G P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 42/115 (36%), Positives = 64/115 (55%), Gaps = 4/115 (3%)
Query: 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS 157
S LR L+L+NN+ +P + LE L++ NN SG IP+D+ S L+VLDL GN
Sbjct: 118 SSLRYLNLSNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
Query: 158 FSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
G + L +LE L+LA N G++P + ++L++ + G + L G IP
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWI-YLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
EKIG G G VY A + + G+ +AI+++ L ++ K L I +EI
Sbjct: 25 FEKIGQGASGTVYTA-MDVATGQEVAIRQM--------NLQQQPKKEL------IINEIL 69
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + ++ N++ L D +V E++ GSL D++ + ++ + R
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE----- 124
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
C L+ L H+ ++IHRD+K N+LL D ++ DFG + Q+ S + GT
Sbjct: 125 --C-LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGT 179
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
++APE + K DI+S G++ ++ G P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM 393
+ E + L +IG G G VY A ++ +++AIKK+ K + N+K
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQS-----------NEKW 59
Query: 394 RQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWL 453
+ I E+ + ++RH N + R LV E+ GS D+L + +E++
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA 118
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
A + G GL YLH SHN +IHRD+K N+LL + ++ DFG A M A +
Sbjct: 119 A---VTHGALQGLAYLH-SHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV 172
Query: 514 TTSNVAGTVGYIAPEYHQTL---KFTDKCDIYSFGV 546
GT ++APE + ++ K D++S G+
Sbjct: 173 ------GTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 27/222 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPP--KDAAELTEEDSKLLNKKMRQIRSEI 400
E +G G G VY + G++IA+K+V AAE K+ +++ E+
Sbjct: 6 EVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAE----------KEYEKLQEEV 53
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVY-EFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ + ++H N++ L D + ++ EF+ GS+ ILN L K
Sbjct: 54 DLLKSLKHVNIVQYLG-TCLDDNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYT 108
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN-- 517
+ G+ YLH N ++HRD+K NV+L + ++ DFG A+ + H T SN
Sbjct: 109 KQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 518 --VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ GT ++APE + K DI+S G + + G+ P
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 32/230 (13%)
Query: 344 KIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
++G G G+V+ AE L + KM+ K ++ P AA + + E
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-------------KDFQREA 58
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------NDVSQGRR 448
+ ++H +++ D ++V+E+MK+G L L Q +
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
EL IA +A G+ YL H +HRDL N L+ ++ +I DFG+++ +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + + ++ PE KFT + D++SFGV+L + G+ P
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 43/237 (18%)
Query: 341 SLEKI-GSGGCGEVYKAELP---GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
L KI G G G V + +L GS K +A+K + KL +I
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLK-VAVKTM---------------KLDIHTYSEI 45
Query: 397 R---SEINTVGQIRHRNLLPLL------AHMARPDCHLLVYEFMKNGSLQDIL--NDVSQ 445
SE + H N++ L+ + + + +++ FMK+G L L + +
Sbjct: 46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG 105
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
+L K + +A G+EYL N IHRDL N +L +DM +ADFGL+K
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
Query: 506 MPDA----QTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ Q I V +IA E +T K D+++FGV + + G+ P
Sbjct: 163 IYSGDYYRQGRIAKM----PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 63/238 (26%), Positives = 100/238 (42%), Gaps = 52/238 (21%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ L +L +IGSG CG+VYK + G ++A+ K+MR+
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKT-GHVMAV----------------------KQMRRT 51
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVY---EFMKN----------GSLQDILNDV 443
++ R L+ L + DC +V F+ + + D L
Sbjct: 52 GNKEE-----NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKR 106
Query: 444 SQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA 503
QG D L K+ + + L YL H +IHRD+KP+N+LLD ++ DFG++
Sbjct: 107 IQGPIPEDILG--KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS 162
Query: 504 KAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDI----YSFGVLLAVLVMGRLP 557
+ D++ + AG Y+APE K DI +S G+ L L G+ P
Sbjct: 163 GRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 43/133 (32%), Positives = 69/133 (51%), Gaps = 8/133 (6%)
Query: 426 LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485
+V EFM+NG L + L QG+ D L + V G+EYL + IHRDL
Sbjct: 76 IVTEFMENGCLLNYLRQ-RQGKLSKDMLL--SMCQDVCEGMEYLERNS---FIHRDLAAR 129
Query: 486 NVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFG 545
N L+ +++DFG+ + + D + + ++S V + PE K++ K D++SFG
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG 188
Query: 546 VLL-AVLVMGRLP 557
VL+ V G++P
Sbjct: 189 VLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 67/279 (24%), Positives = 121/279 (43%), Gaps = 33/279 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ-IRSEIN 401
+KIG G EVY+A +G +A+KKV + L++ K R EI+
Sbjct: 8 KKIGRGQFSEVYRATCL-LDGVPVALKKV------------QIFDLMDAKARADCIKEID 54
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q+ H N++ A + +V E G L ++ + +R + K +
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ LE++H + R++HRD+KPANV + ++ D GL + T ++ GT
Sbjct: 115 LCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGT 169
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
Y++PE + K DI+S G LL + + P + ++M+L + + +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIEQCD 224
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620
P L + Y E++ ++ C P +RP+
Sbjct: 225 YP------PLPSDHYSEEL---RQLVNMCINPDPEKRPD 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 344 KIGSGGCGEVYKAE-LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
IG G G VYKA+ G +GK AIKK + ++ R EI
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS----------QSACR-EIAL 55
Query: 403 VGQIRHRNLLPL----LAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-GRRELDWLARHK 457
+ +++H N++ L L H + L++++ ++ Q I+ Q R +
Sbjct: 56 LRELKHENVVSLVEVFLEHADK--SVYLLFDYAEHDLWQ-IIKFHRQAKRVSIPPSMVKS 112
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR----IADFGLAKAMPDAQTHI 513
+ + G+ YLH + ++HRDLKPAN+L+ + R I D GLA+ +
Sbjct: 113 LLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 514 TTSN-VAGTVGYIAPEY-----HQTLKFTDKCDIYSFGVLLAVLV 552
+ V T+ Y APE H +T DI++ G + A L+
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARH----YTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 44/274 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE-I 400
L+ I G G VY A+ S G AIK + K ++ +K ++ +++E
Sbjct: 1 LKPISKGAFGSVYLAK-KRSTGDYFAIKVL---KK-----SDMIAK---NQVTNVKAERA 48
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ Q + L D LV E++ G ++ + G DW A+ IA
Sbjct: 49 IMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDW-AKQYIA- 104
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
V G+E LH IIHRD+KP N+L+D ++ DFGL++ + G
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVG 155
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP-----SDDFFQHTEEMSLVKWMR 575
T Y+APE + D +S G ++ + G P D F + + W
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-RRINWPE 214
Query: 576 NVMTSENPTRAID--AKLL---------ENGYEE 598
V +P A+D +LL NGY+E
Sbjct: 215 EVKEFCSP-EAVDLINRLLCMDPAKRLGANGYQE 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 31/210 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++++GSG G+VYKA G++ A+K + P D L I+ EI
Sbjct: 14 IQRVGSGTYGDVYKAR-NLHTGELAAVKIIKLEPGDDFSL--------------IQQEIF 58
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD--WLARHKIA 459
V + +H N++ + + E+ GSLQDI + V+ EL ++ R +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQ 117
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
GL YLH +HRD+K AN+LL D+ + ++ADFG+A + T +
Sbjct: 118 -----GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFI 167
Query: 520 GTVGYIAPEYHQTLK---FTDKCDIYSFGV 546
GT ++APE K + CDI++ G+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 33/228 (14%)
Query: 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM 393
+ + L S KIG G G V A + GK +A+KK+ + EL L N
Sbjct: 19 DPREYLDSFIKIGEGSTGIVCIATEKHT-GKQVAVKKMDLRKQQRREL------LFN--- 68
Query: 394 RQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWL 453
E+ + H N++ + D +V EF++ G+L DI V+ R + +
Sbjct: 69 -----EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQI 120
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG----LAKAMPDA 509
A + L V L YLH N +IHRD+K ++LL D +++DFG ++K +P
Sbjct: 121 A--TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175
Query: 510 QTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
++ + GT ++APE L + + DI+S G+++ ++ G P
Sbjct: 176 KS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 65/250 (26%), Positives = 115/250 (46%), Gaps = 40/250 (16%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L + KIG G G V A S G+ +A+KK+ + EL L N
Sbjct: 21 LDNFVKIGEGSTGIVCIAT-DKSTGRQVAVKKMDLRKQQRREL------LFN-------- 65
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E+ + +H N++ + + D +V EF++ G+L DI V+ R + +A +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIA--TV 120
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG----LAKAMPDAQTHIT 514
L V L +LH +IHRD+K ++LL D +++DFG ++K +P ++
Sbjct: 121 CLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--- 174
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
+ GT ++APE L + + DI+S G+++ +V G P +F ++ M
Sbjct: 175 ---LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP---YFNE----PPLQAM 224
Query: 575 RNVMTSENPT 584
+ + + P
Sbjct: 225 KRIRDNLPPK 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 67/242 (27%), Positives = 113/242 (46%), Gaps = 36/242 (14%)
Query: 329 DLAFLEKEDGLASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSK 387
DL+ L G+ L E +G+G G+VYK + G++ AIK ++TE++ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKT-GQLAAIK--------VMDVTEDEEE 57
Query: 388 LLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMAR--PDCH----LLVYEFMKNGSLQDIL 440
+I+ EIN + + HRN+ + P H LV EF GS+ D++
Sbjct: 58 -------EIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV 110
Query: 441 NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500
+ + DW+A I + GL +LH +IHRD+K NVLL ++ E ++ DF
Sbjct: 111 KNTKGNALKEDWIAY--ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDF 165
Query: 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEY-----HQTLKFTDKCDIYSFGVLLAVLVMGR 555
G++ + +T + GT ++APE + + + DI+S G+ + G
Sbjct: 166 GVSAQLD--RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223
Query: 556 LP 557
P
Sbjct: 224 PP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-13
Identities = 44/127 (34%), Positives = 67/127 (52%), Gaps = 2/127 (1%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L+G + IG S L+ L L N LV +P + + LE L + +NQ G IP +L +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 146 IRLRVLDLSGNSFSGNLGF-LKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L+ + L N+ SG + + + +L HL L N TG +P+S+ +NLQ+ F +
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYL-FLYQN 270
Query: 205 LLEGPIP 211
L GPIP
Sbjct: 271 KLSGPIP 277
|
Length = 968 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+V A L +G++ A+K + K L ++D + + R + N
Sbjct: 3 LGKGSFGKVMLARLK-ESGRLYAVKVL----KKDVILQDDDVECTMTEKRILSLARN--- 54
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
H L L PD V EF+ G D++ + + RR + AR A +
Sbjct: 55 ---HPFLTQLYCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARF-YAAEITS 107
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGY 524
L +LH + II+RDLK NVLLD + ++ADFG+ K TTS GT Y
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GIFNGKTTSTFCGTPDY 162
Query: 525 IAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP-----SDDFFQ 563
IAPE Q + + D ++ GVLL ++ G P DD F+
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 10/129 (7%)
Query: 429 EFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488
E M GSL +L + + E+ K+++ V GL YL H +I+HRD+KP+N+L
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNIL 136
Query: 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
++ E ++ DFG++ + D+ ++ GT Y++PE Q ++ + DI+S G+ L
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 549 AVLVMGRLP 557
L +GR P
Sbjct: 193 VELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 31/221 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+V AE G I K +P A ++ ++D+ +K + + SE+ +
Sbjct: 20 LGEGCFGQVVMAEAIG-----IDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMK 72
Query: 405 QI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRR--------------- 448
I +H+N++ LL + ++ E+ G+L++ L + RR
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL----RARRPPGMDYSFDTCKLPE 128
Query: 449 -ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
+L + A VA G+EYL + + IHRDL NVL+ +D +IADFGLA+ +
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185
Query: 508 DAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + T+N V ++APE +T + D++SFGVLL
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 75/304 (24%), Positives = 131/304 (43%), Gaps = 56/304 (18%)
Query: 345 IGSGGCGEVYKA---ELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+G G G+V KA L G G K+++ ++EL R + SE N
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL------------RDLLSEFN 55
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------NDVSQGRRE 449
+ Q+ H +++ L ++ LL+ E+ K GSL+ L +D ++
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 450 LDWLARHKIALG--------VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501
LD + +G ++ G++YL +++HRDL NVL+ + + +I+DFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV-MGRLPSDD 560
L++ + + +++ S V ++A E +T + D++SFGVLL +V +G P
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--- 229
Query: 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620
+ L ++ E P EN EE L+L C P +RP
Sbjct: 230 -YPGIAPERLFNLLKTGYRMERP---------ENCSEEMYNLMLT----CWKQEPDKRPT 275
Query: 621 SKDV 624
D+
Sbjct: 276 FADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 68/259 (26%), Positives = 116/259 (44%), Gaps = 40/259 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ IGSG G V A G +A+KK+ +P ++ ++ E+
Sbjct: 26 LKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTH------------AKRAYRELV 72
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ + H+N++ LL ++ P L LV E M Q I ++ R + +L
Sbjct: 73 LLKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER--MSYLL 129
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
+ CG+++LH + IIHRDLKP+N+++ D +I DFGLA+ A T+
Sbjct: 130 YQ-----MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---ACTNFM 178
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
+ T Y APE + + + DI+S G ++ LV G + FQ T+ + +W
Sbjct: 179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV----IFQGTDHID--QWN 232
Query: 575 RNVMTSENPTRAIDAKLLE 593
+ + P+ +L
Sbjct: 233 KVIEQLGTPSAEFMNRLQP 251
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 36/260 (13%)
Query: 329 DLAFLEKEDGLAS-LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSK 387
+L F E + L + L +IG G G VY A +N +++AIKK+ K +
Sbjct: 16 ELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQS--------- 65
Query: 388 LLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR 447
N+K + I E+ + +I+H N + R LV E+ GS D+L +
Sbjct: 66 --NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPL 122
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
+E++ A I G GL YLH SHN +IHRD+K N+LL + + ++ADFG A
Sbjct: 123 QEVEIAA---ITHGALQGLAYLH-SHN--MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176
Query: 508 DAQTHITTSNVAGTVGYIAPEYHQTL---KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564
A + + GT ++APE + ++ K D++S G+ L + P F
Sbjct: 177 PANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFN- 226
Query: 565 TEEMSLVKWMRNVMTSENPT 584
M+ + + ++ +E+PT
Sbjct: 227 ---MNAMSALYHIAQNESPT 243
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 65/242 (26%), Positives = 100/242 (41%), Gaps = 53/242 (21%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
D L +E++G G G V K + G ++A+K+ I
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPT-GTIMAVKR-------------------------I 34
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVY---------------EFMKNGSLQDILN 441
R+ +N+ Q R L+ L M DC V E M SL
Sbjct: 35 RATVNSQEQ--KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYK 91
Query: 442 DVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501
V + KIA+ + LEYLH +IHRD+KP+NVL++ + + ++ DFG
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPEY---HQTLKFTD-KCDIYSFGVLLAVLVMGRLP 557
++ + D+ + + AG Y+APE K D K D++S G+ + L GR P
Sbjct: 150 ISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
Query: 558 SD 559
D
Sbjct: 207 YD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 345 IGSGGCGE--VYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+G G GE +Y+ + ++ K+V + L+E K+ R +EI
Sbjct: 8 LGKGAFGEATLYRRT---EDDSLVVWKEV-----NLTRLSE-------KERRDALNEIVI 52
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG----RRELDWLARHKI 458
+ ++H N++ H + L+ E+ G+L D + L +L +I
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL--FQI 110
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
V+ H I+HRD+K N+ L ++ DFG++K + + T V
Sbjct: 111 VSAVSY-------IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--V 161
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
GT Y++PE Q +K+ K DI++ G +L
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 66/221 (29%), Positives = 113/221 (51%), Gaps = 34/221 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEK+G G VYK + G+++A+K++ DA E T + IR EI+
Sbjct: 5 LEKLGEGTYATVYKG-RNRTTGEIVALKEI---HLDAEEGTPSTA---------IR-EIS 50
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDW-LAR---HK 457
+ +++H N++ L + + +LV+E+M L+ + D R LD + ++
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYM-DTHGVRGALDPNTVKSFTYQ 108
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MPDAQTHITT 515
+ G+A H R++HRDLKP N+L++ E ++ADFGLA+A +P T
Sbjct: 109 LLKGIA-------FCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN----TF 157
Query: 516 SNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
SN T+ Y AP+ + ++ DI+S G ++A ++ GR
Sbjct: 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 73/274 (26%)
Query: 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
SL+++GSG G V A + G+ +AIKK+ +P + S++ K R R E
Sbjct: 18 TSLKQVGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQ---------SEIFAK--RAYR-E 64
Query: 400 INTVGQIRHRNLLPLL-AHMARPDCH-----LLVYEFMKNGSLQDILNDVSQGRRELDWL 453
+ + ++H N++ LL + LV +M+ LQ I+ L
Sbjct: 65 LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP---------L 114
Query: 454 ARHKIALGV---ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ 510
+ K+ V CGL+Y+H + IIHRDLKP N+ +++D E +I DFGLA+ A
Sbjct: 115 SEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH---AD 168
Query: 511 THITTSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR-------- 555
+T V T Y APE Y+QT+ DI+S G ++A ++ G+
Sbjct: 169 AEMTGYVV--TRWYRAPEVILNWMHYNQTV------DIWSVGCIMAEMLTGKTLFKGKDY 220
Query: 556 ------------LPSDDFFQHTEEMSLVKWMRNV 577
+P +F Q E+ + +++++
Sbjct: 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSL 254
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 66/239 (27%), Positives = 103/239 (43%), Gaps = 52/239 (21%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQ-PPKDAAELTEEDSKLLNKKMRQIRSEI 400
L K+G G GEVYKA G+++A+KK++ KD +T +R EI
Sbjct: 13 LGKLGEGTFGEVYKAR-QIKTGRVVALKKILMHNEKDGFPIT---------ALR----EI 58
Query: 401 NTVGQIRHRNLLPLL--------AHMARPDCHLLVYEFMK---NGSL--QDILNDVSQGR 447
+ +++H N++PL+ + +V +M +G L + SQ +
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA---- 503
L + G+ YLH +H I+HRD+K AN+L+D+ +IADFGLA
Sbjct: 119 ---------CYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 504 ------KAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGR 555
K T T+ V T Y PE + +T DI+ G + A + R
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 68/224 (30%), Positives = 112/224 (50%), Gaps = 29/224 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+EKIG G G VYKA +N + IA+KK+ L +ED + + +R EI+
Sbjct: 7 VEKIGEGTYGVVYKARDRVTN-ETIALKKI--------RLEQEDEGVPSTAIR----EIS 53
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR--HKIA 459
+ +++H N++ L + LV+E++ + L+ ++ + + ++I
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA-RIADFGLAKAMPDAQTHITTSNV 518
G+A Y H SH R++HRDLKP N+L+D A ++ADFGLA+A T V
Sbjct: 113 RGIA----YCH-SH--RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165
Query: 519 AGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGR--LPSD 559
T+ Y APE + ++ DI+S G + A +V + P D
Sbjct: 166 --TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 55/228 (24%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 344 KIGSGGCGEVYKAEL----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
++G G G+V+ AE P + ++A+K + KDA++ +D E
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTL----KDASDNARKD----------FHRE 57
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILND-------VSQGR--REL 450
+ ++H +++ D ++V+E+MK+G L L +++G EL
Sbjct: 58 AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAEL 117
Query: 451 DWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ 510
IA +A G+ YL H +HRDL N L+ +++ +I DFG+++ +
Sbjct: 118 TQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174
Query: 511 THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + + ++ PE KFT + D++S GV+L + G+ P
Sbjct: 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 76/297 (25%), Positives = 128/297 (43%), Gaps = 39/297 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
++IG+G G+V E+ N + V++ + +A + E+ + E
Sbjct: 1 KEIGNGWFGKVILGEV---NSGYTPAQVVVKELRVSASVQEQ---------MKFLEEAQP 48
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRREL---DWLARHKIA 459
++H NLL L +LLV EF G L+ L S + EL D ++A
Sbjct: 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR--SCRKAELMTPDPTTLQRMA 106
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+A GL +LH +N IH DL N LL D+ +I D+GL+ ++T +
Sbjct: 107 CEIALGLLHLH-KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW 163
Query: 520 GTVGYIAPEY----HQTLKFTDKC---DIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572
+ +IAPE H L D+ +++S GV + L L S + ++E L
Sbjct: 164 VPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLTY 221
Query: 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629
+R + P + L + YE + FC + P +RP++++V +LS
Sbjct: 222 TVRE-QQLKLPKPRLKLPLSDRWYE--------VMQFCWL-QPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 32/229 (13%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIK----KVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
IG G G+V A+ ++GK A+K K I K+ + E + LL
Sbjct: 3 IGKGSFGKVLLAK-HKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLK---------- 51
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
++H L+ L D V +++ G L + + R + AR A
Sbjct: 52 ----NVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARF-YAA 103
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+A L YLH + II+RDLKP N+LLD + DFGL K + TTS G
Sbjct: 104 EIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCG 158
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFF-QHTEEM 568
T Y+APE + + D + G +L ++ G P F+ + T EM
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP---FYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 60/230 (26%), Positives = 108/230 (46%), Gaps = 27/230 (11%)
Query: 338 GLASLEKIGSGGCGEVYKAELPG---SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
L + +G G GEV+ A+ G G+ + + K +Q KD +E
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE----------- 54
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWL- 453
R E++ ++ H+N++ LL + H ++ E+ G L+ L ++ + E
Sbjct: 55 -FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPP 112
Query: 454 ---ARHKIALG--VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
+ K+AL +A G+++L N R +HRDL N L+ E +++ L+K + +
Sbjct: 113 PLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
++ + N + ++APE Q F+ K D++SFGVL+ V G LP
Sbjct: 170 SEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 40/103 (38%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MPDAQTHITTS 516
A +A GL +LH + II+RDLK NV+LD + +IADFG+ K TT
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTR 159
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559
GT YIAPE + D ++FGVLL ++ G+ P D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E +G G G VYKA + +++A+K + P EL +QI SE+
Sbjct: 6 QEILGHGNGGTVYKAYHLLT-RRILAVKVI--PLDITVEL-----------QKQIMSELE 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ---GRRELDWLARHKI 458
+ + ++ + + EFM GSL D+ + + GR I
Sbjct: 52 ILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIPEHVLGR----------I 100
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
A+ V GL YL + +I+HRD+KP+N+L++ + ++ DFG++ + ++ I + V
Sbjct: 101 AVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYV 154
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564
GT Y+APE ++ D++S G+ L +GR P ++
Sbjct: 155 -GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 52/230 (22%), Positives = 101/230 (43%), Gaps = 25/230 (10%)
Query: 337 DGLASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM 393
D + + + G G ++ L + + +K V KD A + L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLLL----- 56
Query: 394 RQIRSEINTVGQIRHRNLLPLL-AHMARPDCHLLVYEFMKNGSLQDILNDVS----QGRR 448
E + + H+N+LP+L + + ++Y +M G+L+ L +
Sbjct: 57 ----QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
L +A+ +ACG+ YLH +IH+D+ N ++D++++ +I D L++ +
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV-MGRLP 557
H N V ++A E +++ D++SFGVLL L+ +G+ P
Sbjct: 170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E +G+G G V A+ G+ G+ AIK ++ L K+++ + E +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT-GEYYAIK-----------CLKKREILKMKQVQHVAQEKSI 71
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ ++ H ++ ++ + + EF+ G L L GR D +A+ A +
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR--KAGRFPND-VAKFYHA-EL 127
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
EYLH + II+RDLKP N+LLD+ ++ DFG AK +PD T + GT
Sbjct: 128 VLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTP 179
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT 565
Y+APE Q+ D ++ GVLL + G P FF T
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP---FFDDT 219
|
Length = 329 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 68/244 (27%), Positives = 114/244 (46%), Gaps = 24/244 (9%)
Query: 328 EDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSK 387
ED + D L + +G G G+V AE G + + K + K A ++ + D+
Sbjct: 9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKE-----KPNRVTKVAVKMLKSDAT 63
Query: 388 LLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------ 440
K + + SE+ + I +H+N++ LL + ++ E+ G+L++ L
Sbjct: 64 --EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 121
Query: 441 ------NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494
N +L + A VA G+EYL + + IHRDL NVL+ +D
Sbjct: 122 GMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNV 178
Query: 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVM 553
+IADFGLA+ + + T+N V ++APE +T + D++SFGVLL + +
Sbjct: 179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
Query: 554 GRLP 557
G P
Sbjct: 239 GGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 40/237 (16%)
Query: 342 LEKIGSGGCGEVYKA--ELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
L+ +G G G V A +L G N +AIKK+++P L K+ + E
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQN---VAIKKIMKPFSTPV---------LAKRTYR---E 59
Query: 400 INTVGQIRHRNLLPLLAHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+ + +RH N++ L P D + V E + L+ + R ++
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDIYF-VTELLGTD-----LHRLLTSRPLEKQFIQY- 112
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+ GL+Y+H + ++HRDLKP+N+L++++ + +I DFGLA+ Q T
Sbjct: 113 FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR----IQDPQMTGY 165
Query: 518 VAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGR--LPSDDFFQHTEEMSLV 571
V+ T Y APE T K+ + DI+S G + A ++ G+ P D H + S++
Sbjct: 166 VS-TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD---HVNQFSII 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 36/96 (37%), Positives = 54/96 (56%), Gaps = 8/96 (8%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ C LEYLH S I++RDLKP N+LLD + ++ DFG AK + D T + GT
Sbjct: 110 IVCALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGT 161
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
Y+APE Q+ D ++ G+L+ +++G P
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 340 ASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
++KIG G G KA L S +GK IK++ SK+ K+ + R
Sbjct: 3 VKVKKIGEGSFG---KAILVKSKEDGKQYVIKEI------------NISKMSPKEREESR 47
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILND----VSQGRRELDWL 453
E+ + ++H N++ +V ++ + G L +N + + LDW
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF 107
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD----A 509
+ +AL H+ H+ +I+HRD+K N+ L D ++ DFG+A+ + A
Sbjct: 108 VQICLALK--------HV-HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158
Query: 510 QTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+T I GT Y++PE + + +K DI++ G +L
Sbjct: 159 RTCI------GTPYYLSPEICENRPYNNKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 40/129 (31%), Positives = 71/129 (55%), Gaps = 10/129 (7%)
Query: 429 EFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488
E M GSL +L + ++ K+++ V GL YL H +I+HRD+KP+N+L
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLREKH--KIMHRDVKPSNIL 136
Query: 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
++ E ++ DFG++ + D+ ++ GT Y++PE Q ++ + DI+S G+ L
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 549 AVLVMGRLP 557
+ +GR P
Sbjct: 193 VEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 67/240 (27%), Positives = 113/240 (47%), Gaps = 34/240 (14%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
D L + +G G G+V AE G + A+ ++ KD A TE+D L +M
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEME 72
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
++ +G +H+N++ LL + ++ E+ G+L++ L + RR
Sbjct: 73 MMK----MIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEY 122
Query: 455 RHKIA----------------LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498
+ IA VA G+EYL + + IHRDL NVL+ ++ +IA
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIA 179
Query: 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
DFGLA+ + + + T+N V ++APE +T + D++SFGVL+ + +G P
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 32/214 (14%)
Query: 387 KLLNKKMRQIRSEI-NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ 445
K+L+KK + E+ +T+G+ RN+L P L + F + L + + +S
Sbjct: 24 KVLSKKEIVAKKEVAHTIGE---RNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80
Query: 446 GRRELDW-----------LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494
G EL W A+ IA + LE+LH ++ I++RDLKP N+LLD
Sbjct: 81 G--ELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH-KYD--IVYRDLKPENILLDATGH 134
Query: 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVM 553
+ DFGL+K + + TT+ GT Y+APE K +T D +S GVL+ +
Sbjct: 135 IALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC 192
Query: 554 GRLPSDDFFQHTEEM------SLVKWMRNVMTSE 581
G P + + T++M V++ +NV++ E
Sbjct: 193 GWSPF--YAEDTQQMYRNIAFGKVRFPKNVLSDE 224
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 32/223 (14%)
Query: 342 LEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+E++G G+VYK L PG + +AIK + KD AE + + +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL----KDKAEGPLRE---------EFK 56
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------NDVSQ 445
E +++H N++ LL + + +++ + + L + L +D
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
+ L+ I +A G+E+L H ++H+DL NVL+ D + +I+D GL +
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 506 MPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ A + N + +++PE KF+ DI+S+GV+L
Sbjct: 174 VYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 26/224 (11%)
Query: 335 KEDGLASLEKIGSGGCGEVY----KAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLN 390
+ + + ++G G G VY K + G +AIK V + A + E
Sbjct: 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV----NENASMRER------ 53
Query: 391 KKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------NDVS 444
+ +E + + + +++ LL ++ L+V E M G L+ L + +
Sbjct: 54 ---IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENN 110
Query: 445 QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504
G ++A +A G+ YL +HRDL N ++ +D+ +I DFG+ +
Sbjct: 111 PGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTR 167
Query: 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + + V ++APE + FT K D++SFGV+L
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 10/162 (6%)
Query: 389 LNKKMRQ-IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR 447
+ K R ++E + + H N++ + ++V E+ G+L + + +
Sbjct: 38 MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCN 95
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-DMEARIADFGLAKAM 506
LD I L LH H I+HRDLK N+LLD M +I DFG++K +
Sbjct: 96 SLLD---EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152
Query: 507 PDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ V GT YI+PE + + K DI++ G +L
Sbjct: 153 ---SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 48/206 (23%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK----MRQIR 397
L KIG G GEV+KA +++A+KKV+ + N+K + +R
Sbjct: 17 LAKIGQGTFGEVFKAR-HKKTKQIVALKKVL---------------MENEKEGFPITALR 60
Query: 398 SEINTVGQIRHRNLLPLL---------AHMARPDCHLLVYEFMKN---GSLQDILNDVSQ 445
EI + ++H N++ L+ + + +L V+EF ++ G L + +
Sbjct: 61 -EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL-VFEFCEHDLAGLLSNKNVKFTL 118
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
E+ + + + GL Y+H + +I+HRD+K AN+L+ D ++ADFGLA+A
Sbjct: 119 S--EIKKVMKMLLN-----GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168
Query: 506 MP---DAQTHITTSNVAGTVGYIAPE 528
+++ + T+ V T+ Y PE
Sbjct: 169 FSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK--KMRQIRSE 399
L ++G GG G+V+ A+ + G+++A+K++ LL K ++R + +E
Sbjct: 6 LTQVGQGGYGQVFLAKKKDT-GEIVALKRM-------------KKSLLFKLNEVRHVLTE 51
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ + + L+ LL + L E++ G + +LN++ + AR +A
Sbjct: 52 RDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH---ARFYMA 108
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN-V 518
++ LH IHRDLKP N L+D ++ DFGL+K + +T +N V
Sbjct: 109 EMF-EAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI------VTYANSV 158
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
G+ Y+APE + + D +S G +L
Sbjct: 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCML 188
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 345 IGSGGCGEVYKAEL-----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+GSG GEVY+ PGS +A+K + + D +E + L E
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-----QEKKEFL--------KE 49
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK-- 457
+ + H N++ LL + ++ E M+ G L L D R L +
Sbjct: 50 AHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELL 109
Query: 458 -IALGVACGLEYLHISHNPRIIHRDLKPANVLL-----DDDMEARIADFGLAKAMPDAQT 511
I L VA G YL H IHRDL N L+ D D +I DFGLA+ + +
Sbjct: 110 DICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ V ++APE KFT + D++SFGVL+ +L +G+ P
Sbjct: 167 YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
KIG G G V A + S+GK++A+KK+ + EL L N E+ +
Sbjct: 27 KIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRREL------LFN--------EVVIM 71
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+H N++ + D +V EF++ G+L DI V+ R + +IA
Sbjct: 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCL 123
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG----LAKAMPDAQTHITTSNVA 519
L+ L + H +IHRD+K ++LL D +++DFG ++K +P ++ +
Sbjct: 124 AVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS------LV 177
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT ++APE L + + DI+S G+++ +V G P
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++KIG G G++Y A+ S+ + IK++ +LT K+ K+ + E+
Sbjct: 5 IKKIGEGSFGKIYLAK-AKSDSEHCVIKEI--------DLT----KMPVKEKEASKKEVI 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILND----VSQGRRELDWLARHK 457
+ +++H N++ A +V E+ G L +N + + L W +
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--Q 109
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD-MEARIADFGLAKAMPDAQTHITTS 516
I+LG+ HI H+ +I+HRD+K N+ L + M A++ DFG+A+ + D+ T
Sbjct: 110 ISLGLK------HI-HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT- 161
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT Y++PE Q + +K DI+S G +L L + P
Sbjct: 162 -CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 32/227 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+E IG G G+VYK +G + A+K ++ P D E +I +E N
Sbjct: 27 IETIGKGTYGKVYKVT-NKKDGSLAAVK-ILDPISDVDE--------------EIEAEYN 70
Query: 402 TVGQI-RHRNLLPLLAHMARPDCHL-----LVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ + H N++ + D + LV E GS+ +++ + + LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
I G GL++LH N RIIHRD+K N+LL + ++ DFG++ + + T
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 516 SNVAGTVGYIAPEY-----HQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
S GT ++APE + +CD++S G+ L G P
Sbjct: 188 S--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 62/267 (23%), Positives = 103/267 (38%), Gaps = 51/267 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++ +G G G V+ L G+ GK+ A+K + D E+ + K++++ +E
Sbjct: 6 IKLLGKGDVGRVFLVRLKGT-GKLFALKVL-----DKKEMIKR------NKVKRVLTEQE 53
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + H L L A LV ++ G L +L G+ + +AR A
Sbjct: 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFYAA-E 111
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK--AMPDAQTHITTSNVA 519
V LEYLH I++RDLKP N+LL + ++DF L+K + +
Sbjct: 112 VLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 520 -------------------------GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMG 554
GT YIAPE D ++ G+LL ++ G
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 555 RLPSDDFFQHTEEMSLVKWMRNVMTSE 581
P F + + N++ E
Sbjct: 229 TTP---FKGSNRDETF----SNILKKE 248
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 39/248 (15%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
++G G G+VYKA+ +A KVI+ K EL ED + EI +
Sbjct: 19 ELGDGAFGKVYKAK--NKETGALAAAKVIET-KSEEEL--EDYMV----------EIEIL 63
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
H ++ LL ++ EF G++ I+ ++ +G E + V
Sbjct: 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ--------IQVI 115
Query: 464 CG--LEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
C LE L H+ +IIHRDLK NVLL D + ++ADFG++ + +T + GT
Sbjct: 116 CRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGT 173
Query: 522 VGYIAPE--YHQTLK---FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
++APE +T+K + K DI+S G+ L + P E++ ++ +
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-------HELNPMRVLLK 226
Query: 577 VMTSENPT 584
+ SE PT
Sbjct: 227 IAKSEPPT 234
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 45/115 (39%), Positives = 61/115 (53%), Gaps = 12/115 (10%)
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSN 517
A +A GL +LH + II+RDLK NV+LD + +IADFG+ K M D +TT
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKT 160
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP-----SDDFFQHTEE 567
GT YIAPE + D ++FGVLL ++ G+ P D+ FQ E
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 42/281 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQ--PPKDAAELTEEDSKLLNKKMRQIRSEI 400
E+IG G GEV+ L N +A+K + PP A+ +E +++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADN-TPVAVKSCRETLPPDLKAKFLQE-ARILK---------- 48
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
Q H N++ L+ + +V E ++ G L ++G R L ++
Sbjct: 49 ----QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGPR-LKVKELIQMVE 101
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
A G+EYL H IHRDL N L+ + +I+DFG+++ D T
Sbjct: 102 NAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
V + APE +++ + D++SFG+LL +G +P + + N T
Sbjct: 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN-------------LSNQQT 205
Query: 580 SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620
E + + E + L+ + C P +RP+
Sbjct: 206 REAIEQGVRLPCPELCPDAVYRLMER----CWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 345 IGSGGCGEVY--KAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+G G GEV + + G M +KK + ++ EE+ R I S
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEE--------RDILS---- 56
Query: 403 VGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
I + +P L + + +L LV E+ G L +LN R D
Sbjct: 57 ---ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN------RYEDQFDEDMAQFY 107
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+A + +H H +HRD+KP NVL+D ++ADFG A + A + + GT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGT 166
Query: 522 VGYIAPEYHQTLKFTDK------CDIYSFGVLLAVLVMGRLP 557
YIAPE T+ K CD +S GV+ ++ GR P
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 69/228 (30%), Positives = 100/228 (43%), Gaps = 41/228 (17%)
Query: 342 LEKIGSGGCGEVYKAE-LPGSN-GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
L+ +G GG G+V++ + G++ GK+ A+K + KK +R++
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVL-------------------KKATIVRNQ 41
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRREL-DWLARHKI 458
+T RN+L + H P L+Y F G L IL +S G EL L R I
Sbjct: 42 KDTAHTKAERNILEAVKH---PFIVDLIYAFQTGGKLYLILEYLSGG--ELFMHLEREGI 96
Query: 459 AL-GVAC--------GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA 509
+ AC LE+LH II+RDLKP N+LLD ++ DFGL K
Sbjct: 97 FMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE--SI 151
Query: 510 QTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
T GT+ Y+APE D +S G L+ ++ G P
Sbjct: 152 HEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 42/106 (39%), Positives = 59/106 (55%), Gaps = 23/106 (21%)
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGY 524
GL+Y+H + IIHRDLKP+NV +++D E RI DFGLA+ D T T Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----GYVATRWY 181
Query: 525 IAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR--LPSDDF 561
APE Y+QT+ DI+S G ++A L+ G+ P +D+
Sbjct: 182 RAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGKALFPGNDY 221
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E IG G G V A + G+ +AIKK+ D E + +++L EI
Sbjct: 5 QEVIGKGSYGVVCSA-IDTHTGEKVAIKKI----NDVFEHVSDATRILR--------EIK 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCH-----LLVYEFMKNGSLQDILNDVSQGRRELDWLAR- 455
+ +RH +++ + M P +V+E M++ D+ Q + D L
Sbjct: 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES--------DLHQVIKANDDLTPE 103
Query: 456 -HKIAL-GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM-PDAQTH 512
H+ L + L+Y+H ++ + HRDLKP N+L + D + +I DFGLA+ D T
Sbjct: 104 HHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 513 ITTSNVAGTVGYIAPEYHQTL--KFTDKCDIYSFGVLLAVLVMGR 555
I ++ T Y APE + K+T DI+S G + A ++ G+
Sbjct: 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 22/234 (9%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
D LEKIG G G+VYKA + GK++A+KK L ++ + +R+I
Sbjct: 1 DAYEKLEKIGEGTYGKVYKAR-DKNTGKLVALKK--------TRLEMDEEGIPPTALREI 51
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPD---CHLLVYEFMKNGSLQDILNDVSQGRRELDWL 453
S + + + + L + H+ + LV+E++ + + + ++ R L
Sbjct: 52 -SLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAK 110
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA-RIADFGLAKAMPDAQTH 512
+ G+ + H H ++HRDLKP N+L+D +IAD GL +A
Sbjct: 111 TIKSFMYQLLKGVAHCH-KHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167
Query: 513 ITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR--LPSDDFFQ 563
T V T+ Y APE + ++ DI+S G + A + + P D Q
Sbjct: 168 YTHEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 20/166 (12%)
Query: 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
LEKIG G G V+KA+ + +++A+K+V L ++D + + +R E
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRET-HEIVALKRV--------RLDDDDEGVPSSALR----E 49
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
I + +++H+N++ L + LV+E+ QD+ ++D
Sbjct: 50 ICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFM 105
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
+ GL + H SHN ++HRDLKP N+L++ + E ++ADFGLA+A
Sbjct: 106 FQLLKGLAFCH-SHN--VLHRDLKPQNLLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 41/118 (34%), Positives = 59/118 (50%), Gaps = 13/118 (11%)
Query: 469 LHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPE 528
+H H +HRD+KP NVLLD + R+ADFG M T + +S GT YI+PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173
Query: 529 YHQTL-----KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
Q + K+ +CD +S GV + ++ G P F+ SLV+ +M E
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP---FYAE----SLVETYGKIMNHE 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 45/138 (32%), Positives = 71/138 (51%), Gaps = 8/138 (5%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
++ L + +G + +G LSEL +L L+ N L +P ++ CKKL L++ +NQ
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSG----NLGFLKYFPNLEHLSLAKNLFTGKVPTSIR 190
SG IP+ S + L LDLS N SG NLG ++ +L ++++ N G +P S
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE---SLVQVNISHNHLHGSLP-STG 591
Query: 191 TFRNLQFFDFSGNSLLEG 208
F + +GN L G
Sbjct: 592 AFLAINASAVAGNIDLCG 609
|
Length = 968 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 72/305 (23%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ L L +IG G G V K S G ++A+K++ S + K+ +++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPS-GTIMAVKRI-------------RSTVDEKEQKRL 49
Query: 397 RSEINTVGQIRHRNLLPLL----AHMARPDCHLLVYEFMKNGSLQD---ILNDVSQGRRE 449
+++ V +R + ++ A DC + E M + SL + +V +
Sbjct: 50 LMDLDVV--MRSSDCPYIVKFYGALFREGDC-WICMELM-DISLDKFYKYVYEVLKSVIP 105
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD- 508
+ L KIA+ L YL IIHRD+KP+N+LLD + ++ DFG++ + D
Sbjct: 106 EEILG--KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 509 -AQTHITTSNVAGTVGYIAPEYHQTL---KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564
A+T AG Y+APE + + D++S G+ L + G+ P +
Sbjct: 162 IAKTR-----DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW--- 213
Query: 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQ--MLLVLKIACFCTVDSPRERPNSK 622
S+ + V+ + P +L N E + V I C + +RP K
Sbjct: 214 ---NSVFDQLTQVVKGDPP-------ILSNSEEREFSPSFVNFIN-LCLIKDESKRPKYK 262
Query: 623 DVRCM 627
++
Sbjct: 263 ELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 36/229 (15%)
Query: 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+L+ IGSG G V A G+ +AIKK+ +P ++ +K R R E+
Sbjct: 20 NLKPIGSGAQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTH-----AK------RAYR-EL 66
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRRELDWL 453
+ + H+N++ LL ++ P L LV E M + +L ++ +LD
Sbjct: 67 VLMKLVNHKNIIGLL-NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ------MDLDHE 118
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
+ + CG+++LH + IIHRDLKP+N+++ D +I DFGLA+ A T
Sbjct: 119 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSF 172
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRL--PSDD 560
+ T Y APE + + + DI+S G ++ ++ G + P D
Sbjct: 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 10/199 (5%)
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV-GQIRHRNLLPLLAHM 418
GS GK++ K+ A ++ ++ + L K+ I +E N + ++H L+ L
Sbjct: 6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65
Query: 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRII 478
+ V +++ G L + + R L+ AR A VA + YLH S N II
Sbjct: 66 QTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARF-YAAEVASAIGYLH-SLN--II 118
Query: 479 HRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDK 538
+RDLKP N+LLD + DFGL K + + TTS GT Y+APE + +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 539 CDIYSFGVLLAVLVMGRLP 557
D + G +L ++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 68/239 (28%), Positives = 103/239 (43%), Gaps = 47/239 (19%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIK-----KVIQPPKDAAELTEEDSKLLNKK-----MR 394
+G G G+V AE G+ ++ AIK VIQ D E T + ++L + +
Sbjct: 8 LGKGSFGKVMLAERKGT-DELYAIKILKKDVVIQ--DDDVECTMVEKRVLALQDKPPFLT 64
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
Q+ S TV ++ V E++ G L + V + +
Sbjct: 65 QLHSCFQTVDRL------------------YFVMEYVNGGDLMYHIQQVGKFKEPQAVFY 106
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHI 513
+I++G L H II+RDLK NV+LD + +IADFG+ K M D +
Sbjct: 107 AAEISVG-------LFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---V 156
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP-----SDDFFQHTEE 567
TT GT YIAPE + D +++GVLL ++ G+ P D+ FQ E
Sbjct: 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 73/259 (28%), Positives = 123/259 (47%), Gaps = 45/259 (17%)
Query: 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM 393
E + +L +GSG G V A G +A+KK+ +P + +++ K
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQ----------SIIHAK- 61
Query: 394 RQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYE--FMKNGSLQDILNDVSQGRRELD 451
R R E+ + ++H N++ LL + P L + ++ + LN++ + ++ D
Sbjct: 62 RTYR-ELRLLKHMKHENVIGLL-DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 119
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
+ I + GL+Y+H + IIHRDLKP+N+ +++D E +I DFGLA+ D T
Sbjct: 120 DHVQFLI-YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 175
Query: 512 HITTSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR--LPSDDFF 562
T Y APE Y+QT+ DI+S G ++A L+ GR P D
Sbjct: 176 -----GYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGRTLFPGTD-- 222
Query: 563 QHTEEMSLVKWMRNVMTSE 581
H +++ L+ +R V T
Sbjct: 223 -HIDQLKLI--LRLVGTPG 238
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 59/220 (26%), Positives = 109/220 (49%), Gaps = 31/220 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
L +I G G VY+A G+++A+KK+ ++ K+ +T +R EI
Sbjct: 10 LNRIEEGTYGVVYRA-RDKKTGEIVALKKLKMEKEKEGFPIT------------SLR-EI 55
Query: 401 NTVGQIRHRNLLPL--LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRR--ELDWLARH 456
N + +++H N++ + + + D +V E++++ L+ ++ + Q E+ L
Sbjct: 56 NILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM-L 113
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
++ GVA +LH N I+HRDLK +N+LL++ +I DFGLA+ T
Sbjct: 114 QLLSGVA----HLH--DN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY-TQ 165
Query: 517 NVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
V T+ Y APE +++ D++S G + A L+ +
Sbjct: 166 LVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G+G G+V +A G + +K ++ K A +E ++ + K+ ++ +G
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI------MSHLG 96
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG--- 461
H N++ LL L++ E+ G L + L RR+ + + L
Sbjct: 97 N--HENIVNLLGACTIGGPILVITEYCCYGDLLNFL------RRKRESFLTLEDLLSFSY 148
Query: 462 -VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
VA G+ +L S N IHRDL NVLL +I DFGLA+ + + ++ N
Sbjct: 149 QVAKGMAFLA-SKN--CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
V ++APE +T + D++S+G+LL
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+IG G G VYKA P S G +A+K V +Q +D L+ L K++
Sbjct: 7 EIGVGAYGTVYKARDPHS-GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD----- 60
Query: 403 VGQIRHRNLLPLL--AHMARPDCHL---LVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
H N++ L+ +R D LV+E + + L+ L+ V + +
Sbjct: 61 -----HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETI--KD 112
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+ GL++LH + I+HRDLKP N+L+ + ++ADFGLA+ + +
Sbjct: 113 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTP 166
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLA 549
V T+ Y APE + D++S G + A
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNG--KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ-IRSE 399
EK+G G GEV+ E G A + QP A ++ D + K R E
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKE 67
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK-- 457
I + ++++ N++ LL D ++ E+M+NG L L+ +RE++ H
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS-----QREIESTFTHANN 122
Query: 458 -----------IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM 506
+A+ +A G++YL S N +HRDL N L+ + +IADFG+++ +
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL-ASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
Query: 507 PDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + ++A E KFT D+++FGV L
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-11
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
IG GG GEVY A P + +A+KK+ +D + ++ LL K R +R E
Sbjct: 9 LIGKGGMGEVYLAYDPVC-SRRVALKKI---REDLS-----ENPLLKK--RFLR-EAKIA 56
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH------- 456
+ H ++P+ + + D +++ +L+ +L V Q LA
Sbjct: 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA----------- 505
I + +EY+H + ++HRDLKP N+LL E I D+G A
Sbjct: 117 SIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 506 ---MPDAQTHITT--SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ T + GT Y+APE + ++ DIY+ GV+L
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 40/128 (31%), Positives = 72/128 (56%), Gaps = 7/128 (5%)
Query: 426 LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485
L+ EF+ +GSL++ L + + +++ + K A+ + G++YL + + +HRDL
Sbjct: 85 LIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAAR 138
Query: 486 NVLLDDDMEARIADFGLAKAMPDAQTHITTS-NVAGTVGYIAPEYHQTLKFTDKCDIYSF 544
NVL++ + + +I DFGL KA+ + + T ++ V + APE KF D++SF
Sbjct: 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198
Query: 545 GVLLAVLV 552
GV L L+
Sbjct: 199 GVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 42/233 (18%)
Query: 341 SLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+L+ IGSG G V Y A L + +AIKK+ +P ++ ++
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVL----DRNVAIKKLSRPFQNQTH------------AKRAY 64
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRREL 450
E+ + + H+N++ LL ++ P L LV E M Q I + EL
Sbjct: 65 RELVLMKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVI-------QMEL 116
Query: 451 DWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ 510
D + + CG+++LH + IIHRDLKP+N+++ D +I DFGLA+ A
Sbjct: 117 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AG 170
Query: 511 THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRL--PSDDF 561
T + T Y APE + + + DI+S G ++ +V ++ P D+
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
K D LEK+G G VYK + NGK++A+K + L EE+
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGK-SKVNGKLVALKVI--------RLQEEEGT----PFT 49
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
IR E + + ++H N++ L + + LV+E++ Q + D G + +
Sbjct: 50 AIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVK 106
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
L GL Y+H + I+HRDLKP N+L+ D E ++ADFGLA+A +H T
Sbjct: 107 LFLFQL--LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSH-T 159
Query: 515 TSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMG 554
SN T+ Y P+ + +++ D++ G + ++ G
Sbjct: 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 42/98 (42%), Positives = 58/98 (59%), Gaps = 9/98 (9%)
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK---AMPDAQTHITTSNVAG 520
CGL+Y+H S N ++HRDLKP N+L++ D E +I DFGLA+ P T VA
Sbjct: 116 CGLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA- 171
Query: 521 TVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLP 557
T Y APE + + +T D++S G +LA L +GR P
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 5e-11
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+E +G+G G+VYK + G++ AIK V+ D E +I+ EIN
Sbjct: 11 VELVGNGTYGQVYKGRHVKT-GQLAAIK-VMDVTGDEEE--------------EIKQEIN 54
Query: 402 TVGQI-RHRNLLPLLAHMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ + HRN+ + D LV EF GS+ D++ + + +W+A
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
I + GL +LH ++IHRD+K NVLL ++ E ++ DFG++ + +T
Sbjct: 115 Y--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGR 167
Query: 515 TSNVAGTVGYIAPEY-----HQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ GT ++APE + + K D++S G+ + G P
Sbjct: 168 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-11
Identities = 61/247 (24%), Positives = 106/247 (42%), Gaps = 33/247 (13%)
Query: 378 AAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLL-VYEFMKNGSL 436
A +L D+ + + R E ++ H N++ LL P L V+E++ +L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 437 QDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDM 493
+++L + G L ++ L V L+ L +HN I+HRDLKP N+++
Sbjct: 67 REVL--AADG--ALPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 494 EARIADFGLAKAMP-----DAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
A++ DFG+ +P D T T+ V GT Y APE + T D+Y++G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 549 ------AVLVMGRLPSDDFFQH--TEEMSLVKW---------MRNVMTSENPTRAIDAKL 591
+V G ++ +Q ++SL W +R + + RA A
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPA 239
Query: 592 LENGYEE 598
L +
Sbjct: 240 LAERFRA 246
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
++GSG G V K + K+++ + L +E + E N +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDE-----------LLREANVM 50
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
Q+ + ++ ++ + + +LV E + G L L Q + + ++ V+
Sbjct: 51 QQLDNPYIVRMIG-ICEAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVS 105
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM-PDAQTHITTSNVAGTV 522
G++YL N +HRDL NVLL A+I+DFGL+KA+ D + ++ V
Sbjct: 106 MGMKYLE-ETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV 162
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ APE KF+ K D++SFGVL+
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 66/259 (25%), Positives = 114/259 (44%), Gaps = 35/259 (13%)
Query: 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK 392
L E+ + ++G G G+VYKA+ ++A KVI K EL ED +
Sbjct: 1 LNPEEFWEIIGELGDGAFGKVYKAQ--NKETGVLAAAKVIDT-KSEEEL--EDYMV---- 51
Query: 393 MRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDW 452
EI+ + H N++ LL + ++ EF G++ ++ ++ +
Sbjct: 52 ------EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP------ 99
Query: 453 LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
L +I + LE L+ H +IIHRDLK N+L D + ++ADFG++ + +T
Sbjct: 100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTI 157
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTD-----KCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
+ GT ++APE D K D++S G+ L + P E
Sbjct: 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH-------HE 210
Query: 568 MSLVKWMRNVMTSENPTRA 586
++ ++ + + SE PT A
Sbjct: 211 LNPMRVLLKIAKSEPPTLA 229
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 33/184 (17%)
Query: 393 MRQIRSEINTVGQIRHRNLLPLLAHMARP-----------DCHL-LVYEFMKNGSLQDIL 440
M++IR ++ R LLA M P D HL +V E+ G D++
Sbjct: 30 MKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG---DLM 86
Query: 441 NDVSQGRREL-------DWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493
+ R +L W ++ LGV HI H R++HRD+K N+ L +
Sbjct: 87 QKIKLQRGKLFPEDTILQWFV--QMCLGVQ------HI-HEKRVLHRDIKSKNIFLTQNG 137
Query: 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553
+ ++ DFG A+ + + T GT Y+ PE + + + +K DI+S G +L L
Sbjct: 138 KVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
Query: 554 GRLP 557
+ P
Sbjct: 196 LKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG G G V+ P +GK +A+KK+ P L +++ E+ +
Sbjct: 8 IGYGAFGVVWSVTDP-RDGKRVALKKM---PNVFQNLVS---------CKRVFRELKMLC 54
Query: 405 QIRHRNLLPLL--AHMARPDCHLLVY---EFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+H N+L L D +Y E M++ L I+ VS D + K+
Sbjct: 55 FFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKII--VSPQPLSSDHV---KVF 108
Query: 460 L-GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM-PDAQTHITTSN 517
L + GL+YLH + I+HRD+KP N+L++ + +I DFGLA+ PD H+T
Sbjct: 109 LYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEV 165
Query: 518 VAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRL 556
V T Y APE + +T DI+S G + A L+ R+
Sbjct: 166 V--TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 71/226 (31%), Positives = 106/226 (46%), Gaps = 44/226 (19%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG G G V A+ +N K +AIKK+ +A + D+K R +R EI +
Sbjct: 13 IGRGAYGIVCSAKNSETNEK-VAIKKIA----NAFD-NRIDAK------RTLR-EIKLLR 59
Query: 405 QIRHRNLLPLLAHMARPDCH------LLVYEFMKNG------SLQDILNDVSQGRRELDW 452
+ H N++ + M P +VYE M S Q + +D Q L
Sbjct: 60 HLDHENVIAIKDIM-PPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQ--YFLYQ 116
Query: 453 LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
L R GL+Y+H S N ++HRDLKP+N+LL+ + + +I DFGLA+ +
Sbjct: 117 LLR---------GLKYIH-SAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF 164
Query: 513 ITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+T V T Y APE ++T D++S G + A L +GR P
Sbjct: 165 MTEYVV--TRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL-LGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 32/219 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+K+G G V+K ++A+K++ ++ A T IR E++
Sbjct: 10 LDKLGEGTYATVFKGR-SKLTENLVALKEIRLEHEEGAPCT------------AIR-EVS 55
Query: 402 TVGQIRHRNLLPL--LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ ++H N++ L + H R C LV+E++ + L+ L++ + ++ H +
Sbjct: 56 LLKNLKHANIVTLHDIIHTER--CLTLVFEYLDS-DLKQYLDNCG------NLMSMHNVK 106
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MPDAQTHITTSN 517
+ + L L H +I+HRDLKP N+L+++ E ++ADFGLA+A +P T SN
Sbjct: 107 IFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK----TYSN 162
Query: 518 VAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
T+ Y P+ + +++ D++ G +L + GR
Sbjct: 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G VY A S IAIK++ P +D+ + L++ EI
Sbjct: 16 LGKGTYGIVYAAR-DLSTQVRIAIKEI--PERDS-----RYVQPLHE-------EIALHS 60
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG--- 461
++HRN++ L + + E + GSL +L R + L ++ +
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL------RSKWGPLKDNEQTIIFYT 114
Query: 462 --VACGLEYLHISHNPRIIHRDLKPANVLLDD-DMEARIADFGLAKAMPDAQTHITTSNV 518
+ GL+YLH + +I+HRD+K NVL++ +I+DFG +K + A + T
Sbjct: 115 KQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETF 169
Query: 519 AGTVGYIAPEY--HQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT+ Y+APE + DI+S G + + G+ P
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 5/135 (3%)
Query: 426 LVYEFMKNGSL-QDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484
LV ++ G L Q+I + R H+ L L +H H+ +IHRD+K
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRT----FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKS 171
Query: 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSF 544
AN+LL + ++ DFG +K + GT Y+APE + ++ K D++S
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 545 GVLLAVLVMGRLPSD 559
GVLL L+ + P D
Sbjct: 232 GVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 42/233 (18%)
Query: 341 SLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+L+ IGSG G V Y A L + +AIKK+ +P ++ ++
Sbjct: 28 NLKPIGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQNQTH------------AKRAY 71
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRREL 450
E+ + + H+N++ LL ++ P L +V E M Q I + EL
Sbjct: 72 RELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELMDANLCQVI-------QMEL 123
Query: 451 DWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ 510
D + + CG+++LH + IIHRDLKP+N+++ D +I DFGLA+ A
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AG 177
Query: 511 THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRL--PSDDF 561
T + T Y APE + + + DI+S G ++ ++ G + P D
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 32/227 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG G G+V +A + KM A K+++ E E+ R E+ +
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK------EFASENDH------RDFAGELEVLC 57
Query: 405 QI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH------- 456
++ H N++ LL + E+ G+L D L + + H
Sbjct: 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 457 -----KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
+ A VA G++YL + IHRDL NVL+ +++ ++IADFGL++ +
Sbjct: 118 SQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRG---EEV 171
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
++ + V ++A E +T K D++SFGVLL ++ +G P
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419
G+ GK+I +++ A ++ +++ + ++ +E + RH L L
Sbjct: 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ 65
Query: 420 RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIH 479
D V E++ G L +S+ R + R A + L+YLH + +I++
Sbjct: 66 TKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGA-EIVSALDYLH---SGKIVY 118
Query: 480 RDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDK 538
RDLK N++LD D +I DFGL K + DA T T GT Y+APE + +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT---FCGTPEYLAPEVLEDNDYGRA 175
Query: 539 CDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
D + GV++ ++ GRLP F+ E
Sbjct: 176 VDWWGLGVVMYEMMCGRLP---FYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 50/265 (18%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK---- 392
D + +IG G G+VYKA G+++A+KKV +L N+K
Sbjct: 7 DKFDIIGQIGEGTYGQVYKAR-DKDTGELVALKKV---------------RLDNEKEGFP 50
Query: 393 MRQIRSEINTVGQIRHRNLLPL----------LAHMARPDCHLLVYEFMKN---GSLQDI 439
+ IR EI + Q+ HRN++ L L LV+E+M + G L+
Sbjct: 51 ITAIR-EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG 109
Query: 440 LNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIAD 499
L S+ I + LE L+ H +HRD+K +N+LL++ + ++AD
Sbjct: 110 LVHFSE----------DHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159
Query: 500 FGLAKAMPDAQTHITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGRLPS 558
FGLA+ ++ T+ V T+ Y PE ++ D++S G +L L +
Sbjct: 160 FGLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK--- 215
Query: 559 DDFFQHTEEMSLVKWMRNVMTSENP 583
FQ +E++ ++ + + S P
Sbjct: 216 -PIFQANQELAQLELISRLCGSPCP 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 41/94 (43%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDA-QTHITTSNVAGTV 522
GL+Y+H S N ++HRDLKP+N+LL+ + + +I DFGLA+ A P+ T T VA T
Sbjct: 118 GLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-TR 173
Query: 523 GYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGR 555
Y APE K +T DI+S G +LA ++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 24/163 (14%)
Query: 426 LVYEFMKNGSLQDILN--DVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLK 483
+V E+M G L ++++ D+ + W AR A V L H+ IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-----KW-ARFYTAEVV----LALDAIHSMGFIHRDVK 169
Query: 484 PANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL----KFTDKC 539
P N+LLD ++ADFG M DA + GT YI+PE ++ + +C
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 540 DIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN 582
D +S GV L +++G P F+ SLV +M +N
Sbjct: 229 DWWSVGVFLYEMLVGDTP---FYAD----SLVGTYSKIMDHKN 264
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 8/115 (6%)
Query: 53 DPCSTP-----GVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLAN 107
DPC G C+ D+ I L + L G + I +L L+ ++L+
Sbjct: 395 DPCVPQQHPWSGADCQ---FDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSG 451
Query: 108 NSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL 162
NS+ +PP + LE+L++ N F+G+IP L L LR+L+L+GNS SG +
Sbjct: 452 NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 43/156 (27%), Positives = 77/156 (49%), Gaps = 3/156 (1%)
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
RSE++ + H ++ D LL+ E+ GS D+ + Q +E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY---GSGGDLNKQIKQRLKEHLPFQEY 169
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
++ L + L H+ +++HRDLK AN+ L ++ DFG +K D+ + S
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV 552
+ GT Y+APE + +++ K D++S GV+L L+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 28/217 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+K+G G VYK ++ ++A+K++ ++ A T IR E++
Sbjct: 11 LDKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCT------------AIR-EVS 56
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++H N++ L + LV+E++ + L+ L+D + + H + L
Sbjct: 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG------NSINMHNVKLF 109
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA--MPDAQTHITTSNVA 519
+ L L+ H +++HRDLKP N+L+++ E ++ADFGLA+A +P T SN
Sbjct: 110 LFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK----TYSNEV 165
Query: 520 GTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
T+ Y P+ + ++ + D++ G + + GR
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 46/177 (25%), Positives = 69/177 (38%), Gaps = 48/177 (27%)
Query: 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRD 481
D V +++ G + +L + G E D LAR IA + C +E +H IHRD
Sbjct: 74 DNLYFVMDYIPGGDMMSLL--IRLGIFEED-LARFYIA-ELTCAIESVH---KMGFIHRD 126
Query: 482 LKPANVLLDDDMEARIADFGLAKAM---------------------PD------------ 508
+KP N+L+D D ++ DFGL P
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186
Query: 509 --------AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
++ GT YIAPE +T CD +S GV+L +++G+ P
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 466 LEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYI 525
L YLH + +++RDLK N++LD D +I DFGL K T GT Y+
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 526 APEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
APE + + D + GV++ ++ GRLP
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 67/296 (22%), Positives = 121/296 (40%), Gaps = 37/296 (12%)
Query: 345 IGSGGCGEVYKAELPGSNGKM--IAIKKV---IQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+G G G V +A+L +G +A+K + I D E E + + +
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL--NDVSQGRRELDWLARHK 457
I + R + LP+ +++ FMK+G L L + + + L +
Sbjct: 67 IGVSLRSRAKGRLPI---------PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+ +A G+EYL + IHRDL N +L+++M +ADFGL+K + +
Sbjct: 118 FMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
V ++A E +T D+++FGV + ++ G+ P + E + ++
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP----YAGVENSEIYNYLIK 230
Query: 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
+ P LE+ YE + C C P+ RP+ + +R L I
Sbjct: 231 GNRLKQP-----PDCLEDVYE--------LMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 19/197 (9%)
Query: 352 EVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411
V K PGS G++ K QP ++ ++ + L+ + Q + H ++
Sbjct: 69 TVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQ---------NVNHPSV 119
Query: 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHI 471
+ + + +V + D+ +++ R L I + GL YLH
Sbjct: 120 IRMKDTLVSGAITCMVLPHYSS----DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH- 174
Query: 472 SHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ 531
RIIHRD+K N+ ++D + I D G A+ A + +AGTV APE
Sbjct: 175 --AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGTVETNAPEVLA 229
Query: 532 TLKFTDKCDIYSFGVLL 548
K+ K DI+S G++L
Sbjct: 230 RDKYNSKADIWSAGIVL 246
|
Length = 357 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 12/210 (5%)
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV-GQIRHRNLLPLLAHM 418
GS GK++ + + A ++ ++ + L K+ + I SE N + ++H L+ L
Sbjct: 6 GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 65
Query: 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRII 478
D V +++ G L + + R L+ AR A +A L YLH + I+
Sbjct: 66 QTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNIV 118
Query: 479 HRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDK 538
+RDLKP N+LLD + DFGL K + + + TTS GT Y+APE +
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 539 CDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
D + G +L ++ G P + ++T EM
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF--YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L + KIG G G V A S G+ +A+K + + EL L N
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHS-GRQVAVKMMDLRKQQRREL------LFN-------- 67
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E+ + +H+N++ + + ++ EF++ G+L DI VSQ R L +I
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQTR-----LNEEQI 119
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG----LAKAMPDAQTHIT 514
A L+ L H+ +IHRD+K ++LL D +++DFG ++K +P ++
Sbjct: 120 ATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--- 176
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ GT ++APE + + DI+S G+++ +V G P
Sbjct: 177 ---LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 25/211 (11%)
Query: 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARH---KIALGVACGLEYLHISHNPRIIHRD 481
+++ FMK+G L L G +L K +A G+EYL + IHRD
Sbjct: 82 VVILPFMKHGDLHSFLLYSRLGDCPQ-YLPTQMLVKFMTDIASGMEYLS---SKSFIHRD 137
Query: 482 LKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDI 541
L N +L+++M +ADFGL+K + + + V +IA E +T K D+
Sbjct: 138 LAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDV 197
Query: 542 YSFGVLL-AVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQM 600
+SFGV + + G+ P + E + ++R + P +D
Sbjct: 198 WSFGVTMWEIATRGQTP----YPGVENSEIYDYLRQGNRLKQPPDCLDG----------- 242
Query: 601 LLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
L L +C+ +P++RP+ + +RC L +
Sbjct: 243 LYSLMSSCWLL--NPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 10/92 (10%)
Query: 473 HNPRIIHRDLKPANVLLDDDMEARIADFG-LAKAMPDAQTHITTSNVA-GTVGYIAPEYH 530
H +HRD+KP NVLLD + R+ADFG + + D SNVA GT YI+PE
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ---SNVAVGTPDYISPEIL 175
Query: 531 QTL-----KFTDKCDIYSFGVLLAVLVMGRLP 557
Q + ++ +CD +S GV + ++ G P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 68/217 (31%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN-------TVGQIRHRNLL 412
GS GK++ ++K +D + K + K RSE+ + Q+ ++
Sbjct: 4 GSFGKVMQVRK-----RDTQRIYA--LKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS 472
PL P+ LV F+ G L L +GR +L AR A + C LE LH
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHHLQ--REGRFDL-SRARFYTA-ELLCALENLH-K 111
Query: 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSNVAGTVGYIAPEYHQ 531
N +I+RDLKP N+LLD + DFGL K M D T+ GT Y+APE
Sbjct: 112 FN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLL 166
Query: 532 TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
+T D ++ GVLL ++ G P D ++ EM
Sbjct: 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYD--ENVNEM 201
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+IG G G+V+KA + G+ +A+K+V +Q T E+ L+ +R++ + +
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--------TGEEGMPLST-IREV-AVLRH 57
Query: 403 VGQIRHRNLLPL--LAHMARPDCHL---LVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+ H N++ L + ++R D LV+E + + L L+ V + + +
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI--KD 114
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+ + GL++LH SH R++HRDLKP N+L+ + ++ADFGLA+ + ++
Sbjct: 115 MMFQLLRGLDFLH-SH--RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTS 168
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLA 549
V T+ Y APE + D++S G + A
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 66/290 (22%), Positives = 124/290 (42%), Gaps = 50/290 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LE IG G G VY+ G+++A+K +I ++++ I+ E+
Sbjct: 6 LELIGRGAYGAVYRG-KHVPTGRVVALK-IINLDTPDDDVSD------------IQREVA 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL------LVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ Q+R + + +L ++ E+ + GS++ ++ + + + R
Sbjct: 52 LLSQLRQSQPPNITKYYG---SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR 108
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
V L+Y+H +IHRD+K AN+L+ + ++ DFG+A + Q
Sbjct: 109 E-----VLVALKYIH--KVG-VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKR 158
Query: 516 SNVAGTVGYIAPEYHQTLKFTD-KCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
S GT ++APE K+ D K DI+S G+ + + G P D M + K
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-- 216
Query: 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
P R L +NGY + + + C + P+ER +++++
Sbjct: 217 ------SKPPR-----LEDNGYSKLL---REFVAACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 345 IGSGGCGEVYKA--ELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+G+G GE+ + +LP +AI + + +K+ R +E T
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTL----RAGCS---------DKQRRGFLAEALT 59
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL-- 460
+GQ H N++ L + R + ++V E+M NG+L L + E +A + +
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-----KHEGQLVAGQLMGMLP 114
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
G+A G++YL +H+ L VL++ D+ +I+ F + ++ TT +
Sbjct: 115 GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKS 170
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
V + APE Q F+ D++SFG+++ V+ G P
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 69/299 (23%), Positives = 132/299 (44%), Gaps = 44/299 (14%)
Query: 343 EKIGSGGCGEVYKAEL-PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++IG+G G+V +E+ + + +K++ K A E++ L +I
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKEL----KANASSKEQNEFLQQGDPYRI----- 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
++H N+L L +LLV+E+ + G L+ L+ RR L ++A
Sbjct: 52 ----LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+A G+ ++H HN +H DL N L D+ ++ D+G+ + T +
Sbjct: 108 IAAGVTHMH-KHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 522 VGYIAPE----YHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
+ ++APE +H T + T ++++ GV L L ++ Q +S + +
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF------ENAAQPYSHLSDREVL 218
Query: 575 RNVMTSENPTRAIDAKL----LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629
+V+ + KL LE Y E+ VL+ FC + SP +R +++V +L+
Sbjct: 219 NHVIKDQ------QVKLFKPQLELPYSERWYEVLQ---FCWL-SPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 18/218 (8%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKD----AAELTEEDSKLLNKKMRQ-IR 397
EK+G G GEV+ E G M + A ++ ED+ NK R
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFL 67
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILND-------VSQGRREL 450
EI + +++ N++ LLA D ++ E+M+NG L L+ +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 451 DWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ 510
+ +A +A G++YL S N +HRDL N L+ + +IADFG+++ +
Sbjct: 128 SYSTLIFMATQIASGMKYLS-SLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 511 THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + +++ E KFT D+++FGV L
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 2/91 (2%)
Query: 469 LHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPE 528
L+ H II+RDLK NVLLD + ++ D+G+ K + TTS GT YIAPE
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPE 166
Query: 529 YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559
+ + D ++ GVL+ ++ GR P D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484
LV E++ G D++ + + R+ + AR A + L +LH II+RDLK
Sbjct: 72 FLVIEYVNGG---DLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGIIYRDLKL 124
Query: 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSF 544
NVLLD D ++ D+G+ K TTS GT YIAPE + ++ D ++
Sbjct: 125 DNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWAL 182
Query: 545 GVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTR 585
GVL+ ++ GR P D +M+ ++ V+ E P R
Sbjct: 183 GVLMFEMMAGRSPF-DIITDNPDMNTEDYLFQVIL-EKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 335 KEDGLASLEKIGSGGCGEVYKA-ELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK 392
KE L L+ +GSG G V+K +P G + K+ K IQ ++
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ----------------DRS 48
Query: 393 MRQIRSEIN----TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRR 448
RQ EI +G + H ++ LL L V + GSL L+ V Q R
Sbjct: 49 GRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSL---LDHVRQHRD 104
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
LD + +A G+ YL R++HR+L N+LL D +IADFG+A +
Sbjct: 105 SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
S + ++A E ++T + D++S+GV +
Sbjct: 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 35/254 (13%)
Query: 339 LASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELT-------EEDSKL 388
L +EK+G G GEV+ E L + K A DA L +
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDN----ADAPVLVAVKVLRPDASDNA 62
Query: 389 LNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL-------N 441
+++++ + ++ N+ LL ++ E+M+NG L L +
Sbjct: 63 REDFLKEVK----ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 442 DVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501
++ + L + +A +A G+ YL S N +HRDL N L+ + +IADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLE-SLN--FVHRDLATRNCLVGKNYTIKIADFG 175
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGR----- 555
+++ + + + + ++A E KFT K D+++FGV L +L + R
Sbjct: 176 MSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 556 -LPSDDFFQHTEEM 568
L ++
Sbjct: 236 HLTDQQVIENAGHF 249
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 20/220 (9%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G GEVY G+ +A+K+V P DS+ +K++ + EI +
Sbjct: 10 LGRGAFGEVYLC-YDADTGRELAVKQVPFDP---------DSQETSKEVNALECEIQLLK 59
Query: 405 QIRHRNLLPLLAHMARPDCHLL--VYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+RH ++ + P+ L E+M GS++D L + +I GV
Sbjct: 60 NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGV 119
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-TSNVAGT 521
+ YLH + I+HRD+K AN+L D ++ DFG +K + T +V GT
Sbjct: 120 S----YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
+++PE + K D++S + ++ + P ++
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 12/166 (7%)
Query: 388 LLNKKMRQIRSEINTVGQIRHRNLLPLLAHM---ARPDCHLLVYEFMKNGSLQDILNDVS 444
L N+ + +R E+ +I H+ P + M + +LV E G L L S
Sbjct: 30 LKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL---S 86
Query: 445 QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504
+ E+ ++ V+ G++YL +HRDL NVLL + A+I+DFGL+K
Sbjct: 87 GKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143
Query: 505 AMPDAQTHITTSNVAGT--VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
A+ A + AG + + APE KF+ + D++S+G+ +
Sbjct: 144 AL-GADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419
G+ GK+I +K+ A ++ +++ + ++ +E + RH L L
Sbjct: 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 65
Query: 420 RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIH 479
D V E+ G L +S+ R + AR A + L+YLH N +++
Sbjct: 66 THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKN--VVY 119
Query: 480 RDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDK 538
RDLK N++LD D +I DFGL K + D T T GT Y+APE + +
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPEVLEDNDYGRA 176
Query: 539 CDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
D + GV++ ++ GRLP F+ E
Sbjct: 177 VDWWGLGVVMYEMMCGRLP---FYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 49/226 (21%), Positives = 86/226 (38%), Gaps = 35/226 (15%)
Query: 346 GSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ 405
+ K + ++A+KK+ +L ++ EI T Q
Sbjct: 11 EDLMIVHLAKHK---PTNTLVAVKKINLDSCSKEDLK------------LLQQEIITSRQ 55
Query: 406 IRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL-NDVSQGRRELDWLARHKIAL---G 461
++H N+LP + +V M GS +D+L +G EL IA
Sbjct: 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKD 109
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM-----PDAQTHITTS 516
V L+Y+H IHR +K +++LL D + ++ + +M H
Sbjct: 110 VLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166
Query: 517 NVAGTVGYIAPE--YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
+ + +++PE + +K DIYS G+ L G +P D
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 24/229 (10%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
KE ++ +GSG G VYK L G+ + I I+ EL E S NK
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIK------ELREATSPKANK--- 54
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL---NDVSQGRRELD 451
+I E + + + ++ LL + L+ + M G L D + D + L+
Sbjct: 55 EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 113
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
W + +A G+ YL ++HRDL NVL+ +I DFGLAK + +
Sbjct: 114 WCVQ------IAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSD 559
+ ++A E +T + D++S+GV + ++ G P D
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV-GQIRHRNLLPLLAHM 418
GS GK++ K+ + A ++ ++ L K+ + I +E N + ++H L+ L
Sbjct: 6 GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF 65
Query: 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRII 478
+ V +F+ G L + + R + AR A +A L YLH + I+
Sbjct: 66 QTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAA-EIASALGYLH---SINIV 118
Query: 479 HRDLKPANVLLDDDMEARIADFGLAK---AMPDAQTHITTSNVAGTVGYIAPEYHQTLKF 535
+RDLKP N+LLD + DFGL K A D TT+ GT Y+APE + +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-----TTTTFCGTPEYLAPEVIRKQPY 173
Query: 536 TDKCDIYSFGVLLAVLVMGRLP 557
+ D + G +L ++ G P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 24/229 (10%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
KE L ++ +GSG G VYK G + + ++ P L E N
Sbjct: 5 KETELKRVKVLGSGAFGTVYK-------GIWVPEGETVKIPVAIKILNETTGPKANV--- 54
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILN---DVSQGRRELD 451
+ E + + H +L+ LL P L V + M +G L D ++ D + L+
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLN 113
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
W + +A G+ YL R++HRDL NVL+ +I DFGLA+ + +
Sbjct: 114 WCVQ------IAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSD 559
+ ++A E KFT + D++S+GV + ++ G P D
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR-QIRSEIN 401
E +G G GEV+K L + +A+K +ED L ++++ + SE
Sbjct: 1 ELLGKGNFGEVFKGTL--KDKTPVAVKTC-----------KED---LPQELKIKFLSEAR 44
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q H N++ L+ + +V E + G D L+ + + + EL K AL
Sbjct: 45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALD 101
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
A G+ YL + IHRDL N L+ ++ +I+DFG+++ D + ++
Sbjct: 102 AAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIP 157
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + APE +++ + D++S+G+LL
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 15/149 (10%)
Query: 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484
V E++ G D++ + + R+ + AR A ++ L YLH II+RDLK
Sbjct: 72 FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKL 124
Query: 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSF 544
NVLLD + ++ D+G+ K + TTS GT YIAPE + + D ++
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182
Query: 545 GVLLAVLVMGRLP------SDDFFQHTEE 567
GVL+ ++ GR P SD+ Q+TE+
Sbjct: 183 GVLMFEMMAGRSPFDIVGSSDNPDQNTED 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 64/303 (21%), Positives = 119/303 (39%), Gaps = 61/303 (20%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
IG G G+VY+ + IA+ A + + + ++ + E
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAV---------AVKTCKNCTSPSVRE--KFLQEAYI 60
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ Q H +++ L+ + + +V E G L+ L + LD + + +
Sbjct: 61 MRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQL 116
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
+ L YL + R +HRD+ NVL+ ++ DFGL++ + D +++ S +
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPI 172
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQHTEEMSLVKWMRN---VM 578
++APE +FT D++ FGV + +L++G P FQ ++N +
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP----FQ---------GVKNNDVIG 219
Query: 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDS---------PRERPNSKDVRCMLS 629
EN R L + C T+ S P +RP +++ LS
Sbjct: 220 RIENGER----------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
Query: 630 QIR 632
I
Sbjct: 264 DIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)
Query: 473 HNPRIIHRDLKPANVLLDDDMEARIADFG-LAKAMPDAQTHITTSNVAGTVGYIAPEYHQ 531
H +HRD+KP N+L+D + R+ADFG K M D + +S GT YI+PE Q
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQ 176
Query: 532 TL-----KFTDKCDIYSFGVLLAVLVMGRLP 557
+ K+ +CD +S GV + ++ G P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 331 AFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLN 390
+F + D +E IG G G+V+K L NG A+K ++ P D E
Sbjct: 12 SFPDPSDTWEIIETIGKGTYGKVFKV-LNKKNGSKAAVK-ILDPIHDIDE---------- 59
Query: 391 KKMRQIRSEINTVGQIR-HRNLLPLLAHMARPDCH-----LLVYEFMKNGSLQDILNDVS 444
+I +E N + + H N++ + D LV E GS+ D++
Sbjct: 60 ----EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115
Query: 445 QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504
+ ++ I GL++LH + IHRD+K N+LL + ++ DFG++
Sbjct: 116 KRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172
Query: 505 AMPDAQTHITTSNVAGTVGYIAPEY---HQTL--KFTDKCDIYSFGV 546
+ + TS GT ++APE Q L + +CD++S G+
Sbjct: 173 QLTSTRLRRNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 32/250 (12%)
Query: 342 LEKIGSGGCGEVYKA-ELPGSN-GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
L+ +G+G G+V+ ++ G + GK+ A+K + K A + + K R+E
Sbjct: 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVL----KKATIVQKA------KTTEHTRTE 54
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ IR L L + + D L L+ +++ G L +SQ R ++
Sbjct: 55 RQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL---FTHLSQRER----FKEQEV 107
Query: 459 AL---GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+ + LE+LH II+RD+K N+LLD + + DFGL+K + +
Sbjct: 108 QIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY 164
Query: 516 SNVAGTVGYIAPEYHQTLKFT-DKC-DIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573
S GT+ Y+AP+ + DK D +S GVL+ L+ G P F E+ S +
Sbjct: 165 S-FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP---FTVDGEKNSQAEI 220
Query: 574 MRNVMTSENP 583
R ++ SE P
Sbjct: 221 SRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 34/233 (14%)
Query: 326 KAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEED 385
K ED F+ +G+G G V A + +AIK+ E
Sbjct: 28 KYEDFNFIRT---------LGTGSFGRVILATYKNEDFPPVAIKRF------------EK 66
Query: 386 SKLL-NKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVS 444
SK++ K++ + SE + I H + L LV EF+ G L
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK 126
Query: 445 QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504
+ ++ +I L EYL + I++RDLKP N+LLD D ++ DFG AK
Sbjct: 127 RFPNDVGCFYAAQIVLI----FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179
Query: 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ D +T+ + GT YIAPE + D ++ G+ + +++G P
Sbjct: 180 VV-DTRTY----TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 10/107 (9%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAG 520
+ LEYLH S + +++RD+K N++LD D +I DFGL K + D T T G
Sbjct: 104 IVSALEYLH-SRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCG 157
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
T Y+APE + + D + GV++ ++ GRLP F+ E
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP---FYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 52/215 (24%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEK+G G V+K + ++A+K++ ++ A T IR E++
Sbjct: 11 LEKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCT------------AIR-EVS 56
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++H N++ L + LV+E++ + L+ ++D + ++ H + +
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCG------NIMSMHNVKIF 109
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ L L H +++HRDLKP N+L+++ E ++ADFGLA+A + T SN T
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVT 167
Query: 522 VGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+ Y P+ + +++ + D++ G + + GR
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 59/224 (26%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKM-IAIKKVIQPPKDAAELTEEDSKLLNKKMRQI------R 397
IG G G+V KA + +M AIK++ K+ A +++D + ++ +
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRM----KEYA--SKDDHRDFAGELEVLCKLGHHP 68
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+ IN +G HR L L A P +LL +F++ + + + L+ +
Sbjct: 69 NIINLLGACEHRGYLYLAIEYA-PHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 458 I---ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
+ A VA G++YL + IHRDL N+L+ ++ A+IADFGL++ + ++
Sbjct: 126 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVK 179
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ V ++A E +T D++S+GVLL ++ +G P
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 14/141 (9%)
Query: 422 DCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480
D +L +V E+M G L +++++ + W + + +A L H+ +IHR
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYDVPEK---WAKFYTAEVVLA-----LDAIHSMGLIHR 166
Query: 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK----FT 536
D+KP N+LLD ++ADFG M D + GT YI+PE ++ +
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 537 DKCDIYSFGVLLAVLVMGRLP 557
+CD +S GV L +++G P
Sbjct: 226 RECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG G G+V KA + +M A K ++ E +D R E+ +
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK------EYASKDDH------RDFAGELEVLC 50
Query: 405 QI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH------- 456
++ H N++ LL L E+ +G+L D L + + +
Sbjct: 51 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 110
Query: 457 -----KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
A VA G++YL + IHRDL N+L+ ++ A+IADFGL++ +
Sbjct: 111 SQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEV 164
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
++ + V ++A E +T D++S+GVLL ++ +G P
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 27/143 (18%)
Query: 72 YVLKITKLVFV---PRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILN 128
+ +T L F+ +L G + +G++ L+ + L N+L +P +I L L+
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242
Query: 129 VQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTS 188
+ N +G IPS L GNL NL++L L +N +G +P S
Sbjct: 243 LVYNNLTGPIPSSL-----------------GNL------KNLQYLFLYQNKLSGPIPPS 279
Query: 189 IRTFRNLQFFDFSGNSLLEGPIP 211
I + + L D S NS L G IP
Sbjct: 280 IFSLQKLISLDLSDNS-LSGEIP 301
|
Length = 968 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 24/231 (10%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
KE L ++ +GSG G VYK G I + ++ P L E S NK
Sbjct: 5 KETELKKVKVLGSGAFGTVYK-------GIWIPDGENVKIPVAIKVLRENTSPKANK--- 54
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL--NDVSQGRREL-D 451
+I E + + + LL + LV + M G L D + N G ++L +
Sbjct: 55 EILDEAYVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN 113
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
W + +A G+ YL R++HRDL NVL+ +I DFGLA+ + +T
Sbjct: 114 WCVQ------IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDF 561
+ ++A E +FT + D++S+GV + ++ G P D
Sbjct: 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 20/220 (9%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G VY G+ +A+K+V P +S +K++ + EI +
Sbjct: 10 LGQGAFGRVYLC-YDADTGRELAVKQVQFDP---------ESPETSKEVNALECEIQLLK 59
Query: 405 QIRHRNLLPLLAHMARPDCHLL--VYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ H ++ + P L E M GS++D L + +I
Sbjct: 60 NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI---- 115
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-TSNVAGT 521
LE + H+ I+HRD+K AN+L D ++ DFG +K + T +V GT
Sbjct: 116 ---LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
+++PE + K DI+S G + ++ + P +F
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 67/261 (25%), Positives = 116/261 (44%), Gaps = 51/261 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L KIG G EV KA+ GK AIK + + K ++ +R+I++
Sbjct: 4 LGKIGEGTFSEVLKAQ-SRKTGKYYAIKCMKKHFKSLEQVNN---------LREIQA--- 50
Query: 402 TVGQIR----HRNLLPLLAHM--ARPDCHLLVYEFMKNGSLQDI-LNDVSQGRRELDWLA 454
+R H N+L L+ + + LV+E M D+ L ++ +GR+ L
Sbjct: 51 ----LRRLSPHPNILRLIEVLFDRKTGRLALVFELM------DMNLYELIKGRKRP--LP 98
Query: 455 RHKIAL---GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
++ + L+++H + I HRD+KP N+L+ DD ++ADFG + +
Sbjct: 99 EKRVKSYMYQLLKSLDHMH-RNG--IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP 154
Query: 512 HITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFG-VLLAVLVMGRLPSDDFFQHTEEMS 569
+ T ++ T Y APE T + K DI++ G V +L + L F T E+
Sbjct: 155 Y--TEYIS-TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL-----FPGTNELD 206
Query: 570 LVKWMRNVMTSENPTRAIDAK 590
+ + +V+ + P + K
Sbjct: 207 QIAKIHDVLGT--PDAEVLKK 225
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
VA G+++L S N IHRD+ NVLL D A+I DFGLA+ + + ++ N
Sbjct: 221 VAQGMDFLA-SKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
V ++APE +T + D++S+G+LL + +G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 59/300 (19%), Positives = 117/300 (39%), Gaps = 59/300 (19%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
I +YK N K + I+ + K K+L + +EI +
Sbjct: 28 IKENDQNSIYKGIF---NNKEVIIRTFKKFHKG--------HKVL---IDITENEIKNLR 73
Query: 405 QIRHRNLLPLLAH---MARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+I N+L + + L L+ E+ G L+++L+ ++L + + +A+
Sbjct: 74 RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAI 129
Query: 461 GVACGLEYLHISHN-PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
GL L+ N P +++L + L+ ++ + +I GL K +
Sbjct: 130 DCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILS-----SPPFKNV 181
Query: 520 GTVGYIAPEYHQTL--KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577
+ Y + + + ++T K DIYS GV+L + G++P F++
Sbjct: 182 NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP----FEN------------- 224
Query: 578 MTSENPTRAIDAKLLENGYEEQM-----LLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
+T T+ I ++ ++ L + I CT +RPN K++ LS +
Sbjct: 225 LT----TKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280
|
Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS--- 398
+ +G G GEV ++GK IKK+ L N R+ ++
Sbjct: 5 VRVVGKGSYGEVSLVR-HRTDGKQYVIKKL---------------NLRNASRRERKAAEQ 48
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQG-----RRELDW 452
E + Q++H N++ D L +V F + G L L + +G + ++W
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE-QKGKLLPENQVVEW 107
Query: 453 LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
+ +A L+YLH H I+HRDLK NV L ++ D G+A+ + +
Sbjct: 108 FVQ------IAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFG 545
S + GT Y++PE + K D+++ G
Sbjct: 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALG 189
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 51/158 (32%), Positives = 75/158 (47%), Gaps = 24/158 (15%)
Query: 424 HL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482
HL +V E+++ G +L ++ G +D +AR A V LEYLH N I+HRDL
Sbjct: 75 HLCMVMEYVEGGDCATLLKNI--GALPVD-MARMYFAETV-LALEYLH---NYGIVHRDL 127
Query: 483 KPANVLLDDDMEARIADFGLAK------AMPDAQTHITT-------SNVAGTVGYIAPEY 529
KP N+L+ ++ DFGL+K + HI V GT YIAPE
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV 187
Query: 530 HQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
+ D ++ G++L ++G +P FF T E
Sbjct: 188 ILRQGYGKPVDWWAMGIILYEFLVGCVP---FFGDTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G VY G+ +A K+V P +S +K++ + EI +
Sbjct: 10 LGQGAFGRVYLC-YDVDTGRELAAKQVQFDP---------ESPETSKEVSALECEIQLLK 59
Query: 405 QIRHRNLLPLLAHMA-RPDCHLLVY-EFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
++H ++ + R + L ++ E+M GS++D L + L K +
Sbjct: 60 NLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQI 115
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD-AQTHITTSNVAGT 521
G+ YLH + I+HRD+K AN+L D ++ DFG +K + + +V GT
Sbjct: 116 LEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+++PE + K D++S G + ++ + P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 426 LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485
+V E+M G L +++++ + W AR A V L+ +H + IHRD+KP
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK---W-ARFYTA-EVVLALDAIH---SMGFIHRDVKPD 171
Query: 486 NVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK----FTDKCDI 541
N+LLD ++ADFG M + + + GT YI+PE ++ + +CD
Sbjct: 172 NMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230
Query: 542 YSFGVLLAVLVMGRLP 557
+S GV L +++G P
Sbjct: 231 WSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 7e-08
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 16/110 (14%)
Query: 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480
H+L+ +++K+G L D+L + +L KI + L LH HN IIH
Sbjct: 81 LKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEALNDLH-KHN--IIHN 133
Query: 481 DLKPANVLLDDDME-ARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPE 528
D+K NVL D + + D+GL K I T S GT+ Y +PE
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 426 LVYEFMKNGSLQDILNDVSQG-------RRELDWLARHKIALG-VACGLEYLHISHNPRI 477
L Y F + L IL+ V+ G +RE + ++ + + L++LH I
Sbjct: 70 LHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGI 126
Query: 478 IHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK--F 535
I+RD+K N+LLD + + DFGL+K + S GT+ Y+APE +
Sbjct: 127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGSGGH 185
Query: 536 TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENP 583
D +S GVL L+ G P F E+ S + R ++ S+ P
Sbjct: 186 DKAVDWWSLGVLTFELLTGASP---FTVDGEQNSQSEISRRILKSKPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEK+G G VYK + NG+++A+K + ++ T IR E +
Sbjct: 10 LEKLGEGSYATVYKG-ISRINGQLVALKVISMKTEEGVPFT------------AIR-EAS 55
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++H N++ L + + V+E+M D+ + Q L
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA--KAMPDAQTHITTSNVA 519
+ GL Y+H H I+HRDLKP N+L+ E ++ADFGLA K++P +QT+ +S V
Sbjct: 112 LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTY--SSEVV 165
Query: 520 GTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
T+ Y P+ ++ DI+ G + ++ G+
Sbjct: 166 -TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ VA G+E+L + + IHRDL N+LL ++ +I DFGLA+ + ++ +
Sbjct: 179 SFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ ++APE +T + D++SFGVLL
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLL 265
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G V K + +++AIKK KD+ E EE + ++++ +R+
Sbjct: 9 VGEGAYGVVLKCRHKETK-EIVAIKKF----KDSEE-NEEVKETTLRELKMLRT------ 56
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
++ N++ L R LV+E+++ L+ +L ++ G + K+ +
Sbjct: 57 -LKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNG------VPPEKVRSYIYQ 108
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGY 524
++ +H H I+HRD+KP N+L+ + ++ DFG A+ + + T VA T Y
Sbjct: 109 LIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWY 167
Query: 525 IAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+PE + D++S G +L L G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 18/160 (11%)
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRREL---- 450
Q E + ++ H ++ A D ++ E+ + L L ++ + L
Sbjct: 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ 107
Query: 451 --DWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
+W ++ LGV H H RI+HRDLK N+ L +++ +I DFG+++ +
Sbjct: 108 VCEWFI--QLLLGV-------HYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG 157
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ TT GT Y++PE + + K DI+S G +L
Sbjct: 158 SCDLATT--FTGTPYYMSPEALKHQGYDSKSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +G G G V+ A + K +A+KK++ D + ++ EI
Sbjct: 10 LRPLGCGSNGLVFSA-VDSDCDKRVAVKKIVL--TDP------------QSVKHALREIK 54
Query: 402 TVGQIRHRNLLPL---LAHMARPDCHLL-----------VYEFMKNGSLQDILNDVSQGR 447
+ ++ H N++ + L + V E+M+ D+ N + QG
Sbjct: 55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGP 110
Query: 448 RELDWLARHKIAL---GVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLA 503
L+ L + GL+Y+H S N ++HRDLKPANV ++ +D+ +I DFGLA
Sbjct: 111 -----LSEEHARLFMYQLLRGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLA 162
Query: 504 KAM-PDAQTHITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+ + P S T Y +P +T D+++ G + A ++ G+
Sbjct: 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 33/86 (38%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 127 LNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGF-LKYFPNLEHLSLAKNLFTGKV 185
L + N G IP+D+S L L+ ++LSGNS GN+ L +LE L L+ N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 186 PTSIRTFRNLQFFDFSGNSLLEGPIP 211
P S+ +L+ + +GNS L G +P
Sbjct: 483 PESLGQLTSLRILNLNGNS-LSGRVP 507
|
Length = 623 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 33/170 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+K+G G VYK G+++A+K++ ++ A T IR E +
Sbjct: 10 LDKLGEGSYATVYKGR-SKLTGQLVALKEIRLEHEEGAPFT------------AIR-EAS 55
Query: 402 TVGQIRHRNLLPL--LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDW----LAR 455
+ ++H N++ L + H + LV+E++ D+ Q +D L+
Sbjct: 56 LLKDLKHANIVTLHDIIHTKK--TLTLVFEYLDT--------DLKQ---YMDDCGGGLSM 102
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
H + L + L L H R++HRDLKP N+L+ + E ++ADFGLA+A
Sbjct: 103 HNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 21/161 (13%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM-RQIRSEINTV 403
I G G+VY +N K+ A+K V + + ++NK M Q+++E + +
Sbjct: 12 ISRGAFGKVYLGR-KKNNSKLYAVKVV------------KKADMINKNMVHQVQAERDAL 58
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+ ++ L + + LV E++ G ++ +L+ E+ A I+ VA
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVA 114
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504
L+YLH H IIHRDLKP N+L+ ++ ++ DFGL+K
Sbjct: 115 LALDYLH-RHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
VA G+E+L + + IHRDL N+LL ++ +I DFGLA+ + ++ +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ ++APE +T + D++SFGVLL
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLL 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 41/120 (34%), Positives = 56/120 (46%), Gaps = 4/120 (3%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
L + LS L L L+ N + DL PP+I LE L++ NN + S LS+L L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKISDL-PPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 150 VLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
L+LS N + NLE L L+ N +S+ + NL+ D SGNSL
Sbjct: 236 GLELSNNKLEDLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNAL 293
|
Length = 394 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 2e-07
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 388 LLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR 447
L ++ Q+ E+N + +++H+N++ + L Y M+ D+ ++ +
Sbjct: 51 LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL-YILMEFCDAGDLSRNIQKCY 109
Query: 448 RELDWLARHKIALGVACGLEYLHISHN-------PRIIHRDLKPANVLLDDDME------ 494
+ + H I L L HN R++HRDLKP N+ L +
Sbjct: 110 KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169
Query: 495 -----------ARIADFGLAKAMP-DAQTHITTSNVAGTVGYIAPE--YHQTLKFTDKCD 540
A+I DFGL+K + ++ H + GT Y +PE H+T + DK D
Sbjct: 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAH----SCVGTPYYWSPELLLHETKSYDDKSD 225
Query: 541 IYSFGVLLAVLVMGRLP---SDDFFQHTEEM 568
+++ G ++ L G+ P +++F Q E+
Sbjct: 226 MWALGCIIYELCSGKTPFHKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 36/227 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
L+ +G+G G+V+ + GK+ A+K + + AA + + K + R+E
Sbjct: 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVL----QKAALVQKA------KTVEHTRTE 54
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG-------RRELDW 452
N + +R P L L Y F L IL+ VS G +R+
Sbjct: 55 RNVLEHVRQS---PFLV--------TLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS 103
Query: 453 LARHKIALG-VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
+ G + LE+LH I++RD+K N+LLD + + DFGL+K +
Sbjct: 104 EDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKC-DIYSFGVLLAVLVMGRLP 557
T S GT+ Y+APE + K D +S G+L+ L+ G P
Sbjct: 161 ERTYS-FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
VA G+E+L + + IHRDL N+LL ++ +I DFGLA+ + ++ +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ ++APE +T + D++SFGVLL
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLL 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 41/132 (31%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 428 YEFMKNGSLQDILND-VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486
Y+ + ++++L+D S+G LD L+ VA G+E+L S N +HRDL N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLS---FTYQVARGMEFL-ASKN--CVHRDLAARN 267
Query: 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGV 546
VLL +I DFGLA+ + +++ + V ++APE +T D++S+G+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 547 LL-AVLVMGRLP 557
LL + +G P
Sbjct: 328 LLWEIFSLGGTP 339
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 342 LEKIGSGGCGEVY----KAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
L ++G G G VY + + G +A+K V ++A L E + LN
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV----NESASLRER-IEFLN------- 58
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDV------SQGRRELD 451
E + + +++ LL +++ L+V E M +G L+ L + + GR
Sbjct: 59 -EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
++A +A G+ YL+ + +HRDL N ++ D +I DFG+ + + +
Sbjct: 118 LQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ V ++APE + FT D++SFGV+L
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 3/87 (3%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
VA G+ +L S N IHRDL N+LL +I DFGLA+ + + ++ N
Sbjct: 223 VAKGMSFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
V ++APE +T + D++S+G+LL
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILL 306
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 57/254 (22%), Positives = 97/254 (38%), Gaps = 52/254 (20%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
D SL+ IG G GEV + G + A+K + + L +++ I
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQ-KKDTGHIYAMK-----------ILRKADMLEKEQVAHI 48
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
R+E + + + ++ + L+ EF+ G + +L + D L+
Sbjct: 49 RAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-------MKKDTLSEE 101
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ------ 510
+A + + H IHRD+KP N+LLD +++DFGL + A
Sbjct: 102 ATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 511 --THITTSNVA-------------------------GTVGYIAPEYHQTLKFTDKCDIYS 543
TH S+ + GT YIAPE + CD +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 544 FGVLLAVLVMGRLP 557
GV++ +++G P
Sbjct: 222 LGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/262 (22%), Positives = 104/262 (39%), Gaps = 58/262 (22%)
Query: 360 GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419
G+ G++ +KV A + + LL ++ +++E + + + + ++ L
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ 71
Query: 420 RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIH 479
D V +++ G + +L + G D LAR IA + C +E +H IH
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLL--IRMGIFPED-LARFYIA-ELTCAVESVH---KMGFIH 124
Query: 480 RDLKPANVLLDDDMEARIADFGLAKAM----------------------------PD--- 508
RD+KP N+L+D D ++ DFGL P
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 509 ------------AQTH--ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMG 554
A+ H ++ GT YIAPE +T CD +S GV+L +++G
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
Query: 555 RLPSDDFFQHT---EEMSLVKW 573
+ P F T +M ++ W
Sbjct: 245 QPP---FLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
++G G G VY+ G + I+ +AA + E + LN+ + E N
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER-IEFLNEA--SVMKEFNCH 69
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL--------NDVSQGRRELDWLAR 455
+R LL +++ L++ E M G L+ L N+ Q L +
Sbjct: 70 HVVR------LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI- 122
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
++A +A G+ YL+ + + +HRDL N ++ +D +I DFG+ + + + +
Sbjct: 123 -QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
V +++PE + FT D++SFGV+L
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 33/126 (26%), Positives = 50/126 (39%), Gaps = 38/126 (30%)
Query: 473 HNPRIIHRDLKPANVLLDDDMEARIADFGL----------------AKAMPDAQTHITTS 516
H IHRD+KP N+LLD +++DFGL + A+P +
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177
Query: 517 N--------------------VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRL 556
GT YIAPE + +CD +S GV++ +++G
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237
Query: 557 P--SDD 560
P SD+
Sbjct: 238 PFCSDN 243
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 40/165 (24%), Positives = 64/165 (38%), Gaps = 40/165 (24%)
Query: 426 LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485
L+ EF+ G + +L + D L + +A + + H IHRD+KP
Sbjct: 78 LIMEFLPGGDMMTLL-------MKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPD 130
Query: 486 NVLLDDDMEARIADFGLAKAMPDAQ-------------THITTSNV-------------- 518
N+LLD +++DFGL + A + T N+
Sbjct: 131 NLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRR 190
Query: 519 ------AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT YIAPE + CD +S GV++ +++G P
Sbjct: 191 QLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
VA G+E+L S N +HRDL NVL+ + +I DFGLA+ + +I+ +
Sbjct: 248 VANGMEFL-ASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDF 561
+ ++APE +T D++SFG+LL + +G P +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 4e-06
Identities = 20/59 (33%), Positives = 29/59 (49%)
Query: 100 LRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSF 158
L+ L L+NN L + L++L++ N + P S L LR LDLSGN+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 41/166 (24%), Positives = 73/166 (43%), Gaps = 20/166 (12%)
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLV--------YEFMKNGSLQDILNDVSQG 446
Q+ +EI +G++ H N+L + + ++ Y FM + +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-------WK 261
Query: 447 RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM 506
R L R I + C +EY+H + ++IHRD+K N+ L+ D + + DFG A
Sbjct: 262 DRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 507 PDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV 552
+ V GTV +PE + + DI+S G++L ++
Sbjct: 318 EKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 57/232 (24%), Positives = 105/232 (45%), Gaps = 28/232 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIA-----IKKVIQPPKDAAELTEEDSKLLNKKMRQ-I 396
EK+G G GEV+ E+ ++K +P A ++ D+ NK R
Sbjct: 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG-RPLLVAVKILRPDA---NKNARNDF 66
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE------- 449
E+ + +++ N++ LL D ++ E+M+NG L L+ +E
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 450 --------LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501
+ + + +AL +A G++YL S N +HRDL N L+ +++ +IADFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLS-SLN--FVHRDLATRNCLVGENLTIKIADFG 183
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553
+++ + + + ++A E KFT D+++FGV L ++M
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 39/148 (26%), Positives = 62/148 (41%), Gaps = 16/148 (10%)
Query: 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRREL--DWLARHKIALGVACGLE 467
N++ L ++ D LV + + G L ++ E W A +AL +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL------D 99
Query: 468 YLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAP 527
LH I+ RDL P N+LLDD ++ F + D+ N+ Y AP
Sbjct: 100 ALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 528 EYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
E + T+ CD +S G +L L+ G+
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 3e-05
Identities = 22/60 (36%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 147 RLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L+ LDLS N + G K PNL+ L L+ N T P + +L+ D SGN+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 344 KIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
K+G G G VYKA+ G + + A+K++ E + + R EI
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI------------EGTGISMSACR----EIAL 51
Query: 403 VGQIRHRNLLPL----LAHMARPDCHLLVYEFMKNGSLQDI-LNDVSQGRRELDWLARHK 457
+ +++H N++ L L+H R L++++ ++ I + S+ ++ L R
Sbjct: 52 LRELKHPNVISLQKVFLSHADRK--VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 109
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR----IADFGLAKAMPDAQTHI 513
+ + L+ +H H ++HRDLKPAN+L+ + R IAD G A+ +
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 514 TTSN-VAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
+ V T Y APE + +T DI++ G + A L L S+ F +E
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL----LTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 344 KIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
K+G G G VYKA+ G + K A+K++ E + + R EI
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI------------EGTGISMSACR----EIAL 51
Query: 403 VGQIRHRNLLPL----LAHMARPDCHLLVYEFMKNGSLQDI-LNDVSQGRRELDWLARHK 457
+ +++H N++ L L+H R L++++ ++ I + S+ ++ L R
Sbjct: 52 LRELKHPNVIALQKVFLSHSDRK--VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM 109
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR----IADFGLAKAMPDAQTHI 513
+ + L+ +H H ++HRDLKPAN+L+ + R IAD G A+ +
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 514 TTSN-VAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
+ V T Y APE + +T DI++ G + A L L S+ F +E
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL----LTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 6/86 (6%)
Query: 466 LEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYI 525
LE L H IIHRD+K N+ LD+ A + DFG A + H T G G +
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTPQCYGWSGTL 251
Query: 526 ---APEYHQTLKFTDKCDIYSFGVLL 548
+PE + K DI+S G++L
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVL 277
|
Length = 392 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 466 LEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYI 525
++YLH RIIHRD+K N+ ++ + + DFG A P AGT+
Sbjct: 195 IQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIATN 250
Query: 526 APEYHQTLKFTDKCDIYSFGVLL 548
APE + DI+S G++L
Sbjct: 251 APELLARDPYGPAVDIWSAGIVL 273
|
Length = 391 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 54/229 (23%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG+G G VY+A ++ K +AIKKV+Q P+ K R E+ +
Sbjct: 74 IGNGSFGVVYEAICIDTSEK-VAIKKVLQDPQ--------------YKNR----ELLIMK 114
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG-RRELDWLARHKIALGV- 462
+ H N++ L +C + KN L ++ + Q + + AR+ AL +
Sbjct: 115 NLNHINII-FLKDYYYTEC---FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF 170
Query: 463 --------AC-GLEYLHISHNPRIIHRDLKPANVLLDDDMEA-RIADFGLAKAMPDAQTH 512
C L Y+H + I HRDLKP N+L+D + ++ DFG AK + Q
Sbjct: 171 LVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR- 226
Query: 513 ITTSNVAGTVGYIAPEYHQ-------TLKFTDKCDIYSFGVLLAVLVMG 554
+V YI +++ +T D++S G ++A +++G
Sbjct: 227 --------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 34/130 (26%), Positives = 49/130 (37%), Gaps = 45/130 (34%)
Query: 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLAK--------------------AMPDAQTH 512
H IHRD+KP N+L+D D ++ DFGL +M +
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 513 ITTSN-------------------------VAGTVGYIAPEYHQTLKFTDKCDIYSFGVL 547
SN + GT YIAPE +T CD +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 548 LAVLVMGRLP 557
L +++G+ P
Sbjct: 238 LFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 40/136 (29%), Positives = 49/136 (36%), Gaps = 23/136 (16%)
Query: 84 RELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTI----- 138
L P I LS L EL L+NNS+++LL + + K L L + NN+
Sbjct: 195 GNKISDLPPEIELLSALEELDLSNNSIIELLSS-LSNLKNLSGLELSNNKLEDLPESIGN 253
Query: 139 ----------------PSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFT 182
S L SL LR LDLSGNS S L + L L L T
Sbjct: 254 LSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL-ELLLNLLLT 312
Query: 183 GKVPTSIRTFRNLQFF 198
K L
Sbjct: 313 LKALELKLNSILLNNN 328
|
Length = 394 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 37/143 (25%), Positives = 55/143 (38%), Gaps = 22/143 (15%)
Query: 84 RELTGVLSPSIGRLSELRELSLANNSLVD----LLPPQIVDCKKLEILNVQNNQFSGTIP 139
L L + L +EL+LANN + D L + LE+L++ NN +
Sbjct: 155 EALAKAL-RANRDL---KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210
Query: 140 SDLS----SLIRLRVLDLSGNSFSGN------LGFLKYFPNLEHLSLAKNLFT----GKV 185
S L+ SL L VL+L N+ + L +L LSL+ N T +
Sbjct: 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDL 270
Query: 186 PTSIRTFRNLQFFDFSGNSLLEG 208
+ +L D GN E
Sbjct: 271 AEVLAEKESLLELDLRGNKFGEE 293
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 48/135 (35%), Positives = 67/135 (49%), Gaps = 28/135 (20%)
Query: 86 LTGVLSPSIGRLSELRELSLANN-SLVDLLPPQIVDCKKLEILNVQNNQFSGTIPS--DL 142
L +LSPS L L L++ SLV+L P I + KLE L ++N T+P+ +L
Sbjct: 772 LMTMLSPS------LTRLFLSDIPSLVEL-PSSIQNLHKLEHLEIENCINLETLPTGINL 824
Query: 143 SSLIRLRVLDLSGNSFSGNLGFLKYFP----NLEHLSLAKNLFTG--KVPTSIRTFRNLQ 196
SL LDLSG S L+ FP N+ L+L++ TG +VP I F NL
Sbjct: 825 ESLES---LDLSGCS------RLRTFPDISTNISDLNLSR---TGIEEVPWWIEKFSNLS 872
Query: 197 FFDFSGNSLLEGPIP 211
F D +G + L+
Sbjct: 873 FLDMNGCNNLQRVSL 887
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 24/84 (28%), Positives = 42/84 (50%), Gaps = 12/84 (14%)
Query: 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480
P+ ++V E+++ L+D++N E L+R +G G H+ IIH
Sbjct: 71 PENFIIVMEYIEGEPLKDLIN---SNGMEELELSR---EIGRLVGK-----LHSAGIIHG 119
Query: 481 DLKPANVLLDDDMEARIADFGLAK 504
DL +N++L + + DFGLA+
Sbjct: 120 DLTTSNMILSGG-KIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 8/85 (9%)
Query: 466 LEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA-----G 520
LEY+H H I H D+KP N+++D + I D+G+A HI S G
Sbjct: 139 LEYIH-EHG--ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRG 195
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFG 545
T+ Y + H T + D+ S G
Sbjct: 196 TLYYAGLDAHNGACVTRRGDLESLG 220
|
Length = 294 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 9/99 (9%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
+ G + PS+G ++ L L L+ NS +P + L ILN+ N SG +P+ L
Sbjct: 454 IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG- 512
Query: 146 IRLRVLDLSGNSFSGNLGFLKYFPNLE----HLSLAKNL 180
R+L + +F+ N G L P L HLS+ +
Sbjct: 513 ---RLLHRASFNFTDNAG-LCGIPGLRACGPHLSVGAKI 547
|
Length = 623 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 33/165 (20%), Positives = 61/165 (36%), Gaps = 45/165 (27%)
Query: 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLA----------------------------K 504
H IHRD+KP N+L+D +++DFGL+
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 505 AMPDAQTHITTSN-----------------VAGTVGYIAPEYHQTLKFTDKCDIYSFGVL 547
++ ++T S+ GT YIAPE + +CD +S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 548 LAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLL 592
+ ++G P H ++ W + ++ +++A+ L
Sbjct: 238 MFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDL 282
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.002
Identities = 16/46 (34%), Positives = 24/46 (52%), Gaps = 7/46 (15%)
Query: 100 LRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L L L+NN + DL P + + LE L++ N+ +DLS L
Sbjct: 3 LETLDLSNNQITDL--PPLSNLPNLETLDLSGNKI-----TDLSPL 41
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 26/76 (34%), Positives = 39/76 (51%)
Query: 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT 532
H IIHRD+K NVL++ + + DFG A + + +AGTV APE
Sbjct: 277 HGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG 336
Query: 533 LKFTDKCDIYSFGVLL 548
+T DI+S G+++
Sbjct: 337 DPYTPSVDIWSAGLVI 352
|
Length = 461 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 10/86 (11%)
Query: 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480
P C + EFM G + I +++ Q +R+++ + + V GL LH I+HR
Sbjct: 284 PGC---LEEFMMAG--KKIPDNMPQDKRDINVI--KGVMRQVLTGLRKLH---RIGIVHR 333
Query: 481 DLKPANVLLDDDMEARIADFGLAKAM 506
D+KP N+L+ D + +I DFG A M
Sbjct: 334 DIKPENLLVTVDGQVKIIDFGAAVDM 359
|
Length = 507 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 633 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.48 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.48 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.48 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.45 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.43 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.41 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.41 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.23 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.22 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.15 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.15 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.14 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.08 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.02 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.98 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.77 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.71 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.65 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.62 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.53 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.43 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.36 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.34 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.34 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.31 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.27 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-58 Score=539.09 Aligned_cols=265 Identities=27% Similarity=0.475 Sum_probs=213.2
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.+....+...+.||+|+||.||+|+.. .++..||||++..... ....|++++++++|||||
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~------------------~~~~~~~~l~~l~HpnIv 746 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNS------------------IPSSEIADMGKLQHPNIV 746 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCcc------------------ccHHHHHHHhhCCCCCcc
Confidence 333456777889999999999999864 4789999998853221 112357788999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+++++|.+.+..++||||+++|+|.++++. ++|..+.+|+.|+++||+|||+.++++|+||||||+||+++.+
T Consensus 747 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~ 819 (968)
T PLN00113 747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819 (968)
T ss_pred eEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC
Confidence 999999999999999999999999999963 8999999999999999999986668999999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+++. ||.+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||+.... ....+.+
T Consensus 820 ~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~ 890 (968)
T PLN00113 820 DEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVE 890 (968)
T ss_pred CceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHH
Confidence 888875 6654433211 223678999999999999999999999999999999999999965332 3445667
Q ss_pred HHHHhhccCCcchhhhhhhhh--cCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLE--NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
|.+...........+|+.+.. ....++...+.+++.+||+.||++||||+|++++|+++.
T Consensus 891 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 891 WARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 776655444444445554422 233456677899999999999999999999999998873
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-53 Score=432.74 Aligned_cols=279 Identities=38% Similarity=0.636 Sum_probs=242.3
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..++++|...+.||+|+||.||+|.+. +|..||||++....... .++|.+|+.++.+++|||+|
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~~--------------~~eF~~Ei~~ls~l~H~Nlv 134 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQG--------------EREFLNEVEILSRLRHPNLV 134 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCcc--------------hhHHHHHHHHHhcCCCcCcc
Confidence 778999999999999999999999986 77999999875443210 24599999999999999999
Q ss_pred ccceeeecCC-ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 413 PLLAHMARPD-CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 413 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++|||.+.+ +.+||||||++|+|.++++..... .++|..|.+||.++|+||+|||+.+.++||||||||+|||+|+
T Consensus 135 ~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~ 212 (361)
T KOG1187|consen 135 KLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE 212 (361)
T ss_pred cEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence 9999999988 599999999999999999864322 8999999999999999999999888889999999999999999
Q ss_pred CCceEEcccccccccCC-CCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPD-AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
++++||+|||+|+..+. ...... .. .||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... ......+
T Consensus 213 ~~~aKlsDFGLa~~~~~~~~~~~~-~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l 289 (361)
T KOG1187|consen 213 DFNAKLSDFGLAKLGPEGDTSVST-TV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSL 289 (361)
T ss_pred CCCEEccCccCcccCCccccceee-ec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccH
Confidence 99999999999976654 222111 11 79999999999999999999999999999999999999887543 2345568
Q ss_pred HHHHHHhhccCCcchhhhhhhh-hcCCH-HHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLL-ENGYE-EQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~-~~~~~-~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.+|...........+++|+.+. ..... +++..+..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999988888899999999987 44443 68889999999999999999999999999997653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=373.06 Aligned_cols=255 Identities=28% Similarity=0.459 Sum_probs=212.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++++.++.||+|..|+|||++++ .+++.+|+|.+..... ....+++.+|+++++..+||+||+++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~~~~-------------~~~~~Qi~rEl~il~~~~spyIV~~yg 144 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHK-PTGKIYALKVILLNID-------------PALQKQILRELEILRSCQSPYIVGFYG 144 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEc-CCCeEEEEEeecccCC-------------HHHHHHHHHHHHHHhhCCCCCeeeEeE
Confidence 45677899999999999999986 5799999999843321 122789999999999999999999999
Q ss_pred eeecCC-ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 417 HMARPD-CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 417 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
.|..+. ...++||||++|||++++... ..+++...-+|+.+|++||.||| ++++||||||||+|||++..|++
T Consensus 145 aF~~~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeV 218 (364)
T KOG0581|consen 145 AFYSNGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEV 218 (364)
T ss_pred EEEeCCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCE
Confidence 999988 599999999999999999863 56999999999999999999996 46899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||||||.++.+.+. .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ........+.+.
T Consensus 219 KicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~ 292 (364)
T KOG0581|consen 219 KICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLC 292 (364)
T ss_pred EeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHH
Confidence 99999999987665 224578999999999999999999999999999999999999998653 123344455555
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..+..+. +.... ...++..++..||++||.+|||++++++
T Consensus 293 ~Iv~~ppP~------lP~~~---fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 293 AIVDEPPPR------LPEGE---FSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHhcCCCCC------CCccc---CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 555444332 11111 2233778888999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=388.19 Aligned_cols=258 Identities=32% Similarity=0.509 Sum_probs=209.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeE-EEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
+++...+.||+|+||+||+|.++ |+. ||||++.....+... .++|.+|+.++.+++|||||+++
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~------------~~~f~~E~~il~~l~HpNIV~f~ 105 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDES------------RKAFRREASLLSRLRHPNIVQFY 105 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHH------------HHHHHHHHHHHHhCCCCCeeeEE
Confidence 44555677999999999999984 555 999998655432211 56899999999999999999999
Q ss_pred eeeecCC-ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCCeEecCCC
Q 006739 416 AHMARPD-CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR-IIHRDLKPANVLLDDDM 493 (633)
Q Consensus 416 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~-ivH~Dikp~Nill~~~~ 493 (633)
|+|.++. ..++|||||++|+|.++++.. .+..+++..+..++.|||+||.|| |+.+ ||||||||+|||++.++
T Consensus 106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDLK~~NiLv~~~~ 180 (362)
T KOG0192|consen 106 GACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDLKSDNILVDLKG 180 (362)
T ss_pred EEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeecccChhhEEEcCCC
Confidence 9999988 799999999999999999864 357899999999999999999999 6667 99999999999999997
Q ss_pred -ceEEcccccccccCCCCCcceecccccCcccccccccc--cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 494 -EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ--TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 494 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
++||+|||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+... ...
T Consensus 181 ~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~ 254 (362)
T KOG0192|consen 181 KTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQV 254 (362)
T ss_pred CEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHH
Confidence 99999999998766532 2334478999999999999 66899999999999999999999999987532 122
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
...+-. ...++. .+......+..++.+||+.||++||++.+++..|+.+.
T Consensus 255 ~~~v~~--~~~Rp~----------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 255 ASAVVV--GGLRPP----------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HHHHHh--cCCCCC----------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 111111 111111 01113334778888999999999999999999998763
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=354.71 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=211.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|++.++||+|+||+||+++.. .+|..+|.|.+.-.. ...++.++...|+.++++++|||||+++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~-~~g~l~a~K~i~f~~------------md~k~rq~~v~Ei~lLkQL~HpNIVqYy 84 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCL-LDGKLVALKKIQFGM------------MDAKARQDCVKEISLLKQLNHPNIVQYY 84 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeec-cCcchhhhhhcchhh------------ccHHHHHHHHHHHHHHHhcCCchHHHHH
Confidence 457899999999999999999864 689999999985322 2234477889999999999999999999
Q ss_pred ee-eecCC-ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCeEecC
Q 006739 416 AH-MARPD-CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR--IIHRDLKPANVLLDD 491 (633)
Q Consensus 416 ~~-~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~Dikp~Nill~~ 491 (633)
++ +.+.. .+++||||+..|+|..+++..+..++.+++..+|++..|+++||.++|+.- ++ |+||||||.||+++.
T Consensus 85 ~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~ 163 (375)
T KOG0591|consen 85 AHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTA 163 (375)
T ss_pred HHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcC
Confidence 93 44444 488999999999999999998888999999999999999999999995321 44 899999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+|.+||+|||+++.+...... ....+|||.||+||.+...+|+.++||||+||++|||..-+.||.+. ...+++
T Consensus 164 ~gvvKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~ 237 (375)
T KOG0591|consen 164 NGVVKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLC 237 (375)
T ss_pred CCceeeccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHH
Confidence 999999999999998765433 24578999999999999999999999999999999999999998763 334444
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
+-+.+. + .+. +..+.++ ..+..++..|+..||+.||+...++..+
T Consensus 238 ~KI~qg---d-~~~-----~p~~~YS---~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 238 KKIEQG---D-YPP-----LPDEHYS---TDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHHcC---C-CCC-----CcHHHhh---hHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 443332 1 111 1112222 3467788899999999999955544433
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=358.89 Aligned_cols=203 Identities=31% Similarity=0.500 Sum_probs=180.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
...+|...+.||.|+||.||+|+++ .++..||||.+.+.. ...+..+-...|+.+++.++|||||.+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~-~~~~~VAIK~i~~~~------------l~~k~~e~L~~Ei~iLkel~H~nIV~l 74 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHK-KSGTEVAIKCIAKKK------------LNKKLVELLLSEIKILKELKHPNIVRL 74 (429)
T ss_pred ccccceehhhccCcceEEEEEeEec-cCCceEEeeeehhhc------------cCHHHHHHHHHHHHHHHhcCCcceeeE
Confidence 3468888999999999999999986 567999999985432 122335667899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC--
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD-- 492 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~-- 492 (633)
++++..++..|+|||||.||||.+++++ ...+++.....++.|+|.||++| |+++||||||||.|||++..
T Consensus 75 ~d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~ 147 (429)
T KOG0595|consen 75 LDCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTAR 147 (429)
T ss_pred EEEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCC
Confidence 9999999999999999999999999987 34699999999999999999999 89999999999999999864
Q ss_pred ----CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 493 ----MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 493 ----~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
..+||+|||+|+.+.+.... ...+|++-|||||++..+.|+.|+|+||+|+++||+++|+.||+.
T Consensus 148 ~~~~~~LKIADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 148 NDTSPVLKIADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CCCCceEEecccchhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 46899999999998865543 347899999999999999999999999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=365.15 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=206.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|.+.+.||+|+||.|-+|. ++.+|+.||||++.+......+.. ......+++|+++|++++|||||+++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~-e~~tgk~vAiKIi~krk~~~~s~~-------~~~~~~v~~EieILkkL~HP~IV~~~ 242 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAY-EKKTGKQVAIKIINKRKSTGCSRA-------IAKTRDVQNEIEILKKLSHPNIVRIK 242 (475)
T ss_pred cceeEeeeeecCCceeEEEEEE-EcccCcEEEeeeeehhhccccccc-------ccchhhhHHHHHHHHhcCCCCEEEEe
Confidence 4567888999999999999996 557999999999987654332210 00133478999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC---
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD--- 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~--- 492 (633)
++|..++..|+|||||+||+|.+.+-. ...+.+..-+.++.|++.|+.|| |++||+||||||+|||+..+
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCCcc
Confidence 999999999999999999999999875 44577777899999999999999 89999999999999999866
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCC---CCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF---TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
..+||+|||+|+..+.... +...+||+.|.|||++.+..+ ..++|+||+||++|-+++|.+||.+..... +
T Consensus 316 ~llKItDFGlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---s 389 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---S 389 (475)
T ss_pred eEEEecccchhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---c
Confidence 6799999999999875443 345899999999999987553 347899999999999999999998754321 1
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+-+ ..+.-.. ....+.+..++..++|.+||..||++|||+.|+++
T Consensus 390 l~eQI---~~G~y~f-------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 LKEQI---LKGRYAF-------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHH---hcCcccc-------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 21111 1111000 01123344556889999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=373.86 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=214.8
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....+.+...+.||+|.||.||.|.++ ....||+|.++..... .++|.+|+++|.+|+|+|||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~--~~~~vavk~ik~~~m~---------------~~~f~~Ea~iMk~L~H~~lV 264 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWN--GSTKVAVKTIKEGSMS---------------PEAFLREAQIMKKLRHEKLV 264 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEc--CCCcccceEEeccccC---------------hhHHHHHHHHHHhCcccCeE
Confidence 344556778899999999999999995 4458999998765332 35688999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+++|+|..++.+|||||||+.|+|.++|+. ..+..+...+.+.++.|||+||+|| +++++|||||.++|||++++
T Consensus 265 ~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~ 339 (468)
T KOG0197|consen 265 KLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDED 339 (468)
T ss_pred EEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccC
Confidence 999999998899999999999999999986 3467789999999999999999999 89999999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
..+||+|||+|+...++... ......-...|.|||.+..++++.|||||||||+||||+| |+.||..... .
T Consensus 340 ~~vKIsDFGLAr~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------~ 411 (468)
T KOG0197|consen 340 LVVKISDFGLARLIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------E 411 (468)
T ss_pred ceEEEcccccccccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-------H
Confidence 99999999999965554332 2222334668999999999999999999999999999999 9999876432 2
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.+..+..+.+.+. ++.+...+.+++..||+.+|++|||++.+...|+++.
T Consensus 412 ev~~~le~GyRlp~----------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 412 EVLELLERGYRLPR----------PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HHHHHHhccCcCCC----------CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 33444444444332 2223445888999999999999999999999998863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=353.25 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=206.1
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|+++++||+|+||+||+++.+ ++++.||+|++++.... ..+..+..+.|..++.+++||+||++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv-----------~~~e~~~~~~Er~IL~~v~hPFiv~l 90 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIV-----------EKKEVRHTKAERNILSKIKHPFIVKL 90 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhh-----------hhhhHHHHHHHHHHHHhCCCCcEeee
Confidence 3578999999999999999999875 78999999999664321 11346788999999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+-.|++++.+|+|+||+.||.|...|.+ +..+++..+.-++..|+.||.|| |+.+||||||||+|||+|.+|+
T Consensus 91 ~ysFQt~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GH 163 (357)
T KOG0598|consen 91 IYSFQTEEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGH 163 (357)
T ss_pred EEecccCCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCc
Confidence 9999999999999999999999999975 56699999999999999999999 8999999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
++|+|||+++..-..... +...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||... +..+++
T Consensus 164 i~LtDFgL~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-------~~~~~~ 234 (357)
T KOG0598|consen 164 IKLTDFGLCKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-------DVKKMY 234 (357)
T ss_pred EEEeccccchhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-------cHHHHH
Confidence 999999999965444332 24479999999999999999999999999999999999999999763 233444
Q ss_pred HHhhccC-Cc-chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC
Q 006739 575 RNVMTSE-NP-TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP 619 (633)
Q Consensus 575 ~~~~~~~-~~-~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP 619 (633)
+.+.... .. +..++ ....+++...++.||++|.
T Consensus 235 ~~I~~~k~~~~p~~ls------------~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 235 DKILKGKLPLPPGYLS------------EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHhcCcCCCCCccCC------------HHHHHHHHHHhccCHHHhc
Confidence 4444433 11 11122 2267788899999999996
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=369.93 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=208.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
..|...+.||+|||+.||+++.. .+|+.||+|++.+..... ....+.+.+|+++-+.|+|||||++++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-~tge~~A~KvVpk~~l~k-----------~~~reKv~~EIeIHr~L~HpnIV~f~~ 85 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-DTGEVVAVKVVPKKLLKK-----------PKQREKVLNEIEIHRSLKHPNIVQFYH 85 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-CCCcEEEEEEeehHHhcC-----------cchHHHHHHHHHHHHhcCCCcEEeeee
Confidence 56899999999999999999862 489999999986533211 112567889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
+|++.+..|+|.|+|++++|..++++ .+++++.++..++.||+.||.|| |+.+|+|||||..|++++++.++|
T Consensus 86 ~FEDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 86 FFEDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred EeecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcEE
Confidence 99999999999999999999999985 56799999999999999999999 889999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+|..+..+.... ...+|||.|+|||++....++..+||||+||++|-|+.|++||+.... .+....++
T Consensus 159 IgDFGLAt~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v----kety~~Ik- 231 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV----KETYNKIK- 231 (592)
T ss_pred ecccceeeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH----HHHHHHHH-
Confidence 99999999887653332 347999999999999999999999999999999999999999976321 11111111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+...+..+ .....++|..+|+.||.+|||+++|++
T Consensus 232 -~~~Y~~P~~l------------s~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 -LNEYSMPSHL------------SAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -hcCccccccc------------CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122222211 223678999999999999999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=338.92 Aligned_cols=264 Identities=22% Similarity=0.363 Sum_probs=208.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+.|+.+.++|+|+||.||+++.+ ++|+.||||++.....+.. ..+-..+|++++++++|+|+|.++.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk-~TgqIVAIKkF~Esedd~~------------VkKIAlREIrmLKqLkH~NLVnLiE 68 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK-DTGQIVAIKKFVESEDDPV------------VKKIALREIRMLKQLKHENLVNLIE 68 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC-CcccEEEEEeeccCCccHH------------HHHHHHHHHHHHHhcccchHHHHHH
Confidence 45788899999999999999864 7899999999966543221 1456789999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
+|.....+++|+||++. ++-+-+... ...++...+.+++.|+++|+.|+ |+++||||||||+|||++.+|.+|
T Consensus 69 VFrrkrklhLVFE~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvK 141 (396)
T KOG0593|consen 69 VFRRKRKLHLVFEYCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVK 141 (396)
T ss_pred HHHhcceeEEEeeecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEE
Confidence 99999999999999987 444444432 34588899999999999999999 889999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|||||+|+.+....... +..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|..-|.+.. +.+..-.++
T Consensus 142 LCDFGFAR~L~~pgd~Y--TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S----DiDQLy~I~ 215 (396)
T KOG0593|consen 142 LCDFGFARTLSAPGDNY--TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS----DIDQLYLIR 215 (396)
T ss_pred eccchhhHhhcCCcchh--hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc----hHHHHHHHH
Confidence 99999999987443332 34678999999999887 789999999999999999999998876532 222222222
Q ss_pred Hhhc-----------------cCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMT-----------------SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~-----------------~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..++ +-..++.-+++-.+..++....-+.+++..|++.||++|++.++++.
T Consensus 216 ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 216 KTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 2111 11222233333344455555667899999999999999999999863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=351.97 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=208.7
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...+.|+.+++||+|.||.||+|+. ..+|+.||+|++.....+... .....+|+.+|++|.||||++
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~-~~tgkivALKKvr~d~~~~~~------------~~t~~REI~ILr~l~HpNIik 180 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARD-LETGKIVALKKVRFDNEKEGF------------PITAIREIKILRRLDHPNIIK 180 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeee-cccCcEEEEEEeecccCCCcc------------hHHHHHHHHHHHhcCCCcccc
Confidence 3457788999999999999999986 478999999999765533221 456789999999999999999
Q ss_pred cceeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 414 LLAHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 414 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+.+...+. ..+|+|+|||+. ||.-++.. ....++..++..++.|+++||+|+ |+++|+|||||.+|||||.
T Consensus 181 L~eivt~~~~~siYlVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn 253 (560)
T KOG0600|consen 181 LEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDN 253 (560)
T ss_pred eeeEEEecCCceEEEEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcC
Confidence 99998776 689999999976 88888864 356799999999999999999999 8999999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+|.+||+|||+|+++....... .+..+-|.+|+|||.+.+ ..|+.++|+||.|||+.||++|++.|.+..+ .+.
T Consensus 254 ~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE----veQ 328 (560)
T KOG0600|consen 254 NGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE----VEQ 328 (560)
T ss_pred CCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH----HHH
Confidence 9999999999999887655433 245678999999998887 5799999999999999999999999876432 222
Q ss_pred HHHHHHhhccC----Ccch------------hhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSE----NPTR------------AIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~----~~~~------------~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+-.+.+.. |... .....+.+ .+.......++++..+|..||++|.|+.++++
T Consensus 329 l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 329 LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 22232222221 1100 00011100 01112234678888999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=374.64 Aligned_cols=264 Identities=25% Similarity=0.426 Sum_probs=219.5
Q ss_pred hhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
...+....+.||+|.||+||+|+.. ..+...||||.++.... ++...+|++|+++++.++|||
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-------------~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-------------NQARQDFRREAELLAELQHPN 550 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-------------HHHHHHHHHHHHHHHhccCCC
Confidence 3455667789999999999999773 34567899999865442 123789999999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG----------RRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
||+++|.|.+++.+++|+|||..|||.++|...... ..+++..+.+.||.|||.||+|| -++..|||
T Consensus 551 IVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YL---s~~~FVHR 627 (774)
T KOG1026|consen 551 IVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYL---SSHHFVHR 627 (774)
T ss_pred eEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCccccc
Confidence 999999999999999999999999999999764431 23388999999999999999999 78889999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||..+|+|+.++..|||+|||+++.....+.++......-..+|||||.+..++|+++||||||||++||+++ |+.||.
T Consensus 628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 9999999999999999999999998887766654334445779999999999999999999999999999998 999987
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.. .+++.+.+++. .. -..++.++..+..++..||+.+|.+||+++||-..|+..
T Consensus 708 glS----n~EVIe~i~~g----~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 708 GLS----NQEVIECIRAG----QL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ccc----hHHHHHHHHcC----Cc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 743 23444444321 11 233445566699999999999999999999999999764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=334.55 Aligned_cols=270 Identities=26% Similarity=0.390 Sum_probs=212.2
Q ss_pred hhhhhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC
Q 006739 330 LAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR 409 (633)
Q Consensus 330 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 409 (633)
..|....+.|+..+.||.|..++||+|+... .+..||||++.... .+...+.+++|+..|+.++||
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEk-------------c~~~ld~l~kE~~~msl~~HP 84 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEK-------------CNNDLDALRKEVQTMSLIDHP 84 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhh-------------hhhhHHHHHHHHHHhhhcCCC
Confidence 3445566889999999999999999998764 55999999984322 222378899999999999999
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
||++++..|..+..+|+||.||.+||+.++++.... ..+++..+..|++++++||.|| |.+|.||||||+.|||+
T Consensus 85 NIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi 159 (516)
T KOG0582|consen 85 NIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILI 159 (516)
T ss_pred CcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEE
Confidence 999999999999999999999999999999987654 4499999999999999999999 78999999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcc-ee-cccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHI-TT-SNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT 565 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 565 (633)
+.+|.+||+|||.+-.+.+..... .. ....||++|||||+++. ..|+.|+||||||++..||.+|..||....+
T Consensus 160 ~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-- 237 (516)
T KOG0582|consen 160 DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-- 237 (516)
T ss_pred cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--
Confidence 999999999999877665443221 11 44689999999999544 5699999999999999999999999987543
Q ss_pred ccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 566 EEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.+...+.+..+ ...-..+..+........+.+++..||+.||++|||++++++
T Consensus 238 -----mkvLl~tLqn~pp-~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 238 -----MKVLLLTLQNDPP-TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -----HHHHHHHhcCCCC-CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1222222222221 111000001111112235788888999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=348.18 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=208.9
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
...+|...+.||+|+|++||+|+.. ..++.||||++.+.. -..++..+.+.+|-.+|.+| .||.|++
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~-~t~keYAiKVl~K~~-----------Iike~KvkYV~~Ek~~l~~L~~hPgivk 138 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREK-ATGKEYAIKVLDKRY-----------IIKEKKVKYVTREKEALTQLSGHPGIVK 138 (604)
T ss_pred ChhhcchhheeccccceeEEEeeec-CCCceeeHhhhhHHH-----------HHhhcccchhhHHHHHHHHhhCCCCeEE
Confidence 3468899999999999999999864 689999999984321 12234467888999999999 7999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++-.|.+...+|+|+||+++|+|.+++++. ..+++.....++.+|+.||+|| |+.|||||||||+|||+|++|
T Consensus 139 Ly~TFQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 139 LYFTFQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKDG 211 (604)
T ss_pred EEEEeecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCCC
Confidence 999999999999999999999999999975 4599999999999999999999 899999999999999999999
Q ss_pred ceEEcccccccccCCCCCc---------cee--cccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccc
Q 006739 494 EARIADFGLAKAMPDAQTH---------ITT--SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 562 (633)
++||+|||.|+.+.+.... ... ...+||-.|.+||++.....+..+|+|+|||++|+|+.|.+||.+..
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9999999999988643221 111 45789999999999999999999999999999999999999997643
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+ +.-..+.+. +.. . +.+..+ ..+.+++.+.|..||.+|+|.+++.+
T Consensus 292 e---yliFqkI~~-l~y--~--------fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 292 E---YLIFQKIQA-LDY--E--------FPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred H---HHHHHHHHH-hcc--c--------CCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence 2 222222221 111 1 111111 23678888999999999999988754
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=346.76 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=209.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.++|...++||.|.||.||+|+- ..+|..||||++++...... .---.||+..++++. |||||++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~-~~~~~~VAIK~MK~Kf~s~e-------------e~~nLREvksL~kln~hpniikL 74 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKS-KETGELVAIKKMKKKFYSWE-------------ECMNLREVKSLRKLNPHPNIIKL 74 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeee-cCCCceeeHHHHHhhhccHH-------------HHHHHHHHHHHHhcCCCCcchhh
Confidence 46789999999999999999985 46889999999976543211 223357999999998 9999999
Q ss_pred ceeeecCC-ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 415 LAHMARPD-CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 415 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
.+.+.+.+ .+++|||||+ .+|.++++.. ++.+++..+..|+.||.+||+|+ |.+|+.|||+||+|||+....
T Consensus 75 ~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~~ 147 (538)
T KOG0661|consen 75 KEVIRDNDRILYFVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGND 147 (538)
T ss_pred HHHhhccCceEeeeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEecccc
Confidence 99999988 8999999995 5999999863 67899999999999999999999 899999999999999999888
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||+||.+.....+ +..+-|.+|+|||++. .+-|+.+.|+|++||+++|+.+-+.-|.+..+.++.-.+++
T Consensus 148 ~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~ 224 (538)
T KOG0661|consen 148 VIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE 224 (538)
T ss_pred eeEecccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence 9999999999988765443 3467899999999875 46789999999999999999999988776543333233333
Q ss_pred HHHHhhccCCcc-hhhhhhh-----------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 573 WMRNVMTSENPT-RAIDAKL-----------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 573 ~~~~~~~~~~~~-~~~d~~~-----------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.+.......++. ..+...+ .....+....+..+++..|+.+||++|||++++++.
T Consensus 225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 332211122221 1111111 011112344568889999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=353.39 Aligned_cols=267 Identities=25% Similarity=0.376 Sum_probs=205.9
Q ss_pred hhhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CC
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RH 408 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 408 (633)
...++|++.++||+|+||.||+|.+. ..+++.||||++...... ...+.+.+|+.++.++ +|
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h 70 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA-------------SEHKALMSELKILIHIGNH 70 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch-------------HHHHHHHHHHHHHHHhccC
Confidence 34578999999999999999999752 235678999998643211 1145688999999999 89
Q ss_pred CcccccceeeecCC-ccEEEEecccCCCHHHHHhhhcC------------------------------------------
Q 006739 409 RNLLPLLAHMARPD-CHLLVYEFMKNGSLQDILNDVSQ------------------------------------------ 445 (633)
Q Consensus 409 ~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------ 445 (633)
|||+++++++...+ ..++||||+++|+|.+++.....
T Consensus 71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (338)
T cd05102 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQ 150 (338)
T ss_pred cceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccc
Confidence 99999999887644 57899999999999999875321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCC
Q 006739 446 ----------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA 509 (633)
Q Consensus 446 ----------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~ 509 (633)
....+++..+..++.||++||+|| |+.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~ 227 (338)
T cd05102 151 PSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227 (338)
T ss_pred cccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccC
Confidence 023578889999999999999999 6789999999999999999999999999999876543
Q ss_pred CCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhh
Q 006739 510 QTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAID 588 (633)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 588 (633)
..........++..|+|||++.+..++.++|||||||++|||++ |..||..... .....+.+ ...... ..
T Consensus 228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~---~~~~~~~~---~~~~~~-~~-- 298 (338)
T cd05102 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI---NEEFCQRL---KDGTRM-RA-- 298 (338)
T ss_pred cchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc---cHHHHHHH---hcCCCC-CC--
Confidence 33222233456789999999999899999999999999999997 9999875322 11111111 111111 00
Q ss_pred hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 589 AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+......+.+++.+||+.||++|||+.|++++|+++.
T Consensus 299 -------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 299 -------PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111234778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=349.88 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=206.0
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....+++.+.+.||+|.||+||+|+|.+ .||||++........ ..+.|+.|+.++++-+|.||+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt~~------------qlqaFKnEVa~lkkTRH~NIl 451 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPTPE------------QLQAFKNEVAVLKKTRHENIL 451 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc----ceEEEEEecCCCCHH------------HHHHHHHHHHHHhhcchhhhe
Confidence 3344567788999999999999999864 499999976554322 278899999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
-+.|||..+.. .+|+.+|+|.+|+.++|.. +..++..+.+.||.||++|+.|| |.++|||||||..||++.++
T Consensus 452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl~~~ 524 (678)
T KOG0193|consen 452 LFMGACMNPPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFLHED 524 (678)
T ss_pred eeehhhcCCce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEEccC
Confidence 99999998887 9999999999999999864 35688999999999999999999 89999999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
++|||+|||++..-..-..........|...|||||++.. .+|++.+||||||+++|||+||..||..... +..
T Consensus 525 ~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dqI-- 601 (678)
T KOG0193|consen 525 LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQI-- 601 (678)
T ss_pred CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hhe--
Confidence 9999999999865432211111123457889999999864 4689999999999999999999999973211 110
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+-.+-.+.. ..|.......++ +.+.+++..||..++++||.+.+++..|+++
T Consensus 602 ----ifmVGrG~l---~pd~s~~~s~~p---k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 602 ----IFMVGRGYL---MPDLSKIRSNCP---KAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ----EEEeccccc---CccchhhhccCH---HHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 100111111 112222223333 3466777799999999999999999988775
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=345.10 Aligned_cols=249 Identities=25% Similarity=0.430 Sum_probs=212.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|.+.+.||+|+||.||||+ ++.+.+.||+|.+.+..+. +++.+.+++|+++++.++|||||.+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgr-rK~t~~~vAik~i~K~gr~------------~k~l~~l~~ev~i~r~lkHpniv~m~e 68 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGR-RKYTIQVVAIKFIDKSGRN------------EKELKNLRQEVRILRSLKHPNIVEMLE 68 (808)
T ss_pred cchhHHHHhcCCccceeeecc-cccceeEEEEEEehhcCCc------------hHHHHHHHHHHHHHHhcCCcchhhHHH
Confidence 568888999999999999998 4578999999998665432 234778999999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
+|+...++++|+||+.| +|..++.. ...++++.+..|+.+++.||.|| |+.+|+|||+||.|||++..|.+|
T Consensus 69 sfEt~~~~~vVte~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~K 140 (808)
T KOG0597|consen 69 SFETSAHLWVVTEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTLK 140 (808)
T ss_pred hhcccceEEEEehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCcee
Confidence 99999999999999977 99999975 56799999999999999999999 899999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
++|||+|+.+..... ..+.+.||+-|||||+..+..|+..+|+||+||++||+++|++||.. .++.+.++.
T Consensus 141 lcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~ 211 (808)
T KOG0597|consen 141 LCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKS 211 (808)
T ss_pred echhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHH
Confidence 999999998776432 22467899999999999999999999999999999999999999854 234455555
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+..++... +.+....+..++...+.+||.+|.+..+++.
T Consensus 212 I~~d~v~~-----------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 212 ILKDPVKP-----------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HhcCCCCC-----------cccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 54433221 1223344788889999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=316.59 Aligned_cols=240 Identities=24% Similarity=0.332 Sum_probs=200.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||.|+||.|.+++.+ .+|..+|+|++.+... ..-+..+...+|..+++.+.||++++++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k~~v-----------VklKQveH~~nEk~vL~~v~~PFlv~l~ 110 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDKQKV-----------VKLKQVEHTHNEKRVLKAVSHPFLVKLY 110 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEc-cCCceeehhhcCHHHH-----------HHHHHHHHHhhHHHHHhhccCceeEEEE
Confidence 468899999999999999999975 6799999999854321 1112255678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+.+.+.+.+|+||||++||.|.+++++. .++++..+.-+|.+|+.||+|| |+..|++||+||+|||+|.+|.+
T Consensus 111 ~t~~d~~~lymvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~i 183 (355)
T KOG0616|consen 111 GTFKDNSNLYMVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHI 183 (355)
T ss_pred EeeccCCeEEEEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcE
Confidence 9999999999999999999999999873 4699999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||.|+.+... +...+||+.|+|||++.+..|..++|+|||||++|||+.|..||.+..+ .+...
T Consensus 184 KitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~ 251 (355)
T KOG0616|consen 184 KITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYE 251 (355)
T ss_pred EEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHH
Confidence 99999999987664 3457999999999999999999999999999999999999999976433 22222
Q ss_pred Hhhcc-CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCC
Q 006739 576 NVMTS-ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRER 618 (633)
Q Consensus 576 ~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 618 (633)
.+... -..+..+.+ .+.+++...++.|-.+|
T Consensus 252 KI~~~~v~fP~~fs~------------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 KILEGKVKFPSYFSS------------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHhCcccCCcccCH------------HHHHHHHHHHhhhhHhh
Confidence 22222 222222222 26677778888888888
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=337.19 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=199.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.++...+.||+|+||.||++... ++|...|||.+..... ...+.+.+|+.++.+++|||||+.+|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~-~~g~~~AvK~v~~~~~--------------~~~~~l~~Ei~iL~~l~~p~IV~~~G 81 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNK-KTGELMAVKSVELEDS--------------PTSESLEREIRILSRLNHPNIVQYYG 81 (313)
T ss_pred chhhhhccccCccceEEEEEEec-CCCcceeeeeeecccc--------------hhHHHHHHHHHHHHhCCCCCEEeeCC
Confidence 45777899999999999999865 4589999998744310 00456889999999999999999999
Q ss_pred eeecCC--ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC-CC
Q 006739 417 HMARPD--CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-DM 493 (633)
Q Consensus 417 ~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~-~~ 493 (633)
...... .+++.|||+++|+|.+++.+.. + .+++..+..++.||++||+|| |+++||||||||+|||++. ++
T Consensus 82 ~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~ 155 (313)
T KOG0198|consen 82 SSSSRENDEYNIFMEYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNG 155 (313)
T ss_pred ccccccCeeeEeeeeccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCC
Confidence 855544 5889999999999999998632 2 699999999999999999999 7999999999999999999 79
Q ss_pred ceEEcccccccccCCCC-CcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 494 EARIADFGLAKAMPDAQ-THITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+++...... .........||+.|||||++..+ ....++||||+||++.||+||+.||...+ ...
T Consensus 156 ~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~ 229 (313)
T KOG0198|consen 156 DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEA 229 (313)
T ss_pred eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chH
Confidence 99999999998776411 11123457899999999999963 33459999999999999999999998641 111
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.++-........+ . .++.......+++..|++.||++|||++++++-
T Consensus 230 ~~~~~ig~~~~~P-----~----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 230 EALLLIGREDSLP-----E----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred HHHHHHhccCCCC-----C----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 2222222122111 1 111122337788889999999999999999864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.59 Aligned_cols=265 Identities=26% Similarity=0.345 Sum_probs=207.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+.|...++||+|.||.||+|++. .+|+.||+|+++.......- .....+|+..++.++|+||+.+++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~-~t~~~VAIKKIkl~~~kdGi------------~~talREIK~Lqel~h~nIi~LiD 68 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT-ETGKRVAIKKIKLGNAKDGI------------NRTALREIKLLQELKHPNIIELID 68 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec-CCCcEEEEEEeeccccccCc------------cHHHHHHHHHHHHccCcchhhhhh
Confidence 46778899999999999999864 68999999999766432111 345678999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.|...+..-+|+|||+. +|+..++. ....++..++..++.++++|++|+ |++.|+||||||.|+|++++|.+|
T Consensus 69 ~F~~~~~l~lVfEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~lK 141 (318)
T KOG0659|consen 69 VFPHKSNLSLVFEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQLK 141 (318)
T ss_pred hccCCCceEEEEEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcEE
Confidence 99999999999999965 99999875 356789999999999999999999 899999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+|+.+.......+ ..+-|.+|+|||.+.+. .|+..+|+||.||++.||+-|.+-|.+ +.+.+....+-
T Consensus 142 iADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If 215 (318)
T KOG0659|consen 142 IADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIF 215 (318)
T ss_pred eecccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHH
Confidence 999999999886654332 33679999999988775 589999999999999999998765544 22223333333
Q ss_pred HhhccC----Ccc--hhhhhh--------hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 576 NVMTSE----NPT--RAIDAK--------LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 576 ~~~~~~----~~~--~~~d~~--------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
...+.. |+. .+-|-. .....++.......+++..++..||.+|++++|++++
T Consensus 216 ~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 216 RALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 322211 111 000100 0111233344456899999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=344.24 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=208.7
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+....|+..++||+|..|.||.+.. ..+++.||||++....... .+-+.+|+.+|+..+|+|||+
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~-~~~~~~VaiK~m~l~~Q~~--------------keLilnEi~Vm~~~~H~NiVn 334 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARK-ISTKQEVAIKRMDLRKQPK--------------KELLLNEILVMRDLHHPNIVN 334 (550)
T ss_pred Chhhhhcchhhhccccccceeeeee-ccCCceEEEEEEEeccCCc--------------hhhhHHHHHHHHhccchHHHH
Confidence 3456788899999999999999975 4678999999986554321 445789999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++.|...+.++.|||||+||+|.+.+.. ..+++.++..|+.++++||+|| |.++|+|||||.+|||++.+|
T Consensus 335 fl~Sylv~deLWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g 406 (550)
T KOG0578|consen 335 FLDSYLVGDELWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDG 406 (550)
T ss_pred HHHHhcccceeEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCC
Confidence 99999999999999999999999999874 4589999999999999999999 899999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||++..+....... +..+||+.|||||++....|++++||||||++++||+.|.+||-...+ .+-
T Consensus 407 ~vKltDFGFcaqi~~~~~KR--~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrA 477 (550)
T KOG0578|consen 407 SVKLTDFGFCAQISEEQSKR--STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRA 477 (550)
T ss_pred cEEEeeeeeeeccccccCcc--ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHH
Confidence 99999999998887765432 457899999999999999999999999999999999999999854211 111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+..+...+.+. + ...+.....+.+|+.+||+.||++||++.|+++
T Consensus 478 lyLIa~ng~P~-l-------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 478 LYLIATNGTPK-L-------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHhhcCCCC-c-------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 22222222221 1 111222334788899999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.12 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=208.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|+.+..||+|+||.||+|+- +++|..+|+|++++...- .....+.++.|-.+|....+|+||++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarK-k~Tg~iyAmK~LkKS~M~-----------~~~Qv~hV~aERdiL~~~ds~~vVKL 206 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARK-KDTGEIYAMKILKKSEML-----------KKNQVEHVRAERDILAEVDSPWVVKL 206 (550)
T ss_pred CcccchhheeeccccceeEEEEEE-ccCCcEEeeecccHHHHH-----------hhhhHHHHHHHHHHhhhcCCCcEEEE
Confidence 458899999999999999999984 579999999999765432 11225678889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+-.|++.+.+||||||++||++..+|.+ ...+++.....++.+++-|++.+ |+.|+|||||||+|+|||..|+
T Consensus 207 yYsFQD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GH 279 (550)
T KOG0605|consen 207 YYSFQDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGH 279 (550)
T ss_pred EEEecCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCC
Confidence 9999999999999999999999999986 56799999999999999999999 8999999999999999999999
Q ss_pred eEEcccccccccCC----------------------CCCc-----ce------------------ecccccCcccccccc
Q 006739 495 ARIADFGLAKAMPD----------------------AQTH-----IT------------------TSNVAGTVGYIAPEY 529 (633)
Q Consensus 495 ~kl~DfG~a~~~~~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~ 529 (633)
+||+|||++.-... .+.. .. .-..+|||.|||||+
T Consensus 280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV 359 (550)
T KOG0605|consen 280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV 359 (550)
T ss_pred EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence 99999999743211 0000 00 013469999999999
Q ss_pred cccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhH
Q 006739 530 HQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACF 609 (633)
Q Consensus 530 ~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~ 609 (633)
+.+..|+..+|+||+||++||||.|.+||....+.+....+..|........... ...+..++|.+
T Consensus 360 ll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~--------------~s~eA~DLI~r 425 (550)
T KOG0605|consen 360 LLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD--------------LSDEAKDLITR 425 (550)
T ss_pred HhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc--------------ccHHHHHHHHH
Confidence 9999999999999999999999999999988766666677777765443322111 11347788889
Q ss_pred hccCCCCCCCC
Q 006739 610 CTVDSPRERPN 620 (633)
Q Consensus 610 cl~~dP~~RPs 620 (633)
|+. ||++|-.
T Consensus 426 ll~-d~~~RLG 435 (550)
T KOG0605|consen 426 LLC-DPENRLG 435 (550)
T ss_pred Hhc-CHHHhcC
Confidence 999 9999987
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=343.97 Aligned_cols=243 Identities=29% Similarity=0.459 Sum_probs=203.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+....++.||+|+.|.||+|++ .++.||||+++ +.-..++.-|++|+||||+.+.|
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl---~netVAVKKV~---------------------elkETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL---HNETVAVKKVR---------------------ELKETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred HHhhhhhhhccCcccceeeeec---cCceehhHHHh---------------------hhhhhhHHHHHhccCcceeeEee
Confidence 4455678999999999999998 57889999873 22345788899999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
+|.....+|||||||..|-|...|+. +..+.-.....+..+||.|+.|| |.+.|||||||.-||||..+..+|
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEeeccceEE
Confidence 99999999999999999999999986 56688888899999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||-++...+.. +...++||..|||||++...+.++|+||||||||||||+||..||.+...... +
T Consensus 253 IsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-------I-- 320 (904)
T KOG4721|consen 253 ISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-------I-- 320 (904)
T ss_pred eccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-------E--
Confidence 99999999876653 33568999999999999999999999999999999999999999976432110 0
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
.+ +-...+--..++.+.+.+.-++++||+..|.+||++++++.-|+
T Consensus 321 -wG------VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 321 -WG------VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred -Ee------ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 00 00111112234555666888888999999999999999998875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=332.36 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=198.8
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec-
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR- 420 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~- 420 (633)
...||+|++|.||+|.+ +|+.||||.+....... ....+.+.+|+.++++++||||+++++++.+
T Consensus 25 ~~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGH-----------KVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred CeEEeeCCceEEEEEEE---CCEEEEEEecccccccc-----------HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 36799999999999987 78999999986543211 1114678899999999999999999999876
Q ss_pred ---CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 421 ---PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 421 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
....++||||+++|+|.+++.. ...+++..+..++.+++.||.||| ...+++||||||+||++++++.+||
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHH--hcCCCCCCcCChhhEEECCCCcEEE
Confidence 3467899999999999999975 346899999999999999999995 2347889999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|||+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+ ..
T Consensus 165 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~---~~ 232 (283)
T PHA02988 165 ICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEI---YD 232 (283)
T ss_pred cccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHH---HH
Confidence 9999998764432 22458899999999876 6899999999999999999999999975321 111 11
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhhC
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~~ 633 (633)
.......... .+ ......+.+++.+||+.||++|||++|+++.|+++++
T Consensus 233 ~i~~~~~~~~-~~--------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 LIINKNNSLK-LP--------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHhcCCCCC-CC--------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111111100 00 0122347889999999999999999999999998864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=353.05 Aligned_cols=266 Identities=23% Similarity=0.381 Sum_probs=220.6
Q ss_pred hhhhhhhcCcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC
Q 006739 330 LAFLEKEDGLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR 407 (633)
Q Consensus 330 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 407 (633)
++.+.+.....+.++||.|.||.||+|+++ ++....||||.++.... ++.+.+|..|+.||.++.
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-------------ekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-------------EKQRRDFLSEASIMGQFD 688 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-------------HHHHhhhhhhhhhcccCC
Confidence 333344556678899999999999999884 44567899999976553 233789999999999999
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
||||+++.|+.......++|+|||++|+|+.+|+.. ..++.+.+...++++||.||+|| .+++.|||||..+||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNI 762 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNI 762 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhhe
Confidence 999999999999999999999999999999999863 45699999999999999999999 899999999999999
Q ss_pred EecCCCceEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccccc
Q 006739 488 LLDDDMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHT 565 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~ 565 (633)
|++.+...|++|||+++.+.++... .++..-.-..+|.|||.+...+++.++||||||+++||.++ |.+||.++..
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-- 840 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-- 840 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--
Confidence 9999999999999999988665422 22211222568999999999999999999999999999987 9999987643
Q ss_pred ccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 566 EEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+ +.++.+..+.+.+.. .++...+.+++..||++|-.+||.+.+++..|+++
T Consensus 841 --Q---dVIkaIe~gyRLPpP----------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 841 --Q---DVIKAIEQGYRLPPP----------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred --H---HHHHHHHhccCCCCC----------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 2 234444444444433 33555689999999999999999999999999885
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=337.75 Aligned_cols=269 Identities=22% Similarity=0.343 Sum_probs=204.2
Q ss_pred hcCcccccccccccCeeEEEEEecC---------------CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHH
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG---------------SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 400 (633)
.++|++.++||+|+||.||++.++. .++..||+|.+...... ....++.+|+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~ 70 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-------------NARNDFLKEV 70 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-------------HHHHHHHHHH
Confidence 3578889999999999999997532 23457999988643211 1145788999
Q ss_pred HHhhcCCCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC---------------CCCCCCHHHHHHHHHHHHHH
Q 006739 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ---------------GRRELDWLARHKIALGVACG 465 (633)
Q Consensus 401 ~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~~ 465 (633)
+++.+++||||+++++++.+.+..++||||+++|+|.+++..... ....+++..+..++.||+.|
T Consensus 71 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 150 (304)
T cd05096 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG 150 (304)
T ss_pred HHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999865321 12357889999999999999
Q ss_pred HHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHH
Q 006739 466 LEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFG 545 (633)
Q Consensus 466 L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G 545 (633)
|+|| |+.+|+||||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||
T Consensus 151 l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 227 (304)
T cd05096 151 MKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227 (304)
T ss_pred HHHH---HHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHH
Confidence 9999 6789999999999999999999999999999876544332222344568899999999888999999999999
Q ss_pred HHHHHHHh--CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 006739 546 VLLAVLVM--GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 546 ~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
+++|||++ +..||..... ......+............ ...++.....+.+++.+||+.||++|||+.+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTD----EQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred HHHHHHHHccCCCCCCcCCH----HHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 99999987 5567765322 1222222221111100000 0001112234788999999999999999999
Q ss_pred HHHHHHh
Q 006739 624 VRCMLSQ 630 (633)
Q Consensus 624 v~~~l~~ 630 (633)
+.+.|++
T Consensus 298 i~~~l~~ 304 (304)
T cd05096 298 IHAFLTE 304 (304)
T ss_pred HHHHHhC
Confidence 9998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.60 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=203.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~ 413 (633)
....|...+.||+|+||+|+.|.+. .++..||+|++........ . ....+.+.+|+.++++++ ||||++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~--------~-~~~~~~i~rEi~~~~~~~~HpnI~~ 84 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSK--------S-QKLDELIKREISILRRLRSHPNIIR 84 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhccccc--------c-cccchhhHHHHHHHHHhccCCCEeE
Confidence 3468899999999999999999865 5779999997654311100 0 011456678999999999 999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC-
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD- 492 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~- 492 (633)
++.++......++||||+.||+|.+++.. ..++.+.....++.|++.|++|+ |+++|+||||||+|||+|.+
T Consensus 85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 85 LLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNE 157 (370)
T ss_pred EEEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCC
Confidence 99999999999999999999999999986 45688899999999999999999 89999999999999999999
Q ss_pred CceEEcccccccccC-CCCCcceecccccCcccccccccccCC-CC-CccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 493 MEARIADFGLAKAMP-DAQTHITTSNVAGTVGYIAPEYHQTLK-FT-DKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+++||+|||++.... ... .....+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++..
T Consensus 158 ~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------- 227 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------- 227 (370)
T ss_pred CCEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------
Confidence 999999999999874 222 224578999999999999977 86 68999999999999999999998722
Q ss_pred HHHHHHHhhcc-CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 006739 570 LVKWMRNVMTS-ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625 (633)
Q Consensus 570 ~~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~ 625 (633)
.....+.+... ...+..++ ...+..++.+|+..||.+|+++.+++
T Consensus 228 ~~~l~~ki~~~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 228 VPNLYRKIRKGEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHHHHhcCCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11222221111 11121110 23378899999999999999999998
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=342.92 Aligned_cols=264 Identities=24% Similarity=0.373 Sum_probs=205.1
Q ss_pred hcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRN 410 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~n 410 (633)
.++|++.+.||+|+||.||+|+.. ..++..||+|++...... .....+.+|+++++.+ +|+|
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~il~~l~~h~n 103 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-------------DEREALMSELKILSHLGQHKN 103 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-------------HHHHHHHHHHHHHHhhccCCc
Confidence 467999999999999999999752 234468999998654321 1145688899999999 8999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcC---------------------------------------------
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ--------------------------------------------- 445 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------- 445 (633)
||+++++|...+..++||||+++|+|.+++.....
T Consensus 104 Iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (374)
T cd05106 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE 183 (374)
T ss_pred eeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence 99999999999999999999999999999864221
Q ss_pred ---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 446 ---------------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 446 ---------------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
....+++..+.+++.||++||+|| |+++|+||||||+||++++++.+||+|||+++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla~ 260 (374)
T cd05106 184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260 (374)
T ss_pred cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceeee
Confidence 123578899999999999999999 68899999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhccCCc
Q 006739 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENP 583 (633)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (633)
...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ....+.+.. ....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~---~~~~~~~~~---~~~~ 334 (374)
T cd05106 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN---SKFYKMVKR---GYQM 334 (374)
T ss_pred eccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc---HHHHHHHHc---ccCc
Confidence 7654332222223345678999999998899999999999999999997 99998754321 111111111 1000
Q ss_pred chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 584 TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 584 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
. . ... ....+.+++.+||+.||++|||+.+++++|+++
T Consensus 335 ~---~----~~~---~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 S---R----PDF---APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred c---C----CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0 000 123478899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=314.68 Aligned_cols=272 Identities=21% Similarity=0.259 Sum_probs=207.3
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|+.++.|++|+||.||+|+.+ .+++.||+|+++.......- --.-.+|+.++.+.+|||||
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk-~t~eIVALKr~kmekek~GF------------PItsLREIniLl~~~H~NIV 138 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDK-KTDEIVALKRLKMEKEKEGF------------PITSLREINILLKARHPNIV 138 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccC-CcceeEEeeecccccccCCC------------cchhHHHHHHHHhcCCCCee
Confidence 344578999999999999999999864 68899999999755421111 12346899999999999999
Q ss_pred ccceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 413 PLLAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 413 ~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
.+..+... -+..|+|||||+. +|.++++... .++...++..++.|+++|++|| |...|+|||||++|+|+.
T Consensus 139 ~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~ 211 (419)
T KOG0663|consen 139 EVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLS 211 (419)
T ss_pred eeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeec
Confidence 99887744 4678999999977 9999998754 5799999999999999999999 789999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+.|.+||+|||+|+.++..... .+..+-|.+|+|||.+.+. .|+++.|+||+||++.||+++++-|.+..+.++...
T Consensus 212 ~~G~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~ 289 (419)
T KOG0663|consen 212 HKGILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK 289 (419)
T ss_pred cCCcEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH
Confidence 9999999999999999876433 2456779999999998875 589999999999999999999998876443322222
Q ss_pred HHHHHHHhhccCCcchhhhhhh------------hhcCCHH--HHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKL------------LENGYEE--QMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~------------~~~~~~~--~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+.+.......|+....-+.. ....+.. ..+.-.+++..++..||.+|-|++|.++
T Consensus 290 If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 290 IFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred HHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 2222221122222221111100 0111111 1245678888999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.90 Aligned_cols=265 Identities=23% Similarity=0.325 Sum_probs=206.0
Q ss_pred hhcCcccccccccccCeeEEEEEe----cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCC
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHR 409 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 409 (633)
..++|++.+.||+|+||.||+|++ ...++..||||++...... ...+.+.+|++++..+ +||
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-------------~~~~~~~~Ei~il~~l~~Hp 99 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-------------TEREALMSELKVLSYLGNHI 99 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-------------HHHHHHHHHHHHHHHhcCCc
Confidence 346799999999999999999974 2235678999998543211 1145678899999999 899
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcC--------------------------------------------
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-------------------------------------------- 445 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------- 445 (633)
||++++++|...+..++||||+++|+|.++++....
T Consensus 100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 999999999999999999999999999999865321
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 446 ---------------------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 446 ---------------------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
....+++..+..++.||++||+|| |+.+|+||||||+||++++++.+||+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~ 256 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKIC 256 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEe
Confidence 113578999999999999999999 67899999999999999999999999
Q ss_pred ccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHh
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... .....+++...
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~ 333 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV---DSKFYKMIKEG 333 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc---hHHHHHHHHhC
Confidence 9999987654432222223345678999999999999999999999999999998 8889865322 11222222211
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.... . +......+.+++..||+.||++||++.|++++|++.
T Consensus 334 ---~~~~---~-------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 ---YRML---S-------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---ccCC---C-------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1110 0 001123478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.20 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=214.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCe----EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.+..+..+.||+|.||.||.|.+...+|. .||||.+...... ....+|.+|..+|++++||||
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~-------------~~~~~Fl~Ea~~m~~f~HpNi 757 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE-------------QEVSDFLKEALLMSKFDHPNI 757 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH-------------HHHHHHHHHHHHHhcCCCcce
Confidence 34566778999999999999999766665 4899988654321 226789999999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ---GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
|+++|.|.+....++++|||++|+|..+|++.+. ....++..+.+.++.|||+|+.|| ++++.|||||..+|+|
T Consensus 758 v~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YL---e~~~fvHRDLAaRNCL 834 (1025)
T KOG1095|consen 758 VSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYL---ESKHFVHRDLAARNCL 834 (1025)
T ss_pred eeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHH---HhCCCcCcchhhhhee
Confidence 9999999999999999999999999999987543 246688999999999999999999 8899999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEE 567 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 567 (633)
++....+||+|||+|+.+.+.+.+.......-...|||||.+..+.++.|+|||||||++||++| |..||.+...
T Consensus 835 L~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---- 910 (1025)
T KOG1095|consen 835 LDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---- 910 (1025)
T ss_pred ecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----
Confidence 99999999999999996665544433222233468999999999999999999999999999999 8899876432
Q ss_pred chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.++ +.....+++. ..++.+.+.+.+++..||+.+|++||++.++++.+..+.
T Consensus 911 ~~v---~~~~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 911 FEV---LLDVLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred HHH---HHHHHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 222 2222223322 123445556889999999999999999999999887663
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.10 Aligned_cols=266 Identities=25% Similarity=0.374 Sum_probs=209.4
Q ss_pred hhhhhcCcccccccccccCeeEEEEEecCCCC--eE-EEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 006739 332 FLEKEDGLASLEKIGSGGCGEVYKAELPGSNG--KM-IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH 408 (633)
Q Consensus 332 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 408 (633)
|....++....++||+|.||.||+|++...++ .. ||||..+... ........+|.+|+++|++++|
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-----------~~~~~~~~e~m~EArvMr~l~H 220 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-----------ELTKEQIKEFMKEARVMRQLNH 220 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-----------cccHHHHHHHHHHHHHHHhCCC
Confidence 34455667777999999999999999976555 23 8999875421 1122337899999999999999
Q ss_pred CcccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 409 RNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 409 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
||||+++|++.....+++|||+|+||+|.++|++.. ..++..++..++.+.|+||+|| |+++++||||..+|+|
T Consensus 221 ~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YL---h~k~~IHRDIAARNcL 294 (474)
T KOG0194|consen 221 PNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYL---HSKNCIHRDIAARNCL 294 (474)
T ss_pred CCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHH---HHCCCcchhHhHHHhe
Confidence 999999999999999999999999999999998632 3699999999999999999999 8999999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEE 567 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 567 (633)
++.++.+||+|||+++.-..-.... ....-...|+|||.+....|++++|||||||++||+++ |..||.+...
T Consensus 295 ~~~~~~vKISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---- 368 (474)
T KOG0194|consen 295 YSKKGVVKISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---- 368 (474)
T ss_pred ecCCCeEEeCccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----
Confidence 9999999999999987644211111 11234678999999999999999999999999999999 8889876432
Q ss_pred chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..+..++. ..+..... ....+ ..+..++.+||..+|++||+|.++.+.++.+.
T Consensus 369 ~~v~~kI~---~~~~r~~~------~~~~p---~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 369 YEVKAKIV---KNGYRMPI------PSKTP---KELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred HHHHHHHH---hcCccCCC------CCCCH---HHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 23333331 11111100 11222 33666777999999999999999999998763
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.60 Aligned_cols=269 Identities=23% Similarity=0.351 Sum_probs=209.2
Q ss_pred hhhhhhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC
Q 006739 331 AFLEKEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI 406 (633)
Q Consensus 331 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 406 (633)
.+....++|.+.+.||+|+||.||+|++.+ ..+..||||++...... ...+.+.+|+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-------------~~~~~~~~Ei~~l~~l 97 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-------------SEKQALMSELKIMTHL 97 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh-------------HHHHHHHHHHHHHHhc
Confidence 344556789999999999999999998632 23457999998654321 1145688999999999
Q ss_pred C-CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC----------------------------------------
Q 006739 407 R-HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ---------------------------------------- 445 (633)
Q Consensus 407 ~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------- 445 (633)
. ||||+++++++.+.+..++||||+++|+|.++++....
T Consensus 98 ~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (400)
T cd05105 98 GPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDY 177 (400)
T ss_pred CCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccc
Confidence 6 99999999999999999999999999999999875321
Q ss_pred ----------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006739 446 ----------------------------------------------------GRRELDWLARHKIALGVACGLEYLHISH 473 (633)
Q Consensus 446 ----------------------------------------------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h 473 (633)
....+++..+..++.|+++||+|| |
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H 254 (400)
T cd05105 178 MDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---A 254 (400)
T ss_pred cccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---H
Confidence 013478889999999999999999 6
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 553 (633)
+.+|+||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++
T Consensus 255 ~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 78999999999999999999999999999987654333222233457788999999998899999999999999999997
Q ss_pred -CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 554 -GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 554 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
|..||...... ......+. ...... ........+.+++..||+.||++||++.++.++|+++
T Consensus 335 ~g~~P~~~~~~~---~~~~~~~~---~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 335 LGGTPYPGMIVD---STFYNKIK---SGYRMA----------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred CCCCCCcccchh---HHHHHHHh---cCCCCC----------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 99998653221 11111111 111110 0111233478899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.17 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=207.0
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
....|+..+.||+|.||.||+|... ..++.||+|++..... +....++++|+.++.+++++||.++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~-~t~k~vAiKii~Le~~-------------~deIediqqei~~Ls~~~~~~it~y 76 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDN-KTKKVVAIKIIDLEEA-------------EDEIEDIQQEISVLSQCDSPNITEY 76 (467)
T ss_pred cccccccchhccccccceeeeeeec-cccceEEEEEechhhc-------------chhhHHHHHHHHHHHhcCcchHHhh
Confidence 3457888899999999999999764 6889999999843321 1225678999999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++.+..+..++++||||.||++.+.++. +..+++.....|+.++..|+.|| |..+.+|||||+.||++..+|.
T Consensus 77 ygsyl~g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~ 149 (467)
T KOG0201|consen 77 YGSYLKGTKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGD 149 (467)
T ss_pred hhheeecccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCc
Confidence 9999999999999999999999999975 34458888889999999999999 7889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||++..+....... ...+||+.|||||++.+..|+.|+|+||+|++.+||.+|.+|+.+..+......
T Consensus 150 vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----- 222 (467)
T KOG0201|consen 150 VKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----- 222 (467)
T ss_pred EEEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-----
Confidence 9999999998877654332 457899999999999999999999999999999999999999987654211111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... .+.+.+ . ....+.+++..||+.||++||++.++++
T Consensus 223 ---Ipk~~-----PP~L~~-~---~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 223 ---IPKSA-----PPRLDG-D---FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---ccCCC-----CCcccc-c---cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 01111 111212 2 2234778888999999999999999975
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=328.13 Aligned_cols=267 Identities=22% Similarity=0.327 Sum_probs=215.9
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
+.+.+.+.++||+|-||.|.++... .+..||||+++....+. ..++|.+|+++|.+++|||||++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~~~-------------~r~~F~kEIkiLsqLkhPNIveL 600 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDATKN-------------ARNDFLKEIKILSRLKHPNIVEL 600 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccchh-------------HHHHHHHHHHHHhccCCCCeeEE
Confidence 3456788999999999999999885 46999999997654321 25789999999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+|+|..++.+++++|||++|+|.+++.+... .......-.+|+.|||.||+|| .+..+|||||.++|+|+|.+++
T Consensus 601 vGVC~~DePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~ 675 (807)
T KOG1094|consen 601 LGVCVQDDPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFT 675 (807)
T ss_pred EeeeecCCchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCccc
Confidence 9999999999999999999999999986432 2245556678999999999999 8899999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh--CCCCCcccccccccchHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM--GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~~~~~~~~~~~ 572 (633)
+||+|||+++-+..++.+...+..+-..+|||+|.+.-+++++++|||+||+++||+++ ...||..... .+.++
T Consensus 676 iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vve 751 (807)
T KOG1094|consen 676 IKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVE 751 (807)
T ss_pred EEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHH
Confidence 99999999998877776665556667889999999999999999999999999999976 7788876433 22323
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
-........... .+ ...+.-+...+.+++.+||..|-++||+++++...|.+.
T Consensus 752 n~~~~~~~~~~~-~~-----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 752 NAGEFFRDQGRQ-VV-----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhhhcCCCCcc-ee-----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 222222222111 11 112233445578999999999999999999999988764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=332.41 Aligned_cols=201 Identities=26% Similarity=0.463 Sum_probs=174.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+++.. .+|..||+|.+..... .....++.+|++++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 69 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIK-------------PAIRNQIIRELQVLHECNSPYIVGFY 69 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccC-------------HHHHHHHHHHHHHHHHCCCCCCCeEE
Confidence 478999999999999999999875 5788999998854321 11245788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.||| +..+|+||||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH--~~~~ivH~dlkp~Nil~~~~~~~ 143 (331)
T cd06649 70 GAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEI 143 (331)
T ss_pred EEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh--hcCCEEcCCCChhhEEEcCCCcE
Confidence 999999999999999999999999975 345889999999999999999995 23469999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
||+|||++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 144 kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 144 KLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred EEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999987654322 1335689999999999998999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=328.57 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=199.2
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|+..+.||+|+||.||++... .+|+.||+|.+...... .......+.+|+.++++++|+||+++.++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~~~~iv~~~~~ 68 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIK-----------KRKGEAMALNEKRILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhh-----------hhhhHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 3677899999999999999864 47899999987432210 01113457789999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl 143 (285)
T cd05631 69 YETKDALCLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRI 143 (285)
T ss_pred EccCCeEEEEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEE
Confidence 999999999999999999998876422 34689999999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||++........ .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+...+
T Consensus 144 ~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--- 217 (285)
T cd05631 144 SDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV--- 217 (285)
T ss_pred eeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh---
Confidence 99999987644322 123568999999999999999999999999999999999999997543211111111111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
..... .........+.+++.+||+.||++||+ ++++++
T Consensus 218 -~~~~~----------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 218 -KEDQE----------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -hcccc----------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11000 001111234778999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=326.12 Aligned_cols=268 Identities=27% Similarity=0.372 Sum_probs=200.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|.||.|-+|+.. .+++.||+|++.+................--..+..++|+.+|++++|||||++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~-~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDE-VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeec-CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4588999999999999999999764 689999999997654321111000000000113578999999999999999999
Q ss_pred ceeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+.+..++ +.+|||+|||..|.+...- ..+..++..++++++.++..||+|| |.++||||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEcCC
Confidence 9998774 5789999999988765432 2223389999999999999999999 78999999999999999999
Q ss_pred CceEEcccccccccCCCCC---cceecccccCcccccccccccCC----CCCccchHHHHHHHHHHHhCCCCCccccccc
Q 006739 493 MEARIADFGLAKAMPDAQT---HITTSNVAGTVGYIAPEYHQTLK----FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT 565 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 565 (633)
|++||+|||.+.....+.. ...-...+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||-+.+.
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 9999999999987743311 11123468999999999887633 35678999999999999999999865332
Q ss_pred ccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 566 EEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ....+.. ..+.-...++..+.+.+++.++|.+||++|.+..+|..
T Consensus 325 --~~---l~~KIvn---------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 --LE---LFDKIVN---------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred --HH---HHHHHhc---------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 11 1111111 11111112234556889999999999999999998864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=297.05 Aligned_cols=253 Identities=26% Similarity=0.343 Sum_probs=207.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|-||.||+|+.+ .++-.||+|++.+... ......+++.+|+++-+.++||||.+++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi-----------~~~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQI-----------LKTQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred hhhccccccccCCccccEeEeeec-cCCcEEEEeeeeHHHH-----------HHhcchhhhhheeEeecccCCccHHhhh
Confidence 478999999999999999999875 6789999999855331 1123367899999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
++|.+....|+++||..+|++...|.... ...+++.....++.|+|.||.|+ |.++|+||||||+|+|++.++..
T Consensus 89 ~~fhd~~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 89 GYFHDSKRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred hheeccceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCe
Confidence 99999999999999999999999998422 45688888899999999999999 89999999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|++|||-+..-+... ....+||..|.+||+..+..++..+|+|++|++.||++.|..||...... ...+.+.
T Consensus 164 kiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----etYkrI~ 235 (281)
T KOG0580|consen 164 KIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----ETYKRIR 235 (281)
T ss_pred eccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----HHHHHHH
Confidence 999999887654221 23478999999999999999999999999999999999999999764322 2211121
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
... ...+ +.......++|..|+..+|.+|.+..|+++-
T Consensus 236 k~~--~~~p------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 KVD--LKFP------------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred Hcc--ccCC------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 110 0111 1122337889999999999999999998763
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=320.98 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=200.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
-.|+..+++|.|+||.||+|... ++++.||||+..+... .-.+|+++|+.+.|||||+++-
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~-e~~~~vAIKKv~~d~r------------------~knrEl~im~~l~HpNIV~L~~ 84 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLR-ETEEEVAIKKVLQDKR------------------YKNRELQIMRKLDHPNIVRLLY 84 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEc-CCCceeEEEEecCCCC------------------cCcHHHHHHHhcCCcCeeeEEE
Confidence 45777899999999999999986 4589999999865442 2346899999999999999999
Q ss_pred eeecCC-----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 417 HMARPD-----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 417 ~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+|.... ...+|||||+. +|.+.++.....+..++...++-++.||.+||.|| |+.+|+||||||.|+|+|.
T Consensus 85 ~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~ 160 (364)
T KOG0658|consen 85 FFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDP 160 (364)
T ss_pred EEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcC
Confidence 885432 23489999976 99999987666678899999999999999999999 6799999999999999996
Q ss_pred C-CceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 492 D-MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 492 ~-~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+ |.+||||||.|+....+... .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+... ..+
T Consensus 161 ~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~---~dQ 234 (364)
T KOG0658|consen 161 DTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS---VDQ 234 (364)
T ss_pred CCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH---HHH
Confidence 5 99999999999998776544 23567999999998877 5699999999999999999999998876322 223
Q ss_pred HHHHHHHhhccCCcch----------hhhhhhhhc-----CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTR----------AIDAKLLEN-----GYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~----------~~d~~~~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+...++ +.+-....+ .-.+.+... ..........+++.++++.+|.+|.++.|++.
T Consensus 235 L~eIik-~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 235 LVEIIK-VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHH-HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 333332 111111110 001111111 11222335788999999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=333.64 Aligned_cols=249 Identities=26% Similarity=0.322 Sum_probs=205.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.-|...+.||.|+.|.|-+|++. .+|+.+|||++.+...-.. .....+.+|+-+|+-+.||||+++++
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~-~TGqlaaiKii~k~~~~s~-----------s~~~~IerEIviMkLi~HpnVl~Lyd 79 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHA-ETGQLAAIKIIPKRSELSS-----------SQPAGIEREIVIMKLIEHPNVLRLYD 79 (786)
T ss_pred cceeccccccCCCCceehhhhcc-cccceeEEEeecccccccc-----------ccccchhhhhHHHHHhcCCCeeeeee
Confidence 45678899999999999999864 7899999999976532111 11456889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++++..++|+|.||+++|.|++++-+ +.++++.+..++..||..|+.|+ |..+|+|||+||+|+|+|..+++|
T Consensus 80 Vwe~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 80 VWENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred eeccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEe
Confidence 99999999999999999999999976 56799999999999999999999 677899999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+|..-.++.... ..+|++.|.|||++.+.+|+ .++||||+||+||.|+||+.||++. ++...+.
T Consensus 153 IADFGMAsLe~~gklLe---TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------Nir~LLl 222 (786)
T KOG0588|consen 153 IADFGMASLEVPGKLLE---TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------NIRVLLL 222 (786)
T ss_pred eeccceeecccCCcccc---ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------cHHHHHH
Confidence 99999998766554433 35899999999999999985 5899999999999999999999852 1222222
Q ss_pred Hhhcc-CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTS-ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..+ ...+..+ ..+..+++++|+..||++|.|++||++
T Consensus 223 KV~~G~f~MPs~I------------s~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 223 KVQRGVFEMPSNI------------SSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHcCcccCCCcC------------CHHHHHHHHHHhccCccccccHHHHhh
Confidence 22211 1122222 223788999999999999999999986
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=306.34 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=203.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
++.|++-+.||+|+|+.||++. ++.+|+.+|+|++..... .....+++.+|+++-+.++|||||++.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~-~~~tg~~fa~kiin~~k~------------~~~~~e~l~rEarIC~~LqHP~IvrL~ 76 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCV-HKTTGLEFAAKIINTKKL------------SARDFQKLEREARICRKLQHPNIVRLH 76 (355)
T ss_pred chhhhHHHHHccCchHHHHHHH-hccchHHHHHHHhhhhhh------------ccccHHHHHHHHHHHHhcCCCcEeehh
Confidence 4678889999999999999995 457899999998743322 122367789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC---C
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD---D 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~---~ 492 (633)
+.+.+....|+|+|+|+|++|..-+-. +..+++..+-..+.||+++|.|. |.++|||||+||+|+++-+ .
T Consensus 77 ~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK~~~ 149 (355)
T KOG0033|consen 77 DSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASKAKG 149 (355)
T ss_pred hhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeeccCC
Confidence 999999999999999999999765543 24478888999999999999999 8999999999999999964 3
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
-.+||+|||+|..+.++.. ....+|||+|||||++...+|+..+|||+.||++|-|+.|+.||.+... ..+.+
T Consensus 150 A~vKL~~FGvAi~l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----~rlye 222 (355)
T KOG0033|consen 150 AAVKLADFGLAIEVNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYE 222 (355)
T ss_pred CceeecccceEEEeCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----HHHHH
Confidence 4589999999999884432 2457899999999999999999999999999999999999999976332 22222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.....+- ....++.......+++++||..||.+|.|+.|.+.
T Consensus 223 ~I~~g~yd~----------~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 223 QIKAGAYDY----------PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHhccccCC----------CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 222111110 11122233344778999999999999999999864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.04 Aligned_cols=269 Identities=17% Similarity=0.242 Sum_probs=200.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+++.. .+++.||+|++....... ...+.+.+|+.+++.++||||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENE------------EVKETTLRELKMLRTLKQENIVELKE 67 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccc------------cchhhHHHHHHHHHhCCCccccchhh
Confidence 36889999999999999999875 578899999986542211 11456778999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++||||++++++..+... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+|
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~k 140 (287)
T cd07848 68 AFRRRGKLYLVFEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLK 140 (287)
T ss_pred hEecCCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEE
Confidence 99999999999999998777655432 34689999999999999999999 688999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH---
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW--- 573 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~--- 573 (633)
|+|||++......... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+...
T Consensus 141 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07848 141 LCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP 219 (287)
T ss_pred EeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9999999876543221 113356899999999999888999999999999999999999999753221111111100
Q ss_pred -----HHHhhccCCcchhhhhh------hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 -----MRNVMTSENPTRAIDAK------LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 -----~~~~~~~~~~~~~~d~~------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.............+. ............+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000 000001112245889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=331.39 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=198.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|... .+++.||+|++..... ...+..+.+.+|++++++++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 68 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEV-----------IRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHH-----------hhhHHHHHHHHHHHHHHhCCCCcHhhhHh
Confidence 46888999999999999999864 4689999999843211 01122456889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+....++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~k 141 (291)
T cd05612 69 TEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIK 141 (291)
T ss_pred hhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEE
Confidence 99999999999999999999999875 34689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....
T Consensus 142 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~---~~~~ 209 (291)
T cd05612 142 LTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP----FG---IYEK 209 (291)
T ss_pred EEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH---HHHH
Confidence 99999998764421 234689999999999998899999999999999999999999865321 11 1111
Q ss_pred hhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 577 VMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 577 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
..... ..... ....+.+++.+||+.||.+||+ ++|+++
T Consensus 210 i~~~~~~~~~~------------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 210 ILAGKLEFPRH------------LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHhCCcCCCcc------------CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 11111 11111 1223778999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=323.42 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=203.7
Q ss_pred hcCcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
..+|++.+.||+|+||.||+|.+. ...+..||+|.+...... .....+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~ 70 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD-------------KQRRGFLAEALTLGQFDHSNIVR 70 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH-------------HHHHHHHHHHHHHhcCCCCCcCe
Confidence 357889999999999999999764 235678999998654211 11356889999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++...+..++||||+++|+|.+++... ...+++..++.++.|++.||+|| |+.+++||||||+||+++.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~ 144 (266)
T cd05064 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDL 144 (266)
T ss_pred EEEEEecCCCcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCC
Confidence 999999999999999999999999998752 34689999999999999999999 688999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
.++++|||.+......... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ....+
T Consensus 145 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~----~~~~~ 219 (266)
T cd05064 145 VCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG----QDVIK 219 (266)
T ss_pred cEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHH
Confidence 9999999987654322111 1112345678999999999999999999999999999875 9999865322 22222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+. ...... .+......+.+++..||+.+|++||+++++++.|+.+
T Consensus 220 ~~~---~~~~~~----------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 AVE---DGFRLP----------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHH---CCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 221 111111 0111223478889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.35 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=206.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+.|+.++.||+|.-|+||++++.+ ++..+|+|++.+... ...++..+.+.|-+||+.+.||.++.+|+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l-----------~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESL-----------ASRKKLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC-CCceEEEEEecHHHH-----------hhhhHHHHHHHHHHHHHhcCCCccchhhh
Confidence 567889999999999999999864 558999999854321 22344778899999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.++.++..|+|||||+||+|..++++ +.++.+++..+.-++..|+-||+|| |..|||+|||||+|||+.++|++-
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcEE
Confidence 99999999999999999999999986 4578899999999999999999999 899999999999999999999999
Q ss_pred EcccccccccCC---------------------------------CCC---------------------cceecccccCc
Q 006739 497 IADFGLAKAMPD---------------------------------AQT---------------------HITTSNVAGTV 522 (633)
Q Consensus 497 l~DfG~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~ 522 (633)
|+||.++..... ... ...+...+||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 999998654311 000 00123457999
Q ss_pred ccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHH
Q 006739 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLL 602 (633)
Q Consensus 523 ~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 602 (633)
.|+|||++.+...+.++|+|+|||++|||+.|..||-+... .+.+...+.+ . +.....+.....
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~---~~Tl~NIv~~----~---------l~Fp~~~~vs~~ 363 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN---KETLRNIVGQ----P---------LKFPEEPEVSSA 363 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc---hhhHHHHhcC----C---------CcCCCCCcchhH
Confidence 99999999999999999999999999999999999976432 2222222211 1 101111234456
Q ss_pred HHHHHhHhccCCCCCCCC----HHHHH
Q 006739 603 VLKIACFCTVDSPRERPN----SKDVR 625 (633)
Q Consensus 603 ~~~l~~~cl~~dP~~RPs----~~ev~ 625 (633)
+.++|++.|.+||.+|-. +.||-
T Consensus 364 akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred HHHHHHHHhccChhhhhccccchHHhh
Confidence 889999999999999998 66553
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=325.98 Aligned_cols=262 Identities=28% Similarity=0.459 Sum_probs=207.1
Q ss_pred cCcccccccccccCeeEEEEEecCC----CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
++|++.+.||+|+||.||+|..... ....||+|.+...... ....++.+|++++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-------------~~~~~~~~ei~~l~~l~h~~i~ 71 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-------------KVQQEFRQEAELMSDLQHPNIV 71 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-------------HHHHHHHHHHHHHHhcCCcccc
Confidence 5788899999999999999987432 2367999988543211 1145688999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG------------RRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
++++++...+..+++|||+++++|.+++...... ...+++..+..++.|++.||+|| |+.+|+||
T Consensus 72 ~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~ 148 (283)
T cd05048 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHR 148 (283)
T ss_pred eEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecc
Confidence 9999999988999999999999999999764221 14588999999999999999999 67899999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||||+||++++++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 149 dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred ccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987654433222234457889999999988899999999999999999998 999987
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.... .++.+.+.. .. ... ........+.+++.+||+.||++||+++|+++.|+++
T Consensus 229 ~~~~----~~~~~~i~~---~~-~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 229 GFSN----QEVIEMIRS---RQ-LLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCH----HHHHHHHHc---CC-cCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 5432 222222221 11 110 1112234588899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=314.44 Aligned_cols=267 Identities=29% Similarity=0.410 Sum_probs=201.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhh--cCCCCccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG--QIRHRNLLPL 414 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l 414 (633)
......+.||+|.||.||||++ +++.||||++... ....|+.|-++.+ .|+|+||+++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL---~~~~VAVKifp~~-----------------~kqs~~~Ek~Iy~lp~m~h~nIl~F 269 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL---DNRLVAVKIFPEQ-----------------EKQSFQNEKNIYSLPGMKHENILQF 269 (534)
T ss_pred CchhhHHHhhcCccceeehhhc---cCceeEEEecCHH-----------------HHHHHHhHHHHHhccCccchhHHHh
Confidence 4566788999999999999998 6799999998321 1556777777765 4689999999
Q ss_pred ceeeecCC----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeeCCCCC
Q 006739 415 LAHMARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS------HNPRIIHRDLKP 484 (633)
Q Consensus 415 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~------h~~~ivH~Dikp 484 (633)
+++-.... +++||+||.+.|+|.++|+. ..++|....+|+.-+++||+|||++ |+++|+|||||+
T Consensus 270 i~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkS 344 (534)
T KOG3653|consen 270 IGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKS 344 (534)
T ss_pred hchhccCCccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccc
Confidence 99876555 78999999999999999985 5699999999999999999999965 688999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCC-CC-----CccchHHHHHHHHHHHhCCCCC
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FT-----DKCDIYSFGVLLAVLVMGRLPS 558 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~s~G~~l~elltg~~p~ 558 (633)
+|||+.+|++..|+|||+|..+..+.........+||.+|||||++.+.- +. .+.||||+|.|+|||+++..-+
T Consensus 345 kNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 345 KNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 99999999999999999999988766555555689999999999998732 22 3689999999999999876443
Q ss_pred c--------ccccccc--cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 559 D--------DFFQHTE--EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 559 ~--------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
+ -.|+.+. .-.+.+.-..+...+..+.+-|.-. .. .-+..+.+.+..||+.||+.|.|+.=+-+.+
T Consensus 425 ~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~-~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 425 DPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWR-KH---AGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred cCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhh-cC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 2 1111100 0001111111111111111111111 11 3455688889999999999999999998888
Q ss_pred Hhhh
Q 006739 629 SQIR 632 (633)
Q Consensus 629 ~~~~ 632 (633)
.++.
T Consensus 501 ~~l~ 504 (534)
T KOG3653|consen 501 AELM 504 (534)
T ss_pred HHHh
Confidence 7763
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=332.07 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=200.8
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|.+...++..||+|++..... ........+.+|+++++.++||||+++
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~Iv~~ 96 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-----------IKQKQVDHVFSERKILNYINHPFCVNL 96 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-----------hhhhhHHHHHHHHHHHHhCCCCCCcce
Confidence 446899999999999999999987655567999998843211 111224568899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ 169 (340)
T PTZ00426 97 YGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGF 169 (340)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCC
Confidence 9999999999999999999999999975 34689999999999999999999 7889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... .
T Consensus 170 ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~---~ 237 (340)
T PTZ00426 170 IKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLI---Y 237 (340)
T ss_pred EEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHH---H
Confidence 9999999998764321 235699999999999988899999999999999999999999975321 111 1
Q ss_pred HHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 575 RNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
+...... ..+..+ ...+.+++.+|++.||++|+ +++++++
T Consensus 238 ~~i~~~~~~~p~~~------------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 238 QKILEGIIYFPKFL------------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHhcCCCCCCCCC------------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1111111 111111 12367888999999999995 7888765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.64 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=201.3
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||+|+||.||+|+.. .+++.||+|++..... ......+.+.+|++++..++||||++++++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~ 69 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLL-----------FKLNEVRHVLTERDILTTTKSEWLVKLLYA 69 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHH-----------hhhhHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 6889999999999999999875 4688999999853211 011224578889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||
T Consensus 70 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 70 FQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999975 34688999999999999999999 6889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..|....
T Consensus 143 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 217 (333)
T cd05600 143 TDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217 (333)
T ss_pred EeCcCCcccccc-----cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc
Confidence 999999865441 234578999999999999999999999999999999999999997532211111111111000
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
......++. ......+.+++.+|+..+|++||+++++++.
T Consensus 218 ----~~~~~~~~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 ----QRPVYDDPR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----cCCCCCccc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000 1122347788889999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=313.56 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=209.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
...|++.+.||+|.||+|-+|.. ...|+.||||.+++..... +...-.+++|+++|+.++||||+.++
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e-~~sgR~VAiKsIrKdkIkd-----------eqDlvhIRREIeIMSsLNHPhII~Iy 119 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYE-HKSGREVAIKSIRKDKIKD-----------EQDLVHIRREIEIMSSLNHPHIIQIY 119 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhh-ccCCcEeehhhhhhhhccc-----------HHHHHHHHHHHHHHhhcCCCceeehh
Confidence 35789999999999999999965 3589999999987654321 12256789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
.+|.+.+...+||||..+|.|.+++.+ ...+++.+..++..||..|+.|. |..+++|||||.+|||+|.++++
T Consensus 120 EVFENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~Ni 192 (668)
T KOG0611|consen 120 EVFENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNI 192 (668)
T ss_pred hhhcCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCe
Confidence 999999999999999999999999986 45699999999999999999998 89999999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||++.++.+.... ..++|++-|.+||++.+.+| ++.+|-||+||++|-|+.|..||++... ...+
T Consensus 193 KIADFGLSNly~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lv 262 (668)
T KOG0611|consen 193 KIADFGLSNLYADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLV 262 (668)
T ss_pred eeeccchhhhhccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHH
Confidence 99999999988776543 34799999999999999988 4689999999999999999999987432 2233
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
+++..+. ..+ ++......-+|++||..+|++|.|+.++..-
T Consensus 263 rQIs~Ga-YrE-----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 263 RQISRGA-YRE-----------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHhhccc-ccC-----------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 3332211 110 1111225678899999999999999998764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=328.36 Aligned_cols=201 Identities=26% Similarity=0.465 Sum_probs=173.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.++||+|+||.||++... .++..+|+|.+...... ....++.+|++++++++||||++++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~ 69 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGFY 69 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCH-------------HHHHHHHHHHHHHHHCCCCccccee
Confidence 478999999999999999999875 46888999987543211 1145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++|+|.+++.. ...+++.....++.|++.||.||| +..+|+||||||+||++++++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~ 143 (333)
T cd06650 70 GAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEI 143 (333)
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCE
Confidence 999999999999999999999999975 345889999999999999999995 34579999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
||+|||++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 144 kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 144 KLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred EEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999987654321 1234689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.42 Aligned_cols=265 Identities=23% Similarity=0.392 Sum_probs=204.5
Q ss_pred hhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCC
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHR 409 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 409 (633)
..++|++.+.||+|+||.||+|...+ .+++.||+|++...... ...+.+.+|+.++.++ +|+
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~E~~~~~~l~~h~ 71 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA-------------SEYKALMTELKILIHIGHHL 71 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH-------------HHHHHHHHHHHHHHhhccCc
Confidence 34679999999999999999996532 24578999988543211 1145677899999999 799
Q ss_pred cccccceeeecC-CccEEEEecccCCCHHHHHhhhcCC------------------------------------------
Q 006739 410 NLLPLLAHMARP-DCHLLVYEFMKNGSLQDILNDVSQG------------------------------------------ 446 (633)
Q Consensus 410 niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------ 446 (633)
||++++++|... ...+++|||+++++|.+++......
T Consensus 72 niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (337)
T cd05054 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDK 151 (337)
T ss_pred chhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCc
Confidence 999999988654 5678999999999999998642210
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCC
Q 006739 447 ---------------RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511 (633)
Q Consensus 447 ---------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~ 511 (633)
...+++..+..++.||+.||+|| |+.+|+||||||+||++++++.++|+|||+++.+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~ 228 (337)
T cd05054 152 SLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 228 (337)
T ss_pred chhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc
Confidence 13689999999999999999999 688999999999999999999999999999987654433
Q ss_pred cceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhhhh
Q 006739 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAK 590 (633)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 590 (633)
........++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+.+.+.. .....
T Consensus 229 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~---~~~~~~~~~---~~~~~------ 296 (337)
T cd05054 229 YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID---EEFCRRLKE---GTRMR------ 296 (337)
T ss_pred hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc---HHHHHHHhc---cCCCC------
Confidence 323334456788999999999999999999999999999998 99998653221 111111111 11100
Q ss_pred hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 591 LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 591 ~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 297 ----~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 297 ----APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred ----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111223478899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=330.32 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=199.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|.+..... ...+..+.+.+|+.++++++||||++++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 84 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREI-----------LKMKQVQHVAQEKSILMELSHPFIVNMM 84 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHH-----------hhhhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 367999999999999999999875 5788999999853210 1112256788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||+++++.+
T Consensus 85 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~ 157 (329)
T PTZ00263 85 CSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHV 157 (329)
T ss_pred EEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCE
Confidence 999999999999999999999999875 34588899999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... . +...
T Consensus 158 kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~---~~~~ 225 (329)
T PTZ00263 158 KVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----F---RIYE 225 (329)
T ss_pred EEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----H---HHHH
Confidence 999999998764432 234689999999999999999999999999999999999999865321 1 1112
Q ss_pred HhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHH
Q 006739 576 NVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVR 625 (633)
Q Consensus 576 ~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~ 625 (633)
...... .....+ ...+.+++.+||+.||.+||+ +++++
T Consensus 226 ~i~~~~~~~p~~~------------~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 226 KILAGRLKFPNWF------------DGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred HHhcCCcCCCCCC------------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 221111 111111 123678999999999999997 56665
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=317.51 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=205.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.++||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.++++++|+||+++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGTM---------------SVQAFLEEANLMKTLQHDKLVRL 66 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCch---------------hHHHHHHHHHHHHhCCCCCeeeE
Confidence 3468899999999999999999865 677899998753221 13568889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..+++|||+++++|.++++... ...+++..+..++.|+++||+|| |+.+++||||||+||++++++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~ 141 (261)
T cd05072 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLM 141 (261)
T ss_pred EEEEcCCCCcEEEEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCc
Confidence 999999999999999999999999997532 45688999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 573 (633)
++|+|||++.......... .....++..|+|||+..+..++.++|||||||++|||++ |+.||.... .......
T Consensus 142 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~ 216 (261)
T cd05072 142 CKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS----NSDVMSA 216 (261)
T ss_pred EEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC----HHHHHHH
Confidence 9999999998765432211 122346778999999988889999999999999999998 999986432 1122222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.. ...... .......+.+++.+|++.+|++||+++++.++|+++
T Consensus 217 ~~~---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 217 LQR---GYRMPR----------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHc---CCCCCC----------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 221 111100 011123477899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.47 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=210.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+++.||+|.+....... .+....+.+|+++++.++||||+++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMD-----------AKARQDCVKEIDLLKQLNHPNVIKYLD 69 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccccCC-----------HHHHHHHHHHHHHHHhCCCcceeeeee
Confidence 57889999999999999999864 478999999875422110 112456888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++|+||+++++|.+++.........+++..+..++.|+++||+|| |+.+++|+||||+||+++.++.++
T Consensus 70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~~ 146 (267)
T cd08228 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999875444456689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||++......... .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... ....+...
T Consensus 147 l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~ 219 (267)
T cd08228 147 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQK 219 (267)
T ss_pred ECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHH
Confidence 9999998876543221 1234688899999999888899999999999999999999999854221 11222222
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
......+.. ........+.+++.+||+.+|++||++.++++.++++|
T Consensus 220 ~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 IEQCDYPPL---------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HhcCCCCCC---------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 211111110 01122344788999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=325.46 Aligned_cols=264 Identities=19% Similarity=0.311 Sum_probs=197.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|+.. .+++.||+|.+....... ....+.+|++++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~~~ 69 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEG-------------APCTAIREVSLLKNLKHANIVTLH 69 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCC-------------cchhHHHHHHHHHhCCCCCEeeEE
Confidence 357999999999999999999864 578899999986432111 023567899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++ +|.+++... ...+++..+..++.||++||+|| |+.+|+||||||+||++++++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~ 142 (288)
T cd07871 70 DIIHTERCLTLVFEYLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGEL 142 (288)
T ss_pred EEEcCCCeEEEEEeCCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCE
Confidence 999999999999999975 999888642 34578999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+
T Consensus 143 kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~----~~~~~~ 216 (288)
T cd07871 143 KLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK----EELHLI 216 (288)
T ss_pred EECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 9999999876543221 1133468999999998865 56899999999999999999999998653221 111111
Q ss_pred HHhhccCCc------------chhhhhhhhhc----CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENP------------TRAIDAKLLEN----GYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~------------~~~~d~~~~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......... .....+..... ..+.......+++.+|++.||.+|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111110000 00000000000 00011234678999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=327.79 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=194.1
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
+.||+|+||.||+++.. .+|+.||+|++..... ........+.+|+.++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 68 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVI-----------IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD 68 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC
Confidence 46899999999999864 5789999999853211 11122456778999999999999999999999999
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+||+++.++.+||+|||+
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG~ 141 (323)
T cd05571 69 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999875 35689999999999999999999 788999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCC
Q 006739 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN 582 (633)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (633)
++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .....+.+ ....
T Consensus 142 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~~---~~~~- 211 (323)
T cd05571 142 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELI---LMEE- 211 (323)
T ss_pred CcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC----HHHHHHHH---HcCC-
Confidence 875432211 1234579999999999999999999999999999999999999986522 11111111 1111
Q ss_pred cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 583 PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 583 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
. .. +......+.+++.+||+.||++|| ++.++++
T Consensus 212 ~------~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 I------RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred C------CC----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0 00 011123377888999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.79 Aligned_cols=256 Identities=20% Similarity=0.265 Sum_probs=203.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
..|...+.||+|++|.||+|......+..||+|.+..... .....+++|+.+++.++|||||++++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~~~~ 132 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--------------RQAAYARSELHCLAACDHFGIVKHFD 132 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--------------HHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 3488999999999999999976543378889987633211 11346778999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++..++..++||||+++|+|.++++........+++..+..++.|++.||+|| |+.+|+||||||+|||++.++.+|
T Consensus 133 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~k 209 (478)
T PTZ00267 133 DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIK 209 (478)
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEE
Confidence 99999999999999999999998875444456789999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+..
T Consensus 210 L~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~ 282 (478)
T PTZ00267 210 LGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQ 282 (478)
T ss_pred EEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 9999999876544322222445799999999999999999999999999999999999999864211 122222
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ . +......+.+++..||+.||++||++++++.
T Consensus 283 ~~~~~~~~--~--------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 283 VLYGKYDP--F--------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHhCCCCC--C--------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 22211110 0 0011234788899999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=328.45 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=210.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+.|..++++|+|+||.++.++++ .+++.|++|++...... ++..+....|+.++++++|||||.+.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~t------------~~~r~~A~~E~~lis~~~hP~iv~y~d 70 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKLT------------EPERRSAIQEMDLLSKLLHPNIVEYKD 70 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc-cCCceEEEEEEeccccC------------chhhHHHHHHHHHHHhccCCCeeeecc
Confidence 67889999999999999999865 57889999998654322 122457889999999999999999999
Q ss_pred eeecCCc-cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 417 HMARPDC-HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 417 ~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
.|.+++. .++||+|++||++.+.+.+.. +..+++..+..++.|+..|+.|| |+..|+|||||+.||+++.++.+
T Consensus 71 s~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~V 145 (426)
T KOG0589|consen 71 SFEEDGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKKV 145 (426)
T ss_pred chhcCCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCce
Confidence 9999888 899999999999999998754 57799999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+|+.+...... ...+.||+.||.||.+.+.+|+.|+|+||+||++|||.+-+++|....- ...+.
T Consensus 146 kLgDfGlaK~l~~~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ 216 (426)
T KOG0589|consen 146 KLGDFGLAKILNPEDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELIL 216 (426)
T ss_pred eecchhhhhhcCCchhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHHH
Confidence 99999999998876522 2457899999999999999999999999999999999999999876321 12222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.+.... ....+......+..++..|++.+|+.||++.+++..
T Consensus 217 ki~~~~----------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 217 KINRGL----------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcc----------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 221111 011112223346778889999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=307.84 Aligned_cols=266 Identities=25% Similarity=0.383 Sum_probs=201.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
...|...+.||+|+||.|..+... .+|+.||+|++..+..... ..++..+|+.+++.++|+||+.+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~-~t~~~VAIKKi~~~F~~~~------------~akRtlRElklLr~~~HeNIi~l~ 87 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDK-RTGEKVAIKKILNPFENQI------------DAKRTLRELKLLRHLRHENIIGLL 87 (359)
T ss_pred cceecccccccCcceeeEEEEEEc-CCCCEeehhhhhhhhhchH------------HHHHHHHHHHHHHHhcCCCcceEE
Confidence 345666799999999999999865 6789999999864432211 145678899999999999999999
Q ss_pred eeeec-----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMAR-----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+.+.. -...|+|+|+| +.+|...++. +..++.....-++.|+++||+|+ |+.+|+|||+||+|++++
T Consensus 88 di~~p~~~~~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n 159 (359)
T KOG0660|consen 88 DIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLN 159 (359)
T ss_pred eecccccccccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchh---hcccccccccchhheeec
Confidence 98754 34679999999 5699999985 45599999999999999999999 899999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
.+..+||+|||+|+..........++..+.|.+|+|||++. ...|+.+.||||.||++.||++|+.-|.+.. ..+
T Consensus 160 ~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d----~v~ 235 (359)
T KOG0660|consen 160 ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD----YVH 235 (359)
T ss_pred cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc----hHH
Confidence 99999999999999886542222346677899999999765 4679999999999999999999998876532 222
Q ss_pred HHHHHHHhhccCCcchh--hh--------hhh---h----hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRA--ID--------AKL---L----ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~--~d--------~~~---~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+....+....... +. ..+ . ...++.......+++.+||..||.+|+|++|+++
T Consensus 236 Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 236 QLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 22333322221111000 00 000 0 0001111233678888999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=318.00 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=200.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++.+. ++..+|+|.+...... ..++.+|++++++++||||+++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~~ 66 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGAMS---------------EEDFIEEAKVMMKLSHPKLVQLYG 66 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec--cCceEEEEecccCCcc---------------HHHHHHHHHHHHHCCCCCceeEEE
Confidence 46788899999999999999875 5678999987533211 346788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++||||+++|+|.++++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+|
T Consensus 67 ~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05114 67 VCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVK 140 (256)
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEE
Confidence 999999999999999999999998742 23589999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 575 (633)
++|||.++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.... .....+.+.
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~~~~~~~i~ 215 (256)
T cd05114 141 VSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----NYEVVEMIS 215 (256)
T ss_pred ECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHH
Confidence 9999998865433221 1122345678999999998889999999999999999999 899986532 122222222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
....... +. .....+.+++.+||+.+|++||+++++++.|.
T Consensus 216 ---~~~~~~~---~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 216 ---RGFRLYR---PK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCCCC---CC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111110 00 11234789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=295.21 Aligned_cols=268 Identities=24% Similarity=0.333 Sum_probs=209.7
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|++.+.+|+|||+-||+++. -.++..||+|++..... +..+..++|++.-++++||||++
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~-~s~~~~YAlKkI~c~~~--------------~~~e~~~rEid~~rkf~s~~vl~ 82 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKG-LSTGHLYALKKILCHSQ--------------EDIEEALREIDNHRKFNSPNVLR 82 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecc-cCcccchhhheeeccch--------------HHHHHHHHHHHHHHhhCCcchHH
Confidence 3457899999999999999999984 46899999999976552 12567889999999999999999
Q ss_pred cceeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 414 LLAHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 414 l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
++++...+ ...|+++.|...|+|.+.+......+..+++.+.++|+.+|.+||++||.. ..+..||||||.||+
T Consensus 83 l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NIL 161 (302)
T KOG2345|consen 83 LVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANIL 161 (302)
T ss_pred HHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeE
Confidence 99987543 348999999999999999998777778899999999999999999999532 234999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCc-------ceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCC
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTH-------ITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPS 558 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~ 558 (633)
+.+++.+++.|||.+...+-.-.. ........|..|+|||.+. +...++++|||||||++|+|+.|.-||
T Consensus 162 ls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 162 LSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF 241 (302)
T ss_pred ecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence 999999999999998765422110 1123445799999999875 456789999999999999999999999
Q ss_pred cccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 559 DDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+...+......+.- ....+.-.......+.+.+++.+|++.||.+||++.+++..++.+
T Consensus 242 e~~~~~GgSlaLAv--------------~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 242 ERIYQQGGSLALAV--------------QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred hHHhhcCCeEEEee--------------eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 86554222211110 000000000011234478889999999999999999999998875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=325.62 Aligned_cols=269 Identities=21% Similarity=0.305 Sum_probs=193.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc---CCCCcccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ---IRHRNLLP 413 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~ 413 (633)
++|++.+.||+|+||.||+|+....+++.||+|++......... ...+.+|+.+++. ++||||++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~~e~~~l~~l~~~~hpniv~ 68 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------------PLSTIREVAVLRHLETFEHPNVVR 68 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc------------hHHHHHHHHHHHhhcccCCCCcce
Confidence 36888999999999999999875556789999988654322110 1233445555554 47999999
Q ss_pred cceeeec-----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 414 LLAHMAR-----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 414 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
+++++.. ....++||||++ ++|.+++.... ...+++..+..++.|++.||+|| |+.+|+||||||+||+
T Consensus 69 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil 142 (290)
T cd07862 69 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNIL 142 (290)
T ss_pred EEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEE
Confidence 9998852 345789999996 69999887532 34589999999999999999999 7889999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+...
T Consensus 143 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~ 219 (290)
T cd07862 143 VTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 219 (290)
T ss_pred EcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence 9999999999999998765432 1234568999999999988899999999999999999999999987643211111
Q ss_pred hHHHHHHHhhccCCcchh-hhhhh--------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRA-IDAKL--------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~-~d~~~--------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.+.........++... ..... .....+.....+.+++.+|++.||++|||+.|+++
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 220 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111111000000000000 00000 00000112234678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=321.99 Aligned_cols=263 Identities=19% Similarity=0.345 Sum_probs=204.1
Q ss_pred hhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|+..+.||+|+||.||+|.+.+ .++..||+|++...... ....++.+|+.+++.++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~ 70 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-------------RERIEFLNEASVMKEFNCHH 70 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999997642 24578999987432210 11356888999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG------RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp 484 (633)
|+++++++......++||||+++|+|.+++...... ...+++..+..++.|+++||+|| |+.+++||||||
T Consensus 71 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp 147 (277)
T cd05062 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAA 147 (277)
T ss_pred eeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcch
Confidence 999999999999999999999999999998753321 23467889999999999999999 678999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccc
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQ 563 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~ 563 (633)
+||++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 148 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 148 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred heEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999886654332222122345788999999998889999999999999999999 7888864321
Q ss_pred ccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
....+.+. ...... ........+.+++.+|++.||++|||+.|+++.|++
T Consensus 228 ----~~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 228 ----EQVLRFVM---EGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----HHHHHHHH---cCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22222221 111110 011122347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=318.03 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=204.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|+..+.||+|++|.||+|... .+++.||+|.+..... ...++.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~ 68 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQLL 68 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEe-cCCceEEEEEecCCch---------------HHHHHHHHHHHHHhCCCCChhheE
Confidence 356888899999999999999875 4688999998753321 135678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++++|.+++.... ...+++..+..++.|+++||+|| |+.+++||||||+||++++++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~ 143 (263)
T cd05052 69 GVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLV 143 (263)
T ss_pred EEEcCCCCcEEEEEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcE
Confidence 99999999999999999999999986532 35689999999999999999999 68899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....+.+
T Consensus 144 kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~ 218 (263)
T cd05052 144 KVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYELL 218 (263)
T ss_pred EeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH
Confidence 99999999876543221 1112234678999999998899999999999999999998 8999864321 1111111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
....... . .......+.+++.+||+.||++||++.+++++|+++
T Consensus 219 ---~~~~~~~------~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 ---EKGYRME------R----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---HCCCCCC------C----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111110 0 011123478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=322.25 Aligned_cols=263 Identities=21% Similarity=0.368 Sum_probs=206.6
Q ss_pred hcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|.+.+.||+|+||.||++... ..++..+|+|.+..... ...+.+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i 69 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--------------NARKDFHREAELLTNLQHEHI 69 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--------------HHHHHHHHHHHHHHhCCCCCc
Confidence 467889999999999999999752 23456799998754321 114568899999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ---------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di 482 (633)
+++++++...+..++||||+++++|.+++..... ....+++..+..++.|++.||+|| |+.+++||||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dl 146 (288)
T cd05093 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDL 146 (288)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccc
Confidence 9999999999999999999999999999975321 123589999999999999999999 6789999999
Q ss_pred CCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccc
Q 006739 483 KPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDF 561 (633)
Q Consensus 483 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~ 561 (633)
||+||++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 147 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 147 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred CcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986654332222233446788999999998889999999999999999998 89998653
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.. ....+.+ ....... .... ....+.+++.+||+.||.+|||+.|+.+.|+++.
T Consensus 227 ~~----~~~~~~i---~~~~~~~------~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 227 SN----NEVIECI---TQGRVLQ------RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CH----HHHHHHH---HcCCcCC------CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 22 1111111 1111110 0001 1234788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=317.79 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=204.6
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|++|.||+|... +++.||+|.+...... .+++.+|++++++++||||+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGTMD---------------PKDFLAEAQIMKKLRHPKLIQL 66 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCccc---------------HHHHHHHHHHHHHCCCCCccce
Confidence 3467899999999999999999864 5678999998543211 3457889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+++++|.+++.... ...+++..+..++.|++.|+.|| |+.+|+||||||+||++++++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~ 141 (261)
T cd05068 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNI 141 (261)
T ss_pred eEEEecCCCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCC
Confidence 999999999999999999999999987532 35689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 573 (633)
++|+|||+++.......... .....+..|+|||+..+..++.++||||||+++|||++ |+.||.... .......
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~ 216 (261)
T cd05068 142 CKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT----NAEVLQQ 216 (261)
T ss_pred EEECCcceEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Confidence 99999999987753322111 11223468999999998899999999999999999999 999986532 1122221
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+. ...... ........+.+++.+|++.+|++||++.++++.|+++
T Consensus 217 ~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 217 VD---QGYRMP----------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HH---cCCCCC----------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11 111110 0111224588899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.03 Aligned_cols=247 Identities=26% Similarity=0.331 Sum_probs=199.0
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
..++|...++||+|+||+|+++.+++ +++.+|||.+++...=..+ ..+..+.|.+++... +||.++.
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~Il~~d-----------~Ve~~~~EkrI~~la~~HPFL~~ 433 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDILQRD-----------EVESLMCEKRIFELANRHPFLVN 433 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccceeccc-----------cHHHHHHHHHHHHHhccCCeEee
Confidence 45789999999999999999999874 6779999999876542111 144556666666655 5999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++..|+.++++|+||||+.||++..+.+ ...+++..+.-++..|+.||+|| |+++|||||||.+|||+|.+|
T Consensus 434 L~~~fQT~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~eG 505 (694)
T KOG0694|consen 434 LFSCFQTKEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTEG 505 (694)
T ss_pred cccccccCCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEcccC
Confidence 9999999999999999999999655443 46799999999999999999999 899999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
++||+|||+++.--.... +++..+||+.|||||++.+..|+.++|+|||||++|||+.|..||.+..+ .++-+-
T Consensus 506 h~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE----ee~Fds 579 (694)
T KOG0694|consen 506 HVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE----EEVFDS 579 (694)
T ss_pred cEEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHH
Confidence 999999999986542222 44678999999999999999999999999999999999999999976332 222221
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
+ ..++.. ++.....+...++++++.++|++|..+
T Consensus 580 I---~~d~~~-----------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 I---VNDEVR-----------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred H---hcCCCC-----------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 111111 111122347788889999999999987
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=316.04 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=210.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|++|.||+++.. .+++.+|||.+...... ..+...++.+|+.+++.++|+||+++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~i~~~~~ 69 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLM-----------DAKARADCIKEIDLLKQLNHPNVIKYYA 69 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhh-----------hHHHHHHHHHHHHHHHHccCCchhhhhh
Confidence 46888899999999999999864 47899999987543211 1122467889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++..++..+++|||+++++|.+++.........+++..++.++.|+++||+|| |+.+++|+||||+||+++.++.++
T Consensus 70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~ 146 (267)
T cd08229 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999876544456789999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
++|||++......... .....|+..|+|||+..+..++.++|+||||+++|||++|..||..... ....+.+.
T Consensus 147 l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~ 219 (267)
T cd08229 147 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKK 219 (267)
T ss_pred ECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhh
Confidence 9999998876543221 1234688999999999888899999999999999999999999864211 11122222
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
........ . ........+.+++.+||+.||++|||+.+|+++++++.
T Consensus 220 ~~~~~~~~------~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 IEQCDYPP------L---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhcCCCCC------C---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111110 0 01112334788999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.82 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=206.2
Q ss_pred hcCcccccccccccCeeEEEEEecCC--CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+|.+... +...||+|.+...... ....++.+|+.++++++||||++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~ 69 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD-------------KQRLDFLTEASIMGQFDHPNIIR 69 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh-------------HHHHHHHHHHHHHHhCCCCCcce
Confidence 35788999999999999999987532 3568999987543211 11456888999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++...+..++||||+++++|.+++... ...+++..+..++.|++.|++|| |+.+|+||||||+||++++++
T Consensus 70 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~ 143 (266)
T cd05033 70 LEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNL 143 (266)
T ss_pred EeEEEecCCceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCC
Confidence 999999999999999999999999998752 23689999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....+
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~ 219 (266)
T cd05033 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIK 219 (266)
T ss_pred CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Confidence 999999999998753222222223345678999999998899999999999999999998 9999864321 12222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+. ....... .......+.+++.+|++.+|++||+++|+++.|+++
T Consensus 220 ~~~---~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 AVE---DGYRLPP----------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHH---cCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 221 1111110 011223478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=322.70 Aligned_cols=262 Identities=22% Similarity=0.381 Sum_probs=206.7
Q ss_pred cCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.+|...+.||+|+||.||+|.... .++..+++|.+..... ...+.+.+|++++++++|+||+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~ 70 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--------------AARKDFQREAELLTNLQHEHIV 70 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--------------HHHHHHHHHHHHHhcCCCCCcc
Confidence 457888999999999999997532 3456799998753321 1145688899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|| |+++|+||
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~ 147 (291)
T cd05094 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHR 147 (291)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeec
Confidence 999999999999999999999999999975321 124589999999999999999999 78899999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 148 dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred ccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986654432222234457889999999999899999999999999999999 999986
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.... ....+.+. ...... ........+.+++.+||+.+|++||++++++++|+++.
T Consensus 228 ~~~~----~~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 228 QLSN----TEVIECIT---QGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred CCCH----HHHHHHHh---CCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 5322 11222211 111110 00112234788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.70 Aligned_cols=262 Identities=23% Similarity=0.387 Sum_probs=206.6
Q ss_pred hcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|.+.+.||+|+||.||+|.... .++..||+|.+...... +..+.+.+|+++++.++|+||
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i 70 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-------------DARKDFEREAELLTNFQHENI 70 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-------------HHHHHHHHHHHHHHhcCCCCc
Confidence 3568889999999999999997632 24578999998654321 114678899999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVS----------QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRD 481 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~D 481 (633)
+++++++......++||||+++++|.+++.... .....+++..+..++.|++.|++|| |+.+++|||
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~d 147 (280)
T cd05049 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRD 147 (280)
T ss_pred hheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccc
Confidence 999999999999999999999999999997532 1234578999999999999999999 788999999
Q ss_pred CCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcc
Q 006739 482 LKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDD 560 (633)
Q Consensus 482 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~ 560 (633)
|||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 148 lkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 148 LATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred cccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986543322222233456788999999999999999999999999999998 9999865
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
... ....+.+. ... ... ........+.+++.+||+.||++||++.|+++.|++
T Consensus 228 ~~~----~~~~~~~~---~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 228 LSN----EEVIECIT---QGR-LLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCH----HHHHHHHH---cCC-cCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 322 22222222 111 100 001122347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.19 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=204.9
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+++.. .+|+.||||++....... .....+.+|+.++..++|+|++++
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~------------~~~~~~~~Ei~~l~~~~h~~iv~~ 96 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSE------------ADKNRAQAEVCCLLNCDFFSIVKC 96 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCH------------HHHHHHHHHHHHHhcCCCCcEEEe
Confidence 4578999999999999999999864 578999999986543211 114567889999999999999998
Q ss_pred ceeeecCC--------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 415 LAHMARPD--------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 415 ~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
+..+...+ ..++||||+++|+|.++++........+++..+..++.|++.||+|| |+.+|+||||||+|
T Consensus 97 ~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~N 173 (496)
T PTZ00283 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSAN 173 (496)
T ss_pred ecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHH
Confidence 88765432 25799999999999999976544456799999999999999999999 78899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 174 ILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---- 249 (496)
T PTZ00283 174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---- 249 (496)
T ss_pred EEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----
Confidence 9999999999999999987654322222234679999999999999999999999999999999999999986521
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
..+.+.......... + +......+.+++..||+.||++||++.++++.
T Consensus 250 ---~~~~~~~~~~~~~~~--~--------~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 ---MEEVMHKTLAGRYDP--L--------PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---HHHHHHHHhcCCCCC--C--------CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 112222222211110 0 11112347788999999999999999998763
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=326.75 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=201.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCe----EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
..+|+..+.||+|+||.||+|++.. ++. .||+|.+...... ...+++.+|+.+++.++||||
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni 71 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSP-------------KANKEILDEAYVMASVDNPHV 71 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCCC
Confidence 4579999999999999999998642 233 4899988532210 114568889999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
++++++|... ..++|+||+++|+|.+++... ...+++..+..++.||++||+|| |+.+|+||||||+||++++
T Consensus 72 v~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~~ 144 (316)
T cd05108 72 CRLLGICLTS-TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVKT 144 (316)
T ss_pred CeEEEEEcCC-CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEecC
Confidence 9999998764 567999999999999998752 34588999999999999999999 7889999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||++... ..+
T Consensus 145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~ 220 (316)
T cd05108 145 PQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEI 220 (316)
T ss_pred CCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999987765433222222345678999999999999999999999999999998 9999875321 122
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+.+. ....... .......+.+++..||+.+|++||++.+++..+.++
T Consensus 221 ~~~~~---~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 221 SSILE---KGERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred HHHHh---CCCCCCC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22221 1111110 001122477889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.10 Aligned_cols=261 Identities=20% Similarity=0.223 Sum_probs=196.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|++.+.||+|+||.||++... .+++.||+|... ...+.+|++++++++||||++++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~-~~~~~vaiK~~~--------------------~~~~~~E~~il~~l~HpnIv~~~ 149 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQ--------------------RGGTATEAHILRAINHPSIIQLK 149 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEEC-CCCCEEEEechh--------------------hhhhHHHHHHHHhCCCCCCCCEe
Confidence 357999999999999999999864 578899999641 23467899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++......++|+|++. ++|.+++.. ...+++..++.++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 150 ~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~v 221 (391)
T PHA03212 150 GTFTYNKFTCLILPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGDV 221 (391)
T ss_pred EEEEECCeeEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCCE
Confidence 99999999999999995 688888764 34589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccc---ccchHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT---EEMSLVK 572 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~---~~~~~~~ 572 (633)
||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+
T Consensus 222 kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~ 300 (391)
T PHA03212 222 CLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300 (391)
T ss_pred EEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH
Confidence 99999999754332211 1234579999999999999899999999999999999999998864322111 0111111
Q ss_pred HHHHhhccCCcc------hhhhhhh----------hhc-----CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPT------RAIDAKL----------LEN-----GYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~------~~~d~~~----------~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.......... ..++... ... ........+.+++.+||+.||++|||++|+++
T Consensus 301 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 111111100000 0000000 000 00112345788999999999999999999985
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.77 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=193.1
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
+.||+|+||.||+++.. .+|+.||+|++..... ........+.+|+++++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~ 68 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVI-----------IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 68 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 46899999999999864 5789999999853211 11122456778999999999999999999999999
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||+++++.+||+|||+
T Consensus 69 ~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 141 (323)
T cd05595 69 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccHH
Confidence 99999999999999988865 34689999999999999999999 788999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhcc-C
Q 006739 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS-E 581 (633)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 581 (633)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ....... .
T Consensus 142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~---~~~~~~~~~ 212 (323)
T cd05595 142 CKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERL---FELILMEEI 212 (323)
T ss_pred hccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----HHH---HHHHhcCCC
Confidence 875432211 12335689999999999999999999999999999999999999865321 111 1111111 1
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
..... ....+.+++.+||+.||++|| ++.++++
T Consensus 213 ~~p~~------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 RFPRT------------LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCC------------CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11111 122367888899999999998 7887764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.05 Aligned_cols=243 Identities=24% Similarity=0.332 Sum_probs=191.0
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCcc
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH 424 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 424 (633)
||+|+||.||+++.. .+++.||+|++..... ........+.+|+.++.+++||||+++++++...+..
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 68 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHI-----------VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL 68 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE
Confidence 799999999999864 5788999999853210 0112245678899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 425 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+||+|||+++
T Consensus 69 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 69 YLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLCK 141 (312)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECcccc
Confidence 999999999999999875 34589999999999999999999 68899999999999999999999999999988
Q ss_pred ccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcc
Q 006739 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPT 584 (633)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (633)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+..+........
T Consensus 142 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~~~~- 211 (312)
T cd05585 142 LNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQEPLR- 211 (312)
T ss_pred cCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCC-
Confidence 6433221 12345799999999999999999999999999999999999999865321 1222222221110
Q ss_pred hhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 585 RAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 585 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. .......+.+++.+||+.||++||++.++.+
T Consensus 212 ------~----~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 212 ------F----PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred ------C----CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 0 0111233678889999999999986544333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.06 Aligned_cols=270 Identities=22% Similarity=0.335 Sum_probs=208.3
Q ss_pred hhhhhhhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc
Q 006739 330 LAFLEKEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ 405 (633)
Q Consensus 330 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 405 (633)
..+..+.++|.+.+.||+|+||.||+|++.+ ..++.||+|++...... ...+.+.+|++++.+
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-------------~~~~~~~~E~~~l~~ 96 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-------------SEKQALMSELKIMSH 96 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-------------hHHHHHHHHHHHHHh
Confidence 3345566788999999999999999998642 24578999999654321 013468899999999
Q ss_pred CC-CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC---------------------------------------
Q 006739 406 IR-HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ--------------------------------------- 445 (633)
Q Consensus 406 l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------- 445 (633)
+. |||||++++++...+..++||||+++|+|.+++++...
T Consensus 97 l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (401)
T cd05107 97 LGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDG 176 (401)
T ss_pred cCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCc
Confidence 97 99999999999999999999999999999999975321
Q ss_pred -------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 006739 446 -------------------------------------------------------GRRELDWLARHKIALGVACGLEYLH 470 (633)
Q Consensus 446 -------------------------------------------------------~~~~l~~~~~~~i~~~ia~~L~~Lh 470 (633)
....+++.....++.|++.||+||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L- 255 (401)
T cd05107 177 GYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL- 255 (401)
T ss_pred cccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH-
Confidence 113467888999999999999999
Q ss_pred hcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHH
Q 006739 471 ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAV 550 (633)
Q Consensus 471 ~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~e 550 (633)
|+.+|+||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||
T Consensus 256 --H~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e 333 (401)
T cd05107 256 --ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333 (401)
T ss_pred --hcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHH
Confidence 688999999999999999999999999999986543322212223457889999999998889999999999999999
Q ss_pred HHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 551 LVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 551 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
|++ |+.||..... .....+.+ ....... .+......+.+++..||+.+|.+||+++|+++.|+
T Consensus 334 ~l~~g~~P~~~~~~---~~~~~~~~---~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 334 IFTLGGTPYPELPM---NEQFYNAI---KRGYRMA----------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred HHHcCCCCCCCCCc---hHHHHHHH---HcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 998 8899864321 11111111 1111110 00111234788889999999999999999999998
Q ss_pred hh
Q 006739 630 QI 631 (633)
Q Consensus 630 ~~ 631 (633)
++
T Consensus 398 ~~ 399 (401)
T cd05107 398 DL 399 (401)
T ss_pred HH
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=317.51 Aligned_cols=253 Identities=27% Similarity=0.486 Sum_probs=193.1
Q ss_pred cccccccccCeeEEEEEec---CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 341 SLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
..+.||.|.||.||+|.+. ...+..|+||.+...... +..+.+.+|++.+++++||||++++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~~~~g~ 69 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSE-------------EEEEEFLNEIQILRKLRHPNIVKLYGF 69 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSH-------------HHHHHHHHHHHHHHTHSBTTBE-EEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccccc-------------ccceeeeeccccccccccccccccccc
Confidence 4578999999999999986 234678999998542211 115678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++||||+++|+|.+++... ....+++..+..|+.||++||+|| |+.+++|+||+++||++++++.+||
T Consensus 70 ~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~~~~~Kl 144 (259)
T PF07714_consen 70 CIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDSNGQVKL 144 (259)
T ss_dssp EESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEETTTEEEE
T ss_pred cccccccccccccccccccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence 99888899999999999999999874 246789999999999999999999 5678999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
+|||++................+...|+|||.+....++.++||||||+++|||++ |+.||.+.. ...+...+..
T Consensus 145 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~----~~~~~~~~~~ 220 (259)
T PF07714_consen 145 SDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD----NEEIIEKLKQ 220 (259)
T ss_dssp ESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC----HHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccccc
Confidence 99999987743333222334457889999999999889999999999999999999 788876542 1222222221
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
..... .. ......+.+++..||+.||++|||++++++.|
T Consensus 221 ~~~~~-~~------------~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 GQRLP-IP------------DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TEETT-SB------------TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccce-ec------------cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11100 01 01122377899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=320.01 Aligned_cols=261 Identities=23% Similarity=0.412 Sum_probs=203.9
Q ss_pred cCcccccccccccCeeEEEEEe---cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
++|++.+.||+|+||.||+|.. ...++..||+|.+...... .....+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~ 71 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-------------QQWGEFQQEASLMAELHHPNIVC 71 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-------------HHHHHHHHHHHHHhhCCCCCeee
Confidence 5678889999999999999975 2236689999998643211 11456888999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
+++++...+..++||||+++++|.+++..... ....+++.....++.|++.||+|| |+++|+||
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~ 148 (283)
T cd05090 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHK 148 (283)
T ss_pred EEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeehh
Confidence 99999999999999999999999999864221 123578999999999999999999 67899999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 149 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred ccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987654332222233456778999999988889999999999999999998 988986
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
... ...+.+.+.. ..... . +......+.+++.+|++.||++||++.++.+.|+.
T Consensus 229 ~~~----~~~~~~~~~~---~~~~~------~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 229 GFS----NQEVIEMVRK---RQLLP------C----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCC----HHHHHHHHHc---CCcCC------C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 432 1222222221 11110 0 01112347788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=321.26 Aligned_cols=265 Identities=22% Similarity=0.328 Sum_probs=196.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++....... ....+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~~~ 69 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEG-------------TPFTAIREASLLKGLKHANIVLLH 69 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccc-------------cchhHHHHHHHHhhCCCCCcCeEE
Confidence 478999999999999999999864 578899999986433211 023467799999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||++ ++|.+++... ...++...+..++.|++.||+|| |+.+|+||||||+||++++++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~ 142 (303)
T cd07869 70 DIIHTKETLTLVFEYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGEL 142 (303)
T ss_pred EEEecCCeEEEEEECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCE
Confidence 99999999999999995 6888777642 34588899999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... .....+.+
T Consensus 143 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~ 217 (303)
T cd07869 143 KLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERI 217 (303)
T ss_pred EECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHH
Confidence 9999999875433221 1133568999999998865 4578899999999999999999999975422 11111111
Q ss_pred HHhhccCCcc---h-----hhhhh-h---hhcCCHH------HHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPT---R-----AIDAK-L---LENGYEE------QMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~---~-----~~d~~-~---~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... . ..++. . ....... ....+.+++..|++.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 218 FLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1111100000 0 00000 0 0000000 1134678999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=313.23 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=195.6
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
+.||+|+||.||+|+.. .+++.||+|.+...... +....+.+|++++++++||||+++++++....
T Consensus 1 ~~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 66 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPP-------------DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 66 (252)
T ss_pred CccCcccCccEEEEEEe-cCCceEEEEecCccCCH-------------HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC
Confidence 46899999999999874 47889999987533210 11456888999999999999999999999999
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||+++++|.+++... ...+++..++.++.|+++||+|| |+.+|+||||||+||+++.++.+||+|||+
T Consensus 67 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 140 (252)
T cd05084 67 PIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFGM 140 (252)
T ss_pred CeEEEEeeccCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECcccc
Confidence 999999999999999998642 34588999999999999999999 788999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhccC
Q 006739 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+....+...........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+. ...
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~~~~~---~~~ 213 (252)
T cd05084 141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTREAIE---QGV 213 (252)
T ss_pred CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHHHHHH---cCC
Confidence 876543221111111223567999999998889999999999999999998 8888865321 11111111 111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
... ........+.+++.+|++.+|++|||+.+++++|+.
T Consensus 214 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 214 RLP----------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 100 011112347889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.78 Aligned_cols=261 Identities=25% Similarity=0.302 Sum_probs=204.9
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLL 412 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv 412 (633)
.....+++.+.|.+|||+.||.|+..+ .|..||+|++..... ...+.+++|+++|++|+ |+|||
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~de--------------~~L~~v~~EI~~MK~L~gh~nIV 98 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVNDE--------------EALNAVKREIDIMKLLSGHKNIV 98 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecC-CCceeeeeeeecCCH--------------HHHHHHHHHHHHHHHhcCCCcee
Confidence 345677889999999999999999863 349999999865531 22678999999999997 99999
Q ss_pred ccce-eeec------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 006739 413 PLLA-HMAR------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485 (633)
Q Consensus 413 ~l~~-~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~ 485 (633)
.+++ .... .-+.+|+||||+||.|-+++....+ ..|++.++++|+.|+++|+++||+ ...+|||||||-+
T Consensus 99 ~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiE 175 (738)
T KOG1989|consen 99 SYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIE 175 (738)
T ss_pred eEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhh
Confidence 9999 3321 1356799999999999999986544 339999999999999999999985 4678999999999
Q ss_pred CeEecCCCceEEcccccccccCCCCC-cce------ecccccCccccccccc---ccCCCCCccchHHHHHHHHHHHhCC
Q 006739 486 NVLLDDDMEARIADFGLAKAMPDAQT-HIT------TSNVAGTVGYIAPEYH---QTLKFTDKCDIYSFGVLLAVLVMGR 555 (633)
Q Consensus 486 Nill~~~~~~kl~DfG~a~~~~~~~~-~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~elltg~ 555 (633)
||||+.+++.||||||.|...-.... ... .-...-|+.|+|||++ .+..+++|+|||++||+||-|....
T Consensus 176 NvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t 255 (738)
T KOG1989|consen 176 NVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFT 255 (738)
T ss_pred heEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhC
Confidence 99999999999999999875432221 100 0112359999999976 5678999999999999999999999
Q ss_pred CCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 556 LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 556 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.||++.... . +++....-...+.....+.+||+.||+.||++||++-+|++.+-++.
T Consensus 256 ~PFe~sg~l----a----------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 256 TPFEESGKL----A----------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred CCcCcCcce----e----------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 999864221 0 01111111112445566899999999999999999999999998774
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=333.61 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=200.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+++.||+|++..... ........+.+|++++..++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDM-----------IKRNQIAHVRAERDILADADSPWIVKLYY 68 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHH-----------hhccHHHHHHHHHHHHHhcCCCCccchhh
Confidence 36889999999999999999864 4789999999853211 01122457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~k 141 (350)
T cd05573 69 SFQDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIK 141 (350)
T ss_pred heecCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEE
Confidence 999999999999999999999999752 5689999999999999999999 679999999999999999999999
Q ss_pred EcccccccccCCCC---------------------------CcceecccccCcccccccccccCCCCCccchHHHHHHHH
Q 006739 497 IADFGLAKAMPDAQ---------------------------THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLA 549 (633)
Q Consensus 497 l~DfG~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ 549 (633)
|+|||++....... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 221 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence 99999998765433 001123356899999999999999999999999999999
Q ss_pred HHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-HHHHHH
Q 006739 550 VLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-SKDVRC 626 (633)
Q Consensus 550 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~ev~~ 626 (633)
||++|+.||...........+..|.. ...... . ......+.+++.+|+. ||.+||+ ++++++
T Consensus 222 ell~g~~Pf~~~~~~~~~~~i~~~~~----~~~~p~--~--------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 222 EMLYGFPPFYSDTLQETYNKIINWKE----SLRFPP--D--------PPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred hhccCCCCCCCCCHHHHHHHHhccCC----cccCCC--C--------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 99999999976432111111111100 000000 0 0012337788889997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=317.11 Aligned_cols=258 Identities=23% Similarity=0.333 Sum_probs=199.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCe----EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
++|+..+.||+|+||.||+|.+.. ++. .+++|.+..... .....++..|+.++++++||||+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~~~~~l~~l~h~~iv 72 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSG-------------RQTFQEITDHMLAMGSLDHAYIV 72 (279)
T ss_pred hhceeccccCccCCcceEEEEEcC-CCCceeeEEEEeecccccc-------------hHHHHHHHHHHHHHhcCCCCCcc
Confidence 578889999999999999998742 343 477777642211 11245678888899999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.. ...++++||+++|+|.+++... ...+++..+..++.||+.||+|| |+++++||||||+||+++++
T Consensus 73 ~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~ 145 (279)
T cd05111 73 RLLGICPG-ASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKSD 145 (279)
T ss_pred eEEEEECC-CccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCC
Confidence 99998754 4578899999999999999752 34689999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |+.||.+... ....
T Consensus 146 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~ 221 (279)
T cd05111 146 SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVP 221 (279)
T ss_pred CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHH
Confidence 9999999999987654433222334557789999999998899999999999999999998 9999865322 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+++.. ..... .+ ..+ ...+.+++.+||..||++|||+.|+++.|..+.
T Consensus 222 ~~~~~---~~~~~---~~----~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 222 DLLEK---GERLA---QP----QIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHHHC---CCcCC---CC----CCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 22221 11111 00 011 123677888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.45 Aligned_cols=264 Identities=24% Similarity=0.381 Sum_probs=194.1
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||+|+||.||+|+.. .++..||+|++....... ....++.+|++++++++||||++++++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~~~ 67 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-HTGEKVAIKKINDVFEHV------------SDATRILREIKLLRLLRHPDIVEIKHI 67 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-CCCCEEEEEEechhhccc------------hhHHHHHHHHHHHHhCCCCCEeeecce
Confidence 4788899999999999999864 578999999885322110 113467889999999999999999998
Q ss_pred eecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 418 MARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 418 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+... ...|+||||++ ++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+|||++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 68 MLPPSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANAD 139 (338)
T ss_pred EeccCCCCCceEEEEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCC
Confidence 7543 24799999995 689988864 34589999999999999999999 68899999999999999999
Q ss_pred CceEEcccccccccCCCCC-cceecccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 493 MEARIADFGLAKAMPDAQT-HITTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~----~~ 215 (338)
T cd07859 140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV----VH 215 (338)
T ss_pred CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh----HH
Confidence 9999999999986533221 111234578999999999876 6789999999999999999999999865321 11
Q ss_pred HHHHHHHhhccCCcc-----------hhhhhhh------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPT-----------RAIDAKL------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~-----------~~~d~~~------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+.......... ..+.... .....+.....+.+++.+||+.||++|||++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 111111111110000 0000000 00000111234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.86 Aligned_cols=266 Identities=25% Similarity=0.361 Sum_probs=211.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|+||.||+|... .+|+.||+|.++....... ...+.+.+|++++++++|+|++++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~-----------~~~~~~~~ei~~l~~~~~~~i~~~~~ 69 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDA-----------KARQDCLKEIDLLKQLDHPNVIKYLA 69 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccch-----------hhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 57889999999999999999875 5789999998864322110 11457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++||||+++++|.+++.........+++..+..++.++++||+|| |+.+|+||||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~~ 146 (267)
T cd08224 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcEE
Confidence 99999999999999999999999876544456789999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||++......... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||.... ....+....
T Consensus 147 l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~ 219 (267)
T cd08224 147 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK 219 (267)
T ss_pred EeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhh
Confidence 9999998765443221 123458889999999988889999999999999999999999985422 122222222
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhhC
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~~ 633 (633)
........ . ..+.....+.+++.+||+.+|++|||+.+++++|++++.
T Consensus 220 ~~~~~~~~------~---~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 220 IEKCDYPP------L---PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred hhcCCCCC------C---ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 21111110 0 011223347889999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.39 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=196.5
Q ss_pred CcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
+|++.+.||+|+||.||+++.. ..+++.||+|++.+... .......+.+.+|++++.+++ |+||+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~ 70 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL----------VQKAKTVEHTRTERNVLEHVRQSPFLVTL 70 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH----------hhhhhHHHHHHHHHHHHHhccCCCCcccE
Confidence 4788999999999999998753 24688999999853211 001122456788999999995 9999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~~ 143 (332)
T cd05614 71 HYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEGH 143 (332)
T ss_pred EEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCCC
Confidence 9999999999999999999999999865 34589999999999999999999 6889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||+++......... .....||..|+|||++.+. .++.++|||||||++|||++|+.||...........+
T Consensus 144 ~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--- 219 (332)
T cd05614 144 VVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--- 219 (332)
T ss_pred EEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH---
Confidence 9999999998654432221 2345799999999998765 4788999999999999999999999753222111111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
.......... +. ......+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~~~~~-------~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 220 SRRILKCDPP-------FP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHhcCCCC-------CC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111111100 00 01122367888899999999999 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=322.85 Aligned_cols=245 Identities=23% Similarity=0.331 Sum_probs=193.9
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
+.||+|+||.||+++.. .+++.||+|++..... ........+.+|+++++.++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 68 (328)
T cd05593 1 KLLGKGTFGKVILVREK-ASGKYYAMKILKKEVI-----------IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD 68 (328)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 46899999999999864 5789999999853211 11122457788999999999999999999999999
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.+||+|||+
T Consensus 69 ~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG~ 141 (328)
T cd05593 69 RLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFGL 141 (328)
T ss_pred EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCcC
Confidence 99999999999999988865 34689999999999999999999 788999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCC
Q 006739 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN 582 (633)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (633)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ..........
T Consensus 142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~~---~~~~~~~~~~ 212 (328)
T cd05593 142 CKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EK---LFELILMEDI 212 (328)
T ss_pred CccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----HH---HHHHhccCCc
Confidence 875432211 12345799999999999998999999999999999999999999865221 11 1111111110
Q ss_pred cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 583 PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 583 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
.+... ....+.+++.+||+.||++|| ++.++++
T Consensus 213 -------~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 213 -------KFPRT----LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred -------cCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 00011 122367888899999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=328.06 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=192.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|++. .+++.||+|++...... .....+.+|+++++.++|+||++++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~ 138 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHED-------------TVRRQICREIEILRDVNHPNVVKCH 138 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcH-------------HHHHHHHHHHHHHHhCCCCCcceee
Confidence 356778899999999999999864 57899999998543211 1145788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++|+|.+. ....+..+..++.||+.||+|| |+.+|+||||||+|||+++++.+
T Consensus 139 ~~~~~~~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~ 207 (353)
T PLN00034 139 DMFDHNGEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNV 207 (353)
T ss_pred eEeccCCeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCE
Confidence 999999999999999999998653 2345677889999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
||+|||+++........ .....||..|+|||++.. ...+.++|||||||++|||++|+.||..... ...
T Consensus 208 kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~ 281 (353)
T PLN00034 208 KIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDW 281 (353)
T ss_pred EEcccccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----ccH
Confidence 99999999876543221 123578999999998743 2235689999999999999999999973221 111
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+.......... ........+.+++.+||+.||++||++.|+++
T Consensus 282 ~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 282 ASLMCAICMSQPPE----------APATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHhccCCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111111110 01112234788999999999999999999986
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=314.75 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=202.7
Q ss_pred cccccccccccCeeEEEEEecCC--CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 339 LASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
|.+.+.||+|+||.||+|..... .+..||+|++....... ....++.+|++.++.++||||+++++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 68 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY------------SEIEEFLSEAACMKDFDHPNVMKLIG 68 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH------------HHHHHHHHHHHHHHhCCCCCeeeEEe
Confidence 46788999999999999987432 24789999986432211 11457889999999999999999999
Q ss_pred eeecCCc------cEEEEecccCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 417 HMARPDC------HLLVYEFMKNGSLQDILNDVSQ--GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 417 ~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
++..... .++++||+++|+|.+++..... ....+++..+..++.|++.||+|| |+.+|+||||||+||+
T Consensus 69 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Nil 145 (273)
T cd05035 69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCM 145 (273)
T ss_pred eeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheEE
Confidence 8866554 6899999999999999865432 234689999999999999999999 6789999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEE 567 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 567 (633)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 146 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05035 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---- 221 (273)
T ss_pred ECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987655433322222345678999999988889999999999999999999 8888865321
Q ss_pred chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
....+++. ...... .+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 222 ~~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 222 HEIYDYLR---HGNRLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHHHH---cCCCCC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22222222 111111 0111233588899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=317.21 Aligned_cols=251 Identities=27% Similarity=0.365 Sum_probs=195.1
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCcc
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH 424 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 424 (633)
||+|+||+||++... .+++.||+|++...... .....+.+..|+++++.++|+||+++.+++......
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 68 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLK-----------KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL 68 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHh-----------hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE
Confidence 799999999999864 57899999987432210 111245678899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 425 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
++||||+++|+|.+++.........+++..+..++.||+.||+|| |+.+|+||||||+||++++++.++|+|||++.
T Consensus 69 ~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 145 (280)
T cd05608 69 CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLAV 145 (280)
T ss_pred EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccce
Confidence 999999999999988865444456799999999999999999999 67899999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcc
Q 006739 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPT 584 (633)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (633)
........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ...........
T Consensus 146 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~-- 218 (280)
T cd05608 146 ELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRILNDSV-- 218 (280)
T ss_pred ecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHhhcccCC--
Confidence 76543322 123578999999999999999999999999999999999999997532211111 11111111110
Q ss_pred hhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 585 RAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 585 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
...+.....+.+++..||+.||++|| +++++++
T Consensus 219 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 ---------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ---------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 00111223477888899999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.20 Aligned_cols=256 Identities=20% Similarity=0.346 Sum_probs=193.8
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|+.++.||+|+||+||+|+.. .+++.||+|++..... ........+.+|++++++++||||++++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~-----------~~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 69 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDV-----------LNRNQVAHVKAERDILAEADNEWVVKLYYS 69 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhHHHHHHHHHHHHHHhcCCCCeeeeEEE
Confidence 5788999999999999999865 5789999999853211 111225678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||++.++.+||
T Consensus 70 ~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~kL 142 (381)
T cd05626 70 FQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIKL 142 (381)
T ss_pred EecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEEE
Confidence 9999999999999999999999875 34588999999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCC---------------------------------------------cceecccccCccccccccccc
Q 006739 498 ADFGLAKAMPDAQT---------------------------------------------HITTSNVAGTVGYIAPEYHQT 532 (633)
Q Consensus 498 ~DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 532 (633)
+|||+++.+..... ........||+.|+|||++.+
T Consensus 143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence 99999764321000 000123469999999999998
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhH--h
Q 006739 533 LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACF--C 610 (633)
Q Consensus 533 ~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~--c 610 (633)
..++.++|||||||++|||++|+.||...........+..|.. ....... .... ..+.+++.+ |
T Consensus 223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~------~~~s----~~~~dli~~ll~ 288 (381)
T cd05626 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN----TLHIPPQ------VKLS----PEAVDLITKLCC 288 (381)
T ss_pred CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc----ccCCCCC------CCCC----HHHHHHHHHHcc
Confidence 8999999999999999999999999975332111111111100 0000000 0011 225556655 5
Q ss_pred ccCCCCCCCCHHHHHH
Q 006739 611 TVDSPRERPNSKDVRC 626 (633)
Q Consensus 611 l~~dP~~RPs~~ev~~ 626 (633)
+..+|..||+++|+++
T Consensus 289 ~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 289 SAEERLGRNGADDIKA 304 (381)
T ss_pred CcccccCCCCHHHHhc
Confidence 5667777999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=318.61 Aligned_cols=268 Identities=22% Similarity=0.335 Sum_probs=202.0
Q ss_pred cCcccccccccccCeeEEEEEec---------------CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHH
Q 006739 337 DGLASLEKIGSGGCGEVYKAELP---------------GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 401 (633)
++|++.++||+|+||.||++... ..++..||+|.+...... ....++.+|++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-------------~~~~~~~~E~~ 71 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-------------NARNDFLKEIK 71 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-------------HHHHHHHHHHH
Confidence 56899999999999999998532 123457999988543211 11457889999
Q ss_pred HhhcCCCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006739 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG-------RRELDWLARHKIALGVACGLEYLHISHN 474 (633)
Q Consensus 402 ~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~ 474 (633)
+++.++|+||+++++++...+..++||||+++++|.+++...... ...+++..+..++.|++.||+|| |+
T Consensus 72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~ 148 (296)
T cd05095 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SS 148 (296)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---HH
Confidence 999999999999999999999999999999999999999764321 23478889999999999999999 67
Q ss_pred CCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-
Q 006739 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM- 553 (633)
Q Consensus 475 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt- 553 (633)
.+|+||||||+||+++.++.++|+|||+++.+.............++..|+|||...+..++.++|||||||++|||++
T Consensus 149 ~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 149 LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred CCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 8999999999999999999999999999986644332222223345678999999888889999999999999999998
Q ss_pred -CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 554 -GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 554 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
|..||..............+... ....... .........+.+++.+||+.||++||++.|+++.|++
T Consensus 229 ~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 229 CKEQPYSQLSDEQVIENTGEFFRD----QGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCCCccccChHHHHHHHHHHHhh----ccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 77887643221111111111110 0000000 0011122457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.55 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=200.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++.+. ++..+|+|.+...... ..++.+|+.++.+++||||+++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~~~ 66 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMKLSHEKLVQLYG 66 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCccc---------------HHHHHHHHHHHhcCCCCCeeeEEE
Confidence 46788899999999999999874 4567999987543221 345788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++||||+++|+|.+++... ...+++..++.++.||+.||+|| |+.+++|+||||+||++++++.+|
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~k 140 (256)
T cd05113 67 VCTKQRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVK 140 (256)
T ss_pred EEccCCCcEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEE
Confidence 999888999999999999999998752 23689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||.++........ ......++..|+|||+..+..++.++|||||||++|||++ |+.||..... ......+
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~- 214 (256)
T cd05113 141 VSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEKV- 214 (256)
T ss_pred ECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHH-
Confidence 9999998866543221 1122345678999999988889999999999999999998 9999865322 1121222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
........ .......+.+++.+||+.+|++||++.++++.|+
T Consensus 215 --~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 215 --SQGLRLYR----------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --hcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11111110 0011244788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=329.04 Aligned_cols=206 Identities=25% Similarity=0.410 Sum_probs=175.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|+||+||+++.. .+++.||+|++.+... ........+++|+.++.+++|+||+++++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~il~~~~~~~iv~~~~ 68 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADM-----------LEKEQVGHIRAERDILVEADSLWVVKMFY 68 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHH-----------HHhhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 46889999999999999999864 5789999999853210 11122467888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.+.+....++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vk 141 (363)
T cd05628 69 SFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVK 141 (363)
T ss_pred EEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEE
Confidence 99999999999999999999999975 35689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCc---------------------------------ceecccccCcccccccccccCCCCCccchHH
Q 006739 497 IADFGLAKAMPDAQTH---------------------------------ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYS 543 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 543 (633)
|+|||+++........ .......||+.|+|||++.+..++.++||||
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS 221 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence 9999998765321100 0012347999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCccc
Q 006739 544 FGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 544 ~G~~l~elltg~~p~~~~ 561 (633)
|||++|||++|+.||...
T Consensus 222 lGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 222 LGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred hHHHHHHHHhCCCCCCCC
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=314.32 Aligned_cols=263 Identities=22% Similarity=0.362 Sum_probs=206.6
Q ss_pred hhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|++.+.||+|+||.||+|.... ..+..||+|.+...... .....+.+|+.++..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~ 70 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-------------RERIEFLNEASVMKEFNCHH 70 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-------------HHHHHHHHHHHHHHhCCCCc
Confidence 45688999999999999999998742 24578999997543211 11346788999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG------RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp 484 (633)
|+++++++......++||||+++|+|.+++...... ...+++..+..++.|++.||.|| |+.+|+||||||
T Consensus 71 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p 147 (277)
T cd05032 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAA 147 (277)
T ss_pred eeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCh
Confidence 999999999999999999999999999999753321 23478999999999999999999 688999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccc
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQ 563 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~ 563 (633)
+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||....
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~- 226 (277)
T cd05032 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS- 226 (277)
T ss_pred heEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-
Confidence 999999999999999999987654433222233456889999999988889999999999999999998 899986422
Q ss_pred ccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
.....++.. ...... .... ....+.+++.+||+.+|++|||+.++++.|++
T Consensus 227 ---~~~~~~~~~---~~~~~~------~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 227 ---NEEVLKFVI---DGGHLD------LPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---HHHHHHHHh---cCCCCC------CCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 222223222 111110 0011 13347899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.94 Aligned_cols=257 Identities=19% Similarity=0.344 Sum_probs=195.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++... .+++.||+|++.... .......+.+++|++++++++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~-----------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~ 68 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSE-----------MFKKDQLAHVKAERDVLAESDSPWVVSLYY 68 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHH-----------HHHhHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 46888999999999999999764 578999999874311 111223567889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~k 141 (377)
T cd05629 69 SFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIK 141 (377)
T ss_pred EEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEE
Confidence 99999999999999999999999875 34588999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCc------------c---------------------------------eecccccCcccccccccc
Q 006739 497 IADFGLAKAMPDAQTH------------I---------------------------------TTSNVAGTVGYIAPEYHQ 531 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~ 531 (633)
|+|||+++.+...... . ......||+.|+|||++.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 9999998643211000 0 001246999999999999
Q ss_pred cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhc
Q 006739 532 TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCT 611 (633)
Q Consensus 532 ~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl 611 (633)
+..++.++|||||||++|||++|+.||...........+..|.. ..... . .......+.+++.+|+
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----~~~~p--------~--~~~~s~~~~dli~~lL 287 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE----TLYFP--------D--DIHLSVEAEDLIRRLI 287 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC----ccCCC--------C--CCCCCHHHHHHHHHHh
Confidence 98999999999999999999999999965322111111111100 00000 0 0001123677888899
Q ss_pred cCCCCCC---CCHHHHHHH
Q 006739 612 VDSPRER---PNSKDVRCM 627 (633)
Q Consensus 612 ~~dP~~R---Ps~~ev~~~ 627 (633)
. +|.+| +++.|+++.
T Consensus 288 ~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 288 T-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred c-CHhhcCCCCCHHHHhcC
Confidence 7 66665 599888753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=317.37 Aligned_cols=271 Identities=24% Similarity=0.321 Sum_probs=200.2
Q ss_pred cccccccccccCeeEEEEEe---cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 339 LASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
|+..+.||+|+||+||++.+ ...++..||+|.+...... .....+.+|++++++++||||++++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~ 72 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-------------QNTSGWKKEINILKTLYHENIVKYK 72 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-------------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 37889999999999988754 2346789999988543211 1135678899999999999999999
Q ss_pred eeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 416 AHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 416 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++... ...++||||+++++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||++++++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~~ 144 (283)
T cd05080 73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDNDR 144 (283)
T ss_pred EEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCCC
Confidence 988654 357899999999999999864 3489999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
.++|+|||+++.......... .....++..|+|||...+..++.++||||||+++|||++|+.|+...... ......
T Consensus 145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~ 222 (283)
T cd05080 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIG 222 (283)
T ss_pred cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhc
Confidence 999999999987654332111 12234566799999998888999999999999999999999997643211 000000
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..............++..............+.+++..||+.+|++|||+++++++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000000000011111111111122345888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=314.14 Aligned_cols=257 Identities=27% Similarity=0.397 Sum_probs=206.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
...+|+..+.||.|+||.||+|... ++..+|+|.+..... ....++.+|+.+++.++|+||+++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~ 67 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKSDDL--------------LKQQDFQKEVQALKRLRHKHLISL 67 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEec--CCCcEEEEeccccch--------------hhHHHHHHHHHHHhcCCCcchhhe
Confidence 3467899999999999999999876 488999999854331 114467889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+++++|.+++.... ...+++..+..++.|+++||+|| |+.+|+|+||||+||++++++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~ 142 (261)
T cd05148 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLV 142 (261)
T ss_pred eeeEecCCCeEEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCce
Confidence 999999999999999999999999997532 45689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||.+.......... ....++..|+|||...+..++.++||||||+++|+|++ |+.||.... .....+.
T Consensus 143 ~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~----~~~~~~~ 216 (261)
T cd05148 143 CKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN----NHEVYDQ 216 (261)
T ss_pred EEEccccchhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHH
Confidence 9999999998765432211 23346778999999988889999999999999999998 899986532 1122222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+. ...... ........+.+++.+|++.||++|||++++++.|+.+
T Consensus 217 ~~---~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 217 IT---AGYRMP----------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HH---hCCcCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 22 111110 0111223478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=319.91 Aligned_cols=266 Identities=27% Similarity=0.388 Sum_probs=208.2
Q ss_pred hhhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CC
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RH 408 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 408 (633)
...++|+..+.||+|+||.||++.... .+...+|+|.+...... +...++.+|++++.++ +|
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h 75 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE-------------KDLSDLVSEMEMMKMIGKH 75 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH-------------HHHHHHHHHHHHHHhhcCC
Confidence 345678999999999999999998642 23478999988543211 1145678899999999 79
Q ss_pred CcccccceeeecCCccEEEEecccCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006739 409 RNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVS------------QGRRELDWLARHKIALGVACGLEYLHISHNPR 476 (633)
Q Consensus 409 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ 476 (633)
+||+++++++...+..+++|||+++|+|.++++... .....+++..+..++.|++.||+|| |+.+
T Consensus 76 ~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ 152 (293)
T cd05053 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKK 152 (293)
T ss_pred CCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCC
Confidence 999999999999999999999999999999997532 2345689999999999999999999 6889
Q ss_pred eeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CC
Q 006739 477 IIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GR 555 (633)
Q Consensus 477 ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~ 555 (633)
|+||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 153 ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 232 (293)
T cd05053 153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 232 (293)
T ss_pred ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence 99999999999999999999999999987655433222223345678999999988899999999999999999998 99
Q ss_pred CCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 556 LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 556 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.||..... ....+.+. ...... ........+.+++.+|++.||++|||+.|+++.|+++-
T Consensus 233 ~p~~~~~~----~~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 233 SPYPGIPV----EELFKLLK---EGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCCH----HHHHHHHH---cCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 99865321 11222111 111111 01112234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=319.90 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=207.0
Q ss_pred hhhhcCcccccccccccCeeEEEEEe----cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
....++|...+.||+|+||.||++.. ...++..||+|++...... ...+.+.+|+.+++++ +
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 97 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-------------SEREALMSELKIMSHLGN 97 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-------------HHHHHHHHHHHHHHhccC
Confidence 34456899999999999999999975 2235678999987643221 1145788999999999 7
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
||||+++++++...+..++||||+++|+|.++++... ...+++.++..++.|++.||+|| |+.+|+|+||||+||
T Consensus 98 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Ni 172 (302)
T cd05055 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNV 172 (302)
T ss_pred CCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceE
Confidence 9999999999999999999999999999999997522 23489999999999999999999 678999999999999
Q ss_pred EecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccc
Q 006739 488 LLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTE 566 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~ 566 (633)
+++.++.++++|||+++...............++..|+|||.+.+..++.++||||+||++|||++ |+.||......
T Consensus 173 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-- 250 (302)
T cd05055 173 LLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-- 250 (302)
T ss_pred EEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--
Confidence 999999999999999986654332222223456788999999998889999999999999999998 99998653221
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
....+.... ..... ........+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 251 -~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 -SKFYKLIKE---GYRMA----------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHHHHHc---CCcCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111121111 11000 0001123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=318.42 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=203.3
Q ss_pred CcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+|++.+.||+|+||.||+|.... .....+++|.+...... ....++.+|+.+++.++||||++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~ 67 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS-------------SELRDLLSEFNLLKQVNHPHVIK 67 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH-------------HHHHHHHHHHHHHhhCCCCCEee
Confidence 46778999999999999997632 12357888887543311 11456889999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ--------------------GRRELDWLARHKIALGVACGLEYLHISH 473 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h 473 (633)
+++.+...+..++|+||+++++|.+++..... ....+++..++.++.|++.||+|| |
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H 144 (290)
T cd05045 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---A 144 (290)
T ss_pred EEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---H
Confidence 99999999999999999999999999875321 124588999999999999999999 6
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 553 (633)
+.+|+||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++
T Consensus 145 ~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t 224 (290)
T cd05045 145 EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224 (290)
T ss_pred HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence 78999999999999999999999999999986644333222223345778999999988889999999999999999998
Q ss_pred -CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 554 -GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 554 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
|+.||.... ...+.++......... .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 225 ~g~~p~~~~~----~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 225 LGGNPYPGIA----PERLFNLLKTGYRMER-------------PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred cCCCCCCCCC----HHHHHHHHhCCCCCCC-------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 999986532 2222232221111000 011123477899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.57 Aligned_cols=256 Identities=20% Similarity=0.349 Sum_probs=196.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|+||.||+++.. .+++.||||++..... ........+.+|+.++..++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~E~~il~~l~h~~iv~~~~ 68 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEM-----------LEKEQVAHVRAERDILAEADNPWVVKLYY 68 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCCcceEE
Confidence 46889999999999999999875 4688999999853210 01122456888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~k 141 (364)
T cd05599 69 SFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIK 141 (364)
T ss_pred EEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEE
Confidence 99999999999999999999999875 34589999999999999999999 688999999999999999999999
Q ss_pred EcccccccccCCCCCcc------------------------------------eecccccCcccccccccccCCCCCccc
Q 006739 497 IADFGLAKAMPDAQTHI------------------------------------TTSNVAGTVGYIAPEYHQTLKFTDKCD 540 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 540 (633)
|+|||++..+....... ......||+.|+|||++.+..++.++|
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence 99999987653221000 001246999999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC
Q 006739 541 IYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620 (633)
Q Consensus 541 v~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 620 (633)
||||||++|||++|+.||...... .. ............ .... ... ...+.+++.+|+. +|.+|++
T Consensus 222 iwSlG~il~el~~G~~Pf~~~~~~----~~---~~~i~~~~~~~~-~~~~---~~~---s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 222 WWSLGVIMYEMLVGYPPFCSDNPQ----ET---YRKIINWKETLQ-FPDE---VPL---SPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred eecchhHHHHhhcCCCCCCCCCHH----HH---HHHHHcCCCccC-CCCC---CCC---CHHHHHHHHHHcc-CHhhcCC
Confidence 999999999999999999753221 11 111111110000 0000 011 1236677778886 9999998
Q ss_pred ---HHHHHH
Q 006739 621 ---SKDVRC 626 (633)
Q Consensus 621 ---~~ev~~ 626 (633)
++|+++
T Consensus 287 ~~~~~~ll~ 295 (364)
T cd05599 287 NNGVNEIKS 295 (364)
T ss_pred CCCHHHHhc
Confidence 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=317.85 Aligned_cols=261 Identities=22% Similarity=0.355 Sum_probs=203.5
Q ss_pred cCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.+|++.+.||+|+||.||+|.... .++..||+|++...... .....+.+|+.++.+++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~~iv 71 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-------------PLREEFKHEAMMRSRLQHPNIV 71 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-------------HHHHHHHHHHHHHhcCCCCCcC
Confidence 457788999999999999998642 24578999998643211 1145688899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVS------------QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
++++++...+..++++||+++++|.+++.... .....+++..+..++.|+++||+|+ |+.+|+||
T Consensus 72 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~ 148 (283)
T cd05091 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHK 148 (283)
T ss_pred eEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCcccc
Confidence 99999999999999999999999999985321 1123588899999999999999999 68899999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||||+||++++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 228 (283)
T cd05091 149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228 (283)
T ss_pred ccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999887654432222233456789999999988889999999999999999998 888876
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
.... ....+.+ ....... ........+.+++..||+.+|++||+++++++.|+.
T Consensus 229 ~~~~----~~~~~~i---~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 229 GYSN----QDVIEMI---RNRQVLP----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCH----HHHHHHH---HcCCcCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 5321 2222222 2211110 011122337789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=305.29 Aligned_cols=268 Identities=23% Similarity=0.306 Sum_probs=203.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc-ccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN-LLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~ 415 (633)
..|+.+++||+|.||+||+|+.. .+|+.||+|++.....+.. .-....+|+.+++.++|+| ||+++
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG------------~P~taiREisllk~L~~~~~iv~L~ 77 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEG------------VPSTAIREISLLKRLSHANHIVRLH 77 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccC------------CCchhhHHHHHHHHhCCCcceEEEE
Confidence 45778899999999999999875 5789999999976543211 0234578999999999999 99999
Q ss_pred eeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++...+ ..++|+||++ -+|..++.........++...+..++.|+++||+|+ |+++|+||||||.|||+
T Consensus 78 dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 78 DVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLI 153 (323)
T ss_pred eeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEE
Confidence 9998877 7889999995 499999987553324577789999999999999999 89999999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+++|.+||+|||+|+...-.... .+...+|..|+|||++.+. .|++..|+||+||+++||++++.-|.+..+ .
T Consensus 154 ~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~ 227 (323)
T KOG0594|consen 154 SSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----I 227 (323)
T ss_pred CCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----H
Confidence 99999999999999976633221 2456789999999999886 689999999999999999999888766432 2
Q ss_pred hHHHHHHHhhc----cCCcchh--hhhhh--h----hcCC----HHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 569 SLVKWMRNVMT----SENPTRA--IDAKL--L----ENGY----EEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 569 ~~~~~~~~~~~----~~~~~~~--~d~~~--~----~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
+....+-+..+ ..|+.-. .+-.. . .... +.......+++.+|++.+|.+|.|++.+++.
T Consensus 228 ~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 228 DQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 22222222222 1111111 01000 0 0000 1111257788899999999999999999875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=321.29 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=193.0
Q ss_pred cccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 343 EKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
+.||+|+||.||+++.. ..+++.||+|.+..... .........+.+|+++++.++||||+++++++..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~ 71 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI----------VRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT 71 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHH----------HhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec
Confidence 67999999999999763 24688999999853210 0011224567889999999999999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
++..|+||||+++|+|.+++.. ...+.+..+..++.|+++||+|| |+.+|+||||||+||+++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~Df 144 (323)
T cd05584 72 GGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTDF 144 (323)
T ss_pred CCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999999999875 34578888999999999999999 6789999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhcc
Q 006739 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580 (633)
Q Consensus 501 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 580 (633)
|+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . +.+......
T Consensus 145 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~---~~~~~~~~~ 215 (323)
T cd05584 145 GLCKESIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----K---KTIDKILKG 215 (323)
T ss_pred cCCeecccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----H---HHHHHHHcC
Confidence 998754332221 1235689999999999998899999999999999999999999875321 1 112222111
Q ss_pred CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 581 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
... + +......+.+++.+||+.||++|| +++++++
T Consensus 216 ~~~---~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 216 KLN---L--------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCC---C--------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 110 0 001122377899999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=318.12 Aligned_cols=269 Identities=21% Similarity=0.340 Sum_probs=206.3
Q ss_pred hcCcccccccccccCeeEEEEEecCC---------------CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHH
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGS---------------NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~---------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 400 (633)
..+|++.+.||+|+||.||++..... .+..||+|.+...... ....++.+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e~ 70 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-------------NAREDFLKEV 70 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-------------HHHHHHHHHH
Confidence 35789999999999999999976432 2356899987644321 1256788999
Q ss_pred HHhhcCCCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006739 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-------GRRELDWLARHKIALGVACGLEYLHISH 473 (633)
Q Consensus 401 ~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h 473 (633)
+++++++||||+++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|| |
T Consensus 71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H 147 (296)
T cd05051 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---E 147 (296)
T ss_pred HHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---H
Confidence 999999999999999999999999999999999999999976431 123689999999999999999999 6
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 553 (633)
+.+|+||||||+||++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence 78999999999999999999999999999987654433323334557889999999988889999999999999999998
Q ss_pred --CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 554 --GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 554 --g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
|..||..... ....+...............+ ........+.+++.+|++.||++|||+.|+++.|++
T Consensus 228 ~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 228 LCREQPYEHLTD----QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cCCCCCCCCcCh----HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 6778754321 122222221111111100000 011122358899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.38 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=193.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
...|+..+.||+|+||.||+|... .+++.||||++.... ....+|+.+++.++||||++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~------------------~~~~~Ei~il~~l~h~niv~l~ 125 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQDP------------------QYKNRELLIMKNLNHINIIFLK 125 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecCc------------------chHHHHHHHHHhcCCCCCccee
Confidence 357999999999999999999864 578899999874321 1234689999999999999999
Q ss_pred eeeecC--------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 416 AHMARP--------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 416 ~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
+++... ...++||||+++ +|.+++.........+++..+..++.||++||+|| |+.+|+||||||+||
T Consensus 126 ~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~NI 201 (440)
T PTZ00036 126 DYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQNL 201 (440)
T ss_pred eeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHHE
Confidence 876432 235689999974 78887765544567799999999999999999999 688999999999999
Q ss_pred EecCCC-ceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccccccc
Q 006739 488 LLDDDM-EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT 565 (633)
Q Consensus 488 ll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 565 (633)
|++.++ .+||+|||+|+........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....
T Consensus 202 Ll~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~- 277 (440)
T PTZ00036 202 LIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV- 277 (440)
T ss_pred EEcCCCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-
Confidence 999664 6999999999876543321 23568999999998865 46899999999999999999999999753221
Q ss_pred ccchHHHHHHHhhccCCc---------------chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 566 EEMSLVKWMRNVMTSENP---------------TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~---------------~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+.++. ...... .......+....+......+.+++.+||+.||.+|||+.|+++
T Consensus 278 --~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 278 --DQLVRIIQV-LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred --HHHHHHHHH-hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 122222111 111000 0000001101111112245788999999999999999999874
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.40 Aligned_cols=265 Identities=21% Similarity=0.377 Sum_probs=208.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCC---CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGS---NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
..++|++.+.||+|+||.||+|.+... .+..|++|.+..... ......+.+|+.++++++|+||
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni 70 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-------------EIQVTLLLQESCLLYGLSHQNI 70 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-------------HHHHHHHHHHHHHHHhCCCCCC
Confidence 346888999999999999999987532 268899998753221 1114567889999999999999
Q ss_pred cccceeeec-CCccEEEEecccCCCHHHHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 412 LPLLAHMAR-PDCHLLVYEFMKNGSLQDILNDVSQG----RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 412 v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
+++++++.. +...++++||+++++|.+++...... ...+++..+..++.|++.||+|| |+.+++||||||+|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~n 147 (280)
T cd05043 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARN 147 (280)
T ss_pred CeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhh
Confidence 999998766 56788999999999999999764332 15689999999999999999999 67899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHT 565 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~ 565 (633)
|++++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||....
T Consensus 148 il~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--- 224 (280)
T cd05043 148 CVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--- 224 (280)
T ss_pred EEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---
Confidence 9999999999999999987654433222233456778999999988889999999999999999999 999986532
Q ss_pred ccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 566 EEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
...+..++.. ...... .......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 225 -~~~~~~~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 225 -PFEMAAYLKD---GYRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -HHHHHHHHHc---CCCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1223232221 111110 0111234788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=314.50 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=202.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCe----EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|+..++||+|+||.||+|++.. ++. .||+|.+...... ....++.+|+.++..++|+||
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i 71 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENTSP-------------KANKEILDEAYVMAGVGSPYV 71 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecCCCCH-------------HHHHHHHHHHHHHHhcCCCCC
Confidence 4678899999999999999998643 333 5899988543211 114567889999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++++.. ...++++||+++|+|.++++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||++++
T Consensus 72 ~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~~ 144 (279)
T cd05109 72 CRLLGICLT-STVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVKS 144 (279)
T ss_pred ceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEcC
Confidence 999999875 4578999999999999998742 34689999999999999999999 7889999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
++.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||+... ...+
T Consensus 145 ~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~ 220 (279)
T cd05109 145 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----AREI 220 (279)
T ss_pred CCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHH
Confidence 99999999999987754332222222345678999999998899999999999999999998 899986532 2223
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..++... ..... .......+.+++..||+.||++||++.++++.|++++
T Consensus 221 ~~~~~~~---~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 221 PDLLEKG---ERLPQ----------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHHHHCC---CcCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 3333221 11110 0112234778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=319.65 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=207.3
Q ss_pred hhhcCcccccccccccCeeEEEEEec------CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELP------GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI- 406 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 406 (633)
...++|++.+.||+|+||.||++++. ..++..||+|.+..... .+..+++.+|+.+++.+
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-------------~~~~~~~~~E~~~l~~l~ 78 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-------------EKDLSDLVSEMEMMKMIG 78 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-------------hHHHHHHHHHHHHHHhhc
Confidence 34578889999999999999999752 12356799998753211 11245788999999999
Q ss_pred CCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006739 407 RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHN 474 (633)
Q Consensus 407 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~ 474 (633)
+||||+++++++......++||||+++|+|.+++..... ....+++..+..++.|+++||+|| |+
T Consensus 79 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~ 155 (304)
T cd05101 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---AS 155 (304)
T ss_pred cCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HH
Confidence 799999999999999999999999999999999976322 124578999999999999999999 67
Q ss_pred CCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-
Q 006739 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM- 553 (633)
Q Consensus 475 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt- 553 (633)
.+|+||||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++
T Consensus 156 ~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 235 (304)
T cd05101 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235 (304)
T ss_pred CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 8999999999999999999999999999987755433322233456788999999988889999999999999999998
Q ss_pred CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 554 GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 554 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
|..||.... ..++............ .......+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 236 g~~p~~~~~-------~~~~~~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 236 GGSPYPGIP-------VEELFKLLKEGHRMDK----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred CCCCcccCC-------HHHHHHHHHcCCcCCC----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 788875421 1222222222111110 1112234778899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=315.95 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=198.9
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|+..+.||+|+||.||++... .+++.||+|++...... .......+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIK-----------KRKGEAMALNEKQILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhh-----------hhhhHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 3778899999999999999864 47899999998432210 01113457789999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+..++..++||||+++|+|.+++... ....+++..+..++.|++.||+|| |+.+|+||||||+||++++++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l 143 (285)
T cd05605 69 YETKDALCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred ecCCCeEEEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999888642 235689999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||++......... ....|+..|+|||++.+..++.++||||+||++|||++|+.||...........+...+
T Consensus 144 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~--- 217 (285)
T cd05605 144 SDLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV--- 217 (285)
T ss_pred eeCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh---
Confidence 999999876443221 23468999999999998899999999999999999999999997532211111111111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
. .... .........+.+++..||+.||++|| +++++++
T Consensus 218 ~-~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 218 K-EDQE----------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred h-hccc----------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1 1100 01111233477899999999999999 7878754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.63 Aligned_cols=247 Identities=27% Similarity=0.346 Sum_probs=190.1
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHH---HhhcCCCCcccccc
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN---TVGQIRHRNLLPLL 415 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~l~ 415 (633)
|++.+.||+|+||.||+|... .+++.||+|++...... .....+.+.+|.+ +++.++||||++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~-----------~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~ 68 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDII-----------ARDEVESLMCEKRIFETANSERHPFLVNLF 68 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhccccCCCChhcee
Confidence 567899999999999999865 57899999998532110 0111334555544 45677899999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..|+||||+++|+|..+++. ..+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+
T Consensus 69 ~~~~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 69 ACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred eEEEcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCcE
Confidence 999999999999999999999988753 4689999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ..
T Consensus 141 kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~~~---~~ 211 (324)
T cd05589 141 KIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----EEV---FD 211 (324)
T ss_pred EeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----HHH---HH
Confidence 9999999875432221 12346799999999999999999999999999999999999999865321 111 11
Q ss_pred HhhccCC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 576 NVMTSEN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 576 ~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
....... ... .....+.+++.+||+.||.+||+ +.++++
T Consensus 212 ~i~~~~~~~p~------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 212 SIVNDEVRYPR------------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhCCCCCCC------------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1111111 111 11233678899999999999994 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.16 Aligned_cols=268 Identities=21% Similarity=0.314 Sum_probs=201.9
Q ss_pred hcCcccccccccccCeeEEEEEecCC-------------CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHH
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGS-------------NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 402 (633)
.++|++.+.||+|+||.||+++..+. ....||+|.+...... .....+.+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~ei~~ 70 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-------------TARNDFLKEIKI 70 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-------------HHHHHHHHHHHH
Confidence 36789999999999999999976421 1235899988643211 114568899999
Q ss_pred hhcCCCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006739 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ--------GRRELDWLARHKIALGVACGLEYLHISHN 474 (633)
Q Consensus 403 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~ 474 (633)
+++++|+|++++++++......++||||+++++|.+++..... ....+++..+..++.|+++||+|| |+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~ 147 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---AS 147 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---Hh
Confidence 9999999999999999999999999999999999999864321 112478899999999999999999 78
Q ss_pred CCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-
Q 006739 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM- 553 (633)
Q Consensus 475 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt- 553 (633)
.+++||||||+||++++++.+||+|||++................++..|+|||+..+..++.++|||||||++|||++
T Consensus 148 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 148 LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred cCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 8999999999999999999999999999986654332222233456788999999988899999999999999999998
Q ss_pred -CCCCCcccccccccchHHHHHHHhhcc-CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 554 -GRLPSDDFFQHTEEMSLVKWMRNVMTS-ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 554 -g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
|..||..... ....+........ ...... ...+.....+.+++.+|++.||++||++.++++.|++
T Consensus 228 ~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 228 CKEQPYSLLSD----EQVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCCcccCh----HHHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 5667764322 1111111111110 000000 0000112358899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=292.71 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=207.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 415 (633)
+.|...+.||.|..+.|.++.++ .+|..+|+|++.......... ...+..+.-.+|+.+++++ .||+|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e------~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGE------TPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCc------cHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 45677789999999999999765 578889999886554332221 1233356677899999998 599999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++..+...++|+|.|+.|.|.|++.. ...+++....+|+.|+.+|++|| |...|||||+||+|||+|++.++
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~i 162 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMNI 162 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccce
Confidence 999999999999999999999999975 56699999999999999999999 78999999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccc------cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ------TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
||+|||+|+.+.++... ...+||++|+|||.+. ...|+..+|.|++||++|-|+.|..||... ...-
T Consensus 163 ~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQml 235 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQML 235 (411)
T ss_pred EEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHHH
Confidence 99999999998876543 4579999999999874 346888999999999999999999998652 2222
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+...+.+....-.. ..+.+......+++.+||+.||.+|.|++|+++
T Consensus 236 MLR~ImeGkyqF~s----------peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 MLRMIMEGKYQFRS----------PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHhcccccCC----------cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22222221111111 112333445788999999999999999999875
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.73 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=196.2
Q ss_pred ccccccCeeEEEEEec-CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 344 KIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
.||+|+||.||+|.++ ..++..+|+|++.....+. ...+++.+|+.+++.++||||+++++++. .+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 68 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP------------ALKDELLREANVMQQLDNPYIVRMIGICE-AE 68 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH------------HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CC
Confidence 6899999999999753 3467899999885443211 12467889999999999999999999875 45
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+++|+||||||+||++++++.+||+|||+
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg~ 141 (257)
T cd05116 69 SWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFGL 141 (257)
T ss_pred CcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCcc
Confidence 67899999999999999864 34689999999999999999999 688999999999999999999999999999
Q ss_pred ccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhcc
Q 006739 503 AKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTS 580 (633)
Q Consensus 503 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 580 (633)
++.......... .....++..|+|||.+....++.++|+|||||++|||++ |+.||..... ....+.+. ..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i~---~~ 214 (257)
T cd05116 142 SKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIE---SG 214 (257)
T ss_pred ccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH---CC
Confidence 987654432211 122234678999999988889999999999999999998 9999875322 22222222 11
Q ss_pred CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 581 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.... .... ....+.+++.+||+.||++||++.+|++.|+++
T Consensus 215 ~~~~------~~~~----~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ERME------CPQR----CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCC------CCCC----CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1111 0011 123477899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=311.20 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=198.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.+|++.+.||+|+||.||++.++ ++..+|+|.+...... ...+.+|++++++++||||+++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMS---------------EDDFIEEAKVMMKLSHPNLVQLYG 66 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCCCC---------------HHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45788999999999999999875 5678999987543221 235778999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++||||+++++|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||++++++.+|
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05059 67 VCTKQRPIFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVK 140 (256)
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEE
Confidence 999999999999999999999998752 23689999999999999999999 688999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+++...+.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||+.... ......+
T Consensus 141 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~~- 214 (256)
T cd05059 141 VSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN----SEVVESV- 214 (256)
T ss_pred ECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH----HHHHHHH-
Confidence 9999998866443221 1112234568999999998899999999999999999999 8999865321 1111111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
........ .......+.+++.+||+.+|++|||+.|+++.|
T Consensus 215 --~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 215 --SAGYRLYR----------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --HcCCcCCC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11111110 011223488899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=312.20 Aligned_cols=261 Identities=24% Similarity=0.367 Sum_probs=197.9
Q ss_pred cccccccccccCeeEEEEEecCCCC-eEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNG-KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
|.+.+.||+|+||.||+|++..... ..||+|.+...... ....+.+.+|+.+++.++|+||++++++
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT------------RSEMEDFLSEAVCMKEFDHPNVMRLIGV 68 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC------------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3467899999999999998753222 36999987543211 1114678889999999999999999998
Q ss_pred eecC------CccEEEEecccCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 418 MARP------DCHLLVYEFMKNGSLQDILNDVSQ--GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 418 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+... ...+++|||+++|+|.+++..... ....+++.....++.|++.||+|| |+++|+||||||+||++
T Consensus 69 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~ 145 (272)
T cd05075 69 CLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCML 145 (272)
T ss_pred EccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhheEE
Confidence 7432 246899999999999998753221 234589999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~ 568 (633)
++++.+||+|||+++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||..... .
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~ 221 (272)
T cd05075 146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----S 221 (272)
T ss_pred cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----H
Confidence 9999999999999987654332222122346778999999999899999999999999999999 7888865221 1
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
...+.+ ........ .+.....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 222 ~~~~~~---~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 222 EIYDYL---RQGNRLKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHH---HcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222211 11111110 111223478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=310.07 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=202.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.++||+|+||.||+|..+ +++.||+|.+...... ..++.+|+.++++++|+||++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~~ 67 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSMS---------------PEAFLAEANLMKQLQHPRLVRLY 67 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCCCc---------------HHHHHHHHHHHHhcCCcCeeeEE
Confidence 467899999999999999999864 7789999988644321 34678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++. .+..++||||+++++|.+++.... ...+++..+..++.|++.||+|| |+.+++||||||+||++++++.+
T Consensus 68 ~~~~-~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~~ 141 (260)
T cd05067 68 AVVT-QEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETLCC 141 (260)
T ss_pred EEEc-cCCcEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCCCE
Confidence 9864 456899999999999999986532 45689999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 574 (633)
+|+|||++......... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..... ....+.+
T Consensus 142 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~ 216 (260)
T cd05067 142 KIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNL 216 (260)
T ss_pred EEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHH
Confidence 99999999876532221 1123346778999999998889999999999999999999 9999875322 1222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.. ..... ........+.+++.+|++.+|++||+++++++.|+.+
T Consensus 217 ~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 217 ER---GYRMP----------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred Hc---CCCCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 11 11110 0011123488899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=320.86 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=190.3
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+++.. .+++.||+|++.+..... ......+.+|..++.++ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 68 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVND-----------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 68 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcc-----------hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC
Confidence 46899999999999865 578899999986432110 11245677888888776 799999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~DfG 141 (329)
T cd05618 69 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDYG 141 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999988864 34689999999999999999999 67899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc-cchHHHHHHHhhcc
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE-EMSLVKWMRNVMTS 580 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~ 580 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......++......
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 219 (329)
T cd05618 142 MCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred ccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence 9875432221 12345789999999999999999999999999999999999999964322111 11122222221111
Q ss_pred CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 581 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
.... + +......+.+++.+||+.||++||++
T Consensus 220 ~~~~------~----p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 KQIR------I----PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCC------C----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1110 0 11112336789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=320.75 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=193.5
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+++.. .+++.||+|++...... ..+..+.+++|..++..+ +||||+++++++.+.
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~-----------~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~ 68 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVN-----------DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE 68 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC
Confidence 46899999999999865 57899999998542110 112245678899999888 699999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
...++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Dfg 141 (329)
T cd05588 69 SRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDYG 141 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcCc
Confidence 999999999999999988864 35699999999999999999999 78899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccc-ccchHHHHHHHhhcc
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT-EEMSLVKWMRNVMTS 580 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~ 580 (633)
+++....... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||+...... ......++..+....
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (329)
T cd05588 142 MCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred cccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence 9875322211 1234579999999999999999999999999999999999999997432211 111122222222211
Q ss_pred CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC------HHHHH
Q 006739 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN------SKDVR 625 (633)
Q Consensus 581 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs------~~ev~ 625 (633)
.... +.. .....+.+++.+||+.||.+||+ +++++
T Consensus 220 ~~~~------~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 220 KQIR------IPR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCC------CCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 1110 000 11223778899999999999998 55654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.45 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=191.8
Q ss_pred cccccccCeeEEEEEecC-CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPG-SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|.... .++..+|+|.+...... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 67 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-------------QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV 67 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-------------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 468999999999997642 34567999987543311 1134688899999999999999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQ-GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
...++||||+++|+|.+++..... .....++..+..++.|++.|++|| |+.+++||||||+||+++.++.+||+||
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~df 144 (269)
T cd05087 68 TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGDY 144 (269)
T ss_pred CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECCc
Confidence 999999999999999999975432 234567788889999999999999 6789999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccccccccccC-------CCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-------KFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 501 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
|.++...............|+..|+|||++.+. .++.++|+||||+++|||++ |+.||...... ....
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~ 220 (269)
T cd05087 145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLT 220 (269)
T ss_pred cccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHH
Confidence 998765443332222334578899999988642 35789999999999999996 99999653221 1111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
... .. ......++.+... . ...+.+++..|+ .+|++|||++|+++.|+
T Consensus 221 ~~~---~~-~~~~~~~~~~~~~-~---~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 221 YTV---RE-QQLKLPKPRLKLP-L---SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHh---hc-ccCCCCCCccCCC-C---ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 110 00 0011111111111 1 123667888898 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.84 Aligned_cols=255 Identities=27% Similarity=0.424 Sum_probs=200.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.++||+|+||.||+|... ++..||+|++...... .+++.+|++++++++||||++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~~~~~---------------~~~~~~E~~~l~~l~~~~i~~~~ 67 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQLY 67 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEec--CCceEEEEecccCccC---------------HHHHHHHHHHHHhCCCCCcceEE
Confidence 356899999999999999999875 4457999998642210 24678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++. .+..++||||+++|+|.+++.... ...+++..+..++.|+++||+|| |+.+|+||||||+||++++++.+
T Consensus 68 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~~ 141 (262)
T cd05071 68 AVVS-EEPIYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVC 141 (262)
T ss_pred EEEC-CCCcEEEEEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCcE
Confidence 9875 456789999999999999997532 34679999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 574 (633)
+|+|||.++......... .....++..|+|||+..+..++.++||||||+++|||++ |..||..... ... .
T Consensus 142 ~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~----~~~---~ 213 (262)
T cd05071 142 KVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REV---L 213 (262)
T ss_pred EeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh----HHH---H
Confidence 999999998765433211 123346778999999988899999999999999999999 8888864321 111 1
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.......... ........+.+++.+|++.||++||++.++++.|++.
T Consensus 214 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 214 DQVERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHhcCCCCC----------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1111111110 0112234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.26 Aligned_cols=266 Identities=23% Similarity=0.352 Sum_probs=202.4
Q ss_pred hhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCC
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHR 409 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 409 (633)
..++|++.+.||+|+||.||+|.+. ..+++.||||++...... .....+.+|+.++.++ +||
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~ 71 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGHHL 71 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh-------------HHHHHHHHHHHHHHhccCCc
Confidence 3468999999999999999999742 246789999998543211 1145678899999999 689
Q ss_pred cccccceeeecC-CccEEEEecccCCCHHHHHhhhcC-------------------------------------------
Q 006739 410 NLLPLLAHMARP-DCHLLVYEFMKNGSLQDILNDVSQ------------------------------------------- 445 (633)
Q Consensus 410 niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------- 445 (633)
||+++++++... ...++||||+++|+|.+++.....
T Consensus 72 niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (343)
T cd05103 72 NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSG 151 (343)
T ss_pred cHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccc
Confidence 999999988654 457899999999999999875321
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccc
Q 006739 446 --------------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505 (633)
Q Consensus 446 --------------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 505 (633)
....+++..+..++.|+++||+|| |+.+|+||||||+||++++++.+||+|||++..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~ 228 (343)
T cd05103 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 228 (343)
T ss_pred ccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEecccccc
Confidence 013478889999999999999999 788999999999999999999999999999987
Q ss_pred cCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhccCCcc
Q 006739 506 MPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPT 584 (633)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (633)
..............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......+. ......
T Consensus 229 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~---~~~~~~ 302 (343)
T cd05103 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLK---EGTRMR 302 (343)
T ss_pred cccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---HHHHHHHh---ccCCCC
Confidence 644332222223345778999999988899999999999999999997 89998653221 11111111 111110
Q ss_pred hhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 585 RAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 585 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
. ... ....+.+++..||+.||++|||+.|+++.|+.+-
T Consensus 303 ~-------~~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 303 A-------PDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred C-------CCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000 1123788889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=326.60 Aligned_cols=262 Identities=23% Similarity=0.338 Sum_probs=196.0
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|+||.||++... .+|+.||+|++.....+. ...+++.+|+++++.++|+||++++++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 67 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNL------------VSCKRVFRELKMLCFFKHDNVLSALDI 67 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccch------------HHHHHHHHHHHHHHhCCCCCcCCHhhe
Confidence 4778899999999999999864 578999999885432111 113567889999999999999999999
Q ss_pred eecCC-----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 418 MARPD-----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 418 ~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+...+ ..|+||||+. ++|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~ 139 (372)
T cd07853 68 LQPPHIDPFEEIYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSN 139 (372)
T ss_pred ecCCCccccceEEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCC
Confidence 98776 7899999996 588887754 45689999999999999999999 78899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++........ ......+|..|+|||++.+. .++.++||||+||++|||++|+.||....... ..
T Consensus 140 ~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~ 214 (372)
T cd07853 140 CVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ----QL 214 (372)
T ss_pred CCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH----HH
Confidence 99999999999865433221 12334679999999998774 47899999999999999999999997543211 11
Q ss_pred HHHHHhhccCCcchh-------------------hhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRA-------------------IDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~-------------------~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+............ ..... ..........+.+++.+||+.||++|||+.|+++
T Consensus 215 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 215 DLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 111111111100000 00000 0001111335778999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=313.53 Aligned_cols=259 Identities=22% Similarity=0.358 Sum_probs=201.9
Q ss_pred cCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.+|...++||+|+||.||++... ..++..+|+|.+..... .....+.+|+++++.++|+||+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~ 70 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--------------SARQDFQREAELLTVLQHQHIV 70 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--------------HHHHHHHHHHHHHhcCCCCCCc
Confidence 56788899999999999999642 23567899998754321 1145788999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG-----------RRELDWLARHKIALGVACGLEYLHISHNPRIIHRD 481 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~D 481 (633)
++++++...+..++||||+++++|.+++...... ...+++..+..++.|++.|++|| |+.+|+|||
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~d 147 (280)
T cd05092 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRD 147 (280)
T ss_pred eEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeeccc
Confidence 9999999999999999999999999999754321 13588999999999999999999 688999999
Q ss_pred CCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcc
Q 006739 482 LKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDD 560 (633)
Q Consensus 482 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~ 560 (633)
|||+||++++++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 148 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred ccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999986644332222223345788999999999899999999999999999998 8999865
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
... ....... ........ .......+.+++.+||+.||.+||++.|+++.|+
T Consensus 228 ~~~----~~~~~~~---~~~~~~~~----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 228 LSN----TEAIECI---TQGRELER----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCH----HHHHHHH---HcCccCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 322 1111111 11111100 0011233778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=310.04 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=200.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|..+ ++..+|+|.+...... .+.+.+|+.++++++|+|+++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~~---------------~~~~~~E~~~l~~l~~~~i~~~~ 67 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTMS---------------PESFLEEAQIMKKLRHDKLVQLY 67 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCCC---------------HHHHHHHHHHHHhcCCCceEEEE
Confidence 467899999999999999999865 6678999998643321 23578899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++. ....+++|||+++++|.++++... ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+
T Consensus 68 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~~ 141 (260)
T cd05070 68 AVVS-EEPIYIVTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLVC 141 (260)
T ss_pred eEEC-CCCcEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCceE
Confidence 9875 456789999999999999987522 34589999999999999999999 67889999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 574 (633)
+|+|||++........... ....++..|+|||+..+..++.++|+||||+++|||++ |+.||.+.. .....+.+
T Consensus 142 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~----~~~~~~~~ 216 (260)
T cd05070 142 KIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----NREVLEQV 216 (260)
T ss_pred EeCCceeeeeccCcccccc-cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH
Confidence 9999999987654322111 22345678999999988889999999999999999999 888986532 12222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
. ...... ........+.+++.+|++.+|++|||+.++.+.|++
T Consensus 217 ~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 E---RGYRMP----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred H---cCCCCC----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1 111110 011122348889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.78 Aligned_cols=242 Identities=27% Similarity=0.379 Sum_probs=186.5
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc-CCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ-IRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|+.. .+++.||+|.+...... .....+.+..|..++.. .+||||+++++++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~ 68 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVL-----------EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK 68 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhh-----------hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 46899999999999875 46889999998542110 01113344556666654 4799999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Dfg 141 (316)
T cd05592 69 EHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADFG 141 (316)
T ss_pred CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccCc
Confidence 999999999999999998875 34689999999999999999999 67899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ........
T Consensus 142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~---~~~i~~~~ 212 (316)
T cd05592 142 MCKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DEL---FDSILNDR 212 (316)
T ss_pred CCeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHH---HHHHHcCC
Confidence 9976533221 22345799999999999998999999999999999999999999975321 111 11111111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
+. + +......+.+++.+||+.||++||++.+
T Consensus 213 -~~--~--------~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 213 -PH--F--------PRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred -CC--C--------CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 00 0 0011223678888999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.42 Aligned_cols=263 Identities=27% Similarity=0.383 Sum_probs=203.7
Q ss_pred hcCcccccccccccCeeEEEEEecC------CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CC
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RH 408 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 408 (633)
.++|.+.+.||+|+||.||+++..+ .++..+|+|.+...... +...++.+|+.++..+ +|
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~h 83 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE-------------KDLSDLISEMEMMKMIGKH 83 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh-------------HHHHHHHHHHHHHHHhcCC
Confidence 4679999999999999999997632 12357999988643210 1145678899999999 79
Q ss_pred CcccccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006739 409 RNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNPR 476 (633)
Q Consensus 409 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ 476 (633)
|||+++++++...+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|| |+.+
T Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~g 160 (307)
T cd05098 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKK 160 (307)
T ss_pred CCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCC
Confidence 9999999999999999999999999999999976322 123589999999999999999999 6789
Q ss_pred eeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CC
Q 006739 477 IIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GR 555 (633)
Q Consensus 477 ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~ 555 (633)
++||||||+||+++.++.+||+|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~ 240 (307)
T cd05098 161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 240 (307)
T ss_pred cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999886644322211122234578999999988889999999999999999998 88
Q ss_pred CCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 556 LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 556 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.||.... ...+.+.+. ...... .+......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 241 ~p~~~~~----~~~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 241 SPYPGVP----VEELFKLLK---EGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred CCCCcCC----HHHHHHHHH---cCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 8875421 112222111 111110 0111223477889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.61 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=199.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++... .+++.||+|++..... ...+..+.+.+|+.+++.++|+||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~i~~~~~~~~i~~~~~ 68 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVL-----------LAQETVSFFEEERDILSISNSPWIPQLQY 68 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCCcceee
Confidence 36888999999999999999865 5789999999853211 11122567888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~k 142 (330)
T cd05601 69 AFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIK 142 (330)
T ss_pred EEecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEE
Confidence 999999999999999999999999753 24689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccc------cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ------TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
|+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 143 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------- 214 (330)
T cd05601 143 LADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------- 214 (330)
T ss_pred eccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-------
Confidence 9999999876543322 223356899999999986 45678899999999999999999999865321
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+....+.........- ........+.+++..|++ +|++||++.++++
T Consensus 215 ~~~~~~i~~~~~~~~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 215 AKTYNNIMNFQRFLKFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11122221111110000 000112336778888998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.33 Aligned_cols=260 Identities=22% Similarity=0.259 Sum_probs=198.5
Q ss_pred cCcccccccccccCeeEEEEEecC-CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPG-SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+|.+.+.||+|+||.||++...+ ..+..||+|.+... +...+|++++++++||||++++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------------~~~~~E~~il~~l~h~~iv~~~ 152 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------------KTPGREIDILKTISHRAIINLI 152 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------------ccHHHHHHHHHhcCCCCcccee
Confidence 579999999999999999997532 34678999987432 2345799999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++......++||||+. ++|.+++.. ...+++..++.++.|++.||+|| |+.+|+||||||+|||++.++.+
T Consensus 153 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~~ 224 (392)
T PHA03207 153 HAYRWKSTVCMVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPENA 224 (392)
T ss_pred eeEeeCCEEEEEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCE
Confidence 99999999999999995 688888843 45689999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...++
T Consensus 225 ~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred EEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 99999999876554333333346799999999999999999999999999999999999999865433222222222221
Q ss_pred Hhhc----------------------cCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMT----------------------SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~----------------------~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... ...........+.... ....+.+++.+|+..||++|||+.|++.
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 305 CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYG---MHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccC---cchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 1100 0000000000000001 1234677889999999999999999986
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.04 Aligned_cols=265 Identities=22% Similarity=0.363 Sum_probs=204.5
Q ss_pred hhhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR 409 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 409 (633)
...++|++.+.||+|+||.||+|..+ +..+..||+|.+...... .....+.+|+.+++.++||
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~ 69 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-------------RERIEFLNEASVMKGFTCH 69 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-------------HHHHHHHHHHHHHHhCCCC
Confidence 34578999999999999999999753 234568999987533210 1134577899999999999
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLK 483 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dik 483 (633)
||+++++++.+.+..++||||+++|+|.+++..... .....++..+..++.|++.||+|| |+++|+|||||
T Consensus 70 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dik 146 (288)
T cd05061 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLA 146 (288)
T ss_pred CeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCC
Confidence 999999999999999999999999999999975332 123457788899999999999999 78899999999
Q ss_pred CCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccc
Q 006739 484 PANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFF 562 (633)
Q Consensus 484 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~ 562 (633)
|+||++++++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 147 p~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 147 ARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred hheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986654332222222345778999999998899999999999999999999 788886422
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
. ... ............ .......+.+++.+|++.||++|||+.++++.|++.
T Consensus 227 ~----~~~---~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 227 N----EQV---LKFVMDGGYLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred H----HHH---HHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1 122 222211111110 011123588999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=312.98 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=201.9
Q ss_pred hcCcccccccccccCeeEEEEEecCC----CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|.+.+.||+|++|.||+|.+... .+..||+|.+...... .....+.+|+.++++++|+||
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i 71 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-------------QDESDFLMEALIMSKFNHQNI 71 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH-------------HHHHHHHHHHHHHHhCCCCCE
Confidence 46789999999999999999987531 4678999987533211 113468889999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ---GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
+++++++.+.+..++||||+++++|.++++.... ....+++..+..++.||+.||+|| |+.+++||||||+||+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil 148 (277)
T cd05036 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCL 148 (277)
T ss_pred eeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEE
Confidence 9999999999999999999999999999976432 123589999999999999999999 6789999999999999
Q ss_pred ecCCC---ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccc
Q 006739 489 LDDDM---EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQH 564 (633)
Q Consensus 489 l~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~ 564 (633)
++.++ .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||+....
T Consensus 149 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~- 227 (277)
T cd05036 149 LTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN- 227 (277)
T ss_pred EeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 98754 589999999987643322111112234568999999998899999999999999999997 9999865321
Q ss_pred cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
....+.+ ....... ........+.+++.+|++.+|++||++.++++.|++
T Consensus 228 ---~~~~~~~---~~~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 228 ---QEVMEFV---TGGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ---HHHHHHH---HcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1222211 1111111 011112347889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=315.25 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=204.9
Q ss_pred hcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|+..+.||+|+||.||+|...+ .++..||+|.+...... ...+++.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~ei~~l~~l~h~~i 70 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------------DMQADFQREAALMAEFDHPNI 70 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-------------HHHHHHHHHHHHHHhcCCCch
Confidence 4678999999999999999998642 36789999988543210 114568899999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------------GRRELDWLARHKIALGVACGLEYLHISH 473 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h 473 (633)
+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|| |
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---H 147 (288)
T cd05050 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---S 147 (288)
T ss_pred heEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---H
Confidence 9999999999999999999999999999974321 123578899999999999999999 6
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 553 (633)
+.+++||||||+||++++++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++
T Consensus 148 ~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 227 (288)
T cd05050 148 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227 (288)
T ss_pred hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh
Confidence 78999999999999999999999999999876544322222223345678999999988899999999999999999998
Q ss_pred -CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 554 -GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 554 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
|..||..... . +............ ..+.....+.+++.+|++.||++|||+.|+++.|++
T Consensus 228 ~~~~p~~~~~~----~---~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 228 YGMQPYYGMAH----E---EVIYYVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCCCCCCH----H---HHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 8888754321 1 1222222111110 011122347889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=320.20 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=192.2
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
+.||+|+||.||++... .+|+.||+|++..... ........+.+|++++..++||||+++++++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~ 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVI-----------VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC
Confidence 46899999999999864 5789999999853211 01112456678999999999999999999999999
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHN-PRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+ .+|+||||||+|||+++++.+||+|||
T Consensus 69 ~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~kL~Dfg 141 (325)
T cd05594 69 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDFG 141 (325)
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCEEEecCC
Confidence 99999999999999988864 34689999999999999999999 54 799999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+.+.. ...
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~~~~i~~--~~~ 213 (325)
T cd05594 142 LCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELILM--EEI 213 (325)
T ss_pred CCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHHHHHHhc--CCC
Confidence 9875433221 11235699999999999998999999999999999999999999865321 111111110 111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
..... ....+.+++.+||+.||++|+ ++.++++
T Consensus 214 ~~p~~------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 RFPRT------------LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCC------------CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 11111 112367888999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=327.18 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=198.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+++.. .+++.||+|++..... ........+.+|+.+++.++||||+++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~il~~~~h~~iv~~ 108 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEM-----------IKRSDSAFFWEERDIMAHANSEWIVQL 108 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhhHHHHHHHHHHHHhCCCCCcceE
Confidence 4578999999999999999999865 5788999999843110 011123457789999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+++..++||||+++|+|.+++.. ..++...+..++.|++.||+|| |+.+|+||||||+|||+++++.
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~ 180 (370)
T cd05596 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGH 180 (370)
T ss_pred EEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCC
Confidence 9999999999999999999999999864 3478888899999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccC----CCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL----KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 181 ~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------- 252 (370)
T cd05596 181 LKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------- 252 (370)
T ss_pred EEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------
Confidence 999999999876443221 11345799999999988653 378899999999999999999999875321
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCC--CCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE--RPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~ev~~ 626 (633)
......+......... . . .......+.+++..|++.+|++ ||+++|+++
T Consensus 253 ~~~~~~i~~~~~~~~~-~----~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 253 VGTYSKIMDHKNSLTF-P----D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHHHHHHcCCCcCCC-C----C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1111222111100000 0 0 0011234778889999999998 999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.30 Aligned_cols=240 Identities=28% Similarity=0.372 Sum_probs=188.5
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|+.. .+++.||+|++..... ........+..|..++..+ +||||+++++++...
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 68 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVI-----------LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP 68 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHH-----------hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC
Confidence 46899999999999864 5789999999853210 0111245567788888776 699999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~DfG 141 (320)
T cd05590 69 DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADFG 141 (320)
T ss_pred CEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeCC
Confidence 999999999999999998875 34689999999999999999999 68899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ ........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~---~~~i~~~~ 212 (320)
T cd05590 142 MCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----DDL---FEAILNDE 212 (320)
T ss_pred CCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHH---HHHHhcCC
Confidence 9875432221 12345799999999999998999999999999999999999999975321 111 22222111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
... .. .....+.+++.+|++.||++||++
T Consensus 213 ~~~--------~~---~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 VVY--------PT---WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCC--------CC---CCCHHHHHHHHHHcccCHHHCCCC
Confidence 100 00 112236788999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=306.08 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=201.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|...+.||+|++|.||++... .+++.||+|.+........ .....+.+.+|++++++++||||+++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 71 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPE---------TKKEVNALECEIQLLKNLQHERIVQYYG 71 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchh---------hHHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence 46888999999999999999754 5789999998864432111 1122467889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|| |+.+|+||||+|+||++++++.++
T Consensus 72 ~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~~ 144 (263)
T cd06625 72 CLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNVK 144 (263)
T ss_pred EEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999875 34588999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+++.......... .....|+..|+|||++.+..++.++||||+|+++|||++|+.||..... .... .
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~---~- 217 (263)
T cd06625 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAI---F- 217 (263)
T ss_pred EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHH---H-
Confidence 999999876543221111 1234578899999999998899999999999999999999999865321 1111 1
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
......... ..+......+.+++.+||+.+|++|||+.++++.
T Consensus 218 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 KIATQPTNP---------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHhccCCCC---------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111000 0011122347789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=321.74 Aligned_cols=241 Identities=23% Similarity=0.329 Sum_probs=191.3
Q ss_pred cccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 343 EKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
+.||+|+||.||+++.. ..+|+.||+|++..... .......+.+|++++++++||||+++++++.+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL------------KVRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh------------hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 67999999999998752 34789999999853211 11124456789999999999999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
++..|+||||+++|+|.+++.+ ...+++..+..++.|+++||+|| |+.+|+||||||+||++++++.+||+||
T Consensus 70 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~Df 142 (318)
T cd05582 70 EGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTDF 142 (318)
T ss_pred CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEeec
Confidence 9999999999999999999865 34589999999999999999999 6789999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhcc
Q 006739 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580 (633)
Q Consensus 501 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 580 (633)
|+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ... .......
T Consensus 143 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~---~~~i~~~ 213 (318)
T cd05582 143 GLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KET---MTMILKA 213 (318)
T ss_pred cCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHH---HHHHHcC
Confidence 99886544322 12345789999999999988899999999999999999999999865321 111 1111111
Q ss_pred CC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 006739 581 EN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 581 ~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
.. .... ....+.+++.+||+.||++||++.+
T Consensus 214 ~~~~p~~------------~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 KLGMPQF------------LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCC------------CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 1111 1223678889999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.82 Aligned_cols=205 Identities=24% Similarity=0.409 Sum_probs=172.2
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|+.++.||+|+||.||+|+.. .+++.||+|++.... .........+.+|+.++++++||||+++++.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~-----------~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~ 69 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKD-----------VLLRNQVAHVKAERDILAEADNEWVVRLYYS 69 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHH-----------hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEE
Confidence 5788999999999999999864 578899999884321 1112235678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++|+|.+++.+ ...+++.....++.||+.||+|| |+.+|+||||||+|||++.++.+||
T Consensus 70 ~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~kL 142 (382)
T cd05625 70 FQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIKL 142 (382)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999875 24588889999999999999999 7789999999999999999999999
Q ss_pred cccccccccCCCCC---------------------------------------------cceecccccCccccccccccc
Q 006739 498 ADFGLAKAMPDAQT---------------------------------------------HITTSNVAGTVGYIAPEYHQT 532 (633)
Q Consensus 498 ~DfG~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 532 (633)
+|||++..+..... ........||+.|+|||++.+
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (382)
T cd05625 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222 (382)
T ss_pred eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence 99999753311000 000112468999999999999
Q ss_pred CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 533 LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 533 ~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
..++.++||||+||++|||++|+.||...
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CCCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=330.66 Aligned_cols=205 Identities=23% Similarity=0.410 Sum_probs=172.3
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||+|+||.||+++.. .+++.||+|++.... .........+.+|++++++++|+||+++++.
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~-----------~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~ 69 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKAD-----------VLMRNQAAHVKAERDILAEADNEWVVKLYYS 69 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHH-----------HHhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 6889999999999999999865 568999999984321 0111224568899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+++..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+||+++.++.+||
T Consensus 70 ~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 70 FQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999975 34588889999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCC-----------------------------------------CcceecccccCcccccccccccCCCC
Q 006739 498 ADFGLAKAMPDAQ-----------------------------------------THITTSNVAGTVGYIAPEYHQTLKFT 536 (633)
Q Consensus 498 ~DfG~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 536 (633)
+|||+|..+.... .........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 9999975331000 00001234699999999999999999
Q ss_pred CccchHHHHHHHHHHHhCCCCCccc
Q 006739 537 DKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 537 ~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
.++|||||||++|||++|+.||...
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCC
Confidence 9999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=304.36 Aligned_cols=252 Identities=22% Similarity=0.378 Sum_probs=202.2
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||+|... .+++.|++|.+...... ......+.+|++++++++||||++++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMN------------RREREEAIDEARVLAKLDSSYIIRYYES 67 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCC------------HHHHHHHHHHHHHHHhcCCCCeehheee
Confidence 4677899999999999999865 57899999987543211 1125678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++++|.++++... ...+++..++.++.|++.||.|| |+.+|+|+||||+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l 142 (256)
T cd08529 68 FLDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKI 142 (256)
T ss_pred eccCCEEEEEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEE
Confidence 999999999999999999999998632 45789999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||+++......... ....|++.|+|||+..+..++.++|+||||+++|||++|+.||.... ...... ..
T Consensus 143 ~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~---~~ 213 (256)
T cd08529 143 GDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN----QGALIL---KI 213 (256)
T ss_pred cccccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHH---HH
Confidence 9999988765443221 23468899999999999889999999999999999999999986432 111111 11
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... ........+.+++.+||+.+|++||++.++++
T Consensus 214 ~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 214 IRGVFPP----------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HcCCCCC----------CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111100 01112234788999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=317.36 Aligned_cols=245 Identities=25% Similarity=0.344 Sum_probs=191.0
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|+.. .+++.||+|++..... ........+..|.+++..+ +||||+++++++...
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~ 68 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVI-----------LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK 68 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHh-----------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 46899999999999864 5688999999853211 0111245567788888765 799999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Dfg 141 (321)
T cd05591 69 DRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADFG 141 (321)
T ss_pred CeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeecc
Confidence 999999999999999988865 34689999999999999999999 67899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~---~~~i~~~~ 212 (321)
T cd05591 142 MCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDL---FESILHDD 212 (321)
T ss_pred cceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHH---HHHHHcCC
Confidence 9875433221 12345689999999999998999999999999999999999999975321 111 12222111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-------CHHHHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-------NSKDVRC 626 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-------s~~ev~~ 626 (633)
... ... ....+.+++..|++.||++|| +++++++
T Consensus 213 ~~~--------p~~---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 213 VLY--------PVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCC--------CCC---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 110 000 112377888999999999999 6676653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.20 Aligned_cols=264 Identities=21% Similarity=0.259 Sum_probs=197.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|.+.+.||+|+||.||++.+. ..++.||||... ...+.+|++++++++|+|||+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~--------------------~~~~~~E~~iL~~L~HpnIv~l~ 226 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGW--------------------YASSVHEARLLRRLSHPAVLALL 226 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEEC-CCCCEEEEeccc--------------------ccCHHHHHHHHHHCCCCCCCcEE
Confidence 457999999999999999999875 467899999631 22356799999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++|||++. ++|.+++... ...+++..+..|+.|+++||+|| |+.+|+||||||+|||++.++.+
T Consensus 227 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~v 299 (461)
T PHA03211 227 DVRVVGGLTCLVLPKYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPEDI 299 (461)
T ss_pred EEEEECCEEEEEEEccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCCE
Confidence 99999999999999995 6888887642 34699999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc----cccchHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH----TEEMSLV 571 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~----~~~~~~~ 571 (633)
||+|||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+...... .....+.
T Consensus 300 kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~ 379 (461)
T PHA03211 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL 379 (461)
T ss_pred EEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHH
Confidence 999999998765432222223456999999999999999999999999999999999988765322111 1112222
Q ss_pred HHHHHhhc--cCCcc----hhhhhhh-----------hhcCCH---HHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 572 KWMRNVMT--SENPT----RAIDAKL-----------LENGYE---EQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 572 ~~~~~~~~--~~~~~----~~~d~~~-----------~~~~~~---~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
+.++.... ..... +...... ....+. .....+.+++.+||+.||.+|||+.|+++.
T Consensus 380 ~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 380 RIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 33322111 00000 0000000 000000 111247789999999999999999999863
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.37 Aligned_cols=267 Identities=24% Similarity=0.369 Sum_probs=200.2
Q ss_pred cCcccccccccccCeeEEEEEe---cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
..|++.+.||+|+||.||++.+ ...++..||+|++..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~ 69 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--------------EHLRDFEREIEILKSLQHDNIVK 69 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCCeeE
Confidence 5788899999999999999975 234688999999754321 11457889999999999999999
Q ss_pred cceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 414 LLAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 414 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++.. ....++||||+++++|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||++++
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~~ 143 (284)
T cd05081 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVES 143 (284)
T ss_pred EEEEEccCCCCceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEECC
Confidence 9998754 34678999999999999998642 24589999999999999999999 7889999999999999999
Q ss_pred CCceEEcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccc-----
Q 006739 492 DMEARIADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT----- 565 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~----- 565 (633)
++.+||+|||+++.......... .....++..|+|||+..+..++.++|||||||++|||++|..|+.......
T Consensus 144 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd05081 144 ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG 223 (284)
T ss_pred CCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcc
Confidence 99999999999987654332211 111223456999999988889999999999999999999887754321100
Q ss_pred --cc-chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 566 --EE-MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 566 --~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.. ......+......... ..........+.+++.+||+.+|++|||+.|+++.|+.++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 224 NDKQGQMIVYHLIELLKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cccccccchHHHHHHHhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00 0000000000000000 0001112234888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.83 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=201.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.+|++.++||+|+||.||+|... .+|+.||+|++....... ....+++.+|++++++++||||+++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~-~tg~~VAIK~I~~~l~~~-----------e~~~~rflrEi~ILs~L~HPNIVkl~~ 69 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP-VCSRRVALKKIREDLSEN-----------PLLKKRFLREAKIAADLIHPGIVPVYS 69 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC-CCCcEEEEEEECcccccC-----------HHHHHHHHHHHHHHHhCCCcCcCeEEE
Confidence 47889999999999999999864 568999999986432111 112457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQ-------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
++.+.+..++||||++||+|.+++..... .....++..+..++.||++||+|| |+.+|+||||||+||++
T Consensus 70 v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNILL 146 (932)
T PRK13184 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNILL 146 (932)
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEEE
Confidence 99999999999999999999999875321 123466788899999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCc----------------ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh
Q 006739 490 DDDMEARIADFGLAKAMPDAQTH----------------ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 553 (633)
+.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 147 d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT 226 (932)
T PRK13184 147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226 (932)
T ss_pred cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 99999999999999876211100 01123469999999999999999999999999999999999
Q ss_pred CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHhh
Q 006739 554 GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-NSKDVRCMLSQI 631 (633)
Q Consensus 554 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~ev~~~l~~~ 631 (633)
|+.||..... .... ..... . .+... .........+.+++.+|++.||++|| +++++.+.|+.+
T Consensus 227 G~~PF~~~~~----~ki~-~~~~i-~--~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 227 LSFPYRRKKG----RKIS-YRDVI-L--SPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCCCCCCcch----hhhh-hhhhc-c--Chhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999865211 1110 00000 0 00000 00111223477888999999999995 566677777654
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.94 Aligned_cols=265 Identities=28% Similarity=0.390 Sum_probs=204.3
Q ss_pred hhcCcccccccccccCeeEEEEEec------CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELP------GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
..++|.+.+.||+|+||.||+++.. ..+...+|+|.+...... +...++.+|+++++++ +
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 76 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-------------KDLADLISEMELMKLIGK 76 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-------------HHHHHHHHHHHHHHhccC
Confidence 4467889999999999999999752 124567999987543211 1145678899999999 5
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNP 475 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~ 475 (633)
||||+++++++......++||||+++|+|.+++..... ....+++..+..++.|++.||+|| |+.
T Consensus 77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~ 153 (314)
T cd05099 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESR 153 (314)
T ss_pred CCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHC
Confidence 99999999999998899999999999999999975321 124589999999999999999999 678
Q ss_pred CeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-C
Q 006739 476 RIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-G 554 (633)
Q Consensus 476 ~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g 554 (633)
+|+||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |
T Consensus 154 gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g 233 (314)
T cd05099 154 RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG 233 (314)
T ss_pred CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654322221122234568999999988889999999999999999999 8
Q ss_pred CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 555 RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 555 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..||..... ....+.+. ...... . .......+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 234 ~~p~~~~~~----~~~~~~~~---~~~~~~------~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 234 GSPYPGIPV----EELFKLLR---EGHRMD------K----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCCCCCCCH----HHHHHHHH---cCCCCC------C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 888864321 12222221 111110 0 1111234778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=320.47 Aligned_cols=245 Identities=25% Similarity=0.290 Sum_probs=191.4
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC-cccccce
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR-NLLPLLA 416 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~ 416 (633)
+|++.+.||+|+||.||+|+.. .+++.||+|++..... ......+.+..|.+++..++|+ +|+++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVI-----------IQDDDVECTMVEKRVLALPGKPPFLTQLHS 68 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhcCCCCceeeeEE
Confidence 4788899999999999999865 4678999999854211 0112245677889999988765 6888999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~k 141 (324)
T cd05587 69 CFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHIK 141 (324)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCEE
Confidence 99999999999999999999998865 34588999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+..
T Consensus 142 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~ 215 (324)
T cd05587 142 IADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIME 215 (324)
T ss_pred EeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHc
Confidence 999999875322211 12345799999999999999999999999999999999999999975321 122111111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
. ....... ....+.+++.+||+.||.+|++.
T Consensus 216 ~--~~~~~~~------------~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 216 H--NVSYPKS------------LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C--CCCCCCC------------CCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 0011111 12236788899999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=310.80 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=192.7
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCcc
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH 424 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 424 (633)
||+|+||.||+++.. .+|+.||+|.+...... .....+.+..|++++++++||||+++++++..+...
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~-----------~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~ 68 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLK-----------KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL 68 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhh-----------cchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE
Confidence 799999999999865 47899999988432110 001133456799999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 425 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
++||||+++++|.+++... ....+++..+..++.|++.||+|| |+.+|+||||||+||++++++.++|+|||++.
T Consensus 69 ~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 69 CLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAV 143 (277)
T ss_pred EEEEecCCCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceeee
Confidence 9999999999999888642 234588999999999999999999 68899999999999999999999999999988
Q ss_pred ccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcc
Q 006739 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPT 584 (633)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (633)
....... .....||..|+|||++.+..++.++||||+||++|||++|+.||....... ...+..+.........
T Consensus 144 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 217 (277)
T cd05607 144 ELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTLEDEVKF 217 (277)
T ss_pred ecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhhcccccc
Confidence 7654322 123568999999999998889999999999999999999999987532211 1111222211111000
Q ss_pred hhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 585 RAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 585 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.... ....+.+++..||+.||++||+++|+++.
T Consensus 218 -------~~~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 218 -------EHQN---FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred -------cccc---CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 0011 12236788999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.59 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=203.6
Q ss_pred cCcccccccccccCeeEEEEEecCC--CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
.+|++.+.||+|+||.||+|..... .+..+|+|.+...... +..+.+.+|+.++.+++||||+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~ 70 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-------------KQRRDFLSEASIMGQFDHPNIIHL 70 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-------------HHHHHHHHHHHHHHhCCCCCcceE
Confidence 5688899999999999999986422 3347999988543211 114578889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+++++|.+++... ...+++.++..++.|++.||+|| |+.+++||||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~~ 144 (267)
T cd05066 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLV 144 (267)
T ss_pred EEEEecCCccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCCe
Confidence 99999999999999999999999999752 34689999999999999999999 7889999999999999999999
Q ss_pred eEEcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 495 ARIADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
++++|||++........... .....++..|+|||++.+..++.++|+||||+++||+++ |+.||..... ....+
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~~~ 220 (267)
T cd05066 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDVIK 220 (267)
T ss_pred EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHHHH
Confidence 99999999987655432211 112234568999999998889999999999999999887 9999865322 12222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+.. ...... .......+.+++.+|++.+|.+||++.++++.|+++
T Consensus 221 ~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 AIEE---GYRLPA----------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHhC---CCcCCC----------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 2221 111110 011123478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=306.41 Aligned_cols=268 Identities=25% Similarity=0.406 Sum_probs=206.4
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc-CCCCcccccce
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ-IRHRNLLPLLA 416 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~ 416 (633)
+|++.+.||+|+||.||+|......++.+|+|.+.......... .........++.+|+.++.+ ++||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~----~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKD----KRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccc----cccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 47788999999999999999875467899999876433221100 00111224567788888865 78999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++||||+++++|.+++.........+++..++.++.|++.||.||| ...+++|+||+|+||++++++.++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc--cCCceeecCCCHHHEEECCCCcEE
Confidence 999999999999999999999998765444567999999999999999999994 247899999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||.+....... ......|+..|+|||+..+..++.++||||||+++|||++|+.||.... .... ...
T Consensus 155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~----~~~~---~~~ 224 (269)
T cd08528 155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----MLSL---ATK 224 (269)
T ss_pred Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC----HHHH---HHH
Confidence 99999998765443 2234568999999999998889999999999999999999999986421 1111 111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
........ . ... .....+.+++.+||+.||++||++.|+.+++++
T Consensus 225 ~~~~~~~~-~-----~~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 225 IVEAVYEP-L-----PEG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HhhccCCc-C-----Ccc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 11111100 0 000 112347788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.56 Aligned_cols=259 Identities=26% Similarity=0.360 Sum_probs=198.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCC--eEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
++|++.+.||+|+||.||+|.... ++ ..+++|.++..... ...+.+.+|++++.++ +||||++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~ik~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp~iv~ 67 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKEFASE-------------NDHRDFAGELEVLCKLGHHPNIIN 67 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-CCCcceeEEEEccccCCH-------------HHHHHHHHHHHHHHhhcCCCchhh
Confidence 578889999999999999998753 33 34788877532211 1135688899999999 7999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRD 481 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~D 481 (633)
+++++......++|+||+++++|.+++..... ....+++..+..++.|++.||+|| |+.+|+|||
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~d 144 (297)
T cd05089 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRD 144 (297)
T ss_pred eEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCc
Confidence 99999999999999999999999999975321 123588999999999999999999 678999999
Q ss_pred CCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcc
Q 006739 482 LKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDD 560 (633)
Q Consensus 482 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~ 560 (633)
|||+||++++++.+||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||..
T Consensus 145 lkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 145 LAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred CCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999986432211 1111223567999999998889999999999999999997 9999865
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
... ... ........... ........+.+++.+||+.+|.+||+++++++.|+++.
T Consensus 222 ~~~----~~~---~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 222 MTC----AEL---YEKLPQGYRME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CCH----HHH---HHHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 322 111 11111111110 00111234778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.84 Aligned_cols=241 Identities=26% Similarity=0.353 Sum_probs=186.7
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHH-HhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN-TVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|+.. .+|+.||+|++..... .......++..|.. +++.++||||+++++++.+.
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~ 68 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAI-----------LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA 68 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHH-----------hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC
Confidence 46899999999999864 5789999999843211 00111234444444 56789999999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.||++||+|| |+.+|+||||||+|||+++++.+||+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Dfg 141 (323)
T cd05575 69 DKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFG 141 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeccC
Confidence 999999999999999998875 35688999999999999999999 67899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~ 212 (323)
T cd05575 142 LCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKP 212 (323)
T ss_pred CCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCC
Confidence 9875432221 22345799999999999999999999999999999999999999865321 11222222111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK 622 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 622 (633)
.. +. . .....+.+++.+|++.||.+||++.
T Consensus 213 ~~---~~----~----~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 LR---LK----P----NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC---CC----C----CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 00 00 1 1123377889999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=309.92 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=199.0
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|+..+.||+|+||+||+++.. .+++.||+|.+........ ......+|+.++++++||||+++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~------------~~~~~~~e~~~~~~l~~~~i~~~~~~~ 67 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEE------------EREENIREIKILRRLRHPNIVQILDVF 67 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHH------------HHHHHHHHHHHHHHHTBTTBCHEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEecccccccc------------ccchhhhhhhccccccccccccccccc
Confidence 577899999999999999875 5788999999976543211 122344599999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
......++||||+++++|.+++.. ...+++..+..++.|+++||++| |+.+|+|+||||+||++++++.++|+
T Consensus 68 ~~~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~~~~~l~ 140 (260)
T PF00069_consen 68 QDDNYLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDENGEVKLI 140 (260)
T ss_dssp EESSEEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTTSEEEES
T ss_pred cccccccccccccccccccccccc----ccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence 999999999999999999999983 35689999999999999999999 66799999999999999999999999
Q ss_pred ccccccccCCCCCcceecccccCcccccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
|||.+...... ........++..|+|||+.. +..++.++||||+|+++|+|++|+.||.............+.....
T Consensus 141 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~ 218 (260)
T PF00069_consen 141 DFGSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP 218 (260)
T ss_dssp SGTTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH
T ss_pred ccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc
Confidence 99998765221 12234567899999999998 7889999999999999999999999987641111111111111100
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... .. .........+.+++.+||+.||++||++.++++
T Consensus 219 ~~~---------~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 LPS---------SS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHH---------HT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccc---------cc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00 000001145889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.57 Aligned_cols=244 Identities=29% Similarity=0.411 Sum_probs=188.6
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc-CCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ-IRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|+.. .+++.||+|.+..... ........+..|..++.. .+||||+++++++.+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~ 68 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVV-----------LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK 68 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC
Confidence 46899999999999875 4688999999854211 001113445567777765 4899999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+||+|||
T Consensus 69 ~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05619 69 ENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADFG 141 (316)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccCC
Confidence 999999999999999999875 34588999999999999999999 78899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||..|+|||++.+..++.++||||+||++|||++|+.||..... ..+.+.+.. ...
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~~--~~~ 213 (316)
T cd05619 142 MCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIRM--DNP 213 (316)
T ss_pred cceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh--CCC
Confidence 9875432211 12345689999999999998999999999999999999999999875321 122221111 000
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH-HHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK-DVR 625 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-ev~ 625 (633)
.... .....+.+++.+||+.||++||++. ++.
T Consensus 214 ~~~~------------~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 CYPR------------WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCc------------cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0010 1122367888999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.83 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=196.9
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|++.+.||+|+||.||+++.. .+++.||+|.+.+... ........+.+|+.+++.++||||++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEM-----------IKRSDSAFFWEERDIMAFANSPWVVQ 107 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhhHHHHHHHHHHHHhCCCCCEee
Confidence 34578999999999999999999875 5788999999843210 01112456788999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|| |+.+|+||||||+|||+++++
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~ 179 (370)
T cd05621 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHG 179 (370)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCC
Confidence 99999999999999999999999999864 3478889999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCC----CCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK----FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
.+||+|||++......... ......||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... .
T Consensus 180 ~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~-- 253 (370)
T cd05621 180 HLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---V-- 253 (370)
T ss_pred CEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---H--
Confidence 9999999999876543221 123457999999999987543 78899999999999999999999965321 1
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCC--CCCHHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE--RPNSKDVRCM 627 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~ev~~~ 627 (633)
.....+......... . . .......+.+++..|+..+|.+ ||++.|+++.
T Consensus 254 --~~~~~i~~~~~~~~~-p----~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 --GTYSKIMDHKNSLNF-P----E--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --HHHHHHHhCCcccCC-C----C--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111111110000 0 0 0011233667778888755544 8999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=308.36 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=197.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..++||+|+||.||+|... .+++.||+|.+...... ...+++.+|++++.+++||||+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 66 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITV-------------ELQKQIMSELEILYKCDSPYIIGFYG 66 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCh-------------HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 35778899999999999999864 47889999988543210 11456889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++||||+++++|..+. .+++..+..++.|++.||+|| |+.+|+|+||||+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~ 135 (279)
T cd06619 67 AFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVK 135 (279)
T ss_pred EEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEE
Confidence 999999999999999999996542 367888999999999999999 688999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||++....... .....||..|+|||++.+..++.++||||||+++|+|++|+.||..............+...
T Consensus 136 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 211 (279)
T cd06619 136 LCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211 (279)
T ss_pred EeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH
Confidence 99999987654332 13357899999999999989999999999999999999999999764432222111122211
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
...... .. +... .....+.+++.+|++.+|++||+++|+++.
T Consensus 212 ~~~~~~-~~-----~~~~---~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 212 IVDEDP-PV-----LPVG---QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HhccCC-CC-----CCCC---cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111 00 0001 112237788999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=321.04 Aligned_cols=246 Identities=25% Similarity=0.301 Sum_probs=188.0
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHH-HHhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI-NTVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|+.. .+++.||+|++...... .......+..|. .+++.++||||+++++++...
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~ 68 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAIL-----------KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 68 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHH-----------hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC
Confidence 46899999999999865 57889999998532110 011122333343 456788999999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+.+.....++.||++||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~DfG 141 (325)
T cd05602 69 DKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDFG 141 (325)
T ss_pred CeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccCC
Confidence 999999999999999999875 34578888899999999999999 78899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ........
T Consensus 142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~---~~~i~~~~ 212 (325)
T cd05602 142 LCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEM---YDNILNKP 212 (325)
T ss_pred CCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHH---HHHHHhCC
Confidence 9875433221 12345799999999999999999999999999999999999999865321 111 11111111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.. .. +.....+.+++.+|++.||.+||++.+.+..
T Consensus 213 ~~---~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 213 LQ---LK--------PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred cC---CC--------CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 00 00 1112237788889999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=310.04 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=205.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||+||++... .+++.||+|++...... +..+++.+|+++++.++||||++++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~ 69 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKS-------------SVRKQILRELQIMHECRSPYIVSFY 69 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcc-------------hHHHHHHHHHHHHHHcCCCCcceEe
Confidence 467889999999999999999864 56889999987543211 1145788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++......++||||+++++|.+++.. ...+++.....++.++++||.||| +..+++||||||+||++++++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~ 143 (284)
T cd06620 70 GAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQI 143 (284)
T ss_pred eeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcE
Confidence 999999999999999999999998875 345899999999999999999996 34689999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccc----ccchHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT----EEMSLV 571 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~----~~~~~~ 571 (633)
+|+|||++....... .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||+...... ....+.
T Consensus 144 ~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~ 219 (284)
T cd06620 144 KLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL 219 (284)
T ss_pred EEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH
Confidence 999999986543321 123568999999999988889999999999999999999999997643321 112222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
++........... . ........+.+++.+|++.||++|||+.|++++.
T Consensus 220 ~~~~~~~~~~~~~-~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 220 DLLQQIVQEPPPR-L--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHhhccCCC-C--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 3333322221110 0 0011223478899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=314.94 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=199.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCe--EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGK--MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 412 (633)
.++|++.+.||+|+||.||+|.+.. ++. .+|+|.+..... .....++.+|++++.++ +|+||+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~~~-------------~~~~~~~~~Ei~~l~~l~~h~~iv 71 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYAS-------------KDDHRDFAGELEVLCKLGHHPNII 71 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEecccCC-------------HHHHHHHHHHHHHHHHhcCCCCcc
Confidence 4678899999999999999998753 454 457776643211 01145788899999999 899999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
++++++...+..++||||+++++|.++++.... ....+++..++.++.|+++||+|| |+.+|+||
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~ 148 (303)
T cd05088 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 148 (303)
T ss_pred eEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCcccc
Confidence 999999999999999999999999999975321 123588999999999999999999 78899999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||||+||++++++.+||+|||+++...... ......++..|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 149 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 149 DLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred ccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 999999999999999999999986432111 1112234678999999988889999999999999999998 999986
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.... ....+.+ ........ .......+.+++.+||+.+|++||+++++++.|+++
T Consensus 226 ~~~~----~~~~~~~---~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 226 GMTC----AELYEKL---PQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred cCCh----HHHHHHH---hcCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4322 1111111 11111100 001122478899999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=313.69 Aligned_cols=244 Identities=30% Similarity=0.405 Sum_probs=188.5
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc-CCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ-IRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|+.. .+|+.||+|.+..... ........+..|..++.. .+||||+++++++.+.
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 68 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVV-----------LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK 68 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC
Confidence 46999999999999875 5788999999854211 001113445667777765 4899999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05620 69 EHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADFG 141 (316)
T ss_pred CEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCccC
Confidence 999999999999999998865 34588999999999999999999 68899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...+.+.+.. ...
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~~~~~~~~~~--~~~ 213 (316)
T cd05620 142 MCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELFESIRV--DTP 213 (316)
T ss_pred CCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHh--CCC
Confidence 9875322211 1234579999999999999999999999999999999999999996532 1122221111 011
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH-HHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK-DVR 625 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-ev~ 625 (633)
..... ....+.+++.+||+.||++||++. ++.
T Consensus 214 ~~~~~------------~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRW------------ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCC------------CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11111 112367888999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.26 Aligned_cols=246 Identities=26% Similarity=0.344 Sum_probs=190.4
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|... .+++.||+|++..... ...+..+.+.+|..++.++ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 68 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELV-----------HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT 68 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC
Confidence 46999999999999865 5788999999854221 1112245678899998888 599999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg 141 (327)
T cd05617 69 SRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDYG 141 (327)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEeccc
Confidence 999999999999999988864 34699999999999999999999 67899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+....... ....++........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 218 (327)
T cd05617 142 MCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEK 218 (327)
T ss_pred cceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhC
Confidence 9875332211 12345799999999999999999999999999999999999999964322111 11111121111111
Q ss_pred --CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH
Q 006739 582 --NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK 622 (633)
Q Consensus 582 --~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 622 (633)
..+.. ....+.+++.+||+.||++|+++.
T Consensus 219 ~~~~p~~------------~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 219 PIRIPRF------------LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCC------------CCHHHHHHHHHHhccCHHHcCCCC
Confidence 11111 112367888899999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=306.02 Aligned_cols=250 Identities=29% Similarity=0.418 Sum_probs=198.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||++.. .|..||+|.+..... .+.+.+|+.++++++|+|+++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~~~~----------------~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----------------AQAFLAEASVMTQLRHSNLVQLL 65 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCCCch----------------HHHHHHHHHHHHhCCCCCeeeEE
Confidence 35788899999999999999976 578899998743221 34678899999999999999999
Q ss_pred eeee-cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 416 AHMA-RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 416 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+++. .....++||||+++++|.+++.... ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~ 140 (256)
T cd05082 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNV 140 (256)
T ss_pred EEEEcCCCceEEEEECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCc
Confidence 9764 4567899999999999999987522 34588999999999999999999 7889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||+++...... ....++..|+|||+..+..++.++|||||||++|||++ |+.||... ....+...
T Consensus 141 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~~~~~ 211 (256)
T cd05082 141 AKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPR 211 (256)
T ss_pred EEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHH
Confidence 9999999987654322 12345678999999998889999999999999999998 99998642 11222222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+. ... ... . .......+.+++.+|++.+|++|||+.++++.|+++
T Consensus 212 ~~---~~~-~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 VE---KGY-KMD-----A----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred Hh---cCC-CCC-----C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 21 111 110 0 011123477889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.43 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=191.6
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|... .+++.||+|++.+... ........+.+|..++..+ +||||+++++++.+.
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~ 68 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVI-----------LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK 68 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHH-----------hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 46899999999999875 4688999999853211 0111245567788888877 699999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Dfg 141 (318)
T cd05570 69 DRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADFG 141 (318)
T ss_pred CEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEecccC
Confidence 999999999999999988875 34689999999999999999999 78899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ........
T Consensus 142 ~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~---~~~i~~~~ 212 (318)
T cd05570 142 MCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDEL---FQSILEDE 212 (318)
T ss_pred CCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHH---HHHHHcCC
Confidence 9875322221 1123568999999999999999999999999999999999999996532 1111 11111111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH-----HHHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS-----KDVRC 626 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~-----~ev~~ 626 (633)
.. . +......+.+++.+||+.||++||++ .++++
T Consensus 213 ~~---~--------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 VR---Y--------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CC---C--------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 10 0 00112347889999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=306.14 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=199.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|.+.+.||+|++|.||++... ++..+|+|.+..... ..+.+.+|++++++++|+|++++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~ 68 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPGTM---------------MPEAFLQEAQIMKKLRHDKLVPLYA 68 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccCCc---------------cHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 56888899999999999999875 445799998753221 0345788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++. .+..++||||+++++|.++++.. ....+++..+..++.|+++||+|| |+.+|+|+||||+||++++++.++
T Consensus 69 ~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~~ 142 (260)
T cd05069 69 VVS-EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVCK 142 (260)
T ss_pred EEc-CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeEE
Confidence 875 45678999999999999999753 234589999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+++........ ......++..|+|||...+..++.++||||||+++|||++ |+.||.+... .....++.
T Consensus 143 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~ 217 (260)
T cd05069 143 IADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLEQVE 217 (260)
T ss_pred ECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH
Confidence 9999999876443221 1122346778999999988889999999999999999999 8999865321 12222221
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
...... ........+.+++.+||+.||++||+++++++.|+++
T Consensus 218 ---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 218 ---RGYRMP----------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred ---cCCCCC----------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 111110 0111234478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.98 Aligned_cols=245 Identities=25% Similarity=0.288 Sum_probs=191.5
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccce
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLA 416 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 416 (633)
+|++.+.||+|+||.||+|+.. .+++.||+|.+.+... ........+..|..++..+ +|++|+++++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVV-----------IQDDDVECTMVEKRVLALSGKPPFLTQLHS 68 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhccCCCeEeeEEE
Confidence 4778899999999999999875 5788999999854221 0111234566677777776 5899999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||+++++.+|
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~k 141 (323)
T cd05616 69 CFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcEE
Confidence 99999999999999999999998865 34588999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.+.
T Consensus 142 L~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~- 214 (323)
T cd05616 142 IADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIM- 214 (323)
T ss_pred EccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHH-
Confidence 999999875432221 12345799999999999999999999999999999999999999975321 22222111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
..... . +......+.+++.+|++.||++|++.
T Consensus 215 --~~~~~---~--------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 215 --EHNVA---Y--------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --hCCCC---C--------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11100 0 01112346788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=307.71 Aligned_cols=258 Identities=25% Similarity=0.336 Sum_probs=188.4
Q ss_pred cccccccCeeEEEEEec-CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|... +.....+|+|.+..... ......+.+|+++++.++|+||+++++++...
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~ 67 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-------------PDEQLLFLQEVQPYRELNHPNVLQCLGQCIES 67 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC-------------hHHHHHHHHHHHHHHhCCCCCcceEEEEECCC
Confidence 36899999999999753 22446788887643321 11145678899999999999999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQG-RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
...++||||+++|+|.+++...... ....++.....++.|++.||+|| |+.+|+||||||+||++++++.+||+||
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~df 144 (269)
T cd05042 68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDY 144 (269)
T ss_pred CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEecc
Confidence 9999999999999999999764322 23356788899999999999999 7889999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCccccccccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-------LKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 501 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
|+++...............++..|+|||+... ..++.++|||||||++|||++ |..||..... ...+.+
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~ 221 (269)
T cd05042 145 GLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQ 221 (269)
T ss_pred ccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHH
Confidence 99876543322222233456778999998643 356789999999999999999 7888765321 111111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
.. .... ....++... . .....+.+++..|+ .||++|||++||++.|.
T Consensus 222 ~~----~~~~-~~~~~~~~~-~---~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 222 VV----REQD-IKLPKPQLD-L---KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred Hh----hccC-ccCCCCccc-c---cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 1111 011111111 1 11233556777888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.72 Aligned_cols=265 Identities=26% Similarity=0.366 Sum_probs=205.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCC------CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGS------NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
...+|++.+.||+|+||.||+++..+. .+..||+|.+...... +..+++.+|+++++++ +
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 76 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-------------KDLSDLVSEMEMMKMIGK 76 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-------------HHHHHHHHHHHHHHhhcC
Confidence 345789999999999999999975321 2347899987543211 1246788999999999 7
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNP 475 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~ 475 (633)
||||+++++++...+..+++|||+++|+|.+++..... ....+++..+..++.|+++||+|| |+.
T Consensus 77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~ 153 (334)
T cd05100 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQ 153 (334)
T ss_pred CCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHC
Confidence 99999999999999999999999999999999975321 134588999999999999999999 678
Q ss_pred CeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-C
Q 006739 476 RIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-G 554 (633)
Q Consensus 476 ~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g 554 (633)
+|+||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |
T Consensus 154 givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 233 (334)
T cd05100 154 KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 233 (334)
T ss_pred CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcC
Confidence 999999999999999999999999999987654332222222344678999999999899999999999999999998 8
Q ss_pred CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 555 RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 555 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..||.... .. ++.+......... ........+.+++.+|++.+|++||++.|+++.|+++.
T Consensus 234 ~~p~~~~~----~~---~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 234 GSPYPGIP----VE---ELFKLLKEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCCCCCCC----HH---HHHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 88876432 11 2222222111111 01111234778999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=311.04 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=199.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++... .++..+|+|.+..... .....++.+|++++.+++||||+++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 66 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIK-------------PAIRNQIIRELKVLHECNSPYIVGFYG 66 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 46889999999999999999865 4678899998754321 012456888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++..++..++||||+++++|.++++. ...+++..+..++.|+++||.||| ...+++||||||+||++++++.+|
T Consensus 67 ~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dl~p~nil~~~~~~~~ 140 (308)
T cd06615 67 AFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIK 140 (308)
T ss_pred EEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH--hhCCEEECCCChHHEEEecCCcEE
Confidence 99999999999999999999999975 255889999999999999999995 235899999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||++....... .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... .....+...
T Consensus 141 l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~ 212 (308)
T cd06615 141 LCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGR 212 (308)
T ss_pred EccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhhcC
Confidence 99999987654322 1235689999999999888899999999999999999999999864221 111111110
Q ss_pred hhccCCc--------------------chhhhhhhhh---c-CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 577 VMTSENP--------------------TRAIDAKLLE---N-GYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 577 ~~~~~~~--------------------~~~~d~~~~~---~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
....... .+..+....+ . ........+.+++.+||+.+|++||++.++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0000000000 0 000122347899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=307.14 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=202.9
Q ss_pred hcCcccccccccccCeeEEEEEecCC--CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|+..+.||+|+||.||+|..... +...+|+|.+..... ....+++..|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~ 70 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-------------EKQRQDFLSEASIMGQFSHHNIIR 70 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-------------HHHHHHHHHHHHHHhcCCCCCeeE
Confidence 35678889999999999999987422 234799998754321 011456888999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+.+++...+..++||||+++++|.+++... ...+++..+..++.|++.|++|| |+.+++||||||+||++++++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~ 144 (268)
T cd05063 71 LEGVVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNL 144 (268)
T ss_pred EEEEEccCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCC
Confidence 999999999999999999999999998652 34689999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 494 EARIADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
.+|++|||++........... ......+..|+|||++.+..++.++|||||||++|||++ |+.||..... ...
T Consensus 145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~- 219 (268)
T cd05063 145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEV- 219 (268)
T ss_pred cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHH-
Confidence 999999999886654322111 111223567999999988889999999999999999998 9999864321 122
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+.......... .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 220 --~~~i~~~~~~~~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 220 --MKAINDGFRLPA----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --HHHHhcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222221111111 111223478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=302.49 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=198.7
Q ss_pred cccccccCeeEEEEEecCCCCe--EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 343 EKIGSGGCGEVYKAELPGSNGK--MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
+.||+|++|.||+|.+...+++ .||+|.+...... ...+.+.+|++++++++||||+++++++..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 67 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT 67 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------------HHHHHHHHHHHHHhhcCCCCccceeEEEcC
Confidence 4689999999999987543343 6999988654321 225678999999999999999999999988
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
...++||||+++++|.+++..... ..+++...+.++.|+++||+|| |+.+++|+||||+||+++.++.+||+||
T Consensus 68 -~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~df 141 (257)
T cd05040 68 -HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGDF 141 (257)
T ss_pred -CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEeccc
Confidence 888999999999999999976321 5689999999999999999999 7889999999999999999999999999
Q ss_pred ccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhh
Q 006739 501 GLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVM 578 (633)
Q Consensus 501 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 578 (633)
|+++......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+.+..
T Consensus 142 g~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~-- 215 (257)
T cd05040 142 GLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKIDK-- 215 (257)
T ss_pred cccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHh--
Confidence 9998775533221 1123457889999999998899999999999999999999 9999864322 112111111
Q ss_pred ccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 579 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
..... .........+.+++.+|++.+|++||++.++++.|.
T Consensus 216 -~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 -EGERL---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCcC---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11000 001112234788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=304.27 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=197.9
Q ss_pred cccccccCeeEEEEEecCCC--CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 343 EKIGSGGCGEVYKAELPGSN--GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
++||+|+||.||+|.+...+ +..+|+|.+...... ...+++.+|+++++++.|+||+++++++.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 66 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------------AGKKEFLREASVMAQLDHPCIVRLIGVCK- 66 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-
Confidence 47999999999999875444 378999988644321 12457888999999999999999999876
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |..+++|+||||+||+++.++.+||+||
T Consensus 67 ~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~df 139 (257)
T cd05060 67 GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISDF 139 (257)
T ss_pred CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEeccc
Confidence 4567999999999999999975 23689999999999999999999 6788999999999999999999999999
Q ss_pred ccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhh
Q 006739 501 GLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVM 578 (633)
Q Consensus 501 G~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 578 (633)
|+++.......... .....++..|+|||...+..++.++||||||+++|||++ |+.||.... .....+++...
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~----~~~~~~~~~~~- 214 (257)
T cd05060 140 GMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK----GAEVIAMLESG- 214 (257)
T ss_pred cccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC----HHHHHHHHHcC-
Confidence 99987654332211 112234568999999998899999999999999999998 999986532 22233333221
Q ss_pred ccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 579 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.... ........+.+++.+|++.+|++||++.++++.|+.+.
T Consensus 215 --~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 215 --ERLP----------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CcCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1110 00111234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=306.62 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=204.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|..+ ++..||+|.+...... .+++.+|+.++++++|+||+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTMS---------------PEAFLQEAQIMKKLRHDKLVQL 66 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCccC---------------HHHHHHHHHHHhhCCCCCEeee
Confidence 4578999999999999999999865 5678999988643321 3467889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++......++||||+++++|.+++.... ...+++..+..++.+++.|++|| |+.+++|+||||+||++++++.
T Consensus 67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~ 141 (261)
T cd05034 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLV 141 (261)
T ss_pred eeeeecCCceEEEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCC
Confidence 999998889999999999999999997532 35689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 573 (633)
++++|||+++.......... ....++..|+|||.+.+..++.++|+||+|+++||+++ |+.||.... .....+.
T Consensus 142 ~~l~d~g~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~----~~~~~~~ 216 (261)
T cd05034 142 CKIADFGLARLIEDDEYTAR-EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT----NREVLEQ 216 (261)
T ss_pred EEECccccceeccchhhhhh-hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHH
Confidence 99999999887654221111 12234678999999998889999999999999999999 999986422 1122222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+. ....... .......+.+++.+|++.+|++||+++++++.|+.+
T Consensus 217 ~~---~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 217 VE---RGYRMPR----------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred HH---cCCCCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 21 1111100 001123478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=302.65 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=195.5
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
++||+|+||.||+|... ++..+|+|.+...... +....+.+|++++++++||||+++++++...+
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 65 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQ-------------ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ 65 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCH-------------HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC
Confidence 46899999999999864 7889999987644321 11346888999999999999999999999999
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||+++++|.+++... ...+++..+..++.|++.+|.|+ |+.+++||||||+||++++++.+||+|||+
T Consensus 66 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g~ 139 (250)
T cd05085 66 PIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFGM 139 (250)
T ss_pred ccEEEEECCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCcc
Confidence 999999999999999988642 34578999999999999999999 788999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhccC
Q 006739 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+......... ......++..|+|||+..+..++.++||||||+++||+++ |..||..... ......+ ....
T Consensus 140 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----~~~~~~~---~~~~ 211 (250)
T cd05085 140 SRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----QQAREQV---EKGY 211 (250)
T ss_pred ceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHH---HcCC
Confidence 8765433221 1122244678999999998899999999999999999998 9999865322 1111111 1111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
... ........+.+++.+|++.+|++||++.|++++|.
T Consensus 212 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 212 RMS----------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 110 01112235888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=304.90 Aligned_cols=259 Identities=23% Similarity=0.392 Sum_probs=202.0
Q ss_pred cCcccccccccccCeeEEEEEecCCC--CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..|++.+.||+|+||.||+|...... +..||+|.+..... .....+|..|+.++++++||||+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni~~~ 70 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-------------EKQRRDFLSEASIMGQFDHPNIIHL 70 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-------------HHHHHHHHHHHHHHHhCCCcCcceE
Confidence 35788899999999999999875322 34799999854321 1114678899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+....++||||+++++|.+++... ...+++..+..++.|++.||+|| |+.+++|+||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~ 144 (269)
T cd05065 71 EGVVTKSRPVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLV 144 (269)
T ss_pred EEEECCCCceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCc
Confidence 99999999999999999999999998752 34689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceec-ccc--cCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 495 ARIADFGLAKAMPDAQTHITTS-NVA--GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
+|++|||++............. ... .+..|+|||++.+..++.++|||||||++||+++ |..||.... ....
T Consensus 145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~----~~~~ 220 (269)
T cd05065 145 CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----NQDV 220 (269)
T ss_pred EEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC----HHHH
Confidence 9999999988665432211111 111 2457999999999899999999999999999986 999986532 2223
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+++.. ...... ..+....+.+++..||+.+|++||++++++++|+++
T Consensus 221 ~~~i~~---~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 221 INAIEQ---DYRLPP----------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHc---CCcCCC----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 333321 111110 011123477899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=315.23 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=209.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.+.|+..+.||+|.||.||+++.+ .+|+.+|+|.+.+....... ....+.+|+++|+++. |||||.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~-----------~~~~v~~Ev~il~~l~~hpniv~l 101 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKE-----------DREDVRREVAILQQLSGHPNIVQL 101 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccc-----------cHHHHHHHHHHHHhccCCCCEEEE
Confidence 467888899999999999999865 56999999999766542211 2467899999999998 9999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC--
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD-- 492 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~-- 492 (633)
.+.|.+....++|||+++||.|.+.+... .+++..+..++.|++.+++|+ |+.+|+|||+||+|+|+...
T Consensus 102 ~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 102 KDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKDE 173 (382)
T ss_pred EEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeeccccC
Confidence 99999999999999999999999999763 399999999999999999999 78999999999999999743
Q ss_pred --CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 493 --MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 --~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+.+|++|||++....... .....+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.... ...
T Consensus 174 ~~~~ik~~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---~~~ 247 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---EIF 247 (382)
T ss_pred CCCcEEEeeCCCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---HHH
Confidence 479999999999887722 335678999999999999999999999999999999999999999764321 111
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+ +..... ......++.....+.+++..++..||.+|+|+.++++
T Consensus 248 ~~----i~~~~~-------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 248 LA----ILRGDF-------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HH----HHcCCC-------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11 111111 1112234444556888999999999999999999986
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=299.82 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=209.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
++-|.++++||+|+||.||++.++ ..|+.+|+|.+.... ..+++..|+.++++.+.|++|+++
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~-EsG~v~AIK~VPV~s----------------DLQEIIKEISIMQQC~S~yVVKYY 94 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHR-ESGHVLAIKKVPVDT----------------DLQEIIKEISIMQQCKSKYVVKYY 94 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHh-ccCcEEEEEecCccc----------------hHHHHHHHHHHHHHcCCchhhhhh
Confidence 455788999999999999999764 789999999874322 167899999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
|.+.....+++|||||..|+..++++.. ++++++.++..++...++||+|| |..+-+|||||..|||++.+|.+
T Consensus 95 GSYFK~sDLWIVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YL---H~~~KIHRDIKAGNILLNT~G~A 168 (502)
T KOG0574|consen 95 GSYFKHSDLWIVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYL---HDLKKIHRDIKAGNILLNTDGIA 168 (502)
T ss_pred hhhccCCceEeehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHH---HHHHHHHhhcccccEEEcccchh
Confidence 9999999999999999999999998752 57899999999999999999999 67778999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||.|..+.+..... ..+.||+.|||||++..-.|+.++|+||+|++..||..|++||.+..+-.. +-
T Consensus 169 KLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IF 239 (502)
T KOG0574|consen 169 KLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IF 239 (502)
T ss_pred hhhhccccchhhhhHHhh--CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eE
Confidence 999999998766543222 347899999999999999999999999999999999999999987654110 00
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. .....++- ...++.....+-++++.||-+.|++|-|+.++++
T Consensus 240 M-IPT~PPPT-------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 240 M-IPTKPPPT-------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred e-ccCCCCCC-------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 0 01111111 1234555667899999999999999999988765
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.67 Aligned_cols=264 Identities=19% Similarity=0.300 Sum_probs=196.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|...+.||+|+||.||+|+.. .+++.||+|.+........ ...+.+|++++++++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~-------------~~~~~~E~~~l~~l~h~~iv~~~ 70 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGA-------------PCTAIREVSLLKDLKHANIVTLH 70 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCc-------------chhHHHHHHHHHhCCCCCcceEE
Confidence 367899999999999999999864 4688999999864432110 23466799999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++..++..++||||+++ +|.+++... +..+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 71 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~ 143 (309)
T cd07872 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGEL 143 (309)
T ss_pred EEEeeCCeEEEEEeCCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCE
Confidence 999999999999999975 888877642 34588999999999999999999 68899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++........ .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||......+.... +
T Consensus 144 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----~ 217 (309)
T cd07872 144 KLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL----I 217 (309)
T ss_pred EECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----H
Confidence 99999998765432211 123467899999998765 4688999999999999999999999965322111111 1
Q ss_pred HHhhccCCcc---------hhhhhhhhh-------cCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPT---------RAIDAKLLE-------NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~---------~~~d~~~~~-------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... ...+..... .........+.+++.+|++.||.+|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 1111000000 000000000 000112234678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=303.68 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=193.9
Q ss_pred ccccccCeeEEEEEecCC-CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 344 KIGSGGCGEVYKAELPGS-NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
.||+|+||.||+|.+... ++..||+|.+..... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~ 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-------------KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AE 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-------------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CC
Confidence 389999999999977533 456799998854321 111457889999999999999999999875 45
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||+++++|.+++... ...+++..+..++.|+++||+|| |+.+++||||||+||+++.++.+||+|||+
T Consensus 68 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg~ 141 (257)
T cd05115 68 ALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFGL 141 (257)
T ss_pred CeEEEEEeCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCCc
Confidence 678999999999999998642 34689999999999999999999 678999999999999999999999999999
Q ss_pred ccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhcc
Q 006739 503 AKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTS 580 (633)
Q Consensus 503 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 580 (633)
+.......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||..... ......+ ...
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~---~~~ 214 (257)
T cd05115 142 SKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----PEVMSFI---EQG 214 (257)
T ss_pred cccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHH---HCC
Confidence 98654432211 1112234678999999988889999999999999999996 9999875422 1122222 111
Q ss_pred CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 581 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.... ........+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 215 ~~~~----------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 KRLD----------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1110 0111223477899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=318.82 Aligned_cols=193 Identities=25% Similarity=0.316 Sum_probs=164.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
...+|++.+.||+|+||.||+|... .+++.||+|..... ....|+.++++++||||+++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~--------------------~~~~E~~~l~~l~h~~iv~~ 122 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG--------------------TTLIEAMLLQNVNHPSVIRM 122 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc--------------------ccHHHHHHHHhCCCCCCcCh
Confidence 3467999999999999999999875 46788999974321 23458889999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++......++|+||+. ++|.+++.. ....+++..+..|+.||+.||+|| |+.+|+||||||+||+++.++.
T Consensus 123 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~ 195 (357)
T PHA03209 123 KDTLVSGAITCMVLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVDQ 195 (357)
T ss_pred hheEEeCCeeEEEEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCC
Confidence 999999999999999995 688888764 245689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPS 558 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 558 (633)
+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 196 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 196 VCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred EEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999999875432211 12356899999999999999999999999999999999966554
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=315.25 Aligned_cols=241 Identities=26% Similarity=0.335 Sum_probs=186.1
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHH-HHhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI-NTVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|+.. .+++.||+|++..... ........+..|. .+++.++||||+++++++.+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~ 68 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTI-----------LKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA 68 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHH-----------HHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence 46899999999999864 5789999999853211 0111133444454 457889999999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|...+.. ...+++..+..++.||++||+|| |+.+|+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 141 (321)
T cd05603 69 EKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDFG 141 (321)
T ss_pred CEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccCC
Confidence 999999999999999988864 35688889999999999999999 67899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .+.........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~---~~~~~~i~~~~ 212 (321)
T cd05603 142 LCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----V---SQMYDNILHKP 212 (321)
T ss_pred CCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----H---HHHHHHHhcCC
Confidence 9875432221 2234578999999999998899999999999999999999999986531 1 11122222111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK 622 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 622 (633)
.. + +......+.+++.+|++.||.+||++.
T Consensus 213 ~~-------~----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 LQ-------L----PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC-------C----CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00 0 011123477889999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=311.98 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=190.8
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc---CCCCccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ---IRHRNLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l 414 (633)
+|++.+.||+|+||.||+|+.. .+++.||+|.+......... ...+.+|+++++. ++||||+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~------------~~~~~~e~~~l~~l~~~~h~ni~~~ 67 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGL------------PLSTVREVALLKRLEAFDHPNIVRL 67 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCC------------chHHHHHHHHHHHhhhcCCCCeeee
Confidence 4788899999999999999864 57899999988653321110 1223445555544 479999999
Q ss_pred ceeeec-----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 415 LAHMAR-----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 415 ~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
++++.. ....++||||++ ++|.+++.... ...+++..+..++.|++.||+|| |+.+|+||||||+||++
T Consensus 68 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili 141 (288)
T cd07863 68 MDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENILV 141 (288)
T ss_pred eeeeccccCCCCceEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEE
Confidence 998764 245789999997 48988887532 34589999999999999999999 78899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
++++.+||+|||+++....... .....||..|+|||++.+..++.++||||+||++|||++|+.||...........
T Consensus 142 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (288)
T cd07863 142 TSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218 (288)
T ss_pred CCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence 9999999999999987653321 1235689999999999988999999999999999999999999865322111111
Q ss_pred HHHHHHHhhccCCcch------hhhhh---hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTR------AIDAK---LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~------~~d~~---~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+..++.......++.. ...+. ......+.....+.+++.+|++.||++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 219 IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111100000000000 00000 000011122345788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=307.74 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=197.7
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|+..+.||+|+||.||++... .+++.||+|.+....... ......+.+|+.++++++|+|++++++.+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~~~~i~~~~~~~ 69 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKK-----------RKGESMALNEKQILEKVNSRFVVSLAYAY 69 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccc-----------hHHHHHHHHHHHHHHhCCCCCeeeeeEEE
Confidence 667789999999999999875 578999999875432110 11134567899999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
.+.+..++||||+++++|.+++.... ...+++..+..++.|++.||.|| |+.+|+||||||+||++++++.++|+
T Consensus 70 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 70 ETKDALCLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred ecCCEEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999886432 34689999999999999999999 68899999999999999999999999
Q ss_pred ccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhh
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 578 (633)
|||++......... ....||..|+|||++.+..++.++||||+|+++|||++|+.||....................
T Consensus 145 Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 221 (285)
T cd05630 145 DLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221 (285)
T ss_pred eccceeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh
Confidence 99998765443221 234689999999999998999999999999999999999999975322111111111111000
Q ss_pred ccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 579 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
... .......+.+++..||+.||++||| ++|+++
T Consensus 222 ----------~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 ----------EEY----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ----------hhc----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 0111223678889999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=323.66 Aligned_cols=206 Identities=26% Similarity=0.426 Sum_probs=174.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|+||.||+++.. .+++.||+|++.... ....+....+++|+.++..++|+||+++++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~-----------~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~ 68 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKAD-----------MLEKEQVAHIRAERDILVEADGAWVVKMFY 68 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHH-----------HhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 46888999999999999999865 578999999985321 011122567888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.+.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vk 141 (360)
T cd05627 69 SFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVK 141 (360)
T ss_pred EEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEE
Confidence 99999999999999999999999875 34689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCc---------------------------------ceecccccCcccccccccccCCCCCccchHH
Q 006739 497 IADFGLAKAMPDAQTH---------------------------------ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYS 543 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 543 (633)
|+|||+++........ .......||+.|+|||++.+..++.++||||
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 221 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence 9999998754321100 0011346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCccc
Q 006739 544 FGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 544 ~G~~l~elltg~~p~~~~ 561 (633)
|||++|||++|+.||...
T Consensus 222 lGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 222 LGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccceeeecccCCCCCCCC
Confidence 999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.03 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=187.5
Q ss_pred cccccccCeeEEEEEecCC-CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGS-NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||++..... ....+++|.+..... .+..+.+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 67 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-------------SKEQNEFLQQGDPYRILQHPNILQCLGQCVEA 67 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-------------hHHHHHHHHHHHHHhccCCcchhheEEEecCC
Confidence 3689999999999975322 234566776543221 01146788999999999999999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
...++||||+++|+|.++++.........++.....++.||++||+|| |+.+|+||||||+||+++.++.++|+|||
T Consensus 68 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Dfg 144 (268)
T cd05086 68 IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDYG 144 (268)
T ss_pred CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEecccc
Confidence 999999999999999999986443344567788889999999999999 67889999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCccccccccccc-------CCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHH
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-------LKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 573 (633)
++................++..|+|||+... ..++.++||||||+++|||++ |..||..... . +.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~---~~ 217 (268)
T cd05086 145 IGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----R---EV 217 (268)
T ss_pred cccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----H---HH
Confidence 9864332221112234567899999998753 245789999999999999997 5667754321 1 11
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
+.....+. .....++.+... +. ..+.+++..|| .+|++||+++++++.|.
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~-~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 LNHVIKDQ-QVKLFKPQLELP-YS---ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHhhc-ccccCCCccCCC-Cc---HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111111 111122222111 12 23666778899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=304.26 Aligned_cols=251 Identities=30% Similarity=0.436 Sum_probs=202.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||++++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~ 66 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKDDST---------------AAQAFLAEASVMTTLRHPNLVQLL 66 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe---cCcEEEEEEeccchh---------------HHHHHHHHHHHHHhcCCcceeeeE
Confidence 45788899999999999999986 578999999854321 146788899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+....++||||+++++|.+++.... ...+++..+..++.|++.||.|| |+.+++|+||||+||+++.++.+
T Consensus 67 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~~ 141 (256)
T cd05039 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLVA 141 (256)
T ss_pred EEEcCCCCeEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCCE
Confidence 99998899999999999999999987522 24689999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 574 (633)
+|+|||.++....... ...++..|+|||++.+..++.++||||||+++||+++ |+.||.... ...+...+
T Consensus 142 ~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~ 212 (256)
T cd05039 142 KVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPHV 212 (256)
T ss_pred EEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH
Confidence 9999999987643221 2234678999999988889999999999999999997 999986432 11221211
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.. .... . ........+.+++.+|++.+|++||+++|++++|+++
T Consensus 213 ~~---~~~~-~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 213 EK---GYRM-E---------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred hc---CCCC-C---------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11 1110 0 0011123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.89 Aligned_cols=196 Identities=29% Similarity=0.403 Sum_probs=169.5
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CC-----cc
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HR-----NL 411 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----ni 411 (633)
.|++.+.||+|+||.|.+|.. ..+++.||||+++.... ..++...|+.+|..++ |. |+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d-~~T~e~VAIKIiKN~k~---------------f~~Q~~~Ei~iL~~ln~~d~~~~~n~ 250 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYD-HKTGEIVAIKIIKNKKR---------------FLRQAQIEIRILELLNKHDPDDKYNI 250 (586)
T ss_pred EEEEEEEecccccceeEEEEe-cCCCcEEEEEeeccChH---------------HHHHHHHHHHHHHHHhccCCCCCeeE
Confidence 678899999999999999965 46899999999965432 1566778999999987 43 89
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
|+++++|...+++|||+|.+ .-+|.++++... ...++...+..|+.||+.||..| |+.+|||+||||+|||+.+
T Consensus 251 Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 251 VRMLDYFYFRNHLCIVFELL-STNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLKD 324 (586)
T ss_pred EEeeeccccccceeeeehhh-hhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeecc
Confidence 99999999999999999999 459999998744 35589999999999999999999 7899999999999999975
Q ss_pred C--CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 492 D--MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 492 ~--~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
. ..+||+|||.|+....... ...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 3 4799999999998665432 24568899999999999999999999999999999999766654
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=306.58 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=202.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCC---CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..+|+..+.||+|+||.||+|...... ...+|+|....... .....++.+|+.++++++||||+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~ 72 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------------PKANKEILDEAYVMASVDHPHVV 72 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------------HHHHHHHHHHHHHHHhCCCCCcc
Confidence 467888999999999999999864322 23689998754432 11245788899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.. ...++||||+++|+|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++++
T Consensus 73 ~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~ 145 (279)
T cd05057 73 RLLGICLS-SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTP 145 (279)
T ss_pred eEEEEEec-CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCC
Confidence 99999887 7889999999999999998752 34589999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++...............++..|+|||.+....++.++|+||||+++||+++ |+.||+.... .++.
T Consensus 146 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~ 221 (279)
T cd05057 146 QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIP 221 (279)
T ss_pred CeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHH
Confidence 9999999999987764433222122234678999999988889999999999999999998 9999876422 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+. ....... +......+.+++.+||..+|.+||++.++++.|+++
T Consensus 222 ~~~~---~~~~~~~----------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 222 DLLE---KGERLPQ----------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HHHh---CCCCCCC----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 2222 1111110 000112367888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.34 Aligned_cols=265 Identities=22% Similarity=0.346 Sum_probs=201.8
Q ss_pred CcccccccccccCeeEEEEEec---CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
-|++.+.||+|+||.||++.+. ..++..||+|.+...... .....+.+|++++++++|||++++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~ 71 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------------NHIADLKKEIEILRNLYHENIVKY 71 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-------------HHHHHHHHHHHHHHhCCCCCeeee
Confidence 4678899999999999999753 346889999997543210 114568899999999999999999
Q ss_pred ceeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++... ...++||||+++++|.+++.+. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.+
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~~ 145 (284)
T cd05079 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESE 145 (284)
T ss_pred eeEEecCCCCceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcCC
Confidence 9998775 5678999999999999998642 23589999999999999999999 68899999999999999999
Q ss_pred CceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc-------
Q 006739 493 MEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH------- 564 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~------- 564 (633)
+.++|+|||+++......... ......++..|+|||+..+..++.++||||||+++|||++++.|+......
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~ 225 (284)
T cd05079 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP 225 (284)
T ss_pred CCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc
Confidence 999999999998765433211 112345677899999998888999999999999999999988764321110
Q ss_pred -cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 565 -TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 565 -~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
........++.......... ........+.+++.+|++.+|++|||++++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 226 THGQMTVTRLVRVLEEGKRLP----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccHHHHHHHHHcCccCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 01111111111111111100 0111234588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=307.32 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=196.7
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|+..+.||+|+||+||++... .+++.||+|.+...... .......+.+|++++++++|+|++.+.+++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~ 69 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIK-----------KRKGESMALNEKQILEKVNSQFVVNLAYAY 69 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhh-----------hhhHHHHHHHHHHHHHHcCCcCceeEEEEE
Confidence 667789999999999999875 47889999988442211 011134567899999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
..++..++||||+++++|.+++.... ...+++..+..++.|++.||.|| |+.+|+||||||+||++++++.++|+
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl~ 144 (285)
T cd05632 70 ETKDALCLVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred ecCCEEEEEEEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEEe
Confidence 99999999999999999998886432 34699999999999999999999 78899999999999999999999999
Q ss_pred ccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhh
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 578 (633)
|||++......... ....|+..|+|||++.+..++.++|+|||||++|||++|+.||...... .....+.....
T Consensus 145 Dfg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~---~~~~~~~~~~~ 218 (285)
T cd05632 145 DLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK---VKREEVDRRVL 218 (285)
T ss_pred cCCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhh
Confidence 99998765433221 2346899999999999889999999999999999999999999753221 11111111111
Q ss_pred ccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 579 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
..... . .......+.+++..|++.||++||+ +.+++.
T Consensus 219 ~~~~~---~--------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 219 ETEEV---Y--------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccccc---c--------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11100 0 0111223678888999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=300.20 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=203.0
Q ss_pred cccccccCeeEEEEEecC--CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 343 EKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
+.||+|+||.||+|.... ..+..|++|.+....... ..+++.+|+++++.++|+||+++++++..
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 67 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-------------ERKDFLKEARVMKKLGHPNVVRLLGVCTE 67 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-------------HHHHHHHHHHHHhhcCCCChheeeeeecC
Confidence 479999999999998752 127899999986543211 25678899999999999999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQG-----RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
....++||||+++++|.+++...... ...+++..++.++.|+++||+|| |+.+++|+||||+||++++++.+
T Consensus 68 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~~ 144 (262)
T cd00192 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLVV 144 (262)
T ss_pred CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCcE
Confidence 99999999999999999999864221 36799999999999999999999 78999999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 574 (633)
+|+|||.+................++..|+|||.+....++.++||||+|+++|||++ |+.||.... ...+.+.+
T Consensus 145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~ 220 (262)
T cd00192 145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NEEVLEYL 220 (262)
T ss_pred EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH
Confidence 9999999988765432222334567889999999988889999999999999999999 699987642 12222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
. ...... ........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 221 ~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 R---KGYRLP----------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred H---cCCCCC----------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2 111110 01111334788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=337.38 Aligned_cols=259 Identities=21% Similarity=0.335 Sum_probs=199.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||++... .++..||+|.+....... .....+..|+.++++++|||||++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e------------~~~~~~~~EI~IL~~L~HPNIVrl 77 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKE------------REKSQLVIEVNVMRELKHKNIVRY 77 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCH------------HHHHHHHHHHHHHHHcCCCCcCeE
Confidence 3468999999999999999999875 578899999885433211 124578889999999999999999
Q ss_pred ceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeeCCCCCCCeE
Q 006739 415 LAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISH----NPRIIHRDLKPANVL 488 (633)
Q Consensus 415 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h----~~~ivH~Dikp~Nil 488 (633)
+++|.. ....|+||||+++|+|.+++.........+++..++.|+.||+.||+|||... ..+||||||||+|||
T Consensus 78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 998854 35688999999999999999865444567999999999999999999996432 256999999999999
Q ss_pred ecC-----------------CCceEEcccccccccCCCCCcceecccccCccccccccccc--CCCCCccchHHHHHHHH
Q 006739 489 LDD-----------------DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLA 549 (633)
Q Consensus 489 l~~-----------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~ 549 (633)
++. .+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 964 33489999999987644322 123578999999998854 45889999999999999
Q ss_pred HHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 550 VLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 550 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
||++|+.||..... ....+.......... ... ....+.+++..||+.+|++||++.+++.
T Consensus 235 ELLTGk~PF~~~~~------~~qli~~lk~~p~lp--------i~~---~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 235 ELCSGKTPFHKANN------FSQLISELKRGPDLP--------IKG---KSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHCCCCCCcCCc------HHHHHHHHhcCCCCC--------cCC---CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999999964321 112222221111110 000 1234778999999999999999999983
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.19 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=201.2
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
......|+..+.||+|++|.||+|... .+++.||+|.+...... ....+.+|+.+++.++|+||+
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~v~ 80 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQP--------------KKELIINEILVMRENKNPNIV 80 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEEC-CCCcEEEEEEEecCCcc--------------hHHHHHHHHHHHHhCCCCCEe
Confidence 344568899999999999999999753 57889999988543321 134578899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++......++||||+++++|.+++.. ..+++.++..++.|++.||+|| |+.+|+||||||+||+++.+
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~ 152 (296)
T cd06654 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMD 152 (296)
T ss_pred eEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCC
Confidence 999999999999999999999999999863 3478999999999999999999 78899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.++|+|||++......... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ......
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~---~~~~~~ 227 (296)
T cd06654 153 GSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYL 227 (296)
T ss_pred CCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH---HHhHHH
Confidence 99999999998765433221 1234688999999999988899999999999999999999999865321 111111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.. ..... . .........+.+++.+||..+|++||++.|+++
T Consensus 228 ~~~----~~~~~-~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 228 IAT----NGTPE-L-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred Hhc----CCCCC-C-------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111 11000 0 001112234778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.40 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=160.8
Q ss_pred ccccccccCeeEEEEEec-CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 342 LEKIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
.++||+|+||.||+|+.. ..+++.||+|.+..... ...+.+|++++++++||||+++++++..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------------SMSACREIALLRELKHPNVISLQKVFLS 69 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------------cHHHHHHHHHHHhcCCCCCcceeeeEec
Confidence 468999999999999863 23668899998854321 2346679999999999999999998854
Q ss_pred --CCccEEEEecccCCCHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe----
Q 006739 421 --PDCHLLVYEFMKNGSLQDILNDVSQ-----GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---- 489 (633)
Q Consensus 421 --~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---- 489 (633)
....++||||++ ++|.+++..... ....+++..+..++.||+.||+|| |+.+|+||||||+|||+
T Consensus 70 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~ 145 (317)
T cd07868 70 HADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEG 145 (317)
T ss_pred CCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCC
Confidence 456789999995 588888754221 123589999999999999999999 78899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCc-ceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
+.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 45678999999999876543221 12234578999999999876 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=306.22 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=198.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+.. .+++.||+|++...... ....+++|+.++++++||||+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~ii~~ 71 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGD--------------DFSLIQQEIFMVKECKHCNIVAY 71 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccc--------------hHHHHHHHHHHHHhcCCCCeeee
Confidence 3467999999999999999999864 47889999998543211 13457789999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+++++|.++++. ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.
T Consensus 72 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~ 144 (267)
T cd06646 72 FGSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGD 144 (267)
T ss_pred eEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCC
Confidence 9999999999999999999999999864 34689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||..........
T Consensus 145 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--- 219 (267)
T cd06646 145 VKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--- 219 (267)
T ss_pred EEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---
Confidence 99999999987643221 112346889999999874 4457889999999999999999999986432211100
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.+... ........ ........+.+++.+||+.+|++||+++++++.
T Consensus 220 ~~~~~---~~~~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 220 LMSKS---NFQPPKLK-------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred eeecC---CCCCCCCc-------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00000 00000000 001122357889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.29 Aligned_cols=200 Identities=29% Similarity=0.432 Sum_probs=167.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||++... .+|..||+|++....... .....+.+|+.+++.++||||++++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~ 86 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQ------------THAKRAYRELVLLKCVNHKNIISLL 86 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccch------------hHHHHHHHHHHHHHhCCCCCEeeee
Confidence 478999999999999999999764 578999999986543211 1145677899999999999999999
Q ss_pred eeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++...+ ..|+||||+++ +|.+.++ ..+++..+..++.|+++||+|| |+.+|+||||||+||++
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~ 156 (359)
T cd07876 87 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVV 156 (359)
T ss_pred eeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEE
Confidence 9886543 46899999965 6666654 2378889999999999999999 78899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 157 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 157 KSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999976543221 13356899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=303.30 Aligned_cols=252 Identities=25% Similarity=0.400 Sum_probs=199.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.+|+..+.||+|+||.||++.+. ++..+|+|.+...... ..++.+|++++++++|||++++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAMS---------------EEDFIEEAQVMMKLSHPKLVQLYG 66 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCCC---------------HHHHHHHHHHHHhCCCCCeeeEEE
Confidence 46788899999999999999874 5778999988643321 245788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++......++||||+++++|.+++... ...+++..+..++.+++.|++|| |+.+++|+||||+||+++.++.++
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~ 140 (256)
T cd05112 67 VCTERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVK 140 (256)
T ss_pred EEccCCceEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEE
Confidence 999999999999999999999998742 24578999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||.++........ ......++.+|+|||+..+..++.++||||||+++|||++ |+.||..... ..+.+.+
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~- 214 (256)
T cd05112 141 VSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVVETI- 214 (256)
T ss_pred ECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHH-
Confidence 9999998866443221 1122335678999999998889999999999999999998 9999865321 1222211
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
...... ..+.. ....+.+++.+||+.+|++||++.|+++.|.
T Consensus 215 --~~~~~~---~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 215 --NAGFRL---YKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --hCCCCC---CCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111111 00110 1234888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.83 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=199.3
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|+||.||+|... +++.+|+|.+........ ...+....+.+|++++++++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVL--------AAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchh--------hHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 4678899999999999999764 788999998765432111 111224678999999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++++|.+++.+ ...+++..+..++.|++.||+|| |+.+|+|+||+|+||++++++.++|
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~l 143 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIKL 143 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEEe
Confidence 9999999999999999999999975 24578999999999999999999 6788999999999999999999999
Q ss_pred cccccccccCCCCCc----ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 498 ADFGLAKAMPDAQTH----ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
+|||++......... .......|+..|+|||++.+..++.++||||||+++|||++|+.||...... .....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~- 219 (265)
T cd06631 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---AAMFY- 219 (265)
T ss_pred ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---HHHHH-
Confidence 999998765321111 1112346899999999999888999999999999999999999998653211 11100
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ...... .+ .......+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~--~~~~~~-----~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGA--HRGLMP-----RL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhh--ccCCCC-----CC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 100 000000 01 1112234788899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.11 Aligned_cols=245 Identities=26% Similarity=0.323 Sum_probs=188.3
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHH-HhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN-TVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+++.. .+|+.||+|++..... .......++..|.. +++.++||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~ 68 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIV-----------LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT 68 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC
Confidence 46899999999999864 5789999999853211 01111334455544 46778999999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|..++.. ...+++..+..++.||++||+|| |+.+|+||||||+||++++++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~DfG 141 (325)
T cd05604 69 EKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDFG 141 (325)
T ss_pred CEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeecC
Confidence 999999999999999988864 35689999999999999999999 68899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . +..+......
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~---~~~~~~~~~~ 212 (325)
T cd05604 142 LCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV----A---EMYDNILHKP 212 (325)
T ss_pred CcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH----H---HHHHHHHcCC
Confidence 9875432211 12345799999999999999999999999999999999999999865321 1 1122222111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. +. .. ....+.+++.+|++.+|.+||++.+.++
T Consensus 213 ~~---~~----~~----~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 213 LV---LR----PG----ASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred cc---CC----CC----CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 10 00 01 1223678889999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=304.56 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=193.6
Q ss_pred cccccccCeeEEEEEecCCCCe--EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccceeee
Q 006739 343 EKIGSGGCGEVYKAELPGSNGK--MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMA 419 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 419 (633)
+.||+|+||.||+|.... ++. .+++|.+...... ...+.+.+|++++.++ +||||+++++++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 66 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK-------------DDHRDFAGELEVLCKLGHHPNIINLLGACE 66 (270)
T ss_pred CcCCCCCCceEEEEEEcC-CCCeeEEEEEEccccCCH-------------HHHHHHHHHHHHHHhhccCCCeeeEEEEEe
Confidence 468999999999998753 443 4688877532210 1145678899999999 7999999999999
Q ss_pred cCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 420 RPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 420 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
.....++||||+++|+|.+++..... ....+++..+..++.|++.||+|| |+.+++||||||+||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~ni 143 (270)
T cd05047 67 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNI 143 (270)
T ss_pred cCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccceE
Confidence 99999999999999999999975321 123578999999999999999999 678999999999999
Q ss_pred EecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccc
Q 006739 488 LLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTE 566 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~ 566 (633)
++++++.+|++|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||.....
T Consensus 144 li~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--- 217 (270)
T cd05047 144 LVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--- 217 (270)
T ss_pred EEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---
Confidence 9999999999999998632211 11111234667999999988889999999999999999997 9999865321
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
... ............ .......+.+++.+|++.+|.+|||+.++++.|+++-
T Consensus 218 -~~~---~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 218 -AEL---YEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -HHH---HHHHhCCCCCCC----------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 111111111110 0111234789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=303.06 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=201.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||++... ++..+|+|.+..... ....+.+|++++++++|+||+++.
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~ 67 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSM---------------SVEAFLAEANVMKTLQHDKLVKLH 67 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec--CCccEEEEecCCChh---------------HHHHHHHHHHHHHhcCCCCcceEE
Confidence 467899999999999999999864 567799998753211 135688899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+ ...+++|||+++++|.+++.... ...+++..+..++.|++.||+|| |+.+++|+||||+||+++.++.+
T Consensus 68 ~~~~~-~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~~~ 141 (260)
T cd05073 68 AVVTK-EPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVC 141 (260)
T ss_pred EEEcC-CCeEEEEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcE
Confidence 99887 77899999999999999997532 35688999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||.+......... ......++..|+|||++....++.++|+|||||++|++++ |+.||.... ......++
T Consensus 142 ~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~----~~~~~~~~ 216 (260)
T cd05073 142 KIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS----NPEVIRAL 216 (260)
T ss_pred EECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC----HHHHHHHH
Confidence 99999999866543221 1122345678999999998889999999999999999999 899986532 12222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.. ..... ........+.+++.+|++.+|++||++.++.++|+.+
T Consensus 217 ~~---~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 217 ER---GYRMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred hC---CCCCC----------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 11 11110 0111223478899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=300.44 Aligned_cols=252 Identities=18% Similarity=0.314 Sum_probs=200.2
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||+|+||.||++... .+++.+|+|.+...... ...+.+.+|+.+++.++|+||+++++.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 66 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSS-------------SAVEDSRKEAVLLAKMKHPNIVAFKES 66 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcch-------------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4778899999999999999864 57889999988543211 114567789999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++||||+++++|.+++.... ...++......++.|++.||.|| |+.+|+|+||||+||++++++.+++
T Consensus 67 ~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~l 141 (255)
T cd08219 67 FEADGHLYIVMEYCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVKL 141 (255)
T ss_pred EEECCEEEEEEeeCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEEE
Confidence 999999999999999999999886422 35578999999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||.+......... .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||..... . ......
T Consensus 142 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~---~~~~~~ 212 (255)
T cd08219 142 GDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----K---NLILKV 212 (255)
T ss_pred cccCcceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----H---HHHHHH
Confidence 999998866543221 1235689999999999988899999999999999999999999864211 1 111111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
....... + .......+.+++.+||+.||++||++.|++..
T Consensus 213 ~~~~~~~--~--------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 213 CQGSYKP--L--------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hcCCCCC--C--------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111110 0 01112237788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.43 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=197.0
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|++.+.||+|+||.||+++.. .+++.||+|++..... ........+.+|+.+++.++||||++
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~-----------~~~~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEM-----------IKRSDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHh-----------hhhHHHHHHHHHHHHHHhCCCCCCCe
Confidence 44589999999999999999999875 5788999999743110 11112455788999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..++||||+++|+|.+++.. ..++...+..++.||+.||+|| |+.+|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCC
Confidence 99999999999999999999999999864 3478888999999999999999 788999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccC----CCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL----KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 180 ~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------ 252 (371)
T cd05622 180 HLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------ 252 (371)
T ss_pred CEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------
Confidence 9999999999876543222 12345799999999998754 378899999999999999999999975321
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCC--CCCHHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE--RPNSKDVRCM 627 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~ev~~~ 627 (633)
......+..........+ .......+.+++..|++.++.+ ||+++|+++.
T Consensus 253 -~~~~~~i~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 253 -VGTYSKIMNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -HHHHHHHHcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111122221111110000 0011233677888899844443 7888888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.41 Aligned_cols=267 Identities=24% Similarity=0.383 Sum_probs=205.5
Q ss_pred cCcccccccccccCeeEEEEEec---CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
..|+..+.||+|+||.||++.+. ..++..||+|.+...... ...+++.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------------~~~~~~~~ei~~l~~l~~~~i~~ 70 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------------QHRSDFEREIEILRTLDHENIVK 70 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------------HHHHHHHHHHHHHHhCCCCChhe
Confidence 46778899999999999999864 235789999998654321 12567899999999999999999
Q ss_pred cceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 414 LLAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 414 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++.. ....++||||+++++|.+++... ...+++..+..++.|++.||+|| |+.+++|+||||+||+++.
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~~ 144 (284)
T cd05038 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVES 144 (284)
T ss_pred EEeeeecCCCCceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcC
Confidence 9999877 55789999999999999999753 23589999999999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccccc---
Q 006739 492 DMEARIADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE--- 567 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~--- 567 (633)
++.++|+|||.+........... .....++..|+|||...+..++.++||||||+++|||++|+.|+.........
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 224 (284)
T cd05038 145 EDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG 224 (284)
T ss_pred CCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc
Confidence 99999999999987764322211 11234566799999998889999999999999999999999997643221100
Q ss_pred -----chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 568 -----MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 568 -----~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.....+........... ........+.+++.+||+.+|++|||+.|++++|+.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 225 IAQGQMIVTRLLELLKEGERLP----------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cccccccHHHHHHHHHcCCcCC----------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 01111111111111110 01112245888999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=305.78 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=197.0
Q ss_pred cccccccCeeEEEEEecC-----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 343 EKIGSGGCGEVYKAELPG-----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+.||+|+||.||+|+... .++..+|+|.+..... .....++.+|+++++.++||||++++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------------DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-------------hhhHHHHHHHHHHHHhcCCCCeeeEeee
Confidence 468999999999998642 2336899998743221 0114568889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC-
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQ---GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM- 493 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~- 493 (633)
+...+..++||||+++++|.+++..... ....+++..+..++.|+++||+|| |+.+++|+||||+||+++.++
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~ 144 (269)
T cd05044 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKGY 144 (269)
T ss_pred ecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCCC
Confidence 9999999999999999999999975332 224578999999999999999999 678899999999999999877
Q ss_pred ----ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccc
Q 006739 494 ----EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEM 568 (633)
Q Consensus 494 ----~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~ 568 (633)
.++++|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~ 220 (269)
T cd05044 145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----Q 220 (269)
T ss_pred CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----H
Confidence 899999999986654332222223345788999999999999999999999999999998 9999864321 1
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
.....+. ...... ........+.+++.+||+.+|.+||++++++++|++
T Consensus 221 ~~~~~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 221 EVLQHVT---AGGRLQ----------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHHh---cCCccC----------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2222221 111110 011122347789999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=310.85 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=200.9
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCe----EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
+.++|+..+.||+|+||.||+|.+.. +|. .||+|.+...... ....++.+|+.+++.++|||
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~n 70 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTGP-------------KANVEFMDEALIMASMDHPH 70 (303)
T ss_pred chhhceeccccccCCCccEEEEEEec-CCCcceeeEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCC
Confidence 34678889999999999999998643 343 5788887533210 11346788999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
|+++++++... ..++++||+++|+|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++
T Consensus 71 iv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~ 143 (303)
T cd05110 71 LVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVK 143 (303)
T ss_pred cccEEEEEcCC-CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeec
Confidence 99999998754 467999999999999998742 34588999999999999999999 788999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccch
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMS 569 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 569 (633)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.... ...
T Consensus 144 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~ 219 (303)
T cd05110 144 SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----TRE 219 (303)
T ss_pred CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHH
Confidence 999999999999987654332222223445778999999998899999999999999999997 899986532 122
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..+++.. ...... .......+.+++..||..+|++||+++++++.|+++.
T Consensus 220 ~~~~~~~---~~~~~~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 220 IPDLLEK---GERLPQ----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHC---CCCCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2233221 111110 0011234778899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=328.56 Aligned_cols=260 Identities=20% Similarity=0.252 Sum_probs=186.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC------CC
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI------RH 408 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h 408 (633)
...+|++.+.||+|+||.||+|... .+++.||||++...... .+++..|+++++.+ .|
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~~~---------------~~~~~~e~~~l~~l~~~~~~~~ 190 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVPKY---------------TRDAKIEIQFMEKVRQADPADR 190 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecchhh---------------HHHHHHHHHHHHHHhhcCcccC
Confidence 3578999999999999999999864 46889999998532210 12233344444444 45
Q ss_pred CcccccceeeecC-CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 409 RNLLPLLAHMARP-DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 409 ~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
.+++++++++... ...++|||++ +++|.+++.+ ...+++..+..|+.||+.||+||| ++.+|+||||||+||
T Consensus 191 ~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH--~~~gIiHrDlKP~NI 263 (467)
T PTZ00284 191 FPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENI 263 (467)
T ss_pred cceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH--hcCCeecCCCCHHHE
Confidence 6688999988764 4678999998 7789888865 346899999999999999999994 236999999999999
Q ss_pred EecCCC----------------ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHH
Q 006739 488 LLDDDM----------------EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVL 551 (633)
Q Consensus 488 ll~~~~----------------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el 551 (633)
|++.++ .+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 998765 4999999987643221 2346799999999999999999999999999999999
Q ss_pred HhCCCCCcccccccccchHHHHHHHhhccCC---------------------cchhhhhhh----hhcC-C--HHHHHHH
Q 006739 552 VMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN---------------------PTRAIDAKL----LENG-Y--EEQMLLV 603 (633)
Q Consensus 552 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~d~~~----~~~~-~--~~~~~~~ 603 (633)
++|+.||+.... ......+........ .....++.. .... . ......+
T Consensus 339 ltG~~pf~~~~~----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (467)
T PTZ00284 339 YTGKLLYDTHDN----LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414 (467)
T ss_pred HhCCCCCCCCCh----HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHH
Confidence 999999975322 111111111111000 000000000 0000 0 0012357
Q ss_pred HHHHhHhccCCCCCCCCHHHHHH
Q 006739 604 LKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 604 ~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+|+.+||+.||++|||++|+++
T Consensus 415 ~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 415 CDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHHHhCCcChhhCCCHHHHhc
Confidence 79999999999999999999986
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=314.00 Aligned_cols=205 Identities=26% Similarity=0.373 Sum_probs=172.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+++.. .+++.||+|++.+.. .......+.+.+|..++..++|+||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~-----------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWE-----------MLKRAETACFREERDVLVNGDRRWITNLHY 68 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHH-----------HhhhhhHHHHHHHHHHHHhCCCCCCCceEE
Confidence 46889999999999999999875 468899999984211 111122456888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..++||||+++|+|.+++.+. ...+++..+..++.||+.||+|| |+++|+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 69 AFQDENNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred EEecCCeEEEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEE
Confidence 999999999999999999999999642 34688999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
|+|||++.......... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||..
T Consensus 143 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 143 LADFGSCLRLLADGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EEECCceeecCCCCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 99999987665433221 123468999999999863 4578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.98 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=190.8
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccce
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLA 416 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~ 416 (633)
+|+..+.||+|+||.||+|... .+|+.||+|++.+... ......+.+..|..++..+. |++|+++.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVV-----------IQDDDVECTMVEKRVLALQDKPPFLTQLHS 68 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhccCCCchhheee
Confidence 3677899999999999999864 5789999999853210 01112455677888888775 577888999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+|
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ik 141 (323)
T cd05615 69 CFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEE
Confidence 99999999999999999999998865 34589999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....+.+
T Consensus 142 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i-- 213 (323)
T cd05615 142 IADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELFQSI-- 213 (323)
T ss_pred EeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHH--
Confidence 999999875433221 12345689999999999998999999999999999999999999975321 1222211
Q ss_pred hhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 577 VMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 577 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
.... .... .....+.+++.+|++.+|.+|++.
T Consensus 214 -~~~~~~~p~------------~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 214 -MEHNVSYPK------------SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -HhCCCCCCc------------cCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111 1111 112236788899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.91 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=201.1
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|.+.+.||+|++|.||+|... .+++.||+|.+......... .....+..+.+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASS-----KDRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred ccccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccch-----hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 667789999999999999864 46889999988665432211 111222356788999999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
...+..++||||+++++|.+++.. ...+++..+..++.|++.||+|| |+.+++||||+|+||++++++.++|+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEec
Confidence 999999999999999999999975 34588899999999999999999 67899999999999999999999999
Q ss_pred ccccccccCCCCCcc----eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 499 DFGLAKAMPDAQTHI----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 499 DfG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
|||.++......... ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||..... ... +
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~----~ 221 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQA----I 221 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHH----H
Confidence 999988765322111 11234588999999999988899999999999999999999999875321 111 1
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ +.. .......+.+++.+||+.||++||++.|+++
T Consensus 222 ~~~~~~~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 FKIGENAS------PEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHhccCC------CcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111100 001 1112234778889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.80 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=209.3
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.....+....++||-|.||.||.|.|++ -.-.||||.++...+ ...+|..|..+|+.++|||+|
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKk-yslTvAVKtLKEDtM---------------eveEFLkEAAvMKeikHpNLV 326 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLV 326 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeec-cceeeehhhhhhcch---------------hHHHHHHHHHHHHhhcCccHH
Confidence 4445667788999999999999999974 467799998854332 167899999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+++|+|..+...|||+|||..|+|-++|++.. +..++....+.+|.||+.||+|| ..+.+|||||..+|.|+.++
T Consensus 327 qLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVgEn 401 (1157)
T KOG4278|consen 327 QLLGVCTHEPPFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGEN 401 (1157)
T ss_pred HHhhhhccCCCeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhcccccc
Confidence 99999999999999999999999999998754 35577777889999999999999 88899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
..+||+|||+++++..+.. .......-...|.|||.+....++.|+|||+|||+|||+.| |--||.+..- .++.
T Consensus 402 hiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----SqVY 476 (1157)
T KOG4278|consen 402 HIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVY 476 (1157)
T ss_pred ceEEeeccchhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HHHH
Confidence 9999999999999876432 11112223668999999999999999999999999999998 7778765422 1111
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
..+. .+.+ -+.++.+...++++++.||+++|.+||++.|+-+.|+.+
T Consensus 477 ~LLE---kgyR----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 477 GLLE---KGYR----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHh---cccc----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1111 1111 112223344588899999999999999999999998765
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.96 Aligned_cols=259 Identities=23% Similarity=0.327 Sum_probs=198.6
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNL 411 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni 411 (633)
....++|++.+.||+|+||.||++... .+++.+|+|++..... ...++.+|+.+++++ +||||
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~---------------~~~~~~~e~~~l~~l~~h~~i 77 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPIHD---------------IDEEIEAEYNILKALSDHPNV 77 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEEC-CCCceeEEEeeccccc---------------hHHHHHHHHHHHHHHhcCCCe
Confidence 456789999999999999999999865 4688999998743211 024567888999998 69999
Q ss_pred cccceeee-----cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 412 LPLLAHMA-----RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 412 v~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
+++++++. ..+..++||||+++++|.++++........+++..+..++.|+++||.|| |+.+|+||||||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~n 154 (286)
T cd06638 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNN 154 (286)
T ss_pred eeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHh
Confidence 99999874 34568999999999999998875433456789999999999999999999 67899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCccccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
|++++++.++|+|||+++........ .....|+..|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 155 ILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEECCCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999998876443221 123468999999998753 45788999999999999999999998653
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
... ..+.+. ... ......++ .. ....+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~---~~~~~~----~~~-~~~~~~~~----~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 233 HPM---RALFKI----PRN-PPPTLHQP----EL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred chh---HHHhhc----ccc-CCCcccCC----CC---cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 211 111111 011 00111111 11 12247789999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.85 Aligned_cols=269 Identities=22% Similarity=0.321 Sum_probs=196.0
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||+|++|.||+|+.. .++..||+|++.....+. ...+.+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEE------------GVPSTAIREISLLKELQHPNIVCLQDV 67 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccC------------CchHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 4778899999999999999864 568899999885432211 113467789999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+++..++||||++ ++|.+++..... +..+++..+..++.|+++||+|| |+.+|+|+||||+||++++++.++|
T Consensus 68 ~~~~~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l 142 (285)
T cd07861 68 LMQESRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKL 142 (285)
T ss_pred EeeCCeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEE
Confidence 999999999999997 689888865332 35689999999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd07861 143 ADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT 220 (285)
T ss_pred CcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999876543221 1123457889999998765 45788999999999999999999998753221111111000000
Q ss_pred hhccCC--cchhhh--hhh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSEN--PTRAID--AKL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~--~~~~~d--~~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+ .....+ ... ...........+.+++.+||+.||++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 221 PTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000000 000 00000011234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.83 Aligned_cols=254 Identities=24% Similarity=0.374 Sum_probs=195.9
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLL 412 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 412 (633)
++...|+..+.||+|+||.||+|... .+++.||+|.+...... ...+.+|+.++.++ +|+||+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~---------------~~~~~~e~~~l~~~~~h~~i~ 66 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTGDE---------------EEEIKQEINMLKKYSHHRNIA 66 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcCCcc---------------HHHHHHHHHHHHHhcCCCCee
Confidence 34567889999999999999999864 57889999998543211 34567888899888 699999
Q ss_pred ccceeeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 413 PLLAHMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 413 ~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
++++++... ...++||||+++++|.+++.... ...+++..+..++.|++.||+|| |+.+|+|+||||+|
T Consensus 67 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~dl~~~n 141 (272)
T cd06637 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQN 141 (272)
T ss_pred eEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHH
Confidence 999998653 45789999999999999987532 35689999999999999999999 67899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
|++++++.++|+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 142 ili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 142 VLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred EEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999999999999886543221 123456899999999886 345788999999999999999999998653
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ..... ..... ..... ... ....+.+++.+||+.+|.+|||+.|+++
T Consensus 220 ~~~------~~~~~-~~~~~-~~~~~-----~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 220 HPM------RALFL-IPRNP-APRLK-----SKK---WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CHH------HHHHH-HhcCC-CCCCC-----CCC---cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 211 11111 00110 00000 111 1234788999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.52 Aligned_cols=259 Identities=21% Similarity=0.332 Sum_probs=201.8
Q ss_pred hcCcccccccccccCeeEEEEEecCC--CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+|.+... +...||+|........ +..+.+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~h~~i~~ 71 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-------------SVREKFLQEAYIMRQFDHPHIVK 71 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-------------HHHHHHHHHHHHHHhCCCCchhc
Confidence 45688899999999999999986422 2346899987543310 11457888999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+ ...++||||+++|+|.+++... ...+++..+..++.+++.||+|| |+.+++||||||+||+++.++
T Consensus 72 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~ 144 (270)
T cd05056 72 LIGVITE-NPVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPD 144 (270)
T ss_pred eeEEEcC-CCcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCC
Confidence 9998875 4578999999999999999752 34589999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
.++++|||+++.......... ....++..|+|||.+....++.++||||||+++||+++ |..||..... .....
T Consensus 145 ~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~ 219 (270)
T cd05056 145 CVKLGDFGLSRYLEDESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN----NDVIG 219 (270)
T ss_pred CeEEccCceeeecccccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHH
Confidence 999999999987655432222 22335678999999988889999999999999999996 9999865422 11212
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.+. ...... . .......+.+++.+|+..+|++|||+.++++.|++++
T Consensus 220 ~~~---~~~~~~------~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 220 RIE---NGERLP------M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred HHH---cCCcCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 221 111111 0 1111234788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.12 Aligned_cols=261 Identities=22% Similarity=0.359 Sum_probs=199.7
Q ss_pred cccccccccccCeeEEEEEecC--CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 339 LASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
|.+.+.||+|+||.||+|.+.. .++..||+|++....... ...+++.+|++++++++||||+++++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~ 68 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS------------SDIEEFLREAACMKEFDHPNVIKLIG 68 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh------------HHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 5667899999999999998643 346899999985433211 11456888999999999999999999
Q ss_pred eeecCC------ccEEEEecccCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 417 HMARPD------CHLLVYEFMKNGSLQDILNDVSQ--GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 417 ~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
++...+ ..++++||+++|+|.+++..... ....+++.....++.|++.||+|| |+.+|+||||||+||+
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~nil 145 (273)
T cd05074 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCM 145 (273)
T ss_pred EEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhEE
Confidence 886532 23689999999999988764322 123578999999999999999999 6789999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEE 567 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 567 (633)
+++++.+|++|||+++...............++..|++||...+..++.++|||||||++|||++ |+.||.....
T Consensus 146 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05074 146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---- 221 (273)
T ss_pred EcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----
Confidence 99999999999999987654332222223345678999999988889999999999999999999 8888765322
Q ss_pred chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.....++. ....... .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 222 ~~~~~~~~---~~~~~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 222 SEIYNYLI---KGNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHHH---cCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22222221 1111110 011223588899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.74 Aligned_cols=254 Identities=27% Similarity=0.379 Sum_probs=191.8
Q ss_pred cccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeee-
Q 006739 343 EKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA- 419 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~- 419 (633)
+.||+|+||.||+|... ..++..||+|.+..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 67 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-------------LEEVEQFLKEGIIMKDFSHPNVLSLLGICLP 67 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-------------HHHHHHHHHHHHHHccCCCCCcceEEEEeec
Confidence 46899999999999863 23456899998743221 011456788999999999999999999775
Q ss_pred cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcc
Q 006739 420 RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIAD 499 (633)
Q Consensus 420 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~D 499 (633)
.++..++||||+.+|+|.+++... ....++..+..++.|+++||+|| |+.+|+||||||+||++++++.+||+|
T Consensus 68 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~d 141 (262)
T cd05058 68 SEGSPLVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVAD 141 (262)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEECC
Confidence 455678999999999999998752 23467788899999999999999 678999999999999999999999999
Q ss_pred cccccccCCCCCcc--eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCC-CCCcccccccccchHHHHHHH
Q 006739 500 FGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR-LPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 500 fG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~ 576 (633)
||+++......... ......++..|+|||...+..++.++|||||||++|||++|+ .||... ...... ..
T Consensus 142 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~----~~~~~~---~~ 214 (262)
T cd05058 142 FGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----DSFDIT---VY 214 (262)
T ss_pred ccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC----CHHHHH---HH
Confidence 99998654322111 112234677899999998889999999999999999999964 455432 111222 22
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
......... .......+.+++..||+.+|++||++.|+++.|+++.
T Consensus 215 ~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 215 LLQGRRLLQ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HhcCCCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 222111110 0011234788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=307.69 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=200.4
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNL 411 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni 411 (633)
......|+++++||+||.+.||++.. .+.+.||+|++.....+ +.....|..|+..|.+++ |.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~--s~~~iyalkkv~~~~~D------------~qtl~gy~nEI~lL~KLkg~~~I 422 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLN--SDKQIYALKKVVLLEAD------------NQTLDGYRNEIALLNKLKGHDKI 422 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeec--CCCcchhhhHHHHhhcC------------HHHHHHHHHHHHHHHHhcCCceE
Confidence 34567899999999999999999964 46688898887433322 223678999999999996 9999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
|.+++|-..++.+|+||||- +.+|..+|.+.. .....| .++.+..|++.++.++ |..||||.||||.|+|+-+
T Consensus 423 IqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 423 IQLYDYEVTDGYLYMVMECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred EEEeeeeccCceEEEEeecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEEe
Confidence 99999999999999999987 559999998633 223334 7888999999999999 7889999999999999986
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCC-----------CCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-----------FTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
|.+||+|||+|..+..+.+.......+||+.||+||.+.... .+.++||||+||++|+|+.|+.||..
T Consensus 496 -G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 496 -GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred -eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 589999999999998877666667789999999999875422 56789999999999999999999976
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ....-+..+.... .++--+.+ . ....++++++.||.+||++||++.|+++
T Consensus 575 ~~------n~~aKl~aI~~P~--~~Iefp~~-~-----~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 575 II------NQIAKLHAITDPN--HEIEFPDI-P-----ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HH------HHHHHHHhhcCCC--ccccccCC-C-----CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 32 1111122222111 00001111 0 1112788999999999999999999985
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=297.94 Aligned_cols=242 Identities=18% Similarity=0.278 Sum_probs=185.7
Q ss_pred cccccccCeeEEEEEecCC-----------CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 343 EKIGSGGCGEVYKAELPGS-----------NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
+.||+|+||.||+|.+..+ ....|++|.+..... .....+.+|+.+++.++||||
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------------~~~~~~~~~~~~l~~l~hp~i 66 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--------------DISLAFFETASMMRQVSHKHI 66 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--------------hHHHHHHHHHHHHHhCCCCCE
Confidence 4689999999999986322 223588887643211 114567889999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++++......++||||+++|+|..++... ...+++..+..++.||++||+|| |+++|+||||||+||+++.
T Consensus 67 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~ 140 (262)
T cd05077 67 VLLYGVCVRDVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLAR 140 (262)
T ss_pred eeEEEEEecCCCCEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEec
Confidence 99999999999999999999999999887642 34589999999999999999999 7899999999999999987
Q ss_pred CCc-------eEEcccccccccCCCCCcceecccccCcccccccccc-cCCCCCccchHHHHHHHHHHH-hCCCCCcccc
Q 006739 492 DME-------ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-TLKFTDKCDIYSFGVLLAVLV-MGRLPSDDFF 562 (633)
Q Consensus 492 ~~~-------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~ell-tg~~p~~~~~ 562 (633)
++. ++++|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+....
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 654 899999998754322 2345788999999886 466889999999999999998 5888875421
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
. ...... ...... . .......+.+++.+||+.||++||++.++++.++
T Consensus 215 ~----~~~~~~----~~~~~~--~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 215 L----AEKERF----YEGQCM--L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h----hHHHHH----HhcCcc--C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1 111111 011000 0 0011234788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.15 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=195.0
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|+..+.||+|+||.||++... ..++.||+|++....... .....+.+|+.+++.++||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~ 81 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEec-CCCceEEEEEeCCcccCh------------HHHHHHHHHHHHHHHhCCCchhce
Confidence 3478999999999999999999753 578899999986543211 113566789999999999999999
Q ss_pred ceeeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 415 LAHMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 415 ~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
++++... ...++||||+++ ++.+.+. ..+++..+..++.|+++||+|| |+.+|+||||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nil 151 (355)
T cd07874 82 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIV 151 (355)
T ss_pred eeeeeccccccccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEE
Confidence 9988543 346899999965 6766664 2478889999999999999999 7889999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
++.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 152 l~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--- 225 (355)
T cd07874 152 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--- 225 (355)
T ss_pred ECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 99999999999999986544321 133568999999999999899999999999999999999999997532111
Q ss_pred hHHHHHHHh------------------hcc-CCcchhhhhhh-----h---hcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 569 SLVKWMRNV------------------MTS-ENPTRAIDAKL-----L---ENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 569 ~~~~~~~~~------------------~~~-~~~~~~~d~~~-----~---~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
...+.+... ... ........+.. . ..........+.+++.+|++.||++|||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~ 305 (355)
T cd07874 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_pred HHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH
Confidence 111111100 000 00000000000 0 00011122457899999999999999999
Q ss_pred HHHHH
Q 006739 622 KDVRC 626 (633)
Q Consensus 622 ~ev~~ 626 (633)
.|+++
T Consensus 306 ~ell~ 310 (355)
T cd07874 306 DEALQ 310 (355)
T ss_pred HHHhc
Confidence 99986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=300.32 Aligned_cols=241 Identities=17% Similarity=0.262 Sum_probs=184.3
Q ss_pred ccccccCeeEEEEEecC-----------------------CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHH
Q 006739 344 KIGSGGCGEVYKAELPG-----------------------SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~~-----------------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~ 400 (633)
.||+|+||.||+|.+.. ..+..||+|.+.... .....++.+|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------------~~~~~~~~~~~ 67 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--------------RDIALAFFETA 67 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--------------HHHHHHHHHHH
Confidence 68999999999997531 112458888873211 11135678889
Q ss_pred HHhhcCCCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 401 ~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
.++++++||||+++++++.+....++||||+++|+|..++... ...+++..+..++.|+++||+|| |+++|+||
T Consensus 68 ~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~ 141 (274)
T cd05076 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYL---EDKNLVHG 141 (274)
T ss_pred HHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HcCCccCC
Confidence 9999999999999999999999999999999999999988642 34688999999999999999999 78899999
Q ss_pred CCCCCCeEecCCC-------ceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHH
Q 006739 481 DLKPANVLLDDDM-------EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLV 552 (633)
Q Consensus 481 Dikp~Nill~~~~-------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~ell 552 (633)
||||+||++++.+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||+
T Consensus 142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred CCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999998643 3799999987654322 12357888999998865 56889999999999999995
Q ss_pred -hCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 553 -MGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 553 -tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
+|+.||...... ....+... ...... .. ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 216 ~~g~~p~~~~~~~----~~~~~~~~---~~~~~~--------~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 216 FDGEVPLKERTPS----EKERFYEK---KHRLPE--------PS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hCCCCCccccChH----HHHHHHHh---ccCCCC--------CC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 699998653221 11111111 011110 01 123788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=303.60 Aligned_cols=255 Identities=22% Similarity=0.372 Sum_probs=198.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++... .++..||+|.+..... .....++.+|+.++++++|+||+++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~-------------~~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELD-------------ESKFNQIIMELDILHKAVSPYIVDFYG 66 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccC-------------HHHHHHHHHHHHHHHhcCCCcHHhhhh
Confidence 36788999999999999999875 4689999998753221 011456888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.+...+..++||||+++++|.+++.... ....+++..+..++.|+++||.||| ++.+|+|+||||+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~ 143 (286)
T cd06622 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVK 143 (286)
T ss_pred heecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999887532 2346899999999999999999995 346899999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCC------CCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK------FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
|+|||++........ ....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||..... ...
T Consensus 144 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~ 215 (286)
T cd06622 144 LCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANI 215 (286)
T ss_pred EeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhH
Confidence 999999876543321 2345788999999885543 47899999999999999999999864321 111
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+......... .........+.+++.+||+.+|++||++.+++.
T Consensus 216 ~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 216 FAQLSAIVDGDPP----------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHhhcCCC----------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111111111111 011122334778899999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.36 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=199.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+.|+..+.||+|+||.||+|... .++..||+|.+...... ...+.+.+|+.++++++||||+++++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYITRYYG 69 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccch-------------HHHHHHHHHHHHHHcCCCCccHhhhc
Confidence 45777899999999999999764 46889999987533211 12457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++..+...++||||+++++|.+++.. ..+++..+..++.|+++|+.|| |+.+++|+||+|+||++++++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~ 141 (277)
T cd06642 70 SYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred ccccCCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEE
Confidence 99999999999999999999998853 4588999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
++|||++........ ......|+..|+|||++.+..++.++|||||||++|||++|+.|+...... .....+
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~-- 213 (277)
T cd06642 142 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLFLI-- 213 (277)
T ss_pred EccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHhhh--
Confidence 999999876654321 112346889999999999988999999999999999999999998653221 111111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... .. .+ .......+.+++.+||+.+|++||++.++++
T Consensus 214 -~~~~-~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 214 -PKNS-PP-----TL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -hcCC-CC-----CC----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111 00 00 1112344788999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=300.55 Aligned_cols=261 Identities=22% Similarity=0.402 Sum_probs=201.7
Q ss_pred cCcccccccccccCeeEEEEEecCC----CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
++|+..+.||+|+||.||+|+.... +.+.|++|.+...... .....+.+|++++++++|+||+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv 71 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-------------NLQSEFRRELDMFRKLSHKNVV 71 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-------------HHHHHHHHHHHHHHhcCCccee
Confidence 5788899999999999999986422 3567999987443210 1145788999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-----RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
++++++.+.+..++||||+++|+|.+++....... ..+++..+..++.|+++||+|| |+.+|+||||||+||
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~Ni 148 (275)
T cd05046 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNC 148 (275)
T ss_pred eeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccceE
Confidence 99999999899999999999999999997543211 2689999999999999999999 788999999999999
Q ss_pred EecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccc
Q 006739 488 LLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTE 566 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~ 566 (633)
+++.++.++++|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 149 li~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--- 224 (275)
T cd05046 149 LVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--- 224 (275)
T ss_pred EEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---
Confidence 9999999999999998754332211 1123356778999999988888999999999999999999 7888854321
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
......... .. ..... .......+.+++.+||+.+|++||++.|+++.|++
T Consensus 225 -~~~~~~~~~---~~-~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 225 -EEVLNRLQA---GK-LELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -HHHHHHHHc---CC-cCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 122222211 11 00000 00112347889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.55 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=196.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+-|++.+.||+|+||.||++... .++..+++|.+..... +..+.+.+|+++++.++|||++++++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ii~~~~ 69 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSE--------------EELEDYMVEIDILASCDHPNIVKLLD 69 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCH--------------HHHHHHHHHHHHHHHCCCCCeeeEEE
Confidence 34678899999999999999875 4678899998744321 11456788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++......++||||+++++|..++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+|
T Consensus 70 ~~~~~~~~~~v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~k 143 (282)
T cd06643 70 AFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDIK 143 (282)
T ss_pred EEeeCCEEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCEE
Confidence 999999999999999999999887642 34689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
|+|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||..... .....
T Consensus 144 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~ 218 (282)
T cd06643 144 LADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLL 218 (282)
T ss_pred Ecccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHH
Confidence 999999876543221 123356899999999874 34578899999999999999999999875321 11111
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+... ..... ... .. .....+.+++.+||+.||++||++.++++
T Consensus 219 ~~~~----~~~~~-~~~----~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 219 KIAK----SEPPT-LAQ----PS---RWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHhh----cCCCC-CCC----cc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 11110 000 01 11234778999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=298.94 Aligned_cols=251 Identities=28% Similarity=0.442 Sum_probs=200.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|... .+++.|++|.+.... . .+++.+|++++++++|+||++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~----------~------~~~~~~e~~~~~~l~~~~i~~~~ 64 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHK-ETGQVVAIKVVPVEE----------D------LQEIIKEISILKQCDSPYIVKYY 64 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEc-CCCcEEEEEEeecHH----------H------HHHHHHHHHHHHhCCCCcEeeee
Confidence 468899999999999999999875 357899999874321 0 45788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++......++++||+++++|.+++... ...+++..+..++.|+++||.|| |+.+|+|+||+|+||++++++.+
T Consensus 65 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~~ 138 (256)
T cd06612 65 GSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQA 138 (256)
T ss_pred eeeecCCcEEEEEecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCcE
Confidence 9999999999999999999999998642 35689999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|+|||++......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... . +.
T Consensus 139 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~----~~ 209 (256)
T cd06612 139 KLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---A----IF 209 (256)
T ss_pred EEcccccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---h----hh
Confidence 99999998876543221 123457899999999998899999999999999999999999987532211 0 00
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... ...... .........+.+++.+||+.||++|||++|+++
T Consensus 210 ~~~~-~~~~~~-------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 MIPN-KPPPTL-------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcc-CCCCCC-------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000 000000 001111234788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.23 Aligned_cols=203 Identities=23% Similarity=0.354 Sum_probs=166.0
Q ss_pred cccccccc--cCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 341 SLEKIGSG--GCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 341 ~~~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
+.++||+| +|++||+++.. .+|+.||+|++...... ....+.+++|+++++.++||||+++++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 68 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACT------------NEMVTFLQGELHVSKLFNHPNIVPYRATF 68 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhcc------------HHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 46789999 78999999864 57999999998543211 11245678899999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
..++..++||||+++|+|.+++.... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.++++
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l~ 143 (327)
T cd08227 69 IADNELWVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLS 143 (327)
T ss_pred EECCEEEEEEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEEc
Confidence 99999999999999999999986532 24589999999999999999999 67899999999999999999999999
Q ss_pred ccccccccCCCCCcc-----eecccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 499 DFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 499 DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
||+............ ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 998654432211100 1122356788999999876 46889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.65 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=194.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.++||+|+||.||+++.+ .+++.||+|++.+.. .........+.+|+.++..++|+||+++++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~-----------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWE-----------MLKRAETACFREERDVLVNGDNQWITTLHY 68 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHH-----------HHHhhHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 46888999999999999999875 467899999874211 111122445788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++|+|.+++.+. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~k 142 (332)
T cd05623 69 AFQDENNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIR 142 (332)
T ss_pred EEecCCEEEEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEE
Confidence 999999999999999999999999752 34689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
|+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..
T Consensus 143 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-------~~ 214 (332)
T cd05623 143 LADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-------LV 214 (332)
T ss_pred EeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-------HH
Confidence 9999998765433221 223457999999999886 3467889999999999999999999986532 11
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCC--CCCHHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE--RPNSKDVRCM 627 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~ev~~~ 627 (633)
+............. + ..........+.+++.+|+..+|++ |++++|+++.
T Consensus 215 ~~~~~i~~~~~~~~-~-----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 ETYGKIMNHKERFQ-F-----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHhCCCcccc-C-----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 22222222111000 0 0001111233667777877554444 7899888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.99 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=194.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||++... ..++.||||++....... .....+.+|+.+++.++||||++++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~ii~~~ 89 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIIGLL 89 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCc------------hhHHHHHHHHHHHHhcCCCCccccc
Confidence 468999999999999999999764 578899999986543211 1134577899999999999999999
Q ss_pred eeeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++... ...|+||||+++ +|.+.+.. .+++..+..++.|+++||+|| |+++|+||||||+||++
T Consensus 90 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll 159 (364)
T cd07875 90 NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVV 159 (364)
T ss_pred eeecccccccccCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEEE
Confidence 987543 346899999965 77776642 378889999999999999999 78899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 160 ~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~ 233 (364)
T cd07875 160 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQ 233 (364)
T ss_pred CCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HH
Confidence 9999999999999986544321 12356899999999999999999999999999999999999999753221 11
Q ss_pred HHHHHHHh------------------hccCCc-chh-hh---hhh-hh---cCCHHHHHHHHHHHhHhccCCCCCCCCHH
Q 006739 570 LVKWMRNV------------------MTSENP-TRA-ID---AKL-LE---NGYEEQMLLVLKIACFCTVDSPRERPNSK 622 (633)
Q Consensus 570 ~~~~~~~~------------------~~~~~~-~~~-~d---~~~-~~---~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 622 (633)
..+.+... ...... ... .+ +.. .. .........+.+++.+|++.||++|||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~ 313 (364)
T cd07875 234 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313 (364)
T ss_pred HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHH
Confidence 11111100 000000 000 00 000 00 00011123578999999999999999999
Q ss_pred HHHH
Q 006739 623 DVRC 626 (633)
Q Consensus 623 ev~~ 626 (633)
|+++
T Consensus 314 e~L~ 317 (364)
T cd07875 314 EALQ 317 (364)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=297.80 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=196.7
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
++||+|+||.||++... +++.||+|.+...... +....+.+|++++++++|+||+++++++....
T Consensus 1 ~~lg~g~~g~v~~~~~~--~~~~v~~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 65 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLPP-------------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ 65 (251)
T ss_pred CccccCCCceEEEEEEe--CCCcEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Confidence 47899999999999875 3899999987544321 11457889999999999999999999999999
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||+++++|.+++... ...+++..+..++.+++.||+|| |+.+++||||||+||+++.++.++|+|||.
T Consensus 66 ~~~~v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g~ 139 (251)
T cd05041 66 PIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFGM 139 (251)
T ss_pred CeEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeeccc
Confidence 999999999999999998652 23578999999999999999999 788999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhccC
Q 006739 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
++...............++..|+|||.+.+..++.++|+||||+++|||++ |..||..... ....+.+. ...
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~----~~~~~~~~---~~~ 212 (251)
T cd05041 140 SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN----QQTRERIE---SGY 212 (251)
T ss_pred cccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH----HHHHHHHh---cCC
Confidence 886543222111122334667999999988899999999999999999999 8888865322 11111111 111
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
... ........+.+++.+|++.+|++||++.|+++.|+.
T Consensus 213 ~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 213 RMP----------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCC----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 000 011122358889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.67 Aligned_cols=268 Identities=22% Similarity=0.346 Sum_probs=198.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|++|.||+|+.. .+|+.||+|++........ ..+.+.+|+.++++++|+|++++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~------------~~~~~~~e~~~l~~~~h~~i~~~~~ 67 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPV------------IKKIALREIRMLKQLKHPNLVNLIE 67 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCcc------------ccHHHHHHHHHHHhCCCCCEeeeee
Confidence 46888899999999999999875 4689999998854321110 1345788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++......++||||+++++|..+... ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.++
T Consensus 68 ~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~~ 140 (286)
T cd07847 68 VFRRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQIK 140 (286)
T ss_pred EEeeCCEEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcEE
Confidence 99999999999999999888887653 34589999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||++......... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+......+...
T Consensus 141 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07847 141 LCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218 (286)
T ss_pred ECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999876554321 123457889999999876 4578899999999999999999999975332111111111100
Q ss_pred Hh-------hccCC-cchhhhhhh-----hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NV-------MTSEN-PTRAIDAKL-----LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~-------~~~~~-~~~~~d~~~-----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ..... ......+.. .....+.....+.+++.+||+.+|++||++.|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 00000 000000000 00001112345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.47 Aligned_cols=264 Identities=20% Similarity=0.309 Sum_probs=196.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|+.. .+++.||+|.+....... ....+.+|+++++.++||||++++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~nI~~~~ 70 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEG-------------APCTAIREVSLLKDLKHANIVTLH 70 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccC-------------chhHHHHHHHHHHhcCCCCcceEE
Confidence 467999999999999999999865 467899999885432211 023466799999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++..++..++||||++ ++|.+++... ...+++..+..++.|+++||+|| |+.+|+|+||||+||++++++.+
T Consensus 71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~ 143 (301)
T cd07873 71 DIIHTEKSLTLVFEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGEL 143 (301)
T ss_pred EEEecCCeEEEEEeccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcE
Confidence 99999999999999996 5898888652 34588999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+|+|||++........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ......+
T Consensus 144 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~----~~~~~~~ 217 (301)
T cd07873 144 KLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV----EEQLHFI 217 (301)
T ss_pred EECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 9999999876543221 1123457899999998765 4578899999999999999999999875322 1111111
Q ss_pred HHhhccCC---cchhhhh---------hhh----hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSEN---PTRAIDA---------KLL----ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~---~~~~~d~---------~~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ .....+. ... ..........+.+++.+|++.||.+|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 0000000 000 0000111234678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=303.90 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=199.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
....|+..+.||.|++|.||+|... .+++.||+|.+...... ..+.+.+|+.+++.++|||++++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~iv~~ 81 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDV-ATGQEVAIKQINLQKQP--------------KKELIINEILVMKELKNPNIVNF 81 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEc-CCCcEEEEEEEecccCc--------------hHHHHHHHHHHHHhcCCCceeee
Confidence 3457999999999999999999753 57899999988533211 13467889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+++++|.+++.. ..+++.++..++.|++.|++|| |+.+++||||||+||+++.++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~ 153 (296)
T cd06655 82 LDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGS 153 (296)
T ss_pred eeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCC
Confidence 9999999999999999999999998863 3589999999999999999999 7889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
++|+|||++......... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...... +
T Consensus 154 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~---~~~~~~-~ 227 (296)
T cd06655 154 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYL-I 227 (296)
T ss_pred EEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH-H
Confidence 999999998865443221 1234688999999999988899999999999999999999999865322 111111 1
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. ..... .. .........+.+++.+||..||++||++.++++
T Consensus 228 ~---~~~~~-~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 228 A---TNGTP-EL-------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred H---hcCCc-cc-------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1 11100 00 001111234778899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=300.86 Aligned_cols=265 Identities=26% Similarity=0.401 Sum_probs=200.6
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|...+.||+|+||.||+|... .+|+.||+|.+.......... ........+.+.+|+.++++++|||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRH----DSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeec-CCCceeeeeeeechhhhhccc----chHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 3667789999999999999754 578999999886543221110 11112234578889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++||||+++++|.+++... ..+++..+..++.|++.||.|| |+.+++||||+|+||+++.++.+++
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEE
Confidence 99999999999999999999998753 4689999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK--FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|||+++...............|+..|+|||.+.... ++.++||||||+++||+++|+.||..... .....
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~- 222 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMF- 222 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHH-
Confidence 9999988654432222223356889999999987654 78899999999999999999999864211 11111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... ...++... .......+.+++..|++.+|++||+++++++
T Consensus 223 ~~~~~~~-~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 223 KLGNKRS-APPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred Hhhcccc-CCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111110 00111111 1112345788889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=301.80 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=197.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+++.|++|.+..... +..+.+.+|+.+++.++|+||++++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSE--------------EELEDYMVEIEILATCNHPYIVKLL 75 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCcEeeeE
Confidence 467999999999999999999875 4688999999854321 1145688899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++..+...++||||+++++|..++.+. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~ 149 (292)
T cd06644 76 GAFYWDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDGDI 149 (292)
T ss_pred EEEEeCCeEEEEEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCCCE
Confidence 9999999999999999999998887642 34589999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+|+|||++......... .....++..|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 150 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------- 220 (292)
T cd06644 150 KLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------- 220 (292)
T ss_pred EEccCccceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------
Confidence 99999988754332211 12346889999999884 34578899999999999999999999865321
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..........+. .. ........+.+++.+||+.+|++||+++++++
T Consensus 221 ~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 221 MRVLLKIAKSEPPT-LS-------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHhcCCCcc-CC-------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111111111110 00 01111234778899999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=300.86 Aligned_cols=262 Identities=24% Similarity=0.371 Sum_probs=202.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||.|++|.||++... .+++.+|+|.+...... ....++.+|++++++++||||+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 66 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNP-------------DLQKQILRELEINKSCKSPYIVKYYG 66 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC-CCCeEEEEEEEecCCch-------------HHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 36788899999999999999875 47899999988643221 11456888999999999999999999
Q ss_pred eeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 417 HMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 417 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++.+. ...++||||+++++|.+++.........+++..+..++.|+++||+|| |+.+++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~ 143 (287)
T cd06621 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQ 143 (287)
T ss_pred EEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCe
Confidence 88653 467999999999999998876544456789999999999999999999 7889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc-cccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH-TEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~-~~~~~~~~~ 573 (633)
++|+|||++........ ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+..... ........+
T Consensus 144 ~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (287)
T cd06621 144 VKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219 (287)
T ss_pred EEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH
Confidence 99999999876543221 2345788999999999889999999999999999999999999754221 111222233
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.. ... ... ..... ........+.+++.+||+.+|++|||+.|+++
T Consensus 220 ~~~---~~~-~~~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 220 IVN---MPN-PEL-KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred Hhc---CCc-hhh-ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 221 111 110 00000 00112345789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.49 Aligned_cols=259 Identities=25% Similarity=0.358 Sum_probs=193.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|+..+.||+|+||.||+|... .+++.||||++...... ....+.+.+|++++++++||||++++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 80 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQS------------LIHARRTYRELRLLKHMKHENVIGLL 80 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhh------------hHHHHHHHHHHHHHHhcCCCchhhhh
Confidence 468999999999999999999864 57889999998543211 01134577899999999999999999
Q ss_pred eeeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++... ...++++|++ +++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~ 151 (343)
T cd07878 81 DVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAV 151 (343)
T ss_pred hhhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEE
Confidence 987543 3468999998 7899888753 4589999999999999999999 68899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
++++.+||+|||+++...... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .
T Consensus 152 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~ 223 (343)
T cd07878 152 NEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---D 223 (343)
T ss_pred CCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---H
Confidence 999999999999998654421 23568999999999876 56889999999999999999999998653211 1
Q ss_pred hHHHHHHHhhccCCcchhhhh-------hh---hhcCC--------HHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDA-------KL---LENGY--------EEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~-------~~---~~~~~--------~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..+ ........ ...... .. ..... ......+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 224 QLKRI-MEVVGTPS-PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHH-HHHhCCCC-HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111 11111100 000000 00 00000 001123678999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=311.11 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=199.3
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeee
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 419 (633)
+..++||+|+|-+||+|.+ ..+|..||=-.++ ..+.....+...+|..|+++|+.|+|||||+++.++.
T Consensus 43 k~~evLGrGafKtVYka~D-e~~giEVAWnqvk----------~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFD-EEEGIEVAWNQVK----------IRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ehhhhcccccceeeeeccc-cccchhhHHHHHh----------HHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 4567899999999999976 3566666522110 0111112233578999999999999999999999998
Q ss_pred cCCc--cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec-CCCceE
Q 006739 420 RPDC--HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEAR 496 (633)
Q Consensus 420 ~~~~--~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~-~~~~~k 496 (633)
+... ..+|+|.|..|+|..|+++.+ .++....+.|+.||++||.|||. |.++|||||||-+||+++ ..|.||
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCcee
Confidence 7665 668999999999999998754 47888999999999999999986 788999999999999998 468999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|+|+|........ ..+.|||.|||||++. ..|++.+||||||+.++||+|+..||... ....+..+.
T Consensus 187 IGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC------~n~AQIYKK 255 (632)
T KOG0584|consen 187 IGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC------TNPAQIYKK 255 (632)
T ss_pred ecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh------CCHHHHHHH
Confidence 999999998765432 3478999999999998 68999999999999999999999999754 344566666
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+..+..+..+- . -..+ .+.+||.+|+.. .++|||+.|+++
T Consensus 256 V~SGiKP~sl~-k----V~dP----evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 256 VTSGIKPAALS-K----VKDP----EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHcCCCHHHhh-c----cCCH----HHHHHHHHHhcC-chhccCHHHHhh
Confidence 66655443221 0 0111 278899999999 999999999975
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=299.97 Aligned_cols=250 Identities=28% Similarity=0.434 Sum_probs=199.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||.|++|.||+|... .+++.||+|.+...... .....+.+|+++++.++|+||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAE-------------DEIEDIQQEIQFLSQCRSPYITKYYG 66 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccc-------------hHHHHHHHHHHHHHHcCCCCeeeeeE
Confidence 36788899999999999999865 57899999998543210 11356788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.++...++|+||+++++|.+++.. ..+++..+..++.|++.|+.|| |+.+++|+||+|+||++++++.++
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~ 138 (274)
T cd06609 67 SFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVK 138 (274)
T ss_pred EEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999874 2689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+++........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||..... .. ....
T Consensus 139 l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----~~---~~~~ 209 (274)
T cd06609 139 LADFGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----MR---VLFL 209 (274)
T ss_pred Ecccccceeecccccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch----HH---HHHH
Confidence 9999999877654221 1335688899999999988899999999999999999999999865321 11 1111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... ...... ... ....+.+++.+||..+|++|||++++++
T Consensus 210 ~~~~-~~~~~~-----~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 210 IPKN-NPPSLE-----GNK---FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hhhc-CCCCCc-----ccc---cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 111110 010 1223778889999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.78 Aligned_cols=242 Identities=17% Similarity=0.260 Sum_probs=184.9
Q ss_pred cccccccCeeEEEEEecCC------CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 343 EKIGSGGCGEVYKAELPGS------NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+.||+|+||.||+|..... ....||+|.+.... ....+.+.+|+.+++.++||||+++++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~~~h~~iv~~~~ 66 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--------------RNYSESFFEAASMMSQLSHKHLVLNYG 66 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--------------HHHHHHHHHHHHHHHhCCCCChhheee
Confidence 4799999999999976421 12347777653211 112456788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc--
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME-- 494 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~-- 494 (633)
++..++..++||||+++|+|.++++.. +..+++..+..++.||+.||+|| |+.+|+||||||+||+++.++.
T Consensus 67 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~~ 140 (258)
T cd05078 67 VCVCGDESIMVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDRK 140 (258)
T ss_pred EEEeCCCcEEEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEecccccc
Confidence 999999999999999999999998752 23689999999999999999999 7889999999999999987765
Q ss_pred ------eEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCC-CCCcccccccc
Q 006739 495 ------ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGR-LPSDDFFQHTE 566 (633)
Q Consensus 495 ------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~-~p~~~~~~~~~ 566 (633)
++++|||.+...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+.....
T Consensus 141 ~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--- 211 (258)
T cd05078 141 TGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--- 211 (258)
T ss_pred cCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---
Confidence 599999988755432 234578899999998864 5788999999999999999995 55443211
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
........ .....+ ......+.+++.+||+.||++|||++++++.|+
T Consensus 212 -~~~~~~~~---~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 -QKKLQFYE---DRHQLP------------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHHHHHHH---ccccCC------------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111111 111111 011134788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=297.02 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=194.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.+|+..+.||+|+||.||+|... .++..||+|++........ ..+....+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 71 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPE---------TSKEVSALECEIQLLKNLQHERIVQYYG 71 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCch---------hHHHHHHHHHHHHHHHHcCCCCeeeEEE
Confidence 36888999999999999999764 4688999998765432111 1122457889999999999999999999
Q ss_pred eeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 417 HMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 417 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++.+. ...++++||+++++|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~ 144 (266)
T cd06651 72 CLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGN 144 (266)
T ss_pred EEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCC
Confidence 88653 567899999999999999875 23588999999999999999999 6889999999999999999999
Q ss_pred eEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
++|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~---- 217 (266)
T cd06651 145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAA---- 217 (266)
T ss_pred EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHH----
Confidence 999999998765432111 111234588999999999988899999999999999999999999875321 111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+......... +.+ .......+.+++ .|+..+|++||+++|+++
T Consensus 218 ~~~~~~~~~~-----~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQPTN-----PQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCCCC-----CCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111111110 000 111112244555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=306.05 Aligned_cols=268 Identities=26% Similarity=0.408 Sum_probs=197.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|+||.||+|... .+++.||+|++....... ...+.+.+|+++++.++||||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 67 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDK------------MVKKIAMREIRMLKQLRHENLVNLIE 67 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcc------------hhhHHHHHHHHHHHhcCCcchhhHHH
Confidence 36888999999999999999875 468899999875433211 11356788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++..++..++||||+++++|.++... ...+++..+..++.|+++||+|| |+.+|+|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~~~~~~~ 140 (286)
T cd07846 68 VFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVSQSGVVK 140 (286)
T ss_pred hcccCCeEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCcEE
Confidence 99999999999999999999887653 33489999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||++......... .....++..|+|||+..+ ..++.++||||||+++|||++|+.||......+....+..+..
T Consensus 141 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07846 141 LCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218 (286)
T ss_pred EEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC
Confidence 9999998876443321 123457899999998875 4578899999999999999999999864221111111111100
Q ss_pred Hh-------hccCCc-chhhhhhh-----hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NV-------MTSENP-TRAIDAKL-----LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~-------~~~~~~-~~~~d~~~-----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ...... .....+.. .....+.....+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 000000 00000000 00001122345888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=299.14 Aligned_cols=247 Identities=29% Similarity=0.430 Sum_probs=195.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++.. +++.||+|.+..... ...+.+|+.++++++|||++++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~~----------------~~~~~~e~~~l~~~~~~~i~~~~~ 66 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDVT----------------AQAFLEETAVMTKLHHKNLVRLLG 66 (254)
T ss_pred HHceeeeeeccCCCCceEeccc---CCCceEEEeecCcch----------------HHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5688899999999999999974 678899998753211 346788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++... ..++||||+++++|.+++... ....+++..+..++.|++.|+.|| |+.+++||||||+||+++.++.+|
T Consensus 67 ~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~k 140 (254)
T cd05083 67 VILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVAK 140 (254)
T ss_pred EEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcEE
Confidence 98654 479999999999999999753 234688999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||++....... .....+..|+|||++.+..++.++|+||||+++|||++ |+.||..... ... ..
T Consensus 141 l~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~---~~ 208 (254)
T cd05083 141 VSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEV---KE 208 (254)
T ss_pred ECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHH---HH
Confidence 99999987644321 12234678999999988899999999999999999998 9999865321 111 11
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
......... . .......+.+++.+||+.+|++||+++++++.|++
T Consensus 209 ~~~~~~~~~-~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 209 CVEKGYRME-P---------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHhCCCCCC-C---------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111111110 0 01122347789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.98 Aligned_cols=252 Identities=31% Similarity=0.429 Sum_probs=205.1
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+...-|..++.||.|+||.||-++.. .+.+.||||++.-... ...+...++..|+..+++++|||.+.
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~-~n~evVAIKKMsySGK-----------Qs~EKWqDIlKEVrFL~~l~HPntie 90 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGK-----------QSNEKWQDILKEVRFLRQLRHPNTIE 90 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeecc-Cccceeeeeecccccc-----------ccHHHHHHHHHHHHHHHhccCCCccc
Confidence 34456788899999999999999864 5789999999854332 23345789999999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+.|+|-.+...+|||||| -||-.|++.. +++++-+.++..|+.+.+.||+|| |+.+.||||||..|||+++.|
T Consensus 91 YkgCyLre~TaWLVMEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g 163 (948)
T KOG0577|consen 91 YKGCYLREHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPG 163 (948)
T ss_pred ccceeeccchHHHHHHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCC
Confidence 999999999999999999 5588888875 357899999999999999999999 788999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
.|||+|||.|....+.. .++|||.|||||++.. +.|+-++||||+|++..||.-.++|+-.+.. .+
T Consensus 164 ~VKLaDFGSAsi~~PAn------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MS- 232 (948)
T KOG0577|consen 164 LVKLADFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MS- 232 (948)
T ss_pred eeeeccccchhhcCchh------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HH-
Confidence 99999999998876643 4689999999998754 6799999999999999999999999654321 11
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..+..++.+ .+. ..+..+.+..|+..||++-|.+|||.+++++
T Consensus 233 --ALYHIAQNesP------tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 233 --ALYHIAQNESP------TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --HHHHHHhcCCC------CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11112222211 111 2233445788888999999999999999875
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.73 Aligned_cols=258 Identities=23% Similarity=0.291 Sum_probs=195.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+++.. .+++.||+|.+.+.. .........+.+|..++..++|+||+++++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~-----------~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~ 68 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWE-----------MLKRAETACFREERNVLVNGDCQWITTLHY 68 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHH-----------HHhhHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 47889999999999999999865 578899999874311 011122456788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..|+||||+++|+|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~k 142 (331)
T cd05624 69 AFQDENYLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHIR 142 (331)
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCEE
Confidence 999999999999999999999999752 34688999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus 143 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~ 214 (331)
T cd05624 143 LADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------V 214 (331)
T ss_pred EEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------H
Confidence 9999999876543322 1233569999999998875 4678899999999999999999999864321 1
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCC--CCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE--RPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~ev~~ 626 (633)
+............. +. .........+.+++.+|+..++++ |++++++++
T Consensus 215 ~~~~~i~~~~~~~~-~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 215 ETYGKIMNHEERFQ-FP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHcCCCccc-CC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 11111111110000 00 001112234677888888865544 567877764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=300.30 Aligned_cols=255 Identities=25% Similarity=0.413 Sum_probs=197.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+.. .+++.||+|.+...... ....+++|+.+++.++||||+++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~--------------~~~~~~~e~~~~~~l~h~~ii~~ 71 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGE--------------DFAVVQQEIIMMKDCKHSNIVAY 71 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchh--------------HHHHHHHHHHHHHhCCCCCeeeE
Confidence 3468899999999999999999864 57889999988543210 13457789999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+++++|.+++.. ...+++..+..++.|++.|++|| |+.+|+|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~ 144 (267)
T cd06645 72 FGSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGH 144 (267)
T ss_pred EEEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999865 34689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
++|+|||++........ ......|+..|+|||++. ...++.++||||+||++|||++|+.||....... ...
T Consensus 145 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~ 219 (267)
T cd06645 145 VKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALF 219 (267)
T ss_pred EEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHH
Confidence 99999999876543221 123456899999999874 4568889999999999999999999985432211 111
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... ....... .... ......+.+++.+|++.+|++||+++++++
T Consensus 220 ~~~~---~~~~~~~-~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 220 LMTK---SNFQPPK-LKDK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhhc---cCCCCCc-cccc------CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1000 0000000 0000 001123778999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=296.72 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=196.2
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..+.+.+.....||+|+||.||+|... .++..||+|.+..... ...+.+.+|+.++++++|+||+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv 68 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDL-STQVRIAIKEIPERDS--------------RYVQPLHEEIALHSYLKHRNIV 68 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEec-CCCcEEEEEEecCCCH--------------HHHHHHHHHHHHHHhcCCCCee
Confidence 345566667789999999999999864 4788999998754321 1145688999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC-
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD- 491 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~- 491 (633)
++++++..++..++|+||+++++|.+++..... ....++..+..++.|+++||+|| |+.+|+||||||+||+++.
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~ 144 (268)
T cd06624 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTY 144 (268)
T ss_pred eeeeeeccCCEEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCC
Confidence 999999999999999999999999999875321 11227888899999999999999 6889999999999999986
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK--FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
++.++|+|||.+........ ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||.......
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---- 218 (268)
T cd06624 145 SGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---- 218 (268)
T ss_pred CCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----
Confidence 67899999999876543222 112345899999999986643 7889999999999999999999986432111
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+...... .. +.+ +......+.+++.+||+.+|++|||+.|+++
T Consensus 219 ~~~~~~~~~~-~~------~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 219 AAMFKVGMFK-IH------PEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhHhhhhhhc-cC------CCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1111110000 00 000 1112234778899999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.92 Aligned_cols=253 Identities=20% Similarity=0.318 Sum_probs=202.2
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|+..+.||.|+||.||.++.. .+++.+++|.+....... ...+++.+|++++++++|+||++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~------------~~~~~~~~e~~~l~~~~h~~i~~~~~~ 67 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSE------------KERRDALNEIVILSLLQHPNIIAYYNH 67 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccch------------hHHHHHHHHHHHHHhCCCCCeeEEEeE
Confidence 4788999999999999999864 578899999875432211 124567899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++++|.+++.... ...+++..+..++.|+++||+|| |+.+++|+||+|+||++++++.+||
T Consensus 68 ~~~~~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~kl 142 (256)
T cd08221 68 FMDDNTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIKL 142 (256)
T ss_pred EecCCeEEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEEE
Confidence 999999999999999999999997532 35689999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||++......... .....|++.|+|||+..+..++.++||||||+++|||++|+.||..... .+.....
T Consensus 143 ~d~~~~~~~~~~~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~ 213 (256)
T cd08221 143 GDFGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKI 213 (256)
T ss_pred CcCcceEEccccccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence 999999876543321 1335689999999999888889999999999999999999999864221 1222222
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
........ .......+.+++.+||+.+|++||+++|+++.
T Consensus 214 ~~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 214 VQGNYTPV----------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcCCCCCC----------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 22111110 01122347788899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=298.68 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=203.5
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||.|+||.||++... .+++.||+|.+...... ....+++..|++++++++|+||++++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMT------------EKEKQQLVSEVNILRELKHPNIVRYYDR 67 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCC------------HHHHHHHHHHHHHHHhcCCCccceeeee
Confidence 4778899999999999999865 47889999988543321 1114567889999999999999999998
Q ss_pred eec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCeEecCCC
Q 006739 418 MAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISH--NPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 418 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h--~~~ivH~Dikp~Nill~~~~ 493 (633)
+.. ....+++|||+++++|.+++.........+++..++.++.|++.||+|||..+ +.+++|+||||+||++++++
T Consensus 68 ~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~ 147 (265)
T cd08217 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN 147 (265)
T ss_pred eecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC
Confidence 754 44578999999999999999875555677999999999999999999995332 89999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||++.......... ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ...+.+.
T Consensus 148 ~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~ 221 (265)
T cd08217 148 NVKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASK 221 (265)
T ss_pred CEEEecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHH
Confidence 99999999998765543211 23468999999999998889999999999999999999999987532 2222222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.. .. .. .........+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~---~~-~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 222 IKE---GK-FR---------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred Hhc---CC-CC---------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 221 11 10 011122345788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=301.77 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=199.1
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNL 411 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni 411 (633)
....++|++.+.||+|+||.||++... .+++.+|+|.+..... ...++.+|+.+++++ +|||+
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~~~---------------~~~~~~~e~~~l~~l~~h~ni 81 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPISD---------------VDEEIEAEYNILQSLPNHPNV 81 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEeccccc---------------HHHHHHHHHHHHHHhcCCCCe
Confidence 345688999999999999999999864 5788999998753211 124566788888888 79999
Q ss_pred cccceeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 412 LPLLAHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 412 v~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
+++++++... ...++||||+++++|.++++........+++..++.++.|++.||+|| |+.+|+||||||+|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~n 158 (291)
T cd06639 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNN 158 (291)
T ss_pred EEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHH
Confidence 9999998654 357899999999999999875444456789999999999999999999 67899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccC-----CCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-----KFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
|++++++.+||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||...
T Consensus 159 ili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 159 ILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred EEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999998876543221 1234688999999987543 3688999999999999999999998653
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ...+.++. .. ......+ .+.....+.+++.+|++.+|++||++.|+++
T Consensus 237 ~~---~~~~~~~~----~~-~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 237 HP---VKTLFKIP----RN-PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cH---HHHHHHHh----cC-CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 22 11111111 11 1111111 1112234888999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=297.72 Aligned_cols=252 Identities=20% Similarity=0.296 Sum_probs=197.9
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||+|++|.||++... .+++.||+|++...... ....+.+.+|++++++++|+|++++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNAS------------RRERKAAEQEAQLLSQLKHPNIVAYRES 67 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcC------------HHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 4788999999999999999874 46889999998432211 1124567889999999999999999998
Q ss_pred eecC-CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 418 MARP-DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 418 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
+... ...++||||+++++|.+++.... ...+++.++..++.+++.|++|| |+.+|+||||||+||+++.++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~~ 142 (257)
T cd08223 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNIIK 142 (257)
T ss_pred ecCCCCEEEEEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcEE
Confidence 7644 45789999999999999997532 34689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||++......... .....|++.|+|||+..+..++.++||||+|+++|||++|+.||+... . .+....
T Consensus 143 l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~---~~~~~~ 213 (257)
T cd08223 143 VGDLGIARVLENQCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----M---NSLVYR 213 (257)
T ss_pred EecccceEEecccCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----H---HHHHHH
Confidence 9999999876443221 123568999999999999899999999999999999999999986421 1 111111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...... . .........+.+++.+|++.+|++||++.++++
T Consensus 214 ~~~~~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 214 IIEGKL-P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHhcCC-C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111 0 001112234788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=299.15 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=200.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
..|+..+.||.|+||.||+|... .++..||+|.+..... ......+.+|+.++++++||||+++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEA-------------EDEIEDIQQEITVLSQCDSPYVTKYYG 69 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEecccc-------------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 46778899999999999999864 4688999998753321 112467889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+....++||||+++++|.+++.. ..+++.....++.|++.||+|| |+.+++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~ 141 (277)
T cd06640 70 SYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred EEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEE
Confidence 99999999999999999999998863 3588899999999999999999 688999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
++|||++......... .....++..|+|||++.+..++.++|||||||++|||++|..||...... ... ..
T Consensus 142 l~dfg~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~---~~ 212 (277)
T cd06640 142 LADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM----RVL---FL 212 (277)
T ss_pred EcccccceeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----hHh---hh
Confidence 9999999776543321 12346788999999998888999999999999999999999998653221 111 11
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
. ..... ..........+.+++.+||+.+|++||++.++++.
T Consensus 213 ~-~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 213 I-PKNNP---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred h-hcCCC---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1 00101 11122234457899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=299.11 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=200.6
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLL 412 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 412 (633)
.+.++|++.+.||+|++|.||+|... .+++.+++|.+..... ...++.+|+++++++ .|+||+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~---------------~~~~~~~e~~~l~~~~~h~~i~ 66 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIED---------------EEEEIKEEYNILRKYSNHPNIA 66 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCch---------------hHHHHHHHHHHHHHhcCCCChh
Confidence 45688999999999999999999875 4678999998754321 145688999999999 699999
Q ss_pred ccceeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 413 PLLAHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 413 ~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
++++++.... ..++||||+++++|.+++......+..+++..+..++.|+++||+|| |+.+++|+||+|+|
T Consensus 67 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~n 143 (275)
T cd06608 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQN 143 (275)
T ss_pred eEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHH
Confidence 9999996644 47999999999999999876543456789999999999999999999 78899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCccccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
|++++++.++|+|||++......... .....|+..|+|||++.. ..++.++|||||||++|+|++|+.||...
T Consensus 144 i~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 144 ILLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred EEEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 99999999999999998765443221 123568999999998753 34678999999999999999999998643
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. .....+. .... ..... ........+.+++.+||+.||++|||+.++++
T Consensus 222 ~~---~~~~~~~----~~~~-~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 222 HP---MRALFKI----PRNP-PPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ch---HHHHHHh----hccC-CCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 21 1111111 1111 11110 01112335778999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=301.15 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=199.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||.|+||.||++... .++..||+|.+..... ...+.+.+|++++++++||||++++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~ 68 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHK-ETGLFAAAKIIQIESE--------------EELEDFMVEIDILSECKHPNIVGLY 68 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEc-CCCcEEEEEEEeeCCH--------------HHHHHHHHHHHHHHhCCCCceeEEE
Confidence 467999999999999999999875 3788999999854321 1145688899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++..+...++||||+++++|.+++... ...+++..+..++.|++.||.|| |+.+|+|+||||+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~~ 142 (280)
T cd06611 69 EAYFYENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGDV 142 (280)
T ss_pred EEEecCCeEEEEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCCE
Confidence 9999999999999999999999998752 34689999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+|+|||++......... .....|+..|+|||.+. +..++.++|+||||+++|||++|+.||..... .
T Consensus 143 ~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~--- 214 (280)
T cd06611 143 KLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---M--- 214 (280)
T ss_pred EEccCccchhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---H---
Confidence 99999988765432221 12346899999999874 34577899999999999999999999875321 1
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
+.+........+. ... .......+.+++..||+.+|++||++.++++.
T Consensus 215 -~~~~~~~~~~~~~-~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 215 -RVLLKILKSEPPT-LDQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -HHHHHHhcCCCCC-cCC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111111111110 000 01112247788899999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.07 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=200.7
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.....+|+..+.||+|+||.||++... .+++.||+|.+...... ..+.+.+|+.+++.++|+||+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~i~ 79 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDI-ATGQEVAIKQMNLQQQP--------------KKELIINEILVMRENKNPNIV 79 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEEC-CCCCEEEEEEEecCccc--------------hHHHHHHHHHHHHhCCCCCEe
Confidence 344578999999999999999999753 57899999988543211 134578899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|| |+.+|+||||||+||+++.+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~ 151 (297)
T cd06656 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMD 151 (297)
T ss_pred eEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCC
Confidence 999999999999999999999999999863 3478899999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.++|+|||++......... .....+++.|+|||...+..++.++|+|||||++|+|++|+.||........ ...
T Consensus 152 ~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~---~~~ 226 (297)
T cd06656 152 GSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYL 226 (297)
T ss_pred CCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh---eee
Confidence 99999999998765443221 1234688999999999988899999999999999999999999965322110 000
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. .....+. . .........+.+++.+||+.+|++||+++++++
T Consensus 227 ~----~~~~~~~-~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 227 I----ATNGTPE-L-------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred e----ccCCCCC-C-------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0000000 0 001112233678889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.57 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=197.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|.....||+|+||.||++... .++..||+|++..... ...+.+.+|+.+++.++|+||++++
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ii~~~ 85 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYHHENVVDMY 85 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEEC-CCCCEEEEEEEecchH--------------HHHHHHHHHHHHHHhCCCCcHHHHH
Confidence 345566788999999999999764 4688999998743211 1245688899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+.+...+..++||||+++++|.+++.. ..+++.++..++.||+.||+|| |+.+|+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~ 157 (292)
T cd06658 86 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRI 157 (292)
T ss_pred HheecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCE
Confidence 999999999999999999999998853 3588999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|+|||++......... .....|+..|+|||+..+..++.++||||||+++|||++|+.||..... ......+.
T Consensus 158 kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~ 231 (292)
T cd06658 158 KLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMRRIR 231 (292)
T ss_pred EEccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 99999998765433221 1234689999999999888899999999999999999999999864221 11111111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
...... .. + .......+.+++..|+..||.+|||++|+++.
T Consensus 232 ~~~~~~-~~---~-------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 232 DNLPPR-VK---D-------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred hcCCCc-cc---c-------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111000 00 0 00112236788889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=297.91 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=203.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||.|+||.||+|... .++..+|+|++....... ..+.+.+|+++++.++|+||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQT-------------SVDELRKEVQAMSQCNHPNVVKYYT 66 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCCcch-------------HHHHHHHHHHHHHhcCCCCEEEEEE
Confidence 46888999999999999999864 478899999985433211 1467889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.+...+..++||||+++++|.+++..... ...+++.....++.|++.||+|| |+.+|+|+||+|+||++++++.++
T Consensus 67 ~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~ 142 (267)
T cd06610 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVK 142 (267)
T ss_pred EEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEE
Confidence 99999999999999999999999975322 34689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcc--eecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 497 IADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
|+|||++.......... ......|+..|+|||++... .++.++|+||||+++|||++|+.||...... ....+.
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~ 219 (267)
T cd06610 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLT 219 (267)
T ss_pred EcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHH
Confidence 99999988766543221 11334689999999998776 7899999999999999999999999754321 111121
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ..... ..... ........+.+++..|++.||++||++.++++
T Consensus 220 ~~----~~~~~--~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 220 LQ----NDPPS--LETGA---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hc----CCCCC--cCCcc---ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11 11100 00000 01122345788999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=295.37 Aligned_cols=260 Identities=23% Similarity=0.385 Sum_probs=200.6
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||++... .+++.||+|.+......... ..+..+.+.+|++++++++|+||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~alk~~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV-KTGTLMAVKQVTYVRNTSSE--------QEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEc-CCCcEEEEEEeecccCCchh--------HHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 4777899999999999999763 57899999988643321111 11225678999999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC-ceE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-EAR 496 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~-~~k 496 (633)
+.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|| |+.+++|+||+|+||+++.++ .++
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~ 144 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLR 144 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999875 34688999999999999999999 778999999999999998776 599
Q ss_pred EcccccccccCCCCCcc--eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 497 IADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
|+|||.+.......... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .....+
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~ 220 (268)
T cd06630 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS----NHLALI 220 (268)
T ss_pred EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc----chHHHH
Confidence 99999988765432111 112346889999999998888999999999999999999999998643211 111111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... ..+......+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKIASATTAP---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhccCCCC---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1111111000 111122234778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=297.00 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=202.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|++|.||++... .+++.+|+|.+...... ...+++.+|++++++++||||+++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINE-------------AIQKQILRELDILHKCNSPYIVGFYG 66 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccCh-------------HHHHHHHHHHHHHHHCCCCchhhhhe
Confidence 35778899999999999999874 57899999988654321 12467888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCeEecCCCce
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHN-PRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~Dikp~Nill~~~~~~ 495 (633)
.+......++|+||+++++|.+++.... ..+++..+..++.|+++||+|| |+ .+++|+||||+||++++++.+
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~ 140 (265)
T cd06605 67 AFYNNGDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQI 140 (265)
T ss_pred eeecCCEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999997532 5688999999999999999999 67 899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|+|||.+........ ....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.++
T Consensus 141 ~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~ 214 (265)
T cd06605 141 KLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQ 214 (265)
T ss_pred EEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHH
Confidence 9999999876543221 125688999999999998999999999999999999999999865422 1112222233
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......+... .......+.+++..||..||++|||+.++++
T Consensus 215 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 215 YIVNEPPPRLP---------SGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHhcCCCCCCC---------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 22222111100 0002334788999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.46 Aligned_cols=199 Identities=26% Similarity=0.370 Sum_probs=159.9
Q ss_pred ccccccccCeeEEEEEec-CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 342 LEKIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
..+||+|+||.||+|+.. +.++..||+|.+..... ...+.+|++++++++||||+++++++..
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------------SMSACREIALLRELKHPNVIALQKVFLS 69 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------------cHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 367999999999999864 23568899998754321 2346789999999999999999998854
Q ss_pred --CCccEEEEecccCCCHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe----
Q 006739 421 --PDCHLLVYEFMKNGSLQDILNDVSQ-----GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---- 489 (633)
Q Consensus 421 --~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---- 489 (633)
....++||||+++ +|.+++..... ....+++..+..++.|++.||+|| |+.+|+||||||+||++
T Consensus 70 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~ 145 (317)
T cd07867 70 HSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEG 145 (317)
T ss_pred cCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCC
Confidence 4567899999964 78877753221 123588999999999999999999 78899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCc-ceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
+.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 56678999999999876543221 11234568999999999876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=303.35 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=199.6
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||+|... .+++.||+|++...... ....+.+.+|++++++++|+||++++++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 68 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDD------------EDVKKTALREVKVLRQLRHENIVNLKEA 68 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhccc------------ccchhHHHHHHHHHHhcCCCCeeehhhe
Confidence 5888999999999999999865 46889999988543211 1114678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++||||++++.+..+... ...+++..+..++.|+++||+|| |+.+++|+||+|+||++++++.+||
T Consensus 69 ~~~~~~~~iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~kl 141 (288)
T cd07833 69 FRRKGRLYLVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLKL 141 (288)
T ss_pred EEECCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEE
Confidence 9999999999999998777666543 34589999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH-
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR- 575 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~- 575 (633)
+|||++........... ....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+..........
T Consensus 142 ~d~g~~~~~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 220 (288)
T cd07833 142 CDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220 (288)
T ss_pred EeeecccccCCCccccc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999887665432111 335678999999999887 789999999999999999999999875322111000000000
Q ss_pred ------Hhh-ccC-----CcchhhhhhhhhcC-CHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 ------NVM-TSE-----NPTRAIDAKLLENG-YEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ------~~~-~~~-----~~~~~~d~~~~~~~-~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ... ......+....... .......+.+++..||+.+|++||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000 00000001100111 1112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=294.10 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=201.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|... .+++.+++|.+...... ..+.+.+|++++++++||||++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~i~~~~ 66 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEPGD--------------DFEIIQQEISMLKECRHPNIVAYF 66 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCchh--------------hHHHHHHHHHHHHhCCCCChhceE
Confidence 367889999999999999999864 46788999998643211 146788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..+++|||+++++|.+++... ...+++..+..++.|++.||+|| |+.+|+|+||+|+||++++++.+
T Consensus 67 ~~~~~~~~~~l~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~ 140 (262)
T cd06613 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDV 140 (262)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCE
Confidence 9999999999999999999999998753 24688999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccC---CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL---KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+|+|||++........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....
T Consensus 141 ~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~---~~~~~ 215 (262)
T cd06613 141 KLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM---RALFL 215 (262)
T ss_pred EECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence 9999999876554321 11235688899999998776 7899999999999999999999998753221 11111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... ........ ........+.+++.+||+.+|.+|||+.+++.
T Consensus 216 ~~~~---~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 ISKS---NFPPPKLK-------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHhc---cCCCcccc-------chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1110 00000000 11122345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=312.09 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=196.1
Q ss_pred ccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCc
Q 006739 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDC 423 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 423 (633)
+||+|.||+||.|++. ++...+|||.+..... +..+-+..|+.+-++++|.|||+++|.+.+++.
T Consensus 582 VLGKGTYG~VYA~RD~-~tqvrIaIKEIpekds--------------r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf 646 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM-DTQVRIAIKEIPEKDS--------------REVQPLHEEIALHSTLRHKNIVRYLGSVSENGF 646 (1226)
T ss_pred EeecCceeEEEeeccc-cceeEEEeeecccccc--------------hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe
Confidence 6999999999999864 5778899998743221 124567889999999999999999999999999
Q ss_pred cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec-CCCceEEccccc
Q 006739 424 HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGL 502 (633)
Q Consensus 424 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~-~~~~~kl~DfG~ 502 (633)
.-+.||-++||+|.++++.... .-.-++.+.--+..||++||.|| |+..|||||||-.|||++ -.|.+||+|||-
T Consensus 647 ~kIFMEqVPGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISDFGT 722 (1226)
T KOG4279|consen 647 FKIFMEQVPGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISDFGT 722 (1226)
T ss_pred EEEEeecCCCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEeccccc
Confidence 8999999999999999986442 22237888888999999999999 788999999999999997 578999999999
Q ss_pred ccccCCCCCcceecccccCcccccccccccC--CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhcc
Q 006739 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTL--KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580 (633)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 580 (633)
++.+..- ...+....||..|||||++..+ .|+.++|||||||++.||.||++||.....+.... .+ .+-
T Consensus 723 sKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-----Fk--VGm 793 (1226)
T KOG4279|consen 723 SKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-----FK--VGM 793 (1226)
T ss_pred chhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-----hh--hcc
Confidence 8876542 2233557799999999999875 47889999999999999999999997654321111 11 111
Q ss_pred CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 581 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... +.-+++...+...++.+|+.+||.+||+++++++
T Consensus 794 yKvH--------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 YKVH--------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eecC--------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1111 1123444556889999999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=311.42 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=210.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCe--EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGK--MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..++....++||+|.||.|++|.|...+|+ .||||.++...... ...+|.+|+.+|.+|+|||++
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------------~mddflrEas~M~~L~H~hli 174 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------------IMDDFLREASHMLKLQHPHLI 174 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------------hHHHHHHHHHHHHhccCccee
Confidence 345566778999999999999999655554 68999997654321 267899999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++||...+ ....+|+|.++.|+|.+.|++ .....+.......++.|||.||.|| .+++.|||||..+|+++-..
T Consensus 175 RLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNlllasp 248 (1039)
T KOG0199|consen 175 RLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLLLASP 248 (1039)
T ss_pred EEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhheeccc
Confidence 99999887 667899999999999999987 3356688888899999999999999 89999999999999999999
Q ss_pred CceEEcccccccccCCCCCccee-cccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 493 MEARIADFGLAKAMPDAQTHITT-SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
..+||+|||+.+-++.+..+..+ ....-...|-|||.+...+++.++|||+|||++|||+| |..||-+... .++
T Consensus 249 rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qI 324 (1039)
T KOG0199|consen 249 RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQI 324 (1039)
T ss_pred ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHH
Confidence 99999999999998877655433 33345678999999999999999999999999999999 7889876432 222
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
.+ .+-..++. ..+..+.+.+++++..||..+|.+|||+..+.+.+
T Consensus 325 L~---~iD~~erL----------pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 325 LK---NIDAGERL----------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HH---hccccccC----------CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22 22122222 22344556699999999999999999999997543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=309.20 Aligned_cols=244 Identities=24% Similarity=0.283 Sum_probs=183.3
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC---CCCcccccceeeecC
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI---RHRNLLPLLAHMARP 421 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~ 421 (633)
||+|+||.||+|+.. .+++.||+|++..... ........+..|..++... +||||+++++++.+.
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~ 68 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEI-----------VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD 68 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHH-----------hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC
Confidence 799999999999864 5789999999843210 0111133445566666554 699999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..++.||++||+|| |+.+|+||||||+|||++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Dfg 141 (330)
T cd05586 69 SDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDFG 141 (330)
T ss_pred CeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecCC
Confidence 999999999999999988864 35689999999999999999999 68899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhcc
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 580 (633)
+++....... ......||..|+|||++.+. .++.++||||+||++|||++|+.||..... . +..+.....
T Consensus 142 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~----~---~~~~~i~~~ 212 (330)
T cd05586 142 LSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT----Q---QMYRNIAFG 212 (330)
T ss_pred cCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH----H---HHHHHHHcC
Confidence 9875433221 12345699999999998764 478999999999999999999999865221 1 112222111
Q ss_pred CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC----HHHHHH
Q 006739 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN----SKDVRC 626 (633)
Q Consensus 581 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs----~~ev~~ 626 (633)
... +.... ....+.+++.+||+.||.+||+ +.++++
T Consensus 213 ~~~-------~~~~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 KVR-------FPKNV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCC-------CCCcc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 100 00000 1223678889999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=293.26 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=198.4
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||+|... .+++.|++|.+........ ..+..+.+.+|+++++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~---------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 70 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQT---------GQEAVKQLEQEIALLSKLQHPNIVQYLGT 70 (258)
T ss_pred CccccceeeecCCceEEEEEEc-CCCcEEEEEEEEEcccccc---------chHHHHHHHHHHHHHHhcCCCCchheeee
Confidence 3667789999999999999764 4789999998855432111 11225678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+......++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+|+|+||+|+||+++.++.+||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl 143 (258)
T cd06632 71 EREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKL 143 (258)
T ss_pred EecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999875 24588999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
+|||++....... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..... .....++
T Consensus 144 ~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~--- 214 (258)
T cd06632 144 ADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKI--- 214 (258)
T ss_pred ccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHH---
Confidence 9999987754433 113356889999999987766 89999999999999999999999875421 1111111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ + .......+.+++.+||+.+|++||++.++++
T Consensus 215 -~~~~~~~~-~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 215 -GRSKELPP-I--------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -HhcccCCC-c--------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11000000 0 1111233678889999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.81 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=192.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHH-hhcCCCCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT-VGQIRHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~ 415 (633)
++|++.+.||+|+||.||+++.. .+|+.||+|++....... ...++..|+.. ++..+||||++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~~~~iv~~~ 66 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQ-------------EQKRLLMDLDISMRSVDCPYTVTFY 66 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcH-------------HHHHHHHHHHHHHHHcCCCCeeeee
Confidence 46888999999999999999865 579999999886442210 02233445444 5667899999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCeEecCCCc
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNP-RIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~Dikp~Nill~~~~~ 494 (633)
+++..+...++||||++ |+|.+++.........+++..++.++.|++.||+|| |++ +++||||||+||+++.++.
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil~~~~~~ 142 (283)
T cd06617 67 GALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQ 142 (283)
T ss_pred EEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCC
Confidence 99999999999999996 689888876544456799999999999999999999 555 8999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCccccccccccc----CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT----LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+||+|||++........ .....|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... ....+
T Consensus 143 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~ 217 (283)
T cd06617 143 VKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQL 217 (283)
T ss_pred EEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHH
Confidence 99999999886643221 123468899999998865 4568899999999999999999999864321 11111
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ....... ..... ....+.+++..||..+|++||++.++++
T Consensus 218 ~~~----~~~~~~~------~~~~~---~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 218 KQV----VEEPSPQ------LPAEK---FSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHH----HhcCCCC------CCccc---cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1111110 00011 1234778899999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=293.86 Aligned_cols=256 Identities=22% Similarity=0.317 Sum_probs=196.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++... .++..||+|.+......... .+..+.+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 71 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPET---------SKEVNALECEIQLLKNLLHERIVQYYG 71 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCccc---------HHHHHHHHHHHHHHHhcCCCCeeeEEe
Confidence 46888999999999999999764 57899999987543211110 112467888999999999999999999
Q ss_pred eeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 417 HMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 417 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++.+. ...++||||+++++|.+++.. ...+++.....++.|++.||+|| |+.+|+|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~ 144 (265)
T cd06652 72 CLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGN 144 (265)
T ss_pred EeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCC
Confidence 88764 457799999999999999874 23478889999999999999999 6788999999999999999999
Q ss_pred eEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
++|+|||+++........ .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ....
T Consensus 145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~--- 218 (265)
T cd06652 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAI--- 218 (265)
T ss_pred EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHH---
Confidence 999999998865432111 111234689999999999888899999999999999999999999865321 1111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......... ...+......+.+++.+|+. +|++||+++|+++
T Consensus 219 -~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 219 -FKIATQPTN---------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -HHHhcCCCC---------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111111100 01122233457788888984 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=291.71 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=199.9
Q ss_pred cccccccccccCeeEEEEEecCCC---CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
+++.+.||.|+||.||++.....+ +..||+|.+....... ..+.+..|++++..++|+||++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~~~~ 67 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-------------QIEEFLREARIMRKLDHPNIVKLL 67 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-------------HHHHHHHHHHHHHhcCCCchheEE
Confidence 356789999999999999875322 4889999985443210 146788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..+++|||+++++|.+++..... ..+++..+..++.|++.||+|| |+.+++|+||||+||++++++.+
T Consensus 68 ~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~ 142 (258)
T smart00219 68 GVCTEEEPLMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVV 142 (258)
T ss_pred EEEcCCCeeEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeE
Confidence 999999999999999999999999975321 2289999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 574 (633)
+|+|||+++.......... ....++..|+|||...+..++.++||||+|+++|||++ |+.||... ....+.+.+
T Consensus 143 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~ 217 (258)
T smart00219 143 KISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVLEYL 217 (258)
T ss_pred EEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHH
Confidence 9999999987765433222 12337889999999988889999999999999999998 78887642 112222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
. ....... .......+.+++.+|++.||++|||+.|+++.|
T Consensus 218 ~---~~~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 K---KGYRLPK----------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred h---cCCCCCC----------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 1111110 011233478899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=303.58 Aligned_cols=258 Identities=20% Similarity=0.320 Sum_probs=207.4
Q ss_pred cCcccccccccccCeeEEEEEecCC---CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGS---NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+..+..++||.|.||.||+|.+..- ..--||||.-+..-.. ...+.|..|..+|++++|||||+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-------------d~tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-------------DDTEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-------------hhHHHHHHHHHHHHhCCCcchhh
Confidence 4445567899999999999988422 2346888876542211 01457899999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++|.|.+. ..++|||.++-|.|.+++.. .+..++......++.||..||+|| |+.+.|||||..+|||+....
T Consensus 456 LIGv~~e~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsSp~ 528 (974)
T KOG4257|consen 456 LIGVCVEQ-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSSPQ 528 (974)
T ss_pred eeeeeecc-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecCcc
Confidence 99999865 46899999999999999986 356688889999999999999999 899999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||+++.+.+...+..+ ...-...|||||.+.-.+++.++|||.|||.+||++. |..||.+....+....
T Consensus 529 CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~--- 604 (974)
T KOG4257|consen 529 CVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH--- 604 (974)
T ss_pred eeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE---
Confidence 9999999999999887666543 3344678999999999999999999999999999987 9999987543322221
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+..+++.+ .++.+...+..++.+||..||.+||.+.|+...|.++.
T Consensus 605 ----iEnGeRlP----------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 605 ----IENGERLP----------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ----ecCCCCCC----------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 11222221 23334445788999999999999999999999998874
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.80 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=198.7
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||++... .+++.+|+|.+....... +..+.+.+|+++++.++|||++++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTK------------DERLAAQNECQVLKLLSHPNIIEYYEN 67 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-CCCcEEEEEEEecccccc------------HHHHHHHHHHHHHhhCCCCchhheeee
Confidence 4788899999999999999864 478899999985433211 124678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC-CceE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD-MEAR 496 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~-~~~k 496 (633)
+...+..++||||+++++|.+++.... ...+++..+..++.++++||+|| |+.+|+|+||+|+||+++++ +.+|
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~~ 142 (256)
T cd08220 68 FLEDKALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVVK 142 (256)
T ss_pred EecCCEEEEEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEE
Confidence 999999999999999999999997532 34589999999999999999999 78899999999999999865 4579
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
++|||.+......... ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... .... ..
T Consensus 143 l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~---~~ 212 (256)
T cd08220 143 IGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PALV---LK 212 (256)
T ss_pred EccCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHHH---HH
Confidence 9999999876543221 234688999999999988899999999999999999999999865321 1111 11
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ + .......+.+++.+||+.+|++|||+.|+++
T Consensus 213 ~~~~~~~~------~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 213 IMSGTFAP------I----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHhcCCCC------C----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11111100 0 0011223778899999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=296.18 Aligned_cols=252 Identities=19% Similarity=0.325 Sum_probs=200.5
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|+||.||++... .+|+.||+|.+...... ....+++.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMS------------PKEREESRKEVAVLSNMKHPNIVQYQES 67 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCC------------hHHHHHHHHHHHHHHhCCCCCeeeeEee
Confidence 4788999999999999999865 57889999987543211 1124578899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++++|.+++.... ...+++..+..++.|++.|+.|| |+.+++|+||+|+||+++.++.+++
T Consensus 68 ~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~l 142 (256)
T cd08218 68 FEENGNLYIVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIKL 142 (256)
T ss_pred ecCCCeEEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEEE
Confidence 999999999999999999999887522 34578999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||++......... .....|++.|+|||+..+..++.++|+|||||++|+|++|+.||.... ..+.....
T Consensus 143 ~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-------~~~~~~~~ 213 (256)
T cd08218 143 GDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-------MKNLVLKI 213 (256)
T ss_pred eeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-------HHHHHHHH
Confidence 999999866543221 123458899999999998889999999999999999999999986421 11122222
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... ........+.+++.+||+.+|++||++.|+++
T Consensus 214 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 214 IRGSYPP----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred hcCCCCC----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2211110 01112234788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=300.87 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=194.1
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|+..+.||+|+||.||+|+.. .+|+.||+|.+........ ....+.+|++++++++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~------------~~~~~~~ei~~l~~l~h~~i~~~~~~ 67 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEG------------VPSSALREICLLKELKHKNIVRLYDV 67 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-CCCcEEEEEEeeccccccc------------CccchhHHHHHHHhcCCCCeeeHHHH
Confidence 3778899999999999999875 5788999998864322110 12456779999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+....++|+||++ ++|.+++... ...+++..+..++.||++||.|| |+.+|+||||||+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~l 140 (284)
T cd07839 68 LHSDKKLTLVFEYCD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELKL 140 (284)
T ss_pred hccCCceEEEEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEEE
Confidence 999999999999996 5888877642 34589999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
+|||+++........ .....++..|+|||++.+. .++.++|||||||++|||++|+.|+..... .....+.+..
T Consensus 141 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~---~~~~~~~~~~ 215 (284)
T cd07839 141 ADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIFR 215 (284)
T ss_pred CccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC---HHHHHHHHHH
Confidence 999998865433221 1234578999999988764 478999999999999999999999643221 1111111111
Q ss_pred hhccCCcc--------------hhhhhhhh-hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPT--------------RAIDAKLL-ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~--------------~~~d~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ ........ ....+.....+.+++.+||+.||.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 11100000 00000000 0001112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=321.93 Aligned_cols=286 Identities=18% Similarity=0.232 Sum_probs=194.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchh---hhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAA---ELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.++|++.+.||+|+||+||++.++..++..++.|.+........ ...............++.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46899999999999999999987655555555543321111100 000000111122355788999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
++++++...+..|+|+|++. ++|.+++..... ............|+.|++.||+|| |+.+|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECC
Confidence 99999999999999999995 577777653221 122334566778999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
++.+||+|||+++.+........ ....||..|+|||++.+..++.++|||||||++|||++|..++...........+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFD-YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCccccccc-ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999987754432221 23579999999999999999999999999999999999886432211111222222
Q ss_pred HHHHHhh--ccCCcc---hhhh---hhhhh---cCCHH------HHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVM--TSENPT---RAID---AKLLE---NGYEE------QMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~--~~~~~~---~~~d---~~~~~---~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+.... ....+. +..+ ..... ...+. ....+.+++.+||+.||.+|||+.|+++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 2222110 000000 0000 00000 00000 1123567788999999999999999986
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.09 Aligned_cols=259 Identities=21% Similarity=0.296 Sum_probs=198.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|+||.||++... .+++.||+|.+..... ........+.+|+++++.++||||+++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~ik~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK-ETRQRFAMKKINKQNL-----------ILRNQIQQVFVERDILTFAENPFVVSMFC 68 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC-CCCcEEEEEEeehhhh-----------hhHHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence 36888999999999999999864 5688999998743211 11122457888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.+..++..++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+++||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~ 141 (305)
T cd05609 69 SFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIK 141 (305)
T ss_pred EEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEE
Confidence 99999999999999999999999965 34589999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCC-------------cceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccc
Q 006739 497 IADFGLAKAMPDAQT-------------HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 497 l~DfG~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
++|||+++....... ........|+..|+|||.+.+..++.++|+|||||++|||++|+.||.+..
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~- 220 (305)
T cd05609 142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT- 220 (305)
T ss_pred EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 999999874211100 001112357889999999988889999999999999999999999986421
Q ss_pred ccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
.. ++........... +.. .. .....+.+++.+||+.||++||++.++.+.|+
T Consensus 221 ---~~---~~~~~~~~~~~~~----~~~-~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 221 ---PE---ELFGQVISDDIEW----PEG-DE---ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ---HH---HHHHHHHhcccCC----CCc-cc---cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11 1222211111000 000 00 11223678999999999999999776666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.75 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=200.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..+.|+.-++||+||||.||-++.+ .+|+.||.|++.+... ...+...-...|-.++.++..+.||.+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRi-----------Kkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRI-----------KKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred cccceeeeEEEecccccceeEEEEe-cchhhHHHHHHHHHHH-----------HHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 4467888999999999999999865 6899999998733211 011123446788999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
--.|...+.+|+|+..|.||+|.-+|... +...+++..+.-++.+|+.||++| |+.+||+||+||+|||+|+.|+
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHGH 325 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCCC
Confidence 99999999999999999999998877653 346799999999999999999999 8999999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
++|+|.|+|..+.++... ...+||.+|||||++....|+...|+||+||++|||+.|+.||...-+-....++.+.
T Consensus 326 vRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr- 401 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR- 401 (591)
T ss_pred eEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH-
Confidence 999999999999887654 3358999999999999999999999999999999999999998642211111111111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK 622 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 622 (633)
... |+....+.+++ ...++.+..|..||++|...+
T Consensus 402 --~~~--------~~~ey~~kFS~---eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 --TLE--------DPEEYSDKFSE---EAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --Hhc--------chhhcccccCH---HHHHHHHHHHccCHHHhccCC
Confidence 111 11111222333 355666689999999997543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=300.20 Aligned_cols=264 Identities=26% Similarity=0.340 Sum_probs=199.0
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||+|++|.||+|... .+|+.||+|++....... .....+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEG------------GIPNQALREIKALQACQHPYVVKLLDV 67 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccc------------hhhHHHHHHHHHHHhCCCCCCcceeeE
Confidence 4778899999999999999864 468999999986543211 114568889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+......++||||+ +++|.+++... ...+++..+..++.|+++||+|| |+.+++|+||||+||+++.++.++|
T Consensus 68 ~~~~~~~~~v~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~l 140 (286)
T cd07832 68 FPHGSGFVLVMEYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLKI 140 (286)
T ss_pred EecCCeeEEEeccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEEE
Confidence 99999999999999 99999998753 25689999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
+|||++......... ......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||..... ......+..
T Consensus 141 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~ 215 (286)
T cd07832 141 ADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFR 215 (286)
T ss_pred eeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHH
Confidence 999999876544321 12335689999999988654 468899999999999999999877754221 111111111
Q ss_pred hhccCCcc------hhhh----------hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPT------RAID----------AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~------~~~d----------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ ...+ ........++....+.+++.+|++.+|++||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11100000 0000 00000011122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.61 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=196.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
..|+....||+|+||.||++... .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~--------------~~~~~~~e~~~l~~l~hp~i~~~~~ 85 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQ--------------RRELLFNEVVIMRDYQHQNVVEMYK 85 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccc--------------hHHHHHHHHHHHHhCCCCchhhhhh
Confidence 34455678999999999999864 47889999998432210 1345778999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++..++..++||||+++++|.+++.. ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.++
T Consensus 86 ~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~k 157 (297)
T cd06659 86 SYLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVK 157 (297)
T ss_pred heeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEE
Confidence 99999999999999999999998753 4589999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||++......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.
T Consensus 158 L~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~- 230 (297)
T cd06659 158 LSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLR- 230 (297)
T ss_pred EeechhHhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh-
Confidence 9999998765443221 1235689999999999988899999999999999999999999864221 11111111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...... . .........+.+++.+|++.+|++||+++++++
T Consensus 231 --~~~~~~-~-------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 231 --DSPPPK-L-------KNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred --ccCCCC-c-------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 111000 0 000011233778899999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.52 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=197.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|++|.||++... .+++.||+|.+..... ...+....+.+|++++++++||||+++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKI-----------VKLKQVEHVLNEKRILQSIRHPFLVNLYG 68 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHHhCCCCCccceee
Confidence 36888999999999999999875 4789999998753211 01122466889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+|+|+||+|+||+++.++.+|
T Consensus 69 ~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~k 141 (290)
T cd05580 69 SFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIK 141 (290)
T ss_pred EEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999875 35689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+++..... .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ... .+.
T Consensus 142 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~---~~~ 209 (290)
T cd05580 142 ITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQI---YEK 209 (290)
T ss_pred EeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHH---HHH
Confidence 9999998876543 1234689999999999888889999999999999999999999865321 111 111
Q ss_pred hhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHH
Q 006739 577 VMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVR 625 (633)
Q Consensus 577 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~ 625 (633)
..... ..... ....+.+++.+||+.||.+|| +++|++
T Consensus 210 ~~~~~~~~~~~------------~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 210 ILEGKVRFPSF------------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred HhcCCccCCcc------------CCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11111 11111 123477888999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=291.59 Aligned_cols=240 Identities=19% Similarity=0.295 Sum_probs=186.7
Q ss_pred cccccccCeeEEEEEecCCC---------CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 343 EKIGSGGCGEVYKAELPGSN---------GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+.||+|+||.||+|.+.... ...+++|.+..... ....+.+|+.++++++||||++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~ 65 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---------------DSLAFFETASLMSQLSHKHLVK 65 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---------------hHHHHHHHHHHHHcCCCcchhh
Confidence 46899999999999885322 13577776532211 0356788999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.. ...++||||+++|+|.+++.... ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++
T Consensus 66 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~~ 138 (259)
T cd05037 66 LYGVCVR-DENIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARYG 138 (259)
T ss_pred eeeEEec-CCcEEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecCc
Confidence 9999988 77899999999999999997532 2689999999999999999999 788999999999999999887
Q ss_pred -------ceEEcccccccccCCCCCcceecccccCcccccccccccC--CCCCccchHHHHHHHHHHHh-CCCCCccccc
Q 006739 494 -------EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL--KFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQ 563 (633)
Q Consensus 494 -------~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~ 563 (633)
.+||+|||++...... ....++..|+|||++.+. .++.++||||||+++|||++ |..||.....
T Consensus 139 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 139 LNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred cccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 7999999998865441 223567789999998876 78999999999999999999 5777755321
Q ss_pred ccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
.....+.. ....... . ....+.+++.+||..+|++|||+.++++.|+
T Consensus 213 ----~~~~~~~~---~~~~~~~-~-----------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 213 ----SEKERFYQ---DQHRLPM-P-----------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----hhHHHHHh---cCCCCCC-C-----------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111111 1110000 0 0145788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=295.43 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=204.8
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
-|...+.||+|.|+.|-+|++- -+|++||||++.+...+... ...+.+|+++|+.++|||||++|.+
T Consensus 19 LYDLekTlG~GHFAVVKLArHV-FTGekVAVKviDKTKlD~~s------------t~hlfqEVRCMKLVQHpNiVRLYEV 85 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDTLS------------TGHLFQEVRCMKLVQHPNIVRLYEV 85 (864)
T ss_pred eehhhhhhcCCceehhhhhhhh-cccceeEEEEecccccchhh------------hhHHHHHHHHHHHhcCcCeeeeeeh
Confidence 4677789999999999999764 47999999999776654332 4567889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec-CCCceE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEAR 496 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~-~~~~~k 496 (633)
......+|||.|.-++|+|++++-+ +...+.+....++..||+.|+.|. |+..+|||||||+||.+- +-|-+|
T Consensus 86 iDTQTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YC---HqLHVVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 86 IDTQTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYC---HQLHVVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred hcccceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHH---hhhhhhcccCCcceeEEeeecCceE
Confidence 9999999999999999999999976 345689999999999999999999 455599999999998765 568899
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|.|||++..+.++.... ..+|+..|-|||++.+..|+ +++||||+||++|.|++|+.||+.... ...+...+
T Consensus 160 LTDFGFSNkf~PG~kL~---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmIm- 232 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGKKLT---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIM- 232 (864)
T ss_pred eeeccccccCCCcchhh---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhh-
Confidence 99999999888776443 36899999999999999986 579999999999999999999976432 12221111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... ..+.....++.++|..||..||.+|.+.+|++.
T Consensus 233 DCKY--------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKY--------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccc--------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1110 122334456889999999999999999999874
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=298.83 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=195.6
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||.|++|.||+|+.. .+++.||+|++....... .....+.+|++++++++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 67 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETE------------GVPSTAIREISLLKELNHPNIVKLLDV 67 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-CCCCEEEEEEcccccccc------------ccchHHHHHHHHHHhcCCCCCcchhhh
Confidence 4788899999999999999864 578899999885432111 113467889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+. ++|.+++.... ...+++..+..++.|+++||+|| |+.+++|+||+|+||++++++.+||
T Consensus 68 ~~~~~~~~~v~e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l 141 (284)
T cd07860 68 IHTENKLYLVFEFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKL 141 (284)
T ss_pred cccCCcEEEEeeccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEE
Confidence 999999999999995 68988886532 35689999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
+|||++......... .....++..|+|||++.+.. ++.++||||||+++|||+||+.||..... .....+....
T Consensus 142 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~ 216 (284)
T cd07860 142 ADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRT 216 (284)
T ss_pred eeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHH
Confidence 999998766433211 12345788999999887644 58899999999999999999999864221 1122221111
Q ss_pred hhccCC---------------cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSEN---------------PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~---------------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...... ......... ....+.....+.+++.+|++.||++|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 217 LGTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hCCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 100000 000000000 0000111234678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.66 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=195.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|++|.||+|..+ .+++.||+|.+........ ...+.+|++++++++|+||++++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~-------------~~~~~~E~~~l~~l~h~~i~~~~ 69 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGA-------------PFTAIREASLLKDLKHANIVTLH 69 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCC-------------chhHHHHHHHHhhCCCcceeeEE
Confidence 367899999999999999999864 5788999999864332110 23456799999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++ +|.+++... ...+++.....++.|+++||.|| |+.+|+||||||+||++++++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~ 142 (291)
T cd07844 70 DIIHTKKTLTLVFEYLDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGEL 142 (291)
T ss_pred EEEecCCeEEEEEecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCE
Confidence 999999999999999975 999988652 24688999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++........ .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||....... ...+.+
T Consensus 143 kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~ 217 (291)
T cd07844 143 KLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE---DQLHKI 217 (291)
T ss_pred EECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHH
Confidence 99999998754322111 122346889999998865 457899999999999999999999986533111 111111
Q ss_pred HHhhccCCcch----------------hh-hhhhhhcCCHHH--HHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTR----------------AI-DAKLLENGYEEQ--MLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~----------------~~-d~~~~~~~~~~~--~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........... .. ...+ ....... ...+.+++.+|++.+|++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPL-INHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHhcCCCChhhhhhhhhccccccccccccCChhH-HHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 11111000000 00 0000 0000001 145678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=290.62 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=204.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|++|.||+|+.. .+++.|++|++...... .....+.+|+.++.+++|+|++++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~vk~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDE-------------EFRKQLLRELKTLRSCESPYVVKCYG 66 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeccCcch-------------HHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 36788899999999999999876 46899999998654321 12567889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCeEecCCCce
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHN-PRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~Dikp~Nill~~~~~~ 495 (633)
++......++||||+++++|.+++... ..+++..+..++.|+++|++|| |+ .+++|+||+|+||+++.++.+
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~ 139 (264)
T cd06623 67 AFYKEGEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEV 139 (264)
T ss_pred EEccCCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCE
Confidence 999999999999999999999999752 5689999999999999999999 77 999999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|+|||.+.......... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ..... ..
T Consensus 140 ~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~---~~ 213 (264)
T cd06623 140 KIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFEL---MQ 213 (264)
T ss_pred EEccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHH---HH
Confidence 999999988765433221 2345789999999999888999999999999999999999998764321 11122 22
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
......... .+ .. .....+.+++..|++.+|++||++.++++.
T Consensus 214 ~~~~~~~~~--~~----~~---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 AICDGPPPS--LP----AE---EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHhcCCCCC--CC----cc---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222111111 00 00 022357888999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=299.27 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=197.8
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||+|... .+++.||+|.+......... ......+..|++++++++|+||++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~---------~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 70 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAK---------DGINFTALREIKLLQELKHPNIIGLLDV 70 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC-CCCcEEEEEEEecccccccc---------chhhHHHHHHHHHHhhcCCCCChhhhhe
Confidence 3677889999999999999864 46889999998655432100 0113456789999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+ +++|.+++.... ..+++..+..++.||++||+|| |+.+|+|+||||+||+++.++.++|
T Consensus 71 ~~~~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l 143 (298)
T cd07841 71 FGHKSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKL 143 (298)
T ss_pred eecCCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEE
Confidence 99999999999999 899999997522 3699999999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
+|||+++......... ....++..|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+.+....
T Consensus 144 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~ 218 (298)
T cd07841 144 ADFGLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEA 218 (298)
T ss_pred ccceeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHH
Confidence 9999998765432211 22356888999998855 45788999999999999999998777543221 111111111
Q ss_pred hhccCCc---------chhhhhhh-----hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 577 VMTSENP---------TRAIDAKL-----LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 577 ~~~~~~~---------~~~~d~~~-----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
...... ........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 219 -LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred -cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 00000000 000111223457899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=295.25 Aligned_cols=270 Identities=17% Similarity=0.196 Sum_probs=188.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCC---CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..+|.+.+.||+|+||.||+|.... + +..+|+|+........ ..+..............++..+..+.|+|++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~~~~~~~k~~~~~~~~~---~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCAS-DHCINNQAVAKIENLENETI---VMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcC-CcccccceEEEeccccCCch---hhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 3579999999999999999998752 3 4567777543322111 0010001111122334455667778999999
Q ss_pred ccceeeecCC----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 413 PLLAHMARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 413 ~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
++++++.... ..++++|++. .++.+.+.. ....++..+..|+.|+++||+|| |+.+|+||||||+|||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nil 158 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIM 158 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEE
Confidence 9999765543 2367888774 467666654 22357888899999999999999 6789999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCc-----ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTH-----ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
++.++.++|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999876432211 111234699999999999999999999999999999999999999976422
Q ss_pred ccccch--HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 564 HTEEMS--LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 564 ~~~~~~--~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
...... ..++........ .. .......+.+++..|++.+|++||++.++++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~---------~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNLIHAAKCDFIKRLHEGK---------IK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHHHHHhHHHHHHHhhhhh---------hc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111111 112222221111 00 1111344788889999999999999999998763
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=297.35 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=195.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~ 415 (633)
++|+..+.||+|+||.||++... .+++.||+|.+...... .....+.+|+.++.++. |+||++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~~iv~~~ 69 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDE-------------KEQKRLLMDLDVVMRSSDCPYIVKFY 69 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccCh-------------HHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 45677889999999999999865 57899999988543211 12456888999999996 99999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVS-QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+++..+...+++|||++ +++.++..... .....+++..+..++.++++||+||| ++.+|+||||||+||+++.++.
T Consensus 70 ~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~ 146 (288)
T cd06616 70 GALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGN 146 (288)
T ss_pred eEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCc
Confidence 99999999999999985 46666543211 12356899999999999999999996 4568999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccC---CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL---KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
++|+|||+++........ ....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...
T Consensus 147 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~ 217 (288)
T cd06616 147 IKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVF 217 (288)
T ss_pred EEEeecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHH
Confidence 999999999765443221 223588999999998776 68899999999999999999999986532 111
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+........+. +...........+.+++.+||+.||++|||++++++
T Consensus 218 ~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 218 DQLTQVVKGDPPI------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHhhhcCCCCCc------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122221111110 101111112334788999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=299.83 Aligned_cols=273 Identities=21% Similarity=0.259 Sum_probs=197.6
Q ss_pred CcccccccccccCeeEEEEEecCC-CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGS-NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.|++.+.||+|+||.||+|..... +++.||+|.+......... ....+.+|+.++.+++||||+++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG-----------ISQSACREIALLRELKHENVVSLVE 69 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccC-----------ccHHHHHHHHHHHhcCCCCccceEE
Confidence 477889999999999999987532 6899999998764311000 1345678999999999999999999
Q ss_pred eeecC--CccEEEEecccCCCHHHHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC--
Q 006739 417 HMARP--DCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-- 491 (633)
Q Consensus 417 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~-- 491 (633)
++.+. +..++||||+++ +|.+++....... ..++...++.++.|++.||+|| |+.+|+||||||+||+++.
T Consensus 70 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~ 145 (316)
T cd07842 70 VFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEG 145 (316)
T ss_pred EEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCC
Confidence 99887 789999999975 7777775433322 3789999999999999999999 7889999999999999999
Q ss_pred --CCceEEcccccccccCCCCC-cceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccc-
Q 006739 492 --DMEARIADFGLAKAMPDAQT-HITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE- 566 (633)
Q Consensus 492 --~~~~kl~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~- 566 (633)
++.+||+|||+++....... ........++..|+|||++.+. .++.++||||||+++|||++|+.||........
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 225 (316)
T cd07842 146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK 225 (316)
T ss_pred CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence 99999999999987654322 1122345678999999987664 578999999999999999999999975433210
Q ss_pred -----cchHHHHHHHhhccCCc------------ch--------hhh-hhhhhcCC--HHHHHHHHHHHhHhccCCCCCC
Q 006739 567 -----EMSLVKWMRNVMTSENP------------TR--------AID-AKLLENGY--EEQMLLVLKIACFCTVDSPRER 618 (633)
Q Consensus 567 -----~~~~~~~~~~~~~~~~~------------~~--------~~d-~~~~~~~~--~~~~~~~~~l~~~cl~~dP~~R 618 (633)
...+.+.+... ..... .. ... ..+..... ......+.+++.+|++.||++|
T Consensus 226 ~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 304 (316)
T cd07842 226 SNPFQRDQLERIFEVL-GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR 304 (316)
T ss_pred cchhHHHHHHHHHHHh-CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccC
Confidence 01111111110 00000 00 000 00000000 0122357889999999999999
Q ss_pred CCHHHHHH
Q 006739 619 PNSKDVRC 626 (633)
Q Consensus 619 Ps~~ev~~ 626 (633)
||+.|+++
T Consensus 305 ps~~eil~ 312 (316)
T cd07842 305 ITAEEALE 312 (316)
T ss_pred cCHHHHhc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=289.54 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=199.7
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|+||.||++... .+++.||+|.+...... .+..+.+.+|+.++++++|+||++++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~ 67 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDND------------PKTIKEIADEMKVLELLKHPNLVKYYGV 67 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccc------------hHHHHHHHHHHHHHHhCCCCChhheeee
Confidence 4778899999999999999864 46889999998654321 1225778999999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++|+||+++++|.+++.. ...+++..+..++.++++||+|| |+.+|+|+||+|+||++++++.+||
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~kl 140 (264)
T cd06626 68 EVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIKL 140 (264)
T ss_pred EecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999875 34578999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcce--ecccccCcccccccccccCC---CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 498 ADFGLAKAMPDAQTHIT--TSNVAGTVGYIAPEYHQTLK---FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+|||++........... .....++..|+|||++.+.. ++.++||||||+++||+++|+.||..... ....
T Consensus 141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~-- 215 (264)
T cd06626 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EFQI-- 215 (264)
T ss_pred cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hHHH--
Confidence 99999887655432211 11346788999999988766 88999999999999999999999965321 1111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........... +. . .......+.+++.+||+.+|++||++.|++.
T Consensus 216 -~~~~~~~~~~~--~~----~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 216 -MFHVGAGHKPP--IP----D--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -HHHHhcCCCCC--CC----c--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111100 00 0 0011233678889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=294.14 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=196.0
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC---CCccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR---HRNLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l 414 (633)
.|+..+.||+|+||.||+|.+. .+++.||+|.+...... ....++.+|+.++++++ |||++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~~~~vi~~ 67 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPD-------------DDVSDIQREVALLSQLRQSQPPNITKY 67 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCc-------------hhHHHHHHHHHHHHHhccCCCCCeeeE
Confidence 4777899999999999999864 57899999987543211 11346778888888886 9999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++......++||||+++++|.+++.. ..+++.....++.|+++||.|| |+.+|+|+||+|+||++++++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~~ 139 (277)
T cd06917 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTGN 139 (277)
T ss_pred eeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCCC
Confidence 9999999999999999999999998864 2689999999999999999999 7889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
++|+|||++......... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .+.
T Consensus 140 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-------~~~ 210 (277)
T cd06917 140 VKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-------FRA 210 (277)
T ss_pred EEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-------hhh
Confidence 999999999876554321 123468999999998865 4468899999999999999999999875321 111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...... .... .+.... ....+.+++.+||+.||++||++.|+++
T Consensus 211 ~~~~~~-~~~~-----~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 211 MMLIPK-SKPP-----RLEDNG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred hhcccc-CCCC-----CCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111111 1111 111111 2234778899999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=294.94 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=199.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+-|+..+.||+|+||.||+|... .++..||+|.+..... ......+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 69 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEA-------------EDEIEDIQQEITVLSQCDSPYVTKYYG 69 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccc-------------hHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 45778899999999999999764 4788999998743221 111457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++..++..++||||+++++|.+++.. ..+++..+..++.|++.|+.|| |+.+++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~~ 141 (277)
T cd06641 70 SYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEVK 141 (277)
T ss_pred EEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCEE
Confidence 99999999999999999999999863 3588999999999999999999 789999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
++|||++......... .....|+..|+|||...+..++.++|+|||||++|+|++|..||..... .. ....
T Consensus 142 l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~---~~~~ 212 (277)
T cd06641 142 LADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MK---VLFL 212 (277)
T ss_pred Eeecccceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HH---HHHH
Confidence 9999998766543211 1234678899999999888889999999999999999999999865321 11 1111
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
....... .+ .......+.+++.+|++.+|++||++.++++.
T Consensus 213 ~~~~~~~--~~--------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 213 IPKNNPP--TL--------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HhcCCCC--CC--------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111110 01 11122347788999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.60 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=194.8
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLL 412 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 412 (633)
.....|++.+.||+|+||.||+|... .+++.+|+|.+..... ...++..|+.++.++ +|+||+
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~~~---------------~~~~~~~e~~~l~~~~~h~~i~ 76 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTED---------------EEEEIKLEINMLKKYSHHRNIA 76 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecChH---------------HHHHHHHHHHHHHHhcCCCcEE
Confidence 34578899999999999999999875 4788999998743211 134577888898888 699999
Q ss_pred ccceeeec------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 413 PLLAHMAR------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 413 ~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
++++++.. ....+++|||+++|+|.+++.... ...+++..+..++.|+++||+|| |+.+|+|+||||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~n 151 (282)
T cd06636 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQN 151 (282)
T ss_pred EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHH
Confidence 99999853 456789999999999999987533 34578888999999999999999 67899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
|++++++.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 152 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 152 VLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 9999999999999999876543221 112356899999999875 346788999999999999999999998653
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... .... ...... .. .... ......+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~---~~~~----~~~~~~-~~-----~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPM---RALF----LIPRNP-PP-----KLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHH---hhhh----hHhhCC-CC-----CCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 211 1110 000000 00 0001 112234888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.58 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=200.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|++|.||++... .+++.||+|.+....... ....+.+.+|+++++.++|+||+++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 68 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIK-----------RNKVKRVLTEQEILATLDHPFLPTLYA 68 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccch-----------HHHHHHHHHHHHHHHhCCCCCchhhee
Confidence 36888899999999999999875 468999999986543211 112567889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.+......++||||+++++|.+++... ....+++..+..++.|+++||+|| |+.+++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~ 143 (316)
T cd05574 69 SFQTETYLCLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIM 143 (316)
T ss_pred eeecCCEEEEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEE
Confidence 999999999999999999999998742 245689999999999999999999 688999999999999999999999
Q ss_pred EcccccccccCCCCCcc---------------------------eecccccCcccccccccccCCCCCccchHHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHI---------------------------TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLA 549 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ 549 (633)
|+|||++.......... ......||..|+|||+..+..++.++||||||+++|
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~ 223 (316)
T cd05574 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223 (316)
T ss_pred EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHH
Confidence 99999987653221100 011246889999999999888999999999999999
Q ss_pred HHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC----HHHHH
Q 006739 550 VLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN----SKDVR 625 (633)
Q Consensus 550 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs----~~ev~ 625 (633)
+|++|+.||..... ...+.+. ....... .........+.+++.+||+.||++||+ ++|++
T Consensus 224 ~l~~g~~pf~~~~~---~~~~~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 224 EMLYGTTPFKGSNR---DETFSNI----LKKEVTF---------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHhhCCCCCCCCch---HHHHHHH----hcCCccC---------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 99999999865322 1111111 1111000 000012345888999999999999999 66665
Q ss_pred H
Q 006739 626 C 626 (633)
Q Consensus 626 ~ 626 (633)
.
T Consensus 288 ~ 288 (316)
T cd05574 288 Q 288 (316)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=307.32 Aligned_cols=270 Identities=23% Similarity=0.351 Sum_probs=203.4
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeee
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 419 (633)
...+.||+|+||.||+|+. +.+|+.||||.+.....- +..+...+|++++++++|+|||++.+.=.
T Consensus 16 ~~~e~LG~Ga~g~V~rgrn-ketG~~vAvK~~~~~~~~-------------r~~e~~~~EieilkKLnh~NIVk~f~iee 81 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRN-KETGRLVAVKTFNKESSL-------------RPRERWCREIEILKKLNHPNIVKLFDIEE 81 (732)
T ss_pred eehhhhcCCccceeeeecc-cccccchhHHhhhhhccc-------------chHHHHHHHHHHHHHcCchhhhhhcccCC
Confidence 4457899999999999985 468999999998654311 11456788999999999999999998754
Q ss_pred cC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec--C
Q 006739 420 RP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD--D 491 (633)
Q Consensus 420 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~--~ 491 (633)
+. +...+|||||.+|||...+.+ ..+...+++.+.+.++.++..||.|| |+.+|+||||||.||++- .
T Consensus 82 ~~~~~~~~~~~vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~Ge 157 (732)
T KOG4250|consen 82 TKFLGLVTRLPVLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQIGE 157 (732)
T ss_pred ccccCcccccceEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEeecC
Confidence 43 356899999999999999986 33467799999999999999999999 788999999999999984 3
Q ss_pred CCc--eEEcccccccccCCCCCcceecccccCcccccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 492 DME--ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 492 ~~~--~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+|+ .||+|||.|+..+++.. ....+||..|.+||++. ...|+..+|.|||||++|+..||..||.....+....
T Consensus 158 dgq~IyKLtDfG~Arel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~ 234 (732)
T KOG4250|consen 158 DGQSIYKLTDFGAARELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK 234 (732)
T ss_pred CCceEEeeecccccccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc
Confidence 343 69999999999988763 35588999999999999 4889999999999999999999999997655442211
Q ss_pred hHHHHHHHhhccCCcchhhhhhh------------hhcCCHHHHHHHHHHHhHhccCCCCCCC--CHHHHHHHHHhh
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKL------------LENGYEEQMLLVLKIACFCTVDSPRERP--NSKDVRCMLSQI 631 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~------------~~~~~~~~~~~~~~l~~~cl~~dP~~RP--s~~ev~~~l~~~ 631 (633)
.+ .|...........-.+.+.. ...-.+.....+.+++..++..+|.+|. ...+....+.+|
T Consensus 235 ~~-~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 235 EI-MWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred hh-hhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11 11111000000000011111 1112234455677888889999999999 777777666654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=273.45 Aligned_cols=254 Identities=23% Similarity=0.457 Sum_probs=198.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.++++.+..||.|..|.|++++++ +.|...|||.+....- .++.+++...+.++..-+ .|.||+.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~N-------------kee~kRILmDldvv~~s~dcpyIV~c 156 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGN-------------KEENKRILMDLDVVLKSHDCPYIVQC 156 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEc-ccceEEEEEeecccCC-------------HHHHHHHHHhhhHHhhccCCCeeeee
Confidence 456677889999999999999986 5789999999865542 122567778888877665 8999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+|||..+...++.||.|. ..++.++++. ..++++.-.-++...+..||.||. ..++|+|||+||+|||+|+.|+
T Consensus 157 ~GyFi~n~dV~IcMelMs-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLK--eKH~viHRDvKPSNILlDe~Gn 230 (391)
T KOG0983|consen 157 FGYFITNTDVFICMELMS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGN 230 (391)
T ss_pred eeEEeeCchHHHHHHHHH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHH--HhcceeecccCccceEEccCCC
Confidence 999999999999999994 4677777754 356888888899999999999997 5668999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+|+||||++..+-+...+ +...|.+.|||||.+.- .+|+.++||||||++++||.||+.||..... +....
T Consensus 231 iKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t---dFe~l 304 (391)
T KOG0983|consen 231 IKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT---DFEVL 304 (391)
T ss_pred EEeecccccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc---cHHHH
Confidence 999999999877665443 34579999999998864 4689999999999999999999999976422 12222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+..++. + .++... .+ ...+.+++..||.+|+.+||...++++
T Consensus 305 ---tkvln~eP-P-~L~~~~---gF---Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 305 ---TKVLNEEP-P-LLPGHM---GF---SPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ---HHHHhcCC-C-CCCccc---Cc---CHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22222221 1 111111 11 123778888999999999999998875
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=297.84 Aligned_cols=268 Identities=21% Similarity=0.270 Sum_probs=197.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|+||.||+|..+ .+++.+|+|.+....... .....+.+|+.++.+++||||+++++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~ni~~~~~ 71 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKE------------GFPITSLREINILLKLQHPNIVTVKE 71 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccc------------cchhhHHHHHHHHHhcCCCCEEEEEE
Confidence 57899999999999999999875 468899999986443210 11345678999999999999999999
Q ss_pred eeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 417 HMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 417 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++... ...++||||++ ++|.+++... ...+++..+..++.|++.||+|| |+.+|+|+||||+||++++++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~~ 144 (293)
T cd07843 72 VVVGSNLDKIYMVMEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRGI 144 (293)
T ss_pred EEEecCCCcEEEEehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCc
Confidence 98877 88999999997 4999988652 23689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
++|+|||+++........ .....++..|+|||.+.+. .++.++|+||+|+++|||++|+.||...........+...
T Consensus 145 ~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (293)
T cd07843 145 LKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL 222 (293)
T ss_pred EEEeecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999876554221 1234578899999988764 4688999999999999999999998753221111111100
Q ss_pred HH-----------Hhh--ccCCcchhhhhhhhhcCCHH-HHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MR-----------NVM--TSENPTRAIDAKLLENGYEE-QMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~-----------~~~--~~~~~~~~~d~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ... ............+....... ....+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 223 LGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000 00000000000010011111 2345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=298.09 Aligned_cols=268 Identities=23% Similarity=0.278 Sum_probs=194.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~ 415 (633)
++|+..+.||+|+||.||+|... .+++.||+|++....... .....+.+|+.+++.++ ||||++++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~i~~~~ 67 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEE------------GIPPTALREISLLQMLSESIYIVRLL 67 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhcccc------------CCchHHHHHHHHHHHccCCCCcccee
Confidence 36888999999999999999875 578999999875432211 01346778999999995 69999999
Q ss_pred eeeecCCc-----cEEEEecccCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPDC-----HLLVYEFMKNGSLQDILNDVSQG-RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++...+. .|+||||+++ +|.+++...... ...+++..+..++.||++||+|| |+.+|+||||||+||++
T Consensus 68 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~ 143 (295)
T cd07837 68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLV 143 (295)
T ss_pred eeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEE
Confidence 99877665 7999999985 898888754332 45689999999999999999999 78899999999999999
Q ss_pred cC-CCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 490 DD-DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 490 ~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
+. ++.+||+|||+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||......
T Consensus 144 ~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--- 218 (295)
T cd07837 144 DKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--- 218 (295)
T ss_pred ecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---
Confidence 98 889999999998865432211 122356889999998765 45789999999999999999999998653221
Q ss_pred chHHHHHHHhhccC--Ccchhh-----------hhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 568 MSLVKWMRNVMTSE--NPTRAI-----------DAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 568 ~~~~~~~~~~~~~~--~~~~~~-----------d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....+......... ...... .+.......+.....+.+++.+||+.||.+||++.|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 219 QQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11111111100000 000000 000000001112344788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.58 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=196.8
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.....|+..+.||+|+||.||+|... .+++.||+|++....... .+..+++.+|+++++.++||||++
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~h~niv~ 79 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQQLRHPNTIE 79 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCc-----------HHHHHHHHHHHHHHHhCCCCCEEE
Confidence 34467899999999999999999864 468899999885432211 112456889999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+.+++.+.+..++||||++ |++.+++... ...+++..+..++.|++.||.|| |+.+|+||||+|+||++++++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~ 152 (307)
T cd06607 80 YKGCYLREHTAWLVMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPG 152 (307)
T ss_pred EEEEEEeCCeEEEEHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCC
Confidence 9999999999999999996 5777776532 34589999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
.++|+|||++...... ....|+..|+|||++. ...++.++||||||+++|||++|+.||..... ...
T Consensus 153 ~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~----~~~ 222 (307)
T cd06607 153 TVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSA 222 (307)
T ss_pred CEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH----HHH
Confidence 9999999998765432 2245788999999874 35688899999999999999999999864321 111
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.......... .. ........+.+++.+||+.+|++||++.++++.
T Consensus 223 ---~~~~~~~~~~-~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 223 ---LYHIAQNDSP-TL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---HHHHhcCCCC-CC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111111111 00 011123357889999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=290.97 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=199.4
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||.|+||.||+|... .+++.||+|.+...... ..+..+.+.+|++++++++||||+++++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 68 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCV-----------EKGSVRNVLNERRILQELNHPFLVNLWYS 68 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhc-----------chhHHHHHHHHHHHHHhCCCCChHHHHHh
Confidence 4788899999999999999864 56889999998542211 11225678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.++...++|+||+++++|.+++.. ...+++..+..++.|+++||.|| |+.+++|+||+|+||++++++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 69 FQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred hcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEEE
Confidence 9999999999999999999999875 24688999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||.+........ .....|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .. ......
T Consensus 142 ~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~-~~~~~~ 213 (258)
T cd05578 142 TDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IR-DQIRAK 213 (258)
T ss_pred eecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HH-HHHHHH
Confidence 99999887654321 12356888999999998888999999999999999999999998754321 11 111111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH--HHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS--KDVR 625 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~--~ev~ 625 (633)
...... ..+......+.+++.+||+.||.+||++ +|++
T Consensus 214 ~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 214 QETADV----------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred hccccc----------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111000 0111122457889999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=290.44 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=203.1
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||+|++|.||++... .+++.+|+|.+...... .....++.+|++++++++|+||++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMS------------QKEREDAVNEIRILASVNHPNIISYKEA 67 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhcc------------HHHHHHHHHHHHHHHhCCCCCchhhhhh
Confidence 4778899999999999999764 57889999998543211 1124567789999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+......++||||+++++|.+++.........+++..++.++.|+++||+|| |+.+++|+||+|+||++++++.+||
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~kl 144 (256)
T cd08530 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVKI 144 (256)
T ss_pred hccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEEE
Confidence 9999999999999999999999876544456789999999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||++........ ....++..|+|||...+..++.++|+||+|+++|||++|+.||..... ..+...+
T Consensus 145 ~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~--- 213 (256)
T cd08530 145 GDLGISKVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLRYKV--- 213 (256)
T ss_pred eeccchhhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH---
Confidence 99999987765421 234578999999999998899999999999999999999999865321 1111111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... .. .........+.+++..|++.+|++||++.++++
T Consensus 214 ~~~~-~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 214 QRGK-YP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred hcCC-CC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111 11 111122344889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=295.58 Aligned_cols=264 Identities=26% Similarity=0.329 Sum_probs=194.8
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|+..+.||.|++|.||+|... .+|..||+|++....... .....+.+|++++++++|||++++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~iv~~~~~~ 67 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETEDE------------GVPSTAIREISLLKELNHPNIVRLLDVV 67 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-CCCCEEEEEEeecccccc------------cchhHHHHHHHHHHhcCCCCccCHhhee
Confidence 567889999999999999864 478999999886432111 0134577899999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
.+.+..+++|||++ ++|.+++.... ...+++..+..++.|+++||+|| |+.+++||||+|+||++++++.++|+
T Consensus 68 ~~~~~~~iv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~~~~~l~ 141 (283)
T cd07835 68 HSENKLYLVFEFLD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKLA 141 (283)
T ss_pred ccCCeEEEEEeccC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCcEEEe
Confidence 99999999999995 69999887533 24689999999999999999999 67899999999999999999999999
Q ss_pred ccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
|||+++........ .....++..|+|||++.+. .++.++||||||+++|||++|+.||..... ...+.+..+..
T Consensus 142 df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~ 216 (283)
T cd07835 142 DFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE---IDQLFRIFRTL 216 (283)
T ss_pred ecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHh
Confidence 99998765432211 1223568899999987664 568899999999999999999999865321 11122211111
Q ss_pred hccCC--------cchhhh------hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSEN--------PTRAID------AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~--------~~~~~d------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... ..+... ........+.....+.+++.+|++.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000000 00000001111235778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=294.58 Aligned_cols=267 Identities=24% Similarity=0.365 Sum_probs=197.3
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||.|++|.||+|+.. .+|+.||+|++....... ....+.+|++++++++|+||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~~~~~ 66 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEG-------------TPSTAIREISLMKELKHENIVRLHDV 66 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-CCCeEEEEEEeccccccc-------------chHHHHHHHHHHHhhcCCCEeeeeee
Confidence 4788999999999999999864 578999999986543211 13456679999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+.+..++||||+++ +|.+++..... ...+++..+..++.|+++||+|| |+.+++||||||+||++++++.+++
T Consensus 67 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~l 141 (284)
T cd07836 67 IHTENKLMLVFEYMDK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELKL 141 (284)
T ss_pred EeeCCcEEEEEecCCc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEEE
Confidence 9999999999999975 88888865332 35689999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH-
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR- 575 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~- 575 (633)
+|||++......... .....++..|++||++.+. .++.++||||||+++|||++|+.||......+....+.+...
T Consensus 142 ~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (284)
T cd07836 142 ADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT 219 (284)
T ss_pred eecchhhhhcCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 999999765433211 1234578899999988653 568899999999999999999999875432211111111100
Q ss_pred -------Hhhcc----CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 -------NVMTS----ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 -------~~~~~----~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... .......+... ....+.....+.+++.+|++.||++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 00000000000 0111122345788999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=310.06 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=209.0
Q ss_pred hhcCcccccccccccCeeEEEEEecCCC---CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
++......++||+|+||+||+|.+-.+. ..+||+|++...... +...++.+|+.+|.+++|||+
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-------------~~s~e~LdeAl~masldHpnl 760 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-------------KASIELLDEALRMASLDHPNL 760 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-------------hhhHHHHHHHHHHhcCCCchH
Confidence 3445667789999999999999884331 247888887543321 225678999999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
++++|+|.... ..||++||+.|+|.++++. ++..+.....+.+..|||+||.|| |.+++|||||..+|||+.+
T Consensus 761 ~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVks 833 (1177)
T KOG1025|consen 761 LRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKS 833 (1177)
T ss_pred HHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecC
Confidence 99999998766 7799999999999999986 456788899999999999999999 7899999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
-..+|+.|||+|+....+..........-.+.|||-|.+....|+.++|||||||++||++| |..|+++.... ++
T Consensus 834 P~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----eI 909 (1177)
T KOG1025|consen 834 PNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----EI 909 (1177)
T ss_pred CCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----Hh
Confidence 99999999999999877655544444445778999999999999999999999999999999 99998875432 11
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+.++. +++ -..++-....+.-++.+||..|++.||+++++..++.++
T Consensus 910 ~dlle~---geR----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 910 PDLLEK---GER----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred hHHHhc---ccc----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 111111 111 122333334467778889999999999999999999875
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=294.62 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=199.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|.+.+.||+|+||.||++... .++..||+|.+..... ...+.+.+|+.++++++||||++++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~hp~i~~~~ 82 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQ--------------PKKELIINEILVMRENKHPNIVNYL 82 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccc--------------hHHHHHHHHHHHHhhcCCCCeeehh
Confidence 468899999999999999999753 4678899998743211 1135678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++|+||+++++|.+++.+ ..+++..+..++.|++.||.|| |+.+++|+||||+||+++.++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~ 154 (293)
T cd06647 83 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSV 154 (293)
T ss_pred heeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCE
Confidence 999999999999999999999999864 3478999999999999999999 78899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|+|||++.......... ....|++.|+|||.+.+..++.++||||||+++|++++|+.||....... .+...
T Consensus 155 kL~dfg~~~~~~~~~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~~~-- 227 (293)
T cd06647 155 KLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLI-- 227 (293)
T ss_pred EEccCcceeccccccccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---heeeh--
Confidence 999999987665433221 23468899999999988889999999999999999999999996532211 00000
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.....+. ..........+.+++.+||+.+|++||++.+++..
T Consensus 228 --~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 --ATNGTPE--------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --hcCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011000 00011122347789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=302.62 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=201.8
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..+-|.++..||.|+||.||+|..+ ..+-..|.|.+.... ++...++.-|++++....||+||++
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nk-et~~lAAaKvIetks--------------eEELEDylVEIeILa~CdHP~ivkL 94 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKS--------------EEELEDYLVEIEILAECDHPVIVKL 94 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcc-cchhhhhhhhhcccc--------------hhHHhhhhhhhhhhhcCCChHHHHH
Confidence 3456788899999999999999754 556666777663222 2336788999999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++.|+..+.++++.|||.||-.+.++-.. +..+.+.++.-+++|++.||.|| |++.|||||||..|||++-+|.
T Consensus 95 l~ayy~enkLwiliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGd 168 (1187)
T KOG0579|consen 95 LSAYYFENKLWILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGD 168 (1187)
T ss_pred HHHHhccCceEEEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCc
Confidence 99999999999999999999999887653 56799999999999999999999 8999999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCccccccccc-----ccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH-----QTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
++|+|||.+...... ......+.||+.|||||+. ...+|+.++||||||+++.||..+.+|.+...
T Consensus 169 irLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------- 239 (1187)
T KOG0579|consen 169 IRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------- 239 (1187)
T ss_pred EeeecccccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------
Confidence 999999987543221 1122457899999999976 45789999999999999999999999966532
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....+-.+...+.+. ++ .++.....+.+++..||..||+.||++.++++
T Consensus 240 pMRVllKiaKSePPT-Ll-------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 240 PMRVLLKIAKSEPPT-LL-------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hHHHHHHHhhcCCCc-cc-------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 222222222222221 11 12333445788889999999999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.42 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=193.6
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
+.++|...+.||+|+||.||+|... .+++.||+|.+........ ...+.+|+.+++.++|+||+++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~-------------~~~~~~e~~~l~~l~h~ni~~~ 68 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGV-------------PFTAIREASLLKGLKHANIVLL 68 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCC-------------cHHHHHHHHHHHhcCCCCEeEE
Confidence 3578999999999999999999764 4688999999854432110 2345679999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++..++..++||||++ +++.+++... ...+++..+..++.|+++||.|| |+.+|+|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~ 141 (291)
T cd07870 69 HDIIHTKETLTFVFEYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGE 141 (291)
T ss_pred EEEEecCCeEEEEEeccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCc
Confidence 999999999999999995 6777766532 24578888999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
++|+|||+++........ .....++..|+|||++.+ ..++.++||||||+++|||++|+.||+..... ...+.+.
T Consensus 142 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~ 217 (291)
T cd07870 142 LKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKI 217 (291)
T ss_pred EEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHH
Confidence 999999998765432211 123457899999999875 45788999999999999999999999753321 1111111
Q ss_pred HHHhhccC-------------Ccchhhh----hhh--hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSE-------------NPTRAID----AKL--LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~-------------~~~~~~d----~~~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ..... ....... ... ..... .....+.+++.+|++.||++|||++|++.
T Consensus 218 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 218 WT-VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRL-SRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HH-HcCCCChhhhhhhhhcccccchhccccCCcchhhhcccc-CCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 00000 0000000 000 00000 01234678899999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=283.91 Aligned_cols=265 Identities=28% Similarity=0.412 Sum_probs=198.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhh--cCCCCccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG--QIRHRNLLPL 414 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l 414 (633)
.+....+.||+|.||.||+|.| -|+.||||++.... .+.+.+|.++.+ .|+|+||..+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w---rGe~VAVKiF~srd-----------------E~SWfrEtEIYqTvmLRHENILgF 270 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW---RGEDVAVKIFSSRD-----------------ERSWFRETEIYQTVMLRHENILGF 270 (513)
T ss_pred heeEEEEEecCccccceeeccc---cCCceEEEEecccc-----------------hhhhhhHHHHHHHHHhccchhhhh
Confidence 4567789999999999999998 57889999985432 344556666665 4699999999
Q ss_pred ceeeecC----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCC
Q 006739 415 LAHMARP----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS-----HNPRIIHRDLKPA 485 (633)
Q Consensus 415 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~Dikp~ 485 (633)
++.-... .+++||++|.+.|||+|+|.+ ..++.....+++.-+|.||+|||.+ ..+.|.|||||+.
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSK 345 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSK 345 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccc
Confidence 9976443 357899999999999999985 4588999999999999999999943 6789999999999
Q ss_pred CeEecCCCceEEcccccccccCCCCCc--ceecccccCcccccccccccCC----C--CCccchHHHHHHHHHHHhC---
Q 006739 486 NVLLDDDMEARIADFGLAKAMPDAQTH--ITTSNVAGTVGYIAPEYHQTLK----F--TDKCDIYSFGVLLAVLVMG--- 554 (633)
Q Consensus 486 Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~s~G~~l~elltg--- 554 (633)
|||+.+++...|+|+|+|......... ......+||.+|||||++...- + -..+||||||.++||+..+
T Consensus 346 NILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ 425 (513)
T KOG2052|consen 346 NILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCES 425 (513)
T ss_pred cEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhc
Confidence 999999999999999999877654221 1224568999999999986521 1 2368999999999999853
Q ss_pred -------CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 555 -------RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 555 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
+.||.+.-+.+. +..+ |+.+.=..+....+++ .-...+.+..+.++++.||..+|..|-|+-.+.+.
T Consensus 426 ggi~eey~~Pyyd~Vp~DP--s~ee-MrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 426 GGIVEEYQLPYYDVVPSDP--SFEE-MRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred CCEehhhcCCcccCCCCCC--CHHH-HhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 356665433221 1111 1111111111111111 11235577889999999999999999999999999
Q ss_pred HHhhh
Q 006739 628 LSQIR 632 (633)
Q Consensus 628 l~~~~ 632 (633)
|.++.
T Consensus 500 l~~l~ 504 (513)
T KOG2052|consen 500 LAKLS 504 (513)
T ss_pred HHHHh
Confidence 88764
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=287.49 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=194.9
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCcc
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH 424 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 424 (633)
||.|++|.||+++.. .+++.||+|.+....... ....+.+.+|+++++.++||||+++++++.++...
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVE-----------TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI 68 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchh-----------hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc
Confidence 699999999999875 468899999986433211 11245788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 425 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
++||||+++++|.+++.+ ...+++..+..++.|+++||+|| |+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~~ 141 (262)
T cd05572 69 YMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK 141 (262)
T ss_pred EEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence 999999999999999975 24589999999999999999999 78999999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhc-cCCc
Q 006739 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT-SENP 583 (633)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 583 (633)
....... .....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||..... +..+....... ....
T Consensus 142 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~ 213 (262)
T cd05572 142 KLKSGQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGKL 213 (262)
T ss_pred ccCcccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCCC
Confidence 7755421 1234688999999999888899999999999999999999999875421 11222222221 1111
Q ss_pred chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 584 TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 584 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
. .+......+.+++.+||+.+|++||+ ++|+++
T Consensus 214 ~----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 E----------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred C----------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0 01111334889999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=290.93 Aligned_cols=254 Identities=29% Similarity=0.415 Sum_probs=202.1
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+..+.|+..+.||+|++|.||+|.+. .++..|++|.+..... ....+.+|++++++++|+|+++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~ 79 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLRKQ---------------NKELIINEILIMKDCKHPNIVD 79 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEc-cCCcEEEEEEEecCch---------------hHHHHHHHHHHHHHCCCCCeeE
Confidence 44577889999999999999999875 4688999999854321 1456788999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++......++|+||+++++|.+++.... ..+++..+..++.|++.||+|| |+.+|+|+||+|+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~ 153 (286)
T cd06614 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDG 153 (286)
T ss_pred EEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCC
Confidence 9999999999999999999999999998632 3699999999999999999999 779999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.++|+|||++......... .....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ......
T Consensus 154 ~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~---~~~~~~- 227 (286)
T cd06614 154 SVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFL- 227 (286)
T ss_pred CEEECccchhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH---HHHHHH-
Confidence 9999999988765433211 1234578899999999888899999999999999999999999864321 111111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...... ....+ .......+.+++.+|++.+|.+||++.++++
T Consensus 228 ---~~~~~~-~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 228 ---ITTKGI-PPLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---HHhcCC-CCCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111111 11000 0112234778999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=289.99 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=198.4
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|+||.||++..+ .+|..+|+|.+...... .+..+.+.+|++++++++|+||+++++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~E~~~l~~~~h~~i~~~~~~ 67 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMP------------VKEKEASKKEVILLAKMKHPNIVTFFAS 67 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc-CCCceEEEEEeeHhhcc------------chhhHHHHHHHHHHHhCCCCChhhhhhe
Confidence 4778899999999999999875 56888999987442211 0114567889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc-eE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME-AR 496 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~-~k 496 (633)
+......++|+||+++++|.+++.... ...+++..+..++.|+++||.|| |+.+++|+||||+||++++++. ++
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~~ 142 (257)
T cd08225 68 FQENGRLFIVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVAK 142 (257)
T ss_pred eccCCeEEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeEE
Confidence 999999999999999999999987522 34579999999999999999999 6789999999999999998864 69
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
++|||.+.......... ....|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+++..
T Consensus 143 l~d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~ 213 (257)
T cd08225 143 LGDFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLK 213 (257)
T ss_pred ecccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHH
Confidence 99999988765432211 23458999999999988889999999999999999999999986421 1222222
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... . . .......+.+++.+|++.+|++|||+.|+++
T Consensus 214 ~~~~~~~-~-~--------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 214 ICQGYFA-P-I--------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HhcccCC-C-C--------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2221111 0 0 0111234788889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=278.98 Aligned_cols=246 Identities=26% Similarity=0.320 Sum_probs=196.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
-++|+.+++||+|.||+|-+++- +.+|+.||+|++++...-+. .+...-..|-++++..+||.+..+.
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rE-Kat~k~YAiKIlkKeviiak-----------dEVAHTlTE~RVL~~~~HPFLt~LK 234 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCRE-KATGKLYAIKILKKEVIIAK-----------DEVAHTLTENRVLQNCRHPFLTSLK 234 (516)
T ss_pred cchhhHHHHhcCCccceEEEEee-cccCceeehhhhhhhheeeh-----------HHhhhhhhHHHHHHhccCcHHHHhh
Confidence 36789999999999999999974 57899999999976543211 1134456788899999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
-.|+..+.+|+||||..||.|.-.+.+ .+.+++....-+-..|..||.|| |+++||.||+|.+|.|+|++|++
T Consensus 235 YsFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 235 YSFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred hhhccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCce
Confidence 999999999999999999999988875 45688888888899999999999 78999999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++.--. ...++...+||+.|+|||++....|+.++|+|.+||++|||++|+.||..... ..+-+.+-
T Consensus 308 KitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----~kLFeLIl 381 (516)
T KOG0690|consen 308 KITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----EKLFELIL 381 (516)
T ss_pred Eeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----hHHHHHHH
Confidence 9999999885322 22245678999999999999999999999999999999999999999875321 22222221
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 620 (633)
..+...++.+.+ +...++...|.+||.+|..
T Consensus 382 --~ed~kFPr~ls~------------eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 382 --MEDLKFPRTLSP------------EAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred --hhhccCCccCCH------------HHHHHHHHHhhcChHhhcC
Confidence 112222222221 2556777899999999964
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=331.40 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=201.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
-++.....||.|.||.||-+.. .++|...|||.++....+. +..+.+.+|+.++..++|||+|+++|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN-~~tGellAvKEI~iq~~~~------------k~~~~i~eEm~vlE~lnHpNlV~YyG 1301 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVN-LDTGELLAVKEIKIQDSDH------------KTFKLIAEEMKVLEGLNHPNLVRYYG 1301 (1509)
T ss_pred eeeccccccCCcceeeeEEeec-CCccchhhhhhhhcCcccc------------ccCcchHHHHHHHHhccCccccccCc
Confidence 3456678899999999999964 4789999999887665431 22567889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
+=...+..+|.||||++|+|.+++.. ++..++.....+..|++.|+.|| |+.|||||||||.||+++.+|.+|
T Consensus 1302 VEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1302 VEVHREKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred eeecHHHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEE
Confidence 99999999999999999999999975 45577777888999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCc--ceecccccCcccccccccccCC---CCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 497 IADFGLAKAMPDAQTH--ITTSNVAGTVGYIAPEYHQTLK---FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
++|||.|..+...... ..-....||+-|||||++.+.. ...+.||||+|||+.||+||++||......-
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~------ 1448 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW------ 1448 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh------
Confidence 9999999988765311 1123457999999999997643 4568999999999999999999998654311
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.|-.+.-+..+ ..++.....-.+++..|+..||++|.++.++++
T Consensus 1449 aIMy~V~~gh~P----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKP----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHHhHHhccCCC----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 111111111111 111112233568888999999999999998875
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=297.38 Aligned_cols=272 Identities=22% Similarity=0.309 Sum_probs=196.7
Q ss_pred hhhhhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC
Q 006739 330 LAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR 409 (633)
Q Consensus 330 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 409 (633)
+.+....++|+..+.||+|+||.||+|... .+++.||+|.+........ ....+.+|++++++++||
T Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~ 71 (310)
T cd07865 5 FPFCDEVSKYEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEG------------FPITALREIKILQLLKHE 71 (310)
T ss_pred CcccchhhheEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCC------------chhHHHHHHHHHHhCCCC
Confidence 344556678999999999999999999865 5789999998854321110 023456799999999999
Q ss_pred cccccceeeecCCc--------cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 006739 410 NLLPLLAHMARPDC--------HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRD 481 (633)
Q Consensus 410 niv~l~~~~~~~~~--------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~D 481 (633)
||+++++++..... .++||||++ ++|.+++... ...+++.+++.++.|++.||+|| |+.+++|+|
T Consensus 72 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~d 144 (310)
T cd07865 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRD 144 (310)
T ss_pred CccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HHCCeeccC
Confidence 99999999866543 489999996 4888877642 34689999999999999999999 677999999
Q ss_pred CCCCCeEecCCCceEEcccccccccCCCCCc--ceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCC
Q 006739 482 LKPANVLLDDDMEARIADFGLAKAMPDAQTH--ITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPS 558 (633)
Q Consensus 482 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~ 558 (633)
|||+||+++.++.+||+|||++......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||
T Consensus 145 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 145 MKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred CCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999876443221 111234578899999987664 4688999999999999999999998
Q ss_pred cccccccccchHHHHHHHhhccCCcchh---------hhh-hhhhcC---------CHHHHHHHHHHHhHhccCCCCCCC
Q 006739 559 DDFFQHTEEMSLVKWMRNVMTSENPTRA---------IDA-KLLENG---------YEEQMLLVLKIACFCTVDSPRERP 619 (633)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~d~-~~~~~~---------~~~~~~~~~~l~~~cl~~dP~~RP 619 (633)
..... ......+....... +... .+. ...... .......+.+++.+||+.||++||
T Consensus 225 ~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~ 299 (310)
T cd07865 225 QGNTE----QHQLTLISQLCGSI-TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299 (310)
T ss_pred CCCCH----HHHHHHHHHHhCCC-ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc
Confidence 65322 11111111111100 0000 000 000000 000123467899999999999999
Q ss_pred CHHHHHH
Q 006739 620 NSKDVRC 626 (633)
Q Consensus 620 s~~ev~~ 626 (633)
|++|+++
T Consensus 300 t~~e~l~ 306 (310)
T cd07865 300 DADTALN 306 (310)
T ss_pred CHHHHhc
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.23 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=196.7
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|...+.||+|++|.||++... .+++.+++|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~vv~~~~~ 84 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYQHPNIVEMYSS 84 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC-CCCCEEEEEEEeccch--------------hHHHHHHHHHHHHHHcCCCChheEEEE
Confidence 4566789999999999999764 4688999998743221 113457889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++|+||+++++|.+++.. ..+++..+..++.|++.||+|| |+.+|+||||+|+||+++.++.++|
T Consensus 85 ~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~l 156 (285)
T cd06648 85 YLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVKL 156 (285)
T ss_pred EEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEEE
Confidence 9999999999999999999999864 3588999999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||.+........ ......|+..|+|||...+..++.++||||||+++|||++|+.||..... ...+...
T Consensus 157 ~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~ 227 (285)
T cd06648 157 SDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRI 227 (285)
T ss_pred cccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHH
Confidence 99998876543221 11234689999999999888899999999999999999999999864211 1112222
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... ...... .......+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~-~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 228 RDNL-PPKLKN-------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HhcC-CCCCcc-------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1111 110000 0011234788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=302.77 Aligned_cols=265 Identities=24% Similarity=0.351 Sum_probs=194.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|... .+++.||+|.+.....+. ....++.+|+.++++++||||++++
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNV------------THAKRAYRELVLMKLVNHKNIIGLL 81 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccCh------------hHHHHHHHHHHHHHhcCCCCCccee
Confidence 467999999999999999999864 578999999885432211 1134567899999999999999999
Q ss_pred eeeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++... ...|+||||++ ++|.+.+.. .++...+..++.|+++||+|| |+.+|+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil~ 151 (353)
T cd07850 82 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVV 151 (353)
T ss_pred eeeccCCCccccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEE
Confidence 988543 34689999995 588887753 288889999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+.++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........
T Consensus 152 ~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 228 (353)
T cd07850 152 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228 (353)
T ss_pred CCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999999999987654322 1234578999999999999999999999999999999999999864321111000
Q ss_pred HHH--------HHH-------HhhccCC------cchhhhhhhh----hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHH
Q 006739 570 LVK--------WMR-------NVMTSEN------PTRAIDAKLL----ENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624 (633)
Q Consensus 570 ~~~--------~~~-------~~~~~~~------~~~~~d~~~~----~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 624 (633)
+.+ +.. ....... .......... ..........+.+++.+||+.||++|||+.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 308 (353)
T cd07850 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308 (353)
T ss_pred HHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence 000 000 0000000 0000000000 00011224457899999999999999999999
Q ss_pred HH
Q 006739 625 RC 626 (633)
Q Consensus 625 ~~ 626 (633)
++
T Consensus 309 L~ 310 (353)
T cd07850 309 LQ 310 (353)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=283.11 Aligned_cols=250 Identities=32% Similarity=0.470 Sum_probs=200.6
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||++... .+++.+++|++..... +..+.+.+|++++++++|+|+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~~~ 65 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK-RTGKEVAIKVIKLESK--------------EKKEKIINEIQILKKCKHPNIVKYYGS 65 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC-CCCcEEEEEEecccch--------------hHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4678899999999999999875 4788999999865432 125678899999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+......++++||+++++|.+++... ...+++..+..++.|+++||+|| |+.+++||||+|+||++++++.++|
T Consensus 66 ~~~~~~~~l~~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l 139 (253)
T cd05122 66 YLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKL 139 (253)
T ss_pred EecCCeEEEEEecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEE
Confidence 99999999999999999999998752 25689999999999999999999 6799999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........
T Consensus 140 ~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-- 210 (253)
T cd05122 140 IDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKALFKIA-- 210 (253)
T ss_pred eecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHH--
Confidence 99999887665432 2345688999999999888899999999999999999999999865321 11111111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ...... .......+.+++.+|++.||++|||+.|+++
T Consensus 211 -~~~-~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 211 -TNG-PPGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -hcC-CCCcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110 100000 0001234788999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=299.49 Aligned_cols=265 Identities=23% Similarity=0.344 Sum_probs=195.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+|+.||+|++...... .....+.+|+.++++++|+||++++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~ 69 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQ-------------TFCQRTLREIKILRRFKHENIIGIL 69 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccc-------------hhHHHHHHHHHHHHhCCCCCcCchh
Confidence 467999999999999999999864 57899999988532211 1134567899999999999999999
Q ss_pred eeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++... ...++|+||+++ +|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||+++
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~ 140 (336)
T cd07849 70 DIIRPPSFESFNDVYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLN 140 (336)
T ss_pred heeecccccccceEEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEC
Confidence 987544 347899999964 88877753 4689999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcc-eecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 491 DDMEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
.++.+||+|||++.......... ......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||..... .
T Consensus 141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~----~ 216 (336)
T cd07849 141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY----L 216 (336)
T ss_pred CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 99999999999988764432211 1123568999999998654 5688999999999999999999999865321 1
Q ss_pred hHHHHHHHhhccCCcchh---hhhh-------hh-------hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRA---IDAK-------LL-------ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~---~d~~-------~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.....+............ .+.. .. ....+.....+.+++.+||+.||++|||+.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 217 HQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111222211111111000 0000 00 00011123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=287.21 Aligned_cols=243 Identities=22% Similarity=0.273 Sum_probs=186.5
Q ss_pred cCccccccc--ccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 337 DGLASLEKI--GSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 337 ~~~~~~~~i--g~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
+.|++.+.+ |+|+||.||++... .++..+|+|.+...... .. |+.....+ +||||++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~-----------------~~--e~~~~~~~~~h~~iv~ 73 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFN-----------------AI--EPMVHQLMKDNPNFIK 73 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEc-CCCcEEEEEEEehhhcc-----------------hh--hHHHHHHhhcCCCEEE
Confidence 456666666 99999999999864 57889999987532211 00 11111112 6999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++...+..++||||+++++|.+++.. ...+++..+..++.|+++||.|| |+.+++||||||+||+++.++
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRAK 146 (267)
T ss_pred EEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCCC
Confidence 99999999999999999999999999975 23789999999999999999999 778999999999999999988
Q ss_pred -ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 494 -EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
.++|+|||+++..... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||..... ......+
T Consensus 147 ~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~ 218 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLES 218 (267)
T ss_pred CeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHH
Confidence 9999999998765432 224588999999999998999999999999999999999999974322 1222223
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-HHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-SKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~ev~~ 626 (633)
+............ .....+.+++..||+.+|.+||+ ++++++
T Consensus 219 ~~~~~~~~~~~~~------------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 219 LLKRQQKKLPFIK------------NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHhhcccCCccc------------ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 3222211111111 12234788899999999999996 588874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.03 Aligned_cols=246 Identities=25% Similarity=0.332 Sum_probs=184.5
Q ss_pred ccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHH---HHHhhcCCCCcccccceeeec
Q 006739 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE---INTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~ 420 (633)
.||+|+||.||++... .+++.+|+|.+......... . ...+.+| ..++...+||||+.+++++..
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~---~--------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 68 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQ---G--------ETLALNERIMLSLVSTGDCPFIVCMTYAFHT 68 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccch---H--------HHHHHHHHHHHHHHhhCCCCcEeEEEEEEec
Confidence 4899999999999864 57899999988654321110 0 1112223 334445579999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
++..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.++|+||
T Consensus 69 ~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~df 141 (279)
T cd05633 69 PDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDL 141 (279)
T ss_pred CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999998864 34599999999999999999999 6788999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccccccccc-cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhc
Q 006739 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579 (633)
Q Consensus 501 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 579 (633)
|++........ ....||..|+|||... +..++.++||||+||++|||++|+.||....... ...+.+. ..
T Consensus 142 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~----~~ 212 (279)
T cd05633 142 GLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRM----TL 212 (279)
T ss_pred CcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHHH----hh
Confidence 99876543221 2346899999999886 4568899999999999999999999997543211 1111111 00
Q ss_pred cCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHHH
Q 006739 580 SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRCM 627 (633)
Q Consensus 580 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~~ 627 (633)
.. ...+ +......+.+++..|++.||++|| +++|+++.
T Consensus 213 ~~------~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 TV------NVEL----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cC------CcCC----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00 0011 111223477888999999999999 59888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.75 Aligned_cols=248 Identities=29% Similarity=0.387 Sum_probs=190.6
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCcc
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH 424 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 424 (633)
||+|+||+||++... .+|+.||+|.+....... ......+..|++++++++||||+++++++...+..
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 68 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKK-----------RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL 68 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhh-----------hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE
Confidence 699999999999764 578999999885432110 11134567899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 425 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
|+||||+++++|.+++.... ...+++..+..++.|++.||.|| |+.+++||||+|+||++++++.++|+|||.+.
T Consensus 69 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~ 143 (277)
T cd05577 69 CLVMTLMNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLAV 143 (277)
T ss_pred EEEEecCCCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcchh
Confidence 99999999999999987532 24689999999999999999999 67899999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcc
Q 006739 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPT 584 (633)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (633)
....... .....++..|+|||+..+..++.++||||+|+++|+|++|+.||...........+ ...... ...
T Consensus 144 ~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~-~~~- 215 (277)
T cd05577 144 ELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRRTLE-MAV- 215 (277)
T ss_pred hhccCCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhcccc-ccc-
Confidence 6544221 12346788999999998888999999999999999999999998653321111111 111110 000
Q ss_pred hhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 585 RAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 585 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
. ........+.+++.+||+.||++|| ++.++++
T Consensus 216 -----~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 -----E----YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -----c----CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0 0111123477889999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=289.91 Aligned_cols=266 Identities=22% Similarity=0.341 Sum_probs=196.0
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|++.+.||+|++|.||+|... .+++.+|+|++....... .....+.+|++++++++|+|++++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 67 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKE------------GFPITAIREIKLLQKLRHPNIVRLKEIV 67 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccc------------cchHHHHHHHHHHHhccCCCeeeheeeE
Confidence 567889999999999999875 468999999987543110 1134677899999999999999999999
Q ss_pred ecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 419 ARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 419 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
... +..++||||+++ +|.+++... ...+++..+..++.|+++||+|| |+.+++|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~~~~~~~ 140 (287)
T cd07840 68 TSKGKGSIYMVFEYMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILINNDGVLK 140 (287)
T ss_pred ecCCCCcEEEEeccccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEcCCCCEE
Confidence 887 789999999975 888887642 24689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||++......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+..........+.+...
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07840 141 LADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG 219 (287)
T ss_pred EccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999876554321 1123457889999997764 4578999999999999999999999875432111111111000
Q ss_pred HhhccCC-------------cchhhhhhhhhcCCHH-HHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSEN-------------PTRAIDAKLLENGYEE-QMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~-------------~~~~~d~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......+ ........+. ..... ....+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 220 SPTDENWPGVSKLPWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCchhhccccccchhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 0000000000 00111 1445889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=284.28 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=202.9
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||+|... .+++.|++|++...... ....+.+.+|+.++++++|+||+++++.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK-DTGELMAVKSVELSGDS------------EEELEALEREIRILSSLQHPNIVRYYGS 67 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC-CCCcEEEEEEeeccccc------------hHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence 3677899999999999999875 47899999998654321 1225678899999999999999999999
Q ss_pred eecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 418 MARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 418 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+... ...++|+||+++++|.+++... ..+++..+..++.|+++||+|| |+.+++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i~~~~~~ 140 (260)
T cd06606 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILVDSDGVV 140 (260)
T ss_pred EecCCCCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCE
Confidence 9888 8899999999999999998752 3789999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+|+|||.+................++..|+|||...+...+.++||||||+++|+|++|+.||..... ....+.
T Consensus 141 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~ 214 (260)
T cd06606 141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALY 214 (260)
T ss_pred EEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHH
Confidence 99999999877665431112345688999999999888899999999999999999999999876431 111111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... ........+.+++.+|++.+|++||++.|+++
T Consensus 215 ~~~~~~~~~~---------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 215 KIGSSGEPPE---------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred hccccCCCcC---------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111011110 11111345888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=291.81 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=195.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
..|+..+.||+|+||.||+++.. .++..||+|++....... .+...++.+|++++++++|||++++++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 92 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQS-----------NEKWQDIIKEVKFLQRIKHPNSIEYKG 92 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCc-----------hHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45788899999999999999864 478899999885432211 112456888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||++ |+|.+++... ...+++..+..++.|++.||.|| |+.+|+||||+|+||+++.++.++
T Consensus 93 ~~~~~~~~~lv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~k 165 (317)
T cd06635 93 CYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVK 165 (317)
T ss_pred EEeeCCeEEEEEeCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEE
Confidence 9999999999999996 5787777542 35689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
|+|||++...... ....|+..|+|||++. ...++.++|||||||++|||++|+.||..... ......+
T Consensus 166 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~ 236 (317)
T cd06635 166 LADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHI 236 (317)
T ss_pred EecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHH
Confidence 9999998754432 2346889999999873 45688999999999999999999999865311 1111111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
. ...... .........+.+++.+||+.+|.+||++.++++..
T Consensus 237 ~----~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 237 A----QNESPT---------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred H----hccCCC---------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 1 111110 00111223478899999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=277.39 Aligned_cols=259 Identities=23% Similarity=0.402 Sum_probs=199.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 415 (633)
++++.+..||.|+||+|+|..++ ..|+..|||++..... ++..+++..|.+...+- +.||||+++
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk-~sg~~mAVKrIr~~n~-------------~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHK-PSGKLMAVKRIRSNNI-------------EKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcC-ccCcEEEEEEeeeccc-------------hHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 45666788999999999999875 5899999999965442 23367788888775554 699999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVS-QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
|.+..++..++.||.| .-||+.+.+... ..+..+++.-.-+|+.....||.||. ....||||||||+|||+|..|.
T Consensus 130 Ga~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK--~~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLK--EELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHH--HHhhhhhccCChhheEEecCCC
Confidence 9999999999999999 458877655432 23567889888999999999999997 4567999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+||||||++..+.+.- ..+.-+|...|||||.+.. ..|+.++||||+|+++||+.||+.||..+.. +.+
T Consensus 207 vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------vfe 277 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------VFE 277 (361)
T ss_pred EeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------HHH
Confidence 9999999987665432 2244579999999998864 3589999999999999999999999976532 223
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
-+.++..++.+. +.. . ....+....+.+++..|+-+|-+.||...++.+
T Consensus 278 ql~~Vv~gdpp~-l~~-~---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 278 QLCQVVIGDPPI-LLF-D---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHcCCCCe-ecC-c---ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 333333333222 111 1 111223345788888999999999999999865
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=297.22 Aligned_cols=266 Identities=25% Similarity=0.345 Sum_probs=195.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|... .+|+.||+|++........ ....+.+|+.++++++|+||+++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~i~~~ 71 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDG------------IPISSLREITLLLNLRHPNIVEL 71 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCC------------CcchhhHHHHHHHhCCCCCCcce
Confidence 3478999999999999999999865 5789999998864322110 02245679999999999999999
Q ss_pred ceeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++... +..++||||++ ++|.+++... ...+++..+..++.|+++||+|| |+.+++||||||+||+++++
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~ 144 (309)
T cd07845 72 KEVVVGKHLDSIFLVMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDK 144 (309)
T ss_pred EEEEecCCCCeEEEEEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCC
Confidence 9998654 46799999996 4888888653 25689999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||++......... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ...
T Consensus 145 ~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~----~~~ 218 (309)
T cd07845 145 GCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI----EQL 218 (309)
T ss_pred CCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHH
Confidence 99999999999876543211 122345788999998865 45789999999999999999999998753221 111
Q ss_pred HHHHHhhccCCcc---h--------hh--hhhh---hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPT---R--------AI--DAKL---LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~---~--------~~--d~~~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.......... . .. .... ...........+.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 219 DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1111111100000 0 00 0000 00000112344678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=286.08 Aligned_cols=254 Identities=22% Similarity=0.386 Sum_probs=203.9
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||.|+||.||++... .++..||+|++.....+ .+..+++.+|+++++.++|+|++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~~ 67 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMS------------EKEREDALNEVKILKKLNHPNIIKYYES 67 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCC------------hHHHHHHHHHHHHHHhcCCCChhheEEE
Confidence 4778899999999999999875 46889999998654322 1125568889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++|+||+++++|.+++.........+++..+..++.++++||.|| |+.+++|+||+|+||++++++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~l 144 (258)
T cd08215 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVKL 144 (258)
T ss_pred EecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEEE
Confidence 9999999999999999999999986543357799999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||.+........ ......|++.|+|||...+..++.++||||+|+++|+|++|+.||+... ..+.....
T Consensus 145 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~~~ 215 (258)
T cd08215 145 GDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-------LLELALKI 215 (258)
T ss_pred CCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-------HHHHHHHH
Confidence 99999987655431 1233468899999999988889999999999999999999999986532 11222222
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... + .......+.+++.+||+.+|++||++.|+++
T Consensus 216 ~~~~~~~------~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 216 LKGQYPP------I----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred hcCCCCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2211110 0 1112234788899999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.39 Aligned_cols=263 Identities=18% Similarity=0.316 Sum_probs=190.9
Q ss_pred cccccc--cCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 343 EKIGSG--GCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 343 ~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
+.||+| +||+||++.+. .+|+.||+|++....... +..+.+++|+.+++.++||||+++++++..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 70 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT-PTGTLVTVRITDLENCTE------------EHLKALQNEVVLSHFFRHPNIMTSWTVFTT 70 (328)
T ss_pred HHhCCcccCceeEEEEEEc-CCCcEEEEEEeccccCCH------------HHHHHHHHHHHHHHhCCCCCcceEeeeEec
Confidence 456666 99999999864 578999999986433211 124678889999999999999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
++..++|+||+.+++|.+++.... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.++++||
T Consensus 71 ~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~~ 145 (328)
T cd08226 71 GSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSGL 145 (328)
T ss_pred CCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEech
Confidence 999999999999999999987643 34588999999999999999999 6889999999999999999999999999
Q ss_pred ccccccCCCCCcc-----eecccccCcccccccccccC--CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 501 GLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTL--KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 501 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
+.+.......... ......++..|+|||++.+. .++.++|||||||++|||++|+.||....... .....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~ 222 (328)
T cd08226 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQK 222 (328)
T ss_pred HHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHH
Confidence 8654332211100 01112356679999998763 47889999999999999999999997643211 11111
Q ss_pred HHHhh--------------------------------ccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 574 MRNVM--------------------------------TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 574 ~~~~~--------------------------------~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
+.... .........+..+...........+.+++.+||+.||++|||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta 302 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA 302 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH
Confidence 00000 0000000000001111112344568899999999999999999
Q ss_pred HHHHH
Q 006739 622 KDVRC 626 (633)
Q Consensus 622 ~ev~~ 626 (633)
.|+++
T Consensus 303 ~e~l~ 307 (328)
T cd08226 303 SSLLS 307 (328)
T ss_pred HHHhh
Confidence 99974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=273.92 Aligned_cols=276 Identities=22% Similarity=0.306 Sum_probs=201.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCC---eEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNG---KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
....|+....||+|.||.||+|.-.+.++ +.+|+|+++....... . .....+|+.+++.++||||
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-i-----------S~SAcREiaL~REl~h~nv 89 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-I-----------SMSACREIALLRELKHPNV 89 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-c-----------CHHHHHHHHHHHHhcCCcc
Confidence 34678999999999999999995543333 3699999876532111 1 3356789999999999999
Q ss_pred cccceeeec-CCccEEEEecccCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 412 LPLLAHMAR-PDCHLLVYEFMKNGSLQDILNDVSQ-GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 412 v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+.+..++-. +...++++||.+. +|.++++-.+. ..+.++-..+..|+.||+.|+.|| |+.-|+||||||.|||+
T Consensus 90 i~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlv 165 (438)
T KOG0666|consen 90 ISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILV 165 (438)
T ss_pred hhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEE
Confidence 999998876 7788999999987 99998875443 246789999999999999999999 88899999999999999
Q ss_pred cCC----CceEEcccccccccCCCCCcc-eecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCccccc
Q 006739 490 DDD----MEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 490 ~~~----~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
..+ |.+||+|||+++.+.+.-... +...++-|..|+|||.+.+. .||.+.|||+.||++.||+|-.+-|.....
T Consensus 166 mgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 166 MGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred eccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 877 899999999999987654322 33456789999999998875 488999999999999999998877754322
Q ss_pred ccc-----cchHHHHHHHhhccCCcchhhhh-----------hhhhcCCH-----H-------HHHHHHHHHhHhccCCC
Q 006739 564 HTE-----EMSLVKWMRNVMTSENPTRAIDA-----------KLLENGYE-----E-------QMLLVLKIACFCTVDSP 615 (633)
Q Consensus 564 ~~~-----~~~~~~~~~~~~~~~~~~~~~d~-----------~~~~~~~~-----~-------~~~~~~~l~~~cl~~dP 615 (633)
... ..+..+.+-++++-....+--+- ......+. . ......+++..+|..||
T Consensus 246 k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP 325 (438)
T KOG0666|consen 246 KIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDP 325 (438)
T ss_pred hcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCc
Confidence 111 11122223222221111000000 00000000 0 00126778889999999
Q ss_pred CCCCCHHHHHH
Q 006739 616 RERPNSKDVRC 626 (633)
Q Consensus 616 ~~RPs~~ev~~ 626 (633)
.+|.|++++++
T Consensus 326 ~kRIta~qAle 336 (438)
T KOG0666|consen 326 IKRITAEQALE 336 (438)
T ss_pred hhhccHHHHhc
Confidence 99999999875
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=292.97 Aligned_cols=268 Identities=23% Similarity=0.278 Sum_probs=193.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|++|.||+|... .+++.||+|++....... ...+.+.+|++++++++||||+++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDE------------GVPSTAIREISLLKEMQHGNIVRLQD 68 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccc------------cchHHHHHHHHHHHhccCCCEeeEEE
Confidence 46888999999999999999864 478899999875432210 11356788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC-CCce
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-DMEA 495 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~-~~~~ 495 (633)
++.+....++||||++ ++|.+++... ....+++.....++.||+.||+|| |+++++|+||+|+||+++. ++.+
T Consensus 69 ~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~~ 142 (294)
T PLN00009 69 VVHSEKRLYLVFEYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNAL 142 (294)
T ss_pred EEecCCeEEEEEeccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCEE
Confidence 9999999999999996 5888777542 233467888899999999999999 6789999999999999985 5579
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||++......... .....+++.|+|||++.+. .++.++||||+|+++|+|+||+.||......+.......+.
T Consensus 143 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~ 220 (294)
T PLN00009 143 KLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220 (294)
T ss_pred EEcccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999765432211 1234578899999988664 57889999999999999999999986532211111111100
Q ss_pred HHhhccCCc-----ch-------hhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENP-----TR-------AIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~-----~~-------~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......+. .. ...... ....+.....+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDL-ATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCCChhhccccccchhhhhhcccCCCCCH-HHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000000 00 000000 0001112234778999999999999999999975
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.44 Aligned_cols=259 Identities=23% Similarity=0.259 Sum_probs=191.0
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccccee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLAH 417 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~ 417 (633)
|++.+.||+|+||.||+|... .+++.||+|++.....+.. .....+|+.++.++. |+|+++++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~-------------~~~~~~e~~~l~~l~~h~~i~~~~~~ 66 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLE-------------QVNNLREIQALRRLSPHPNILRLIEV 66 (282)
T ss_pred CceEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCch-------------hhhHHHHHHHHhhcCCCCCccceEEE
Confidence 567889999999999999864 5788999998864322110 122346788888885 9999999999
Q ss_pred eecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 418 MARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 418 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+.+. +..++||||++ ++|.+.+... ...+++..+..++.|++.||+|| |+.+|+||||+|+||+++. +.+
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~-~~~ 138 (282)
T cd07831 67 LFDRKTGRLALVFELMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKD-DIL 138 (282)
T ss_pred EecCCCCcEEEEEecCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcC-CCe
Confidence 9887 88999999996 5888777642 24689999999999999999999 6789999999999999999 999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++........ ....++..|+|||++.+ ..++.++||||+||++|||++|..||..... .....+.
T Consensus 139 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~----~~~~~~~ 211 (282)
T cd07831 139 KLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE----LDQIAKI 211 (282)
T ss_pred EEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH----HHHHHHH
Confidence 99999999876543221 22457899999997654 5578899999999999999999999965322 1122222
Q ss_pred HHhhccCCc-----------chhhhhhh----hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENP-----------TRAIDAKL----LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~-----------~~~~d~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......... .....+.. .....+.....+.+++.+||+.+|++||+++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 212 HDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 211111000 00000000 00001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=290.04 Aligned_cols=261 Identities=22% Similarity=0.283 Sum_probs=198.8
Q ss_pred CcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
+|++.+.||+|++|.||+++.. ..+++.||||.+..... ....+..+.+.+|++++.++ +||||+++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~----------~~~~~~~~~~~~E~~~l~~~~~~~~i~~~ 70 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----------VQKAKTAEHTRTERQVLEAVRRCPFLVTL 70 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH----------HhhhhHHHHHHHHHHHHHhccCCcchhhh
Confidence 3677899999999999999753 23678899998853211 01112245678899999999 59999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++.+......++||||+++|+|.+++.. ...+++..+..++.|+++||.|| |+.+++||||+|+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~ 143 (288)
T cd05583 71 HYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGH 143 (288)
T ss_pred heeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCC
Confidence 9999999999999999999999998864 34588999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK--FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
++|+|||+++......... .....|+..|+|||...+.. .+.++||||||+++|||++|+.||...... ....+
T Consensus 144 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~ 219 (288)
T cd05583 144 VVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSE 219 (288)
T ss_pred EEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHH
Confidence 9999999988765432221 12346899999999987655 788999999999999999999998532111 11112
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
..+......... .......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 220 ISRRILKSKPPF-----------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHccCCCC-----------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 222222111110 01112236788899999999999999988877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.58 Aligned_cols=270 Identities=23% Similarity=0.364 Sum_probs=195.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|++.+.||+|+||.||+|... .+++.+|+|++....... .....+.+|+.+++++ +||||+++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~h~ni~~~ 72 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNA------------TDAQRTFREIMFLQELGDHPNIVKL 72 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcc------------hhhhhhhHHHHHHHHhcCCCCccce
Confidence 467899999999999999999864 468899999885432111 0134567899999999 99999999
Q ss_pred ceeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++... ...++||||++ ++|.+++.. ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~ 143 (337)
T cd07852 73 LNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSD 143 (337)
T ss_pred eeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCC
Confidence 9998654 35799999997 599888864 2688999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCc---ceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 493 MEARIADFGLAKAMPDAQTH---ITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+.+||+|||++......... .......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 144 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~ 223 (337)
T cd07852 144 CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223 (337)
T ss_pred CcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999876543321 12233568999999998755 457889999999999999999999986532211111
Q ss_pred hHHHHHHHh-------hccCCcchhhhhh------hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 569 SLVKWMRNV-------MTSENPTRAIDAK------LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 569 ~~~~~~~~~-------~~~~~~~~~~d~~------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.+....... .........++.. ............+.+++..|++.||++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 110000000 0000000000000 0000011123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.97 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=196.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|++|.||+|... .+|+.||+|++....... ...+.+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~ 70 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVP------------TLAKRTLRELKILRHFKHDNIIAIR 70 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccc------------cchHHHHHHHHHHHhcCCCCccCHH
Confidence 368899999999999999999864 578999999986432111 1145667899999999999999999
Q ss_pred eeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 416 AHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 416 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++.. ....++||||++ ++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||++++
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~ 142 (334)
T cd07855 71 DILRPPGADFKDVYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNE 142 (334)
T ss_pred HhccccCCCCceEEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcC
Confidence 98753 346789999995 689888864 34589999999999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCcc--eecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
++.+||+|||+++......... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~---- 218 (334)
T cd07855 143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV---- 218 (334)
T ss_pred CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH----
Confidence 9999999999997664332211 1123468999999998765 46889999999999999999999999653221
Q ss_pred hHHHHHHHhhccCCcchhhh----h-------hhh-------hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAID----A-------KLL-------ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d----~-------~~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+....+.. +....+ . ... ....+.....+.+++.+|++.+|++||++++++.
T Consensus 219 ~~~~~~~~~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 219 HQLKLILSVLGSP-SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHHHHHHHHhCCC-hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111111111100 000000 0 000 0001122455889999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=285.81 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=194.2
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCcc
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH 424 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 424 (633)
||+|+||.||+++.. .+|+.+++|.+...... .......+.+|++++++++||||+++++.+......
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 68 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMI-----------RKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL 68 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhh-----------hhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE
Confidence 689999999999875 46899999988543211 112256788899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 425 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
++||||+++++|.+++.+. ..+++..+..++.|+++||+|| |+.+++|+||+|+||++++++.++|+|||++.
T Consensus 69 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~~ 141 (265)
T cd05579 69 YLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSK 141 (265)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccch
Confidence 9999999999999999752 3689999999999999999999 67899999999999999999999999999987
Q ss_pred ccCCCCC------cceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhh
Q 006739 505 AMPDAQT------HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578 (633)
Q Consensus 505 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 578 (633)
....... ........++..|+|||.......+.++||||||+++||+++|+.||..... ... .....
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~---~~~~~ 214 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP----EEI---FQNIL 214 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH----HHH---HHHHh
Confidence 6543321 1122345678899999999888899999999999999999999999865321 111 11111
Q ss_pred ccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 579 TSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 579 ~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
... ...... .....+.+++.+|++.+|++|||+.++.+.|+
T Consensus 215 ~~~~~~~~~~----------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 215 NGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCcCCCccc----------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111 000000 01344788999999999999999966665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=272.43 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=197.9
Q ss_pred hcCcccc-cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 336 EDGLASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
+++|++. ++||-|-.|.|..+..+ .+|+.+|+|++... ...++|++.--.. .|||||.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k-~T~ekfALKvL~Ds-------------------~KARrEVeLHw~~s~h~~iV~ 119 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHK-RTQEKFALKVLLDS-------------------PKARREVELHWMASGHPHIVS 119 (400)
T ss_pred hhhheehhhhhccccCCceEEEEec-cchhhhHHHHHhcC-------------------HHHHhHhhhhhhhcCCCceEE
Confidence 4666653 68999999999999764 68999999998432 2345666664444 5999999
Q ss_pred cceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 414 LLAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 414 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
++++|.+ ...+.+|||.|+||.|.+.+... +...+++.++..|+.||..|+.|| |+..|.||||||+|+|+
T Consensus 120 IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLy 194 (400)
T KOG0604|consen 120 IIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLY 194 (400)
T ss_pred eehhhhhhccCceeeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheee
Confidence 9998754 45678999999999999999863 357799999999999999999999 89999999999999999
Q ss_pred cC---CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 490 DD---DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 490 ~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
.. +..+||+|||+|+.-..... ....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.....
T Consensus 195 t~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--- 268 (400)
T KOG0604|consen 195 TTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--- 268 (400)
T ss_pred ecCCCCcceEecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---
Confidence 74 45689999999997654332 2345789999999999999999999999999999999999999975433
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+...|+.....+... .....++...+...++|+.+|..+|++|.|+.++++
T Consensus 269 -~aispgMk~rI~~gqy~------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 269 -LAISPGMKRRIRTGQYE------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -ccCChhHHhHhhccCcc------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 22223333332222111 112234555667889999999999999999999875
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=288.08 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=195.0
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|+...+||+|+||.||++... .+++.||+|++..... .....+.+|+.+++.++|+|+++++++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~~ 85 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYQHENVVEMYNS 85 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEc-CCCeEEEEEEecccch--------------hHHHHHHHHHHHHHhcCCcchhheeeE
Confidence 3444578999999999999864 5789999998743221 114568889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++||||+++++|.+++.. ..+++..+..++.|++.|++|| |+.+++|+||+|+||++++++.++|
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l 157 (292)
T cd06657 86 YLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKL 157 (292)
T ss_pred EEeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999998753 3578999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||++......... .....|+..|+|||...+..++.++|+||+|+++|||++|..||..... ......+...
T Consensus 158 ~dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~~~~ 231 (292)
T cd06657 158 SDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDN 231 (292)
T ss_pred cccccceeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhh
Confidence 999998765443211 1235689999999999888899999999999999999999999864211 1111222111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... . ........+.+++.+||+.+|.+||++.++++
T Consensus 232 ~~~~~-~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 232 LPPKL-K----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCccc-C----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11000 0 00011223678888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=280.36 Aligned_cols=250 Identities=26% Similarity=0.432 Sum_probs=200.0
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|+..+.||+|++|.||++... .+++.|++|.+...... ......+.+|++++++++|+|+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIK------------EEALKSIMQEIDLLKNLKHPNIVKYIGS 67 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccC------------HHHHHHHHHHHHHHHhCCCCCccEEEEE
Confidence 4678899999999999999864 56789999998654321 1125678999999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+....++||||+++++|.+++... ..+++..+..++.|++.||.|| |+.+|+||||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~l 140 (254)
T cd06627 68 IETSDSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKL 140 (254)
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999998752 5689999999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||.+......... .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... .....+.
T Consensus 141 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~---- 211 (254)
T cd06627 141 ADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRI---- 211 (254)
T ss_pred eccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHH----
Confidence 999999877654321 1234688999999999888889999999999999999999999865321 1111111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...... .+. ......+.+++.+||+.+|++||++.+++.
T Consensus 212 ~~~~~~--~~~--------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 VQDDHP--PLP--------EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred hccCCC--CCC--------CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111100 000 111234778889999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=289.14 Aligned_cols=258 Identities=22% Similarity=0.431 Sum_probs=193.6
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNL 411 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni 411 (633)
....++|++.+.||+|++|.||+|.++ .+++.||||.+....... ...++.+|+.++.+.. ||||
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~~~~i 76 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGNKE-------------ENKRILMDLDVVLKSHDCPYI 76 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCChH-------------HHHHHHHHHHHHHhccCCCch
Confidence 334578899999999999999999875 358999999986443210 1334556666666664 9999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++++.+....++||||++ +++.+++... ...+++..+..++.|+++||+||| ...+|+||||+|+||++++
T Consensus 77 ~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH--~~~~i~H~dl~p~nill~~ 150 (296)
T cd06618 77 VKCYGYFITDSDVFICMELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLK--EKHGVIHRDVKPSNILLDA 150 (296)
T ss_pred HhhheeeecCCeEEEEeeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH--hhCCEecCCCcHHHEEEcC
Confidence 999999999999999999995 5787777542 247899999999999999999995 2358999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCC----CCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK----FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
++.+||+|||++......... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..
T Consensus 151 ~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~ 225 (296)
T cd06618 151 SGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EF 225 (296)
T ss_pred CCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HH
Confidence 999999999998766443222 2235788999999987654 78899999999999999999999864211 11
Q ss_pred chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
+............ . .. .. .....+.+++.+||+.||++||++.++++.
T Consensus 226 ----~~~~~~~~~~~~~-~-~~---~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 226 ----EVLTKILQEEPPS-L-PP---NE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----HHHHHHhcCCCCC-C-CC---CC---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111111110 0 00 00 112347888999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=281.95 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=196.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.+|++.+.||+|+||.||+|... .++..||+|.+....... ...+....+++|++++++++|+||+++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~---------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 71 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQ---------ETSKEVNALECEIQLLKNLRHDRIVQYYG 71 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccc---------hhhHHHHHHHHHHHHHHHcCCCCcceEEE
Confidence 46888999999999999999864 578999999874322110 01122567889999999999999999999
Q ss_pred eeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 417 HMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 417 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++.+. ...++|+||+++++|.+++.. ...+++.....++.|++.||.|| |+.+++|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~ 144 (264)
T cd06653 72 CLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGN 144 (264)
T ss_pred EEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCC
Confidence 98764 457899999999999999864 23478999999999999999999 6889999999999999999999
Q ss_pred eEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
++|+|||+++........ .......|+..|+|||++.+..++.++|+|||||++|||++|+.||..... ....
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~--- 218 (264)
T cd06653 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAI--- 218 (264)
T ss_pred EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHH---
Confidence 999999999865432111 111234689999999999988899999999999999999999999865321 1111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... ..+......+.+++.+|++ +|.+||++.+++.
T Consensus 219 -~~~~~~~~~~---------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 219 -FKIATQPTKP---------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HHHHcCCCCC---------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111110 0111223447888889999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=284.38 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=185.3
Q ss_pred ccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCc
Q 006739 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDC 423 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 423 (633)
.||+|+||.||++... .+++.||+|.+.......... +.........+..++...||||+++++++...+.
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQG--------ETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchh--------HHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999999764 468899999886543211100 0001111223445555689999999999999999
Q ss_pred cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccc
Q 006739 424 HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA 503 (633)
Q Consensus 424 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 503 (633)
.++||||+++|+|.+++.. ...+++..+..++.|+++|++|| |+.+|+||||||+||++++++.++|+|||++
T Consensus 72 ~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~~ 144 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGLA 144 (278)
T ss_pred EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcCc
Confidence 9999999999999998864 34699999999999999999999 6789999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCC
Q 006739 504 KAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN 582 (633)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (633)
........ ....|+..|+|||++.+. .++.++|+||+|+++|||++|+.||........ ... ...... .
T Consensus 145 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~---~~~~~~-~- 214 (278)
T cd05606 145 CDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEI---DRMTLT-M- 214 (278)
T ss_pred cccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHH---HHHhhc-c-
Confidence 76543221 234689999999998754 689999999999999999999999975422111 111 110000 0
Q ss_pred cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 583 PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 583 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
+..+.. .....+.+++.+|++.+|.+|| ++.++++
T Consensus 215 -----~~~~~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 -----AVELPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -----CCCCCC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 000101 1123478888999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=290.54 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=195.9
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|... .+|+.||+|.+........ ....+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~------------~~~~~~~e~~~~~~l~h~~i~~~ 71 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEKEG------------FPITAIREIKILRQLNHRNIVNL 71 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecccccC------------chHHHHHHHHHHHhCCCCCeeee
Confidence 4578999999999999999999875 4688999999865432111 12456789999999999999999
Q ss_pred ceeeecCC----------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 006739 415 LAHMARPD----------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484 (633)
Q Consensus 415 ~~~~~~~~----------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp 484 (633)
++++.+.. ..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|| |+.+|+|+||||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p 144 (302)
T cd07864 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKC 144 (302)
T ss_pred eheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCH
Confidence 99987654 78999999976 777766542 34689999999999999999999 678999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccccc
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
+||++++++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 145 ~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~ 223 (302)
T cd07864 145 SNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223 (302)
T ss_pred HHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999999876543321 1122346788999998765 4578899999999999999999999865321
Q ss_pred ccccchHHHHHHHhhccCCcch---h--------hh------hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 564 HTEEMSLVKWMRNVMTSENPTR---A--------ID------AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~---~--------~d------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+.. +........... . .+ .... .........+.+++.+||+.||++||+++++++
T Consensus 224 ---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 224 ---LAQLEL-ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ---HHHHHH-HHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 212111111000 0 00 0000 000112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=286.95 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=194.7
Q ss_pred CcccccccccccCeeEEEEEecC--CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
+|++.+.||+|+||.||++.... .+|..||+|++...... ......+.+.+|++++.++ +|+||+++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~~i~~~ 70 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIV----------QKAKTTEHTRTERQVLEHIRQSPFLVTL 70 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhh----------hcchHHHHHHHHHHHHHhcccCCChhce
Confidence 46788999999999999997632 37889999998542210 0111245678899999999 59999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++..+...++||||+++++|.+++.. ...+++..+..++.|+++||.|| |+.+++||||+|+||++++++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~ 143 (290)
T cd05613 71 HYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGH 143 (290)
T ss_pred eeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCC
Confidence 9999998899999999999999999875 34588999999999999999999 7889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccC--CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL--KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+||+|||+++........ ......|+..|+|||...+. .++.++||||||+++|+|++|+.||..... ......
T Consensus 144 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~ 219 (290)
T cd05613 144 VVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAE 219 (290)
T ss_pred EEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHH
Confidence 999999999876443221 11235689999999998753 467899999999999999999999864211 112222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
+........... .......+.+++.+|++.||++|| ++.++++
T Consensus 220 ~~~~~~~~~~~~-----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 220 ISRRILKSEPPY-----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHhhccCCCC-----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 222222111110 011123367888999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=288.90 Aligned_cols=262 Identities=26% Similarity=0.363 Sum_probs=197.6
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|+..+.||+|++|.||++... .+++.+++|.+....... .....+.+|++++++++|+||+++++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 67 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESE------------GIPKTALREIKLLKELNHPNIIKLLDVF 67 (283)
T ss_pred CccceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccc------------hhHHHHHHHHHHHHHhcCCCcchHHHhh
Confidence 566789999999999999864 578999999886543221 1145677899999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
..++..++||||+++ +|.+++... ...+++..+..++.|+++||+|| |+.+|+|+||||+||++++++.++|+
T Consensus 68 ~~~~~~~~v~e~~~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l~ 140 (283)
T cd05118 68 RHKGDLYLVFEFMDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKLA 140 (283)
T ss_pred ccCCCEEEEEeccCC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEEe
Confidence 999999999999975 888887652 25689999999999999999999 67899999999999999999999999
Q ss_pred ccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+ .+.+... .
T Consensus 141 df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~-~ 214 (283)
T cd05118 141 DFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFR-T 214 (283)
T ss_pred eeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH-H
Confidence 9999987765431 11234578899999998776 78899999999999999999999986532211 1111111 0
Q ss_pred hccCCc---chhhh------hhh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENP---TRAID------AKL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~---~~~~d------~~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...... ....+ ... .....+.....+.+++..||+.||.+||++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 00000 000 00111223456889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.59 Aligned_cols=264 Identities=23% Similarity=0.357 Sum_probs=195.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|.+.+.||+|+||.||+++.. .+++.||+|.+....... .....+.+|+.+++.++|+||++++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~ni~~~~ 70 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNR------------IDAKRTLREIKLLRHLDHENVIAIK 70 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEec-CCCCeEEEEEeccccccc------------chhHHHHHHHHHHHhcCCCCccchH
Confidence 357899999999999999999864 578999999886432111 0134566799999999999999999
Q ss_pred eeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++... ...++||||+. ++|.+++.. ...+++..+..++.|++.||.|| |+.+++||||||+||+++
T Consensus 71 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~ 142 (337)
T cd07858 71 DIMPPPHREAFNDVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLN 142 (337)
T ss_pred HheecccccccCcEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEc
Confidence 988654 24799999995 689888864 34689999999999999999999 688999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
.++.+||+|||+++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .
T Consensus 143 ~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~ 216 (337)
T cd07858 143 ANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV----H 216 (337)
T ss_pred CCCCEEECcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH----H
Confidence 9999999999999876543211 123467889999998765 46889999999999999999999998653211 1
Q ss_pred HHHHHHHhhccCCc-----------chhh-------hhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 570 LVKWMRNVMTSENP-----------TRAI-------DAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 570 ~~~~~~~~~~~~~~-----------~~~~-------d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
..+.+......... .+.+ +... ....+.....+.+++.+||+.+|++|||++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 217 QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 11111111100000 0000 0000 00011223457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=281.18 Aligned_cols=247 Identities=22% Similarity=0.290 Sum_probs=186.1
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHH-hhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT-VGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|... .+++.||+|.+....... ......+..|..+ ....+|+|++++++++...
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 69 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIA-----------KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK 69 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhH-----------HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC
Confidence 57899999999999864 478899999875432110 0112233344443 4455899999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++++|.+++.. ...+++..+..++.|+++||.|| |+.+++||||+|+||++++++.++|+|||
T Consensus 70 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~dfg 142 (260)
T cd05611 70 DYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDFG 142 (260)
T ss_pred CeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeecc
Confidence 999999999999999999875 24588999999999999999999 67899999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccC
Q 006739 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581 (633)
Q Consensus 502 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 581 (633)
+++..... ....|+..|+|||...+..++.++||||||+++|||++|..||..... ... ........
T Consensus 143 ~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~---~~~~~~~~ 209 (260)
T cd05611 143 LSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAV---FDNILSRR 209 (260)
T ss_pred cceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHH---HHHHHhcc
Confidence 98754331 234588899999999888889999999999999999999999864321 111 11111110
Q ss_pred CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 582 ~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
... ... ........+.+++.+||+.+|++||++.++.+.+
T Consensus 210 ~~~---~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 210 INW---PEE----VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCC---CCc----ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 000 000 0111223478899999999999999887665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=287.59 Aligned_cols=264 Identities=21% Similarity=0.301 Sum_probs=194.0
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccccee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLAH 417 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~ 417 (633)
|++.+.||+|++|.||+|... .+++.|++|++....... ......+|+..+.+++ |+|+++++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~~~~h~~i~~~~~~ 66 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSW-------------EECMNLREVKSLRKLNEHPNIVKLKEV 66 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccch-------------hHHHHHHHHHHHHhccCCCCchhHHHH
Confidence 567889999999999999874 467899999875432210 0223456888899999 9999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+..++..++||||+ +|+|.+++.... ...+++..+..++.|++++|.|| |+.+++|+||+|+||++++++.++|
T Consensus 67 ~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~l 140 (283)
T cd07830 67 FRENDELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKI 140 (283)
T ss_pred hhcCCcEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEEE
Confidence 99999999999999 889998887532 34689999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH---
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW--- 573 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~--- 573 (633)
+|||.+......... ....++..|+|||++.+ ..++.++|+||||++++||++|+.||......+.......+
T Consensus 141 ~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 217 (283)
T cd07830 141 ADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT 217 (283)
T ss_pred eecccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCC
Confidence 999999876543221 23457889999998754 45789999999999999999999998653221111111111
Q ss_pred ------HHHhhccCCc----chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 ------MRNVMTSENP----TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ------~~~~~~~~~~----~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... .......+ ....+.....+.+++.+|++.||++||+++|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 218 PTKQDWPEGYKLASKLGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CChhhhhhHhhhhccccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 00000000 0111111345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=290.83 Aligned_cols=270 Identities=23% Similarity=0.313 Sum_probs=193.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+++.+|+|++......... ...+.+|+++++.++||||++++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~~~ 73 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGF------------PITALREIKILKKLKHPNVVPLI 73 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCc------------chhHHHHHHHHHhcCCCCccchh
Confidence 478999999999999999999864 57889999988543321100 23456799999999999999999
Q ss_pred eeeecCC--------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 416 AHMARPD--------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 416 ~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
+++.+.. ..++|+||+++ ++.+.+.. ....+++..+..++.|+++||+|| |+.+|+|+||||+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~ni 146 (311)
T cd07866 74 DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANI 146 (311)
T ss_pred hheecccccccccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHE
Confidence 9875433 35899999965 77776653 235699999999999999999999 788999999999999
Q ss_pred EecCCCceEEcccccccccCCCCCcc---------eecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCC
Q 006739 488 LLDDDMEARIADFGLAKAMPDAQTHI---------TTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLP 557 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p 557 (633)
++++++.++|+|||+++......... ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 147 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred EECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence 99999999999999998654332111 1123457888999998765 4578999999999999999999999
Q ss_pred CcccccccccchHHHHHHHhhccC-------------CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHH
Q 006739 558 SDDFFQHTEEMSLVKWMRNVMTSE-------------NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624 (633)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 624 (633)
|.+.........+........... .......+.+. .........+.+++.+|++.||++|||+.|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 865332111111111100000000 00000000000 0111122457899999999999999999998
Q ss_pred HH
Q 006739 625 RC 626 (633)
Q Consensus 625 ~~ 626 (633)
+.
T Consensus 306 l~ 307 (311)
T cd07866 306 LE 307 (311)
T ss_pred hc
Confidence 74
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=287.32 Aligned_cols=263 Identities=26% Similarity=0.342 Sum_probs=193.0
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC---CCCcccccc
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI---RHRNLLPLL 415 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~ 415 (633)
|++.+.||+|+||.||+|+.+ .+++.||+|++.....+.. ....+.+|+.++.++ +|+|+++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~h~~i~~~~ 67 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPLSEEG------------IPLSTLREIALLKQLESFEHPNIVRLL 67 (287)
T ss_pred CeEEEEecccCceEEEEEEEC-CCCCEEEEEEeccccccch------------hhhhHHHHHHHHHHhhccCCCCcceEE
Confidence 567889999999999999875 4689999999865432110 022344566665544 699999999
Q ss_pred eeeecCCc-----cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMARPDC-----HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++...+. .+++|||+. ++|.+++.... ...+++..+..++.|+++||+|| |+.+++|+||+|+||+++
T Consensus 68 ~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili~ 141 (287)
T cd07838 68 DVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILVT 141 (287)
T ss_pred EEEeeccCCCCceeEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEEc
Confidence 99988776 899999996 48998887532 23589999999999999999999 678899999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+++.++|+|||.+......... ....++..|+|||++.+..++.++|+|||||++|||++|+.||..... ....
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~---~~~~ 215 (287)
T cd07838 142 SDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE---ADQL 215 (287)
T ss_pred cCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh---HHHH
Confidence 9999999999998876543221 223578899999999998999999999999999999999999875322 1122
Q ss_pred HHHHHHhhccCC---cch------hhhhhh---hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSEN---PTR------AIDAKL---LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~---~~~------~~d~~~---~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.++......... ... ...... .....+.....+.+++.+||+.||++||++.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 216 DKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 222221110000 000 000000 00111223355788999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.70 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=204.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
....|.+...||+|.|+.|.++++. .++..||+|.+.+...+.. ....+.+|+++|..++|||||++
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~ln~~------------~~~k~~rev~imk~l~HPnIvkl 120 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQLNPS------------KRQKLGREVDIMKSLNHPNIVKL 120 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEec-CCCceEEEEEehhcccChH------------HHHHHHHHHHHHHhcCCcceeee
Confidence 3467899999999999999999876 4689999999876654322 13448899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+.+...+..+|+||||+.+|.+++++.+. ..+....+..+..|+.+|++|+ |++.|+|||||++|||++.+.+
T Consensus 121 ~~v~~t~~~lylV~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mn 193 (596)
T KOG0586|consen 121 FSVIETEATLYLVMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMN 193 (596)
T ss_pred eeeeeecceeEEEEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccc
Confidence 99999999999999999999999999863 3355588889999999999999 8999999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||++..+...... ...+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||++..-. .+..
T Consensus 194 ikIaDfgfS~~~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk----~Lr~- 265 (596)
T KOG0586|consen 194 IKIADFGFSTFFDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK----ELRP- 265 (596)
T ss_pred eeeeccccceeecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----cccc-
Confidence 999999999988755432 34689999999999999887 56899999999999999999999863211 1000
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+....++...+. ..+.+++++++..+|.+|++++++.+
T Consensus 266 -rvl~gk~rIp~~ms------------~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 266 -RVLRGKYRIPFYMS------------CDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -hheeeeecccceee------------chhHHHHHHhhccCccccCCHHHhhh
Confidence 00111122222221 12667888999999999999999865
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=310.70 Aligned_cols=267 Identities=25% Similarity=0.370 Sum_probs=211.7
Q ss_pred hhhhhhcCcccccccccccCeeEEEEEecCCC------CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhh
Q 006739 331 AFLEKEDGLASLEKIGSGGCGEVYKAELPGSN------GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404 (633)
Q Consensus 331 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 404 (633)
.|....+++.+.+.||+|.||.|++|...+.. ...||||.++....+ ...+.+..|+++|+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-------------~~~~~~~~El~~m~ 356 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-------------SEKKDLMSELNVLK 356 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-------------HHHHHHHHHHHHHH
Confidence 34445566677789999999999999864322 467999998655432 12678999999999
Q ss_pred cCC-CCcccccceeeecCCccEEEEecccCCCHHHHHhhhc---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHh
Q 006739 405 QIR-HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVS---QG-------R--RELDWLARHKIALGVACGLEYLHI 471 (633)
Q Consensus 405 ~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~ia~~L~~Lh~ 471 (633)
.+. |+||+.++|+|......++|+||++.|+|.++++..+ .. . ..++..+.+.++.|||.|++||
T Consensus 357 ~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L-- 434 (609)
T KOG0200|consen 357 ELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL-- 434 (609)
T ss_pred HhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH--
Confidence 995 9999999999999999999999999999999998765 10 1 2388999999999999999999
Q ss_pred cCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceeccccc--CcccccccccccCCCCCccchHHHHHHHH
Q 006739 472 SHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG--TVGYIAPEYHQTLKFTDKCDIYSFGVLLA 549 (633)
Q Consensus 472 ~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ 549 (633)
.+.++||||+..+|||+.++..+||+|||+|+...+...+... .-.| ...|||||.+....|+.++|||||||++|
T Consensus 435 -~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~ 512 (609)
T KOG0200|consen 435 -ASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLW 512 (609)
T ss_pred -hhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHH
Confidence 8899999999999999999999999999999977665544321 1122 44699999999999999999999999999
Q ss_pred HHHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 550 VLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 550 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
|++| |..||.+.. ....+.++++.....+. +..+..++.++++.||+.+|++||++.++++.|
T Consensus 513 EifsLG~~PYp~~~---~~~~l~~~l~~G~r~~~-------------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 513 EIFTLGGTPYPGIP---PTEELLEFLKEGNRMEQ-------------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred HHhhCCCCCCCCCC---cHHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 9999 889987522 12233344433222111 222234478999999999999999999999999
Q ss_pred Hh
Q 006739 629 SQ 630 (633)
Q Consensus 629 ~~ 630 (633)
+.
T Consensus 577 ~~ 578 (609)
T KOG0200|consen 577 EK 578 (609)
T ss_pred HH
Confidence 76
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=281.08 Aligned_cols=256 Identities=19% Similarity=0.296 Sum_probs=196.3
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|.+.+.||+|+||.||++.... .+..+++|.++........ .....++.+|+.++++++||||++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELN---------PNETVQANQEAQLLSKLDHPAIVKFHAS 70 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccC---------cchHHHHHHHHHHHHhCCCCcHHHHHHH
Confidence 47788999999999999998642 3455666665433221110 0113456678999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+.+....++||||+++++|.+++.........+++..++.++.|+++||.|| |+.+++|+||+|+||++++ +.++|
T Consensus 71 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~l 146 (260)
T cd08222 71 FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLKI 146 (260)
T ss_pred HhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEee
Confidence 9999999999999999999999976555567799999999999999999999 6889999999999999986 56999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||+++........ .....|+..|+|||...+..++.++|+||||+++|+|++|..||.... ..+.....
T Consensus 147 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~ 217 (260)
T cd08222 147 GDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRI 217 (260)
T ss_pred cccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHH
Confidence 999998876543221 123467899999999988888999999999999999999999985421 11222222
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... ........+.+++.+||+.+|++||++.|+++
T Consensus 218 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 VEGPTPS----------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HcCCCCC----------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111110 11122335788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=287.03 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=194.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|+..+.||+|+||.||+|+.. .++..+|+|.+....... ....+++.+|+++++.++|+|+++++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~ 81 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQYR 81 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccC-----------hHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 345788899999999999999864 468899999875322110 11245678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++......++||||+. |++.+++... ...+++..+..++.|++.|+.|| |+.+++||||+|+||+++.++.+
T Consensus 82 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~ 154 (308)
T cd06634 82 GCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLV 154 (308)
T ss_pred EEEEcCCeeEEEEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCcE
Confidence 99999999999999996 6888777532 34589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+|+|||++...... ....|+..|+|||.+. ...++.++|||||||++|||++|+.||..... ......
T Consensus 155 kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~ 225 (308)
T cd06634 155 KLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYH 225 (308)
T ss_pred EECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH---HHHHHH
Confidence 99999998765432 2345788999999874 35678899999999999999999999865321 111111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
+. ....+. .. .......+.+++.+||+.+|++||++.++++.-
T Consensus 226 ~~----~~~~~~------~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 226 IA----QNESPA------LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred Hh----hcCCCC------cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 11 111110 00 111223477889999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=284.94 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=199.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~ 415 (633)
++|...+.||+|++|.||++... .+++.||+|++...... ..+..+.+.+|.+++++++ ||||++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~-----------~~~~~~~~~~e~~~~~~l~~~~~i~~~~ 68 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLI-----------KEKKVKYVKIEKEVLTRLNGHPGIIKLY 68 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhcc-----------chHHHHHHHHHHHHHHhcccCCCchhHH
Confidence 36888999999999999999864 57899999988542210 0112457888999999998 99999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++++|.+++.+ ...+++..+..++.|++.||.|| |+.+++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~ 141 (280)
T cd05581 69 YTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHI 141 (280)
T ss_pred HHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCE
Confidence 999999999999999999999999975 23699999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCc------------------ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 006739 496 RIADFGLAKAMPDAQTH------------------ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p 557 (633)
+++|||++......... .......|+..|+|||...+..++.++|+||+|++++++++|+.|
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p 221 (280)
T cd05581 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221 (280)
T ss_pred EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 99999998876543211 111234578999999999888899999999999999999999999
Q ss_pred CcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH----HHHHH
Q 006739 558 SDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS----KDVRC 626 (633)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~----~ev~~ 626 (633)
|..... .... +.+ ...... .+......+.+++.+||+.+|++||++ +++++
T Consensus 222 ~~~~~~---~~~~-~~~---~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 222 FRGSNE---YLTF-QKI---LKLEYS-----------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCccH---HHHH-HHH---HhcCCC-----------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 875321 1111 111 111100 011112347889999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.57 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=187.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|+.++.||+||||.||+++. +-||+.||||++..... .+....+.+|+.++++|+|||||+++
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRN-KlDGr~YAIKKIpl~~s-------------~~~~skI~rEVk~LArLnHpNVVRYy 543 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRN-KLDGREYAIKKIPLKAS-------------DKLYSKILREVKLLARLNHPNVVRYY 543 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEee-cccchhhhhhhccCchH-------------HHHHHHHHHHHHHHhhcCCcceeeee
Confidence 36788999999999999999985 46999999999865431 12256788999999999999999987
Q ss_pred eeeec---------------------------------------------------------------------------
Q 006739 416 AHMAR--------------------------------------------------------------------------- 420 (633)
Q Consensus 416 ~~~~~--------------------------------------------------------------------------- 420 (633)
..+.+
T Consensus 544 sAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ 623 (1351)
T KOG1035|consen 544 SAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDS 623 (1351)
T ss_pred hhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccc
Confidence 21100
Q ss_pred --------------C------------------------------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHH
Q 006739 421 --------------P------------------------------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456 (633)
Q Consensus 421 --------------~------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~ 456 (633)
+ ..+|+=||||+..++.+++++... .-.....+
T Consensus 624 dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~---~~~~d~~w 700 (1351)
T KOG1035|consen 624 DEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF---NSQRDEAW 700 (1351)
T ss_pred cccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc---chhhHHHH
Confidence 0 114678999999888888875221 11467889
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccC------C----------CCCcceeccccc
Q 006739 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP------D----------AQTHITTSNVAG 520 (633)
Q Consensus 457 ~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~------~----------~~~~~~~~~~~g 520 (633)
++..+|++||.|+ |+++||||||||.||++|++..|||+|||+|.... + .......+..+|
T Consensus 701 rLFreIlEGLaYI---H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VG 777 (1351)
T KOG1035|consen 701 RLFREILEGLAYI---HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVG 777 (1351)
T ss_pred HHHHHHHHHHHHH---HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccc
Confidence 9999999999999 89999999999999999999999999999998721 0 011112345689
Q ss_pred CcccccccccccC---CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCH
Q 006739 521 TVGYIAPEYHQTL---KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYE 597 (633)
Q Consensus 521 t~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 597 (633)
|.-|+|||++.+. +|+.|+|+||+||+++||+. ||... .+... .+..+.. +..+.. +. ...
T Consensus 778 TalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---MERa~---iL~~LR~-g~iP~~--~~----f~~ 841 (1351)
T KOG1035|consen 778 TALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---MERAS---ILTNLRK-GSIPEP--AD----FFD 841 (1351)
T ss_pred eeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch---HHHHH---HHHhccc-CCCCCC--cc----ccc
Confidence 9999999998765 49999999999999999985 45431 11122 2222222 222111 11 122
Q ss_pred HHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 598 EQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 598 ~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+...-.+++.++++.||.+|||+.|++.
T Consensus 842 ~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 842 PEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 22333567888999999999999999975
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=285.63 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=191.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
+-|...+.||+|+||.||+|+.. .+++.|++|++....... ......+.+|+++++.++|||++++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 88 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQT-----------NEKWQDIIKEVKFLQQLKHPNTIEYKG 88 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCc-----------hHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 33666788999999999999864 578999999885432211 111456788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+. |++.+++... ...+++..+..++.|++.|+.|| |+.+|+|+||+|+||++++++.+|
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~k 161 (313)
T cd06633 89 CYLKEHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVK 161 (313)
T ss_pred EEEeCCEEEEEEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEE
Confidence 9999999999999995 5787777542 35689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
|+|||++...... ....|+..|+|||++. ...++.++|||||||++|||++|+.||..... ......
T Consensus 162 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~----~~~~~~ 231 (313)
T cd06633 162 LADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYH 231 (313)
T ss_pred EeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHH
Confidence 9999988643221 2346889999999874 45688899999999999999999999865321 111111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. .....+. .. .. .....+.+++.+||+.+|.+||++.++++
T Consensus 232 ~---~~~~~~~-~~-----~~---~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 232 I---AQNDSPT-LQ-----SN---EWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred H---HhcCCCC-CC-----cc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1111111 00 00 11123778889999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=293.86 Aligned_cols=276 Identities=22% Similarity=0.256 Sum_probs=195.2
Q ss_pred cCccc-ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 337 DGLAS-LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
+.|.. .+.||+|+||.||+|... .+++.||+|++........................+.+|+++++.++|+||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45554 577999999999999864 5789999999865432210000000000000123577899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||++ |+|.+++.. ...+++.....++.|++.||+|| |+.+|+|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCCE
Confidence 99999999999999996 689988864 34589999999999999999999 68899999999999999999999
Q ss_pred EEcccccccccCCCCC------------cceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccc
Q 006739 496 RIADFGLAKAMPDAQT------------HITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 562 (633)
+|+|||.+........ ........++..|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999886651110 0011223468889999998764 46889999999999999999999987543
Q ss_pred cccccchHHHHHHHhhccCCc----ch-----------hhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 563 QHTEEMSLVKWMRNVMTSENP----TR-----------AIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~----~~-----------~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ....+......... .. ...... ..........+.+++..|++.+|++||+++|++.
T Consensus 239 ~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EID----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 211 11111111111000 00 000000 0001112345778999999999999999999985
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.66 Aligned_cols=263 Identities=20% Similarity=0.266 Sum_probs=189.4
Q ss_pred cccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
+.+.+|.|+++.||++.. +++.||+|++....... +..+.+.+|+++++.++|+||+++++++.+
T Consensus 6 i~~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~ 70 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSK------------EDLKLLQQEIITSRQLQHPNILPYVTSFIV 70 (314)
T ss_pred hhHhhcCCceEEEEEecC---CCCEEEEEEEeccccch------------hHHHHHHHHHHHHHhcCCcchhhhhheeec
Confidence 344555566666665543 78999999986532111 125678999999999999999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
.+..+++|||+++|+|.+++.... ...+++.....++.|+++||+|| |+.+|+||||||+||+++.++.+|++||
T Consensus 71 ~~~~~~~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~d~ 145 (314)
T cd08216 71 DSELYVVSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGL 145 (314)
T ss_pred CCeEEEEEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEecC
Confidence 999999999999999999997532 34588999999999999999999 6789999999999999999999999999
Q ss_pred ccccccCCCCCc-----ceecccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 501 GLAKAMPDAQTH-----ITTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 501 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
|.+......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~---~~~~~~ 222 (314)
T cd08216 146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT---QMLLEK 222 (314)
T ss_pred ccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH
Confidence 988755432111 11123457889999999866 35888999999999999999999999753221 111111
Q ss_pred HHHhh----ccCC-------cch----hhhhhh----hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVM----TSEN-------PTR----AIDAKL----LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~----~~~~-------~~~----~~d~~~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... .... ... ..+... ...........+.+++..||+.||++|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 10000 0000 000 000000 00011122345788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.59 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=192.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|...+.||+|+||.||+|+.. .+|+.||+|++....... .....+.+|+.++++++||||++++
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSE------------IFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccc------------cchhHHHHHHHHHHhcCCCCccchh
Confidence 367889999999999999999864 478999999986543211 0134577899999999999999999
Q ss_pred eeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++.... ..++|+||+.. +|.++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll 150 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAV 150 (342)
T ss_pred heecccccCCCCceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEE
Confidence 9986543 45899999964 7766542 3588999999999999999999 78899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+.++.+||+|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~ 222 (342)
T cd07879 151 NEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---D 222 (342)
T ss_pred CCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence 999999999999987653321 23457889999998876 46888999999999999999999999753211 1
Q ss_pred hHHHHHHHhhccCCcchhhhhh--------------hhh----cCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH--H
Q 006739 569 SLVKWMRNVMTSENPTRAIDAK--------------LLE----NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM--L 628 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~--------------~~~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~--l 628 (633)
.+...+ .... .......+.. ... ...+.....+.+++.+||+.||++||+++|+++. +
T Consensus 223 ~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 223 QLTQIL-KVTG-VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred HHHHHH-HhcC-CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 111111 1000 0000000000 000 0001122347789999999999999999999843 5
Q ss_pred Hhh
Q 006739 629 SQI 631 (633)
Q Consensus 629 ~~~ 631 (633)
+.+
T Consensus 301 ~~~ 303 (342)
T cd07879 301 DSF 303 (342)
T ss_pred hhc
Confidence 544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=294.04 Aligned_cols=269 Identities=25% Similarity=0.356 Sum_probs=200.6
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|++.+.||.|++|.||+|+.. .+++.||+|++.....+. ...+.+.+|+.+++.++|+||++++++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDL------------IDAKRILREIKLLRHLRHENIIGLLDI 67 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccc------------hhhhhHHHHHHHHHhcCCcchhhhhhh
Confidence 4778899999999999999864 468999999886533211 114568889999999999999999999
Q ss_pred eecCC-----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 418 MARPD-----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 418 ~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+...+ ..|+||||++ ++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 68 LRPPSPEDFNDVYIVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred hcccCcccccceEEEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCC
Confidence 87775 7899999997 588888864 34799999999999999999999 78899999999999999999
Q ss_pred CceEEcccccccccCCCCCc-ceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 493 MEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+.++|+|||++......... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...... ..
T Consensus 140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~----~~ 215 (330)
T cd07834 140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI----DQ 215 (330)
T ss_pred CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH----HH
Confidence 99999999999876554311 112334678899999999887 7899999999999999999999998754321 11
Q ss_pred HHHHHHhhccCCc-----------chhhhhhh------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH--HHhh
Q 006739 571 VKWMRNVMTSENP-----------TRAIDAKL------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM--LSQI 631 (633)
Q Consensus 571 ~~~~~~~~~~~~~-----------~~~~d~~~------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~--l~~~ 631 (633)
.+.+......... ...+.... .....+.....+.+++.+||+.+|++||+++++++. ++++
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 1111111100000 00000000 000011123457889999999999999999999873 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=288.38 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=193.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||++... .++..||||++...... ......+.+|++++++++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQS------------ELFAKRAYRELRLLKHMKHENVIGL 79 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccc------------hHHHHHHHHHHHHHHhcCCCCccce
Confidence 3567999999999999999999864 57899999988543211 0113467789999999999999999
Q ss_pred ceeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 415 LAHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 415 ~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
++++.... ..++||||+ +++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nil 150 (343)
T cd07880 80 LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLA 150 (343)
T ss_pred eeeecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEE
Confidence 99886543 358999999 7799888753 4589999999999999999999 7889999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
+++++.++++|||++....... ....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||.........
T Consensus 151 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 151 VNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred EcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999988654321 23457889999998876 45788999999999999999999998753211111
Q ss_pred chHHH--------HHHHhhccCCcchhh-------hhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 006739 568 MSLVK--------WMRNVMTSENPTRAI-------DAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625 (633)
Q Consensus 568 ~~~~~--------~~~~~~~~~~~~~~~-------d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~ 625 (633)
....+ +....... ...... ...+ ....+.....+.+++.+|++.||++|||+.+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSE-DAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcch-hHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 11000 00000000 000000 0000 000111223477899999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=287.56 Aligned_cols=266 Identities=23% Similarity=0.352 Sum_probs=194.9
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|++.+.||.|+||.||++... .+++.||+|++....... ...+.+.+|++++++++||||++
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~ 73 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTP------------VLAKRTYRELKLLKHLRHENIIS 73 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEEC-CCCCEEEEEEeccccccc------------chhHHHHHHHHHHHhcCCCCeee
Confidence 34678999999999999999999754 578999999875432211 11356778999999999999999
Q ss_pred cceeeec-CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 414 LLAHMAR-PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 414 l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+.+++.. ....++|+||+ +++|.++++. ..+++.....++.|+++||+|| |+.+|+||||+|+||+++++
T Consensus 74 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 74 LSDIFISPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINEN 144 (328)
T ss_pred EeeeEecCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCC
Confidence 9998865 55788999999 5689888763 3578888899999999999999 78899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+.++|+|||.+....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.
T Consensus 145 ~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~ 219 (328)
T cd07856 145 CDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT 219 (328)
T ss_pred CCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999987543321 23457889999998765 568999999999999999999999986532211111111
Q ss_pred HH--------HHHhhccCCcchhhhhhh-hhc-----CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 572 KW--------MRNVMTSENPTRAIDAKL-LEN-----GYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 572 ~~--------~~~~~~~~~~~~~~d~~~-~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
++ ........ ..+.+..-. ... ..+.....+.+++.+|++.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 220 DLLGTPPDDVINTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhCCCCHHHHHhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11 11000000 000000000 000 001112457889999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.02 Aligned_cols=208 Identities=27% Similarity=0.367 Sum_probs=179.6
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|.++++||+|+||.|..++++ .+++.||+|++.+... ........|..|-.+|..-..+-|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK~eM-----------lKr~~tA~F~EERDimv~~ns~Wiv 138 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNKWEM-----------LKRAETACFREERDIMVFGNSEWIV 138 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEee-ccccchhHHHhhHHHH-----------hhchhHHHHHHHhHHHHcCCcHHHH
Confidence 456789999999999999999999975 5789999999855221 0011245688899999988899999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
.+.-.|.++.++|+|||||+||+|-.++.+. . .+++..+.-++..|+-||.-+ |+.|+|||||||+|||+|..
T Consensus 139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~ 211 (1317)
T KOG0612|consen 139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKS 211 (1317)
T ss_pred HHHHHhcCccceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEeccc
Confidence 9999999999999999999999999999763 2 689999999999999999999 89999999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCccccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
|++||+|||.+-.+..++. ..+...+|||-|++||++.. +.|+..+|+||+||++|||+.|..||..
T Consensus 212 GHikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 212 GHIKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CcEeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 9999999998877765443 34466789999999998853 5689999999999999999999999865
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=283.98 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=196.1
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|+..+.||+|++|.||+|+.. .+++.||+|.+....... ...+.+..|+.++++++|+|++++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 67 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEE------------GIPSTALREISLLKELKHPNIVKLLDVI 67 (282)
T ss_pred CeeehcccccCcceEEEeeec-CCCcEEEEEEeccccccc------------cccHHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 456788999999999999864 468999999986543111 1134567899999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
.+.+..++||||++ ++|.+++.... ..+++..+..++.++++||+|| |+.+|+||||+|+||++++++.++|+
T Consensus 68 ~~~~~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~~~~~l~ 140 (282)
T cd07829 68 HTERKLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRDGVLKLA 140 (282)
T ss_pred hcCCceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCCCCEEEe
Confidence 99999999999997 59999997532 4689999999999999999999 67899999999999999999999999
Q ss_pred ccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
|||.++........ .....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+...
T Consensus 141 d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~~~ 214 (282)
T cd07829 141 DFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI----DQLFKIFQI 214 (282)
T ss_pred cCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHHH
Confidence 99998876543221 1223467889999998776 7899999999999999999999998653221 111111111
Q ss_pred hccCCcc---------------hhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPT---------------RAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~---------------~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... ............+.....+.+++..||+.||++||++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000000000011112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=288.91 Aligned_cols=262 Identities=25% Similarity=0.352 Sum_probs=193.0
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||++... .+++.||+|++....... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~h~~iv 79 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSI------------IHAKRTYRELRLLKHMKHENVI 79 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhh------------HHHHHHHHHHHHHHHcCCCccc
Confidence 345688999999999999999999754 578999999986532110 1134577899999999999999
Q ss_pred ccceeeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 413 PLLAHMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 413 ~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
++++++... ...+++++++ +++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~N 150 (345)
T cd07877 80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSN 150 (345)
T ss_pred ceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHH
Confidence 999987543 3467888887 7899888753 3589999999999999999999 67899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccccccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT 565 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 565 (633)
|++++++.+||+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 151 Ill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~ 225 (345)
T cd07877 151 LAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225 (345)
T ss_pred EEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999998765332 123467899999998766 567889999999999999999999986432211
Q ss_pred ccchHHHHHHHhhccCCcchhh-----------hhhh---hhcCC----HHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 566 EEMSLVKWMRNVMTSENPTRAI-----------DAKL---LENGY----EEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~-----------d~~~---~~~~~----~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.+..+. .. ....... ...+ ..... ......+.+++.+|++.||.+||++.++++
T Consensus 226 ---~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 226 ---QLKLILRL-VG-TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred ---HHHHHHHH-hC-CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 11111110 00 0000000 0000 00000 011234778999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.67 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=194.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|++|.||+|+.. .+++.||+|++.....+. ...+.+.+|+.++++++|+|+++++
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~ 80 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRPFQSA------------IHAKRTYRELRLLKHMDHENVIGLL 80 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEEC-CCCcEEEEEecccccchh------------hHHHHHHHHHHHHHhccCCCHHHHH
Confidence 568999999999999999999875 468899999875432111 1134567899999999999999999
Q ss_pred eeeecCCc------cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPDC------HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++...+. .++|+||+ +++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nill 151 (343)
T cd07851 81 DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIAV 151 (343)
T ss_pred HHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEE
Confidence 98766554 89999999 6799998863 4589999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
++++.++|+|||++....... ....++..|+|||...+ ..++.++||||+||++|||++|+.||......
T Consensus 152 ~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---- 222 (343)
T cd07851 152 NEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---- 222 (343)
T ss_pred CCCCCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----
Confidence 999999999999988654321 23467889999998765 46788999999999999999999998653221
Q ss_pred hHHHHHHHhhccCCcchhhhhhhh-------------------hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLL-------------------ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~-------------------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+.+...... ...... .... ...+......+.+++.+|++.||++|||+.|+++
T Consensus 223 ~~~~~i~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 223 DQLKRIMNLVGT-PDEELL-QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHHHhcCC-CCHHHH-hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 111111111100 000000 0000 0000112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=273.17 Aligned_cols=240 Identities=26% Similarity=0.332 Sum_probs=190.7
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCcc
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH 424 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 424 (633)
||+|+||.||++... .+++.+|+|.+........ .....+..|+.++++++|+||+++++.+..++..
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKR-----------KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL 68 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcch-----------HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee
Confidence 699999999999875 4688999998855432111 1245788899999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 425 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
++||||+++++|.+++.. ...+++.....++.|+++|+.|| |+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~ 141 (250)
T cd05123 69 YLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLTDFGLAK 141 (250)
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEeecCcce
Confidence 999999999999999975 23589999999999999999999 67899999999999999999999999999988
Q ss_pred ccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcc
Q 006739 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPT 584 (633)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (633)
....... ......++..|+|||...+...+.++|+||||+++||+++|+.||..... ....+.+.. ......
T Consensus 142 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~--~~~~~~ 213 (250)
T cd05123 142 ELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILK--DPLRFP 213 (250)
T ss_pred ecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhc--CCCCCC
Confidence 7654321 12345688999999999888889999999999999999999999865321 111111111 111111
Q ss_pred hhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 006739 585 RAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 585 ~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
.. ....+.+++.+||..||++||++.+
T Consensus 214 ~~------------~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EF------------LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CC------------CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11 1234778999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=277.06 Aligned_cols=265 Identities=24% Similarity=0.318 Sum_probs=197.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|-.++.||+|||+.||++.+ ....+.||||+-... .+.. .+..+.-.+...+|.++-+.+.||.||+++
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFD-l~EqRYvAvKIHqlN-K~Wr------dEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFD-LTEQRYVAVKIHQLN-KNWR------DEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcc-cchhheeeEeeehhc-cchh------hHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 35678889999999999999975 356788999975332 2211 111122255678899999999999999999
Q ss_pred eeee-cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC---
Q 006739 416 AHMA-RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD--- 491 (633)
Q Consensus 416 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~--- 491 (633)
+|+. +.+..|-|.|||+|.+|+-+++. .+.+++.++..|+.||+.||.||.+ -+.+|||-||||.|||+-+
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~Gta 608 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTA 608 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcc
Confidence 9996 46678899999999999999986 4568999999999999999999953 5789999999999999964
Q ss_pred CCceEEcccccccccCCCCCcc-----eecccccCccccccccccc----CCCCCccchHHHHHHHHHHHhCCCCCcccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQT----LKFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 562 (633)
-|.+||.|||+++.+.++.... .++...||.+|++||++.- .+++.|+||||.||++|+.+.|+.||....
T Consensus 609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq 688 (775)
T KOG1151|consen 609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ 688 (775)
T ss_pred cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence 5789999999999998764431 2356689999999998753 457889999999999999999999997532
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~ 625 (633)
. .+++.+... ++....+.... -+....+...+|++||+..-++|.+..++.
T Consensus 689 s---QQdILqeNT-IlkAtEVqFP~--------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 689 S---QQDILQENT-ILKATEVQFPP--------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred h---HHHHHhhhc-hhcceeccCCC--------CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1 122222111 11100000000 011122367889999999999888877664
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.83 Aligned_cols=257 Identities=22% Similarity=0.369 Sum_probs=192.3
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccceeeec
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLAHMAR 420 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 420 (633)
.+.||+|+|+.|--+. ...+|..||||++.+.+.. .+.++.+|++++.+.+ |+||+.++++|.+
T Consensus 83 ~e~LGeGAyasVqtcv-~i~t~~EYAVKiidKq~gH--------------sR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCV-SIQTGKEYAVKIIDKQPGH--------------SRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred HHHhcCccceeeeeee-eeccchhhhhhhhhcCCch--------------HHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3679999999998775 3468999999999765431 1567889999999986 9999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc---eEE
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME---ARI 497 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~---~kl 497 (633)
+...|||||-|.||+|-+.+++ .+-+++.++.+++.+|+.||.+| |.++|.|||+||+|||..+... +||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999886 45699999999999999999999 8999999999999999976544 799
Q ss_pred cccccccccCCCC--C---cceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCccccccc--
Q 006739 498 ADFGLAKAMPDAQ--T---HITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT-- 565 (633)
Q Consensus 498 ~DfG~a~~~~~~~--~---~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~-- 565 (633)
+||.+..-..... . ...-...+|+..|||||+.. ...|+.++|.||+||++|-|++|..||.+.-..+
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 9998865432111 1 11113457888999999763 3568999999999999999999999997543211
Q ss_pred -ccchHHHHHHHhh----ccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 566 -EEMSLVKWMRNVM----TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 566 -~~~~~~~~~~~~~----~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+....+...++.+ .++.. ++ .+..+........+++...+..|+.+|.++..++.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkY-eF-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKY-EF-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCC-cC-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111111111111 01100 01 11112223345677888899999999999988765
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=284.35 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=189.3
Q ss_pred CcccccccccccCeeEEEEEecCCC--CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
+|++.+.||+|+||.||+++.. .. +..||+|++....... ...+.+.+|+++++++ +||||+++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~-~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~h~~iv~~ 67 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNVFSKK------------ILAKRALRELKLLRHFRGHKNITCL 67 (332)
T ss_pred CceEEEEccccCCeEEEEEEeC-CCCcCceEEEEEeccccccc------------hhHHHHHHHHHHHHHhcCCCChhee
Confidence 4778899999999999999875 34 7889999875322110 1134677899999999 49999999
Q ss_pred ceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 415 LAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 415 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++++.. ....++++||++ ++|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+||+++
T Consensus 68 ~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili~ 139 (332)
T cd07857 68 YDMDIVFPGNFNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLVN 139 (332)
T ss_pred eeeeeeccccCCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEEc
Confidence 987533 245678899985 689888864 45689999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCc--ceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 491 DDMEARIADFGLAKAMPDAQTH--ITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
+++.+||+|||+++........ .......||..|+|||+..+ ..++.++|+||+||++|+|++|+.||......
T Consensus 140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--- 216 (332)
T cd07857 140 ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--- 216 (332)
T ss_pred CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---
Confidence 9999999999999866543221 11123568999999998765 46889999999999999999999998653211
Q ss_pred chHHHHHHHhhccCCcchhh----hh--------------hhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 568 MSLVKWMRNVMTSENPTRAI----DA--------------KLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~----d~--------------~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+.+....... ..+.+ ++ .......+.....+.+++.+|++.||++|||+.++++
T Consensus 217 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 217 -DQLNQILQVLGTP-DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred -HHHHHHHHHhCCC-CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111110000 00000 00 0000000111245788999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=286.39 Aligned_cols=263 Identities=21% Similarity=0.329 Sum_probs=189.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.+|+..+.||.|+||.||+|... .+|+.||+|++...... ..+.+.+|++++++++||||+++++
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~~--------------~~~~~~~Ei~~l~~l~h~~i~~~~~ 69 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDPQ--------------SVKHALREIKIIRRLDHDNIVKVYE 69 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCCc--------------hHHHHHHHHHHHHhcCCCcchhhHh
Confidence 67899999999999999999764 57899999988544321 1456778999999999999999998
Q ss_pred eeecC--------------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 006739 417 HMARP--------------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482 (633)
Q Consensus 417 ~~~~~--------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di 482 (633)
++... ...++||||++ ++|.+++.. ..+++..+..++.|+++||.|| |+.+|+||||
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~L---H~~givH~di 140 (342)
T cd07854 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYI---HSANVLHRDL 140 (342)
T ss_pred hhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCC
Confidence 76543 34689999996 588887753 3588999999999999999999 6789999999
Q ss_pred CCCCeEecC-CCceEEcccccccccCCCCCcc-eecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCc
Q 006739 483 KPANVLLDD-DMEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSD 559 (633)
Q Consensus 483 kp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~ 559 (633)
||+||+++. ++.++++|||+++......... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 141 kp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 141 KPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred CHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999984 5578999999997654322111 1122357889999997654 567889999999999999999999997
Q ss_pred ccccccccchHHHHHHHhhccC--Ccc---hhhhhhhh----------hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHH
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSE--NPT---RAIDAKLL----------ENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~d~~~~----------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 624 (633)
....... ............ ... ........ ....+.....+.+++.+|++.||++|||+.|+
T Consensus 221 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el 297 (342)
T cd07854 221 GAHELEQ---MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297 (342)
T ss_pred CCCHHHH---HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHH
Confidence 5432111 111110000000 000 00000000 00001122347789999999999999999999
Q ss_pred HH
Q 006739 625 RC 626 (633)
Q Consensus 625 ~~ 626 (633)
++
T Consensus 298 l~ 299 (342)
T cd07854 298 LM 299 (342)
T ss_pred hC
Confidence 74
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=271.31 Aligned_cols=259 Identities=19% Similarity=0.274 Sum_probs=204.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--CC----
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR--HR---- 409 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~---- 409 (633)
...|.++..+|+|.||.|-++.++. .+..||+|+++... +-.+..+-|+++++++. .|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V~---------------kYreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRE-TKEHVALKIIKNVD---------------KYREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecC-CCceehHHHHHHHH---------------HHhhHHHHHHHHHHHHHhcCCCCce
Confidence 5789999999999999999997764 48999999984322 22456678999999994 23
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
-+|.+.+||...++.|+|+|.+ |-|+.+++... +..+++...+..|+.|+.+++++| |+.+++|-||||+|||+
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENILf 225 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENILF 225 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEEE
Confidence 2788889999999999999999 77999999863 357899999999999999999999 89999999999999998
Q ss_pred cC--------------------CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHH
Q 006739 490 DD--------------------DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLA 549 (633)
Q Consensus 490 ~~--------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ 549 (633)
.+ +..++|+|||.|....... +..+.|..|+|||++.+..++.++||||+||+|+
T Consensus 226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred eccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 42 3458999999998755432 3466799999999999999999999999999999
Q ss_pred HHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhh---------------------------------hhhcCC
Q 006739 550 VLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAK---------------------------------LLENGY 596 (633)
Q Consensus 550 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~---------------------------------~~~~~~ 596 (633)
|+.||..-|..- +..+....|+.+++ ..+..++... ..-...
T Consensus 301 ElytG~~LFqtH----en~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~ 375 (415)
T KOG0671|consen 301 ELYTGETLFQTH----ENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD 375 (415)
T ss_pred EeeccceecccC----CcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence 999999887642 23333345554444 2222222222 001122
Q ss_pred HHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 597 EEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 597 ~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+...+.+++..||..||.+|+|+.|+++
T Consensus 376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 376 DLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred cHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 445667999999999999999999999975
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=307.61 Aligned_cols=149 Identities=28% Similarity=0.440 Sum_probs=130.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|.+.++||+|+||.||+|.+. .+++.||+|++....... .....++.+|+.++..++||||+++++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 71 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMIN-----------KNMVHQVQAERDALALSKSPFIVHLYY 71 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccC-----------HHHHHHHHHHHHHHHhcCCCCcCeEEE
Confidence 67899999999999999999874 478999999986432110 112457888999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++...+..|+||||+++++|.+++.. ...+++..++.|+.||+.||+|| |+.+|+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 72 SLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred EEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEEcCCCCEE
Confidence 99999999999999999999999975 23578899999999999999999 677999999999999999999999
Q ss_pred Eccccccc
Q 006739 497 IADFGLAK 504 (633)
Q Consensus 497 l~DfG~a~ 504 (633)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.04 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=197.2
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecC
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 421 (633)
.++||+|.||+||-|.++ .+|+.||||++.+.... .+...++++|+.++++++||.||.+.-.|+.+
T Consensus 569 devLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp------------~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ 635 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFP------------TKQESQLRNEVAILQNLHHPGIVNLECMFETP 635 (888)
T ss_pred HhhccCCcceeeecceec-ccCceeeeeeeecccCC------------CchHHHHHHHHHHHHhcCCCCeeEEEEeecCC
Confidence 478999999999999876 68999999998654322 12246789999999999999999999999999
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC---CceEEc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD---MEARIA 498 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~---~~~kl~ 498 (633)
+..+.|||-+ +|+.-+++-. ..+.++++..-.-++.||+.||.|| |-++|+|+||||+|||+.+. ..+|||
T Consensus 636 ervFVVMEKl-~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 636 ERVFVVMEKL-HGDMLEMILS--SEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred ceEEEEehhh-cchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeec
Confidence 9999999999 4566666543 2357789988899999999999999 77899999999999999753 479999
Q ss_pred ccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhh
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 578 (633)
|||+|+.+++.... ..++||+.|+|||++....|...-|+||.||++|--++|..||..... +.+-+++..
T Consensus 710 DFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQNAa 780 (888)
T KOG4236|consen 710 DFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED------INDQIQNAA 780 (888)
T ss_pred cccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc------hhHHhhccc
Confidence 99999999886554 347899999999999999999999999999999999999999865322 111121111
Q ss_pred ccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 579 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
--. ....+.+.....+++|...|+..-++|-|.+.-+.
T Consensus 781 FMy----------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 781 FMY----------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ccc----------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 000 11223344445778888899999999998876543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=290.82 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=207.4
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNL 411 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni 411 (633)
.+.++.|++.++||+|.+|.||+++.. ++++.+|+|++...... ..++..|.++++.. .|||+
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~~d~---------------deEiE~eynil~~~~~hpnv 78 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPTEDE---------------EEEIELEYNMLKKYSHHPNV 78 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeee-ecCceeeeEeecCCccc---------------cHHHHHHHHHHHhccCCCCc
Confidence 566788999999999999999999864 68999999998654321 34567788888887 49999
Q ss_pred cccceeeec-----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 412 LPLLAHMAR-----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 412 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
+.++|++.. ++.++||||||.+||..|+++... +..+.|..+..|+..++.|+.+| |...++|||||-.|
T Consensus 79 ~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~N 153 (953)
T KOG0587|consen 79 ATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQN 153 (953)
T ss_pred ceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCce
Confidence 999999843 578999999999999999998755 67899999999999999999999 78899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCccccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
||++.++.+|++|||++..+...... .....||+.|||||++.- ..|+.++|+||+|++..||.-|.+|+.++
T Consensus 154 iLLT~e~~VKLvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm 231 (953)
T KOG0587|consen 154 VLLTENAEVKLVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM 231 (953)
T ss_pred EEEeccCcEEEeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc
Confidence 99999999999999998877654332 234679999999999854 34778999999999999999999998876
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+. ..+-.+.... ++. -..+....+++.++|..|+..|-++||++.++++
T Consensus 232 HPm-------raLF~IpRNP-PPk-------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 232 HPM-------RALFLIPRNP-PPK-------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred chh-------hhhccCCCCC-Ccc-------ccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 541 1111111111 111 1234455667889999999999999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=262.42 Aligned_cols=271 Identities=24% Similarity=0.364 Sum_probs=200.1
Q ss_pred hhhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 332 FLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 332 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
|.+....|+...+||+|.||.||+|+.. ..|+.||+|++........ + -....+|+.++..++|+|+
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~-n~~kkvalkkvlmeneKeG--------f----pitalreikiL~~lkHenv 78 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSK-NTGKKVALKKVLMENEKEG--------F----PITALREIKILQLLKHENV 78 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhc-CccchhHHHHHHHhccccC--------C----cHHHHHHHHHHHHhcchhH
Confidence 3455667888899999999999999864 5788899987643221100 0 2345689999999999999
Q ss_pred cccceeeec--------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 006739 412 LPLLAHMAR--------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLK 483 (633)
Q Consensus 412 v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dik 483 (633)
+.++..|.. ....|+||++|+. +|..++.. ....++..++.+++.++..||.|+ |+..|+|||+|
T Consensus 79 ~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmK 151 (376)
T KOG0669|consen 79 VNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMK 151 (376)
T ss_pred HHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhccc
Confidence 999988743 2347899999977 88888864 246789999999999999999999 88999999999
Q ss_pred CCCeEecCCCceEEcccccccccCCCCC--cceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 484 PANVLLDDDMEARIADFGLAKAMPDAQT--HITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 484 p~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
++|+|++.+|.+||+|||+++.+..... ....+..+.|..|++||.+.+ ..|+++.|+|..||++.||+||.+-+.+
T Consensus 152 aaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 152 AANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred HhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 9999999999999999999986643321 122345567999999998877 4689999999999999999999887654
Q ss_pred cccccccchHHHHHHHhhccCCc---chhhhhh---------hhhcC---CHHHHH------HHHHHHhHhccCCCCCCC
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENP---TRAIDAK---------LLENG---YEEQML------LVLKIACFCTVDSPRERP 619 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~d~~---------~~~~~---~~~~~~------~~~~l~~~cl~~dP~~RP 619 (633)
+.++.....+....++... +....-. +.... .++..+ ...+++..++..||.+|+
T Consensus 232 ----nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 232 ----NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred ----ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 3334444445444332111 0000000 11111 111222 467888999999999999
Q ss_pred CHHHHHH
Q 006739 620 NSKDVRC 626 (633)
Q Consensus 620 s~~ev~~ 626 (633)
++++++.
T Consensus 308 ~ad~aln 314 (376)
T KOG0669|consen 308 DADQALN 314 (376)
T ss_pred chHhhhc
Confidence 9999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=268.94 Aligned_cols=247 Identities=26% Similarity=0.303 Sum_probs=189.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
...+|..+.+||+|+||.|.++.-+ .+.+.||||++++...-..+ . .+--+.|-+++... +-|.++.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerk-gtdELyAiKiLkKDViiQdD---D--------vectm~EKrvLAL~~kppFL~q 414 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERK-GTDELYAIKILKKDVIIQDD---D--------VECTMVEKRVLALPGKPPFLVQ 414 (683)
T ss_pred eecccceEEEeccCccceeeeeccc-CcchhhhhhhhccceeeecC---c--------ccceehhhhheecCCCCchHHH
Confidence 4567889999999999999999754 56789999999876532111 0 11123355556554 4789999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+..+|+..+.+|+||||+.||+|--.+.... .+.+..+.-+|..||-||-+| |+++|+.||||..|||+|.+|
T Consensus 415 lHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 415 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEG 487 (683)
T ss_pred HHHHhhhhhheeeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCC
Confidence 9999999999999999999999988887644 466677788999999999999 899999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
++||+|||+++.---+ ..++...+||+.|+|||++...+|+..+|+|||||++|||+.|+.||++..+ ..+-+-
T Consensus 488 HiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----~elF~a 561 (683)
T KOG0696|consen 488 HIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQA 561 (683)
T ss_pred ceEeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHH
Confidence 9999999998753222 2244568999999999999999999999999999999999999999987432 233222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 620 (633)
+... .. ..+.....+...+....+...|.+|..
T Consensus 562 I~eh----nv----------syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 IMEH----NV----------SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHc----cC----------cCcccccHHHHHHHHHHhhcCCccccC
Confidence 2211 00 011111233566667788889988854
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=267.11 Aligned_cols=222 Identities=21% Similarity=0.193 Sum_probs=173.1
Q ss_pred ccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCccEEE
Q 006739 348 GGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLV 427 (633)
Q Consensus 348 G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 427 (633)
|.+|.||+++.. .+++.||+|++.... .+.+|...+....||||+++++++.+.+..++|
T Consensus 4 g~~~~v~~~~~~-~~~~~~~~K~i~~~~-------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 63 (237)
T cd05576 4 GVIDKVLLVMDT-RTQQTFILKGLRKSS-------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLV 63 (237)
T ss_pred cccceEEEEEEc-cCCcEEEEEeecchh-------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEE
Confidence 889999999864 678999999985432 122233344455799999999999999999999
Q ss_pred EecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccC
Q 006739 428 YEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507 (633)
Q Consensus 428 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~ 507 (633)
|||+++|+|.+++... ..+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.++++|||.+....
T Consensus 64 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 64 LQHAEGGKLWSHISKF----LNIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred EecCCCCCHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 9999999999998752 3489999999999999999999 67899999999999999999999999999876654
Q ss_pred CCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhh
Q 006739 508 DAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAI 587 (633)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (633)
... ....++..|+|||...+..++.++||||+|+++|||++|+.|+....... . .. .....+
T Consensus 137 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~-------~~-~~~~~~--- 198 (237)
T cd05576 137 DSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--N-------TH-TTLNIP--- 198 (237)
T ss_pred ccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--c-------cc-cccCCc---
Confidence 321 22345778999999988889999999999999999999998865321100 0 00 000000
Q ss_pred hhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 006739 588 DAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 588 d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
......+.+++.+|++.||++||++.+
T Consensus 199 ---------~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 199 ---------EWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred ---------ccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 111234778899999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=281.10 Aligned_cols=240 Identities=22% Similarity=0.294 Sum_probs=188.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|.....+|.|+|+.|-.+.+. .+++..+||++.+... +-.+|+.++... +||||+++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~-~t~~~~~vkii~~~~~------------------~~~~e~~~~~~~~~h~niv~~ 381 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESS-PTDQEPAVKIISKRAD------------------DNQDEIPISLLVRDHPNIVKS 381 (612)
T ss_pred chhhccccccCCCCccceeeeecc-ccccchhheecccccc------------------ccccccchhhhhcCCCcceee
Confidence 467777888999999999999764 5788999999866522 123455454444 69999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe-cCCC
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL-DDDM 493 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill-~~~~ 493 (633)
.+.+.+..+.|+|||++.|+-+.+.+... +.+. .++..|+.+|+.|+.|| |+++|||||+||+|||+ ++.+
T Consensus 382 ~~v~~~~~~~~~v~e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~g 453 (612)
T KOG0603|consen 382 HDVYEDGKEIYLVMELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSAG 453 (612)
T ss_pred cceecCCceeeeeehhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCCC
Confidence 99999999999999999999877776542 2233 77788999999999999 77999999999999999 6899
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
+++|+|||.++..... ....+-|..|.|||+.....|++++|+||+|++||+|++|+.||..... ..++...
T Consensus 454 ~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~---~~ei~~~ 525 (612)
T KOG0603|consen 454 HLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA---GIEIHTR 525 (612)
T ss_pred cEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc---hHHHHHh
Confidence 9999999999987665 1234568899999999999999999999999999999999999875322 1222222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+ ..+... ....+...+++.+||+.||.+||+|.++..
T Consensus 526 i----~~~~~s------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 I----QMPKFS------------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred h----cCCccc------------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1 111111 122234778888999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=278.56 Aligned_cols=248 Identities=25% Similarity=0.311 Sum_probs=200.0
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
+..++..+..||-|+||.|-++..+.+ ...+|+|++++...-.. +..+.+..|-++|...+.|.||++
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~-~~~fAlKilkK~hIVdt-----------kQqeHv~sEr~Im~~~~s~fIvrL 485 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQ-KATFALKILKKKHIVDT-----------KQQEHVFSERNIMMECRSDFIVRL 485 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEeccc-chHHHHHHHhHhhccch-----------hHHHHHHhHHHHHHhcCchHHHHH
Confidence 345677788999999999999988522 22488888865432111 124567889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
|..|.+....|++||-|-||.|+..+++ +..++..+..-++..+.+|++|| |+++||+|||||+|.++|.+|-
T Consensus 486 YrTfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy 558 (732)
T KOG0614|consen 486 YRTFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGY 558 (732)
T ss_pred HHHhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCc
Confidence 9999999999999999999999999986 45688888889999999999999 8999999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||.|||+|+.+..+... ...+||+.|.|||++.....+.++|.||+|+++|||++|.+||....+-..+..+.+.+
T Consensus 559 ~KLVDFGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 559 LKLVDFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred eEEeehhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 999999999998776532 34799999999999999999999999999999999999999998765433333333333
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 620 (633)
....- +....+...+++++....+|.+|..
T Consensus 636 d~i~~----------------Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 636 DKIEF----------------PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhhc----------------ccccchhHHHHHHHHHhcCcHhhhc
Confidence 22211 1112233567777888899999976
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=243.75 Aligned_cols=211 Identities=24% Similarity=0.411 Sum_probs=178.1
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNL 411 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni 411 (633)
..+.+++.....||+|++|.|-+.++. .+|...|+|++..... ++..++..+|+.+..+- ..|.+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~-~sg~imAvKri~~tvn-------------~q~q~r~L~dldi~~r~~~CPf~ 107 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHI-QSGTIMAVKRIRATVN-------------SQEQKRLLMDLDIIMRTVDCPFT 107 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeec-cCCeEEEEeeehhhcC-------------hHHHHHHHHhhhhhccCCCCCeE
Confidence 344566677889999999999988875 6899999999865432 23366777888886655 69999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
|.++|...+....++.||.|. .||+.+-++.-..+..+++.-.-+||..+.+||.||| .+..++|||+||+|||++.
T Consensus 108 V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~--~kL~vIHRDvKPsNiLIn~ 184 (282)
T KOG0984|consen 108 VHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLH--SKLSVIHRDVKPSNILINY 184 (282)
T ss_pred EEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHH--HHhhhhhccCCcceEEEcc
Confidence 999999999999999999994 5999888777777888999999999999999999998 6678999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCccccccccccc----CCCCCccchHHHHHHHHHHHhCCCCCccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT----LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
+|++|+||||.+-.+.+.-.. +...|...|||||.+.. ..|+-++||||+|+++.||.+++.||+.++.
T Consensus 185 ~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 185 DGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred CCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 999999999999877654321 23468899999998753 4689999999999999999999999987665
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=293.07 Aligned_cols=265 Identities=22% Similarity=0.264 Sum_probs=168.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCC----CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|+..+.||+|+||.||+|++. .+ +..||+|++...... + ....| .+....+.+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~-~~~~~~~~~vAvK~~~~~~~~--------e--------~~~~e--~l~~~~~~~ 190 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLV-NKQSKKEGKYVLKKATEYGAV--------E--------IWMNE--RVRRACPNS 190 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEc-CCccccCcEEEEEEecccchh--------H--------HHHHH--HHHhhchhh
Confidence 5678999999999999999999875 35 789999987532210 0 00000 011111222
Q ss_pred cccccee------eecCCccEEEEecccCCCHHHHHhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHH
Q 006739 411 LLPLLAH------MARPDCHLLVYEFMKNGSLQDILNDVSQG----------------RRELDWLARHKIALGVACGLEY 468 (633)
Q Consensus 411 iv~l~~~------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~~L~~ 468 (633)
+..+... .......++||||+++++|.+++...... ........+..++.|+++||+|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~y 270 (566)
T PLN03225 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDG 270 (566)
T ss_pred HHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHH
Confidence 2222111 24566789999999999999998642110 0011233456899999999999
Q ss_pred HHhcCCCCeeeCCCCCCCeEecC-CCceEEcccccccccCCCCCcceecccccCcccccccccccC--------------
Q 006739 469 LHISHNPRIIHRDLKPANVLLDD-DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-------------- 533 (633)
Q Consensus 469 Lh~~h~~~ivH~Dikp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------- 533 (633)
| |+++|+||||||+|||+++ ++.+||+|||+|+......... .....||+.|+|||.+...
T Consensus 271 L---H~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~ 346 (566)
T PLN03225 271 L---HSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346 (566)
T ss_pred H---HHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCcccccccc
Confidence 9 6789999999999999996 5799999999998765433222 2346789999999965322
Q ss_pred --------CCCCccchHHHHHHHHHHHhCCCCCcccccc------cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHH
Q 006739 534 --------KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH------TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQ 599 (633)
Q Consensus 534 --------~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 599 (633)
.++.++|||||||++|||+++..|++..... ........|........ ..+ +.... ......
T Consensus 347 ~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~-~~~~~--~~~d~~ 422 (566)
T PLN03225 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRA-SPD-LRRGF--EVLDLD 422 (566)
T ss_pred ccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcccc-chh-hhhhh--hhcccc
Confidence 2345679999999999999987775431100 00011222222111100 000 00000 000001
Q ss_pred HHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 600 MLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 600 ~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+++.+|++.||++|||++++++
T Consensus 423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 423 GGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred chHHHHHHHHHccCCcccCCCHHHHhC
Confidence 112457999999999999999999986
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=232.16 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=193.8
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|...++||+|.||+||+++. ..+++.||+|+++....+..- -....+|+-+++.++|.|||++++.
T Consensus 3 ~ydkmekigegtygtvfkarn-~~t~eivalkrvrlddddegv------------pssalreicllkelkhknivrl~dv 69 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARN-RETHEIVALKRVRLDDDDEGV------------PSSALREICLLKELKHKNIVRLHDV 69 (292)
T ss_pred chHHHHhhcCCcceeeEeccc-CCccceEEEEEEeccCCCCCC------------cHHHHHHHHHHHHhhhcceeehhhh
Confidence 566779999999999999975 468899999998765433221 2346789999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
...+..+-+|+|||. .+|..+.... +..++......++.|+.+||.+. |++.+.|||+||.|.+++.+|+.|+
T Consensus 70 lhsdkkltlvfe~cd-qdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelkl 142 (292)
T KOG0662|consen 70 LHSDKKLTLVFEFCD-QDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELKL 142 (292)
T ss_pred hccCceeEEeHHHhh-HHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEEe
Confidence 999999999999994 5888887653 45688899999999999999999 7889999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCC-CCCccchHHHHHHHHHHHhCCCC-CcccccccccchHHHHHH
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLP-SDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p-~~~~~~~~~~~~~~~~~~ 575 (633)
+|||+++.++-... ..+..+-|..|++|.++.+.+ |++..|+||.||++.|+....+| |.+ .+..+..+.+-
T Consensus 143 adfglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg----~dvddqlkrif 216 (292)
T KOG0662|consen 143 ADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG----NDVDDQLKRIF 216 (292)
T ss_pred cccchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC----CcHHHHHHHHH
Confidence 99999998765432 223456799999999988755 88899999999999999985555 433 33333333333
Q ss_pred Hhhc----cCCcc--hhhhhhhhhcC-----CHHHH----HHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMT----SENPT--RAIDAKLLENG-----YEEQM----LLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~----~~~~~--~~~d~~~~~~~-----~~~~~----~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+ +.++. ..-|-...+.. ..+.+ ..=.+++...+.-+|.+|.++++.++
T Consensus 217 ~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 217 RLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222 11111 01111111111 01111 12245555667779999999998875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=274.35 Aligned_cols=221 Identities=23% Similarity=0.433 Sum_probs=181.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..-|..++.||-|+||.|.+++- .++...||+|.+.+.. -........++.|-.||.....+-||+++
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~K-vDT~~lYAmKTLrKaD-----------Vl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRK-VDTRALYAMKTLRKAD-----------VLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred ccceEEEeeecccccceeEEEee-cchhhHHHHhhhHHHH-----------HHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 35677888999999999999974 4567889999885432 11122245678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
-.|.+.+.+|+||||++||++-++|.+. ..+++..+.-++..+..|+++. |..|.|||||||+|||||.+|++
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCce
Confidence 9999999999999999999999998763 4588888888889999999999 89999999999999999999999
Q ss_pred EEccccccccc---------CCCCCcc-------------------------------eecccccCcccccccccccCCC
Q 006739 496 RIADFGLAKAM---------PDAQTHI-------------------------------TTSNVAGTVGYIAPEYHQTLKF 535 (633)
Q Consensus 496 kl~DfG~a~~~---------~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~ 535 (633)
||.|||++.-+ ..++... .....+||+.|+|||++....|
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 99999996432 2111000 0123469999999999999999
Q ss_pred CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 536 TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 536 ~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
+..+|+||.||+||||+.|+.||.+....+....+..|..
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 9999999999999999999999987766666666666643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=254.99 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=196.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|+.+++||+|+|++|.++++. ++.+.||+|++++.-..... ...-.+.|-.+..+. +||.+|.+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~ndde-----------didwvqtek~vfe~asn~pflvgl 316 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDE-----------DIDWVQTEKHVFEQASNNPFLVGL 316 (593)
T ss_pred cccceeeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcc-----------cchhHHhhHHHHHhccCCCeEEeh
Confidence 478999999999999999999986 57889999998764322111 133455566666555 69999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
..+|..+..+++|.||++||+|--.+.+ .+.+++..+.-+...|.-||.|| |++||+.||+|..|||+|.+|+
T Consensus 317 hscfqtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvlldaegh 389 (593)
T KOG0695|consen 317 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLLDAEGH 389 (593)
T ss_pred hhhhcccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEEccCCc
Confidence 9999999999999999999999655544 46699999999999999999999 8999999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+|+.|+|+.+.--.... +++..+||+.|+|||++.+..|...+|+|++||+++||+.|+.||+.......+++-.+++
T Consensus 390 ikltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 390 IKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred eeecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence 99999999886433222 3466899999999999999999999999999999999999999998654433334433444
Q ss_pred HHhhcc--CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC
Q 006739 575 RNVMTS--ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620 (633)
Q Consensus 575 ~~~~~~--~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 620 (633)
-++.-+ .+.++.+. .....+++.-+++||.+|..
T Consensus 468 fqvilekqiriprsls------------vkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 468 FQVILEKQIRIPRSLS------------VKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHhhhcccccceee------------hhhHHHHHHhhcCCcHHhcC
Confidence 333221 12222211 12456677889999999854
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=279.79 Aligned_cols=278 Identities=21% Similarity=0.264 Sum_probs=183.6
Q ss_pred hhcCcccccccccccCeeEEEEEec---------------CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHH
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELP---------------GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 399 (633)
..++|++.++||+|+||.||+|... ..+++.||||++......................+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999641 1245789999986432211000000000011112345567
Q ss_pred HHHhhcCCCCcc-----cccceeeec--------CCccEEEEecccCCCHHHHHhhhcC--------------------C
Q 006739 400 INTVGQIRHRNL-----LPLLAHMAR--------PDCHLLVYEFMKNGSLQDILNDVSQ--------------------G 446 (633)
Q Consensus 400 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 446 (633)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 677887753 3567999999999999999874211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCccccc
Q 006739 447 RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIA 526 (633)
Q Consensus 447 ~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~a 526 (633)
...+++..+..++.|++++|.|+ |+.+|+||||||+||+++.++.+||+|||+++........ ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 12356788999999999999999 6788999999999999999999999999999765443221 1122335889999
Q ss_pred ccccccCC--------------------C--CCccchHHHHHHHHHHHhCCC-CCccccccc-----ccchHHHHHHHhh
Q 006739 527 PEYHQTLK--------------------F--TDKCDIYSFGVLLAVLVMGRL-PSDDFFQHT-----EEMSLVKWMRNVM 578 (633)
Q Consensus 527 PE~~~~~~--------------------~--~~~~Dv~s~G~~l~elltg~~-p~~~~~~~~-----~~~~~~~~~~~~~ 578 (633)
||.+.... + ..+.||||+||++|||++|.. |+.....-. .......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875422 1 124799999999999999885 665321100 0112222322111
Q ss_pred ccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCC---CCCCCHHHHHH
Q 006739 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSP---RERPNSKDVRC 626 (633)
Q Consensus 579 ~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP---~~RPs~~ev~~ 626 (633)
... +-.. .........+++.+++..+| .+|+|++|+++
T Consensus 459 ~~~------~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY------DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC------Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 110 1001 11122346778888998765 78999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=241.27 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=197.5
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~ 413 (633)
..++|++.+++|+|.++.||.|.. -.+.+.++||+++... .+.+.+|+.++..++ ||||++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~-~~~~eK~ViKiLKPVk-----------------kkKIkREikIL~nL~gg~NIi~ 97 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGIN-ITNNEKCVIKILKPVK-----------------KKKIKREIKILQNLRGGPNIIK 97 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccc-cCCCceEEEeeechHH-----------------HHHHHHHHHHHHhccCCCCeee
Confidence 457899999999999999999963 4578899999985432 577999999999997 999999
Q ss_pred cceeeecCCc--cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 414 LLAHMARPDC--HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 414 l~~~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++...++.. ..+++||+++.+...+.. .++...+.-.+.+++.||.|+ |++||+|||+||.||++|.
T Consensus 98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmIdh 167 (338)
T KOG0668|consen 98 LLDIVKDPESKTPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMIDH 167 (338)
T ss_pred hhhhhcCccccCchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeech
Confidence 9999987654 569999999988877654 377788899999999999999 8999999999999999996
Q ss_pred C-CceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 492 D-MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 492 ~-~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
. -.++|+|||+|.++.++.... ..+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||-. ..+...+
T Consensus 168 ~~rkLrlIDWGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh--G~dN~DQ 242 (338)
T KOG0668|consen 168 ELRKLRLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQ 242 (338)
T ss_pred hhceeeeeecchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC--CCCCHHH
Confidence 4 569999999999988776543 2456788999998765 5588899999999999999999999843 2334455
Q ss_pred HHHHHHHhhccCCcch-------hhhhhh---hhcC-------------CHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTR-------AIDAKL---LENG-------------YEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~-------~~d~~~---~~~~-------------~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+++.++-.-.++ ... .+|+.. .+.. -.-...+..+++...|..|-.+|+|++|.++
T Consensus 243 LVkIakVLGt~e-l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 243 LVKIAKVLGTDE-LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHhChHH-HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 555443211100 000 011111 0000 0001134778888999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=254.17 Aligned_cols=240 Identities=29% Similarity=0.407 Sum_probs=190.2
Q ss_pred cCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCccEEEE
Q 006739 349 GCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVY 428 (633)
Q Consensus 349 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 428 (633)
+||.||+|... .+++.+|+|++........ .+.+.+|++.+++++|+|++++++++......+++|
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~-------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 66 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKK-------------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVM 66 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccH-------------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEE
Confidence 58999999875 3688999999865432110 457889999999999999999999999999999999
Q ss_pred ecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCC
Q 006739 429 EFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508 (633)
Q Consensus 429 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 508 (633)
||+++++|.+++... ..+++..+..++.++++++.|| |+.+++|+||+|+||++++++.++++|||.+.....
T Consensus 67 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 67 EYCDGGDLFDLLKKR----GRLSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred eCCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 999999999998752 2288999999999999999999 677999999999999999999999999999987765
Q ss_pred CCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhh
Q 006739 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAID 588 (633)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 588 (633)
.. ......++..|++||...+..++.++||||+|+++|++++|..||.... ......++...........
T Consensus 140 ~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~---- 209 (244)
T smart00220 140 GG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPPP---- 209 (244)
T ss_pred cc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHhccCCCCccc----
Confidence 42 1234568889999999988889999999999999999999999986531 1122222222111110000
Q ss_pred hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 589 AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. ......+.+++.+|+..+|++||++.++++
T Consensus 210 ----~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 ----E---WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ----c---ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 002234788999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=252.40 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=192.5
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
.+-.+.||-|+||.||.++++ .+|+.||.|++......- ...+.+.+|+.++...+|.|+...++..
T Consensus 55 i~PDRPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~L------------~s~krvFre~kmLcfFkHdNVLSaLDIL 121 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQNL------------ASCKRVFREIKMLSSFRHDNVLSLLDIL 121 (449)
T ss_pred CCCCCcccccceeEEEeccCC-CCccchhHhhcchHHHHH------------HHHHHHHHHHHHHHhhccccHHHHHHhc
Confidence 345689999999999999876 589999999984332211 1156788999999999999999998876
Q ss_pred ecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 419 ARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 419 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
.-. .+.|.++|.|. .+|..++-. ...++...++-++.||++||+|| |+.+|+||||||.|.|++++.
T Consensus 122 QPph~dfFqEiYV~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSNC 193 (449)
T KOG0664|consen 122 QPANPSFFQELYVLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSNC 193 (449)
T ss_pred CCCCchHHHHHHHHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccCc
Confidence 443 25678899995 488777653 56788999999999999999999 899999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
..||||||+|+.....+... ++..+-|..|+|||.+++. .|+.+.||||.||++.|++.++.-|....+ .+..+
T Consensus 194 vLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P----iqQL~ 268 (449)
T KOG0664|consen 194 ILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP----IEQLQ 268 (449)
T ss_pred eEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh----HHHHH
Confidence 99999999999776554333 3556779999999999885 488999999999999999999988765332 12222
Q ss_pred HHHHhhccCCcch-----------hhh--------hhhhh-cCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 573 WMRNVMTSENPTR-----------AID--------AKLLE-NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 573 ~~~~~~~~~~~~~-----------~~d--------~~~~~-~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.+...++....+. ++. +.+.. ......-.....+...++..||++|.+..+.+.-
T Consensus 269 lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 269 MIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 2222222111100 000 00000 0001112234556667899999999999887653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=279.90 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=187.0
Q ss_pred cccccccccccCe-eEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccce
Q 006739 339 LASLEKIGSGGCG-EVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLA 416 (633)
Q Consensus 339 ~~~~~~ig~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~ 416 (633)
|...+.+|.|+.| .||+|.+ +|+.||||++... ...-.++|+..++.-+ |||||++++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll~e-----------------~~~~A~rEi~lL~eSD~H~NviRyyc 570 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY---EGREVAVKRLLEE-----------------FFDFAQREIQLLQESDEHPNVIRYYC 570 (903)
T ss_pred eccHHHcccCCCCcEEEEEee---CCceehHHHHhhH-----------------hHHHHHHHHHHHHhccCCCceEEEEe
Confidence 3344678899888 4799998 6889999987321 1446788999998884 999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC---C-
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD---D- 492 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~---~- 492 (633)
.-.+....|+..|.| ..+|.+++...............+.+..|++.||++| |+.+||||||||.||||+. +
T Consensus 571 ~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~~ 646 (903)
T KOG1027|consen 571 SEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSADG 646 (903)
T ss_pred eccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCCc
Confidence 989999999999999 4599999986311111112145578899999999999 7789999999999999975 3
Q ss_pred -CceEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhC-CCCCcccccccccch
Q 006739 493 -MEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMG-RLPSDDFFQHTEEMS 569 (633)
Q Consensus 493 -~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~~~~~~~ 569 (633)
..++|+|||+++.+..+... .......||.||+|||++....-+.++|+||+||++|+.++| .+||.+.... +.+
T Consensus 647 ~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~N 724 (903)
T KOG1027|consen 647 TLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QAN 724 (903)
T ss_pred ceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhh
Confidence 46899999999988765433 234567899999999999998888899999999999999996 8999864321 111
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+..+......+ .. ..++ ...++|.+|++.||..||++.+|+.
T Consensus 725 -------Il~~~~~L~~L-----~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 725 -------ILTGNYTLVHL-----EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------hhcCccceeee-----cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111100000 00 0111 4778999999999999999999873
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=249.41 Aligned_cols=262 Identities=20% Similarity=0.289 Sum_probs=205.2
Q ss_pred cCcccccccccccCeeEEEEEecCC----CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
++++....+-+|.||.||.|.++.. +.+.|-||.++.... + -....+..|.-++..+.|||+.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-------~------iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-------Q------IQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-------H------HHHHHHHHHHHHHhcCcCCCcc
Confidence 4566677889999999999976422 234555565533221 1 1145677888888899999999
Q ss_pred ccceeeec-CCccEEEEecccCCCHHHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 413 PLLAHMAR-PDCHLLVYEFMKNGSLQDILNDVSQ----GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 413 ~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
.+.+.+.+ .+..+.+|.++.-|+|..++.-.+. ..+.++..+...++.|++.|++|| |+.+|||.||..+|.
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAaRNC 427 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAARNC 427 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhhhcc
Confidence 99998754 5567889999999999999984332 345577888999999999999999 899999999999999
Q ss_pred EecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccc
Q 006739 488 LLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTE 566 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~ 566 (633)
++|+..++||+|=.+++.+-+.+.+.-.........||+||.+....|+.++|||||||++|||+| |+.|+.+..+
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--- 504 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--- 504 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---
Confidence 999999999999999998877776655455667889999999999999999999999999999999 9999876433
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.++..++ ..+.+.. .+-.+.+++..++.-||..+|++||++++++.-|.++
T Consensus 505 -fEm~~yl---kdGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 505 -FEMEHYL---KDGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -HHHHHHH---hccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2222222 2233222 1223445588888899999999999999999998876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=257.52 Aligned_cols=206 Identities=28% Similarity=0.387 Sum_probs=175.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC---CCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR---HRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv 412 (633)
..+|+....+|.|+||.|+.+.++ .+...|++|.+.+...=. +.....+..-.+-.|+++|..++ |+||+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K-~n~~eVViK~I~KeRIL~------DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl 632 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHK-ENNYEVVIKMIFKERILV------DTWVRDRKLGTVPSEIQILATLNKHSHENIL 632 (772)
T ss_pred cccceeeeeccccccceEEEeeec-ccceEEEeeehhhhhhhh------hhhhcccccCccchhHHHHHHhhhcCccchh
Confidence 356889999999999999999886 468889999987654321 12222333556778999999997 99999
Q ss_pred ccceeeecCCccEEEEeccc-CCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 413 PLLAHMARPDCHLLVYEFMK-NGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++|++++.+||+||-.. +-+|++++.. +..+++.+...|.+||+.|+++| |+++|||||||-+||.++.
T Consensus 633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDS 705 (772)
T ss_pred hhhheeecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccc---cccCceecccccccEEEec
Confidence 99999999999999999864 4499999975 56799999999999999999999 8999999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCC-CccchHHHHHHHHHHHhCCCCCc
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSD 559 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~ 559 (633)
+|-+||+|||.|.....+.. ...+||.+|.|||++.+.+|- ..-|+|++|+++|-++....||.
T Consensus 706 ~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999987766543 346899999999999998884 45899999999999999988875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=242.45 Aligned_cols=133 Identities=29% Similarity=0.403 Sum_probs=109.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-----CC-
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-----HR- 409 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~- 409 (633)
..+|.+.++||.|.|++||++.+ ..+.+.||+|+.+.... + .+....|++++++++ |+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawD-tq~~r~VAlKVvKSAqh-----------Y----tEaAlDEIklL~~v~~~Dp~~~~ 140 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWD-TQNKRYVALKVVKSAQH-----------Y----TEAALDEIKLLQQVREGDPNDPG 140 (590)
T ss_pred CceEEEEEeccccccceeEEEee-ccCCeEEEEEEEehhhH-----------H----HHHHHHHHHHHHHHHhcCCCCCC
Confidence 35789999999999999999964 46789999999854321 1 334567888988884 33
Q ss_pred --cccccceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 006739 410 --NLLPLLAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLK 483 (633)
Q Consensus 410 --niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dik 483 (633)
.||+++++|.. +.+.|+|+|++ |.+|-.++.... .+.++...+++|++||+.||.||| .+-+|||.|||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHTDlK 215 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLH--RECGIIHTDLK 215 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHH--HhcCccccCCC
Confidence 69999999854 56889999999 678989887643 466899999999999999999998 44589999999
Q ss_pred CCCeEe
Q 006739 484 PANVLL 489 (633)
Q Consensus 484 p~Nill 489 (633)
|+|||+
T Consensus 216 PENvLl 221 (590)
T KOG1290|consen 216 PENVLL 221 (590)
T ss_pred cceeee
Confidence 999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=237.28 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=192.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
..|..+..+|.|.- .|..+.+ .-.++.||+|++..+..... ..++..+|..++..+.|+||++++.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D-~v~~~~v~ikk~~~pf~n~~------------~akra~rel~l~~~v~~~nii~l~n 82 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFD-QVLGRPVAIKKLSRPFQNQT------------HAKRAYRELKLMKCVNHKNIISLLN 82 (369)
T ss_pred eeeeeecccCCCCc-eEEecch-hhccCceehhhhcCccccCc------------cchhhhhhhhhhhhhcccceeeeee
Confidence 56777888999988 6666643 34688999999877633211 1456788999999999999999999
Q ss_pred eeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 417 HMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 417 ~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++.-. ...|+||||| ..+|...+.. .++-.....|..|+..|++|| |+.+|+||||||+||++.
T Consensus 83 ~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsnivv~ 152 (369)
T KOG0665|consen 83 VFTPQKTLEEFQEVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIVVN 152 (369)
T ss_pred ccCccccHHHHHhHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccceec
Confidence 88433 3579999999 5599888862 366678899999999999999 899999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
.+..+||.|||+|+..... ...+..+.|..|.|||++-+..+.+.+|+||.||++.||++|+.-|.+... +
T Consensus 153 ~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~------i 223 (369)
T KOG0665|consen 153 SDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH------I 223 (369)
T ss_pred chhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH------H
Confidence 9999999999999875443 234567789999999999998899999999999999999999988764221 1
Q ss_pred HHHHHHhhccCCcc---------------------------hhhhhhh-hh--cCCHHHHHHHHHHHhHhccCCCCCCCC
Q 006739 571 VKWMRNVMTSENPT---------------------------RAIDAKL-LE--NGYEEQMLLVLKIACFCTVDSPRERPN 620 (633)
Q Consensus 571 ~~~~~~~~~~~~~~---------------------------~~~d~~~-~~--~~~~~~~~~~~~l~~~cl~~dP~~RPs 620 (633)
.+|.+-...-+.+. +.+.... .. +...-......+++.+||..||++|-+
T Consensus 224 dQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris 303 (369)
T KOG0665|consen 224 DQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS 303 (369)
T ss_pred HHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence 22222111111100 0000000 00 011122345678889999999999999
Q ss_pred HHHHHH
Q 006739 621 SKDVRC 626 (633)
Q Consensus 621 ~~ev~~ 626 (633)
++++++
T Consensus 304 v~daL~ 309 (369)
T KOG0665|consen 304 VDDALR 309 (369)
T ss_pred HHHHhc
Confidence 999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=226.93 Aligned_cols=212 Identities=33% Similarity=0.545 Sum_probs=181.5
Q ss_pred cccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCcc
Q 006739 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH 424 (633)
Q Consensus 345 ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 424 (633)
||+|++|.||++... .+++.+++|++....... ....+.+|++.++.++|++++++++++......
T Consensus 1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~-------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 66 (215)
T cd00180 1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDSSS-------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66 (215)
T ss_pred CCcCCceEEEEEEec-CCCcEEEEEEeccccchh-------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE
Confidence 689999999999874 358999999986544211 145788999999999999999999999999999
Q ss_pred EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC-CCceEEcccccc
Q 006739 425 LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-DMEARIADFGLA 503 (633)
Q Consensus 425 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~-~~~~kl~DfG~a 503 (633)
++++||+++++|.+++.... ..+++..+..++.++++++++| |+.+++|+||+|.||+++. ++.++|+|||.+
T Consensus 67 ~~~~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~ 140 (215)
T cd00180 67 YLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLS 140 (215)
T ss_pred EEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCce
Confidence 99999999999999987521 4689999999999999999999 6779999999999999999 899999999999
Q ss_pred cccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCC
Q 006739 504 KAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN 582 (633)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (633)
........ ......+...|++||..... .++.+.|+|++|++++++
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------- 187 (215)
T cd00180 141 KLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------- 187 (215)
T ss_pred EEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence 87655421 11234578899999998887 788999999999999998
Q ss_pred cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 583 PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 583 ~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 237788889999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=243.85 Aligned_cols=262 Identities=18% Similarity=0.247 Sum_probs=202.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC------CC
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR------HR 409 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~ 409 (633)
...|.+....|+|-|++|.+|... .-|..||||++...... .+.=..|+++|.+|. --
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnNE~M---------------~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNNEVM---------------HKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred cceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecchHH---------------hhhhhHHHHHHHHhhccCchhhh
Confidence 457888888999999999999865 45779999999654321 344567899999995 23
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
|.++++.+|...+++|||+|-+ .-+|.++|+++.. ...+....+..++.|+.-||..| -.-+|+|.||||.|||+
T Consensus 495 Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNILV 569 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceEe
Confidence 8999999999999999999988 5699999998654 56788899999999999999999 67799999999999999
Q ss_pred cCCC-ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDM-EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
++.- .+||||||.|....+... +.+..+..|.|||++.+.+|+...|+||.||+||||.||+.-|.+.. ..
T Consensus 570 NE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T----NN 641 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT----NN 641 (752)
T ss_pred ccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC----cH
Confidence 9754 579999999988766543 22345678999999999999999999999999999999999876532 22
Q ss_pred hHHHHHHHhhc-----------------------------------------cCCcchhhhhhhhh-----cCCHHHHHH
Q 006739 569 SLVKWMRNVMT-----------------------------------------SENPTRAIDAKLLE-----NGYEEQMLL 602 (633)
Q Consensus 569 ~~~~~~~~~~~-----------------------------------------~~~~~~~~d~~~~~-----~~~~~~~~~ 602 (633)
.+.++...+.+ ...+..-+-..+.. ...+..+.+
T Consensus 642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~ 721 (752)
T KOG0670|consen 642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ 721 (752)
T ss_pred HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence 33333322110 00111111111111 122445667
Q ss_pred HHHHHhHhccCCCCCCCCHHHHHH
Q 006739 603 VLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 603 ~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+++..|+..||++|.|..++++
T Consensus 722 ~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 722 LRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHhccChhhcCCHHHHhc
Confidence 899999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=251.63 Aligned_cols=256 Identities=28% Similarity=0.426 Sum_probs=202.9
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+..++|+.+..+|.|.||.|||++.. ..++..|+|+++....+. ..-+++|+-+++..+|||||.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~-~s~elaavkvVkLep~dd--------------~~~iqqei~~~~dc~h~niva 76 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDK-RSGELAAVKVVKLEPGDD--------------FSGIQQEIGMLRDCRHPNIVA 76 (829)
T ss_pred CCccchhheeeecCCcccchhhhccc-ccCchhhheeeeccCCcc--------------ccccccceeeeecCCCcChHH
Confidence 45678999999999999999999864 578999999997765432 445778999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++|.+-..+..++.|||+.+|+|.+.-+. ..++++.++..+.+...+|++|| |+++-+|||||-.||++++.|
T Consensus 77 y~gsylr~dklwicMEycgggslQdiy~~----TgplselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~g 149 (829)
T KOG0576|consen 77 YFGSYLRRDKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEG 149 (829)
T ss_pred HHhhhhhhcCcEEEEEecCCCcccceeee----cccchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccC
Confidence 99999999999999999999999998764 56799999999999999999999 899999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCccccccccc---ccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH---QTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
.+|+.|||.+-.+..... ......||+.|||||+. ..+.|...+|+|+.|+...|+---+.|..+..+ +..
T Consensus 150 DvklaDfgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~ 223 (829)
T KOG0576|consen 150 DVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRA 223 (829)
T ss_pred ceeecccCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHH
Confidence 999999999876544321 12457899999999975 456789999999999999999877777433221 121
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+. .+...+...-|+. .....+-++++.|+..+|++||+++.++.
T Consensus 224 l~LmT--kS~~qpp~lkDk~-------kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 224 LFLMT--KSGFQPPTLKDKT-------KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHhh--ccCCCCCcccCCc-------cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22221 1222222222211 22334778888999999999999987754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=234.88 Aligned_cols=200 Identities=27% Similarity=0.385 Sum_probs=166.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCC--CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni 411 (633)
..+.|..+++||+|.|++||++.+... .++.||+|.+...+. ...+.+|++++..+. +.||
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------------p~ri~~El~~L~~~gG~~ni 97 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------------PSRILNELEMLYRLGGSDNI 97 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------------chHHHHHHHHHHHhccchhh
Confidence 346788999999999999999987532 568999998865442 346889999999995 9999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++.+++..++..++|+||++..+..++... ++...+..++..+..||+++ |..|||||||||+|++++.
T Consensus 98 ~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 98 IKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNR 167 (418)
T ss_pred hcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhh---hccCccccCCCcccccccc
Confidence 9999999999999999999999999988764 67888999999999999999 8999999999999999984
Q ss_pred -CCceEEcccccccccCCCC---------------------------------Ccc---------eecccccCccccccc
Q 006739 492 -DMEARIADFGLAKAMPDAQ---------------------------------THI---------TTSNVAGTVGYIAPE 528 (633)
Q Consensus 492 -~~~~kl~DfG~a~~~~~~~---------------------------------~~~---------~~~~~~gt~~y~aPE 528 (633)
.+.-.|+|||+|....... .+. ......||+||+|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 5678999999987211000 000 012346999999999
Q ss_pred cccc-CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 529 YHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 529 ~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
++.. ...++++||||.||+++.+++++.||-.
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhcccccccc
Confidence 8876 4568899999999999999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=223.20 Aligned_cols=201 Identities=31% Similarity=0.476 Sum_probs=170.2
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHM 418 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 418 (633)
|+..+.||+|++|.||++... .+++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~ 66 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTE-------------KQREEFLREIRILKKLKHPNIVKLYGVF 66 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccch-------------HHHHHHHHHHHHHHhCCCCChhhheeee
Confidence 456789999999999999875 35789999998654321 1256788899999999999999999999
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
......++++||+++++|.+++.... ..+++..+..++.++++++.+| |+.+++|+||+|+||+++.++.++|+
T Consensus 67 ~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~~~~~l~ 140 (225)
T smart00221 67 EDPEPLYLVMEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMDGLVKLA 140 (225)
T ss_pred ecCCceEEEEeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEEe
Confidence 99899999999999999999997532 1188999999999999999999 67799999999999999999999999
Q ss_pred ccccccccCCCCCcceecccccCccccccccc-ccCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 499 DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH-QTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 499 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
|||.+......... ......++..|++||.. ....++.++|||+||++++||++|+.||+.
T Consensus 141 d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 141 DFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999877654211 11234678899999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=217.63 Aligned_cols=255 Identities=19% Similarity=0.321 Sum_probs=187.3
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNL 411 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni 411 (633)
..-.+.|.+.+.+|+|.||.+-+++++ ...+.+++|.+..+... .++|.+|...--.+. |.||
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p~tt---------------~~dF~rEfhY~~~Ls~H~hI 83 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRPQTT---------------QADFVREFHYSFFLSPHQHI 83 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeecc-CCceEEEeeccCcchhh---------------HHHHHHHhccceeeccchhh
Confidence 445688999999999999999999987 46788999988665432 578889988766664 9999
Q ss_pred ccccee-eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 412 LPLLAH-MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 412 v~l~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+..++. |+..+.+++++||++-|+|.+-+.. ..+.+..-.+++.|++.|+.|+ |++.+||||||.+|||+-
T Consensus 84 i~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif 155 (378)
T KOG1345|consen 84 IDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIF 155 (378)
T ss_pred hHHHHHHhhcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEe
Confidence 988875 5667778899999999999887753 4477788899999999999999 899999999999999984
Q ss_pred --CCCceEEcccccccccCCCCCcceecccccCcccccccccccC-----CCCCccchHHHHHHHHHHHhCCCCCccccc
Q 006739 491 --DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-----KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 491 --~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
+...+||||||.++..+.... ....+..|-+||..... ...+.+|+|.||+++|..+||+.||...
T Consensus 156 ~~df~rvKlcDFG~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-- 228 (378)
T KOG1345|consen 156 DADFYRVKLCDFGLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-- 228 (378)
T ss_pred cCCccEEEeeecccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh--
Confidence 344799999999876544321 22346679999976432 2467899999999999999999999842
Q ss_pred ccccchHHHHHHHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 564 HTEEMSLVKWMRNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
........+|++-..+.. ..++ . +......+.++.++-+..+|++|=-..++.++
T Consensus 229 ~~~d~~Y~~~~~w~~rk~~~~P~-----~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 229 SIMDKPYWEWEQWLKRKNPALPK-----K----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hccCchHHHHHHHhcccCccCch-----h----hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 223344444444322111 1111 1 11112235666678899999999444444433
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=264.07 Aligned_cols=195 Identities=15% Similarity=0.178 Sum_probs=138.6
Q ss_pred CCC-Ccccccceee-------ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 006739 406 IRH-RNLLPLLAHM-------ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRI 477 (633)
Q Consensus 406 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~i 477 (633)
++| +||++++++| ...+..+.++||+ +++|.+++.. ....+++.+++.++.||++||+|| |+++|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAA---HSQGI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHH---HhCCe
Confidence 445 5888888887 2334567889988 6699999974 235699999999999999999999 78999
Q ss_pred eeCCCCCCCeEecC-------------------CCceEEcccccccccCCCCC--------------cceecccccCccc
Q 006739 478 IHRDLKPANVLLDD-------------------DMEARIADFGLAKAMPDAQT--------------HITTSNVAGTVGY 524 (633)
Q Consensus 478 vH~Dikp~Nill~~-------------------~~~~kl~DfG~a~~~~~~~~--------------~~~~~~~~gt~~y 524 (633)
+||||||+|||++. ++.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566677777654321000 0001124589999
Q ss_pred ccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHH
Q 006739 525 IAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVL 604 (633)
Q Consensus 525 ~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 604 (633)
||||++.+..++.++|||||||++|||++|..|+.... ..+..+... ..+ +.. ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~----~~~-----~~~-----~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR----VLP-----PQI-----LLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh----hcC-----hhh-----hhcCHHHH
Confidence 99999999999999999999999999999988864311 111111111 000 100 01112245
Q ss_pred HHHhHhccCCCCCCCCHHHHHH
Q 006739 605 KIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 605 ~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.++.+||+.+|.+||++.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7778899999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=203.51 Aligned_cols=167 Identities=23% Similarity=0.229 Sum_probs=124.9
Q ss_pred CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcc
Q 006739 434 GSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513 (633)
Q Consensus 434 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 513 (633)
|||.++++.. +..+++..++.|+.|+++||+||| +.+ ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899998752 356999999999999999999995 443 999999999999999 99988764422
Q ss_pred eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhh
Q 006739 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLE 593 (633)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 593 (633)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+.............
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~------- 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPADDPRDRS------- 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccCCccccc-------
Confidence 2589999999999999999999999999999999999999865322 111122222211111100000
Q ss_pred cCCHHHH--HHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 594 NGYEEQM--LLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 594 ~~~~~~~--~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
...... ..+.+++.+||+.+|++||++.|+++.+..+
T Consensus 131 -~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 131 -NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred -cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 011111 2588999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=204.87 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=191.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.++....+|.+...|..|+|++ .|..+++|++..... ..+..++|..|.-.++...||||..++|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw---qgndivakil~vr~~------------t~risrdfneefp~lrifshpnilpvlg 254 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW---QGNDIVAKILNVREV------------TARISRDFNEEFPALRIFSHPNILPVLG 254 (448)
T ss_pred hhhhhhhhhccCCCcccccccc---cCcchhhhhhhhhhc------------chhhcchhhhhCcceeeecCCchhhhhh
Confidence 3455567899999999999998 466788888754332 2233678999999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
.|..+....++..||+-|+|+..++.. .....+-.+..+++.+||+|++|||.. ++-|.---+.+..|++|++.+++
T Consensus 255 acnsppnlv~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltar 331 (448)
T KOG0195|consen 255 ACNSPPNLVIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTAR 331 (448)
T ss_pred hccCCCCceEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhh
Confidence 999999999999999999999999863 356678889999999999999999753 33344456889999999999888
Q ss_pred Ec--ccccccccCCCCCcceecccccCcccccccccccCCCC---CccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 497 IA--DFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFT---DKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 497 l~--DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
|+ |--++. ......-.+.||+||.++..+-+ .++|+|||++++||+.|...||.+..+-+-
T Consensus 332 ismad~kfsf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----- 397 (448)
T KOG0195|consen 332 ISMADTKFSF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----- 397 (448)
T ss_pred eecccceeee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-----
Confidence 75 322211 11223457889999998876543 479999999999999999999987544211
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.++-.+.+-+ -.-++.....+.+++.-|++.||.+||.+..++-.|++++
T Consensus 398 -gmkialeglr----------v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 398 -GMKIALEGLR----------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -hhhhhhcccc----------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1111111111 1122223344777778899999999999999999998875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=215.08 Aligned_cols=171 Identities=19% Similarity=0.179 Sum_probs=129.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||+||+|++...+++.||||++......... ......+.+|++++++++|+|++..+
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~---------~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSK---------PLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccccc---------HHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 467999999999999999999876557888999987422110000 01145689999999999999998533
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCeEecCCCc
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL-KPANVLLDDDME 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di-kp~Nill~~~~~ 494 (633)
.. .+..++||||++|++|... . . .. ...++.+++++|+|| |+.+|+|||| ||+|||++.++.
T Consensus 88 ~~---~~~~~LVmE~~~G~~L~~~-~---~----~~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 88 LA---TGKDGLVRGWTEGVPLHLA-R---P----HG---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred EE---cCCcEEEEEccCCCCHHHh-C---c----cc---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCC
Confidence 22 2457999999999999632 1 1 01 146788999999999 7889999999 999999999999
Q ss_pred eEEcccccccccCCCCCcce------ecccccCccccccccccc
Q 006739 495 ARIADFGLAKAMPDAQTHIT------TSNVAGTVGYIAPEYHQT 532 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 532 (633)
+||+|||+|+.+........ -....+++.|+|||++..
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999999997765432111 134568889999998854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=192.89 Aligned_cols=261 Identities=22% Similarity=0.327 Sum_probs=202.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~ 415 (633)
-.|++.++||+|+||..+.|.. --+++.||||.-...+. ..+++.|.+..+.|. .++|...+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~N-l~nne~VAIKfEPrkS~----------------APQLrdEYr~YKlL~g~~GIP~vY 90 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKN-LYNNEPVAIKFEPRKSE----------------APQLRDEYRTYKLLGGTEGIPQVY 90 (449)
T ss_pred ccceeccccccCcceeeecccc-cccCceEEEEeccccCC----------------cchHHHHHHHHHHHcCCCCCCcee
Confidence 3688999999999999999964 45899999996422221 346677888877774 78999998
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC---
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD--- 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~--- 492 (633)
-+..++.+-.||+|.+ |.||+|++.-+ ++.++..++..||.|+..-++|+ |++.+|.|||||+|+||...
T Consensus 91 YFGqeG~~NiLVidLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k 163 (449)
T KOG1165|consen 91 YFGQEGKYNILVIDLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTK 163 (449)
T ss_pred eeccccchhhhhhhhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCC
Confidence 8888888889999999 88999998753 56799999999999999999999 78889999999999999743
Q ss_pred --CceEEcccccccccCCCCCcc-----eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccc
Q 006739 493 --MEARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT 565 (633)
Q Consensus 493 --~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 565 (633)
..+.++|||+|+.+.+..+.. ......||.+||+-....+.+.+.+.|+-|+|-++++.+.|..||.+.-...
T Consensus 164 ~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 164 DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 358999999999998765432 2345679999999999999999999999999999999999999998764433
Q ss_pred ccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 566 EEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
..+.. ..+ +...+......+.+..+++.....+.+++. +=++-|+.+-+...+.++
T Consensus 244 nK~kY----eKI---Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L---~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 244 NKEKY----EKI---GETKRSTPIEVLCEGFPEEFATYLRYVRRL---DFFETPDYDYLRKLFDDV 299 (449)
T ss_pred hHHHH----HHh---ccccccCCHHHHHhcCHHHHHHHHHHHHhc---CcccCCCHHHHHHHHHHH
Confidence 22221 111 112222223333455777777777776654 667778888887777654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-22 Score=206.62 Aligned_cols=261 Identities=22% Similarity=0.294 Sum_probs=190.2
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC----CCcccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR----HRNLLP 413 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~ 413 (633)
.|.+.+.||+|+||.||++.........+|+|......... ...+..|..++..+. -+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--------------~~~l~~E~~vl~~l~~~~~~~~~~~ 84 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--------------PSVLKIEIQVLKKLEKKNGPSHFPK 84 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--------------CccchhHHHHHHHHhhhcCCCCCCE
Confidence 79999999999999999998653334578888765432211 114566777777665 258888
Q ss_pred cceee-ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 414 LLAHM-ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 414 l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+++.. ..+...++||+.+ |.+|.++..... ...++..+..+|+.|++.+|+++ |+.|++||||||.|+++...
T Consensus 85 ~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~~ 158 (322)
T KOG1164|consen 85 LLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQS 158 (322)
T ss_pred EEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecCC
Confidence 88888 4777889999988 889999886543 57899999999999999999999 89999999999999999865
Q ss_pred -----CceEEcccccccccC--CCCC----cce--ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCc
Q 006739 493 -----MEARIADFGLAKAMP--DAQT----HIT--TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559 (633)
Q Consensus 493 -----~~~kl~DfG~a~~~~--~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 559 (633)
..+.+.|||+++.+. .... ... .....||..|.++....+...+.+.|+||++.++.|++.|..||.
T Consensus 159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCc
Confidence 358999999998332 2111 111 123569999999999999999999999999999999999999996
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
............+......... .....+.+.. ++...+-..+..++|....+...+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~---~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 239 ALEMTDLKSKFEKDPRKLLTDR----------FGDLKPEEFA---KILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred cccccchHHHHHHHhhhhcccc----------ccCCChHHHH---HHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 5433222222222111111110 1122333333 333344457999999999999888664
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=184.20 Aligned_cols=261 Identities=24% Similarity=0.328 Sum_probs=195.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC-Cccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH-RNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l 414 (633)
...|..+++||+|+||.+|.|.. ..+|..||+|.-..... ..++..|.++.+.+++ ..|..+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~-i~~ge~VAiK~Es~~a~----------------hpqL~yEskvY~iL~~g~GiP~i 76 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGIS-ITSGEEVAIKLESSKAK----------------HPQLLYESKVYRILQGGVGIPHI 76 (341)
T ss_pred ccceEEEEeecCCchhheeeeee-ccCCceEEEEeecccCC----------------CcchhHHHHHHHHhccCCCCchh
Confidence 46799999999999999999975 46899999998544332 3456678888888874 678888
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC---
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD--- 491 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~--- 491 (633)
.-|..+.+.-.+|||.+ |.||++++.-. .+.++..+++.++.|+..-++|+ |.++.+||||||+|+|+.-
T Consensus 77 ~~y~~e~~ynvlVMdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlgrh 149 (341)
T KOG1163|consen 77 RHYGTEKDYNVLVMDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLGRH 149 (341)
T ss_pred hhhccccccceeeeecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccccc
Confidence 88888888999999999 88999998754 35689999999999999999999 7889999999999999973
Q ss_pred CCceEEcccccccccCCCCCc-----ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTH-----ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
-..+.++|||+|+.+.+..+. .......||.+|.+-....+...+.+.|+-|+|.++.++..|..||.+......
T Consensus 150 ~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 150 CNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred cceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 346899999999988665332 123456799999988877777778899999999999999999999998765444
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
.+...+......+ +..+..-..++.+. .-.+.-|=..-=++-|+..-+.+.++-
T Consensus 230 ~QKyEkI~EkK~s-------~~ie~LC~G~P~EF---~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 230 KQKYEKISEKKMS-------TPIEVLCKGFPAEF---AMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HHHHHHHHHhhcC-------CCHHHHhCCCcHHH---HHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 4433332221111 11122223333333 333334555566666777777666654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-21 Score=196.46 Aligned_cols=264 Identities=28% Similarity=0.415 Sum_probs=196.3
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC-ccccccee
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR-NLLPLLAH 417 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~ 417 (633)
|...+.||.|+||.||++... ..+++|.+........ .....+.+|..+++.+.|+ +++++.++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 66 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKS-----------KEVERFLREIQILASLNHPPNIVKLYDF 66 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccch-----------hHHHHHHHHHHHHHHccCCcceeeEEEE
Confidence 567789999999999999863 7889998865433211 1256788999999999988 79999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC-ceE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-EAR 496 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~-~~k 496 (633)
+......+++++|+.++++.+++...... ..+.......++.|++.+++|+ |+.+++|||+||+||+++..+ .++
T Consensus 67 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~~ 142 (384)
T COG0515 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVVK 142 (384)
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeEE
Confidence 97777789999999999999777642211 3688999999999999999999 788899999999999999988 799
Q ss_pred EcccccccccCCCCCcc----eecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 497 IADFGLAKAMPDAQTHI----TTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
++|||.++......... ......||..|+|||...+ ..++...|+||+|++++++++|..||...........
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~ 222 (384)
T COG0515 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222 (384)
T ss_pred EeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH
Confidence 99999998665543221 2345679999999999987 5788899999999999999999999654322101122
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+...... ......... ........+.+++..|+..+|..|.++.+...
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 223 TLKIILELPTP-SLASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHHHHHhcCCc-ccccccCcc----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 22222221111 000000000 00122235778888999999999999988765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-23 Score=220.48 Aligned_cols=261 Identities=21% Similarity=0.238 Sum_probs=188.7
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeee
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 419 (633)
...+.+|.|.+|.|+.+... ...+..+.|.+..... ... . .. .....+..|+.+-..++|+|++..+..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~-~~~~~~~~~~~r~~~~-~~~-s---~~---~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRR-SDLKSFPEKEFRVRVK-PTE-S---ER---KYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEec-CCCccchhhhhhcccC-Ccc-c---HH---HHhhhhhhheeecccccCCchhhhHHHHh
Confidence 45678999999988777543 3444455554432100 000 0 10 01122778888889999999999888887
Q ss_pred cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcc
Q 006739 420 RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIAD 499 (633)
Q Consensus 420 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~D 499 (633)
+....+-+|||+++ +|..++.. ...+...++..+..|+..|++|+ |+.||.|||+|++|++++.+|.+||+|
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~D 463 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKIID 463 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEee
Confidence 77776667999999 99999875 24688889999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCCCc--ceecccccCcccccccccccCCCCCc-cchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 500 FGLAKAMPDAQTH--ITTSNVAGTVGYIAPEYHQTLKFTDK-CDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 500 fG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
||.+..+.-+... .......|+..|+|||.+.+..|++. .||||.|+++..|.+|+.||-..-..+.... ..
T Consensus 464 fg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~~-- 538 (601)
T KOG0590|consen 464 FGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---TN-- 538 (601)
T ss_pred cCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---hh--
Confidence 9998876554433 33466789999999999999999875 8999999999999999999865332211110 00
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....+.... .-..............++.++++.||.+|-|++++++
T Consensus 539 -~~~~~~~~~---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 539 -NYSDQRNIF---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccccccccc---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000000000 0001112233345778888999999999999999975
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=216.18 Aligned_cols=253 Identities=21% Similarity=0.249 Sum_probs=180.7
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
++...+.+|++.|=+|.+++++ .|. |+||++.+..... ++.. ..+...|++ ...++|||.+++..+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~-sL~~---------~~qrL~~ik-~~l~~~pn~lPfqk~ 89 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTI-SLRP---------FKQRLEEIK-FALMKAPNCLPFQKV 89 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCC-CchH---------HHHHHHHHH-HHhhcCCcccchHHH
Confidence 6777899999999999999874 454 9999987665321 1111 222333444 556689999999998
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
.......|+|-+|+.+ +|+|.+.. +..+...+.+.|+.|++.||... |..+|+|||||.+|||++....+.|
T Consensus 90 ~~t~kAAylvRqyvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 90 LVTDKAAYLVRQYVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHhhHHHHHHHHHHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhhh
Confidence 8888888999999965 99998875 45578889999999999999999 8999999999999999999999999
Q ss_pred cccccccccCCCCCcc-----eecccccCcccccccccccC-----------CCCCccchHHHHHHHHHHHh-CCCCCcc
Q 006739 498 ADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTL-----------KFTDKCDIYSFGVLLAVLVM-GRLPSDD 560 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~l~ellt-g~~p~~~ 560 (633)
+||..-+-..-..... .-.....-.+|+|||.+... ..+++.|+||+||+++||++ |++||.-
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 9998765432111111 11112234579999977431 15678999999999999999 6777642
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
.++.++. ..+....+.+-..+.. ..+.+++..|++.||++|-+++++++.-+
T Consensus 242 -------SQL~aYr---~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 242 -------SQLLAYR---SGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred -------HHHHhHh---ccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1222221 1111111111111110 13778999999999999999999998744
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=180.91 Aligned_cols=155 Identities=19% Similarity=0.147 Sum_probs=112.3
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHH---HHH---------HHHHHHHHHHHHHHHhhcCCCC
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEE---DSK---------LLNKKMRQIRSEINTVGQIRHR 409 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---~~~---------~~~~~~~~~~~e~~~l~~l~h~ 409 (633)
...||+|+||.||+|... +|+.||||+++............ ... ...........|++.+.++.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 468999999999999875 79999999997653221110000 000 0000123345699999999888
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
++.....+.. ...++||||++++++...... ...++......++.|++++|.|+| |+.+|+||||||+||++
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli 151 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEE
Confidence 8754443322 234899999998877654322 246888999999999999999997 67899999999999999
Q ss_pred cCCCceEEcccccccccC
Q 006739 490 DDDMEARIADFGLAKAMP 507 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~ 507 (633)
++ +.++|+|||+|....
T Consensus 152 ~~-~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 HD-GKLYIIDVSQSVEHD 168 (190)
T ss_pred EC-CcEEEEEccccccCC
Confidence 84 789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=221.60 Aligned_cols=170 Identities=28% Similarity=0.531 Sum_probs=130.2
Q ss_pred CChhHHHHHHHHHHhcCCC----CCCCC-CCCCCCCceeeCCCCCCCCcceeeeEEEEecCCCCcccCCccccCCccccE
Q 006739 28 LDRSDYKALSVILRDLGGQ----QLFIP-SDPCSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRE 102 (633)
Q Consensus 28 ~~~~~~~~l~~~~~~~~~~----~~w~~-~~~C~~~gv~c~~~~~~~~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~ 102 (633)
.+++|+.||++||+++.+. ..|.. .++|.|.||.|+.. .+++.|+|++|++++.++..|..+++|+.
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~--------~~v~~L~L~~~~i~~~~~~~~~~l~~L~~ 97 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNS--------SRVVSIDLSGKNISGKISSAIFRLPYIQT 97 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCC--------CcEEEEEecCCCccccCChHHhCCCCCCE
Confidence 3678999999999998643 34854 48999999999742 17888999999988888888888899999
Q ss_pred EEccCCCCCCCCchhcc-CCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCc
Q 006739 103 LSLANNSLVDLLPPQIV-DCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNL 180 (633)
Q Consensus 103 L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~ 180 (633)
|+|++|++++.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|+|++|.+++.. ..+.++++|++|+|++|.
T Consensus 98 L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~ 175 (968)
T PLN00113 98 INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175 (968)
T ss_pred EECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCc
Confidence 99999988877787655 788888888888888777765 35667777777777776543 456677777777777777
Q ss_pred CCccCCcccccCCCCCeeccCCCCCCC
Q 006739 181 FTGKVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 181 l~~~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
+.+.+|..++++++|++|+|++|++..
T Consensus 176 l~~~~p~~~~~l~~L~~L~L~~n~l~~ 202 (968)
T PLN00113 176 LVGKIPNSLTNLTSLEFLTLASNQLVG 202 (968)
T ss_pred ccccCChhhhhCcCCCeeeccCCCCcC
Confidence 777777777777777777777777643
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.5e-21 Score=179.80 Aligned_cols=180 Identities=13% Similarity=0.150 Sum_probs=133.1
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
-...|+..+++|.|+||.||++.. ++..+|+|.+........... ..-...+.+.+|++.+.++.|++|..+
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~-----~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFL-----KSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHH-----HhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 357899999999999999999754 466899999865443221100 000113457899999999999999999
Q ss_pred ceeeecC--------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 415 LAHMARP--------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 415 ~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
..++... ...++||||++|.+|.++.. ++. ....+++.++..+ |+.+++|||+||+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~N 165 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESL---HQHGMVSGDPHKGN 165 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHH---HHcCCccCCCChHH
Confidence 8886533 35789999999999988732 222 2456889999999 78999999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHH
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV 552 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ell 552 (633)
|+++.++ ++++|||........... ..+.....+..++|+|+||+++..+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988 999999987655322110 01333445677999999999887553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.3e-20 Score=169.71 Aligned_cols=190 Identities=17% Similarity=0.114 Sum_probs=139.7
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccceee
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLAHM 418 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 418 (633)
.+...|++|+||+||.+.- ++.+++.+.+...+.- ...-....+++|+++++++. |+++++++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~----------~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWW----------LRGVAWWLARREALALRQLDGLPRTPRLLHW- 70 (218)
T ss_pred ccceeecCCCcceEEEeec---CCceeeecccccchhh----------hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-
Confidence 4568899999999997753 7788887776443310 00011235889999999995 5789999886
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCeEecCCCceEE
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL-KPANVLLDDDMEARI 497 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di-kp~Nill~~~~~~kl 497 (633)
...+++|||++|.+|.+.... ....+..|+.++|+++ |+.+|+|||| ||+|||++.++.++|
T Consensus 71 ---~~~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 71 ---DGRHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred ---cCEEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEEE
Confidence 346999999999998754321 1134678899999999 7889999999 799999999999999
Q ss_pred cccccccccCCCCCc----c-------eecccccCcccccccccccC-CCC-CccchHHHHHHHHHHHhCCCCCcc
Q 006739 498 ADFGLAKAMPDAQTH----I-------TTSNVAGTVGYIAPEYHQTL-KFT-DKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
+|||+|......... . .......++.|++|+-..-. ..+ .+.++++-|+-+|.++||+.++..
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 999999865543311 0 01122367888888854332 222 567999999999999999998644
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=191.50 Aligned_cols=217 Identities=24% Similarity=0.388 Sum_probs=164.5
Q ss_pred hhcCCCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 006739 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482 (633)
Q Consensus 403 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di 482 (633)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.....++.+|+.||+|+| +++-..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeee
Confidence 3568899999999999999999999999999999999975 3567999999999999999999996 4554599999
Q ss_pred CCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCC-------CCCccchHHHHHHHHHHHhCC
Q 006739 483 KPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-------FTDKCDIYSFGVLLAVLVMGR 555 (633)
Q Consensus 483 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~s~G~~l~elltg~ 555 (633)
+++|.++|..-.+|++|||+.....+...........-..-|.|||.+.... .+.++|+||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999988765311111111122345699999887631 466799999999999999999
Q ss_pred CCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 556 LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 556 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.||+..........+...++. ....+ ..+.+.... +....+..++..||..+|++||+++.+...++.+
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~--~~~~~---~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK--GGSNP---FRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHHHHHHHHh--cCCCC---cCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999875544433444444433 11111 112221111 2223588888999999999999999999888765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.3e-20 Score=172.55 Aligned_cols=155 Identities=17% Similarity=0.168 Sum_probs=113.6
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHH------------HHHHHHHHHHHHHHHHHhhcCCCC
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEED------------SKLLNKKMRQIRSEINTVGQIRHR 409 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~ 409 (633)
.+.||+|++|.||+|... +|+.||||++.............. ..........+++|.+.+.++.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 478999999999999865 799999999987643211100000 000011123456899999999999
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHH-HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDI-LNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
++.....+... ..++||||++++++... +. ...++......++.+++.++.++| +..+|+||||||+||+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCChhhEE
Confidence 88655554433 24899999998865433 32 234678889999999999999995 3389999999999999
Q ss_pred ecCCCceEEcccccccccCC
Q 006739 489 LDDDMEARIADFGLAKAMPD 508 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~ 508 (633)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.4e-20 Score=178.36 Aligned_cols=238 Identities=22% Similarity=0.277 Sum_probs=151.4
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC---------
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH--------- 408 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--------- 408 (633)
.+...+.||.|+++.||.+++. .+++.+|||.+..+..... ...+++++|.-....+.+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~-~t~~~~avkvf~~~~~~~~-----------~~~~~~~~e~l~~~~~~~~~~p~~a~~ 80 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDV-ETGEEFAVKVFLLPADASA-----------NEYEQLKEEQLAITLFPGVKNPKEAYR 80 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEEESSTTHT-----------THHHHHHHHHHGGGGSTT--SHHHHHH
T ss_pred EEEEccccccCCceEEEEEEEc-cCCceEEEEEEecccccch-----------HHHHHHHHHHHHhhhhccCCCHHHHHH
Confidence 4456789999999999999975 5789999999876662211 114556666655554332
Q ss_pred -Cccccccee---------eecCC--------ccEEEEecccCCCHHHHHhh---hcCCCCCCCHHHHHHHHHHHHHHHH
Q 006739 409 -RNLLPLLAH---------MARPD--------CHLLVYEFMKNGSLQDILND---VSQGRRELDWLARHKIALGVACGLE 467 (633)
Q Consensus 409 -~niv~l~~~---------~~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~L~ 467 (633)
-.++..++. +.... ..+++|+-+ .+||.+++.. .......+....+..+..|+.+.++
T Consensus 81 ~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA 159 (288)
T PF14531_consen 81 HLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVA 159 (288)
T ss_dssp HH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred hceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHH
Confidence 111111111 11111 236788888 4588887653 2222234556678888899999999
Q ss_pred HHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCccccccccccc--------CCCCCcc
Q 006739 468 YLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT--------LKFTDKC 539 (633)
Q Consensus 468 ~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~ 539 (633)
+| |..|++|+||+|+|++++.+|.++|+||+.....+.... . ...+..|.+||.... ..++.+.
T Consensus 160 ~L---h~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~ 231 (288)
T PF14531_consen 160 NL---HSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFAT 231 (288)
T ss_dssp HH---HHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHH
T ss_pred HH---hhcceEecccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeecc
Confidence 99 788999999999999999999999999998765443211 1 234678999997643 2478899
Q ss_pred chHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCC
Q 006739 540 DIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRER 618 (633)
Q Consensus 540 Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 618 (633)
|.|++|+++|.|++|+.||+.......... .... +.+..+.+..+|..+|+.+|.+|
T Consensus 232 DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 232 DAWQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred CHHHHHHHHHHHHHccCCCCCCCccccccc---------------------cchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 999999999999999999985432111110 1112 22556678889999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-21 Score=195.85 Aligned_cols=229 Identities=24% Similarity=0.300 Sum_probs=173.9
Q ss_pred ccccccCeeEEEEEe--cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccceeeec
Q 006739 344 KIGSGGCGEVYKAEL--PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLAHMAR 420 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 420 (633)
++|+|.||.|++++- ..+.|..||+|.+++....... ......|..++...+ ||.+|++...++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~------------~~~t~~er~il~~~~~~~f~v~lhyafqt 68 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD------------RTHTKQERIILAFVHNTPFLVKLHYAFQT 68 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc------------ccccccHHHHHhhccCCCceeeeeeeecc
Confidence 479999999997642 1235778999988765432111 113345666777776 9999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
+...+++.+|..+|+|...+.. ...+...........++-+++++ |+.+|+|||+|++||+++.+|++++.||
T Consensus 69 ~~kl~l~ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~tdf 141 (612)
T KOG0603|consen 69 DGKLYLILDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTDF 141 (612)
T ss_pred ccchhHhhhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCCc
Confidence 9999999999999999887764 34466777777777888889999 8999999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhcc
Q 006739 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580 (633)
Q Consensus 501 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 580 (633)
|+++..-+... .+||..|||||++. ....++|.||||++++||+||-.||.. +.++.+...
T Consensus 142 glske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~ 202 (612)
T KOG0603|consen 142 GLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA 202 (612)
T ss_pred hhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh
Confidence 99987655432 27999999999998 567899999999999999999999865 122222221
Q ss_pred CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 581 ~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
+.. .+.+......+++..++..+|.+|--.
T Consensus 203 ~~~-----------~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 ELE-----------MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ccC-----------CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 111 112222335667777888888888766
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=198.08 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=178.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC---CCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR---HRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~ni 411 (633)
..+.|.+.+.||+|+||+||+|... +|+.||+|+-+.+..= +|.--.+++.+|+ -+.|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~W-----------------EfYI~~q~~~RLk~~~~~~~ 756 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPW-----------------EFYICLQVMERLKPQMLPSI 756 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCce-----------------eeeehHHHHHhhchhhhcch
Confidence 3467888899999999999999875 6999999987766531 1222223333343 2345
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
..+...+...+..++|+||.+-|+|-+++. +.+.++|.-...++.|+++.+++| |..+|||+||||+|+||..
T Consensus 757 ~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 757 MHISSAHVFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLRR 829 (974)
T ss_pred HHHHHHHccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEeec
Confidence 556666667788899999999999999997 467799999999999999999999 7889999999999999953
Q ss_pred -------CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc
Q 006739 492 -------DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564 (633)
Q Consensus 492 -------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 564 (633)
...++|+|||.+..+.--.....-....+|-.+-.+|+..+..+++..|.|.++-+++-|+.|+.-- ....
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~g- 907 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKNG- 907 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcCC-
Confidence 3458999999987554222222334567899999999999999999999999999999999997531 0000
Q ss_pred cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
..|.. .....+..+.. ..-+++..+|+.|-..=|...++...|+++
T Consensus 908 ------~~~~~----~~~~~Ry~~~~-----------~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 908 ------SSWMV----KTNFPRYWKRD-----------MWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred ------cceec----cccchhhhhHH-----------HHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 00000 00011122222 245666677776666667777777776653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-18 Score=188.05 Aligned_cols=156 Identities=27% Similarity=0.424 Sum_probs=101.3
Q ss_pred hCCChhHHHHHHHHHHhcCCCC--CCCCCCCC-----CCCceeeCCCCCCCCcceeeeEEEEecCCCCcccCCccccCCc
Q 006739 26 LNLDRSDYKALSVILRDLGGQQ--LFIPSDPC-----STPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLS 98 (633)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~~~~--~w~~~~~C-----~~~gv~c~~~~~~~~~~~~~~~~L~l~~n~l~~~~~~~~~~l~ 98 (633)
....++|..||+.+|..++... .|.. ++| .|.||.|...... ....++.|+|++|++.|.+|..+.+++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~g-~~C~p~~~~w~Gv~C~~~~~~---~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWNG-DPCVPQQHPWSGADCQFDSTK---GKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCCC-CCCCCcccccccceeeccCCC---CceEEEEEECCCCCccccCCHHHhCCC
Confidence 3467789999999999987643 5854 566 6999999642110 012466666666666666666666666
Q ss_pred cccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcC
Q 006739 99 ELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAK 178 (633)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~ 178 (633)
+|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+++ +++|+.|+|++
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~-----------------------L~~L~~L~Ls~ 499 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ-----------------------LTSLRILNLNG 499 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhc-----------------------CCCCCEEECcC
Confidence 6666666666666666666666666666666666666665555554 45555555666
Q ss_pred CcCCccCCcccccC-CCCCeeccCCCCCCCC
Q 006739 179 NLFTGKVPTSIRTF-RNLQFFDFSGNSLLEG 208 (633)
Q Consensus 179 N~l~~~~p~~~~~~-~~L~~l~l~~N~l~~~ 208 (633)
|+|+|.+|..+..+ .++..+++++|+..|+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~ 530 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCG 530 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccC
Confidence 66666677666543 4567888888887654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8e-19 Score=169.75 Aligned_cols=197 Identities=19% Similarity=0.236 Sum_probs=134.5
Q ss_pred CCCcccccceeeecC---------------------------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHH
Q 006739 407 RHRNLLPLLAHMARP---------------------------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459 (633)
Q Consensus 407 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 459 (633)
+|||||++.++|.+. ..+|+||...+. +|.+++.. ...+.-.+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 599999998876331 246899998854 99999864 335566677889
Q ss_pred HHHHHHHHHHHhcCCCCeeeCCCCCCCeEec--CCC--ceEEcccccccccCCCCC--cce--ecccccCcccccccccc
Q 006739 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLD--DDM--EARIADFGLAKAMPDAQT--HIT--TSNVAGTVGYIAPEYHQ 531 (633)
Q Consensus 460 ~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~--~~~--~~kl~DfG~a~~~~~~~~--~~~--~~~~~gt~~y~aPE~~~ 531 (633)
.|+++|+.|| |+++|.|||+|++|||+. +|+ ...|+|||++---..... ... .....|.-.-||||+..
T Consensus 348 aQlLEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999 889999999999999984 443 467899998643222111 011 11234777899999886
Q ss_pred cCC------CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHH
Q 006739 532 TLK------FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLK 605 (633)
Q Consensus 532 ~~~------~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 605 (633)
..+ --.|+|.|+.|-+.||+++...||....+ ...+...+-+. . ...-++...-.+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~Yqe~----q----------LPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRTYQES----Q----------LPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhhhhhh----h----------CCCCcccCChHHHH
Confidence 533 23589999999999999999999976221 11111111111 0 01111112223677
Q ss_pred HHhHhccCCCCCCCCHHHHHHHH
Q 006739 606 IACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 606 l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
++...++.||.+|++..-...+|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 88889999999999987665554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-18 Score=161.90 Aligned_cols=142 Identities=23% Similarity=0.347 Sum_probs=115.8
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
+.||+|++|.||+|.+ +|..+++|+............ .......+.+|++++..++|++++....++...+
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELD------ERIRRERTRREARIMSRARKAGVNVPAVYFVDPE 72 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHH------HHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC
Confidence 6799999999999986 677899998654332211111 1112456788999999999999988888887888
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..++||||++|++|.+++... .+ .+..++.+++.+|.++ |+.+++|+|++|.||+++ ++.++++|||.
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECCc
Confidence 899999999999999998641 12 7889999999999999 788999999999999999 78999999998
Q ss_pred ccc
Q 006739 503 AKA 505 (633)
Q Consensus 503 a~~ 505 (633)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.7e-18 Score=158.78 Aligned_cols=137 Identities=18% Similarity=0.244 Sum_probs=103.2
Q ss_pred cccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-----CCCcccc
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-----RHRNLLP 413 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~ 413 (633)
+...+.||+|+||.||. ++ .++.. +||++...... ..+++.+|+.+++.+ .||||++
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp-~~~~k-~IKv~~~~~~~--------------~~~~~~rEi~~l~~L~~~~~~h~nIvr 65 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HP-EDAQR-CIKIVYHRGDG--------------GDKEIRRELKYYAHLSRRLIDWSGIPR 65 (210)
T ss_pred cCCcceecCCCceEEEE--CC-CCcCe-EEEEEeccccc--------------hHHHHHHHHHHHHHhhccCCCCcccce
Confidence 44568899999999996 44 34444 69987543211 135688999999999 5799999
Q ss_pred cceeeecCC---ccE-EEEec--ccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCC
Q 006739 414 LLAHMARPD---CHL-LVYEF--MKNGSLQDILNDVSQGRRELDWLARHKIALGVACGL-EYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 414 l~~~~~~~~---~~~-lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L-~~Lh~~h~~~ivH~Dikp~N 486 (633)
++|++.++. ..+ +|+|| +.+|+|.+++.+ ..+++. ..++.+++.++ +|| |+.+|+||||||+|
T Consensus 66 ~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~N 135 (210)
T PRK10345 66 YYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQN 135 (210)
T ss_pred eeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHH
Confidence 999998864 333 78999 557999999964 125544 35577777777 899 78899999999999
Q ss_pred eEecC----CCceEEcccccc
Q 006739 487 VLLDD----DMEARIADFGLA 503 (633)
Q Consensus 487 ill~~----~~~~kl~DfG~a 503 (633)
|+++. ++.++|+||+.+
T Consensus 136 ILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 136 ILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEeccCCCCCcEEEEECCCC
Confidence 99974 347999995433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-18 Score=159.34 Aligned_cols=139 Identities=22% Similarity=0.353 Sum_probs=110.5
Q ss_pred ccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCc
Q 006739 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDC 423 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 423 (633)
.||+|++|.||+|.+ +|..+++|............. ......++.+|++++..++|+++.....++...+.
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELD------ERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN 71 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHH------HHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence 489999999999985 678899998654432211111 11124678899999999999887766666677777
Q ss_pred cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccc
Q 006739 424 HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA 503 (633)
Q Consensus 424 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a 503 (633)
.++||||++|++|.+++.... ..++.+++++|.++ |+.+++|+|++|.||+++ ++.++++|||++
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEGN-----------DELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred CEEEEEEECCccHHHHHhhcH-----------HHHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 899999999999998875311 07899999999999 789999999999999999 789999999988
Q ss_pred ccc
Q 006739 504 KAM 506 (633)
Q Consensus 504 ~~~ 506 (633)
...
T Consensus 137 ~~~ 139 (199)
T TIGR03724 137 KYS 139 (199)
T ss_pred cCC
Confidence 753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=162.81 Aligned_cols=161 Identities=17% Similarity=0.079 Sum_probs=114.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHH---H-------HHHHHHHHHHHHHHHHhhc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEED---S-------KLLNKKMRQIRSEINTVGQ 405 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~e~~~l~~ 405 (633)
...|++.+.||+|++|.||+|.+...+|+.||+|++.............. . .........+.+|++++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 34578889999999999999973335899999999876432211100000 0 0001113456789999999
Q ss_pred CCCCc--ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCC
Q 006739 406 IRHRN--LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR-IIHRDL 482 (633)
Q Consensus 406 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~-ivH~Di 482 (633)
+.+.+ +.+.+++ ...++||||+++++|...... ...........++.|++.++++| |+.+ |+||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH~Di 175 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKL---YKEGELVHGDL 175 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHH---HhcCCEEeCCC
Confidence 97533 3333332 235899999999888765422 23455666789999999999999 7788 999999
Q ss_pred CCCCeEecCCCceEEcccccccccCC
Q 006739 483 KPANVLLDDDMEARIADFGLAKAMPD 508 (633)
Q Consensus 483 kp~Nill~~~~~~kl~DfG~a~~~~~ 508 (633)
||+||+++ ++.++|+|||.+.....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999 78999999999875433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-17 Score=179.31 Aligned_cols=144 Identities=23% Similarity=0.328 Sum_probs=112.9
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|...+.||+|+||.||++.+. +..+++|+............ .......+.+|++++..++|++++....+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPELD------ERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred ccCccceeccCCcEEEEEEeec---CccceeEEEecccccchhHH------HHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 3456789999999999999873 44555555432221111100 11124568899999999999999988888
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+......++||||+++++|.+++. ....++.+++++|.|| |+.+|+||||||+||++ +++.++|
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEE
Confidence 888788899999999999999875 3467899999999999 78899999999999999 5779999
Q ss_pred ccccccccc
Q 006739 498 ADFGLAKAM 506 (633)
Q Consensus 498 ~DfG~a~~~ 506 (633)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=154.60 Aligned_cols=152 Identities=18% Similarity=0.171 Sum_probs=111.0
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHH--------HHHHHHHHHHHHHHHHhhcCCCC
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDS--------KLLNKKMRQIRSEINTVGQIRHR 409 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~ 409 (633)
-|...+.||+|+||.||++... +|+.||||++............... .........+.+|+.++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 3677899999999999999864 7999999987654322111110000 01112233577899999999877
Q ss_pred c--ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 410 N--LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 410 n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
+ ++..++ ....++||||+++++|.++... .....++.++++++.++ |+.+|+||||||+||
T Consensus 94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p~Ni 156 (198)
T cd05144 94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKA---YKHGIIHGDLSEFNI 156 (198)
T ss_pred CCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCcccE
Confidence 4 344443 2455899999999998765421 23467889999999999 668999999999999
Q ss_pred EecCCCceEEcccccccccCC
Q 006739 488 LLDDDMEARIADFGLAKAMPD 508 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~ 508 (633)
++++++.++|+|||.+.....
T Consensus 157 ll~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EEcCCCcEEEEECCccccCCC
Confidence 999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-17 Score=180.13 Aligned_cols=218 Identities=23% Similarity=0.302 Sum_probs=145.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|..++.|..|++|.||.++++ ...+.+|+|+-++.. +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~-~trqrfa~kiNkq~l--------------------ilRn--ilt~a~npfvv-- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHK-ETRQRFAMKINKQNL--------------------ILRN--ILTFAGNPFVV-- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeecc-ccccchhhcccccch--------------------hhhc--cccccCCccee--
Confidence 3578999999999999999999874 467788885432111 1110 22223344433
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
|+-...++.. ..++... +.+++|+ |+.+|+|||+||+|.+++.=|+
T Consensus 136 -------------------gDc~tllk~~----g~lPvdm--------vla~Eyl---h~ygivhrdlkpdnllIT~mGh 181 (1205)
T KOG0606|consen 136 -------------------GDCATLLKNI----GPLPVDM--------VLAVEYL---HSYGIVHRDLKPDNLLITSMGH 181 (1205)
T ss_pred -------------------chhhhhcccC----CCCcchh--------hHHhHhh---ccCCeecCCCCCCcceeeeccc
Confidence 3444444321 2233222 6789999 8999999999999999999999
Q ss_pred eEEcccccccccCCC--------C----C-cceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 495 ARIADFGLAKAMPDA--------Q----T-HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~--------~----~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+|+.|||+++..... . . ......++||+.|+|||++....|+..+|+|++|+++||.+-|+.||.+.
T Consensus 182 iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 182 IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 999999998753211 0 0 01124568999999999999999999999999999999999999999764
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..++ -+-+.+.... .++.+ |+ ....+..+++.+.|+.+|..|--....++
T Consensus 262 tpee---lfg~visd~i--~wpE~--de--------a~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 262 TPEE---LFGQVISDDI--EWPEE--DE--------ALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred CHHH---HHhhhhhhhc--ccccc--Cc--------CCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 2211 1111121111 11111 11 11223677888899999999976554443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=168.41 Aligned_cols=174 Identities=25% Similarity=0.433 Sum_probs=129.5
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..|+.|++++..+|.+|+...+ ....-++.....++.|++.|++| ++.+|+|+||.||++..+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 5689999999999999997533 35667888899999999999988 7899999999999999999999999999
Q ss_pred ccccCCCC----CcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHh
Q 006739 503 AKAMPDAQ----THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 503 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
........ .....+...||..||+||.+.+..|+.++|+||+|++++|++. =..+++. ..-+..+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhh
Confidence 87766544 1122345679999999999999999999999999999999987 2222221 1111222
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
.....++.++ .+ +++ =..++.++++..|.+||++.+
T Consensus 473 r~g~ip~~~~-----~d-~p~----e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RDGIIPPEFL-----QD-YPE----EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCCCChHHh-----hc-CcH----HHHHHHHhcCCCcccCchHHH
Confidence 2222222221 11 222 235666899999999994443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-18 Score=148.11 Aligned_cols=135 Identities=35% Similarity=0.532 Sum_probs=119.9
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|.||+|+++- +|+.++.+.+|+.|++++|+|+. +|..++.+++|+.|+++-|++. .+|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 378999999999986 56779999999999999999987 8999999999999999999999 99999999999999999
Q ss_pred cCCcCCCC--CccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCccc
Q 006739 154 SGNSFSGN--LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212 (633)
Q Consensus 154 ~~N~l~~~--~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~ 212 (633)
++|+++.. |..|..+..|+.|+|+.|.|. .+|..++++++||.|.+..|.+.++|-+.
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkei 169 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEI 169 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHH
Confidence 99999864 466667888888888888888 78888888888888888888888887653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-15 Score=136.11 Aligned_cols=135 Identities=21% Similarity=0.221 Sum_probs=111.7
Q ss_pred cccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC--Ccccccceee
Q 006739 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH--RNLLPLLAHM 418 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~ 418 (633)
+++.||+|.++.||++.. ++..+++|....... ...+.+|+..+..++| .++++++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~---~~~~~~iK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~ 62 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT---KDEDYVLKINPSREK----------------GADREREVAILQLLARKGLPVPKVLASG 62 (155)
T ss_pred cceecccccccceEEEEe---cCCeEEEEecCCCCc----------------hhHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 457899999999999986 447899998754321 2357788888888876 5888998888
Q ss_pred ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 419 ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 419 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
...+..+++|||++++.+..+ +......++.+++++++++|..+..+++|+|++|+||++++.+.++++
T Consensus 63 ~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~ 131 (155)
T cd05120 63 ESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGII 131 (155)
T ss_pred CCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEE
Confidence 888889999999998776543 456677889999999999976666789999999999999998999999
Q ss_pred ccccccc
Q 006739 499 DFGLAKA 505 (633)
Q Consensus 499 DfG~a~~ 505 (633)
|||.++.
T Consensus 132 Df~~~~~ 138 (155)
T cd05120 132 DWEYAGY 138 (155)
T ss_pred ecccccC
Confidence 9998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.9e-17 Score=174.56 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=193.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
...|...+.||+|.|+.|-...........+|+|.+.....+.. ....+..|..+-..+. |+|++.+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~------------~~~~i~~e~~~~~~~s~h~n~~~~ 86 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSED------------SSEHIDTETDIQKKLSKHSNTVHM 86 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccc------------hhhhcCcccccccccccccccccc
Confidence 35678888999999999998876555667788887765542211 1345556777777776 9999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHH-hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDIL-NDVSQGRRELDWLARHKIALGVACGLEYLHISH-NPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h-~~~ivH~Dikp~Nill~~~ 492 (633)
++...+.+..++..+|.+++++.+-+ +.. ....+......+..|+..++.|+ | ..++.|+||||+|.+++..
T Consensus 87 ~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n~~l~~s 160 (601)
T KOG0590|consen 87 IEPSSSPRSYLLSLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSNSLLDES 160 (601)
T ss_pred CCccCCCcccccccCcccccccccccccCC---ccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCccchhccC
Confidence 99999999999999999999998887 321 12455666778899999999999 7 8999999999999999999
Q ss_pred C-ceEEcccccccccCC-CCCcceeccccc-CcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 493 M-EARIADFGLAKAMPD-AQTHITTSNVAG-TVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 493 ~-~~kl~DfG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+ ..++.|||+|..+.. ...........| ++.|+|||...+. -.....|+||.|+++.-+++|..|++.... ...
T Consensus 161 ~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~--~~~ 238 (601)
T KOG0590|consen 161 GSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR--KDG 238 (601)
T ss_pred CCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc--ccc
Confidence 9 999999999998876 444434455678 9999999998884 446789999999999999999999875433 223
Q ss_pred hHHHHHHHhhc-cCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 006739 569 SLVKWMRNVMT-SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625 (633)
Q Consensus 569 ~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~ 625 (633)
....|+..... ...+ +........++...++..+|.+|.+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 239 RYSSWKSNKGRFTQLP------------WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cceeecccccccccCc------------cccCChhhhhcccccccCCchhcccccccc
Confidence 33344332211 0000 111112255666778889999999988764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.7e-15 Score=138.50 Aligned_cols=151 Identities=21% Similarity=0.201 Sum_probs=98.8
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHH----------HHHHHHHHHHHHHHHHHhhcCCCCc-
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEED----------SKLLNKKMRQIRSEINTVGQIRHRN- 410 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~e~~~l~~l~h~n- 410 (633)
.+.||+|+||.||+|... +++.||||++.............. .............|.+.+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999865 789999999865432211110000 0000000112245566666665443
Q ss_pred -ccccceeeecCCccEEEEecccCCCHHH-HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCe
Q 006739 411 -LLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARHKIALGVACGLEYLHISHN-PRIIHRDLKPANV 487 (633)
Q Consensus 411 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~Dikp~Ni 487 (633)
+.+.++. ...++||||++++++.. .+.... .. .....++.+++.++.++ |. .+|+|+||||+||
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~Ni 146 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEYNI 146 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChhhE
Confidence 3344432 24589999999854321 121110 01 56788999999999999 55 8999999999999
Q ss_pred EecCCCceEEcccccccccCC
Q 006739 488 LLDDDMEARIADFGLAKAMPD 508 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~ 508 (633)
+++ ++.++++|||.+.....
T Consensus 147 li~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE-CCcEEEEECcccccccC
Confidence 999 88999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-15 Score=143.26 Aligned_cols=149 Identities=16% Similarity=0.182 Sum_probs=107.1
Q ss_pred ccccc-cccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc--cccceee
Q 006739 342 LEKIG-SGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL--LPLLAHM 418 (633)
Q Consensus 342 ~~~ig-~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~ 418 (633)
...|| .||.|+||.+.. ++..++||.+.....-.. ...............+.+|++++.+++|+++ ++.+++.
T Consensus 36 ~~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~i~k-v~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGLIGK-LSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred CceeecCCCCccEEEEEe---CCceEEEEEeeEcchHHh-hhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 46788 899999999976 577899998854321000 0000000111224578899999999998875 6677664
Q ss_pred ecCCc----cEEEEecccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 419 ARPDC----HLLVYEFMKN-GSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 419 ~~~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
..... .++||||++| .+|.+++.. ..++.. .+.++++++.+| |+.||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDG 179 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCC
Confidence 43222 2599999997 699988753 234433 356889999999 789999999999999999988
Q ss_pred ceEEccccccccc
Q 006739 494 EARIADFGLAKAM 506 (633)
Q Consensus 494 ~~kl~DfG~a~~~ 506 (633)
.++|+|||.+...
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999987653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.9e-17 Score=139.32 Aligned_cols=140 Identities=26% Similarity=0.328 Sum_probs=129.8
Q ss_pred CcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCC-CCcccccCCCCC
Q 006739 70 NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG-TIPSDLSSLIRL 148 (633)
Q Consensus 70 ~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L 148 (633)
+....+++.|++++|+|+. +|.+++.|+.|+.|+++-|++.- +|..|+.++.|+.|||++|++.. .+|..|..+..|
T Consensus 52 ia~l~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~~-lprgfgs~p~levldltynnl~e~~lpgnff~m~tl 129 (264)
T KOG0617|consen 52 IAELKNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLNI-LPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTL 129 (264)
T ss_pred HHHhhhhhhhhcccchhhh-cChhhhhchhhhheecchhhhhc-CccccCCCchhhhhhccccccccccCCcchhHHHHH
Confidence 3445688999999999987 67889999999999999999975 89999999999999999999973 589999999999
Q ss_pred CEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCccc
Q 006739 149 RVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212 (633)
Q Consensus 149 ~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~ 212 (633)
+.|+|++|.|.-.|+.++++++|+.|.+..|++- .+|..++.+..|+.|.+.+|+++-+|++.
T Consensus 130 ralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel 192 (264)
T KOG0617|consen 130 RALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPEL 192 (264)
T ss_pred HHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhh
Confidence 9999999999999999999999999999999998 79999999999999999999999998874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-14 Score=137.23 Aligned_cols=206 Identities=20% Similarity=0.289 Sum_probs=144.4
Q ss_pred HHHhhcCCCCcccccceeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006739 400 INTVGQIRHRNLLPLLAHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHN 474 (633)
Q Consensus 400 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~ 474 (633)
+..+-++.|.|||+++.|+.+. .+..+++|||..|++.++|++.......+......+++.||..||.|||. +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445556799999999998654 34679999999999999999888778889999999999999999999985 68
Q ss_pred CCeeeCCCCCCCeEecCCCceEEcccccccccCCC--CCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHH
Q 006739 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA--QTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV 552 (633)
Q Consensus 475 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ell 552 (633)
++|+|+++.-+-|++..+|-+|++--.-....... .....+....+-++|.|||+-.....+.++|+|+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999998887632111110000 0000112234678999999988888888999999999999998
Q ss_pred hCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 553 MGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 553 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..--.... .....-.......... ...+ =..++..|++..|..||+|++++.
T Consensus 277 ilEiq~tnse--S~~~~ee~ia~~i~~l-------en~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSE--SKVEVEENIANVIIGL-------ENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCc--ceeehhhhhhhheeec-------cCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 8765311100 0000000001111110 0111 124566799999999999998764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=9.5e-14 Score=146.20 Aligned_cols=155 Identities=19% Similarity=0.274 Sum_probs=103.2
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHH--------------------HHHHHH------HHHHH
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEED--------------------SKLLNK------KMRQI 396 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--------------------~~~~~~------~~~~~ 396 (633)
+.||.|++|.||+|+++ +|+.||||+.+....+....+-.. ....++ ..-+|
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 67999999999999986 899999999865532211100000 000001 11136
Q ss_pred HHHHHHhhcCC-----CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 006739 397 RSEINTVGQIR-----HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACG-LEYLH 470 (633)
Q Consensus 397 ~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~~Lh 470 (633)
.+|++.+.+++ ++++.-..-+.......++||||++|++|.++...... .. .+..++..+++. +..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql- 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQV- 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHH-
Confidence 66777766663 34433222223334567999999999999887653211 11 234566666653 4556
Q ss_pred hcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCC
Q 006739 471 ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508 (633)
Q Consensus 471 ~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 508 (633)
|..+++|+|++|.||++++++.++++|||++..+.+
T Consensus 274 --~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 --LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 778999999999999999999999999999887654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-14 Score=140.71 Aligned_cols=80 Identities=16% Similarity=0.246 Sum_probs=67.2
Q ss_pred ceeeCCCCCCC--CcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccC-ccCC
Q 006739 59 GVFCERRLSDN--NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN-NQFS 135 (633)
Q Consensus 59 gv~c~~~~~~~--~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~ 135 (633)
-|+|....... ...+...+.|+|..|+|+.+.+.+|..+++|+.||||+|+|+.+-|.+|.++++|..|-+-+ |+|+
T Consensus 50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 48998854332 23366899999999999999999999999999999999999999999999999988875555 9988
Q ss_pred CCCc
Q 006739 136 GTIP 139 (633)
Q Consensus 136 ~~~p 139 (633)
.+|
T Consensus 130 -~l~ 132 (498)
T KOG4237|consen 130 -DLP 132 (498)
T ss_pred -hhh
Confidence 444
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.8e-15 Score=151.22 Aligned_cols=136 Identities=23% Similarity=0.340 Sum_probs=88.4
Q ss_pred ceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEE
Q 006739 72 YVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151 (633)
Q Consensus 72 ~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (633)
....++.||||+|+++. .|..+.+-+++-.|+||+|+|..+.-..|.+|+.|-+||||+|++. .+|+.+..|..|++|
T Consensus 101 ~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 101 RLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred ccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence 34567777777777766 4556666777777777777776633335566777777777777777 666666677777777
Q ss_pred EccCCcCCC--------------------------CCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCC
Q 006739 152 DLSGNSFSG--------------------------NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205 (633)
Q Consensus 152 ~l~~N~l~~--------------------------~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l 205 (633)
+||+|.+.- .|.++..+.||..+|||.|++. .+|+.+-++.+|+.|+||+|+|
T Consensus 179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i 257 (1255)
T KOG0444|consen 179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI 257 (1255)
T ss_pred hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence 777773321 1234455566666677777766 6666666666666666666666
Q ss_pred CCCCc
Q 006739 206 LEGPI 210 (633)
Q Consensus 206 ~~~~~ 210 (633)
+++..
T Consensus 258 teL~~ 262 (1255)
T KOG0444|consen 258 TELNM 262 (1255)
T ss_pred eeeec
Confidence 55543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.4e-14 Score=144.24 Aligned_cols=161 Identities=25% Similarity=0.273 Sum_probs=117.9
Q ss_pred CCCCCCceeeCCCCCCC-------CcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCc
Q 006739 53 DPCSTPGVFCERRLSDN-------NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLE 125 (633)
Q Consensus 53 ~~C~~~gv~c~~~~~~~-------~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 125 (633)
.+|...-..|+..-... ...+..+..|++++|++..+-+..|.++++|+.++|.+|.++. +|.......+|+
T Consensus 50 c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~ 128 (873)
T KOG4194|consen 50 CPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLE 128 (873)
T ss_pred CCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-ccccccccccee
Confidence 34555567787642221 2235678889999999999888888999999999999999877 786666666688
Q ss_pred EEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCC
Q 006739 126 ILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204 (633)
Q Consensus 126 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~ 204 (633)
.|+|.+|.|+..-.+.+.-++.|+.||||.|.|+..+ +.+..-.++++|+|++|+|+..--..|..+.+|.+|.|+.|+
T Consensus 129 ~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNr 208 (873)
T KOG4194|consen 129 KLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNR 208 (873)
T ss_pred EEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCc
Confidence 8888888888655666777777788888888777766 556666677777777777775555667777777777777777
Q ss_pred CCCCCccccc
Q 006739 205 LLEGPIPVMR 214 (633)
Q Consensus 205 l~~~~~~~~~ 214 (633)
|+.+|+-.++
T Consensus 209 ittLp~r~Fk 218 (873)
T KOG4194|consen 209 ITTLPQRSFK 218 (873)
T ss_pred ccccCHHHhh
Confidence 7777765544
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.5e-14 Score=144.15 Aligned_cols=131 Identities=24% Similarity=0.263 Sum_probs=57.7
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
++++|+|++|.|+.+-...|.++.+|..|-|++|+|+...+..|.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|.
T Consensus 174 ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklq 253 (873)
T KOG4194|consen 174 NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQ 253 (873)
T ss_pred CceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhh
Confidence 45555555555555444555555555555555555555444455555555555555555541112223333333333333
Q ss_pred CCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCC
Q 006739 155 GNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205 (633)
Q Consensus 155 ~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l 205 (633)
.|.++.+. ..|..|.++++|+|+.|+++..-..++-+++.|+.|+||+|.|
T Consensus 254 rN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI 305 (873)
T KOG4194|consen 254 RNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAI 305 (873)
T ss_pred hcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhh
Confidence 33222222 2233334444444444444433333333444444444444444
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.9e-15 Score=150.55 Aligned_cols=134 Identities=23% Similarity=0.323 Sum_probs=117.1
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..++..+|||.|++.. +|+.+-++.+|+.|+||+|+|+. +.-..+...+|++|+||+|+++ .+|..+++|++|+.|+
T Consensus 221 l~NL~dvDlS~N~Lp~-vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy 297 (1255)
T KOG0444|consen 221 LHNLRDVDLSENNLPI-VPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLY 297 (1255)
T ss_pred hhhhhhccccccCCCc-chHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHH
Confidence 4578889999999875 67888899999999999999987 5666777889999999999999 8999999999999999
Q ss_pred ccCCcC--CCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 153 LSGNSF--SGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 153 l~~N~l--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
+.+|++ .|+|..++.+.+|+.+..++|++. .+|++++.|.+|+.|.|+.|++..+|-
T Consensus 298 ~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPe 356 (1255)
T KOG0444|consen 298 ANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPE 356 (1255)
T ss_pred hccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechh
Confidence 999976 477888999999999999999998 899999999999999999999877763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.2e-15 Score=145.16 Aligned_cols=135 Identities=26% Similarity=0.389 Sum_probs=108.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..++..|++.+|++....|+.+. |+.|++||+..|.++. +|..++.+.+|+.|||.+|+|. .+| +|.+++.|..|+
T Consensus 159 ~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~t-lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh 234 (565)
T KOG0472|consen 159 LSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLET-LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELH 234 (565)
T ss_pred HHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhc-CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHH
Confidence 44678888888888886665555 8888888888888865 7888888888888888888888 777 788888888888
Q ss_pred ccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCccc
Q 006739 153 LSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212 (633)
Q Consensus 153 l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~ 212 (633)
++.|.|+-.+ +...++++|..|||..|+++ ++|+.+..+.+|.+||+|+|.|+.+|+..
T Consensus 235 ~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sL 294 (565)
T KOG0472|consen 235 VGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSL 294 (565)
T ss_pred hcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCccc
Confidence 8888888777 44557888888888888888 78888888888888888888888877764
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.4e-15 Score=145.00 Aligned_cols=131 Identities=25% Similarity=0.339 Sum_probs=62.8
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.+..|+..+|+++. +|+++.++..|..|++.+|+++.. |+..-+++.|+.||..+|-+. .+|+.++.+.+|..|+|.
T Consensus 138 ~l~dl~~~~N~i~s-lp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~ 214 (565)
T KOG0472|consen 138 DLEDLDATNNQISS-LPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLR 214 (565)
T ss_pred hhhhhhcccccccc-CchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhh
Confidence 34444444555443 334444445555555555555442 222222555555555555554 455555555555555555
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccc-cCCCCCeeccCCCCCCCCCc
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIR-TFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~~~L~~l~l~~N~l~~~~~ 210 (633)
.|++...| .|..|..|++|+++.|.|+ .+|.... .++++.+|||..|++.+.|.
T Consensus 215 ~Nki~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pd 269 (565)
T KOG0472|consen 215 RNKIRFLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPD 269 (565)
T ss_pred hcccccCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccCch
Confidence 55554444 4444555555555555554 3443332 44555555555555544443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.2e-13 Score=141.36 Aligned_cols=162 Identities=16% Similarity=0.191 Sum_probs=96.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHH--------------------HHHHHHHHHH--
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEE--------------------DSKLLNKKMR-- 394 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--------------------~~~~~~~~~~-- 394 (633)
..|+. +.||+|++|.||+|+++ ++|+.||||+++.........+-. ......+..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~-~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLK-DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEEC-CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 45665 78999999999999986 249999999997653211000000 0001111112
Q ss_pred ----HHHHHHHHhhcCC----CCcccccceeee-cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 006739 395 ----QIRSEINTVGQIR----HRNLLPLLAHMA-RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACG 465 (633)
Q Consensus 395 ----~~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 465 (633)
++.+|+..+.+++ +.+.+.+-..+. .....++||||++|+.+.++-.-.. ...+ +..++...++.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~---~g~d---~~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA---AGTD---MKLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---cCCC---HHHHHHHHHHH
Confidence 3455555555543 333333323332 2456789999999999987532111 1111 11222222221
Q ss_pred HHHHHhcCCCCeeeCCCCCCCeEecCCC----ceEEcccccccccCC
Q 006739 466 LEYLHISHNPRIIHRDLKPANVLLDDDM----EARIADFGLAKAMPD 508 (633)
Q Consensus 466 L~~Lh~~h~~~ivH~Dikp~Nill~~~~----~~kl~DfG~a~~~~~ 508 (633)
|+.+-...|++|+|+||.||+++.++ .++++|||++..+.+
T Consensus 272 --~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 --FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 22222568999999999999999888 999999999887754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.4e-13 Score=121.14 Aligned_cols=119 Identities=29% Similarity=0.414 Sum_probs=44.1
Q ss_pred eeEEEEecCCCCcccCCcccc-CCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccc-cCCCCCCEEE
Q 006739 75 KITKLVFVPRELTGVLSPSIG-RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRVLD 152 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 152 (633)
+++.|+|.+|+|+.+ +.++ .+.+|+.|||++|.|+.+ + .+..+++|+.|+|++|+|+ .++..+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 567788888877764 3454 467777888888888763 2 5677778888888888887 454444 3577788888
Q ss_pred ccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCCc----ccccCCCCCeec
Q 006739 153 LSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPT----SIRTFRNLQFFD 199 (633)
Q Consensus 153 l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~~~~L~~l~ 199 (633)
|++|+|.... ..+..+++|+.|+|.+|.++.. +. .+..+|+|+.||
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 8888777654 4566777778888887777732 32 245677777776
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-11 Score=110.07 Aligned_cols=139 Identities=24% Similarity=0.356 Sum_probs=107.2
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCC
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD 422 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 422 (633)
..+++|+-+.+|.+.+ -|..+++|.-.+.......++.... ...-.+|++++.+++--.|....-+..+++
T Consensus 2 ~~i~~GAEa~i~~~~~---~g~~av~K~Ri~K~YR~p~LD~klr------r~Rt~~Earil~~a~~~GV~~P~v~dvD~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF---LGLPAVVKERIPKRYRHPELDEKLR------RERTRREARILAKAREAGVPVPIVYDVDPD 72 (204)
T ss_pred chhhCCcceeEEeeec---cCcceEEEeecCcccCChHHHHHHH------HHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence 4678999999999977 4555777765444444443333222 456678999999998777777777888889
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
...++|||++|-.|.+.+... +..++..+-+-+.-| |..+|+|+|+.++||++..+. +.++|||+
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfGL 137 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFGL 137 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECCc
Confidence 999999999999999888752 244566666667778 899999999999999999874 99999999
Q ss_pred ccc
Q 006739 503 AKA 505 (633)
Q Consensus 503 a~~ 505 (633)
+..
T Consensus 138 g~~ 140 (204)
T COG3642 138 GEF 140 (204)
T ss_pred ccc
Confidence 874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-11 Score=114.22 Aligned_cols=153 Identities=16% Similarity=0.117 Sum_probs=103.0
Q ss_pred cccccccCeeEEEEEecCC-----CCeEEEEEEccCCCcchhhhhHHH---HHH---------HHHHHHHHHHHHHHhhc
Q 006739 343 EKIGSGGCGEVYKAELPGS-----NGKMIAIKKVIQPPKDAAELTEED---SKL---------LNKKMRQIRSEINTVGQ 405 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~---~~~---------~~~~~~~~~~e~~~l~~ 405 (633)
..||.|--+.||.|..... ++..+|||+.+....+........ ..+ ..-.....++|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 5789999999999974311 357999999875443222111100 000 00111223489999998
Q ss_pred CCC--CcccccceeeecCCccEEEEecccCCCHHH-HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 006739 406 IRH--RNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482 (633)
Q Consensus 406 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di 482 (633)
+.. -++.+.+++ ...++||||+.++.+.. .++. ..++......+..+++.+|..++ |+.+|+|+|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCC
Confidence 864 456666654 56789999997654422 2221 22444556778899999999986 7789999999
Q ss_pred CCCCeEecCCCceEEcccccccccC
Q 006739 483 KPANVLLDDDMEARIADFGLAKAMP 507 (633)
Q Consensus 483 kp~Nill~~~~~~kl~DfG~a~~~~ 507 (633)
++.||++++ +.+.++|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.4e-12 Score=115.77 Aligned_cols=130 Identities=21% Similarity=0.225 Sum_probs=92.2
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc-ccceeeec
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL-PLLAHMAR 420 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~ 420 (633)
++.|+.|.++.||+++. .+..|++|........ ...+.+|+.+++.+.+.+++ +++.+.
T Consensus 3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~~~---------------~~~~~~E~~~l~~l~~~~~~P~~~~~~-- 62 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGTEL---------------LINRENEAENSKLAAEAGIGPKLYYFD-- 62 (170)
T ss_pred eeecCCcccCceEEEEE---CCeEEEEEeCCCCccc---------------ccCHHHHHHHHHHHHHhCCCCceEEEe--
Confidence 46789999999999986 5788999987443210 12356677888877655544 444433
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCeEecCCCceEEc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISH--NPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h--~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
....++||||++|.++.+.- .....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++
T Consensus 63 ~~~~~lv~e~i~G~~l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~li 129 (170)
T cd05151 63 PETGVLITEFIEGSELLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLI 129 (170)
T ss_pred CCCCeEEEEecCCCcccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEE
Confidence 33468999999998775430 112345678999999995322 22369999999999999 6689999
Q ss_pred cccccc
Q 006739 499 DFGLAK 504 (633)
Q Consensus 499 DfG~a~ 504 (633)
|||.+.
T Consensus 130 Df~~a~ 135 (170)
T cd05151 130 DWEYAG 135 (170)
T ss_pred eccccc
Confidence 999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.7e-12 Score=131.91 Aligned_cols=253 Identities=21% Similarity=0.224 Sum_probs=179.5
Q ss_pred cCccccccccc--ccCeeEEEEEe-cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccc
Q 006739 337 DGLASLEKIGS--GGCGEVYKAEL-PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~--G~~g~Vy~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv 412 (633)
..+.....+|. |.+|.||.+.. ...++..+|+|+-+.+...... ...=.+|+..-..++ |+|.+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~------------~~~k~~~~~s~~~i~~~~~~v 181 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD------------SKRKLREFLSHHKIDSHENPV 181 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc------------cccccchhhcccccCcccccc
Confidence 34566788999 99999999975 1357889999986555432211 112234555556664 99999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC----GLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
+....+...+..++-+|++ +.+|.++.+.. ...++....+.+..+..+ |+.++ |+..|+|-|+||.||+
T Consensus 182 ~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i~ 254 (524)
T KOG0601|consen 182 RDSPAWEGSGILFIQTELC-GESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANIF 254 (524)
T ss_pred ccCcccccCCcceeeeccc-cchhHHhhhcc---cccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhhee
Confidence 9999999999999999999 56888877642 233677777888888888 99888 8999999999999999
Q ss_pred ecCC-CceEEcccccccccCCCCCcce---ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc
Q 006739 489 LDDD-MEARIADFGLAKAMPDAQTHIT---TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564 (633)
Q Consensus 489 l~~~-~~~kl~DfG~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 564 (633)
+..+ ...+++|||+...+.+...... .....|...|++||..++ .++...|+|++|.+..+..+|..+......
T Consensus 255 ~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~- 332 (524)
T KOG0601|consen 255 TTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN- 332 (524)
T ss_pred cccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-
Confidence 9998 8899999999988877653321 112257778999998876 678899999999999999988766432210
Q ss_pred cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..|.+... ...+.+. ++.....+...+.++++.+|..|++.+.+..
T Consensus 333 ------~~W~~~r~-~~ip~e~---------~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 ------SSWSQLRQ-GYIPLEF---------CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------CCcccccc-ccCchhh---------hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 01111000 0011111 1111122444777899999999999887754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.9e-12 Score=115.90 Aligned_cols=112 Identities=31% Similarity=0.460 Sum_probs=44.9
Q ss_pred cccCCccccEEEccCCCCCCCCchhcc-CCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccC-CCCCC
Q 006739 93 SIGRLSELRELSLANNSLVDLLPPQIV-DCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFL-KYFPN 170 (633)
Q Consensus 93 ~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~l~~ 170 (633)
.+.+...++.|+|++|+|+.+ +.++ .+.+|+.||||+|.|+ .++ .+..+++|+.|++++|+|+...+.+ ..+|+
T Consensus 14 ~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~ 89 (175)
T PF14580_consen 14 QYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPN 89 (175)
T ss_dssp ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT
T ss_pred ccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCc
Confidence 466667899999999999873 3566 5899999999999999 555 5888999999999999999876544 46899
Q ss_pred CCeEeCcCCcCCccC-CcccccCCCCCeeccCCCCCCCC
Q 006739 171 LEHLSLAKNLFTGKV-PTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 171 L~~L~l~~N~l~~~~-p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|+.|+|++|+|...- -..+..+++|+.|+|.+|+++.-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~ 128 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK 128 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch
Confidence 999999999998421 24578899999999999999644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-10 Score=102.76 Aligned_cols=151 Identities=21% Similarity=0.282 Sum_probs=110.8
Q ss_pred cccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
....|-+|+-+.|+++.+ .|+.+.||.-.........++.... .++-++|++.+.+++--.|.-..-++.+
T Consensus 11 ~l~likQGAEArv~~~~~---~Ge~~iIK~Rf~K~YRHP~LD~kLt------r~Rt~~Ear~l~k~~~~GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF---SGEAAIIKERFSKRYRHPALDQKLT------RKRTKQEARLLAKCRALGIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeecc---CCceeEEeecccccccchHHHHHHH------HHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence 567889999999999987 7888888865444433333332222 4567789999998876676666666777
Q ss_pred CCccEEEEecccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc---eE
Q 006739 421 PDCHLLVYEFMKN-GSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME---AR 496 (633)
Q Consensus 421 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~---~k 496 (633)
...-.++|||++| .++.+++..... ...........+..|-+.+.-| |...|+|+||..+||++..++. +.
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCceE
Confidence 7777899999976 477887765332 2222233367888888889999 8999999999999999976553 58
Q ss_pred Ecccccccc
Q 006739 497 IADFGLAKA 505 (633)
Q Consensus 497 l~DfG~a~~ 505 (633)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999998754
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.8e-11 Score=134.83 Aligned_cols=57 Identities=25% Similarity=0.231 Sum_probs=36.4
Q ss_pred CCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 147 RLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 147 ~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
+|+.|+|++|+|++.+.. .++|+.|++++|+|+ .+|.. ..+|+.|++++|+|+.+|.
T Consensus 383 ~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~LP~ 439 (788)
T PRK15387 383 GLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLTRLPE 439 (788)
T ss_pred ccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCcccccCh
Confidence 567777777777765532 246777777777777 35543 2356667777777766654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.8e-10 Score=117.45 Aligned_cols=166 Identities=15% Similarity=0.252 Sum_probs=125.2
Q ss_pred CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecCCccEEEEecccCCCHHHHH
Q 006739 361 SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL 440 (633)
Q Consensus 361 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 440 (633)
.++.+|.|.......... .....+-+..++.+|||||++++..+...+..|+|+|.+. -|..++
T Consensus 35 ~~~~~vsVF~~~~~~~~~--------------~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~l 98 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEV--------------TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVL 98 (690)
T ss_pred ccCCceEEEEEeCCCchh--------------hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHH
Confidence 478888888775544210 2345566778889999999999999999999999999995 577777
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceeccccc
Q 006739 441 NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520 (633)
Q Consensus 441 ~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~g 520 (633)
++ +........+.||++||.+|| ++..++|++|.-.-|+++..|+.||++|-++........ ......-
T Consensus 99 k~-------l~~~~v~~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~ 167 (690)
T KOG1243|consen 99 KE-------LGKEEVCLGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYL 167 (690)
T ss_pred HH-------hHHHHHHHHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchh
Confidence 65 335677788999999999998 788999999999999999999999999998765433221 0011111
Q ss_pred CcccccccccccCCCCCccchHHHHHHHHHHHhCC
Q 006739 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555 (633)
Q Consensus 521 t~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~ 555 (633)
-..|..|+.+.... -..|.|.|||+++|++.|.
T Consensus 168 ~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 168 IESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 22466666544322 3469999999999999993
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.4e-13 Score=135.48 Aligned_cols=137 Identities=27% Similarity=0.373 Sum_probs=121.1
Q ss_pred cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCE
Q 006739 71 TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRV 150 (633)
Q Consensus 71 ~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 150 (633)
.....++.|||+.|+++. +|..+..|+ |+.|-+++|+++. +|..++.+..|..||.+.|.+. .+|..++.+.+|+.
T Consensus 118 ~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sNNkl~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~ 193 (722)
T KOG0532|consen 118 CNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSNNKLTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRD 193 (722)
T ss_pred hhhhHHHHhhhccchhhc-CChhhhcCc-ceeEEEecCcccc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHH
Confidence 334578999999999986 555666665 8999999999987 8999999999999999999999 89999999999999
Q ss_pred EEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccc
Q 006739 151 LDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVM 213 (633)
Q Consensus 151 L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~ 213 (633)
|.+..|++...++.+..| .|..||+|.|+++ .+|-.|.+|+.|++|-|.+|++.+-|...+
T Consensus 194 l~vrRn~l~~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC 254 (722)
T KOG0532|consen 194 LNVRRNHLEDLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQIC 254 (722)
T ss_pred HHHhhhhhhhCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHHH
Confidence 999999999999888755 5899999999999 899999999999999999999987665543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-12 Score=139.92 Aligned_cols=128 Identities=27% Similarity=0.408 Sum_probs=110.9
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.++.|++.+|.++...-+.|.++.+|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|..+..+..|++|...
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ah 438 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAH 438 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhc
Confidence 6888999999999887778999999999999999998744457788999999999999999 899999999999999999
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCcc-CCcccccCCCCCeeccCCCCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGK-VPTSIRTFRNLQFFDFSGNSL 205 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~L~~l~l~~N~l 205 (633)
+|+|...| .+..++.|+.+|+|.|+|+.. +|.... -++|++|||+||..
T Consensus 439 sN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 439 SNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNTR 488 (1081)
T ss_pred CCceeech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCcc
Confidence 99999887 788899999999999999843 444332 28999999999985
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.8e-11 Score=126.80 Aligned_cols=249 Identities=18% Similarity=0.188 Sum_probs=172.8
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
...+|..+..||.|.|+.||+...+-.++..|++|...+......+ ...-..|+.+...+ .|.++++
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~------------di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS------------DIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh------------hhcchhhhhHhhHhhcccccCC
Confidence 4567888999999999999998765568899999988766543221 11122344444444 4889999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC-
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD- 492 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~- 492 (633)
....+...+..|+=-||++++++...... ...++...++++..|++.++.++ |++.++|+|+||+||++..+
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccch
Confidence 88888888888899999999988766532 34467778899999999999999 89999999999999999986
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccc--cccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYI--APEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+.-+++|||.+..+.-. . ....++-+++ +|+......+..+.|+||||..+.|..+|..--...
T Consensus 404 ~~~~~~~~~~~t~~~~~----~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------- 469 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFS----S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------- 469 (524)
T ss_pred hhhhcccccccccccee----c-ccccccccccccchhhccccccccccccccccccccccccCcccCccc---------
Confidence 78899999987642111 1 1122333444 566666777888999999999999999987532211
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l 628 (633)
.+|... . .+.... . .. ....+..+...+...++..||.+.++....
T Consensus 470 ~~~~~i-~-~~~~p~-----~----~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 470 VQSLTI-R-SGDTPN-----L----PG-LKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred ccceee-e-cccccC-----C----Cc-hHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 011110 0 010000 0 00 012345566678899999999998876554
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.4e-11 Score=129.81 Aligned_cols=85 Identities=36% Similarity=0.602 Sum_probs=80.2
Q ss_pred CCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccC
Q 006739 123 KLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201 (633)
Q Consensus 123 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~ 201 (633)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+ ..+..+++|+.|+|++|+|+|.+|+.++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3788999999999999999999999999999999999766 579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 006739 202 GNSLLE 207 (633)
Q Consensus 202 ~N~l~~ 207 (633)
+|+++.
T Consensus 499 ~N~l~g 504 (623)
T PLN03150 499 GNSLSG 504 (623)
T ss_pred CCcccc
Confidence 999953
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-12 Score=136.07 Aligned_cols=136 Identities=27% Similarity=0.409 Sum_probs=114.4
Q ss_pred eeeeEEEEecCCCCcccCCcccc-------------------------CCccccEEEccCCCCCCCCchhccCCCCCcEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIG-------------------------RLSELRELSLANNSLVDLLPPQIVDCKKLEIL 127 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~-------------------------~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 127 (633)
...+..|+|..|+|....+..|. .++.|+.|+|.+|.++...-+.+.+..+|+.|
T Consensus 309 ~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL 388 (1081)
T KOG0618|consen 309 LKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL 388 (1081)
T ss_pred cceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence 34688888888887654322111 23457889999999998766788999999999
Q ss_pred EccCccCCCCCccc-ccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCC
Q 006739 128 NVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 128 ~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
+|++|+|. .+|.. +.++..|+.|+||+|+|+.++..+.+++.|++|...+|+|. ..| .+..++.|+++|+|.|+|+
T Consensus 389 hLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 389 HLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred eecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence 99999999 66655 78999999999999999999999999999999999999999 788 8899999999999999998
Q ss_pred CCCcc
Q 006739 207 EGPIP 211 (633)
Q Consensus 207 ~~~~~ 211 (633)
.+-.+
T Consensus 466 ~~~l~ 470 (1081)
T KOG0618|consen 466 EVTLP 470 (1081)
T ss_pred hhhhh
Confidence 87655
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-10 Score=129.76 Aligned_cols=121 Identities=26% Similarity=0.370 Sum_probs=69.1
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+.+.|++++++++. +|..+. ++|+.|+|++|+|+. +|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 35667777777665 343332 356667777776665 454443 46666666666666 5555443 356666666
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|+++.++..+. .+|+.|+|++|+|+ .+|..+. ++|+.|++++|+|+.+|
T Consensus 250 ~N~L~~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP 299 (754)
T PRK15370 250 INRITELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLP 299 (754)
T ss_pred CCccCcCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCc
Confidence 666665543332 35666666666666 3454442 35666666666665554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.2e-11 Score=132.08 Aligned_cols=121 Identities=27% Similarity=0.382 Sum_probs=76.0
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
..++.|+|++|++.. +|..+. ++|+.|+|++|+|+. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 241 ~~L~~L~Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~L 311 (754)
T PRK15370 241 DTIQEMELSINRITE-LPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNV 311 (754)
T ss_pred ccccEEECcCCccCc-CChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHh
Confidence 468899999999885 555553 478999999999986 676654 58899999999888 5665443 35666666
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
++|+|+..+..+ .++|+.|++++|.|++ +|..+ .++|+.|++++|+|..+
T Consensus 312 s~N~Lt~LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~L~~L 361 (754)
T PRK15370 312 QSNSLTALPETL--PPGLKTLEAGENALTS-LPASL--PPELQVLDVSKNQITVL 361 (754)
T ss_pred cCCccccCCccc--cccceeccccCCcccc-CChhh--cCcccEEECCCCCCCcC
Confidence 666666544322 1345555555555542 44333 23455555555555443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.2e-12 Score=119.22 Aligned_cols=130 Identities=20% Similarity=0.260 Sum_probs=84.2
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.++.||||+|.|+. +..+..-++.++.|++|+|.|..+ ..+..|++|+.||||+|.++ .+..+=-+|-+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchhh-hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 46667777776654 344555566777777777777653 23666777777777777776 555555566667777777
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccC-CcccccCCCCCeeccCCCCCCCCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKV-PTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|.|... ..+..+-+|..||+++|+|...- -..+++++.|+.+.|.+|++..++
T Consensus 361 ~N~iE~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 361 QNKIETL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhHhhh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 7766533 33556667777777777776321 135677777777777777775544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.6e-10 Score=106.76 Aligned_cols=144 Identities=20% Similarity=0.266 Sum_probs=106.4
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC--cccccceeee
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR--NLLPLLAHMA 419 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 419 (633)
.+.|+.|..+.||++... +|+.+++|......... ...++.+|.++++.+++. ++.+++.+..
T Consensus 3 ~~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~~-------------~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~ 67 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALLP-------------SAHDVAREYRVLRALAGTGVPVPKVLALCE 67 (223)
T ss_pred ceecCCCccceEEEEEec--CCcceEEEeCCCcccCc-------------ccccHHHHHHHHHHhhCCCCCCCCEEEECC
Confidence 367899999999999864 46889999875432110 034577888899888753 4567777766
Q ss_pred cCC---ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------
Q 006739 420 RPD---CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS------------------------ 472 (633)
Q Consensus 420 ~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~------------------------ 472 (633)
... ..++||||++|.++.+.+.. ..++...+..++.+++++|.+||..
T Consensus 68 ~~~~~~~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (223)
T cd05154 68 DPSVLGTPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARW 142 (223)
T ss_pred CCCccCCceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHH
Confidence 543 56899999999888765421 2366677777888888888888731
Q ss_pred -----------------------------CCCCeeeCCCCCCCeEecC--CCceEEcccccccc
Q 006739 473 -----------------------------HNPRIIHRDLKPANVLLDD--DMEARIADFGLAKA 505 (633)
Q Consensus 473 -----------------------------h~~~ivH~Dikp~Nill~~--~~~~kl~DfG~a~~ 505 (633)
....++|+|+++.||+++. ++.+.++||+.+..
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 143 RRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356799999999999998 66689999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.5e-09 Score=104.01 Aligned_cols=259 Identities=17% Similarity=0.204 Sum_probs=159.5
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccccee-
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAH- 417 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~- 417 (633)
...+.||+|+-+.+|-.- .-...+.|+++.+...... +.+..|... .||-+-.-+.+
T Consensus 14 ~~gr~LgqGgea~ly~l~----e~~d~VAKIYh~Pppa~~a-----------------qk~a~la~~p~~p~~~~rvaWP 72 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG----EVRDQVAKIYHAPPPAAQA-----------------QKVAELAATPDAPLLNYRVAWP 72 (637)
T ss_pred CCCccccCCccceeeecc----hhhchhheeecCCCchHHH-----------------HHHHHhccCCCCcchhhhhccc
Confidence 456889999999999653 2233566888887754321 112223333 45533221221
Q ss_pred -----eec-CCccEEEEecccCC-CHHHHHh--hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 418 -----MAR-PDCHLLVYEFMKNG-SLQDILN--DVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 418 -----~~~-~~~~~lv~e~~~~g-sL~~~l~--~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
..+ .....++|..+.+. -...+.. ..+++-...+|...++.+..+|.+.+.| |..|.+-+|+.++|+|
T Consensus 73 qa~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~l---H~~Gh~vGDVn~~~~l 149 (637)
T COG4248 73 QATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATL---HEHGHVVGDVNQNSFL 149 (637)
T ss_pred HHHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHH---HhcCCcccccCcccee
Confidence 112 22256788888765 2222222 1123345689999999999999999999 6788889999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhC-CCCCcccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMG-RLPSDDFF 562 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~ 562 (633)
+.+++.+.|.|-..-....++..+ ...+|...|.+||.-. +...+...|.|.+|+++++++.| ++||.+..
T Consensus 150 Vsd~~~V~LVdsDsfqi~~ng~~~---~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 150 VSDDSKVVLVDSDSFQINANGTLH---LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eecCceEEEEcccceeeccCCceE---ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 999999999986544433332222 2357899999999654 44567789999999999999986 99998654
Q ss_pred cccccc-----hHHHH----HHHhhcc-CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccC--CCCCCCCHHHHHHHHHh
Q 006739 563 QHTEEM-----SLVKW----MRNVMTS-ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVD--SPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 563 ~~~~~~-----~~~~~----~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~--dP~~RPs~~ev~~~l~~ 630 (633)
.....- .+... ..+.... ..++... ..+-....+..+..+|+.. .+.-|||++-++..|..
T Consensus 227 ~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~-------P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 227 LISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSI-------PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred ccCCCCCcchhhhhcceeeechhccCCCCCCCCCC-------ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 322111 11100 0000000 0000000 0111112245555678754 47789999999999877
Q ss_pred hh
Q 006739 631 IR 632 (633)
Q Consensus 631 ~~ 632 (633)
++
T Consensus 300 l~ 301 (637)
T COG4248 300 LR 301 (637)
T ss_pred HH
Confidence 64
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-11 Score=115.67 Aligned_cols=110 Identities=29% Similarity=0.411 Sum_probs=95.5
Q ss_pred ccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCe
Q 006739 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEH 173 (633)
Q Consensus 94 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~ 173 (633)
+.....|+.||||+|.|+. +.++..-++.++.|++|+|.|. .+.. +..|++|+.||||+|.++....+-..+.|.+.
T Consensus 280 ~dTWq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKT 356 (490)
T ss_pred cchHhhhhhccccccchhh-hhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEee
Confidence 3345679999999999987 7888888999999999999998 5554 88999999999999999988777778889999
Q ss_pred EeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 174 LSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 174 L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|.|+.|.|. --.++.++-+|..||+++|+|...
T Consensus 357 L~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~l 389 (490)
T KOG1259|consen 357 LKLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEEL 389 (490)
T ss_pred eehhhhhHh--hhhhhHhhhhheeccccccchhhH
Confidence 999999997 234678899999999999999654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.4e-10 Score=124.94 Aligned_cols=119 Identities=29% Similarity=0.298 Sum_probs=57.5
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccC-----------------CCCCcEEEccCccCCCC
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVD-----------------CKKLEILNVQNNQFSGT 137 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----------------l~~L~~L~Ls~N~l~~~ 137 (633)
+++.|++++|+|+.+ |. .+++|++|+|++|+|+. +|..+.+ ..+|+.|+|++|+|+ .
T Consensus 223 ~L~~L~L~~N~Lt~L-P~---lp~~Lk~LdLs~N~Lts-LP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt-~ 296 (788)
T PRK15387 223 HITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-S 296 (788)
T ss_pred CCCEEEccCCcCCCC-CC---CCCCCcEEEecCCccCc-ccCcccccceeeccCCchhhhhhchhhcCEEECcCCccc-c
Confidence 566666666666653 22 13566666666666665 3432110 123344444444444 3
Q ss_pred CcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 138 IPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 138 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|. .+++|+.|+|++|+|++.+.. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+.+|
T Consensus 297 LP~---~p~~L~~LdLS~N~L~~Lp~l---p~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~LP 358 (788)
T PRK15387 297 LPV---LPPGLQELSVSDNQLASLPAL---PSELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLASLP 358 (788)
T ss_pred ccc---cccccceeECCCCccccCCCC---cccccccccccCccc-ccccc---ccccceEecCCCccCCCC
Confidence 332 124555566666655554321 123344444444444 23321 135666666666666555
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.4e-11 Score=128.59 Aligned_cols=255 Identities=24% Similarity=0.266 Sum_probs=167.1
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...+++.+.+.+-+|.++.++.+. +...|...+.|.......-. ....+....+-.+.-..+||.+++
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~-pa~sgh~~~~~v~~~ap~i~-----------~~~~~s~r~~s~~~i~p~~P~v~~ 868 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPAS-PAGSGHTRPSKVHGLAPKIR-----------TNDYESIRSKSNILITPRSPAVVR 868 (1205)
T ss_pred CCCccceecccccCCCCcccccCC-ccccccccchhhhccchhhc-----------cccccccCCccCccccCCCCceec
Confidence 345677888889999999999875 33455455555443222100 000122233333333345677776
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
....+.-....++|++|..+++|...++... ..+.......+..+.++++|| |...+.|+|++|.|.+...++
T Consensus 869 ~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~g 941 (1205)
T KOG0606|consen 869 SFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDG 941 (1205)
T ss_pred ccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccC
Confidence 6555555667899999999999999998633 344444455566677889999 777799999999999999999
Q ss_pred ceEEcccccccccCCC-------------------------CC----cceecccccCcccccccccccCCCCCccchHHH
Q 006739 494 EARIADFGLAKAMPDA-------------------------QT----HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSF 544 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~-------------------------~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~ 544 (633)
..++.|||........ .. ........||+.|.+||...+......+|+|+.
T Consensus 942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 9999999843322110 00 001234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH
Q 006739 545 GVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK 622 (633)
Q Consensus 545 G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 622 (633)
|++++|.++|..||........ .+.+.....+- .....+......+++...+..+|.+|-.+.
T Consensus 1022 g~~l~e~l~g~pp~na~tpq~~-------f~ni~~~~~~~--------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQI-------FENILNRDIPW--------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhcCCCCCCCcchhhh-------hhccccCCCCC--------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999876543211 11111111110 011122222355666678888898887765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.5e-10 Score=101.30 Aligned_cols=141 Identities=19% Similarity=0.222 Sum_probs=86.4
Q ss_pred eEEEEEecCCCCeEEEEEEccCCCcchhhhhHH------------HHHHHHHHHHHHHHHHHHhhcCCCC--ccccccee
Q 006739 352 EVYKAELPGSNGKMIAIKKVIQPPKDAAELTEE------------DSKLLNKKMRQIRSEINTVGQIRHR--NLLPLLAH 417 (633)
Q Consensus 352 ~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~ 417 (633)
.||.|... +|..+|||+.+............ ............++|.+.|.++..- ++.+.+++
T Consensus 1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 48999764 78999999987653322111000 0011122345678899999999866 45666644
Q ss_pred eecCCccEEEEeccc--CCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 418 MARPDCHLLVYEFMK--NGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
...++||||++ |..+..+.... ++......++.++++.+..++ |..+|+|+|+.+.||+++++ .+
T Consensus 79 ----~~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 ----NRNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----ETTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CE
T ss_pred ----eCCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eE
Confidence 24579999998 55555443321 112344567777777666654 78899999999999999988 99
Q ss_pred EEcccccccccC
Q 006739 496 RIADFGLAKAMP 507 (633)
Q Consensus 496 kl~DfG~a~~~~ 507 (633)
.++|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.1e-11 Score=126.02 Aligned_cols=118 Identities=29% Similarity=0.459 Sum_probs=67.8
Q ss_pred CCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCC
Q 006739 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFP 169 (633)
Q Consensus 90 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~ 169 (633)
+|..+.++..|+.|||+.|+++. +|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+...+..++.+.
T Consensus 113 ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~ 189 (722)
T KOG0532|consen 113 IPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLT 189 (722)
T ss_pred cchhhhhhhHHHHhhhccchhhc-CChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHH
Confidence 44445555555555555555544 444444443 555555555555 555555555555555555555555555555555
Q ss_pred CCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCccc
Q 006739 170 NLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212 (633)
Q Consensus 170 ~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~ 212 (633)
+|+.|.+..|++. .+|..+..| .|..||+|.|+++.+|...
T Consensus 190 slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis~iPv~f 230 (722)
T KOG0532|consen 190 SLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKISYLPVDF 230 (722)
T ss_pred HHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCceeecchhh
Confidence 5666666666655 455555533 4777788888887777653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.98 E-value=1e-10 Score=119.71 Aligned_cols=134 Identities=27% Similarity=0.333 Sum_probs=98.3
Q ss_pred eeeEEEEecCCCCcccCCccccCCcc---ccEEEccCCCCCC----CCchhccCC-CCCcEEEccCccCCCC----Cccc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSE---LRELSLANNSLVD----LLPPQIVDC-KKLEILNVQNNQFSGT----IPSD 141 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~ 141 (633)
.+++.|++++|.+.+..+..+..+.. |++|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 37888999988887766666655555 8999999988873 233455666 8889999999988843 3445
Q ss_pred ccCCCCCCEEEccCCcCCCCC-----ccCCCCCCCCeEeCcCCcCCcc----CCcccccCCCCCeeccCCCCCCC
Q 006739 142 LSSLIRLRVLDLSGNSFSGNL-----GFLKYFPNLEHLSLAKNLFTGK----VPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
+..+.+|+.|+|++|.+++.. ..+..+++|+.|++++|.+++. ++..+..+++|++|++++|++..
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 667778899999998888532 2345567899999999888743 33455667889999999988754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.2e-10 Score=84.32 Aligned_cols=59 Identities=37% Similarity=0.590 Sum_probs=29.9
Q ss_pred cccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCc
Q 006739 99 ELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS 157 (633)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 157 (633)
+|+.|+|++|+|+.+.+..|.++++|++|+|++|+++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554333455555555555555555554434445555555555555554
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.8e-09 Score=97.55 Aligned_cols=148 Identities=21% Similarity=0.231 Sum_probs=103.5
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHH--------HHHHHHHHHHHHHHHhhcCCCC--
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSK--------LLNKKMRQIRSEINTVGQIRHR-- 409 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~-- 409 (633)
.+.+.||.|--+.||.|..+ +|.++|||.-+....+.......... ...-.....++|.++|.++...
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred hhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45689999999999999875 79999999765544333222211111 1122345678899999998755
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
.|.+.+++ +..++||||++|-.|...- ++......|+..|.+-+..+ -..||||+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheEEE
Confidence 67777664 5678999999986654432 12233344555555555555 35789999999999999
Q ss_pred cCCCceEEcccccccc
Q 006739 490 DDDMEARIADFGLAKA 505 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~ 505 (633)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-08 Score=99.82 Aligned_cols=151 Identities=18% Similarity=0.133 Sum_probs=101.0
Q ss_pred ccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc--cccceeeec-
Q 006739 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL--LPLLAHMAR- 420 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~- 420 (633)
.+-......|+++.+ +|+.|.||......... ....... ...-...+.+|.+.+.++...+| +..+++...
T Consensus 29 ~v~~~~~rrvvr~~~---~g~~~~vKr~~~~~~~~--~~k~l~~-~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~ 102 (268)
T PRK15123 29 VFRELEGRRTLRFEL---AGKSYFLKWHRGTGWGE--IFKNLLS-LRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERG 102 (268)
T ss_pred EEecCCCceEEEEEE---CCEEEEEEEecCCcHHH--Hhhhhcc-cccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEec
Confidence 333334445777776 67899999774332110 0000000 00001247788888888864444 344556543
Q ss_pred ----CCccEEEEecccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC----
Q 006739 421 ----PDCHLLVYEFMKNG-SLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD---- 491 (633)
Q Consensus 421 ----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~---- 491 (633)
....++|||++++. +|.+++.... ....+...+..++.++++.+.-| |..||+|+|++++|||++.
T Consensus 103 ~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 103 SNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPG 177 (268)
T ss_pred CCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccC
Confidence 23467999999886 8999885321 23455667789999999999999 8899999999999999985
Q ss_pred ---CCceEEcccccccc
Q 006739 492 ---DMEARIADFGLAKA 505 (633)
Q Consensus 492 ---~~~~kl~DfG~a~~ 505 (633)
++.+.++||+.++.
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 46789999998754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.5e-10 Score=116.74 Aligned_cols=132 Identities=24% Similarity=0.314 Sum_probs=100.0
Q ss_pred eeEEEEecCCCCcc----cCCccccCC-ccccEEEccCCCCCCC----CchhccCCCCCcEEEccCccCCCC----Cccc
Q 006739 75 KITKLVFVPRELTG----VLSPSIGRL-SELRELSLANNSLVDL----LPPQIVDCKKLEILNVQNNQFSGT----IPSD 141 (633)
Q Consensus 75 ~~~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 141 (633)
+++.|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++. ++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 48999999999873 233456667 8899999999999842 445667788999999999999842 3445
Q ss_pred ccCCCCCCEEEccCCcCCCCC-----ccCCCCCCCCeEeCcCCcCCccCCcccc-----cCCCCCeeccCCCCCC
Q 006739 142 LSSLIRLRVLDLSGNSFSGNL-----GFLKYFPNLEHLSLAKNLFTGKVPTSIR-----TFRNLQFFDFSGNSLL 206 (633)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~L~~l~l~~N~l~ 206 (633)
+..+++|+.|+|++|.+++.. ..+..+++|+.|++++|.+++.....+. ..++|+.|++++|.++
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 666779999999999987543 3466788999999999998853333322 2378999999999885
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.3e-09 Score=81.07 Aligned_cols=60 Identities=27% Similarity=0.439 Sum_probs=56.9
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccC
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 134 (633)
+++.|++++|+++.+.+..|.++++|++|++++|.|+.+.|..|.++++|++|+|++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 689999999999998888999999999999999999998788999999999999999986
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.8e-10 Score=115.86 Aligned_cols=129 Identities=32% Similarity=0.483 Sum_probs=97.3
Q ss_pred eeEEEEecCCCCcccCCccccCCc-cccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLS-ELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.++.|++.+|.++.+ ++....+. +|+.|++++|++.. +|..+..+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~~i-~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNITDI-PPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCcccccC-ccccccchhhcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 588888999888874 44455564 88999999999877 6677888899999999999998 77777768888888899
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCC
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
++|+++..+.....+..|+.|.+++|.+. .++..+.++.++..+.+.+|++..
T Consensus 194 s~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 194 SGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred cCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence 99888887765555556777777777543 355556666666666666666654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.84 E-value=8.3e-09 Score=122.51 Aligned_cols=134 Identities=27% Similarity=0.327 Sum_probs=91.3
Q ss_pred eeeEEEEecCCCC-------cccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCC
Q 006739 74 LKITKLVFVPREL-------TGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLI 146 (633)
Q Consensus 74 ~~~~~L~l~~n~l-------~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 146 (633)
.+++.|++.++.. ....+......++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ +++
T Consensus 747 ~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~ 825 (1153)
T PLN03210 747 ENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLE 825 (1153)
T ss_pred cccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Ccc
Confidence 3566666665332 11112223344678888888887767788888888888888888865444777765 678
Q ss_pred CCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCC-CCCCCCCcc
Q 006739 147 RLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSG-NSLLEGPIP 211 (633)
Q Consensus 147 ~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~-N~l~~~~~~ 211 (633)
+|+.|+|++|..-...+. ..++|+.|+|++|.|+ .+|..+..+++|+.|+|++ |++..+|..
T Consensus 826 sL~~L~Ls~c~~L~~~p~--~~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~ 888 (1153)
T PLN03210 826 SLESLDLSGCSRLRTFPD--ISTNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLN 888 (1153)
T ss_pred ccCEEECCCCCccccccc--cccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcc
Confidence 888888888643322221 2367888888888887 6788888888888888887 667666654
|
syringae 6; Provisional |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=9.1e-08 Score=97.45 Aligned_cols=172 Identities=17% Similarity=0.256 Sum_probs=127.0
Q ss_pred cCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec----CCcc
Q 006739 349 GCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR----PDCH 424 (633)
Q Consensus 349 ~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 424 (633)
-..+.|++... .||..|++|+++....... .....-+++++++.|+|+|++..++.. ...+
T Consensus 288 ~~~Ttyk~~s~-~DG~~YvLkRlhg~r~~~~--------------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Sl 352 (655)
T KOG3741|consen 288 FSITTYKATSN-VDGNAYVLKRLHGDRDQST--------------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSL 352 (655)
T ss_pred ccceeEeeeec-cCCceeeeeeeccccccCc--------------ccchHHHHHHHHhccCceeehhhhhhhhccCcceE
Confidence 34678999754 6899999999943321111 011234667888999999999998752 4467
Q ss_pred EEEEecccCC-CHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 425 LLVYEFMKNG-SLQDILNDVSQ-----------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 425 ~lv~e~~~~g-sL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++||+|.++. +|.++-..... .+...++...|.++.|+..||.++ |+.|..-+-+.+.+|+++.+
T Consensus 353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~ 429 (655)
T KOG3741|consen 353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGK 429 (655)
T ss_pred EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCc
Confidence 8999999864 77766533221 234577899999999999999999 77888889999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p 557 (633)
.+++|+.+|.......+.. |.+.+ -.+-|.=.||.+++.|.||..-
T Consensus 430 ~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 430 MRIRISGCGIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ceEEEecccceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 9999999998766554431 11111 2357999999999999999653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=4.7e-10 Score=109.59 Aligned_cols=129 Identities=21% Similarity=0.255 Sum_probs=111.0
Q ss_pred EEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccC-Cc
Q 006739 79 LVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG-NS 157 (633)
Q Consensus 79 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~ 157 (633)
.+-++-+++.+ |..+ -.+-..|+|..|+|+.+.|.+|+.+++|+.||||+|+|+-+-|..|.++.+|..|-+-+ |+
T Consensus 51 VdCr~~GL~eV-P~~L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLTEV-PANL--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcccC-cccC--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 45566666664 3333 13568899999999998889999999999999999999988899999999998886666 99
Q ss_pred CCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 158 FSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 158 l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|+.++ ..|..+..|+-|.+.-|++.-...+.|..+++|..|.+-.|.+..++-
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~ 181 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICK 181 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhcc
Confidence 99999 789999999999999999997778899999999999999999976653
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.6e-08 Score=118.36 Aligned_cols=129 Identities=21% Similarity=0.265 Sum_probs=58.7
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
++..|++++|++.. ++..+..+++|+.|+|++|...+.+| .+..+++|+.|+|++|.....+|..+..+++|+.|+|+
T Consensus 612 ~L~~L~L~~s~l~~-L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLEK-LWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCccccc-cccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 34444444444432 23334444555555555443223233 24445555555555544333455555555555555555
Q ss_pred CC-cCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 155 GN-SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 155 ~N-~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+| .++..+..+ ++++|+.|++++|...+.+|.. ..+|+.|++++|.+..+|
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP 741 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFP 741 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccccc
Confidence 43 233333222 4455555555555433334422 234555555556555544
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.4e-09 Score=110.92 Aligned_cols=130 Identities=32% Similarity=0.447 Sum_probs=101.9
Q ss_pred EEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCC-CCcEEEccCccCCCCCcccccCCCCCCEEEccCC
Q 006739 78 KLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCK-KLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156 (633)
Q Consensus 78 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (633)
.|+++.|.+...+ ..+..++.++.|++.+|.++. +|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccCc-hhhhcccceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4777777764432 235556788999999999987 677777775 8999999999998 77778888999999999999
Q ss_pred cCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 157 SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 157 ~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+++..+.....+++|+.|++++|+++ .+|........|+.|++++|++...+..
T Consensus 174 ~l~~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~ 227 (394)
T COG4886 174 DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSS 227 (394)
T ss_pred hhhhhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchh
Confidence 99888876667889999999999998 7777666667789999999965454443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.2e-08 Score=102.24 Aligned_cols=154 Identities=23% Similarity=0.282 Sum_probs=101.3
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhh---------------------------HHHHHHHHHHHHH
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELT---------------------------EEDSKLLNKKMRQ 395 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~ 395 (633)
+.|+.++-|.||+|+++ +|+.||||+.+......-..+ ++..+.... .-+
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~-ElD 207 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE-ELD 207 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH-HhC
Confidence 67999999999999996 799999999887554322111 111111111 123
Q ss_pred HHHHHHHhhcCC-----CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH-HHHH
Q 006739 396 IRSEINTVGQIR-----HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACG-LEYL 469 (633)
Q Consensus 396 ~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~-L~~L 469 (633)
+.+|...+.+++ .+++.-..-|........++|||++|-.+.+...-... .++ +..++..++++ +..+
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d---~k~ia~~~~~~f~~q~ 281 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GID---RKELAELLVRAFLRQL 281 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCC---HHHHHHHHHHHHHHHH
Confidence 556666666653 34444333344456677899999999888887432111 123 33444444443 2333
Q ss_pred HhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCC
Q 006739 470 HISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508 (633)
Q Consensus 470 h~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~ 508 (633)
-..+++|+|..|.||+++.+|++.+.|||+.....+
T Consensus 282 ---~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 282 ---LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 347899999999999999999999999999876654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.4e-07 Score=87.21 Aligned_cols=143 Identities=16% Similarity=0.131 Sum_probs=102.7
Q ss_pred ccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc--ccccceeeec---
Q 006739 346 GSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN--LLPLLAHMAR--- 420 (633)
Q Consensus 346 g~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~--- 420 (633)
|+||-+.|+...+ +|+.+-+|+........-... --...|.+|+..+.++...+ +.+.. ++..
T Consensus 27 ~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s~r~P--------~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~ 94 (216)
T PRK09902 27 RRNGMSGVQCVER---NGKKLYVKRMTHHLFHSVRYP--------FGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKI 94 (216)
T ss_pred CCCCcceEEEEEe---CCcEEEEEeccCcccccccCC--------CCchHHHHHHHHHHHHHHcCCCCCccc-eeeeecc
Confidence 6789999999987 456799998752221111000 01467899999999886433 44444 3321
Q ss_pred --CCccEEEEecccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc--e
Q 006739 421 --PDCHLLVYEFMKN-GSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME--A 495 (633)
Q Consensus 421 --~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~--~ 495 (633)
.-.-+||+|-++| -+|.+++.... -.+.+...+..++.++++.++-| |+.++.|+|+.+.||+++.++. +
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~L---H~~Gv~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKM---HSVNRQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHhheeecCCCCeeE
Confidence 1134799998864 48998885421 23567788899999999999999 8999999999999999986667 9
Q ss_pred EEcccccccc
Q 006739 496 RIADFGLAKA 505 (633)
Q Consensus 496 kl~DfG~a~~ 505 (633)
+++||--++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999986654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.3e-09 Score=114.02 Aligned_cols=130 Identities=22% Similarity=0.310 Sum_probs=105.4
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCccc-ccCCCCCCEEEc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDL 153 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l 153 (633)
.+...+.+.|.+.- ...++.-++.|+.|||++|+++.. ..+..|++|+.|||++|.+. .+|.- ..++. |+.|+|
T Consensus 165 ~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 56677788888865 345688889999999999999884 38899999999999999999 66653 34454 999999
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCC-cccccCCCCCeeccCCCCCCCCCc
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVP-TSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
++|.++.+- .+.++.+|..||+++|-|.+.-- ..+..+..|+.|+|.||++.|-|-
T Consensus 240 rnN~l~tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 240 RNNALTTLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred cccHHHhhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 999998554 46789999999999999985322 235667889999999999977764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3e-09 Score=88.85 Aligned_cols=130 Identities=18% Similarity=0.265 Sum_probs=90.2
Q ss_pred eEEEEecCCCCcccCCc---cccCCccccEEEccCCCCCCCCchhccC-CCCCcEEEccCccCCCCCcccccCCCCCCEE
Q 006739 76 ITKLVFVPRELTGVLSP---SIGRLSELRELSLANNSLVDLLPPQIVD-CKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151 (633)
Q Consensus 76 ~~~L~l~~n~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (633)
+-.++|+++.+-- ++. .+.....|+.++|++|.+.. +|+.|.. .+.++.|+|++|.|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 4456777776532 233 34455667777888888877 5665554 457888888888888 788888888888888
Q ss_pred EccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 152 ~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+++.|.|.-.+..+..+.+|..|+..+|.+. .+|..+---...-..++.+|++....
T Consensus 106 Nl~~N~l~~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~ 162 (177)
T KOG4579|consen 106 NLRFNPLNAEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDET 162 (177)
T ss_pred ccccCccccchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccC
Confidence 8888888888766666888888888888887 56544322233345566777775443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.5e-09 Score=89.36 Aligned_cols=110 Identities=21% Similarity=0.253 Sum_probs=54.2
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.++.++|++|.+....+..-..++.++.|+|++|.|+. +|.++..++.|+.|+++.|.|. ..|.-+..|.+|..|+..
T Consensus 54 el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisd-vPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 54 ELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISD-VPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred eEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhh-chHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 45555555555554333322334455555555555554 4555555555555555555555 455555555555555555
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVP 186 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p 186 (633)
+|.+..++-.+-.-.++-..++.+|.+.+.-+
T Consensus 132 ~na~~eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 132 ENARAEIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCccccCcHHHhccccHHHHHhcCCcccccCc
Confidence 55555444222222222233334555554444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.4e-07 Score=87.87 Aligned_cols=107 Identities=23% Similarity=0.311 Sum_probs=83.6
Q ss_pred HHHHHHHHHHhhcCCCCc--ccccceeeecCC----ccEEEEecccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 006739 393 MRQIRSEINTVGQIRHRN--LLPLLAHMARPD----CHLLVYEFMKNG-SLQDILNDVSQGRRELDWLARHKIALGVACG 465 (633)
Q Consensus 393 ~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~ 465 (633)
.....+|.+.+..+...+ .++.+++..... ..++|+|++++. +|.+++.... ..+...+..++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 345778888888776443 456666665432 347999999884 8999887522 25666788999999999
Q ss_pred HHHHHhcCCCCeeeCCCCCCCeEecCCC---ceEEccccccccc
Q 006739 466 LEYLHISHNPRIIHRDLKPANVLLDDDM---EARIADFGLAKAM 506 (633)
Q Consensus 466 L~~Lh~~h~~~ivH~Dikp~Nill~~~~---~~kl~DfG~a~~~ 506 (633)
++-| |..+|+|+|+++.|||++.++ .+.++||+-++..
T Consensus 131 i~~l---H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKL---HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH---HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 889999999999999999887 7999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.1e-08 Score=104.52 Aligned_cols=95 Identities=22% Similarity=0.443 Sum_probs=75.4
Q ss_pred HHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcce-------ecccccCcccccccccccC
Q 006739 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-------TSNVAGTVGYIAPEYHQTL 533 (633)
Q Consensus 461 ~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 533 (633)
+++.|+.|+| .+.++||++|.|++|.++..+..|++.|+.+........+.. ..-..-...|.|||++...
T Consensus 107 ~v~dgl~flh--~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLH--RSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhc--cCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999998 788999999999999999999999999998766554222111 1112345679999999998
Q ss_pred CCCCccchHHHHHHHHHHHhCCCC
Q 006739 534 KFTDKCDIYSFGVLLAVLVMGRLP 557 (633)
Q Consensus 534 ~~~~~~Dv~s~G~~l~elltg~~p 557 (633)
..+.++|+||+|+++|-+..|..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred cccccccceeeeeEEEEEecCCcc
Confidence 889999999999999999855444
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.1e-07 Score=84.93 Aligned_cols=140 Identities=15% Similarity=0.183 Sum_probs=83.2
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc--ccccceeee
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN--LLPLLAHMA 419 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~ 419 (633)
-..||+|..+.||+. .|..+++|....... .....+|.++++.+..-. +.+.+++..
T Consensus 6 ~~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~~----------------~~~i~~E~~~l~~l~~~glpvP~~~~~~~ 64 (226)
T TIGR02172 6 WTQTGEGGNGESYTH-----KTGKWMLKLYNPGFD----------------KETIKREFDASRKVFSLGIPTPHPFDLVE 64 (226)
T ss_pred heeecCCCCcceeEe-----cCCCEEEEeCCCCCC----------------HHHHHHHHHHHHHHHHcCCCCCceEEEEe
Confidence 367899999999984 244678888754221 234567888888876433 467777777
Q ss_pred cCCccEEEEecccCCC-HHHH---------------------HhhhcCCCCCCCHHHHHHHHH----------HHHH-HH
Q 006739 420 RPDCHLLVYEFMKNGS-LQDI---------------------LNDVSQGRRELDWLARHKIAL----------GVAC-GL 466 (633)
Q Consensus 420 ~~~~~~lv~e~~~~gs-L~~~---------------------l~~~~~~~~~l~~~~~~~i~~----------~ia~-~L 466 (633)
..+...+|||+++|.+ +... +|........++.. ...+-. .+.+ ..
T Consensus 65 ~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~ 143 (226)
T TIGR02172 65 DGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKAR 143 (226)
T ss_pred cCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHH
Confidence 7777889999998863 2111 11110001111100 000000 0001 11
Q ss_pred HHHHh-cCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 467 EYLHI-SHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 467 ~~Lh~-~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
.+|.. .....++|+|+.|.||++++++ +.++||+.+.
T Consensus 144 ~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 144 AFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 22211 1244678999999999999988 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.3e-08 Score=99.35 Aligned_cols=138 Identities=18% Similarity=0.204 Sum_probs=78.2
Q ss_pred eeeeEEEEecCCCCcccCC--ccccCCccccEEEccCCCCCCCCchhc-cCCCCCcEEEccCccCCCC-CcccccCCCCC
Q 006739 73 VLKITKLVFVPRELTGVLS--PSIGRLSELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGT-IPSDLSSLIRL 148 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L 148 (633)
.++++.|||++|-+....+ .-...|++|+.|+|+.|++........ ..++.|+.|.|+.+.|+.. +-..+..+++|
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl 224 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSL 224 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcH
Confidence 4578888888887765432 235677888888888888865433322 2356677777777776621 11223345666
Q ss_pred CEEEccCCcCCCC-CccCCCCCCCCeEeCcCCcCCccCC--cccccCCCCCeeccCCCCCCCCCcc
Q 006739 149 RVLDLSGNSFSGN-LGFLKYFPNLEHLSLAKNLFTGKVP--TSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 149 ~~L~l~~N~l~~~-~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+.|+|..|..-.. ......+..|+.|||++|++- ..+ ...+.++.|..|+++.+.+.++..+
T Consensus 225 ~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~ 289 (505)
T KOG3207|consen 225 EVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEP 289 (505)
T ss_pred HHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCC
Confidence 6666666641111 122334455666666666655 222 2345556666666666666555444
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.1e-08 Score=99.56 Aligned_cols=135 Identities=27% Similarity=0.275 Sum_probs=87.2
Q ss_pred eeEEEEecCCCCcccCC-ccccCCccccEEEccCCCCCCCCc--hhccCCCCCcEEEccCccCCCCCccc-ccCCCCCCE
Q 006739 75 KITKLVFVPRELTGVLS-PSIGRLSELRELSLANNSLVDLLP--PQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRV 150 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~ 150 (633)
.++.+.|.+....-... .....+++++.||||.|-|....| .....|++|+.|+||.|++.-..... -..++.|+.
T Consensus 122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~ 201 (505)
T KOG3207|consen 122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ 201 (505)
T ss_pred hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence 45666666665543221 245667888888888888776322 34566888888888888876322222 124567888
Q ss_pred EEccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 151 LDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 151 L~l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|.|+.+.|+..- ..+..+|+|+.|+|+.|...+.-.....-+..|+.|||++|++...+
T Consensus 202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~ 262 (505)
T KOG3207|consen 202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFD 262 (505)
T ss_pred EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccc
Confidence 888888887433 33456788888888888533333334455777888888888876554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.3e-08 Score=101.89 Aligned_cols=129 Identities=23% Similarity=0.306 Sum_probs=89.4
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.+..+++..|.+.. +-..+..+++|+.|+|.+|+|.. +...+..+++|++|+|++|.|+... .+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhheec
Confidence 45555666666655 23447777888888888888877 3434777888888888888887332 35566678888888
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcc-cccCCCCCeeccCCCCCCCCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTS-IRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|.|+... .+..+++|+.+++++|.++..-+ . ...+.+++.+++.+|.+..+.
T Consensus 149 ~N~i~~~~-~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~~i~ 202 (414)
T KOG0531|consen 149 GNLISDIS-GLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIREIE 202 (414)
T ss_pred cCcchhcc-CCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchhccc
Confidence 88887554 34447788888888888874333 2 466778888888888876553
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.4e-06 Score=90.38 Aligned_cols=154 Identities=18% Similarity=0.225 Sum_probs=94.0
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHH-----------------HHHHHHH------HHHHH
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSK-----------------LLNKKMR------QIRSE 399 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~-----------------~~~~~~~------~~~~e 399 (633)
+.||..+.|.||+|+.+ +|+.||||+.+..-.+....+-...+ ..++..+ +|.+|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 68999999999999997 79999999988765543211111000 0111111 24445
Q ss_pred HHHhhcC----CCCc------ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 006739 400 INTVGQI----RHRN------LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYL 469 (633)
Q Consensus 400 ~~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~L 469 (633)
.+...+. +|-+ |.+++- .......|+||||+|.-+.|.-.- . ...++.. .|+..+.++...+
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i-~--~~gi~~~---~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI-D--KRGISPH---DILNKLVEAYLEQ 316 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH-H--HcCCCHH---HHHHHHHHHHHHH
Confidence 5444433 3444 223322 223467899999999866554221 1 1224444 3444444433222
Q ss_pred HhcCCCCeeeCCCCCCCeEecC----CCceEEcccccccccCC
Q 006739 470 HISHNPRIIHRDLKPANVLLDD----DMEARIADFGLAKAMPD 508 (633)
Q Consensus 470 h~~h~~~ivH~Dikp~Nill~~----~~~~kl~DfG~a~~~~~ 508 (633)
.-..|.+|+|-.|.||+++. ++.+.+.|||+......
T Consensus 317 --If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 --IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 24567999999999999994 67899999999776543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=9.5e-08 Score=101.05 Aligned_cols=130 Identities=23% Similarity=0.267 Sum_probs=103.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..++..|++.+|+|.++. ..+..+++|+.|+|++|.|+.+ ..+..++.|+.|++++|.|+ .+. .+..+.+|+.++
T Consensus 94 ~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchhhcc-cchhhhhcchheeccccccccc--cchhhccchhhheeccCcch-hcc-CCccchhhhccc
Confidence 347999999999999863 2278899999999999999985 35778888999999999998 443 466689999999
Q ss_pred ccCCcCCCCCcc-CCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 153 LSGNSFSGNLGF-LKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 153 l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+++|+++..... +..+.+|+.+++.+|.+. ....+..+..+..+++..|.+..+.
T Consensus 169 l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~ 224 (414)
T KOG0531|consen 169 LSYNRIVDIENDELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLE 224 (414)
T ss_pred CCcchhhhhhhhhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceecc
Confidence 999999876653 578899999999999997 3334455556666677777775543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.4e-06 Score=77.14 Aligned_cols=146 Identities=18% Similarity=0.238 Sum_probs=91.1
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC---cc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR---NL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---ni 411 (633)
...+|...+++-......|.+... +|..+++|..+......... -..+. .-....+++..+.+++.. ..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~---~~sf~--kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERR---FKSFF--KGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHH---HHHHh--ccHHHHHHHHHHHHHHHcCcccc
Confidence 346778888888888888888876 78899999875433221100 00000 012233444444444322 22
Q ss_pred cccceee-----ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 412 LPLLAHM-----ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 412 v~l~~~~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
..++... ......+++|||++|..|.+... ++. .++..+++++.-+ |+.|++|+|..|.|
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikql---H~~G~~HGD~hpgN 165 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQL---HKHGFYHGDPHPGN 165 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHH---HHcCCccCCCCcCc
Confidence 3323222 22234568999999987766532 222 2445666777778 78999999999999
Q ss_pred eEecCCCceEEccccccc
Q 006739 487 VLLDDDMEARIADFGLAK 504 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~ 504 (633)
++++++ .++++||+..+
T Consensus 166 Flv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 166 FLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEECC-cEEEEECcccc
Confidence 999966 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.31 E-value=5.2e-06 Score=77.99 Aligned_cols=151 Identities=21% Similarity=0.234 Sum_probs=94.2
Q ss_pred cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHH---H-------HHHHHHHHHHHHHHhhcCC--CCc
Q 006739 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSK---L-------LNKKMRQIRSEINTVGQIR--HRN 410 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~---~-------~~~~~~~~~~e~~~l~~l~--h~n 410 (633)
-.|..|--+.||+|.- .++..+|||+++............... + ......-..+|+..|.++. +-.
T Consensus 54 g~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 54 GCISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eeecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 3677888899999964 478999999997655433221111000 0 0001112345666666653 334
Q ss_pred ccccceeeecCCccEEEEecccCCCHH-HHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQ-DILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+.+.+++. .-.|||||+...... =.|+ ..++.......+..++.+.+.-|. +..++||+||+.-|||+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~--~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLY--KEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHH--HhcCcccccchhhheEE
Confidence 44555543 346999999653110 0111 112223256667777888887775 56899999999999999
Q ss_pred cCCCceEEcccccccccC
Q 006739 490 DDDMEARIADFGLAKAMP 507 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~ 507 (633)
. ++.+.++|||-|....
T Consensus 201 ~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred E-CCeEEEEECccccccC
Confidence 9 7799999999887554
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.8e-07 Score=60.46 Aligned_cols=36 Identities=47% Similarity=0.785 Sum_probs=19.4
Q ss_pred cccEEEccCCCCCCCCchhccCCCCCcEEEccCccCC
Q 006739 99 ELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFS 135 (633)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 135 (633)
+|++|+|++|+|+. +|..+.+|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~~-l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITD-LPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SS-HGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcc-cCchHhCCCCCCEEEecCCCCC
Confidence 45555556655554 4445555555555555555555
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 633 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-24 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-08 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 8e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 9e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = 2e-98
Identities = 107/286 (37%), Positives = 163/286 (56%), Gaps = 17/286 (5%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
+G GG G+VYK L +G ++A+K+ L EE ++ Q ++E+ +
Sbjct: 37 ILGRGGFGKVYKGRLA--DGTLVAVKR----------LKEERTQ---GGELQFQTEVEMI 81
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
HRNLL L P LLVY +M NGS+ L + + + LDW R +IALG A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
GL YLH +P+IIHRD+K AN+LLD++ EA + DFGLAK M TH+TT V GT+G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIG 200
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD-DFFQHTEEMSLVKWMRNVMTSEN 582
+IAPEY T K ++K D++ +GV+L L+ G+ D + +++ L+ W++ ++ +
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 583 PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628
+D L N +E++ ++++A CT SP ERP +V ML
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 1e-85
Identities = 96/289 (33%), Positives = 140/289 (48%), Gaps = 23/289 (7%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV 403
K+G GG G VYK + N +A+KK L + +Q EI +
Sbjct: 38 KMGEGGFGVVYKGYV---NNTTVAVKK----------LAAMVDITTEELKQQFDQEIKVM 84
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+ +H NL+ LL + D LVY +M NGSL D L+ G L W R KIA G A
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAA 143
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP-DAQTHITTSNVAGTV 522
G+ +LH IHRD+K AN+LLD+ A+I+DFGLA+A AQT +T+ + GT
Sbjct: 144 NGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS-RIVGTT 199
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSEN 582
Y+APE + T K DIYSFGV+L ++ G D +H E L+ + E
Sbjct: 200 AYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD---EHREPQLLLDIKEEIEDEEK 255
Query: 583 PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
K + + + + +A C + +RP+ K V+ +L ++
Sbjct: 256 TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 9e-84
Identities = 87/290 (30%), Positives = 138/290 (47%), Gaps = 30/290 (10%)
Query: 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK----MRQIRSE 399
IG G G+VYK L +G +A+K+ + + + +E
Sbjct: 46 LIGHGVFGKVYKGVLR--DGAKVALKR------------------RTPESSQGIEEFETE 85
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
I T+ RH +L+ L+ + +L+Y++M+NG+L+ L + W R +I
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA-QTHITTSNV 518
+G A GL YLH IIHRD+K N+LLD++ +I DFG++K + QTH++T V
Sbjct: 146 IGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VV 201
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578
GT+GYI PEY + T+K D+YSFGV+L ++ R E ++L +W
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-SLPREMVNLAEWAVESH 260
Query: 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCML 628
+ + +D L + E + A C S +RP+ DV L
Sbjct: 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 9e-65
Identities = 74/320 (23%), Positives = 120/320 (37%), Gaps = 46/320 (14%)
Query: 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
L LE G G V+KA+L + +A+K P +D E
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIF--PIQDKQSWQNE----------- 66
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCH----LLVYEFMKNGSLQDILNDVSQGRRELD 451
E+ ++ ++H N+L + R L+ F + GSL D L +
Sbjct: 67 --YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVS 119
Query: 452 WLARHKIALGVACGLEYLH-------ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504
W IA +A GL YLH H P I HRD+K NVLL +++ A IADFGLA
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 505 AMPDAQTHITTSNVAGTVGYIAPEY-----HQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559
++ T GT Y+APE + + D+Y+ G++L L +D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLEN------GYEEQMLLVLKIACFCTVD 613
+ + + + E+ + K M ++ + C
Sbjct: 240 G-PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 614 SPRERPNSKDVRCMLSQIRH 633
R ++ V ++Q++
Sbjct: 299 DAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-57
Identities = 67/219 (30%), Positives = 117/219 (53%), Gaps = 19/219 (8%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
EKIG+G G V++AE +G +A+K + + +++ + E+
Sbjct: 43 EKIGAGSFGTVHRAEW---HGSDVAVKIL------------MEQDFHAERVNEFLREVAI 87
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ ++RH N++ + + +P +V E++ GSL +L+ S R +LD R +A V
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDV 146
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
A G+ YLH + NP I+HR+LK N+L+D ++ DFGL++ A T +++ + AGT
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTP 203
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
++APE + +K D+YSFGV+L L + P +
Sbjct: 204 EWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 6e-57
Identities = 63/226 (27%), Positives = 111/226 (49%), Gaps = 26/226 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
++IG GG G V+K L + ++AIK +I E + +K ++ + E+
Sbjct: 25 KQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGD-------SEGETEMIEKFQEFQREVFI 76
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ + H N++ L M P +V EF+ G L L D + W + ++ L +
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDI 131
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLD-----DDMEARIADFGLAKAMPDAQTHITTSN 517
A G+EY+ + NP I+HRDL+ N+ L + A++ADFGL++ + S
Sbjct: 132 ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSG 185
Query: 518 VAGTVGYIAPE--YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
+ G ++APE + +T+K D YSF ++L ++ G P D++
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-55
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E +G G G V KA+ K +AIK++ + + E+
Sbjct: 13 EEVVGRGAFGVVCKAKW---RAKDVAIKQIESE----------------SERKAFIVELR 53
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H N++ L P C LV E+ + GSL ++L+ ++ L
Sbjct: 54 QLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQ 110
Query: 462 VACGLEYLHISHNPR-IIHRDLKPANVLLDDDME-ARIADFGLAKAMPDAQTHITTSNVA 519
+ G+ YLH S P+ +IHRDLKP N+LL +I DFG A + +N
Sbjct: 111 CSQGVAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNK 164
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
G+ ++APE + +++KCD++S+G++L ++ R P D+
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E IG GG G+VY+A G +A+K + + +++ + +R E
Sbjct: 13 EIIGIGGFGKVYRAFW---IGDEVAVKA----------ARHDPDEDISQTIENVRQEAKL 59
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
++H N++ L + LV EF + G L +L+ + + A+ +
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQI 114
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR--------IADFGLAKAMPDAQTHIT 514
A G+ YLH IIHRDLK +N+L+ +E I DFGLA+ T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTT 170
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
+ AG ++APE + F+ D++S+GVLL L+ G +P
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 56/225 (24%), Positives = 91/225 (40%), Gaps = 30/225 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L K+ GE++K G I +K + + + K R E
Sbjct: 15 LTKLNENHSGELWKGRW---QGNDIVVKVLKVR-----DWSTR-------KSRDFNEECP 59
Query: 402 TVGQIRHRNLLPLL-AHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ H N+LP+L A + P H L+ +M GSL ++L++ +D K A
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFA 117
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
L +A G+ +LH + P I L +V++D+DM ARI+ + + +
Sbjct: 118 LDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRM 169
Query: 520 GTVGYIAPE---YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
++APE D++SF VLL LV +P D
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 2e-51
Identities = 71/332 (21%), Positives = 117/332 (35%), Gaps = 61/332 (18%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
D L LE IG G G VYK L + + +A+K + E
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSL---DERPVAVKVF--SFANRQNFINE------------ 55
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCH-----LLVYEFMKNGSLQDILNDVSQGRRELD 451
I V + H N+ + R LLV E+ NGSL L+ D
Sbjct: 56 -KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSD 109
Query: 452 WLARHKIALGVACGLEYLH------ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK- 504
W++ ++A V GL YLH + P I HRDL NVL+ +D I+DFGL+
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 505 -----AMPDAQTHITTSNVAGTVGYIAPEY-------HQTLKFTDKCDIYSFGVLLAVLV 552
+ + + GT+ Y+APE + D+Y+ G++ +
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 553 MGRLPSDDFFQHTEEMSL-----------VKWMRNVMTSENPTRAIDAKLLENGYEEQML 601
M R + E + + M+ +++ E EN +
Sbjct: 230 M-RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN--SLAVR 286
Query: 602 LVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
+ + C R ++ ++++
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMM 318
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-50
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 58/307 (18%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E +G G G+ K + G+++ +K++I+ ++ R E+
Sbjct: 16 EVLGKGCFGQAIKVTHRET-GEVMVMKELIRFDEET--------------QRTFLKEVKV 60
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ + H N+L + + + + E++K G+L+ I+ + W R A +
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDI 117
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN----- 517
A G+ YLH S N IIHRDL N L+ ++ +ADFGLA+ M D +T
Sbjct: 118 ASGMAYLH-SMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 518 -------VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570
V G ++APE + +K D++SFG++L ++ D+
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY--------- 225
Query: 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQM-----LLVLKIACFCTVDSPRERPNSKDVR 625
P + + I C P +RP+ +
Sbjct: 226 -----------LPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274
Query: 626 CMLSQIR 632
L +R
Sbjct: 275 HWLETLR 281
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++IGSG G VYK + +G +A+K + T + +++ ++E+
Sbjct: 29 GQRIGSGSFGTVYKGKW---HGD-VAVKMLNVT-----APTPQ-------QLQAFKNEVG 72
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + RH N+L + + P +V ++ + SL L+ + + IA
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQ 128
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
A G++YLH + + IIHRDLK N+ L +D +I DFGLA ++G+
Sbjct: 129 TARGMDYLH-AKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 522 VGYIAPE---YHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ ++APE + ++ + D+Y+FG++L L+ G+LP
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 73/346 (21%), Positives = 126/346 (36%), Gaps = 60/346 (17%)
Query: 312 GRDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV 371
G SG + A+ + +++ IG G GEV+ + G+ +A+K V
Sbjct: 22 GSGSGLPLLVQRTI-AKQIQMVKQ---------IGKGRYGEVWMGKW---RGEKVAVK-V 67
Query: 372 IQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDC----HLLV 427
++A+ E +EI +RH N+L +A + L+
Sbjct: 68 FFTTEEASWFRE--------------TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113
Query: 428 YEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLH-----ISHNPRIIHRDL 482
++ +NGSL D L LD + K+A GL +LH P I HRDL
Sbjct: 114 TDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 483 KPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN--VAGTVGYIAPE------YHQTLK 534
K N+L+ + IAD GLA + GT Y+ PE +
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228
Query: 535 FTDKCDIYSFGVLLAVLVMGRLPSDD-------FFQHTEEMSLVKWMRNVMTSENPTRAI 587
D+YSFG++L + + + + MR ++ + +
Sbjct: 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSF 288
Query: 588 DAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
+ + QM ++ C +P R + V+ L+++
Sbjct: 289 PNRWSSDECLRQMGKLMTE---CWAHNPASRLTALRVKKTLAKMSE 331
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 70/314 (22%), Positives = 122/314 (38%), Gaps = 50/314 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LE +G G GEV++ G+ +A+K + + + E +E+
Sbjct: 13 LECVGKGRYGEVWRGSW---QGENVAVK-IFSSRDEKSWFRE--------------TELY 54
Query: 402 TVGQIRHRNLLPLLA----HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+RH N+L +A L+ + + GSL D L LD ++ +
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLR 109
Query: 458 IALGVACGLEYLH-----ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
I L +A GL +LH P I HRDLK N+L+ + + IAD GLA +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 513 ITTSN--VAGTVGYIAPE------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD---- 560
+ N GT Y+APE + DI++FG++L + + +
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
Query: 561 ---FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE 617
F+ + MR V+ + I + + + ++K C +P
Sbjct: 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPSA 286
Query: 618 RPNSKDVRCMLSQI 631
R + ++ L++I
Sbjct: 287 RLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 66/253 (26%), Positives = 104/253 (41%), Gaps = 46/253 (18%)
Query: 313 RDSGPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVI 372
SG PL+ + + + E IG G GEV++ + G+ +A+K +
Sbjct: 24 TTSGSGSGLPLLVQRTIARTIVLQ------ESIGKGRFGEVWRGKW---RGEEVAVK-IF 73
Query: 373 QPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD----CHLLVY 428
++ + E +EI +RH N+L +A + + LV
Sbjct: 74 SSREERSWFRE--------------AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119
Query: 429 EFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLH-----ISHNPRIIHRDLK 483
++ ++GSL D LN R + K+AL A GL +LH P I HRDLK
Sbjct: 120 DYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174
Query: 484 PANVLLDDDMEARIADFGLAKAMPDAQTHITTSN--VAGTVGYIAPE------YHQTLKF 535
N+L+ + IAD GLA A I + GT Y+APE + +
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234
Query: 536 TDKCDIYSFGVLL 548
+ DIY+ G++
Sbjct: 235 FKRADIYAMGLVF 247
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-45
Identities = 52/228 (22%), Positives = 87/228 (38%), Gaps = 35/228 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E IG G G+VY +G+ +AI+ + + +L + + E+
Sbjct: 38 GELIGKGRFGQVYHGRW---HGE-VAIRLIDIERDNEDQL------------KAFKREVM 81
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
Q RH N++ + P ++ K +L ++ D + LD +IA
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQE 138
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT---HITTSNV 518
+ G+ YLH I+H+DLK NV D+ + I DFGL Q
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 519 AGTVGYIAPE---------YHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
G + ++APE L F+ D+++ G + L P
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-38
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR-QIRSEINTV 403
+G G VY+AE + G +AIK +I K + M ++++E+
Sbjct: 19 LGKGSFAGVYRAESIHT-GLEVAIK-MI--DK---------KAMYKAGMVQRVQNEVKIH 65
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
Q++H ++L L + + LV E NG + L ++ + + ARH + +
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH-QII 122
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA-KAMPDAQTHITTSNVAGTV 522
G+ YLH SH I+HRDL +N+LL +M +IADFGLA + + H T GT
Sbjct: 123 TGMLYLH-SHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL---CGTP 176
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
YI+PE + D++S G + L++GR P D
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 20/229 (8%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIK---KVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
+ + G ++ E + K A+K K + K + D + K ++
Sbjct: 36 IRTLNQGKFNKIILCE---KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL-----NDVSQGRRELDWL 453
E+ + I++ L + D ++YE+M+N S+ D + +
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
+ I V Y+H N I HRD+KP+N+L+D + +++DFG ++ M D +
Sbjct: 153 IKCIIK-SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK- 208
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTD--KCDIYSFGVLLAVLVMGRLPSDD 560
S GT ++ PE+ + K DI+S G+ L V+ +P
Sbjct: 209 -GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR-QIRSEINTV 403
+G GG + ++ + ++ A K ++ PK S LL R ++ EI+
Sbjct: 23 LGKGGFAKCFEISDADT-KEVFAGK-IV--PK---------SLLLKPHQREKMSMEISIH 69
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+ H++++ D +V E + SL ++ + AR+ + +
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEP-EARYYLR-QIV 125
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA-KAMPDAQTHITTSNVAGTV 522
G +YLH + R+IHRDLK N+ L++D+E +I DFGLA K D + GT
Sbjct: 126 LGCQYLH-RN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGTP 179
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
YIAPE + + D++S G ++ L++G+ P + +E
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET--SCLKET 223
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR-QIRSEINTV 403
+G GG + ++ + ++ A K ++ PK S LL R ++ EI+
Sbjct: 49 LGKGGFAKCFEISDADT-KEVFAGK-IV--PK---------SLLLKPHQREKMSMEISIH 95
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALGV 462
+ H++++ D +V E + SL ++ + E AR+ + +
Sbjct: 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTE--PEARYYLR-QI 150
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA-KAMPDAQTHITTSNVAGT 521
G +YLH + R+IHRDLK N+ L++D+E +I DFGLA K D + GT
Sbjct: 151 VLGCQYLH-RN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL---CGT 204
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
YIAPE + + D++S G ++ L++G+ P +
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 56/241 (23%), Positives = 98/241 (40%), Gaps = 38/241 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L++IGSGG +V++ ++ AIK V + N+ + R+EI
Sbjct: 33 LKQIGSGGSSKVFQVL--NEKKQIYAIKYV------------NLEEADNQTLDSYRNEIA 78
Query: 402 TVGQIRHRNL--LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD-WLARHKI 458
+ +++ + + L + +V E N L L ++ +D W +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERKS-Y 132
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ + +H H I+H DLKPAN L+ D M ++ DFG+A M T + +
Sbjct: 133 WKNMLEAVHTIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 519 AGTVGYIAPE-----------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GTV Y+ PE K + K D++S G +L + G+ P +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 568 M 568
+
Sbjct: 249 L 249
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-37
Identities = 56/241 (23%), Positives = 98/241 (40%), Gaps = 38/241 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L++IGSGG +V++ ++ AIK V + N+ + R+EI
Sbjct: 14 LKQIGSGGSSKVFQVL--NEKKQIYAIKYV------------NLEEADNQTLDSYRNEIA 59
Query: 402 TVGQIRHRNL--LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD-WLARHKI 458
+ +++ + + L + +V E N L L ++ +D W +
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKS-Y 113
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ + +H H I+H DLKPAN L+ D M ++ DFG+A M T + +
Sbjct: 114 WKNMLEAVHTIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 519 AGTVGYIAPE-----------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GTV Y+ PE K + K D++S G +L + G+ P +
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 568 M 568
+
Sbjct: 230 L 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 66/310 (21%), Positives = 120/310 (38%), Gaps = 55/310 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++K+G GG V E +G A+K+++ + + + + E +
Sbjct: 34 IQKLGEGGFSYVDLVE-GLHDGHFYALKRILCHEQ--------------QDREEAQREAD 78
Query: 402 TVGQIRHRNLLPLLAHMARPDCH----LLVYEFMKNGSLQDILNDVSQGRRELD----WL 453
H N+L L+A+ R L+ F K G+L + + + L
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL- 137
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK----AMPDA 509
+ LG+ GLE +H HRDLKP N+LL D+ + + D G + +
Sbjct: 138 ---WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 510 QTHITTSNVA---GTVGYIAPE---YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563
+ +T + A T+ Y APE ++ D++S G +L ++ G P D FQ
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
+ ++L + ++P + L + TVD P +RP+
Sbjct: 252 KGDSVALAV-QNQLSIPQSPRHSSALWQL-------------LNSMMTVD-PHQRPHIPL 296
Query: 624 VRCMLSQIRH 633
+ L ++
Sbjct: 297 LLSQLEALQP 306
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 43/286 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+IG G VYK L +A ++ +D KL + ++ + E
Sbjct: 32 IEIGRGSFKTVYKG-LDTETTVEVAWCEL------------QDRKLTKSERQRFKEEAEM 78
Query: 403 VGQIRHRNLLPLL---AHMARPDCHLLVY-EFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ ++H N++ + +++ E M +G+L+ L + +
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSW 134
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHITTSN 517
+ GL++LH + P IIHRDLK N+ + +I D GLA +
Sbjct: 135 CRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----A 189
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577
V GT ++APE ++ K+ + D+Y+FG+ + + P ++E + + R V
Sbjct: 190 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRV 242
Query: 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
TS + D + E ++ C + ER + KD
Sbjct: 243 -TSGVKPASFD----KVAIPEVKEIIEG--CIRQ--NKDERYSIKD 279
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 38/241 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L++IGSGG +V++ ++ AIK V + N+ + R+EI
Sbjct: 61 LKQIGSGGSSKVFQVL--NEKKQIYAIKYV------------NLEEADNQTLDSYRNEIA 106
Query: 402 TVGQIRHRNL--LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD-WLARHKI 458
+ +++ + + L + +V E N L L ++ +D W +
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKS-Y 160
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ + +H H I+H DLKPAN L+ D M ++ DFG+A M T + +
Sbjct: 161 WKNMLEAVHTIH-QHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 519 AGTVGYIAPE-----------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
G V Y+ PE K + K D++S G +L + G+ P +
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 568 M 568
+
Sbjct: 277 L 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM-RQIRSEINTV 403
+G G G VY A + ++A+K V+ K ++L + Q+R E+
Sbjct: 17 LGKGKFGNVYLAREK-QSKFILALK-VLF--K---------AQLEKAGVEHQLRREVEIQ 63
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+RH N+L L + L+ E+ G++ L + + + I +A
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFD-EQRTATYITE-LA 119
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
L Y H S +IHRD+KP N+LL E +IADFG + P ++ GT+
Sbjct: 120 NALSYCH-SKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL---CGTLD 172
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
Y+ PE + +K D++S GVL ++G+ P +
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 53/270 (19%), Positives = 100/270 (37%), Gaps = 38/270 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G V++ G + AIK ++ + + E
Sbjct: 15 DILGQGATANVFRGRHK-KTGDLFAIKVF-------------NNISFLRPVDVQMREFEV 60
Query: 403 VGQIRHRNLLPLLAHMARPDCHL--LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ ++ H+N++ L A L+ EF GSL +L + S + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR- 119
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL----DDDMEARIADFGLAKAMPDAQTHITTS 516
V G+ +L + I+HR++KP N++ D ++ DFG A+ + D + ++
Sbjct: 120 DVVGGMNHLR-ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-- 174
Query: 517 NVAGTVGYIAPE--------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
+ GT Y+ P+ K+ D++S GV G LP F
Sbjct: 175 -LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---FRPFEGPR 230
Query: 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEE 598
+ M ++T + + ENG +
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPID 260
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM-RQIRSEINTV 403
+G G G VY A N ++A+K V+ S+L + + Q+R EI
Sbjct: 22 LGKGKFGNVYLAREK-QNKFIMALK-VL-----------FKSQLEKEGVEHQLRREIEIQ 68
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
+RH N+L + + L+ EF G L L GR + + + + +A
Sbjct: 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSATFMEE-LA 124
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVG 523
L Y H +IHRD+KP N+L+ E +IADFG + P + T GT+
Sbjct: 125 DALHYCH-ERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM---CGTLD 177
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
Y+ PE + +K D++ GVL ++G P D
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 53/270 (19%), Positives = 100/270 (37%), Gaps = 38/270 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G V++ G + AIK ++ + + E
Sbjct: 15 DILGQGATANVFRGRHK-KTGDLFAIKVF-------------NNISFLRPVDVQMREFEV 60
Query: 403 VGQIRHRNLLPLLAHMARPDCHL--LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ ++ H+N++ L A L+ EF GSL +L + S + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR- 119
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL----DDDMEARIADFGLAKAMPDAQTHITTS 516
V G+ +L + I+HR++KP N++ D ++ DFG A+ + D + ++
Sbjct: 120 DVVGGMNHLR-ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS-- 174
Query: 517 NVAGTVGYIAPE--------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
+ GT Y+ P+ K+ D++S GV G LP F
Sbjct: 175 -LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP---FRPFEGPR 230
Query: 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEE 598
+ M ++T + + ENG +
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPID 260
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 31/239 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L IG+G G K S+GK++ K++ D +TE + + + SE+N
Sbjct: 11 LYTIGTGSYGRCQKIRRK-SDGKILVWKEL-----DYGSMTEAE-------KQMLVSEVN 57
Query: 402 TVGQIRHRNLLPLLAH-MARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELD----WLAR 455
+ +++H N++ + R + L +V E+ + G L ++ ++ R+ LD
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL--- 114
Query: 456 HKIALGVACGLEYLHISHNP--RIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
++ + L+ H + ++HRDLKPANV LD ++ DFGLA+ +
Sbjct: 115 -RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTS 171
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572
GT Y++PE + + +K DI+S G LL L P F + L
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAG 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 65/242 (26%), Positives = 103/242 (42%), Gaps = 34/242 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E++G+GG G V + + G+ +AIK+ +L K + EI
Sbjct: 19 KERLGTGGFGYVLRWIHQDT-GEQVAIKQC-------------RQELSPKNRERWCLEIQ 64
Query: 402 TVGQIRHRNLLPLLA------HMARPDCHLLVYEFMKNGSLQDILNDV--SQGRRELDWL 453
+ ++ H N++ +A D LL E+ + G L+ LN G +E
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-- 122
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR---IADFGLAKAMPDAQ 510
R ++ ++ L YLH + IIHRDLKP N++L + I D G AK +
Sbjct: 123 IRTLLSD-ISSALRYLH-ENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-G 177
Query: 511 THITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570
T GT+ Y+APE + K+T D +SFG L + G P +Q +
Sbjct: 178 ELCTEF--VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 571 VK 572
V+
Sbjct: 236 VR 237
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 62/309 (20%), Positives = 124/309 (40%), Gaps = 64/309 (20%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ +G G G+V KA + + AIKK+ + +K+ I SE+
Sbjct: 11 IAVLGQGAFGQVVKAR-NALDSRYYAIKKI---------------RHTEEKLSTILSEVM 54
Query: 402 TVGQIRHRN-------------LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRR 448
+ + H+ + + + + + E+ +NG+L D++ S+
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLN 112
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
+ ++ + L Y+H S IIHRDLKP N+ +D+ +I DFGLAK +
Sbjct: 113 QQRDEYW-RLFRQILEALSYIH-SQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 509 AQTHITTSNVA------------GTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+ + + GT Y+A E T + +K D+YS G++ ++
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP- 227
Query: 556 LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSP 615
F E ++++K +R + + +N + + ++ + D P
Sbjct: 228 -----FSTGMERVNILKKLR------SVSIEFPPDFDDNKMKVEKKIIRLL---IDHD-P 272
Query: 616 RERPNSKDV 624
+RP ++ +
Sbjct: 273 NKRPGARTL 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 46/338 (13%), Positives = 89/338 (26%), Gaps = 40/338 (11%)
Query: 264 HHHKHKKSKGKKAAGWILGFIAGAVAGTISGFVFSVLFKLILAAVRGGGRDSGPAIFSPL 323
HHH H + G G V I + + + + + L
Sbjct: 3 HHHHHSSGRENLYFQGFRGTDPGDVV--IEELFNRIPQANVRTTSEYMQSAADSLVSTSL 60
Query: 324 IKKAEDLAFLEKEDG----LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAA 379
+ + L +G +A G+ + V +
Sbjct: 61 WNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVH-VPYFTERPP 118
Query: 380 ELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCH--------------- 424
+ K ++R +R N H + + P
Sbjct: 119 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 178
Query: 425 --LLVYEFMK--NGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480
+Y M+ + ++L S + L AR ++ L V L LH + ++H
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHT 235
Query: 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPE-----YHQTLKF 535
L+P +++LD + F + A H
Sbjct: 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLM 294
Query: 536 TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573
T D ++ G+ + + LP + +W
Sbjct: 295 TFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEW 328
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 57/195 (29%), Positives = 80/195 (41%), Gaps = 23/195 (11%)
Query: 31 SDYKALSVILRDLGGQQLF---IPSDPCST---PGVFCERRLSDNNTYVLKITKLVFVPR 84
D +AL I +DLG +P+ C GV C D +T ++ L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLC-----DTDTQTYRVNNLDLSGL 60
Query: 85 ELTGV--LSPSIGRLSELRELSLAN-NSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD 141
L + S+ L L L + N+LV +PP I +L L + + SG IP
Sbjct: 61 NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF 120
Query: 142 LSSLIRLRVLDLSGNSFSGN----LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNL-Q 196
LS + L LD S N+ SG + L PNL ++ N +G +P S +F L
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSL---PNLVGITFDGNRISGAIPDSYGSFSKLFT 177
Query: 197 FFDFSGNSLLEGPIP 211
S N L G IP
Sbjct: 178 SMTISRNR-LTGKIP 191
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 38/128 (29%), Positives = 63/128 (49%), Gaps = 4/128 (3%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L G + P+I +L++L L + + ++ +P + K L L+ N SGT+P +SSL
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148
Query: 146 IRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
L + GN SG + + + +++++N TGK+P + NL F D S N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 204 SLLEGPIP 211
LEG
Sbjct: 208 M-LEGDAS 214
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 32/127 (25%), Positives = 56/127 (44%), Gaps = 3/127 (2%)
Query: 86 LTGVLSPSIGRLSELRE-LSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
++G + S G S+L ++++ N L +PP + L +++ N G S
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGS 219
Query: 145 LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
+ + L+ NS + +LG + NL L L N G +P + + L + S N+
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 205 LLEGPIP 211
L G IP
Sbjct: 280 -LCGEIP 285
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 31/127 (24%), Positives = 51/127 (40%), Gaps = 26/127 (20%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L G S G +++ LA NSL L ++ K L L+++NN+ GT+P L+ L
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 146 IRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L L++S N+ G++P + ++ N
Sbjct: 268 KFLHSLNVSFNNLC-----------------------GEIPQGGN-LQRFDVSAYANNKC 303
Query: 206 LEG-PIP 211
L G P+P
Sbjct: 304 LCGSPLP 310
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-33
Identities = 42/127 (33%), Positives = 57/127 (44%), Gaps = 2/127 (1%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
TG + P++ SEL L L+ N L +P + KL L + N G IP +L +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465
Query: 146 IRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L L L N +G + L NL +SL+ N TG++P I NL S NS
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 205 LLEGPIP 211
G IP
Sbjct: 526 -FSGNIP 531
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-31
Identities = 38/128 (29%), Positives = 58/128 (45%), Gaps = 6/128 (4%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
+ + P +G S L+ L ++ N L I C +L++LN+ +NQF G IP L
Sbjct: 212 FSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPL 268
Query: 146 IRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
L+ L L+ N F+G + L L L+ N F G VP + L+ S N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 204 SLLEGPIP 211
+ G +P
Sbjct: 329 N-FSGELP 335
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 38/130 (29%), Positives = 59/130 (45%), Gaps = 7/130 (5%)
Query: 86 LTGVLS-PSIGRLSELRELSLANNSLVDLLPPQIVD---CKKLEILNVQNNQFSGTIPSD 141
L +L+ L L L+ NS+ V C +L+ L + N+ SG +
Sbjct: 138 LDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-- 195
Query: 142 LSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201
+S + L LD+S N+FS + FL L+HL ++ N +G +I T L+ + S
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255
Query: 202 GNSLLEGPIP 211
N GPIP
Sbjct: 256 SNQ-FVGPIP 264
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 6/128 (4%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L G + + + L L L N L +P + +C L +++ NN+ +G IP + L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 146 IRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L +L LS NSFSGN+ L +L L L NLF G +P ++ Q + N
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM----FKQSGKIAAN- 568
Query: 205 LLEGPIPV 212
+ G V
Sbjct: 569 FIAGKRYV 576
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 43/132 (32%), Positives = 58/132 (43%), Gaps = 7/132 (5%)
Query: 86 LTGVLSPSI-GRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LS 143
TG + + G L L L+ N +PP C LE L + +N FSG +P D L
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 144 SLIRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSI--RTFRNLQFFD 199
+ L+VLDLS N FSG L +L L L+ N F+G + ++ LQ
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 200 FSGNSLLEGPIP 211
N G IP
Sbjct: 401 LQNNG-FTGKIP 411
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 39/146 (26%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 70 NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNV 129
N + K E G+ S + RLS ++ + P + + L++
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639
Query: 130 QNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG----NLGFLKYFPNLEHLSLAKNLFTGKV 185
N SG IP ++ S+ L +L+L N SG +G L+ L L L+ N G++
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR---GLNILDLSSNKLDGRI 696
Query: 186 PTSIRTFRNLQFFDFSGNSLLEGPIP 211
P ++ L D S N+ L GPIP
Sbjct: 697 PQAMSALTMLTEIDLSNNN-LSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 48/185 (25%), Positives = 68/185 (36%), Gaps = 29/185 (15%)
Query: 52 SDPCSTPGVFCERR------LSDNNTYVLK------ITKLVFVPR------ELTGVLSPS 93
+PC+ GV C LS V + L + + G +
Sbjct: 37 KNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SG 95
Query: 94 IGRLSELRELSLANNSLVDLLPP--QIVDCKKLEILNVQNNQFSGTIP-SDLSSLIRLRV 150
+ L L L+ NSL + + C L+ LNV +N S L L V
Sbjct: 96 FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155
Query: 151 LDLSGNSFSG----NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206
LDLS NS SG L+HL+++ N +G V + NL+F D S N+
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN-F 212
Query: 207 EGPIP 211
IP
Sbjct: 213 STGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 2/136 (1%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
R G SP+ + L ++ N L +P +I L ILN+ +N
Sbjct: 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI 668
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFR 193
SG+IP ++ L L +LDLS N G + + L + L+ N +G +P F
Sbjct: 669 SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFE 727
Query: 194 NLQFFDFSGNSLLEGP 209
F N L G
Sbjct: 728 TFPPAKFLNNPGLCGY 743
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-23
Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 8/129 (6%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
LTG + IGRL L L L+NNS +P ++ DC+ L L++ N F+GTIP+ +
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 146 IRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNL--FTGKVPTSIRTFRNLQFFDFSG 202
++ N +G ++K + A NL F G + + +
Sbjct: 562 S----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617
Query: 203 NSLLEGPIP 211
G
Sbjct: 618 RV-YGGHTS 625
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-15
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 3/92 (3%)
Query: 123 KLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFT 182
+++ + N + S L SL L L LS + +G++ K +L L L++N +
Sbjct: 54 SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLS 113
Query: 183 GKVPT--SIRTFRNLQFFDFSGNSLLEGPIPV 212
G V T S+ + L+F + S N+ L+ P V
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNT-LDFPGKV 144
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 67/317 (21%), Positives = 120/317 (37%), Gaps = 54/317 (17%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
K+D + ++G+G G V+K S G ++A K + L + +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLI--------HLEIKPAI-----RN 76
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
QI E+ + + ++ + E M GSL +L GR L
Sbjct: 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG 134
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD--AQTH 512
K+++ V GL YL H I+HRD+KP+N+L++ E ++ DFG++ + D A +
Sbjct: 135 --KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR--LPSDDFFQHTEEMSL 570
+ GT Y++PE Q ++ + DI+S G+ L + +GR +P D +
Sbjct: 191 V------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244
Query: 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACF--------------------- 609
T P + + ++ +
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 304
Query: 610 ---CTVDSPRERPNSKD 623
C + +P ER + K
Sbjct: 305 VNKCLIKNPAERADLKQ 321
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 49/235 (20%), Positives = 101/235 (42%), Gaps = 32/235 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+KIG G G+ + +G+ IK++ + + ++ ++ + R E+
Sbjct: 29 LQKIGEGSFGKAILVK-STEDGRQYVIKEI-----NISRMSSKE-------REESRREVA 75
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RE---LDWLARHK 457
+ ++H N++ +V ++ + G L +N +E LDW +
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ-- 133
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+ L+++H + +I+HRD+K N+ L D ++ DFG+A+ +
Sbjct: 134 ----ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-- 184
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572
GT Y++PE + + +K DI++ G +L L + F+ +LV
Sbjct: 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKNLVL 235
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 59/295 (20%), Positives = 115/295 (38%), Gaps = 62/295 (21%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++ +G GG G V++A+ + AIK++ P ++ ++ E+
Sbjct: 10 IQCLGRGGFGVVFEAKN-KVDDCNYAIKRIRLPNRE-------------LAREKVMREVK 55
Query: 402 TVGQIRHRNLL---------PLLAHMARPDCHLLVY---EFMKNGSLQDILNDVSQGRRE 449
+ ++ H ++ + + +Y + + +L+D +N E
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEE 114
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA 509
+ I L +A +E+LH + ++HRDLKP+N+ D ++ DFGL AM
Sbjct: 115 RERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 510 QTHITTSNVA----------GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM------ 553
+ T GT Y++PE ++ K DI+S G++L L+
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQM 231
Query: 554 -----------GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAK-LLENGY 596
+ P ++ E +V+ M S +P +A ++EN
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD----MLSPSPMERPEAINIIENAV 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 39/287 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+KIG G EVY+A +G +A+KKV +L + ++ EI+
Sbjct: 37 EKKIGRGQFSEVYRA-ACLLDGVPVALKKV-----QIFDLMDAKAR------ADCIKEID 84
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD----WLARHK 457
+ Q+ H N++ A + +V E G L ++ + +R + W K
Sbjct: 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----K 140
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+ + LE++H + R++HRD+KPANV + ++ D GL + T +
Sbjct: 141 YFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-- 195
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577
+ GT Y++PE + K DI+S G LL + + P F + ++M+L + +
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---F--YGDKMNLYSLCKKI 250
Query: 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ P L + Y E++ ++ C D P +RP+ V
Sbjct: 251 EQCDYP------PLPSDHYSEELRQLVN-MCI-NPD-PEKRPDVTYV 288
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 30/224 (13%)
Query: 342 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
E +G GG EV+ A + +A+K V++ +L + S + R
Sbjct: 17 GEILGFGGMSEVHLARDLRD----HRDVAVK-VLRA-----DLARDPSFY-----LRFRR 61
Query: 399 EINTVGQIRHRNLLPLL----AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
E + H ++ + A +V E++ +L+DI++ +
Sbjct: 62 EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKR 117
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
++ L + SH IIHRD+KPAN+++ ++ DFG+A+A+ D+ +T
Sbjct: 118 AIEVIADACQALNF---SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 515 -TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
T+ V GT Y++PE + + D+YS G +L ++ G P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 30/212 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E+IG G GEV+ L N +A+K ++ + +K L E
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTL-VAVKSC----RETL-PPDLKAKFLQ--------EAR 164
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q H N++ L+ + +V E ++ G L L ++
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGD 221
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
A G+EYL S IHRDL N L+ + +I+DFG+++ D +G
Sbjct: 222 AAAGMEYLE-SKC--CIHRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGG 273
Query: 522 VGYI-----APEYHQTLKFTDKCDIYSFGVLL 548
+ + APE +++ + D++SFG+LL
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 328 EDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIQPPKDAAELTEEDS 386
+ L +KE +GSG G V K +A+K + K+ A
Sbjct: 16 KLLTLEDKE--------LGSGNFGTVKKGYYQMKKVVKTVAVKIL----KNEANDPALKD 63
Query: 387 KLLNKKMRQIRSEINTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQ 445
+LL +E N + Q+ + ++ ++ A +LV E + G L L Q
Sbjct: 64 ELL--------AEANVMQQLDNPYIVRMIGICEAES--WMLVMEMAELGPLNKYL----Q 109
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
R + ++ V+ G++YL N +HRDL NVLL A+I+DFGL+KA
Sbjct: 110 QNRHVKDKNIIELVHQVSMGMKYLE-ESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA 166
Query: 506 MPDAQTHITTSNVAGT---VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + + V + APE KF+ K D++SFGVL+
Sbjct: 167 LRADENYYKAQ--THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 43/301 (14%), Positives = 75/301 (24%), Gaps = 37/301 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIK----KVIQPPKDAAELTEEDSKLLNKKMRQIR- 397
E + G V+ + A+K + L E
Sbjct: 68 EPLRVGDRSVVFLVRDVER-LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 398 ----------SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMK--NGSLQDILNDVSQ 445
S+ V L +LL+ L L+ V
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
R + LA H + + L S ++H P N+ + D + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQ-SKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 506 MPDAQTHITTSNVAGTVGYIAPEY--HQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563
+ + V Y E+ T FT + + G+ + + LP F
Sbjct: 244 VGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----FG 294
Query: 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
W R + ++ + L+ + F D R R +
Sbjct: 295 LVTPGIKGSWKRPSLRVPGT-DSLAFGSCTPLPDFVKTLIGR---FLNFD-RRRRLLPLE 349
Query: 624 V 624
Sbjct: 350 A 350
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 63/220 (28%), Positives = 113/220 (51%), Gaps = 28/220 (12%)
Query: 342 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
++K+G GG VY AE L +AIK I E++ L ++
Sbjct: 16 VDKLGGGGMSTVYLAEDTIL----NIKVAIK-AIFI-----PPREKEETL-----KRFER 60
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E++ Q+ H+N++ ++ DC+ LV E+++ +L + + L
Sbjct: 61 EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINF 116
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-TSN 517
+ G+++ +H+ RI+HRD+KP N+L+D + +I DFG+AKA+ ++T +T T++
Sbjct: 117 TNQILDGIKH---AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNH 171
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
V GTV Y +PE + + DIYS G++L +++G P
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 68/236 (28%), Positives = 107/236 (45%), Gaps = 31/236 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +GSG CGEV A K +AI+ +I K A E + +EI
Sbjct: 141 KTLGSGACGEVKLAFER-KTCKKVAIR-IISKRKFAIGSAREA-----DPALNVETEIEI 193
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR-RELDWLARHKIAL 460
+ ++ H ++ + D ++ V E M+ G L D + V R +E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLKEAT--CKL-YFY 246
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSN 517
+ ++YLH + IIHRDLKP NVLL ++D +I DFG +K + + T
Sbjct: 247 QMLLAVQYLH-ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--- 300
Query: 518 VAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570
+ GT Y+APE T + D +S GV+L + + G P F +H ++SL
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 353
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK 391
+E L L+++G G G V L + G+++A+KK+ + + E D
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRD------ 57
Query: 392 KMRQIRSEINTVGQIRHRNLLPLLA----HMARPDCHLLVYEFMKNGSLQDILNDVSQGR 447
EI + ++H N++ R L+ E++ GSL+D L + +
Sbjct: 58 ----FEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYL---QKHK 108
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
+D + + + G+EYL + IHRDL N+L++++ +I DFGL K +P
Sbjct: 109 ERIDHIKLLQYTSQICKGMEYLG-TKR--YIHRDLATRNILVENENRVKIGDFGLTKVLP 165
Query: 508 DAQTHITTSNVAGT-VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + + + APE KF+ D++SFGV+L
Sbjct: 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 33/224 (14%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGK---MIAIK--KVIQPPKDAAELTEEDSKLL 389
++ L + +G G G+V +A+K K A+L
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL-------- 70
Query: 390 NKKMRQIRSEINTVGQIRHRNLLPLLA----HMARPDCHLLVYEFMKNGSLQDILNDVSQ 445
+ EI + + H N++ L+ EF+ +GSL++ L
Sbjct: 71 -------KKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPK--- 118
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
+ +++ + K A+ + G++YL S +HRDL NVL++ + + +I DFGL KA
Sbjct: 119 NKNKINLKQQLKYAVQICKGMDYLG-SRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA 175
Query: 506 MPDAQTHITTSNVAGT-VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + + T + + V + APE KF D++SFGV L
Sbjct: 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 51/242 (21%), Positives = 91/242 (37%), Gaps = 42/242 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ GG VY+A+ +G+ A+K+++ ++ K R I E+
Sbjct: 33 RRVLAEGGFAFVYEAQ-DVGSGREYALKRLLSNEEE--------------KNRAIIQEVC 77
Query: 402 TVGQIR-HRNLLPLLAH-------MARPDCHLLVYEFMKNGSLQDILNDVSQGRR--ELD 451
+ ++ H N++ + L+ + G L + L +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM---PD 508
L KI ++++H P IIHRDLK N+LL + ++ DFG A + PD
Sbjct: 138 VL---KIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 509 AQTHITTSNVA-------GTVGYIAPE---YHQTLKFTDKCDIYSFGVLLAVLVMGRLPS 558
+ T Y PE + +K DI++ G +L +L + P
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
Query: 559 DD 560
+D
Sbjct: 254 ED 255
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 50/220 (22%), Positives = 87/220 (39%), Gaps = 29/220 (13%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAEL--PGSNGKM-IAIK--KVIQPPKDAAELTEEDSKLL 389
KE ++ +GSG G VYK G K+ +AIK + PK E+
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL------- 65
Query: 390 NKKMRQIRSEINTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRR 448
E + + + ++ LL + L+ + M G L D + + +
Sbjct: 66 --------DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVR---EHKD 112
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
+ + +A G+ YL ++HRDL NVL+ +I DFGLAK +
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLE-DRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + ++A E +T + D++S+GV +
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-31
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
+ K+G G GEVY+ + +A+K + E T E + L
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLK-------EDTMEVEEFL--------K 265
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E + +I+H NL+ LL R ++ EFM G+L D L R+E+ + +
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYM 323
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
A ++ +EYL N IHR+L N L+ ++ ++ADFGL++ M T+ +
Sbjct: 324 ATQISSAMEYLE-KKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGA 379
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + APE KF+ K D+++FGVLL + G P
Sbjct: 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-31
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 56/295 (18%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G G + + + + +A+K++ L + E+
Sbjct: 30 DVLGHGAEGTIVYRGM--FDNRDVAVKRI-----------------LPECFSFADREVQL 70
Query: 403 VGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + H N++ + E +LQ+ + L+ +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE---PITLLQQ 126
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL-----DDDMEARIADFGLAKAMPDAQTHIT-T 515
GL +LH S N I+HRDLKP N+L+ ++A I+DFGL K + + +
Sbjct: 127 TTSGLAHLH-SLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 516 SNVAGTVGYIAPEY---HQTLKFTDKCDIYSFGVLLA-VLVMGRLPSDDFFQHTEEMSLV 571
S V GT G+IAPE T DI+S G + V+ G P F + + + +
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP---FGKSLQRQANI 240
Query: 572 KWMRNVMTSENPTRAID--AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ +P + D A+ L I +D P++RP++K V
Sbjct: 241 LLGACSLDCLHPEKHEDVIAREL-------------IEKMIAMD-PQKRPSAKHV 281
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 7e-31
Identities = 34/232 (14%), Positives = 71/232 (30%), Gaps = 33/232 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+G G +VY+A N + +K V +P +
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK-VQKPANP-------------WEFYIGT 115
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDV-SQGRRELDWLARH 456
+ + + + + +LV E G+L + +N + + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA-----------RIADFGLAKA 505
A+ + +E +H + IIH D+KP N +L + + D G +
Sbjct: 176 SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 506 MPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
M + T G+ E + + D + + ++ G
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 34/224 (15%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK 391
+E L L+++G G G V L + G+++A+KK+ + + E D
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRD------ 88
Query: 392 KMRQIRSEINTVGQIRHRNLLPLLA----HMARPDCHLLVYEFMKNGSLQDILNDVSQGR 447
EI + ++H N++ R L+ E++ GSL+D L + +
Sbjct: 89 ----FEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYL---QKHK 139
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
+D + + + G+EYL + IHRDL N+L++++ +I DFGL K +P
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYLG-TKR--YIHRDLATRNILVENENRVKIGDFGLTKVLP 196
Query: 508 DAQTHITTSNVAGT---VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + + + APE KF+ D++SFGV+L
Sbjct: 197 QDKEYYKVK--EPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 69/236 (29%), Positives = 107/236 (45%), Gaps = 31/236 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +GSG CGEV A K +AIK +I K A E + +EI
Sbjct: 16 KTLGSGACGEVKLAFE-RKTCKKVAIK-IISKRKFAIGSAREA-----DPALNVETEIEI 68
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR-RELDWLARHKIAL 460
+ ++ H ++ + D ++ V E M+ G L D + V R +E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLKEAT--CKL-YFY 121
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSN 517
+ ++YLH + IIHRDLKP NVLL ++D +I DFG +K + + T
Sbjct: 122 QMLLAVQYLH-ENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--- 175
Query: 518 VAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570
+ GT Y+APE T + D +S GV+L + + G P F +H ++SL
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSL 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 61/269 (22%), Positives = 111/269 (41%), Gaps = 35/269 (13%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK 391
+E L + ++G G G V L + G ++A+K++ + + + D
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQRD------ 70
Query: 392 KMRQIRSEINTVGQIRHRNLLPLLA--HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE 449
+ EI + + ++ + LV E++ +G L+D L R
Sbjct: 71 ----FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRAR 123
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA 509
LD + + G+EYL S +HRDL N+L++ + +IADFGLAK +P
Sbjct: 124 LDASRLLLYSSQICKGMEYLG-SRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
Query: 510 QTHITTSNVAGT-VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQHTEE 567
+ + + + + APE F+ + D++SFGV+L + E
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS---CSPSAEF 237
Query: 568 MSLVKWMRNVMTSENPTRAIDAKLLENGY 596
+ ++ R+V R + +LLE G
Sbjct: 238 LRMMGCERDVPALS---RLL--ELLEEGQ 261
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 28/235 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIK------------KVIQPPKDAAELTEEDSKLLN 390
++IG G G V A A+K +PP
Sbjct: 19 DEIGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 391 KKMRQIRSEINTVGQIRHRNLLPLLAHMARP-DCHL-LVYEFMKNGSLQDILNDVSQGRR 448
+ Q+ EI + ++ H N++ L+ + P + HL +V+E + G + ++ +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPL 134
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
D AR + G+EYLH IIHRD+KP+N+L+ +D +IADFG++
Sbjct: 135 SED-QAR-FYFQDLIKGIEYLH-YQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFT---DKCDIYSFGVLLAVLVMGRLPSDD 560
+ ++ + GT ++APE + D+++ GV L V G+ P D
Sbjct: 190 SDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 49/223 (21%), Positives = 94/223 (42%), Gaps = 43/223 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+E IGSGG G+V+KA+ +GK IK+V + E+
Sbjct: 16 IELIGSGGFGQVFKAKHR-IDGKTYVIKRV------------------KYNNEKAEREVK 56
Query: 402 TVGQIRHRN---------------LLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQ 445
+ ++ H N L + EF G+L+ +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
+ + ++ + G++Y+H + ++I+RDLKP+N+ L D + +I DFGL +
Sbjct: 117 EKLDKVLAL--ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 506 MPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + + GT+ Y++PE + + + D+Y+ G++L
Sbjct: 172 LKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLIL 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 344 KIGSGGCGEVYKAELPGSNGKM-IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
++G G G V + ++ +AIK + + + E+ + E
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEE----------MMREAQI 63
Query: 403 VGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q+ + ++ L+ A +LV E G L L R E+ ++
Sbjct: 64 MHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQ 118
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
V+ G++YL N +HRDL NVLL + A+I+DFGL+KA+ ++ T +
Sbjct: 119 VSMGMKYLE-EKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAG 173
Query: 522 ---VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + APE KF+ + D++S+GV +
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTM 203
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 37/261 (14%), Positives = 80/261 (30%), Gaps = 45/261 (17%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSK---LLNKKMRQIRSE 399
+G +A + G+ + V + + K L + +R I+++
Sbjct: 79 TVLGQEDPYAYLEATDQET-GESFEVH-VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 136
Query: 400 INTVGQIRHRNLLPLLAHMARPDCH--------------LLVYEFMK--NGSLQDILNDV 443
+R L+ + +Y M+ + ++L
Sbjct: 137 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 196
Query: 444 SQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA 503
S + L AR ++ L V L LH + ++H L+P +++LD + F
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLH-HYG--LVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 504 KAMPDAQTHITTSNVAGTVGYIAPEY-----------HQTLKFTDKCDIYSFGVLLAVLV 552
+ + G+ PE + T D ++ G+++ +
Sbjct: 254 VRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 553 MGRLPSDDFFQHTEEMSLVKW 573
LP + +W
Sbjct: 308 CADLP----ITKDAALGGSEW 324
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 24/233 (10%)
Query: 321 SPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDA 378
S L+ + +D+ + S IG G G VY E I AIK +
Sbjct: 5 SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL----SRI 60
Query: 379 AELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLL-VYEFMKNGSLQ 437
E+ + ++ L E + + H N+L L+ M P+ + +M +G L
Sbjct: 61 TEMQQVEAFL---------REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111
Query: 438 DILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497
+ +R L VA G+EYL +HRDL N +LD+ ++
Sbjct: 112 QFIRS---PQRNPTVKDLISFGLQVARGMEYLA-EQK--FVHRDLAARNCMLDESFTVKV 165
Query: 498 ADFGLAKAMPDAQTHITTSNVAGT--VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
ADFGLA+ + D + + + V + A E QT +FT K D++SFGVLL
Sbjct: 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 67/311 (21%), Positives = 114/311 (36%), Gaps = 67/311 (21%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G G V G+ +A+K+ +L EI
Sbjct: 21 KILGYGSSGTVVFQGS--FQGRPVAVKR-----------------MLIDFCDIALMEIKL 61
Query: 403 VGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL---NDVSQGRRELDWLARHKI 458
+ + H N++ + E N +LQD++ N + + +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLD-------------DDMEARIADFGLAKA 505
+A G+ +LH S IIHRDLKP N+L+ +++ I+DFGL K
Sbjct: 121 LRQIASGVAHLH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 506 MPDAQT--HITTSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLL-AVLVMGR 555
+ Q+ +N +GT G+ APE + T DI+S G + +L G+
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 556 LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYE--EQMLLVLKIACFCTVD 613
P F S + +R + + + D L+ + QM+ D
Sbjct: 238 HP---FGDKYSRESNI--IRGIFSLDEMKCLHDRSLIAEATDLISQMI---------DHD 283
Query: 614 SPRERPNSKDV 624
P +RP + V
Sbjct: 284 -PLKRPTAMKV 293
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 24/231 (10%)
Query: 323 LIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAE 380
L++ + + + E IG G G VY L ++GK I A+K + +
Sbjct: 11 LVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL----NRITD 66
Query: 381 LTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDC-HLLVYEFMKNGSLQDI 439
+ E S+ L +E + H N+L LL R + L+V +MK+G L++
Sbjct: 67 IGEV-SQFL--------TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 117
Query: 440 LNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIAD 499
+ + L VA G++YL S +HRDL N +LD+ ++AD
Sbjct: 118 IRN---ETHNPTVKDLIGFGLQVAKGMKYLA-SKK--FVHRDLAARNCMLDEKFTVKVAD 171
Query: 500 FGLAKAMPDAQTHITTSNVAGT--VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
FGLA+ M D + + + V ++A E QT KFT K D++SFGVLL
Sbjct: 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 68/239 (28%), Positives = 97/239 (40%), Gaps = 31/239 (12%)
Query: 316 GPAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQ 373
G A PL + E L LEK+G G G V + E +GK + A+K ++
Sbjct: 1 GSAGEGPLQSLTCLI----GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVK-CLK 55
Query: 374 PPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMK 432
P + +D E+N + + HRNL+ L + P +V E
Sbjct: 56 PDVLSQPEAMDD----------FIREVNAMHSLDHRNLIRLYGVVLTPPMK--MVTELAP 103
Query: 433 NGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492
GSL D L + + + A+ VA G+ YL S IHRDL N+LL
Sbjct: 104 LGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLE-SKR--FIHRDLAARNLLLATR 157
Query: 493 MEARIADFGLAKAMPDAQTHITTSNVAGT---VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+I DFGL +A+P H + APE +T F+ D + FGV L
Sbjct: 158 DLVKIGDFGLMRALPQNDDHYVMQ--EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 62/241 (25%), Positives = 98/241 (40%), Gaps = 26/241 (10%)
Query: 317 PAIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQP 374
P L K ED+ + L + +G G G V + L +G + A+K +
Sbjct: 16 PRGSEELQNKLEDVVI--DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM--- 70
Query: 375 PKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA-----HMARPDCHLLVYE 429
K E + L SE + H N++ LL +++
Sbjct: 71 -KLDNSSQREIEEFL--------SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 430 FMKNGSLQDIL--NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487
FMK G L L + + G + + K + +A G+EYL + N +HRDL N
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS-NRN--FLHRDLAARNC 178
Query: 488 LLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVL 547
+L DDM +ADFGL+K + + V +IA E +T K D+++FGV
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 548 L 548
+
Sbjct: 239 M 239
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-30
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 33/239 (13%)
Query: 327 AEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKM-IAIK--KVIQPPKDAAELTE 383
+ FL++++ L + ++G G G V + ++ +AIK K D E+
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 384 EDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILND 442
E + Q+ + ++ L+ A +LV E G L L
Sbjct: 386 E---------------AQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFL-- 426
Query: 443 VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502
R E+ ++ V+ G++YL N +HR+L NVLL + A+I+DFGL
Sbjct: 427 -VGKREEIPVSNVAELLHQVSMGMKYLE-EKN--FVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 503 AKAMPDAQTHITTSNVAGT---VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+KA+ ++ T + + + APE KF+ + D++S+GV + L G+ P
Sbjct: 483 SKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 30/298 (10%)
Query: 262 SPHHHKHKKSKGKKAAGWIL-----GFIAGAVAGTISGFVFSVLFKLILAAVRGGGRDSG 316
HHH H + + AAG ++ G +S ++ L
Sbjct: 8 GHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHID 67
Query: 317 PAIFSP-LIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQ 373
+ +P L++ + + + E IG G G VY L ++GK I A+K +
Sbjct: 68 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-- 125
Query: 374 PPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDC-HLLVYEFMK 432
++ E L +E + H N+L LL R + L+V +MK
Sbjct: 126 --NRITDIGEVSQFL---------TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174
Query: 433 NGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492
+G L++ + + L VA G+++L S +HRDL N +LD+
Sbjct: 175 HGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLA-SKK--FVHRDLAARNCMLDEK 228
Query: 493 MEARIADFGLAKAMPDAQTHITTSNVAGT--VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
++ADFGLA+ M D + + V ++A E QT KFT K D++SFGVLL
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 286
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIQPPKDAAELTEEDSKLLNK 391
+ L + +G G G+V +N G+M+A+K L + +
Sbjct: 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA----------LKADAGP---Q 75
Query: 392 KMRQIRSEINTVGQIRHRNLLPLLA--HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE 449
+ EI+ + + H +++ A LV E++ GSL+D L R
Sbjct: 76 HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHS 130
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDA 509
+ A + G+ YLH + + IHRDL NVLLD+D +I DFGLAKA+P+
Sbjct: 131 IGLAQLLLFAQQICEGMAYLH-AQH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187
Query: 510 QTHITTSNVAGTVGYI-----APEYHQTLKFTDKCDIYSFGVLL 548
+ G APE + KF D++SFGV L
Sbjct: 188 HEYYR----VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 57/244 (23%), Positives = 108/244 (44%), Gaps = 29/244 (11%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
K D L + ++G G G V K S G+++A+K++ A + ++ +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPS-GQIMAVKRI------RATVNSQE-------QK 50
Query: 395 QIRSEINTV-GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRREL--D 451
++ +++ + + + R + E M + SL V + + D
Sbjct: 51 RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPED 109
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
L KIA+ + LE+LH + +IHRD+KP+NVL++ + ++ DFG++ + D
Sbjct: 110 ILG--KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165
Query: 512 HITTSNVAGTVGYIAPE----YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
AG Y+APE ++ K DI+S G+ + L + R P D + ++
Sbjct: 166 KDI---DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222
Query: 568 MSLV 571
+ V
Sbjct: 223 LKQV 226
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 69/313 (22%), Positives = 123/313 (39%), Gaps = 46/313 (14%)
Query: 321 SPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAE 380
S +K + + + + L L +IG G G V K S G+++A+K++ +
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPS-GQIMAVKRI------RST 58
Query: 381 LTEEDSKLLNKKMRQIRSEINTV-GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDI 439
+ E++ K Q+ +++ V ++ + R + E M + S
Sbjct: 59 VDEKEQK-------QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKF 110
Query: 440 LNDV---SQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496
V + L KI L L +L + IIHRD+KP+N+LLD +
Sbjct: 111 YKYVYSVLDDVIPEEILG--KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIK 166
Query: 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPE----YHQTLKFTDKCDIYSFGVLLAVLV 552
+ DFG++ + D+ I + AG Y+APE + + D++S G+ L L
Sbjct: 167 LCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 553 MGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLK--IACFC 610
GR P + + S+ + V+ + P L N E + + C
Sbjct: 224 TGRFP------YPKWNSVFDQLTQVVKGDPPQ-------LSNSEEREFSPSFINFVNL-C 269
Query: 611 TVDSPRERPNSKD 623
+RP K+
Sbjct: 270 LTKDESKRPKYKE 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 32/223 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L ++G G GEV+K +G++ A+K+ + P + + + +E+
Sbjct: 62 LSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDR------------ARKLAEVG 108
Query: 402 TVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE---LDWLARHK 457
+ ++ +H + L L E SLQ E +L
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD-- 165
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
L +LH + ++H D+KPAN+ L ++ DFGL + A
Sbjct: 166 ----TLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--- 215
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR-LPSD 559
G Y+APE Q + D++S G+ + + LP
Sbjct: 216 QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 50/220 (22%), Positives = 87/220 (39%), Gaps = 29/220 (13%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAEL--PGSNGKM-IAIK--KVIQPPKDAAELTEEDSKLL 389
KE ++ +GSG G VYK G K+ +AIK + PK E+
Sbjct: 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL------- 65
Query: 390 NKKMRQIRSEINTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRR 448
E + + + ++ LL + L+ + M G L D + + +
Sbjct: 66 --------DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVR---EHKD 112
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
+ + +A G+ YL ++HRDL NVL+ +I DFGLAK +
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLE-DRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ + ++A E +T + D++S+GV +
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 73/225 (32%), Positives = 110/225 (48%), Gaps = 35/225 (15%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
L L+ IG G G+V + G +A+K + K+ A T + L
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCI----KNDA--TAQA--FL------- 234
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+E + + Q+RH NL+ LL + L +V E+M GSL D L S+GR L
Sbjct: 235 -AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCL 291
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
K +L V +EYL +N +HRDL NVL+ +D A+++DFGL K ++
Sbjct: 292 LKFSLDVCEAMEYLE-GNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASS 341
Query: 516 SNVAGT--VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ G V + APE + KF+ K D++SFG+LL + GR+P
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
K+G G GEVY+ + +A+K + K+ E + + L E
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLT-VAVKTL----KEDT--MEVE-EFL--------KEAA 61
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +I+H NL+ LL R ++ EFM G+L D L R+E+ + +A
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQ 119
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
++ +EYL N IHRDL N L+ ++ ++ADFGL++ M T+ +
Sbjct: 120 ISSAMEYLE-KKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFP 175
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + APE KF+ K D+++FGVLL + G P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ L K+G G GEV+ G+ +AIK + T L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLK-------PGTMSPEAFL------- 227
Query: 397 RSEINTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
E + ++RH L+ L A P +V E+M GSL D L + + L
Sbjct: 228 -QEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLK--GETGKYLRLPQL 282
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+A +A G+ Y+ N +HRDL+ AN+L+ +++ ++ADFGLA+ + D +
Sbjct: 283 VDMAAQIASGMAYVE-RMN--YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTAR 338
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + APE +FT K D++SFG+LL + GR+P
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 29/220 (13%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAEL--PGSNGKM-IAIK--KVIQPPKDAAELTEEDSKLL 389
KE L L+ +GSG G V+K G + K+ + IK + + +T
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT------- 63
Query: 390 NKKMRQIRSEINTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRR 448
+ +G + H +++ LL LV +++ GSL D + Q R
Sbjct: 64 --------DHMLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVR---QHRG 110
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
L + +A G+ YL H ++HR+L NVLL + ++ADFG+A +P
Sbjct: 111 ALGPQLLLNWGVQIAKGMYYLE-EHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167
Query: 509 AQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ S + ++A E K+T + D++S+GV +
Sbjct: 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+G G G V +A+L +G + A+K + K + + + L E
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML----KADIIASSDIEEFL--------RE 75
Query: 400 INTVGQIRHRNLLPLLA------HMARPDCHLLVYEFMKNGSLQDIL--NDVSQGRRELD 451
+ + H ++ L+ R +++ FMK+G L L + + + L
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
+ + +ACG+EYL S N IHRDL N +L +DM +ADFGL++ +
Sbjct: 136 LQTLVRFMVDIACGMEYLS-SRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ V ++A E +T D+++FGV +
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 342 LEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+ IGSG GEV L PG +AIK + K + L SE
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL----KAGYTERQRRDFL---------SE 100
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ +GQ H N++ L + R ++V E+M+NGSL L + + +
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGML 157
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
GV G+ YL +HRDL NVL+D ++ +++DFGL++ + D T+
Sbjct: 158 RGVGAGMRYLS-DLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT--- 211
Query: 520 GTVGYI-----APEYHQTLKFTDKCDIYSFGVLL 548
T G I APE F+ D++SFGV++
Sbjct: 212 -TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 59/327 (18%), Positives = 119/327 (36%), Gaps = 81/327 (24%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAE--------------------- 380
++ +G GG G V++A+ + AIK++ P ++ A
Sbjct: 11 IQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 381 --------------------LTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420
L +E + + + + ++ + + +
Sbjct: 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 421 PDCHLLVY---EFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRI 477
+ +Y + + +L+D +N + + I + +A +E+LH + +
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNR-RCSLEDREHGVCLHIFIQIAEAVEFLH---SKGL 185
Query: 478 IHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA----------GTVGYIAP 527
+HRDLKP+N+ D ++ DFGL AM + T GT Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 528 EYHQTLKFTDKCDIYSFGVLLAVLVM-----------------GRLPSDDFFQHTEEMSL 570
E ++ K DI+S G++L L+ + P ++ +E +
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 571 VKWMRNVMTSENPTRAIDAK-LLENGY 596
V+ M S +PT +A ++EN
Sbjct: 306 VQD----MLSPSPTERPEATDIIENAI 328
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ L K+G G GEV+ G+ +AIK + T L
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGT--TRVAIKTLK-------PGTMSPEAFL------- 310
Query: 397 RSEINTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
E + ++RH L+ L A P +V E+M GSL D L + + L
Sbjct: 311 -QEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLK--GETGKYLRLPQL 365
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+A +A G+ Y+ N +HRDL+ AN+L+ +++ ++ADFGLA+ + D +
Sbjct: 366 VDMAAQIASGMAYVE-RMN--YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTAR 421
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + APE +FT K D++SFG+LL + GR+P
Sbjct: 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 73/221 (33%), Positives = 108/221 (48%), Gaps = 31/221 (14%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L L+ IG G G+V + G +A+K + K+ A T + L +
Sbjct: 23 LKLLQTIGKGEFGDVMLGDY---RGNKVAVKCI----KNDA--TAQA--FL--------A 63
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
E + + Q+RH NL+ LL + L +V E+M GSL D L S+GR L K
Sbjct: 64 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLK 121
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+L V +EYL +N +HRDL NVL+ +D A+++DFGL K + T
Sbjct: 122 FSLDVCEAMEYLE-GNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDT 173
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
V + APE + KF+ K D++SFG+LL + GR+P
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 28/220 (12%)
Query: 342 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
+G GG G+VY+AE +++A+K ++ L+ + +++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVR----ERIVALK-LMSE-----TLSSDPVFR-----TRMQR 83
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E T G+++ +++P+ + + L +L QG I
Sbjct: 84 EARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVA--I 139
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-TSN 517
+ L+ +H HRD+KP N+L+ D A + DFG+A A +T N
Sbjct: 140 VRQIGSALDA---AHAAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGN 194
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT+ Y+APE T + DIY+ +L + G P
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 30/242 (12%)
Query: 322 PLIKKAEDLAFLEKE-----DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPK 376
P + + + + L +K+G+G GEV+ A +A+K +
Sbjct: 168 PCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH--TKVAVKTMKPGSM 225
Query: 377 DAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSL 436
E N + ++H L+ L A + + ++ EFM GSL
Sbjct: 226 SVEAFLAE---------------ANVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSL 269
Query: 437 QDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496
D L S + + +A G+ ++ N IHRDL+ AN+L+ + +
Sbjct: 270 LDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIE-QRN--YIHRDLRAANILVSASLVCK 324
Query: 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GR 555
IADFGLA+ + D + + + APE FT K D++SFG+LL +V GR
Sbjct: 325 IADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383
Query: 556 LP 557
+P
Sbjct: 384 IP 385
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 23/220 (10%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+ +G+G GEV L + K I AIK + K + L E
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL----KVGYTEKQRRDFL---------GE 96
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ +GQ H N++ L + + ++V E+M+NGSL L + + + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGML 153
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD-AQTHITTSNV 518
G+A G++YL +HRDL N+L++ ++ +++DFGL + + D + TT
Sbjct: 154 RGIASGMKYLS-DMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
+ + +PE KFT D++S+G++L V+ G P
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKM---IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
+ IG+G GEVYK L S+GK +AIK + K + L
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL----KAGYTEKQRVDFL---------G 95
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E +GQ H N++ L +++ +++ E+M+NG+L L + E L +
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGM 152
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
G+A G++YL + N +HRDL N+L++ ++ +++DFGL++ + D T++
Sbjct: 153 LRGIAAGMKYLA-NMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS- 208
Query: 519 AGT---VGYIAPEYHQTLKFTDKCDIYSFGVLL 548
G + + APE KFT D++SFG+++
Sbjct: 209 -GGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
++G G G+V+ AE + ++A+K + KD +D
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKD--FQ-------- 65
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------NDVSQ 445
E + ++H +++ D ++V+E+MK+G L L Q
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
+ EL IA +A G+ YL S + +HRDL N L+ ++ +I DFG+++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLA-SQH--FVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 506 MPDAQTHITTSNVAGTVGYI-----APEYHQTLKFTDKCDIYSFGVLL 548
+ + G + PE KFT + D++SFGV+L
Sbjct: 183 VYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 46/215 (21%), Positives = 82/215 (38%), Gaps = 35/215 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+G G GEVY+ G+ I A+K K L ++ + SE
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC----KKDCTLDNKEKFM---------SE 63
Query: 400 INTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ + H +++ L+ P ++ E G L L + + L L
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLE---RNKNSLKVLTLVLY 118
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
+L + + YL S N +HRD+ N+L+ ++ DFGL++ + D
Sbjct: 119 SLQICKAMAYLE-SIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIED------EDYY 169
Query: 519 AGTVGYI-----APEYHQTLKFTDKCDIYSFGVLL 548
+V + +PE +FT D++ F V +
Sbjct: 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCM 204
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 35/221 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
I GG G +Y A NG+ + +K + DA +E
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQ------------AMAMAERQ 131
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-----LVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
+ ++ H +++ + + D H +V E++ SL+ + +
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIA- 186
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
L + L YLH S +++ DLKP N++L ++ + ++ D G +
Sbjct: 187 -YLLEILPALSYLH-SIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FG 235
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ GT G+ APE +T T DIY+ G LA L +
Sbjct: 236 YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT 275
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+E +G+G G+VYK G++ AIK + ++T ++ + I+ EIN
Sbjct: 29 VELVGNGTYGQVYKG-RHVKTGQLAAIKVM--------DVTGDEEEE-------IKQEIN 72
Query: 402 TVGQI-RHRNLLP-----LLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ + HRN+ + + D L LV EF GS+ D++ + + +W+A
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
I + GL +LH ++IHRD+K NVLL ++ E ++ DFG++ +
Sbjct: 133 --YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 515 TSNVAGTVGYIAPEYHQTLKFTD-----KCDIYSFGV 546
T GT ++APE + D K D++S G+
Sbjct: 188 T--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+++IGSG G V+ + +AIK + ++ A E+ + E
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKD--KVAIKTI----REGA--MSEEDFI---------EEAE 55
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H L+ L LV EFM++G L D L R + L
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLD 112
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
V G+ YL +IHRDL N L+ ++ +++DFG+ + + D + +++
Sbjct: 113 VCEGMAYLE-EAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFP 168
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
V + +PE +++ K D++SFGVL+ V G++P
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ IG G +V A + G+ +AIK +I + ++L ++++ E+
Sbjct: 20 LKTIGKGNFAKVKLARHILT-GREVAIK-II-----------DKTQLNPTSLQKLFREVR 66
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIAL 460
+ + H N++ L + L+ E+ G + D L V+ GR +E + AR K
Sbjct: 67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKE--ARSKFR- 121
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ ++Y H I+HRDLK N+LLD DM +IADFG + + G
Sbjct: 122 QIVSAVQYCH-QKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF--CG 175
Query: 521 TVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDD 560
Y APE Q K+ + D++S GV+L LV G LP D
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 8e-28
Identities = 57/221 (25%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
L+++GSG G V + G+ +A+K + K+ + ED + E
Sbjct: 13 LKELGSGQFGVVKLGKW---KGQYDVAVKMI----KEGS--MSED-EFF--------QEA 54
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
T+ ++ H L+ ++ +V E++ NG L + L + L+ ++
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLLEMCY 111
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
V G+ +L SH IHRDL N L+D D+ +++DFG+ + + D Q + G
Sbjct: 112 DVCEGMAFLE-SHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----G 164
Query: 521 T---VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
T V + APE K++ K D+++FG+L+ V +G++P
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 50/207 (24%), Positives = 77/207 (37%), Gaps = 31/207 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
++G G GEV++ G A+KKV L + E+
Sbjct: 64 PRVGRGSFGEVHRM-KDKQTGFQCAVKKV--------RLEVFRVE-----------ELVA 103
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ ++PL + + E ++ GSL ++ Q + A +
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRALY-YLGQA 159
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDD-MEARIADFGLAKAMPDAQTHITTSN---V 518
GLEYLH RI+H D+K NVLL D A + DFG A + + +
Sbjct: 160 LEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFG 545
GT ++APE K DI+S
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSC 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 50/225 (22%), Positives = 93/225 (41%), Gaps = 38/225 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
++G G G+V+ AE + ++A+K + K+A+E +D
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL----KEASESARQD--FQ-------- 91
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL-----------NDVSQG 446
E + ++H++++ L+V+E+M++G L L
Sbjct: 92 REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 447 RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM 506
L +A VA G+ YL + +HRDL N L+ + +I DFG+++ +
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLA-GLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDI 208
Query: 507 PDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
+ + ++ PE Y KFT + D++SFGV+L
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVL 250
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/227 (23%), Positives = 97/227 (42%), Gaps = 29/227 (12%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ L +L ++GSG CG+V+K + G +IA+K++ +E+ ++I
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKT-GHVIAVKQM------RRSGNKEE-------NKRI 70
Query: 397 RSEINTV-GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+++ V ++ + E M + + + E L
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE-RILG- 127
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
K+ + + L YL H +IHRD+KP+N+LLD+ + ++ DFG++ + D
Sbjct: 128 -KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAK 181
Query: 516 SNVAGTVGYIAPEYHQTLKFTD-----KCDIYSFGVLLAVLVMGRLP 557
AG Y+APE T + D++S G+ L L G+ P
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 33/226 (14%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
L L+++G+G G V + G+ +AIK + K+ + ED +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKW---RGQYDVAIKMI----KEGS--MSEDEFI------- 67
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
E + + H L+ L + ++ E+M NG L + L + R
Sbjct: 68 --EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQL 122
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
++ V +EYL S +HRDL N L++D +++DFGL++ + D + T+
Sbjct: 123 LEMCKDVCEAMEYLE-SKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TS 177
Query: 516 SNVAGT---VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
S G+ V + PE KF+ K DI++FGVL+ + +G++P
Sbjct: 178 S--VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKM-IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ IG G G+V KA + +M AIK++ K+ A +++D R E+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM----KEYA--SKDD-------HRDFAGELE 77
Query: 402 TVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------NDVSQGRR 448
+ ++ H N++ LL L E+ +G+L D L +
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
L A VA G++YL IHRDL N+L+ ++ A+IADFGL++
Sbjct: 138 TLSSQQLLHFAADVARGMDYLS-QKQ--FIHRDLAARNILVGENYVAKIADFGLSR---G 191
Query: 509 AQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
+ ++ + V ++A E Y +T D++S+GVLL
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVLL 231
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 24/206 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+G G G VY SN IAIK++ E DS+ + + EI
Sbjct: 28 VVLGKGTYGIVYAG-RDLSNQVRIAIKEI----------PERDSR----YSQPLHEEIAL 72
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
++H+N++ L + + E + GSL +L ++ + +
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQI 131
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDM-EARIADFGLAKAMPDAQTHITTSNVAGT 521
GL+YLH + +I+HRD+K NVL++ +I+DFG +K + T GT
Sbjct: 132 LEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
Query: 522 VGYIAPE--YHQTLKFTDKCDIYSFG 545
+ Y+APE + DI+S G
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLG 212
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 74/293 (25%), Positives = 123/293 (41%), Gaps = 39/293 (13%)
Query: 342 LEKIGSGGCGEVYKA-ELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
E IGSG V A P + +AIK++ L + + + ++ EI
Sbjct: 20 QEVIGSGATAVVQAAYCAP--KKEKVAIKRI--------NLEKCQTSM-----DELLKEI 64
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL-NDVSQGRRELDWLARHKIA 459
+ Q H N++ D LV + + GS+ DI+ + V++G + L IA
Sbjct: 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 460 L---GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
V GLEYLH IHRD+K N+LL +D +IADFG++ +
Sbjct: 125 TILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 517 N---VAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572
GT ++APE Q + K DI+SFG+ L G P + M K
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP----YHKYPPM---K 234
Query: 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLK--IACFCTVDSPRERPNSKD 623
+ ++T +N +++ + + ++ + I+ C P +RP + +
Sbjct: 235 VL--MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPTAAE 284
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 34/238 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G GEV A + +A+K ++ D K I+ EI
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVK-IV------------DMKRAVDCPENIKKEICINK 60
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHK----IA 459
+ H N++ H + L E+ G L D + E D A+ +
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPD--AQRFFHQLM- 115
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
G+ YLH I HRD+KP N+LLD+ +I+DFGLA + +
Sbjct: 116 ----AGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 520 GTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
GT+ Y+APE + +F + D++S G++L ++ G LP D +E W
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEK 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 44/215 (20%), Positives = 84/215 (39%), Gaps = 29/215 (13%)
Query: 342 LEKIGSGGC--GEVYKA-ELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L IG G V A P G+ + ++++ + + E ++
Sbjct: 30 LTVIGKGFEDLMTVNLARYKP--TGEYVTVRRI-----NLEACSNEMVTF-------LQG 75
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
E++ H N++P A + +V FM GS +D++ +A I
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YI 133
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT-----HI 513
GV L+Y+H + +HR +K +++L+ D + ++ +M H
Sbjct: 134 LQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 514 TTSNVAGTVGYIAPE-YHQTLK-FTDKCDIYSFGV 546
+ +++PE Q L+ + K DIYS G+
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 35/215 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
IG G G+V++ + AIK K+ + + L E
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC----KNCTSDSVREKFL---------QE 66
Query: 400 INTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
T+ Q H +++ L+ P ++ E G L+ L + LD +
Sbjct: 67 ALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILY 121
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
A ++ L YL S +HRD+ NVL+ + ++ DFGL++ M D+
Sbjct: 122 AYQLSTALAYLE-SKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------Y 172
Query: 519 AGTVGYI-----APEYHQTLKFTDKCDIYSFGVLL 548
+ G + APE +FT D++ FGV +
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 28/233 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E +G G V + K A+K +I D ++ + + E++
Sbjct: 23 EILGRGVSSVVRRCIHK-PTCKEYAVK-II----DVTGGGSFSAEEVQELREATLKEVDI 76
Query: 403 VGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIAL 460
+ ++ H N++ L LV++ MK G L D L + E + R I
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKE--TRK-IMR 131
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ + LH N I+HRDLKP N+LLDDDM ++ DFG + + + V G
Sbjct: 132 ALLEVICALH-KLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCG 185
Query: 521 TVGYIAPE------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
T Y+APE + + D++S GV++ L+ G P F+ +
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWHRKQM 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 70/231 (30%), Positives = 112/231 (48%), Gaps = 25/231 (10%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
K+GSG GEV + + AIK VI+ + +D+K + K +I +EI+
Sbjct: 42 RKLGSGAYGEVLLCKEK-NGHSEKAIK-VIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALG 461
+ + H N++ L LV EF + G L + + +++ + E D A I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECD--AA-NIMKQ 154
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ G+ YLH HN I+HRD+KP N+LL + + +I DFGL+ +
Sbjct: 155 ILSGICYLH-KHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDR 208
Query: 519 AGTVGYIAPEYHQTLK--FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT YIAPE LK + +KCD++S GV++ +L+ G P F ++
Sbjct: 209 LGTAYYIAPE---VLKKKYNEKCDVWSCGVIMYILLCGYPP---FGGQNDQ 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 61/238 (25%), Positives = 96/238 (40%), Gaps = 34/238 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G GEV A + +A+K ++ D K I+ EI
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVK-IV------------DMKRAVDCPENIKKEICINK 60
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHK----IA 459
+ H N++ H + L E+ G L D + E D A+ +
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPD--AQRFFHQLM- 115
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
G+ YLH I HRD+KP N+LLD+ +I+DFGLA + +
Sbjct: 116 ----AGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 520 GTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
GT+ Y+APE + +F + D++S G++L ++ G LP D +E W
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEK 224
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 72/237 (30%), Positives = 107/237 (45%), Gaps = 23/237 (9%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G GG GEV ++ + GKM A KK+ E+ K +E +
Sbjct: 192 LGKGGFGEVCACQVRAT-GKMYACKKL-----------EKKRIKKRKGEAMALNEKQILE 239
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
++ R ++ L D LV M G L+ + + Q A A + C
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAA-EICC 297
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGY 524
GLE LH RI++RDLKP N+LLDD RI+D GLA +P+ Q T GTVGY
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGY 351
Query: 525 IAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
+APE + ++T D ++ G LL ++ G+ P F Q +++ + R V
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP---FQQRKKKIKREEVERLVKEVP 405
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 37/250 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+GSGG G VY S+ +AIK V KD E ++ E+
Sbjct: 48 GPLLGSGGFGSVYSGI-RVSDNLPVAIKHV---EKDRISDWGELPNG-----TRVPMEVV 98
Query: 402 TVGQIRHR--NLLPLLAHMARPDCHLLVYEFMKN-GSLQDILNDVSQGRRELDWLARHKI 458
+ ++ ++ LL RPD +L+ E + L D + +G + + LAR
Sbjct: 99 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEE-LAR-SF 154
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHITTSN 517
V + + H + ++HRD+K N+L+D + E ++ DFG + D T T
Sbjct: 155 FWQVLEAVRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDF- 208
Query: 518 VAGTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDD------------FFQH 564
GT Y PE+ + ++ ++S G+LL +V G +P +
Sbjct: 209 -DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 267
Query: 565 TEEMSLVKWM 574
+E L++W
Sbjct: 268 SECQHLIRWC 277
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-27
Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 37/228 (16%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ L +E++G+G GEV+ G +A+K + K + + L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT--KVAVKSL----KQGSMSPDA---FL------- 56
Query: 397 RSEINTVGQIRHRNLLPLLAH-MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+E N + Q++H+ L+ L A P ++ E+M+NGSL D L + +L
Sbjct: 57 -AEANLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLK--TPSGIKLTINKL 111
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+A +A G+ ++ N IHRDL+ AN+L+ D + +IADFGLA+ + D
Sbjct: 112 LDMAAQIAEGMAFIE-ERN--YIHRDLRAANILVSDTLSCKIADFGLARLIED------N 162
Query: 516 SNVAGTVGYI-----APEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
A APE FT K D++SFG+LL ++ GR+P
Sbjct: 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 45/232 (19%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKM--RQIRSEINT 402
+G G G+V + A+K + + KL ++ EI
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVKIL------------KKKKLRRIPNGEANVKKEIQL 59
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDI---LNDVSQGRREL-DWLARHKI 458
+ ++RH+N++ L + + N Q + + G +E+ D + +
Sbjct: 60 LRRLRHKNVIQL-------------VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF 106
Query: 459 ALGVAC--------GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ 510
+ A GLEYLH S I+H+D+KP N+LL +I+ G+A+A+
Sbjct: 107 PVCQAHGYFCQLIDGLEYLH-SQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 511 THITTSNVAGTVGYIAPEYHQTLKFTD--KCDIYSFGVLLAVLVMGRLPSDD 560
T G+ + PE L K DI+S GV L + G P +
Sbjct: 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 37/211 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
EKIG G G VY A + + G+ +AI+++ L ++ K L I +EI
Sbjct: 25 FEKIGQGASGTVYTA-MDVATGQEVAIRQM--------NLQQQPKKEL------IINEIL 69
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL------LVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ + ++ N++ L D +L +V E++ GSL D+ V++ + +A
Sbjct: 70 VMRENKNPNIVNYL------DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAA 120
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+ LE+LH + ++IHRD+K N+LL D ++ DFG + Q+ +T
Sbjct: 121 --VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGV 546
+ GT ++APE + K DI+S G+
Sbjct: 176 --MVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEK+G G G VYKA G+++AIK+V + + +++ EI+
Sbjct: 34 LEKLGEGSYGSVYKAI-HKETGQIVAIKQV--------PVESDLQEIIK--------EIS 76
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q +++ + +V E+ GS+ DI+ ++ E D +A I
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-DEIAT--ILQS 133
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
GLEYLH R IHRD+K N+LL+ + A++ADFG+A + D T V GT
Sbjct: 134 TLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGT 188
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGV 546
++APE Q + + DI+S G+
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGI 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEKIG G GEV+K + K++AIK + +L E + ++ I+ EI
Sbjct: 27 LEKIGKGSFGEVFKG-IDNRTQKVVAIKII--------DLEEAEDEI-----EDIQQEIT 72
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q + + ++ E++ GS D+L G + +A I
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIA--TILRE 127
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ GL+YLH + + IHRD+K ANVLL + E ++ADFG+A + D Q T GT
Sbjct: 128 ILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGV 546
++APE + + K DI+S G+
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGI 207
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
++G G G VY+ G +AIK V +AA + E + L
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV----NEAASMRER-IEFL-------- 76
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------NDVSQGRRELD 451
+E + + + +++ LL +++ L++ E M G L+ L +
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
++A +A G+ YL+ ++ +HRDL N ++ +D +I DFG+ + + +
Sbjct: 137 LSKMIQMAGEIADGMAYLN-ANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ V +++PE + FT D++SFGV+L
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR-QIRSEINTV 403
+G G G+V E + G +A+K ++ K+ + + +I+ EI +
Sbjct: 19 LGVGTFGKVKIGEHQLT-GHKVAVK-IL-----------NRQKIRSLDVVGKIKREIQNL 65
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALGV 462
RH +++ L ++ P +V E++ G L D + GR E++ AR +
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEME--ARRLFQ-QI 120
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
++Y H H ++HRDLKP NVLLD M A+IADFGL+ M D + T+ G+
Sbjct: 121 LSAVDYCH-RHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSP 174
Query: 523 GYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDD 560
Y APE + + DI+S GV+L L+ G LP DD
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/230 (29%), Positives = 101/230 (43%), Gaps = 34/230 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+G G GEV K + + A+K + K + NK I E+
Sbjct: 28 CMLGKGSFGEVLKCK-DRITQQEYAVKVI---NK---------ASAKNKDTSTILREVEL 74
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR-RELDWLARHKIAL 460
+ ++ H N++ L + +V E G L D I + + R E D A I
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHD--AAR-IIK 128
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSN 517
V G+ Y+H HN I+HRDLKP N+LL + D + +I DFGL+
Sbjct: 129 QVFSGITYMH-KHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--- 182
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT YIAPE + + +KCD++S GV+L +L+ G P F+ E
Sbjct: 183 RIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP---FYGKNEY 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 33/231 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
K+GSG G+V+ E S G IK + KD +++ E I +EI
Sbjct: 28 RKLGSGAFGDVHLVEERSS-GLERVIKTI---NKDRSQVPMEQ----------IEAEIEV 73
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRR--ELDWLARHKIA 459
+ + H N++ + +V E + G L + I++ ++G+ E +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY--VAE-LM 130
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTS 516
+ L Y H S + ++H+DLKP N+L +I DFGLA+ + +
Sbjct: 131 KQMMNALAYFH-SQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---T 184
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
N AGT Y+APE + T KCDI+S GV++ L+ G LP F + E
Sbjct: 185 NAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLP---FTGTSLE 231
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ ++G G G+VYKA G + A K + E E+ ++ EI
Sbjct: 24 VGELGDGAFGKVYKA-KNKETGALAAAKVI--------ETKSEE------ELEDYIVEIE 68
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ H ++ LL ++ EF G++ I+ ++ +G E + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQV--VCRQ 125
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ L +LH + RIIHRDLK NVL+ + + R+ADFG++ + GT
Sbjct: 126 MLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
Query: 522 VGYIAPE-----YHQTLKFTDKCDIYSFGV 546
++APE + + K DI+S G+
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGI 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 34/244 (13%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKK-----VIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+G GG GEV+ ++ + GK+ A KK + + + + E
Sbjct: 193 LGRGGFGEVFACQMKAT-GKLYACKKLNKKRLKK--RKGYQGA--------------MVE 235
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELD-WLARHK 457
+ ++ R ++ L L LV M G ++ + +V + A
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
A + GLE+LH N II+RDLKP NVLLDDD RI+D GLA + QT T
Sbjct: 295 TA-QIVSGLEHLH-QRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKG 348
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577
AGT G++APE ++ D ++ GV L ++ R P F E++ + + V
Sbjct: 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP---FRARGEKVENKELKQRV 405
Query: 578 MTSE 581
+
Sbjct: 406 LEQA 409
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 63/258 (24%), Positives = 102/258 (39%), Gaps = 35/258 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ +GSG G V+ A K + +K I+ K + ED KL ++ EI
Sbjct: 29 MSPLGSGAFGFVWTAVDK-EKNKEVVVK-FIKKEKVLEDCWIEDPKL-----GKVTLEIA 81
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGS-LQDILNDVSQGRRELDWLARHKIAL 460
+ ++ H N++ +L LV E +G L + R + LA +
Sbjct: 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDEP-LASYIFR- 137
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ + YL + IIHRD+K N+++ +D ++ DFG A A + T G
Sbjct: 138 QLVSAVGYLR-LKD--IIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTF--CG 191
Query: 521 TVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDDFFQ------------HTEE 567
T+ Y APE + + +++S GV L LV P + + E
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKEL 251
Query: 568 MSLVKWMRNVMTSENPTR 585
MSLV + P R
Sbjct: 252 MSLVSGLLQP----VPER 265
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
KIG G G V A +G+ +A+K + +L ++ + L + +E+
Sbjct: 50 YVKIGEGSTGIVCLA-REKHSGRQVAVKMM--------DLRKQQRREL------LFNEVV 94
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +H N++ + + ++ EF++ G+L DI VSQ R + +A +
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQVRLNEEQIAT--VCEA 149
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
V L YLH +IHRD+K ++LL D +++DFG + + + GT
Sbjct: 150 VLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGV 546
++APE + + DI+S G+
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGI 229
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 36/230 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E +GSG EV+ + GK+ A+K + K + + +EI
Sbjct: 15 EVLGSGAFSEVFLVK-QRLTGKLFALKCI--------------KKSPAFRDSSLENEIAV 59
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR-RELDWLARHKIAL 460
+ +I+H N++ L + LV + + G L D I + +G E D A +
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKD--ASL-VIQ 113
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSN 517
V ++YLH + I+HRDLKP N+L +++ + I DFGL+K + S
Sbjct: 114 QVLSAVKYLH-ENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MST 166
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT GY+APE ++ D +S GV+ +L+ G P F++ TE
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP---FYEETES 213
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+E++G G+VYK L G +AIK + A E+
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREE--FR-------- 60
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------NDVSQ 445
E +++H N++ LL + + +++ + +G L + L +D
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
+ L+ + +A G+EYL SH+ ++H+DL NVL+ D + +I+D GL +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLS-SHH--VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 506 MPDAQTHITTSNVAGTVGYI-----APEYHQTLKFTDKCDIYSFGVLL 548
+ A + N + APE KF+ DI+S+GV+L
Sbjct: 178 VYAADYYKLLGN-----SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-26
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 32/229 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+K+GSG GEV AIK + K + + ++ E+
Sbjct: 43 KKLGSGAYGEVLLCRDK-VTHVERAIKII---RK---------TSVSTSSNSKLLEEVAV 89
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALG 461
+ + H N++ L + LV E K G L D + + + + E+D A I
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVD--AAV-IIKQ 144
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSNV 518
V G+ YLH HN I+HRDLKP N+LL + D +I DFGL+ + +
Sbjct: 145 VLSGVTYLH-KHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---R 198
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT YIAPE + K+ +KCD++S GV+L +L+ G P F T++
Sbjct: 199 LGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPP---FGGQTDQ 243
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 29/233 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ IG G V + + G A+K ++ A L+ E + + R E +
Sbjct: 100 DVIGRGVSSVVRRCVHR-ATGHEFAVK-IM--EVTAERLSPEQLE---EVREATRRETHI 152
Query: 403 VGQIR-HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIAL 460
+ Q+ H +++ L+ LV++ M+ G L D L + E + R I
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKE--TRS-IMR 207
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ + +LH ++N I+HRDLKP N+LLDD+M+ R++DFG + + + + G
Sbjct: 208 SLLEAVSFLH-ANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCG 261
Query: 521 TVGYIAPE------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
T GY+APE + + D+++ GV+L L+ G P F+ +
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP---FWHRRQI 311
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++G G V + + G A K +I KL + +++ E
Sbjct: 12 EELGKGAFSVVRRCVHK-TTGLEFAAK-II--NT---------KKLSARDFQKLEREARI 58
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALG 461
+++H N++ L + H LV++ + G L + + V++ E D A H
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--ASH-CIQQ 113
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ + Y H S+ I+HR+LKP N+LL ++ADFGLA + D++
Sbjct: 114 ILESIAYCH-SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGF 167
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
AGT GY++PE + ++ DI++ GV+L +L++G P F+ +
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP---FWDEDQH 213
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 28/232 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E IG G V + G+ A+K V D A+ T ++ E +
Sbjct: 30 EVIGKGPFSVVRRCINR-ETGQQFAVKIV-----DVAKFTSSPGLSTED----LKREASI 79
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRR--ELDWLARHKIA 459
++H +++ LL + +V+EFM L I+ G E A H
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--ASH-YM 136
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTS 516
+ L Y H +N IIHRD+KP VLL ++ ++ FG+A + ++
Sbjct: 137 RQILEALRYCH-DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG- 192
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
GT ++APE + + D++ GV+L +L+ G LP F T+E
Sbjct: 193 -RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP----FYGTKER 239
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 53/304 (17%), Positives = 103/304 (33%), Gaps = 63/304 (20%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEKIGSG G V+K + +G + AIK+ +P + + + E+
Sbjct: 16 LEKIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGSVDE------------QNALREVY 62
Query: 402 TVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ +H +++ + A D L+ E+ GSL D +++ + + L
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDD-------------------MEARIADFG 501
V GL Y+H + ++H D+KP+N+ + + +I D G
Sbjct: 123 QVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
+ Q G ++A E + K DI++ + +
Sbjct: 180 HVTRISSPQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--- 230
Query: 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620
+ + P + ++ +LK D P RP+
Sbjct: 231 PRNGDQ-------WHEIRQGRLPR-------IPQVLSQEFTELLK-VMI-HPD-PERRPS 273
Query: 621 SKDV 624
+ +
Sbjct: 274 AMAL 277
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 60/267 (22%), Positives = 90/267 (33%), Gaps = 58/267 (21%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
IG G G V A + AIK + ++ +D + +I++E+
Sbjct: 32 GAIGQGSYGVVRVAIEN-QTRAIRAIKIM--NKNKIRQINPKD-------VERIKTEVRL 81
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ ++ H N+ L LV E G L D LN + K +
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 463 AC------------------------------------GLEYLHISHNPRIIHRDLKPAN 486
L YLH + I HRD+KP N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-NQG--ICHRDIKPEN 198
Query: 487 VLLDDDMEAR--IADFGLAKAMPDAQTH--ITTSNVAGTVGYIAPE--YHQTLKFTDKCD 540
L + + DFGL+K + AGT ++APE + KCD
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 541 IYSFGVLLAVLVMGRLPSDDFFQHTEE 567
+S GVLL +L+MG +P F +
Sbjct: 259 AWSAGVLLHLLLMGAVP---FPGVNDA 282
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 35/215 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
IG G G+V++ + AIK K+ + + L E
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC----KNCTSDSVREKFL---------QE 441
Query: 400 INTVGQIRHRNLLPLLA-HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
T+ Q H +++ L+ P ++ E G L+ L + LD +
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQ---VRKFSLDLASLILY 496
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
A ++ L YL S +HRD+ NVL+ + ++ DFGL++ M D ++
Sbjct: 497 AYQLSTALAYLE-SKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYY 547
Query: 519 AGTVGYI-----APEYHQTLKFTDKCDIYSFGVLL 548
+ G + APE +FT D++ FGV +
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 582
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +G G GEVY+ ++ G +A+K + P+ +E E D L
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD--FL-------- 81
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH- 456
E + + H+N++ + + ++ E M G L+ L + + LA
Sbjct: 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 457 --KIALGVACGLEYLHISHNPRIIHRDLKPANVLLD---DDMEARIADFGLAKAMPDAQT 511
+A +ACG +YL ++ IHRD+ N LL A+I DFG+A+ + A
Sbjct: 142 LLHVARDIACGCQYLE-ENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
+ V ++ PE FT K D +SFGVLL
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 68/231 (29%), Positives = 103/231 (44%), Gaps = 36/231 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+G G GEV K + + A+K + K + NK I E+
Sbjct: 28 CMLGKGSFGEVLKCKDR-ITQQEYAVKVI---NK---------ASAKNKDTSTILREVEL 74
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALG 461
+ ++ H N++ L + +V E G L D + + + R E D A I
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHD--AAR-IIKQ 129
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSNV 518
V G+ Y+H HN I+HRDLKP N+LL + D + +I DFGL+ +
Sbjct: 130 VFSGITYMH-KHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDR 183
Query: 519 AGTVGYIAPEYHQTLK--FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT YIAPE L+ + +KCD++S GV+L +L+ G P F+ E
Sbjct: 184 IGTAYYIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPP---FYGKNEY 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 63/230 (27%), Positives = 91/230 (39%), Gaps = 36/230 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
IG G GEV A G+ A KK+ PK + + + EI
Sbjct: 15 NTIGRGSWGEVKIAVQKGT-RIRRAAKKI---PK---------YFVEDVDR--FKQEIEI 59
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR-RELDWLARHKIAL 460
+ + H N++ L LV E G L + + V + RE D A I
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV---VHKRVFRESD--AAR-IMK 113
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSN 517
V + Y H N + HRDLKP N L D ++ DFGLA + T
Sbjct: 114 DVLSAVAYCH-KLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--- 167
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT Y++P+ + + +CD +S GV++ VL+ G P F T+
Sbjct: 168 KVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPP---FSAPTDS 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 41/229 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK------MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
+ +G G G+V AE G + +A+K + KD A + S L+
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML----KDDATEKDL-SDLV------ 88
Query: 396 IRSEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------ND 442
SE+ + I +H+N++ LL + ++ E+ G+L++ L +
Sbjct: 89 --SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 443 VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502
++ + +A G+EYL S IHRDL NVL+ ++ +IADFGL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLA-SQK--CIHRDLAARNVLVTENNVMKIADFGL 203
Query: 503 AKAMPDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
A+ + + + T+N V ++APE +T + D++SFGVL+
Sbjct: 204 ARDINNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLM 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 337 DGLASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKK 392
+ + +G G GEVY+ ++ G +A+K + P+ +E E D L
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELD--FL--- 122
Query: 393 MRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDW 452
E + + H+N++ + + ++ E M G L+ L + +
Sbjct: 123 -----MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 453 LARH---KIALGVACGLEYLHISHNPRIIHRDLKPANVLLD---DDMEARIADFGLAKAM 506
LA +A +ACG +YL +H IHRD+ N LL A+I DFG+A+ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 507 PDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548
A + V ++ PE FT K D +SFGVLL
Sbjct: 235 YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 41/229 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +G+G G+V +A G +A+K + K +A LTE + L+
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML----KPSAHLTERE-ALM-------- 74
Query: 398 SEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL--------------ND 442
SE+ + + H N++ LL L++ E+ G L + L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 443 VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502
+ LD + VA G+ +L S N IHRDL N+LL +I DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLA-SKN--CIHRDLAARNILLTHGRITKICDFGL 191
Query: 503 AKAMPDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
A+ + + ++ N V ++APE +T + D++S+G+ L
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFL 237
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +IG G G VY A N +++AIKK+ + + S +K + I E+
Sbjct: 59 LREIGHGSFGAVYFA-RDVRNSEVVAIKKM--------SYSGKQSN---EKWQDIIKEVR 106
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++RH N + R LV E+ GS D+L + +E +A + G
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE-VEIAA--VTHG 162
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
GL YLH + +IHRD+K N+LL + ++ DFG A M A + + GT
Sbjct: 163 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GT 213
Query: 522 VGYIAPE---YHQTLKFTDKCDIYSFGV 546
++APE ++ K D++S G+
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGI 241
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR-QIRSEINTV 403
+G G G+V + G +A+K ++ K+ + + +IR EI +
Sbjct: 24 LGVGTFGKVKVGK-HELTGHKVAVK-IL-----------NRQKIRSLDVVGKIRREIQNL 70
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALGV 462
RH +++ L ++ P +V E++ G L D + GR E + +R +
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKE--SRRLFQ-QI 125
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
G++Y H H ++HRDLKP NVLLD M A+IADFGL+ M D + T+ G+
Sbjct: 126 LSGVDYCH-RHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSP 179
Query: 523 GYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDD 560
Y APE + + DI+S GV+L L+ G LP DD
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 40/228 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +G G G+V +A+ G + +A+K + K+ A +E L+
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML----KEGATHSEH-RALM-------- 78
Query: 398 SEINTVGQI-RHRNLLPLLAHMARPDCHLLV-YEFMKNGSLQDIL------------NDV 443
SE+ + I H N++ LL +P L+V EF K G+L L
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 444 SQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA 503
+ L + VA G+E+L S IHRDL N+LL + +I DFGLA
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLA-SRK--CIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 504 KAMPDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
+ + ++ + + ++APE +T + D++SFGVLL
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLL 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 37/225 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +G+G G+V +A G + +A+K + K A E+ L+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----KSTAHADEK-EALM-------- 97
Query: 398 SEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL----------NDVSQG 446
SE+ + + +H N++ LL L++ E+ G L + L +
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 447 RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM 506
+ VA G+ +L S N IHRD+ NVLL + A+I DFGLA+ +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLA-SKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 507 PDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
+ +I N V ++APE +T + D++S+G+LL
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILL 256
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 50/252 (19%), Positives = 93/252 (36%), Gaps = 39/252 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+G GG G V+ ++ +AIK + P++ S E+
Sbjct: 36 GPLLGKGGFGTVFAGHRL-TDRLQVAIKVI---PRNRVLGWSPLSDS-----VTCPLEVA 86
Query: 402 TVGQIR----HRNLLPLLAHMARPDCHLLVYEFMKNGS-LQDILNDVSQGRRELDWLARH 456
+ ++ H ++ LL + +LV E L D + +G +R
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEG-PSR- 142
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-EARIADFGLAKAMPDAQTHITT 515
V +++ H S ++HRD+K N+L+D A++ DFG + D T
Sbjct: 143 CFFGQVVAAIQHCH-SRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTD 197
Query: 516 SNVAGTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDD------------FF 562
GT Y PE+ ++ ++S G+LL +V G +P +
Sbjct: 198 F--DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAH 255
Query: 563 QHTEEMSLVKWM 574
+ +L++
Sbjct: 256 VSPDCCALIRRC 267
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 67/243 (27%), Positives = 100/243 (41%), Gaps = 35/243 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKK-----VIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
IG GG GEVY GKM A+K + + L E R + S
Sbjct: 197 IGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNE----------RIMLSL 245
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
++T ++ + PD + + M G L L SQ + R A
Sbjct: 246 VSTG---DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAA 299
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ GLE++H N +++RDLKPAN+LLD+ RI+D GLA + H
Sbjct: 300 -EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASV 351
Query: 520 GTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578
GT GY+APE + + + D +S G +L L+ G P F+ + + R +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTL 407
Query: 579 TSE 581
T
Sbjct: 408 TMA 410
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 41/229 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK------MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
+ +G G G+V AE G + +A+K + DA E D L+
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSD--LV------ 134
Query: 396 IRSEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------ND 442
SE+ + I +H+N++ LL + ++ E+ G+L++ L +
Sbjct: 135 --SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 443 VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502
++ + +A G+EYL S IHRDL NVL+ ++ +IADFGL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLA-SQK--CIHRDLAARNVLVTENNVMKIADFGL 249
Query: 503 AKAMPDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
A+ + + + T+N V ++APE +T + D++SFGVL+
Sbjct: 250 ARDINNIDYYKKTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLM 295
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 31/229 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++G G V + + G A K + KL + +++ E
Sbjct: 35 EELGKGAFSVVRRCVHK-TTGLEFAAKII---NT---------KKLSARDFQKLEREARI 81
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALG 461
+++H N++ L + H LV++ + G L + + V++ E D A H
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--ASH-CIQQ 136
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ + Y H S+ I+HR+LKP N+LL ++ADFGLA + D++
Sbjct: 137 ILESIAYCH-SNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGF 190
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
AGT GY++PE + ++ DI++ GV+L +L++G P F+ +
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP---FWDEDQH 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-25
Identities = 67/230 (29%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ-IRSEIN 401
+G G GEV + G+ A+K + K ++ K ++ + E+
Sbjct: 32 RVLGKGSFGEVILCKDK-ITGQECAVKVI---SK---------RQVKQKTDKESLLREVQ 78
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIAL 460
+ Q+ H N++ L LV E G L D + +S+ R E+D A I
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVD--AAR-IIR 133
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSN 517
V G+ Y+H + I+HRDLKP N+LL D RI DFGL+ ++
Sbjct: 134 QVLSGITYMH-KNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--- 187
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT YIAPE + +KCD++S GV+L +L+ G P F E
Sbjct: 188 KIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP---FNGANEY 233
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 41/229 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK------MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
+ +G G G+V AE G + +A+K + K A + S L+
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML----KSDATEKDL-SDLI------ 122
Query: 396 IRSEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------ND 442
SE+ + I +H+N++ LL + ++ E+ G+L++ L N
Sbjct: 123 --SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 443 VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502
+L A VA G+EYL S IHRDL NVL+ +D +IADFGL
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLA-SKK--CIHRDLAARNVLVTEDNVMKIADFGL 237
Query: 503 AKAMPDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
A+ + + T+N V ++APE +T + D++SFGVLL
Sbjct: 238 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLL 283
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 46/234 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +G G G+V KA G+ +A+K + K+ A +E LL
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSEL-RDLL-------- 74
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL----------------- 440
SE N + Q+ H +++ L ++ LL+ E+ K GSL+ L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 441 ---NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497
+ R L A ++ G++YL ++HRDL N+L+ + + +I
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA-EMK--LVHRDLAARNILVAEGRKMKI 191
Query: 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
+DFGL++ + + +++ S V ++A E H +T + D++SFGVLL
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH---IYTTQSDVWSFGVLL 242
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 54/230 (23%), Positives = 99/230 (43%), Gaps = 32/230 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++G G V + G+ A +I KL + +++ E
Sbjct: 17 EELGKGAFSVVRRCV-KVLAGQEYAAM-II--NT---------KKLSARDHQKLEREARI 63
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR-RELDWLARHKIAL 460
++H N++ L ++ H L+++ + G L + I V++ E D A H
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEAD--ASH-CIQ 117
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSN 517
+ + + H ++HR+LKP N+LL ++ADFGLA + Q
Sbjct: 118 QILEAVLHCH-QMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-- 172
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
AGT GY++PE + + D+++ GV+L +L++G P F+ +
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP---FWDEDQH 219
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 29/218 (13%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIK-----KVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+G G V A + + AIK +I+ K+ + E
Sbjct: 38 LGEGSFSTVVLAREL-ATSREYAIKILEKRHIIK----------------ENKVPYVTRE 80
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ + ++ H + L + + KNG L + + + R A
Sbjct: 81 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA 137
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ LEYLH IIHRDLKP N+LL++DM +I DFG AK + ++
Sbjct: 138 -EIVSALEYLH-GKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 193
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT Y++PE D+++ G ++ LV G P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 28/219 (12%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR-QIRSEINTV 403
+G G G+V A + +A+K I L M ++ EI+ +
Sbjct: 17 LGEGSFGKVKLAT-HYKTQQKVALK-FI-----------SRQLLKKSDMHMRVEREISYL 63
Query: 404 GQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGR-RELDWLARHKIALGV 462
+RH +++ L + P ++V E+ G L D + V + R E + R +
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI--VEKKRMTEDE--GRRFFQ-QI 117
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTV 522
C +EY H H I+HRDLKP N+LLDD++ +IADFGL+ M D + TS G+
Sbjct: 118 ICAIEYCH-RHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS--CGSP 171
Query: 523 GYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDD 560
Y APE + + D++S G++L V+++GRLP DD
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 46/234 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +GSG G+V A G + +A+K + K+ A+ +E L+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML----KEKADSSER-EALM-------- 96
Query: 398 SEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL---------------- 440
SE+ + Q+ H N++ LL L++E+ G L + L
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 441 ---NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497
+ + L + A VA G+E+L +HRDL NVL+ +I
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKI 213
Query: 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
DFGLA+ + ++ N V ++APE +T K D++S+G+LL
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG---IYTIKSDVWSYGILL 264
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 46/234 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ IG G G V++A PG M+A+K + ++A+ + D
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQAD--FQ-------- 98
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL----------------- 440
E + + + N++ LL A L++E+M G L + L
Sbjct: 99 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 441 ---NDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497
S G L + IA VA G+ YL +HRDL N L+ ++M +I
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERK--FVHRDLATRNCLVGENMVVKI 215
Query: 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPE---YHQTLKFTDKCDIYSFGVLL 548
ADFGL++ + A + N A + ++ PE Y+ ++T + D++++GV+L
Sbjct: 216 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVL 266
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 38/242 (15%)
Query: 331 AFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLN 390
F + D + +G G K S + A+K +I SK
Sbjct: 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKS-NQAFAVK-II-------------SK--- 46
Query: 391 KKMRQIRSEINTVGQIR-HRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR- 447
+ + EI + H N++ L LV E + G L + I +
Sbjct: 47 RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI---KKKKHF 103
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAK 504
E + A + I + + ++H ++HRDLKP N+L +D++E +I DFG A+
Sbjct: 104 SETE--ASY-IMRKLVSAVSHMH-DVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
Query: 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564
P + T T+ Y APE + + CD++S GV+L ++ G++P F H
Sbjct: 158 LKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP---FQSH 212
Query: 565 TE 566
Sbjct: 213 DR 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 61/234 (26%), Positives = 94/234 (40%), Gaps = 44/234 (18%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E IG G + + A+K +++K R EI
Sbjct: 28 EDIGVGSYSVCKRCIHK-ATNMEFAVK------------------IIDKSKRDPTEEIEI 68
Query: 403 VGQ-IRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR---RELDWLARHK 457
+ + +H N++ L +V E MK G L D I + Q RE A
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFSERE----ASA- 120
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA----RIADFGLAKAMPDAQTHI 513
+ + +EYLH + ++HRDLKP+N+L D+ RI DFG AK + +
Sbjct: 121 VLFTITKTVEYLH-AQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
T T ++APE + + CDI+S GVLL ++ G P F ++
Sbjct: 178 MT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP---FANGPDD 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 38/222 (17%), Positives = 79/222 (35%), Gaps = 41/222 (18%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKM------IAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
E +G G +++K + +K + A E
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL----DKAHRNYSES---------- 58
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ + ++ H++L+ D ++LV EF+K GSL L + ++ L +
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWK 115
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR--------IADFGLAKAMP 507
++A +A + +L + +IH ++ N+LL + + + ++D G++ +
Sbjct: 116 LEVAKQLAAAMHFLE-ENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 508 DAQTHITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLL 548
I + PE D +SFG L
Sbjct: 173 PKD--ILQERIPWV----PPECIENPKNLNLATDKWSFGTTL 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
++G G VY+ + K A+K + K ++KK+ +R+EI
Sbjct: 59 SELGRGATSIVYRCK-QKGTQKPYALKVL--------------KKTVDKKI--VRTEIGV 101
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR-RELDWLARHKIAL 460
+ ++ H N++ L P LV E + G L D I V +G E D A
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI---VEKGYYSERD--AAD-AVK 155
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTSN 517
+ + YLH + I+HRDLKP N+L D +IADFGL+K + T
Sbjct: 156 QILEAVAYLH-ENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--- 209
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570
V GT GY APE + + + D++S G++ +L+ G P F+ + +
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---FYDERGDQFM 259
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++GSG V K GK A K I+ + ++ +I E+N
Sbjct: 11 EELGSGQFAIVRKCR-QKGTGKEYAAK-FIKKRRLSSSRRGVS-------REEIEREVNI 61
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARHKIALG 461
+ +IRH N++ L +L+ E + G L D + S E +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ----- 116
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL----DDDMEARIADFGLAKAMPDAQTHITTSN 517
+ G+ YLH S I H DLKP N++L + ++ DFG+A + N
Sbjct: 117 ILDGVHYLH-SKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KN 170
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMG 554
+ GT ++APE + D++S GV+ +L+ G
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 26/128 (20%), Positives = 44/128 (34%), Gaps = 3/128 (2%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L + S S EL+ L L+ + + L L + N S L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 146 IRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGN 203
L+ L + + + + L+ L++A NL K+P NL+ D S N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 204 SLLEGPIP 211
++
Sbjct: 160 K-IQSIYC 166
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 28/123 (22%), Positives = 49/123 (39%), Gaps = 3/123 (2%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIV-DCKKLEILNVQNNQFSGTIPSDLSS 144
+ LS L L +A NS + P I + + L L++ Q P+ +S
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 145 LIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIR-TFRNLQFFDFSG 202
L L+VL++S N+F K +L+ L + N ++ +L F + +
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
Query: 203 NSL 205
N
Sbjct: 553 NDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 26/119 (21%), Positives = 49/119 (41%), Gaps = 3/119 (2%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGTIPSDLSSLIRL 148
+S + L +L L +++L + + + + L L++ + + L L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 149 RVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
VL ++GNSF N NL L L++ PT+ + +LQ + S N+
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 22/115 (19%), Positives = 40/115 (34%), Gaps = 1/115 (0%)
Query: 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS 157
+ L L+ N L L +L++L++ + SL L L L+GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 158 FSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
LG +L+ L + I + L+ + + N + +P
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 26/129 (20%), Positives = 43/129 (33%), Gaps = 4/129 (3%)
Query: 86 LTGVLSPSI-GRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LS 143
L + S+ L L L +++ LE+L + N F D +
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 144 SLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSG 202
L L LDLS +L+ L+++ N F + +LQ D+S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 203 NSLLEGPIP 211
N +
Sbjct: 528 NH-IMTSKK 535
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 28/128 (21%), Positives = 44/128 (34%), Gaps = 8/128 (6%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
E+ + + LS L L L N + L L+ L + +
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 145 LIRLRVLDLSGNSFSGNLGFLKYF---PNLEHLSLAKNLFTGKVPTSIRTFRNLQFF--- 198
L L+ L+++ N +YF NLEHL L+ N T +R +
Sbjct: 123 LKTLKELNVAHNLIQS-FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 199 -DFSGNSL 205
D S N +
Sbjct: 182 LDLSLNPM 189
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 33/128 (25%), Positives = 54/128 (42%), Gaps = 8/128 (6%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDL-LPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
L + + IG L L+EL++A+N + LP + LE L++ +N+ +DL
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 145 LIRLRV----LDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVP-TSIRTFRNLQFF 198
L ++ + LDLS N + G K L L+L N + V T I+ L+
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230
Query: 199 DFSGNSLL 206
Sbjct: 231 RLVLGEFR 238
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 37/251 (14%), Positives = 66/251 (26%), Gaps = 49/251 (19%)
Query: 7 KLNLSLFALLSL--LFLSHARLNLD--RSDYKALSV--ILRDLGGQQLFIPSDPCSTPGV 60
+ F + L L L + +L+ ++ + L+ + R + G+ +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 61 FCERRLSDNNTYVLKITKLVFVPRELTGVLS------------------PSIGRLSELRE 102
L + ++ L + ++ + + +
Sbjct: 251 L--EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308
Query: 103 LSLANNSLVDL-------------------LPPQIVDCKKLEILNVQNNQ--FSGTIPSD 141
L L N VD LE L++ N F G
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 142 LSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSI-RTFRNLQFFDF 200
L+ LDLS N LEHL + S+ + RNL + D
Sbjct: 369 DFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 201 SGNSLLEGPIP 211
S
Sbjct: 429 SHTH-TRVAFN 438
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 26/101 (25%), Positives = 36/101 (35%), Gaps = 3/101 (2%)
Query: 86 LTGVLSPSI-GRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
P I L L L L+ L L P L++LN+ +N F
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 145 LIRLRVLDLSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTG 183
L L+VLD S N + +L L+L +N F
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 20/135 (14%), Positives = 42/135 (31%), Gaps = 16/135 (11%)
Query: 86 LTGVLSPSIGRLSELR----ELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD 141
+ + + L ++ L L+ N + + P +L L ++NN S +
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLHKLTLRNNFDSLNVMKT 219
Query: 142 -LSSLIRLRVLDLSGNSFSGNLGFLK----YFPNLEHLSLAKN------LFTGKVPTSIR 190
+ L L V L F K L +L++ + + +
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 191 TFRNLQFFDFSGNSL 205
N+ F ++
Sbjct: 280 CLTNVSSFSLVSVTI 294
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 13/79 (16%), Positives = 26/79 (32%), Gaps = 3/79 (3%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSD--L 142
+ + L+ L+ L + N ++ ++ L LN+ N F+ T L
Sbjct: 506 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFL 565
Query: 143 SSLIRLRVLDLSGNSFSGN 161
+ R L +
Sbjct: 566 QWIKDQRQLLVEVERMECA 584
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 41/231 (17%), Positives = 85/231 (36%), Gaps = 41/231 (17%)
Query: 11 SLFALLSLLFLSHARLNLDRSDYKALS-VILRDLGGQQLFIPSDPCSTPGVFCERRLSDN 69
+ A +S R++ ++ DL + I SDP + +
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL--IKDCINSDPQQKS-------IKKS 178
Query: 70 NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL---------------- 113
+ LK T++ + +T +S ++ RL++LR+ + N+ V
Sbjct: 179 SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237
Query: 114 ---LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG---------N 161
+ + K L + V N +P+ L +L +++++++ N
Sbjct: 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 162 LGFLKYFPNLEHLSLAKN-LFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
L ++ + + N L T V TS++ + L + N LEG +P
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ-LEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 27/155 (17%), Positives = 46/155 (29%), Gaps = 22/155 (14%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCK--K 123
L N +T++ P+ + + L + L N L L
Sbjct: 464 LMGNM-----LTEI---PKNSLKDENENFKNTYLLTSIDLRFNKLTKL-SDDFRATTLPY 514
Query: 124 LEILNVQNNQFSGTIPSDLSSLIRLRVL------DLSGNSFSGNL-GFLKYFPNLEHLSL 176
L +++ N FS P+ + L+ D GN + P+L L +
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI 573
Query: 177 AKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
N V I N+ D N + +
Sbjct: 574 GSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 21/134 (15%), Positives = 41/134 (30%), Gaps = 11/134 (8%)
Query: 87 TGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLI 146
T + S+ ++ +L L N L P KL LN+ NQ + +
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGK-LPAFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 147 RLRVLDLSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTG-------KVPTSIRTFRNLQF 197
++ L + N N+ K + + + N + + N+
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 198 FDFSGNSLLEGPIP 211
+ S N +
Sbjct: 438 INLSNNQ-ISKFPK 450
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 32/135 (23%), Positives = 54/135 (40%), Gaps = 14/135 (10%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIV-DCKKLEILNVQNNQFSGTIPS--DL 142
L G L P+ G +L L+LA N + ++ P +++E L+ +N+ IP+ D
Sbjct: 342 LEGKL-PAFGSEIKLASLNLAYNQITEI-PANFCGFTEQVENLSFAHNKLK-YIPNIFDA 398
Query: 143 SSLIRLRVLDLSGNSFSGNLG--------FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN 194
S+ + +D S N G N+ ++L+ N + T
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 195 LQFFDFSGNSLLEGP 209
L + GN L E P
Sbjct: 459 LSSINLMGNMLTEIP 473
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 23/171 (13%), Positives = 44/171 (25%), Gaps = 30/171 (17%)
Query: 55 CSTPGVFCERR-------LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLAN 107
+ PGV L +G + +IG+L+EL L+L +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFG---------------ASGRVPDAIGQLTELEVLALGS 114
Query: 108 NSL----VDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS--SLIRLRVLDLSGNSFSGN 161
+ P I E + T L ++ + +
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
Query: 162 LGFLKY-FPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+ + N T V ++ L+ F + + I
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENIC 224
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-18
Identities = 26/135 (19%), Positives = 41/135 (30%), Gaps = 24/135 (17%)
Query: 91 SPSIGRLSELRELSLANNSLVDL-------LPPQIVDCKKLEILNVQNNQFSGTIPSDLS 143
+S + + + N + + L P + +N+ NNQ S S
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 144 SLIRLRVLDLSGNSFSG-----------NLGFLKYFPNLEHLSLAKNLFTGKVPTSIR-- 190
+ L ++L GN + N L + L N T + R
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY---LLTSIDLRFNKLTK-LSDDFRAT 510
Query: 191 TFRNLQFFDFSGNSL 205
T L D S NS
Sbjct: 511 TLPYLVGIDLSYNSF 525
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-16
Identities = 24/149 (16%), Positives = 45/149 (30%), Gaps = 29/149 (19%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLE 125
L N K+TKL + L L + L+ NS P Q ++ L+
Sbjct: 495 LRFN-----KLTKL---SDDF------RATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLK 539
Query: 126 ILNVQN------NQFSGTIPSDLSSLIRLRVLDLSGNSFSG---NLGFLKYFPNLEHLSL 176
++N N+ P ++ L L + N + PN+ L +
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI-----TPNISVLDI 594
Query: 177 AKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + + + + +
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 25/220 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++GSG V K S G A K I+ + A +I E++
Sbjct: 18 EELGSGQFAIVKKCR-EKSTGLEYAAK-FIKKRQSRASRRGVS-------REEIEREVSI 68
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARHKIALG 461
+ Q+ H N++ L +L+ E + G L D + S E +
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----- 123
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL----DDDMEARIADFGLAKAMPDAQTHITTSN 517
+ G+ YLH + I H DLKP N++L ++ DFGLA + D N
Sbjct: 124 ILDGVNYLH-TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ GT ++APE + D++S GV+ +L+ G P
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 25/220 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++GSG V K S G A K I+ + A + +I E++
Sbjct: 18 EELGSGQFAIVKKCR-EKSTGLEYAAK-FIKKRQSRASRRGVCRE-------EIEREVSI 68
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARHKIALG 461
+ Q+ H N++ L +L+ E + G L D + S E +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ----- 123
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL----DDDMEARIADFGLAKAMPDAQTHITTSN 517
+ G+ YLH + I H DLKP N++L ++ DFGLA + D N
Sbjct: 124 ILDGVNYLH-TKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ GT ++APE + D++S GV+ +L+ G P
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 30/219 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++GSG G V++ + G++ K + L+K +++EI+
Sbjct: 57 EELGSGAFGVVHRCVEK-ATGRVFVAKFI---NT---------PYPLDKYT--VKNEISI 101
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH--KIAL 460
+ Q+ H L+ L +L+ EF+ G L D + E + + + A
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE--VINYMRQAC 159
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR--IADFGLAKAMPDAQTHITTSNV 518
GL+++H H+ I+H D+KP N++ + + I DFGLA + +
Sbjct: 160 E---GLKHMH-EHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---T 210
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
T + APE D+++ GVL VL+ G P
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 26/217 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++G+G G V++ + G A K V E +R EI T
Sbjct: 163 EELGTGAFGVVHRVTERAT-GNNFAAKFV---MTPHESDKET-----------VRKEIQT 207
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ +RH L+ L + +++YEFM G L + + D E + A V
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE--AVE-YMRQV 264
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI--ADFGLAKAMPDAQTHITTSNVAG 520
GL ++H +N +H DLKP N++ + DFGL + Q + G
Sbjct: 265 CKGLCHMH-ENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTG 318
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
T + APE + D++S GVL +L+ G P
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 30/223 (13%)
Query: 339 LASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
++ E +G G G+V+K E + G +A K +I + EE +++
Sbjct: 91 VSKTEILGGGRFGQVHKCEET-ATGLKLAAK-II--KTRGMKDKEE-----------VKN 135
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH-- 456
EI+ + Q+ H NL+ L + +LV E++ G L D + D S ELD
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD--TILFM 193
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI--ADFGLAKAMPDAQTHIT 514
K G+ ++H I+H DLKP N+L + +I DFGLA+ +
Sbjct: 194 KQICE---GIRHMH-QMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT ++APE + D++S GV+ +L+ G P
Sbjct: 248 ---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 60/256 (23%), Positives = 96/256 (37%), Gaps = 43/256 (16%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G V + A+K +I E + + E+
Sbjct: 19 DVLGEGAHARVQTCINL-ITSQEYAVK-II-----------EKQPGHIRSR--VFREVEM 63
Query: 403 VGQIR-HRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGR-RELDWLARHKIA 459
+ Q + HRN+L L+ D LV+E M+ GS+ I + EL+ A +
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELE--ASV-VV 117
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHITTS 516
VA L++LH + I HRDLKP N+L + +I DF L + S
Sbjct: 118 QDVASALDFLH-NKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 517 N-----VAGTVGYIAPE-----YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566
G+ Y+APE + + +CD++S GV+L +L+ G P F
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP---FVGRCG 231
Query: 567 EMSLVKWMRNVMTSEN 582
+N
Sbjct: 232 SDCGWDRGEACPACQN 247
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 63/230 (27%), Positives = 95/230 (41%), Gaps = 51/230 (22%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IGSG G + +++A+K I E +++ ++ EI
Sbjct: 28 IGSGNFGVARLMRDKLT-KELVAVK-YI-----------ERGAAIDEN---VQREIINHR 71
Query: 405 QIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGR-RELDWLARHK----I 458
+RH N++ + P HL ++ E+ G L + + + GR E + AR +
Sbjct: 72 SLRHPNIVRFKEVILTPT-HLAIIMEYASGGELYERI--CNAGRFSEDE--ARFFFQQLL 126
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR--IADFGLAKAMPDAQTHITTS 516
G+ Y H S I HRDLK N LLD R I DFG +K+ +T
Sbjct: 127 -----SGVSYCH-SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 517 NVAGTVGYIAPE------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560
GT YIAPE Y D++S GV L V+++G P +D
Sbjct: 179 ---GTPAYIAPEVLLRQEYDGK-----IADVWSCGVTLYVMLVGAYPFED 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 56/220 (25%), Positives = 88/220 (40%), Gaps = 25/220 (11%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E++GSG V K S G A K I+ + + I E++
Sbjct: 17 EELGSGQFAVVKKCR-EKSTGLQYAAK-FIKKRRTKSSRRGVS-------REDIEREVSI 67
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARHKIALG 461
+ +I+H N++ L +L+ E + G L D + S E +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ----- 122
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL----DDDMEARIADFGLAKAMPDAQTHITTSN 517
+ G+ YLH S I H DLKP N++L +I DFGLA + N
Sbjct: 123 ILNGVYYLH-SLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ GT ++APE + D++S GV+ +L+ G P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 27/157 (17%), Positives = 53/157 (33%), Gaps = 17/157 (10%)
Query: 66 LSDNNTYVLKITKLVFVPRE-------------LTGVLSPSIGRLSELRELSLANNSLVD 112
LS++ T + +T FV ++ + S + L L L L N +
Sbjct: 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419
Query: 113 LLPPQ-IVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG---NLGFLKYF 168
L Q + + + + N++ + + + L+ L L + + +
Sbjct: 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479
Query: 169 PNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
NL L L+ N + L+ D N+L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 29/121 (23%), Positives = 46/121 (38%), Gaps = 1/121 (0%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L + + + R S+L L + N++ L P L++LN+Q+N+ S +
Sbjct: 37 LRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 146 IRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L L L NS NL L L+ N + + NLQ S N
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 205 L 205
+
Sbjct: 157 I 157
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-20
Identities = 28/124 (22%), Positives = 43/124 (34%), Gaps = 5/124 (4%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L+ + + + L EL L +NS+ + V K L L++ +N S T L
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 146 IRLRVLDLSGNSFSG----NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201
L+ L LS N L +L+ L L+ N P L +
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFAN-SSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 202 GNSL 205
L
Sbjct: 204 NVQL 207
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-20
Identities = 33/131 (25%), Positives = 51/131 (38%), Gaps = 11/131 (8%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSL--VDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS 143
+ S + L+ L L +L VD P + L IL++ NN + L
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501
Query: 144 SLIRLRVLDLSGNSFS---------GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN 194
L +L +LDL N+ + G + FLK +L L+L N F +
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
Query: 195 LQFFDFSGNSL 205
L+ D N+L
Sbjct: 562 LKIIDLGLNNL 572
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 30/124 (24%), Positives = 47/124 (37%), Gaps = 3/124 (2%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
++ + +L L+ L+L +N L L C L L++ +N +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 145 LIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN--LQFFDFS 201
L LDLS N S LG NL+ L L+ N + F N L+ + S
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 202 GNSL 205
N +
Sbjct: 180 SNQI 183
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 23/138 (16%), Positives = 47/138 (34%), Gaps = 12/138 (8%)
Query: 86 LTGVLSPSIG--RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS 143
L+ + + + + L L L+ N+L + +LE ++ N L
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293
Query: 144 SLIRLRVLDLSGNSFSGNLGF----------LKYFPNLEHLSLAKNLFTGKVPTSIRTFR 193
L +R L+L + ++ ++ LEHL++ N G
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353
Query: 194 NLQFFDFSGNSLLEGPIP 211
NL++ S + +
Sbjct: 354 NLKYLSLSNSFTSLRTLT 371
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-18
Identities = 31/130 (23%), Positives = 49/130 (37%), Gaps = 10/130 (7%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDL--------LPPQIVDCKKLEILNVQNNQFSGT 137
+ + + L +L L L +N+L L + L ILN+++N F
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 138 IPSDLSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRT-FRNL 195
L L+++DL N+ + +L+ L+L KNL T FRNL
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 196 QFFDFSGNSL 205
D N
Sbjct: 612 TELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-18
Identities = 29/110 (26%), Positives = 40/110 (36%), Gaps = 1/110 (0%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
+ + L+L +N L L +L L+V N S P L L+VL+L N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 157 SFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
S + + NL L L N +NL D S N L
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGL 133
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 8/120 (6%)
Query: 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS---SLIRLR 149
I S L++L L++N + + P +L L + N Q ++ L + +R
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 150 VLDLSGNSFSG----NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L LS + S LK + NL L L+ N S L++F N++
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLK-WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 29/150 (19%), Positives = 52/150 (34%), Gaps = 22/150 (14%)
Query: 65 RLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKL 124
L + + P L L L L+NN++ ++ + +KL
Sbjct: 460 MLRRVA-----LKNVDSSPSPFQP--------LRNLTILDLSNNNIANINDDMLEGLEKL 506
Query: 125 EILNVQNNQFS--------GTIPSDLSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLS 175
EIL++Q+N + G L L L +L+L N F + K L+ +
Sbjct: 507 EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566
Query: 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L N + +L+ + N +
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-16
Identities = 31/140 (22%), Positives = 54/140 (38%), Gaps = 15/140 (10%)
Query: 86 LTGVLSPSIGRLSELRELSLANN---------SLVDLLPPQIVDCKKLEILNVQNNQFSG 136
+ + S S+ L +R L+L + SL + K LE LN+++N G
Sbjct: 284 IQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG 343
Query: 137 TIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPN-----LEHLSLAKNLFTGKVPTSIRT 191
+ + LI L+ L LS + S + F + L L+L KN + +
Sbjct: 344 IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403
Query: 192 FRNLQFFDFSGNSLLEGPIP 211
+L+ D N + +
Sbjct: 404 LGHLEVLDLGLNE-IGQELT 422
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 31/131 (23%), Positives = 51/131 (38%), Gaps = 10/131 (7%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLE 125
L NN + +L G + LS L L+L +N ++ D +L+
Sbjct: 511 LQHNN-----LARLW--KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 126 ILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTG 183
I+++ N + S ++ + L+ L+L N + F F NL L + N F
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
Query: 184 KVPTSIRTFRN 194
SI F N
Sbjct: 624 -TCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 11/63 (17%), Positives = 20/63 (31%), Gaps = 8/63 (12%)
Query: 146 IRLRVLDLSGNSFS---GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSG 202
+ V D S + +L N+ L+L N + + L D
Sbjct: 4 VSHEVADCSHLKLTQVPDDL-----PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 203 NSL 205
N++
Sbjct: 59 NTI 61
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 39/226 (17%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+++G G V + S G+ A K + K + +I EI
Sbjct: 35 KELGRGKFAVVRQCI-SKSTGQEYAAKFL---KK---------RRRGQDCRAEILHEIAV 81
Query: 403 VGQIRHR-NLLPLLAHMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARH---K 457
+ + ++ L +L+ E+ G + L ++++ E D +
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND--VIRLIKQ 139
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHIT 514
I GV YLH +N I+H DLKP N+LL + +I DFG+++ + A
Sbjct: 140 ILEGV----YYLH-QNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---E 189
Query: 515 TSNVAGTVGYIAPEYHQTLKF---TDKCDIYSFGVLLAVLVMGRLP 557
+ GT Y+APE L + T D+++ G++ +L+ P
Sbjct: 190 LREIMGTPEYLAPE---ILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 42/246 (17%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G G+V + G+ A+K + + R E++
Sbjct: 35 QVLGLGVNGKVLECFHR-RTGQKCALKLL-------------------YDSPKARQEVDH 74
Query: 403 VGQI-RHRNLLPLLA----HMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARH 456
Q +++ +L C L++ E M+ G L I Q E + A
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE--AAE 132
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHI 513
I + +++LH SHN I HRD+KP N+L + D ++ DFG AK +
Sbjct: 133 -IMRDIGTAIQFLH-SHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--L 186
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573
T T Y+APE K+ CD++S GV++ +L+ G P F+ +T +
Sbjct: 187 QT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP---FYSNTGQAISPGM 241
Query: 574 MRNVMT 579
R +
Sbjct: 242 KRRIRL 247
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 35/109 (32%), Positives = 50/109 (45%), Gaps = 12/109 (11%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ L+YL + IIHRD+KP N+LLD+ I DF +A +P T +AGT
Sbjct: 124 LVMALDYLQ-NQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGT 177
Query: 522 VGYIAPE--YHQTLKFTDKC-DIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
Y+APE + D +S GV L+ GR P + +
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP---YHIRSST 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 38/223 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ IGSG G V A + +AIKK+ +P ++ + +K R R E+
Sbjct: 30 LKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQN-----QTHAK------RAYR-ELV 76
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ + H+N++ LL ++ P L +V E M + +L ++ + ELD
Sbjct: 77 LMKCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELM-DANLCQVI------QMELD--H 126
Query: 455 RHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
+ + CG+++LH + IIHRDLKP+N+++ D +I DFGLA+ +
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SF 181
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+ T V T Y APE + + + DI+S G ++ ++ G
Sbjct: 182 MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 5e-21
Identities = 27/155 (17%), Positives = 49/155 (31%), Gaps = 22/155 (14%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCK--K 123
LS+N +T + P + L + L N L L
Sbjct: 704 LSNNL-----MTSI---PENSLKPKDGNYKNTYLLTTIDLRFNKLTSL-SDDFRATTLPY 754
Query: 124 LEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFP-------NLEHLSL 176
L ++V N FS + P+ + +L+ + + L+ +P +L L +
Sbjct: 755 LSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813
Query: 177 AKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
N KV + L D + N + +
Sbjct: 814 GSNDIR-KVDEKL--TPQLYILDIADNPNISIDVT 845
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 8e-19
Identities = 33/233 (14%), Positives = 65/233 (27%), Gaps = 38/233 (16%)
Query: 3 LSPAKLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFC 62
+S H + + L Q I +P P
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP---- 416
Query: 63 ERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL--------- 113
+ ++ LK T++ + +T +S +I RL++L+ + AN+
Sbjct: 417 ---IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDA 472
Query: 114 ----------LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL- 162
+ K L + + N +P L L L+ L+++ N
Sbjct: 473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ 532
Query: 163 ---------GFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNSL 205
P ++ + N S++ L D N +
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV 585
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 23/128 (17%), Positives = 44/128 (34%), Gaps = 13/128 (10%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGTIPSD--LSSLIRL 148
+ G +L +L L N + ++ P ++E L +N+ IP+ S+ +
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEEI-PEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646
Query: 149 RVLDLSGNSFSG-------NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201
+D S N ++ K N ++L+ N T + S
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYK-GINASTVTLSYNEIQKFPTELFATGSPISTIILS 705
Query: 202 GNSLLEGP 209
N + P
Sbjct: 706 NNLMTSIP 713
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-16
Identities = 37/215 (17%), Positives = 64/215 (29%), Gaps = 49/215 (22%)
Query: 31 SDYKALSVILRDLGGQQLFIPSDPCST-------------------PGVFCERR------ 65
DYKAL I L G+ S + PGV +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 66 -LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKL 124
L+ G + +IG+L+EL+ LS +S +
Sbjct: 329 SLAGFG---------------AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373
Query: 125 EILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTG 183
++ + ++ L RL + DL ++ + N +K +SL
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE-MKPIKKDSRISLKDTQIGN 432
Query: 184 ------KVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212
+ +I+ LQ F+ + I V
Sbjct: 433 LTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 23/123 (18%), Positives = 39/123 (31%), Gaps = 11/123 (8%)
Query: 91 SPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLR 149
S S+ ++ +L L +N + L KL L + NQ IP D + ++
Sbjct: 566 SASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 150 VLDLSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGK-----VPTSIRTFRNLQFFDFSG 202
L S N N+ K + + + N + N S
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682
Query: 203 NSL 205
N +
Sbjct: 683 NEI 685
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 5e-15
Identities = 17/128 (13%), Positives = 33/128 (25%), Gaps = 16/128 (12%)
Query: 93 SIGRLSELRELSLANNSLVDL-----LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIR 147
+ + + + + N + + + N+ ++
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 148 LRVLDLSGNSFS--------GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIR--TFRNLQF 197
+ + LS N + G K L + L N T + R T L
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSN 757
Query: 198 FDFSGNSL 205
D S N
Sbjct: 758 MDVSYNCF 765
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 19/184 (10%), Positives = 50/184 (27%), Gaps = 21/184 (11%)
Query: 42 DLGGQQLFIPSDPCSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLS---------P 92
G + + + + + K+ + + P
Sbjct: 353 SFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP 412
Query: 93 SIGRLSELRELSLANNSLVDL------LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLI 146
+ + + +SL + + +L + I KL+I+ N+ F+ + +
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----V 467
Query: 147 RLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ N +L + L ++P + LQ + + N
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527
Query: 206 LEGP 209
+
Sbjct: 528 ISAA 531
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 10/72 (13%), Positives = 26/72 (36%), Gaps = 3/72 (4%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
+ I L +L + +N + + ++ +L IL++ +N + +
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPY 850
Query: 146 IRLRVLDLSGNS 157
I + L +
Sbjct: 851 IEAGMYVLLYDK 862
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ KIG G G V+K G+++AIKK + +E+D + K +R EI
Sbjct: 8 IGKIGEGSYGVVFKCR-NRDTGQIVAIKKFL--------ESEDDPVI---KKIALR-EIR 54
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q++H NL+ LL R LV+E+ +L+++ + +R + I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ + H H IHRD+KP N+L+ ++ DFG A+ + + VA T
Sbjct: 111 TLQAVNFCH-KH--NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-T 165
Query: 522 VGYIAPEYHQTLKFTDKC-----DIYSFGVLLAVLVMGR 555
Y +PE L D D+++ G + A L+ G
Sbjct: 166 RWYRSPE----LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-21
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 24/225 (10%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+V + + G+ A+K +++ K+ + ++ +E +
Sbjct: 156 LGKGTFGKVILVKEKAT-GRYYAMK-ILK--KEVI--------VAKDEVAHTLTENRVLQ 203
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
RH L L D V E+ G ++ +S+ R + AR A +
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGA-EIVS 259
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAGTVG 523
L+YLH N +++RDLK N++LD D +I DFGL K + D T GT
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPE 314
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
Y+APE + + D + GV++ ++ GRLP + Q E++
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHEKL 357
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +G G G V K G+++AIKK + +++D + K +R EI
Sbjct: 30 LGLVGEGSYGMVMKCR-NKDTGRIVAIKKFL--------ESDDDKMV---KKIAMR-EIK 76
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q+RH NL+ LL + LV+EF+ IL+D+ LD+ K
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQ 132
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ G+ + H SH IIHRD+KP N+L+ ++ DFG A+ + + VA T
Sbjct: 133 IINGIGFCH-SH--NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-T 187
Query: 522 VGYIAPEYHQTLKFTDKC-----DIYSFGVLLAVLVMGR 555
Y APE L D D+++ G L+ + MG
Sbjct: 188 RWYRAPE----LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 27/217 (12%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
E +G G G V++ S+ K K V D + ++ EI+
Sbjct: 11 EDLGRGEFGIVHRCV-ETSSKKTYMAKFVKVKGTD-----QVL----------VKKEISI 54
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ RHRN+L L + ++++EF+ + + +N + E + V
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE--IVS-YVHQV 111
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA--RIADFGLAKAMPDAQTHITTSNVAG 520
L++LH SHN I H D++P N++ + +I +FG A+ + +
Sbjct: 112 CEALQFLH-SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFT 165
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
Y APE HQ + D++S G L+ VL+ G P
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 34/221 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ IGSG G V A + +AIKK+ +P ++ + +K R R E+
Sbjct: 67 LKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQN-----QTHAK------RAYR-ELV 113
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ + H+N++ LL ++ P L LV E M + +L ++ + ELD
Sbjct: 114 LMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVI------QMELDHER 165
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
+ + CG+++LH + IIHRDLKP+N+++ D +I DFGLA+ + +
Sbjct: 166 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 220
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
T V T Y APE + + + DI+S G ++ +V +
Sbjct: 221 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 42/229 (18%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
G G G V + S G +AIKKVIQ P+ + R+++ +
Sbjct: 28 ERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDPRF--------------RNRELQ-IMQ 71
Query: 402 TVGQIRHRNLLPLLAHMARP------DCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ + H N++ L ++ D +L +V E++ +L + + + +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHI 513
+ + LH + + HRD+KP NVL++ D ++ DFG AK + ++ +
Sbjct: 131 IKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN- 188
Query: 514 TTSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+ + + Y APE Y T DI+S G + A +++G
Sbjct: 189 -VAYIC-SRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 24/123 (19%), Positives = 44/123 (35%), Gaps = 2/123 (1%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIV-DCKKLEILNVQNNQFSGTIPSDLS 143
L+ L L +A NS D + + L L++ Q
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 144 SLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSG 202
+L RL++L++S N+ + +L L + N ++L FF+ +
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 203 NSL 205
NS+
Sbjct: 555 NSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 27/122 (22%), Positives = 40/122 (32%), Gaps = 2/122 (1%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L + S S SEL+ L L+ + + L L + N P S L
Sbjct: 44 LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103
Query: 146 IRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGN 203
L L + + L+ L++A N K+P NL D S N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 204 SL 205
+
Sbjct: 164 YI 165
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-17
Identities = 24/127 (18%), Positives = 41/127 (32%), Gaps = 6/127 (4%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
E+ + + L L L L N + P LE L + + +
Sbjct: 67 EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126
Query: 145 LIRLRVLDLSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFF---- 198
LI L+ L+++ N + NL H+ L+ N ++ R
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186
Query: 199 DFSGNSL 205
D S N +
Sbjct: 187 DMSLNPI 193
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 30/156 (19%), Positives = 52/156 (33%), Gaps = 12/156 (7%)
Query: 58 PGVFC-ERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPP 116
PG + N TY KL VP ++ S + + L+ N L L
Sbjct: 1 PGSLNPCIEVVPNITYQCMDQKLSKVPDDI----------PSSTKNIDLSFNPLKILKSY 50
Query: 117 QIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLS 175
+ +L+ L++ + L L L L+GN + G +LE+L
Sbjct: 51 SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110
Query: 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+ I L+ + + N + +P
Sbjct: 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLP 146
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 20/126 (15%), Positives = 39/126 (30%), Gaps = 5/126 (3%)
Query: 90 LSPSIGRLSELRELSLANNSL--VDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIR 147
+S L L L L+ N+L + L L++ N + ++ L
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEE 400
Query: 148 LRVLDLSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L+ LD ++ L +L ++ +L +GNS
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSF 460
Query: 206 LEGPIP 211
+ +
Sbjct: 461 KDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 20/98 (20%), Positives = 32/98 (32%), Gaps = 1/98 (1%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
LS + L L L+ L + +L++LN+ +N S + L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520
Query: 146 IRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFT 182
L LD S N + +L +L N
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 26/112 (23%), Positives = 38/112 (33%), Gaps = 5/112 (4%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL--IRLRVLDLS 154
L L+ L+L N + + V L L++ N S + S L LR LDLS
Sbjct: 327 LPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTS-IRTFRNLQFFDFSGNSL 205
N L+HL + S + L + D S +
Sbjct: 385 FNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNT 436
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 8e-11
Identities = 29/160 (18%), Positives = 47/160 (29%), Gaps = 38/160 (23%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDL-LPPQIVDCKKLEILNVQNNQFSG-------- 136
L + S IG+L L++L++A+N + LP + L +++ N
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQF 175
Query: 137 -------------------TIPSDLSSLIRLRVLDLSGNSFSGNL--GFLKYFPNLEHLS 175
I I+L L L GN S N+ L+ L
Sbjct: 176 LRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 176 LAKNLFTGKVPTSI---RTFRNLQ-----FFDFSGNSLLE 207
L F + I L F + +
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFS 275
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 15/129 (11%), Positives = 33/129 (25%), Gaps = 12/129 (9%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLE--------ILNVQNNQFSGT 137
+ ++ + L+ L L D +I + +E +
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 138 IPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQF 197
L + + L+G S L + + LS+ + L+
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKS 332
Query: 198 FDFSGNSLL 206
+ N
Sbjct: 333 LTLTMNKGS 341
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 58/232 (25%), Positives = 84/232 (36%), Gaps = 45/232 (19%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
I SG G V S G +AIK+V D + L K R +R EI
Sbjct: 27 QRFISSGSYGAVCAGV--DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK--RVLR-EIR 81
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL------LVYEFMKN------GSLQDILNDVSQGRRE 449
+ H N+L L + LV E M+ + +++
Sbjct: 82 LLNHFHHPNILGLR-DIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ------ 134
Query: 450 LDWLARHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
H + GL LH ++HRDL P N+LL D+ + I DF LA+
Sbjct: 135 ------HIQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLARE-- 183
Query: 508 DAQTHITTSNVAGTVGYIAPE----YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
D T V Y APE + FT D++S G ++A + +
Sbjct: 184 DTADANKTHYVT-HRWYRAPELVMQFKG---FTKLVDMWSAGCVMAEMFNRK 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G G+V + + + A+K + + + R E+
Sbjct: 68 QVLGLGINGKVLQIFNKRT-QEKFALKML-------------------QDCPKARREVEL 107
Query: 403 VGQI-RHRNLLPLLA----HMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARH 456
+ + +++ ++ A C L+V E + G L I + Q E + A
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--ASE 165
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHI 513
I + ++YLH S N I HRD+KP N+L + ++ DFG AK +
Sbjct: 166 -IMKSIGEAIQYLH-SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
T T Y+APE K+ CD++S GV++ +L+ G P
Sbjct: 222 T---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 46/228 (20%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ IG+G G VY+A+L S G+++AIKKV+Q + K R E+
Sbjct: 59 TKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQDKRF--------------KNR----ELQ 99
Query: 402 TVGQIRHRNLLPLLAHM-----ARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ ++ H N++ L + + +L LV +++ ++ + S+ ++ L +
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYV 158
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA-RIADFGLAKAMPDAQTHIT 514
+ L Y+H S I HRD+KP N+LLD D ++ DFG AK + +
Sbjct: 159 KLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPN 213
Query: 515 TSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
S + + Y APE Y T D++S G +LA L++G+
Sbjct: 214 VSYIC-SRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 22/189 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEK+G+G VYK L + G +A+K+V ++ T IR EI+
Sbjct: 10 LEKLGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTPST------------AIR-EIS 55
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH--KIA 459
+ +++H N++ L + + LV+EFM + L+ ++ + G
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
+ GL + H + +I+HRDLKP N+L++ + ++ DFGLA+A + +S V
Sbjct: 115 WQLLQGLAFCH-EN--KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-PVNTFSSEVV 170
Query: 520 GTVGYIAPE 528
T+ Y AP+
Sbjct: 171 -TLWYRAPD 178
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 24/121 (19%), Positives = 39/121 (32%), Gaps = 1/121 (0%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L + + + RL L L L + + +L+ L + N + LS
Sbjct: 45 LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104
Query: 146 IRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L+ L S + L LE L L N + L+ DF N+
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 205 L 205
+
Sbjct: 165 I 165
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 31/124 (25%), Positives = 48/124 (38%), Gaps = 5/124 (4%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
+ S + S L+EL L L +L P +V L+ L + N+F S+
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 146 IRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFT--GKVPTSIRTFRNLQFFDFS 201
L L + GN+ L G L+ NL L L+ + +R +LQ + S
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 202 GNSL 205
N
Sbjct: 385 YNEP 388
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 24/125 (19%), Positives = 44/125 (35%), Gaps = 5/125 (4%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPP-QIVDCKKLEILNVQNNQFSGTIPSDLSS 144
+ + + +L L LA L + L++LN+ ++ +
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDG 447
Query: 145 LIRLRVLDLSGNSFSGN----LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200
L L+ L+L GN F L+ LE L L+ + + + + + D
Sbjct: 448 LPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDL 507
Query: 201 SGNSL 205
S N L
Sbjct: 508 SHNRL 512
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-17
Identities = 21/124 (16%), Positives = 37/124 (29%), Gaps = 3/124 (2%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
++ + + L L L N L+ + + K L+ L S L +
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 145 LIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQ--FFDFS 201
L L L N S L L+ L N + + + + +
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 202 GNSL 205
GN +
Sbjct: 188 GNDI 191
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-17
Identities = 25/125 (20%), Positives = 45/125 (36%), Gaps = 7/125 (5%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDL---LPPQIVDCKKLEILNVQNNQFSGTIPSDL 142
L L L+ L+L N + +LEIL + S
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
Query: 143 SSLIRLRVLDLSGNSFSGNLGFLKYFPNLE--HLSLAKNLFTGKVPTSIRTFRNLQFFDF 200
+SL + +DLS N + + +L+ +L+LA N + +P+ + + +
Sbjct: 497 TSLKMMNHVDLSHNRLTSSSIEA--LSHLKGIYLNLASNHISIILPSLLPILSQQRTINL 554
Query: 201 SGNSL 205
N L
Sbjct: 555 RQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-16
Identities = 24/124 (19%), Positives = 45/124 (36%), Gaps = 4/124 (3%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSL--VDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS 143
+ + + L LREL L+++ + D Q+ + L+ LN+ N+
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 144 SLIRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201
+L +LDL+ + L+ L+L+ +L LQ +
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 202 GNSL 205
GN
Sbjct: 458 GNHF 461
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 19/117 (16%), Positives = 33/117 (28%), Gaps = 1/117 (0%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
+ L + N L + L L++ Q S RL L L+ N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 157 SFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212
L L+HL + + + + L+ N + +P
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 23/112 (20%), Positives = 39/112 (34%), Gaps = 2/112 (1%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKK--LEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154
+ L + + D+ P + +E +N+Q + F + L+ LDL+
Sbjct: 227 IQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLT 286
Query: 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206
S L L+ L L+ N F S F +L GN+
Sbjct: 287 ATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 18/101 (17%), Positives = 37/101 (36%), Gaps = 2/101 (1%)
Query: 84 RELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS 143
+ + S+ L L L L+ L + K + +++ +N+ + + LS
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 144 SLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTG 183
L + L+L+ N S L ++L +N
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 17/76 (22%), Positives = 32/76 (42%), Gaps = 1/76 (1%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L+ + + L + + L++N L + + K LN+ +N S +PS L L
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSS-SIEALSHLKGIYLNLASNHISIILPSLLPIL 546
Query: 146 IRLRVLDLSGNSFSGN 161
+ R ++L N
Sbjct: 547 SQQRTINLRQNPLDCT 562
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 51/233 (21%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ K+G G EV++A + +N + + +K ++P K E K+L + +R
Sbjct: 41 VRKLGRGKYSEVFEA-INITNNEKVVVKI-LKPVKKKKIKRE--IKIL-ENLRG------ 89
Query: 402 TVGQIRHRNLLPLLAHMARPDCH---LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
N++ L + + LV+E + N + + ++ D+ R +
Sbjct: 90 ------GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYM 136
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHITTSN 517
+ L+Y H S I+HRD+KP NV++D + + R+ D+GLA+ Q +
Sbjct: 137 -YEILKALDYCH-SMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVR 190
Query: 518 VAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563
VA + + PE Y +L D++S G +LA ++ + P FF
Sbjct: 191 VA-SRYFKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP---FFH 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 31/223 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+ +IG G G+V+KA + G+ +A+K+V +Q ++ L+ IR E+
Sbjct: 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS------------TIR-EV 62
Query: 401 NTVGQIR---HRNLLPLL--AHMARPDCHL---LVYEFMKNGSLQDILNDVSQGRRELDW 452
+ + H N++ L ++R D LV+E + L L+ V + +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 453 LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
+ + + GL++LH SH R++HRDLKP N+L+ + ++ADFGLA+
Sbjct: 122 IK--DMMFQLLRGLDFLH-SH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
TS V T+ Y APE + D++S G + A + +
Sbjct: 177 --TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 7e-19
Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 38/222 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
LEK+G G G VYKA+ S G+++A+K++ + + T IR EI
Sbjct: 26 LEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEGIPST------------AIR-EI 70
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ + ++ H N++ L+ + C LV+EFM+ L+ +L++ G L
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG---LQDSQIKIYLY 126
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ G+ + H H RI+HRDLKP N+L++ D ++ADFGLA+A T V
Sbjct: 127 QLLRGVAHCH-QH--RILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEVV- 181
Query: 521 TVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
T+ Y AP+ Y + DI+S G + A ++ G+
Sbjct: 182 TLWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 29/190 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+K+G G VYK + ++A+K++ ++ A T IR E++
Sbjct: 7 LDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCT------------AIR-EVS 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++H N++ L + LV+E++ L+ L+D + H + L
Sbjct: 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI------INMHNVKLF 105
Query: 462 VA---CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ GL Y H +++HRDLKP N+L+++ E ++ADFGLA+A T + V
Sbjct: 106 LFQLLRGLAYCH-RQ--KVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEV 161
Query: 519 AGTVGYIAPE 528
T+ Y P+
Sbjct: 162 V-TLWYRPPD 170
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 38/97 (39%), Positives = 57/97 (58%), Gaps = 7/97 (7%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAG 520
+A L++LH S II+RDLKP N+LLD++ ++ DFGL+K ++ + + G
Sbjct: 135 LALALDHLH-SLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFCG 188
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
TV Y+APE T D +SFGVL+ ++ G LP
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 25/225 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
+G G G+V + G+ A+K +++ K+ + ++ +E +
Sbjct: 13 LGKGTFGKVILVREKAT-GRYYAMK-ILR--KEVI--------IAKDEVAHTVTESRVLQ 60
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
RH L L D V E+ G ++ +S+ R + AR A +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGA-EIVS 116
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSNVAGTVG 523
LEYLH S + +++RD+K N++LD D +I DFGL K + D T GT
Sbjct: 117 ALEYLH-SRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPE 170
Query: 524 YIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
Y+APE + + D + GV++ ++ GRLP + Q E +
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHERL 213
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+GSG G V A + +G+ +AIKK+ +P + E +K R R E+
Sbjct: 29 PTHVGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQS-----EIFAK------RAYR-ELL 75
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ ++H N++ LL + P L LV FM LQ I+ +
Sbjct: 76 LLKHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFM-QTDLQKIM------GLKFS--E 125
Query: 455 RHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
+ + GL+Y+H S ++HRDLKP N+ +++D E +I DFGLA+ T
Sbjct: 126 EKIQYLVYQMLKGLKYIH-SAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 513 ITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
V T Y APE + + DI+S G ++A ++ G+
Sbjct: 183 ----YVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 19/178 (10%)
Query: 387 KLLNK----KMRQ---IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDI 439
K+L+K K++Q +E + + L+ L +V E++ G +
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131
Query: 440 LNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIAD 499
L + R + AR A + EYLH S + +I+RDLKP N+L+D ++ D
Sbjct: 132 LRRI---GRFSEPHARFYAA-QIVLTFEYLH-SLD--LIYRDLKPENLLIDQQGYIQVTD 184
Query: 500 FGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
FG AK + T + GT +APE + + D ++ GVL+ + G P
Sbjct: 185 FGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-18
Identities = 56/224 (25%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
LEKIG G G V+KA +++A+K+V + + + +R EI
Sbjct: 7 LEKIGEGTYGTVFKA-KNRETHEIVALKRVRLDDDDEGVPSS------------ALR-EI 52
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ +++H+N++ L + LV+EF L+ + + LD
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD---LDPEIVKSFLF 108
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ GL + H S ++HRDLKP N+L++ + E ++A+FGLA+A ++ V
Sbjct: 109 QLLKGLGFCH-SR--NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVV- 163
Query: 521 TVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
T+ Y P+ Y + D++S G + A L P
Sbjct: 164 TLWYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP 201
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAG 520
++ L +LH II+RDLKP N++L+ ++ DFGL K ++ D T G
Sbjct: 130 ISMALGHLH-QKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VTHTFCG 183
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
T+ Y+APE D +S G L+ ++ G P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 2e-18
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 33/228 (14%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAI----KKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+G G G+V +E G+ ++ A+ K V+ D E +++ +
Sbjct: 349 LGKGSFGKVMLSERKGT-DELYAVKILKKDVVIQDDDVECTMVE---------KRVLALP 398
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ L L + D V E++ G D++ + Q R + A A
Sbjct: 399 G-----KPPFLTQLHSCFQTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAA- 449
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSNVA 519
+A GL +L S II+RDLK NV+LD + +IADFG+ K + D TT
Sbjct: 450 EIAIGLFFLQ-SKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFC 503
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
GT YIAPE + D ++FGVLL ++ G+ P F E+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP---FEGEDED 548
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 64/243 (26%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ------ 395
L+ +G G VYKA + +++AIKK+ KL ++ +
Sbjct: 15 LDFLGEGQFATVYKARDK-NTNQIVAIKKI---------------KLGHRSEAKDGINRT 58
Query: 396 -IRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD--- 451
+R EI + ++ H N++ LL LV++FM E D
Sbjct: 59 ALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-----------------ETDLEV 100
Query: 452 WLARHKIALGVA----------CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501
+ + + L + GLEYLH H I+HRDLKP N+LLD++ ++ADFG
Sbjct: 101 IIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QH--WILHRDLKPNNLLLDENGVLKLADFG 157
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPE--YHQTLKFTDKCDIYSFGVLLAVLVMGR--LP 557
LAK+ T V T Y APE + + D+++ G +LA L++ LP
Sbjct: 158 LAKSFGSP-NRAYTHQVV-TRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLP 214
Query: 558 SDD 560
D
Sbjct: 215 GDS 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 38/225 (16%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK----KMRQI---R 397
IG G GEV +L K+ A+K +LNK K + R
Sbjct: 82 IGRGAFGEVAVVKLKN-ADKVFAMK------------------ILNKWEMLKRAETACFR 122
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
E + + + + L + LV ++ G L +L+ + R + AR
Sbjct: 123 EERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEM-ARFY 180
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+A + ++ +H + +HRD+KP N+L+D + R+ADFG + + T ++
Sbjct: 181 LA-EMVIAIDSVH-QLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 518 VAGTVGYIAPEYHQTLKFTDK-----CDIYSFGVLLAVLVMGRLP 557
V GT YI+PE Q ++ CD +S GV + ++ G P
Sbjct: 237 V-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 53/231 (22%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ IG+G G V++A+L S+ +AIKKV+Q + K R E+
Sbjct: 45 CKVIGNGSFGVVFQAKLVESD--EVAIKKVLQDKRF--------------KNR----ELQ 84
Query: 402 TVGQIRHRNLLPLLAHM-----ARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDW--- 452
+ ++H N++ L A + + L LV E++ ++ ++ ++ +
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLI 143
Query: 453 ------LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-EARIADFGLAKA 505
L R L Y+H S I HRD+KP N+LLD ++ DFG AK
Sbjct: 144 KLYMYQLLR---------SLAYIH-SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191
Query: 506 MPDAQTHITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+ + + S + + Y APE +T DI+S G ++A L+ G+
Sbjct: 192 LIAGEPN--VSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 38/123 (30%), Positives = 59/123 (47%), Gaps = 11/123 (8%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAG 520
+ LE+LH II+RD+K N+LLD + + DFGL+K + D + G
Sbjct: 168 IVLALEHLH-KLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE--RAYDFCG 222
Query: 521 TVGYIAPEYHQTLK--FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578
T+ Y+AP+ + D +S GVL+ L+ G P F E+ S + R ++
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRRIL 279
Query: 579 TSE 581
SE
Sbjct: 280 KSE 282
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 48/234 (20%)
Query: 343 EKIGSGGCGEVYKA-ELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
K+G G G VYKA G + K A+K++ E ++ R EI
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQI-----------EGTGISMSA----CR-EIA 70
Query: 402 TVGQIRHRNLLPLL-AHMARPDCHL-LVYEFMKN--GSLQDILNDVSQGRRELDWLARH- 456
+ +++H N++ L ++ D + L++++ ++ + ++ +
Sbjct: 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 457 -KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR----IADFGLAKAM---PD 508
+ + G+ YLH ++ ++HRDLKPAN+L+ + R IAD G A+
Sbjct: 131 KSLLYQILDGIHYLH-AN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 509 AQTHITTSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+ V T Y APE Y T DI++ G + A L+
Sbjct: 188 PLADLDPVVV--TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 40/224 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +GSG G V A + G +A+KK+ +P + +K R R E+
Sbjct: 34 LSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQS-----IIHAK------RTYR-ELR 80
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ ++H N++ LL + P L LV M D LN++ + ++ D
Sbjct: 81 LLKHMKHENVIGLL-DVFTPARSLEEFNDVYLVTHLMGA----D-LNNIVKCQKLTD--- 131
Query: 455 RHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH 512
H + + GL+Y+H S + IIHRDLKP+N+ +++D E +I DFGLA+ D
Sbjct: 132 DHVQFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-- 186
Query: 513 ITTSNVAGTVGYIAPEYH-QTLKFTDKCDIYSFGVLLAVLVMGR 555
T VA T Y APE + + DI+S G ++A L+ GR
Sbjct: 187 --TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG G EV ++ + G++ A+K + + L ++ R E + +
Sbjct: 69 IGRGAFSEVAVVKMKQT-GQVYAMKIM-----------NKWDMLKRGEVSCFREERDVLV 116
Query: 405 QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVAC 464
R + L + LV E+ G L +L+ G R +AR +A +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLA-EIVM 173
Query: 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGY 524
++ +H +HRD+KP N+LLD R+ADFG + A + + GT Y
Sbjct: 174 AIDSVH-RLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGTPDY 229
Query: 525 IAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
++PE T + +CD ++ GV + G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 32/205 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
IG+G G V +A +++AIKK+++ +D D K R +R EI
Sbjct: 58 RHLIGTGSYGHVCEA-YDKLEKRVVAIKKILRVFED-----LIDCK------RILR-EIA 104
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL------LVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ ++ H +++ +L + P +V E D + + L
Sbjct: 105 ILNRLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIAD----SD-FKKLFRTPVYLT--EL 156
Query: 456 HK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
H + + G++Y+H S I+HRDLKPAN L++ D ++ DFGLA+ + +
Sbjct: 157 HIKTLLYNLLVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDK 538
+ ++ + K +
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKR 238
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 48/237 (20%), Positives = 94/237 (39%), Gaps = 32/237 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAA-EL------------------T 382
+ +G+G G V + S GK A+KKV+Q P+ EL
Sbjct: 12 GKTLGTGSFGIVCEVFDIES-GKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 383 EEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILN 441
+ N + + +L ++ E++ + +L +L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLK 129
Query: 442 DVSQGRRELDWLARHKIAL-GVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIAD 499
+ R + + I + + + ++H S I HRD+KP N+L++ D ++ D
Sbjct: 130 SFIRSGRSIP-MNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 500 FGLAKAMPDAQTHITTSNVAGTVGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
FG AK + ++ + + + Y APE ++T D++S G + L++G+
Sbjct: 186 FGSAKKLIPSEPS--VAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 7e-18
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 38/222 (17%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
LEKIG G G VYKA+ + G+ A+KK+ ++ + T IR EI
Sbjct: 7 LEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPST------------TIR-EI 51
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ + +++H N++ L + +LV+E + L+ +L+ G L+ + L
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG---LESVTAKSFLL 107
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ G+ Y H R++HRDLKP N+L++ + E +IADFGLA+A T +
Sbjct: 108 QLLNGIAYCH-DR--RVLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV- 162
Query: 521 TVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
T+ Y AP+ Y + DI+S G + A +V G
Sbjct: 163 TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 30/126 (23%), Positives = 49/126 (38%), Gaps = 13/126 (10%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
RLS L+ +++ L++ LP + LE L + N +P+ ++SL RLR
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 150 VLDLSGNSFSGNL----------GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFD 199
L + L G + NL+ L L +P SI +NL+
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 200 FSGNSL 205
+ L
Sbjct: 213 IRNSPL 218
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 31/148 (20%), Positives = 51/148 (34%), Gaps = 19/148 (12%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSP-SIGRLSELRELSLANNSLVDLLPPQIVDCKKL 124
+ +L +P L + L L+ L L + L P I + + L
Sbjct: 157 IRACP-------ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNL 208
Query: 125 EILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL----GFLKYFPNLEHLSLA-KN 179
+ L ++N+ S + + L +L LDL G + N G L+ L L +
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA---PLKRLILKDCS 264
Query: 180 LFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
+P I L+ D G L
Sbjct: 265 NLL-TLPLDIHRLTQLEKLDLRGCVNLS 291
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 27/130 (20%), Positives = 50/130 (38%), Gaps = 17/130 (13%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL------- 142
L ++ + + L L+LA N L LP I +L L+++ +P L
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 143 --SSLIRLRVLDLSGNSFSG---NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQF 197
L+ L+ L L ++ L+ NL+ L + + + + +I L+
Sbjct: 178 EHQGLVNLQSLRLEWTGIRSLPASIANLQ---NLKSLKIRNSPLS-ALGPAIHHLPKLEE 233
Query: 198 FDFSGNSLLE 207
D G + L
Sbjct: 234 LDLRGCTALR 243
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 26/127 (20%), Positives = 41/127 (32%), Gaps = 14/127 (11%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
L SI L L+ L + N+ L L P I KLE L+++ P L+
Sbjct: 198 LPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256
Query: 150 VLDLSG-NSFS------GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSG 202
L L ++ L LE L L + ++P+ I
Sbjct: 257 RLILKDCSNLLTLPLDIHRL------TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPP 310
Query: 203 NSLLEGP 209
+ +
Sbjct: 311 HLQAQLD 317
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 17/126 (13%), Positives = 34/126 (26%), Gaps = 17/126 (13%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCK--KLEILNVQNNQFSGTIPSDLSSLIR 147
+ + + + +L + D L +++ P L
Sbjct: 48 SAWRQANSNNPQIETRTGRALKAT-ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH 105
Query: 148 LRVLDLSGNSFS------GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201
L+ + + LE L+LA+N +P SI + L+
Sbjct: 106 LQHMTIDAAGLMELPDTMQQF------AGLETLTLARNPLR-ALPASIASLNRLRELSIR 158
Query: 202 GNSLLE 207
L
Sbjct: 159 ACPELT 164
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 9e-06
Identities = 12/56 (21%), Positives = 20/56 (35%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L I RL++L +L L + LP I I+ V + + +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 16/109 (14%), Positives = 22/109 (20%), Gaps = 23/109 (21%)
Query: 121 CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-------------FLKY 167
E L Q + LS R D + + LK
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 168 FP---------NLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
L L + P +LQ L+E
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME 118
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 8e-18
Identities = 40/110 (36%), Positives = 53/110 (48%), Gaps = 13/110 (11%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSNVAG 520
+A L YLH S N I++RDLKP N+LLD + DFGL K + TTS G
Sbjct: 148 IASALGYLH-SLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCG 201
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP--SDDFFQHTEEM 568
T Y+APE + D + G +L ++ G P S + T EM
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN----TAEM 247
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 8e-18
Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 387 KLLNK----KMRQI---RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDI 439
K+L K +++Q+ E + + H ++ + ++ ++++ G L +
Sbjct: 37 KVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL 96
Query: 440 LNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIAD 499
L + +R + +A+ A V LEYLH S + II+RDLKP N+LLD + +I D
Sbjct: 97 L---RKSQRFPNPVAKFYAA-EVCLALEYLH-SKD--IIYRDLKPENILLDKNGHIKITD 149
Query: 500 FGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
FG AK +PD T + GT YIAPE T + D +SFG+L+ ++ G P
Sbjct: 150 FGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-18
Identities = 43/108 (39%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK-AMPDAQTHITTSNVAG 520
+ GL++LH S I++RDLK N+LLD D +IADFG+ K M T+ G
Sbjct: 127 IILGLQFLH-SKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCG 180
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
T YIAPE K+ D +SFGVLL +++G+ P Q EE+
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEEL 226
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 42/225 (18%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ +GSG G V A + G G +AIKK+ +P + E +K R R E+
Sbjct: 30 LQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQS-----ELFAK------RAYR-ELR 76
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-------LVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+ +RH N++ LL + PD L LV FM L ++ + +L
Sbjct: 77 LLKHMRHENVIGLL-DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HE---KLGEDR 129
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
+ + GL Y+H + IIHRDLKP N+ +++D E +I DFGLA+ T
Sbjct: 130 IQFLVYQMLKGLRYIH-AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-- 184
Query: 515 TSNVAGTVGYIAPE----YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
V T Y APE + ++T DI+S G ++A ++ G+
Sbjct: 185 --YVV-TRWYRAPEVILNWM---RYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 60/224 (26%), Positives = 86/224 (38%), Gaps = 39/224 (17%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK----KMRQI---R 397
IG G GEV K+ A+K LL+K K
Sbjct: 77 IGRGAFGEVQLVRHKS-TRKVYAMK------------------LLSKFEMIKRSDSAFFW 117
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
E + + ++ L +V E+M G D++N +S W AR
Sbjct: 118 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKW-ARFY 173
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
A V L+ +H S IHRD+KP N+LLD ++ADFG M +
Sbjct: 174 TA-EVVLALDAIH-SMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 518 VAGTVGYIAPE----YHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
V GT YI+PE + +CD +S GV L +++G P
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ +IG G G VYKA +G +A+K V + + +R E+
Sbjct: 14 VAEIGVGAYGTVYKA-RDPHSGHFVALKSV--------RVPNGGGGGGGLPISTVR-EVA 63
Query: 402 TVGQIR---HRNLLPLL--AHMARPDCHL---LVYEFMKNGSLQDILNDVSQGRRELDWL 453
+ ++ H N++ L+ +R D + LV+E + L+ L+ L
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAE 120
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
+ GL++LH ++ I+HRDLKP N+L+ ++ADFGLA+
Sbjct: 121 TIKDLMRQFLRGLDFLH-AN--CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL- 176
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
T V T+ Y APE + D++S G + A + +
Sbjct: 177 -TPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 40/108 (37%), Positives = 58/108 (53%), Gaps = 9/108 (8%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSNVAG 520
+A GL +L S II+RDLK NV+LD + +IADFG+ K + D TT G
Sbjct: 130 IAIGLFFLQ-SKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCG 183
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568
T YIAPE + D ++FGVLL ++ G+ P + + +E+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG--EDEDEL 229
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 27/114 (23%), Positives = 47/114 (41%), Gaps = 5/114 (4%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ ++ L L + NN + DL P + + +L L + NQ S + + L +L++L
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
++ N S ++ L L L L N + I NL S N +
Sbjct: 271 NVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 31/131 (23%), Positives = 55/131 (41%), Gaps = 8/131 (6%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
ITKLV ++ + I L+ L L+L N + D+ P + + KL L + N+
Sbjct: 45 SITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI 100
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN 194
T S L +L LR L L+ ++ S + L + L+L N + +
Sbjct: 101 --TDISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTG 156
Query: 195 LQFFDFSGNSL 205
L + + + +
Sbjct: 157 LNYLTVTESKV 167
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 23/114 (20%), Positives = 49/114 (42%), Gaps = 7/114 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L+ L + N + D+ P + + +L L + NN+ + P L++L +L L
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWL 248
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
++ N S ++ +K L+ L++ N + + + L + N L
Sbjct: 249 EIGTNQIS-DINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQL 299
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 22/114 (19%), Positives = 45/114 (39%), Gaps = 6/114 (5%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L +L L + N + D+ + + L L + + S P L++L ++ L
Sbjct: 82 SPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSL 137
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+L N +L L L +L++ ++ T I +L + N +
Sbjct: 138 NLGANHNLSDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQI 189
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 24/114 (21%), Positives = 45/114 (39%), Gaps = 7/114 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
I L++L LSL N + D+ P + L NQ + P ++++ RL L
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSL 226
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ N + +L L L L + N + +++ L+ + N +
Sbjct: 227 KIGNNKIT-DLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 28/138 (20%), Positives = 55/138 (39%), Gaps = 9/138 (6%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
+ + V +T V + L + +L +A + + I LE LN+ NQ
Sbjct: 23 EGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQI 78
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN 194
+ P LS+L++L L + N + ++ L+ NL L L ++ + + +
Sbjct: 79 TDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISD--ISPLANLTK 133
Query: 195 LQFFDFSGNSLLEGPIPV 212
+ + N L P+
Sbjct: 134 MYSLNLGANHNLSDLSPL 151
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 31/115 (26%), Positives = 54/115 (46%), Gaps = 7/115 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ LS+L L + N + D+ + D KL++LNV +NQ S S L++L +L L
Sbjct: 237 SPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292
Query: 152 DLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L+ N ++ + NL L L++N T P + + + DF+ +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 20/109 (18%), Positives = 45/109 (41%), Gaps = 7/109 (6%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L+E L S+ D++ + + + L V + + L L L+L+GN
Sbjct: 21 LAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGN 76
Query: 157 SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ ++ L L +L + N T ++++ NL+ + +++
Sbjct: 77 QIT-DISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNI 122
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSNVAG 520
+ L +LH II+RDLK NVLLD + ++ADFG+ K + + TT+ G
Sbjct: 133 IISALMFLH-DKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCG 186
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
T YIAPE Q + + D ++ GVLL ++ G P F E+
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP---FEAENED 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 54/273 (19%), Positives = 98/273 (35%), Gaps = 63/273 (23%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK---MRQIRSE 399
+ +G G G+V +A+ G + ++ K+ A T + + L + + I
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHH 85
Query: 400 INTVGQI-----------------RHRNLLPLL--------------------------- 415
+N V + + NL L
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 416 -------AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH---KIALGVACG 465
F++ SL D+ + + D+L + VA G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 466 LEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYI 525
+E+L + + IHRDL N+LL + +I DFGLA+ + ++ + + ++
Sbjct: 206 MEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262
Query: 526 APEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLP 557
APE +T + D++SFGVLL + +G P
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-17
Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 53/236 (22%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKK----MRQIR 397
L KIG G GEV+KA G+ +A+KKV + N+K + +R
Sbjct: 22 LAKIGQGTFGEVFKA-RHRKTGQKVALKKV---------------LMENEKEGFPITALR 65
Query: 398 SEINTVGQIRHRNLLPLL-------AHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRE 449
EI + ++H N++ L+ + R + LV++F + D+ +S +
Sbjct: 66 -EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVK 120
Query: 450 LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM--- 506
++ + GL Y+H + +I+HRD+K ANVL+ D ++ADFGLA+A
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIH-RN--KILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 507 PDAQTHITTSNVAGTVGYIAPE-------YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
++Q + T+ V T+ Y PE Y D++ G ++A +
Sbjct: 178 KNSQPNRYTNRVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 8e-17
Identities = 52/204 (25%), Positives = 81/204 (39%), Gaps = 32/204 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
IG G G VY A + K +AIKKV + +D D K R +R EI
Sbjct: 31 KHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFED-----LIDCK------RILR-EIT 77
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL------LVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ +++ ++ L + PD L +V E D L + + L
Sbjct: 78 ILNRLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLT--EE 129
Query: 456 HK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
H I + G ++H IIHRDLKPAN LL+ D ++ DFGLA+ + +
Sbjct: 130 HIKTILYNLLLGENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTD 537
+++ + + T
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTS 210
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG G +V L + ++ A+K V++ K+ ++ + +++E +
Sbjct: 17 IGRGSYAKVLLVRLKKT-DRIYAMK-VVK--KELV--------NDDEDIDWVQTEKHVFE 64
Query: 405 QI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
Q H L+ L + V E++ G D++ + + R+ + AR A ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSA-EIS 120
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSNVAGTV 522
L YLH II+RDLK NVLLD + ++ D+G+ K + TTS GT
Sbjct: 121 LALNYLH-ERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTP 174
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
YIAPE + + D ++ GVL+ ++ GR P
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 345 IGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG 404
IG G +V L + ++ A++ V++ K+ ++ + +++E +
Sbjct: 60 IGRGSYAKVLLVRLKKT-DRIYAMR-VVK--KELV--------NDDEDIDWVQTEKHVFE 107
Query: 405 QI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVA 463
Q H L+ L + V E++ G D++ + + R+ + AR A ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSA-EIS 163
Query: 464 CGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA-MPDAQTHITTSNVAGTV 522
L YLH II+RDLK NVLLD + ++ D+G+ K + TTS GT
Sbjct: 164 LALNYLH-ERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTP 217
Query: 523 GYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
YIAPE + + D ++ GVL+ ++ GR P
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 56/234 (23%), Positives = 102/234 (43%), Gaps = 47/234 (20%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVI-QPPKDAAELTEEDSKLLNKKMRQIRSEI 400
L+ +G GG G V+ A + K +AIKK++ P+ +R EI
Sbjct: 16 LKPLGCGGNGLVFSA-VDNDCDKRVAIKKIVLTDPQSVK--------------HALR-EI 59
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDI----------LNDVSQGRREL 450
+ ++ H N++ + + P L + L + L +V + L
Sbjct: 60 KIIRRLDHDNIVKVF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL 118
Query: 451 DWLARHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMP 507
+ H + GL+Y+H S N ++HRDLKPAN+ ++ +D+ +I DFGLA+ M
Sbjct: 119 E---EHARLFMYQLLRGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 508 DAQTHIT--TSNVAGTVGYIAPE----YHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+H + + T Y +P + +T D+++ G + A ++ G+
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEMLTGK 222
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 32/121 (26%), Positives = 51/121 (42%), Gaps = 9/121 (7%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
L L+ ++EL L+ N L + + KLE+LN+ +N DL S
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLES 78
Query: 145 LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L LR LDL+ N + L P++E L A N + +V S + + + N
Sbjct: 79 LSTLRTLDLNNN----YVQELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNK 131
Query: 205 L 205
+
Sbjct: 132 I 132
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 29/130 (22%), Positives = 49/130 (37%), Gaps = 10/130 (7%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQ-IVDCKKLEILNVQNNQFSGTIPSDLSS 144
+T + G S ++ L L N + + + LE LN+Q N + +
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV- 189
Query: 145 LIRLRVLDLSGN---SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFS 201
+L+ LDLS N + +SL N + ++R +NL+ FD
Sbjct: 190 FAKLKTLDLSSNKLAFMGPEFQSA---AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLR 245
Query: 202 GNSLLEGPIP 211
GN G +
Sbjct: 246 GNGFHCGTLR 255
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 19/118 (16%), Positives = 42/118 (35%), Gaps = 6/118 (5%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
+ + + ++SL L ++ L++ N S +DL+ +L +L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 157 SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMR 214
L+ L L L N + +++ + N++ +
Sbjct: 69 VLY-ETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 25/115 (21%), Positives = 41/115 (35%), Gaps = 7/115 (6%)
Query: 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152
+ + L ANN++ + + + + + NN+ + D R++ LD
Sbjct: 94 ELLVGPSIETLHAANNNISRV-SCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 153 LSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L N LEHL+L N V + F L+ D S N L
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 19/88 (21%), Positives = 34/88 (38%), Gaps = 3/88 (3%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFS-GTIPSDLSSLIRL 148
+ P + + +SL NN LV + + + LE +++ N F GT+ S R+
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 149 RVLDLSGNSF-SGNLGFLKYFPNLEHLS 175
+ + +G P L H
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 32/121 (26%), Positives = 51/121 (42%), Gaps = 9/121 (7%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
L L+ ++EL L+ N L + + KLE+LN+ +N DL S
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLES 78
Query: 145 LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L LR LDL+ N + L P++E L A N + +V S + + + N
Sbjct: 79 LSTLRTLDLNNN----YVQELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNK 131
Query: 205 L 205
+
Sbjct: 132 I 132
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 9e-15
Identities = 19/118 (16%), Positives = 42/118 (35%), Gaps = 6/118 (5%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
+ + + ++SL L ++ L++ N S +DL+ +L +L+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 157 SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMR 214
L+ L L L N + +++ + N++ +
Sbjct: 69 VLY-ETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 9e-13
Identities = 25/115 (21%), Positives = 41/115 (35%), Gaps = 7/115 (6%)
Query: 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152
+ + L ANN++ + + + + + NN+ + D R++ LD
Sbjct: 94 ELLVGPSIETLHAANNNISRV-SCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 153 LSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L N LEHL+L N V + F L+ D S N L
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL 203
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 22/119 (18%), Positives = 41/119 (34%), Gaps = 2/119 (1%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
++L+ L L++N L + P+ + ++++NN+ I L L DL GN
Sbjct: 190 FAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
Query: 157 SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRR 215
F + N ++AK + + + P P R
Sbjct: 248 GFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 18/152 (11%), Positives = 35/152 (23%), Gaps = 12/152 (7%)
Query: 62 CERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC 121
R N V + + + + + + DL P
Sbjct: 253 TLRDFFSKNQRVQTVA-----KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307
Query: 122 KKL-----EILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGN-LGFLKYFPNLEHLS 175
L +L+ Q ++ + + + R R +D + L
Sbjct: 308 IALKRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLE 366
Query: 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
K +V R L +E
Sbjct: 367 QKKKALDEQVSNGRRAHAELDGTLQQAVGQIE 398
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 12/123 (9%), Positives = 30/123 (24%), Gaps = 5/123 (4%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
+ R ++A ++ L +C + + LI L+
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311
Query: 150 -----VLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
+L G+ + + K + + + + +
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371
Query: 205 LLE 207
L E
Sbjct: 372 LDE 374
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 13/204 (6%), Positives = 40/204 (19%), Gaps = 9/204 (4%)
Query: 3 LSPAKLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFC 62
L + ++ + + + P
Sbjct: 249 FHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLI 308
Query: 63 ERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCK 122
+ ++ L+ T L + RE+ ++ + +
Sbjct: 309 ALKRKEH--------ALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360
Query: 123 KLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFT 182
L + + + + L + L+ L +
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
Query: 183 GK-VPTSIRTFRNLQFFDFSGNSL 205
V ++ +D +
Sbjct: 421 EMYVEQQSVQNNAIRDWDMYQHKE 444
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 31/219 (14%), Positives = 64/219 (29%), Gaps = 56/219 (25%)
Query: 342 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRS 398
L G + ++A L + +A+ V ++ +E S
Sbjct: 36 LIFHGGVPPLQFWQALDTAL----DRQVALTFVDPQGVLPDDVLQE-----------TLS 80
Query: 399 EINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ +I + +L + L+V E+++ GSLQ++ + +
Sbjct: 81 RTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRA 134
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
+A + H + + P+ V + D + +A
Sbjct: 135 MQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP------------------ 173
Query: 519 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+ Q DI G L L++ R P
Sbjct: 174 ----ATMPDANPQD-------DIRGIGASLYALLVNRWP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 58/243 (23%), Positives = 94/243 (38%), Gaps = 67/243 (27%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+G G G V A G+++AIKK+ + + + R +R EI
Sbjct: 16 KSLLGEGAYGVVCSA-THKPTGEIVAIKKI-----EPFD-KPLFAL------RTLR-EIK 61
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL------LVYEFM--------KNGSLQDILNDVSQGR 447
+ +H N++ + ++ RPD ++ E M L D
Sbjct: 62 ILKHFKHENIITIF-NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD-------- 112
Query: 448 RELDWLARHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA-- 503
H ++ LH N +IHRDLKP+N+L++ + + ++ DFGLA
Sbjct: 113 --------HIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 504 -------KAMPDAQTHITTSNVAGTVGYIAPE----YHQTLKFTDKCDIYSFGVLLAVLV 552
+ P Q VA T Y APE K++ D++S G +LA L
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVA-TRWYRAPEVMLTSA---KYSRAMDVWSCGCILAELF 217
Query: 553 MGR 555
+ R
Sbjct: 218 LRR 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 25/122 (20%), Positives = 44/122 (36%), Gaps = 2/122 (1%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L + S S EL+ L L+ + + L L + N S L
Sbjct: 40 LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL 99
Query: 146 IRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKN-LFTGKVPTSIRTFRNLQFFDFSGN 203
L+ L + + + + L+ L++A N + + K+P NL+ D S N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 204 SL 205
+
Sbjct: 160 KI 161
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 28/128 (21%), Positives = 45/128 (35%), Gaps = 8/128 (6%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
E+ + + LS L L L N + L L+ L + +
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 145 LIRLRVLDLSGNSFSGNLGFLKYF---PNLEHLSLAKNLFTGKVPTSIRTFRNLQFF--- 198
L L+ L+++ N + +YF NLEHL L+ N T +R +
Sbjct: 123 LKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181
Query: 199 -DFSGNSL 205
D S N +
Sbjct: 182 LDLSLNPM 189
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 26/119 (21%), Positives = 48/119 (40%), Gaps = 3/119 (2%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVD-CKKLEILNVQNNQFSGTIPSDLSSLIRL 148
+S + L +L L +++L + + + L L++ + + L L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 149 RVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
VL ++GNSF N NL L L++ PT+ + +LQ + + N L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 25/112 (22%), Positives = 37/112 (33%), Gaps = 4/112 (3%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSG 155
L L L +++ LE+L + N F D + L L LDLS
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 156 NSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNSL 205
+ +L+ L++A N VP I +LQ N
Sbjct: 480 CQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 38/209 (18%), Positives = 65/209 (31%), Gaps = 15/209 (7%)
Query: 16 LSLLFLSHARLNLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFCER----RLSDNNT 71
L++ A L+ D L L ++ L + + L +
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKF 316
Query: 72 YVLKITKLVFVPRELT-----GVLSPSIGRLSELRELSLANNSL--VDLLPPQIVDCKKL 124
KL + + LT G + S L L L L+ N L L
Sbjct: 317 GQFPTLKLKSL-KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 125 EILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG--NLGFLKYFPNLEHLSLAKNLFT 182
+ L++ N T+ S+ L +L LD ++ NL +L ++
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
Query: 183 GKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+L+ +GNS E +P
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 22/115 (19%), Positives = 40/115 (34%), Gaps = 1/115 (0%)
Query: 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS 157
+ L L+ N L L +L++L++ + SL L L L+GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 158 FSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
LG +L+ L + I + L+ + + N + +P
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 32/153 (20%), Positives = 49/153 (32%), Gaps = 33/153 (21%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDL-LPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
L + + IG L L+EL++A+N + LP + LE L++ +N+ +DL
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 145 L---------------------------IRLRVLDLSGNSFSGNL--GFLKYFPNLEHLS 175
L IRL L L N S N+ ++ LE
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 176 LAKNLFTGK---VPTSIRTFRNLQFFDFSGNSL 205
L F + L L
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 24/107 (22%), Positives = 36/107 (33%), Gaps = 7/107 (6%)
Query: 86 LTGVLSPSI-GRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
P I L L L L+ L L P L++LN+ +NQ
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516
Query: 145 LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRT 191
L L+ + L N + + + Y L KN + K S +
Sbjct: 517 LTSLQKIWLHTNPWDCSCPRIDYLSRW----LNKN--SQKEQGSAKC 557
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 66/233 (28%), Positives = 96/233 (41%), Gaps = 54/233 (23%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L IG G G V A N +AIKK I P + + + R +R EI
Sbjct: 32 LSYIGEGAYGMVCSA-YDNLNKVRVAIKK-ISPFEH-----QTYCQ------RTLR-EIK 77
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL------LVYEFM--------KNGSLQDILNDVSQGR 447
+ + RH N++ + + R +V + M K L +
Sbjct: 78 ILLRFRHENIIGIN-DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-------- 128
Query: 448 RELDWLARHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505
H + GL+Y+H S N ++HRDLKP+N+LL+ + +I DFGLA+
Sbjct: 129 --------HICYFLYQILRGLKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 506 MPDAQTHIT--TSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGR 555
H T VA T Y APE K +T DI+S G +LA ++ R
Sbjct: 178 ADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 23/114 (20%), Positives = 46/114 (40%), Gaps = 3/114 (2%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
+P I LS L L + + P + L +L++ ++ +I + +++L ++
Sbjct: 81 YNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139
Query: 150 VLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
+DLS N ++ LK P L+ L++ + I F L
Sbjct: 140 SIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 24/115 (20%), Positives = 48/115 (41%), Gaps = 5/115 (4%)
Query: 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152
+ +++ L ++LAN ++ DL I ++ L + N + P +S L L L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 153 LSGNSFSGN-LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206
+ G + + + L +L L ++ + + T I T + D S N +
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 20/109 (18%), Positives = 48/109 (44%), Gaps = 2/109 (1%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
+ +L + +++T P++ L+ L L +++++ D + +I K+ +++ N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTG 183
I L +L L+ L++ + + ++ FP L L G
Sbjct: 149 ITDI-MPLKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 15/115 (13%), Positives = 38/115 (33%), Gaps = 6/115 (5%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L +S ++ Q+ L + + N + + + ++ L ++
Sbjct: 22 FKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 157 SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+ N + NLE L + T ++ +L D S ++ + +
Sbjct: 77 HAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 37/201 (18%), Positives = 67/201 (33%), Gaps = 3/201 (1%)
Query: 8 LNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFCERRLS 67
LS F+L + S ++ + +++L L D + +
Sbjct: 174 KTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233
Query: 68 DNNTYVLKITKLVFVPRELTGVLSPSIGRL--SELRELSLANNSLVDLLPPQIVDCKKLE 125
+ I F + + L S +R L L++ + L K L+
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLK 293
Query: 126 ILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGK 184
+LN+ N+ + L L+VL+LS N P + ++ L KN
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 185 VPTSIRTFRNLQFFDFSGNSL 205
+ + LQ D N+L
Sbjct: 354 QDQTFKFLEKLQTLDLRDNAL 374
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 32/157 (20%), Positives = 54/157 (34%), Gaps = 18/157 (11%)
Query: 67 SDNNTYVLKITKLVFVPREL-------------TGVLSPSIGRLSELRELSLANNSLVDL 113
D + L VP+ L V + S L +L+ L L +
Sbjct: 4 FDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 114 LPPQI-VDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL---GFLKYFP 169
+ + + L IL++ +++ P L L L L S + G+ +
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 170 NLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNSL 205
L L L+KN + S +L+ DFS N +
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-13
Identities = 39/204 (19%), Positives = 68/204 (33%), Gaps = 25/204 (12%)
Query: 9 NLSLFALLSLLFLSHARL-NLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFCERRLS 67
+ + +FLS +L L + + A + L + + L I P + L+
Sbjct: 376 TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHL-QILILN 434
Query: 68 DNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQI-----VDCK 122
N + T L +L L N L ++
Sbjct: 435 QNR--------FSSCSGDQT------PSENPSLEQLFLGENMLQLAWETELCWDVFEGLS 480
Query: 123 KLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFT 182
L++L + +N + P S L LR L L+ N + L NLE L +++N
Sbjct: 481 HLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLL 539
Query: 183 GKVPTSIRTFRNLQFFDFSGNSLL 206
+ F +L D + N +
Sbjct: 540 A---PNPDVFVSLSVLDITHNKFI 560
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 31/122 (25%), Positives = 41/122 (33%), Gaps = 14/122 (11%)
Query: 97 LSELRELSLANNSLVDLLPPQ--IVDCKKLEILNVQNNQFSG-TIPSDLSSLIRLRVLDL 153
L L EL L L D + + K L L++ NQ + L L+ +D
Sbjct: 96 LFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF 155
Query: 154 SGNSFS----GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN------LQFFDFSGN 203
S N L L+ L SLA N +V N L+ D SGN
Sbjct: 156 SSNQIFLVCEHELEPLQ-GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGN 214
Query: 204 SL 205
Sbjct: 215 GW 216
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 22/109 (20%), Positives = 42/109 (38%), Gaps = 15/109 (13%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L L+ L+L+ N L +L K+ +++Q N + L +L+ LDL N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372
Query: 157 SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L + + P++ + L+ N L + + N +
Sbjct: 373 ----ALTTIHFIPSIPDIFLSGNKLV-----------TLPKINLTANLI 406
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 19/112 (16%), Positives = 36/112 (32%), Gaps = 7/112 (6%)
Query: 104 SLANNSLVDL--LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGN 161
+A +L +P + E L + N S L +L++L+L
Sbjct: 7 RIAFYRFCNLTQVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 162 L--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+ + PNL L L + P + + +L L + +
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 25/114 (21%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L++L EL L N + ++ P + L L + NQ P +S+L L L
Sbjct: 259 APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L N+ S ++ + L+ L N + +S+ N+ + N +
Sbjct: 315 TLYFNNIS-DISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQI 365
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 7/114 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
++ L+ L +L LANN + +L P + KL L + NQ S P L+ L L L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+L+ N ++ + NL +L+L N + + + + LQ F N +
Sbjct: 293 ELNENQLE-DISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKV 343
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 8/114 (7%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
++ L+ L++LS N + DL P + + LE L++ +N+ S S L+ L L L
Sbjct: 150 SALSGLTSLQQLSFGNQ-VTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 204
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ N S ++ L NL+ LSL N ++ + NL D + N +
Sbjct: 205 IATNNQIS-DITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 255
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 28/114 (24%), Positives = 51/114 (44%), Gaps = 8/114 (7%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L++L ++ + NN + D+ P + + L L + NNQ + P L +L L L
Sbjct: 84 TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRL 139
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+LS N+ S ++ L +L+ LS + + L+ D S N +
Sbjct: 140 ELSSNTIS-DISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV 189
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 29/112 (25%), Positives = 52/112 (46%), Gaps = 7/112 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L+ L +++ +NN L D+ P + + KL + + NNQ + P L++L L L
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
L N + ++ LK NL L L+ N + +++ +LQ F
Sbjct: 118 TLFNNQIT-DIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 18/114 (15%), Positives = 36/114 (31%), Gaps = 7/114 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L+E + L ++ D + D ++ L + L L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 73
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ S N + ++ LK L + + N T + NL N +
Sbjct: 74 NFSNNQLT-DITPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI 124
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 24/119 (20%), Positives = 50/119 (42%), Gaps = 7/119 (5%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L++L+ L NN + D+ + + + L+ +NQ S P L++L R+ L
Sbjct: 325 SPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKV-PTSIRTFRNLQFFDFSGNSLLEGP 209
L+ +++ + Y N+ + KN+ + P +I + D + N
Sbjct: 381 GLNDQAWTNAP--VNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTN 437
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 18/120 (15%), Positives = 38/120 (31%), Gaps = 24/120 (20%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG--------------- 136
S+ L+ + LS +N + DL P + + ++ L + + ++
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 137 -------TIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSI 189
P+ +S D++ N S F + F+G V +
Sbjct: 405 KNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 30/193 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+ K+G G GEVYKA + +AIK++ ++ ++ T IR E+
Sbjct: 39 ITKLGEGTYGEVYKAI-DTVTNETVAIKRIRLEHEEEGVPGT------------AIR-EV 84
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ + +++HRN++ L + + L++E+ +N L+ ++ ++
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK----NPDVSMRVIKSFLY 139
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR-----IADFGLAKAMPDAQTHITT 515
+ G+ + H S R +HRDLKP N+LL + I DFGLA+A T
Sbjct: 140 QLINGVNFCH-SR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI-PIRQFT 195
Query: 516 SNVAGTVGYIAPE 528
+ T+ Y PE
Sbjct: 196 HEII-TLWYRPPE 207
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 29/135 (21%), Positives = 48/135 (35%), Gaps = 12/135 (8%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC----KKLEILNVQNNQF---SGTI 138
+ L L L++N + C L++L ++N SG
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 139 PSDLSSLIRLRVLDLSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQ 196
+ ++ ++L+ LDLS NS + L L+L+ +VP + L
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLS 277
Query: 197 FFDFSGNSLLEGPIP 211
D S N L P P
Sbjct: 278 VLDLSYNRLDRNPSP 292
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 34/151 (22%), Positives = 51/151 (33%), Gaps = 14/151 (9%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLS--ELRELSLANNSLVDLLP--PQIVDCKK--LEILN 128
+ +L E+TG P + + +L L+L N S ++ K L++L+
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 129 VQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGF-----LKYFPNLEHLSLAKNLFT- 182
+ + L LDLS N G G FP L+ L+L
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 183 --GKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
G LQ D S NSL +
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 37/213 (17%), Positives = 60/213 (28%), Gaps = 28/213 (13%)
Query: 8 LNLSLFALLSLLFLSHARLNLDRSD------YKALSVILRDLGGQQLFIPSDPCSTPGVF 61
L L L+ ++ D + L L+ L Q + C VF
Sbjct: 113 PPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172
Query: 62 CERR---LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL---LP 115
LSDN E + + + L+ L+L N +
Sbjct: 173 PALSTLDLSDNPELG-----------ERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 116 PQIVDCKKLEILNVQNNQFSGTIPSDLSS-LIRLRVLDLSGNSFSGNLGFLKYFPNLEHL 174
+L+ L++ +N + +L L+LS L L L
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGL--PAKLSVL 279
Query: 175 SLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
L+ N P S + GN L+
Sbjct: 280 DLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 41/207 (19%), Positives = 72/207 (34%), Gaps = 11/207 (5%)
Query: 9 NLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLGGQQLFIPSDPCS--TPGVFCERRL 66
LS L L + AR +S ++ L + + + + + L
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253
Query: 67 SDNNTYVLKITKLVFVPRELTGVLSPSIG-RLSELRELSLANNSLVDLLPPQIVDCKKLE 125
S+ + L + V+S +R L + L L +K++
Sbjct: 254 SEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313
Query: 126 ILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFS----GNLGFLKYFPNLEHLSLAKNL 180
+ V+N++ +P L L LDLS N N +P+L+ L L++N
Sbjct: 314 RITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372
Query: 181 FT--GKVPTSIRTFRNLQFFDFSGNSL 205
K + T +NL D S N+
Sbjct: 373 LRSMQKTGEILLTLKNLTSLDISRNTF 399
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 24/124 (19%), Positives = 46/124 (37%), Gaps = 5/124 (4%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSS 144
+T + + + L+ L L ++ + + LE L++ +N S ++ S
Sbjct: 38 ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGP 96
Query: 145 LIRLRVLDLSGNSFS--GNLGFLKYFPNLEHLSLA-KNLFTGKVPTSIRTFRNLQFFDFS 201
L L+ L+L GN + G NL+ L + F+ +L +
Sbjct: 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIK 156
Query: 202 GNSL 205
SL
Sbjct: 157 ALSL 160
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 36/204 (17%), Positives = 65/204 (31%), Gaps = 26/204 (12%)
Query: 9 NLSLFALLSLLFLSHARLNLDRSDYKALSVILR----DLGGQQLF-IPSDPCSTPGVFCE 63
L +++ L + L S++ + + ++F +P
Sbjct: 279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEF 338
Query: 64 RRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL-LPPQIVDC- 121
LS+N + + S G L+ L L+ N L + +I+
Sbjct: 339 LDLSEN-----LMVEEYLKN-------SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386
Query: 122 KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLF 181
K L L++ N F +P ++R L+LS + LE L ++ N
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VV-KTCIPQTLEVLDVSNNNL 443
Query: 182 TGKVPTSIRTFRNLQFFDFSGNSL 205
+ LQ S N L
Sbjct: 444 D-SFSLFL---PRLQELYISRNKL 463
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 24/116 (20%), Positives = 43/116 (37%), Gaps = 8/116 (6%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
+ S ++R L+L++ + ++ I LE+L+V NN + L L +
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGI-RVVKTCIPQ--TLEVLDVSNNNLD-SFSLFLPRL---Q 454
Query: 150 VLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L +S N L FP L + +++N +LQ N
Sbjct: 455 ELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 26/113 (23%), Positives = 49/113 (43%), Gaps = 4/113 (3%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSG 155
+ ++ L L+ N + + + C L++L +++++ + TI D SL L LDLS
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSD 83
Query: 156 NSFSG-NLGFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNSLL 206
N S + + +L++L+L N + V + NLQ
Sbjct: 84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 19/110 (17%), Positives = 41/110 (37%), Gaps = 4/110 (3%)
Query: 103 LSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG-N 161
+ S + P + ++ L++ N+ + DL + L+VL L + +
Sbjct: 10 CDGRSRSFTSI-PSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 162 LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+LEHL L+ N + + +L++ + GN +
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 20/154 (12%), Positives = 53/154 (34%), Gaps = 6/154 (3%)
Query: 64 RRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLAN-----NSLVDLLPPQI 118
R L +T + + E++ + R S L + S +++L +
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEF 258
Query: 119 VDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLA 177
DC + + ++ + +R L + +L ++ +++
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318
Query: 178 KNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+ + + ++L+F D S N ++E +
Sbjct: 319 NSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 18/129 (13%), Positives = 46/129 (35%), Gaps = 8/129 (6%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
+ + L+ L EL + SL + + + + L + ++ + + L
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195
Query: 146 IRLRVLDLSGNSFSGN----LGFLKYFPNLEHLSLAKNLFT----GKVPTSIRTFRNLQF 197
+R L+L + + L + ++ L+ ++ T ++ +R L
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255
Query: 198 FDFSGNSLL 206
+F +L
Sbjct: 256 VEFDDCTLN 264
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 16/73 (21%), Positives = 27/73 (36%), Gaps = 2/73 (2%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155
L L+EL ++ N L L P L ++ + NQ L L+ + L
Sbjct: 449 FLPRLQELYISRNKLKTL--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 156 NSFSGNLGFLKYF 168
N + + + Y
Sbjct: 507 NPWDCSCPRIDYL 519
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 51/254 (20%), Positives = 105/254 (41%), Gaps = 79/254 (31%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQP---PKDAA----ELTEEDSKLLNKKMR 394
++K+G G G V+K+ + G+++A+KK+ DA E+ +L ++
Sbjct: 14 VKKLGKGAYGIVWKS-IDRRTGEVVAVKKIFDAFQNSTDAQRTFREI-----MIL-TELS 66
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHL---LVYEFM--------KNGSLQDILNDV 443
H N++ LL ++ R D LV+++M + L+ +
Sbjct: 67 G------------HENIVNLL-NVLRADNDRDVYLVFDYMETDLHAVIRANILEPV---- 109
Query: 444 SQGRRELDWLARHK--IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501
HK + + ++YLH S ++HRD+KP+N+LL+ + ++ADFG
Sbjct: 110 ------------HKQYVVYQLIKVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFG 154
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL--------------------KFTDKCDI 541
L+++ + + ++ + Q + K+T D+
Sbjct: 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDM 214
Query: 542 YSFGVLLAVLVMGR 555
+S G +L ++ G+
Sbjct: 215 WSLGCILGEILCGK 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 29/114 (25%), Positives = 44/114 (38%), Gaps = 4/114 (3%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L E+ L+ N L ++ V ++LE L + NN+ + + L+VL
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
DLS N F LE+L L N + S T L+ S N
Sbjct: 301 DLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 25/110 (22%), Positives = 43/110 (39%), Gaps = 5/110 (4%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSG 155
EL L L +N+L D +++ L +++ N+ I + RL L +S
Sbjct: 225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISN 281
Query: 156 NSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + + P L+ L L+ N V + F L+ NS+
Sbjct: 282 NRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 23/154 (14%), Positives = 54/154 (35%), Gaps = 8/154 (5%)
Query: 55 CSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLL 114
P C + + + +++ L+ + ++ N+++ L
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVH-IDMQTQDVYFGFEDI--TLNNQKIVTFKNSTMRKLP 61
Query: 115 PPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLE 172
+ +++E+LN+ + Q I + + ++ L + N+ + P L
Sbjct: 62 AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120
Query: 173 HLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNSL 205
L L +N + +P I L S N+L
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 153
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 23/111 (20%), Positives = 48/111 (43%), Gaps = 6/111 (5%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDLSG 155
+++L + N++ L P + L +L ++ N S ++P + + +L L +S
Sbjct: 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSN 150
Query: 156 NSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N+ + +L++L L+ N T V + +L + S N L
Sbjct: 151 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 23/113 (20%), Positives = 42/113 (37%), Gaps = 10/113 (8%)
Query: 95 GRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154
+L LS++NN+L + L+ L + +N+ + + LS + L ++S
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVS 194
Query: 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
N L L +E L + N V + L N+L +
Sbjct: 195 YN----LLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD 240
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 22/127 (17%), Positives = 45/127 (35%), Gaps = 3/127 (2%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSS 144
+ + + + ++ L+L + + ++ ++ L + N +P +
Sbjct: 57 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 115
Query: 145 LIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
+ L VL L N S G P L LS++ N + + +LQ S N
Sbjct: 116 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175
Query: 204 SLLEGPI 210
L +
Sbjct: 176 RLTHVDL 182
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 21/90 (23%), Positives = 38/90 (42%), Gaps = 5/90 (5%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
L+ + L+ L L++N L+ + +LE L + +N T+ LS+ L+
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLLHV-ERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLK 342
Query: 150 VLDLSGNSFSGNLGFLKYFPNLEHLSLAKN 179
L LS N + N F N+ ++
Sbjct: 343 NLTLSHNDWDCNS-LRALFRNVARPAVDDA 371
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 29/114 (25%), Positives = 44/114 (38%), Gaps = 4/114 (3%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L E+ L+ N L ++ V ++LE L + NN+ + + L+VL
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
DLS N F LE+L L N + S T L+ S N
Sbjct: 307 DLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 25/110 (22%), Positives = 43/110 (39%), Gaps = 5/110 (4%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSG 155
EL L L +N+L D +++ L +++ N+ I + RL L +S
Sbjct: 231 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISN 287
Query: 156 NSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + + P L+ L L+ N V + F L+ NS+
Sbjct: 288 NRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 336
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 27/166 (16%), Positives = 61/166 (36%), Gaps = 10/166 (6%)
Query: 43 LGGQQLFIPSDPCSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRE 102
+GGQQ + + P C + + + +++ L+ +
Sbjct: 1 VGGQQRY--NVKPRQPEYKCIDSNLQYDCVFYDVH-IDMQTQDVY--FGFEDITLNNQKI 55
Query: 103 LSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFSG- 160
++ N+++ L + +++E+LN+ + Q I + + ++ L + N+
Sbjct: 56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYL 114
Query: 161 NLGFLKYFPNLEHLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNSL 205
+ P L L L +N + +P I L S N+L
Sbjct: 115 PPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 159
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 9/110 (8%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSG 155
+ L L L N L L + KL L++ NN I D + L+ L LS
Sbjct: 122 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS 180
Query: 156 NSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + ++ P+L H +++ NL +++ ++ D S NS+
Sbjct: 181 NRLT-HVDL-SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI 223
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 22/127 (17%), Positives = 46/127 (36%), Gaps = 3/127 (2%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SS 144
+ + + + ++ L+L + + ++ ++ L + N +P + +
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 121
Query: 145 LIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
+ L VL L N S G P L LS++ N + + +LQ S N
Sbjct: 122 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181
Query: 204 SLLEGPI 210
L +
Sbjct: 182 RLTHVDL 188
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 26/116 (22%), Positives = 44/116 (37%), Gaps = 7/116 (6%)
Query: 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152
++ + EL ++NS+ + P +L IL +Q+N + L + L +D
Sbjct: 206 TLAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLT-DTAW-LLNYPGLVEVD 260
Query: 153 LSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
LS N LE L ++ N + + L+ D S N LL
Sbjct: 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH 315
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 21/90 (23%), Positives = 38/90 (42%), Gaps = 5/90 (5%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
L+ + L+ L L++N L+ + +LE L + +N T+ LS+ L+
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLLHV-ERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLK 348
Query: 150 VLDLSGNSFSGNLGFLKYFPNLEHLSLAKN 179
L LS N + N F N+ ++
Sbjct: 349 NLTLSHNDWDCNS-LRALFRNVARPAVDDA 377
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 29/118 (24%), Positives = 43/118 (36%), Gaps = 19/118 (16%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
P + S L+ + + NNSL LP LE + NNQ +P +L +L L +
Sbjct: 147 PELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAI 200
Query: 152 DLSGNSFSGNLGFLKYFP----NLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
NS LK P +LE + N+ ++ L N L
Sbjct: 201 YADNNS-------LKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLL 249
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 28/118 (23%), Positives = 43/118 (36%), Gaps = 10/118 (8%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
P + L L + NNSL LP + LE + NN +L +L L +
Sbjct: 189 PELQNLPFLTAIYADNNSLKK-LPDLPL---SLESIVAGNNIL--EELPELQNLPFLTTI 242
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
N P+LE L++ N T +P ++ L + + L E P
Sbjct: 243 YADNNLLK---TLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP 296
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 35/155 (22%), Positives = 49/155 (31%), Gaps = 26/155 (16%)
Query: 64 RRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSE-------------LRELSLANNSL 110
+ V T+ E P G E EL L N L
Sbjct: 24 TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83
Query: 111 VDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPN 170
L P LE L N + +P SL L V + + + S P
Sbjct: 84 SSL-PELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP------PL 132
Query: 171 LEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
LE+L ++ N K+P ++ L+ D NSL
Sbjct: 133 LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL 165
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 32/128 (25%), Positives = 47/128 (36%), Gaps = 23/128 (17%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
P + L L + NN L L P LE LNV++N + +P SL L V
Sbjct: 231 PELQNLPFLTTIYADNNLLKTL-PDLP---PSLEALNVRDNYLT-DLPELPQSLTFLDVS 285
Query: 152 DLSGNSFSGNLGFLKY--------------FPNLEHLSLAKNLFTGKVPTSIRTFRNLQF 197
+ + S L Y P+LE L+++ N ++P L+
Sbjct: 286 ENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLER 341
Query: 198 FDFSGNSL 205
S N L
Sbjct: 342 LIASFNHL 349
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 19/129 (14%), Positives = 48/129 (37%), Gaps = 18/129 (13%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLI--- 146
++P + L+E +++L + +P + + K +++ P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLTE-MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 147 ----------RLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQ 196
+ L+L+ S + P+LE L + N T ++P ++ ++L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS---SLPELPPHLESLVASCNSLT-ELPELPQSLKSLL 117
Query: 197 FFDFSGNSL 205
+ + +L
Sbjct: 118 VDNNNLKAL 126
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 26/158 (16%), Positives = 53/158 (33%), Gaps = 34/158 (21%)
Query: 74 LKITKLVFVPRELTGV------LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEIL 127
+ L +P L + + L EL+++NN L++ LP +LE L
Sbjct: 287 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERL 342
Query: 128 NVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFS------GNLGFLKY----------FPNL 171
N + +P + L+ L + N ++ L+ NL
Sbjct: 343 IASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNL 398
Query: 172 EHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
+ L + N + P + +L + +++
Sbjct: 399 KQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPY 432
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 24/134 (17%), Positives = 41/134 (30%), Gaps = 35/134 (26%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIR-- 147
L RL L + N L ++ P + L+ L+V+ N P S+
Sbjct: 332 LPALPPRL---ERLIASFNHLAEV-PELP---QNLKQLHVEYNPLR-EFPDIPESVEDLR 383
Query: 148 --------------LRVLDLSGNSFSGNLGFLKYFP----NLEHLSLAKNLFTGKVPTSI 189
L+ L + N L+ FP ++E L + +
Sbjct: 384 MNSHLAEVPELPQNLKQLHVETNP-------LREFPDIPESVEDLRMNSERVVDPYEFAH 436
Query: 190 RTFRNLQFFDFSGN 203
T L+ F +
Sbjct: 437 ETTDKLEDDVFEHH 450
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 30/154 (19%), Positives = 55/154 (35%), Gaps = 15/154 (9%)
Query: 66 LSDNNTYVLKITKLVFVP----RELT------GVLSPSIGRLSELRELSLANNSLVDLLP 115
LS N + L +S + L +L L +++L +
Sbjct: 59 LSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE 118
Query: 116 PQI-VDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFSGNL--GFLKYFPNL 171
+ + + L L++ + + + L L VL ++GNSF N NL
Sbjct: 119 FSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177
Query: 172 EHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L L++ PT+ + +LQ + S N+
Sbjct: 178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 27/114 (23%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 97 LSELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLS 154
LS L L +A NS + P I + + L L++ Q + +SL L+VL++S
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207
Query: 155 GNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSI--RTFRNLQFFDFSGNSL 205
N+F + K +L+ L + N +L F + + N
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 33/154 (21%), Positives = 46/154 (29%), Gaps = 25/154 (16%)
Query: 55 CSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLL 114
CS + C + L VP + S L L +N L L
Sbjct: 7 CSGTEIRCNSK------------GLTSVPTGI----------PSSATRLELESNKLQSLP 44
Query: 115 PPQIVDCKKLEILNVQNNQ--FSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLE 172
+L L++ +N F G L+ LDLS N LE
Sbjct: 45 HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLE 104
Query: 173 HLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNSL 205
HL + S+ + RNL + D S
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 16/65 (24%), Positives = 28/65 (43%), Gaps = 3/65 (4%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIR-LRVLDLS 154
LS L+ L++++N+ L L++L+ N T L L L+L+
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLT 256
Query: 155 GNSFS 159
N F+
Sbjct: 257 QNDFA 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 4e-13
Identities = 37/216 (17%), Positives = 60/216 (27%), Gaps = 45/216 (20%)
Query: 325 KKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEE 384
K + + L EKIG G GEV++ + +AIK + D + +
Sbjct: 8 KGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 385 DSKLLNKKMRQIRSEI---------NTVGQIRHRNLLPLLAHM----ARPDCHLLVYEFM 431
K +I EI + R + L + + P L ++
Sbjct: 65 ------KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118
Query: 432 --KNGSLQDILNDVSQ-------------------GRRELDWLARHKIALGVACGLEYLH 470
GS D + + I + L
Sbjct: 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 471 ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM 506
+ R HRDL NVLL ++ K+
Sbjct: 179 --ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 4e-13
Identities = 31/112 (27%), Positives = 46/112 (41%), Gaps = 7/112 (6%)
Query: 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153
I L + +L L N L D+ P + + K L L + N+ + S L L +L+ L L
Sbjct: 61 IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSL 116
Query: 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N S ++ L + P LE L L N T T + L N +
Sbjct: 117 EHNGIS-DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 165
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 5/116 (4%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L +L L L NN + D+ + KL+ L++++NQ S I L+ L +L+ L
Sbjct: 125 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNL 180
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
LS N S +L L NL+ L L K + SL+
Sbjct: 181 YLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 235
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 2e-10
Identities = 15/106 (14%), Positives = 38/106 (35%), Gaps = 7/106 (6%)
Query: 100 LRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFS 159
+ E + + + P + N++ + + + L + + + +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 160 GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
++ ++Y PN+ L L N T P + +NL + N +
Sbjct: 57 -SVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 19/110 (17%), Positives = 45/110 (40%), Gaps = 7/110 (6%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155
+E + +L S+ D + + ++ + N+ ++ + L + L L+G
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 156 NSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + ++ L NL L L +N + +S++ + L+ N +
Sbjct: 75 NKLT-DIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGI 121
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 23/115 (20%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLE 125
L +N KIT + + RL++L LSL +N + D++P + KL+
Sbjct: 138 LGNN-----KITDI------------TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ 178
Query: 126 ILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNL 180
L + N S + L+ L L VL+L + + NL + KN
Sbjct: 179 NLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNK--PINHQSNLVVPNTVKNT 229
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 21/149 (14%), Positives = 50/149 (33%), Gaps = 20/149 (13%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLE 125
L DN +I+ + + L++L+ L L+ N + DL + K L+
Sbjct: 160 LEDN-----QISDI------------VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLD 200
Query: 126 ILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKV 185
+L + + + + S+L+ + + S + + E ++ +L
Sbjct: 201 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEIISDDGDYEKPNVKWHLPEFTN 259
Query: 186 PTSIRTFRNLQFFDFSGNSLLEGPIPVMR 214
S ++ + P+
Sbjct: 260 EVSFIFYQPVTIGKAKARFHGRVTQPLKE 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 45/240 (18%), Positives = 89/240 (37%), Gaps = 45/240 (18%)
Query: 343 EKIGSGGCGEVYKAE-------LPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
G +Y+A G + ++K L +D +L N++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----------LDAKDGRLFNEQNFF 96
Query: 396 IRSEINTVGQIRHRNLLPLLAHMARPDCH----------LLVYEFMKNG-SLQDILNDVS 444
R Q+ L +A P C LV + G SLQ L+
Sbjct: 97 QR--AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDV-- 150
Query: 445 QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI--ADFGL 502
+ L + ++A + LE+LH + +H ++ N+ +D + ++++ A +G
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLH-ENE--YVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 503 AKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
A + H+ + S G + +I+ + H+ + + D+ S G + + G LP
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 59/224 (26%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G G+V + + A+K + + + R E+
Sbjct: 24 QVLGLGINGKVLQIFNK-RTQEKFALKML-------------------QDCPKARREVEL 63
Query: 403 VGQI-RHRNLLPLLA----HMARPDCHLLVYEFMKNGSLQD-ILNDVSQGRRELDWLARH 456
+ + +++ ++ A C L+V E + G L I + Q E + A
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--ASE 121
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFGLAKAMPDAQTHI 513
I + ++YLH S N I HRD+KP N+L + ++ DFG AK
Sbjct: 122 -IMKSIGEAIQYLH-SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET------- 170
Query: 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+Y + CD++S GV++ +L+ G P
Sbjct: 171 -----------TGEKYDK------SCDMWSLGVIMYILLCGYPP 197
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-12
Identities = 27/111 (24%), Positives = 39/111 (35%), Gaps = 7/111 (6%)
Query: 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153
EL LS N L + + KL+ L + +N+ SG + L L+L
Sbjct: 38 TDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 154 SGNSFS--GNLGFLKYFPNLEHLSLAKNLFTGKV---PTSIRTFRNLQFFD 199
SGN + LK NL+ L L T + L + D
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-11
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVD-CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154
S+++EL L N+ + + D ++LE L+ N + +I ++L L +L+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 155 GNSFSGNLGFL-KYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGN 203
N SG L L + PNL HL+L+ N ++ NL+ D
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 16/87 (18%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 120 DCKKLEILNVQNNQFS-GTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAK 178
++ L + N++ + G + L L + ++ L L+ L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73
Query: 179 NLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N +G + NL + SGN +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 7/118 (5%)
Query: 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152
S+ L +L+ LSL +N + D+ +V +LE L + NN+ T + LS L +L L
Sbjct: 107 SLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLS 162
Query: 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210
L N S ++ L L++L L+KN + ++ +NL + L PI
Sbjct: 163 LEDNQIS-DIVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPI 217
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 31/112 (27%), Positives = 46/112 (41%), Gaps = 7/112 (6%)
Query: 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153
I L + +L L N L D+ P + + K L L + N+ + S L L +L+ L L
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSL 119
Query: 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N S ++ L + P LE L L N T T + L N +
Sbjct: 120 EHNGIS-DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 7/112 (6%)
Query: 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153
+ L L L L N + DL + D KKL+ L++++N S I + L L +L L L
Sbjct: 86 LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYL 141
Query: 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + ++ L L+ LSL N + + + LQ S N +
Sbjct: 142 GNNKIT-DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 5/116 (4%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L +L L L NN + D+ + KL+ L++++NQ S I L+ L +L+ L
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNL 183
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
LS N S +L L NL+ L L K + SL+
Sbjct: 184 YLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 19/110 (17%), Positives = 45/110 (40%), Gaps = 7/110 (6%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155
+E + +L S+ D + + ++ + N+ ++ + L + L L+G
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 156 NSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + ++ L NL L L +N + +S++ + L+ N +
Sbjct: 78 NKLT-DIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI 124
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 13/104 (12%), Positives = 34/104 (32%), Gaps = 7/104 (6%)
Query: 102 ELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGN 161
E + + + N++ + + + L + + + + +
Sbjct: 6 ETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-S 60
Query: 162 LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ ++Y PN+ L L N T + +NL + N +
Sbjct: 61 VQGIQYLPNVTKLFLNGNKLT--DIKPLANLKNLGWLFLDENKV 102
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 15/89 (16%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L++L+ L L+ N + DL + K L++L + + + + S+L+ +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNL 180
+ S + + E ++ +L
Sbjct: 230 KNTDGSLV-TPEIISDDGDYEKPNVKWHL 257
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 28/121 (23%), Positives = 46/121 (38%), Gaps = 10/121 (8%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS 144
E+ + S +L+ L L N+S+ D+ I L L +N + T+ DLS
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TL--DLSQ 83
Query: 145 LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
L L N + NL L +L+ N T + L + + + N+
Sbjct: 84 NTNLTYLACDSNKLT-NLDVTP-LTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNT 138
Query: 205 L 205
L
Sbjct: 139 L 139
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 23/118 (19%), Positives = 45/118 (38%), Gaps = 11/118 (9%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
I +L+ L +L +N++ L + L L +N+ + + ++ L +L L
Sbjct: 58 TGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
+ N + L + P L +L+ A+N T + L D N +
Sbjct: 112 NCDTNKLT-KLDVSQ-NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKL 164
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 38/200 (19%), Positives = 70/200 (35%), Gaps = 33/200 (16%)
Query: 7 KLNLSLFALLSLLFLSHARL-NLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFCERR 65
L+LS L+ L +L NLD + L+ + + +L S +
Sbjct: 78 TLDLSQNTNLTYLACDSNKLTNLDVTPLTKLTYL--NCDTNKL--TKLDVSQNPLLTYLN 133
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLE 125
+ N +T++ + ++L EL N + L + +L
Sbjct: 134 CARN-----TLTEI-------------DVSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 126 ILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKV 185
L+ N+ + + D+S L L+ N+ + L L L + N T ++
Sbjct: 174 TLDCSFNKIT-EL--DVSQNKLLNRLNCDTNNIT-KLDL-NQNIQLTFLDCSSNKLT-EI 227
Query: 186 PTSIRTFRNLQFFDFSGNSL 205
+ L +FD S N L
Sbjct: 228 D--VTPLTQLTYFDCSVNPL 245
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 20/121 (16%), Positives = 40/121 (33%), Gaps = 14/121 (11%)
Query: 91 SPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRV 150
+ ++L L + +L + KL L + N + + + D+S +L+
Sbjct: 290 ELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-EL--DVSHNTKLKS 343
Query: 151 LDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQF------FDFSGNS 204
L + + P L + A+ +P T +L D GN
Sbjct: 344 LSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNP 401
Query: 205 L 205
+
Sbjct: 402 M 402
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 36/221 (16%), Positives = 68/221 (30%), Gaps = 32/221 (14%)
Query: 7 KLNLSLFALLSLLFLSHARL-NLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFCERR 65
KL++S LL+ L + L +D S L+ + D + D +
Sbjct: 120 KLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTEL--DCHLNKKITKLDVTPQTQL-TTLD 176
Query: 66 LSDNNTYVLKITKLVFVPRELT----GVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC 121
S N L +++ + L + + + +L L ++N L ++ +
Sbjct: 177 CSFNKITELDVSQNKLL-NRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTEI---DVTPL 232
Query: 122 KKLEILNVQNNQFSGTIPSDLSSLIRLRV-------LDLSGN------SFSGN----LGF 164
+L + N + S LS L L +DL+ N G
Sbjct: 233 TQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELD 292
Query: 165 LKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ + L L T + L + + L
Sbjct: 293 VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL 330
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 17/114 (14%), Positives = 39/114 (34%), Gaps = 12/114 (10%)
Query: 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152
+ LS+L L L+++ + +L + + + D++ +L +LD
Sbjct: 249 DVSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLD 303
Query: 153 LSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ +L P L +L L T ++ + L+ +
Sbjct: 304 CQAAGITELDLSQN---PKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 17/112 (15%), Positives = 34/112 (30%), Gaps = 9/112 (8%)
Query: 100 LRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFS 159
A + L L+ N+ + + + L L L + N+ +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 160 G-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210
+L NL +L+ N T + L + + N L + +
Sbjct: 78 TLDLSQN---TNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKLDV 123
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 14/95 (14%), Positives = 24/95 (25%), Gaps = 4/95 (4%)
Query: 116 PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLS 175
+ T L L LD +S + ++ ++ L L
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLI 70
Query: 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210
N T + NL + N L +
Sbjct: 71 CTSNNITT---LDLSQNTNLTYLACDSNKLTNLDV 102
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-12
Identities = 29/114 (25%), Positives = 40/114 (35%), Gaps = 11/114 (9%)
Query: 94 IGRLSELRELSLANNSLVDL--LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
L LSL N L+ + LP KL+ L + N+ G + L L L
Sbjct: 45 TAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100
Query: 152 DLSGNSFS--GNLGFLKYFPNLEHLSLAKNLFTGKV---PTSIRTFRNLQFFDF 200
+LSGN L LK L+ L L T + + L + D
Sbjct: 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDG 154
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 24/109 (22%), Positives = 41/109 (37%), Gaps = 11/109 (10%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
+ L L N + + ++L + N ++N G I + + L L L
Sbjct: 10 MKRRIHLELRNRTPAAV--------RELVLDNCKSND--GKIEGLTAEFVNLEFLSLINV 59
Query: 157 SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
++ L P L+ L L++N G + NL + SGN L
Sbjct: 60 GLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 26/114 (22%), Positives = 50/114 (43%), Gaps = 7/114 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L+++ EL L+ N L ++ I + ++ L++ + Q + P L+ L L+VL
Sbjct: 79 APLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL 134
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L N + N+ L NL++LS+ + T + L N +
Sbjct: 135 YLDLNQIT-NISPLAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKI 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 31/131 (23%), Positives = 53/131 (40%), Gaps = 9/131 (6%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
IT L +T + + L+ L L L +N + DL P + + K+ L + N
Sbjct: 42 GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN 194
S ++ L ++ LDL+ + ++ L NL+ L L N T P + N
Sbjct: 98 --KNVSAIAGLQSIKTLDLTSTQIT-DVTPLAGLSNLQVLYLDLNQITNISP--LAGLTN 152
Query: 195 LQFFDFSGNSL 205
LQ+ +
Sbjct: 153 LQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 5/91 (5%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ L+ L+ LS+ N + DL P + + KL L +N+ S I S L+SL L +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DI-SPLASLPNLIEV 200
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFT 182
L N S ++ L NL ++L T
Sbjct: 201 HLKNNQIS-DVSPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 16/99 (16%), Positives = 33/99 (33%), Gaps = 7/99 (7%)
Query: 107 NNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLK 166
++ + P + + + T+ + L + L G + + ++
Sbjct: 6 PTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQ 60
Query: 167 YFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
Y NL L L N T ++ + + SGN L
Sbjct: 61 YLNNLIGLELKDNQIT--DLAPLKNLTKITELELSGNPL 97
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 3/69 (4%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRL-RV 150
+ L L E+ L NN + D+ P + + L I+ + N + ++L+ V
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
Query: 151 LDLSGNSFS 159
SG +
Sbjct: 247 KGPSGAPIA 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 48/226 (21%), Positives = 87/226 (38%), Gaps = 20/226 (8%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+KIGSGG G +Y A P + + A V ++ L E K + ++ +
Sbjct: 43 KKIGSGGFGLIYLAF-PTNKPEKDARHVVKVEYQENGPLFSE-LKFYQRVAKKDCIKKWI 100
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFM---KNG-SLQDILNDVSQGRRELDWLARHKI 458
+ +PL + Y FM + G LQ I ++
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQL 156
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI--ADFGLAKAMPDAQTHI--- 513
+ + LEY+H + +H D+K AN+LL ++ AD+GL+ H
Sbjct: 157 GIRMLDVLEYIH-ENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 514 --TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
GT+ + + + H+ + + + D+ G + + G+LP
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 24/90 (26%), Positives = 40/90 (44%), Gaps = 5/90 (5%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+ +L + L L++N L L PP + + LE+L +N + +++L RL+ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALE-NVD-GVANLPRLQEL 513
Query: 152 DLSGNSFSG--NLGFLKYFPNLEHLSLAKN 179
L N + L P L L+L N
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 27/110 (24%), Positives = 45/110 (40%), Gaps = 5/110 (4%)
Query: 101 RELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG 160
R L LA+ L L + + L++ +N+ +P L++L L VL S N+
Sbjct: 444 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 161 NLGFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNSLLEGP 209
N+ + P L+ L L N + + L + GNSL +
Sbjct: 500 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 2e-09
Identities = 22/91 (24%), Positives = 42/91 (46%), Gaps = 9/91 (9%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPS--DLSSLIR 147
L P++ L L L ++N+L ++ + + +L+ L + NN+ + L S R
Sbjct: 478 LPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPR 534
Query: 148 LRVLDLSGNSFSGNLGF----LKYFPNLEHL 174
L +L+L GNS G + P++ +
Sbjct: 535 LVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 7e-08
Identities = 27/145 (18%), Positives = 51/145 (35%), Gaps = 2/145 (1%)
Query: 61 FCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVD 120
+ + + + +L + E L I + L L +L + VD
Sbjct: 356 LSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVD 415
Query: 121 CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNL 180
+ L+ ++F +RVL L+ + L L+ + HL L+ N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNR 474
Query: 181 FTGKVPTSIRTFRNLQFFDFSGNSL 205
+P ++ R L+ S N+L
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 25/154 (16%), Positives = 49/154 (31%), Gaps = 14/154 (9%)
Query: 62 CERRLSDNNTYVLKITKLVFVPRELTGVLSP--SIGRLSELREL--------SLANNSLV 111
C+ + ++ + R L +L ++ S L+ + + +
Sbjct: 371 CKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFL 430
Query: 112 DLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNL 171
++ + +L++ + T+ L L+ + LDLS N L L
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCL 488
Query: 172 EHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
E L + N V + LQ N L
Sbjct: 489 EVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 520
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-11
Identities = 25/109 (22%), Positives = 43/109 (39%), Gaps = 7/109 (6%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L + + ++N + L ++L+ L V NN+ +L L L L+ N
Sbjct: 41 LDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98
Query: 157 SFS--GNLGFLKYFPNLEHLSLAKNLFTGKV---PTSIRTFRNLQFFDF 200
S G+L L +L +L + +N T K I ++ DF
Sbjct: 99 SLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 147
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 20/113 (17%), Positives = 38/113 (33%), Gaps = 13/113 (11%)
Query: 97 LSELRELSLANNSLVDLLPPQI----VDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152
REL L + P I + + ++ +N+ + L RL+ L
Sbjct: 18 AVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70
Query: 153 LSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGN 203
++ N G + P+L L L N + + ++L + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 23/107 (21%), Positives = 36/107 (33%), Gaps = 17/107 (15%)
Query: 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFS--GTIPSDLSSLIRLRVL 151
L L+ L + NN + + L L + NN G + L+SL L L
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYL 118
Query: 152 DLSGNSFSGNLGFLKY----FPNLEHL----------SLAKNLFTGK 184
+ N + + Y P + L A+ +F GK
Sbjct: 119 CILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKERQEAEKMFKGK 165
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 15/90 (16%), Positives = 31/90 (34%), Gaps = 2/90 (2%)
Query: 116 PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLS 175
Q + + L+++ + I + ++L + +D S N L L+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLL 70
Query: 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ N + +L + NSL
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 43/237 (18%), Positives = 85/237 (35%), Gaps = 39/237 (16%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
IG GG G +Y A++ ++ + + ++ D+ L +++ +
Sbjct: 41 LPIGQGGFGCIYLADM--NSSESVGSDAPC-----VVKVEPSDNGPLFTELKFYQ-RAAK 92
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNG------------SLQDILNDVSQGRREL 450
QI+ L ++ P LQ I +R
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA--NAKR-- 148
Query: 451 DWLARH---KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI--ADFGLAKA 505
+R +++L + LEY+H H +H D+K +N+LL+ ++ D+GLA
Sbjct: 149 --FSRKTVLQLSLRILDILEYIH-EHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 506 MPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
H GT+ + + + H + + + D+ G + + G LP
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 27/136 (19%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLS 154
RL L+ L +++ +D + P + L L++ + + +P + L+ LR L+LS
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256
Query: 155 GNSFS-------GNLGFLKY------------------FPNLEHLSLAKNLFTGKVPTSI 189
N S L L+ L L+++ N T +
Sbjct: 257 YNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316
Query: 190 RTFRNLQFFDFSGNSL 205
+ NL+ N L
Sbjct: 317 HSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 21/111 (18%), Positives = 38/111 (34%), Gaps = 3/111 (2%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDLSG 155
L LR L L +N L + L L++ N+ + + L L+ L++
Sbjct: 79 LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGD 137
Query: 156 NSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + +LE L+L K T ++ L ++
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 27/113 (23%), Positives = 40/113 (35%), Gaps = 3/113 (2%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSG 155
LS L +L ++ N +V LL D L+ L V +N I S L L L L
Sbjct: 103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEK 161
Query: 156 NSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
+ + L + L L L S + L+ + S L+
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 19/121 (15%), Positives = 48/121 (39%), Gaps = 1/121 (0%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
LT + + ++ L L L L + ++ + +L++L + + + T+ +
Sbjct: 164 LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 146 IRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204
+ L L ++ + + +++ L L+L+ N + + + LQ G
Sbjct: 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283
Query: 205 L 205
L
Sbjct: 284 L 284
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 23/122 (18%), Positives = 41/122 (33%), Gaps = 3/122 (2%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSS 144
+ + L EL L N + + P + L L +++N+ IP +
Sbjct: 44 IKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTG 102
Query: 145 LIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
L L LD+S N + NL+ L + N + +L+
Sbjct: 103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162
Query: 204 SL 205
+L
Sbjct: 163 NL 164
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 18/64 (28%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDLSG 155
L L+E+ L L + P L +LNV NQ + T+ + S+ L L L
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDS 329
Query: 156 NSFS 159
N +
Sbjct: 330 NPLA 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 25/120 (20%), Positives = 39/120 (32%), Gaps = 17/120 (14%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
L + + + L + +N+L L P +L L V NQ + ++P L+ L
Sbjct: 55 LPDCLP--AHITTLVIPDNNLTSL-PALP---PELRTLEVSGNQLT-SLPVLPPGLLELS 107
Query: 150 VLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
+ L L + N T +P LQ S N L P
Sbjct: 108 IFSNPLTHLPALP------SGLCKLWIFGNQLT-SLPVLP---PGLQELSVSDNQLASLP 157
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 35/136 (25%), Positives = 57/136 (41%), Gaps = 26/136 (19%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
S L+ELS+++N L L P +L L NN+ + ++P+ S L + L +SGN
Sbjct: 180 PSGLQELSVSDNQLASL-PTLP---SELYKLWAYNNRLT-SLPALPSGL---KELIVSGN 231
Query: 157 SFS------GNLG-------FLKYFP----NLEHLSLAKNLFTGKVPTSIRTFRNLQFFD 199
+ L L P L LS+ +N T ++P S+ + +
Sbjct: 232 RLTSLPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVN 290
Query: 200 FSGNSLLEGPIPVMRR 215
GN L E + +R
Sbjct: 291 LEGNPLSERTLQALRE 306
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 26/116 (22%), Positives = 34/116 (29%), Gaps = 18/116 (15%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
L L EL S L L L L + NQ + ++P L+
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLT-SLPVLPPG---LQ 144
Query: 150 VLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L +S N + L L N T +P LQ S N L
Sbjct: 145 ELSVSDNQLA---SLPALPSELCKLWAYNNQLT-SLPMLP---SGLQELSVSDNQL 193
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 18/89 (20%), Positives = 30/89 (33%), Gaps = 7/89 (7%)
Query: 121 CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNL 180
+LNV + + T+P L + + L + N+ + P L L ++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT---SLPALPPELRTLEVSGNQ 92
Query: 181 FTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
T +P L F L P
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLPALP 120
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 4/111 (3%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQ-NNQFSGTIPSD-LSSLIRLRVLDLS 154
LS+L+EL L NN + + L L++ + S I L LR L+L+
Sbjct: 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLA 193
Query: 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ + L L+ L L+ N + P S + +LQ + +
Sbjct: 194 MCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 3/110 (2%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
LS LR L+LA +L ++ P + KL+ L++ N S P L+ L+ L + +
Sbjct: 184 LSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 157 SFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+L ++LA N T +L+ N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 21/90 (23%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
P++ L +L EL L+ N L + P L+ L + +Q + +L L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 152 DLSGNSFSGNL--GFLKYFPNLEHLSLAKN 179
+L+ N+ + L +LE + L N
Sbjct: 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 30/140 (21%), Positives = 44/140 (31%), Gaps = 36/140 (25%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLS 154
L L L L+ N + + L L + +N+ + TIP+ L +L+ L L
Sbjct: 86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLR 144
Query: 155 GNSFS-------GNLGFLKY----------------F---PNLEHLSLAKNLFTGKVPTS 188
N + L+ F NL +L+LA
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-----RE 199
Query: 189 IRTFR---NLQFFDFSGNSL 205
I L D SGN L
Sbjct: 200 IPNLTPLIKLDELDLSGNHL 219
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 14/75 (18%), Positives = 32/75 (42%), Gaps = 2/75 (2%)
Query: 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LS 143
L+ + S L L++L + + + + + + L +N+ +N + +P D +
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFT 276
Query: 144 SLIRLRVLDLSGNSF 158
L L + L N +
Sbjct: 277 PLHHLERIHLHHNPW 291
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 2/110 (1%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSG 155
LS+LREL L NN + + L L++ + I L L+ L+L
Sbjct: 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 156 NSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ ++ L LE L ++ N F P S +L+ + +
Sbjct: 206 CNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 24/110 (21%), Positives = 37/110 (33%), Gaps = 3/110 (2%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L L+ L+L ++ D+ P + LE L + N F P L L+ L + +
Sbjct: 195 LFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 157 SFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
S +L L+LA N + R L N
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 24/90 (26%), Positives = 37/90 (41%), Gaps = 3/90 (3%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
P++ L L EL ++ N ++ P L+ L V N+Q S + L L L
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271
Query: 152 DLSGNSFSGNL--GFLKYFPNLEHLSLAKN 179
+L+ N+ S +L L L L N
Sbjct: 272 NLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 28/150 (18%), Positives = 45/150 (30%), Gaps = 36/150 (24%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSS 144
+ + + + L L L L NS+ + L L + +N + IPS
Sbjct: 87 IQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEY 145
Query: 145 LIRLRVLDLSGNSFS-------GNLGFLKY----------------F---PNLEHLSLAK 178
L +LR L L N + L F NL++L+L
Sbjct: 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205
Query: 179 NLFTGKVPTSIRTFR---NLQFFDFSGNSL 205
+ L+ + SGN
Sbjct: 206 CNI-----KDMPNLTPLVGLEELEMSGNHF 230
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 29/112 (25%), Positives = 42/112 (37%), Gaps = 5/112 (4%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSG 155
L L L L L +L P L+ L +Q+N +P D L L L L G
Sbjct: 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHG 162
Query: 156 NSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N S ++ + +L+ L L +N P + R L N+L
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 27/111 (24%), Positives = 40/111 (36%), Gaps = 3/111 (2%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L+ L+ L L +N+L L D L L + N+ S L L L L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 157 SFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNSL 205
+ + + L L L N + +PT R LQ+ + N
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 23/112 (20%), Positives = 43/112 (38%), Gaps = 6/112 (5%)
Query: 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGN 156
+ + + L N + + C+ L IL + +N + I + + L L LDLS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90
Query: 157 SFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNSL 205
+ ++ L L L + ++ + R LQ+ N+L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 19/221 (8%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ K+G G V+ A N +A+K +++ K E E++ KLL + ++ +
Sbjct: 24 VRKLGWGHFSTVWLA-KDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
++G LL H H+ +V+E + +L ++ L ++ +I+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYV--KQISK 138
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDD------DMEARIADFGLAKAMPDAQTHIT 514
+ GL+Y+H IIH D+KP NVL++ ++ +IAD G A + +
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY-- 192
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+N T Y +PE + DI+S L+ L+ G
Sbjct: 193 -TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 27/204 (13%), Positives = 58/204 (28%), Gaps = 6/204 (2%)
Query: 10 LSLFALLSLLFLSHARLNLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFCERRLSDN 69
L L L+ + + + + ++ I G R +
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI--SNVKLQGQLDFRDFDYS 271
Query: 70 NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNV 129
T + ++ V S S + + + + L+
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331
Query: 130 QNNQFSGTIPSDLSSLIRLRVLDLSGN---SFSGNLGFLKYFPNLEHLSLAKNLFTGKVP 186
NN + T+ + L L L L N S +L+ L +++N +
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 187 TSIRTF-RNLQFFDFSGNSLLEGP 209
++ ++L + S N L +
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTI 415
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 27/128 (21%), Positives = 49/128 (38%), Gaps = 5/128 (3%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
++ + + I LS+LR L +++N + L ++LE L++ +N+ I
Sbjct: 33 ISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PT 89
Query: 146 IRLRVLDLSGNSFS--GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
+ L+ LDLS N+F L+ L L+ I + G
Sbjct: 90 VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149
Query: 204 SLLEGPIP 211
+ E P
Sbjct: 150 TYGEKEDP 157
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 17/87 (19%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155
L L++++N L D + + ++++L++ +N+ +IP + L L+ L+++
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVAS 453
Query: 156 NSFSG-NLGFLKYFPNLEHLSLAKNLF 181
N G +L+ + L N +
Sbjct: 454 NQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 30/127 (23%), Positives = 46/127 (36%), Gaps = 6/127 (4%)
Query: 84 RELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS 143
L V P + L+++ N + +L I+ KL IL + +N+ S
Sbjct: 10 NGLIHV--PK-DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66
Query: 144 SLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSG 202
L LDLS N + NL+HL L+ N F + L+F S
Sbjct: 67 FNQELEYLDLSHNKLV-KISCHP-TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLST 124
Query: 203 NSLLEGP 209
L +
Sbjct: 125 THLEKSS 131
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 10/131 (7%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
K + +T + S LS ++ + N+++ L + L+ L++ +NQ
Sbjct: 20 NAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQI 75
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN 194
S + S L L +L L ++ N NL + L L L N S+ +N
Sbjct: 76 S-DL-SPLKDLTKLEELSVNRNRLK-NLNGIP-SACLSRLFLDNNELRD--TDSLIHLKN 129
Query: 195 LQFFDFSGNSL 205
L+ N L
Sbjct: 130 LEILSIRNNKL 140
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 21/83 (25%), Positives = 38/83 (45%), Gaps = 5/83 (6%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L+ + +L S+ DL+ + ++ N N+ ++ + + L+ L LS N
Sbjct: 18 LANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHN 73
Query: 157 SFSGNLGFLKYFPNLEHLSLAKN 179
S +L LK LE LS+ +N
Sbjct: 74 QIS-DLSPLKDLTKLEELSVNRN 95
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 23/89 (25%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
S+ L L LS+ NN L ++ + KLE+L++ N+ + L+ L ++ +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWI 177
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNL 180
DL+G +KY P L + K+
Sbjct: 178 DLTGQKCVNEP--VKYQPELYITNTVKDP 204
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 24/114 (21%), Positives = 44/114 (38%), Gaps = 14/114 (12%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151
+++ EL L +L LP + ++ +L + N ++P +S L L
Sbjct: 53 LKECLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLPELPAS---LEYL 105
Query: 152 DLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
D N S + +L+HL + N T +P L++ + N L
Sbjct: 106 DACDNRLS---TLPELPASLKHLDVDNNQLT-MLPELP---ALLEYINADNNQL 152
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 26/125 (20%), Positives = 42/125 (33%), Gaps = 17/125 (13%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
+ L ++ NN L L P LE+L+V+NNQ + +P SL LD+S N
Sbjct: 139 PALLEYINADNNQLTML-PELP---TSLEVLSVRNNQLT-FLPELPESL---EALDVSTN 190
Query: 157 SFS------GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210
+ +N T +P +I + N L
Sbjct: 191 LLESLPAVPVRNHHSE--ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247
Query: 211 PVMRR 215
+ +
Sbjct: 248 ESLSQ 252
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 20/125 (16%), Positives = 35/125 (28%), Gaps = 15/125 (12%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR----VLD 152
+ L LS+ NN L L P + LE L+V N ++P+
Sbjct: 159 PTSLEVLSVRNNQLTFL-PELP---ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213
Query: 153 LSGNSFSG---NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
N + N+ L + L N + ++ S+ +
Sbjct: 214 CRENRITHIPENILSL---DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSD 270
Query: 210 IPVMR 214
Sbjct: 271 GQQNT 275
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 14/95 (14%), Positives = 24/95 (25%), Gaps = 5/95 (5%)
Query: 90 LSPSIGRLSELRE----LSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L R E N + + P I+ + +++N S I LS
Sbjct: 195 LPAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQ 253
Query: 146 IRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNL 180
FS + G ++
Sbjct: 254 TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWF 288
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 60/237 (25%), Positives = 86/237 (36%), Gaps = 65/237 (27%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPK--DAAELTEEDSKLLNKKMRQIRSE 399
L+ IG G G+V KA + +A+K V + A + L K+ +
Sbjct: 102 LKVIGKGSFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 400 INTVGQIR------HRNLLPLLAHMARPDC---HLL---VYEFMKNGSLQDI-LNDVSQG 446
+ I RN H+ C LL +YE +K Q L V
Sbjct: 161 V-----IHMLENFTFRN------HI----CMTFELLSMNLYELIKKNKFQGFSLPLV--- 202
Query: 447 RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL--DDDMEARIADFGLAK 504
K A + L+ LH RIIH DLKP N+LL ++ DFG
Sbjct: 203 ---------RKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS-- 248
Query: 505 AMPDAQTHITTSNVAGTVGYI------APEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
+ + Q T YI APE ++ D++S G +LA L+ G
Sbjct: 249 SCYEHQRVYT---------YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-10
Identities = 31/118 (26%), Positives = 48/118 (40%), Gaps = 15/118 (12%)
Query: 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153
+ + LR LSL N + + V LE L + NQ + ++ S + L+ LRVL +
Sbjct: 66 LSGMENLRILSLGRNLIKKIENLDAV-ADTLEELWISYNQIA-SL-SGIEKLVNLRVLYM 122
Query: 154 SGNSFS--GNLGFLKYFPNLEHLSLAKNLFTGKVPTS----------IRTFRNLQFFD 199
S N + G + L LE L LA N + ++ NL+ D
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 27/159 (16%), Positives = 63/159 (39%), Gaps = 14/159 (8%)
Query: 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQ 133
+ +L + + + ++ L + L+L+ N++ + + + L IL++ N
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNL 81
Query: 134 FSGTIPSDLSSLI-RLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTG-KVPTSIRT 191
I +L ++ L L +S N + +L ++ NL L ++ N T +
Sbjct: 82 IK-KI-ENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAA 138
Query: 192 FRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLA 230
L+ +GN P+ + + +Y + V+
Sbjct: 139 LDKLEDLLLAGN-----PLYNDYKENNATSEY-RIEVVK 171
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 38/164 (23%), Positives = 54/164 (32%), Gaps = 38/164 (23%)
Query: 55 CSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLL 114
C V C L VP+E++ + L L NN + +L
Sbjct: 33 CHLRVVQCSDL------------GLKAVPKEIS----------PDTTLLDLQNNDISELR 70
Query: 115 PPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGN---SFSGNLGFLKYFPN 170
+ L L + NN+ S I S L +L+ L +S N NL +
Sbjct: 71 KDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVEIPPNL-----PSS 124
Query: 171 LEHLSLAKNLFTGKVPTSIRTF---RNLQFFDFSGNSLLEGPIP 211
L L + N KVP F RN+ + GN L
Sbjct: 125 LVELRIHDNRIR-KVPKG--VFSGLRNMNCIEMGGNPLENSGFE 165
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 34/162 (20%), Positives = 50/162 (30%), Gaps = 19/162 (11%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSE--------LRELSLANNSLVDLLPPQ 117
+ N F +L L S +L+ L EL L +N + +
Sbjct: 154 MGGNPLENSGFEPGAFDGLKLN-YLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELED 212
Query: 118 IVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSL 176
++ KL L + +NQ I + LS L LR L L N S L L+ + L
Sbjct: 213 LLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYL 271
Query: 177 AKNLFTGKVP-------TSIRTFRNLQFFDFSGNSLLEGPIP 211
N T KV N + +
Sbjct: 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQ 312
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 35/163 (21%), Positives = 53/163 (32%), Gaps = 36/163 (22%)
Query: 55 CSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLL 114
C V C L VP++L + L L NN + ++
Sbjct: 31 CHLRVVQCSDL------------GLEKVPKDLP----------PDTALLDLQNNKITEIK 68
Query: 115 PPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN---SFSGNLGFLKYFPNL 171
+ K L L + NN+ S P + L++L L LS N + L
Sbjct: 69 DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM-----PKTL 123
Query: 172 EHLSLAKNLFTGKVPTSIRTF---RNLQFFDFSGNSLLEGPIP 211
+ L + +N T KV S F + + N L I
Sbjct: 124 QELRVHENEIT-KVRKS--VFNGLNQMIVVELGTNPLKSSGIE 163
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 21/114 (18%), Positives = 42/114 (36%), Gaps = 10/114 (8%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF-SGTIPSD-LSSLIRLRVLDLS 154
L+EL + N + + ++ ++ + N S I + + +L + ++
Sbjct: 120 PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 155 GNSFSG---NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ + L P+L L L N T S++ NL S NS+
Sbjct: 180 DTNITTIPQGL-----PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 22/121 (18%), Positives = 35/121 (28%), Gaps = 6/121 (4%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L EL L N + + + L L + N S L++ LR L L+ N
Sbjct: 191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 250
Query: 157 SFSGNLGFLKYFPNLEHLSLAKNLFTG------KVPTSIRTFRNLQFFDFSGNSLLEGPI 210
G L ++ + L N + P + N + I
Sbjct: 251 KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 310
Query: 211 P 211
Sbjct: 311 Q 311
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 63/225 (28%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
KIGSG G++Y + G+ +AIK E K K Q+ E
Sbjct: 15 RKIGSGSFGDIYLGTDI-AAGEEVAIKL-------------ECVK---TKHPQLHIESKI 57
Query: 403 VGQIRHRNLLP-LLAHMARPDCHLLVYEFMKNG-SLQDILNDVSQGRRELDWLARHKIAL 460
++ +P + A D +++V E + G SL+D+ N R+ +A
Sbjct: 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFN--FCSRK-FSLKTVLLLAD 112
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA---RIADFGLAKAMPDAQT--HI-- 513
+ +EY+H + IHRD+KP N L+ + I DFGLAK DA+T HI
Sbjct: 113 QMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 169
Query: 514 -TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
N+ GT Y + H ++ + + D+ S G +L +G LP
Sbjct: 170 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 49/229 (21%), Positives = 93/229 (40%), Gaps = 41/229 (17%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+IG G G +++ N + +AIK E D+ L + R +
Sbjct: 16 RRIGEGSFGVIFEGT-NLLNNQQVAIKF---------EPRRSDAPQLRDEYRTYKLLAGC 65
Query: 403 VG--QIRHRNLLPLLAHMARPDCHLLVYEFMKNG-SLQDILNDVSQGRR-ELDWLARHKI 458
G + + ++LV + + G SL+D+L+ GR+ + +A
Sbjct: 66 TGIPNVYY--------FGQEGLHNVLVIDLL--GPSLEDLLD--LCGRKFSVKTVAM--A 111
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR-----IADFGLAKAMPDAQT-- 511
A + ++ +H + +++RD+KP N L+ + DFG+ K D T
Sbjct: 112 AKQMLARVQSIH-EKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168
Query: 512 HI---TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
HI N++GT Y++ H + + + D+ + G + + G LP
Sbjct: 169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 56/231 (24%), Positives = 88/231 (38%), Gaps = 51/231 (22%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR-QIRSEI 400
IG G G+V KA + +AIK +I K+ K Q + E+
Sbjct: 59 DSLIGKGSFGQVVKA-YDRVEQEWVAIK-II---KN------------KKAFLNQAQIEV 101
Query: 401 NTVGQIRHR------NLLPLLAH-MARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDW 452
+ + ++ L H M R HL LV+E + +L D+L + R +
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRN--TNFRGVSL 156
Query: 453 LARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA--RIADFGLAKAMPDAQ 510
K A + L +L + IIH DLKP N+LL + + +I DFG + Q
Sbjct: 157 NLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQ 213
Query: 511 THITTSNVAGTVGYI------APEYHQTLKFTDKCDIYSFGVLLAVLVMGR 555
YI +PE + + D++S G +L + G
Sbjct: 214 RIYQ---------YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 20/96 (20%), Positives = 46/96 (47%), Gaps = 4/96 (4%)
Query: 87 TGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLI 146
+ + + L+L++N L + + K+++L++ NN+ +IP D++ L
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQ 473
Query: 147 RLRVLDLSGNSF-SGNLGFLKYFPNLEHLSLAKNLF 181
L+ L+++ N S G +L+++ L N +
Sbjct: 474 ALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 34/211 (16%), Positives = 61/211 (28%), Gaps = 16/211 (7%)
Query: 7 KLNLSLFALLSLLFLSHARLNLDRSDYKALSVI-----LRDLGGQQLFIPSDPCSTPGVF 61
L +LL ++ + L + L L I +
Sbjct: 240 TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY 299
Query: 62 CERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC 121
E L +K +F + S +E+ L+ + +
Sbjct: 300 SETALKSLMIEHVKNQVFLFSK---EALYS----VFAEMNIKMLSISDTPFIHMVCPPSP 352
Query: 122 KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN---SFSGNLGFLKYFPNLEHLSLAK 178
LN N F+ ++ S+L RL+ L L N +F K +LE L ++
Sbjct: 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412
Query: 179 NLFT-GKVPTSIRTFRNLQFFDFSGNSLLEG 208
N + ++ + S N L
Sbjct: 413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 4/89 (4%)
Query: 124 LEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFT 182
+ L++ N S D+S L LRVL LS N + + +LE+L ++ N
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ 113
Query: 183 GKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+ +L+ D S N P+
Sbjct: 114 -NISCC--PMASLRHLDLSFNDFDVLPVC 139
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 27/214 (12%), Positives = 70/214 (32%), Gaps = 15/214 (7%)
Query: 7 KLNLSLFALLSLLFLSHARLNLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVFCERRL 66
+L+L A L L + ++ + S+ + + L + + V +
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN----M 215
Query: 67 SDNNTYVLKITKLVFVPRELTGVLSPS--IGRLSELRELSLANNSLVDLLPPQI---VDC 121
S N L+++ + +++ + R L ++L + ++
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275
Query: 122 KKLEILNVQNNQFSGTIPSDL-----SSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLS 175
+ +E LN+ N + I + ++L L + + F + F +
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
L+ + + + F +F+ N +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 63/229 (27%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
KIGSG GE+Y + +AIK E+ K K Q+ E
Sbjct: 13 RKIGSGSFGEIYLGTNI-QTNEEVAIKL-------------ENVK---TKHPQLLYESKI 55
Query: 403 VGQIRHRNLLP-LLAHMARPDCHLLVYEFMKNG-SLQDILNDVSQGRRELDWLARHKIAL 460
++ +P + D ++LV + + G SL+D+ N R+ K L
Sbjct: 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFN--FCSRK-----LSLKTVL 106
Query: 461 GVAC----GLEYLHISHNPRIIHRDLKPANVLLDDDMEAR---IADFGLAKAMPDAQT-- 511
+A +E++H S + +HRD+KP N L+ A I DFGLAK D T
Sbjct: 107 MLADQMINRVEFVH-SKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 512 HI---TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
HI N+ GT Y + H ++ + + D+ S G +L + G LP
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 23/115 (20%), Positives = 39/115 (33%), Gaps = 7/115 (6%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDL 153
R L+ L L +N + + LE L++ N S + S L L L+L
Sbjct: 74 RCVNLQALVLTSNGINTI-EEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 154 SGNSFS--GNLGFLKYFPNLEHLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNSL 205
GN + G + L+ L + K+ L+ + + L
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 24/118 (20%), Positives = 38/118 (32%), Gaps = 3/118 (2%)
Query: 96 RLSELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDL 153
LS L L+L N L + KL+IL V N I + L L L++
Sbjct: 122 PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI 181
Query: 154 SGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210
+ LK N+ HL L + + +++ + L
Sbjct: 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 17/120 (14%), Positives = 33/120 (27%), Gaps = 12/120 (10%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDLS 154
L+ L EL + + L P + + + L + Q + + L+L
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230
Query: 155 GNSFSGN---------LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L ++ + +V + L +FS N L
Sbjct: 231 DTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQL 289
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 25/130 (19%), Positives = 41/130 (31%), Gaps = 12/130 (9%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSDLSS 144
L S+ + + L L LL VD +E L +++ S+LS+
Sbjct: 186 LQSYEPKSLKSIQNVSHLILHMKQH-ILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244
Query: 145 --------LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSI-RTFRNL 195
R + ++ S + L L L ++N VP I +L
Sbjct: 245 GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSL 303
Query: 196 QFFDFSGNSL 205
Q N
Sbjct: 304 QKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 19/124 (15%), Positives = 37/124 (29%), Gaps = 10/124 (8%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVD-CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154
L++L+ L + N + + LE L + + P L S+ + L L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 155 GNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRT--------FRNLQFFDFSGNSL 205
F+ ++E L L + + T + + SL
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 206 LEGP 209
+
Sbjct: 267 FQVM 270
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 15/76 (19%), Positives = 29/76 (38%), Gaps = 3/76 (3%)
Query: 84 RELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-L 142
EL+ + S+ + R + + + SL + + L L NQ ++P
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLK-SVPDGIF 297
Query: 143 SSLIRLRVLDLSGNSF 158
L L+ + L N +
Sbjct: 298 DRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 25/122 (20%), Positives = 50/122 (40%), Gaps = 10/122 (8%)
Query: 88 GVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIR 147
+ + ++ SL + P + + ++ L++ NN+ + SDL +
Sbjct: 21 ESSNQASLSCDRNGICKGSSGSLNSI-PSGL--TEAVKSLDLSNNRITYISNSDLQRCVN 77
Query: 148 LRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFR---NLQFFDFSGN 203
L+ L L+ N + +LEHL L+ N + + +S F+ +L F + GN
Sbjct: 78 LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSS--WFKPLSSLTFLNLLGN 134
Query: 204 SL 205
Sbjct: 135 PY 136
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 56/233 (24%), Positives = 94/233 (40%), Gaps = 49/233 (21%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+KIG G GE+ + + +AIK E + + L+ + R + +
Sbjct: 15 KKIGCGNFGELRLGKNL-YTNEYVAIK---------LEPMKSRAPQLHLEYRFYKQLGSG 64
Query: 403 VG--QIRHRNLLPLLAHMARPDCHLLVYEFMKNG-SLQDILNDVSQGRR-ELDWLARHKI 458
G Q+ + + +V E + G SL+D+ + R L K
Sbjct: 65 DGIPQVYY--------FGPCGKYNAMVLELL--GPSLEDLFD--LCDRTFSL------KT 106
Query: 459 ALGVAC----GLEYLHISHNPRIIHRDLKPANVLLDDDMEAR-----IADFGLAKAMPDA 509
L +A +EY+H S N +I+RD+KP N L+ I DF LAK D
Sbjct: 107 VLMIAIQLISRMEYVH-SKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163
Query: 510 QT--HI---TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
+T HI ++ GT Y++ H + + + D+ + G + + G LP
Sbjct: 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 37/197 (18%), Positives = 65/197 (32%), Gaps = 10/197 (5%)
Query: 16 LSLLFLSHARLNLDRSD--YKALSVI-LRDLGGQQLFIPSDPCSTPGVFCERRLSDNNTY 72
++ L LS + + A++ ++ L + +
Sbjct: 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273
Query: 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVD-CKKLEILNVQN 131
+ ++ +L ++L +L+LA N + + L LN+
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI-DDNAFWGLTHLLKLNLSQ 332
Query: 132 NQFSGTIPSDL-SSLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSI 189
N +I S + +L +L VLDLS N PNL+ L+L N VP I
Sbjct: 333 NFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGI 390
Query: 190 -RTFRNLQFFDFSGNSL 205
+LQ N
Sbjct: 391 FDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 19/91 (20%), Positives = 26/91 (28%), Gaps = 4/91 (4%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF-SGTIPSDL-SSLIRLRVLDL 153
LS L L L N + L LE+L + + + L L +L L
Sbjct: 77 GLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVL 136
Query: 154 SGNSFS--GNLGFLKYFPNLEHLSLAKNLFT 182
N+ F L L N
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 30/126 (23%), Positives = 47/126 (37%), Gaps = 28/126 (22%)
Query: 96 RLSELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDL 153
RL+ L L L++N L + + V L L++ +N T+ S L L VL L
Sbjct: 62 RLTNLHSLLLSHNHLNFI-SSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 154 SGN--------SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN------LQFFD 199
N +F L+ L L++N + + P ++ L D
Sbjct: 120 YNNHIVVVDRNAFED-------MAQLQKLYLSQNQIS-RFPV--ELIKDGNKLPKLMLLD 169
Query: 200 FSGNSL 205
S N L
Sbjct: 170 LSSNKL 175
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 26/86 (30%), Positives = 35/86 (40%), Gaps = 6/86 (6%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIP----SDLSSLIRLRVL 151
L L L L NN +V + D +L+ L + NQ S P D + L +L +L
Sbjct: 110 DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLL 168
Query: 152 DLSGNSFSG-NLGFLKYFPNLEHLSL 176
DLS N L L+ P L
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 50/254 (19%), Positives = 90/254 (35%), Gaps = 83/254 (32%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIK--KVIQPPKDAAELTEEDS-KLLNKKMRQIRS 398
++ +G G G+V + + G+ +A+K K + +AA +E + LN
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-RSEIQVLEHLNTTDPNSTF 77
Query: 399 EINTVGQIR------HRNLLPLLAHMARPDC---HLL---VYEFMKNGSLQDI-LNDVSQ 445
++ H H+ C LL Y+F+K L+ +
Sbjct: 78 RC-----VQMLEWFEHHG------HI----CIVFELLGLSTYDFIKENGFLPFRLDHI-- 120
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-------------- 491
K+A + + +LH + ++ H DLKP N+L
Sbjct: 121 ----------RKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167
Query: 492 -----DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYI------APEYHQTLKFTDKCD 540
+ + ++ DFG A D + H T + APE L ++ CD
Sbjct: 168 ERTLINPDIKVVDFG--SATYDDEHHST---------LVSTRHYRAPEVILALGWSQPCD 216
Query: 541 IYSFGVLLAVLVMG 554
++S G +L +G
Sbjct: 217 VWSIGCILIEYYLG 230
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 38/120 (31%), Positives = 50/120 (41%), Gaps = 12/120 (10%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRV 150
G L L L L++N L L P L +L+V N+ + ++P L L+
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQE 128
Query: 151 LDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFR---NLQFFDFSGNSL 205
L L GN L G L P LE LSLA N T ++P + NL NSL
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL--LNGLENLDTLLLQENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 29/119 (24%), Positives = 44/119 (36%), Gaps = 10/119 (8%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVD-CKKLEILNVQNNQFSGTIPSDL-SSLIR 147
L L L L ++ N L LP + +L+ L ++ N+ T+P L + +
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149
Query: 148 LRVLDLSGN---SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
L L L+ N L NL+ L L +N +P L F GN
Sbjct: 150 LEKLSLANNNLTELPAGL-LNG-LENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 28/124 (22%), Positives = 48/124 (38%), Gaps = 17/124 (13%)
Query: 90 LSPSI-GRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRL 148
S + + L +L+L L L L L++ +NQ ++P +L L
Sbjct: 46 FSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPAL 102
Query: 149 RVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSI--RTFR---NLQFFDFS 201
VLD+S N + +L G L+ L+ L L N ++ L+ +
Sbjct: 103 TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL-----KTLPPGLLTPTPKLEKLSLA 156
Query: 202 GNSL 205
N+L
Sbjct: 157 NNNL 160
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 27/110 (24%), Positives = 41/110 (37%), Gaps = 7/110 (6%)
Query: 97 LSELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155
++ E++ +L L PP + D IL++ N + L RL L+L
Sbjct: 9 VASHLEVNCDKRNLTAL-PPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 156 NSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
+ L P L L L+ N +P +T L D S N L
Sbjct: 65 AELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL 112
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 52/266 (19%), Positives = 89/266 (33%), Gaps = 85/266 (31%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIK--KVIQPPKDAAELTEEDS-KLLNKKMRQIRS 398
+ +G G G+V + +A+K + + ++AA E + K + +K ++ +
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-RLEINVLKKIKEKDKENKF 82
Query: 399 EINTVGQIR------HRNLLPLLAHMARPDC---HLL---VYEFMKNGSLQDI-LNDVSQ 445
+ HM C LL +EF+K + Q L V
Sbjct: 83 LC-----VLMSDWFNFHG------HM----CIAFELLGKNTFEFLKENNFQPYPLPHV-- 125
Query: 446 GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA---------- 495
+A + L +LH ++ H DLKP N+L +
Sbjct: 126 ----------RHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 496 ---------RIADFGLAKAMPDAQTHITTSNVAGTVGYI------APEYHQTLKFTDKCD 540
R+ADFG A D + H T + PE L + CD
Sbjct: 173 EKSVKNTSIRVADFG--SATFDHEHHTT---------IVATRHYRPPEVILELGWAQPCD 221
Query: 541 IYSFGVLLAVLVMGRL--PSDDFFQH 564
++S G +L G + + +H
Sbjct: 222 VWSIGCILFEYYRGFTLFQTHENREH 247
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 26/125 (20%), Positives = 47/125 (37%), Gaps = 18/125 (14%)
Query: 66 LSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSE----LRELSLANNSLVDL--LPPQIV 119
L + + + + V ++ ++ + E L L+L+NN L L + +
Sbjct: 134 LKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQ 193
Query: 120 DCKKLEILNVQNNQFSGTIPSDLSSL--IRLRVLDLSGNSFSGNLG--------FLKYFP 169
L+ILN+ N+ +L + ++L L L GNS + FP
Sbjct: 194 KAPNLKILNLSGNELKS--ERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFP 251
Query: 170 NLEHL 174
L L
Sbjct: 252 KLLRL 256
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 16/129 (12%), Positives = 42/129 (32%), Gaps = 10/129 (7%)
Query: 84 RELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL- 142
+++ + PS+ + L L L + + + + V + + S
Sbjct: 21 KDIQRI--PSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF 76
Query: 143 SSLIRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVP--TSIRTFRNLQFF 198
+L ++ +++ + LK P L+ L + P T + +
Sbjct: 77 YNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFIL 135
Query: 199 DFSGNSLLE 207
+ + N +
Sbjct: 136 EITDNPYMT 144
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 16/110 (14%), Positives = 40/110 (36%), Gaps = 9/110 (8%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVD--CKKLEILNVQNNQFSGTIPSDLSSLIRLR 149
+ L + +N + +P C + L + NN F+ ++ + +L
Sbjct: 124 TKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD 182
Query: 150 VLDLSGNSFSGNLG---FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQ 196
+ L+ N + + F + L +++ T +P+ +L+
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLK 229
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 31/135 (22%), Positives = 50/135 (37%), Gaps = 19/135 (14%)
Query: 90 LSPSIGRLSELRELSLANNSLVD-----LLPPQIVDCKKLEILNVQNNQFSGT----IPS 140
+S ++ L EL+L +N L D +L K++ L++QN +G + S
Sbjct: 48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107
Query: 141 DLSSLIRLRVLDLSGNSFSGN------LGFLKYFPNLEHLSLAKNLFTGKVPTSI----R 190
L +L L+ L LS N G L LE L L + + R
Sbjct: 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR 167
Query: 191 TFRNLQFFDFSGNSL 205
+ + S N +
Sbjct: 168 AKPDFKELTVSNNDI 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 44/168 (26%), Positives = 63/168 (37%), Gaps = 36/168 (21%)
Query: 66 LSDNNTYVLKITKLVFVPRELT----GVLSPSIGRLSELRELSLANNSLVD--------- 112
L + KI KL LT GVLS ++ L L+EL L++N L D
Sbjct: 80 LQTPSC---KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG 136
Query: 113 LLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIR----LRVLDLSGNSFSGNLGF---- 164
LL P +LE L ++ S L+S++R + L +S N G
Sbjct: 137 LLDP----QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI-NEAGVRVLC 191
Query: 165 --LKYFP-NLEHLSLAKNLFTGK----VPTSIRTFRNLQFFDFSGNSL 205
LK P LE L L T + + + +L+ N L
Sbjct: 192 QGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 31/135 (22%), Positives = 47/135 (34%), Gaps = 19/135 (14%)
Query: 90 LSPSIGRLSELRELSLANNSLVD-----LLPPQIVDCKKLEILNVQNNQFS----GTIPS 140
L + + LREL+L +N L D L P + +L L + + G +
Sbjct: 219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278
Query: 141 DLSSLIRLRVLDLSGNSFSGN------LGFLKYFPNLEHLSLAKNLFTGK----VPTSIR 190
L + L+ L L+GN L+ LE L + FT + +
Sbjct: 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 338
Query: 191 TFRNLQFFDFSGNSL 205
R L S N L
Sbjct: 339 QNRFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 29/128 (22%), Positives = 53/128 (41%), Gaps = 25/128 (19%)
Query: 98 SELRELSLANNSLVD-----LLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIR----L 148
+++ L + L D LLP ++ +++ + + + D+SS +R L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLP----LLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 58
Query: 149 RVLDLSGNSFSGNLGF------LKYF-PNLEHLSLAKNLFTGK----VPTSIRTFRNLQF 197
L+L N G++G L+ ++ LSL TG + +++RT LQ
Sbjct: 59 AELNLRSNEL-GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQE 117
Query: 198 FDFSGNSL 205
S N L
Sbjct: 118 LHLSDNLL 125
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 31/125 (24%), Positives = 44/125 (35%), Gaps = 21/125 (16%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDL 153
L L L + +N L LP + D L L + NQ ++P + SL +L L L
Sbjct: 83 ELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140
Query: 154 SGNSFSGNLGFLKYFP--------NLEHLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNS 204
N L+ P +L+ L L N +VP L+ N
Sbjct: 141 GYNE-------LQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQ 192
Query: 205 LLEGP 209
L P
Sbjct: 193 LKRVP 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 34/110 (30%), Positives = 45/110 (40%), Gaps = 22/110 (20%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDL 153
RL++LR L L +N L LP I K LE L V +N+ +P + L+ L L L
Sbjct: 59 RLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 154 SGNSFSGNLGFLKYFP--------NLEHLSLAKNLFTGKVPTSIRTFRNL 195
N LK P L +LSL N +P + F L
Sbjct: 117 DRNQ-------LKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV--FDKL 156
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 2e-06
Identities = 21/93 (22%), Positives = 33/93 (35%), Gaps = 3/93 (3%)
Query: 115 PPQIVDCKKLEILNVQNNQFSGTIPS-DLSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLE 172
+ + L L ++N Q + DL L LR L + + + P L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 173 HLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L+L+ N + +LQ SGN L
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 2e-06
Identities = 23/128 (17%), Positives = 38/128 (29%), Gaps = 24/128 (18%)
Query: 55 CSTP-GVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL 113
G+ C R + L G L EL + N +
Sbjct: 7 PHGSSGLRCTRDG------------ALDSLHHLPG--------AENLTELYIENQQHLQH 46
Query: 114 LPPQ-IVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFSGNLGFLKYFPNL 171
L + + +L L + + + D RL L+LS N+ +L
Sbjct: 47 LELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL 105
Query: 172 EHLSLAKN 179
+ L L+ N
Sbjct: 106 QELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 14/92 (15%), Positives = 26/92 (28%), Gaps = 11/92 (11%)
Query: 116 PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL--GFLKYFPNLEH 173
+ C + L L L + +L L+ L +
Sbjct: 10 SSGLRC---------TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 174 LSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L++ K+ P + L + S N+L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 31/117 (26%), Positives = 46/117 (39%), Gaps = 9/117 (7%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD--LSSLIRLRVLDL 153
LS L++L +L L I K L+ LNV +N + S+L L LDL
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDL 156
Query: 154 SGNSF-SGNLGFLKYFPNLEHLSLAKNLFTGKVPTSI--RTFR--NLQFFDFSGNSL 205
S N S L+ + L+L+ +L + I F+ L+ N L
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQL 212
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 24/117 (20%), Positives = 43/117 (36%), Gaps = 5/117 (4%)
Query: 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDLSGN 156
+ L L+ N L L +L++L++ + TI SL L L L+GN
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 157 SFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
+L G +L+ L + I + L+ + + N + +P
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 23/121 (19%), Positives = 41/121 (33%), Gaps = 22/121 (18%)
Query: 65 RLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVD-CKK 123
++ N I +L S L+ L L L++N + + + +
Sbjct: 130 NVAHN-----LIQSF-----KLPEYFS----NLTNLEHLDLSSNKIQSI-YCTDLRVLHQ 174
Query: 124 LEILNVQ----NNQFSGTIPSDLSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLEHLSLAK 178
+ +LN+ N + I IRL+ L L N G +L+ + L
Sbjct: 175 MPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 233
Query: 179 N 179
N
Sbjct: 234 N 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 52/265 (19%), Positives = 85/265 (32%), Gaps = 67/265 (25%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR-SEI 400
+ K+G G V+ + K +A+K V +E +LL + +R S+
Sbjct: 42 IRKLGWGHFSTVWLSW-DIQGKKFVAMKVVKSAEHYTETALDE-IRLL----KSVRNSDP 95
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
N + LL H+ +V+E + + L + + L + + I
Sbjct: 96 NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--II 152
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLL------------------------------ 489
V GL+YLH RIIH D+KP N+LL
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 490 -------------------DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH 530
+ ++ +IAD G A + T T Y + E
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVL 265
Query: 531 QTLKFTDKCDIYSFGVLLAVLVMGR 555
+ DI+S + L G
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGD 290
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 7e-06
Identities = 15/112 (13%), Positives = 34/112 (30%), Gaps = 17/112 (15%)
Query: 88 GVLSPSIGRLSELRELSL--------ANNSLVDLLP-PQIVDCKKLEILNVQNNQFSGTI 138
V L L +L L + + P L+ L + + + +
Sbjct: 209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVV 268
Query: 139 PSDLSS---LIRLRVLDLSGNSFSGN-----LGFLKYFPNLEHLSLAKNLFT 182
L +L +D+S + L + +L+ +++ N +
Sbjct: 269 VEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 23/131 (17%), Positives = 40/131 (30%), Gaps = 18/131 (13%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL--SSLIR 147
LSP + + L L + + + + L+ L + + ++ D+ S L
Sbjct: 164 LSPVLDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDILGSDLPN 220
Query: 148 LRVLDLSGNS--FSGNLG--------FLKYFPNLEHLSLAKNLFTGKVPTSIRTFR---N 194
L L L + + FPNL+ L + V
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 195 LQFFDFSGNSL 205
L+ D S L
Sbjct: 281 LETMDISAGVL 291
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.5 bits (96), Expect = 6e-04
Identities = 9/84 (10%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 83 PRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC---KKLEILNVQNNQFSGT-- 137
+ S R L+ L + + +++ ++ +LE +++ +
Sbjct: 239 MNVFRPLFSK--DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGA 296
Query: 138 --IPSDLSSLIRLRVLDLSGNSFS 159
+ + + L+ +++ N S
Sbjct: 297 RLLLDHVDKIKHLKFINMKYNYLS 320
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 25/159 (15%), Positives = 44/159 (27%), Gaps = 31/159 (19%)
Query: 55 CSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLL 114
CS C+ K+ +P +L EL L +
Sbjct: 9 CSNRVFLCQES------------KVTEIPSDL----------PRNAIELRFVLTKLRVIQ 46
Query: 115 PPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLDLSGNSFSGNL-----GFLKYF 168
LE + + N I +D S+L +L + + + NL +
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN---NLLYINPEAFQNL 103
Query: 169 PNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207
PNL++L ++ D N +
Sbjct: 104 PNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 142
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 18/112 (16%), Positives = 33/112 (29%), Gaps = 3/112 (2%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSL-IRLRVLDLS 154
L L+ L ++N + L + + +L++Q+N TI + L +L L+
Sbjct: 103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162
Query: 155 GNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
N + E N D S +
Sbjct: 163 KNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 6/89 (6%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGTIPSD-LSSLIR 147
+ S ++L EL+L++N+ ++ LP + IL++ + ++PS L +L +
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKK 227
Query: 148 LRVLDLSGNSFSGNLGFLKYFPNLEHLSL 176
LR L L+ L SL
Sbjct: 228 LRARSTYNLK---KLPTLEKLVALMEASL 253
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 20/89 (22%), Positives = 41/89 (46%), Gaps = 5/89 (5%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVD-CKKLEILNVQNNQFSGTIPSDL-SSLIRLRVLDL 153
S + E+ L +N L + + ++ + L+ L +++N+ + + +D L +R+L L
Sbjct: 79 GASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136
Query: 154 SGNSF-SGNLGFLKYFPNLEHLSLAKNLF 181
N + G +L L+L N F
Sbjct: 137 YDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 20/103 (19%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154
+L +LR+++ +NN + D + + + + + +N+ L L+ L L
Sbjct: 55 KLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113
Query: 155 GNSFSG-NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQ 196
N + ++ LSL N T V F L
Sbjct: 114 SNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG--AFDTLH 153
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 54/257 (21%), Positives = 85/257 (33%), Gaps = 85/257 (33%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIK--KVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+ K+G G G V N K A+K + I+ +A E + +L KK++
Sbjct: 40 IRKMGDGTFGRVLLC-QHIDNKKYYAVKVVRNIKKYTRSA-KIE--ADIL-KKIQNDDIN 94
Query: 400 INTVGQIR----HRNLLPLLAHMARPDC---HLL---VYEFMKNGSLQDI-LNDVSQGRR 448
N + + + + HM C L +YE + + + D+
Sbjct: 95 NNNIVKYHGKFMYYD------HM----CLIFEPLGPSLYEIITRNNYNGFHIEDI----- 139
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA------------- 495
+ + L YL + H DLKP N+LLDD
Sbjct: 140 -------KLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189
Query: 496 ------------RIADFGLAKAMPDAQTHITTSNVAGTVGYI------APEYHQTLKFTD 537
++ DFG A + H + I APE L +
Sbjct: 190 KIQIYRTKSTGIKLIDFG--CATFKSDYHGS---------IINTRQYRAPEVILNLGWDV 238
Query: 538 KCDIYSFGVLLAVLVMG 554
D++SFG +LA L G
Sbjct: 239 SSDMWSFGCVLAELYTG 255
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 27/117 (23%), Positives = 44/117 (37%), Gaps = 17/117 (14%)
Query: 96 RLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154
+LR + L+NN + + L P + L L + N+ + S L L++L L+
Sbjct: 54 PYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112
Query: 155 GN--------SFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
N +F +L NL LSL N + R +Q + N
Sbjct: 113 ANKINCLRVDAFQ-DL------HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 22/120 (18%), Positives = 42/120 (35%), Gaps = 4/120 (3%)
Query: 62 CERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVD-LLPPQIVD 120
+ + PR ++ + L+N+ + L +
Sbjct: 57 KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQ 116
Query: 121 CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGF---LKYFPNLEHLSLA 177
C KL+ L+++ + S I + L+ L L+LSG S L L+ L+L+
Sbjct: 117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 176
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 19/145 (13%), Positives = 44/145 (30%), Gaps = 29/145 (20%)
Query: 89 VLSPSIGRLSELRELSLANNSL----VDLLPPQIVDCKKLEILNVQNNQFS--------- 135
+L ++ + +L + L++N+ + L + LE L + NN
Sbjct: 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 136 ----GTIPSDLSSLIRLRVLDLSGNSFSGNLG------FLKYFPNLEHLSLAKNLFTGK- 184
+ + LR + N N + L + + +N +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 185 ----VPTSIRTFRNLQFFDFSGNSL 205
+ + + L+ D N+
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTF 228
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 32/149 (21%), Positives = 47/149 (31%), Gaps = 34/149 (22%)
Query: 90 LSPSIGRLSELRELSLANNSLVD----LLPPQIVDCKKLEILNVQNNQ---FSGTIPSDL 142
+ + ++E+ L+ N++ L I K LEI + IP L
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 143 SSLIR-------LRVLDLSGNSFSGNLG------FLKYFPNLEHLSLAKN---------- 179
L++ L + LS N+F G FL LEHL L N
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAF-GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 142
Query: 180 ---LFTGKVPTSIRTFRNLQFFDFSGNSL 205
L V + L+ N L
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 27/129 (20%), Positives = 43/129 (33%), Gaps = 22/129 (17%)
Query: 98 SELRELSLANNSL----VDLLPPQIVDCKKLEILNVQNNQF-----SGTIPSDLSSLIRL 148
LR + N L + + L + + N + L+ L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218
Query: 149 RVLDLSGNSFSGNLG------FLKYFPNLEHLSLAKNLFTGKVPTSI------RTFRNLQ 196
+VLDL N+F +LG LK +PNL L L L + + ++ LQ
Sbjct: 219 KVLDLQDNTF-THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ 277
Query: 197 FFDFSGNSL 205
N +
Sbjct: 278 TLRLQYNEI 286
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 15/110 (13%), Positives = 35/110 (31%), Gaps = 3/110 (2%)
Query: 96 RLSELRELSLANNSLVDL--LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153
L + + + +++L + ++ ++ + +L +L L L
Sbjct: 218 NCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGL 277
Query: 154 SGNSFSGNLGFLKYFPNLEHLSLAK-NLFTGKVPTSIRTFRNLQFFDFSG 202
S + + + L L L T T I+ NL+ +
Sbjct: 278 SYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN 327
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 38/144 (26%), Positives = 53/144 (36%), Gaps = 21/144 (14%)
Query: 77 TKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFS 135
KL L + + L++L L+L N L L + D +L L + NNQ +
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA 96
Query: 136 GTIPSDL-SSLIRLRVLDLSGNSFSGNLGFLKYFP--------NLEHLSLAKNLFTGKVP 186
++P + L +L L L GN LK P L+ L L N +P
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQ-------LKSLPSGVFDRLTKLKELRLNTNQLQ-SIP 147
Query: 187 TSI-RTFRNLQFFDFSGNSLLEGP 209
NLQ S N L P
Sbjct: 148 AGAFDKLTNLQTLSLSTNQLQSVP 171
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 35/165 (21%), Positives = 58/165 (35%), Gaps = 45/165 (27%)
Query: 50 IPSD-PCSTPGVFCE-RRLSDNNTY--VLKITKLVFVPRELTGVLSPSIGRLSELRELSL 105
P D T + + ++D T + I +++ ++ V I L +R L+L
Sbjct: 13 FPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLAL 70
Query: 106 ANN---------SLVDL------------LPPQIVDC-KKLEILNVQNNQFSGTIPSDL- 142
N L +L LP + D L+ L + NQ ++P +
Sbjct: 71 GGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVF 129
Query: 143 SSLIRLRVLDLSGNSFSGNLGFLKYFP--------NLEHLSLAKN 179
L L L+L+ N L+ P NL L L+ N
Sbjct: 130 DKLTNLTYLNLAHNQ-------LQSLPKGVFDKLTNLTELDLSYN 167
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 633 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.93 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.88 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.85 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.83 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.82 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.79 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.79 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.78 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.76 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.76 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.76 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.76 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.76 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.76 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.76 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.76 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.74 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.74 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.74 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.74 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.74 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.73 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.73 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.73 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.72 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.72 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.72 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.7 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.7 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.7 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.7 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.7 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.69 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.69 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.68 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.68 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.68 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.68 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.68 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.68 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.66 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.66 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.66 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.65 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.65 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.65 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.65 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.64 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.63 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.63 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.63 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.63 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.63 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.63 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.63 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.63 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.62 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.62 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.62 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.62 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.62 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.61 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.61 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.61 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.61 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.61 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.6 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.6 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.6 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.6 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.6 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.59 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.59 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.58 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.58 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.58 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.57 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.57 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.56 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.55 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.55 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.54 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.53 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.53 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.52 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.5 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.48 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.47 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.46 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.45 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.44 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.43 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.42 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.41 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.4 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.38 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.37 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.36 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.36 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.33 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.14 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.14 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.04 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.02 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.01 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.98 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.85 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.73 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.67 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.55 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.51 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.5 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.46 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.42 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.41 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.07 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.83 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.8 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.77 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.51 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.44 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.42 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.38 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.36 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.32 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.23 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.21 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.2 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.12 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.09 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.08 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.87 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.28 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.58 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.83 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.2 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.39 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=439.70 Aligned_cols=263 Identities=21% Similarity=0.377 Sum_probs=212.7
Q ss_pred hcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|.+.+.||+|+||+||+|++.+ .++..||||++..... ...++|.+|++++++++||||
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------------~~~~~f~~E~~il~~l~HpnI 77 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--------------NARKDFHREAELLTNLQHEHI 77 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--------------HHHHHHHHHHHHHTTCCCTTB
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--------------HHHHHHHHHHHHHHhCCCCCC
Confidence 4678889999999999999998742 3578999999864321 115679999999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVS---------QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di 482 (633)
|+++|+|.+++..++|||||++|+|.++++... .....++|.++..|+.||++||+|| |+++|+||||
T Consensus 78 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDl 154 (299)
T 4asz_A 78 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDL 154 (299)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred ccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCcc
Confidence 999999999999999999999999999997632 2245799999999999999999999 6789999999
Q ss_pred CCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccc
Q 006739 483 KPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDF 561 (633)
Q Consensus 483 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~ 561 (633)
||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.
T Consensus 155 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~ 234 (299)
T 4asz_A 155 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234 (299)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999997765544433344679999999999999999999999999999999999 89999764
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
. ..++...+ .....+.. +......+.+++.+||+.||++|||++|+.+.|+++.
T Consensus 235 ~----~~~~~~~i---~~~~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 235 S----NNEVIECI---TQGRVLQR----------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp C----HHHHHHHH---HHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----HHHHHHHH---HcCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2 22222222 22222110 1111234788999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-55 Score=435.21 Aligned_cols=265 Identities=24% Similarity=0.398 Sum_probs=203.5
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...+++++.++||+|+||+||+|+++ ..||||+++...... +..++|.+|++++++++|||||+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~------------~~~~~f~~E~~il~~l~HpNIV~ 96 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTP------------EQFQAFRNEVAVLRKTRHVNILL 96 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCH------------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCH------------HHHHHHHHHHHHHHhCCCCCEee
Confidence 34578889999999999999999863 259999986543221 12567999999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++|++.+ +..++|||||++|+|.++++.. ...++|..+..|+.|||+||+|| |+++||||||||+|||+++++
T Consensus 97 l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NILl~~~~ 169 (307)
T 3omv_A 97 FMGYMTK-DNLAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIFLHEGL 169 (307)
T ss_dssp EEEEECS-SSCEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEEEETTE
T ss_pred EEEEEEC-CeEEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEEECCCC
Confidence 9998865 5689999999999999999752 35699999999999999999999 568999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
.+||+|||+|+...............||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+... ...+
T Consensus 170 ~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~---~~~~ 246 (307)
T 3omv_A 170 TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN---RDQI 246 (307)
T ss_dssp EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHH
T ss_pred cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh---HHHH
Confidence 999999999987765443333345689999999999864 4689999999999999999999999975422 1112
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhhC
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~~ 633 (633)
...+.. ....+.. ...+......+.+++.+||+.||++||||.|+++.|+.+++
T Consensus 247 ~~~~~~---~~~~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 247 IFMVGR---GYASPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp HHHHHT---TCCCCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred HHHHhc---CCCCCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 222211 1111100 01111222347889999999999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=439.69 Aligned_cols=263 Identities=22% Similarity=0.362 Sum_probs=204.6
Q ss_pred hcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|...++||+|+||.||+|++++ .+++.||||++..... ...++|.+|++++++++||||
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------------~~~~~f~~E~~il~~l~HpnI 105 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--------------SARQDFQREAELLTMLQHQHI 105 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--------------HHHHHHHHHHHHHTTCCCTTB
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--------------HHHHHHHHHHHHHHhCCCCCC
Confidence 3567888999999999999998742 4688999999864321 115679999999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-----------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
|+++|+|.+.+..++|||||++|+|.++++.... ...+++|.++..|+.||++||+|| |+++||||
T Consensus 106 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHR 182 (329)
T 4aoj_A 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHR 182 (329)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred CcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecc
Confidence 9999999999999999999999999999976432 134699999999999999999999 57889999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 183 DLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~ 262 (329)
T 4aoj_A 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262 (329)
T ss_dssp CCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred cccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999998765544444455679999999999999999999999999999999999 899997
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.. ...+.+.+. ....+.. ++.....+.+++.+||+.||++||||+||++.|+.+.
T Consensus 263 ~~~----~~~~~~~i~---~g~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 263 QLS----NTEAIDCIT---QGRELER----------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp SSC----HHHHHHHHH---HTCCCCC----------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCC----HHHHHHHHH---cCCCCCC----------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 632 222222222 2222110 1111234788999999999999999999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=437.84 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=212.4
Q ss_pred cCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.+++..++||+|+||+||+|++. +.+++.||||++....... ..++|.+|+.++++++|||||
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~-------------~~~~f~~E~~il~~l~HpNIV 92 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP-------------LREEFRHEAMLRARLQHPNVV 92 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH-------------HHHHHHHHHHHHHhCCCCCCC
Confidence 45677899999999999999873 2467899999986443211 146799999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
+++|+|.+++..++|||||++|||.+++..... ....++|..+..|+.|||+||+|| |+++||||
T Consensus 93 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHR 169 (308)
T 4gt4_A 93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHK 169 (308)
T ss_dssp CEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred CcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCCCCC
Confidence 999999999999999999999999999975322 134689999999999999999999 67889999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||||+|||+++++.+||+|||+|+...........+...||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 170 DLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~ 249 (308)
T 4gt4_A 170 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 249 (308)
T ss_dssp CCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999997755443333455689999999999999999999999999999999998 899997
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.. ..++.+.+. .....+. ++.....+.+++.+||+.||++||||+||++.|+.+.
T Consensus 250 ~~~----~~~~~~~i~---~~~~~~~----------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 250 GYS----NQDVVEMIR---NRQVLPC----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TCC----HHHHHHHHH---TTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCC----HHHHHHHHH---cCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 642 223333332 2222110 1112234788999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=426.98 Aligned_cols=254 Identities=19% Similarity=0.347 Sum_probs=202.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
-++|++++.||+|+||+||+|++. .+|+.||||++....... +..+.+.+|++++++++|||||+++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~------------~~~~~~~~E~~il~~l~HpnIV~~~ 89 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKST-EDGRQYVIKEINISRMSS------------KEREESRREVAVLANMKHPNIVQYR 89 (350)
T ss_dssp CCCEEEEEEC------CEEEEEET-TTCCEEEEEEEECTTSCH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHCCH------------HHHHHHHHHHHHHHHCCCCCCCcEE
Confidence 368999999999999999999864 579999999997654321 1256789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..|+|||||+||+|.+++... ....+++..++.|+.||+.||+|| |+++|+||||||+|||+++++.+
T Consensus 90 ~~~~~~~~~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~v 164 (350)
T 4b9d_A 90 ESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTV 164 (350)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCCE
Confidence 9999999999999999999999999752 245689999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+|+....... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.... ..+.+.
T Consensus 165 Kl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~ 235 (350)
T 4b9d_A 165 QLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVL 235 (350)
T ss_dssp EECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHH
T ss_pred EEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHH
Confidence 9999999987654221 1234679999999999999999999999999999999999999997532 122222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.....+. .. ... ...+.+++.+||+.||++|||++|+++
T Consensus 236 ~i~~~~~~~--~~-----~~~---s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 236 KIISGSFPP--VS-----LHY---SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHTCCCC--CC-----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCC--CC-----ccC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 232222211 00 111 223778999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=424.51 Aligned_cols=257 Identities=23% Similarity=0.284 Sum_probs=205.1
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....+.|+..++||+|+||.||+|++. .+|+.||||++..... ..+|+.++++++|||||
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~-~~g~~vAiK~i~~~~~-------------------~~~E~~il~~l~HpnIV 113 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDK-QTGFQCAVKKVRLEVF-------------------RVEELVACAGLSSPRIV 113 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTC-------------------CTHHHHTTTTCCCTTBC
T ss_pred hcchhheEeCcEeccCCCeEEEEEEEC-CCCCEEEEEEECHHHh-------------------HHHHHHHHHhCCCCCCC
Confidence 334567888899999999999999875 5799999999864321 24689999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+++..|+|||||+||+|.+++++. ..+++..+..++.||+.||+|| |+++||||||||+|||++.+
T Consensus 114 ~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~ 186 (336)
T 4g3f_A 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSD 186 (336)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTT
T ss_pred cEEEEEEECCEEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCC
Confidence 9999999999999999999999999999863 4699999999999999999999 78899999999999999998
Q ss_pred C-ceEEcccccccccCCCCCcc---eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 493 M-EARIADFGLAKAMPDAQTHI---TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 493 ~-~~kl~DfG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
| .+||+|||+|+.+....... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.....
T Consensus 187 g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--- 263 (336)
T 4g3f_A 187 GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--- 263 (336)
T ss_dssp SCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---
T ss_pred CCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---
Confidence 7 69999999999876543221 2234679999999999999999999999999999999999999997643321
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
...+. .....+... + ++.....+.+++.+||+.||++|||+.|+++.|...
T Consensus 264 ~~~~i----~~~~~~~~~----~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 264 LCLKI----ASEPPPIRE----I----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp CHHHH----HHSCCGGGG----S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH----HcCCCCchh----c----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11111 112211111 1 111223477889999999999999999999887653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=423.50 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=205.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|+..++||+|+||.||+|++. .+|+.||||++....... .+.+.+|++++++++|||||+++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~--------------~~~~~~Ei~il~~l~HpnIV~l~ 137 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQR--------------RELLFNEVVIMRDYQHENVVEMY 137 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCSS--------------GGGGHHHHHHHHHCCCTTBCCEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEEC-CCCCEEEEEEEecCchhH--------------HHHHHHHHHHHHhCCCCCCCcEE
Confidence 356899999999999999999875 579999999985432111 34578899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..|+|||||+||+|.+++.. ..+++..+..++.||+.||+|| |+++|+||||||+|||++.++.+
T Consensus 138 ~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~v 209 (346)
T 4fih_A 138 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRV 209 (346)
T ss_dssp EEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEECCCCCE
Confidence 999999999999999999999999974 3589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+|+.+...... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. .....+.+.
T Consensus 210 Kl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~ 283 (346)
T 4fih_A 210 KLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIR 283 (346)
T ss_dssp EECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHH
T ss_pred EEecCcCceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHH
Confidence 99999999987654332 235689999999999999999999999999999999999999997532 222222222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....+. .-. .......+.+++.+||+.||++|||++|+++
T Consensus 284 ---~~~~~~-~~~-------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 284 ---DNLPPR-LKN-------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp ---HSSCCC-CSC-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cCCCCC-CCc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 211111 000 0111223778999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=419.28 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=207.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||+||+|+.. .+|+.||||++.+... ......+.+.+|++++++++|||||++++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~-~~~~~~AiK~i~k~~~-----------~~~~~~~~~~~E~~il~~l~HpnIv~l~~ 99 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHI-----------IKENKVPYVTRERDVMSRLDHPFFVKLYF 99 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEEHHHC-----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 57999999999999999999865 6899999999853211 01112567899999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..|+||||++||+|.+++.+ ...+++..+..++.||+.||+|| |+++|+||||||+|||+++++.+|
T Consensus 100 ~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNILl~~~g~vK 172 (311)
T 4aw0_A 100 TFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQ 172 (311)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEE
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEEcCCCCEE
Confidence 99999999999999999999999986 34699999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ...+ ...
T Consensus 173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~---~~~ 245 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EGLI---FAK 245 (311)
T ss_dssp ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---HHH
T ss_pred EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC----HHHH---HHH
Confidence 999999998765544334456789999999999999999999999999999999999999997532 2222 222
Q ss_pred hhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 006739 577 VMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625 (633)
Q Consensus 577 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~ 625 (633)
+.... ..++.+ ...+.+++.+||+.||++|||++|++
T Consensus 246 i~~~~~~~p~~~------------s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 246 IIKLEYDFPEKF------------FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHTCCCCCTTC------------CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHcCCCCCCccc------------CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 22211 111111 12377899999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=419.79 Aligned_cols=267 Identities=27% Similarity=0.343 Sum_probs=201.0
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
+|.+.++||+|+||+||+|++ +|+.||||++.... . . ...++.|+..+.+++|||||+++++
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~--------~-~------~~~~e~Ei~~~~~l~HpNIv~l~g~ 65 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE--------E-R------SWFREAEIYQTVMLRHENILGFIAA 65 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGG--------H-H------HHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccc--------h-h------hHHHHHHHHHHhcCCCCCCCcEEEE
Confidence 467789999999999999987 68999999984321 0 0 1233467777888999999999999
Q ss_pred eecCC----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCeE
Q 006739 418 MARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS-----HNPRIIHRDLKPANVL 488 (633)
Q Consensus 418 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~Dikp~Nil 488 (633)
|.+++ ..|+|||||++|+|.++++. ..++|..+.+++.|+++||+|||.. |+++|+||||||+|||
T Consensus 66 ~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NIL 140 (303)
T 3hmm_A 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140 (303)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEE
T ss_pred EEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEE
Confidence 97654 57899999999999999975 4589999999999999999999743 4569999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcc--eecccccCcccccccccccC------CCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTL------KFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
+++++++||+|||+|+......... ......||+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 141 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 9999999999999998775543321 22345799999999998764 367799999999999999999887653
Q ss_pred ccccc--------ccchHHHHHHHhhccCCcchhhhhhhhhc-CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 561 FFQHT--------EEMSLVKWMRNVMTSENPTRAIDAKLLEN-GYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 561 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
..... .......+.+........ +.+... ...+....+.+++.+||+.||++||||.|+++.|+++
T Consensus 221 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~r-----p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-----CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccchhcccccchHHHHHHHHhcccCC-----CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22110 011122222222221111 111111 1224556688999999999999999999999999988
Q ss_pred h
Q 006739 632 R 632 (633)
Q Consensus 632 ~ 632 (633)
+
T Consensus 296 ~ 296 (303)
T 3hmm_A 296 S 296 (303)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=430.26 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=215.1
Q ss_pred hhhcCcccccccccccCeeEEEEEecCC----CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC-
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH- 408 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h- 408 (633)
...++|++.+.||+|+||.||+|++.+. .++.||||++...... ...++|.+|++++.+++|
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~-------------~~~~~~~~E~~il~~l~hh 127 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGHH 127 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCCC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh-------------HHHHHHHHHHHHHHHcCCC
Confidence 3457899999999999999999987532 3468999998654321 114678999999999965
Q ss_pred CcccccceeeecC-CccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006739 409 RNLLPLLAHMARP-DCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNP 475 (633)
Q Consensus 409 ~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~ 475 (633)
||||+++|+|.++ +..++|||||++|+|.++++.... ....+++..+..++.|||+||+|| |++
T Consensus 128 pnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL---H~~ 204 (353)
T 4ase_A 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASR 204 (353)
T ss_dssp TTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH---HHT
T ss_pred CcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH---hhC
Confidence 8999999999764 568999999999999999976432 135589999999999999999999 678
Q ss_pred CeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-C
Q 006739 476 RIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-G 554 (633)
Q Consensus 476 ~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g 554 (633)
+||||||||+|||+++++.+||+|||+|+...........+...||+.|||||++.+..|+.++|||||||++|||+| |
T Consensus 205 ~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 999999999999999999999999999998776655555566789999999999999999999999999999999998 9
Q ss_pred CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 555 RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 555 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.||.+... ...+.+.+.. ..++.. ... ....+.+++.+||+.||++|||++|+++.|+++
T Consensus 285 ~~Pf~~~~~---~~~~~~~i~~---g~~~~~------p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 285 ASPYPGVKI---DEEFCRRLKE---GTRMRA------PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSSTTCCC---SHHHHHHHHH---TCCCCC------CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCH---HHHHHHHHHc---CCCCCC------Ccc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 999976432 2223333322 111110 011 122377889999999999999999999999886
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-52 Score=410.33 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=195.5
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeee
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 419 (633)
+..++||+|+||.||+|.+. .++..||+|++...... ....+.|.+|++++++++|||||+++++|.
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~ 95 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCC------------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 56678999999999999875 57899999998643221 112567999999999999999999999986
Q ss_pred c----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCeEecC-C
Q 006739 420 R----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR--IIHRDLKPANVLLDD-D 492 (633)
Q Consensus 420 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~Dikp~Nill~~-~ 492 (633)
+ ++..|+|||||++|+|.+++++ ...+++..+..++.||++||+||| +++ |+||||||+|||++. +
T Consensus 96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~ 168 (290)
T 3fpq_A 96 STVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPT 168 (290)
T ss_dssp EEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTT
T ss_pred eccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCC
Confidence 5 3457999999999999999986 346999999999999999999994 555 999999999999984 7
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+|+...... ....+||+.|||||++.+ +|+.++|||||||++|||+||+.||.+... ...
T Consensus 169 g~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~ 237 (290)
T 3fpq_A 169 GSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQ 237 (290)
T ss_dssp SCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHH
T ss_pred CCEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHH
Confidence 899999999998654322 234689999999998865 699999999999999999999999965321 112
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+.....+. ..+ ....+ .+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~i~~~~~~~-~~~----~~~~~----~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 238 IYRRVTSGVKPA-SFD----KVAIP----EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHTTTCCCG-GGG----GCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCC-CCC----ccCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence 222222222221 111 11122 3778899999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=402.29 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=189.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||+||+|+.. .+|+.||+|++.+...... .....+.+|++++++++|||||++++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~~~~ 80 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT-TTGQKVALKIINKKVLAKS-----------DMQGRIEREISYLRLLRHPHIIKLYD 80 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT-TTCCEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEeHHHcCCH-----------HHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence 68999999999999999999864 5799999999865432111 11457899999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..|+||||+ +|+|.+++.+ ...+++..+..++.||+.||+|| |+++|+||||||+|||+++++.+|
T Consensus 81 ~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 81 VIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp EEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTCCEE
T ss_pred EEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEECCCCCEE
Confidence 999999999999999 6799999875 35699999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+|+...+... ....+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.. ...+ .+
T Consensus 153 l~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~----~~~~---~~ 222 (275)
T 3hyh_A 153 IADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES----IPVL---FK 222 (275)
T ss_dssp ECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---HH
T ss_pred EeecCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC----HHHH---HH
Confidence 999999987654332 234689999999999998876 579999999999999999999997521 1222 22
Q ss_pred HhhccCC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSEN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..... .++.+ ...+.+++.+||+.||++|||++|+++
T Consensus 223 ~i~~~~~~~p~~~------------s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 223 NISNGVYTLPKFL------------SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHTCCCCCTTS------------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCCC------------CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222211 11111 123678999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=424.23 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=206.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|+..++||+|+||.||+|++. .+|+.||||++....... .+.+.+|+.++++++|||||+++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~-~tg~~vAiK~i~~~~~~~--------------~~~~~~Ei~il~~l~HpnIV~l~ 214 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVR-SSGKLVAVKKMDLRKQQR--------------RELLFNEVVIMRDYQHENVVEMY 214 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEESTTCSS--------------GGGHHHHHHHHHHCCCTTBCCEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEEC-CCCCEEEEEEEeccchhH--------------HHHHHHHHHHHHhCCCCCCCceE
Confidence 467999999999999999999875 579999999996543211 34578899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..|+|||||+||+|.++++. ..+++..+..++.||+.||+|| |+++||||||||+|||++.+|.+
T Consensus 215 ~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NILl~~~g~v 286 (423)
T 4fie_A 215 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRV 286 (423)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCCE
Confidence 999999999999999999999999974 3589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+|+.+...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.. .....+.+.
T Consensus 287 Kl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~ 360 (423)
T 4fie_A 287 KLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIR 360 (423)
T ss_dssp EECCCTTCEECCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHH
T ss_pred EEecCccceECCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHH
Confidence 99999999987654332 235689999999999999999999999999999999999999996532 222222222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....+. .- ........+.+|+.+||+.||++|||++|+++
T Consensus 361 ---~~~~~~-~~-------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 361 ---DNLPPR-LK-------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---HSCCCC-CS-------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cCCCCC-Cc-------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 211111 00 00111223778999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=409.06 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=193.5
Q ss_pred cCcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
++|++.+.||+|+||+||+|+.. +.+++.||+|++.+....... ..++.+|++++++++|||||++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------------~~~~~~E~~il~~l~HpnIv~l 91 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------------RVRTKMERDILVEVNHPFIVKL 91 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------------CC------CCCCCCCCTTEECE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------------HHHHHHHHHHHHHCCCCCCCeE
Confidence 67999999999999999999863 346789999998754322111 2357789999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+++..|+|||||+||+|.+++.+ ...+++..+..++.||+.||+|| |+++|+||||||+|||+++++.
T Consensus 92 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~ 164 (304)
T 3ubd_A 92 HYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGH 164 (304)
T ss_dssp EEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeEEcCCCC
Confidence 9999999999999999999999999986 34699999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+|+...+.... ....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.. ...+ +
T Consensus 165 vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~~~~---~ 235 (304)
T 3ubd_A 165 IKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD----RKET---M 235 (304)
T ss_dssp EEEESSEEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---H
T ss_pred EEecccccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC----HHHH---H
Confidence 999999999876543322 234689999999999999999999999999999999999999997532 1222 2
Q ss_pred HHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 575 RNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 575 ~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
..+.... ..+..+ ...+.+++.+||+.||++|||+
T Consensus 236 ~~i~~~~~~~p~~~------------s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 236 TMILKAKLGMPQFL------------SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHHHHCCCCCCTTS------------CHHHHHHHHHHTCSSGGGSTTC
T ss_pred HHHHcCCCCCCCcC------------CHHHHHHHHHHcccCHHHCCCC
Confidence 2222211 111111 1237789999999999999995
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=396.64 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=188.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+|+.||||++.....+ ...+.+.+|++++++++|||||++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~-------------~~~~~~~~E~~il~~l~HpnIV~~~~ 70 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRE-------------LAREKVMREVKALAKLEHPGIVRYFN 70 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSH-------------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCH-------------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45899999999999999999864 57899999998654321 11457889999999999999999999
Q ss_pred eeecCC------------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 006739 417 HMARPD------------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484 (633)
Q Consensus 417 ~~~~~~------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp 484 (633)
++.+.+ ..|+||||+++|+|.+++..... ....++..++.++.||++||+|| |+++|+||||||
T Consensus 71 ~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~yl---H~~~IiHRDlKp 146 (299)
T 4g31_A 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKP 146 (299)
T ss_dssp EEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCG
T ss_pred EEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHH---HHCcCccccCcH
Confidence 986544 36899999999999999975322 23456778899999999999999 678999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcc----------eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhC
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHI----------TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMG 554 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg 554 (633)
+|||++.++.+||+|||+|+......... ..+..+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 147 ~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225 (299)
T ss_dssp GGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS-
T ss_pred HHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc-
Confidence 99999999999999999999876543211 1234579999999999999999999999999999999996
Q ss_pred CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 555 RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 555 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
||.... +....+........+ ... ........+++.+||+.||++|||+.|+++
T Consensus 226 --Pf~~~~------~~~~~~~~~~~~~~p-~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 --PFSTQM------ERVRTLTDVRNLKFP-PLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --CCSSHH------HHHHHHHHHHTTCCC-HHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcc------HHHHHHHHHhcCCCC-CCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 765321 111222222222211 111 111223567899999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=394.97 Aligned_cols=265 Identities=22% Similarity=0.339 Sum_probs=200.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++++.||+|+||.||+|++. .+|+.||||++....... ...+.+.+|+++|++++|||||++++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~-~t~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~HpnIv~l~~ 120 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR-LTGQQVAIKKIPNAFDVV------------TNAKRTLRELKILKHFKHDNIIAIKD 120 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEETTTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEECccccch------------HHHHHHHHHHHHHHhcCCCCcceEee
Confidence 57999999999999999999864 579999999996543211 11456889999999999999999999
Q ss_pred eeec------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 417 HMAR------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 417 ~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++.. .+..|+|||||+ |+|.+++.. ...+++..+..++.||+.||+|| |+++|+||||||+|||++
T Consensus 121 ~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NIl~~ 192 (398)
T 4b99_A 121 ILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDLKPSNLLVN 192 (398)
T ss_dssp ECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEEC
T ss_pred eeecccccccCCEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCcCccccccC
Confidence 8754 357899999995 689999865 45799999999999999999999 688999999999999999
Q ss_pred CCCceEEcccccccccCCCCC--cceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 491 DDMEARIADFGLAKAMPDAQT--HITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
.++.+||+|||+|+.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.. .
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~----~ 268 (398)
T 4b99_A 193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN----Y 268 (398)
T ss_dssp TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS----H
T ss_pred CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC----H
Confidence 999999999999987654321 1123457899999999998875 46899999999999999999999997532 2
Q ss_pred chHHHHHHHhhccCCcchh----------hhhhhhh-------cCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 568 MSLVKWMRNVMTSENPTRA----------IDAKLLE-------NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~----------~d~~~~~-------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......+............ ....+.. ...+.....+.+++.+||+.||++|||++|+++
T Consensus 269 ~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 269 VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 2222222222221111000 0000000 000011234778999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=387.56 Aligned_cols=200 Identities=27% Similarity=0.409 Sum_probs=170.1
Q ss_pred hhcCcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni 411 (633)
-.+.|++.+.||+|+||+||+|+.+ ..+++.||+|++..... ..++.+|+++++.+ +||||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----------------~~~~~~E~~~l~~~~~h~nI 82 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----------------PIRIAAELQCLTVAGGQDNV 82 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----------------HHHHHHHHHHHHHTCSBTTB
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----------------HHHHHHHHHHHHHhcCCCCC
Confidence 4578999999999999999999764 24578999999865431 34577899999988 69999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
|++++++.+.+..|+||||+++|+|.+++. .+++.++..++.|++.||+|| |+++|+||||||+|||++.
T Consensus 83 v~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeNiLl~~ 152 (361)
T 4f9c_A 83 MGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSNFLYNR 152 (361)
T ss_dssp CCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEET
T ss_pred ceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHHeEEeC
Confidence 999999999999999999999999999984 388999999999999999999 6889999999999999987
Q ss_pred C-CceEEcccccccccCCCCCc--------------------------ceecccccCcccccccccccC-CCCCccchHH
Q 006739 492 D-MEARIADFGLAKAMPDAQTH--------------------------ITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYS 543 (633)
Q Consensus 492 ~-~~~kl~DfG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s 543 (633)
+ +.+||+|||+|+...+.... ......+||+.|+|||++.+. .|+.++||||
T Consensus 153 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS 232 (361)
T 4f9c_A 153 RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232 (361)
T ss_dssp TTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred CCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh
Confidence 6 79999999999866543211 011335799999999998775 5899999999
Q ss_pred HHHHHHHHHhCCCCCcc
Q 006739 544 FGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 544 ~G~~l~elltg~~p~~~ 560 (633)
+||++|||++|+.||..
T Consensus 233 lG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 233 AGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHHHTCSSSSC
T ss_pred hHHHHHHHHHCCCCCCC
Confidence 99999999999999854
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=377.29 Aligned_cols=279 Identities=30% Similarity=0.502 Sum_probs=234.4
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|+..+.||+|+||.||+|++. +++.||||++...... ..+.+.+|++++++++||||+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~iv 98 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQ--------------GIEEFETEIETLSFCRHPHLV 98 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSS--------------HHHHHHHHHHGGGSCCCTTBC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccChH--------------HHHHHHHHHHHHHhCCCCCEe
Confidence 445689999999999999999999864 7899999988654321 145788999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+.+..++||||+++|+|.+++.........+++..++.++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDEN 175 (321)
T ss_dssp CEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCSTTEEECTT
T ss_pred eEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999976444445799999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......+
T Consensus 176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~-~~~~~~~~ 254 (321)
T 2qkw_B 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAE 254 (321)
T ss_dssp CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-SSCCCHHH
T ss_pred CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc-HHHHHHHH
Confidence 99999999999876543322222345689999999999988999999999999999999999999976443 23344556
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
|.............+++.......++....+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 65555555555556666665666777888899999999999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=401.51 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=200.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.++||+|+||.||+|+.. .+|+.||+|++.+....... ........+.++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~-~tg~~~AiK~i~K~~i~~~~--------~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTT--------CHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEEC-CCCCEEEEEEEeHHHcchhh--------hHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 478999999999999999999875 68999999998542211000 001122334567788889999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+.+|+|||||+||+|.+++.+. ..+++..+..++.||+.||+|| |+++||||||||+|||++.+|.+
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~v 331 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHV 331 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCE
Confidence 9999999999999999999999999863 4699999999999999999999 78999999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+|+....... ...+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+.... ...+..
T Consensus 332 KL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~----~~~~i~ 403 (689)
T 3v5w_A 332 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEID 403 (689)
T ss_dssp EECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC----CHHHHH
T ss_pred EecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHH
Confidence 9999999998765432 34689999999999964 57999999999999999999999999753321 111222
Q ss_pred HHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHH
Q 006739 575 RNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVR 625 (633)
Q Consensus 575 ~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~ 625 (633)
+...... ..+..+ ...+.+++.+||+.||.+|++ ++|++
T Consensus 404 ~~i~~~~~~~p~~~------------S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 404 RMTLTMAVELPDSF------------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HHHHHCCCCCCTTS------------CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred HhhcCCCCCCCccC------------CHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 2222211 111111 123778999999999999998 56664
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=378.39 Aligned_cols=282 Identities=37% Similarity=0.641 Sum_probs=239.6
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|+..+.||+|+||.||+|+.. +|+.||||++....... ....+.+|++++++++||||+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~iv 90 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQG-------------GELQFQTEVEMISMAVHRNLL 90 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC------------------CCCHHHHHHHGGGTCCCTTBC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCch-------------HHHHHHHHHHHHHhccCCCcc
Confidence 456789999999999999999999754 78999999986543211 023588999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++...+..++||||+++|+|.+++.........+++..+..++.|++.||+|||..+..+|+||||||+||+++++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 99999999999999999999999999998765556679999999999999999999976555699999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccc-ccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ-HTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~-~~~~~~~~ 571 (633)
+.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||+.... ........
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 999999999998776543332 2445699999999999888899999999999999999999999974322 23445567
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
+|+.............+.........+....+.+++.+||+.||++|||++|+++.|+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 77777777777777777777777788888999999999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=396.71 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=205.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+|+.||+|++...... ..+.+.+|+++|+.++|||||+++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~-~tg~~~AiK~i~~~~~~--------------~~~~~~~Ei~il~~l~hpnIv~l~ 220 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHES--------------DKETVRKEIQTMSVLRHPTLVNLH 220 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHH--------------HHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred ccccEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEeccchh--------------hHHHHHHHHHHHHhCCCCCCCeEE
Confidence 368999999999999999999865 68999999998654311 145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC--C
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD--M 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~--~ 493 (633)
+++.+.+..|+|||||+||+|.+++.. ....+++..+..++.||+.||+|| |+++|+||||||+|||++.+ +
T Consensus 221 ~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill~~~~~~ 294 (573)
T 3uto_A 221 DAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSN 294 (573)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCC
T ss_pred EEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccccCCCCC
Confidence 999999999999999999999998864 234699999999999999999999 67899999999999999854 8
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+|+.+..... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.. ......
T Consensus 295 ~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~----~~~~~~- 366 (573)
T 3uto_A 295 ELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDETLR- 366 (573)
T ss_dssp CEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHH-
T ss_pred CEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHH-
Confidence 999999999998765432 234579999999999999999999999999999999999999997532 122222
Q ss_pred HHHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.... ..... .... ....+.+|+.+||+.||++|||+.|+++
T Consensus 367 --~i~~~~~~~~~~----~~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 367 --NVKSCDWNMDDS----AFSG----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --HHHTTCCCCCSG----GGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHhCCCCCCcc----cccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222211 11110 0011 1223778999999999999999999976
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=361.03 Aligned_cols=261 Identities=28% Similarity=0.437 Sum_probs=201.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+. +|+.||||++....... +..+++.+|++++++++||||+++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~ 99 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHA------------ERVNEFLREVAIMKRLRHPNIVLF 99 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSH------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCH------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence 457899999999999999999986 68899999986554321 114678899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCeEecCC
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR--IIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~Dikp~Nill~~~ 492 (633)
++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|+++||+|| |+.+ |+||||||+||+++.+
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~NIll~~~ 175 (309)
T 3p86_A 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPNLLVDKK 175 (309)
T ss_dssp EEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGGEEECTT
T ss_pred EEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhhEEEeCC
Confidence 999999999999999999999999997522 123489999999999999999999 6677 9999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 176 ~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~ 249 (309)
T 3p86_A 176 YTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVA 249 (309)
T ss_dssp CCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHH
T ss_pred CcEEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 9999999999986544322 12345799999999999999999999999999999999999999975322 12222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.+............ ....+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 250 ~~~~~~~~~~~~~~------------~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 250 AVGFKCKRLEIPRN------------LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp HHHHSCCCCCCCTT------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCcc------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22111111111111 1123778999999999999999999999998863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.33 Aligned_cols=259 Identities=25% Similarity=0.454 Sum_probs=209.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|...+.||+|+||.||+|.+. .+++.||+|++..... ...+.+.+|++++++++||||++++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~~--------------~~~~~~~~E~~~l~~l~hp~iv~~~ 73 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDE--------------ETQRTFLKEVKVMRCLEHPNVLKFI 73 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCCH--------------HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhHeeccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCcCcccEE
Confidence 467899999999999999999875 5789999998854321 1256789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil~~~~~~~ 147 (310)
T 3s95_A 74 GVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNV 147 (310)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEECTTSCE
T ss_pred EEEecCCeeEEEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEEECCCCCE
Confidence 9999999999999999999999999752 35699999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcce------------ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccc
Q 006739 496 RIADFGLAKAMPDAQTHIT------------TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
||+|||+++.......... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.....
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 148 VVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp EECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred EEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 9999999987654332110 1145799999999999999999999999999999999999999875433
Q ss_pred ccc--cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 564 HTE--EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 564 ~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
... ............. ......+.+++.+||+.||++|||+.|+++.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 228 RTMDFGLNVRGFLDRYCP-----------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp BCTTSSBCHHHHHHHTCC-----------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHhhhhhccccccCC-----------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 221 1122222211111 111123778999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=364.21 Aligned_cols=268 Identities=27% Similarity=0.341 Sum_probs=207.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|++ .++.||||++..... ....+.+|+.++++++||||+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~~ 83 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPIQDK---------------QSWQNEYEVYSLPGMKHENILQF 83 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECGGGH---------------HHHHHHHHHHTSTTCCCTTBCCE
T ss_pred chhhchhhheecccCceEEEEEEE---CCCEEEEEEeecCch---------------HHHHHHHHHHHHhcCCCCCchhh
Confidence 457899999999999999999987 579999999843210 13345669999999999999999
Q ss_pred ceeeecCCc----cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeeeC
Q 006739 415 LAHMARPDC----HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNP----------RIIHR 480 (633)
Q Consensus 415 ~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~----------~ivH~ 480 (633)
++++..... .++||||+++|+|.++++. ..+++..++.++.|+++||+|| |+. +|+||
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~L---H~~~~~l~~~~~~~ivH~ 155 (322)
T 3soc_A 84 IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYL---HEDIPGLKDGHKPAISHR 155 (322)
T ss_dssp EEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHH---TCCEEEETTEEECEEECS
T ss_pred cceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HhhccccccccCCCEEeC
Confidence 999987543 6999999999999999975 3499999999999999999999 666 99999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccC-----CCCCccchHHHHHHHHHHHhCC
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-----KFTDKCDIYSFGVLLAVLVMGR 555 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~elltg~ 555 (633)
||||+||+++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 156 Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 235 (322)
T 3soc_A 156 DIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235 (322)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred CCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence 99999999999999999999999877655443333446799999999998863 4556889999999999999999
Q ss_pred CCCccccccccc---------chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 556 LPSDDFFQHTEE---------MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 556 ~p~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.||......... .....+........... .+.... ........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRP-VLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCC-CCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCC-Cccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999754321110 01122222211111111 111110 11234456889999999999999999999999
Q ss_pred HHHhhh
Q 006739 627 MLSQIR 632 (633)
Q Consensus 627 ~l~~~~ 632 (633)
.|++++
T Consensus 312 ~L~~l~ 317 (322)
T 3soc_A 312 RITQMQ 317 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999885
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.43 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=213.0
Q ss_pred hhcCcccccccccccCeeEEEEEecC------CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
..++|++.+.||+|+||.||+|++.+ .++..||||++...... +..+++.+|+++++++ +
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 145 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-------------KDLSDLVSEMEMMKMIGK 145 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-------------HHHHHHHHHHHHHHHSCC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-------------HHHHHHHHHHHHHHHhcC
Confidence 45789999999999999999998632 35678999998654321 1256789999999999 8
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNP 475 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~ 475 (633)
||||+++++++.+.+..|+||||+++|+|.+++..... ....+++..++.++.||++||+|| |+.
T Consensus 146 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~ 222 (370)
T 2psq_A 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQ 222 (370)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH---HHT
T ss_pred CCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhC
Confidence 99999999999999999999999999999999986432 124589999999999999999999 678
Q ss_pred CeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-C
Q 006739 476 RIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-G 554 (633)
Q Consensus 476 ~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g 554 (633)
+|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 223 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 223 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999997765443333344567899999999999999999999999999999999 9
Q ss_pred CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 555 RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 555 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.||.... ...+.+.+... .... .+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 303 ~~p~~~~~----~~~~~~~~~~~---~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 303 GSPYPGIP----VEELFKLLKEG---HRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp CCSSTTCC----GGGHHHHHHTT---CCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCC----HHHHHHHHhcC---CCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99987532 22232222221 1110 0111123478899999999999999999999999886
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=352.08 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=204.3
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|+..+.||+|+||.||+|... .+++.||+|++....... .+.+.+|+.++++++||||++
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~hp~iv~ 81 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPK--------------KELIINEILVMRENKNPNIVN 81 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBT-TTCCEEEEEEEEGGGCSC--------------HHHHHHHHHHHHHCCCTTBCC
T ss_pred ChhhceeeeeeeccCCCeEEEEEEEC-CCCcEEEEEEeecccccH--------------HHHHHHHHHHHhcCCCCCCCe
Confidence 34578999999999999999999854 578999999985432110 345788999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~ 153 (297)
T 3fxz_A 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDG 153 (297)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTC
T ss_pred EeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEECCCC
Confidence 99999999999999999999999999975 3589999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 154 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~ 228 (297)
T 3fxz_A 154 SVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLI 228 (297)
T ss_dssp CEEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHH
T ss_pred CEEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH
Confidence 9999999999877654332 2346799999999999999999999999999999999999999965321 1111111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........... ......+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~------------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 229 ATNGTPELQNP------------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHCSCCCSCG------------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhCCCCCCCCc------------cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11110000001 111233778999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=350.15 Aligned_cols=270 Identities=34% Similarity=0.540 Sum_probs=214.7
Q ss_pred cccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
..+.||+|+||.||+|.. +++.||||++......... +..+.+.+|+.++++++||||+++++++.+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 101 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTE----------ELKQQFDQEIKVMAKCQHENLVELLGFSSD 101 (307)
T ss_dssp TCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTT----------THHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchH----------HHHHHHHHHHHHHHhcCCCCeEEEEEEEec
Confidence 348999999999999986 6889999998654321110 114678899999999999999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
.+..++||||+++++|.+++..... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl~Df 177 (307)
T 2nru_A 102 GDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLDEAFTAKISDF 177 (307)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEcCCCcEEEeec
Confidence 9999999999999999999975432 45699999999999999999999 6789999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhcc
Q 006739 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580 (633)
Q Consensus 501 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 580 (633)
|+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||...........+ .......
T Consensus 178 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~ 253 (307)
T 2nru_A 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI---KEEIEDE 253 (307)
T ss_dssp TTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH---HHHHHTT
T ss_pred ccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH---HHHhhhh
Confidence 99987765443333345679999999998865 5889999999999999999999999865433222222 2222221
Q ss_pred C-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 581 E-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 581 ~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
. .....++..+ ..........+.+++.+||+.||.+|||++++++.|++++
T Consensus 254 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 254 EKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1 1122222222 2345566777999999999999999999999999999885
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=356.73 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=203.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|++.+.||+|+||.||+|++. .+|+.||||++....... ...+.+.+|+++++.++||||++++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~l~ 80 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNP------------TSLQKLFREVRIMKILNHPNIVKLF 80 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCH------------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 468999999999999999999864 578999999986433211 1145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++|+|.+++... ..+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIll~~~~~~ 153 (328)
T 3fe3_A 81 EVIETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLLLDADMNI 153 (328)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEEEcCCCCE
Confidence 9999999999999999999999999763 4589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++....... .....||+.|+|||++.+..++ .++||||+||++|||++|+.||++.. ...+ .
T Consensus 154 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----~~~~---~ 223 (328)
T 3fe3_A 154 KIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN----LKEL---R 223 (328)
T ss_dssp EECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---H
T ss_pred EEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC----HHHH---H
Confidence 9999999987655432 2346799999999999888875 78999999999999999999997532 1122 2
Q ss_pred HHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... ..+..+ ...+.+++.+||+.||.+|||++|+++
T Consensus 224 ~~i~~~~~~~p~~~------------s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 224 ERVLRGKYRIPFYM------------STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHCCCCCCTTS------------CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCCCCC------------CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222211 111111 123678899999999999999999975
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=362.91 Aligned_cols=268 Identities=23% Similarity=0.343 Sum_probs=212.2
Q ss_pred hhhhcCcccccccccccCeeEEEEEe----cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
....++|++.+.||+|+||.||+|++ ...+++.||||++...... ...+.+.+|++++.++ +
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 84 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGH 84 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCC
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH-------------HHHHHHHHHHHHHHhhcC
Confidence 44568899999999999999999985 3356789999998654321 1146789999999999 7
Q ss_pred CCcccccceeeecCCc-cEEEEecccCCCHHHHHhhhcCC----------------------------------------
Q 006739 408 HRNLLPLLAHMARPDC-HLLVYEFMKNGSLQDILNDVSQG---------------------------------------- 446 (633)
Q Consensus 408 h~niv~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------- 446 (633)
||||+++++++.+.+. .++||||+++|+|.++++.....
T Consensus 85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 9999999999987654 89999999999999999864321
Q ss_pred ----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 447 ----------------------RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 447 ----------------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
...+++..++.++.|+++||+|| |+.+|+||||||+||+++.++.+||+|||+++
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 241 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEecccee
Confidence 12289999999999999999999 67899999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhccCCc
Q 006739 505 AMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENP 583 (633)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (633)
...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..... .......+....... .
T Consensus 242 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~~~~~-~ 317 (359)
T 3vhe_A 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---DEEFCRRLKEGTRMR-A 317 (359)
T ss_dssp CTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC---SHHHHHHHHHTCCCC-C
T ss_pred eecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch---hHHHHHHHHcCCCCC-C
Confidence 7765544444455678999999999999999999999999999999998 9999875332 122222222111111 1
Q ss_pred chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 584 TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 584 ~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
... ....+.+++..||+.||++|||+.|+++.|+++.
T Consensus 318 ~~~------------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 318 PDY------------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC------------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111 1123778899999999999999999999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.76 Aligned_cols=258 Identities=22% Similarity=0.385 Sum_probs=210.1
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+++.+|++++.+++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~ 68 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMS---------------EDEFFQEAQTMMKLSHPKLVKF 68 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTTBC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred chhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCCCc---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 4578999999999999999999875 6788999998654321 3457889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+....++||||+++++|.+++... ...+++..++.++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~ 142 (268)
T 3sxs_A 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLC 142 (268)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEEECTTCC
T ss_pred EEEEccCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEEECCCCC
Confidence 99999999999999999999999999763 34589999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||+++........ ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||+.... ...
T Consensus 143 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~--- 214 (268)
T 3sxs_A 143 VKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN----SEV--- 214 (268)
T ss_dssp EEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH----HHH---
T ss_pred EEEccCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh----HHH---
Confidence 999999999877654322 2234456788999999998889999999999999999999 9999875322 111
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhhC
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~~ 633 (633)
............ ... ....+.+++..||+.||++|||+.|+++.|+++++
T Consensus 215 ~~~~~~~~~~~~-------~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 215 VLKVSQGHRLYR-------PHL---ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHTTCCCCC-------CTT---SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCCCCC-------CCc---ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 111111111110 000 11237789999999999999999999999999853
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=351.28 Aligned_cols=258 Identities=25% Similarity=0.379 Sum_probs=209.6
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|+..+.||+|+||.||+|++. +++.||+|++...... .+++.+|++++++++||||++
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~ 69 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQ 69 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHHTCCCTTBCC
T ss_pred eChhhceeeheecCCCccEEEEEEec--CCCeEEEEEecccccC---------------HHHHHHHHHHHHhCCCCCEee
Confidence 34578999999999999999999875 6888999998754421 346889999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..++||||+++++|.+++... ...+++..++.++.|+++||+|| |+.+|+||||||+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~ 143 (269)
T 4hcu_A 70 LYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQ 143 (269)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGGG
T ss_pred EEEEEecCCceEEEEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchheEEEcCCC
Confidence 999999999999999999999999999652 35689999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ....
T Consensus 144 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----~~~~- 217 (269)
T 4hcu_A 144 VIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVV- 217 (269)
T ss_dssp CEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHH-
T ss_pred CEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----HHHH-
Confidence 9999999999876543211 1233457888999999998999999999999999999999 9999875321 1222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
........... .......+.+++..||+.||++|||++|+++.|++++
T Consensus 218 --~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 218 --EDISTGFRLYK----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp --HHHHTTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHhcCccCCC----------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 22211111100 0011233788999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=367.37 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=210.4
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|+..+.||+|+||.||+|++. .+++.||||.+...... ....++.+|++++++++||||+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv 175 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPP-------------DLKAKFLQEARILKQYSHPNIV 175 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSCH-------------HHHTTTTHHHHHHTTCCCTTBC
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCCH-------------HHHHHHHHHHHHHHhCCCCCEE
Confidence 345578999999999999999999875 47899999998643211 1145688999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++...+..++||||+++|+|.+++... +..+++..+..++.|+++||+|| |+.+|+||||||+|||++.+
T Consensus 176 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nil~~~~ 249 (377)
T 3cbl_A 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVTEK 249 (377)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTT
T ss_pred EEEEEEecCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCcccCHHHEEEcCC
Confidence 9999999999999999999999999999753 34589999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 250 ~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~~ 325 (377)
T 3cbl_A 250 NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQTR 325 (377)
T ss_dssp CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHHH
T ss_pred CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 9999999999987544322111122345778999999998889999999999999999998 9999875322 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.+.. ..... .+......+.+++.+||+.||++|||++++++.|++++
T Consensus 326 ~~~~~---~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 326 EFVEK---GGRLP----------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHHHT---TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHc---CCCCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 22221 11111 00111234778999999999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=348.52 Aligned_cols=263 Identities=24% Similarity=0.431 Sum_probs=205.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++........ ...+.+.+|+.++++++||||++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~hp~iv~~~ 77 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREKE-----------ETLKRFEREVHNSSQLSHQNIVSMI 77 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCCH-----------HHHHHHHHHHHHHTTCCBTTBCCEE
T ss_pred hccEEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCccccH-----------HHHHHHHHHHHHHhcCCCCCCceEE
Confidence 467999999999999999999864 5789999999865543211 1256789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++++|.+++... ..+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 78 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~~ 150 (294)
T 4eqm_A 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNILIDSNKTL 150 (294)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCE
T ss_pred EeeeeCCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999763 4689999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++........ ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... ....
T Consensus 151 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~ 222 (294)
T 4eqm_A 151 KIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAI 222 (294)
T ss_dssp EECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHH
T ss_pred EEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHH
Confidence 99999999876543322 223457999999999999999999999999999999999999999753211 1111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHhh
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-NSKDVRCMLSQI 631 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~ev~~~l~~~ 631 (633)
.......+. ..... .......+.+++.+|++.||.+|| +++++.+.|+++
T Consensus 223 ~~~~~~~~~--~~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 223 KHIQDSVPN--VTTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHSSCCCC--HHHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HHhhccCCC--cchhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 111111111 11111 111223478899999999999999 999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=362.01 Aligned_cols=264 Identities=23% Similarity=0.358 Sum_probs=208.7
Q ss_pred hcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|++.+.||+|+||.||+|++.+ .+++.||||++...... ....++.+|+.++++++||||
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnI 136 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-------------QDELDFLMEALIISKFNHQNI 136 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH-------------HHHHHHHHHHHHHHHCCCTTB
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh-------------hhHHHHHHHHHHHHhCCCCCC
Confidence 4678999999999999999998632 36779999998643221 114468889999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ---GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
+++++++.+....++||||+++|+|.+++..... ....+++..++.++.||++||+|| |+.+|+||||||+|||
T Consensus 137 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIl 213 (367)
T 3l9p_A 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCL 213 (367)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred CeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEE
Confidence 9999999999999999999999999999986542 234589999999999999999999 6789999999999999
Q ss_pred ecCCC---ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccc
Q 006739 489 LDDDM---EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQH 564 (633)
Q Consensus 489 l~~~~---~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~ 564 (633)
++.++ .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 214 l~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-- 291 (367)
T 3l9p_A 214 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-- 291 (367)
T ss_dssp ESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred EecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99555 599999999986543322222234568999999999999999999999999999999998 999986532
Q ss_pred cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
...+.+.+. ....... .......+.+++.+||+.||++|||+.++++.|+.++
T Consensus 292 --~~~~~~~i~---~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 292 --NQEVLEFVT---SGGRMDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp --HHHHHHHHH---TTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHH---cCCCCCC----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 222222222 2111110 0111223778999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=361.92 Aligned_cols=267 Identities=24% Similarity=0.390 Sum_probs=212.9
Q ss_pred hhhhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH 408 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 408 (633)
....++|++.+.||+|+||.||+|++.+ .+++.||+|++...... ...+.+.+|+.++++++|
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h 109 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------------DMQADFQREAALMAEFDN 109 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------------HHHHHHHHHHHHHHTCCC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-------------HHHHHHHHHHHHHHhCCC
Confidence 3456789999999999999999998853 35689999998654321 125678999999999999
Q ss_pred CcccccceeeecCCccEEEEecccCCCHHHHHhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHH
Q 006739 409 RNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG--------------------RRELDWLARHKIALGVACGLEY 468 (633)
Q Consensus 409 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~ 468 (633)
|||+++++++.+.+..++||||+++|+|.+++...... ...+++..++.++.||++||+|
T Consensus 110 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 189 (343)
T 1luf_A 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 189 (343)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999864321 2579999999999999999999
Q ss_pred HHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHH
Q 006739 469 LHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548 (633)
Q Consensus 469 Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l 548 (633)
| |+.+|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++
T Consensus 190 L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 266 (343)
T 1luf_A 190 L---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266 (343)
T ss_dssp H---HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred H---HhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHH
Confidence 9 6789999999999999999999999999999876544332233445689999999999988999999999999999
Q ss_pred HHHHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 549 AVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 549 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
|||++ |+.||..... ......+ ....... .+......+.+++.+||+.||++|||+.++++.
T Consensus 267 ~el~t~g~~p~~~~~~----~~~~~~~---~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 267 WEIFSYGLQPYYGMAH----EEVIYYV---RDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHTTTCCTTTTSCH----HHHHHHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCcCCCCCh----HHHHHHH---hCCCcCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 99999 9999875321 2222222 2211110 001112347889999999999999999999999
Q ss_pred HHhhh
Q 006739 628 LSQIR 632 (633)
Q Consensus 628 l~~~~ 632 (633)
|+++.
T Consensus 330 L~~~~ 334 (343)
T 1luf_A 330 LQRMC 334 (343)
T ss_dssp HHHTT
T ss_pred HHHHH
Confidence 99874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=349.27 Aligned_cols=275 Identities=19% Similarity=0.257 Sum_probs=211.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+++.||||++....... ..+.+.+|++++++++||||++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~~~ 73 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLR-------------PVDVQMREFEVLKKLNHKNIVKLF 73 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGS-------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccc-------------hHHHHHHHHHHHHhcCCCCcceEE
Confidence 467899999999999999999875 468999999985422110 135677899999999999999999
Q ss_pred eeeecCC--ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe----
Q 006739 416 AHMARPD--CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---- 489 (633)
Q Consensus 416 ~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---- 489 (633)
+++.... ..++||||+++++|.+++..... ...+++..++.++.|+++||+|| |+.+|+||||||+||++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~ 149 (319)
T 4euu_A 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGE 149 (319)
T ss_dssp EEEECTTTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEECT
T ss_pred EEeecCCCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEeccC
Confidence 9987655 67999999999999999986432 34499999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccc--------cCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ--------TLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+.++.+||+|||+++........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 150 ~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 150 DGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp TSCEEEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CCCceEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 78888999999999887654332 2356999999999886 567899999999999999999999999764
Q ss_pred ccccccchHHHHHHHhhccCCcchh---------hhhh--hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRA---------IDAK--LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~d~~--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
............+............ .... ............+.+++.+||+.||++|||++|+++...+
T Consensus 227 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp TCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 4333322222222111111100000 0000 0112335566678899999999999999999999998876
Q ss_pred h
Q 006739 631 I 631 (633)
Q Consensus 631 ~ 631 (633)
-
T Consensus 307 ~ 307 (319)
T 4euu_A 307 I 307 (319)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=364.76 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=197.8
Q ss_pred hhhcCcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
...++|++.+.||+|+||.||+|++. ..++..||||++...... ...+++.+|+.++++++||||
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni 108 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-------------KQRRDFLGEASIMGQFDHPNI 108 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-------------HHHHHHHHHHHHHTTCCCTTB
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-------------HHHHHHHHHHHHHHhCCCCCC
Confidence 34568999999999999999999864 235778999998654311 125678999999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++++.+.+..++||||+++|+|.++++. ....+++..+..++.||++||+|| |+.+|+||||||+||+++.
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~ 182 (373)
T 2qol_A 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINS 182 (373)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECT
T ss_pred CeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEEcC
Confidence 9999999999999999999999999999975 245699999999999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccch
Q 006739 492 DMEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMS 569 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 569 (633)
++.+||+|||+++......... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 183 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~ 258 (373)
T 2qol_A 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QD 258 (373)
T ss_dssp TCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HH
T ss_pred CCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 9999999999998775543211 1122345788999999999999999999999999999998 9999865321 22
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+.+....... ........+.+++.+||+.||++||++.+++++|+++
T Consensus 259 ~~~~i~~~~~~~-------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 259 VIKAVDEGYRLP-------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHHHHHTTEECC-------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC-------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 222222111110 0111223478899999999999999999999999886
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=347.73 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=197.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||++++ .++.||+|++.... ..+.+.+|++++++++||||++++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~hp~iv~~~ 67 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIESES----------------ERKAFIVELRQLSRVNHPNIVKLY 67 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSSTT----------------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecChh----------------HHHHHHHHHHHHhcCCCCCcCeEE
Confidence 46788999999999999999987 57899999985322 145788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc-
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME- 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~- 494 (633)
+++.+ ..++||||+++|+|.+++.... ....+++..++.++.|+++||+|||..|..+|+||||||+||+++.++.
T Consensus 68 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 144 (307)
T 2eva_A 68 GACLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144 (307)
T ss_dssp EBCTT--TTEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTE
T ss_pred EEEcC--CcEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCE
Confidence 98874 4899999999999999997532 1235789999999999999999997666689999999999999998886
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||+..... .. +..
T Consensus 145 ~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~---~~~ 214 (307)
T 2eva_A 145 LKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AF---RIM 214 (307)
T ss_dssp EEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HH---HHH
T ss_pred EEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HH---HHH
Confidence 7999999997654321 2346899999999999999999999999999999999999999753221 11 111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.......... .... ....+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 215 ~~~~~~~~~~------~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 215 WAVHNGTRPP------LIKN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HHHHTTCCCC------CBTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HHHhcCCCCC------cccc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1111111111 0011 1223778999999999999999999999998874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=356.36 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=206.7
Q ss_pred hcCcccccccccccCeeEEEEEecC--CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+|++.. ..+..||||++...... ...+.+.+|+.++++++||||++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~ 114 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-------------RQRRDFLSEASIMGQFDHPNIIR 114 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-------------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-------------HHHHHHHHHHHHHHhCCCCCCCc
Confidence 4678999999999999999998742 24456999998654321 11467889999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|| |+.+|+||||||+||+++.++
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~ 188 (325)
T 3kul_A 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNL 188 (325)
T ss_dssp EEEEECGGGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTC
T ss_pred EEEEEEeCCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEECCCC
Confidence 999999999999999999999999999642 35699999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 494 EARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 189 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~~ 264 (325)
T 3kul_A 189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDVI 264 (325)
T ss_dssp CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHH
T ss_pred CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHHH
Confidence 99999999999876543221 2233456889999999998899999999999999999999 9999865322 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..+. ....... .......+.+++..||+.||++|||+.++++.|+.+.
T Consensus 265 ~~~~---~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 265 SSVE---EGYRLPA----------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HHHH---TTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---cCCCCCC----------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2221 1111110 1111234788999999999999999999999998863
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=360.19 Aligned_cols=265 Identities=27% Similarity=0.376 Sum_probs=213.7
Q ss_pred hhhcCcccccccccccCeeEEEEEecC------CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI- 406 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 406 (633)
...++|.+.+.||+|+||.||+|++.+ .++..||||++...... +...++.+|+++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~ 132 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-------------KDLSDLISEMEMMKMIG 132 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCH-------------HHHHHHHHHHHHHHHhc
Confidence 345789999999999999999998642 34478999998654321 1146788999999999
Q ss_pred CCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006739 407 RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG------------RRELDWLARHKIALGVACGLEYLHISHN 474 (633)
Q Consensus 407 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~ 474 (633)
+||||+++++++...+..++||||+++|+|.+++...... ...+++..++.++.|+++||+|| |+
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H~ 209 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---AS 209 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH---HH
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH---Hh
Confidence 8999999999999999999999999999999999864321 24599999999999999999999 67
Q ss_pred CCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-
Q 006739 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM- 553 (633)
Q Consensus 475 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt- 553 (633)
.+|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++
T Consensus 210 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 8999999999999999999999999999987765443333345567899999999999999999999999999999999
Q ss_pred CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 554 GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 554 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
|+.||.... ...+.+.+.. ...... .......+.+++.+||+.||++|||++|+++.|+++
T Consensus 290 g~~p~~~~~----~~~~~~~~~~---~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 290 GGSPYPGVP----VEELFKLLKE---GHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp SCCSSTTCC----HHHHHHHHHT---TCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCC----HHHHHHHHHc---CCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999986532 2222222222 111110 011123478899999999999999999999999886
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=354.39 Aligned_cols=258 Identities=25% Similarity=0.322 Sum_probs=206.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+|+.||+|++............ ..+.+.+|+.++++++||||++++
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~~~--------~~~~~~~E~~il~~l~hpnIv~l~ 81 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGV--------CREEIEREVSILRQVLHPNIITLH 81 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSB--------CHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccchh--------HHHHHHHHHHHHHhCCCcCCCcEE
Confidence 467999999999999999999865 57899999998765432211000 035688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC--
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-- 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~-- 493 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 82 DVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSS
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeCCCCC
Confidence 999999999999999999999999964 45699999999999999999999 678999999999999998877
Q ss_pred --ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 494 --EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.... ....
T Consensus 155 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~----~~~~- 226 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQET- 226 (361)
T ss_dssp SCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS----HHHH-
T ss_pred ccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHH-
Confidence 799999999988765432 234579999999999999999999999999999999999999996532 1122
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+...... .++...... ...+.+++.+||+.||++|||+.|+++
T Consensus 227 --~~~i~~~~~~---~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 --LANITAVSYD---FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --HHHHHTTCCC---CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHhcCCC---CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222111110 011111111 233778999999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=357.49 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=201.5
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCe----EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|+..+.||+|+||.||+|++.. +++ +||+|.+..... ....+++.+|+.++++++|||
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~ 78 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPH 78 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC--------------------CHHHHHHHHHHHHHCCBTT
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccccC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 35689999999999999999998743 344 368887743211 112467889999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
|+++++++.+.. .++|+||+++|+|.+++... ...+++..++.++.|+++||+|| |+.+|+||||||+||+++
T Consensus 79 iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIll~ 151 (327)
T 3poz_A 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVK 151 (327)
T ss_dssp BCCEEEEEESSS-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEE
T ss_pred EeEEEEEEecCC-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCChheEEEC
Confidence 999999998754 78999999999999999752 35699999999999999999999 677999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccch
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMS 569 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 569 (633)
.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++ |+.||+.... ..
T Consensus 152 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~ 227 (327)
T 3poz_A 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 227 (327)
T ss_dssp ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG
T ss_pred CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH----HH
Confidence 999999999999998765544333344567889999999999999999999999999999999 9999976422 22
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.+.+........ .......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 228 ~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 228 ISSILEKGERLPQ-------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHTTCCCCC-------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCC-------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 3233222111110 1111234778999999999999999999999998763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=348.90 Aligned_cols=267 Identities=24% Similarity=0.386 Sum_probs=204.0
Q ss_pred hcCcccccccccccCeeEEEEEe---cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.++|++.+.||+|+||.||+|++ ...+++.||||++..... ...+.+.+|++++++++||||+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv 74 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--------------EHLRDFEREIEILKSLQHDNIV 74 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--------------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--------------HHHHHHHHHHHHHHhCCCCCEe
Confidence 46889999999999999999985 345789999999864431 1146788999999999999999
Q ss_pred ccceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 413 PLLAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 413 ~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++++++.. ....++||||+++|+|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~ 148 (295)
T 3ugc_A 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 148 (295)
T ss_dssp CEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEE
T ss_pred eEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHhhEEEc
Confidence 99999855 35689999999999999999763 34589999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc-----
Q 006739 491 DDMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH----- 564 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~----- 564 (633)
.++.+||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++|..|+......
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~ 228 (295)
T 3ugc_A 149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228 (295)
T ss_dssp ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHH
T ss_pred CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhh
Confidence 9999999999999877544322 1223345788899999999999999999999999999999999998643210
Q ss_pred --c-ccchHH-HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 565 --T-EEMSLV-KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 565 --~-~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
. ...... ............. .+......+.+++.+||+.||++|||++|+++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 229 GNDKQGQMIVFHLIELLKNNGRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp CTTCCTHHHHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCccccchhHHHHHHHHhccCcCC----------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 000000 1111111111110 11122244788999999999999999999999999885
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=348.60 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=200.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc--CCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ--IRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+.+|.+++.. ++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~l~h~niv~ 66 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSRD-----------------EKSWFRETELYNTVMLRHENILG 66 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGGG-----------------HHHHHHHHHHHHHTCCCCTTBCC
T ss_pred cCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEecccc-----------------chhhHHHHHHHHHhhccCcCeee
Confidence 46899999999999999999987 68999999984321 2234445555554 79999999
Q ss_pred cceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCC
Q 006739 414 LLAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS-----HNPRIIHRDLKP 484 (633)
Q Consensus 414 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~Dikp 484 (633)
+++++.. ....++||||+++|+|.++++. ..+++..++.++.|+++||+|||.. ++.+|+||||||
T Consensus 67 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp 141 (301)
T 3q4u_A 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141 (301)
T ss_dssp EEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCG
T ss_pred EEEeeccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCCh
Confidence 9998654 3457899999999999999953 4699999999999999999999521 288999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcce--ecccccCcccccccccccC------CCCCccchHHHHHHHHHHHhC--
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHIT--TSNVAGTVGYIAPEYHQTL------KFTDKCDIYSFGVLLAVLVMG-- 554 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~elltg-- 554 (633)
+||+++.++.+||+|||+++.......... .....||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 142 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~ 221 (301)
T 3q4u_A 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221 (301)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhc
Confidence 999999999999999999987655433211 2234799999999999876 445689999999999999999
Q ss_pred --------CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 555 --------RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 555 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.||.......... ................ ... .........+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 222 SNGIVEDYKPPFYDVVPNDPSF--EDMRKVVCVDQQRPNI-PNR---WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCH--HHHHHHHTTSCCCCCC-CGG---GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CccccccccccccccCCCCcch--hhhhHHHhccCCCCCC-Chh---hccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 78876543322221 1111111111111111 110 012234556889999999999999999999999
Q ss_pred HHHhh
Q 006739 627 MLSQI 631 (633)
Q Consensus 627 ~l~~~ 631 (633)
.|++|
T Consensus 296 ~L~~i 300 (301)
T 3q4u_A 296 TLTKI 300 (301)
T ss_dssp HHHHH
T ss_pred HHhcc
Confidence 99876
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.35 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=202.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|+.. .+|+.||+|++.+... ........+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~l~ 71 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVI-----------IAKDEVAHTVTESRVLQNTRHPFLTALK 71 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHh-----------hhhhHHHHHHHHHHHHHhCCCCcCcceE
Confidence 367999999999999999999864 5789999999853210 0111245678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.+
T Consensus 72 ~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~v 144 (337)
T 1o6l_A 72 YAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEECCCCCE
Confidence 999999999999999999999999975 34689999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...+. .
T Consensus 145 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~---~ 215 (337)
T 1o6l_A 145 KITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLF---E 215 (337)
T ss_dssp EECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH---H
T ss_pred EEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----HHHHH---H
Confidence 9999999986433222 2234679999999999999999999999999999999999999986532 11221 1
Q ss_pred Hhhcc-CCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 576 NVMTS-ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 576 ~~~~~-~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
.+... ...+..+ ...+.+++.+||+.||++|| +++|+++
T Consensus 216 ~i~~~~~~~p~~~------------s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 216 LILMEEIRFPRTL------------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHCCCCCCTTS------------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHcCCCCCCCCC------------CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11111 1111111 12377889999999999999 8888865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=353.24 Aligned_cols=266 Identities=24% Similarity=0.364 Sum_probs=213.3
Q ss_pred hhhhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH 408 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 408 (633)
....++|.+.+.||+|+||.||+|... ..+++.||+|++...... ...+.+.+|++++++++|
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h 85 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP-------------SELRDLLSEFNVLKQVNH 85 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH-------------HHHHHHHHHHHHHTTCCC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH-------------HHHHHHHHHHHHHhhCCC
Confidence 334578999999999999999999863 235689999998644311 114678899999999999
Q ss_pred CcccccceeeecCCccEEEEecccCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHH
Q 006739 409 RNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ--------------------GRRELDWLARHKIALGVACGLEY 468 (633)
Q Consensus 409 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~ 468 (633)
|||+++++++.+.+..++||||+++|+|.+++..... ....+++..++.++.|+++||+|
T Consensus 86 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 165 (314)
T 2ivs_A 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQY 165 (314)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHH
T ss_pred CceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999986432 12348999999999999999999
Q ss_pred HHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHH
Q 006739 469 LHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548 (633)
Q Consensus 469 Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l 548 (633)
| |+.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++
T Consensus 166 l---H~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 242 (314)
T 2ivs_A 166 L---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242 (314)
T ss_dssp H---HHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred H---HHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHH
Confidence 9 6789999999999999999999999999999877654433333445678899999999988899999999999999
Q ss_pred HHHHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 549 AVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 549 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
|||++ |+.||..... ..+.+.+........ .......+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~-------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 243 WEIVTLGGNPYPGIPP----ERLFNLLKTGHRMER-------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHTTSCCSSTTCCG----GGHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCH----HHHHHHhhcCCcCCC-------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999 9999875322 223222222111110 01112347889999999999999999999999
Q ss_pred HHhh
Q 006739 628 LSQI 631 (633)
Q Consensus 628 l~~~ 631 (633)
|+++
T Consensus 306 l~~~ 309 (314)
T 2ivs_A 306 LEKM 309 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=347.83 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=214.5
Q ss_pred hhhhcCcccccccccccCeeEEEEEe----cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
....++|+..+.||+|+||.||+|++ ...+++.||+|++...... ...+.+.+|+.+++++ +
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 85 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-------------TEREALMSELKVLSYLGN 85 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH-------------HHHHHHHHHHHHHhhccc
Confidence 34457899999999999999999986 3457889999998654321 1146788999999999 8
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ--------------GRRELDWLARHKIALGVACGLEYLHISH 473 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h 473 (633)
||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|+++||+|| |
T Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H 162 (313)
T 1t46_A 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---A 162 (313)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---H
Confidence 99999999999999999999999999999999986432 123589999999999999999999 6
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 553 (633)
+.+|+||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++
T Consensus 163 ~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 242 (313)
T 1t46_A 163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (313)
T ss_dssp HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 78999999999999999999999999999988766544433345567889999999999999999999999999999999
Q ss_pred -CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 554 -GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 554 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
|+.||..... .....+.+........ .......+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 243 ~g~~p~~~~~~---~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 243 LGSSPYPGMPV---DSKFYKMIKEGFRMLS-------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp TTCCSSTTCCS---SHHHHHHHHHTCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcccc---hhHHHHHhccCCCCCC-------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 9999875432 1122222222111100 011123478899999999999999999999999876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=357.07 Aligned_cols=280 Identities=17% Similarity=0.195 Sum_probs=210.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCC----CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|++.+.||+|+||.||+|.+... .++.||||++....... ..+...........+..|+..+..++|||
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL---FTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHH---HHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhH---HHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 346899999999999999999987532 25889999986554211 11111111222345667888899999999
Q ss_pred ccccceeeecC----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 411 LLPLLAHMARP----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 411 iv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
|+++++++... ...++||||+ +++|.+++... ...+++..+..|+.||+.||+|| |+.+|+||||||+|
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHrDlkp~N 182 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYI---HEHEYVHGDIKASN 182 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGG
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEecCCHHH
Confidence 99999998764 4478999999 99999999752 35699999999999999999999 67799999999999
Q ss_pred eEec--CCCceEEcccccccccCCCCCcc-----eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCc
Q 006739 487 VLLD--DDMEARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559 (633)
Q Consensus 487 ill~--~~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 559 (633)
||++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 88999999999998765432211 1123459999999999999999999999999999999999999998
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
..... ........... .......++..+.....+ ..+.+++..||+.||++||+++++++.|+++
T Consensus 263 ~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 263 DNLKD---PKYVRDSKIRY-RENIASLMDKCFPAANAP---GEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp GGTTC---HHHHHHHHHHH-HHCHHHHHHHHSCTTCCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccC---HHHHHHHHHHh-hhhHHHHHHHhcccccCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 63321 12222222111 112233333333222222 3477888899999999999999999999876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=352.96 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=201.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++...... ...+.+.+|+.+++.++||||++++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~~ 71 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAV-------------DCPENIKKEICINKMLNHENVVKFY 71 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhceeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccc-------------chHHHHHHHHHHHHhCCCCCCCeEE
Confidence 468999999999999999999865 57899999998543211 1135678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~ 144 (323)
T 3tki_A 72 GHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNL 144 (323)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCE
T ss_pred EEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEEeCCCCE
Confidence 999999999999999999999998864 45699999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .......+.
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~~~ 222 (323)
T 3tki_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWK 222 (323)
T ss_dssp EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT--TSHHHHHHH
T ss_pred EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHh
Confidence 9999999987654332222345679999999999987765 7789999999999999999999975432 112222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~----~~~~~~---------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 223 EK----KTYLNP---------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TT----CTTSTT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc----cccCCc---------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 100000 0111223678899999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=347.87 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=206.3
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||++.+. ++..||+|++...... .+++.+|++++.+++||||+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~ 82 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLV 82 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHHTCCCTTBC
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCCCC---------------HHHHHHHHHHHhcCCCCCEe
Confidence 344578999999999999999999875 7788999998754321 34578899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+.+..++||||+++++|.+++... ...+++..++.++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nili~~~ 156 (283)
T 3gen_A 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQ 156 (283)
T ss_dssp CEEEEECSSSSEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTT
T ss_pred eEEEEEecCCCeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccceEEEcCC
Confidence 9999999999999999999999999999753 34599999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ....
T Consensus 157 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~ 231 (283)
T 3gen_A 157 GVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETA 231 (283)
T ss_dssp SCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHH
T ss_pred CCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHH
Confidence 99999999999876543211 1123457888999999998899999999999999999998 9999876422 1121
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+....... .... ....+.+++.+||+.||++|||++++++.|+++
T Consensus 232 ~~~~~~~~~~-~~~~------------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 232 EHIAQGLRLY-RPHL------------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp HHHHTTCCCC-CCTT------------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcccCCC-CCCc------------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1121111100 1111 113477899999999999999999999999886
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.74 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=203.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|++ +++.||||++....... ...+.+.+|+.++++++||||++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~ 73 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVRDWST------------RKSRDFNEECPRLRIFSHPNVLPVL 73 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCTTCCH------------HHHHHHHHHGGGGCCCSCTTEECEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEecccccCH------------HHHHHHHHHHHHHHhcCCCchhheE
Confidence 46899999999999999999987 58899999987643221 1145789999999999999999999
Q ss_pred eeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCeEecC
Q 006739 416 AHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR--IIHRDLKPANVLLDD 491 (633)
Q Consensus 416 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~Dikp~Nill~~ 491 (633)
+++.+. ...++||||+++|+|.+++... ....+++..++.++.|+++||+|| |+.+ |+||||||+||+++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~ 148 (271)
T 3kmu_A 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDE 148 (271)
T ss_dssp EEECTTTSSSCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECT
T ss_pred EEEccCCCCCeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcC
Confidence 999887 7789999999999999999752 234689999999999999999999 7777 999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCC---ccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTD---KCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
++.++++|||++..... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... .
T Consensus 149 ~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~ 217 (271)
T 3kmu_A 149 DMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----M 217 (271)
T ss_dssp TSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----H
T ss_pred CcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----H
Confidence 99999999988754322 2346899999999998765554 79999999999999999999975322 1
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhhC
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~~ 633 (633)
.. ............ . +......+.+++..||+.||++|||++|+++.|+++++
T Consensus 218 ~~---~~~~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 EI---GMKVALEGLRPT-----I----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HH---HHHHHHSCCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HH---HHHHHhcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11 111111111110 0 01112237888999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=352.84 Aligned_cols=266 Identities=23% Similarity=0.373 Sum_probs=193.7
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCC--eEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
...++|++.+.||+|+||.||+|++...++ ..||||++....... ...+++.+|++++++++||||
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i 87 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS------------SDIEEFLREAACMKEFDHPHV 87 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C------------HHHHHHHHHHHHHTTCCCTTB
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH------------HHHHHHHHHHHHHHHCCCCce
Confidence 345789999999999999999998753322 379999985432111 125678899999999999999
Q ss_pred cccceeeecCCcc------EEEEecccCCCHHHHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 006739 412 LPLLAHMARPDCH------LLVYEFMKNGSLQDILNDVSQG--RRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLK 483 (633)
Q Consensus 412 v~l~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~~--~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dik 483 (633)
+++++++...... ++||||+++|+|.+++...... ...+++..++.++.|+++||+|| |+.+|+|||||
T Consensus 88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~Dik 164 (323)
T 3qup_A 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLA 164 (323)
T ss_dssp CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCS
T ss_pred ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCCcccCCCC
Confidence 9999999877655 8999999999999999764432 23689999999999999999999 67899999999
Q ss_pred CCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccc
Q 006739 484 PANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFF 562 (633)
Q Consensus 484 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~ 562 (633)
|+||++++++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp GGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999999987755443333334567889999999999999999999999999999999 999987643
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
. ....+.+. ....... .......+.+++.+||+.||++|||+.++++.|+++
T Consensus 245 ~----~~~~~~~~---~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 245 N----AEIYNYLI---GGNRLKQ----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp G----GGHHHHHH---TTCCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred h----HHHHHHHh---cCCCCCC----------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2 22222221 1111110 111123478899999999999999999999999886
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=352.87 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=211.7
Q ss_pred hhhhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
....++|++.+.||+|+||.||+|++. ..++..||+|++...... ...+.+.+|+.++.++ +
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 107 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-------------SEREALMSELKMMTQLGS 107 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHCC
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH-------------HHHHHHHHHHHHHHhhcC
Confidence 445678999999999999999999862 346778999998643211 1145788999999999 8
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHH
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG-------------------RRELDWLARHKIALGVACGLEY 468 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~L~~ 468 (633)
||||+++++++...+..++||||+++|+|.+++...... ...+++..++.++.|+++||+|
T Consensus 108 hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 187 (344)
T 1rjb_A 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187 (344)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999763321 1348999999999999999999
Q ss_pred HHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHH
Q 006739 469 LHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL 548 (633)
Q Consensus 469 Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l 548 (633)
| |+.+|+||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++
T Consensus 188 L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 264 (344)
T 1rjb_A 188 L---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264 (344)
T ss_dssp H---HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred H---HhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHH
Confidence 9 6789999999999999999999999999999877654444344456688999999999998999999999999999
Q ss_pred HHHHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 549 AVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 549 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
|||+| |+.||..... .....+.+........ +......+.+++.+||+.||++|||+.|+++.
T Consensus 265 ~el~t~g~~p~~~~~~---~~~~~~~~~~~~~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 265 WEIFSLGVNPYPGIPV---DANFYKLIQNGFKMDQ-------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHTTTSCCSSTTCCC---SHHHHHHHHTTCCCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCcccCCc---HHHHHHHHhcCCCCCC-------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99998 9999976432 1222222222111110 01112347889999999999999999999999
Q ss_pred HHhh
Q 006739 628 LSQI 631 (633)
Q Consensus 628 l~~~ 631 (633)
|+.+
T Consensus 329 l~~~ 332 (344)
T 1rjb_A 329 LGCQ 332 (344)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.40 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=203.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+|+.||+|++....... ...+.+.+|++++++++||||++++
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~-~~~~~~a~K~i~~~~~~~------------~~~~~~~~E~~il~~l~hpnIv~l~ 76 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKV-LAGQEYAAMIINTKKLSA------------RDHQKLEREARICRLLKHPNIVRLH 76 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEET-TTTEEEEEEEEESCSCHH------------HHHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEEC-CCCcEEEEEEEEcccCCH------------HHHHHHHHHHHHHHhCCCcCCCeEE
Confidence 567999999999999999999764 589999999987654321 1245788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec---CC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD---DD 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~---~~ 492 (633)
+++.+.+..++||||+++|+|.+.+.. ...+++..+..++.||++||+|| |+.+|+||||||+|||++ ++
T Consensus 77 ~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIll~~~~~~ 149 (444)
T 3soa_A 77 DSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLLLASKLKG 149 (444)
T ss_dssp EEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEEESBSSTT
T ss_pred EEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEeccCCC
Confidence 999999999999999999999999875 35699999999999999999999 678999999999999998 46
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.. ...+.+
T Consensus 150 ~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~~~~ 223 (444)
T 3soa_A 150 AAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHRLYQ 223 (444)
T ss_dssp CCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHH
T ss_pred CcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHHHHH
Confidence 78999999999877654322 234679999999999999999999999999999999999999986532 222222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..... ..... ........+.+++..||+.||++|||+.|+++
T Consensus 224 ~i~~~~~--~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 224 QIKAGAY--DFPSP--------EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHTCC--CCCTT--------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCC--CCCcc--------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2221111 11100 00111234778999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=350.86 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=207.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|++.+.||+|+||.||+|+.. .+|+.||||++..... .+++.+|+++++++ +||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~~h~~i~~~ 70 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNL-YTNEYVAIKLEPMKSR----------------APQLHLEYRFYKQLGSGDGIPQV 70 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEET-TTTEEEEEEEEETTCS----------------SCCHHHHHHHHHHHCSCTTSCCE
T ss_pred cCCeEEEEEeeccCCceEEEEEEC-CCCcEEEEEEeccccc----------------hHHHHHHHHHHHHhhCCCCCCEE
Confidence 467999999999999999999864 5799999999864432 23477899999999 89999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+ +++|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Nill~~~~~ 143 (330)
T 2izr_A 71 YYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENFLIGRPGN 143 (330)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGG
T ss_pred EEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeeccCCC
Confidence 99999999999999999 99999999753 35799999999999999999999 6779999999999999998887
Q ss_pred -----eEEcccccccccCCCCCcc-----eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc
Q 006739 495 -----ARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564 (633)
Q Consensus 495 -----~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 564 (633)
+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 144 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 144 KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 9999999998765443211 123567999999999999999999999999999999999999999864322
Q ss_pred cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
........+... .... .........+ .+.+++..||+.||.+||+++++++.|+++
T Consensus 224 ~~~~~~~~i~~~-~~~~------~~~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 224 TLKERYQKIGDT-KRAT------PIEVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SHHHHHHHHHHH-HHHS------CHHHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHHHHHHHhh-hccC------CHHHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 211111111111 1100 0111111122 488899999999999999999999999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=349.03 Aligned_cols=264 Identities=25% Similarity=0.381 Sum_probs=200.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. +|+.||+|++.....+ ......+.+|++++++++||||++++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hp~iv~~~ 85 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAED------------EGIPSTAIREISLLKELHHPNIVSLI 85 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------------------CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEeccccc------------chhhHHHHHHHHHHHHcCCCCEeeee
Confidence 478999999999999999999875 6899999998543221 11145678999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..++||||+++ +|.+++.. ....+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl~~~~~~~ 158 (311)
T 3niz_A 86 DVIHSERCLTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGAL 158 (311)
T ss_dssp EEECCSSCEEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCE
T ss_pred eEEccCCEEEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEEECCCCCE
Confidence 999999999999999975 88888764 235689999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ....+
T Consensus 159 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i 232 (311)
T 3niz_A 159 KLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----QLPKI 232 (311)
T ss_dssp EECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT----HHHHH
T ss_pred EEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH----HHHHH
Confidence 99999999876543222 234578999999999876 568999999999999999999999997643322 12222
Q ss_pred HHhhccCCcchhhh----------------hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAID----------------AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d----------------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.............. ........+.....+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22222111110000 00000000111234778999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=344.83 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=201.1
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccccee
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAH 417 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 417 (633)
.|+..+.||+|+||.||+|+.. .+|+.||||++....... .+.+.+|+.++++++||||++++++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~~ 110 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQR--------------RELLFNEVVIMRDYQHFNVVEMYKS 110 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCS--------------HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccchhH--------------HHHHHHHHHHHHhCCCCCcceEEEE
Confidence 3667789999999999999864 578999999986543211 3567889999999999999999999
Q ss_pred eecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEE
Q 006739 418 MARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl 497 (633)
+...+..++||||+++++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+||
T Consensus 111 ~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl 182 (321)
T 2c30_A 111 YLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTLDGRVKL 182 (321)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCcEEE
Confidence 9999999999999999999999863 4589999999999999999999 6789999999999999999999999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.
T Consensus 183 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~~~~~~~~-- 254 (321)
T 2c30_A 183 SDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLR-- 254 (321)
T ss_dssp CCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHH--
T ss_pred eeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHh--
Confidence 999999876553322 2345799999999999999999999999999999999999999865321 12222222
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... .. ....+.+++.+||+.||++|||++|+++
T Consensus 255 -~~~~~~~~~~----~~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 255 -DSPPPKLKNS----HK----VSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -HSSCCCCTTG----GG----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cCCCCCcCcc----cc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111110000 01 1123778889999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.44 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=203.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+|+.||+|++....... +..+.+.+|+.++++++||||++++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~------------~~~~~~~~E~~il~~l~hpnIv~~~ 94 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSA------------RDFQKLEREARICRKLQHPNIVRLH 94 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCH------------HHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 467999999999999999999864 578999999986543321 1145788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC--
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-- 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~-- 493 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.||++||+|| |+.+|+||||||+||+++.++
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~ 167 (362)
T 2bdw_A 95 DSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKG 167 (362)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEESCSSTT
T ss_pred EEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCC
Confidence 999999999999999999999998864 35689999999999999999999 678999999999999998654
Q ss_pred -ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 494 -EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+..
T Consensus 168 ~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~~~~ 240 (362)
T 2bdw_A 168 AAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRLYA 240 (362)
T ss_dssp CCEEECCCTTCBCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH
T ss_pred CCEEEeecCcceEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHHHHH
Confidence 5999999999877654322 34579999999999999999999999999999999999999986532 122222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.... ....... .......+.+++.+||+.||++|||+.|+++
T Consensus 241 ~i~~~~--~~~~~~~--------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 241 QIKAGA--YDYPSPE--------WDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHTC--CCCCTTG--------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhCC--CCCCccc--------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 222111 1111000 0111233778999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=340.59 Aligned_cols=262 Identities=19% Similarity=0.242 Sum_probs=208.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++..... ...+.+|+.++.++ +|+|++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~~ 71 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPNV 71 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCCE
T ss_pred ccceEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeccCCc----------------cHHHHHHHHHHHHHhcCCCCCeE
Confidence 467999999999999999999864 5799999998854331 23467788999998 79999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++......++||||+ +++|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~~ 144 (298)
T 1csn_A 72 YYFGQEGLHNVLVIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNS 144 (298)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSS
T ss_pred EeecCCCceeEEEEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEeccCCC
Confidence 99999999999999999 99999999753 34699999999999999999999 6889999999999999987776
Q ss_pred -----eEEcccccccccCCCCCc-----ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc
Q 006739 495 -----ARIADFGLAKAMPDAQTH-----ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564 (633)
Q Consensus 495 -----~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 564 (633)
+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 145 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 999999999877654321 1124467999999999999999999999999999999999999999864332
Q ss_pred cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
............ ...... +..... ....+.+++..||+.||++||+++++++.|+++
T Consensus 225 ~~~~~~~~~~~~-~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 225 TNKQKYERIGEK-KQSTPL-----RELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHHHHHHHHHH-HHHSCH-----HHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHhh-ccCccH-----HHHHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 222222111111 111111 011111 123478899999999999999999999999886
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.22 Aligned_cols=252 Identities=22% Similarity=0.292 Sum_probs=204.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+++.||+|.+..... ....+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~---------------~~~~~~~E~~~l~~l~hpnIv~~~ 67 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGT---------------DQVLVKKEISILNIARHRNILHLH 67 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCTH---------------HHHHHHHHHHHHHHSCCTTBCCEE
T ss_pred hhceEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecCcc---------------cHHHHHHHHHHHHhCCCCCCCeEe
Confidence 468999999999999999999864 5789999999864321 134678999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC--CC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD--DM 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~--~~ 493 (633)
+++.+.+..++||||+++|+|.+++.. ....+++..+..++.|+++||+|| |+.+|+||||||+||+++. ++
T Consensus 68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~~~~~~~ 141 (321)
T 1tki_A 68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCC
T ss_pred EEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEccCCCC
Confidence 999999999999999999999999864 234699999999999999999999 6789999999999999997 78
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...
T Consensus 142 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~--- 211 (321)
T 1tki_A 142 TIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQI--- 211 (321)
T ss_dssp CEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHH---
T ss_pred CEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----HHH---
Confidence 999999999988765432 2345789999999999988889999999999999999999999975321 122
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.......... +....... ...+.+++.+||+.||++|||+.|+++
T Consensus 212 ~~~i~~~~~~~---~~~~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 212 IENIMNAEYTF---DEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTCCCC---CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCC---ChhhhccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22222211111 11111111 234788999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=354.40 Aligned_cols=256 Identities=22% Similarity=0.324 Sum_probs=194.0
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+++.. .+++.||+|++...... .+.+.+|+.+++.++||||+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGAAI---------------DENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESSTTS---------------CHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCccc---------------cHHHHHHHHHHHhCCCCCCC
Confidence 344578999999999999999999865 57899999998654321 23577899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dlkp~Nill~~~ 152 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGS 152 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCCCGGGEEECSS
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCC
Confidence 999999999999999999999999999975 24599999999999999999999 67899999999999999877
Q ss_pred Cc--eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCc-cchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 493 ME--ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDK-CDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 493 ~~--~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+. +||+|||+++....... .....||+.|+|||++.+..++.+ +||||+||++|||++|+.||........
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--- 226 (361)
T 3uc3_A 153 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--- 226 (361)
T ss_dssp SSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---
T ss_pred CCceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---
Confidence 65 99999999875433221 234579999999999988887666 8999999999999999999976433222
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+........... . ... ....+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~---~---~~~---~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 227 YRKTIQRILSVKYSIP---D---DIR---ISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHHHHTTCCCCC---T---TSC---CCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCCCCC---C---cCC---CCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 2222332222111100 0 000 1123778999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=372.74 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=211.0
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|+..+.||+|+||.||+|.+. .++..||||.+...... .++|.+|+.++++++||||++
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hpniv~ 280 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTME---------------VEEFLKEAAVMKEIKHPNLVQ 280 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSSSC---------------HHHHHHHHHHHHHCCCTTBCC
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCcccc---------------hHHHHHHHHHHHhcCCCCEee
Confidence 34567899999999999999999875 35889999998654321 456889999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++++|...+..++||||+++|+|.+++.... ...+++..+..++.||++||+|| |+.+|+||||||+|||++.++
T Consensus 281 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~ 355 (495)
T 1opk_A 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENH 355 (495)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECGGG
T ss_pred EEEEEecCCcEEEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChhhEEECCCC
Confidence 9999999999999999999999999997532 45689999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+
T Consensus 356 ~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~----~~~~~ 430 (495)
T 1opk_A 356 LVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYE 430 (495)
T ss_dssp CEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHH
T ss_pred cEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 999999999987654322 12233456789999999998899999999999999999999 9999876432 22333
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+... .... .+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 431 ~~~~~---~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 431 LLEKD---YRME----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp HHHTT---CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHcC---CCCC----------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 22221 1110 0111123477889999999999999999999999876
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=344.29 Aligned_cols=263 Identities=23% Similarity=0.391 Sum_probs=194.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|++ ...||+|++....... ...+.+.+|++++++++||||+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~----~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 85 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKW----HGDVAVKMLNVTAPTP------------QQLQAFKNEVGVLRKTRHVNILLF 85 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEES----SSEEEEEEESCSSCCH------------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CccceeeeeEecCCCCeEEEEEEE----cCceEEEEEeccCCCH------------HHHHHHHHHHHHHHhCCCCcEEEE
Confidence 356899999999999999999975 3359999986554321 115678899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++ .....++||||+++++|.+++.. ....+++..++.++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 86 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil~~~~~~ 158 (289)
T 3og7_A 86 MGYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNT 158 (289)
T ss_dssp EEEE-CSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTE
T ss_pred Eeec-cCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCCC
Confidence 9965 45668999999999999999864 245699999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+||+|||+++...............||+.|+|||.+. +..++.++||||||+++|||++|+.||..... ...+.
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~ 235 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQII 235 (289)
T ss_dssp EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC---HHHHH
T ss_pred EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch---HHHHH
Confidence 9999999998665433222234457999999999986 56688899999999999999999999976432 12222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.+.......... .........+.+++..||+.||++|||+.++++.|+++.
T Consensus 236 ~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 236 EMVGRGSLSPDLS---------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHTSCCCCTT---------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHhcccccCcchh---------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2222211111110 001112234788999999999999999999999999885
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=352.71 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=204.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|... .+|+.||||++......... ....+.+.+|+.+++.++||||++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hpnIv~~~ 92 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSP---------GLSTEDLKREASICHMLKHPHIVELL 92 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTSS---------SCCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccccc---------cchHHHHHHHHHHHHhCCCCCCCcEE
Confidence 357899999999999999999864 57899999998432110000 00145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc-
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME- 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~- 494 (633)
+++.+.+..++||||+++|+|.+++.........+++..+..++.||++||+|| |+.+|+||||||+||+++.++.
T Consensus 93 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~~~~~~~ 169 (351)
T 3c0i_A 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLLASKENS 169 (351)
T ss_dssp EEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECSSSTT
T ss_pred EEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEEecCCCC
Confidence 999999999999999999999988876544456789999999999999999999 6789999999999999987654
Q ss_pred --eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 495 --ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 --~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+||+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.
T Consensus 170 ~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~~~- 241 (351)
T 3c0i_A 170 APVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-----ERLF- 241 (351)
T ss_dssp CCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-----HHHH-
T ss_pred CcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-----HHHH-
Confidence 999999999887654321 234579999999999999999999999999999999999999997521 1111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... ++..... ....+.+++.+||+.||++|||+.|+++
T Consensus 242 --~~i~~~~~~~---~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 242 --EGIIKGKYKM---NPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --HHHHHTCCCC---CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHcCCCCC---Ccccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111110 0111011 1234778999999999999999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=340.15 Aligned_cols=258 Identities=27% Similarity=0.404 Sum_probs=193.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|.+ .++.||||++....... .....+.+.+|+++++.++||||++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 72 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDPDED----------ISQTIENVRQEAKLFAMLKHPNIIALR 72 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC--------------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCCccc----------HHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 46899999999999999999986 58899999986543211 112246788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC----
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD---- 491 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~---- 491 (633)
+++.+.+..++||||+++++|.+++. ...+++..++.++.|+++||+|||.....+|+||||||+||+++.
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp EEECCC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred EEEecCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 99999999999999999999999985 356899999999999999999995433233999999999999986
Q ss_pred ----CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 492 ----DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 492 ----~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
++.+||+|||+++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 219 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---- 219 (271)
T ss_dssp SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----
T ss_pred ccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 67899999999986654322 235689999999999998999999999999999999999999975321
Q ss_pred chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
... ............ ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 220 ~~~---~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 220 LAV---AYGVAMNKLALP---------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHH---HHHHHTSCCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHH---HHhhhcCCCCCC---------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111 111111111100 0111123478899999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=365.00 Aligned_cols=253 Identities=29% Similarity=0.413 Sum_probs=205.0
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|+..+.||+|+||.||+|.+ .|+.||||+++.... .+.+.+|++++++++||||++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~ 250 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----------------AQAFLAEASVMTQLRHSNLVQ 250 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSCTT----------------SHHHHHHHHHHHTCCCTTBCC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCchH----------------HHHHHHHHHHHHhccCCCEEE
Confidence 3457889999999999999999987 578999999865321 356889999999999999999
Q ss_pred cceeeecCC-ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 414 LLAHMARPD-CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 414 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+++++...+ ..++||||+++|+|.+++.... ...+++..+..++.||++||+|| |+.+|+||||||+|||++.+
T Consensus 251 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~ 325 (450)
T 1k9a_A 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSED 325 (450)
T ss_dssp EEEEEECTTSCEEEEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTT
T ss_pred EEEEEEcCCCceEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEECCC
Confidence 999987665 7899999999999999998632 34579999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++...... ....+|..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 326 ~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~ 396 (450)
T 1k9a_A 326 NVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVV 396 (450)
T ss_dssp SCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TTHH
T ss_pred CCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 999999999998654321 12357889999999999999999999999999999998 9999976432 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.+. ...... .+......+.+++.+||+.||++|||+.++++.|++++
T Consensus 397 ~~i~---~~~~~~----------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 397 PRVE---KGYKMD----------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HHHH---TTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---cCCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2222 111111 01111234778899999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=369.92 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=207.9
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|+..+.||+|+||.||+|.+. ++..||||++...... .+++.+|++++++++||||+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~iv 246 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSMS---------------VEAFLAEANVMKTLQHDKLV 246 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHTTCCCTTBC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCCcc---------------HHHHHHHHHHHhhCCCCCEe
Confidence 445678999999999999999999985 6788999998654321 45788999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++. .+..++||||+++|+|.++++... ...+++..+..++.||++||+|| |+.+|+||||||+|||++.+
T Consensus 247 ~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~ 320 (454)
T 1qcf_A 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSAS 320 (454)
T ss_dssp CEEEEEC-SSSCEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTT
T ss_pred eEEEEEe-CCccEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCHHHEEECCC
Confidence 9999986 567899999999999999997532 23588999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++........ ......+|..|+|||++....++.++|||||||++|||++ |+.||..... ..+.
T Consensus 321 ~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~~~~ 395 (454)
T 1qcf_A 321 LVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVI 395 (454)
T ss_dssp CCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHH
T ss_pred CcEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 99999999999876543211 1123456889999999998899999999999999999999 9999975322 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+.. ...... +......+.+++.+||+.||++|||++++++.|+++
T Consensus 396 ~~i~~---~~~~~~----------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 396 RALER---GYRMPR----------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp HHHHH---TCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHc---CCCCCC----------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 22221 111110 111123478899999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.25 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=205.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+|+.||+|++............ ..+.+.+|+.++++++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGV--------SREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSSSB--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccchh--------hHHHHHHHHHHHHhCCCCCCCcEE
Confidence 467899999999999999999864 57899999998765432111000 045688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC--
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-- 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~-- 493 (633)
+++.+....++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~ 153 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVP 153 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEEEecCCCC
Confidence 999999999999999999999999964 45699999999999999999999 678999999999999999887
Q ss_pred --ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 494 --EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~ 226 (326)
T 2y0a_A 154 KPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETL 226 (326)
T ss_dssp SCCEEECCCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHH
T ss_pred CCCEEEEECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH----HHHH
Confidence 7999999999877543321 345799999999999999999999999999999999999999865321 1111
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+... ..... ....... ...+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~--~~~~~----~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 227 ANVSAV--NYEFE----DEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHT--CCCCC----HHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhc--CCCcC----ccccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111 11111 1111111 233778899999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.82 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=197.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|++.++||+|+||.||+|+.. .+++.||+|++.+...... .....+.+|..++.++ +||||+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~-----------~~~~~~~~E~~il~~~~~hp~Iv~l 118 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDD-----------EDIDWVQTEKHVFEQASNHPFLVGL 118 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC---------------CCHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCH-----------HHHHHHHHHHHHHHhcCCCCCcCee
Confidence 468999999999999999999875 5789999999865422110 1134577888888876 89999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.
T Consensus 119 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~ 191 (396)
T 4dc2_A 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGH 191 (396)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEECCCCC
Confidence 99999999999999999999999999763 4599999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc-cchHHH-
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE-EMSLVK- 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-~~~~~~- 572 (633)
+||+|||+++....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........ .....+
T Consensus 192 ikL~DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~ 269 (396)
T 4dc2_A 192 IKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269 (396)
T ss_dssp EEECCCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred EEEeecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence 99999999986433222 22456899999999999999999999999999999999999999964322111 011111
Q ss_pred HHHHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 573 WMRNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 573 ~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
......... ..+.. ....+.+++.+||+.||++||++
T Consensus 270 ~~~~i~~~~~~~p~~------------~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 270 LFQVILEKQIRIPRS------------LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHCCCCCCTT------------SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHhccccCCCCc------------CCHHHHHHHHHHhcCCHhHcCCC
Confidence 111111111 11111 12237789999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=352.50 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=197.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|++.+.||+|+||.||+|+.. .+|+.||+|++.+... ........+.+|.+++..+ +||||+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~-----------~~~~~~~~~~~E~~il~~~~~hp~Iv~l 89 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVI-----------LQDDDVECTMTEKRILSLARNHPFLTQL 89 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHHTTHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHh-----------cchhHHHHHHHHHHHHHhccCCCceeeE
Confidence 478999999999999999999875 5789999999853211 1112245678899999988 69999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEEECCCCC
Confidence 99999999999999999999999999763 4599999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+++....... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+ .
T Consensus 163 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~---~ 233 (353)
T 3txo_A 163 CKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE----DDL---F 233 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH---H
T ss_pred EEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH----HHH---H
Confidence 99999999986433222 22446799999999999998999999999999999999999999975321 122 2
Q ss_pred HHhhccCC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH------HHHHH
Q 006739 575 RNVMTSEN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS------KDVRC 626 (633)
Q Consensus 575 ~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~------~ev~~ 626 (633)
..+..... .+.. ....+.+++.+||+.||++||++ +|+++
T Consensus 234 ~~i~~~~~~~p~~------------~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 234 EAILNDEVVYPTW------------LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHHCCCCCCTT------------SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHcCCCCCCCC------------CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 22222111 1111 11237788999999999999998 66653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=337.98 Aligned_cols=261 Identities=27% Similarity=0.494 Sum_probs=202.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|++. .+++.||+|++.......... ..+..+.+.+|++++++++||||++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETE-------MIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHH-------HHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hccceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchh-------HHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 478999999999999999999875 578999999986554321110 011136789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCeEecCCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR--IIHRDLKPANVLLDDDM 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~Dikp~Nill~~~~ 493 (633)
+++.+.. ++||||+++|+|.+.+.. ....+++..++.++.|+++||+|| |+.+ |+||||||+||+++.++
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGGEEESCCC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcceEEEeccC
Confidence 9986654 799999999999988864 245799999999999999999999 5667 99999999999998877
Q ss_pred c-----eEEcccccccccCCCCCcceecccccCcccccccccc--cCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 494 E-----ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ--TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 494 ~-----~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
. +||+|||+++..... .....||+.|+|||++. ...++.++||||+||++|||++|+.||......
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-- 234 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-- 234 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC--
T ss_pred CCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc--
Confidence 6 999999999754332 23467999999999984 455788999999999999999999999754321
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.......+. ....... . .......+.+++..||+.||++|||++|+++.|+++
T Consensus 235 ~~~~~~~~~---~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 235 KIKFINMIR---EEGLRPT-----I----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHH---HSCCCCC-----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHHh---ccCCCCC-----C----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111111111 1111110 0 111123478899999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=343.77 Aligned_cols=263 Identities=26% Similarity=0.390 Sum_probs=197.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. +|+.||+|++.....+... .+.+.+|++++++++||||+++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv~~~~ 67 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGI------------PSTTIREISILKELKHSNIVKLYD 67 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCC------------CHHHHHHHHGGGGCCCTTBCCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcC--CCCEEEEEEEecccccccc------------chhHHHHHHHHHhcCCCCEeeeee
Confidence 57899999999999999999873 7899999998654422110 346778999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++ +|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+|
T Consensus 68 ~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~k 140 (288)
T 1ob3_A 68 VIHTKKRLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELK 140 (288)
T ss_dssp EEECSSCEEEEEECCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEE
T ss_pred EEccCCeEEEEEEecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999975 999988752 35689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+++........ .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+....+
T Consensus 141 l~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~ 215 (288)
T 1ob3_A 141 IADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFR 215 (288)
T ss_dssp ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred EeECccccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHH
Confidence 9999999876543221 1335689999999998764 589999999999999999999999975422 111222221
Q ss_pred HhhccCCcch--------hhhhhhh-------hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTR--------AIDAKLL-------ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~--------~~d~~~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......... ..++... ..........+.+++.+||+.||++|||++|+++
T Consensus 216 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 216 -ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp -HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111110000 0000000 0001112234778999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=342.88 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=202.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+|+.||+|++.+... ......+.+.+|..+++.++||||++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~Iv~~~ 72 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIV-----------VRLKQVEHTNDERLMLSIVTHPFIIRMW 72 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHSCCBTTBCCEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hhhhHHHHHHHHHHHHhhCCCCCCceEe
Confidence 367999999999999999999864 5789999999853211 0011245678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+||+++.++.+
T Consensus 73 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~ 145 (318)
T 1fot_A 73 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHI 145 (318)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEEcCCCCE
Confidence 999999999999999999999999976 34689999999999999999999 68899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .. ...
T Consensus 146 kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~---~~~ 213 (318)
T 1fot_A 146 KITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MK---TYE 213 (318)
T ss_dssp EECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HH---HHH
T ss_pred EEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HH---HHH
Confidence 99999999876542 1345799999999999999999999999999999999999999965321 11 122
Q ss_pred HhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 576 NVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 576 ~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
.+.... .....+ ...+.+++.+|++.||++|| +++|+++
T Consensus 214 ~i~~~~~~~p~~~------------~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 214 KILNAELRFPPFF------------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHCCCCCCTTS------------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhCCCCCCCCC------------CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 222211 111111 12377889999999999999 8888864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=342.76 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=195.5
Q ss_pred hhhcCcccccccccccCeeEEEEEecC--CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
...++|++.+.||+|+||.||+|.+.. ..+..||+|.+...... ...+.+.+|+.++++++||||
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i 78 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-------------SVREKFLQEALTMRQFDHPHI 78 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCcc
Confidence 345789999999999999999998753 23567999998643211 124578899999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++++. .+..++||||+++++|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.
T Consensus 79 v~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~ 151 (281)
T 1mp8_A 79 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSS 151 (281)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEE
T ss_pred ceEEEEEc-cCccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHEEECC
Confidence 99999984 46789999999999999999752 34689999999999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~----~~~ 226 (281)
T 1mp8_A 152 NDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDV 226 (281)
T ss_dssp TTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGH
T ss_pred CCCEEECccccccccCcccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----HHH
Confidence 9999999999998775543221 233457889999999998899999999999999999997 9999876432 222
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
...+.. ..... . .......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 227 ~~~i~~---~~~~~--~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 227 IGRIEN---GERLP--M--------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HHHHHT---TCCCC--C--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHc---CCCCC--C--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 222221 11110 0 011123477899999999999999999999999887
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=352.61 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=201.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++..... ......+.+.+|+++++.++|||||+++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~-----------~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 81 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKC-----------VERNEVRNVFKELQIMQGLEHPFLVNLW 81 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhc-----------ccHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 368999999999999999999865 5789999999843211 0111246788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~v 154 (384)
T 4fr4_A 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILLDEHGHV 154 (384)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEECCCCCE
Confidence 999999999999999999999999975 45699999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 155 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~-- 228 (384)
T 4fr4_A 155 HITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEI-- 228 (384)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHH--
T ss_pred EEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-cHHHH--
Confidence 9999999987754432 234679999999999864 45899999999999999999999999753221 11122
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-HHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-SKDVR 625 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~ev~ 625 (633)
........... +......+.+++.+||+.||++||+ ++++.
T Consensus 229 -~~~~~~~~~~~-----------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 229 -VHTFETTVVTY-----------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -HHHHHHCCCCC-----------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -HHHHhhcccCC-----------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 22111111100 0111234788999999999999999 66654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=342.52 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=200.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+|+.||+|++........ ....++.+|+.++++++||||++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~ 98 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMDA-----------KARADCIKEIDLLKQLNHPNVIKYY 98 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCCH-----------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccceEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccCH-----------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 467999999999999999999864 5789999999865322110 1256788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++++|.+++.........+++..++.++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVV 175 (310)
T ss_dssp EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCE
T ss_pred EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEEEcCCCCE
Confidence 999999999999999999999999986555567799999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......
T Consensus 176 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~ 248 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK 248 (310)
T ss_dssp EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHH
T ss_pred EEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHH
Confidence 99999999876543221 1235689999999999999999999999999999999999999865321 1112222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
......... .. .... ...+.+++.+||+.||++|||++++++.|++++
T Consensus 249 ~~~~~~~~~-~~-----~~~~---~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 249 KIEQCDYPP-LP-----SDHY---SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp HHHTTCSCC-CC-----TTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcccCCC-Cc-----cccc---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 222111111 00 0111 223778899999999999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=345.31 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=198.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|+..+.||+|+||.||+|+.. .+++.||+|++.+..... ....+.+.+|..++.++ +||||+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~~~~hp~iv~l 75 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVND-----------DEDIDWVQTEKHVFEQASNHPFLVGL 75 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCS-----------HHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhheEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcc-----------hHHHHHHHHHHHHHHhcCCCCccCeE
Confidence 467999999999999999999875 578999999986542211 01245678899999887 89999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..|+||||+++|+|.+++... ..+++..++.++.||+.||+|| |+.+|+||||||+||+++.++.
T Consensus 76 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~ 148 (345)
T 3a8x_A 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGH 148 (345)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCC
Confidence 99999999999999999999999999753 4589999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccccc--chHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE--MSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~--~~~~~ 572 (633)
+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......... .....
T Consensus 149 ~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 226 (345)
T 3a8x_A 149 IKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226 (345)
T ss_dssp EEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred EEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence 99999999986433222 224467999999999999999999999999999999999999999753221110 11111
Q ss_pred HHHHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 573 WMRNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 573 ~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
......... ..+. .....+.+++.+||+.||++||++
T Consensus 227 ~~~~i~~~~~~~p~------------~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 227 LFQVILEKQIRIPR------------SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHCCCCCCT------------TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHcCCCCCCC------------CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111111111 1111 112237788999999999999996
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=350.13 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=210.2
Q ss_pred hhhcCcccccccccccCeeEEEEEecC------CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI- 406 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 406 (633)
...++|++.+.||+|+||.||+|++.+ .++..||+|++...... ...+.+.+|+++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~ 98 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-------------KDLSDLVSEMEMMKMIG 98 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCH-------------HHHHHHHHHHHHHHHHC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcH-------------HHHHHHHHHHHHHHHhh
Confidence 345789999999999999999998742 35778999998654321 1156788999999999
Q ss_pred CCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006739 407 RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG------------RRELDWLARHKIALGVACGLEYLHISHN 474 (633)
Q Consensus 407 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~ 474 (633)
+||||+++++++.+.+..++||||+++|+|.+++...... ...+++..++.++.|+++||+|| |+
T Consensus 99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~ 175 (334)
T 2pvf_A 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---AS 175 (334)
T ss_dssp CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH---HH
T ss_pred cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---Hh
Confidence 8999999999999999999999999999999999864321 23589999999999999999999 67
Q ss_pred CCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-
Q 006739 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM- 553 (633)
Q Consensus 475 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt- 553 (633)
.+|+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++
T Consensus 176 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 255 (334)
T 2pvf_A 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255 (334)
T ss_dssp TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhC
Confidence 8999999999999999999999999999987765543333344567889999999988889999999999999999999
Q ss_pred CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 554 GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 554 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
|+.||.... ...+.+.+... .... ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 256 g~~p~~~~~----~~~~~~~~~~~---~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 256 GGSPYPGIP----VEELFKLLKEG---HRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp SCCSSTTCC----HHHHHHHHHHT---CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCcCC----HHHHHHHHhcC---CCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999986532 12222222221 1111 0011123477899999999999999999999999886
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=340.92 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=200.5
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+++.||+|++........ ....+.+|+.++++++||||+++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~ 68 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEG------------VPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTT------------HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcCC------------cchHHHHHHHHHhcCCCCCEeeEEe
Confidence 57899999999999999999875 5789999999875543211 1456788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++ ++.+.+.. ....+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~~~~~~k 141 (292)
T 3o0g_A 69 VLHSDKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEeCCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999976 66555543 235699999999999999999999 677999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+++........ .....||+.|+|||++.+.. ++.++||||+||++|||++|+.||... .......+.+.
T Consensus 142 l~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~---~~~~~~~~~i~ 216 (292)
T 3o0g_A 142 LANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIF 216 (292)
T ss_dssp ECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHHH
T ss_pred EeecccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC---CCHHHHHHHHH
Confidence 9999999876543222 23457899999999987765 799999999999999999999886432 12222222222
Q ss_pred HhhccCCcchh--hh-------------hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRA--ID-------------AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~--~d-------------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........... .. ........+.....+.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 22111110000 00 00000011122334778999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=348.75 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=198.1
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeE----EEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKM----IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|++.+.||+|+||.||+|++.. +++. ||+|.+....... ..+++.+|+.++++++|||
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hp~ 78 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPK-------------ANKEILDEAYVMASVDNPH 78 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSSCC-------------CHHHHHHHHHHHTTCCBTT
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccCHH-------------HHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999998753 4443 5777765332111 1457889999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
|+++++++.... .++|+||+++|+|.+++... ...+++..++.++.|+++||+|| |+.+|+||||||+||+++
T Consensus 79 iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~ 151 (327)
T 3lzb_A 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVK 151 (327)
T ss_dssp BCCCCEEEESSS-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEE
T ss_pred eeEEEEEEecCC-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCHHHEEEc
Confidence 999999998755 78999999999999999753 35699999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccch
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMS 569 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 569 (633)
.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 152 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~ 227 (327)
T 3lzb_A 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 227 (327)
T ss_dssp ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG
T ss_pred CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH----HH
Confidence 999999999999988765443333334567889999999999999999999999999999999 9999976432 22
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.+.+....... .. ......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 228 ~~~~~~~~~~~~-~~------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 228 ISSILEKGERLP-QP------------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHTTCCCC-CC------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC-CC------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 323222211111 01 111223778999999999999999999999998874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=340.92 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=208.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|+..+.||+|+||.||++.+. +++.||+|++...... .+++.+|++++++++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~ 68 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQL 68 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTBC---------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred chhheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCCC---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 4468999999999999999999875 6789999998654321 2467889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++++|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nili~~~~~ 142 (267)
T 3t9t_A 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQV 142 (267)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECGGGC
T ss_pred EEEEccCCCeEEEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEECCCCC
Confidence 99999999999999999999999999752 34689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||+++....... .......+|..|+|||++.+..++.++||||+|+++|||++ |+.||..... ...
T Consensus 143 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~--- 214 (267)
T 3t9t_A 143 IKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEV--- 214 (267)
T ss_dssp EEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH---
T ss_pred EEEcccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH----HHH---
Confidence 99999999987654211 11123457889999999998899999999999999999999 8999875321 122
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
............ .......+.+++.+||+.||++|||++++++.|+++.
T Consensus 215 ~~~i~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 215 VEDISTGFRLYK----------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHTTCCCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCcCCC----------CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 222221111100 0011233778999999999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.10 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=190.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|... .+|+.||+|++........ ...+.+|++++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~-------------~~~~~~E~~~l~~l~hp~iv~~~ 69 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK-TTGVYVALKEVKLDSEEGT-------------PSTAIREISLMKELKHENIVRLY 69 (317)
T ss_dssp ---------------CEEEEEECS-SSCCEEEEEEEECCSTTCS-------------CHHHHHHHHHHTTCCBTTBCCEE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC-CCCcEEEEEEeeccccccc-------------HHHHHHHHHHHHhcCCCCcceEE
Confidence 367899999999999999999864 5789999999865432110 34577899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQ--GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++.+++..++||||++ |+|.+++..... ....+++..+..++.|+++||+|| |+.+|+||||||+||+++.++
T Consensus 70 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~ 145 (317)
T 2pmi_A 70 DVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQNLLINKRG 145 (317)
T ss_dssp EEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTC
T ss_pred EEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHHeEEcCCC
Confidence 99999999999999997 599999876432 234589999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~ 219 (317)
T 2pmi_A 146 QLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND----EEQLK 219 (317)
T ss_dssp CEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHH
T ss_pred CEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHH
Confidence 9999999999876543221 134578999999999876 4689999999999999999999999975322 12222
Q ss_pred HHHHhhccCCc--------------------chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENP--------------------TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~--------------------~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+......... ...+...+...........+.+++.+||+.||++|||++|+++
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 22221111100 0000000000001112235788999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.20 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=202.8
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeE----EEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKM----IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|++.+.||+|+||.||+|++.. +++. ||+|.+........ ...+.+|+.++++++|||
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~~~-------------~~~~~~e~~~l~~l~h~~ 76 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQS-------------FQAVTDHMLAIGSLDHAH 76 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSCSC-------------BCSCCHHHHHHHTCCCTT
T ss_pred CHhHceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccHHH-------------HHHHHHHHHHHhcCCCCC
Confidence 34689999999999999999998753 4443 78887754321110 235677899999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
|+++++++. .+..++||||+++|+|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+|||++
T Consensus 77 iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~ 149 (325)
T 3kex_A 77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLK 149 (325)
T ss_dssp BCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSSTTEEES
T ss_pred cCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccchheEEEC
Confidence 999999886 45688999999999999998752 34688999999999999999999 677999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccch
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMS 569 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 569 (633)
.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 150 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~ 225 (325)
T 3kex_A 150 SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL----AE 225 (325)
T ss_dssp SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT----TH
T ss_pred CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH----HH
Confidence 999999999999998766544433345678889999999999999999999999999999999 9999976432 22
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..+.+....... ..... ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 226 ~~~~~~~~~~~~-~~~~~------------~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 226 VPDLLEKGERLA-QPQIC------------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHHHHHTTCBCC-CCTTB------------CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCC-CCCcC------------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222222211111 11111 112678889999999999999999999998763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=349.16 Aligned_cols=251 Identities=21% Similarity=0.335 Sum_probs=180.3
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccceeeec
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLAHMAR 420 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 420 (633)
.+.||+|+||.||+|+.. .+++.||||++.... ...+.+|+.++..+. ||||+++++++.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~-----------------~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHK-KSNQAFAVKIISKRM-----------------EANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp SCCSEEETTEEEEEEEET-TTCCEEEEEEEEGGG-----------------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CCccccCCCeEEEEEEEC-CCCCEEEEEEEChhh-----------------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 478999999999999875 578999999984321 345678999999997 9999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC---ceEE
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM---EARI 497 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~---~~kl 497 (633)
....++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++ .+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~kl 150 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKI 150 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC----CEEEE
T ss_pred CCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCCcccEEE
Confidence 9999999999999999999976 35699999999999999999999 678999999999999998765 7999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.............+.+...
T Consensus 151 ~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i 228 (325)
T 3kn6_A 151 IDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228 (325)
T ss_dssp CCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH
T ss_pred eccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH
Confidence 999999876543322 234568999999999999999999999999999999999999997654332223333334333
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ ... .......+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~---~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 229 KKGDFSFE---GEA----WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TTTCCCCC---SHH----HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HcCCCCCC---ccc----ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 33221110 000 0111234788999999999999999998863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=344.50 Aligned_cols=268 Identities=23% Similarity=0.337 Sum_probs=212.1
Q ss_pred hhhhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
....++|++.+.||+|+||.||+|++. ..+++.||||++...... ...+.+.+|+.++.++ +
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 89 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGH 89 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc-------------HHHHHHHHHHHHHHhccc
Confidence 345678999999999999999999853 356789999998654321 1145788999999999 6
Q ss_pred CCcccccceeeecCC-ccEEEEecccCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006739 408 HRNLLPLLAHMARPD-CHLLVYEFMKNGSLQDILNDVSQG------------RRELDWLARHKIALGVACGLEYLHISHN 474 (633)
Q Consensus 408 h~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~L~~Lh~~h~ 474 (633)
||||+++++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|+++||+|| |+
T Consensus 90 hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~ 166 (316)
T 2xir_A 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---AS 166 (316)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH---HH
T ss_pred CCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH---Hh
Confidence 999999999987754 489999999999999999864321 22389999999999999999999 67
Q ss_pred CCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-
Q 006739 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM- 553 (633)
Q Consensus 475 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt- 553 (633)
.+|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++
T Consensus 167 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 167 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 8999999999999999999999999999987765544444455678999999999999999999999999999999998
Q ss_pred CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 554 GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 554 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
|+.||..... .......+...... ..... ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 247 g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 247 GASPYPGVKI---DEEFCRRLKEGTRM-RAPDY------------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp SCCSSTTCCC---SHHHHHHHHHTCCC-CCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccch---hHHHHHHhccCccC-CCCCC------------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999875322 11222222211110 01111 1123778899999999999999999999998863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=349.78 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=199.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|.+.+.||+|+||.||+|++. .+++.||+|++...... .......+.+|+.+++.++||||++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~l~ 75 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLK-----------KSDMHMRVEREISYLKLLRHPHIIKLY 75 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHH-----------HTTCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHcc-----------chhHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 468999999999999999999874 57899999998421100 001134688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..++||||+ +|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++++++.+
T Consensus 76 ~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~ 147 (336)
T 3h4j_B 76 DVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLLLDDNLNV 147 (336)
T ss_dssp EEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEEECTTCCE
T ss_pred EEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEEEcCCCCE
Confidence 9999999999999999 7899998875 34599999999999999999999 67789999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||++......... ....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||++.........+.
T Consensus 148 kl~DFG~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--- 221 (336)
T 3h4j_B 148 KIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--- 221 (336)
T ss_dssp EECCSSCTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC---
T ss_pred EEEEeccceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH---
Confidence 99999999876554322 33579999999999988776 679999999999999999999997643321111100
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......+.. ....+.+++.+||+.||.+|||++|+++
T Consensus 222 ---~~~~~~p~~------------~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 ---SCVYVMPDF------------LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ---SSCCCCCTT------------SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ---cCCCCCccc------------CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 000000111 1123778999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.92 Aligned_cols=267 Identities=23% Similarity=0.329 Sum_probs=211.7
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCC----CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
....++|+..+.||+|+||.||+|.....+ ...||+|.+...... ...+.+.+|+.+++++ +
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~ 108 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA-------------DEKEALMSELKIMSHLGQ 108 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh-------------HHHHHHHHHHHHHHhhcC
Confidence 345678999999999999999999875322 248999998654321 1146788999999999 8
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ----------GRRELDWLARHKIALGVACGLEYLHISHNPRI 477 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~i 477 (633)
||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|| |+.+|
T Consensus 109 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i 185 (333)
T 2i1m_A 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNC 185 (333)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH---HHTTE
T ss_pred CCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH---hcCCc
Confidence 99999999999999999999999999999999975431 134689999999999999999999 67799
Q ss_pred eeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCC
Q 006739 478 IHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRL 556 (633)
Q Consensus 478 vH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~ 556 (633)
+||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 186 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 265 (333)
T 2i1m_A 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLN 265 (333)
T ss_dssp ECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999987655443333344567889999999999899999999999999999999 999
Q ss_pred CCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 557 PSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 557 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
||...... ....+.+........ . ......+.+++..||+.||.+|||+.|+++.|+++
T Consensus 266 p~~~~~~~---~~~~~~~~~~~~~~~-~------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 266 PYPGILVN---SKFYKLVKDGYQMAQ-P------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp SSTTCCSS---HHHHHHHHHTCCCCC-C------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccchh---HHHHHHHhcCCCCCC-C------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 98754321 122222222111110 0 01123477899999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=343.15 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=212.4
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|.+. .++..||+|.+...... .+++.+|++++++++||||+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~ 72 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTME---------------VEEFLKEAAVMKEIKHPNLV 72 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSCSTH---------------HHHHHHHHHHHHHCCCTTBC
T ss_pred cccccceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcCHHH---------------HHHHHHHHHHHHhCCCCCEe
Confidence 345678999999999999999999875 46899999998653321 45688999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+.+..++||||+++++|.+++... ....+++..++.++.|++.||+|| |+.+|+||||||+||+++.+
T Consensus 73 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~ 147 (288)
T 3kfa_A 73 QLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGEN 147 (288)
T ss_dssp CEEEEECSSSSEEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEEECGG
T ss_pred eEEEEEccCCCEEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEEEcCC
Confidence 9999999999999999999999999999753 245699999999999999999999 67789999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 148 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~----~~~~ 222 (288)
T 3kfa_A 148 HLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVY 222 (288)
T ss_dssp GCEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHH
T ss_pred CCEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 99999999999877654322 2234567889999999999999999999999999999999 9999875322 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+........+ ......+.+++..||+.||++|||+.++++.|+++
T Consensus 223 ~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 223 ELLEKDYRMERP-------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHHHTTCCCCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccCCCCCC-------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 222221111111 11123478899999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=344.77 Aligned_cols=268 Identities=24% Similarity=0.355 Sum_probs=199.7
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCC--CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
....++|.+.+.||+|+||.||+|.+... ++..||+|++....... ...+.+.+|+.++++++|||
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~ 97 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ------------REIEEFLSEAACMKDFSHPN 97 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH------------HHHHHHHHHHHHHHTCCCTT
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch------------hHHHHHHHHHHHHhcCCCCC
Confidence 34557899999999999999999987543 45689999986543211 11467889999999999999
Q ss_pred ccccceeeecCCc-----cEEEEecccCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 006739 411 LLPLLAHMARPDC-----HLLVYEFMKNGSLQDILNDVS--QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLK 483 (633)
Q Consensus 411 iv~l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dik 483 (633)
|+++++++.+.+. .++||||+++|+|.+++.... .....+++..++.++.|+++||.|| |+.+|+|||||
T Consensus 98 iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dik 174 (313)
T 3brb_A 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLA 174 (313)
T ss_dssp BCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCS
T ss_pred eeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCC
Confidence 9999999977553 489999999999999986432 2346799999999999999999999 68899999999
Q ss_pred CCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccc
Q 006739 484 PANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFF 562 (633)
Q Consensus 484 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~ 562 (633)
|+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 175 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp GGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 9999999999999999999987655433333334567889999999999999999999999999999999 888986532
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
. ....+.+.. ...... .......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 255 ~----~~~~~~~~~---~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 255 N----HEMYDYLLH---GHRLKQ----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp G----GGHHHHHHT---TCCCCC----------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHHHHHHc---CCCCCC----------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2 222222221 111110 0111234788999999999999999999999998873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=341.87 Aligned_cols=269 Identities=21% Similarity=0.334 Sum_probs=208.1
Q ss_pred hcCcccccccccccCeeEEEEEe---cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
...|+..+.||+|+||.||+|++ ...+++.||+|++...... ...+.+.+|++++++++||||+
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------------NHIADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------------CCHHHHHHHHHHHHTCCCTTBC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc-------------hhHHHHHHHHHHHHhCCCCCee
Confidence 35688999999999999999985 3457899999998643211 1145788999999999999999
Q ss_pred ccceeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 413 PLLAHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 413 ~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++++++... ...++||||+++|+|.+++... ...+++..++.++.|++.||+|| |+.+|+||||||+||+++
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~ 160 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVE 160 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchheEEEc
Confidence 999999876 6689999999999999999653 34599999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccc------
Q 006739 491 DDMEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ------ 563 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~------ 563 (633)
.++.+||+|||+++......... ......||..|+|||.+.+..++.++||||+|+++|||++|+.|+.....
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 240 (302)
T 4e5w_A 161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240 (302)
T ss_dssp ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence 99999999999998876544321 22345688899999999998899999999999999999999998653211
Q ss_pred --ccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhhC
Q 006739 564 --HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633 (633)
Q Consensus 564 --~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~~ 633 (633)
..................... ........+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 241 GPTHGQMTVTRLVNTLKEGKRLP----------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp CSCCGGGHHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCcccccCHHHHHHHHhccCCCC----------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 011111112222211111110 111122347889999999999999999999999998753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=357.63 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=202.6
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|+.. .+++.||+|++.+... ........+.+|+.+++.++|||||
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~-----------~~~~~~~~~~~E~~il~~l~hp~Iv 132 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEM-----------IKRSDSAFFWEERDIMAFANSPWVV 132 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTCCCSTHHHHHHHHHHCCCTTBC
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhh-----------hhhHHHHHHHHHHHHHHhCCCCCCC
Confidence 345678999999999999999999875 5789999999843110 0001123477899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+.+..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|| |+.+|+||||||+|||++.+
T Consensus 133 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~ 204 (410)
T 3v8s_A 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKS 204 (410)
T ss_dssp CEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTT
T ss_pred eEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeeECCC
Confidence 999999999999999999999999999874 3589999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCC----CCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK----FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...... .
T Consensus 205 g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~ 280 (410)
T 3v8s_A 205 GHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---G 280 (410)
T ss_dssp SCEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---H
T ss_pred CCEEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---h
Confidence 99999999999876554322 223567999999999998765 788999999999999999999999753221 1
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCC--CCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE--RPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~ev~~ 626 (633)
...+.+........+.. .. ....+.+++.+||+.+|.+ ||+++|+++
T Consensus 281 ~~~~i~~~~~~~~~p~~--------~~---~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 281 TYSKIMNHKNSLTFPDD--------ND---ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHHTHHHHCCCCTT--------CC---CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHHhccccccCCCc--------cc---ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 11111111100010100 01 1123778889999999999 999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=348.37 Aligned_cols=256 Identities=14% Similarity=0.125 Sum_probs=202.6
Q ss_pred hhhcCcccccccccccCeeEEEEEe----cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-- 407 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-- 407 (633)
...+.|.+.+.||+|+||.||+|.+ ...+++.||+|++.... ..++.+|++++..++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~l~~~ 124 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------------PWEFYIGTQLMERLKPS 124 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------------HHHHHHHHHHHHHSCGG
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------------hhHHHHHHHHHHHhhhh
Confidence 3457899999999999999999952 23478999999986543 234566677776666
Q ss_pred -CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 006739 408 -HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485 (633)
Q Consensus 408 -h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~ 485 (633)
|+||+++++++...+..++||||+++|+|.+++..... ....+++..++.|+.||++||+|| |+.+|+||||||+
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrDiKp~ 201 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPD 201 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGG
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHH
Confidence 99999999999999999999999999999999986443 356799999999999999999999 6789999999999
Q ss_pred CeEecC-----------CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhC
Q 006739 486 NVLLDD-----------DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMG 554 (633)
Q Consensus 486 Nill~~-----------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg 554 (633)
|||++. ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 999998 899999999999765433333334556799999999999999999999999999999999999
Q ss_pred CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCC-CCHHHHHHHHHhh
Q 006739 555 RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRER-PNSKDVRCMLSQI 631 (633)
Q Consensus 555 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R-Ps~~ev~~~l~~~ 631 (633)
+.||.......... ..... .... .+.+.+++..|++.+|.+| |+++++.+.|+++
T Consensus 282 ~~pf~~~~~~~~~~-----------~~~~~--------~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 282 TYMKVKNEGGECKP-----------EGLFR--------RLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp SCCCEEEETTEEEE-----------CSCCT--------TCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred CCccccCCCCceee-----------chhcc--------ccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 99986533211100 00000 0011 2236678889999999998 6788888877664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=347.65 Aligned_cols=248 Identities=19% Similarity=0.266 Sum_probs=202.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|+.. .+|+.||+|++..... ......+.+.+|+++++.++||||++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 107 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKV-----------VKLKQIEHTLNEKRILQAVNFPFLVKLE 107 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHh-----------ccHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 468999999999999999999875 5789999999843211 0111245788899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.+
T Consensus 108 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~ 180 (350)
T 1rdq_E 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCE
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEEECCCCCE
Confidence 9999999999999999999999999863 4589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ..
T Consensus 181 kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~---~~ 248 (350)
T 1rdq_E 181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQI---YE 248 (350)
T ss_dssp EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH---HH
T ss_pred EEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----HHH---HH
Confidence 999999998765431 345799999999999999999999999999999999999999975321 111 22
Q ss_pred HhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 576 NVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 576 ~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
.+.... ..+.. ....+.+++.+||+.||++||+ ++|+++
T Consensus 249 ~i~~~~~~~p~~------------~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 249 KIVSGKVRFPSH------------FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHCCCCCCTT------------CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHcCCCCCCCC------------CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 222211 11111 1223778999999999999998 777764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=339.29 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=195.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhh-H-----------HHHHHHHHHHHHHHHHHHHh
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELT-E-----------EDSKLLNKKMRQIRSEINTV 403 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~e~~~l 403 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++........... . ..........+.+.+|++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 468999999999999999999864 5789999999875532110000 0 00000011245788999999
Q ss_pred hcCCCCcccccceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 006739 404 GQIRHRNLLPLLAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRD 481 (633)
Q Consensus 404 ~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~D 481 (633)
++++||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.|+++||+|| |+.+|+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYL---HYQKIIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccC
Confidence 99999999999999986 567899999999999987653 35699999999999999999999 677999999
Q ss_pred CCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCC---CCCccchHHHHHHHHHHHhCCCCC
Q 006739 482 LKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK---FTDKCDIYSFGVLLAVLVMGRLPS 558 (633)
Q Consensus 482 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~ 558 (633)
|||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 999999999999999999999987755432 223457999999999998765 367899999999999999999998
Q ss_pred cccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 559 DDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... ...+ ............ ........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~----~~~~---~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDER----IMCL---HSKIKSQALEFP---------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSS----HHHH---HHHHHHCCCCCC---------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcc----HHHH---HHHHhcccCCCC---------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 6532 1111 111111111000 00011233788999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.76 Aligned_cols=261 Identities=21% Similarity=0.270 Sum_probs=203.4
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|++.++||+|+||.||+|++. .+++.||+|++.+... ........+.+|..++..++||||++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~-----------~~~~~~~~~~~E~~il~~~~hp~Iv~ 138 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEM-----------LKRAETACFREERDVLVNGDSKWITT 138 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHH-----------HHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHh-----------hhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 34578999999999999999999875 5789999999843110 00011234788999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++++|.+.+..|+||||+++|+|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+|||++.++
T Consensus 139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILl~~~g 212 (437)
T 4aw2_A 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNG 212 (437)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeeEcCCC
Confidence 999999999999999999999999999752 35699999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
.+||+|||+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 213 ~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 291 (437)
T 4aw2_A 213 HIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291 (437)
T ss_dssp CEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred CEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence 9999999999876554332 224467999999999987 4568999999999999999999999997532211111
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCC--CCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE--RPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--RPs~~ev~~ 626 (633)
.+..+.. .-..+.. .......+.+++.+||..+|++ ||+++|+++
T Consensus 292 ~i~~~~~---~~~~p~~----------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKE---RFQFPTQ----------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHH---HCCCCSS----------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhccc---cccCCcc----------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111111 0011100 0011223778888999988888 999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.39 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=200.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
..++|++.+.||+|+||.||+|+.. .+|+.||+|++.+... ........+..|..++..+ +||||++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~E~~il~~~~~hp~iv~ 82 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVV-----------LMDDDVECTMVEKRVLSLAWEHPFLTH 82 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHHHTTCTTBCC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHh-----------hhhhhHHHHHHHHHHHHhcCCCCCCCc
Confidence 4578999999999999999999875 5789999999853211 0011144577888888876 8999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|| |+.+|+||||||+||+++.++
T Consensus 83 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDG 155 (345)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTS
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhEEECCCC
Confidence 999999999999999999999999999763 4589999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...+.+.
T Consensus 156 ~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~----~~~~~~~ 229 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHS 229 (345)
T ss_dssp CEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHH
T ss_pred CEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC----HHHHHHH
Confidence 999999999986543222 1244679999999999999999999999999999999999999997532 1222222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH-HHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK-DVR 625 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-ev~ 625 (633)
+.. ........ ....+.+++.+||+.||++||++. |++
T Consensus 230 i~~--~~~~~p~~------------~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 230 IRM--DNPFYPRW------------LEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHH--CCCCCCTT------------SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHh--CCCCCCcc------------cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 211 11111111 112377889999999999999997 553
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=347.22 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=197.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|++. .+|+.||||++....... ..+.+.+|++++++++||||++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hpniv~~~ 70 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNREL-------------AREKVMREVKALAKLEHPGIVRYF 70 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTTT-------------HHHHHHHHHHHHTSCCCTTBCCEE
T ss_pred hhcCceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCchh-------------HHHHHHHHHHHHHhCCCCCEeeEE
Confidence 357899999999999999999875 578999999986543211 146789999999999999999999
Q ss_pred eeeecCC---------------------------------------------------------ccEEEEecccCCCHHH
Q 006739 416 AHMARPD---------------------------------------------------------CHLLVYEFMKNGSLQD 438 (633)
Q Consensus 416 ~~~~~~~---------------------------------------------------------~~~lv~e~~~~gsL~~ 438 (633)
+++.+.. ..++||||+++|+|.+
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 150 (332)
T 3qd2_B 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150 (332)
T ss_dssp EEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHH
T ss_pred EEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHH
Confidence 9986543 2789999999999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCc------
Q 006739 439 ILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTH------ 512 (633)
Q Consensus 439 ~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~------ 512 (633)
++..... ....++..++.++.|+++||+|| |+.+|+||||||+||+++.++.+||+|||+++........
T Consensus 151 ~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~ 226 (332)
T 3qd2_B 151 WMNRRCS-LEDREHGVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226 (332)
T ss_dssp HHHTCCS-GGGSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC---------
T ss_pred HHhcccC-ccchhhHHHHHHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccc
Confidence 9986332 34567788999999999999999 6789999999999999999999999999999887654221
Q ss_pred ----ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhh
Q 006739 513 ----ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAID 588 (633)
Q Consensus 513 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 588 (633)
.......||+.|+|||++.+..++.++||||+||++|||++|..|+... ........... ....
T Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------~~~~~~~~~~~-~~~~-- 294 (332)
T 3qd2_B 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------VRIITDVRNLK-FPLL-- 294 (332)
T ss_dssp -----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------HHHHHHHHTTC-CCHH--
T ss_pred ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------HHHHHHhhccC-CCcc--
Confidence 1123456999999999999999999999999999999999998774321 11111111111 1111
Q ss_pred hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 589 AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 589 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......+.+++.+||+.||++|||++|+++
T Consensus 295 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 295 -------FTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp -------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred -------cccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 1112234678999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=364.53 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=202.1
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|+..+.||+|+||.||+|.+. ++..||||++...... .+++.+|++++++++||||+
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hp~iv 242 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLV 242 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC---------------HHHHHHHHHHHHHCCCTTBC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCCCC---------------HHHHHHHHHHHHhCCCCCEe
Confidence 345578899999999999999999985 5678999998654321 34688999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+ +..++||||+++|+|.+++.... ...+++..+..++.|+++||+|| |+.+|+||||||+|||++++
T Consensus 243 ~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~ 316 (452)
T 1fmk_A 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGEN 316 (452)
T ss_dssp CEEEEECS-SSCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGG
T ss_pred eEEEEEcC-CceEEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhEEECCC
Confidence 99999876 67899999999999999997532 34589999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++........ ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....
T Consensus 317 ~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~ 391 (452)
T 1fmk_A 317 LVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVL 391 (452)
T ss_dssp GCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHH
T ss_pred CCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 99999999999876543221 1233457889999999999999999999999999999999 9999875322 1222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+ ....... .+......+.+++.+||+.||++|||++++++.|+++
T Consensus 392 ~~i---~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 392 DQV---ERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp HHH---HTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HHH---HcCCCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 222 2221111 0111223477899999999999999999999999886
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=346.43 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=187.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+++.||||++..... .+.+.+|++++++++||||++++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~~ 114 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTVD----------------KKIVRTEIGVLLRLSHPNIIKLK 114 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC--------------------------CHHHHHCCCTTBCCEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccchh----------------HHHHHHHHHHHHhCCCCCCccee
Confidence 467999999999999999999875 4688999999864321 34678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC---C
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD---D 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~---~ 492 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++. +
T Consensus 115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIll~~~~~~ 187 (349)
T 2w4o_A 115 EIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAPD 187 (349)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESSSSTT
T ss_pred eeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEEEecCCCC
Confidence 999999999999999999999999864 35689999999999999999999 6779999999999999975 8
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 188 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~- 260 (349)
T 2w4o_A 188 APLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG---DQFMF- 260 (349)
T ss_dssp CCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC---HHHHH-
T ss_pred CCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc---cHHHH-
Confidence 8999999999987654322 2345799999999999999999999999999999999999999865322 11111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... .. .........+.+++.+||+.||++|||+.|+++
T Consensus 261 --~~i~~~~~~~--~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 261 --RRILNCEYYF--IS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --HHHHTTCCCC--CT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHhCCCcc--CC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111100 00 001112234778999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=355.11 Aligned_cols=272 Identities=20% Similarity=0.284 Sum_probs=211.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|.+.+.||+|+||.||+|++. .+|+.||||++....... ..+.+.+|++++++++||||++++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hpnIv~~~ 73 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLR-------------PVDVQMREFEVLKKLNHKNIVKLF 73 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGS-------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccccc-------------hHHHHHHHHHHHHhcCCCCCCeEE
Confidence 467999999999999999999875 568999999985422110 134677899999999999999999
Q ss_pred eeeecCC--ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe----
Q 006739 416 AHMARPD--CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---- 489 (633)
Q Consensus 416 ~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---- 489 (633)
+++.... ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|| |+.+|+||||||+||++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~ 149 (396)
T 4eut_A 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIGE 149 (396)
T ss_dssp EEEECTTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEECT
T ss_pred EeeccCCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHHEEEeecC
Confidence 9988755 67999999999999999976432 33499999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCccccccccccc--------CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT--------LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+.++.+||+|||+++........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 150 ~~~~~~kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 150 DGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp TSCEEEEECCGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CCceeEEEecCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 77888999999999877554321 33579999999998865 46778999999999999999999999764
Q ss_pred ccccccchHHHHHHHhhccCCcch---h---------hhhh--hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTR---A---------IDAK--LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~---~---------~d~~--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
......... +........... . .... ............+.+++..||+.||++||++.|+++.
T Consensus 227 ~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 227 EGPRRNKEV---MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp TCTTTCHHH---HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CcccchHHH---HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 433322222 222222211100 0 0000 0112235566678899999999999999999999999
Q ss_pred HHhh
Q 006739 628 LSQI 631 (633)
Q Consensus 628 l~~~ 631 (633)
++++
T Consensus 304 l~~i 307 (396)
T 4eut_A 304 TSDI 307 (396)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9876
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=343.13 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=195.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++........ .....+.+|+.++++++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~ 78 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARDP-----------SFYLRFRREAQNAAALNHPAIVAVY 78 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTSH-----------HHHHHHHHHHTTCCCCCCTTBCCEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCCH-----------HHHHHHHHHHHHHHcCCCCCcceEE
Confidence 468999999999999999999864 5799999999865432111 1245788999999999999999999
Q ss_pred eeeecCCcc----EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 416 AHMARPDCH----LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 416 ~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++...... ++||||+++++|.+++... ..+++..++.++.|++.||+|| |+.+|+||||||+||+++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~ 151 (311)
T 3ork_A 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISA 151 (311)
T ss_dssp EEEEEEETTEEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEET
T ss_pred EeeeccCCCCcccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEcC
Confidence 998766544 9999999999999999753 4589999999999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .
T Consensus 152 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~-- 225 (311)
T 3ork_A 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----V-- 225 (311)
T ss_dssp TSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----H--
T ss_pred CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----H--
Confidence 999999999999876544322 122345689999999999999999999999999999999999999965321 1
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHH-HHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR-CMLS 629 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~-~~l~ 629 (633)
.............. ...... ....+.+++.+||+.||++||++.+++ +.+.
T Consensus 226 -~~~~~~~~~~~~~~----~~~~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 226 -SVAYQHVREDPIPP----SARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp -HHHHHHHHCCCCCH----HHHSTT---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -HHHHHHhcCCCCCc----ccccCC---CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 11111111111111 000111 123377888999999999999776655 4443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=346.85 Aligned_cols=278 Identities=17% Similarity=0.211 Sum_probs=202.9
Q ss_pred hcCcccccccccccCeeEEEEEecC--CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+|+... .++..+|+|++........ .+...........+.+|+..+..++||||++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~---~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHH---HHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchH---HHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 4679999999999999999998753 2678999999876543211 1111111222346788999999999999999
Q ss_pred cceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 414 LLAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 414 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++++.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|| |+.+|+||||||+||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcCHHHEEE
Confidence 9999977 67889999999 99999999753 3699999999999999999999 67799999999999999
Q ss_pred cCCC--ceEEcccccccccCCCCCcc-----eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccc
Q 006739 490 DDDM--EARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562 (633)
Q Consensus 490 ~~~~--~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 562 (633)
+.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9877 99999999998765332111 1134579999999999999899999999999999999999999996532
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.. ...... .........+. .+........ ....+.+++..||+.||++|||++++++.|+++
T Consensus 265 ~~--~~~~~~-~~~~~~~~~~~-~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 265 KD--PVAVQT-AKTNLLDELPQ-SVLKWAPSGS---SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp TC--HHHHHH-HHHHHHHTTTH-HHHHHSCTTS---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred cc--cHHHHH-HHHhhcccccH-HHHhhccccc---cHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 21 111111 11111111111 1111111111 123478888899999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.22 Aligned_cols=247 Identities=19% Similarity=0.291 Sum_probs=190.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 415 (633)
++|+..++||+|+||+||+|+.. .+|+.||||++......... ..++..|+..+.++ +||||++++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~------------~~~~~~e~~~~~~~~~h~~iv~l~ 123 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKD------------RARKLAEVGSHEKVGQHPCCVRLE 123 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHH------------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHH------------HHHHHHHHHHHHHhcCCCcEEEEE
Confidence 57899999999999999999875 57899999997654432111 22334444444444 899999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+ +++|.+++... +..+++..++.++.|++.||+|| |+.+|+||||||+|||++.++.+
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 124 QAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECGGGCE
T ss_pred EEEEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCE
Confidence 9999999999999999 67999988753 35699999999999999999999 57799999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++....... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+..... + .
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~-~ 262 (311)
T 3p1a_A 197 KLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------W-Q 262 (311)
T ss_dssp EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------H-H
T ss_pred EEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------H-H
Confidence 9999999987654332 234569999999999876 799999999999999999999777543211 1 1
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...... .. +...... ...+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~-~~----~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 QLRQGY-LP----PEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHTTTC-CC----HHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhccC-CC----cccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 11 1111111 234788999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.62 Aligned_cols=266 Identities=19% Similarity=0.333 Sum_probs=210.7
Q ss_pred hhhhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH 408 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 408 (633)
....++|++.+.||+|+||.||+|++.+ .+++.||+|.+...... +....+.+|+.++++++|
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h 87 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-------------RERIEFLNEASVMKEFNC 87 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-------------HHHHHHHHHHHHGGGCCC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH-------------HHHHHHHHHHHHHHhcCC
Confidence 3456789999999999999999997642 35789999998643311 114568899999999999
Q ss_pred CcccccceeeecCCccEEEEecccCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 006739 409 RNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482 (633)
Q Consensus 409 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di 482 (633)
|||+++++++.+.+..++||||+++|+|.+++..... ....+++..++.++.|+++||+|| |+.+|+||||
T Consensus 88 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~di 164 (322)
T 1p4o_A 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDL 164 (322)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCC
T ss_pred CCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCCccCCC
Confidence 9999999999999999999999999999999976331 124578999999999999999999 6779999999
Q ss_pred CCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccc
Q 006739 483 KPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDF 561 (633)
Q Consensus 483 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~ 561 (633)
||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 165 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 165 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp SGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 99999999999999999999986654332222233457899999999999899999999999999999999 88998653
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.. ......+ ....... ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 245 ~~----~~~~~~~---~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 245 SN----EQVLRFV---MEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp CH----HHHHHHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CH----HHHHHHH---HcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 21 2222222 1111111 0111123477899999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.79 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=203.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|... .+|+.||+|++...... ....+.+|+.++++++||||++++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~--------------~~~~~~~E~~il~~l~hpnIv~~~ 114 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPL--------------DKYTVKNEISIMNQLHHPKLINLH 114 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHH--------------HHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred ccceEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccchh--------------hHHHHHHHHHHHHhCCCcCCCeEE
Confidence 468999999999999999999865 57899999998654310 134688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC--CC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD--DM 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~--~~ 493 (633)
+++.+....++||||+++|+|.+++.. ....+++..+..++.||+.||+|| |+.+|+||||||+|||++. ++
T Consensus 115 ~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~ 188 (387)
T 1kob_A 115 DAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKAS 188 (387)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHHeEEecCCCC
Confidence 999999999999999999999999864 234689999999999999999999 6789999999999999974 57
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 189 ~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~ 261 (387)
T 1kob_A 189 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQN 261 (387)
T ss_dssp CEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHH
T ss_pred ceEEEecccceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence 7999999999887654322 234799999999999999999999999999999999999999975321 122222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.. ..... +... .......+.+++.+||+.||++|||+.|+++
T Consensus 262 i~~---~~~~~---~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 262 VKR---CDWEF---DEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHH---CCCCC---CSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHh---CCCCC---Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 211 11110 0000 1111234788999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=342.53 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=198.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+|+.||+|++....... ...+.+.+|++++++++||||+++++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~ 69 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDP------------VIKKIALREIRMLKQLKHPNLVNLLE 69 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-H------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccch------------HHHHHHHHHHHHHHhCCCCCccchhh
Confidence 57899999999999999999874 568999999986544221 11456788999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+|
T Consensus 70 ~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~k 142 (311)
T 4agu_A 70 VFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILITKHSVIK 142 (311)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEE
T ss_pred eeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEcCCCCEE
Confidence 99999999999999999999998764 35689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+++........ .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+.
T Consensus 143 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~ 216 (311)
T 4agu_A 143 LCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV----DQLYLIR 216 (311)
T ss_dssp ECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHH
T ss_pred EeeCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH
Confidence 9999999876643322 134578999999999876 67899999999999999999999999754321 1111121
Q ss_pred HhhccCCc-----------------chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENP-----------------TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~-----------------~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ ....+........+.....+.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11111000 0000000000000112234788999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=352.40 Aligned_cols=211 Identities=23% Similarity=0.343 Sum_probs=178.9
Q ss_pred hhhhcCcccccccccc--cCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 333 LEKEDGLASLEKIGSG--GCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G--~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
....++|++.+.||+| +||.||+|+.. .+|+.||||++...... .+..+.+.+|+.++++++|||
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~n 87 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACS------------NEMVTFLQGELHVSKLFNHPN 87 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHHHCCCTT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccC------------hHHHHHHHHHHHHHHhCCCCC
Confidence 3455789999999999 99999999875 57899999998643221 112567889999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
||++++++.+.+..++||||+++|+|.+++.... ...+++..+..++.||++||+|| |+.+|+||||||+|||++
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~NIll~ 162 (389)
T 3gni_B 88 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILIS 162 (389)
T ss_dssp BCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEC
T ss_pred CCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEc
Confidence 9999999999999999999999999999997632 35699999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCC-----cceecccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 491 DDMEARIADFGLAKAMPDAQT-----HITTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
.++.+||+|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 163 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999865432211 111233478999999999987 67899999999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=344.61 Aligned_cols=247 Identities=25% Similarity=0.308 Sum_probs=197.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
..++|+..+.||+|+||.||+|+.. .+++.||+|++.+... ........+.+|..++..+ +||||++
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~-----------~~~~~~~~~~~E~~~l~~~~~hp~iv~ 85 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVV-----------IQDDDVECTMVEKRVLALPGKPPFLTQ 85 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHTCTTCCTTBCC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHh-----------hcchHHHHHHHHHHHHHhcCCCCEEee
Confidence 3478999999999999999999875 5689999999853211 0111245678899999988 7999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..|+||||+++|+|.+++... ..+++..++.++.||+.||+|| |+.+|+||||||+|||++.++
T Consensus 86 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g 158 (353)
T 2i0e_A 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEG 158 (353)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTS
T ss_pred EEEEEEcCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEEcCCC
Confidence 999999999999999999999999999763 4599999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+
T Consensus 159 ~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~----~~~~--- 229 (353)
T 2i0e_A 159 HIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED----EDEL--- 229 (353)
T ss_dssp CEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---
T ss_pred cEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC----HHHH---
Confidence 999999999986433222 2244679999999999999999999999999999999999999997532 1122
Q ss_pred HHHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 574 MRNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 574 ~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
...+.... ..+.. ....+.+++.+||+.||++||++
T Consensus 230 ~~~i~~~~~~~p~~------------~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 230 FQSIMEHNVAYPKS------------MSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp HHHHHHCCCCCCTT------------SCHHHHHHHHHHTCSCTTSCTTC
T ss_pred HHHHHhCCCCCCCC------------CCHHHHHHHHHHhhcCHHHcCCC
Confidence 22222211 11111 11237789999999999999964
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=338.78 Aligned_cols=258 Identities=27% Similarity=0.438 Sum_probs=206.3
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|... ++..||+|.+...... .+.+.+|++++++++||||+
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~ 71 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS---------------PDAFLAEANLMKQLQHQRLV 71 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBC
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCccc---------------HHHHHHHHHHHHhCCCcCcc
Confidence 344578999999999999999999875 6788999998654321 34688899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.. +..++||||+++++|.+++.... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++++
T Consensus 72 ~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~ 145 (279)
T 1qpc_A 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDT 145 (279)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTT
T ss_pred eEEEEEcC-CCcEEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHhhEEEcCC
Confidence 99998864 56899999999999999997532 23689999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 146 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~ 220 (279)
T 1qpc_A 146 LSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVI 220 (279)
T ss_dssp SCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHH
T ss_pred CCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----HHHH
Confidence 99999999999877653321 1233457889999999988889999999999999999999 9999865321 1222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+ ........ .......+.+++..|++.||++|||++++++.|+++
T Consensus 221 ~~~---~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 221 QNL---ERGYRMVR----------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp HHH---HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---hcccCCCC----------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 222 11111100 011123478899999999999999999999999886
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=341.04 Aligned_cols=266 Identities=25% Similarity=0.375 Sum_probs=197.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhh--cCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG--QIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+|++ .++.||||++.... ...+.+|.+++. .++||||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~~~h~~i~~ 95 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTTE-----------------EASWFRETEIYQTVLMRHENILG 95 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGGG-----------------HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred ccceEEEeEeecCCCeEEEEEEE---CCceEEEEEEeccc-----------------cchhhhHHHHHHHHhhcCCCeee
Confidence 46899999999999999999987 58999999984321 122333444444 458999999
Q ss_pred cceeeecC----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCC
Q 006739 414 LLAHMARP----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS-----HNPRIIHRDLKP 484 (633)
Q Consensus 414 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~Dikp 484 (633)
+++++... ...++||||+++|+|.++++. ..+++..++.++.|++.||+|||.. +..+|+||||||
T Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp 170 (337)
T 3mdy_A 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170 (337)
T ss_dssp EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred EEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence 99999877 678999999999999999974 3589999999999999999999532 133999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcc--eecccccCcccccccccccCCCCCc------cchHHHHHHHHHHHhC--
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTLKFTDK------CDIYSFGVLLAVLVMG-- 554 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~G~~l~elltg-- 554 (633)
+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.+ +|||||||++|||++|
T Consensus 171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence 99999999999999999998765433221 1124579999999999988776665 9999999999999999
Q ss_pred --------CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 555 --------RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 555 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.||......... ............ ......... ........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDLVPSDPS--YEDMREIVCIKK-LRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp BTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSC-CCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccccccccccHhhhcCCCCc--hhhhHHHHhhhc-cCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 6666543322211 111111111111 111111110 11245566889999999999999999999999
Q ss_pred HHHhhh
Q 006739 627 MLSQIR 632 (633)
Q Consensus 627 ~l~~~~ 632 (633)
.|+++.
T Consensus 325 ~L~~l~ 330 (337)
T 3mdy_A 325 TLAKMS 330 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=345.96 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=193.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC--Ccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH--RNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~ 413 (633)
.+.|++.+.||+|+||.||++... +++.||||++.....+. ...+.+.+|+.++.+++| +||++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~iv~ 73 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKIIR 73 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccch------------HHHHHHHHHHHHHHhhhhcCCceEE
Confidence 467999999999999999999874 78999999986543221 124678899999999986 99999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..++|||| .+++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+|||++ ++
T Consensus 74 ~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~NIll~-~~ 144 (343)
T 3dbq_A 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DG 144 (343)
T ss_dssp EEEEEECSSEEEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-TT
T ss_pred EeeeEeeCCEEEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEE-CC
Confidence 99999999999999995 58899999986 35689999999999999999999 677999999999999997 57
Q ss_pred ceEEcccccccccCCCCCcceecccccCccccccccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCcccc
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----------LKFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 562 (633)
.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 899999999987765443333345679999999999865 678889999999999999999999997532
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. .. ............. .........+.+++..||+.||++|||+.|+++
T Consensus 225 ~-----~~-~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 225 N-----QI-SKLHAIIDPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp S-----HH-HHHHHHHCTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred h-----HH-HHHHHHhcCCccc---------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 2 11 1111111111100 000001123778999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.33 Aligned_cols=261 Identities=20% Similarity=0.262 Sum_probs=197.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++....... ....+.+.+|+.++++++||||++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~iv~~~ 100 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSD-----------PVFRTRMQREARTAGRLQEPHVVPIH 100 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGS-----------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccC-----------HHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 478999999999999999999864 578999999985432110 11246788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++++|.+++... ..+++..++.++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPENILVSADDFA 173 (309)
T ss_dssp EEEEETTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCE
T ss_pred EEEeeCCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHHEEEcCCCCE
Confidence 9999999999999999999999999863 4589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+...+
T Consensus 174 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~- 247 (309)
T 2h34_A 174 YLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----SVMGAHI- 247 (309)
T ss_dssp EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----HHHHHHH-
T ss_pred EEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----HHHHHHh-
Confidence 99999999876543222 12345689999999999999999999999999999999999999875321 1111111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHhh
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-NSKDVRCMLSQI 631 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~ev~~~l~~~ 631 (633)
........... ......+.+++.+||+.||++|| +++++++.|+++
T Consensus 248 --~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 248 --NQAIPRPSTVR--------PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp --HSCCCCGGGTS--------TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred --ccCCCCccccC--------CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 11111111111 11122377889999999999999 999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=335.87 Aligned_cols=255 Identities=25% Similarity=0.366 Sum_probs=197.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|.+.+.||+|+||.||+++.. .++..||+|++....... ..+.+.+|++++++++||||++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hp~iv~~~ 86 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQV-------------PMEQIEAEIEVLKSLDHPNIIKIF 86 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCCS-------------CHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhheeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccch-------------hHHHHHHHHHHHHhCCCchHHhHH
Confidence 367899999999999999999864 578999999986432110 145788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe---cCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDD 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---~~~ 492 (633)
+++.+.+..++||||+++|+|.+++.........+++..++.++.|+++||+|| |+.+|+||||||+||++ +.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl~~~~~~~ 163 (285)
T 3is5_A 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPH 163 (285)
T ss_dssp EEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEESSSSTT
T ss_pred HheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEEEecCCCC
Confidence 999999999999999999999999876544456799999999999999999999 67899999999999999 456
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++....... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||..... .....
T Consensus 164 ~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~----~~~~~ 235 (285)
T 3is5_A 164 SPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL----EEVQQ 235 (285)
T ss_dssp CCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred CCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH----HHHHh
Confidence 7899999999987654322 23457899999999886 4688999999999999999999999975321 11111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ........ . ... ....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~---~~~~~~~~-~----~~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 236 KAT---YKEPNYAV-E----CRP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHH---HCCCCCCC-------CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred hhc---cCCccccc-c----cCc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 11111000 0 000 1123678899999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.25 Aligned_cols=264 Identities=25% Similarity=0.346 Sum_probs=204.6
Q ss_pred CcccccccccccCeeEEEEEec---CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
.|++.+.||+|+||.||++.+. ..+++.||||++...... ...+.+.+|++++++++||||+++
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~ 98 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-------------QHRSGWKQEIDILRTLYHEHIIKY 98 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-------------HHHHHHHHHHHHHHhCCCcchhhE
Confidence 3488999999999999988653 347889999998654211 115678899999999999999999
Q ss_pred ceeeecC--CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMARP--DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++.+. ...++||||+++|+|.+++.. ..+++..++.++.|++.||+|| |+.+|+||||||+||+++.+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil~~~~ 170 (318)
T 3lxp_A 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVLLDND 170 (318)
T ss_dssp EEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTT
T ss_pred EEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEEcCC
Confidence 9999874 567899999999999999974 3489999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccc------
Q 006739 493 MEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT------ 565 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~------ 565 (633)
+.+||+|||+++......... ......||..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~ 250 (318)
T 3lxp_A 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250 (318)
T ss_dssp CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence 999999999999876543321 1234568889999999999889999999999999999999999986532110
Q ss_pred --ccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 566 --EEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 566 --~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.................. .........+.+++.+||+.||++|||++|+++.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 251 AQGQMTVLRLTELLERGERL----------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp CCHHHHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccchhHHHHHHHHhcccCC----------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 001111111111111111 111122234888999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=337.28 Aligned_cols=260 Identities=18% Similarity=0.290 Sum_probs=203.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCC--CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..++|++.+.||+|+||.||+|++... ++..||+|.+...... ...+.+.+|+.++++++||||+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~ 76 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL-------------DNKEKFMSEAVIMKNLDHPHIV 76 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH-------------HHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc-------------hHHHHHHHHHHHHHhCCCCCcc
Confidence 457899999999999999999987533 3456999998654311 1146788999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+ +..++||||+++++|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 77 ~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~ 149 (281)
T 3cc6_A 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASP 149 (281)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEEET
T ss_pred eEEEEEcC-CCCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEECCC
Confidence 99999865 4568999999999999999753 34589999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 150 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~----~~~~ 224 (281)
T 3cc6_A 150 ECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN----KDVI 224 (281)
T ss_dssp TEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG----GGHH
T ss_pred CcEEeCccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh----HHHH
Confidence 999999999998765543221 234567889999999998899999999999999999998 9999865322 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.+..... ...... ....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 225 ~~~~~~~~-~~~~~~------------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 225 GVLEKGDR-LPKPDL------------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHHHHTCC-CCCCTT------------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCC-CCCCCC------------CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 22222111 011111 1123778999999999999999999999998874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.19 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=202.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+++.||+|++....... ...+.+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSA------------RDFQKLEREARICRKLQHPNIVRLH 71 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCH------------HHHHHHHHHHHHHHHcCCCCcCeEE
Confidence 468999999999999999999864 578999999985433211 1246788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc-
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME- 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~- 494 (633)
+++.+.+..++||||+++++|.+.+... ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~~ 144 (284)
T 3kk8_A 72 DSIQEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKG 144 (284)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSTT
T ss_pred EEEEcCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEEecCCCC
Confidence 9999999999999999999999988753 4589999999999999999999 6789999999999999986655
Q ss_pred --eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 495 --ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 --~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+||+|||++......... ....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||..... .....
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~ 217 (284)
T 3kk8_A 145 AAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYA 217 (284)
T ss_dssp CCEEECCCTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred CcEEEeeceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----hHHHH
Confidence 999999999876654322 335799999999999999999999999999999999999999865321 12222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.......... ........+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 218 QIKAGAYDYPSP----------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHTCCCCCTT----------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHhccccCCch----------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 121111110000 00011223778999999999999999999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.38 Aligned_cols=252 Identities=17% Similarity=0.267 Sum_probs=199.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCC------CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSN------GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR 409 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 409 (633)
.++|++.+.||+|+||.||+|+..... +..||+|++...... ..+.+.+|++++++++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--------------~~~~~~~E~~~l~~l~h~ 72 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--------------YSESFFEAASMMSKLSHK 72 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG--------------GHHHHHHHHHHHHTSCCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH--------------HHHHHHHHHHHHHhCCCC
Confidence 468899999999999999999875322 257999998532211 145688999999999999
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||++
T Consensus 73 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll 146 (289)
T 4fvq_A 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILL 146 (289)
T ss_dssp TBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEE
T ss_pred CEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCCcCcceEEE
Confidence 9999999999999999999999999999999762 34589999999999999999999 67899999999999999
Q ss_pred cCCCc--------eEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 490 DDDME--------ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 490 ~~~~~--------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
+.++. +||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++|..|+..
T Consensus 147 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 147 IREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp EECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 98887 999999998754332 23458999999999987 6789999999999999999996655432
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
... ......... ......... ...+.+++.+||+.||++|||++|+++.|+++
T Consensus 221 ~~~---~~~~~~~~~---~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 221 ALD---SQRKLQFYE---DRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp TSC---HHHHHHHHH---TTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred ccc---hHHHHHHhh---ccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 211 111111111 111111111 11267899999999999999999999999886
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.41 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=204.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++..... ..++.+|+.+++.++|++++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~~ 70 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTI 70 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC-------------------CCCHHHHHHHHHHHTTSTTCCCE
T ss_pred CCceEEeeeecCCCCeEEEEEEEc-CCCceEEEEeeccccc----------------chHHHHHHHHHHHhcCCCCCCee
Confidence 478999999999999999999864 5789999998644321 23567899999999988887777
Q ss_pred eee-ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe---cC
Q 006739 416 AHM-ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DD 491 (633)
Q Consensus 416 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---~~ 491 (633)
.++ ...+..++||||+ +++|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||++ ++
T Consensus 71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~~ 143 (296)
T 4hgt_A 71 RWCGAEGDYNVMVMELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKK 143 (296)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECCGGG
T ss_pred eeecCCCCceEEEEEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeeeeccCC
Confidence 766 5667789999999 99999999752 34699999999999999999999 67899999999999999 78
Q ss_pred CCceEEcccccccccCCCCCcc-----eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 144 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 223 (296)
T 4hgt_A 144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223 (296)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred CCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh
Confidence 8999999999998776543211 12345799999999999999999999999999999999999999987544333
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
............... . +...... ...+.+++..||+.||++|||++++++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~--~----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 224 RQKYERISEKKMSTP--I----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp SSHHHHHHHHHHHSC--H----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhhhhhcccccch--h----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 333333222211111 0 0000111 23478899999999999999999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=350.19 Aligned_cols=260 Identities=27% Similarity=0.374 Sum_probs=193.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCC--eEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...|+..+.||+|+||.||+|++...++ ..||+|.+...... ...+++.+|+.++++++||||++
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~il~~l~hpnIv~ 154 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-------------GEVSQFLTEGIIMKDFSHPNVLS 154 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS-------------HHHHHHHHHHTTSTTCCCTTBCC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH-------------HHHHHHHHHHHHHHhCCCCCcce
Confidence 3457778999999999999998753333 46899988643211 11567899999999999999999
Q ss_pred cceeeec-CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 414 LLAHMAR-PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 414 l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+++++.. .+..++||||+++|+|.+++.. ....+++..+..++.||++||+|| |+.+|+||||||+||+++++
T Consensus 155 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~ 228 (373)
T 3c1x_A 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEK 228 (373)
T ss_dssp CCEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTT
T ss_pred EEEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccchheEEECCC
Confidence 9998754 5578999999999999999974 245688999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcc--eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccch
Q 006739 493 MEARIADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMS 569 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 569 (633)
+.+||+|||+++......... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||..... ..
T Consensus 229 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~----~~ 304 (373)
T 3c1x_A 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FD 304 (373)
T ss_dssp CCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS----SC
T ss_pred CCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH----HH
Confidence 999999999998765432211 1233457889999999999999999999999999999999 6777765322 22
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
....+.. ...... ... ....+.+++.+||+.||++|||++|+++.|+++
T Consensus 305 ~~~~~~~---~~~~~~-------p~~---~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 305 ITVYLLQ---GRRLLQ-------PEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp HHHHHHT---TCCCCC-------CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHc---CCCCCC-------CCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2222221 111110 011 123478889999999999999999999999886
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.19 Aligned_cols=260 Identities=22% Similarity=0.282 Sum_probs=201.3
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|++.+.||+|+||.||+++.. .+|+.||+|++.+... ........+.+|..++..++||||++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~-----------~~~~~~~~~~~E~~il~~~~hp~Iv~ 125 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDM-----------LKRGEVSCFREERDVLVNGDRRWITQ 125 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-----------HHHGGGCCHHHHHHHHHHSCTTTBCC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHh-----------hhHHHHHHHHHHHHHHHhcCCCCeee
Confidence 34578999999999999999999874 5789999999843110 01111345788999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..|+||||+++|+|.+++.+. +..+++..+..++.||+.||+|| |+.+|+||||||+|||++.++
T Consensus 126 l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILld~~g 199 (412)
T 2vd5_A 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCG 199 (412)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTS
T ss_pred EEEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHeeecCCC
Confidence 999999999999999999999999999753 24699999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccc-------cCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-------TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
++||+|||+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 200 ~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp CEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999877654322 223467999999999987 35689999999999999999999999975322111
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCC---CCHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRER---PNSKDVRC 626 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R---Ps~~ev~~ 626 (633)
...+..+.. . ...+. .+ .. ....+.+++.+||. +|.+| |+++|+++
T Consensus 279 ~~~i~~~~~---~-~~~p~-~~----~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHYKE---H-LSLPL-VD----EG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTHHH---H-CCCC---------C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhccc---C-cCCCc-cc----cC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111100 0 00000 00 01 12237888999999 99998 58888764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=334.81 Aligned_cols=264 Identities=26% Similarity=0.351 Sum_probs=205.1
Q ss_pred hhhcCcccccccccccCeeEEEEEecC--CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.....|...+.||+|+||.||+|.+.. .++..||+|.+...... ...+.+.+|+.++++++||||
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i 84 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-------------QQVEAFLREGLLMRGLNHPNV 84 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-------------HHHHHHHHHHHHHHhCCCCCe
Confidence 334456777999999999999998632 23447999998643321 114678899999999999999
Q ss_pred cccceeeecCCcc-EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 412 LPLLAHMARPDCH-LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 412 v~l~~~~~~~~~~-~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++++++.+.+.. ++||||+.+|+|.+++.. ....+++..+..++.|+++||+|| |+.+|+||||||+||+++
T Consensus 85 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nili~ 158 (298)
T 3pls_A 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLD 158 (298)
T ss_dssp CCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEC
T ss_pred eeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEc
Confidence 9999999876665 999999999999999975 245689999999999999999999 677999999999999999
Q ss_pred CCCceEEcccccccccCCCCCc--ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 491 DDMEARIADFGLAKAMPDAQTH--ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+.... ...
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~---~~~ 235 (298)
T 3pls_A 159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI---DPF 235 (298)
T ss_dssp TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CGG
T ss_pred CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC---CHH
Confidence 9999999999999866543211 12234567899999999999999999999999999999999666643321 222
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.....+........ . ......+.+++.+||+.||.+|||++++++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~-~------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 236 DLTHFLAQGRRLPQ-P------------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp GHHHHHHTTCCCCC-C------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCC-C------------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 33333322111111 0 011234788999999999999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.61 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=205.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+|+.||+|++............ ..+++.+|+.++++++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGV--------SREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSSSB--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEecccccccccch--------hHHHHHHHHHHHHhCCCCCcceEE
Confidence 467999999999999999999875 57899999998765432211000 045688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC--
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-- 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~-- 493 (633)
+++.+.+..++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEEEecCCCC
Confidence 999999999999999999999999975 35689999999999999999999 678999999999999999887
Q ss_pred --ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 494 --EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+++........ ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~- 226 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QET- 226 (321)
T ss_dssp SCCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----HHH-
T ss_pred cCCEEEccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH----HHH-
Confidence 7999999999877654322 345699999999999999999999999999999999999999865321 111
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... .++....... ..+.+++.+||+.||++|||+.|+++
T Consensus 227 --~~~i~~~~~~---~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 227 --LANITSVSYD---FDEEFFSHTS----ELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --HHHHHTTCCC---CCHHHHTTCC----HHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --HHHHHhcccc---cChhhhcccC----HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111111110 1111111111 23778999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=348.62 Aligned_cols=253 Identities=25% Similarity=0.302 Sum_probs=193.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHH-hhcCCCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT-VGQIRHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l 414 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++.+...... .....+.+|..+ ++.++||||+++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~-----------~~~~~~~~e~~~ll~~~~hp~Iv~l 104 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKK-----------KEEKHIMSERNVLLKNVKHPFLVGL 104 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC------------------------CCBCCCCCTTBCCE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHHhCCCCCCCCE
Confidence 467999999999999999999875 5789999999865432110 113456667776 577899999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.
T Consensus 105 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~ 177 (373)
T 2r5t_A 105 HFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGH 177 (373)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCC
Confidence 9999999999999999999999999976 34588999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+ .
T Consensus 178 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~~~---~ 248 (373)
T 2r5t_A 178 IVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEM---Y 248 (373)
T ss_dssp EEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH----HHH---H
T ss_pred EEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHH---H
Confidence 99999999986433221 22456799999999999999999999999999999999999999965321 111 2
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
..+....... . .. ....+.+++.+||+.||++||++.+.++.
T Consensus 249 ~~i~~~~~~~---~----~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 249 DNILNKPLQL---K----PN----ITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp HHHHHSCCCC---C----SS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred HHHHhcccCC---C----CC----CCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 2222211100 0 01 11237788999999999999998654433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=349.00 Aligned_cols=267 Identities=23% Similarity=0.327 Sum_probs=209.1
Q ss_pred hhcCcccccccccccCeeEEEEEe---cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
..++|++.+.||+|+||.||++++ ...+++.||||++..... ...+.+.+|++++++++||||
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i 86 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--------------DQQRDFQREIQILKALHSDFI 86 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--------------HHHHHHHHHHHHHHhcCCCce
Confidence 347899999999999999999985 345789999999865431 114568899999999999999
Q ss_pred cccceeee--cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 412 LPLLAHMA--RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 412 v~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++++++. +....++||||+++++|.+++.... ..+++..++.++.|+++||+|| |+.+|+||||||+||++
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~ 160 (327)
T 3lxl_A 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILV 160 (327)
T ss_dssp CCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred eEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChhhEEE
Confidence 99999886 4556889999999999999997632 3589999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccc---
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT--- 565 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~--- 565 (633)
+.++.+||+|||+++......... ......||..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 161 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~ 240 (327)
T 3lxl_A 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240 (327)
T ss_dssp EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh
Confidence 999999999999999876543322 2233468889999999998889999999999999999999999986432110
Q ss_pred -----ccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 566 -----EEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 566 -----~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.................. .........+.+++..||+.||++|||++|+++.|+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 241 MGCERDVPALSRLLELLEEGQRL----------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp CC----CCHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred cccccccccHHHHHHHhhcccCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001111111111111111 11112233478899999999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.69 Aligned_cols=254 Identities=27% Similarity=0.352 Sum_probs=204.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|+.. .+|+.||+|++.+... ........+.+|++++++++||||++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~-----------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 251 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRL-----------KKRKGYQGAMVEKKILAKVHSRFIVSLA 251 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHh-----------hhhHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 478999999999999999999874 5789999999843211 0011245688899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..|+||||++||+|.+++.........+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.+
T Consensus 252 ~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NILl~~~g~v 328 (543)
T 3c4z_A 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNV 328 (543)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCE
T ss_pred EEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEEEeCCCCE
Confidence 999999999999999999999999986544456799999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .+
T Consensus 329 kL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~---~~ 403 (543)
T 3c4z_A 329 RISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQ 403 (543)
T ss_dssp EECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH---HH
T ss_pred EEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH---HH
Confidence 99999999887654322 23457999999999999999999999999999999999999999764322122222 22
Q ss_pred HhhccCC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 576 NVMTSEN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 576 ~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
....... ... .....+.+++.+||+.||++||++
T Consensus 404 ~i~~~~~~~p~------------~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 404 RVLEQAVTYPD------------KFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHCCCCCCT------------TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred HHhhcccCCCc------------ccCHHHHHHHHHhccCCHhHCCCC
Confidence 2222111 111 112237788999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.50 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=189.7
Q ss_pred hcCcccc-cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhh-cCCCCcccc
Q 006739 336 EDGLASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG-QIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~ 413 (633)
.++|.+. +.||+|+||.||++... .+++.||||++... ..+.+|+.++. ..+||||++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~-~~~~~vAiK~~~~~-------------------~~~~~E~~~~~~~~~hp~iv~ 119 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQDC-------------------PKARREVELHWRASQCPHIVR 119 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECS-------------------HHHHHHHHHHHHHTTSTTBCC
T ss_pred cccceeccceeeeccCeEEEEEEEC-CCCCEEEEEEeCcc-------------------hhHHHHHHHHHHhcCCCCcce
Confidence 3567776 78999999999999864 57899999998421 23456777664 458999999
Q ss_pred cceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 414 LLAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 414 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++++.. ....|+||||+++|+|.+++... ....+++..+..|+.||+.||+|| |+.+|+||||||+|||+
T Consensus 120 l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill 194 (400)
T 1nxk_A 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLY 194 (400)
T ss_dssp EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred EeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCcceEEE
Confidence 9998865 56789999999999999999752 235699999999999999999999 67899999999999999
Q ss_pred cC---CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 490 DD---DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 490 ~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
+. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 195 ~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 271 (400)
T 1nxk_A 195 TSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_dssp SSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred ecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 97 78999999999987654322 2345789999999999999999999999999999999999999976443222
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......+.... ...... ........+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~~i~~~~--~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 272 SPGMKTRIRMGQ--YEFPNP--------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCSHHHHHHHTC--CCCCTT--------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHcCc--ccCCCc--------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222222222111 111100 00111234788999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.58 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=199.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|+..+.||+|+||.||+|+.. .+++.||||++....... ....+++.+|++++++++||||++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpniv~~~ 120 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQYR 120 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCH-----------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccc-----------hHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 456889999999999999999864 579999999986543211 11256788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||++ |+|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 121 ~~~~~~~~~~lv~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~ 193 (348)
T 1u5q_A 121 GCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLV 193 (348)
T ss_dssp EEEEETTEEEEEEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEE
T ss_pred EEEEECCeEEEEEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCE
Confidence 99999999999999997 6888887642 35689999999999999999999 67799999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
||+|||+++..... ....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..
T Consensus 194 kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~--- 260 (348)
T 1u5q_A 194 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MS--- 260 (348)
T ss_dssp EECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HH---
T ss_pred EEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HH---
Confidence 99999999876432 2357999999999884 56789999999999999999999999865321 11
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+........+. ...... ...+.+++.+||+.||++|||++++++
T Consensus 261 ~~~~~~~~~~~~------~~~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 261 ALYHIAQNESPA------LQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHSCCCC------CCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcCCCC------CCCCCC---CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111111111111 001111 123678889999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.63 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=194.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--CCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR--HRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~ 413 (633)
...|++.+.||+|+||.||++... +++.||||++.....+. ...+.+.+|+.++.+++ ||||++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~~~~~~iv~ 120 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKIIR 120 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred CCceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccH------------HHHHHHHHHHHHHHHcccCCCeEEE
Confidence 356999999999999999999865 58999999986543221 12567899999999996 599999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++...+..++||| +.+++|.+++.. ...+++..+..++.||++||+|| |+.+|+||||||+|||++ ++
T Consensus 121 ~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~-~~ 191 (390)
T 2zmd_A 121 LYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DG 191 (390)
T ss_dssp EEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGGEEES-SS
T ss_pred EEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEEE-CC
Confidence 9999999999999999 568899999976 34689999999999999999999 688999999999999996 57
Q ss_pred ceEEcccccccccCCCCCcceecccccCccccccccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCcccc
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----------LKFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 562 (633)
.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 999999999987765433322345679999999999865 368889999999999999999999997532
Q ss_pred cccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. ....+........... . .... ...+.+++.+||+.||++|||+.|+++
T Consensus 272 ~------~~~~~~~~~~~~~~~~-----~-~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 272 N------QISKLHAIIDPNHEIE-----F-PDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp C------HHHHHHHHHCTTSCCC-----C-CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H------HHHHHHHHhCccccCC-----C-Cccc---hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1 1111222221111100 0 0111 234778999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.79 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=192.6
Q ss_pred hcCcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+++.. ..+++.||+|++........ ......+.+|+.++++++||||++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~ 85 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN----------AKDTAHTKAERNILEEVKHPFIVD 85 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------------HHHHHHHCCCTTBCC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHHhCCCCCccc
Confidence 468999999999999999999863 24789999999875432100 111456788999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++...+..++||||+++|+|.+++... ..+++..+..++.||+.||+|| |+.+|+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Nill~~~~ 158 (327)
T 3a62_A 86 LIYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENIMLNHQG 158 (327)
T ss_dssp EEEEEECSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTS
T ss_pred eeEEEEcCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHeEECCCC
Confidence 999999999999999999999999999763 4589999999999999999999 677999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 159 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~--- 229 (327)
T 3a62_A 159 HVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR----KKT--- 229 (327)
T ss_dssp CEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHH---
T ss_pred cEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH----HHH---
Confidence 999999999876543222 12345799999999999999999999999999999999999999975321 111
Q ss_pred HHHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 574 MRNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
+..+.... ..... ....+.+++.+||+.||++|| ++.|+++
T Consensus 230 ~~~i~~~~~~~p~~------------~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 230 IDKILKCKLNLPPY------------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHTCCCCCTT------------SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHhCCCCCCCC------------CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11111111 11111 122377889999999999999 6677754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=343.22 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=205.5
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+++.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~ 91 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQ--------------QDREEAQREADMHRLFNHPNILRL 91 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESSH--------------HHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred CCeEEEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCCH--------------HHHHHHHHHHHHHhhcCCCCeeeE
Confidence 4578999999999999999999864 5789999998854321 114578899999999999999999
Q ss_pred ceeee----cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 415 LAHMA----RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 415 ~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++++. .....++||||+++|+|.+++.........+++..++.++.|+++||+|| |+.+|+||||||+||+++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp~NIl~~ 168 (317)
T 2buj_A 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLG 168 (317)
T ss_dssp CEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEC
T ss_pred EEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEc
Confidence 99986 33467899999999999999987665567899999999999999999999 677999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcc-------eecccccCcccccccccccCC---CCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 491 DDMEARIADFGLAKAMPDAQTHI-------TTSNVAGTVGYIAPEYHQTLK---FTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 99999999999987654221110 012345799999999987644 68899999999999999999999975
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..... ......... ...... .......+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 249 ~~~~~--~~~~~~~~~---~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 249 VFQKG--DSVALAVQN---QLSIPQ----------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHTT--SCHHHHHHC---C--CCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhccc--chhhHHhhc---cCCCCc----------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 32211 111111111 000000 0111234788999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=331.69 Aligned_cols=262 Identities=25% Similarity=0.352 Sum_probs=206.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++..... .+++.+|+.+++.++|++++..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~~ 70 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTI 70 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCSS----------------CCHHHHHHHHHHHHTTSTTCCCE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCcc----------------hhHHHHHHHHHHHhhcCCCCCcc
Confidence 478999999999999999999864 5899999998865432 23577899999999998877777
Q ss_pred eee-ecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe---cC
Q 006739 416 AHM-ARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DD 491 (633)
Q Consensus 416 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---~~ 491 (633)
.++ ...+..++||||+ +++|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||++ ++
T Consensus 71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~ 143 (296)
T 3uzp_A 71 RWCGAEGDYNVMVMELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKK 143 (296)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGG
T ss_pred ccccCCCCceEEEEEec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHeEEecCCC
Confidence 666 5567779999999 89999999742 34699999999999999999999 67899999999999999 48
Q ss_pred CCceEEcccccccccCCCCCcc-----eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 223 (296)
T 3uzp_A 144 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223 (296)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS
T ss_pred CCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh
Confidence 8899999999998776543211 12345799999999999999999999999999999999999999986543333
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
............... . +.+.... ...+.+++.+||+.||++|||++++++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~-~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 224 RQKYERISEKKMSTP-I-----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp SSHHHHHHHHHHHSC-H-----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred hhhhhhhcccccCCc-h-----HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 333322222211111 0 0011111 13378889999999999999999999999886
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=337.37 Aligned_cols=263 Identities=26% Similarity=0.328 Sum_probs=201.4
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCC--CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
......|++.+.||+|+||.||+|++...+ +..+|+|.+...... ...+.+.+|+.++++++|||
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~ 87 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-------------GEVSQFLTEGIIMKDFSHPN 87 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-------------HHHHHHHHHHHHHHTCCCTT
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-------------HHHHHHHHHHHHHHhCCCCC
Confidence 344567889999999999999999874322 346899988653321 11467889999999999999
Q ss_pred ccccceeee-cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 411 LLPLLAHMA-RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 411 iv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
|+++++++. .++..++||||+++|+|.+++.. ....+++..++.++.|+++||+|| |+.+|+||||||+||++
T Consensus 88 iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~dikp~Nil~ 161 (298)
T 3f66_A 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCML 161 (298)
T ss_dssp BCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred EeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEE
Confidence 999999864 45678999999999999999974 245689999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCc--ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhC-CCCCcccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTH--ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMG-RLPSDDFFQHTE 566 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~~~~ 566 (633)
++++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||+|+++|||++| ..||.....
T Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 238 (298)
T 3f66_A 162 DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--- 238 (298)
T ss_dssp CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---
T ss_pred CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---
Confidence 99999999999999876543221 122345678899999999999999999999999999999995 555544221
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
......+........ . .. ....+.+++.+||+.||++|||++|+++.|+++
T Consensus 239 -~~~~~~~~~~~~~~~-~---------~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 239 -FDITVYLLQGRRLLQ-P---------EY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -TTHHHHHHTTCCCCC-C---------TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHHHhcCCCCCC-C---------cc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 222222211111000 0 01 123478899999999999999999999999886
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.29 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=203.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|.+.+.||+|+||.||+|++. .+|+.||||++...... .......+.+|+.+++.++||||++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~-----------~~~~~~~~~~Ei~~l~~l~HpnIv~l~ 82 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIR-----------SLDVVGKIRREIQNLKLFRHPHIIKLY 82 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHH-----------HTTTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhcc-----------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 468999999999999999999874 57899999998432110 011245788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+||+++.++.+
T Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIll~~~~~v 155 (476)
T 2y94_A 83 QVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVLLDAHMNA 155 (476)
T ss_dssp EEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEEEecCCCe
Confidence 999999999999999999999999864 45699999999999999999999 68899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||+++........ ....||+.|+|||++.+..+ +.++||||+||++|||++|+.||++... ..+ .
T Consensus 156 kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----~~~---~ 225 (476)
T 2y94_A 156 KIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----PTL---F 225 (476)
T ss_dssp EECCCSSCEECCTTCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS----HHH---H
T ss_pred EEEeccchhhccccccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH----HHH---H
Confidence 99999999887654322 33579999999999988765 6799999999999999999999975322 122 1
Q ss_pred HHhhccCC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSEN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+..... .+..+ ...+.+++.+||+.||++|||++|+++
T Consensus 226 ~~i~~~~~~~p~~~------------s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 226 KKICDGIFYTPQYL------------NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHTTCCCCCTTC------------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcCCcCCCccC------------CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 22221111 11111 123778999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=361.71 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=205.6
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|+..+.||+|+||.||+|+.. .+|+.||+|++.+... ........+.+|++++++++|||||++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~-----------~~~~~~~~~~~E~~iL~~l~hp~Iv~l 249 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRI-----------KKRKGEAMALNEKQILEKVNSRFVVSL 249 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhh-----------hhhHHHHHHHHHHHHHHHcCCCCEeeE
Confidence 3467999999999999999999875 5799999999843211 001114567889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..|+||||++||+|.+++.... ...+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.
T Consensus 250 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNILld~~g~ 324 (576)
T 2acx_A 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGH 324 (576)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEEEeCCCC
Confidence 999999999999999999999999987522 34599999999999999999999 6779999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+.+
T Consensus 325 vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i 401 (576)
T 2acx_A 325 IRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 401 (576)
T ss_dssp EEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH
T ss_pred eEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh
Confidence 99999999988765432 234579999999999999899999999999999999999999997643322222222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
... ....... ....+.+++.+||+.||++|| +++|+++
T Consensus 402 ~~~--~~~~p~~------------~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 402 KEV--PEEYSER------------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHC--CCCCCTT------------SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hcc--cccCCcc------------CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 211 1111111 112378899999999999999 6777764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=331.55 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=199.8
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|... .++..||+|++..... ........+.+|+.++++++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 74 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQL-----------EKAGVEHQLRREVEIQSHLRHPNILRL 74 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHHTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEecccc-----------chhhHHHHHHHHHHHHHcCCCCCCcch
Confidence 3478999999999999999999875 5788999999843211 011124578899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nili~~~~~ 147 (279)
T 3fdn_A 75 YGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGE 147 (279)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEEECTTSC
T ss_pred hheEecCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEEEcCCCC
Confidence 99999999999999999999999999763 4589999999999999999999 6889999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||++....... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ....+.+
T Consensus 148 ~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~ 219 (279)
T 3fdn_A 148 LKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QETYKRI 219 (279)
T ss_dssp EEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHH
T ss_pred EEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH----HHHHHHH
Confidence 9999999986554332 1345789999999999999999999999999999999999999875321 1111111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ....... ....+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~--~~~~~~~------------~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 220 SRV--EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHT--CCCCCTT------------SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HhC--CCCCCCc------------CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 1111111 1123678899999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=351.43 Aligned_cols=204 Identities=24% Similarity=0.453 Sum_probs=162.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.++|++.+.||+|+||.||+|.+. .+|+.||||++....... .....+.+|+.++.++. ||||+++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~------------~~~~~~~~E~~~l~~l~~h~niv~l 74 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNS------------TDAQRTFREIMILTELSGHENIVNL 74 (388)
T ss_dssp HTTEEEEEC-------CEEEEEET-TTCCEEEEEEECC--CCH------------HHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccCh------------HHHHHHHHHHHHHHhccCCCCCCee
Confidence 468999999999999999999864 578999999986443211 11456778999999997 9999999
Q ss_pred ceeeecCC--ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMARPD--CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++...+ ..|+||||++ ++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+|||++.+
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~ 145 (388)
T 3oz6_A 75 LNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSNILLNAE 145 (388)
T ss_dssp EEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTT
T ss_pred eeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHeEEcCC
Confidence 99997544 6799999997 599998874 3589999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCC-------------------cceecccccCccccccccccc-CCCCCccchHHHHHHHHHHH
Q 006739 493 MEARIADFGLAKAMPDAQT-------------------HITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLV 552 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~ell 552 (633)
+.+||+|||+|+....... ........||+.|+|||++.+ ..++.++||||+||++|||+
T Consensus 146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 225 (388)
T 3oz6_A 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225 (388)
T ss_dssp CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence 9999999999987643110 111234579999999999876 67899999999999999999
Q ss_pred hCCCCCccc
Q 006739 553 MGRLPSDDF 561 (633)
Q Consensus 553 tg~~p~~~~ 561 (633)
+|+.||.+.
T Consensus 226 ~g~~pf~~~ 234 (388)
T 3oz6_A 226 CGKPIFPGS 234 (388)
T ss_dssp HSSCSCCCS
T ss_pred hCCCCCCCC
Confidence 999999753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=343.09 Aligned_cols=261 Identities=25% Similarity=0.419 Sum_probs=200.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCC---CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
....|+..+.||+|+||.||+|.+...+ +..||+|.+...... .....+.+|+.++++++||||
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i 108 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-------------KQRVDFLGEAGIMGQFSHHNI 108 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-------------HHHHHHHHHHHHHHhCCCCCC
Confidence 3467888999999999999999875333 346999998654321 114568899999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.|+++||+|| |+.+|+||||||+||+++.
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~ 182 (333)
T 1mqb_A 109 IRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNS 182 (333)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECT
T ss_pred CcEEEEEecCCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChheEEECC
Confidence 99999999999999999999999999999752 35699999999999999999999 6779999999999999999
Q ss_pred CCceEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccch
Q 006739 492 DMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMS 569 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 569 (633)
++.+||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~ 258 (333)
T 1mqb_A 183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HE 258 (333)
T ss_dssp TCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH
T ss_pred CCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HH
Confidence 999999999999876543221 11223456889999999998899999999999999999999 9999865321 12
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+ .......... .......+.+++.+||+.||++||++.++++.|+++
T Consensus 259 ~~~---~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 259 VMK---AINDGFRLPT----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HHH---HHHTTCCCCC----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHH---HHHCCCcCCC----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 222 2222211110 011123478899999999999999999999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=345.68 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=202.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++............. .....+.+|+.++++++||||++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~Iv~~~ 95 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIED------PKLGKVTLEIAILSRVEHANIIKVL 95 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEEE------TTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred ccceEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccch------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 468999999999999999999864 578999999987654321100000 0023567899999999999999999
Q ss_pred eeeecCCccEEEEecccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 416 AHMARPDCHLLVYEFMKNG-SLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+++.+.+..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSC
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHEEEcCCCc
Confidence 9999999999999999777 99999875 34699999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||+++........ ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......
T Consensus 169 ~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------- 237 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------- 237 (335)
T ss_dssp EEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------
T ss_pred EEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------
Confidence 999999999887654332 23579999999999988776 778999999999999999999997532100
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.........+ ...+.+++.+||+.||++|||++|+++.
T Consensus 238 ----~~~~~~~~~~------------~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----EAAIHPPYLV------------SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTCCCCSSCC------------CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----hhccCCCccc------------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111111 1237789999999999999999999873
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.90 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=203.5
Q ss_pred hhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|++.+.||+|+||.||+|++. ..++..||||++...... ....++.+|+.++++++|||
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~ 94 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE-------------QDELDFLMEALIISKFNHQN 94 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch-------------hhHHHHHHHHHHHhhCCCCC
Confidence 3478999999999999999999852 246789999998643221 11456888999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ---GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
|+++++++......++||||+++++|.+++..... ....+++..++.++.|+++||+|| |+.+|+||||||+||
T Consensus 95 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dlkp~NI 171 (327)
T 2yfx_A 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNC 171 (327)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGE
T ss_pred CCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcCCHhHE
Confidence 99999999999999999999999999999986432 124589999999999999999999 678999999999999
Q ss_pred EecC---CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCccccc
Q 006739 488 LLDD---DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQ 563 (633)
Q Consensus 488 ll~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~ 563 (633)
+++. +..+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~- 250 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS- 250 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred EEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-
Confidence 9994 44699999999986644333222334568999999999998899999999999999999998 999986532
Q ss_pred ccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.....+.+. ....... .......+.+++.+||+.||++||++.++++.|+.+.
T Consensus 251 ---~~~~~~~~~---~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 251 ---NQEVLEFVT---SGGRMDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ---HHHHHHHHH---TTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHHh---cCCCCCC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 122222222 1111110 0111234778999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.91 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=194.1
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeee
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 419 (633)
...+.||+|+||.||+|+.. .+|+.||+|++..... ...+++.+|++++++++||||+++++++.
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 156 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGM--------------KDKEEVKNEISVMNQLDHANLIQLYDAFE 156 (373)
T ss_dssp EEEEECC-----CEEEEEET-TTCCEEEEEEEECCSH--------------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEc-CCCcEEEEEEEccccc--------------ccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 33678999999999999864 5789999999865431 11457889999999999999999999999
Q ss_pred cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe--cCCCceEE
Q 006739 420 RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL--DDDMEARI 497 (633)
Q Consensus 420 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill--~~~~~~kl 497 (633)
+.+..++||||+++++|.+++... ...+++..+..++.||++||+|| |+.+|+||||||+|||+ +.++.+||
T Consensus 157 ~~~~~~lv~E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl 230 (373)
T 2x4f_A 157 SKNDIVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIKI 230 (373)
T ss_dssp CSSEEEEEEECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTTTEEEE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCCCcEEE
Confidence 999999999999999999988652 34689999999999999999999 67899999999999999 56788999
Q ss_pred cccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHh
Q 006739 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577 (633)
Q Consensus 498 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 577 (633)
+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... +..+
T Consensus 231 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~----~~~i 300 (373)
T 2x4f_A 231 IDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AET----LNNI 300 (373)
T ss_dssp CCCSSCEECCTTCBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH----HHHH
T ss_pred EeCCCceecCCcccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHH----HHHH
Confidence 999999987654322 235699999999999988899999999999999999999999975321 111 1111
Q ss_pred hccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 578 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... ....... ....+.+++.+||+.||.+|||+.|+++
T Consensus 301 ~~~~~~~---~~~~~~~----~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 301 LACRWDL---EDEEFQD----ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHTCCCS---CSGGGTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhccCCC---Chhhhcc----CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111110 0000011 1234788999999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.61 Aligned_cols=261 Identities=24% Similarity=0.330 Sum_probs=193.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+++.||||++....... ...+++.+|+.+++.++||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~l~ 127 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIISLL 127 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEESGGGSH------------HHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEECccccCh------------HHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 478999999999999999999864 578999999986542111 1245788999999999999999999
Q ss_pred eeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++.... ..|+||||+++ +|.+.+. ..+++..+..++.|+++||+|| |+.+|+||||||+|||+
T Consensus 128 ~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDlkp~NIll 197 (464)
T 3ttj_A 128 NVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVV 197 (464)
T ss_dssp EEECSCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEE
T ss_pred EEEccCCccccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChHhEEE
Confidence 9996553 46999999976 5666653 2489999999999999999999 67799999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..
T Consensus 198 ~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~ 271 (464)
T 3ttj_A 198 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQ 271 (464)
T ss_dssp CTTSCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH
T ss_pred eCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HH
Confidence 9999999999999987654322 23467999999999999999999999999999999999999999763221 11
Q ss_pred HHHHHHHhhccCCc-------------------------chhhhhhhhhcCC---HHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 570 LVKWMRNVMTSENP-------------------------TRAIDAKLLENGY---EEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 570 ~~~~~~~~~~~~~~-------------------------~~~~d~~~~~~~~---~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
+.+.+ ...+...+ .......+..... ......+.+++.+||+.||++|||+
T Consensus 272 ~~~i~-~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta 350 (464)
T 3ttj_A 272 WNKVI-EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350 (464)
T ss_dssp HHHHH-HHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHH-HhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH
Confidence 11111 11111000 0000000000000 1123468899999999999999999
Q ss_pred HHHHH
Q 006739 622 KDVRC 626 (633)
Q Consensus 622 ~ev~~ 626 (633)
+|+++
T Consensus 351 ~e~L~ 355 (464)
T 3ttj_A 351 DDALQ 355 (464)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.11 Aligned_cols=268 Identities=22% Similarity=0.286 Sum_probs=195.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC---CCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI---RHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv 412 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++............ ...+.+|+++++++ +||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVPNGGGGGGGL---------PISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECT-TTCCEEEEEEEEEECCCTTSSCC---------CHHHHHHHHHHHHHHHHCCTTBC
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEeccccccccccc---------chhHHHHHHHHHHHhhcCCCCeE
Confidence 578999999999999999999864 57899999998643321110000 12344555555555 599999
Q ss_pred ccceeeecCC-----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 413 PLLAHMARPD-----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 413 ~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
++++++.... ..++||||++ ++|.+++.... ...+++..+..++.|+++||+|| |+.+|+||||||+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Ni 151 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENI 151 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCTTTE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHE
Confidence 9999997755 4789999996 59999997532 34499999999999999999999 678899999999999
Q ss_pred EecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 488 LLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
+++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 152 l~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--- 225 (308)
T 3g33_A 152 LVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--- 225 (308)
T ss_dssp EECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---
T ss_pred EEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 999999999999999987654332 23467899999999999999999999999999999999999999753221
Q ss_pred chHHHHHHHhhccC----Ccchh-h-hhhh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 568 MSLVKWMRNVMTSE----NPTRA-I-DAKL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 568 ~~~~~~~~~~~~~~----~~~~~-~-d~~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+... ..... +.... + .... .....++....+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 226 DQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHH-HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHH-HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11222221 11110 00000 0 0000 00000112234788999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=334.81 Aligned_cols=249 Identities=24% Similarity=0.443 Sum_probs=202.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|+..+.||+|+||.||+|+.. .+++.||+|++.... ..+.+|++++++++||||++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~------------------~~~~~e~~~l~~l~h~~i~~~~ 70 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN------------------EKAEREVKALAKLDHVNIVHYN 70 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS------------------GGGHHHHHHHHHCCCTTBCCEE
T ss_pred ccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc------------------HHHHHHHHHHHhCCCCCEEEEe
Confidence 357899999999999999999874 578999999986532 2356789999999999999999
Q ss_pred eeeec----------------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 006739 416 AHMAR----------------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIH 479 (633)
Q Consensus 416 ~~~~~----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH 479 (633)
+++.. ....++||||+++++|.+++.... ...+++..++.++.|+++||.|| |+.+|+|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H 145 (284)
T 2a19_B 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYI---HSKKLIN 145 (284)
T ss_dssp EEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHH---HHTTEEC
T ss_pred eeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeee
Confidence 98854 345789999999999999997533 35689999999999999999999 6779999
Q ss_pred CCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCc
Q 006739 480 RDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559 (633)
Q Consensus 480 ~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 559 (633)
|||||+||++++++.+||+|||++......... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 146 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp SCCSGGGEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred ccCCHHHEEEcCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999999999999999999877654322 33568999999999999999999999999999999999998864
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhhC
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~~ 633 (633)
... ........ ......++ ..+.+++.+||+.||++|||+.|+++.|+.+++
T Consensus 223 ~~~---------~~~~~~~~-~~~~~~~~------------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 223 ETS---------KFFTDLRD-GIISDIFD------------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHH---------HHHHHHHT-TCCCTTSC------------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hHH---------HHHHHhhc-ccccccCC------------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 311 11111111 11111111 236788899999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.58 Aligned_cols=266 Identities=27% Similarity=0.371 Sum_probs=205.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc--CCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ--IRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+|++ +|+.||||++.... ...+.+|.+++.. ++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~l~h~ni~~ 100 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSRE-----------------ERSWFREAEIYQTVMLRHENILG 100 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGGG-----------------HHHHHHHHHHHHHSCCCCTTBCC
T ss_pred cccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCchh-----------------HHHHHHHHHHHHHhhcCCCcEEE
Confidence 46899999999999999999987 68999999984321 2456677778776 78999999
Q ss_pred cceeeecCC----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCC
Q 006739 414 LLAHMARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS-----HNPRIIHRDLKP 484 (633)
Q Consensus 414 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~Dikp 484 (633)
+++++.... ..++||||+++|+|.+++.. ..+++..++.++.|+++||+|||.. ++.+|+||||||
T Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp 175 (342)
T 1b6c_B 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175 (342)
T ss_dssp EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSG
T ss_pred EEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCH
Confidence 999998776 78999999999999999974 3589999999999999999999521 278999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcc--eecccccCcccccccccccCC------CCCccchHHHHHHHHHHHhC--
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTLK------FTDKCDIYSFGVLLAVLVMG-- 554 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~elltg-- 554 (633)
+||+++.++.+||+|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence 99999999999999999998765543221 123457999999999987753 33689999999999999999
Q ss_pred --------CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 555 --------RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 555 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.||....... .....+............. .... ...+....+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI-PNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp BTTBCCCCCCTTTTTSCSS--CCHHHHHHHHTTSCCCCCC-CGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCcccccccCccccCcCc--ccHHHHHHHHHHHHhCCCC-cccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 77876543321 1222222222222111111 1000 12245566889999999999999999999999
Q ss_pred HHHhhh
Q 006739 627 MLSQIR 632 (633)
Q Consensus 627 ~l~~~~ 632 (633)
.|+++.
T Consensus 330 ~L~~i~ 335 (342)
T 1b6c_B 330 TLSQLS 335 (342)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=333.01 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=203.8
Q ss_pred hhcCccccc-ccccccCeeEEEEEec-CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 335 KEDGLASLE-KIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 335 ~~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..++|++.+ .||+|+||.||+|.+. ..+++.||||++.....+. ...+++.+|++++++++||||+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~ 81 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------------ALKDELLAEANVMQQLDNPYIV 81 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C------------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH------------HHHHHHHHHHHHHHhCCCCCEE
Confidence 346788887 9999999999999653 3457899999986543211 1256789999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++ ..+..++||||+++++|.+++.. ...+++..++.++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 82 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nil~~~~ 153 (291)
T 1xbb_A 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQ 153 (291)
T ss_dssp CEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEET
T ss_pred EEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceEEEeCC
Confidence 999999 56678999999999999999976 34589999999999999999999 67799999999999999999
Q ss_pred CceEEcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 493 MEARIADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
+.+||+|||+++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~ 229 (291)
T 1xbb_A 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEV 229 (291)
T ss_dssp TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHH
T ss_pred CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHH
Confidence 9999999999987765433221 123456789999999988889999999999999999999 9999875322 222
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+.+.. ..... .+......+.+++.+||+.||++||++.++++.|+++
T Consensus 230 ~~~~~~---~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 230 TAMLEK---GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHHHHT---TCCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHc---CCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 222221 11110 0111123478899999999999999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=336.54 Aligned_cols=252 Identities=29% Similarity=0.409 Sum_probs=197.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||++.. +|+.||||++..... .+.+.+|++++++++||||+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~h~~iv~~ 79 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----------------AQAFLAEASVMTQLRHSNLVQL 79 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCE
T ss_pred ChhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecchhH----------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 457899999999999999999986 588999999864321 4568899999999999999999
Q ss_pred ceeeecC-CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 415 LAHMARP-DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 415 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++++.+. +..++||||+++++|.+++.... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~ 154 (278)
T 1byg_A 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 154 (278)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTS
T ss_pred EEEEEcCCCceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCCcceEEEeCCC
Confidence 9987554 47899999999999999997532 23478999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||+++...... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 155 ~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~ 225 (278)
T 1byg_A 155 VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP 225 (278)
T ss_dssp CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHH
T ss_pred cEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 99999999988654432 22357889999999998899999999999999999998 9999875322 22222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.+ ....... . .......+.+++..||+.||++|||+.|+++.|++++
T Consensus 226 ~~---~~~~~~~------~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 226 RV---EKGYKMD------A----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HH---TTTCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---hcCCCCC------C----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 21 1111110 0 1111234778899999999999999999999999885
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.24 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=194.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+|+.||||++..... ........+.+|+.+++.++||||++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~iv~l~ 214 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVI-----------VAKDEVAHTLTENRVLQNSRHPFLTALK 214 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHH-----------C-------------CCCCCSCTTSCCEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEc-CCCCEEEEEEEEhhhh-----------hhhHHHHHHHHHHHHHHhCCCCeEeeEE
Confidence 467999999999999999999864 5789999999853210 0111245678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||. ..+|+||||||+|||++.++.+
T Consensus 215 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 215 YSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp EEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCE
T ss_pred EEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCE
Confidence 999999999999999999999999976 3468999999999999999999942 2789999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+.+.
T Consensus 289 kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~ 362 (446)
T 4ejn_A 289 KITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFELIL 362 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH
T ss_pred EEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----HHHHHHHH
Confidence 9999999986443322 22346799999999999999999999999999999999999999965321 12222111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
. ........+ ...+.+++.+||+.||++|| +++|+++
T Consensus 363 ~--~~~~~p~~~------------~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 363 M--EEIRFPRTL------------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp H--CCCCCCTTS------------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred h--CCCCCCccC------------CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1 111111111 12377899999999999999 9999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=341.29 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=200.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-----CCc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-----HRN 410 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~n 410 (633)
.++|++.++||+|+||.||+|+.. .+++.||||++.... ...+.+..|+.+++.++ |||
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNIK---------------KYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSCH---------------HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred cCEEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccch---------------hhhhhhHHHHHHHHHhcccCCCCCC
Confidence 578999999999999999999875 578999999985321 11345677888888886 999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
|+++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|| |+.+|+||||||+|||++
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILLD 171 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEES
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCcccEEEc
Confidence 999999999999999999999 899999998632 34589999999999999999999 678999999999999997
Q ss_pred C-------------------------CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHH
Q 006739 491 D-------------------------DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFG 545 (633)
Q Consensus 491 ~-------------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G 545 (633)
. ++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 5 7899999999998754432 345789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhh-----------------hhc-CCH----------
Q 006739 546 VLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKL-----------------LEN-GYE---------- 597 (633)
Q Consensus 546 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-----------------~~~-~~~---------- 597 (633)
|++|||++|+.||..... ......+...... .+........ ... ...
T Consensus 247 ~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 321 (360)
T 3llt_A 247 CVLAELYTGSLLFRTHEH----MEHLAMMESIIQP-IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321 (360)
T ss_dssp HHHHHHHHSSCSCCCSSH----HHHHHHHHHHTCC-CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred HHHHHHHHCCCCCCCCcH----HHHHHHHHHhcCC-CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence 999999999999975322 1222222222111 1111100000 000 000
Q ss_pred -----HHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 598 -----EQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 598 -----~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+.+++.+||+.||++|||++|+++
T Consensus 322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00145779999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.21 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=193.2
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+.. .+++.||||++....... ...+.+.+|+.++++++||||+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 98 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDT-VTNETVAIKRIRLEHEEE------------GVPGTAIREVSLLKELQHRNIIEL 98 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TTTEEEEEEECCCCC--------------------CHHHHHHGGGCCCTTBCCE
T ss_pred chhhEEEEEEEEecCCeEEEEEEEC-CCCceEEEEEEccccccc------------ccchhHHHHHHHHHHcCCCCcceE
Confidence 3478999999999999999999864 579999999986543211 114567789999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec----
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD---- 490 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~---- 490 (633)
++++.+.+..++||||+++ +|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++
T Consensus 99 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp EEEEEETTEEEEEEECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEC---
T ss_pred EEEEecCCEEEEEEecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHEEEecCCC
Confidence 9999999999999999974 99999876 34589999999999999999999 678999999999999994
Q ss_pred -CCCceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 491 -DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 491 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
.++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~ 245 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---ID 245 (329)
T ss_dssp --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred CccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HH
Confidence 4556999999999876543222 2345689999999998874 489999999999999999999999875322 12
Q ss_pred hHHHHHHHhhccCCcch--------------------hhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTR--------------------AIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~--------------------~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.+..... ....... .+...+ ... ....+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 246 QLFKIFEVL-GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL-GAL---LDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHHH-CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHH-GGG---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHh-CCCchhhhhhhhhhhhhhhhhhhhccccHhhhc-ccc---cCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 222222211 1000000 000000 000 1234788999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.57 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=202.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++...... ...+.+.+|+.+++.++||||++++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAV-------------DCPENIKKEICINKMLNHENVVKFY 71 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCT-------------THHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ecceEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccch-------------hhhHHHHHHHHHHHhcCCCCceeee
Confidence 367899999999999999999864 57899999998533211 0145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~ 144 (276)
T 2yex_A 72 GHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNL 144 (276)
T ss_dssp EEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCE
T ss_pred eEEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEEccCCCE
Confidence 999999999999999999999998864 35689999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||.+................||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ......+.
T Consensus 145 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~ 222 (276)
T 2yex_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWK 222 (276)
T ss_dssp EECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHH
T ss_pred EEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhh
Confidence 9999999987643322222234578999999999987665 67899999999999999999999764321 12222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ...... .......+.+++.+||+.||++|||++|+++
T Consensus 223 ~~----~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 223 EK----KTYLNP---------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TT----CTTSTT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hc----ccccCc---------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 11 100000 0011223678899999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=328.32 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=200.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|... .++..||+|++....... .+.+.+|++++++++||||++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~--------------~~~~~~E~~~l~~l~h~~i~~~~ 72 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVED--------------VDRFKQEIEIMKSLDHPNIIRLY 72 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCSC--------------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccch--------------HHHHHHHHHHHHhCCCCCEeeEE
Confidence 467999999999999999999875 567899999985432210 45688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe---cCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDD 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---~~~ 492 (633)
+++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++ +.+
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~ 145 (277)
T 3f3z_A 73 ETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFLFLTDSPD 145 (277)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTT
T ss_pred EEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEecCCCC
Confidence 999999999999999999999999875 34589999999999999999999 67899999999999999 788
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||++......... ....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||..... ...
T Consensus 146 ~~~~l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~-- 215 (277)
T 3f3z_A 146 SPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD----SEV-- 215 (277)
T ss_dssp CCEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHH--
T ss_pred CcEEEEecccceeccCccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH----HHH--
Confidence 99999999999876654322 33579999999998876 489999999999999999999999875321 111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
............ ...... ....+.+++.+||+.||++|||+.++++
T Consensus 216 -~~~~~~~~~~~~---~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 216 -MLKIREGTFTFP---EKDWLN----VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -HHHHHHCCCCCC---HHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -HHHHHhCCCCCC---chhhhc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111110 000001 1234778999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=335.35 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=205.1
Q ss_pred hcCccccc-ccccccCeeEEEEEec-CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLE-KIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|.+.+ .||+|+||.||+|.+. ..++..||+|++...... ...+++.+|++++++++||||++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~ 74 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------------ADTEEMMREAQIMHQLDNPYIVR 74 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-------------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-------------hHHHHHHHHHHHHHhCCCCCEeE
Confidence 45666666 9999999999999863 336788999998654311 11567889999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++ ..+..++||||+++++|.+++.. ....+++..+..++.|+++||+|| |+.+|+||||||+||+++.++
T Consensus 75 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~ 147 (287)
T 1u59_A 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRH 147 (287)
T ss_dssp EEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETT
T ss_pred EEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchheEEEcCCC
Confidence 99999 45668999999999999999864 245699999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 494 EARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 148 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~ 223 (287)
T 1u59_A 148 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVM 223 (287)
T ss_dssp EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHH
T ss_pred CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHHH
Confidence 99999999998875443321 1223457899999999988889999999999999999998 9999875422 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+.. ..... .+......+.+++..||+.||++||++.++++.|+++
T Consensus 224 ~~i~~---~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 224 AFIEQ---GKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HHHHT---TCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhc---CCcCC----------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22221 11111 0111123478899999999999999999999999876
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.95 Aligned_cols=268 Identities=25% Similarity=0.318 Sum_probs=193.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+. +++.||||++..... . ......|+..+..++||||++++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~---------~------~~~~e~~~~~~~~~~h~~i~~~~ 73 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANR---------Q------NFINEKNIYRVPLMEHDNIARFI 73 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGGH---------H------HHHHHHHHHTSTTCCCTTBCCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeeccch---------h------hHHHHHHHHHHHhccCcchhhhe
Confidence 47899999999999999999986 789999999853210 0 11123445556668999999999
Q ss_pred eeeec-----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeeeCC
Q 006739 416 AHMAR-----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNP---------RIIHRD 481 (633)
Q Consensus 416 ~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~---------~ivH~D 481 (633)
+++.. ....++||||+++|+|.+++.. ...++..+..++.|+++||+||| +. +|+|||
T Consensus 74 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~D 145 (336)
T 3g2f_A 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRD 145 (336)
T ss_dssp EEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSS
T ss_pred ecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecc
Confidence 85532 3356899999999999999975 33589999999999999999995 55 999999
Q ss_pred CCCCCeEecCCCceEEcccccccccCCCCC------cceecccccCccccccccccc-------CCCCCccchHHHHHHH
Q 006739 482 LKPANVLLDDDMEARIADFGLAKAMPDAQT------HITTSNVAGTVGYIAPEYHQT-------LKFTDKCDIYSFGVLL 548 (633)
Q Consensus 482 ikp~Nill~~~~~~kl~DfG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l 548 (633)
|||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++
T Consensus 146 ikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il 225 (336)
T 3g2f_A 146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225 (336)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHH
Confidence 999999999999999999999987654321 111234569999999999876 3566789999999999
Q ss_pred HHHHhCCCCCcccccccccchH-H---------HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCC
Q 006739 549 AVLVMGRLPSDDFFQHTEEMSL-V---------KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRER 618 (633)
Q Consensus 549 ~elltg~~p~~~~~~~~~~~~~-~---------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 618 (633)
|||++|+.||............ . ..+............+... ..........+.+++.+||+.||++|
T Consensus 226 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~R 303 (336)
T 3g2f_A 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEAR 303 (336)
T ss_dssp HHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhC
Confidence 9999998876432221111100 0 0011111111000000000 01122345568999999999999999
Q ss_pred CCHHHHHHHHHhh
Q 006739 619 PNSKDVRCMLSQI 631 (633)
Q Consensus 619 Ps~~ev~~~l~~~ 631 (633)
||++|+++.|+++
T Consensus 304 ps~~e~l~~L~~l 316 (336)
T 3g2f_A 304 LTAQXAEERMAEL 316 (336)
T ss_dssp CCHHHHHHHHHHH
T ss_pred cchHHHHHHHHHH
Confidence 9999999999886
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.49 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=207.0
Q ss_pred hcCcccccccccccCeeEEEEEe---cCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.++|++.+.||+|+||.||++++ ...+++.||+|++..... ...+.+.+|++++++++||||+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv 105 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--------------EHLRDFEREIEILKSLQHDNIV 105 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS--------------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCCee
Confidence 46789999999999999999985 345789999999865431 1145788999999999999999
Q ss_pred ccceeeecCC--ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 413 PLLAHMARPD--CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 413 ~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++++++...+ ..++||||+++++|.+++... ...+++..++.++.|+++||+|| |+.+|+||||||+||+++
T Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli~ 179 (326)
T 2w1i_A 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVE 179 (326)
T ss_dssp CEEEEECC----CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEE
T ss_pred eEEEEEEecCCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEEc
Confidence 9999986644 789999999999999999753 34689999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc-----
Q 006739 491 DDMEARIADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH----- 564 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~----- 564 (633)
.++.+||+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......
T Consensus 180 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~ 259 (326)
T 2w1i_A 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259 (326)
T ss_dssp ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHH
T ss_pred CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhh
Confidence 999999999999988765433211 12345788899999999888999999999999999999999997642110
Q ss_pred --c-ccchHH-HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 565 --T-EEMSLV-KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 565 --~-~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
. ...... ............. ........+.+++.+||+.||++|||+.|+++.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLKNNGRLP----------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp CTTCCTHHHHHHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccchhhhHHHHHHHhhcCCCCC----------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 000011 1111111111110 01112234788999999999999999999999999885
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=367.92 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=207.0
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|.+. ++..||||++...... .++|.+|++++++++||||+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hpniv 325 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLV 325 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBC
T ss_pred ecchhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCCCC---------------HHHHHHHHHHHHhCCCCCEe
Confidence 345678999999999999999999985 5678999998654321 34688999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+ +..++||||+++|+|.+++.... ...+++..++.|+.||++||+|| |+.+|+||||||+|||++++
T Consensus 326 ~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~ 399 (535)
T 2h8h_A 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGEN 399 (535)
T ss_dssp CEEEEECS-SSCEEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGG
T ss_pred eEEEEEee-ccceEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHhhEEEcCC
Confidence 99999876 67899999999999999997532 24589999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 400 ~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~~~~ 474 (535)
T 2h8h_A 400 LVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REVL 474 (535)
T ss_dssp GCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----HHHH
T ss_pred CcEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 9999999999987654211 11123456889999999999899999999999999999999 9999875321 1222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+ ....... ........+.+++.+||+.||++|||++++++.|+++
T Consensus 475 ~~i---~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 475 DQV---ERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp HHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH---HcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222 2211111 0111123477899999999999999999999999886
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=342.27 Aligned_cols=267 Identities=25% Similarity=0.315 Sum_probs=199.5
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|... .+++.||+|++...... .......+.+.+|++++++++||||+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~hpniv 91 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIR---------QINPKDVERIKTEVRLMKKLHHPNIA 91 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHH---------C---CHHHHHHHHHHHHHHCCCTTBC
T ss_pred hhhhhheeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhc---------ccCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 344678999999999999999999864 57899999998532110 00112256789999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCC------------------------------------CCCCCHHHHH
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG------------------------------------RRELDWLARH 456 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~ 456 (633)
++++++.+.+..++||||+++|+|.+++...... ...+++..++
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 92 RLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred eeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 9999999999999999999999999998531110 1224677888
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC--ceEEcccccccccCCCCC--cceecccccCccccccccccc
Q 006739 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM--EARIADFGLAKAMPDAQT--HITTSNVAGTVGYIAPEYHQT 532 (633)
Q Consensus 457 ~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~--~~kl~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 532 (633)
.++.|+++||+|| |+.+|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+
T Consensus 172 ~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 172 NIMRQIFSALHYL---HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHH---HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9999999999999 677999999999999998776 899999999986643221 112234679999999999875
Q ss_pred --CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHh
Q 006739 533 --LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFC 610 (633)
Q Consensus 533 --~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~c 610 (633)
..++.++|||||||++|||++|+.||..... ... ............ .+. ... ....+.+++.+|
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~----~~~~~~~~~~~~--~~~-~~~----~~~~~~~li~~~ 314 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND---ADT----ISQVLNKKLCFE--NPN-YNV----LSPLARDLLSNL 314 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHCCCCTT--SGG-GGG----SCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh---HHH----HHHHHhcccccC--Ccc-ccc----CCHHHHHHHHHH
Confidence 6789999999999999999999999975322 111 111111111100 000 001 123377899999
Q ss_pred ccCCCCCCCCHHHHHH
Q 006739 611 TVDSPRERPNSKDVRC 626 (633)
Q Consensus 611 l~~dP~~RPs~~ev~~ 626 (633)
|+.||++|||+.|+++
T Consensus 315 l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 315 LNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCSCTTTSCCHHHHHH
T ss_pred cCCChhHCCCHHHHhc
Confidence 9999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=336.70 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=203.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+++.. .+++.||+|++....... ...+.+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTE------------AEKQMLVSEVNLLRELKHPNIVRYY 71 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheeeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCH------------HHHHHHHHHHHHHHhcCCCCCCeEE
Confidence 468999999999999999999864 578999999986543221 1156788999999999999999999
Q ss_pred eeee--cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCeEecC
Q 006739 416 AHMA--RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISH--NPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 416 ~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h--~~~ivH~Dikp~Nill~~ 491 (633)
+++. .....++||||+++++|.+++.........+++..++.++.|++.||+|||... ..+|+||||||+||+++.
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~ 151 (279)
T 2w5a_A 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151 (279)
T ss_dssp EEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS
T ss_pred EEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC
Confidence 9874 456789999999999999999876555567999999999999999999995332 123999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
++.+||+|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+.
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~ 225 (279)
T 2w5a_A 152 KQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELA 225 (279)
T ss_dssp SSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred CCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----HHHH
Confidence 999999999999876543221 1234689999999999998999999999999999999999999875321 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
+.+.. ..... +... ....+.+++.+||+.||++|||+.|+++.+.
T Consensus 226 ~~i~~---~~~~~------~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 226 GKIRE---GKFRR------IPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHH---TCCCC------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHhh---ccccc------CCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 22221 11110 0011 1234778899999999999999999997653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=332.90 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=189.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+.. .+|+.||+|++....... ...+.+.++...++.++||||+++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~~~~~~~~~~h~~iv~~ 71 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQ------------EQKRLLMDLDISMRTVDCPFTVTF 71 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHH------------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcH------------HHHHHHHHHHHHHHhCCCCeEEEE
Confidence 4578999999999999999999864 578999999986442211 113345556666888999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCeEecCCC
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNP-RIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~Dikp~Nill~~~~ 493 (633)
++++.+++..++||||++ |+|.+++.........+++..+..++.|++.||+|| |+. +|+||||||+||+++.++
T Consensus 72 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~ 147 (290)
T 3fme_A 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNVLINALG 147 (290)
T ss_dssp EEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGCEECTTC
T ss_pred eeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCC
Confidence 999999999999999997 599888876555567899999999999999999999 555 899999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCccccccccc----ccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH----QTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
.+||+|||+++........ ....||+.|+|||++ .+..++.++||||+|+++|||++|+.||..... ....
T Consensus 148 ~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~ 222 (290)
T 3fme_A 148 QVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQ 222 (290)
T ss_dssp CEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHH
T ss_pred CEEEeecCCcccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHH
Confidence 9999999999876554322 234689999999996 556788999999999999999999999975322 1111
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+.+ ........ ... ....+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~----~~~~~~~~------~~~---~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 LKQVV----EEPSPQLP------ADK---FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHH----HSCCCCCC------TTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHh----ccCCCCcc------ccc---CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111 11111100 001 1223788999999999999999999976
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=343.10 Aligned_cols=266 Identities=25% Similarity=0.382 Sum_probs=199.1
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+.. .+|+.||+|++....... ...+.+.+|+.++++++||||+++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~ 89 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDK------------MVKKIAMREIKLLKQLRHENLVNL 89 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCH------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhheeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCch------------HHHHHHHHHHHHHhhCCCCCEeeE
Confidence 4578999999999999999999874 568999999986544221 114567889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil~~~~~~ 162 (331)
T 4aaa_A 90 LEVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPENILVSQSGV 162 (331)
T ss_dssp EEEEEETTEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSC
T ss_pred EEEeecCCEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChheEEEcCCCc
Confidence 9999999999999999999999888654 34599999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||+++........ .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~ 237 (331)
T 4aaa_A 163 VKLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI---DQLYHI 237 (331)
T ss_dssp EEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH
T ss_pred EEEEeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHH
Confidence 999999999876543221 2335689999999998775 7899999999999999999999998753221 111111
Q ss_pred HHHhhccC-----------------CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSE-----------------NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~-----------------~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+. ..... ...............+.....+.+++.+||+.||++|||++|+++
T Consensus 238 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 238 MM-CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HH-HHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HH-HhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11 11100 000000000000011122345889999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=339.79 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=194.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|+..+.||+|+||.||+|... .+|+.||||++....... ...+++.+|++++++++||||++++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~l~ 90 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSE------------LFAKRAYRELRLLKHMRHENVIGLL 90 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred cceEEEeEEeeecCCeEEEEEEEC-CCCCEEEEEEeCccccCH------------HHHHHHHHHHHHHHhCCCcCCCCce
Confidence 468999999999999999999864 578999999986543211 1145788999999999999999999
Q ss_pred eeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++.... ..|+||||+ +++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~NIll 161 (367)
T 1cm8_A 91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAV 161 (367)
T ss_dssp EEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred eeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCHHHEEE
Confidence 9997653 459999999 8899999874 3589999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .
T Consensus 162 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~ 232 (367)
T 1cm8_A 162 NEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----L 232 (367)
T ss_dssp CTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred cCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 99999999999999876542 134578999999999877 6799999999999999999999999975322 1
Q ss_pred hHHHHHHHhhccCCcchhhh-----------hhh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAID-----------AKL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d-----------~~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+....... +.+.+. ..+ .....+.....+.+++.+||+.||++|||++|+++
T Consensus 233 ~~l~~i~~~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 233 DQLKEIMKVTGTP-PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHHHHCCC-CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhcCCC-CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1111111111110 000000 000 00011112234788999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=352.83 Aligned_cols=198 Identities=26% Similarity=0.415 Sum_probs=154.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++.....+. ...+++.+|+.++++++|||||+++
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~ 118 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDL------------IDCKRILREIAILNRLNHDHVVKVL 118 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC-C--CEEEEEEECSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCH------------HHHHHHHHHHHHHHhCCCCCCCceE
Confidence 468999999999999999999864 578999999986543221 1146788999999999999999999
Q ss_pred eeeec-----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMAR-----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++.. ....|+||||+ +++|.+++.. ...+++..+..++.||++||+|| |+.+|+||||||+|||++
T Consensus 119 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDlKp~NILl~ 190 (458)
T 3rp9_A 119 DIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVN 190 (458)
T ss_dssp EECCCSCTTTCCCEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEEC
T ss_pred EEEecCCcccCceEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCCChhhEEEC
Confidence 99844 35689999998 5699998864 45699999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCc-------------------------ceecccccCccccccccc-ccCCCCCccchHHH
Q 006739 491 DDMEARIADFGLAKAMPDAQTH-------------------------ITTSNVAGTVGYIAPEYH-QTLKFTDKCDIYSF 544 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~ 544 (633)
.++.+||+|||+++........ .......||+.|+|||++ .+..++.++|||||
T Consensus 191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 9999999999999876532211 112345789999999976 55679999999999
Q ss_pred HHHHHHHHhC
Q 006739 545 GVLLAVLVMG 554 (633)
Q Consensus 545 G~~l~elltg 554 (633)
||++|||++|
T Consensus 271 G~il~elltg 280 (458)
T 3rp9_A 271 GCIFAELLNM 280 (458)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHHHh
Confidence 9999999994
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=329.41 Aligned_cols=257 Identities=25% Similarity=0.337 Sum_probs=201.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+++.. .+++.||+|.+............ ..+.+.+|+.++++++||||+++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGV--------SREEIEREVNILREIRHPNIITLHD 75 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSB--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccccccch--------HHHHHHHHHHHHHhCCCCCeeehhh
Confidence 56899999999999999999875 47899999998765432111000 0456889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC---
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM--- 493 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~--- 493 (633)
++.+....++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSSSS
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEecCCCCC
Confidence 99999999999999999999999975 34689999999999999999999 678999999999999999877
Q ss_pred -ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 494 -EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....
T Consensus 149 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~ 221 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLT 221 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHH
T ss_pred CceEEEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch----HHHHH
Confidence 7999999999876543321 335689999999999999999999999999999999999999875321 11111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+ ...... .+....... ...+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~---~~~~~~---~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 222 NI---SAVNYD---FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HH---HTTCCC---CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred Hh---HhcccC---CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11 111100 011111111 234778999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=343.63 Aligned_cols=263 Identities=19% Similarity=0.305 Sum_probs=194.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+++.||+|++....... ....+.+|++++++++||||+++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEG-------------APCTAIREVSLLKDLKHANIVTLHD 67 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC-------------------CCCCCCCHHHHSCCCCTTBCCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccccc-------------cchhHHHHHHHHHhcCCCCCCeeee
Confidence 57899999999999999999864 578999999985433110 0223557999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..++||||++ |+|.+++... ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.+|
T Consensus 68 ~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~k 140 (324)
T 3mtl_A 68 IIHTEKSLTLVFEYLD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLINERGELK 140 (324)
T ss_dssp EEECSSCEEEEEECCS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEecccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEECCCCCEE
Confidence 9999999999999997 5999888752 35689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+++........ .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.
T Consensus 141 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~ 214 (324)
T 3mtl_A 141 LADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIF 214 (324)
T ss_dssp ECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred EccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 9999999865533221 233568999999999876 5689999999999999999999999976322 22222222
Q ss_pred HhhccCCcc---hhhhhh-hh------------hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPT---RAIDAK-LL------------ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~---~~~d~~-~~------------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......... ...... .. ....+.....+.+++.+||+.||++|||++|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 215 RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 222211110 000000 00 0000111234778999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.53 Aligned_cols=203 Identities=28% Similarity=0.367 Sum_probs=167.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++....... ...+.+.+|++++++++||||++++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~nIv~l~ 91 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDL------------IDCKRILREITILNRLKSDYIIRLY 91 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCCEEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcCh------------HHHHHHHHHHHHHHHcCCCCcceEE
Confidence 578999999999999999999865 578999999986543211 1146788999999999999999999
Q ss_pred eeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++... ...|+||||++ |+|.+++.. ...+++..+..++.||++||+|| |+.+|+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~L---H~~givHrDlkp~NILl~ 163 (432)
T 3n9x_A 92 DLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFI---HESGIIHRDLKPANCLLN 163 (432)
T ss_dssp EECCCSCTTTCCCEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEC
T ss_pred EEEecCCCCcCCeEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHeEEC
Confidence 998765 56899999996 599999874 45699999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCc--------------------ceecccccCccccccccc-ccCCCCCccchHHHHHHHH
Q 006739 491 DDMEARIADFGLAKAMPDAQTH--------------------ITTSNVAGTVGYIAPEYH-QTLKFTDKCDIYSFGVLLA 549 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~ 549 (633)
.++.+||+|||+++........ .......||+.|+|||++ ....++.++||||+||++|
T Consensus 164 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ 243 (432)
T 3n9x_A 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243 (432)
T ss_dssp TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHH
Confidence 9999999999999987543221 112456799999999986 5667999999999999999
Q ss_pred HHHhCCCCCc
Q 006739 550 VLVMGRLPSD 559 (633)
Q Consensus 550 elltg~~p~~ 559 (633)
||++|..||.
T Consensus 244 ell~g~~p~~ 253 (432)
T 3n9x_A 244 ELLNMLQSHI 253 (432)
T ss_dssp HHHTTCTTTC
T ss_pred HHHhcccccc
Confidence 9998665553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.35 Aligned_cols=202 Identities=26% Similarity=0.449 Sum_probs=174.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||++++. .+++.||+|++...... ...+.+.+|+.++++++||||++++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~ 97 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGFY 97 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCH-------------HHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred cccceeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCH-------------HHHHHHHHHHHHHHHCCCCCEEEEe
Confidence 467999999999999999999875 57899999998654311 1146789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||+|||. ..+|+||||||+||+++.++.+
T Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~ 171 (360)
T 3eqc_A 98 GAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEI 171 (360)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCE
Confidence 9999999999999999999999999763 458999999999999999999952 2389999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
||+|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 172 kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 172 KLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp EECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred EEEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999987653321 13357899999999999999999999999999999999999999753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.20 Aligned_cols=264 Identities=27% Similarity=0.396 Sum_probs=198.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCe--EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGK--MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..++|++.+.||+|+||.||+|++...+++ .||+|++....... .+..+.+.+|++++++++||||+
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~ 84 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----------PEAMDDFIREVNAMHSLDHRNLI 84 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------CHHHHHHHHHHHHHHHCCCTTBC
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-----------HHHHHHHHHHHHHHHhCCCCCcc
Confidence 356899999999999999999987544443 68999885432111 11256788999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++..+. .++||||+++++|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nili~~~ 157 (291)
T 1u46_A 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATR 157 (291)
T ss_dssp CEEEEECSSS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEET
T ss_pred cEEEEEccCC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEEcCC
Confidence 9999998765 88999999999999999753 24589999999999999999999 67799999999999999999
Q ss_pred CceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 493 MEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
+.+||+|||+++......... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~ 233 (291)
T 1u46_A 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQI 233 (291)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH
T ss_pred CCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----HHH
Confidence 999999999998876543322 1233467889999999988888999999999999999999 9999875321 122
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
............ ........+.+++.+||+.||++|||+.++++.|++++
T Consensus 234 ---~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 234 ---LHKIDKEGERLP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ---HHHHHTSCCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---HHHHHccCCCCC---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 222211111110 00111234788999999999999999999999998864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.93 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=197.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|++.+.||+|+||.||++... .+++.||+|++..... ...+|++++.++ +||||+++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~------------------~~~~E~~~l~~~~~hp~iv~~ 81 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR------------------DPTEEIEILLRYGQHPNIITL 81 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC------------------CCHHHHHHHHHHTTSTTBCCE
T ss_pred cccEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC------------------ChHHHHHHHHHhcCCCCcCeE
Confidence 467999999999999999999875 5789999999865432 123466777777 79999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC--
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD-- 492 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~-- 492 (633)
++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+||++.++
T Consensus 82 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NIl~~~~~~ 154 (342)
T 2qr7_A 82 KDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDESG 154 (342)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSSC
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHEEEecCCC
Confidence 9999999999999999999999999875 35699999999999999999999 67899999999999998543
Q ss_pred --CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 493 --MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 --~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+.+||+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .....+
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~ 231 (342)
T 2qr7_A 155 NPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEI 231 (342)
T ss_dssp SGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHH
T ss_pred CcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHH
Confidence 35999999999876544322 2345789999999999888889999999999999999999999975321 111222
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+........ ...+......+.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 232 ---LARIGSGKFSLS-------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---HHHHHHCCCCCC-------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---HHHHccCCcccC-------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222222111100 0001112234778999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=365.87 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=200.0
Q ss_pred cCccccc-ccccccCeeEEEEEecC-CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 337 DGLASLE-KIGSGGCGEVYKAELPG-SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 337 ~~~~~~~-~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
+++.+.+ .||+|+||.||+|.+.. .++..||||+++...... ..+++.+|++++++++|||||++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-------------~~~~~~~E~~il~~l~hpniv~l 401 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA-------------DTEEMMREAQIMHQLDNPYIVRL 401 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST-------------THHHHHHHHHHHTTCCCTTBCCE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH-------------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 4444445 79999999999998743 356789999987543211 14678899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.. +..++||||+++|+|.+++.. ....+++..+..++.||++||+|| |+.+|+||||||+|||+++++.
T Consensus 402 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NILl~~~~~ 474 (613)
T 2ozo_A 402 IGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHY 474 (613)
T ss_dssp EEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTE
T ss_pred EEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHEEEcCCCc
Confidence 999976 568999999999999999964 245699999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 495 ARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+
T Consensus 475 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~ 550 (613)
T 2ozo_A 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMA 550 (613)
T ss_dssp EEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS----HHHHH
T ss_pred EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH----HHHHH
Confidence 9999999998775443221 1122346789999999999999999999999999999998 9999976432 22222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+. ...... .+......+.+++..||+.||++||++.++++.|+++
T Consensus 551 ~i~---~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 551 FIE---QGKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HHH---TTCCCC----------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHH---cCCCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222 111111 0111223478899999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.88 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=197.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
...|.+.+.||+|+||.||+|... .++..||+|++...... ....+.+.+|+.++++++||||++++
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~ 91 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFY 91 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhC------------HHHHHHHHHHHHHHHhCCCCCeeeee
Confidence 345788889999999999999865 57889999998643221 11256788999999999999999999
Q ss_pred eeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCeEe
Q 006739 416 AHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR--IIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~Dikp~Nill 489 (633)
+++.. ....++||||+++++|.+++... ..+++..++.++.|+++||+|| |+.+ |+||||||+||++
T Consensus 92 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~ 164 (290)
T 1t4h_A 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFI 164 (290)
T ss_dssp EEEEEESSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEE
T ss_pred eeeccccCCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHH---HcCCCCEEECCCCHHHEEE
Confidence 98865 35578999999999999999763 4589999999999999999999 5666 9999999999999
Q ss_pred c-CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 D-DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+ .++.+||+|||++........ ....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.....
T Consensus 165 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----- 234 (290)
T 1t4h_A 165 TGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----- 234 (290)
T ss_dssp SSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----
T ss_pred ECCCCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----
Confidence 8 789999999999976544321 33569999999998874 689999999999999999999999965322
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
............... ..+ .... ..+.+++..||+.||++|||++|+++
T Consensus 235 -~~~~~~~~~~~~~~~-~~~----~~~~----~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 235 -AAQIYRRVTSGVKPA-SFD----KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -HHHHHHHHTTTCCCG-GGG----GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHhccCCcc-ccC----CCCC----HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112222222221111 111 1111 23788999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.68 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=205.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC-ccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR-NLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l 414 (633)
.++|++.+.||+|+||.||+|++. .+++.||||++..... ..++.+|+++++.++|+ +++.+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~----------------~~~~~~E~~il~~L~~~~~i~~i 68 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTK----------------HPQLLYESKIYRILQGGTGIPNV 68 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTCS----------------SCCHHHHHHHHHHTTTSTTCCCE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEeccccc----------------cHHHHHHHHHHHHhcCCCCCCeE
Confidence 468999999999999999999864 5789999998754432 23467889999999875 55566
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe---cC
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DD 491 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---~~ 491 (633)
..++...+..++||||+ +++|.+++... ...+++..++.|+.||+.||+|| |+.+|+||||||+|||+ +.
T Consensus 69 ~~~~~~~~~~~lvme~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NILl~~~~~ 141 (483)
T 3sv0_A 69 RWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNFLMGLGRR 141 (483)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGG
T ss_pred EEEEeeCCEEEEEEECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceEEEecCCC
Confidence 66667788889999999 99999999753 35699999999999999999999 67899999999999999 68
Q ss_pred CCceEEcccccccccCCCCCcc-----eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
++.+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~ 221 (483)
T 3sv0_A 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (483)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred CCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence 8999999999998876543321 12356799999999999999999999999999999999999999987544322
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
...+.++...... ... ..+.... ...+.+++..||+.||++||++++++++|+++
T Consensus 222 ~~~~~~i~~~~~~-~~~-----~~l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 222 KQKYEKISEKKVA-TSI-----EALCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHHHHHHHH-SCH-----HHHHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhhcccc-ccH-----HHHhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2222222221111 100 0111111 23478899999999999999999999999886
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=329.79 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=181.5
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+.. .+|+.||+|++..... ......+.+.+|+.++++++||||+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~ 76 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAM-----------YKAGMVQRVQNEVKIHCQLKHPSILEL 76 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHTTBCCTTBCCE
T ss_pred ccccceeeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhh-----------hhhhHHHHHHHHHHHHHhCCCCCeEeE
Confidence 3467999999999999999999864 4789999999842110 001114678899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++++|.+++.. ....+++..++.++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nili~~~~~ 150 (278)
T 3cok_A 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNLLLTRNMN 150 (278)
T ss_dssp EEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGEEECTTCC
T ss_pred EEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCC
Confidence 9999999999999999999999999874 235689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... . .
T Consensus 151 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~---~ 221 (278)
T 3cok_A 151 IKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----T---L 221 (278)
T ss_dssp EEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------
T ss_pred EEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----H---H
Confidence 999999999876543221 123568999999999999899999999999999999999999987532211 0 1
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ ..... ....+.+++.+||+.||++|||++++++
T Consensus 222 ~~~~~~~~-------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 NKVVLADY-------EMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCSSCC-------CCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhhccc-------CCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11111000 00001 1223778999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.32 Aligned_cols=260 Identities=22% Similarity=0.379 Sum_probs=204.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|++.+.||+|+||.||+|++. .+|+.||||++......... .......+.+.+|+.++.++ +||||+++
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSP------EQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCH------HHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhcccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCH------HHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467999999999999999999874 47899999998765422111 11223356788999999999 79999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++......++||||+++++|.+++.. ...+++..+..++.||+.||+|| |+.+|+||||||+||+++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999975 34699999999999999999999 6779999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCccccccccccc------CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT------LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..
T Consensus 239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~ 311 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QI 311 (365)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HH
T ss_pred EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HH
Confidence 99999999987765432 234679999999998863 358889999999999999999999986532 11
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+. ....... .+. .... ...+.+++.+||+.||++|||+.|+++
T Consensus 312 ~~~~~i~---~~~~~~~--~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 LMLRMIM---EGQYQFS--SPE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHH---HTCCCCC--HHH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHH---hCCCCCC--Ccc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222111 1111100 000 0111 123778999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.87 Aligned_cols=264 Identities=16% Similarity=0.177 Sum_probs=202.4
Q ss_pred hcCcccccccccccCeeEEEEEecCC-------CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGS-------NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH 408 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 408 (633)
.++|++.+.||+|+||.||+|+.... +++.||+|++... +.+.+|++++++++|
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------------~~~~~E~~~l~~l~h 101 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------------GRLFNEQNFFQRAAK 101 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------------STHHHHHHHHHHHCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------------chHHHHHHHHHHhcc
Confidence 46899999999999999999987632 4889999998532 246788999999999
Q ss_pred Ccccc---------------cceeeec-CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 006739 409 RNLLP---------------LLAHMAR-PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS 472 (633)
Q Consensus 409 ~niv~---------------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~ 472 (633)
|||++ +++++.. ....++||||+ +++|.+++.... ...+++..++.++.|+++||+||
T Consensus 102 ~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~L--- 175 (352)
T 2jii_A 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFL--- 175 (352)
T ss_dssp HHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHH---
T ss_pred cchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHH---
Confidence 99887 5666665 67789999999 999999998632 35699999999999999999999
Q ss_pred CCCCeeeCCCCCCCeEecCCC--ceEEcccccccccCCCCCcc-----eecccccCcccccccccccCCCCCccchHHHH
Q 006739 473 HNPRIIHRDLKPANVLLDDDM--EARIADFGLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFG 545 (633)
Q Consensus 473 h~~~ivH~Dikp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G 545 (633)
|+.+|+||||||+||+++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++||||||
T Consensus 176 H~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 255 (352)
T 2jii_A 176 HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255 (352)
T ss_dssp HHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred HhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence 677999999999999999998 89999999998765432111 11335799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 006739 546 VLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625 (633)
Q Consensus 546 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~ 625 (633)
|++|||++|+.||..... ....+............ ...+........ ...+.+++.+||+.||++|||+++++
T Consensus 256 ~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 256 YCMLKWLYGFLPWTNCLP--NTEDIMKQKQKFVDKPG--PFVGPCGHWIRP---SETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp HHHHHHHHSCCTTGGGTT--CHHHHHHHHHHHHHSCC--CEECTTSCEECC---CHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHHhCCCCcccCCc--CHHHHHHHHHhccCChh--hhhhhccccCCC---cHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 999999999999976432 12222222222221111 111111000111 13377888899999999999999999
Q ss_pred HHHHhh
Q 006739 626 CMLSQI 631 (633)
Q Consensus 626 ~~l~~~ 631 (633)
+.|+++
T Consensus 329 ~~L~~~ 334 (352)
T 2jii_A 329 NNLEAL 334 (352)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999886
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=368.03 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=196.8
Q ss_pred cccccccCeeEEEEEec-CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELP-GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 421 (633)
+.||+|+||.||+|.+. ...++.||||+++....+.. ..+++.+|++++++++|||||++++++..
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~------------~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA------------LKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGG------------GHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHH------------HHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 47999999999999663 23568999999864322111 14678999999999999999999999864
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.+++.. ...+++..+..|+.||+.||+|| |+.+|+||||||+|||++.++.+||+|||
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEEEEEcC
Confidence 557899999999999999975 35689999999999999999999 67899999999999999999999999999
Q ss_pred cccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhc
Q 006739 502 LAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMT 579 (633)
Q Consensus 502 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 579 (633)
+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.+..
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~~i~~--- 587 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEK--- 587 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHT---
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc---
Confidence 99987654322 12233457889999999999999999999999999999998 9999976422 222222221
Q ss_pred cCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 580 SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 580 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
..... .+......+.+++..||+.||++||++.++++.|+++
T Consensus 588 ~~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 588 GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TCCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCC----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 0111223478899999999999999999999999876
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.65 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=191.9
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|.+.+.||+|+||.||+|... .+++.||||++.......... ........+.+|++++++++||||+++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~l 205 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSA------READPALNVETEIEILKKLNHPCIIKI 205 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------------CCHHHHHHHHHHCCCTTBCCC
T ss_pred hhccEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhccccc------ccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence 3578999999999999999999865 578999999986533211110 001113457899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC-
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM- 493 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~- 493 (633)
++++.. +..++||||+++|+|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+|||++.++
T Consensus 206 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~ 277 (419)
T 3i6u_A 206 KNFFDA-EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEE 277 (419)
T ss_dssp CEEEES-SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSS
T ss_pred EEEEec-CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCCC
Confidence 999754 457899999999999988864 45699999999999999999999 677999999999999997544
Q ss_pred --ceEEcccccccccCCCCCcceecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 494 --EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 494 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 278 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~ 351 (419)
T 3i6u_A 278 DCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QV 351 (419)
T ss_dssp SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SC
T ss_pred cceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hH
Confidence 599999999987654322 234679999999999854 5678899999999999999999999975322 22
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.+.+....... .+..... ....+.+++.+||+.||++|||++|+++
T Consensus 352 ~~~~~i~~~~~~~------~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 352 SLKDQITSGKYNF------IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CHHHHHHTTCCCC------CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhcCCCCC------Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2222222111100 0111111 1234788999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.22 Aligned_cols=259 Identities=25% Similarity=0.355 Sum_probs=202.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeE--EEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKM--IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 412 (633)
.++|+..+.||+|+||.||+|+.. .++.. +|+|.+...... ...+.+.+|+++++++ +||||+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~v~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp~iv 89 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEYASK-------------DDHRDFAGELEVLCKLGHHPNII 89 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEE-ETTEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTBC
T ss_pred HHHccceeeeecCCCceEEEEEEc-cCCcccceeeeeeccccch-------------HHHHHHHHHHHHHHhccCCCchh
Confidence 368999999999999999999875 35654 499988643211 1145688999999999 899999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVS------------QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
++++++.+.+..++||||+++|+|.+++.... .....+++..++.++.|+++||+|| |+.+|+||
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~ 166 (327)
T 1fvr_A 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 166 (327)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECS
T ss_pred hhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCccCC
Confidence 99999999999999999999999999997633 2235799999999999999999999 67899999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 559 (633)
||||+||+++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 167 dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 167 DLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999875432211 123457889999999988889999999999999999998 999986
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.... . +............. .......+.+++.+||+.||++|||++|+++.|+++
T Consensus 244 ~~~~----~---~~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 244 GMTC----A---ELYEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp TCCH----H---HHHHHGGGTCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcH----H---HHHHHhhcCCCCCC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 5321 1 12222222111110 011123478899999999999999999999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=335.12 Aligned_cols=258 Identities=20% Similarity=0.284 Sum_probs=198.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++.... .+.+.+|+.++++++ ||||+++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~~~~~i~~~ 96 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK-----------------KKKIKREIKILENLRGGPNIITL 96 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSCC-----------------HHHHHHHHHHHHHHTTSTTBCCE
T ss_pred CCceEEEEEecccCCeEEEEEEEC-CCCcEEEEEEecccc-----------------hHHHHHHHHHHHHcCCCCCEEEe
Confidence 478999999999999999999864 578999999986432 356788999999997 9999999
Q ss_pred ceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++.+ ....++||||+++++|.+++.. +++..+..++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~~ 166 (330)
T 3nsz_A 97 ADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHE 166 (330)
T ss_dssp EEEEECTTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETT
T ss_pred eeeeccCCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEcCC
Confidence 999987 5678999999999999998853 88899999999999999999 67899999999999999977
Q ss_pred C-ceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 493 M-EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 ~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+ .+||+|||+++........ ....||..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+
T Consensus 167 ~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l 241 (330)
T 3nsz_A 167 HRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQL 241 (330)
T ss_dssp TTEEEECCCTTCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHH
T ss_pred CCEEEEEeCCCceEcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHH
Confidence 6 8999999999876654332 33578999999999877 67899999999999999999999998543221 1111
Q ss_pred HHHHH------------HhhccCCc----------chhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMR------------NVMTSENP----------TRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~------------~~~~~~~~----------~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... ........ ...................+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111 10000000 0000000000001112345788999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.22 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=194.5
Q ss_pred hcCcccc-cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 336 EDGLASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
.+.|++. +.||+|+||.||+|+.. .+++.||||++....... ...+.+|++++.++ +||||++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~~~~h~~i~~ 75 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHI--------------RSRVFREVEMLYQCQGHRNVLE 75 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS-SSCCEEEEEEEECCSSCC--------------HHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeEEecCceecCCceEEEEEEEEc-CCCcEEEEEEEeeCcchh--------------HHHHHHHHHHHHHhcCCCCeee
Confidence 3567774 78999999999999854 578999999986543211 34678899999885 7999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|| |+.+|+||||||+||+++.++
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~ 148 (316)
T 2ac3_A 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFL---HNKGIAHRDLKPENILCEHPN 148 (316)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESCSS
T ss_pred EEEEEeeCCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEEccCC
Confidence 999999999999999999999999999763 4589999999999999999999 677999999999999999877
Q ss_pred c---eEEcccccccccCCCCCc-----ceecccccCccccccccccc-----CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 494 E---ARIADFGLAKAMPDAQTH-----ITTSNVAGTVGYIAPEYHQT-----LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 494 ~---~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
. +||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 6 999999998865432111 11123469999999999875 5588999999999999999999999976
Q ss_pred cccccccc--------hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 561 FFQHTEEM--------SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 561 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ ................ ....... ....+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEF---PDKDWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCCSCSCC----CCHHHHHHHHHHHHHCCCCC---CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccccccccccchhHHHHHHHHHhccCccc---Cchhccc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 43221000 0011111111111100 0000001 1234788999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.61 Aligned_cols=250 Identities=25% Similarity=0.333 Sum_probs=201.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++...... .....+.+.+|++++++++||||++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 80 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLE-----------KEGVEHQLRREIEIQSHLRHPNILRMY 80 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccc-----------hHHHHHHHHHHHHHHhcCCCCCEeeEE
Confidence 468999999999999999999874 57889999998432110 011145788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+.+..++||||+++|+|.+++... ..+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~ 153 (284)
T 2vgo_A 81 NYFHDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGEL 153 (284)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTCCE
T ss_pred EEEEcCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEEcCCCCE
Confidence 9999999999999999999999999763 4589999999999999999999 68899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ... ..
T Consensus 154 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~---~~ 222 (284)
T 2vgo_A 154 KIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH----TET---HR 222 (284)
T ss_dssp EECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHH---HH
T ss_pred EEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH----hHH---HH
Confidence 999999987654432 1345789999999999999999999999999999999999999875321 111 11
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ . +......+.+++.+||+.||++|||++++++
T Consensus 223 ~~~~~~~~-------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 223 RIVNVDLK-------F----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHTTCCC-------C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhccccC-------C----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11111110 0 0011223778999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=328.52 Aligned_cols=252 Identities=22% Similarity=0.336 Sum_probs=203.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|.+.+.||+|+||.||++... .+++.||+|++....... ....+.+.+|+.+++.++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~ 80 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLK-----------PHQREKMSMEISIHRSLAHQHVVGF 80 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCS-----------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccceEEEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccC-----------HHHHHHHHHHHHHHHhCCCCCEeee
Confidence 3468999999999999999999874 578899999985432110 0124578899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~ 153 (294)
T 2rku_A 81 HGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLE 153 (294)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCC
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEcCCCC
Confidence 9999999999999999999999998875 24689999999999999999999 6779999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+++........ .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... .. ..
T Consensus 154 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~---~~ 224 (294)
T 2rku_A 154 VKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KE---TY 224 (294)
T ss_dssp EEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HH---HH
T ss_pred EEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH---HH
Confidence 999999999876543222 2345789999999999998899999999999999999999999875321 11 11
Q ss_pred HHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... .....+ ...+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~------------~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 225 LRIKKNEYSIPKHI------------NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHTTCCCCCTTS------------CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHhhccCCCcccc------------CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111111 111111 123778899999999999999999876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=333.72 Aligned_cols=269 Identities=27% Similarity=0.370 Sum_probs=186.1
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|... .+++.||||++..... ....+++.+|+.++++++||||+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~ 76 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKC-------------QTSMDELLKEIQAMSQCHHPNIV 76 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC-----------------------------CCCCCCCTTBC
T ss_pred ccchhhhhhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhc-------------chhHHHHHHHHHHHhhcCCCCEe
Confidence 445678999999999999999999754 4788999998854321 11145688999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ----GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
++++++...+..++||||+++++|.+++..... ....+++..+..++.|+++||+|| |+.+|+||||||+||+
T Consensus 77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil 153 (303)
T 2vwi_A 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQIHRDVKAGNIL 153 (303)
T ss_dssp CEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEE
T ss_pred eEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCCChhhEE
Confidence 999999999999999999999999999875321 235689999999999999999999 6779999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCc---ceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTH---ITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 564 (633)
++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 154 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 233 (303)
T 2vwi_A 154 LGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM 233 (303)
T ss_dssp ECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred EcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh
Confidence 999999999999999876543211 11234568999999999876 56899999999999999999999999764321
Q ss_pred cccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 565 TEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......... ..........+....... ...+.+++.+||+.||++|||+.|+++
T Consensus 234 ---~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 234 ---KVLMLTLQN-DPPSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ---GHHHHHHTS-SCCCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---hHHHHHhcc-CCCccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111100 000000001111111111 234778889999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=335.14 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=203.6
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
...+|.+.+.||+|+||.||+++.. .+++.||+|++....... ....+.+.+|+.+++.++||||+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~ 106 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLK-----------PHQREKMSMEISIHRSLAHQHVVGF 106 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCS-----------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcC-----------HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3468999999999999999999875 578899999985432110 0124678899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++++|.+++.. ...+++..++.++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~ 179 (335)
T 2owb_A 107 HGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLE 179 (335)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCC
T ss_pred EEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhEEEcCCCC
Confidence 9999999999999999999999999875 24689999999999999999999 6779999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+
T Consensus 180 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~ 253 (335)
T 2owb_A 180 VKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KETYLRI 253 (335)
T ss_dssp EEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHH
T ss_pred EEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----HHHHHHH
Confidence 999999999876543222 2345789999999999998999999999999999999999999875321 1111111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.. ........+ ...+.+++.+||+.||++|||++|+++
T Consensus 254 ~~--~~~~~~~~~------------~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 254 KK--NEYSIPKHI------------NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HH--TCCCCCTTS------------CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hc--CCCCCCccC------------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 111111111 123678899999999999999999876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=350.33 Aligned_cols=248 Identities=15% Similarity=0.160 Sum_probs=188.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHH---HHhhcCCCCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI---NTVGQIRHRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~ni 411 (633)
..+.|++.+.||+|+||.||+|++. .+|+.||||++......... ..+.+.+|+ +++++++||||
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~~l~hpni 138 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSN-----------AIKQMKEEVLRLRLLRGIKNQKQ 138 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTT-----------HHHHHHHHHHGGGGSTTCCSHHH
T ss_pred CCceEEEcceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccchH-----------HHHHHHHHHHHHHhccccCCHHH
Confidence 4577999999999999999999864 47899999998744221111 146788899 55666689999
Q ss_pred cccc-------eeeecCC-----------------ccEEEEecccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHH
Q 006739 412 LPLL-------AHMARPD-----------------CHLLVYEFMKNGSLQDILNDVSQ---GRRELDWLARHKIALGVAC 464 (633)
Q Consensus 412 v~l~-------~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~ 464 (633)
|+++ +++.+++ ..++||||+ +|+|.+++..... ....+++..++.|+.||++
T Consensus 139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~ 217 (377)
T 3byv_A 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217 (377)
T ss_dssp HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHH
Confidence 9998 5555443 278999999 6899999986432 1223556889999999999
Q ss_pred HHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccC-----------
Q 006739 465 GLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL----------- 533 (633)
Q Consensus 465 ~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------- 533 (633)
||+|| |+.+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 218 aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 288 (377)
T 3byv_A 218 LLASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRT 288 (377)
T ss_dssp HHHHH---HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred HHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccc
Confidence 99999 677999999999999999999999999999986433 2234567 999999999887
Q ss_pred CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccC
Q 006739 534 KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVD 613 (633)
Q Consensus 534 ~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~ 613 (633)
.++.++|||||||++|||++|+.||........... .... . ... ...+.+++.+||+.
T Consensus 289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~-------~~~~-~----------~~~----~~~~~~li~~~L~~ 346 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW-------IFRS-C----------KNI----PQPVRALLEGFLRY 346 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG-------GGSS-C----------CCC----CHHHHHHHHHHTCS
T ss_pred cCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh-------hhhh-c----------cCC----CHHHHHHHHHHcCC
Confidence 899999999999999999999999965332111100 0000 0 011 12377899999999
Q ss_pred CCCCCCCHHHHHH
Q 006739 614 SPRERPNSKDVRC 626 (633)
Q Consensus 614 dP~~RPs~~ev~~ 626 (633)
||++|||+.|+++
T Consensus 347 dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 347 PKEDRLLPLQAME 359 (377)
T ss_dssp SGGGCCCHHHHHT
T ss_pred CchhCCCHHHHhh
Confidence 9999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.21 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=197.6
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+.. .+|+.||+|++..... ...+|+++++.++||||+++
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~~------------------~~~~E~~il~~l~hpnIv~l 65 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPR------------------YKNRELDIMKVLDHVNIIKL 65 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCTT------------------SCCHHHHHHTTCCCTTBCCE
T ss_pred ccceEEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCcc------------------hHHHHHHHHHHcCCCCccch
Confidence 4578999999999999999999864 5789999999864321 22368999999999999999
Q ss_pred ceeeecC--------------------------------------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHH
Q 006739 415 LAHMARP--------------------------------------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456 (633)
Q Consensus 415 ~~~~~~~--------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~ 456 (633)
++++... ...++||||++ |+|.+.+.........+++..+.
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~ 144 (383)
T 3eb0_A 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLIS 144 (383)
T ss_dssp EEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHH
T ss_pred hheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHH
Confidence 9998443 33789999997 58888887655556789999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec-CCCceEEcccccccccCCCCCcceecccccCcccccccccccC-C
Q 006739 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-K 534 (633)
Q Consensus 457 ~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 534 (633)
.++.|+++||+|| |+.+|+||||||+||+++ .++.+||+|||+++........ ....||+.|+|||.+.+. .
T Consensus 145 ~i~~qi~~aL~~L---H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~ 218 (383)
T 3eb0_A 145 IYIYQLFRAVGFI---HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATE 218 (383)
T ss_dssp HHHHHHHHHHHHH---HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHH---HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCC
Confidence 9999999999999 688999999999999998 6889999999999876554322 335789999999988764 4
Q ss_pred CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhh---------------hhhhhhcCCHHH
Q 006739 535 FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAI---------------DAKLLENGYEEQ 599 (633)
Q Consensus 535 ~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------d~~~~~~~~~~~ 599 (633)
++.++||||+||++|||++|+.||..... ...+.+.++ ........... ............
T Consensus 219 ~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (383)
T 3eb0_A 219 YTPSIDLWSIGCVFGELILGKPLFSGETS---IDQLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGT 294 (383)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCC
Confidence 89999999999999999999999976322 122222221 11111000000 000000011112
Q ss_pred HHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 600 MLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 600 ~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+.+++.+||+.||++|||+.|+++
T Consensus 295 ~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 295 PSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 234788999999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=332.07 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=204.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..+.|+..+.||+|+||.||+|+.. .+++.||+|++....... ..+.+.+|+.++++++||||+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~i~~~ 85 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAED-------------EIEDIQQEITVLSQCDSPYVTKY 85 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCST-------------THHHHHHHHHHHHHCCCTTBCCE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccHH-------------HHHHHHHHHHHHHhCCCCCEeEE
Confidence 4567999999999999999999864 578999999986543211 14578899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+....++||||+++++|.+++.. ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~ 157 (303)
T 3a7i_A 86 YGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGE 157 (303)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSC
T ss_pred EEEEecCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheEEECCCCC
Confidence 9999999999999999999999999863 4689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+
T Consensus 158 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~ 231 (303)
T 3a7i_A 158 VKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLI 231 (303)
T ss_dssp EEECCCTTCEECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHH
T ss_pred EEEeecccceecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHHHHh
Confidence 999999999876543321 2345789999999999999999999999999999999999999875321 1111111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~ 627 (633)
.. ..... +... . ...+.+++..||+.||++|||+.|+++.
T Consensus 232 ~~---~~~~~------~~~~-~---~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 232 PK---NNPPT------LEGN-Y---SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HH---SCCCC------CCSS-C---CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred hc---CCCCC------Cccc-c---CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11 11100 0011 1 1237788999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=331.50 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=197.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l 414 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++........ ...++.+|+..+..+ +||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~~~~l~~h~~iv~~ 76 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSV------------DEQNALREVYAHAVLGQHSHVVRY 76 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSH------------HHHHHHHHHHHHHHSCSCTTBCCE
T ss_pred cchhhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccH------------HHHHHHHHHHHHHHhCCCCCeeee
Confidence 467999999999999999999864 5789999999876432211 145677889999988 89999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC--
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD-- 492 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~-- 492 (633)
++++.+.+..++||||+++++|.+++.........+++..++.++.|+++||+|| |+.+|+||||||+||+++.+
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~ 153 (289)
T 1x8b_A 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNIFISRTSI 153 (289)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC----
T ss_pred eeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHEEEcCCCC
Confidence 9999999999999999999999999987544346799999999999999999999 67899999999999999844
Q ss_pred -----------------CceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhC
Q 006739 493 -----------------MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMG 554 (633)
Q Consensus 493 -----------------~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg 554 (633)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|||++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 227 (289)
T 1x8b_A 154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227 (289)
T ss_dssp ----------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred CcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence 479999999998765432 23589999999998765 566799999999999999999
Q ss_pred CCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 555 RLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 555 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..|+.... .... + ...... . +... ....+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~------~~~~-~---~~~~~~-~-----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 228 EPLPRNGD------QWHE-I---RQGRLP-R-----IPQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCSSSH------HHHH-H---HTTCCC-C-----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCcchh------HHHH-H---HcCCCC-C-----CCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 98754311 1111 1 111110 0 0011 1233778899999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.37 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=200.5
Q ss_pred hcCcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 412 (633)
.++|++.+.||+|+||.||+++.. ..+++.||||++.......... ....+.+|++++.++ +||||+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~----------~~~~~~~E~~~l~~l~~h~~iv 122 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----------TTEHTRTERQVLEHIRQSPFLV 122 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES----------SGGGCCCHHHHHHHHHTCTTBC
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh----------HHHHHHHHHHHHHHccCCCcee
Confidence 468999999999999999999873 2478999999986432110000 023466788899988 699999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++...+..++||||+++|+|.+++... ..+++..+..++.|+++||+|| |+.+|+||||||+|||++.+
T Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~ 195 (355)
T 1vzo_A 123 TLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSN 195 (355)
T ss_dssp CEEEEEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTT
T ss_pred EEEEEEeeCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCC
Confidence 9999999999999999999999999999763 4589999999999999999999 67799999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
+.+||+|||+++......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 196 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~ 271 (355)
T 1vzo_A 196 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---Q 271 (355)
T ss_dssp SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---H
T ss_pred CcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---H
Confidence 999999999998765432221 234579999999999986 3478899999999999999999999975432222 2
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRCM 627 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~~ 627 (633)
..+.+......... +......+.+++.+||+.||++|| +++|+++.
T Consensus 272 ~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 272 AEISRRILKSEPPY-----------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHHHHCCCCC-----------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHhccCCCC-----------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 22222222211110 111123377899999999999999 89998763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=337.96 Aligned_cols=270 Identities=25% Similarity=0.352 Sum_probs=202.0
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|+.. .+|+.||+|++......... ...+.+|++++++++||||+
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~------------~~~~~~E~~~l~~l~h~~iv 79 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGF------------PITALREIKILQLLKHENVV 79 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSSS------------CHHHHHHHHHHHHCCCTTBC
T ss_pred cccccceeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccccc------------hHHHHHHHHHHHhccCCCcc
Confidence 344578999999999999999999874 57899999998655432111 23567899999999999999
Q ss_pred ccceeeecC--------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 006739 413 PLLAHMARP--------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484 (633)
Q Consensus 413 ~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp 484 (633)
++++++... +..++||||+++ +|.+.+... ...+++..+..++.|++.||+|| |+.+|+||||||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp 152 (351)
T 3mi9_A 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKA 152 (351)
T ss_dssp CEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSG
T ss_pred cHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCH
Confidence 999998763 467899999975 777777542 34699999999999999999999 678999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCc--ceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTH--ITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+||+++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 153 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp GGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876533221 12234578999999998876 45899999999999999999999998763
Q ss_pred ccccccchHHHHHHHhhccCCcch--hhhh-hhhh---------cCCHHH------HHHHHHHHhHhccCCCCCCCCHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTR--AIDA-KLLE---------NGYEEQ------MLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~--~~d~-~~~~---------~~~~~~------~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
.. ......+........... ..+. .... ....+. ...+.+++.+||+.||++|||++|
T Consensus 233 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 233 TE----QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp SH----HHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred Ch----HHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 22 222222322222111110 0000 0000 000111 123778999999999999999999
Q ss_pred HHH
Q 006739 624 VRC 626 (633)
Q Consensus 624 v~~ 626 (633)
+++
T Consensus 309 ~l~ 311 (351)
T 3mi9_A 309 ALN 311 (351)
T ss_dssp HHT
T ss_pred HhC
Confidence 975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.83 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=196.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .++..||+|++........ ....+.+|+.+++.++||||++++
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~hpniv~~~ 102 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTS------------SNSKLLEEVAVLKLLDHPNIMKLY 102 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----C------------TTHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCch------------HHHHHHHHHHHHHhCCCCCCCeEE
Confidence 357999999999999999999874 5789999999875432211 135678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC---
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD--- 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~--- 492 (633)
+++.+....++||||+++|+|.+.+... ..+++..+..++.||++||+|| |+.+|+||||||+||+++..
T Consensus 103 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~ 175 (494)
T 3lij_A 103 DFFEDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLLESKEKD 175 (494)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTT
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEEeCCCCC
Confidence 9999999999999999999999988753 4589999999999999999999 67899999999999999764
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++....... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ..+..
T Consensus 176 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~ 247 (494)
T 3lij_A 176 ALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----QEILR 247 (494)
T ss_dssp CCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred CcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 4599999999987654432 23457999999999886 4699999999999999999999999975321 22222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+. ....... .+. .......+.+++.+||+.||.+|||+.|+++
T Consensus 248 ~i~---~~~~~~~--~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 248 KVE---KGKYTFD--SPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHH---HTCCCCC--SGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH---hCCCCCC--chh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 222 1111100 000 0011233778999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.25 Aligned_cols=252 Identities=29% Similarity=0.418 Sum_probs=197.6
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..+.|++.+.||+|+||.||+|... .+|+.||+|.+..... .+.+.+|+.++++++||||+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~----------------~~~~~~e~~~l~~l~h~~i~~~ 89 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVESD----------------LQEIIKEISIMQQCDSPHVVKY 89 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEET-TTCCEEEEEEEETTSC----------------CHHHHHHHHHHHTCCCTTBCCE
T ss_pred chhhhhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCchHH----------------HHHHHHHHHHHHhCCCCCCccE
Confidence 4578999999999999999999874 5789999999865321 3467889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++...+..++||||+++++|.+++... ...+++..+..++.|++.||.|| |+.+|+|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~ 163 (314)
T 3com_A 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNILLNTEGH 163 (314)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCC
T ss_pred EEEEEeCCEEEEEeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEEECCCCC
Confidence 99999999999999999999999998742 35689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .....
T Consensus 164 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-- 235 (314)
T 3com_A 164 AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRAIF-- 235 (314)
T ss_dssp EEECCCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHH--
T ss_pred EEEeecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHH--
Confidence 999999999876543221 2345689999999999999999999999999999999999999875321 11111
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......... ...+ ......+.+++.+||+.||.+|||+.++++
T Consensus 236 -~~~~~~~~~-~~~~-------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 236 -MIPTNPPPT-FRKP-------ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -HHHHSCCCC-CSSG-------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -HHhcCCCcc-cCCc-------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111111110 0000 011234778999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=339.77 Aligned_cols=269 Identities=25% Similarity=0.309 Sum_probs=195.9
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+.. .+|+.||||++........ .....+.+.+|++++++++||||+++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEA---------KDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred HhcccEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchh---------hhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 3578999999999999999999864 4789999999864332110 01113467889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+.+..++||||+++ +|.+++.. ....+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~ 150 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGV 150 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCC
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEEcCCCC
Confidence 9999999999999999976 88888864 235688899999999999999999 6788999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|||++|..||..... ...+.+.
T Consensus 151 ~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i 225 (346)
T 1ua2_A 151 LKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRI 225 (346)
T ss_dssp EEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred EEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHH
Confidence 999999999876543322 2345789999999998764 578899999999999999999999865321 1222222
Q ss_pred HHHhhccCCcchhhhh----h-h----hhc-----CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDA----K-L----LEN-----GYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~----~-~----~~~-----~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.... .........+. . . ... ........+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 226 FETL-GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHH-CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHc-CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 2211 11100000000 0 0 000 00112245888999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.60 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=199.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+++.||||++....... .....+.+|++++++++||||++++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~ 87 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKN------------KDTSTILREVELLKKLDHPNIMKLF 87 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBC------------SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hcceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccc------------hHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 467999999999999999999864 578999999985321110 1145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec---CC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD---DD 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~---~~ 492 (633)
+++.+....++||||+++|+|.+.+... ..+++..+..++.|++.||+|| |+.+|+||||||+||+++ .+
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~ 160 (486)
T 3mwu_A 88 EILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKD 160 (486)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEESSSSTT
T ss_pred EEEEcCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCC
Confidence 9999999999999999999999988753 4589999999999999999999 678999999999999995 45
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ...+.+
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~ 232 (486)
T 3mwu_A 161 CDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDILK 232 (486)
T ss_dssp CCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH
T ss_pred CCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHH
Confidence 6799999999987655432 234579999999999876 58999999999999999999999986532 122222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+. ........- . +......+.+++.+||+.||.+|||+.++++
T Consensus 233 ~i~---~~~~~~~~~--~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 233 RVE---TGKYAFDLP--Q-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHH---HTCCCSCSG--G-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHH---hCCCCCCCc--c-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 222 111111000 0 0111233778999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.01 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=195.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
...|+..+.||+|+||.||+|++. .+|+.||||++..... ...+|++++++++|||||+++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~~------------------~~~~E~~il~~l~hpniv~l~ 113 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR------------------FKNRELQIMRKLDHCNIVRLR 113 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCTT------------------SCCHHHHHHHTCCCTTBCCEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccch------------------hHHHHHHHHHHcCCCCcccee
Confidence 356899999999999999999875 4789999999854321 234689999999999999999
Q ss_pred eeeecC----C--ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARP----D--CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~----~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++... + ..++||||+++ +|.+.+.........+++..+..++.||++||+|| |+.+|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NILl 189 (420)
T 1j1b_A 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLL 189 (420)
T ss_dssp EEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEE
T ss_pred eEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEEE
Confidence 988542 1 35689999975 77777765444567899999999999999999999 67899999999999999
Q ss_pred cCC-CceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 490 DDD-MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 490 ~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
+.+ +.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... .
T Consensus 190 ~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~ 263 (420)
T 1j1b_A 190 DPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---V 263 (420)
T ss_dssp ETTTTEEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H
T ss_pred eCCCCeEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---H
Confidence 965 56899999999876544322 335789999999998764 789999999999999999999999976322 2
Q ss_pred chHHHHHHHhhccCCcc----------hhhhhhhhh-----cCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 568 MSLVKWMRNVMTSENPT----------RAIDAKLLE-----NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~----------~~~d~~~~~-----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+.++.. ...... +...+.+.. .........+.+++.+||+.||++|||+.|+++
T Consensus 264 ~~l~~i~~~l-g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 264 DQLVEIIKVL-GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHHHHH-CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHh-CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 2222322211 100000 000000000 000111235788999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.16 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=199.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|.+.+.||+|+||.||+++.. .+|+.||+|++...... ....+.+|+.++++++||||++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~ 72 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAF--------------RDSSLENEIAVLKKIKHENIVTLE 72 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC--------------------HHHHHHHHHHHCCCTTBCCEE
T ss_pred hccceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEeccccc--------------chHHHHHHHHHHHhCCCCCeeehh
Confidence 467899999999999999999864 57899999998654311 134678899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe---cCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDD 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---~~~ 492 (633)
+++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||+|| |+.+|+||||||+||++ +++
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NIl~~~~~~~ 145 (304)
T 2jam_A 73 DIYESTTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEEN 145 (304)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGCEESSSSTT
T ss_pred hhcccCCEEEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEecCCCC
Confidence 9999999999999999999999998752 4589999999999999999999 67899999999999999 788
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ..+.+
T Consensus 146 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~ 217 (304)
T 2jam_A 146 SKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKLFE 217 (304)
T ss_dssp CCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHH
T ss_pred CCEEEccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHH
Confidence 899999999987654321 1234689999999999999999999999999999999999999865321 12222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+. ...... .... .......+.+++.+||+.||++|||++|+++
T Consensus 218 ~i~---~~~~~~---~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 218 KIK---EGYYEF---ESPF----WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHH---HCCCCC---CTTT----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHH---cCCCCC---Cccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 121 111100 0000 0111234788999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=350.59 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=200.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.++||+|+||.||+|+.. .+++.||+|++............ .....+...+.+.+|+.++++++||||++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSD-DNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC-----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccceEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccccc-cchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 478999999999999999999875 57899999998765432110000 0011112256789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC--
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-- 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~-- 493 (633)
+++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|| |+.+|+||||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEEEecCCCC
Confidence 9999999999999999999999998753 4599999999999999999999 678999999999999999776
Q ss_pred -ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 494 -EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 -~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
.+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ..+..
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~ 257 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDIIK 257 (504)
T ss_dssp SSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred ccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 699999999987765432 234579999999999874 689999999999999999999999975321 22222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+ ........ ...... ....+.+++.+||+.||.+|||++|+++
T Consensus 258 ~i---~~~~~~~~---~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KV---EKGKYYFD---FNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HH---HHCCCCCC---HHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH---HcCCCCCC---ccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22 22111110 000011 1234788999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=337.72 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=185.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~ 413 (633)
...+|++.+.||+|+||.||+|++. .+++.||+|++..... ...+.+.+|+.++.++. ||||++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNEE--------------EKNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESSH--------------HHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred cCceEEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCch--------------HHHHHHHHHHHHHHHhccCCChhh
Confidence 3468999999999999999999864 5789999998854321 11456888999999996 999999
Q ss_pred cceeee--------cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCC
Q 006739 414 LLAHMA--------RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR--IIHRDLK 483 (633)
Q Consensus 414 l~~~~~--------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~Dik 483 (633)
+++++. .....++||||++ |+|.+++..... ...+++..++.++.|++.||+|| |+.+ |+|||||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~ivH~Dik 165 (337)
T 3ll6_A 91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHM---HRQKPPIIHRDLK 165 (337)
T ss_dssp EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCCCCC
T ss_pred ccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHH---HhCCCCEEEccCC
Confidence 999984 3344789999995 799999876443 45699999999999999999999 5667 9999999
Q ss_pred CCCeEecCCCceEEcccccccccCCCCCcc----------eecccccCccccccccc---ccCCCCCccchHHHHHHHHH
Q 006739 484 PANVLLDDDMEARIADFGLAKAMPDAQTHI----------TTSNVAGTVGYIAPEYH---QTLKFTDKCDIYSFGVLLAV 550 (633)
Q Consensus 484 p~Nill~~~~~~kl~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~e 550 (633)
|+||+++.++.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++||
T Consensus 166 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~e 245 (337)
T 3ll6_A 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245 (337)
T ss_dssp GGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHH
T ss_pred cccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHH
Confidence 999999999999999999998765432211 11134589999999998 56678899999999999999
Q ss_pred HHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 551 LVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 551 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
|++|+.||...... . ........ .... .. ...+.+++..||+.||++|||+.|+++.|++
T Consensus 246 l~~g~~p~~~~~~~----~---~~~~~~~~-~~~~--------~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 246 LCFRQHPFEDGAKL----R---IVNGKYSI-PPHD--------TQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp HHHSSCCC-------------------CCC-CTTC--------CS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCCCCCcchhHH----H---hhcCcccC-Cccc--------cc----chHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 99999998653211 1 11111100 0000 00 1126788999999999999999999999987
Q ss_pred hh
Q 006739 631 IR 632 (633)
Q Consensus 631 ~~ 632 (633)
+.
T Consensus 306 ~~ 307 (337)
T 3ll6_A 306 IA 307 (337)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.97 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=203.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+|+.||||++......... ....+.+|+.++++++||||++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~ 92 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKT-----------DKESLLREVQLLKQLDHPNIMKLY 92 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCBSS-----------CHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccch-----------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 467899999999999999999864 57899999998654322111 045688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe---cCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDD 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill---~~~ 492 (633)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||++ +.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~ 165 (484)
T 3nyv_A 93 EFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLLESKSKD 165 (484)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTT
T ss_pred EEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEecCCCC
Confidence 999999999999999999999998875 35699999999999999999999 67899999999999999 567
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ...+..
T Consensus 166 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~ 237 (484)
T 3nyv_A 166 ANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN----EYDILK 237 (484)
T ss_dssp CCEEECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH
T ss_pred CcEEEEeeeeeEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC----HHHHHH
Confidence 89999999999887654322 33579999999999876 69999999999999999999999997532 222222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.. ....... + .+......+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~i~~---~~~~~~~--~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 238 KVEK---GKYTFEL--P-----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHH---CCCCCCS--G-----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHc---CCCCCCC--c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 2221 1111100 0 00111234778999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=323.67 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=193.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+|+.||+|++..... ......+.+.+|+.+++.++||||++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 77 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKI-----------RSLDVVGKIKREIQNLKLFRHPHIIKLY 77 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eccEEEEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccc-----------cchhHHHHHHHHHHHHhcCCCCCEeEEE
Confidence 468999999999999999999874 4789999999843210 0011245788999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++...+..++||||+++++|.+++... ..+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.+
T Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~ 150 (276)
T 2h6d_A 78 QVISTPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVLLDAHMNA 150 (276)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEEECTTSCE
T ss_pred EEEecCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEEECCCCCE
Confidence 9999999999999999999999999763 4589999999999999999999 56789999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
||+|||++......... ....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... .....+.+
T Consensus 151 ~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~ 223 (276)
T 2h6d_A 151 KIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH----VPTLFKKI 223 (276)
T ss_dssp EECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHH
T ss_pred EEeecccccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHh
Confidence 99999999876553321 23568999999999988765 579999999999999999999986532 11222211
Q ss_pred HHhhccCC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 575 RNVMTSEN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 575 ~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. .... .... ....+.+++.+||+.||++|||+.|+++
T Consensus 224 ~---~~~~~~~~~------------~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 224 R---GGVFYIPEY------------LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp H---HCCCCCCTT------------SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h---cCcccCchh------------cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1 1111 1111 1123778899999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.78 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=182.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|... .+|+.||||++....... ...+.+.+|+++++.++||||++++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~~~ 94 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSI------------IHAKRTYRELRLLKHMKHENVIGLL 94 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET-TTTEEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred CCceEEeeEEeecCCeEEEEEEEC-CCCCEEEEEEeCccccCH------------HHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 478999999999999999999864 578999999986543211 1145678999999999999999999
Q ss_pred eeeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++... ...++|+||+ +++|.+++.. ..+++..+..++.||++||+|| |+.+|+||||||+||++
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll 165 (367)
T 2fst_X 95 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAV 165 (367)
T ss_dssp EEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEE
T ss_pred EEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHhhEEE
Confidence 998654 5679999999 7899998863 4699999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... .
T Consensus 166 ~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~ 236 (367)
T 2fst_X 166 NEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----I 236 (367)
T ss_dssp CTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----H
T ss_pred CCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 99999999999999875432 234578999999999877 6789999999999999999999999975322 1
Q ss_pred hHHHHHHHhhccCCcchhhh-----------hhhh-------hcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAID-----------AKLL-------ENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d-----------~~~~-------~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+....+... .+.+. ..+. ..........+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 237 DQLKLILRLVGTPG-AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHHHHCSCC-HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCC-HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 22222222211110 00000 0000 0000011234788999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=336.36 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=198.0
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|.+. ..+|+|++......... .+.+.+|+.++++++||||+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv 92 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQ------------LKAFKREVMAYRQTRHENVV 92 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCC------------CCCCCTTGGGGTTCCCTTBC
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHH------------HHHHHHHHHHHhcCCCCCEe
Confidence 334578999999999999999999863 24999998754322111 23567899999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|+++||+|| |+.+|+||||||+||+++ +
T Consensus 93 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl~~-~ 165 (319)
T 2y4i_B 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYD-N 165 (319)
T ss_dssp CCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEEEC--
T ss_pred EEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEEEe-C
Confidence 999999999999999999999999999964 234689999999999999999999 677999999999999998 6
Q ss_pred CceEEcccccccccCCCCC---cceecccccCccccccccccc---------CCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 493 MEARIADFGLAKAMPDAQT---HITTSNVAGTVGYIAPEYHQT---------LKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
+.+||+|||+++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 166 GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp -CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 7999999999876542211 111233468999999998864 3578899999999999999999999875
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
... .... ........+. ... ... ...+.+++..||+.||++|||+.+++++|++++
T Consensus 246 ~~~----~~~~---~~~~~~~~~~-~~~-----~~~---~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 246 QPA----EAII---WQMGTGMKPN-LSQ-----IGM---GKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp CCH----HHHH---HHHHTTCCCC-CCC-----SSC---CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CCH----HHHH---HHhccCCCCC-CCc-----CCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 321 1111 1111111111 000 001 122778999999999999999999999999875
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=323.65 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=197.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|.....||+|+||.||+|... .+++.||+|.+...... ..+.+.+|+.+++.++||||++++
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~iv~~~ 85 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDSR--------------YSQPLHEEIALHKHLKHKNIVQYL 85 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC-----------------HHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEEC-CCCeEEEEEEccCCchH--------------HHHHHHHHHHHHHhCCCCCEeeEe
Confidence 345666679999999999999864 57899999998654321 145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC-CCc
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-DME 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~-~~~ 494 (633)
+++...+..++||||+++++|.+++.... ....+++..+..++.|+++||+|| |+.+|+||||||+||+++. ++.
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~ 161 (295)
T 2clq_A 86 GSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGV 161 (295)
T ss_dssp EEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTCC
T ss_pred eEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEEEECCCCC
Confidence 99999999999999999999999997632 234678999999999999999999 6789999999999999987 899
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCC--CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK--FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||....... ...
T Consensus 162 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~-- 235 (295)
T 2clq_A 162 LKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAM-- 235 (295)
T ss_dssp EEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHH--
T ss_pred EEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHH--
Confidence 99999999987654322 123457899999999987643 7889999999999999999999997532211 111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... .+ +......+.+++.+||+.||++||++.|+++
T Consensus 236 -~~~~~~~~~~------~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 236 -FKVGMFKVHP------EI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -HHHHHHCCCC------CC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -Hhhccccccc------cc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111100 00 1111234778899999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=332.68 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=199.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+++.||+|++...... ...+.+.+|++++.+++||||++++
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~ 91 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQ-------------TYCQRTLREIKILLRFRHENIIGIN 91 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCH-------------HHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCc-------------HHHHHHHHHHHHHHhcCCCCCccce
Confidence 468999999999999999999864 57899999998643211 1145788999999999999999999
Q ss_pred eeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++... ...++||||++ |+|.+++.. ..+++..+..++.|++.||+|| |+.+|+||||||+||+++
T Consensus 92 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~ 162 (364)
T 3qyz_A 92 DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLN 162 (364)
T ss_dssp EEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEC
T ss_pred eEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChHhEEEC
Confidence 998654 36799999997 599998864 3589999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcc-eecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 491 DDMEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--- 239 (364)
T 3qyz_A 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--- 239 (364)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---
T ss_pred CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---
Confidence 99999999999998765432211 1234579999999998654 458999999999999999999999997643222
Q ss_pred hHHHHHHHhhccCCcch---------------------hhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTR---------------------AIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~---------------------~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....+........... .-..... +.....+.+++.+||+.||++|||+.|+++
T Consensus 240 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 240 -QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF----PNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp -HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhC----CCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2122211111111000 0000000 111234788999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=361.05 Aligned_cols=247 Identities=25% Similarity=0.306 Sum_probs=199.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
..++|++.+.||+|+||.||+|+.. .+++.||||++.+... ........+..|..++..+ +||||++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~-----------~~~~~~~~~~~E~~~l~~~~~~~~i~~ 406 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVV-----------IQDDDVECTMVEKRVLALPGKPPFLTQ 406 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHH-----------HHTTTTHHHHHHHHHHTCTTCCTTBCC
T ss_pred cccceEEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEecccc-----------ccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence 3478999999999999999999875 5788999999853211 0111245677889999887 6999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+.+..|+||||+++|+|.+++... ..+++..+..++.||+.||+|| |+.+|+||||||+|||++.++
T Consensus 407 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NILl~~~g 479 (674)
T 3pfq_A 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEG 479 (674)
T ss_dssp EEEECBCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTEEECSSS
T ss_pred EEEEEEeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhEEEcCCC
Confidence 999999999999999999999999999863 4599999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+
T Consensus 480 ~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~----~~~--- 550 (674)
T 3pfq_A 480 HIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DEL--- 550 (674)
T ss_dssp CEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH---
T ss_pred cEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH----HHH---
Confidence 999999999986443322 22456899999999999999999999999999999999999999975321 222
Q ss_pred HHHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 574 MRNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 574 ~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
...+.... ..+.. ....+.+++..||+.||++||++
T Consensus 551 ~~~i~~~~~~~p~~------------~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 551 FQSIMEHNVAYPKS------------MSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHHHSSCCCCCTT------------SCHHHHHHHHHHSCSSSTTCTTC
T ss_pred HHHHHhCCCCCCcc------------CCHHHHHHHHHHccCCHHHCCCC
Confidence 22222221 11111 12237889999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.91 Aligned_cols=199 Identities=25% Similarity=0.313 Sum_probs=168.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC------CCC
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI------RHR 409 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~ 409 (633)
..+|++.+.||+|+||.||+|... .+++.||||++..... ..+++.+|+++++.+ +|+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~~~~~~ 159 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNEKR---------------FHRQAAEEIRILEHLRKQDKDNTM 159 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSCHH---------------HHHHHHHHHHHHHHHHTTCTTSCS
T ss_pred cCcEEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCccc---------------hHHHHHHHHHHHHHHhhccccCCc
Confidence 457999999999999999999865 5789999999854211 123455566666555 678
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
||+++++++......++||||++ ++|.+++.... ...+++..+..++.||++||+|| |+.+|+||||||+|||+
T Consensus 160 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NILl 233 (429)
T 3kvw_A 160 NVIHMLENFTFRNHICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILL 233 (429)
T ss_dssp CBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCCSGGGEEE
T ss_pred CEEEEEeecccCCeEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEE
Confidence 99999999999999999999995 69999987632 34589999999999999999999 56799999999999999
Q ss_pred cCCCc--eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 490 DDDME--ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 490 ~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+.++. +||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 234 ~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 234 KQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99887 9999999997654432 2357899999999999999999999999999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=322.80 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=204.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.++|++.+.||+|+||.||+|... .+|+.||||++......... ........+.+.+|++++++++ ||||+++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFS-----AEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCC-----HHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhccceeeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccC-----HHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 478999999999999999999874 57899999998655421111 1111233567889999999996 9999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++......++||||+++++|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMN 162 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCC
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEcCCCc
Confidence 9999999999999999999999999975 34689999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccc------cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ------TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+||+|||++......... ....||+.|+|||++. ...++.++||||||+++|||++|+.||..... .
T Consensus 163 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~ 235 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----M 235 (298)
T ss_dssp EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred EEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----H
Confidence 999999999876554322 3356899999999885 45688999999999999999999999865321 1
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+ ........ .+ ........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~---~~~~~~~~--~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 LMLRMI---MSGNYQFG--SP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHH---HHTCCCCC--TT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHH---hcCCcccC--cc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 121111 11111100 00 00111234788999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.08 Aligned_cols=256 Identities=19% Similarity=0.241 Sum_probs=197.7
Q ss_pred hcCcccc-cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccc
Q 006739 336 EDGLASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLP 413 (633)
Q Consensus 336 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~ 413 (633)
.+.|.+. +.||+|+||.||+|+.. .+++.||+|++........ ....+.+|+.++.+++ ||||++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQD------------CRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTEE------------CHHHHHHHHHHHHHTTTCTTBCC
T ss_pred hhEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcchH------------HHHHHHHHHHHHHhccCCCCEEE
Confidence 3456666 88999999999999864 5789999999865432211 1356788999999985 699999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC--
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-- 491 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~-- 491 (633)
+++++.+.+..++||||+++|+|.+++... ....+++..++.++.|++.||+|| |+.+|+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 94 LHEVYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESCBT
T ss_pred EEEEEEeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHEEEecCC
Confidence 999999999999999999999999988542 246699999999999999999999 6789999999999999998
Q ss_pred -CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 492 -DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~ 241 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN----QET 241 (327)
T ss_dssp TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH
T ss_pred CCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHH
Confidence 78999999999987754332 1335799999999999999999999999999999999999999865322 111
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+....... .. .........+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~i~~~~~~~-~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 242 YLNISQVNVDY-SE---------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHHTCCCC-CT---------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHhccccc-Cc---------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 11111111110 00 001112234778999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.02 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=190.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+++.||||++....... ...+.+.+|+.+++.++||||++++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~ 90 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIIGLL 90 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheeEeeeeEecCCEEEEEEEEC-CCCceEEEEEeccccCCh------------HHHHHHHHHHHHHHhcCCCCccceE
Confidence 468999999999999999999864 578999999986543211 1145678999999999999999999
Q ss_pred eeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++...+ ..++||||+++ +|.+.+. ..+++..+..++.|++.||+|| |+.+|+||||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl~ 160 (371)
T 2xrw_A 91 NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVV 160 (371)
T ss_dssp EEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred EeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEE
Confidence 9997655 67999999975 7888775 2488999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..
T Consensus 161 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~ 234 (371)
T 2xrw_A 161 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQ 234 (371)
T ss_dssp CTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HH
T ss_pred cCCCCEEEEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HH
Confidence 9999999999999987654321 23457899999999999999999999999999999999999999753221 11
Q ss_pred HHHHHHHhhccC--------------------Cc-----chhhhhhhhhcC---CHHHHHHHHHHHhHhccCCCCCCCCH
Q 006739 570 LVKWMRNVMTSE--------------------NP-----TRAIDAKLLENG---YEEQMLLVLKIACFCTVDSPRERPNS 621 (633)
Q Consensus 570 ~~~~~~~~~~~~--------------------~~-----~~~~d~~~~~~~---~~~~~~~~~~l~~~cl~~dP~~RPs~ 621 (633)
+.+.+. ..... .. ............ .......+.+++.+||+.||++|||+
T Consensus 235 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 313 (371)
T 2xrw_A 235 WNKVIE-QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313 (371)
T ss_dssp HHHHHC--CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred HHHHHH-HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH
Confidence 111110 00000 00 000000000000 11224568899999999999999999
Q ss_pred HHHHH
Q 006739 622 KDVRC 626 (633)
Q Consensus 622 ~ev~~ 626 (633)
+|+++
T Consensus 314 ~e~l~ 318 (371)
T 2xrw_A 314 DEALQ 318 (371)
T ss_dssp HHHHH
T ss_pred HHHhC
Confidence 99986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.42 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=196.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++.......... ........+.+|++++++++||||++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 81 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSA------READPALNVETEIEILKKLNHPCIIKIK 81 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhccc------ccchhhhhHHHHHHHHHhCCCCCCceEe
Confidence 467999999999999999999865 578999999986543211100 0011234688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc-
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME- 494 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~- 494 (633)
+++...+ .++||||+++++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSSS
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEecCCCC
Confidence 9987655 8999999999999998864 45689999999999999999999 6789999999999999987664
Q ss_pred --eEEcccccccccCCCCCcceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 495 --ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 495 --~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+||+|||+++....... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~ 227 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ---VS 227 (322)
T ss_dssp CCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS---SC
T ss_pred CeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH---HH
Confidence 99999999987654321 12356899999999874 567889999999999999999999999754321 12
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+...+...... . .+...... ...+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~--~----~~~~~~~~----~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 LKDQITSGKYN--F----IPEVWAEV----SEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHTCCC--C----CHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCccc--c----Cchhhhhc----CHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 22222211100 0 01111111 234788999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=327.31 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=197.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||++... .+++.||+|++...... ........+.+|++++++++||||+++++
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 73 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDS-ETLCRRAVKILKKKKLR----------RIPNGEANVKKEIQLLRRLRHKNVIQLVD 73 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBT-TTCCEEEEEEECHHHHH----------HSTTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cceeEeeEEecCCCeEEEEEEEC-CCCcEEEEEEecccccc----------ccchhHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 67999999999999999999864 57899999998532110 00112567899999999999999999999
Q ss_pred eee--cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 417 HMA--RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 417 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++. +....++||||++++ |.+++.... ...+++..+..++.|+++||+|| |+.+|+||||||+||+++.++.
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NIl~~~~~~ 147 (305)
T 2wtk_C 74 VLYNEEKQKMYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGGT 147 (305)
T ss_dssp EEECC---CEEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCC
T ss_pred EEEcCCCCeEEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEcCCCc
Confidence 984 456789999999876 777776532 45799999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCC--CCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF--TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+||+|||++................||+.|+|||++.+... +.++||||||+++|||++|+.||.... ....
T Consensus 148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~-- 221 (305)
T 2wtk_C 148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYKL-- 221 (305)
T ss_dssp EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHH--
T ss_pred EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHHH--
Confidence 99999999987765433333345679999999999876443 679999999999999999999987532 1111
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... .... ....+.+++.+||+.||++|||++|+++
T Consensus 222 -~~~i~~~~~~-------~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 222 -FENIGKGSYA-------IPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -HHHHHHCCCC-------CCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -HHHHhcCCCC-------CCCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2211111110 0011 1223778899999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.45 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=196.6
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+..+.|++.+.||+|+||.||+|+.. .+++.||+|++...... ..+.+.+|+++++.++||||++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~ 80 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEE--------------ELEDYIVEIEILATCDHPYIVK 80 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC----C--------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccceeecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCCHH--------------HHHHHHHHHHHHhcCCCCCEee
Confidence 34578999999999999999999875 46899999998543211 1457888999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++...+..++||||+++++|.+++... ...+++..+..++.|+++||.|| |+.+|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~ 154 (302)
T 2j7t_A 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEG 154 (302)
T ss_dssp EEEEEECC-CEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTS
T ss_pred eeeeeeeCCeEEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEECCCC
Confidence 999999999999999999999999998753 34589999999999999999999 677999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCccccccccc-----ccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH-----QTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
.+||+|||++........ ......||+.|+|||++ .+..++.++||||||+++|||++|+.||..... .
T Consensus 155 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~ 228 (302)
T 2j7t_A 155 DIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----M 228 (302)
T ss_dssp CEEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----H
T ss_pred CEEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----H
Confidence 999999998764321110 11234689999999988 466789999999999999999999999875322 1
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.................. . ....+.+++.+||+.||++|||+.++++
T Consensus 229 ---~~~~~~~~~~~~~~~~~~-----~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 229 ---RVLLKIAKSDPPTLLTPS-----K---WSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---HHHHHHHHSCCCCCSSGG-----G---SCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---HHHHHHhccCCcccCCcc-----c---cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111111111111110010 1 1223778999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=338.08 Aligned_cols=263 Identities=21% Similarity=0.225 Sum_probs=200.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--------
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-------- 407 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-------- 407 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++.... ...+.+.+|+++++.++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~~~~~~~~~ 99 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSAE---------------HYTETALDEIRLLKSVRNSDPNDPN 99 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred CCeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecCC---------------cchHHHHHHHHHHHHHhhcCCCCCC
Confidence 367999999999999999999864 578999999985321 11456778898888885
Q ss_pred CCcccccceeee----cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCC
Q 006739 408 HRNLLPLLAHMA----RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNP-RIIHRDL 482 (633)
Q Consensus 408 h~niv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~Di 482 (633)
|+||+++++++. .....++||||+ +++|.+.+... ....+++..++.++.||++||+|| |++ +|+||||
T Consensus 100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~l---H~~~givHrDi 173 (397)
T 1wak_A 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDI 173 (397)
T ss_dssp GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECCCC
T ss_pred cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCC
Confidence 788999999987 556789999999 56676666542 235699999999999999999999 566 9999999
Q ss_pred CCCCeEecCCC-------------------------------------------------ceEEcccccccccCCCCCcc
Q 006739 483 KPANVLLDDDM-------------------------------------------------EARIADFGLAKAMPDAQTHI 513 (633)
Q Consensus 483 kp~Nill~~~~-------------------------------------------------~~kl~DfG~a~~~~~~~~~~ 513 (633)
||+|||++.++ .+||+|||+++......
T Consensus 174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~--- 250 (397)
T 1wak_A 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--- 250 (397)
T ss_dssp SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS---
T ss_pred CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC---
Confidence 99999999775 79999999998765432
Q ss_pred eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc--cchHHHHHHHhhccCCcchhhhh--
Q 006739 514 TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE--EMSLVKWMRNVMTSENPTRAIDA-- 589 (633)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~-- 589 (633)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+....... +...+..
T Consensus 251 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~ 327 (397)
T 1wak_A 251 --TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKV-PRKLIVAGK 327 (397)
T ss_dssp --CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSC-CHHHHHHCT
T ss_pred --ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCC-ChHHhhccc
Confidence 335789999999999999999999999999999999999999976433221 111222222222111 1110000
Q ss_pred -------------------------hh--hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 590 -------------------------KL--LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 590 -------------------------~~--~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+ ...........+.+++.+||+.||++|||++|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 01224556677899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.92 Aligned_cols=258 Identities=24% Similarity=0.331 Sum_probs=194.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|...+.||+|+||.||+|... .+|+.||+|++....... ...+.+.+|+.+++.++||||++++
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~ 107 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSE------------IFAKRAYRELLLLKHMQHENVIGLL 107 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred cccEEEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccch------------hHHHHHHHHHHHHHhcCCCCchhhh
Confidence 468999999999999999999864 579999999986543221 1146788999999999999999999
Q ss_pred eeeecCCcc------EEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPDCH------LLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++...+.. ++||||++ ++|.+++. ..+++..+..++.|++.||+|| |+.+|+||||||+||++
T Consensus 108 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll 177 (371)
T 4exu_A 108 DVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAV 177 (371)
T ss_dssp EEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred hheeccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCcCHHHeEE
Confidence 999877655 99999997 58888763 3489999999999999999999 67799999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 178 ~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~ 249 (371)
T 4exu_A 178 NEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---D 249 (371)
T ss_dssp CTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---H
T ss_pred CCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---H
Confidence 99999999999999865432 234578999999999887 77899999999999999999999999753221 1
Q ss_pred hHHHHHHHhhccCCcchhhh-----------hhhhh-------cCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAID-----------AKLLE-------NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d-----------~~~~~-------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..... ..... ..+... ..+.. ...+.....+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~i~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 250 QLTQILK-VTGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHH-HHCCC-CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHH-HhCCC-cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1111111 11100 000000 00000 000111245788999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=333.22 Aligned_cols=268 Identities=20% Similarity=0.263 Sum_probs=189.7
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|++.+.||+|+||.||+|+.. .+|+.||||++...... ...+.+|++.+..++||||+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~---------------~~~~~~~~~~l~~l~h~niv 82 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQDPRF---------------RNRELQIMQDLAVLHHPNIV 82 (360)
T ss_dssp HHHHTTEEEC----------CEEEEET-TTCCEEEEEEEECCTTC---------------CCHHHHHHHHHHHHCCTTBC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecCccc---------------cHHHHHHHHHHHhcCCCCcc
Confidence 445689999999999999999999874 57899999988654321 12345677778888999999
Q ss_pred ccceeeecCCc-------cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 006739 413 PLLAHMARPDC-------HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485 (633)
Q Consensus 413 ~l~~~~~~~~~-------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~ 485 (633)
++++++..... .++||||+++ +|.+.+.........+++..+..++.|++.||.||| .|+.+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~ 160 (360)
T 3e3p_A 83 QLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPH 160 (360)
T ss_dssp CEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGG
T ss_pred cHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHH
Confidence 99999865433 7899999976 666655544445677999999999999999999994 23999999999999
Q ss_pred CeEecC-CCceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCccccc
Q 006739 486 NVLLDD-DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 486 Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
||+++. ++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 161 NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 161 NVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp GEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 999996 899999999999877654322 345789999999998664 489999999999999999999999976332
Q ss_pred ccccchHHHHHHHhhccCCcchhhh-------------------hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHH
Q 006739 564 HTEEMSLVKWMRNVMTSENPTRAID-------------------AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~d-------------------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev 624 (633)
. ..+...++. .... ....+. ..............+.+++.+||+.||++|||+.|+
T Consensus 238 ~---~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 312 (360)
T 3e3p_A 238 A---GQLHEIVRV-LGCP-SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312 (360)
T ss_dssp H---HHHHHHHHH-HCCC-CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred H---HHHHHHHHH-cCCC-CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence 1 112222211 1100 000000 000111111134568899999999999999999999
Q ss_pred HH
Q 006739 625 RC 626 (633)
Q Consensus 625 ~~ 626 (633)
++
T Consensus 313 l~ 314 (360)
T 3e3p_A 313 LC 314 (360)
T ss_dssp TT
T ss_pred hc
Confidence 75
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=329.41 Aligned_cols=266 Identities=19% Similarity=0.300 Sum_probs=203.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC------
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR------ 409 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------ 409 (633)
.++|++.+.||+|+||.||+|.....+++.||||++.... ...+.+.+|+++++.++|+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~~~~ 77 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---------------RYCEAARSEIQVLEHLNTTDPNSTF 77 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---------------HHHHHHHHHHHHHHHHHHHCTTCTT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---------------chhHHHHHHHHHHHHhhhcCCCCce
Confidence 3689999999999999999998755688999999985321 1134567788888777655
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++++++++...+..++||||+ +++|.+++.... ...+++..+..++.|+++||+|| |+.+|+||||||+||++
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~ 151 (339)
T 1z57_A 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILF 151 (339)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred eeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEE
Confidence 5999999999999999999999 889999997532 34689999999999999999999 67899999999999999
Q ss_pred cC-------------------CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHH
Q 006739 490 DD-------------------DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAV 550 (633)
Q Consensus 490 ~~-------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~e 550 (633)
+. ++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 226 (339)
T 1z57_A 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226 (339)
T ss_dssp SCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred eccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHH
Confidence 87 6689999999998754432 34578999999999999999999999999999999
Q ss_pred HHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhh-------------------------------hhhcCCHHH
Q 006739 551 LVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAK-------------------------------LLENGYEEQ 599 (633)
Q Consensus 551 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-------------------------------~~~~~~~~~ 599 (633)
|++|+.||..... ......+...... .+....... .........
T Consensus 227 l~~g~~pf~~~~~----~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (339)
T 1z57_A 227 YYLGFTVFPTHDS----KEHLAMMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301 (339)
T ss_dssp HHHSSCSCCCSCH----HHHHHHHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred HHhCCCCCCCCCh----HHHHHHHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhh
Confidence 9999999975322 1122222222111 111000000 000112334
Q ss_pred HHHHHHHHhHhccCCCCCCCCHHHHHHH--HHhhh
Q 006739 600 MLLVLKIACFCTVDSPRERPNSKDVRCM--LSQIR 632 (633)
Q Consensus 600 ~~~~~~l~~~cl~~dP~~RPs~~ev~~~--l~~~~ 632 (633)
...+.+++.+||+.||++|||+.|+++. +++++
T Consensus 302 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 5668899999999999999999999853 45443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=329.12 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=194.1
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNL 411 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni 411 (633)
....+.|++.+.||+|+||.||+|++. .+++.||+|++...... ...+.+|+.+++++ +||||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~~h~~i 83 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVTGDE---------------EEEIKQEINMLKKYSHHRNI 83 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSST---------------THHHHHHHHHHHHHCCSTTB
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecCccc---------------HHHHHHHHHHHHhccCCCCe
Confidence 345678999999999999999999874 47899999998654321 34677899999998 79999
Q ss_pred cccceeeec------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 006739 412 LPLLAHMAR------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485 (633)
Q Consensus 412 v~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~ 485 (633)
+++++++.. .+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|| |+.+|+||||||+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~ 158 (326)
T 2x7f_A 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQ 158 (326)
T ss_dssp CCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGG
T ss_pred eeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCcHH
Confidence 999999976 457899999999999999998632 35689999999999999999999 6779999999999
Q ss_pred CeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcc
Q 006739 486 NVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDD 560 (633)
Q Consensus 486 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 560 (633)
||+++.++.+||+|||++......... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp GEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred HEEEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999998876543211 13356899999999987 56789999999999999999999999865
Q ss_pred cccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 561 FFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ...... ....... ... .... ...+.+++.+||+.||++||++.++++
T Consensus 237 ~~~----~~~~~~---~~~~~~~-~~~-----~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 237 MHP----MRALFL---IPRNPAP-RLK-----SKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCH----HHHHHH---HHHSCCC-CCS-----CSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcH----HHHHHH---hhcCccc-cCC-----cccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 321 111111 1111111 000 1111 124778889999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=342.82 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=192.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
..+|+..+.||+|+||.||+|++. .+..||+|++..... ...+|+++++.++||||++++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~~------------------~~~~E~~il~~l~h~niv~l~ 98 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDKR------------------FKNRELQIMRIVKHPNVVDLK 98 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCTT------------------SCCHHHHHHHTCCCTTBCCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCcc------------------hHHHHHHHHHhCCCCCcceEE
Confidence 457999999999999999999875 455699998854321 123689999999999999999
Q ss_pred eeeecCCc------cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPDC------HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++..... .++||||++++ +.+.+.........+++..+..++.|+++||+|| |+.+|+||||||+|||+
T Consensus 99 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill 174 (394)
T 4e7w_A 99 AFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLLL 174 (394)
T ss_dssp EEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred EEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEE
Confidence 99855433 78999999774 4444433333456799999999999999999999 67899999999999999
Q ss_pred c-CCCceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 490 D-DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 490 ~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
+ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+... .
T Consensus 175 ~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~ 248 (394)
T 4e7w_A 175 DPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG---I 248 (394)
T ss_dssp ETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H
T ss_pred cCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---H
Confidence 9 7999999999999877544322 345789999999998764 589999999999999999999999976432 1
Q ss_pred chHHHHHHHhhccCCcchh--hhhh-------------hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 568 MSLVKWMRNVMTSENPTRA--IDAK-------------LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~--~d~~-------------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+.++. ......... .++. ............+.+++.+||+.||.+|||+.|+++
T Consensus 249 ~~l~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 249 DQLVEIIKV-LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHHHH-HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHH-hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 222222221 111000000 0000 000001112235888999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.13 Aligned_cols=257 Identities=12% Similarity=0.071 Sum_probs=179.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHH---HHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI---NTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv 412 (633)
...|+..+.||+|+||.||+|++. .+|+.||||++........ ...+.+++|+ ..++. +||||+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~~~~l~~-~hp~iv 127 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSR-----------SELERLHEATFAAARLLG-ESPEEA 127 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTHH-----------HHHHHHHHHHHHHHHHHC-------
T ss_pred ceeeeeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecccccc-----------cHHHHHHHHHHHHHHhcc-cChhhh
Confidence 345899999999999999999864 5789999999977543211 1144567774 45555 799988
Q ss_pred ccc-------eeeecC-----------------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHH------HHHHHHH
Q 006739 413 PLL-------AHMARP-----------------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLAR------HKIALGV 462 (633)
Q Consensus 413 ~l~-------~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i 462 (633)
+++ +++..+ ...++||||++ |+|.+++.... ..+++..+ ..++.||
T Consensus 128 ~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi 203 (371)
T 3q60_A 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQL 203 (371)
T ss_dssp ----CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHH
T ss_pred hhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHH
Confidence 755 343322 23799999998 89999998642 23455556 7888999
Q ss_pred HHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCccccccccccc--CCCCCccc
Q 006739 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT--LKFTDKCD 540 (633)
Q Consensus 463 a~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D 540 (633)
++||+|| |+.+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|
T Consensus 204 ~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~D 275 (371)
T 3q60_A 204 IRLAANL---QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALN 275 (371)
T ss_dssp HHHHHHH---HHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHH
T ss_pred HHHHHHH---HHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCcccc
Confidence 9999999 6789999999999999999999999999999876432 123567799999999987 67999999
Q ss_pred hHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC
Q 006739 541 IYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN 620 (633)
Q Consensus 541 v~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs 620 (633)
||||||++|||++|+.||.......... + ........................+.+++.+||+.||++|||
T Consensus 276 iwSlG~il~elltg~~Pf~~~~~~~~~~----~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 346 (371)
T 3q60_A 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGS----W-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346 (371)
T ss_dssp HHHHHHHHHHHHHSSCSTTBCCTTCTTC----C-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcCcccccc----h-----hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC
Confidence 9999999999999999997653211000 0 000000000000000000112234788999999999999999
Q ss_pred HHHHHH
Q 006739 621 SKDVRC 626 (633)
Q Consensus 621 ~~ev~~ 626 (633)
+.|+++
T Consensus 347 ~~e~l~ 352 (371)
T 3q60_A 347 PLEAME 352 (371)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.00 Aligned_cols=269 Identities=23% Similarity=0.331 Sum_probs=198.8
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC---CCC
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI---RHR 409 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~ 409 (633)
....++|++.+.||+|+||.||+|+....+|+.||+|++......... ...+.+|+.+++.+ +||
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------------~~~~~~e~~~l~~l~~~~h~ 74 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------------PLSTIREVAVLRHLETFEHP 74 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------------BCTHHHHHHHHHHHHHTCCT
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------------CchhhHHHHHHHhhhccCCC
Confidence 345678999999999999999999875567899999998643321110 11344555555554 899
Q ss_pred cccccceeee-----cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 006739 410 NLLPLLAHMA-----RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484 (633)
Q Consensus 410 niv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp 484 (633)
||+++++++. .....++||||++ |+|.+++.... ...+++..+..++.|+++||+|| |+.+|+||||||
T Consensus 75 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~l---H~~gi~H~dlkp 148 (326)
T 1blx_A 75 NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKP 148 (326)
T ss_dssp TBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCG
T ss_pred CeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCH
Confidence 9999999987 4567889999997 69999997632 34589999999999999999999 678999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccc
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQH 564 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 564 (633)
+||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (326)
T 1blx_A 149 QNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225 (326)
T ss_dssp GGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 99999999999999999998654322 123457899999999999999999999999999999999999999753221
Q ss_pred cccchHHHHHHHhhccC----Ccchh------hh---hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 565 TEEMSLVKWMRNVMTSE----NPTRA------ID---AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 565 ~~~~~~~~~~~~~~~~~----~~~~~------~d---~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+.+. ..... +.... .. ..............+.+++.+||+.||++|||+.|+++
T Consensus 226 ---~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 ---DQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp ---HHHHHHHH-HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHH-HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11112111 11100 00000 00 00000111112234778999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=359.60 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=203.3
Q ss_pred hhhcCcccccccccccCeeEEEEEecC--CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
...++|++.+.||+|+||.||+|.+.. ..+..||+|.+.....+ ...+.+.+|+.++++++||||
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnI 453 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-------------SVREKFLQEALTMRQFDHPHI 453 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-------------HHHHHHHHHHHHHHHCCCTTB
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-------------HHHHHHHHHHHHHHhCCCCCC
Confidence 345778999999999999999998743 23578999988643211 114678899999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++++++. .+..++||||+++|+|.+++... ...+++..+..++.|+++||+|| |+.+|+||||||+|||++.
T Consensus 454 v~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NILl~~ 526 (656)
T 2j0j_A 454 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSS 526 (656)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEE
T ss_pred CeEEEEEe-cCceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhEEEeC
Confidence 99999985 45689999999999999999752 34689999999999999999999 6779999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
++.+||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+... ...
T Consensus 527 ~~~vkL~DFG~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~ 601 (656)
T 2j0j_A 527 NDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDV 601 (656)
T ss_dssp TTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH
T ss_pred CCCEEEEecCCCeecCCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHH
Confidence 9999999999998775543222 233457889999999998899999999999999999997 9999875322 222
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
...+. ...... . +......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 602 ~~~i~---~~~~~~------~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 602 IGRIE---NGERLP------M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HHHHH---HTCCCC------C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHH---cCCCCC------C----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22222 111111 0 011123477899999999999999999999999886
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=338.84 Aligned_cols=205 Identities=25% Similarity=0.337 Sum_probs=154.7
Q ss_pred cCccc-ccccccccCeeEEEEEecC-CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 337 DGLAS-LEKIGSGGCGEVYKAELPG-SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 337 ~~~~~-~~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
+.|++ .++||+|+||.||+|++.. .+++.||+|++..... ...+.+|+.++++++||||+++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------------~~~~~~E~~~l~~l~hpniv~~ 83 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----------------SMSACREIALLRELKHPNVISL 83 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----------------CHHHHHHHHHHHHCCCTTBCCC
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----------------CHHHHHHHHHHHhcCCCCeeeE
Confidence 44655 4689999999999998642 3678999999864432 2356789999999999999999
Q ss_pred ceeeec--CCccEEEEecccCCCHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCe
Q 006739 415 LAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQ-----GRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANV 487 (633)
Q Consensus 415 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Ni 487 (633)
++++.. ....++||||++ |+|.+++..... ....+++..++.++.||+.||+|| |+.+|+||||||+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~Dlkp~NI 159 (405)
T 3rgf_A 84 QKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANI 159 (405)
T ss_dssp CEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGE
T ss_pred eeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCCCcCHHHe
Confidence 999954 667899999996 588887764321 123589999999999999999999 678899999999999
Q ss_pred Ee----cCCCceEEcccccccccCCCCCc-ceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 488 LL----DDDMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 488 ll----~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
|+ +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 160 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 160 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99 67889999999999877543221 122346799999999998874 4899999999999999999999999653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=329.71 Aligned_cols=201 Identities=24% Similarity=0.307 Sum_probs=169.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CC-----
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HR----- 409 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~----- 409 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++.... ....++.+|+++++.++ |+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~~~~ 116 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNKK---------------AFLNQAQIEVRLLELMNKHDTEMKY 116 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSSH---------------HHHHHHHHHHHHHHHHHHCSSGGGG
T ss_pred eeeEEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEeccH---------------HHHHHHHHHHHHHHHHHhcccccce
Confidence 478999999999999999999864 578999999985321 01345666777777664 44
Q ss_pred cccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 410 NLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 410 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+|+++++++...+..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||. |+.+|+||||||+|||+
T Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 117 YIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILL 192 (382)
T ss_dssp GBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEE
T ss_pred eEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEE
Confidence 59999999999999999999995 59999997632 3458999999999999999999952 36899999999999999
Q ss_pred c--CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 490 D--DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 490 ~--~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+ .++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5 57789999999998775432 3457899999999999999999999999999999999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=325.03 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=192.6
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--CCccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR--HRNLL 412 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv 412 (633)
..++|++.+.||+|+||.||++... +++.||||++....... ...+.+.+|++++.+++ |+||+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCH------------HHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccc------------cchHHHHHHHHHHHhccccCCceE
Confidence 4567999999999999999999874 68999999986543221 11567889999999997 59999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++...+..++||| +.+++|.+++.. ...+++..+..++.|+++||+|| |+.+|+||||||+||++++
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~- 162 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIVD- 162 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEET-
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEEEC-
Confidence 99999999999999999 558899999975 34689999999999999999999 6779999999999999975
Q ss_pred CceEEcccccccccCCCCCcceecccccCccccccccccc-----------CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-----------LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+.+||+|||+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 7999999999987755433222234578999999999875 46788999999999999999999999753
Q ss_pred ccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... . ..+........... . .... ...+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~-----~-~~~~~~~~~~~~~~-----~-~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 243 INQ-----I-SKLHAIIDPNHEIE-----F-PDIP---EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CSH-----H-HHHHHHHCTTSCCC-----C-CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH-----H-HHHHHHHhcccccC-----C-cccc---hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 221 1 11111111111100 0 0011 234778899999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.90 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=199.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++........ ....+.+|++++++++||||++++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~ 87 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNK------------DTSTILREVELLKKLDHPNIMKLF 87 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSSS------------CHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccchH------------HHHHHHHHHHHHHhccCCCccEEE
Confidence 467999999999999999999864 4789999999854332111 145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC---
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD--- 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~--- 492 (633)
+++.+.+..++||||+++++|.+++... ..+++..++.++.|++.||+|| |+.+|+||||||+||+++.+
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 88 EILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKD 160 (287)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEeCCCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEEEecCCCc
Confidence 9999999999999999999999988753 4589999999999999999999 67899999999999999754
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||++......... ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ....+
T Consensus 161 ~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~ 232 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDILK 232 (287)
T ss_dssp CCEEECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred ccEEEeccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 46999999999876544321 23458999999998876 589999999999999999999999875321 12222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........... ..... ....+.+++.+||+.||++|||+.|+++
T Consensus 233 ---~~~~~~~~~~~---~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 233 ---RVETGKYAFDL---PQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---HHHHCCCCCCS---GGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---HHHcCCCCCCc---hhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 22111111100 00011 1233778999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.03 Aligned_cols=274 Identities=21% Similarity=0.249 Sum_probs=193.8
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
...++|++.+.||+|+||.||+|... +|+.||||++............. ......+.+.+|++++++++||||++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNIL---SDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGG---GSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HhccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhh---hhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 44689999999999999999999864 69999999986543322110000 00112467899999999999999999
Q ss_pred cceeeec-----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 414 LLAHMAR-----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 414 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
+++++.. ....++||||++ |+|.+++.. ....+++..+..++.|+++||+|| |+.+|+||||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCCChHHEE
Confidence 9999844 335799999997 588888764 245699999999999999999999 6779999999999999
Q ss_pred ecCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 489 LDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 489 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--- 240 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY--- 240 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred EcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---
Confidence 99999999999999986544322 234578999999999877 67899999999999999999999999753221
Q ss_pred chHHHHHHHhhccCCcchhh-----------hhhh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 568 MSLVKWMRNVMTSENPTRAI-----------DAKL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~-----------d~~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+............. .... .....+.....+.+++.+||+.||++|||+.|+++
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111111111111100000 0000 00000111234788999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=331.51 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=196.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+|+.||||++...... .....+.+|++++++++||||++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~ 75 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKP-------------LFALRTLREIKILKHFKHENIITIF 75 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSH-------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccc-------------hHHHHHHHHHHHHHhCcCCCcCCee
Confidence 478999999999999999999874 57899999998543211 1145678899999999999999999
Q ss_pred eeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++... ...++||||++ ++|.+++.. ..+++..+..++.|+++||+|| |+.+|+||||||+||+++
T Consensus 76 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~Nil~~ 146 (353)
T 2b9h_A 76 NIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDLKPSNLLIN 146 (353)
T ss_dssp EECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEC
T ss_pred eeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEc
Confidence 987654 67899999996 599998874 3589999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcc--------eecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 491 DDMEARIADFGLAKAMPDAQTHI--------TTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999998775432111 1123568999999998754 67899999999999999999999999753
Q ss_pred ccccccchHHHHHHHhhccCCcchhh----hh-------hh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 006739 562 FQHTEEMSLVKWMRNVMTSENPTRAI----DA-------KL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~----d~-------~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
.. ......+............. .. .+ .....+.....+.+++.+||+.||++|||++|
T Consensus 227 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (353)
T 2b9h_A 227 DY----RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302 (353)
T ss_dssp SH----HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred Cc----HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 21 11111111111111000000 00 00 00000112234778999999999999999999
Q ss_pred HHH
Q 006739 624 VRC 626 (633)
Q Consensus 624 v~~ 626 (633)
+++
T Consensus 303 ll~ 305 (353)
T 2b9h_A 303 ALE 305 (353)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=330.87 Aligned_cols=262 Identities=21% Similarity=0.301 Sum_probs=197.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--------
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-------- 407 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-------- 407 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++..... ....+.+|+.++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~~ 81 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDKV---------------YTEAAEDEIKLLQRVNDADNTKED 81 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCHH---------------HHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CCeEEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCCcc---------------chhhhhHHHHHHHHhhcccccchh
Confidence 468999999999999999999864 5789999999853211 1345677888877775
Q ss_pred ---CCcccccceeeecCC----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-Ceee
Q 006739 408 ---HRNLLPLLAHMARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNP-RIIH 479 (633)
Q Consensus 408 ---h~niv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH 479 (633)
||||+++++++...+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|| |++ +|+|
T Consensus 82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~l---H~~~~ivH 155 (373)
T 1q8y_A 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYM---HRRCGIIH 155 (373)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHH---HHTTCEEC
T ss_pred ccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHH---HhcCCEEe
Confidence 899999999987644 678999999 889999997633 34589999999999999999999 566 9999
Q ss_pred CCCCCCCeEec------CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh
Q 006739 480 RDLKPANVLLD------DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553 (633)
Q Consensus 480 ~Dikp~Nill~------~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 553 (633)
|||||+|||++ ..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 156 ~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 230 (373)
T 1q8y_A 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230 (373)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh
Confidence 99999999994 44579999999998765432 33578999999999999999999999999999999999
Q ss_pred CCCCCcccccccc---cchHHHHHHHhhccCCcchhh---------------------------hhhh--hhcCCHHHHH
Q 006739 554 GRLPSDDFFQHTE---EMSLVKWMRNVMTSENPTRAI---------------------------DAKL--LENGYEEQML 601 (633)
Q Consensus 554 g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~---------------------------d~~~--~~~~~~~~~~ 601 (633)
|+.||........ ...+.+.+ ..... .+.... ...+ ..........
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (373)
T 1q8y_A 231 GDFLFEPDEGHSYTKDDDHIAQII-ELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 308 (373)
T ss_dssp SSCCC---------CHHHHHHHHH-HHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHH
T ss_pred CCCCCCCCcccccCChHHHHHHHH-HhcCC-CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHH
Confidence 9999975432211 11111111 11111 111000 0000 1123355667
Q ss_pred HHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 602 LVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 602 ~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.+++.+||+.||++|||++|+++
T Consensus 309 ~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 309 EISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHHHhccCccccCCHHHHhh
Confidence 7899999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=325.65 Aligned_cols=260 Identities=18% Similarity=0.273 Sum_probs=198.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc-----
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN----- 410 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n----- 410 (633)
.++|++.+.||+|+||.||+|.....+++.||+|++.... ...+.+.+|+.++++++|++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---------------KYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---------------cchhHHHHHHHHHHHHhhcCCCCce
Confidence 4689999999999999999998765555899999985321 11356777888888887665
Q ss_pred -ccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 411 -LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 411 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
++.+++++...+..++||||+ ++++.+++... ....+++..+..++.||++||+|| |+.+|+||||||+||++
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dlkp~NIll 156 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILF 156 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEE
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEE
Confidence 899999999999999999999 66777777642 235689999999999999999999 68899999999999999
Q ss_pred -------------------cCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHH
Q 006739 490 -------------------DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAV 550 (633)
Q Consensus 490 -------------------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~e 550 (633)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231 (355)
T ss_dssp SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred ecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence 567899999999998754432 33579999999999999999999999999999999
Q ss_pred HHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhh---------------------hh----------hhcCCHHH
Q 006739 551 LVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDA---------------------KL----------LENGYEEQ 599 (633)
Q Consensus 551 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~---------------------~~----------~~~~~~~~ 599 (633)
|++|+.||..... ......+...... .+...... .. ........
T Consensus 232 l~~g~~pf~~~~~----~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (355)
T 2eu9_A 232 YYRGFTLFQTHEN----REHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306 (355)
T ss_dssp HHHSSCSCCCSSH----HHHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred HHhCCCCCCCCCH----HHHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchh
Confidence 9999999975322 1222222222111 11100000 00 00111233
Q ss_pred HHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 600 MLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 600 ~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+.+++.+||+.||++|||+.|+++
T Consensus 307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 307 HVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 456889999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=326.05 Aligned_cols=258 Identities=23% Similarity=0.332 Sum_probs=193.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|...+.||+|+||.||+|+.. .+|+.||||++....... ...+.+.+|+.++++++||||++++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~ 89 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSE------------IFAKRAYRELLLLKHMQHENVIGLL 89 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred CceEEEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccch------------HHHHHHHHHHHHHHhcCCCCcccHh
Confidence 468999999999999999999864 579999999986543211 1145788999999999999999999
Q ss_pred eeeecCCc------cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPDC------HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++..... .++||||++ ++|.+++. ..+++..+..++.||++||+|| |+.+|+||||||+||++
T Consensus 90 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~NIl~ 159 (353)
T 3coi_A 90 DVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAV 159 (353)
T ss_dssp EEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEE
T ss_pred heEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEeE
Confidence 99987654 499999997 58877763 3489999999999999999999 67799999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .
T Consensus 160 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----~ 230 (353)
T 3coi_A 160 NEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----L 230 (353)
T ss_dssp CTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH----H
T ss_pred CCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence 99999999999999865432 133568999999999877 6789999999999999999999999975322 1
Q ss_pred hHHHHHHHhhccCCcchhhh-----------hhh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAID-----------AKL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d-----------~~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.....+........ .+... ..+ .....+.....+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 231 DQLTQILKVTGVPG-TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHHHHCBCC-HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHhCCCC-HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111111111000 00000 000 00011122345788999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.35 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=189.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+++.||+|++..... ...+++.+|++++++++||||++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~ 74 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDP--------------QSVKHALREIKIIRRLDHDNIVKVF 74 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET-TTTEEEEEEEEECCSH--------------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCceeEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCCh--------------HHHHHHHHHHHHHHhcCCCCeeEEE
Confidence 468999999999999999999875 5689999999864321 1146788999999999999999999
Q ss_pred eeee--------------cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCC
Q 006739 416 AHMA--------------RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRD 481 (633)
Q Consensus 416 ~~~~--------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~D 481 (633)
+++. +....++||||++ |+|.+++.. ..+++..++.++.|+++||+|| |+.+|+|||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~d 145 (320)
T 2i6l_A 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYI---HSANVLHRD 145 (320)
T ss_dssp EEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCC
T ss_pred EeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHH---HhCCEecCC
Confidence 8873 3467799999997 699999863 4689999999999999999999 678999999
Q ss_pred CCCCCeEec-CCCceEEcccccccccCCCCCc-ceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCC
Q 006739 482 LKPANVLLD-DDMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPS 558 (633)
Q Consensus 482 ikp~Nill~-~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~ 558 (633)
|||+||+++ +++.+||+|||+++........ .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||
T Consensus 146 lkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 225 (320)
T 2i6l_A 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225 (320)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC
Confidence 999999997 5679999999999876543221 11233467999999998765 67899999999999999999999999
Q ss_pred cccccccccchHHHHHHHhhccC----------Ccchhhhhhhhh------cCCHHHHHHHHHHHhHhccCCCCCCCCHH
Q 006739 559 DDFFQHTEEMSLVKWMRNVMTSE----------NPTRAIDAKLLE------NGYEEQMLLVLKIACFCTVDSPRERPNSK 622 (633)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~~~~------~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ 622 (633)
...... ......... .... .....+...... ...+.....+.+++.+||+.||++|||++
T Consensus 226 ~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (320)
T 2i6l_A 226 AGAHEL---EQMQLILES-IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAE 301 (320)
T ss_dssp CCSSHH---HHHHHHHHH-SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CCCCHH---HHHHHHHHh-cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHH
Confidence 754321 111111110 0000 000000000000 00011224478899999999999999999
Q ss_pred HHHH
Q 006739 623 DVRC 626 (633)
Q Consensus 623 ev~~ 626 (633)
|+++
T Consensus 302 ell~ 305 (320)
T 2i6l_A 302 EALS 305 (320)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.12 Aligned_cols=276 Identities=21% Similarity=0.294 Sum_probs=201.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhH---HHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTE---EDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.++|++.+.||+|+||.||+|.. +++.||+|++............ ..........+.+.+|+.++++++||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 46899999999999999999987 7999999998532211000000 00000000026788999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHH------HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDI------LNDVSQGRRELDWLARHKIALGVACGLEYLHISHN-PRIIHRDLKPA 485 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~Dikp~ 485 (633)
++++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.|+++||+|| |+ .+|+||||||+
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dl~p~ 181 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRDVKPS 181 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCCCCGG
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecCCChH
Confidence 999999999999999999999999998 432 1246799999999999999999999 55 89999999999
Q ss_pred CeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCC-ccchHHHHHHHHHHHhCCCCCccccc
Q 006739 486 NVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTD-KCDIYSFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 486 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~G~~l~elltg~~p~~~~~~ 563 (633)
||+++.++.+||+|||.+...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999876443 22446799999999999887 5666 99999999999999999999975322
Q ss_pred ccccchHHHHHHHhhccCCcc--hhhhh---hhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 564 HTEEMSLVKWMRNVMTSENPT--RAIDA---KLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~--~~~d~---~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. ....+.+.......... ..... .............+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 L---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp S---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 22222221110000000 00000 0000000112234788999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.27 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=169.4
Q ss_pred hcCccccc-ccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 336 EDGLASLE-KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
.++|.+.+ .||+|+||.||+|+.. .+|+.||+|++.... ....+....++.++||||+++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~------------------~~~~e~~~~~~~~~h~~i~~~ 87 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHR-RTGQKCALKLLYDSP------------------KARQEVDHHWQASGGPHIVCI 87 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESSH------------------HHHHHHHHHHHHTTSTTBCCE
T ss_pred cceeEecceeeeeCCCeEEEEEEEC-CCCCEEEEEEecCcH------------------HHHHHHHHHHHhcCCCChHHH
Confidence 46788855 6999999999999875 578999999985421 011112233456789999999
Q ss_pred ceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 415 LAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 415 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++++.. ....++||||+++|+|.+++... ....+++..++.++.|+++||+|| |+.+|+||||||+||+++
T Consensus 88 ~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dlkp~NIll~ 162 (336)
T 3fhr_A 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDVKPENLLYT 162 (336)
T ss_dssp EEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEES
T ss_pred HHHHhhccCCCceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEE
Confidence 999876 44578999999999999999753 235799999999999999999999 677999999999999998
Q ss_pred C---CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 491 D---DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 491 ~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
. ++.+||+|||+++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 163 ~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 238 (336)
T 3fhr_A 163 SKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS 238 (336)
T ss_dssp CSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ecCCCceEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh
Confidence 6 45599999999987654321 2356899999999998888999999999999999999999999754322111
Q ss_pred chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
......+...... .. ..........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~--~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 239 PGMKRRIRLGQYG--FP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------------C--CC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHhhhccccc--cC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111100000 00 0001112234778999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.06 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=177.9
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHH-HhhcCCCCccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN-TVGQIRHRNLL 412 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv 412 (633)
...++|+..+.||+|+||.||+|... .+|+.||||++....... ...++..|+. +++.++||||+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~h~niv 84 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEK-------------EQKQLLMDLDVVMRSSDCPYIV 84 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHH-------------HHHHHHHHHHHHHSSCCCTTBC
T ss_pred cCHHHhhehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCch-------------HHHHHHHHHHHHHHcCCCCcEe
Confidence 34578999999999999999999864 578999999986543210 1234444555 77888999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeCCCCCCCeEec
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVS-QGRRELDWLARHKIALGVACGLEYLHISHNP-RIIHRDLKPANVLLD 490 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~-~ivH~Dikp~Nill~ 490 (633)
++++++...+..++||||+++ +|.+++.... .....+++..+..++.|+++||.||| +. +|+||||||+||+++
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~ 160 (327)
T 3aln_A 85 QFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLD 160 (327)
T ss_dssp CEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEE
T ss_pred eeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEc
Confidence 999999999999999999975 8888776422 22567899999999999999999994 55 899999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCccccccccc----ccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH----QTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
.++.+||+|||+++....... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 236 (327)
T 3aln_A 161 RSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF- 236 (327)
T ss_dssp TTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----
T ss_pred CCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-
Confidence 999999999999987654322 1234689999999998 45678999999999999999999999997532210
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+......... . +...........+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~~~~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 237 -----DQLTQVVKGDPP-Q-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --------CCCCCSCCC-C-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----HHHHHHhcCCCC-C-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111111100 0 000000111234788999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=318.11 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=189.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||.||+|+.. .+++.||+|++.... ...+.+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---------------~~~~~~~~E~~~l~~l~h~~i~~~~ 68 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHTE---------------EKLSTILSEVMLLASLNHQYVVRYY 68 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEEH---------------HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccchhhheeccCCcEEEEEEEEc-CCCeEEEEEEEeccH---------------HHHHHHHHHHHHHHhcCchHHHHHH
Confidence 467899999999999999999864 578999999984311 1146788999999999999999999
Q ss_pred eeeec-------------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC
Q 006739 416 AHMAR-------------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDL 482 (633)
Q Consensus 416 ~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Di 482 (633)
+++.+ ....++||||+++|+|.+++... ...+++..++.++.|+++||+|| |+.+|+||||
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl 142 (303)
T 1zy4_A 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYI---HSQGIIHRDL 142 (303)
T ss_dssp EEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred HHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHH---HhCCeecccC
Confidence 98855 34578999999999999999752 35678899999999999999999 6779999999
Q ss_pred CCCCeEecCCCceEEcccccccccCCCCC------------cceecccccCcccccccccccC-CCCCccchHHHHHHHH
Q 006739 483 KPANVLLDDDMEARIADFGLAKAMPDAQT------------HITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLA 549 (633)
Q Consensus 483 kp~Nill~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~ 549 (633)
||+||+++.++.+||+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|
T Consensus 143 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 222 (303)
T 1zy4_A 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222 (303)
T ss_dssp CGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHH
T ss_pred CHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHH
Confidence 99999999999999999999987653211 1112345689999999998764 6899999999999999
Q ss_pred HHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 550 VLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 550 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
||++ ||.... ......+.+.... .... ..........+.+++.+||+.||.+|||+.++++
T Consensus 223 ~l~~---p~~~~~---~~~~~~~~~~~~~--~~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 223 EMIY---PFSTGM---ERVNILKKLRSVS--IEFP--------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHS---CCSSHH---HHHHHHHHHHSTT--CCCC--------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh---ccCCch---hHHHHHHhccccc--cccC--------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 9998 543211 1111222221110 0111 1111222334778999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.09 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=183.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 415 (633)
+.|...+.||+|+||+||.+.. .+|+.||||++.... .+.+.+|++++.++ +||||++++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~~-----------------~~~~~~E~~~l~~l~~HpnIv~~~ 75 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLIDF-----------------CDIALMEIKLLTESDDHPNVIRYY 75 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE--SSSSEEEEEEEEGGG-----------------HHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred heeeccCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHHH-----------------HHHHHHHHHHHHhccCCCCcCeEE
Confidence 3455678899999999976543 379999999884321 23467899999876 899999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRE---LDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+++.+.+..++||||++ |+|.+++......... .++..++.++.||+.||+|| |+.+|+||||||+|||++.+
T Consensus 76 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~ 151 (434)
T 2rio_A 76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQNILVSTS 151 (434)
T ss_dssp EEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEECC
T ss_pred EEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecC
Confidence 99999999999999995 6999999763322111 13345678999999999999 67899999999999999754
Q ss_pred -------------CceEEcccccccccCCCCCcc--eecccccCccccccccccc-------CCCCCccchHHHHHHHHH
Q 006739 493 -------------MEARIADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQT-------LKFTDKCDIYSFGVLLAV 550 (633)
Q Consensus 493 -------------~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~e 550 (633)
+.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~e 231 (434)
T 2rio_A 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231 (434)
T ss_dssp HHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHH
T ss_pred cccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHH
Confidence 489999999999876543221 1234579999999999875 568999999999999999
Q ss_pred HHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 551 LVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 551 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
|++ |+.||...... ....+.......... ..........+.+++.+||+.||++|||+.|+++
T Consensus 232 llt~g~~Pf~~~~~~-----~~~i~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 232 ILSKGKHPFGDKYSR-----ESNIIRGIFSLDEMK--------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHTTSCCTTCSTTTH-----HHHHHHTCCCCCCCT--------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhCCCCCCCCchhh-----HHHHhcCCCCccccc--------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 999 99999753221 112222111111110 1112334456889999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=321.11 Aligned_cols=247 Identities=20% Similarity=0.281 Sum_probs=189.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC----CCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI----RHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l----~h~ni 411 (633)
.++|++.+.||+|+||.||+|+.. .+++.||+|++.......... ......+.+|+.++.++ +||||
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~~h~~i 100 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSP--------LSDSVTCPLEVALLWKVGAGGGHPGV 100 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC----------------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred hhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEeccccccccc--------chhhHHHHHHHHHHHhhcccCCCCCe
Confidence 467999999999999999999764 578999999986543211100 01133456788888888 89999
Q ss_pred cccceeeecCCccEEEEec-ccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 412 LPLLAHMARPDCHLLVYEF-MKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++++++...+..++|||| +++++|.+++.. ...+++..++.++.|+++||+|| |+.+|+||||||+||+++
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIKDENILID 173 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCSGGGEEEE
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChhhEEEe
Confidence 9999999999999999999 789999999976 24589999999999999999999 567999999999999999
Q ss_pred -CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCC-CccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 491 -DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFT-DKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 491 -~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+++.+||+|||+++....... ....||..|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----- 244 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----- 244 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred CCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----
Confidence 889999999999987765322 345689999999998876664 489999999999999999999864211
Q ss_pred hHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ....... .....+.+++.+||+.||++|||++|+++
T Consensus 245 ----~~~---~~~~~~~------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ----ILE---AELHFPA------------HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ----HHH---TCCCCCT------------TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----Hhh---hccCCcc------------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 0111111 11223778899999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=319.35 Aligned_cols=257 Identities=21% Similarity=0.381 Sum_probs=180.8
Q ss_pred hhhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
....++|+..+.||+|+||.||+|+.. .+|+.||||++....... ...+.+.++..+++.++||||+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~------------~~~~~~~~~~~~~~~~~h~~i~ 87 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKE------------ENKRILMDLDVVLKSHDCPYIV 87 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEET-TTCCEEEEEEEETTSCHH------------HHHHHHHHHHHHHHTTTCTTBC
T ss_pred hhhhccccccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccch------------HHHHHHHHHHHHHHhcCCCcee
Confidence 344578999999999999999999875 478999999986543211 1123445555678888999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeeCCCCCCCeEecC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHN-PRIIHRDLKPANVLLDD 491 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~-~~ivH~Dikp~Nill~~ 491 (633)
++++++.+.+..++||||+ ++.+..+.... ...+++..+..++.|+++||+||| + .+|+||||||+||+++.
T Consensus 88 ~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~ 160 (318)
T 2dyl_A 88 QCFGTFITNTDVFIAMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDE 160 (318)
T ss_dssp CEEEEEECSSEEEEEECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECT
T ss_pred eEEEEEecCCcEEEEEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECC
Confidence 9999999999999999999 55666665432 356899999999999999999995 4 38999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
++.+||+|||++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 161 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--- 234 (318)
T 2dyl_A 161 RGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--- 234 (318)
T ss_dssp TSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS---
T ss_pred CCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc---
Confidence 99999999999976654322 12356899999999984 45688999999999999999999999975321
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... .+............. ... ....+.+++.+||+.||.+||+++|+++
T Consensus 235 ~~~---~~~~~~~~~~~~~~~-----~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 235 DFE---VLTKVLQEEPPLLPG-----HMG---FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHH---HHHHHHHSCCCCCCS-----SSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHH---HHHHHhccCCCCCCc-----cCC---CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111 122222221111000 000 1123778889999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.82 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=196.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--CCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR--HRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~ 413 (633)
.++|++.+.||+|+||.||+|+.. .+++.||||++............ ....+.+|+.++++++ |+||++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~--------~~~~~~~E~~~l~~l~~~~~~i~~ 112 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELP--------NGTRVPMEVVLLKKVSSGFSGVIR 112 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEECT--------TCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred cCceEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhhh--------hhhHHHHHHHHHHhhccCCCCceE
Confidence 468999999999999999999864 57899999998654321100000 0234567888999886 599999
Q ss_pred cceeeecCCccEEEEecccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec-C
Q 006739 414 LLAHMARPDCHLLVYEFMKN-GSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD-D 491 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~-~ 491 (633)
+++++..++..++||||+.+ ++|.+++.. ...+++..++.++.|+++||+|| |+.+|+||||||+||+++ +
T Consensus 113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 113 LLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETT
T ss_pred EEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHHHEEEeCC
Confidence 99999999999999999986 899999976 34689999999999999999999 678999999999999999 7
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
++.+||+|||+++....... ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------- 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 254 (320)
T ss_dssp TTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence 88999999999987764322 33569999999999887665 6789999999999999999999864211
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
... ...... ... ...+.+++.+||+.||++|||++|+++
T Consensus 255 --~~~---~~~~~~---------~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 --IIR---GQVFFR---------QRV---SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --HHH---CCCCCS---------SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hhc---cccccc---------ccC---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 000000 011 123778999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=341.74 Aligned_cols=269 Identities=26% Similarity=0.336 Sum_probs=199.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|... .+|+.||||++...... ...+.+.+|++++++++||||++++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~~-------------~~~~~~~~Ei~iL~~L~HpnIV~l~ 78 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELSP-------------KNRERWCLEIQIMKKLNHPNVVSAR 78 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCCH-------------HHHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred CCCeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCCH-------------HHHHHHHHHHHHHHhCCCCCCCcee
Confidence 368999999999999999999764 57899999998654211 1145788999999999999999999
Q ss_pred eeeec------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMAR------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++.. .+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|| |+.+|+||||||+||++
T Consensus 79 ~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLKP~NILl 154 (676)
T 3qa8_A 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVL 154 (676)
T ss_dssp ECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCCSTTEEE
T ss_pred eeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEe
Confidence 98755 667899999999999999998633 234688999999999999999999 67899999999999999
Q ss_pred cCCCc---eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 490 DDDME---ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 490 ~~~~~---~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
+.++. +||+|||+++........ ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 155 ~~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-- 229 (676)
T 3qa8_A 155 QPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-- 229 (676)
T ss_dssp ECCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH--
T ss_pred ecCCCceeEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch--
Confidence 97765 899999999877654322 3457999999999999999999999999999999999999999653211
Q ss_pred cchHHHHHHHhhc--------cCCcchh--hhhh--hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHH-----HHHHHH
Q 006739 567 EMSLVKWMRNVMT--------SENPTRA--IDAK--LLENGYEEQMLLVLKIACFCTVDSPRERPNSKD-----VRCMLS 629 (633)
Q Consensus 567 ~~~~~~~~~~~~~--------~~~~~~~--~d~~--~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~e-----v~~~l~ 629 (633)
..|...... ....... .... ............+.+++..||+.||++|||+.+ +.+.++
T Consensus 230 ----~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 230 ----VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp ----HHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred ----hhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 111110000 0000000 0000 001122334456889999999999999999988 455555
Q ss_pred hh
Q 006739 630 QI 631 (633)
Q Consensus 630 ~~ 631 (633)
++
T Consensus 306 ~i 307 (676)
T 3qa8_A 306 SI 307 (676)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=330.39 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=182.6
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLP 413 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~ 413 (633)
...+|...+.||+|+||+||.... .+++.||||++..... ..+.+|+++++++ +|||||+
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~~-----------------~~~~~E~~~l~~l~~HpnIv~ 82 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPECF-----------------SFADREVQLLRESDEHPNVIR 82 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTTE-----------------EECHHHHHHHHHSCCCTTBCC
T ss_pred ccEEEecCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHHH-----------------HHHHHHHHHHHhccCCCCcCe
Confidence 345688999999999999554333 3789999999864332 1245688899988 7999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC--
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-- 491 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~-- 491 (633)
+++++.+....++||||++ |+|.+++.... ....+..+..++.||++||+|| |+.+|+||||||+||+++.
T Consensus 83 l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NIll~~~~ 155 (432)
T 3p23_A 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPN 155 (432)
T ss_dssp EEEEEEETTEEEEEEECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSEEECCCB
T ss_pred EEEEEecCCEEEEEEECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHEEEecCC
Confidence 9999999999999999996 59999997532 2344456678999999999999 6789999999999999953
Q ss_pred ---CCceEEcccccccccCCCCCc-ceecccccCcccccccccc---cCCCCCccchHHHHHHHHHHHh-CCCCCccccc
Q 006739 492 ---DMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQ---TLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQ 563 (633)
Q Consensus 492 ---~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~ 563 (633)
...+||+|||+++........ .......||+.|+|||++. ...++.++|||||||++|||++ |..||.....
T Consensus 156 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp TTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred CCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 335789999999877643221 1224467999999999987 4567889999999999999999 9999864321
Q ss_pred ccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... ....... ....+ .......+.+++.+||+.||++|||+.|+++
T Consensus 236 -----~~~~~---~~~~~~~-~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 236 -----RQANI---LLGACSL-DCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----HHHHH---HTTCCCC-TTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHH---HhccCCc-cccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111 1111111 11100 1112234678999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=344.19 Aligned_cols=241 Identities=21% Similarity=0.310 Sum_probs=191.4
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|.+...+|+.||||++...... .....+.+|++++++++||||++++
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~ 145 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-------------EAQAMAMAERQFLAEVVHPSIVQIF 145 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH-------------HHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH-------------HHHHHHHHHHHHHHhcCCCCcCeEe
Confidence 368999999999999999999886557899999988643211 1145688999999999999999999
Q ss_pred eeeecCCc-----cEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMARPDC-----HLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++...+. .|+||||+++++|.+++.. .+++..++.++.||++||+|| |+.+|+||||||+|||++
T Consensus 146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp~NIll~ 216 (681)
T 2pzi_A 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKPENIMLT 216 (681)
T ss_dssp EEEEEECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEC
T ss_pred eeEeecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHH---HHCCCeecccChHHeEEe
Confidence 99987665 6999999999999987642 699999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
.+ .+||+|||+++..... ....||++|+|||++.+. ++.++|||||||++|||++|..||........
T Consensus 217 ~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---- 284 (681)
T 2pzi_A 217 EE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---- 284 (681)
T ss_dssp SS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----
T ss_pred CC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----
Confidence 86 8999999999876543 335799999999998765 48899999999999999999988765322100
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-HHHHHHHHHh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-SKDVRCMLSQ 630 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-~~ev~~~l~~ 630 (633)
... .+ .......+.+++.+||+.||++||+ ++++.+.|..
T Consensus 285 ------------~~~--~~------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 ------------PED--DP------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------------CTT--CH------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------------ccc--cc------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000 00 0011234788999999999999995 5556666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.42 Aligned_cols=234 Identities=13% Similarity=0.090 Sum_probs=181.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+++.||+|++........ ...+.+.+|+.++.+++||||+++++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~hp~iv~~~~ 98 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLPD-----------DVLQETLSRTLRLSRIDKPGVARVLD 98 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSCH-----------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccCH-----------HHHHHHHHHHHHHhcCCCCCcceeeE
Confidence 57999999999999999999874 5689999999976543211 12467889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..|+||||+++++|.+++.. . ....++.+|+.|+++||+|| |+.+|+||||||+||+++.++.+|
T Consensus 99 ~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 99 VVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp EEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEETTSCEE
T ss_pred EEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEEcCCCCEE
Confidence 99999999999999999999999853 1 35557889999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+++| |++ .++.++|||||||++|||++|+.||.............+ .
T Consensus 170 l~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~---~ 217 (286)
T 3uqc_A 170 LAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER---D 217 (286)
T ss_dssp ECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB---C
T ss_pred EEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH---H
Confidence 98554 222 357899999999999999999999976433211100000 0
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
......... ...... ...+.+++.+||+.||++| |+.|+++.|++++
T Consensus 218 ~~~~~~~~~----~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 218 TAGQPIEPA----DIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp TTSCBCCHH----HHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hccCCCChh----hcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000000000 111111 2237888999999999999 9999999998864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=322.09 Aligned_cols=247 Identities=17% Similarity=0.163 Sum_probs=180.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC-Cccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH-RNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l 414 (633)
...|...+.||+|+||.||+|++. .+|+.||||++........ ...+.+++|+.+++.++| +|....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~~-----------~~~~~~~~E~~~~~~l~~~~~~~~~ 144 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPS-----------NAIKQMKEEVLRLRLLRGIKNQKQA 144 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC---------------CCHHHHHHHHGGGGSTTCCSHHHH
T ss_pred ceeEEEecccccCCCEEEEEEEec-CCCCceEEEEEecCCCccH-----------HHHHHHHHHHHHHHhhccCCCHHHH
Confidence 345778899999999999999864 5789999999864332111 114568899999999987 322211
Q ss_pred cee---------------------eec-----CCccEEEEecccCCCHHHHHhhh---cCCCCCCCHHHHHHHHHHHHHH
Q 006739 415 LAH---------------------MAR-----PDCHLLVYEFMKNGSLQDILNDV---SQGRRELDWLARHKIALGVACG 465 (633)
Q Consensus 415 ~~~---------------------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~ 465 (633)
..+ +.. ....+++|+++ +++|.+++... ......+++..+..++.|+++|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~a 223 (413)
T 3dzo_A 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223 (413)
T ss_dssp HHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred HHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHH
Confidence 111 111 12346677766 67999988532 2234568899999999999999
Q ss_pred HHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCccccccccc----------ccCCC
Q 006739 466 LEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYH----------QTLKF 535 (633)
Q Consensus 466 L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~ 535 (633)
|+|| |+.+|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..+
T Consensus 224 L~~L---H~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~ 294 (413)
T 3dzo_A 224 LASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM 294 (413)
T ss_dssp HHHH---HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred HHHH---HhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC
Confidence 9999 6789999999999999999999999999998875432 234567 999999998 55568
Q ss_pred CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCC
Q 006739 536 TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSP 615 (633)
Q Consensus 536 ~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP 615 (633)
+.++|||||||++|||++|+.||........... ..... .. . ...+.+++.+||+.||
T Consensus 295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~-------~~~~~-----------~~-~---~~~~~~li~~~l~~dP 352 (413)
T 3dzo_A 295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW-------IFRSC-----------KN-I---PQPVRALLEGFLRYPK 352 (413)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-------GGSSC-----------CC-C---CHHHHHHHHHHTCSSG
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-------HHhhc-----------cc-C---CHHHHHHHHHHccCCh
Confidence 8899999999999999999999975432111110 00000 01 1 1347889999999999
Q ss_pred CCCCCHHHHHH
Q 006739 616 RERPNSKDVRC 626 (633)
Q Consensus 616 ~~RPs~~ev~~ 626 (633)
++||++.++++
T Consensus 353 ~~Rpt~~~~l~ 363 (413)
T 3dzo_A 353 EDRLLPLQAME 363 (413)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCcCHHHHHh
Confidence 99999887754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=301.56 Aligned_cols=232 Identities=20% Similarity=0.294 Sum_probs=174.6
Q ss_pred hcCcccc-cccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHh-hcCCCCcccc
Q 006739 336 EDGLASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTV-GQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~-~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~ 413 (633)
.++|.+. +.||+|+||.||++... .+++.||+|++.. ...+.+|+.++ +..+||||++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~-------------------~~~~~~e~~~~~~~~~h~~i~~ 75 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIVR 75 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBCC
T ss_pred ccchhhcCcccccCCCeEEEEEEEc-CCCcEEEEEEecc-------------------cHHHHHHHHHHHHhccCCCchh
Confidence 4677777 78999999999999864 5789999999843 12355677777 5568999999
Q ss_pred cceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 414 LLAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 414 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++++.. ....++||||+++|+|.+++... ....+++..++.++.|++.||+|| |+.+|+||||||+||++
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~ 150 (299)
T 3m2w_A 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLY 150 (299)
T ss_dssp EEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEE
T ss_pred HHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEE
Confidence 9999876 66789999999999999999863 235699999999999999999999 67899999999999999
Q ss_pred cC---CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 490 DD---DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 490 ~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
+. ++.+||+|||++..... ..++.++||||+||++|||++|+.||........
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 151 TSKRPNAILKLTDFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp SSSSTTCCEEECCCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred ecCCCCCcEEEecccccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 98 78899999999865332 2456789999999999999999999965332110
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... ........ ......... ....+.+++.+||+.||++|||+.|+++
T Consensus 207 ~~~~~----~~~~~~~~--~~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 207 SPGMK----TRIRMGQY--EFPNPEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -CCSC----CSSCTTCC--SSCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHH----HHHhhccc--cCCchhccc----CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 00000000 000000011 1234788999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.55 Aligned_cols=250 Identities=20% Similarity=0.156 Sum_probs=178.9
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--------
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-------- 407 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-------- 407 (633)
.++|++.+.||+|+||.||+|+. +|+.||||++.....+....... ...+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~------~~~~~~~~E~~~l~~l~~l~~~~~~ 89 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQ------KTFEEILPEIIISKELSLLSGEVCN 89 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCC------BCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred cccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccc------hhHHHHHHHHHHHHHHHHhhccccc
Confidence 46789999999999999999986 68999999997654221000000 00345667777777665
Q ss_pred ------------------CCcccccceeeec-------------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHH
Q 006739 408 ------------------HRNLLPLLAHMAR-------------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456 (633)
Q Consensus 408 ------------------h~niv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~ 456 (633)
||||+++++++.+ .+..++||||+++|++.+.+.+ ..+++..+.
T Consensus 90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~ 164 (336)
T 2vuw_A 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAK 164 (336)
T ss_dssp BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHH
T ss_pred cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHH
Confidence 4555555555544 6789999999999976665532 458999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC--------------------ceEEcccccccccCCCCCcceec
Q 006739 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM--------------------EARIADFGLAKAMPDAQTHITTS 516 (633)
Q Consensus 457 ~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~ 516 (633)
.++.||+.||+||| ++.+|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 165 ~i~~qi~~aL~~lH--~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------- 235 (336)
T 2vuw_A 165 SILHQLTASLAVAE--ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------- 235 (336)
T ss_dssp HHHHHHHHHHHHHH--HHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred HHHHHHHHHHHHHH--HhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence 99999999999994 278899999999999999887 8999999999876542
Q ss_pred ccccCcccccccccccCCCCCccchHHHHHH-HHHHHhCCCCCcccccccccchHHHHHH-HhhccCCcchhhhhhhhhc
Q 006739 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVL-LAVLVMGRLPSDDFFQHTEEMSLVKWMR-NVMTSENPTRAIDAKLLEN 594 (633)
Q Consensus 517 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~-l~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~ 594 (633)
...||+.|+|||++.+.. +.++||||++++ .+++++|..||.... ......+.+. ...........
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~-------- 303 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTP-------- 303 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSH--------
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchh--------
Confidence 247999999999998766 889999998776 788889999975310 0001111111 11111111111
Q ss_pred CCHHHHHHHHHHHhHhccCCCCCCCCHHHHH
Q 006739 595 GYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625 (633)
Q Consensus 595 ~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~ 625 (633)
........+.+++.+||+.| |++|++
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 11234456889999999976 999887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=282.33 Aligned_cols=196 Identities=19% Similarity=0.117 Sum_probs=134.0
Q ss_pred ccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCcccccceeeecCC
Q 006739 344 KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLLPLLAHMARPD 422 (633)
Q Consensus 344 ~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 422 (633)
..+.|++|.+..++. ...|+.||+|.+.+........ ....+...++|.+|+++|+++ .|+||+++++++.+++
T Consensus 241 ~~~~~~~~~h~~~rr-~~fg~~~~~K~~~~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRR-YFFGEDYVCKFFYYDMPHGILT----AEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ 315 (569)
T ss_dssp C-C--------CCEE-EEECSSEEEEEEESSCSTTCSC----HHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred ccccCCccccccccc-ccccceeEEEEEecccccccch----hhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence 345666665555432 2368899999997654322111 122334467899999999999 6999999999999999
Q ss_pred ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccccc
Q 006739 423 CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502 (633)
Q Consensus 423 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~ 502 (633)
..||||||++|++|.+++.. ..+++.. +|+.||+.||+|+ |+++||||||||+|||++++|.+||+|||+
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeeccc
Confidence 99999999999999999975 3445553 5899999999999 789999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCC
Q 006739 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557 (633)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p 557 (633)
|+........ ....+||++|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 386 Ar~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 386 IVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9977654332 234679999999999876 567789999999998887665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.3e-28 Score=260.27 Aligned_cols=193 Identities=18% Similarity=0.189 Sum_probs=150.5
Q ss_pred cccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
..+.||+|+||.||++.. .+..+++|+............ .....+++.+|++++++++||||+++..++..
T Consensus 340 ~~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~~------~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 410 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERLD------ENIRKSRTAREARYLALVKDFGIPAPYIFDVD 410 (540)
T ss_dssp --------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHHH------HHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred CCCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhhh------hHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence 356899999999999965 678899998755332211111 11225678999999999999999988888878
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
.+..++||||+++++|.+++.. +..++.|+++||+|| |+++|+||||||+|||+++ .+||+||
T Consensus 411 ~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~--~~kL~DF 473 (540)
T 3en9_A 411 LDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK--DLYIIDF 473 (540)
T ss_dssp TTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--SEEECCC
T ss_pred CCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--eEEEEEC
Confidence 8889999999999999999864 468999999999999 6789999999999999999 9999999
Q ss_pred ccccccCCCCCcc-----eecccccCccccccccccc--CCCCCccchHHHHHHHHHHHhCCCCCc
Q 006739 501 GLAKAMPDAQTHI-----TTSNVAGTVGYIAPEYHQT--LKFTDKCDIYSFGVLLAVLVMGRLPSD 559 (633)
Q Consensus 501 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~ 559 (633)
|+++......... ......||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999876542211 1134679999999999987 567888999999998888888777663
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-26 Score=229.26 Aligned_cols=178 Identities=29% Similarity=0.453 Sum_probs=160.5
Q ss_pred CCChhHHHHHHHHHHhcCCCC---CCCC-CCCCC--CCceeeCCCCCCCCcceeeeEEEEecCCCCcc--cCCccccCCc
Q 006739 27 NLDRSDYKALSVILRDLGGQQ---LFIP-SDPCS--TPGVFCERRLSDNNTYVLKITKLVFVPRELTG--VLSPSIGRLS 98 (633)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~~~---~w~~-~~~C~--~~gv~c~~~~~~~~~~~~~~~~L~l~~n~l~~--~~~~~~~~l~ 98 (633)
.|.++|.+||++||.+++++. .|.. .+||. |.||.|+.... ..+|+.|+|++|++++ .+|..|.+++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~-----~~~l~~L~L~~~~l~~~~~~~~~l~~l~ 76 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-----TYRVNNLDLSGLNLPKPYPIPSSLANLP 76 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSS-----CCCEEEEEEECCCCSSCEECCGGGGGCT
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCC-----CceEEEEECCCCCccCCcccChhHhCCC
Confidence 589999999999999997643 4754 48998 99999975321 1289999999999999 8999999999
Q ss_pred cccEEEccC-CCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeC
Q 006739 99 ELRELSLAN-NSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSL 176 (633)
Q Consensus 99 ~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l 176 (633)
+|++|+|++ |.+++.+|..|.++++|++|+|++|++++.+|..|..+++|++|+|++|.+++.. ..+..+++|++|+|
T Consensus 77 ~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (313)
T 1ogq_A 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156 (313)
T ss_dssp TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEEC
Confidence 999999995 9999999999999999999999999999999999999999999999999999654 67899999999999
Q ss_pred cCCcCCccCCcccccCC-CCCeeccCCCCCCCCC
Q 006739 177 AKNLFTGKVPTSIRTFR-NLQFFDFSGNSLLEGP 209 (633)
Q Consensus 177 ~~N~l~~~~p~~~~~~~-~L~~l~l~~N~l~~~~ 209 (633)
++|+|+|.+|..+..++ +|+.|++++|++....
T Consensus 157 ~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~ 190 (313)
T 1ogq_A 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEEC
T ss_pred cCCcccCcCCHHHhhhhhcCcEEECcCCeeeccC
Confidence 99999999999999998 9999999999997433
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-22 Score=192.76 Aligned_cols=162 Identities=19% Similarity=0.179 Sum_probs=143.2
Q ss_pred CCCCCCCCCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCc
Q 006739 48 LFIPSDPCSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLE 125 (633)
Q Consensus 48 ~w~~~~~C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 125 (633)
.|...+.|+|.+|.|........ ....+++.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|+
T Consensus 12 ~~~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 91 (229)
T 3e6j_A 12 ACPSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91 (229)
T ss_dssp CCCTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cCCCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence 35666889999999987422221 2346899999999999999999999999999999999999886667789999999
Q ss_pred EEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCC
Q 006739 126 ILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205 (633)
Q Consensus 126 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l 205 (633)
+|+|++|+|++..+..|..+++|+.|+|++|+|+..+..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++
T Consensus 92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 171 (229)
T 3e6j_A 92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPW 171 (229)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCB
T ss_pred EEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCc
Confidence 99999999997767778999999999999999998888889999999999999999977777899999999999999999
Q ss_pred CCCC
Q 006739 206 LEGP 209 (633)
Q Consensus 206 ~~~~ 209 (633)
.+..
T Consensus 172 ~c~c 175 (229)
T 3e6j_A 172 DCEC 175 (229)
T ss_dssp CTTB
T ss_pred cCCc
Confidence 7654
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-23 Score=235.18 Aligned_cols=175 Identities=27% Similarity=0.332 Sum_probs=151.2
Q ss_pred CCChhHHHHHHHHHHhcCCCCCCCC------CCC--CCC------------CceeeCCCCCCCCcceeeeEEEEecCCCC
Q 006739 27 NLDRSDYKALSVILRDLGGQQLFIP------SDP--CST------------PGVFCERRLSDNNTYVLKITKLVFVPREL 86 (633)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~~~~w~~------~~~--C~~------------~gv~c~~~~~~~~~~~~~~~~L~l~~n~l 86 (633)
+...+|+.||++||++++++ .|.. .+| |.| .||.|+.. .+|+.|+|++|++
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~--------~~V~~L~Ls~~~L 335 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN--------GRVTGLSLAGFGA 335 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT--------SCEEEEECTTTCC
T ss_pred ccchHHHHHHHHHHHHcCCC-CCCcCCCcccccCCccccccccccccccCcCceEecCC--------CCEEEEECccCCC
Confidence 34568999999999999876 6732 256 999 99999852 2899999999999
Q ss_pred cccCCccccCCccccEEEc-cCCCCCCC----------------------------------------------------
Q 006739 87 TGVLSPSIGRLSELRELSL-ANNSLVDL---------------------------------------------------- 113 (633)
Q Consensus 87 ~~~~~~~~~~l~~L~~L~l-~~N~l~~~---------------------------------------------------- 113 (633)
.|.+|++|++|++|+.|+| ++|.++|.
T Consensus 336 ~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~ 415 (876)
T 4ecn_A 336 KGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMK 415 (876)
T ss_dssp EEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSC
T ss_pred CCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccc
Confidence 9999999999999999999 77755443
Q ss_pred ------------------------CchhccCCCCCcEEEccCccCCC-----------------CCccccc--CCCCCCE
Q 006739 114 ------------------------LPPQIVDCKKLEILNVQNNQFSG-----------------TIPSDLS--SLIRLRV 150 (633)
Q Consensus 114 ------------------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~ 150 (633)
+|..|+++++|++|+|++|+|+| .+|..++ ++++|+.
T Consensus 416 ~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~ 495 (876)
T 4ecn_A 416 PIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495 (876)
T ss_dssp CCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred ccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence 78889999999999999999998 3899988 9999999
Q ss_pred EEccCCcCCCCC-ccCCCCCCCCeEeCcCCc-CCc-cCCcccccCC-------CCCeeccCCCCCCCCCc
Q 006739 151 LDLSGNSFSGNL-GFLKYFPNLEHLSLAKNL-FTG-KVPTSIRTFR-------NLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 151 L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~-l~~-~~p~~~~~~~-------~L~~l~l~~N~l~~~~~ 210 (633)
|+|++|++.+.. ..+.++++|+.|+|++|+ |+| .+|..++.++ +|+.|+|++|++..+|.
T Consensus 496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~ 565 (876)
T 4ecn_A 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565 (876)
T ss_dssp EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCC
T ss_pred EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCC
Confidence 999999988765 678999999999999998 998 8888777665 99999999999986664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.9e-23 Score=205.31 Aligned_cols=161 Identities=15% Similarity=0.098 Sum_probs=119.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHH----HHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEED----SKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
...|.+.+.||+|+||.||+|.+ .+|+.||+|.+.............. ..........+.+|++++++++ |
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred CeEEEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 34566779999999999999987 4799999999865432111100000 0001122567899999999999 5
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++.+++.. +..++||||+++++|.+ +.. .....++.|+++||+|| |+.+|+||||||+|||++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEE-
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHEEEE-
Confidence 777776544 56799999999999988 421 12347999999999999 688999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCccccccccccc
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT 532 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 532 (633)
++.+||+|||+|+. +..|+|||++.+
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999863 345788998753
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=224.51 Aligned_cols=172 Identities=23% Similarity=0.324 Sum_probs=152.1
Q ss_pred hhHHHHHHHHHHhcCCCC------------CCCC-CCCCCC---CceeeCCCCCCCCcceeeeEEEEecCCCCcccCCcc
Q 006739 30 RSDYKALSVILRDLGGQQ------------LFIP-SDPCST---PGVFCERRLSDNNTYVLKITKLVFVPRELTGVLSPS 93 (633)
Q Consensus 30 ~~~~~~l~~~~~~~~~~~------------~w~~-~~~C~~---~gv~c~~~~~~~~~~~~~~~~L~l~~n~l~~~~~~~ 93 (633)
..|++||.+++..+++.. .|.. .++|.| .||.|+.. .+|+.|+|++|++.|.+|++
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~--------~~V~~L~L~~~~l~g~lp~~ 100 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSN--------GRVTGLSLEGFGASGRVPDA 100 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTT--------CCEEEEECTTSCCEEEECGG
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCC--------CCEEEEEecCcccCCcCChH
Confidence 479999999999987632 3743 488999 99999754 28999999999999999999
Q ss_pred ccCCccccEEEccCCC----------------------------------------------------------------
Q 006739 94 IGRLSELRELSLANNS---------------------------------------------------------------- 109 (633)
Q Consensus 94 ~~~l~~L~~L~l~~N~---------------------------------------------------------------- 109 (633)
|++|++|+.|+|++|.
T Consensus 101 l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~ 180 (636)
T 4eco_A 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180 (636)
T ss_dssp GGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCC
T ss_pred HhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccc
Confidence 9999999999999983
Q ss_pred --------------CCCCCchhccCCCCCcEEEccCccCCCC-----------------Cccccc--CCCCCCEEEccCC
Q 006739 110 --------------LVDLLPPQIVDCKKLEILNVQNNQFSGT-----------------IPSDLS--SLIRLRVLDLSGN 156 (633)
Q Consensus 110 --------------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N 156 (633)
+++ +|..|+++++|++|+|++|+|+|. +|..++ ++++|++|+|++|
T Consensus 181 ~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred cchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 445 788999999999999999999985 999999 9999999999999
Q ss_pred cCCCCC-ccCCCCCCCCeEeCcCCc-CCc-cCCcccccC------CCCCeeccCCCCCCCCCc
Q 006739 157 SFSGNL-GFLKYFPNLEHLSLAKNL-FTG-KVPTSIRTF------RNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 157 ~l~~~~-~~~~~l~~L~~L~l~~N~-l~~-~~p~~~~~~------~~L~~l~l~~N~l~~~~~ 210 (633)
++.+.. ..+.++++|++|+|++|+ ++| .+|..++.+ ++|+.|++++|+++.+|.
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~ 322 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPV 322 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCC
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCc
Confidence 988865 678999999999999998 998 899888876 899999999999986665
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=222.97 Aligned_cols=173 Identities=28% Similarity=0.334 Sum_probs=101.9
Q ss_pred HhhCCChhHHHHHHHHHHhcCCC---CCCC-CCCCCCCCceeeCCCCCCCCcceeeeEEEEecCCCCccc---CCccccC
Q 006739 24 ARLNLDRSDYKALSVILRDLGGQ---QLFI-PSDPCSTPGVFCERRLSDNNTYVLKITKLVFVPRELTGV---LSPSIGR 96 (633)
Q Consensus 24 ~~~~~~~~~~~~l~~~~~~~~~~---~~w~-~~~~C~~~gv~c~~~~~~~~~~~~~~~~L~l~~n~l~~~---~~~~~~~ 96 (633)
++++..++|++||++||+++.++ ..|. ..|||.|.||.|+.. +|+.|+|+++.+.|. +++++.+
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~gv~C~~~---------~v~~L~L~~~~l~g~~~~l~~~l~~ 75 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDD---------KVTSIDLSSKPLNVGFSAVSSSLLS 75 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTTEEEETT---------EEEEEECTTSCCCEEHHHHHHHTTT
T ss_pred ccccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCcCCcceEECCC---------cEEEEECCCCCcCCccCccChhHhc
Confidence 44455789999999999998764 3485 458999999999732 899999999999887 5554544
Q ss_pred C-----------------------ccccEEEccCCCCCCCCch--hccCCCCCcEEEccCccCCCCCcccc-cCCCCCCE
Q 006739 97 L-----------------------SELRELSLANNSLVDLLPP--QIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRV 150 (633)
Q Consensus 97 l-----------------------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 150 (633)
+ ++|++|+|++|.+++.+|. .++++++|++|+|++|.+++.+|..+ .++++|++
T Consensus 76 L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 155 (768)
T 3rgz_A 76 LTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155 (768)
T ss_dssp CTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSE
T ss_pred cCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCE
Confidence 4 4455555555554444444 44445555555555555544444433 44445555
Q ss_pred EEccCCcCCCCCc-c---CCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCC
Q 006739 151 LDLSGNSFSGNLG-F---LKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 151 L~l~~N~l~~~~~-~---~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
|+|++|++++.++ . +.++++|++|++++|.+++.+|. ..+++|++|++++|++..
T Consensus 156 L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~ 214 (768)
T 3rgz_A 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFST 214 (768)
T ss_dssp EECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCS
T ss_pred EECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCC
Confidence 5555555444431 1 44455555555555555544332 445555555555555543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.85 E-value=4e-21 Score=195.72 Aligned_cols=180 Identities=21% Similarity=0.202 Sum_probs=131.4
Q ss_pred CCChhHHHHHHHHHHhcC-CCC----CCC-----CCCCCCCCceeeCCCCCCC-CcceeeeEEEEecCCCCcccCCcccc
Q 006739 27 NLDRSDYKALSVILRDLG-GQQ----LFI-----PSDPCSTPGVFCERRLSDN-NTYVLKITKLVFVPRELTGVLSPSIG 95 (633)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~-~~~----~w~-----~~~~C~~~gv~c~~~~~~~-~~~~~~~~~L~l~~n~l~~~~~~~~~ 95 (633)
+...+|+.||++||..+. +.. .|. ..++|.|.|+.|....... .....+++.|+|++|+++ .+|+.+.
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~ 101 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAF 101 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGG
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhh
Confidence 456789999999999874 322 262 3478999999995310000 000126788888888887 4666777
Q ss_pred CCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCC--------
Q 006739 96 RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLK-------- 166 (633)
Q Consensus 96 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~-------- 166 (633)
++++|++|+|++|.|+ .+|..++++++|++|+|++|+|+ .+|..++.+++|++|+|++|++.+.. ..+.
T Consensus 102 ~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~ 179 (328)
T 4fcg_A 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179 (328)
T ss_dssp GGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCE
T ss_pred hCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhh
Confidence 7888888888888887 47878888888888888888888 77888888888888888887665544 3333
Q ss_pred -CCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 167 -YFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 167 -~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|++..+|.
T Consensus 180 ~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~ 223 (328)
T 4fcg_A 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGP 223 (328)
T ss_dssp EESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCG
T ss_pred ccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCch
Confidence 3788888888888887 777778888888888888888876554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-21 Score=183.21 Aligned_cols=154 Identities=20% Similarity=0.262 Sum_probs=136.6
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCc
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNN 132 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 132 (633)
|.|..|.|........ ..+.+++.|+|++|+|+++.+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 7889999987422221 12457999999999999988889999999999999999999988999999999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 133 QFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 133 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
+|+...+..|.++++|+.|+|++|+|++.+ ..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.|.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 999555556889999999999999999986 6789999999999999999988888899999999999999999663
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=178.16 Aligned_cols=155 Identities=20% Similarity=0.217 Sum_probs=135.5
Q ss_pred CCCCCceeeCCCCCCC--CcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccC
Q 006739 54 PCSTPGVFCERRLSDN--NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN 131 (633)
Q Consensus 54 ~C~~~gv~c~~~~~~~--~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 131 (633)
.|.|.+|.|....... .....+++.|++++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 6 ~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 85 (208)
T 2o6s_A 6 SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST 85 (208)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence 4889999998743221 22245799999999999988888899999999999999999987677789999999999999
Q ss_pred ccCCCCCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 132 NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|+|++..+..|..+++|+.|+|++|++++.++ .+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+.
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence 99997666678999999999999999999884 578999999999999999977777789999999999999998654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.5e-21 Score=181.18 Aligned_cols=154 Identities=18% Similarity=0.218 Sum_probs=136.5
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCC-ccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccC
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLS-PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN 131 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 131 (633)
|.|..+.|........ .....++.|+|++|+|++..+ ..|.++++|+.|+|++|+|+++.+..|.++++|++|+|++
T Consensus 11 C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 7889999987432221 123467899999999999865 4689999999999999999998778999999999999999
Q ss_pred ccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 132 NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|+|++..|..|..+++|++|+|++|+|++.+ ..+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++.+.
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 9999888888999999999999999999986 6789999999999999999998899999999999999999999654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.8e-20 Score=179.80 Aligned_cols=139 Identities=24% Similarity=0.254 Sum_probs=127.9
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
+.+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 34 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 34 PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 45799999999999999888999999999999999999998888899999999999999999977778889999999999
Q ss_pred ccCCcCCCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 153 LSGNSFSGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 153 l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
|++|+|++.++ .+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..+++.
T Consensus 114 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 173 (251)
T 3m19_A 114 LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHG 173 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHH
Confidence 99999998884 578999999999999999977777899999999999999999877653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-19 Score=178.76 Aligned_cols=158 Identities=22% Similarity=0.219 Sum_probs=132.6
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
+.+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus 36 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 115 (270)
T 2o6q_A 36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELR 115 (270)
T ss_dssp CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEE
T ss_pred CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEE
Confidence 34689999999999998888899999999999999999986666778999999999999999976667789999999999
Q ss_pred ccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccccccCCCCccccccccccc
Q 006739 153 LSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLAE 231 (633)
Q Consensus 153 l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (633)
|++|++++.+ ..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|++..+++. .|..+.++..+.
T Consensus 116 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--------~~~~l~~L~~L~ 187 (270)
T 2o6q_A 116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG--------AFDKLTELKTLK 187 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT--------TTTTCTTCCEEE
T ss_pred CCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChh--------HhccCCCcCEEE
Confidence 9999999887 4578999999999999999976666789999999999999999877653 233344555555
Q ss_pred cccCCCC
Q 006739 232 TTTNGRS 238 (633)
Q Consensus 232 ~~~~~~~ 238 (633)
...+...
T Consensus 188 L~~N~l~ 194 (270)
T 2o6q_A 188 LDNNQLK 194 (270)
T ss_dssp CCSSCCS
T ss_pred CCCCcCC
Confidence 5555443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.79 E-value=9.1e-19 Score=171.24 Aligned_cols=136 Identities=24% Similarity=0.259 Sum_probs=126.6
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|.+++..+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 45899999999999999888999999999999999999998778899999999999999999976666789999999999
Q ss_pred ccCCcCCCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 153 LSGNSFSGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 153 l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|++|+|++.++ .+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999999885 689999999999999999988888899999999999999999765
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-20 Score=203.11 Aligned_cols=132 Identities=19% Similarity=0.164 Sum_probs=113.4
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCccccc-CCCCCCEEE
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS-SLIRLRVLD 152 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 152 (633)
.+++.|++++|.+++..+. .+++|+.|+|++|.|++..|..|+++++|++|+|++|.|++.+|..+. .+++|+.|+
T Consensus 99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 3688999999999887654 357899999999999998888899999999999999999988888886 799999999
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|++|.|++.+. +..+++|+.|+|++|+|++. |..+..+++|+.|+|++|+|..+|.
T Consensus 176 Ls~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~lp~ 231 (487)
T 3oja_A 176 LQYNFIYDVKG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEK 231 (487)
T ss_dssp CTTSCCCEEEC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECT
T ss_pred cCCCccccccc-cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcccch
Confidence 99999998754 44689999999999999964 4458899999999999999976553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.7e-19 Score=198.41 Aligned_cols=154 Identities=18% Similarity=0.138 Sum_probs=135.8
Q ss_pred ceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCC
Q 006739 59 GVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG 136 (633)
Q Consensus 59 gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 136 (633)
.|.|....-..+ ..+.+++.|||++|+|+++.+.+|.++++|++|||++|+|+++.|.+|.++++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 578886422222 234589999999999999988999999999999999999999778899999999999999999997
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCc-cCCcccccCCCCCeeccCCCCCCCCCccc
Q 006739 137 TIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212 (633)
Q Consensus 137 ~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~~~~L~~l~l~~N~l~~~~~~~ 212 (633)
..+..|.++++|++|+|++|+|++.+ ..++++++|++|+|++|.|++ .+|..++.+++|++|++++|+|..+++..
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 192 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 192 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence 77778999999999999999999988 468999999999999999986 46888999999999999999998877654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.4e-19 Score=160.99 Aligned_cols=134 Identities=23% Similarity=0.249 Sum_probs=123.7
Q ss_pred eeEEEEecCCCCc-ccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 75 KITKLVFVPRELT-GVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 75 ~~~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
+++.|++++|+++ +.+|..+..+++|+.|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 7999999999998 77888899999999999999999985 78999999999999999999878988888999999999
Q ss_pred cCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCC---cccccCCCCCeeccCCCCCCCCCc
Q 006739 154 SGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVP---TSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 154 ~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
++|.+++.+ ..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+.+.|.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 999999976 789999999999999999996555 488999999999999999987764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=5.9e-19 Score=173.05 Aligned_cols=152 Identities=19% Similarity=0.208 Sum_probs=106.9
Q ss_pred cccccccccccCeeEEEEEecCCCCeE--EEEEEccCCCcchhhhhHH----------HHHHHHHHHHHHHHHHHHhhcC
Q 006739 339 LASLEKIGSGGCGEVYKAELPGSNGKM--IAIKKVIQPPKDAAELTEE----------DSKLLNKKMRQIRSEINTVGQI 406 (633)
Q Consensus 339 ~~~~~~ig~G~~g~Vy~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~e~~~l~~l 406 (633)
|++.+.||+|+||.||+|... .+|+. ||||+++............ ...........+.+|+.++.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 567889999999999999872 27888 9999875542111100000 0000011234678899999999
Q ss_pred CCCccc--ccceeeecCCccEEEEecccC-C----CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 006739 407 RHRNLL--PLLAHMARPDCHLLVYEFMKN-G----SLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIH 479 (633)
Q Consensus 407 ~h~niv--~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH 479 (633)
+|+++. ..+++ ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| ++.+|+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH--~~~givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLY--QEAELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHH--HTSCEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHH--HHCCEEe
Confidence 888653 33332 367899999942 4 67666432 223456789999999999993 2889999
Q ss_pred CCCCCCCeEecCCCceEEccccccccc
Q 006739 480 RDLKPANVLLDDDMEARIADFGLAKAM 506 (633)
Q Consensus 480 ~Dikp~Nill~~~~~~kl~DfG~a~~~ 506 (633)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-18 Score=168.24 Aligned_cols=150 Identities=14% Similarity=0.170 Sum_probs=130.9
Q ss_pred eeeCCCCCCCCcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCC-CCCCCchhccCCCCCcEEEccC-ccCCCC
Q 006739 60 VFCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNS-LVDLLPPQIVDCKKLEILNVQN-NQFSGT 137 (633)
Q Consensus 60 v~c~~~~~~~~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~ 137 (633)
|.|.. .......+.+++.|++++|+++++.+..|.++++|+.|+|++|. ++++.+..|.++++|++|+|++ |++++.
T Consensus 18 v~c~~-l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i 96 (239)
T 2xwt_C 18 VTCKD-IQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96 (239)
T ss_dssp EEECS-CSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEE
T ss_pred eEccC-ccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEc
Confidence 55876 22222245589999999999999888899999999999999997 9886667899999999999999 999976
Q ss_pred CcccccCCCCCCEEEccCCcCCCCCccCCCCCCCC---eEeCcCC-cCCccCCcccccCCCCC-eeccCCCCCCCCCcc
Q 006739 138 IPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLE---HLSLAKN-LFTGKVPTSIRTFRNLQ-FFDFSGNSLLEGPIP 211 (633)
Q Consensus 138 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~~~~~L~-~l~l~~N~l~~~~~~ 211 (633)
.+..|.++++|+.|+|++|++++.+. +..+++|+ .|++++| ++++..+..|..+++|+ .|++++|++..+|..
T Consensus 97 ~~~~f~~l~~L~~L~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~ 174 (239)
T 2xwt_C 97 DPDALKELPLLKFLGIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGY 174 (239)
T ss_dssp CTTSEECCTTCCEEEEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTT
T ss_pred CHHHhCCCCCCCEEeCCCCCCccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHh
Confidence 67789999999999999999999766 88888888 9999999 99977777899999999 999999999877754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=179.59 Aligned_cols=157 Identities=22% Similarity=0.231 Sum_probs=134.3
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCcccc-CCccccEEEccCCCCCCCCchhccCCCCCcEEEccC
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIG-RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN 131 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 131 (633)
|.+..+.|........ ..+..++.|+|++|+|++..+..+. ++++|+.|+|++|+|+++.|..|.++++|++|+|++
T Consensus 18 C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 18 CASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 6778899987422211 2244689999999999998888888 999999999999999998778899999999999999
Q ss_pred ccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCccc---ccCCCCCeeccCCCCCCC
Q 006739 132 NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSI---RTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~---~~~~~L~~l~l~~N~l~~ 207 (633)
|+|++..+..|..+++|+.|+|++|+|++.. ..+..+++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|..
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 9999777778999999999999999999885 678999999999999999996444445 679999999999999998
Q ss_pred CCcc
Q 006739 208 GPIP 211 (633)
Q Consensus 208 ~~~~ 211 (633)
+|..
T Consensus 178 l~~~ 181 (361)
T 2xot_A 178 LPLT 181 (361)
T ss_dssp CCHH
T ss_pred cCHH
Confidence 8754
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=5.3e-18 Score=169.20 Aligned_cols=153 Identities=19% Similarity=0.223 Sum_probs=129.1
Q ss_pred ceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCcc-CC
Q 006739 59 GVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQ-FS 135 (633)
Q Consensus 59 gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~ 135 (633)
.+.|....-... ..+.+++.|++++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|. ++
T Consensus 15 ~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~ 94 (285)
T 1ozn_A 15 TTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94 (285)
T ss_dssp EEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred EEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCcc
Confidence 367765322211 234589999999999999888889999999999999999999778899999999999999997 87
Q ss_pred CCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 136 GTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 136 ~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
...|..|..+++|+.|+|++|.+++.+ ..+..+++|++|++++|++++..+..|..+++|+.|++++|++..++..
T Consensus 95 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 666888999999999999999999886 5688899999999999999977777788999999999999999876653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=9.1e-19 Score=199.18 Aligned_cols=84 Identities=29% Similarity=0.487 Sum_probs=53.6
Q ss_pred CCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeecc
Q 006739 122 KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200 (633)
Q Consensus 122 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l 200 (633)
++|++|||++|+++|.+|..++++++|+.|+|++|+++|.+ ..++.+++|+.|||++|+++|.+|..+..+++|++|++
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 44556666666666666666666666666666666666544 45666666666666666666666666666666666666
Q ss_pred CCCCC
Q 006739 201 SGNSL 205 (633)
Q Consensus 201 ~~N~l 205 (633)
++|++
T Consensus 712 s~N~l 716 (768)
T 3rgz_A 712 SNNNL 716 (768)
T ss_dssp CSSEE
T ss_pred cCCcc
Confidence 66666
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=3.3e-18 Score=169.83 Aligned_cols=153 Identities=18% Similarity=0.144 Sum_probs=134.8
Q ss_pred ceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCC
Q 006739 59 GVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG 136 (633)
Q Consensus 59 gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 136 (633)
.+.|........ ..+.+++.|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++
T Consensus 11 ~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 90 (276)
T 2z62_A 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (276)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred eEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCc
Confidence 477876422111 234579999999999999888899999999999999999999777799999999999999999998
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCcCCcCCcc-CCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 137 TIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLAKNLFTGK-VPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 137 ~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
..|..|.++++|+.|++++|++++.+. .+..+++|++|++++|++++. +|..|..+++|+.|++++|++..+++.
T Consensus 91 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~ 167 (276)
T 2z62_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (276)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred cChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHH
Confidence 888899999999999999999998874 689999999999999999964 699999999999999999999887654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7e-18 Score=168.45 Aligned_cols=171 Identities=21% Similarity=0.189 Sum_probs=140.1
Q ss_pred CCceeeCCCCCCC--CcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccC
Q 006739 57 TPGVFCERRLSDN--NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134 (633)
Q Consensus 57 ~~gv~c~~~~~~~--~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 134 (633)
...+.|....-.. .....+++.|+|++|.+++..+..|.++++|+.|+|++|.|++ ++.. ..+++|++|+|++|+|
T Consensus 12 l~~l~~~~~~l~~ip~~~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l 89 (290)
T 1p9a_G 12 HLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQL 89 (290)
T ss_dssp CCEEECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCC
T ss_pred ccEEECCCCCCCcCCCCCCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcC
Confidence 3456666532111 1124579999999999999988999999999999999999998 4443 8899999999999999
Q ss_pred CCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccc
Q 006739 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVM 213 (633)
Q Consensus 135 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~ 213 (633)
+ .+|..+..+++|+.|+|++|+|++.+ ..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+.+|...
T Consensus 90 ~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~- 167 (290)
T 1p9a_G 90 Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL- 167 (290)
T ss_dssp S-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT-
T ss_pred C-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHH-
Confidence 9 88999999999999999999999988 67899999999999999999877777899999999999999998777543
Q ss_pred cccCCCCccccccccccccccCCCC
Q 006739 214 RRVGPSGFQYPKRYVLAETTTNGRS 238 (633)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (633)
|..+.++..+....|...
T Consensus 168 -------~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 168 -------LNGLENLDTLLLQENSLY 185 (290)
T ss_dssp -------TTTCTTCCEEECCSSCCC
T ss_pred -------hcCcCCCCEEECCCCcCC
Confidence 334445555555555544
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5.7e-18 Score=167.67 Aligned_cols=135 Identities=20% Similarity=0.210 Sum_probs=99.0
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|.+++. +.+.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 63 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 3677777777777763 36777777777777777777766666777777777777777777666666777777777777
Q ss_pred cCCcCCCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 154 SGNSFSGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 154 ~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
++|++++.++ .+..+++|+.|++++|+|++..+..|..+++|+.|++++|++...++
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPD 198 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCH
Confidence 7777777663 45677777777777777776666666777777777777777766554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.76 E-value=9e-18 Score=166.06 Aligned_cols=139 Identities=20% Similarity=0.221 Sum_probs=127.2
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|.++.+.+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+
T Consensus 60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 45799999999999987777889999999999999999997777889999999999999999987788899999999999
Q ss_pred ccCCcCCCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 153 LSGNSFSGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 153 l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
|++|++++.+. .+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..+|..
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 199 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEG 199 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHH
Confidence 99999999884 588999999999999999987777899999999999999999877654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.76 E-value=2.9e-18 Score=160.16 Aligned_cols=129 Identities=20% Similarity=0.245 Sum_probs=110.7
Q ss_pred EEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCch-hccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccC
Q 006739 77 TKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPP-QIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155 (633)
Q Consensus 77 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 155 (633)
+.|++++|+++. +|..+.. +|+.|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 567788888855 4554533 899999999999886554 488999999999999999988899999999999999999
Q ss_pred CcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 156 NSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 156 N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|+|++.+ ..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|++.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 9999887 4588899999999999999998899999999999999999999653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=176.59 Aligned_cols=133 Identities=24% Similarity=0.357 Sum_probs=86.0
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCC-CCcEEEccCccCCCCC--------------
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCK-KLEILNVQNNQFSGTI-------------- 138 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~-------------- 138 (633)
.+++.|++++|.+++.+|..+.++++|++|+|++|++++.+|..+..++ +|++|+|++|++++.+
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~L 204 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEEC
T ss_pred CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEEC
Confidence 4566666666666666666666666666666666666655666666665 6666666666555444
Q ss_pred ---------cccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCC
Q 006739 139 ---------PSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 139 ---------p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
|..|..+++|+.|+|++|++++.++.+..+++|++|+|++|+|++.+|..|..+++|+.|+|++|+++
T Consensus 205 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred cCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccc
Confidence 44455555666666666666655555666667777777777777677777777777777777777764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.76 E-value=9.3e-18 Score=166.12 Aligned_cols=135 Identities=22% Similarity=0.258 Sum_probs=102.2
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 46777888888887777667777888888888888887766666777888888888888887666666777788888888
Q ss_pred cCCcCCCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 154 SGNSFSGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 154 ~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
++|++++.++ .+..+++|+.|++++|+|++..|..+..+++|+.|++++|++.+.
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence 8888877663 457778888888888888876666677778888888888877543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=178.49 Aligned_cols=158 Identities=19% Similarity=0.238 Sum_probs=135.0
Q ss_pred CCCCCCCceeeCCCCCCCC----cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEE
Q 006739 52 SDPCSTPGVFCERRLSDNN----TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEIL 127 (633)
Q Consensus 52 ~~~C~~~gv~c~~~~~~~~----~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 127 (633)
..+|.|.|+ |+....... ....+++.|++++|++++..+..|.++++|+.|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 467999988 664311111 123489999999999999888899999999999999999999888899999999999
Q ss_pred EccCccCCCCCcccccCCCCCCEEEccCCcCCCCCc--cCCCCCCCCeEeCcCC-cCCccCCcccccCCCCCeeccCCCC
Q 006739 128 NVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG--FLKYFPNLEHLSLAKN-LFTGKVPTSIRTFRNLQFFDFSGNS 204 (633)
Q Consensus 128 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N-~l~~~~p~~~~~~~~L~~l~l~~N~ 204 (633)
+|++|++++..+..|.++++|++|+|++|++++.+. .+..+++|++|++++| .+++..|..|..+++|+.|++++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 999999995555559999999999999999998875 7889999999999999 4776677889999999999999999
Q ss_pred CCCCCc
Q 006739 205 LLEGPI 210 (633)
Q Consensus 205 l~~~~~ 210 (633)
+...++
T Consensus 186 l~~~~~ 191 (353)
T 2z80_A 186 LQSYEP 191 (353)
T ss_dssp CCEECT
T ss_pred cCccCH
Confidence 976543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.74 E-value=6.9e-18 Score=171.71 Aligned_cols=133 Identities=21% Similarity=0.337 Sum_probs=97.2
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccC--------
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSS-------- 144 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------- 144 (633)
..+++.|+|++|.++ .+|..++++++|++|+|++|.++ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 346777888888777 56777777788888888888777 36777777777888888777777777776554
Q ss_pred -CCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 145 -LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 145 -l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
+++|+.|+|++|+++..+..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|++...
T Consensus 181 ~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~ 244 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244 (328)
T ss_dssp ESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCB
T ss_pred cCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhh
Confidence 777777777777777666667777777777777777773 555677777777777777766443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=9.6e-18 Score=160.26 Aligned_cols=132 Identities=21% Similarity=0.256 Sum_probs=119.9
Q ss_pred EEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCC
Q 006739 77 TKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156 (633)
Q Consensus 77 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (633)
+.+++++++++.+ |..+. ++|+.|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSSC-CSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCcC-CCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 5689999999875 44443 68999999999999977779999999999999999999888999999999999999999
Q ss_pred cCCCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 157 SFSGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 157 ~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+|+..+. .+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+.++..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 146 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG 146 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH
Confidence 9998884 578999999999999999998899999999999999999999887754
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.74 E-value=2.8e-18 Score=153.29 Aligned_cols=127 Identities=24% Similarity=0.263 Sum_probs=116.8
Q ss_pred eeeEEEEecCCCCc-ccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 74 LKITKLVFVPRELT-GVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 74 ~~~~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
.+++.|++++|+++ +.+|..+..+++|+.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 37999999999999 78888999999999999999999985 7899999999999999999987999888899999999
Q ss_pred ccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCC---cccccCCCCCeeccCC
Q 006739 153 LSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVP---TSIRTFRNLQFFDFSG 202 (633)
Q Consensus 153 l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~~~~L~~l~l~~ 202 (633)
|++|.+++.+ ..+..+++|+.|++++|++++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999865 788999999999999999997665 5789999999999874
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=166.88 Aligned_cols=137 Identities=31% Similarity=0.333 Sum_probs=117.2
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|+|++|.+++..+. +.+++|+.|+|++|+|+. +|..+..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 55 ~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 55 TRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp TTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 4789999999999886443 788999999999999986 7888889999999999999999766778999999999999
Q ss_pred cCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccc
Q 006739 154 SGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVM 213 (633)
Q Consensus 154 ~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~ 213 (633)
++|+|++.+ ..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|..+|...+
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~ 192 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFF 192 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhc
Confidence 999999887 457889999999999999996666667889999999999999988776543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-17 Score=177.24 Aligned_cols=153 Identities=18% Similarity=0.192 Sum_probs=128.6
Q ss_pred CCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccC
Q 006739 57 TPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134 (633)
Q Consensus 57 ~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 134 (633)
+..|.|....-... ....+++.|+|++|++++..+..|.++++|+.|+|++|+|+++.+..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 45788987422221 2245789999999999999999999999999999999999998889999999999999999999
Q ss_pred CCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCc-CCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNL-FTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 135 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++..+..|..+++|+.|+|++|.+++.+ ..+..+++|+.|+|++|+ ++...+..|..+++|+.|+|++|++..+|
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 201 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP 201 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc
Confidence 9666667999999999999999999877 468889999999999854 44334446888999999999999988765
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=7.3e-18 Score=186.97 Aligned_cols=159 Identities=19% Similarity=0.182 Sum_probs=139.9
Q ss_pred CCCCC----CceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcE
Q 006739 53 DPCST----PGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEI 126 (633)
Q Consensus 53 ~~C~~----~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 126 (633)
+||.+ ..|.|....-... ..+.+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 55654 3588876322111 13468999999999999999989999999999999999999988999999999999
Q ss_pred EEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCc-cCCcccccCCCCCeeccCCCC
Q 006739 127 LNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNS 204 (633)
Q Consensus 127 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~~~~L~~l~l~~N~ 204 (633)
|+|++|++++..|..|+++++|++|+|++|.+++.+ ..++.+++|++|++++|.+++ .+|..|+++++|++|++++|+
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 999999999888999999999999999999999887 679999999999999999986 679999999999999999999
Q ss_pred CCCCCcc
Q 006739 205 LLEGPIP 211 (633)
Q Consensus 205 l~~~~~~ 211 (633)
+...++.
T Consensus 165 l~~~~~~ 171 (606)
T 3vq2_A 165 IQTITVN 171 (606)
T ss_dssp CCEECTT
T ss_pred ceecChh
Confidence 9877654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7.2e-18 Score=180.15 Aligned_cols=159 Identities=21% Similarity=0.279 Sum_probs=136.9
Q ss_pred CCCCCCc--eeeCCCC-CCCCcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCC-chhccCCCCCcEEE
Q 006739 53 DPCSTPG--VFCERRL-SDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLL-PPQIVDCKKLEILN 128 (633)
Q Consensus 53 ~~C~~~g--v~c~~~~-~~~~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ 128 (633)
..|.|.+ |.|.... ......+.+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 3455555 8888742 222234568999999999999999999999999999999999998654 56899999999999
Q ss_pred ccCccCCCCCcccccCCCCCCEEEccCCcCCCCC---ccCCCCCCCCeEeCcCCcCCccCCcc-cccCCCCCeeccCCCC
Q 006739 129 VQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL---GFLKYFPNLEHLSLAKNLFTGKVPTS-IRTFRNLQFFDFSGNS 204 (633)
Q Consensus 129 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~---~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~L~~l~l~~N~ 204 (633)
|++|++++..|..|+++++|++|+|++|++++.. ..+..+++|++|+|++|++++..|.. +..+++|++|++++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999843 34889999999999999999887876 8999999999999999
Q ss_pred CCCCCcc
Q 006739 205 LLEGPIP 211 (633)
Q Consensus 205 l~~~~~~ 211 (633)
+...++.
T Consensus 166 l~~~~~~ 172 (455)
T 3v47_A 166 VKSICEE 172 (455)
T ss_dssp BSCCCTT
T ss_pred ccccChh
Confidence 9877654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.2e-17 Score=176.02 Aligned_cols=153 Identities=18% Similarity=0.189 Sum_probs=127.3
Q ss_pred CCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccC
Q 006739 57 TPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134 (633)
Q Consensus 57 ~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 134 (633)
+..|.|....-... ..+.+++.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 45788887432211 2345899999999999999999999999999999999999998889999999999999999999
Q ss_pred CCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCC-cCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKN-LFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 135 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++..+..|..+++|++|+|++|++++.+ ..+..+++|+.|+|++| .+....+..|..+++|+.|+|++|++..+|
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 212 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP 212 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc
Confidence 9766777999999999999999999877 46788888888888884 444333346788888888888888887664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=1.8e-17 Score=154.74 Aligned_cols=133 Identities=26% Similarity=0.340 Sum_probs=116.7
Q ss_pred CCCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCc-cccCCccccEEEccCCCCCCCCchhccCCCCCcEEEcc
Q 006739 54 PCSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSP-SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQ 130 (633)
Q Consensus 54 ~C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 130 (633)
.|.|..+.|....-... ....+++.|++++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 7 ~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 37899999987422211 1234899999999999998775 59999999999999999999889999999999999999
Q ss_pred CccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCC
Q 006739 131 NNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVP 186 (633)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p 186 (633)
+|+|++..|..|.++++|+.|+|++|+|++.+ ..+..+++|++|+|++|.|++..+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 99999888888999999999999999999885 678999999999999999997655
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2e-17 Score=165.00 Aligned_cols=159 Identities=19% Similarity=0.197 Sum_probs=129.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCC-CCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNS-LVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (633)
..+++.|++++|.+++..+..|.++++|++|+|++|. ++...|..|..+++|++|+|++|++++..|..|..+++|+.|
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 3478999999999998888889999999999999997 877668889999999999999999997778888899999999
Q ss_pred EccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccccccCCCCcccccccccc
Q 006739 152 DLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLA 230 (633)
Q Consensus 152 ~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (633)
+|++|++++.+ ..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++...++. .|..+.++..+
T Consensus 135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--------~~~~l~~L~~L 206 (285)
T 1ozn_A 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH--------AFRDLGRLMTL 206 (285)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT--------TTTTCTTCCEE
T ss_pred ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHh--------HccCcccccEe
Confidence 99999998877 4578899999999999999876666788899999999999988765433 33344455555
Q ss_pred ccccCCCCC
Q 006739 231 ETTTNGRSN 239 (633)
Q Consensus 231 ~~~~~~~~~ 239 (633)
....+....
T Consensus 207 ~l~~n~l~~ 215 (285)
T 1ozn_A 207 YLFANNLSA 215 (285)
T ss_dssp ECCSSCCSC
T ss_pred eCCCCcCCc
Confidence 555555443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.5e-17 Score=155.51 Aligned_cols=133 Identities=23% Similarity=0.257 Sum_probs=118.5
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
..+.++.++++++.+ |..+ .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 20 s~~~v~c~~~~l~~i-p~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHASV-PAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcCcc-CCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 456799999998775 4444 3889999999999999889999999999999999999996555678999999999999
Q ss_pred CCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 155 GNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 155 ~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+|+|++.+ ..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|..++..
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~ 153 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG 153 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH
Confidence 99999988 45789999999999999999 8899999999999999999999877654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=7.5e-18 Score=169.95 Aligned_cols=153 Identities=20% Similarity=0.246 Sum_probs=132.2
Q ss_pred CCCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCC--CchhccCCCCCcEEEc
Q 006739 54 PCSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL--LPPQIVDCKKLEILNV 129 (633)
Q Consensus 54 ~C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~L 129 (633)
.|.|.+|.|....-... ....+++.|+|++|+++...+..|.++++|+.|+|++|+++.. .|..+..+++|++|+|
T Consensus 6 ~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEEC
T ss_pred eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEEC
Confidence 38999999987432221 2345899999999999987666789999999999999999852 3678888999999999
Q ss_pred cCccCCCCCcccccCCCCCCEEEccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCC
Q 006739 130 QNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
++|.++ .+|..+..+++|+.|+|++|++++.+ ..+..+++|++|++++|.+++..|..+..+++|+.|++++|.+..
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 164 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGG
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccc
Confidence 999999 68888999999999999999999877 478899999999999999998888889999999999999999865
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.6e-17 Score=153.69 Aligned_cols=128 Identities=21% Similarity=0.238 Sum_probs=113.0
Q ss_pred EEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCC
Q 006739 77 TKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156 (633)
Q Consensus 77 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (633)
+.+++++|+++.+ |..+. ++|+.|+|++|+|+. +|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLKVL-PKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCSSC-CSCCC--TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCCcC-CCCCC--CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 4678888888864 44442 589999999999986 7899999999999999999999877888999999999999999
Q ss_pred cCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 157 SFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 157 ~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
+|++.+ ..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.|.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 999988 5789999999999999999976666799999999999999999653
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=3e-17 Score=156.81 Aligned_cols=133 Identities=17% Similarity=0.153 Sum_probs=118.0
Q ss_pred eEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCc-hhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 76 ITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLP-PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 76 ~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
-+.+++++|+++. +|..+. ..++.|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus 13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 3589999999987 455553 457899999999999645 458999999999999999998778899999999999999
Q ss_pred CCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 155 GNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 155 ~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+|+|++.+ ..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|+.+++.
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 99999988 4589999999999999999998899999999999999999999877554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=8.5e-18 Score=184.12 Aligned_cols=156 Identities=18% Similarity=0.247 Sum_probs=135.1
Q ss_pred CCCCCceeeCCCCCCCC----cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEc
Q 006739 54 PCSTPGVFCERRLSDNN----TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNV 129 (633)
Q Consensus 54 ~C~~~gv~c~~~~~~~~----~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 129 (633)
.|.|.|+ |+....... ....+++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5999999 875321111 12347999999999999999999999999999999999999988899999999999999
Q ss_pred cCccCCCCCcccccCCCCCCEEEccCCcCCCC--CccCCCCCCCCeEeCcCCcCCccCC-cccccCCCCCeeccCCCCCC
Q 006739 130 QNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGN--LGFLKYFPNLEHLSLAKNLFTGKVP-TSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~L~~l~l~~N~l~ 206 (633)
++|++++..|..|+++++|++|+|++|.+++. +..+.++++|++|++++|++.+.+| ..|..+++|+.|++++|++.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 99999987777799999999999999999964 4678999999999999999555555 68999999999999999997
Q ss_pred CCCc
Q 006739 207 EGPI 210 (633)
Q Consensus 207 ~~~~ 210 (633)
...+
T Consensus 162 ~~~~ 165 (549)
T 2z81_A 162 NYQS 165 (549)
T ss_dssp EECT
T ss_pred ccCh
Confidence 6443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-17 Score=176.41 Aligned_cols=155 Identities=17% Similarity=0.186 Sum_probs=136.8
Q ss_pred CCceeeCCCCCCC--CcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccC
Q 006739 57 TPGVFCERRLSDN--NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134 (633)
Q Consensus 57 ~~gv~c~~~~~~~--~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 134 (633)
|..|.|....-.. ...+.+++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence 5679998742221 12345899999999999999999999999999999999999998899999999999999999999
Q ss_pred CCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 135 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
++..+..|.++++|+.|+|++|++++.+ ..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++..++..
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 9655567899999999999999999876 6789999999999999999988899999999999999999999887754
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=4.3e-17 Score=150.14 Aligned_cols=128 Identities=20% Similarity=0.186 Sum_probs=99.0
Q ss_pred EEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcC
Q 006739 79 LVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSF 158 (633)
Q Consensus 79 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 158 (633)
+++++|+++.. |..+ .++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus 12 l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 88 (177)
T 2o6r_A 12 IRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL 88 (177)
T ss_dssp EECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCc
Confidence 33344455543 3322 36788899999988886666778888999999999999866666678888999999999998
Q ss_pred CCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 159 SGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 159 ~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++.++ .+..+++|++|+|++|+|++..+..+..+++|+.|+|++|++.+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 89 QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 88774 4678889999999999998666666788889999999999886654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-16 Score=147.28 Aligned_cols=133 Identities=20% Similarity=0.300 Sum_probs=115.2
Q ss_pred CCCCCceeeCCCCCCC--CcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccC
Q 006739 54 PCSTPGVFCERRLSDN--NTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN 131 (633)
Q Consensus 54 ~C~~~gv~c~~~~~~~--~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 131 (633)
.|+|.++.|....-.. .....+++.|++++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 6 ~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 6 SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 3789999998742211 12245899999999999998888899999999999999999997777789999999999999
Q ss_pred ccCCCCCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCcCCcCCccCC
Q 006739 132 NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLAKNLFTGKVP 186 (633)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p 186 (633)
|+|++..+..+..+++|+.|+|++|+|++.+. .+..+++|+.|+|++|.+++..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99997777778999999999999999998885 46889999999999999997655
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.8e-17 Score=180.43 Aligned_cols=138 Identities=16% Similarity=0.156 Sum_probs=125.7
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|.+..+.+..|.++++|+.|+|++|.|++..|..|..+++|++|+|++|.|++..|..|+++++|++|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 46789999999999887777899999999999999999987889999999999999999999888888999999999999
Q ss_pred cCCcCCCCCcc-CCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 154 SGNSFSGNLGF-LKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 154 ~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
++|.|++.++. +..+++|++|+|++|.|++..|..|..+++|+.|+|++|.+...+..
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 189 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLS 189 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGG
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChh
Confidence 99999988854 68999999999999999998888999999999999999999877643
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=7.9e-17 Score=159.86 Aligned_cols=139 Identities=19% Similarity=0.200 Sum_probs=124.8
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 34799999999999998888999999999999999999998778999999999999999999977777899999999999
Q ss_pred ccCCcCCC--CCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCC----eeccCCCCCCCCCcc
Q 006739 153 LSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQ----FFDFSGNSLLEGPIP 211 (633)
Q Consensus 153 l~~N~l~~--~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~----~l~l~~N~l~~~~~~ 211 (633)
|++|.+++ .+..+..+++|+.|+|++|++++..+..+..+++|+ .|++++|++..++..
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~ 195 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTT
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCcc
Confidence 99999987 457889999999999999999988778887777777 899999999877654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=4.6e-17 Score=173.87 Aligned_cols=137 Identities=20% Similarity=0.174 Sum_probs=124.1
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|.+++.+|..+.++++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 37899999999999999999999999999999999999988889999999999999999999888889999999999999
Q ss_pred cCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 154 SGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 154 ~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
++|++++.+ ..+..+++|++|+|++|+|++..+..|..+++|+.|++++|++.+..+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999885 678899999999999999997666778899999999999999976543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-16 Score=161.46 Aligned_cols=153 Identities=19% Similarity=0.252 Sum_probs=133.2
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCc
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNN 132 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 132 (633)
|.|..+.|....-... ....+++.|++++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 7899999986422111 12357999999999999988889999999999999999999988999999999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCcCCcCC--ccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 133 QFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLAKNLFT--GKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 133 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~--~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+++ .+|..+. ++|++|+|++|++++.+. .+..+++|+.|++++|.++ +..|..+..+ +|+.|++++|++..+|
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l~ 188 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIP 188 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSCC
T ss_pred cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCccC
Confidence 999 7887765 799999999999998884 5899999999999999996 4778888888 9999999999998877
Q ss_pred cc
Q 006739 210 IP 211 (633)
Q Consensus 210 ~~ 211 (633)
..
T Consensus 189 ~~ 190 (332)
T 2ft3_A 189 KD 190 (332)
T ss_dssp SS
T ss_pred cc
Confidence 54
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=5.7e-17 Score=169.46 Aligned_cols=138 Identities=16% Similarity=0.160 Sum_probs=126.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|.++...+..|.++++|+.|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 35789999999999987766789999999999999999997778999999999999999999988888899999999999
Q ss_pred ccCCcCCCCCcc-CCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 153 LSGNSFSGNLGF-LKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 153 l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|++|.++..+.. +..+++|++|++++|++++..|..|..+++|+.|++++|++...+.
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 182 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL 182 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCG
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcccc
Confidence 999999988854 6899999999999999998888889999999999999999987654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.7e-17 Score=164.83 Aligned_cols=138 Identities=20% Similarity=0.242 Sum_probs=117.4
Q ss_pred eeeEEEEecCCCCcccCC-ccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCC-CCcccccCCCCCCEE
Q 006739 74 LKITKLVFVPRELTGVLS-PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG-TIPSDLSSLIRLRVL 151 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L 151 (633)
.+++.|++++|++++..+ ..+.++++|+.|+|++|.+++..|..|..+++|++|+|++|.+++ .+|..+..+++|+.|
T Consensus 101 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 180 (306)
T 2z66_A 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180 (306)
T ss_dssp TTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEE
Confidence 368889999999888765 578888999999999999988888888889999999999999886 578888889999999
Q ss_pred EccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 152 DLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 152 ~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+|++|++++.+ ..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++...++.
T Consensus 181 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (306)
T 2z66_A 181 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 241 (306)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSS
T ss_pred ECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHH
Confidence 99999998875 6788889999999999999877777788889999999999988766544
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=162.92 Aligned_cols=155 Identities=17% Similarity=0.238 Sum_probs=134.4
Q ss_pred CCCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccC
Q 006739 54 PCSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN 131 (633)
Q Consensus 54 ~C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 131 (633)
.|.+..+.|....-... ....+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 47899999986322211 1245789999999999998888999999999999999999998899999999999999999
Q ss_pred ccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCc--cCCcccccCCCCCeeccCCCCCCCC
Q 006739 132 NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTG--KVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|+++ .+|..+. ++|+.|++++|++++.+ ..+..+++|+.|++++|.++. ..+..+..+++|+.|++++|.+..+
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l 186 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 186 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC
Confidence 9999 7787765 79999999999999887 468899999999999999963 7788899999999999999999877
Q ss_pred Ccc
Q 006739 209 PIP 211 (633)
Q Consensus 209 ~~~ 211 (633)
|..
T Consensus 187 ~~~ 189 (330)
T 1xku_A 187 PQG 189 (330)
T ss_dssp CSS
T ss_pred Ccc
Confidence 653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.69 E-value=4e-17 Score=165.01 Aligned_cols=134 Identities=25% Similarity=0.270 Sum_probs=97.8
Q ss_pred eeEEEEecCCCCcccCCccc--cCCccccEEEccCCCCCCCCchhccCC-----CCCcEEEccCccCCCCCcccccCCCC
Q 006739 75 KITKLVFVPRELTGVLSPSI--GRLSELRELSLANNSLVDLLPPQIVDC-----KKLEILNVQNNQFSGTIPSDLSSLIR 147 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~ 147 (633)
+++.|+|++|++++.+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 67788888888887777765 7788888888888888775 7777666 78888888888888766677888888
Q ss_pred CCEEEccCCcCCCC---CccC--CCCCCCCeEeCcCCcCCc--cCC-cccccCCCCCeeccCCCCCCCCC
Q 006739 148 LRVLDLSGNSFSGN---LGFL--KYFPNLEHLSLAKNLFTG--KVP-TSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 148 L~~L~l~~N~l~~~---~~~~--~~l~~L~~L~l~~N~l~~--~~p-~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|+.|+|++|++.+. +..+ ..+++|++|+|++|+|++ .++ ..+..+++|+.|++++|++...+
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 244 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence 88888888887664 2233 677788888888888773 122 33456677888888888776644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-16 Score=180.08 Aligned_cols=157 Identities=22% Similarity=0.177 Sum_probs=135.7
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCc
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNN 132 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 132 (633)
|.+..|.|....-... ..+.+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 4455578876322211 12458999999999999988888999999999999999999988999999999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 133 QFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 133 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
++++..+..|+++++|++|+|++|++++.+ ..+..+++|++|+|++|.+++..|..+..+++|+.|++++|.+...++.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 999554557999999999999999999887 5789999999999999999998898899999999999999999877654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-17 Score=184.89 Aligned_cols=140 Identities=18% Similarity=0.267 Sum_probs=128.7
Q ss_pred CcceeeeEEEEecCCCCccc-----------------CCcccc--CCccccEEEccCCCCCCCCchhccCCCCCcEEEcc
Q 006739 70 NTYVLKITKLVFVPRELTGV-----------------LSPSIG--RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQ 130 (633)
Q Consensus 70 ~~~~~~~~~L~l~~n~l~~~-----------------~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 130 (633)
.....+++.|+|++|.+++. +|+.++ ++++|++|+|++|++.+.+|..|+++++|++|+|+
T Consensus 202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 281 (636)
T 4eco_A 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281 (636)
T ss_dssp GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence 33455899999999999996 899988 99999999999999999999999999999999999
Q ss_pred Ccc-CCC-CCcccccCC------CCCCEEEccCCcCCCCCc--cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeecc
Q 006739 131 NNQ-FSG-TIPSDLSSL------IRLRVLDLSGNSFSGNLG--FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200 (633)
Q Consensus 131 ~N~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l 200 (633)
+|+ ++| .+|..++.+ ++|+.|+|++|+++..+. .+..+++|+.|++++|+++|.+| .|+.+++|+.|++
T Consensus 282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L 360 (636)
T 4eco_A 282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNL 360 (636)
T ss_dssp TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEEC
T ss_pred CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEEC
Confidence 998 998 899998887 999999999999997777 89999999999999999999999 8999999999999
Q ss_pred CCCCCCCCCc
Q 006739 201 SGNSLLEGPI 210 (633)
Q Consensus 201 ~~N~l~~~~~ 210 (633)
++|++..+|.
T Consensus 361 ~~N~l~~lp~ 370 (636)
T 4eco_A 361 AYNQITEIPA 370 (636)
T ss_dssp CSSEEEECCT
T ss_pred CCCccccccH
Confidence 9999986654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.68 E-value=3.7e-17 Score=168.82 Aligned_cols=136 Identities=22% Similarity=0.200 Sum_probs=122.2
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|+|+++.+..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 34799999999999999888999999999999999999997777899999999999999999988899999999999999
Q ss_pred ccCCcCCCCCcc-C---CCCCCCCeEeCcCCcCCccCCcccccCCC--CCeeccCCCCCCCC
Q 006739 153 LSGNSFSGNLGF-L---KYFPNLEHLSLAKNLFTGKVPTSIRTFRN--LQFFDFSGNSLLEG 208 (633)
Q Consensus 153 l~~N~l~~~~~~-~---~~l~~L~~L~l~~N~l~~~~p~~~~~~~~--L~~l~l~~N~l~~~ 208 (633)
|++|+|++.+.. + ..+++|+.|+|++|+|++..+..+..+++ |+.|+|++|++.|-
T Consensus 143 L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 143 LSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 999999998844 3 67999999999999999766677888887 48999999999763
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.8e-16 Score=146.12 Aligned_cols=134 Identities=20% Similarity=0.174 Sum_probs=116.5
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.-+.++.++++++.+. ..+ .++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 8 ~~~~v~c~~~~l~~~p-~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 8 SGTTVECYSQGRTSVP-TGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp ETTEEECCSSCCSSCC-SCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCccCCC-CCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence 3457889999988753 333 4689999999999999777778999999999999999996666678999999999999
Q ss_pred CCcCCCCCc-cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 155 GNSFSGNLG-FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 155 ~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+|++++.+. .+..+++|++|+|++|+|++..+..|..+++|+.|++++|++..++..
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 142 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG 142 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH
Confidence 999998884 578999999999999999987777789999999999999999877654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.7e-16 Score=174.62 Aligned_cols=153 Identities=18% Similarity=0.158 Sum_probs=134.9
Q ss_pred ceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCC
Q 006739 59 GVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG 136 (633)
Q Consensus 59 gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 136 (633)
-+.|........ ..+.+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++
T Consensus 11 ~~~c~~~~l~~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~ 90 (570)
T 2z63_A 11 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 90 (570)
T ss_dssp EEECCSSCCSSCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEEeCCCCccccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc
Confidence 367765321111 234579999999999999988899999999999999999999878899999999999999999998
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCcCCcCCc-cCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 137 TIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 137 ~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~-~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
..|..|.++++|++|+|++|++++.+. .++.+++|++|++++|.+++ .+|..|+++++|+.|++++|++...++.
T Consensus 91 ~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~ 167 (570)
T 2z63_A 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167 (570)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGG
T ss_pred cCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHH
Confidence 888899999999999999999999874 68999999999999999997 4799999999999999999999877654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-16 Score=177.73 Aligned_cols=155 Identities=19% Similarity=0.094 Sum_probs=132.1
Q ss_pred CCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccC
Q 006739 57 TPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134 (633)
Q Consensus 57 ~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 134 (633)
+..+.|....-... ..+.+++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 34578877422221 2345799999999999999999999999999999999999998899999999999999999999
Q ss_pred CCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 135 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
++..|..|+++++|++|+|++|++++.. ..+..+++|++|++++|++++..+..+..+++|+.|++++|++...++.
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence 9888999999999999999999999874 6788999999999999999974434445589999999999999776553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.8e-16 Score=167.54 Aligned_cols=134 Identities=20% Similarity=0.198 Sum_probs=88.7
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|+++++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+..|..+++|+.|+
T Consensus 98 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 177 (452)
T 3zyi_A 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLD 177 (452)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEe
Confidence 45789999999999998888999999999999999999987777788999999999999999855554565555555555
Q ss_pred ccCC-cCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 153 LSGN-SFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 153 l~~N-~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|++| .++..+ ..+..+++|++|+|++|+|++ +| .+..+++|+.|+|++|++..+
T Consensus 178 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp CCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCccc
Confidence 5552 233222 234444444444444444442 22 234444444444444444333
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.67 E-value=8e-17 Score=162.80 Aligned_cols=155 Identities=17% Similarity=0.142 Sum_probs=126.9
Q ss_pred eeeeEEEEecCCCCcccCCccccCC-----ccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCC--Ccccc--c
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRL-----SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGT--IPSDL--S 143 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~ 143 (633)
..+++.|+|++|++++. |..++.+ ++|++|+|++|+|++..|..|..+++|++|+|++|++.+. +|..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 44899999999999998 7778877 8999999999999998889999999999999999999865 34455 8
Q ss_pred CCCCCCEEEccCCcCCCCC----ccCCCCCCCCeEeCcCCcCCccCC-cccccCCCCCeeccCCCCCCCCCcccccccCC
Q 006739 144 SLIRLRVLDLSGNSFSGNL----GFLKYFPNLEHLSLAKNLFTGKVP-TSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGP 218 (633)
Q Consensus 144 ~l~~L~~L~l~~N~l~~~~----~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~ 218 (633)
.+++|+.|+|++|+|++.+ ..+..+++|+.|+|++|+|++..| ..+..+++|+.|+|++|+|+.+|....
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~----- 273 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP----- 273 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC-----
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc-----
Confidence 8999999999999999644 334678999999999999998775 456678999999999999987764321
Q ss_pred CCccccccccccccccCCCCC
Q 006739 219 SGFQYPKRYVLAETTTNGRSN 239 (633)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~ 239 (633)
.++..+..+.|....
T Consensus 274 ------~~L~~L~Ls~N~l~~ 288 (312)
T 1wwl_A 274 ------AKLSVLDLSYNRLDR 288 (312)
T ss_dssp ------SEEEEEECCSSCCCS
T ss_pred ------CCceEEECCCCCCCC
Confidence 345555555555443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-17 Score=184.90 Aligned_cols=182 Identities=20% Similarity=0.211 Sum_probs=117.8
Q ss_pred CCChhHHHHHHHHHHhcCC-----CCCCCCC--CCCCCCceeeCCCCCCCC---------cceeeeEEEEecCCCCcc--
Q 006739 27 NLDRSDYKALSVILRDLGG-----QQLFIPS--DPCSTPGVFCERRLSDNN---------TYVLKITKLVFVPRELTG-- 88 (633)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~-----~~~w~~~--~~C~~~gv~c~~~~~~~~---------~~~~~~~~L~l~~n~l~~-- 88 (633)
+....+..+|+++..+... ...|... ..+.|.++.+........ .....+..++|+.|.|.+
T Consensus 128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred hccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 4567788899999877643 2235222 446777766655211000 001123455566655544
Q ss_pred -------cCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCC
Q 006739 89 -------VLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGN 161 (633)
Q Consensus 89 -------~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 161 (633)
.++..+..++.|+.|+|++|.|.. +|..+.++++|++|+|++|.|+ .+|..|++|++|+.|+|++|+|+.+
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l 285 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSL 285 (727)
T ss_dssp --------------CCCCCCEEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSC
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCcc
Confidence 346678999999999999999986 7888889999999999999999 9999999999999999999999988
Q ss_pred CccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 162 LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 162 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+..+..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|+..++.
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~ 334 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK 334 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence 888999999999999999998 7898999999999999999999765544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.3e-18 Score=173.89 Aligned_cols=153 Identities=12% Similarity=0.105 Sum_probs=103.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhH------H--HHHHHHHHHHHHHHHHHHhhcCCC
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTE------E--DSKLLNKKMRQIRSEINTVGQIRH 408 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~------~--~~~~~~~~~~~~~~e~~~l~~l~h 408 (633)
.-|++.+.||+|++|.||+|... +|+.||||+++........... . .........-...+|...+.++.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 34889999999999999999864 7999999987643211100000 0 000011112233457777777755
Q ss_pred CcccccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeE
Q 006739 409 RNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVL 488 (633)
Q Consensus 409 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nil 488 (633)
.++....-+.. ...++||||++|++|.++... .....++.|++.+|.|| |+.+||||||||.|||
T Consensus 173 ~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~l---H~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 173 EGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRL---AKHGLIHGDFNEFNIL 237 (397)
T ss_dssp TTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEE
T ss_pred cCCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEE
Confidence 55432222222 234799999999888654321 12356889999999999 5678999999999999
Q ss_pred ecCCC----------ceEEccccccccc
Q 006739 489 LDDDM----------EARIADFGLAKAM 506 (633)
Q Consensus 489 l~~~~----------~~kl~DfG~a~~~ 506 (633)
+++++ .+.|+||+-+...
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EeCCCCcccccccccceEEEEeCCcccC
Confidence 99876 3899999977654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=150.13 Aligned_cols=130 Identities=18% Similarity=0.297 Sum_probs=106.1
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|+++. +| .+..+++|+.|+|++|.++. + ..+..+++|++|+|++|++++..|..++.+++|+.|+|
T Consensus 44 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~~-~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHATN-Y-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCSC-C-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCCc-c-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 368888999988885 34 68888889999999997765 3 47888899999999999998777888888899999999
Q ss_pred cCCcCCCCC-ccCCCCCCCCeEeCcCCc-CCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 154 SGNSFSGNL-GFLKYFPNLEHLSLAKNL-FTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 154 ~~N~l~~~~-~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++|++++.. ..+..+++|+.|++++|+ ++ .+| .+..+++|+.|++++|++..++
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~ 175 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR 175 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH
Confidence 999888743 667888899999999998 55 565 6888888999999999887654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.1e-16 Score=181.60 Aligned_cols=140 Identities=19% Similarity=0.206 Sum_probs=125.5
Q ss_pred ceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCC-chhccCCCCCcEEEccCccCCCCCcccccCCCCCCE
Q 006739 72 YVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLL-PPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRV 150 (633)
Q Consensus 72 ~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 150 (633)
.+.+++.|+|++|.|++..+..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+|++..|..|.++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 4568999999999999999999999999999999999666555 789999999999999999999888999999999999
Q ss_pred EEccCCcCCCCC-c--cCCCCCCCCeEeCcCCcCCccCC-cccccCCCCCeeccCCCCCCCCCcc
Q 006739 151 LDLSGNSFSGNL-G--FLKYFPNLEHLSLAKNLFTGKVP-TSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 151 L~l~~N~l~~~~-~--~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
|+|++|.+++.. . .+.++++|++|+|++|.+++..+ ..|+++++|+.|+|++|.+....+.
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~ 166 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH 166 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSG
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHH
Confidence 999999999843 3 48999999999999999997755 5799999999999999999776543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.3e-16 Score=146.18 Aligned_cols=128 Identities=21% Similarity=0.263 Sum_probs=112.1
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCc
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNN 132 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 132 (633)
|.+..|.|....-... ....+++.|+|++|+|+. +|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 10 C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred eCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 6788889987422111 124579999999999985 6688999999999999999999988889999999999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCcCCcCCc
Q 006739 133 QFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLAKNLFTG 183 (633)
Q Consensus 133 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~ 183 (633)
+|++..|..|..+++|+.|+|++|+|++.+. .+..+++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 9998888889999999999999999999884 68899999999999999974
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.3e-16 Score=146.85 Aligned_cols=130 Identities=20% Similarity=0.292 Sum_probs=114.7
Q ss_pred ceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEE
Q 006739 72 YVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVL 151 (633)
Q Consensus 72 ~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 151 (633)
...+++.|++++|.++.. +.+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..++.+++|+.|
T Consensus 64 ~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L 141 (197)
T 4ezg_A 64 YAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141 (197)
T ss_dssp GCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEE
T ss_pred cCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEE
Confidence 345899999999977653 579999999999999999998778899999999999999999998889999999999999
Q ss_pred EccCCc-CCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCC
Q 006739 152 DLSGNS-FSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 152 ~l~~N~-l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
+|++|. ++..+ .+..+++|+.|++++|.+++ ++ .+..+++|+.|++++|+|.
T Consensus 142 ~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 142 DLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp ECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred EccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 999998 66654 78899999999999999995 44 7899999999999999984
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.66 E-value=7.9e-17 Score=182.59 Aligned_cols=138 Identities=20% Similarity=0.247 Sum_probs=124.2
Q ss_pred cceeeeEEEEecCCCCcc-----------------cCCcccc--CCccccEEEccCCCCCCCCchhccCCCCCcEEEccC
Q 006739 71 TYVLKITKLVFVPRELTG-----------------VLSPSIG--RLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN 131 (633)
Q Consensus 71 ~~~~~~~~L~l~~n~l~~-----------------~~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 131 (633)
....+++.|+|++|.|++ .+|+.++ ++++|+.|+|++|++.+.+|..|.++++|+.|+|++
T Consensus 445 ~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~ 524 (876)
T 4ecn_A 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524 (876)
T ss_dssp GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTT
T ss_pred hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcC
Confidence 335589999999999999 4888877 999999999999999999999999999999999999
Q ss_pred cc-CCC-CCcccccCCC-------CCCEEEccCCcCCCCCc--cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeecc
Q 006739 132 NQ-FSG-TIPSDLSSLI-------RLRVLDLSGNSFSGNLG--FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200 (633)
Q Consensus 132 N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l 200 (633)
|+ |+| .+|..++.++ +|+.|+|++|+++..+. .+.++++|+.|+|++|+|+ .+| .|+.+++|+.|+|
T Consensus 525 N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~L 602 (876)
T 4ecn_A 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKL 602 (876)
T ss_dssp CTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEEC
T ss_pred CCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEEC
Confidence 98 998 8898777665 99999999999997777 7999999999999999999 888 8999999999999
Q ss_pred CCCCCCCCCc
Q 006739 201 SGNSLLEGPI 210 (633)
Q Consensus 201 ~~N~l~~~~~ 210 (633)
++|++..+|.
T Consensus 603 s~N~l~~lp~ 612 (876)
T 4ecn_A 603 DYNQIEEIPE 612 (876)
T ss_dssp CSSCCSCCCT
T ss_pred cCCccccchH
Confidence 9999986653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.7e-16 Score=163.94 Aligned_cols=134 Identities=24% Similarity=0.273 Sum_probs=90.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|+++++.+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 87 l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 166 (440)
T 3zyj_A 87 LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166 (440)
T ss_dssp CSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeC
Confidence 45788889999888888778888888888899988888886666788888888888888888855555666666666666
Q ss_pred ccCC-cCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 153 LSGN-SFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 153 l~~N-~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|++| .++..+ ..+..+++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|+.+
T Consensus 167 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp CCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEE
T ss_pred CCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCcc
Confidence 6663 333322 23555555555555555555 333 244455555555555555444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=6.1e-16 Score=170.81 Aligned_cols=110 Identities=16% Similarity=0.195 Sum_probs=79.8
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|+|++|.+++..+..|+++++|+.|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 46778888888888777777788888888888888887766667777777777777777777444444577777777777
Q ss_pred cCCcCCCCC-ccCCCCCCCCeEeCcCCcCCc
Q 006739 154 SGNSFSGNL-GFLKYFPNLEHLSLAKNLFTG 183 (633)
Q Consensus 154 ~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~ 183 (633)
++|.+++.+ ..+..+++|+.|+|++|.|++
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 777777665 346666666666666666653
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.7e-16 Score=174.11 Aligned_cols=131 Identities=16% Similarity=0.203 Sum_probs=115.7
Q ss_pred EEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCc
Q 006739 78 KLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS 157 (633)
Q Consensus 78 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 157 (633)
..+-++.+++.+ |..+. +++++|||++|+|+++.|..|.++++|++|||++|+|++..|..|.+|++|++|+|++|+
T Consensus 35 ~~~c~~~~l~~v-P~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFYKI-PDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCSSC-CSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcCcc-CCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 346777788764 44442 479999999999999777899999999999999999997777889999999999999999
Q ss_pred CCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 158 FSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 158 l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
|++.+ ..|.++++|++|+|++|+|++..+..|+.+++|++|+|++|.+..++.+
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~ 166 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 166 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCc
Confidence 99988 5689999999999999999987777899999999999999999887654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=146.71 Aligned_cols=128 Identities=20% Similarity=0.195 Sum_probs=112.0
Q ss_pred eeEEEEecCCCCcccCCccccCCc-cccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLS-ELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
+++.|++++|+++.+ + .+..+. +|+.|+|++|.|++. ..|..+++|++|+|++|+|++..|..+..+++|+.|+|
T Consensus 20 ~L~~L~l~~n~l~~i-~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 20 RDRELDLRGYKIPVI-E-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp SCEEEECTTSCCCSC-C-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CceEEEeeCCCCchh-H-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 789999999999975 4 465655 999999999999984 68999999999999999999554455689999999999
Q ss_pred cCCcCCCCCc--cCCCCCCCCeEeCcCCcCCccCCcc----cccCCCCCeeccCCCCCCC
Q 006739 154 SGNSFSGNLG--FLKYFPNLEHLSLAKNLFTGKVPTS----IRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 154 ~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~----~~~~~~L~~l~l~~N~l~~ 207 (633)
++|+|+..+. .+..+++|+.|++++|.++ .+|.. +..+++|+.||+++|.+.+
T Consensus 96 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 96 TNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999988775 7889999999999999998 56764 8999999999999998744
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.9e-16 Score=159.96 Aligned_cols=133 Identities=21% Similarity=0.180 Sum_probs=102.6
Q ss_pred eeEEEEecCCCCcccCCccc--cCCccccEEEccCCCCCCCCc----hhccCCCCCcEEEccCccCCCCCcccccCCCCC
Q 006739 75 KITKLVFVPRELTGVLSPSI--GRLSELRELSLANNSLVDLLP----PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRL 148 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 148 (633)
+++.|++++|++++..|..+ .++++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|+.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 58888999998888888877 888888888888888887554 345568888888888888887777888888888
Q ss_pred CEEEccCCcCCCC---C--ccCCCCCCCCeEeCcCCcCCccCCc----ccccCCCCCeeccCCCCCCCC
Q 006739 149 RVLDLSGNSFSGN---L--GFLKYFPNLEHLSLAKNLFTGKVPT----SIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 149 ~~L~l~~N~l~~~---~--~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~~~~L~~l~l~~N~l~~~ 208 (633)
++|+|++|++.+. + ..+..+++|++|+|++|+|+ .++. .++.+++|++|+|++|++...
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 239 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRAT 239 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCcc
Confidence 8888888887652 2 22357778888888888886 3333 246678888888888887665
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=4.6e-16 Score=167.15 Aligned_cols=138 Identities=17% Similarity=0.157 Sum_probs=126.9
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|.+++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 45899999999999999999999999999999999999986666789999999999999999988899999999999999
Q ss_pred ccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 153 LSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 153 l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|++|.+++.. ..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|.+..++.
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~ 193 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECT
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeCh
Confidence 9999999876 578999999999999999997777779999999999999999977654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.5e-15 Score=153.06 Aligned_cols=127 Identities=20% Similarity=0.309 Sum_probs=93.3
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|.+++..+ +.++++|+.|+|++|++++ ++ .+..+++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 63 ~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 467788888888777544 7777888888888888776 34 57777888888888888874 443 777778888888
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++|.+++.++ +..+++|+.|++++|++++. +. +..+++|+.|++++|++..++
T Consensus 137 ~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 137 DLNQITNISP-LAGLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp CSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCG
T ss_pred CCCccCcCcc-ccCCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCCccCcCh
Confidence 8887776655 66777778888888877743 33 777777777777777776654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.7e-16 Score=153.01 Aligned_cols=128 Identities=30% Similarity=0.385 Sum_probs=102.8
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|++++..+ +.++++|+.|+|++|.+++ +| .+..+++|++|+|++|++++ + ..+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 3478888888888887654 8888888888888888877 44 48888888888888888884 4 4678888888888
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|++|++++. +.+..+++|+.|++++|+|++..| +..+++|+.|++++|+|+.++
T Consensus 141 l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~ 194 (291)
T 1h6t_A 141 LGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR 194 (291)
T ss_dssp CCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG
T ss_pred ccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCCh
Confidence 888888876 667788888888888888886544 788888888888888887653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.8e-15 Score=164.33 Aligned_cols=136 Identities=24% Similarity=0.304 Sum_probs=105.9
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCC--CCchhccCCCCCcEEEccCccCCCCCccc-ccCCCCCC
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVD--LLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLR 149 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~ 149 (633)
..+++.|++++|.+++.+|..+.++++|+.|+|++|++++ .+|..+..+++|++|+|++|++++.+|.. +..+++|+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 3467888888888888788888888888888888888876 45567888888888888888888656654 77788888
Q ss_pred EEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 150 VLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 150 ~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
.|+|++|++++.. ..+. ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+.+|..
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~ 462 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDG 462 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTT
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHH
Confidence 8888888887654 2222 68888888888888 7777777888888888888888766643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.4e-15 Score=157.03 Aligned_cols=108 Identities=18% Similarity=0.264 Sum_probs=60.7
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCccc-ccCCCCCCEEE
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRVLD 152 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ 152 (633)
.+++.|++++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++ .+|.. |..+++|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 35566666666666555555666666666666666666555555556666666666666665 33332 45555666666
Q ss_pred ccCCcCCCCC-ccCCCCCCCCeEeCcCCcCC
Q 006739 153 LSGNSFSGNL-GFLKYFPNLEHLSLAKNLFT 182 (633)
Q Consensus 153 l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~ 182 (633)
|++|++++.+ ..+..+++|+.|++++|+++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 6666555544 23455555555555555544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=6.6e-16 Score=171.19 Aligned_cols=141 Identities=18% Similarity=0.192 Sum_probs=128.8
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|+++++.|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..++++++|++|+
T Consensus 55 l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 134 (606)
T 3vq2_A 55 FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLN 134 (606)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEE
T ss_pred CccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEe
Confidence 45899999999999999999999999999999999999998899999999999999999999977778899999999999
Q ss_pred ccCCcCCC--CCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCC----eeccCCCCCCCCCcccc
Q 006739 153 LSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQ----FFDFSGNSLLEGPIPVM 213 (633)
Q Consensus 153 l~~N~l~~--~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~----~l~l~~N~l~~~~~~~~ 213 (633)
|++|.+++ .+..+.++++|++|++++|++++..|..|+.+.+|+ .|++++|++..++...+
T Consensus 135 L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~ 201 (606)
T 3vq2_A 135 VAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201 (606)
T ss_dssp CCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTT
T ss_pred CCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccc
Confidence 99999986 467899999999999999999998888888777665 89999999987776543
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=168.63 Aligned_cols=141 Identities=16% Similarity=0.093 Sum_probs=129.9
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..++++++|++|+
T Consensus 56 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~ 135 (606)
T 3t6q_A 56 LINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135 (606)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEE
T ss_pred CccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEE
Confidence 45899999999999999999999999999999999999998899999999999999999999976688899999999999
Q ss_pred ccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCC--eeccCCCCCCCCCcccc
Q 006739 153 LSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQ--FFDFSGNSLLEGPIPVM 213 (633)
Q Consensus 153 l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~--~l~l~~N~l~~~~~~~~ 213 (633)
|++|++++.. +.+..+++|+.|++++|++++..|..|+.+++|+ .|++++|++...++..+
T Consensus 136 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~ 199 (606)
T 3t6q_A 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF 199 (606)
T ss_dssp CCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTT
T ss_pred CCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHh
Confidence 9999999864 5566699999999999999988899999999999 89999999988776543
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=7.4e-16 Score=155.56 Aligned_cols=139 Identities=17% Similarity=0.084 Sum_probs=115.2
Q ss_pred eeeeEEEEecCCCCcccCC----ccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCC--Cc--ccccC
Q 006739 73 VLKITKLVFVPRELTGVLS----PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGT--IP--SDLSS 144 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p--~~~~~ 144 (633)
..+++.|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|..+++|++|+|++|++.+. ++ ..+..
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 4478999999999998655 3456789999999999999998888999999999999999998753 22 23468
Q ss_pred CCCCCEEEccCCcCCCCCc----cCCCCCCCCeEeCcCCcCCccCCcccccC---CCCCeeccCCCCCCCCCcc
Q 006739 145 LIRLRVLDLSGNSFSGNLG----FLKYFPNLEHLSLAKNLFTGKVPTSIRTF---RNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 145 l~~L~~L~l~~N~l~~~~~----~~~~l~~L~~L~l~~N~l~~~~p~~~~~~---~~L~~l~l~~N~l~~~~~~ 211 (633)
+++|++|+|++|+++..+. .+..+++|++|+|++|+|++..|..+..+ ++|+.|+|++|+|+.+|..
T Consensus 196 l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~ 269 (310)
T 4glp_A 196 FPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKG 269 (310)
T ss_dssp SCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSC
T ss_pred CCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhh
Confidence 8999999999999986553 35678999999999999998878887777 6999999999999877643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.62 E-value=5.1e-16 Score=150.43 Aligned_cols=158 Identities=18% Similarity=0.178 Sum_probs=125.5
Q ss_pred eeeeEEEEecCCC-CcccCCccccCCccccEEEccC-CCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCC-
Q 006739 73 VLKITKLVFVPRE-LTGVLSPSIGRLSELRELSLAN-NSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLR- 149 (633)
Q Consensus 73 ~~~~~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~- 149 (633)
..+++.|++++|+ ++++.+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|++++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 4479999999997 8887777899999999999998 99998767789999999999999999994 776 88888888
Q ss_pred --EEEccCC-cCCCCC-ccCCCCCCCC-eEeCcCCcCCccCCcccccCCCCCeeccCCCC-CCCCCcccccccCCCCccc
Q 006739 150 --VLDLSGN-SFSGNL-GFLKYFPNLE-HLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS-LLEGPIPVMRRVGPSGFQY 223 (633)
Q Consensus 150 --~L~l~~N-~l~~~~-~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~-l~~~~~~~~~~~~~~~~~~ 223 (633)
.|+|++| ++++.+ ..+..+++|+ .|++++|+++ .+|......++|+.|++++|+ +..+|... |..
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~--------~~~ 202 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDA--------FGG 202 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTT--------TTT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHH--------hhc
Confidence 9999999 998887 4588899999 9999999998 555443334889999999995 87665542 333
Q ss_pred c-ccccccccccCCCCCCC
Q 006739 224 P-KRYVLAETTTNGRSNGP 241 (633)
Q Consensus 224 ~-~~~~~~~~~~~~~~~~p 241 (633)
+ .++..+....+.....|
T Consensus 203 l~~~L~~L~l~~N~l~~l~ 221 (239)
T 2xwt_C 203 VYSGPSLLDVSQTSVTALP 221 (239)
T ss_dssp CSBCCSEEECTTCCCCCCC
T ss_pred cccCCcEEECCCCccccCC
Confidence 3 45555555555554433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-15 Score=138.13 Aligned_cols=105 Identities=21% Similarity=0.238 Sum_probs=65.7
Q ss_pred eEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccC
Q 006739 76 ITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155 (633)
Q Consensus 76 ~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 155 (633)
.+.|++++|+++. +|..+ .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4566777777666 33333 25666777777777666566666667777777777776654444556666666666666
Q ss_pred CcCCCCCc-cCCCCCCCCeEeCcCCcCCc
Q 006739 156 NSFSGNLG-FLKYFPNLEHLSLAKNLFTG 183 (633)
Q Consensus 156 N~l~~~~~-~~~~l~~L~~L~l~~N~l~~ 183 (633)
|+|++.++ .+..+++|+.|+|++|.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 66666553 35566666666666666653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.2e-16 Score=161.37 Aligned_cols=137 Identities=19% Similarity=0.252 Sum_probs=124.3
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcc--cccCCCCCCE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPS--DLSSLIRLRV 150 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~ 150 (633)
..+++.|++++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+|. .+..+++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 458999999999999998899999999999999999999866666999999999999999999 5665 7899999999
Q ss_pred EEccCC-cCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 151 LDLSGN-SFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 151 L~l~~N-~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|++++| .+++.+ ..+..+++|+.|++++|++++..|..+..+++|+.|++++|++..+|.
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 215 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHH
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchh
Confidence 999999 477665 578899999999999999999999999999999999999999976654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.5e-15 Score=153.12 Aligned_cols=132 Identities=17% Similarity=0.257 Sum_probs=80.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCC--CCcccccCCCCCCE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG--TIPSDLSSLIRLRV 150 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~ 150 (633)
..+++.|++++|.++. +|..+. ++|+.|++++|++++..+..|.++++|+.|+|++|.++. ..+..+.++++|+.
T Consensus 99 l~~L~~L~Ls~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~ 175 (330)
T 1xku_A 99 LVKLERLYLSKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 175 (330)
T ss_dssp CTTCCEEECCSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCE
T ss_pred CCCCCEEECCCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCE
Confidence 3467777777777764 333332 567777777777776656666677777777777777642 55566666666666
Q ss_pred EEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 151 LDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 151 L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|++++|.++..+..+. ++|+.|++++|++++..|..|..+++|+.|++++|++...+
T Consensus 176 L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 232 (330)
T 1xku_A 176 IRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 232 (330)
T ss_dssp EECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred EECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeC
Confidence 6666666665543322 45555555555555555555555555555555555554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.1e-16 Score=157.22 Aligned_cols=130 Identities=19% Similarity=0.185 Sum_probs=87.5
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCccccc-CCCCCCEEEc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS-SLIRLRVLDL 153 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l 153 (633)
+++.|++++|++++..+. .+++|+.|+|++|++++..|..+..+++|++|+|++|.+++..|..+. .+++|+.|+|
T Consensus 100 ~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 100 SIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp TCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred CcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 455566666666554433 246677777777777776566777777777777777777766566553 5777777777
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++|.+++.+. ...+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|..+|
T Consensus 177 ~~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~ 230 (317)
T 3o53_A 177 QYNFIYDVKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIE 230 (317)
T ss_dssp TTSCCCEEEC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEEC
T ss_pred CCCcCccccc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCcccchh
Confidence 7777776643 2347777777777777774 4445777777777777777776554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.61 E-value=5.6e-16 Score=166.29 Aligned_cols=126 Identities=21% Similarity=0.151 Sum_probs=74.0
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+++.|+|++|.|++..+ .++|+.|+|++|.|++..+ ..+++|+.|+|++|.|++..|..++.+++|+.|+|+
T Consensus 81 ~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~~N~l~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (487)
T 3oja_A 81 TLRTLDLNNNYVQELLV-----GPSIETLHAANNNISRVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (487)
T ss_dssp TCCEEECCSSEEEEEEE-----CTTCCEEECCSSCCCCEEE---CCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECT
T ss_pred CCCEEEecCCcCCCCCC-----CCCcCEEECcCCcCCCCCc---cccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECC
Confidence 56666666666665432 2566666666666666433 234566666666666666556666666666666666
Q ss_pred CCcCCCCC-ccCC-CCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 155 GNSFSGNL-GFLK-YFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 155 ~N~l~~~~-~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
+|.|++.+ ..+. .+++|+.|+|++|.|++..+ +..+++|+.|+|++|+|+.+|+
T Consensus 153 ~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~ 208 (487)
T 3oja_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP 208 (487)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG
T ss_pred CCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH
Confidence 66666543 3332 56666666666666664422 2236666666666666655443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.7e-15 Score=147.35 Aligned_cols=124 Identities=25% Similarity=0.335 Sum_probs=94.7
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+++.|++++|+++.. + .+..+++|+.|+|++|+|++. |. +..+++|++|+|++|++++ +|... . ++|+.|+|+
T Consensus 42 ~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L~ 114 (263)
T 1xeu_A 42 GVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFLD 114 (263)
T ss_dssp TCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEECC
T ss_pred cCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEcc
Confidence 678888888888764 3 677888888888888888874 44 8888888888888888884 55432 2 788888888
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
+|++++.+ .+..+++|+.|+|++|+|++. + .+..+++|+.|++++|++...
T Consensus 115 ~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 115 NNELRDTD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp SSCCSBSG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCccCCCh-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 88888753 577788888888888888853 3 577788888888888888655
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-15 Score=137.49 Aligned_cols=103 Identities=21% Similarity=0.265 Sum_probs=66.9
Q ss_pred EEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCC
Q 006739 77 TKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156 (633)
Q Consensus 77 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (633)
+.+++++|+++. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 457777777754 344442 66777777777777766667777777777777777777444444566666777777766
Q ss_pred cCCCCCc-cCCCCCCCCeEeCcCCcCC
Q 006739 157 SFSGNLG-FLKYFPNLEHLSLAKNLFT 182 (633)
Q Consensus 157 ~l~~~~~-~~~~l~~L~~L~l~~N~l~ 182 (633)
+|++.++ .+..+++|+.|+|++|.|.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 6666653 3666666666666666666
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.61 E-value=4.2e-15 Score=148.35 Aligned_cols=128 Identities=25% Similarity=0.354 Sum_probs=114.6
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|++... +.+..+++|+.|+|++|++++. +. +..+++|++|+|++|++++ +| .+..+++|+.|+|
T Consensus 46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 4789999999999886 4589999999999999999984 44 9999999999999999994 44 4999999999999
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
++|++++. +.+..+++|+.|++++|++++. ..+..+++|+.|++++|++...++
T Consensus 120 ~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~ 173 (291)
T 1h6t_A 120 EHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 173 (291)
T ss_dssp TTSCCCCC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CCCcCCCC-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh
Confidence 99999986 5688899999999999999965 678999999999999999987654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=4e-15 Score=163.22 Aligned_cols=135 Identities=24% Similarity=0.312 Sum_probs=110.8
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCC--CchhccCCCCCcEEEccCccCCCCCccc-ccCCCCCCE
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL--LPPQIVDCKKLEILNVQNNQFSGTIPSD-LSSLIRLRV 150 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~ 150 (633)
.+++.|++++|.+++.+|..+.++++|+.|+|++|++++. +|..+.++++|++|+|++|++++.+|.. +..+++|+.
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 4788999999999988888899999999999999999873 3467888999999999999998756654 778889999
Q ss_pred EEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 151 LDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 151 L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
|+|++|++++.. ..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++.+|..
T Consensus 433 L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~ 491 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDG 491 (562)
T ss_dssp EECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTT
T ss_pred EECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHH
Confidence 999999987654 2222 68999999999998 6777777889999999999998877654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=163.97 Aligned_cols=133 Identities=23% Similarity=0.301 Sum_probs=88.9
Q ss_pred CCCCC-----CCCce-eeCCCCCCCCcceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCC
Q 006739 51 PSDPC-----STPGV-FCERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKL 124 (633)
Q Consensus 51 ~~~~C-----~~~gv-~c~~~~~~~~~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 124 (633)
..++| .|.|+ .|... +++.|+|++|+|++ +|..+ +++|+.|+|++|+|+. +| ..+++|
T Consensus 39 ~~~~~~~~~~~~~~l~~C~~~---------~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~-ip---~~l~~L 102 (571)
T 3cvr_A 39 QALPGENRNEAVSLLKECLIN---------QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALIS-LP---ELPASL 102 (571)
T ss_dssp TCCTTCCHHHHHHHHHHHHHT---------TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSC-CC---CCCTTC
T ss_pred cCCccccccchhhhccccccC---------CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcc-cc---cccCCC
Confidence 34677 67888 67643 57777777777776 45444 2667777777777774 56 446777
Q ss_pred cEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCC
Q 006739 125 EILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNS 204 (633)
Q Consensus 125 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~ 204 (633)
++|+|++|+|++ +|. +.+ +|+.|+|++|+|++.+. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTMLPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ 171 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCCCCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence 777777777774 666 554 77777777777776555 46677777777777774 554 35667777777777
Q ss_pred CCCCCc
Q 006739 205 LLEGPI 210 (633)
Q Consensus 205 l~~~~~ 210 (633)
|+.+|.
T Consensus 172 L~~lp~ 177 (571)
T 3cvr_A 172 LTFLPE 177 (571)
T ss_dssp CSCCCC
T ss_pred CCCcch
Confidence 766543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=149.35 Aligned_cols=129 Identities=22% Similarity=0.405 Sum_probs=114.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|++++..+ +.++++|+.|+|++|++++ +|. +.. ++|+.|+|++|++++ ++ .+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 4589999999999998755 9999999999999999998 554 333 999999999999995 44 699999999999
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
|++|++++.+ .+..+++|+.|+|++|+|++. ..+..+++|+.|++++|++.+.|..
T Consensus 135 Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~~ 190 (263)
T 1xeu_A 135 IRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVK 190 (263)
T ss_dssp CTTSCCCBCG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCEE
T ss_pred CCCCcCCCCh-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCccc
Confidence 9999999875 688899999999999999976 6789999999999999999777643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.60 E-value=3.9e-15 Score=149.91 Aligned_cols=128 Identities=23% Similarity=0.377 Sum_probs=114.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|.+++. +.+.++++|+.|+|++|++++ ++. +..+++|+.|+|++|++++ ++. +..+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 157 (308)
T 1h6u_A 84 LTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLS 157 (308)
T ss_dssp CCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEE
T ss_pred CCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEE
Confidence 45899999999999885 469999999999999999998 553 9999999999999999995 444 88999999999
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|++|++++.+. +..+++|+.|++++|++++..+ +..+++|+.|++++|++...+
T Consensus 158 l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 158 IGNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp CCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG
T ss_pred ccCCcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc
Confidence 99999998776 8899999999999999996543 889999999999999998776
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.60 E-value=3.3e-15 Score=163.57 Aligned_cols=128 Identities=30% Similarity=0.383 Sum_probs=112.7
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|.|++..+ +.++++|+.|+|++|.|++ +| .+..+++|+.|+|++|+|++ + ..+..|++|+.|+
T Consensus 64 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 64 LPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp CTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 4589999999999998755 8999999999999999987 44 78999999999999999994 4 4588999999999
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|++|+|++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|..++
T Consensus 138 Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~ 191 (605)
T 1m9s_A 138 LGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR 191 (605)
T ss_dssp CCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG
T ss_pred CCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCCh
Confidence 999999987 678899999999999999997666 889999999999999997753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.1e-15 Score=163.82 Aligned_cols=125 Identities=22% Similarity=0.237 Sum_probs=77.3
Q ss_pred EEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCc
Q 006739 78 KLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS 157 (633)
Q Consensus 78 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 157 (633)
.|++++|+++. +|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 4 ~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCccc-cccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 46666666664 444443 566666666666666555666666666666666666665556666666666666666666
Q ss_pred CCCCCccCCCCCCCCeEeCcCCcCCc-cCCcccccCCCCCeeccCCCCCCC
Q 006739 158 FSGNLGFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 158 l~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
|++.+.. .+++|++|+|++|+|++ .+|..|+.+++|++|++++|++..
T Consensus 81 l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~ 129 (520)
T 2z7x_B 81 LVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK 129 (520)
T ss_dssp CCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG
T ss_pred eeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch
Confidence 6654433 56666666666666665 355666666666666666666643
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.5e-15 Score=151.38 Aligned_cols=132 Identities=21% Similarity=0.306 Sum_probs=79.0
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCC--CCCcccccCCCCCCEE
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFS--GTIPSDLSSLIRLRVL 151 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L 151 (633)
.+++.|++++|.++. +|..+. ++|++|+|++|++++..+..|.++++|+.|+|++|.++ +..|..+..+ +|+.|
T Consensus 102 ~~L~~L~L~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L 177 (332)
T 2ft3_A 102 RKLQKLYISKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYL 177 (332)
T ss_dssp TTCCEEECCSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCC
T ss_pred CCCCEEECCCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEE
Confidence 467778888887774 343333 67777777777777755556777777777777777775 3555556555 55555
Q ss_pred EccCCcCCCCC----------------------ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 152 DLSGNSFSGNL----------------------GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 152 ~l~~N~l~~~~----------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++++|++++.+ ..+..+++|+.|+|++|++++..+..+..+++|+.|++++|++..+|
T Consensus 178 ~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp 257 (332)
T 2ft3_A 178 RISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVP 257 (332)
T ss_dssp BCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCC
T ss_pred ECcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecC
Confidence 55555544433 33445555555555555555444445555555555555555554433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.59 E-value=3.3e-15 Score=153.43 Aligned_cols=187 Identities=13% Similarity=0.119 Sum_probs=133.9
Q ss_pred CCCCceeeCCCC-CCCC-cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCc-hhccCCCCCcE-EEcc
Q 006739 55 CSTPGVFCERRL-SDNN-TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLP-PQIVDCKKLEI-LNVQ 130 (633)
Q Consensus 55 C~~~gv~c~~~~-~~~~-~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~-L~Ls 130 (633)
|++..|.|.... ...+ ..+.+++.|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|+. ++++
T Consensus 9 C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 9 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred eeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 788899998732 2211 224579999999999998877889999999999999999977555 57889988775 6778
Q ss_pred CccCCCCCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCcC-CcCCccCCcccccCC-CCCeeccCCCCCCC
Q 006739 131 NNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLAK-NLFTGKVPTSIRTFR-NLQFFDFSGNSLLE 207 (633)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~-N~l~~~~p~~~~~~~-~L~~l~l~~N~l~~ 207 (633)
+|+|+...|..|..+++|++|++++|++++.++ .+....++..|++++ |++....+..|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 899997778889999999999999999998763 344555666777654 456544444555543 46677777777776
Q ss_pred CCcccccc----------------cCCCCccccccccccccccCCCCCCC
Q 006739 208 GPIPVMRR----------------VGPSGFQYPKRYVLAETTTNGRSNGP 241 (633)
Q Consensus 208 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~p 241 (633)
++...+.. .....|..+.++..++.+.|.....|
T Consensus 169 i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp 218 (350)
T 4ay9_X 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 218 (350)
T ss_dssp ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccC
Confidence 66543221 11234555566666666666555444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.58 E-value=6.6e-15 Score=161.45 Aligned_cols=133 Identities=20% Similarity=0.226 Sum_probs=105.2
Q ss_pred cCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCC--CcccccCCCCCCEEEccCCcCCC-CC-ccCCCCCC
Q 006739 95 GRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGT--IPSDLSSLIRLRVLDLSGNSFSG-NL-GFLKYFPN 170 (633)
Q Consensus 95 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~-~~-~~~~~l~~ 170 (633)
..+++|++|+|++|++++.+|..+.++++|++|+|++|++++. +|..+..+++|+.|+|++|++++ .+ ..+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 6788899999999999988888999999999999999999852 34668889999999999999988 55 45778899
Q ss_pred CCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccccccCCCCccccccccccccccCCCC
Q 006739 171 LEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLAETTTNGRS 238 (633)
Q Consensus 171 L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (633)
|+.|++++|+|++.+|..+. ++|+.|+|++|+|+.+|...+ .+.++..+....|...
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~---------~l~~L~~L~L~~N~l~ 486 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVT---------HLQALQELNVASNQLK 486 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTT---------SSCCCSEEECCSSCCC
T ss_pred CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhc---------CCCCCCEEECCCCCCC
Confidence 99999999999887776653 689999999999987765432 2344555555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.9e-15 Score=134.73 Aligned_cols=113 Identities=26% Similarity=0.309 Sum_probs=101.0
Q ss_pred CCccccEEEccCCCCC-CCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCC-CCccCCCCCCCCe
Q 006739 96 RLSELRELSLANNSLV-DLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG-NLGFLKYFPNLEH 173 (633)
Q Consensus 96 ~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~l~~L~~ 173 (633)
..++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|+.|+|++|.+++ .+..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3578999999999998 67899999999999999999999965 789999999999999999999 4456667999999
Q ss_pred EeCcCCcCCcc-CCcccccCCCCCeeccCCCCCCCCCc
Q 006739 174 LSLAKNLFTGK-VPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 174 L~l~~N~l~~~-~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|++++|++++. .+..+..+++|+.|++++|+++..+.
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 99999999963 34789999999999999999987764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.3e-15 Score=152.35 Aligned_cols=126 Identities=21% Similarity=0.157 Sum_probs=81.1
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+++.|++++|.+++.. ..++|+.|++++|++++..+ ..+++|+.|+|++|++++..|..+..+++|+.|+|+
T Consensus 81 ~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~---~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls 152 (317)
T 3o53_A 81 TLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152 (317)
T ss_dssp TCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEE---CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECT
T ss_pred CCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCc---cccCCCCEEECCCCCCCCccchhhhccCCCCEEECC
Confidence 5677777777776542 23667777777777766433 235667777777777776556667777777777777
Q ss_pred CCcCCCCC-ccC-CCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 155 GNSFSGNL-GFL-KYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 155 ~N~l~~~~-~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
+|.+++.+ ..+ ..+++|++|+|++|+|++. | ....+++|+.|+|++|++..+|+
T Consensus 153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~ 208 (317)
T 3o53_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGP 208 (317)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECG
T ss_pred CCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchh
Confidence 77777654 333 3567777777777777644 2 22346777777777777765543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.7e-15 Score=163.81 Aligned_cols=140 Identities=19% Similarity=0.195 Sum_probs=127.9
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..+..++++++|++|+
T Consensus 51 l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 130 (570)
T 2z63_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (570)
T ss_dssp CSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEE
T ss_pred CCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEe
Confidence 45899999999999998888999999999999999999998888999999999999999999965555799999999999
Q ss_pred ccCCcCCC--CCccCCCCCCCCeEeCcCCcCCccCCcccccCCCC----CeeccCCCCCCCCCccc
Q 006739 153 LSGNSFSG--NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNL----QFFDFSGNSLLEGPIPV 212 (633)
Q Consensus 153 l~~N~l~~--~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L----~~l~l~~N~l~~~~~~~ 212 (633)
|++|.+++ .+..+.++++|+.|++++|++++..|..++.+++| ..|++++|.+..+++..
T Consensus 131 L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~ 196 (570)
T 2z63_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196 (570)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTT
T ss_pred cCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHH
Confidence 99999997 46789999999999999999998888889988888 89999999998776653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=4.5e-15 Score=161.54 Aligned_cols=108 Identities=24% Similarity=0.329 Sum_probs=82.9
Q ss_pred cccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcC
Q 006739 99 ELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAK 178 (633)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~ 178 (633)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++++ .+..+++|+.|+|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCC
Confidence 47778888888877 565 777788888888888887 77777778888888888888887765 677778888888888
Q ss_pred CcCCccC-CcccccCCCCCeeccCCCCCCCCCc
Q 006739 179 NLFTGKV-PTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 179 N~l~~~~-p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|+|++.. |..|+.+++|+.|+|++|+++..|+
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 8887665 7777778888888888887766654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=6.1e-16 Score=168.38 Aligned_cols=121 Identities=23% Similarity=0.318 Sum_probs=109.0
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.++.|+|++|+|++ +|. |+++++|+.|+|++|+|+. +|..|+++++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCcccccc-cchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999998 455 9999999999999999995 89999999999999999999995 78 89999999999999
Q ss_pred CCcCCCC--CccCCCCCCCCeEeCcCCcCCccCCcc---cccCCCCCeecc
Q 006739 155 GNSFSGN--LGFLKYFPNLEHLSLAKNLFTGKVPTS---IRTFRNLQFFDF 200 (633)
Q Consensus 155 ~N~l~~~--~~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~~~L~~l~l 200 (633)
+|+|++. +..+..+++|+.|+|++|+|++.+|.. +..+++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 9999999 688999999999999999999766532 345899999875
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-14 Score=163.63 Aligned_cols=164 Identities=14% Similarity=0.108 Sum_probs=118.0
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCc-hhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLP-PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.++.|++++|++++..|..|.++++|+.|+|++|.+++.+| ..|.++++|++|+|++|++++..+..|..+++|+.|++
T Consensus 382 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l 461 (680)
T 1ziw_A 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEEC
T ss_pred cCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchh
Confidence 57777888888888878888888888888888888876555 67888888888888888888777777888888888888
Q ss_pred cCCcCCC---CCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccccccCCCCcccccccccc
Q 006739 154 SGNSFSG---NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRYVLA 230 (633)
Q Consensus 154 ~~N~l~~---~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (633)
++|.+++ .+..+..+++|+.|+|++|+|++..|..|..+++|+.|++++|++..++...........|..+.++..+
T Consensus 462 ~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L 541 (680)
T 1ziw_A 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541 (680)
T ss_dssp TTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEE
T ss_pred ccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEE
Confidence 8887753 2356778888888888888888766777888888888888888886654322111111224444555555
Q ss_pred ccccCCCC
Q 006739 231 ETTTNGRS 238 (633)
Q Consensus 231 ~~~~~~~~ 238 (633)
....|...
T Consensus 542 ~L~~N~l~ 549 (680)
T 1ziw_A 542 NLESNGFD 549 (680)
T ss_dssp ECCSSCCC
T ss_pred ECCCCCCC
Confidence 55555443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.8e-15 Score=165.53 Aligned_cols=137 Identities=16% Similarity=0.197 Sum_probs=123.7
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCC-CCcccccCCCCCCEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG-TIPSDLSSLIRLRVL 151 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L 151 (633)
..++++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++ .+|..++++++|++|
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 128 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence 4589999999999999999999999999999999999999888889999999999999999996 367889999999999
Q ss_pred EccCCc-CCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 152 DLSGNS-FSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 152 ~l~~N~-l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|++|. ++..+ ..+..+++|++|++++|++++.+|..+..+++|+.|++++|.+...|
T Consensus 129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~ 188 (549)
T 2z81_A 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188 (549)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHH
T ss_pred ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccc
Confidence 999998 45454 57899999999999999999999999999988999998888875544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.5e-16 Score=173.49 Aligned_cols=135 Identities=19% Similarity=0.180 Sum_probs=119.7
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
...++.|+|++|.+. .+|..+.++++|+.|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .+|..|++|++|++|+
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 299 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY 299 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEE
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEE
Confidence 347999999999998 56777779999999999999999 58999999999999999999999 8899999999999999
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCC-CCeeccCCCCCCCCCc
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRN-LQFFDFSGNSLLEGPI 210 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~-L~~l~l~~N~l~~~~~ 210 (633)
|++|.|+.++..|..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++...+
T Consensus 300 L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 300 FFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp CCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred CCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 999999988888999999999999999999999988765432 2357899999854333
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-14 Score=131.63 Aligned_cols=109 Identities=19% Similarity=0.226 Sum_probs=98.1
Q ss_pred cccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCc
Q 006739 99 ELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLA 177 (633)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~ 177 (633)
..+.|++++|+|+. +|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.++ .+..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 35789999999988 787663 899999999999998889999999999999999999999884 57899999999999
Q ss_pred CCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 178 KNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 178 ~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
+|+|++..+..|..+++|+.|+|++|++.+.+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999997777779999999999999999987754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.2e-15 Score=168.34 Aligned_cols=136 Identities=20% Similarity=0.231 Sum_probs=122.2
Q ss_pred eeeeEEEEecCCCCcccC-CccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCccc--ccCCCCCC
Q 006739 73 VLKITKLVFVPRELTGVL-SPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSD--LSSLIRLR 149 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~ 149 (633)
..+++.|+|++|.+.+.+ |..|.++++|++|+|++|.|++..|..|.++++|++|+|++|.+++.+|.. |.++++|+
T Consensus 47 l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~ 126 (844)
T 3j0a_A 47 LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126 (844)
T ss_dssp CCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCC
T ss_pred cccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCC
Confidence 457999999999777666 678999999999999999999988999999999999999999999877766 99999999
Q ss_pred EEEccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCCcccccC--CCCCeeccCCCCCCCC
Q 006739 150 VLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTF--RNLQFFDFSGNSLLEG 208 (633)
Q Consensus 150 ~L~l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~--~~L~~l~l~~N~l~~~ 208 (633)
+|+|++|.+++.. ..+.++++|++|+|++|.+++..|..+..+ ++|+.|++++|.+...
T Consensus 127 ~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~ 189 (844)
T 3j0a_A 127 RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSR 189 (844)
T ss_dssp EEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCC
T ss_pred EEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccc
Confidence 9999999999875 468999999999999999999899888877 8899999999988653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-14 Score=131.21 Aligned_cols=108 Identities=18% Similarity=0.194 Sum_probs=97.6
Q ss_pred ccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCc-cCCCCCCCCeEeCcC
Q 006739 100 LRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPNLEHLSLAK 178 (633)
Q Consensus 100 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~ 178 (633)
-+.+++++|+++. +|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.+. .+..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 3789999999976 787664 899999999999998889999999999999999999999885 468999999999999
Q ss_pred CcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 179 NLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 179 N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|+|++..+..|..+++|+.|+|++|++.+.+.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 99997666669999999999999999988764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.54 E-value=2.2e-14 Score=157.05 Aligned_cols=128 Identities=25% Similarity=0.352 Sum_probs=114.6
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|.+... +.+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++ +| .+..+++|+.|+|
T Consensus 43 ~~L~~L~l~~n~i~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCCCC--TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCCC--hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEe
Confidence 3789999999999875 369999999999999999999544 9999999999999999994 55 7999999999999
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
++|+|++. +.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|..+++
T Consensus 117 s~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 117 EHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp TTSCCCCC-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred cCCCCCCC-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 99999986 5688999999999999999965 678999999999999999987654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.8e-14 Score=131.24 Aligned_cols=114 Identities=23% Similarity=0.281 Sum_probs=103.0
Q ss_pred cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCc--ccccCCCCC
Q 006739 71 TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIP--SDLSSLIRL 148 (633)
Q Consensus 71 ~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L 148 (633)
....+++.|++++|.+++. ..+..+++|+.|+|++|++++.+|..+.++++|++|+|++|+|++ +| ..+..+++|
T Consensus 46 ~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L 122 (168)
T 2ell_A 46 AEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD-ISTLEPLKKLECL 122 (168)
T ss_dssp GGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCS-SGGGGGGSSCSCC
T ss_pred HhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCc-chhHHHHhcCCCC
Confidence 3355899999999999987 789999999999999999999888888889999999999999995 44 789999999
Q ss_pred CEEEccCCcCCCCCc----cCCCCCCCCeEeCcCCcCCccCCcc
Q 006739 149 RVLDLSGNSFSGNLG----FLKYFPNLEHLSLAKNLFTGKVPTS 188 (633)
Q Consensus 149 ~~L~l~~N~l~~~~~----~~~~l~~L~~L~l~~N~l~~~~p~~ 188 (633)
+.|+|++|.+++.+. .+..+++|++|++++|.+. .+|+.
T Consensus 123 ~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 123 KSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp CEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred CEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 999999999999886 7899999999999999998 56654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.9e-14 Score=146.29 Aligned_cols=110 Identities=25% Similarity=0.413 Sum_probs=56.5
Q ss_pred ccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCe
Q 006739 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEH 173 (633)
Q Consensus 94 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~ 173 (633)
+..+++|+.|+|++|.+++ ++. +..+++|++|+|++|.+++ + ..+..+++|+.|++++|++++. +.+..+++|+.
T Consensus 217 ~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~ 291 (347)
T 4fmz_A 217 VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNS 291 (347)
T ss_dssp GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSE
T ss_pred hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCE
Confidence 4444455555555555544 222 4455555555555555552 2 2345555555555555555544 33445555555
Q ss_pred EeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 174 LSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 174 L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|++++|.+++..|..+..+++|+.|++++|+++..
T Consensus 292 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 326 (347)
T 4fmz_A 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326 (347)
T ss_dssp EECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCC
T ss_pred EECcCCcCCCcChhHhhccccCCEEEccCCccccc
Confidence 55555555555555555555555555555555444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-14 Score=132.97 Aligned_cols=114 Identities=15% Similarity=0.215 Sum_probs=99.5
Q ss_pred ccccCCccccEEEccCCCCCCCCchhccCC-CCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCcc-CCCCC
Q 006739 92 PSIGRLSELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGF-LKYFP 169 (633)
Q Consensus 92 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~ 169 (633)
+.+.++++|+.|+|++|+++. +|. +..+ ++|++|+|++|.|++. ..+..+++|+.|+|++|+|++.++. +..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 457788999999999999997 565 5554 5999999999999964 6899999999999999999988754 48999
Q ss_pred CCCeEeCcCCcCCccCCc--ccccCCCCCeeccCCCCCCCCCc
Q 006739 170 NLEHLSLAKNLFTGKVPT--SIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 170 ~L~~L~l~~N~l~~~~p~--~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
+|++|+|++|+|+ .+|. .+..+++|+.|++++|++...|.
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~ 130 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKH 130 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTT
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHh
Confidence 9999999999997 5676 78999999999999999987654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.7e-14 Score=146.58 Aligned_cols=126 Identities=27% Similarity=0.389 Sum_probs=111.1
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|++++..+ +..+++|+.|+|++|.+++ + ..+..+++|++|+|++|++++ + ..+..+++|+.|+
T Consensus 220 ~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~ 293 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLF 293 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEE
Confidence 4579999999999998654 9999999999999999998 4 479999999999999999995 4 4688999999999
Q ss_pred ccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCC
Q 006739 153 LSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 153 l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
|++|.+++.. ..+..+++|+.|++++|++++..| +..+++|+.|++++|+|+
T Consensus 294 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 9999999877 668899999999999999997666 889999999999999985
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-14 Score=152.66 Aligned_cols=129 Identities=21% Similarity=0.337 Sum_probs=109.6
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|.+++..+ +..+++|+.|+|++|.+++. +. +..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 242 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 242 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 4478999999999988755 88899999999999999884 43 8889999999999999995443 78899999999
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
|++|++++.++ +..+++|+.|++++|++++. ..+..+++|+.|++++|++...++
T Consensus 316 L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 316 LYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp CCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred CcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence 99999998776 67889999999999999864 468889999999999999876654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=7e-17 Score=151.63 Aligned_cols=130 Identities=20% Similarity=0.250 Sum_probs=97.5
Q ss_pred eeEEEEecCCCCcccCCc------cccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCC
Q 006739 75 KITKLVFVPRELTGVLSP------SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRL 148 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 148 (633)
+++.++++.+.+.|.+|. .+.++++|+.|+|++|.|++ +| .+..+++|++|+|++|.|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455566666666666665 77788888888888888877 66 7778888888888888888 677777777888
Q ss_pred CEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCC-cccccCCCCCeeccCCCCCCCC
Q 006739 149 RVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVP-TSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 149 ~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
+.|+|++|++++.+ .+..+++|+.|++++|+|++..+ ..+..+++|+.|++++|++.+.
T Consensus 96 ~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 96 EELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred CEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 88888888888754 56677888888888888874322 4677788888888888887544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.50 E-value=5.7e-14 Score=152.14 Aligned_cols=121 Identities=26% Similarity=0.346 Sum_probs=93.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 166 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS 166 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence 4578889999998888 555 655 88999999999988 665 67888899999998884 666 567888888
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCC-------CeeccCCCCCCCCCccc
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNL-------QFFDFSGNSLLEGPIPV 212 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L-------~~l~l~~N~l~~~~~~~ 212 (633)
|++|+|++.+. +. ++|+.|+|++|+|+ .+|. |.. +| +.|+|++|+|+.+|...
T Consensus 167 Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l 226 (571)
T 3cvr_A 167 VRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENI 226 (571)
T ss_dssp CCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGG
T ss_pred CCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHH
Confidence 88888888666 54 78888888888888 6666 543 66 88888888888776543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=148.04 Aligned_cols=127 Identities=26% Similarity=0.375 Sum_probs=113.8
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|.+++. +.+..+++|+.|+|++|.+++..| +..+++|+.|+|++|.+++. |. +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEE
Confidence 45799999999999885 568899999999999999998544 89999999999999999954 44 88999999999
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCC
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
|++|++++.++ +..+++|+.|++++|++++..| +..+++|+.|++++|++...
T Consensus 294 L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 294 LNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred cCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 99999998766 7889999999999999998766 78999999999999999765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=142.08 Aligned_cols=101 Identities=21% Similarity=0.177 Sum_probs=86.5
Q ss_pred EecCC-CCcccCCccccCCccccEEEccC-CCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCc
Q 006739 80 VFVPR-ELTGVLSPSIGRLSELRELSLAN-NSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS 157 (633)
Q Consensus 80 ~l~~n-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 157 (633)
+++++ +|++ +|. |..+++|+.|+|++ |+|+++.|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+
T Consensus 14 ~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 14 RCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp ECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 33344 6766 566 99999999999996 99999777899999999999999999999888899999999999999999
Q ss_pred CCCCCcc-CCCCCCCCeEeCcCCcCCc
Q 006739 158 FSGNLGF-LKYFPNLEHLSLAKNLFTG 183 (633)
Q Consensus 158 l~~~~~~-~~~l~~L~~L~l~~N~l~~ 183 (633)
|++.++. +..++ |+.|+|++|.|..
T Consensus 92 l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred cceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9998854 44444 9999999999984
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.9e-13 Score=143.82 Aligned_cols=123 Identities=22% Similarity=0.241 Sum_probs=77.5
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|++++. + ++.+++|++|+|++|+|++ +| ++++++|++|+|++|++++ +| ++.+++|+.|++
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 3566677777776664 2 6666677777777777666 33 6666777777777777764 33 666667777777
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++|++++.+ +..+++|+.|++++|+..+.+ .+..+++|+.|++++|+++.+|
T Consensus 135 ~~N~l~~l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~ 186 (457)
T 3bz5_A 135 ARNTLTEID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD 186 (457)
T ss_dssp TTSCCSCCC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC
T ss_pred CCCccceec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec
Confidence 777766642 555666666666666444444 2555666666666666665554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.45 E-value=4.4e-13 Score=142.29 Aligned_cols=98 Identities=23% Similarity=0.292 Sum_probs=47.5
Q ss_pred ccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCc
Q 006739 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLA 177 (633)
Q Consensus 98 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~ 177 (633)
++|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|+|++|++++.+ .+..+++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECC
Confidence 345555555555554 44 35555555555555555552 44322 34555555555555433 34455555555555
Q ss_pred CCcCCccCCcccccCCCCCeeccCCCCCC
Q 006739 178 KNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 178 ~N~l~~~~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
+|++++ +|... ++|+.|++++|++.
T Consensus 204 ~N~l~~-l~~~~---~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 204 NNSLKK-LPDLP---LSLESIVAGNNILE 228 (454)
T ss_dssp SSCCSS-CCCCC---TTCCEEECCSSCCS
T ss_pred CCcCCc-CCCCc---CcccEEECcCCcCC
Confidence 555543 33221 24444444444444
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=6.2e-16 Score=145.14 Aligned_cols=128 Identities=25% Similarity=0.313 Sum_probs=113.3
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|++++ +| .+.++++|+.|+|++|.|+. +|..+..+++|++|+|++|++++ +| .+..+++|+.|+
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 3479999999999998 55 89999999999999999986 78888889999999999999995 66 688999999999
Q ss_pred ccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCCcc----------cccCCCCCeeccCCCCCCC
Q 006739 153 LSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTS----------IRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 153 l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~----------~~~~~~L~~l~l~~N~l~~ 207 (633)
|++|++++.+ ..+..+++|++|++++|.+++.+|.. +..+++|+.|| +|.++.
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 9999999865 47889999999999999999876653 78899999997 777643
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.44 E-value=5.6e-13 Score=141.63 Aligned_cols=124 Identities=24% Similarity=0.233 Sum_probs=94.5
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|++++. + ++++++|+.|+|++|+|++ ++ ++.+++|++|++++|+..+.+ .+..+++|+.|+
T Consensus 105 l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp CTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 45789999999999885 3 8889999999999999988 43 777888888888888655565 467777888888
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|++|++++.+ +..+++|+.|++++|+|++. .++.+++|+.|++++|++..+|
T Consensus 177 ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip 228 (457)
T 3bz5_A 177 CSFNKITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID 228 (457)
T ss_dssp CCSSCCCCCC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC
T ss_pred CCCCccceec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC
Confidence 8888887764 66677777777777777753 2666777777777777776654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.43 E-value=3.9e-13 Score=147.35 Aligned_cols=57 Identities=25% Similarity=0.239 Sum_probs=28.9
Q ss_pred CCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 146 IRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 146 ~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+.+|
T Consensus 221 ~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp 277 (622)
T 3g06_A 221 SGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLP 277 (622)
T ss_dssp TTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCC
T ss_pred CCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCC
Confidence 44555555555555543 23345555555555555 3333 3445555555555555443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=2.7e-13 Score=139.00 Aligned_cols=106 Identities=22% Similarity=0.238 Sum_probs=94.7
Q ss_pred cEEEccCC-CCCCCCchhccCCCCCcEEEccC-ccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCc
Q 006739 101 RELSLANN-SLVDLLPPQIVDCKKLEILNVQN-NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLA 177 (633)
Q Consensus 101 ~~L~l~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~ 177 (633)
..++++++ +|++ +|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++.+ ..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35799998 9988 888 99999999999996 9999888889999999999999999999988 578999999999999
Q ss_pred CCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 178 KNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 178 ~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|+|++..+..|..++ |+.|+|++|+|.+..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSC 119 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCG
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCC
Confidence 9999976666666665 999999999998753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.42 E-value=3.4e-13 Score=147.86 Aligned_cols=117 Identities=27% Similarity=0.291 Sum_probs=74.0
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|+|++|+|+.+ |. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|+ .+|. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCSCC-CC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCCCC-CC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEEC
Confidence 3567777777777653 33 45667777777777765 454 5667777777777777 3444 4566777777
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++|+|++.+.. +++|++|+|++|+|++ +|.. +.+|+.|++++|+|+.+|
T Consensus 129 ~~N~l~~lp~~---l~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~ 177 (622)
T 3g06_A 129 FGNQLTSLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTSLP 177 (622)
T ss_dssp CSSCCSCCCCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCC
T ss_pred CCCCCCcCCCC---CCCCCEEECcCCcCCC-cCCc---cCCCCEEECCCCCCCCCc
Confidence 77777765543 3677777777777774 4432 345556666666665544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.41 E-value=1.2e-12 Score=139.06 Aligned_cols=123 Identities=28% Similarity=0.336 Sum_probs=104.2
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
+.+++.|++++|.+++ +|.. +++|+.|++++|++++ +|.. .++|++|+|++|++++ +| .|+.+++|++|+
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~ 159 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIID 159 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEE
Confidence 3479999999999998 5543 4789999999999987 4432 2799999999999995 88 699999999999
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
+++|++++.+.. .++|++|++++|++++ +| .++.+++|+.|++++|++..+|.
T Consensus 160 l~~N~l~~lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~ 212 (454)
T 1jl5_A 160 VDNNSLKKLPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPD 212 (454)
T ss_dssp CCSSCCSCCCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCC
T ss_pred CCCCcCcccCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCC
Confidence 999999987654 3599999999999996 67 68999999999999999987653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.40 E-value=2.1e-14 Score=146.67 Aligned_cols=128 Identities=22% Similarity=0.256 Sum_probs=68.8
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCC-CchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL-LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
+++.|++++|.+.+..+. +.++++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|+.|+|
T Consensus 71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 455556666655554433 33455566666666555543 4555555556666666665555555555555555555555
Q ss_pred cCC-cCCC--CCccCCCCCCCCeEeCcCC-cCCcc-CCcccccCC-CCCeeccCCC
Q 006739 154 SGN-SFSG--NLGFLKYFPNLEHLSLAKN-LFTGK-VPTSIRTFR-NLQFFDFSGN 203 (633)
Q Consensus 154 ~~N-~l~~--~~~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~~~-~L~~l~l~~N 203 (633)
++| .+++ .+..+..+++|+.|++++| ++++. ++..+..++ +|+.|++++|
T Consensus 150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 555 4443 2233444555555555555 55532 344455555 5555555555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.38 E-value=3.8e-14 Score=147.67 Aligned_cols=132 Identities=22% Similarity=0.349 Sum_probs=61.8
Q ss_pred eeEEEEecCCCCc-ccCC---ccccCCccccEEEccCCCCCC-----CCchhccCCCCCcEEEccCccCC----CCCccc
Q 006739 75 KITKLVFVPRELT-GVLS---PSIGRLSELRELSLANNSLVD-----LLPPQIVDCKKLEILNVQNNQFS----GTIPSD 141 (633)
Q Consensus 75 ~~~~L~l~~n~l~-~~~~---~~~~~l~~L~~L~l~~N~l~~-----~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~ 141 (633)
+++.|+|++|+++ +.++ ..+..+++|+.|+|++|+|+. ..|..+..+++|+.|+|++|.|+ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 4455555555544 1222 234444455555555555541 12224445555555555555553 344444
Q ss_pred ccCCCCCCEEEccCCcCCCC-----CccC--CCCCCCCeEeCcCCcCCc----cCCccc-ccCCCCCeeccCCCCCC
Q 006739 142 LSSLIRLRVLDLSGNSFSGN-----LGFL--KYFPNLEHLSLAKNLFTG----KVPTSI-RTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~-----~~~~--~~l~~L~~L~l~~N~l~~----~~p~~~-~~~~~L~~l~l~~N~l~ 206 (633)
+..+++|+.|+|++|.+++. +..+ ..+++|+.|+|++|.|++ .+|..+ .++++|+.|++++|++.
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 55555555555555555443 1222 224555555555555554 244444 33455555555555553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.37 E-value=9.9e-14 Score=143.13 Aligned_cols=135 Identities=21% Similarity=0.256 Sum_probs=92.4
Q ss_pred eeEEEEecCCCCcccCC----ccccCCc-cccEEEccCCCCCCCCchhccCC-----CCCcEEEccCccCCCCCccccc-
Q 006739 75 KITKLVFVPRELTGVLS----PSIGRLS-ELRELSLANNSLVDLLPPQIVDC-----KKLEILNVQNNQFSGTIPSDLS- 143 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~- 143 (633)
+++.|+|++|.+++..+ ..|.+++ +|++|+|++|.|++..+..+..+ ++|++|+|++|++++..+..++
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 47788888888777665 5666777 78888888888877666666664 7788888888888766665433
Q ss_pred ---CC-CCCCEEEccCCcCCCCCc-----cCCC-CCCCCeEeCcCCcCCccC----CcccccCC-CCCeeccCCCCCCCC
Q 006739 144 ---SL-IRLRVLDLSGNSFSGNLG-----FLKY-FPNLEHLSLAKNLFTGKV----PTSIRTFR-NLQFFDFSGNSLLEG 208 (633)
Q Consensus 144 ---~l-~~L~~L~l~~N~l~~~~~-----~~~~-l~~L~~L~l~~N~l~~~~----p~~~~~~~-~L~~l~l~~N~l~~~ 208 (633)
.+ ++|+.|+|++|++++... .+.. .++|++|+|++|+|++.. +..+..++ +|+.|+|++|++...
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~ 182 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchh
Confidence 33 678888888888776652 2333 357888888888777433 33344454 778888888877554
Q ss_pred C
Q 006739 209 P 209 (633)
Q Consensus 209 ~ 209 (633)
.
T Consensus 183 ~ 183 (362)
T 3goz_A 183 N 183 (362)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.36 E-value=4.3e-14 Score=147.31 Aligned_cols=132 Identities=20% Similarity=0.275 Sum_probs=68.3
Q ss_pred eeEEEEecCCCCcc----cCCccccCCccccEEEccCCCCCCCCchh----ccCC---------CCCcEEEccCccCC-C
Q 006739 75 KITKLVFVPRELTG----VLSPSIGRLSELRELSLANNSLVDLLPPQ----IVDC---------KKLEILNVQNNQFS-G 136 (633)
Q Consensus 75 ~~~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~----~~~l---------~~L~~L~Ls~N~l~-~ 136 (633)
+++.|+|++|.+++ .++..+.++++|++|+|++|.|+...+.. +..+ ++|++|+|++|+++ +
T Consensus 95 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~ 174 (386)
T 2ca6_A 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 174 (386)
T ss_dssp TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred cccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcH
Confidence 45555555555554 24444555555555555555554322222 2222 55555555555554 2
Q ss_pred CCc---ccccCCCCCCEEEccCCcCC--C---CCc-cCCCCCCCCeEeCcCCcCC----ccCCcccccCCCCCeeccCCC
Q 006739 137 TIP---SDLSSLIRLRVLDLSGNSFS--G---NLG-FLKYFPNLEHLSLAKNLFT----GKVPTSIRTFRNLQFFDFSGN 203 (633)
Q Consensus 137 ~~p---~~~~~l~~L~~L~l~~N~l~--~---~~~-~~~~l~~L~~L~l~~N~l~----~~~p~~~~~~~~L~~l~l~~N 203 (633)
.+| ..+..+++|+.|+|++|+++ | ..+ .+..+++|+.|+|++|.|+ +.+|..+..+++|+.|+|++|
T Consensus 175 ~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n 254 (386)
T 2ca6_A 175 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 254 (386)
T ss_dssp GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTC
T ss_pred HHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCC
Confidence 333 24445555666666666555 2 112 4555556666666666654 345555555666666666666
Q ss_pred CCC
Q 006739 204 SLL 206 (633)
Q Consensus 204 ~l~ 206 (633)
++.
T Consensus 255 ~i~ 257 (386)
T 2ca6_A 255 LLS 257 (386)
T ss_dssp CCC
T ss_pred CCc
Confidence 553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.36 E-value=5.4e-14 Score=143.54 Aligned_cols=134 Identities=23% Similarity=0.261 Sum_probs=115.7
Q ss_pred eeeeEEEEecCCCCccc-CCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCc-cCCCC-CcccccCCCCCC
Q 006739 73 VLKITKLVFVPRELTGV-LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNN-QFSGT-IPSDLSSLIRLR 149 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~ 149 (633)
..+++.|++++|.+++. ++..+.++++|++|+|++|.+++..|..+..+++|++|+|++| .+++. ++..+.++++|+
T Consensus 92 ~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 45899999999999876 7778899999999999999998888889999999999999999 68753 677788999999
Q ss_pred EEEccCC-cCCCC--CccCCCCC-CCCeEeCcCC--cCC-ccCCcccccCCCCCeeccCCCC-CC
Q 006739 150 VLDLSGN-SFSGN--LGFLKYFP-NLEHLSLAKN--LFT-GKVPTSIRTFRNLQFFDFSGNS-LL 206 (633)
Q Consensus 150 ~L~l~~N-~l~~~--~~~~~~l~-~L~~L~l~~N--~l~-~~~p~~~~~~~~L~~l~l~~N~-l~ 206 (633)
.|+|++| .+++. +..+..++ +|+.|++++| .++ +.+|..+..+++|+.|++++|. ++
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~ 236 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 236 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCC
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCC
Confidence 9999999 88863 45677888 9999999999 565 5677788889999999999998 54
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.7e-13 Score=138.85 Aligned_cols=131 Identities=18% Similarity=0.188 Sum_probs=112.2
Q ss_pred EEEecCCCCcccCCccccCCccccEEEccCCCCCCCCc----hhccCCC-CCcEEEccCccCCCCCcccccCC-----CC
Q 006739 78 KLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLP----PQIVDCK-KLEILNVQNNQFSGTIPSDLSSL-----IR 147 (633)
Q Consensus 78 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 147 (633)
.+.++.|++++.+|..+...++|++|+|++|.|++..+ ..|..++ +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46789999999988888888889999999999999766 7888998 99999999999998888888775 99
Q ss_pred CCEEEccCCcCCCCCc-----cCCCC-CCCCeEeCcCCcCCccCCccccc-----CCCCCeeccCCCCCCCC
Q 006739 148 LRVLDLSGNSFSGNLG-----FLKYF-PNLEHLSLAKNLFTGKVPTSIRT-----FRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 148 L~~L~l~~N~l~~~~~-----~~~~l-~~L~~L~l~~N~l~~~~p~~~~~-----~~~L~~l~l~~N~l~~~ 208 (633)
|+.|+|++|.+++... .+..+ ++|+.|+|++|+|++..+..+.. .++|++|+|++|++...
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 153 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGS
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHH
Confidence 9999999999997763 25555 89999999999999766655443 36999999999999743
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.29 E-value=4e-12 Score=130.37 Aligned_cols=138 Identities=17% Similarity=0.163 Sum_probs=105.3
Q ss_pred eeeeEEEEecCCCCcccCCc-cccCCccccE-EEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccc--------
Q 006739 73 VLKITKLVFVPRELTGVLSP-SIGRLSELRE-LSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-------- 142 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~-~~~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-------- 142 (633)
..+++.|+|++|++.+.++. .|.++++|.. +++++|+|+.+.|..|.++++|++|++++|+|++..+..+
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 44789999999998776654 6888888765 6777889988778888999999999999998884433222
Q ss_pred -----------------cCC-CCCCEEEccCCcCCCCCccCCCCCCCCeEeCcC-CcCCccCC-cccccCCCCCeeccCC
Q 006739 143 -----------------SSL-IRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAK-NLFTGKVP-TSIRTFRNLQFFDFSG 202 (633)
Q Consensus 143 -----------------~~l-~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~-N~l~~~~p-~~~~~~~~L~~l~l~~ 202 (633)
..+ ..|+.|+|++|+|+.++.......+|+.|++++ |.++ .+| +.|..+++|+.|||++
T Consensus 133 l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~ 211 (350)
T 4ay9_X 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISR 211 (350)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTT
T ss_pred hhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCC
Confidence 222 246778888888887776555667888888875 5566 555 5688999999999999
Q ss_pred CCCCCCCcc
Q 006739 203 NSLLEGPIP 211 (633)
Q Consensus 203 N~l~~~~~~ 211 (633)
|+|+.+|..
T Consensus 212 N~l~~lp~~ 220 (350)
T 4ay9_X 212 TRIHSLPSY 220 (350)
T ss_dssp SCCCCCCSS
T ss_pred CCcCccChh
Confidence 999888754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=121.82 Aligned_cols=143 Identities=14% Similarity=0.082 Sum_probs=109.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.++|+....++.|+.+.||++.. +++.+++|......... ...+.+|+++++.+. +..+.++
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~~--------------~~~~~~E~~~l~~l~~~~~vP~v 75 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGT--------------TYDVEREKDMMLWLEGKLPVPKV 75 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTTS--------------TTCHHHHHHHHHHHTTTSCCCCE
T ss_pred hccceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCCC--------------HHHHHHHHHHHHHHhcCCCCCeE
Confidence 35788888899999999999974 46889999875321000 124677888888874 6778899
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS---------------------- 472 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~---------------------- 472 (633)
++++...+..|+||||++|.+|.+.... ......++.+++++|+.||..
T Consensus 76 ~~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 76 LHFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEEEEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEEecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 9999888889999999999998875311 112347888999999999861
Q ss_pred ----------------------------------CCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 473 ----------------------------------HNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 473 ----------------------------------h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11568999999999999876556799998654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.21 E-value=4.1e-13 Score=143.39 Aligned_cols=132 Identities=25% Similarity=0.194 Sum_probs=63.8
Q ss_pred eeEEEEecCCCCccc----CCccccCCccccEEEccCCCCCCCCchhccC-----CCCCcEEEccCccCCCC----Cccc
Q 006739 75 KITKLVFVPRELTGV----LSPSIGRLSELRELSLANNSLVDLLPPQIVD-----CKKLEILNVQNNQFSGT----IPSD 141 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~ 141 (633)
+++.|++++|++++. ++..+.++++|++|+|++|.+++..+..+.. .++|+.|+|++|.+++. ++..
T Consensus 257 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 336 (461)
T 1z7x_W 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 336 (461)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHH
Confidence 344444444444432 2333444444555555555443322222211 13555555555555433 3444
Q ss_pred ccCCCCCCEEEccCCcCCCCC-cc----CC-CCCCCCeEeCcCCcCCc----cCCcccccCCCCCeeccCCCCCC
Q 006739 142 LSSLIRLRVLDLSGNSFSGNL-GF----LK-YFPNLEHLSLAKNLFTG----KVPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~~-~~----~~-~l~~L~~L~l~~N~l~~----~~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
+..+++|+.|+|++|.+++.. .. +. ..++|+.|+|++|++++ .+|..+..+++|+.|++++|++.
T Consensus 337 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 337 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 445556666666666555432 11 11 14566666666666654 45555556666666666666654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=2.9e-12 Score=131.93 Aligned_cols=134 Identities=17% Similarity=0.157 Sum_probs=96.8
Q ss_pred eeEEEEecCCCCcccCCccc-cCCccccEEEccCCCCCCCCchhc-----cCCCCCcEEEccCccCCC----CCcccccC
Q 006739 75 KITKLVFVPRELTGVLSPSI-GRLSELRELSLANNSLVDLLPPQI-----VDCKKLEILNVQNNQFSG----TIPSDLSS 144 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~~ 144 (633)
+++.|+|++|.++......+ ..+++|+.|+|++|.|+......+ ...++|+.|+|++|.|+. .++..+..
T Consensus 102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~ 181 (372)
T 3un9_A 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181 (372)
T ss_dssp CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence 78888999888865433322 346678889999998876433333 346789999999998874 24455577
Q ss_pred CCCCCEEEccCCcCCCCC-----ccCCCCCCCCeEeCcCCcCCcc----CCcccccCCCCCeeccCCCCCCCC
Q 006739 145 LIRLRVLDLSGNSFSGNL-----GFLKYFPNLEHLSLAKNLFTGK----VPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 145 l~~L~~L~l~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
+++|++|+|++|.|++.. ..+..+++|+.|+|++|.|+.. +...+...++|++|+|++|+|...
T Consensus 182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 888999999999887532 4466677899999999988742 344556678899999999988543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.14 E-value=3.6e-12 Score=136.02 Aligned_cols=108 Identities=20% Similarity=0.196 Sum_probs=47.4
Q ss_pred eeEEEEecCCCCcccCCcccc-----CCccccEEEccCCCCCCC----CchhccCCCCCcEEEccCccCCCCCccccc--
Q 006739 75 KITKLVFVPRELTGVLSPSIG-----RLSELRELSLANNSLVDL----LPPQIVDCKKLEILNVQNNQFSGTIPSDLS-- 143 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-- 143 (633)
+++.|++++|.+++..+..+. ..++|++|+|++|++++. ++..+..+++|+.|+|++|.++...+..+.
T Consensus 114 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 193 (461)
T 1z7x_W 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQG 193 (461)
T ss_dssp TCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHH
T ss_pred ceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHH
Confidence 555666666665443222211 133455555555555442 233344445555555555554432222222
Q ss_pred ---CCCCCCEEEccCCcCCCC-----CccCCCCCCCCeEeCcCCcCC
Q 006739 144 ---SLIRLRVLDLSGNSFSGN-----LGFLKYFPNLEHLSLAKNLFT 182 (633)
Q Consensus 144 ---~l~~L~~L~l~~N~l~~~-----~~~~~~l~~L~~L~l~~N~l~ 182 (633)
.+++|+.|+|++|.+++. +..+..+++|+.|++++|.++
T Consensus 194 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 194 LKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 133444444444444432 122333444444444444443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=9.1e-11 Score=114.81 Aligned_cols=137 Identities=12% Similarity=0.128 Sum_probs=96.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc--cccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN--LLPL 414 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l 414 (633)
.++......+.|..+.||++.. .+|..+++|...... ...+.+|+++++.+.+.+ +.++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~~-----------------~~~~~~E~~~l~~l~~~~~~vP~~ 80 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA--QGRPVLFVKTDLSGA-----------------LNELQDEAARLSWLATTGVPCAAV 80 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC--TTSCCEEEEEECSCT-----------------TSCHHHHHHHHHHHHTTTCCBCCE
T ss_pred CCCceEecccCCCCceEEEEec--CCCCeEEEEeCCccc-----------------chhhhHHHHHHHHHHhCCCCCCeE
Confidence 3455444444666799999965 367889999865431 123567788887775444 5568
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISH--------------------- 473 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h--------------------- 473 (633)
+++....+..++||||++|.+|. ... .. ...++.++++.|..||...
T Consensus 81 ~~~~~~~~~~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~ 148 (264)
T 1nd4_A 81 LDVVTEAGRDWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRM 148 (264)
T ss_dssp EEEEECSSCEEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHH
T ss_pred EEeccCCCCCEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHH
Confidence 88888777889999999998874 211 11 2356777778888886421
Q ss_pred ----------------------------------CCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 474 ----------------------------------NPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 474 ----------------------------------~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 149 EAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887666799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=6.5e-10 Score=114.27 Aligned_cols=145 Identities=15% Similarity=0.197 Sum_probs=105.7
Q ss_pred cccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--CCcccccceee
Q 006739 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR--HRNLLPLLAHM 418 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~ 418 (633)
.++.|+.|.++.||++.. ++..+++|+...+..... .....+.+|+++++.+. +..+++++.++
T Consensus 42 ~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~~~-----------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~ 107 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSKLL-----------PSAHAIEREYRVMDALAGTDVPVAKMYALC 107 (359)
T ss_dssp EEEECCC-CCSCEEEEEC---SSCEEEEECCCC---------------------CHHHHHHHHHHHTTSSSCCCCEEEEE
T ss_pred eEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCCCC-----------CcHHHHHHHHHHHHHhhcCCCCCCcEEEEC
Confidence 357789999999999975 456788987641111000 01345778899998887 45678888888
Q ss_pred ecC---CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------
Q 006739 419 ARP---DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISH---------------------- 473 (633)
Q Consensus 419 ~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h---------------------- 473 (633)
.+. +..++||||++|..+.+.. ...++...+..++.++++.|+.||...
T Consensus 108 ~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3dxp_A 108 EDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIER 181 (359)
T ss_dssp CCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHH
T ss_pred CCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHH
Confidence 766 4478999999997774311 123678888999999999999998621
Q ss_pred ---------------------------------CCCeeeCCCCCCCeEecCCCc--eEEcccccccc
Q 006739 474 ---------------------------------NPRIIHRDLKPANVLLDDDME--ARIADFGLAKA 505 (633)
Q Consensus 474 ---------------------------------~~~ivH~Dikp~Nill~~~~~--~kl~DfG~a~~ 505 (633)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 182 WTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 367999999999999997753 68999998765
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.04 E-value=3.5e-10 Score=114.80 Aligned_cols=38 Identities=13% Similarity=0.329 Sum_probs=21.8
Q ss_pred CccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCC
Q 006739 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFS 135 (633)
Q Consensus 97 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 135 (633)
+++|+.|+|.+ .++.+-+.+|.++++|+.|+|++|.++
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~ 137 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP 137 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc
Confidence 56666666666 555544455666666666666666543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.02 E-value=3.6e-10 Score=114.65 Aligned_cols=133 Identities=14% Similarity=0.159 Sum_probs=87.6
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccC---------------------------------
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVD--------------------------------- 120 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--------------------------------- 120 (633)
.+++.|+|.+ +++.+.+.+|.++++|+.|+|++|.++.+.+..|.+
T Consensus 101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~ 179 (329)
T 3sb4_A 101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE 179 (329)
T ss_dssp TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence 4788999998 888877788999999999999999875443333333
Q ss_pred ---------------------------------------------CCCCcEEEccCccCCCCCcccccCCCCCCEEEccC
Q 006739 121 ---------------------------------------------CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155 (633)
Q Consensus 121 ---------------------------------------------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 155 (633)
+++|+.|+|++|+++..-+..|.+|++|+.|+|++
T Consensus 180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~ 259 (329)
T 3sb4_A 180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH 259 (329)
T ss_dssp EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence 45666666666666643344466666666666666
Q ss_pred CcCCCCC-ccCCCCCCCC-eEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 156 NSFSGNL-GFLKYFPNLE-HLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 156 N~l~~~~-~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
| ++... ..|.+|++|+ .+++.+ +++..-+..|..|++|+.+++++|++..++
T Consensus 260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~ 313 (329)
T 3sb4_A 260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLG 313 (329)
T ss_dssp T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEEC
T ss_pred c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccc
Confidence 6 54444 4566666666 666666 555444556666666666666666665544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=8.9e-12 Score=128.32 Aligned_cols=135 Identities=19% Similarity=0.160 Sum_probs=104.3
Q ss_pred eeeEEEEecCCCCcccCCccccCC-----ccccEEEccCCCCCCCCchhc-cCCCCCcEEEccCccCCCCCcccc-----
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRL-----SELRELSLANNSLVDLLPPQI-VDCKKLEILNVQNNQFSGTIPSDL----- 142 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~----- 142 (633)
..++.|+|++|.++......+..+ ++|+.|+|++|.|+......+ ..+++|+.|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 368999999999987544443333 789999999999976323333 346789999999999985444444
Q ss_pred cCCCCCCEEEccCCcCCCCC-----ccCCCCCCCCeEeCcCCcCCcc----CCcccccCCCCCeeccCCCCCCCC
Q 006739 143 SSLIRLRVLDLSGNSFSGNL-----GFLKYFPNLEHLSLAKNLFTGK----VPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 143 ~~l~~L~~L~l~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
...++|+.|+|++|.|+... ..+..+++|++|+|++|.|+.. ++..+...++|+.|+|++|.|...
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~ 226 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHH
Confidence 34689999999999997632 3457789999999999999843 356677888999999999999653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.98 E-value=3.7e-11 Score=116.28 Aligned_cols=104 Identities=22% Similarity=0.246 Sum_probs=75.8
Q ss_pred ccCCccccE--EEccCCCCCCCCch----hccCCCCCcEEEccCccCCC--CCcccccCCCCCCEEEccCCcCCCCC--c
Q 006739 94 IGRLSELRE--LSLANNSLVDLLPP----QIVDCKKLEILNVQNNQFSG--TIPSDLSSLIRLRVLDLSGNSFSGNL--G 163 (633)
Q Consensus 94 ~~~l~~L~~--L~l~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~--~ 163 (633)
|...+.|.. ++++.|.... ++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.. .
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~-~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~ 215 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSC-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELD 215 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHH-HHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGG
T ss_pred cCCCcchhhcCccccCCHHHH-HHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhh
Confidence 334444554 6777775432 332 22568899999999999997 45567778999999999999998863 3
Q ss_pred cCCCCCCCCeEeCcCCcCCccCCc-------ccccCCCCCeec
Q 006739 164 FLKYFPNLEHLSLAKNLFTGKVPT-------SIRTFRNLQFFD 199 (633)
Q Consensus 164 ~~~~l~~L~~L~l~~N~l~~~~p~-------~~~~~~~L~~l~ 199 (633)
.+..+ +|+.|+|++|.+.+.+|+ .+..+++|+.||
T Consensus 216 ~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 216 KIKGL-KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hcccC-CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 34444 899999999999887763 367788998886
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=7.5e-10 Score=110.97 Aligned_cols=187 Identities=18% Similarity=0.210 Sum_probs=119.1
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCc--ccccceee
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRN--LLPLLAHM 418 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~ 418 (633)
++.++.|....||++. ..+++|+.... .....+.+|.++++.+. +.. +.+.+...
T Consensus 25 i~~~~~G~~n~v~~v~------~~~vlR~~~~~----------------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~ 82 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN------RDFIFKFPKHS----------------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTG 82 (304)
T ss_dssp CCEEEECSSEEEEEST------TSEEEEEESSH----------------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC
T ss_pred eEecCCCCcceEEEEC------CEEEEEecCCc----------------chHHHHHHHHHHHHHHHhcCCCCCCceEeec
Confidence 4568999999999872 35888875321 01346788898988773 333 34455444
Q ss_pred ecCC---ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------
Q 006739 419 ARPD---CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS----------------------- 472 (633)
Q Consensus 419 ~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~----------------------- 472 (633)
...+ ..|+||||++|.++.+... ..++..++..++.++++.++.||..
T Consensus 83 ~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (304)
T 3sg8_A 83 MPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKK 156 (304)
T ss_dssp CCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHH
T ss_pred CCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHH
Confidence 3333 3478999999988865332 2366677778888888888888741
Q ss_pred --------------------------------CCCCeeeCCCCCCCeEecC--CCceEEcccccccccCCCCCcceecc-
Q 006739 473 --------------------------------HNPRIIHRDLKPANVLLDD--DMEARIADFGLAKAMPDAQTHITTSN- 517 (633)
Q Consensus 473 --------------------------------h~~~ivH~Dikp~Nill~~--~~~~kl~DfG~a~~~~~~~~~~~~~~- 517 (633)
....++|+|++|.||++++ +..+.|+||+.+..-...........
T Consensus 157 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~ 236 (304)
T 3sg8_A 157 IKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED 236 (304)
T ss_dssp HHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT
T ss_pred HHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh
Confidence 1246899999999999998 45678999998875432211000000
Q ss_pred -----------cccCccccc-ccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006739 518 -----------VAGTVGYIA-PEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPS 558 (633)
Q Consensus 518 -----------~~gt~~y~a-PE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 558 (633)
.....++.. |+.... .....+.|+++.++|++.+|+.+|
T Consensus 237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 237 DEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000001111 222211 112368999999999999998775
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.85 E-value=2.3e-10 Score=126.07 Aligned_cols=135 Identities=19% Similarity=0.252 Sum_probs=93.0
Q ss_pred eeEEEEecCCCCcccCCccccC-CccccEEEcc----CCCCCCC-----CchhccCCCCCcEEEccCc--cCCCCCcccc
Q 006739 75 KITKLVFVPRELTGVLSPSIGR-LSELRELSLA----NNSLVDL-----LPPQIVDCKKLEILNVQNN--QFSGTIPSDL 142 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~ 142 (633)
+++.|+++.|++++.....++. +++|+.|+|+ .|.+++. ++..+.++++|+.|+|++| .+++..+..+
T Consensus 379 ~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~ 458 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYI 458 (592)
T ss_dssp TCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHH
T ss_pred cCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHH
Confidence 5677777777776655555544 7777777775 6677663 3334666788888888643 3665555444
Q ss_pred c-CCCCCCEEEccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCcc-CCcccccCCCCCeeccCCCCCCCCC
Q 006739 143 S-SLIRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGK-VPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 143 ~-~l~~L~~L~l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+ .+++|+.|+|++|++++.. ..+..+++|+.|+|++|.|++. ++..+..+++|+.|+|++|+++...
T Consensus 459 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~ 529 (592)
T 3ogk_B 459 GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTG 529 (592)
T ss_dssp HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTC
T ss_pred HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHH
Confidence 4 3788888888888887532 4456788899999999988754 3444567888999999999876543
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.73 E-value=1.8e-09 Score=99.41 Aligned_cols=116 Identities=14% Similarity=0.155 Sum_probs=90.9
Q ss_pred CCccccCCccccEEEccCC-CCCCC----CchhccCCCCCcEEEccCccCCCC----CcccccCCCCCCEEEccCCcCCC
Q 006739 90 LSPSIGRLSELRELSLANN-SLVDL----LPPQIVDCKKLEILNVQNNQFSGT----IPSDLSSLIRLRVLDLSGNSFSG 160 (633)
Q Consensus 90 ~~~~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 160 (633)
+...+...+.|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 4445777889999999999 88652 445667788999999999999742 34455666889999999999986
Q ss_pred C-----CccCCCCCCCCeEeC--cCCcCCcc----CCcccccCCCCCeeccCCCCC
Q 006739 161 N-----LGFLKYFPNLEHLSL--AKNLFTGK----VPTSIRTFRNLQFFDFSGNSL 205 (633)
Q Consensus 161 ~-----~~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~~~~L~~l~l~~N~l 205 (633)
. ...+...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i 163 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 163 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence 4 256777889999999 88999853 345566678999999999987
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.67 E-value=5.3e-09 Score=115.13 Aligned_cols=103 Identities=17% Similarity=0.200 Sum_probs=62.8
Q ss_pred eeEEEEecCCC-Ccc-cCCccccCCccccEEEccCCCCCCC----CchhccCCCCCcEEEccCccCCC----CCcccccC
Q 006739 75 KITKLVFVPRE-LTG-VLSPSIGRLSELRELSLANNSLVDL----LPPQIVDCKKLEILNVQNNQFSG----TIPSDLSS 144 (633)
Q Consensus 75 ~~~~L~l~~n~-l~~-~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~ 144 (633)
+++.|+|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 37777777765 211 1122234667777777777777654 33445567777777777777762 33444556
Q ss_pred CCCCCEEEccCCcCCCCCccCCCCCCCCeEeCc
Q 006739 145 LIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLA 177 (633)
Q Consensus 145 l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~ 177 (633)
+++|+.|+|++|.+.+.+..+..+++|+.|+++
T Consensus 219 ~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILELVGFFKAAANLEEFCGG 251 (592)
T ss_dssp CTTCCEEECSSCBGGGGHHHHHHCTTCCEEEEC
T ss_pred CCCCcEEeccCccHHHHHHHHhhhhHHHhhccc
Confidence 777777777777766654444455555555554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.59 E-value=6.4e-09 Score=100.59 Aligned_cols=79 Identities=29% Similarity=0.466 Sum_probs=65.1
Q ss_pred cCCccccEEEccCCCCCC--CCchhccCCCCCcEEEccCccCCCCCcccccCCC--CCCEEEccCCcCCCCC--------
Q 006739 95 GRLSELRELSLANNSLVD--LLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLI--RLRVLDLSGNSFSGNL-------- 162 (633)
Q Consensus 95 ~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~-------- 162 (633)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++..
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 468899999999999999 3457778999999999999999964 3344454 9999999999998743
Q ss_pred ccCCCCCCCCeEe
Q 006739 163 GFLKYFPNLEHLS 175 (633)
Q Consensus 163 ~~~~~l~~L~~L~ 175 (633)
..+..+|+|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 2367789999886
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=2.9e-07 Score=90.32 Aligned_cols=136 Identities=17% Similarity=0.210 Sum_probs=94.7
Q ss_pred cccccccCe-eEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccceeeec
Q 006739 343 EKIGSGGCG-EVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLLAHMAR 420 (633)
Q Consensus 343 ~~ig~G~~g-~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 420 (633)
+.+..|..| .||+.... .++..+++|+..... ...+.+|...++.+. +-.+.++++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~~~-----------------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~ 91 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGK-PNAPELFLKHGKGSV-----------------ANDVTDEMVRLNWLTAFMPLPTIKHFIRT 91 (272)
T ss_dssp EEEECSSSSCEEEEEECC-TTCCCEEEEEEETHH-----------------HHHHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred EEccCCCcCCeEEEEEec-CCCeEEEEEECCCCC-----------------HhHHHHHHHHHHHhccCCCcCeEEEEEEE
Confidence 345556665 68987643 456789999753210 345677888887774 3447788999998
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHI----------------------------- 471 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~----------------------------- 471 (633)
.+..++|||+++|.++.+...... .....++.++++.|..||.
T Consensus 92 ~~~~~lvme~l~G~~~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (272)
T 4gkh_A 92 PDDAWLLTTAIPGKTAFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVD 163 (272)
T ss_dssp TTEEEEEEECCCSEEHHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCC
T ss_pred CCeEEEEEEeeCCccccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhh
Confidence 899999999999988876653211 1233456666666666661
Q ss_pred --------------------------cCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 472 --------------------------SHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 472 --------------------------~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
.+...++|+|+.+.||++++++.+-|+||+.+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 164 ASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 122347999999999999987767799999764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.51 E-value=8.1e-09 Score=95.03 Aligned_cols=108 Identities=16% Similarity=0.174 Sum_probs=87.9
Q ss_pred eeEEEEecCC-CCccc----CCccccCCccccEEEccCCCCCCC----CchhccCCCCCcEEEccCccCCCC----Cccc
Q 006739 75 KITKLVFVPR-ELTGV----LSPSIGRLSELRELSLANNSLVDL----LPPQIVDCKKLEILNVQNNQFSGT----IPSD 141 (633)
Q Consensus 75 ~~~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 141 (633)
.++.|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +...
T Consensus 37 ~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~ 116 (185)
T 1io0_A 37 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEA 116 (185)
T ss_dssp TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHG
T ss_pred CCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHH
Confidence 7899999999 88653 344567788999999999999752 345566678999999999999853 4566
Q ss_pred ccCCCCCCEEEc--cCCcCCCCC-----ccCCCCCCCCeEeCcCCcCC
Q 006739 142 LSSLIRLRVLDL--SGNSFSGNL-----GFLKYFPNLEHLSLAKNLFT 182 (633)
Q Consensus 142 ~~~l~~L~~L~l--~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~ 182 (633)
+...++|+.|+| ++|.|+... ..+...++|+.|+|++|.+.
T Consensus 117 L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 117 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 778889999999 889998642 45666789999999999986
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.50 E-value=4.3e-09 Score=115.93 Aligned_cols=108 Identities=12% Similarity=0.114 Sum_probs=49.5
Q ss_pred CccccEEEccCCCCCCCCchhcc-CCCCCcEEEcc--C----ccCCCC-----CcccccCCCCCCEEEccCCcCCCCC-c
Q 006739 97 LSELRELSLANNSLVDLLPPQIV-DCKKLEILNVQ--N----NQFSGT-----IPSDLSSLIRLRVLDLSGNSFSGNL-G 163 (633)
Q Consensus 97 l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~-~ 163 (633)
+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.+++. ++..+..+++|+.|+|++ .+++.. .
T Consensus 371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 45555555555555543333333 35555555555 2 344411 111134455555555544 333221 2
Q ss_pred cCCC-CCCCCeEeCcCCcCCccCCccc-ccCCCCCeeccCCCCC
Q 006739 164 FLKY-FPNLEHLSLAKNLFTGKVPTSI-RTFRNLQFFDFSGNSL 205 (633)
Q Consensus 164 ~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~~~~L~~l~l~~N~l 205 (633)
.+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 2222 4555555555555543333332 3455555555555554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.46 E-value=5e-08 Score=99.44 Aligned_cols=130 Identities=15% Similarity=0.212 Sum_probs=75.4
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhcc--CCCCCcEEEccC--ccCCCC-----Ccccc--
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIV--DCKKLEILNVQN--NQFSGT-----IPSDL-- 142 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~Ls~--N~l~~~-----~p~~~-- 142 (633)
++++.|+|++|.-.. +++ +. +++|+.|+|..|.++......+. .+++|+.|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~ 248 (362)
T 2ra8_A 172 PLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK 248 (362)
T ss_dssp TTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCT
T ss_pred CCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhc
Confidence 367777777663111 222 32 66777777777766542223333 577788877753 221111 11122
Q ss_pred cCCCCCCEEEccCCcCCCCC----ccCCCCCCCCeEeCcCCcCCcc----CCcccccCCCCCeeccCCCCCC
Q 006739 143 SSLIRLRVLDLSGNSFSGNL----GFLKYFPNLEHLSLAKNLFTGK----VPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 143 ~~l~~L~~L~l~~N~l~~~~----~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
..+++|+.|+|++|.+++.. .....+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+
T Consensus 249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 24677888888877776422 1113467788888888877753 3444456677888888877764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.5e-08 Score=111.57 Aligned_cols=63 Identities=21% Similarity=0.245 Sum_probs=26.7
Q ss_pred CccccEEEccCCCCCCCCchhcc-CCCCCcEEEccCc-cCCCC-CcccccCCCCCCEEEccCCcCC
Q 006739 97 LSELRELSLANNSLVDLLPPQIV-DCKKLEILNVQNN-QFSGT-IPSDLSSLIRLRVLDLSGNSFS 159 (633)
Q Consensus 97 l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L~l~~N~l~ 159 (633)
+++|++|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+.++++|++|+|++|.++
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~ 169 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVD 169 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEE
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccC
Confidence 34444555554444443333332 3444555555444 23211 2222234444455555444443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.41 E-value=1.1e-06 Score=91.05 Aligned_cols=131 Identities=14% Similarity=0.184 Sum_probs=73.2
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+++.+.+.+ .++.+-+..|.++++|+.++|++|+++.+-...|. ..+|+.+.|..| ++..-...|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 455666654 55555555666666666666666665553333333 355555555422 442333344445455544444
Q ss_pred CC---------------------cCCCCC-ccCCCCCCCCeEeCcCCcCC-----ccCCcccccCCCCCeeccCCCCCCC
Q 006739 155 GN---------------------SFSGNL-GFLKYFPNLEHLSLAKNLFT-----GKVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 155 ~N---------------------~l~~~~-~~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
.| +++... ..|.+|++|+.+++.+|.+. ..-+..|..|++|+.++|.+ .+..
T Consensus 235 ~~l~~I~~~aF~~~~L~~i~lp~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~ 313 (401)
T 4fdw_A 235 ENVSTIGQEAFRESGITTVKLPNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRI 313 (401)
T ss_dssp TTCCEECTTTTTTCCCSEEEEETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCE
T ss_pred CCccCccccccccCCccEEEeCCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEE
Confidence 32 233222 45677788888888777765 34456677788888888773 3544
Q ss_pred CC
Q 006739 208 GP 209 (633)
Q Consensus 208 ~~ 209 (633)
++
T Consensus 314 I~ 315 (401)
T 4fdw_A 314 LG 315 (401)
T ss_dssp EC
T ss_pred Eh
Confidence 43
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.40 E-value=6.9e-07 Score=92.66 Aligned_cols=147 Identities=12% Similarity=0.112 Sum_probs=107.0
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.+.|.+ +++.+-...|.++++|+.|+|.+| ++.+-..+|.+ .+|+.+.| .|+++..-+..|.+|++|+.+++
T Consensus 203 ~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence 4678888874 477777778999999999999875 66655667777 78999999 45566455777888999999999
Q ss_pred cCCcCC-----CCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccccccCCCCccccccc
Q 006739 154 SGNSFS-----GNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYPKRY 227 (633)
Q Consensus 154 ~~N~l~-----~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~ 227 (633)
.+|.+. ... ..|.+|++|+.++|. |+++..-...|.+|.+|+.++|.+| +..+ +..+|..+ ++
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I--------~~~aF~~~-~L 347 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQI--------NFSAFNNT-GI 347 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEE--------CTTSSSSS-CC
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEE--------cHHhCCCC-CC
Confidence 888876 222 568888899999998 4577555677888888998888655 4333 34556555 55
Q ss_pred cccccccC
Q 006739 228 VLAETTTN 235 (633)
Q Consensus 228 ~~~~~~~~ 235 (633)
.......+
T Consensus 348 ~~l~l~~n 355 (401)
T 4fdw_A 348 KEVKVEGT 355 (401)
T ss_dssp CEEEECCS
T ss_pred CEEEEcCC
Confidence 55444443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.6e-06 Score=86.61 Aligned_cols=136 Identities=20% Similarity=0.162 Sum_probs=91.2
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC---cccccceee
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR---NLLPLLAHM 418 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~ 418 (633)
++.++.|....||+. |..+++|+.... .....+.+|.++++.+.+. .+.+.+.++
T Consensus 24 v~~l~~G~~n~v~~v------g~~~VlR~~~~~----------------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~ 81 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------NGDWVFRFPKSQ----------------QGADELNKEIQLLPLLVGCVKVNIPQYVYIG 81 (306)
T ss_dssp EEEEEECSSEEEEEE------TTTEEEEEESSH----------------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEE
T ss_pred eeecCCCcceeEEEE------CCEEEEEecCCc----------------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeec
Confidence 456788888899987 346888874210 0135688899999998742 355666666
Q ss_pred e-cCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------
Q 006739 419 A-RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS------------------------- 472 (633)
Q Consensus 419 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~------------------------- 472 (633)
. ..+..++||||++|.++.+..- ..++...+..++.++++.|+.||..
T Consensus 82 ~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~ 155 (306)
T 3tdw_A 82 KRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEA 155 (306)
T ss_dssp ECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHH
T ss_pred ccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHH
Confidence 4 3455789999999988765321 1133444445555555555555421
Q ss_pred --------------------------------CCCCeeeCCCCCCCeEecC---CCce-EEcccccccc
Q 006739 473 --------------------------------HNPRIIHRDLKPANVLLDD---DMEA-RIADFGLAKA 505 (633)
Q Consensus 473 --------------------------------h~~~ivH~Dikp~Nill~~---~~~~-kl~DfG~a~~ 505 (633)
....++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 156 ~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 156 VEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3446799999999999997 4554 8999997754
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=4.1e-07 Score=92.68 Aligned_cols=131 Identities=18% Similarity=0.233 Sum_probs=91.1
Q ss_pred eeeEEEEecCCCCc---------ccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCccccc-
Q 006739 74 LKITKLVFVPRELT---------GVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLS- 143 (633)
Q Consensus 74 ~~~~~L~l~~n~l~---------~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~- 143 (633)
.+++.|.+.++... +.+...+..+++|+.|+|++|.-.. ++. +. +++|+.|+|..|.++......++
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~-l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS-IGK-KP-RPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB-CCS-CB-CTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce-ecc-cc-CCCCcEEEEecCCCChHHHHHHHH
Confidence 47888888765431 1233456778999999999883112 343 43 89999999999988754444444
Q ss_pred -CCCCCCEEEccC--CcCCCC------CccC--CCCCCCCeEeCcCCcCCccCCcccc---cCCCCCeeccCCCCCCC
Q 006739 144 -SLIRLRVLDLSG--NSFSGN------LGFL--KYFPNLEHLSLAKNLFTGKVPTSIR---TFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 144 -~l~~L~~L~l~~--N~l~~~------~~~~--~~l~~L~~L~l~~N~l~~~~p~~~~---~~~~L~~l~l~~N~l~~ 207 (633)
.+++|+.|+|+. |...+. ...+ ..+|+|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|..
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 789999999864 332222 1223 3589999999999999854443333 47899999999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=4.5e-06 Score=85.34 Aligned_cols=84 Identities=2% Similarity=-0.014 Sum_probs=51.7
Q ss_pred cccc-ccccCeeEEEEEec--CC---CCeEEEEEEccCCCc-chhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-C--Ccc
Q 006739 342 LEKI-GSGGCGEVYKAELP--GS---NGKMIAIKKVIQPPK-DAAELTEEDSKLLNKKMRQIRSEINTVGQIR-H--RNL 411 (633)
Q Consensus 342 ~~~i-g~G~~g~Vy~~~~~--~~---~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~ni 411 (633)
.+.| +.|....+|+.... .. ++..+++|+...... .... ...+.+|+.+++.+. + -.+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~------------~~~~~~E~~~l~~L~~~~~vpv 92 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP------------TYRLDHQFEVIRLVGELTDVPV 92 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS------------CCCHHHHHHHHHHHHHHCCSCC
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc------------hhHHHHHHHHHHHHhhcCCCCC
Confidence 4677 88889999998652 00 167889987532110 0000 123455666666664 2 356
Q ss_pred cccceeeecC---CccEEEEecccCCCHH
Q 006739 412 LPLLAHMARP---DCHLLVYEFMKNGSLQ 437 (633)
Q Consensus 412 v~l~~~~~~~---~~~~lv~e~~~~gsL~ 437 (633)
.+++.++.+. +..++||||++|..+.
T Consensus 93 P~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 93 PRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred CcEEEEccCCCccCCceEEEEecCCCChh
Confidence 7778777654 3568999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=3.1e-05 Score=78.47 Aligned_cols=32 Identities=22% Similarity=0.469 Sum_probs=28.4
Q ss_pred CCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 473 h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 220 ~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 220 KSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 36789999999999999888889999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.83 E-value=5.6e-05 Score=75.07 Aligned_cols=140 Identities=16% Similarity=0.174 Sum_probs=90.8
Q ss_pred cccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC---CCccccccee
Q 006739 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR---HRNLLPLLAH 417 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~ 417 (633)
..+.|+.|....+|+... ++..+++|+..... ...+..|.+.++.+. ...+++++.+
T Consensus 40 ~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~~-----------------~~~~~~E~~~L~~L~~~~~v~VP~vl~~ 99 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND---EVQTVFVKINERSY-----------------RSMFRAEADQLALLAKTNSINVPLVYGI 99 (312)
T ss_dssp EEEEECCSSSSEEEEEES---SSCEEEEEEEEGGG-----------------HHHHHHHHHHHHHHHHTTSSBCCCEEEE
T ss_pred eeEEeCCccceeeeEEEE---CCCeEEEEeCCccc-----------------HHHHHHHHHHHHHHHhhCCCCcceEEEE
Confidence 357789999999999974 56788999863210 345677888887774 3568888888
Q ss_pred eecCCccEEEEecccCCCHH-----------HHHhhhcC-C--C---------------CCCCHHHHH---HHHH-----
Q 006739 418 MARPDCHLLVYEFMKNGSLQ-----------DILNDVSQ-G--R---------------RELDWLARH---KIAL----- 460 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gsL~-----------~~l~~~~~-~--~---------------~~l~~~~~~---~i~~----- 460 (633)
+...+..++||||+++..+. ..+|.... . + ..-+|.... ++..
T Consensus 100 ~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a 179 (312)
T 3jr1_A 100 GNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQIC 179 (312)
T ss_dssp EECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHH
T ss_pred eecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHH
Confidence 88778899999999987542 12333221 0 0 012454321 1111
Q ss_pred -----------HHHHH-HHHHH-hcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 461 -----------GVACG-LEYLH-ISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 461 -----------~ia~~-L~~Lh-~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
.+.+- ...|. ......++|+|+.+.|++++.++ +.|+||.
T Consensus 180 ~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 180 KEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 11111 12331 12357899999999999999887 8899974
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.80 E-value=5.5e-06 Score=74.15 Aligned_cols=34 Identities=12% Similarity=0.098 Sum_probs=16.5
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCC
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANN 108 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 108 (633)
+++.||++++.++..--..+.++++|+.|+|+++
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555544332233444455555555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.78 E-value=5.3e-06 Score=74.26 Aligned_cols=83 Identities=12% Similarity=0.127 Sum_probs=56.4
Q ss_pred ccccEEEccCCCCCCCCchhccCCCCCcEEEccCcc-CCCCCcccccCC----CCCCEEEccCCc-CCCCC-ccCCCCCC
Q 006739 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQ-FSGTIPSDLSSL----IRLRVLDLSGNS-FSGNL-GFLKYFPN 170 (633)
Q Consensus 98 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~-~~~~~l~~ 170 (633)
-.|+.|||+++.|+..--..+.++++|+.|+|+++. |+..--..++.+ ++|+.|+|+++. +|..- ..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888776444556778888888888874 664333334443 368888888864 66433 45566778
Q ss_pred CCeEeCcCCc
Q 006739 171 LEHLSLAKNL 180 (633)
Q Consensus 171 L~~L~l~~N~ 180 (633)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888887765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=7.2e-05 Score=77.50 Aligned_cols=82 Identities=13% Similarity=0.160 Sum_probs=47.0
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCc-chhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC--Cc-cccccee
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPK-DAAELTEEDSKLLNKKMRQIRSEINTVGQIRH--RN-LLPLLAH 417 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~n-iv~l~~~ 417 (633)
.+.||.|.++.||++... .+++.++||....... ...... .....+..|.++++.+.. +. +.+++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~-~~~~~~vvK~~~~~~r~~~~~~~--------~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWP--------LTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCC-------CC--------CCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEEC-CCCcEEEEEecchhhcccCCCCc--------CcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 567999999999999653 2467899997643211 000000 001234567777776632 33 3455543
Q ss_pred eecCCccEEEEecccCC
Q 006739 418 MARPDCHLLVYEFMKNG 434 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~g 434 (633)
+.+..++||||+++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 455678999999763
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.72 E-value=1.1e-05 Score=73.68 Aligned_cols=113 Identities=16% Similarity=0.166 Sum_probs=83.1
Q ss_pred cccCCccccEEEccCC-CCCCC----CchhccCCCCCcEEEccCccCCCC----CcccccCCCCCCEEEccCCcCCCCC-
Q 006739 93 SIGRLSELRELSLANN-SLVDL----LPPQIVDCKKLEILNVQNNQFSGT----IPSDLSSLIRLRVLDLSGNSFSGNL- 162 (633)
Q Consensus 93 ~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~- 162 (633)
.+.+-+.|+.|+|++| +|... +-+.+..-+.|+.|+|++|+|... +...+..-+.|+.|+|++|.|+..-
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3556678999999985 77531 445667778999999999999832 3344556688999999999998643
Q ss_pred ----ccCCCCCCCCeEeCcCCc---CCc----cCCcccccCCCCCeeccCCCCC
Q 006739 163 ----GFLKYFPNLEHLSLAKNL---FTG----KVPTSIRTFRNLQFFDFSGNSL 205 (633)
Q Consensus 163 ----~~~~~l~~L~~L~l~~N~---l~~----~~p~~~~~~~~L~~l~l~~N~l 205 (633)
..+..-+.|+.|+|++|. +.. .+-+.+..-++|+.|+++.|.+
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 456677789999998763 332 2344566678999999988764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00018 Score=70.77 Aligned_cols=79 Identities=15% Similarity=0.202 Sum_probs=53.5
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCC---ccccc
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHR---NLLPL 414 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l 414 (633)
....++.+|.|..+.||+.+.. ||+.|++|+........ ...|..|.+.|+.+.-. .++++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~--------------~~~~~~Ea~~L~~L~~~~~vpvP~v 79 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA--DGTPLFVKALPDDAPAL--------------DGLFRAEALGLDWLGRSFGSPVPQV 79 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCC--------------TTHHHHHHHHHHHHTCSTTCCSCCE
T ss_pred CeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcch--------------hhHHHHHHHHHHHHHhhCCCCcceE
Confidence 3455688999999999999875 89999999864332111 12466788888777422 34455
Q ss_pred ceeeecCCccEEEEecccCCCH
Q 006739 415 LAHMARPDCHLLVYEFMKNGSL 436 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL 436 (633)
+++ +..++||||++++..
T Consensus 80 ~~~----~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 80 AGW----DDRTLAMEWVDERPP 97 (288)
T ss_dssp EEE----ETTEEEEECCCCCCC
T ss_pred Eec----cCceEEEEeecccCC
Confidence 543 234789999987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00049 Score=71.75 Aligned_cols=81 Identities=19% Similarity=0.062 Sum_probs=49.8
Q ss_pred CCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCC---CCCccchHHHHHHHH
Q 006739 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK---FTDKCDIYSFGVLLA 549 (633)
Q Consensus 473 h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~ 549 (633)
+...++|+|+++.|||++.++ ++++||+.+..-........ ....-...|.+|+...... .....++......+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 578899999999999999876 99999998775332111000 0000123466666553211 112345567788888
Q ss_pred HHHhCC
Q 006739 550 VLVMGR 555 (633)
Q Consensus 550 elltg~ 555 (633)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00025 Score=73.35 Aligned_cols=117 Identities=12% Similarity=0.238 Sum_probs=88.3
Q ss_pred CCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-c
Q 006739 85 ELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-G 163 (633)
Q Consensus 85 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~ 163 (633)
.++.+-..+|.+++.|+.+.+.++.. .+-...|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++... .
T Consensus 252 ~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~ 328 (394)
T 4gt6_A 252 GVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDD 328 (394)
T ss_dssp TEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTT
T ss_pred cceEcccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHh
Confidence 44444456788899999999976643 3456788889999999996 5566455567889999999999865 55444 6
Q ss_pred cCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCC
Q 006739 164 FLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205 (633)
Q Consensus 164 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l 205 (633)
.|.+|.+|+.+.|..+ ++..-...|.+|.+|+.+++.+|..
T Consensus 329 aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 329 AFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred HhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 7888999999999655 6644456789999999999988754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00024 Score=60.44 Aligned_cols=56 Identities=14% Similarity=0.115 Sum_probs=32.7
Q ss_pred EEEccCCcCC--CCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCC
Q 006739 150 VLDLSGNSFS--GNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 150 ~L~l~~N~l~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
.++.+++.|+ .+|..+ .++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 5555555555 444322 1356666666666664444556666667777777776643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00051 Score=70.49 Aligned_cols=105 Identities=11% Similarity=0.138 Sum_probs=44.6
Q ss_pred cccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCC
Q 006739 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNL 171 (633)
Q Consensus 93 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L 171 (633)
.+.++..|+.+.+..+ ++.+-...|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.+|.++... ..|.+|.+|
T Consensus 235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L 312 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL 312 (379)
T ss_dssp TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence 3444444444444433 33323334444444444444332 33122233444455555555444444333 344444555
Q ss_pred CeEeCcCCcCCccCCcccccCCCCCeecc
Q 006739 172 EHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200 (633)
Q Consensus 172 ~~L~l~~N~l~~~~p~~~~~~~~L~~l~l 200 (633)
+.+.|..+ ++..-...|.+|.+|+.+.+
T Consensus 313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 313 SSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred CEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 55555432 33222234444444544444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00029 Score=60.01 Aligned_cols=55 Identities=22% Similarity=0.281 Sum_probs=29.9
Q ss_pred EEEccCCCCC-CCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcC
Q 006739 102 ELSLANNSLV-DLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSF 158 (633)
Q Consensus 102 ~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 158 (633)
.++.++++++ ..+|..+. ++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5566666665 12453322 3566666666666633334455566666666666654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00063 Score=70.23 Aligned_cols=85 Identities=9% Similarity=0.134 Sum_probs=46.4
Q ss_pred chhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCC
Q 006739 115 PPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFR 193 (633)
Q Consensus 115 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 193 (633)
..+|.++.+|+.+.+..+..+ .-...|.++++|+.+.+. +.++... ..|.++.+|+.++|..| ++..-...|.+|.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 345566666666666554433 444455666666666664 3343333 45566666666666543 4423344566666
Q ss_pred CCCeeccCC
Q 006739 194 NLQFFDFSG 202 (633)
Q Consensus 194 ~L~~l~l~~ 202 (633)
+|+.+.+..
T Consensus 335 ~L~~i~ip~ 343 (394)
T 4gt6_A 335 QLERIAIPS 343 (394)
T ss_dssp TCCEEEECT
T ss_pred CCCEEEECc
Confidence 666666643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00069 Score=67.07 Aligned_cols=32 Identities=22% Similarity=0.139 Sum_probs=26.4
Q ss_pred CCCCeeeCCCCCCCeEecCCCceEEcccccccc
Q 006739 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505 (633)
Q Consensus 473 h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 505 (633)
....++|+|+.+.||+ ..++.+.++||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3456899999999999 5666889999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.21 E-value=4.2e-05 Score=69.74 Aligned_cols=108 Identities=13% Similarity=0.131 Sum_probs=79.9
Q ss_pred eeEEEEecCC-CCccc----CCccccCCccccEEEccCCCCCCC----CchhccCCCCCcEEEccCccCCCC----Cccc
Q 006739 75 KITKLVFVPR-ELTGV----LSPSIGRLSELRELSLANNSLVDL----LPPQIVDCKKLEILNVQNNQFSGT----IPSD 141 (633)
Q Consensus 75 ~~~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 141 (633)
.++.|+|++| +|... +...+..-+.|+.|+|++|+|... +.+.+..-+.|+.|+|++|.|+.. +-..
T Consensus 42 ~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~a 121 (197)
T 1pgv_A 42 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS 121 (197)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred CccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHH
Confidence 7899999986 76532 344566778899999999999752 445555668999999999999843 2344
Q ss_pred ccCCCCCCEEEccCCcC---CCCC-----ccCCCCCCCCeEeCcCCcCC
Q 006739 142 LSSLIRLRVLDLSGNSF---SGNL-----GFLKYFPNLEHLSLAKNLFT 182 (633)
Q Consensus 142 ~~~l~~L~~L~l~~N~l---~~~~-----~~~~~l~~L~~L~l~~N~l~ 182 (633)
+..-+.|+.|+|++|.. .... ..+..-+.|+.|+++.|.+.
T Consensus 122 L~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 122 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 55667899999997643 3211 34566689999999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00085 Score=67.46 Aligned_cols=34 Identities=26% Similarity=0.337 Sum_probs=28.8
Q ss_pred CCCCeeeCCCCCCCeEecCC----CceEEccccccccc
Q 006739 473 HNPRIIHRDLKPANVLLDDD----MEARIADFGLAKAM 506 (633)
Q Consensus 473 h~~~ivH~Dikp~Nill~~~----~~~kl~DfG~a~~~ 506 (633)
+...++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 45689999999999999874 67899999987653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00085 Score=69.26 Aligned_cols=122 Identities=13% Similarity=0.106 Sum_probs=69.7
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.++.+.+.. .++.+-...+.++..|+.+.+..+.. .+....|..+..|+.+.+..+.+. ...|..+.+|+.+.+.
T Consensus 231 ~l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPD-SFTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECT-TCCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred CCceEEECC-CceecccccccccccceeEEcCCCcc-eeeccccccccccceeccCceeec---cccccccccccccccc
Confidence 455666543 33444445677777788877776643 234456666666666666555432 2345566666666665
Q ss_pred CCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCC
Q 006739 155 GNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203 (633)
Q Consensus 155 ~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N 203 (633)
+| ++... ..|.++.+|+.++|.++ ++..-...|.+|.+|+.+++..|
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 44 33332 45666666666666533 44333455666666666666554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0028 Score=63.39 Aligned_cols=31 Identities=23% Similarity=0.297 Sum_probs=26.2
Q ss_pred CCCCeeeCCCCCCCeEecCCCceEEcccccccc
Q 006739 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505 (633)
Q Consensus 473 h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 505 (633)
....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 356789999999999999 4 899999987654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0012 Score=67.80 Aligned_cols=114 Identities=13% Similarity=0.127 Sum_probs=87.6
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.++.+.+..+ ++.+-...|.++.+|+.+.+..+ ++.+-...|.++++|+.+++.+|.++..-...|.++.+|+.+.|.
T Consensus 241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcC
Confidence 5667777654 66655678899999999999765 655556789999999999999999985556789999999999997
Q ss_pred CCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccC
Q 006739 155 GNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTF 192 (633)
Q Consensus 155 ~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 192 (633)
.| ++... ..|.+|.+|+.+.+..| ++..-...|.++
T Consensus 319 ~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 319 TA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred cc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 65 65554 67899999999998655 553334455444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.001 Score=68.70 Aligned_cols=115 Identities=17% Similarity=0.177 Sum_probs=71.4
Q ss_pred CcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCc-------C
Q 006739 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS-------F 158 (633)
Q Consensus 86 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-------l 158 (633)
++.+-..+|.++++|+.+.|.++ ++.+-..+|.++++|+.++|.+| ++..-...|.++.+|+.+.+..+- +
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF 136 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAF 136 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceee
Confidence 34444456777777777777643 55545566777777777777644 442334456666666665554331 0
Q ss_pred CC--------------C-CccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCC
Q 006739 159 SG--------------N-LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203 (633)
Q Consensus 159 ~~--------------~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N 203 (633)
.+ . ...|.++++|+.+.+.++..+ .-...|..+.+|+.+++..|
T Consensus 137 ~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~ 195 (394)
T 4fs7_A 137 KGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN 195 (394)
T ss_dssp TTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT
T ss_pred ecccccccccCccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC
Confidence 00 0 145777888888888766433 44566788888888888766
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00082 Score=70.09 Aligned_cols=74 Identities=12% Similarity=0.208 Sum_probs=46.4
Q ss_pred ccccccccCeeEEEEEecCC------CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc-ccc
Q 006739 342 LEKIGSGGCGEVYKAELPGS------NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL-LPL 414 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l 414 (633)
++.|+.|....+|++..... ++..+++|+...... ...+.+|..+++.+...++ +++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----------------~~~li~E~~~l~~L~~~g~~P~l 141 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----------------ESHLVAESVIFTLLSERHLGPKL 141 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----------------HHHHHHHHHHHHHHHHTTSSSCE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----------------HHHHHHHHHHHHHHHhCCCCCcE
Confidence 46788898999999986421 257899998743211 0123356677666643333 566
Q ss_pred ceeeecCCccEEEEecccCCC
Q 006739 415 LAHMARPDCHLLVYEFMKNGS 435 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gs 435 (633)
++.+.+ .+||||++|.+
T Consensus 142 ~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 142 YGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp EEEETT----EEEECCCCEEE
T ss_pred EEEeCC----CEEEEEeCCcc
Confidence 665542 38999998643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00076 Score=67.43 Aligned_cols=144 Identities=14% Similarity=0.148 Sum_probs=75.9
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc--cccccee--
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN--LLPLLAH-- 417 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-- 417 (633)
.+.|+.|....+|++... + ..+++|....... ..++..|+.++..+...+ +.+++..
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~-g~~vlk~~~~~~~----------------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~ 87 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--K-DPLILTLYEKRVE----------------KNDLPFFLGLMQHLAAKGLSCPLPLPRKD 87 (322)
T ss_dssp EEEECC---EEEEEEEES--S-CCEEEEEECC-------------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred eeccCCCcccceEEEEeC--C-ccEEEEEeCCCCC----------------HHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence 466788888999999753 3 3688998754210 112334555555443111 2333321
Q ss_pred ----eecCCccEEEEecccCCCHHH--------------HHhhhcCC-CCC-------CCHHHHHH------------HH
Q 006739 418 ----MARPDCHLLVYEFMKNGSLQD--------------ILNDVSQG-RRE-------LDWLARHK------------IA 459 (633)
Q Consensus 418 ----~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~~-------l~~~~~~~------------i~ 459 (633)
....+..+++|+|++|..+.. .+|..... ... ..|..... +.
T Consensus 88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~ 167 (322)
T 2ppq_A 88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 167 (322)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence 122355689999998864310 12221110 000 11322110 00
Q ss_pred HHHHHHHHHHHhc----CCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 460 LGVACGLEYLHIS----HNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 460 ~~ia~~L~~Lh~~----h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
..+.+.++++... ...+++|+|+.+.||+++++..+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 1134445555421 24679999999999999987656899998654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.003 Score=64.40 Aligned_cols=144 Identities=11% Similarity=0.153 Sum_probs=80.3
Q ss_pred ccccccccCeeEEEEEecC------CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc-cccc
Q 006739 342 LEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN-LLPL 414 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l 414 (633)
++.|..|-...+|++.... .+++.+++|+....... ...+.+|.++++.+.-.+ ..++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~---------------~~~~~rE~~vl~~L~~~gv~P~l 119 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG---------------VDSLVLESVMFAILAERSLGPQL 119 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC---------------HHHHHHHHHHHHHHHHTTSSCCE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch---------------HHHHHHHHHHHHHHHhcCCCCeE
Confidence 4667778889999997631 13478999985221100 234457778877774222 3566
Q ss_pred ceeeecCCccEEEEecccCCCHHH--------------H---HhhhcC-CCCCCC--HHHHHHHHHHHHH----------
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQD--------------I---LNDVSQ-GRRELD--WLARHKIALGVAC---------- 464 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~~ia~---------- 464 (633)
++++.+ .+||||++|.+|.. . +|.... ...... |.+..++..++..
T Consensus 120 l~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~ 195 (379)
T 3feg_A 120 YGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMN 195 (379)
T ss_dssp EEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCC
T ss_pred EEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhh
Confidence 666543 38999998865421 1 122111 112222 3444444433321
Q ss_pred ---------HHHHHH----h-cCCCCeeeCCCCCCCeEecCC----CceEEccccccc
Q 006739 465 ---------GLEYLH----I-SHNPRIIHRDLKPANVLLDDD----MEARIADFGLAK 504 (633)
Q Consensus 465 ---------~L~~Lh----~-~h~~~ivH~Dikp~Nill~~~----~~~kl~DfG~a~ 504 (633)
.+..|. . .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 196 ~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 196 LLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 122332 1 234578999999999999876 789999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0034 Score=64.04 Aligned_cols=30 Identities=23% Similarity=0.406 Sum_probs=25.0
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
...++|+|+++.||+++++. +.|+||..+.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 45789999999999998664 8999998765
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0059 Score=63.91 Aligned_cols=75 Identities=15% Similarity=0.127 Sum_probs=45.9
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc-cccceeeec
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL-LPLLAHMAR 420 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~ 420 (633)
++.|+.|-...+|++.... .+..+++|+...... ... ...+|..+++.+...++ .++++.+.
T Consensus 113 i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~---~~i------------dR~~E~~vl~~L~~~gl~P~ll~~~~- 175 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS-KQAKYLIRLYGPKTD---EII------------NREREKKISCILYNKNIAKKIYVFFT- 175 (458)
T ss_dssp EEEECC--CEEEEEEEETT-TTEEEEEEEECC-CC---SCS------------CHHHHHHHHHHHTTSSSBCCEEEEET-
T ss_pred EEEcCCCeEeEEEEEEECC-CCceEEEEECCCChh---hhc------------CHHHHHHHHHHHHhcCCCCCEEEEeC-
Confidence 4678889999999998641 247888998643211 000 12467777777764444 56666653
Q ss_pred CCccEEEEecccCCCH
Q 006739 421 PDCHLLVYEFMKNGSL 436 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL 436 (633)
+ .+||||++|.+|
T Consensus 176 -~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 176 -N--GRIEEFMDGYAL 188 (458)
T ss_dssp -T--EEEEECCCSEEC
T ss_pred -C--eEEEEeeCCccC
Confidence 2 369999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=0.014 Score=58.54 Aligned_cols=32 Identities=22% Similarity=0.337 Sum_probs=28.2
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccc
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 505 (633)
...++|+|+.+.||++++++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45789999999999999888899999987664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.22 E-value=0.018 Score=52.71 Aligned_cols=104 Identities=16% Similarity=0.105 Sum_probs=68.2
Q ss_pred CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcce
Q 006739 435 SLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514 (633)
Q Consensus 435 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 514 (633)
||.++|... +.++++.++|.++.|.+++|.-+-. +..-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 899999864 5689999999999999998877621 11111333456889999999988774 2110
Q ss_pred ecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCc
Q 006739 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSD 559 (633)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 559 (633)
.....+.|||... ...+.+.=|||+|+++|..+--..|-+
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 1122466888764 345678899999999999997666533
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.83 E-value=0.069 Score=55.05 Aligned_cols=31 Identities=23% Similarity=0.400 Sum_probs=26.6
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccc
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 505 (633)
...++|+|+.+.||+ +.++.+.++||..+..
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 356899999999999 7788999999987753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.20 E-value=1.1 Score=40.86 Aligned_cols=118 Identities=10% Similarity=0.123 Sum_probs=77.8
Q ss_pred CCCcccccceeeecCCccEEEEecccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 006739 407 RHRNLLPLLAHMARPDCHLLVYEFMKNG-SLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485 (633)
Q Consensus 407 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~ 485 (633)
.||+.+.. ..-.+.+.+.+.|+.-+.+ ++.. + +..+...+++++..|+....++ ..-+|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~-----~~r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVN-----RTRYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGG-----GSSEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHh-----cCceEEEEecc
Confidence 57777755 3445556655666554322 3322 2 2378889999999998866444 33467889999
Q ss_pred CeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchH-HHHHHHHHHHhCCCCCccccc
Q 006739 486 NVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIY-SFGVLLAVLVMGRLPSDDFFQ 563 (633)
Q Consensus 486 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~-s~G~~l~elltg~~p~~~~~~ 563 (633)
|++++.++.+++.=.|+-..+.+ . ..+ ..|.| .+=+++..+++++..|++...
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P-------------------~-----~~~-ee~fL~qyKAliiall~~K~~Fe~l~~ 162 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDP-------------------L-----PVS-EAEFLTRYKALVICAFNEKQSFDALVE 162 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSC-------------------C-----CCC-HHHHHHHHHHHHHHHHCTTCCHHHHHH
T ss_pred eEEEcCCCCEEEEEccCccCCCC-------------------C-----CCC-HHHHHHHHHHHHHHHHcCCCCHHHHHc
Confidence 99999999999998776433222 1 111 12333 577889999999999876543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.39 E-value=8.4 Score=35.17 Aligned_cols=116 Identities=13% Similarity=0.212 Sum_probs=76.6
Q ss_pred CCCcccccceeeecCCccEEEEecccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 006739 407 RHRNLLPLLAHMARPDCHLLVYEFMKNG-SLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485 (633)
Q Consensus 407 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~ 485 (633)
.||+. -...-.+.+.+.+.|+.-+++ ++. -++ .++...+++++..|+.... .|...-+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~-------~~~~~eKlrll~nl~~L~~----~~~~~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR-------KTTLLSRIRAAIHLVSKVK----HHSARRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH-------TSCHHHHHHHHHHHHHHHS----SCCSSSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH-------hcCHHHHHHHHHHHHHHHH----HhhhCceeEEEeCc
Confidence 57776 333335666766777665443 333 332 3788899999999877443 24455678889999
Q ss_pred CeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchH-HHHHHHHHHHhCCCCCccc
Q 006739 486 NVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIY-SFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 486 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~-s~G~~l~elltg~~p~~~~ 561 (633)
|+++|.++.+++.-.|+-..+ +|.- .+ ..|.| .+=+++..++.++..|++.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~-ee~fl~qyKali~all~~K~~Fe~l 165 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL-------------------PPDE-----WD-DERLLREVKATVLALTEGEYRFDEY 165 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB-------------------SSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHHHH
T ss_pred eEEEeCCCcEEEEEcCCcccC-------------------CCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 999999999999987764332 2221 11 12333 4778888999999888653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 633 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 8e-60
Identities = 61/294 (20%), Positives = 124/294 (42%), Gaps = 38/294 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++IGSG G VYK + G +A+K + + ++++ ++E+
Sbjct: 13 GQRIGSGSFGTVYKGKWHGD----VAVKML------------NVTAPTPQQLQAFKNEVG 56
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + RH N+L + + +V ++ + SL L+ + + + + IA
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 112
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
A G++YLH IIHRDLK N+ L +D+ +I DFGLA ++G+
Sbjct: 113 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 522 VGYIAPEYHQTLK---FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578
+ ++APE + ++ + D+Y+FG++L L+ G+LP + + + +M
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRG 225
Query: 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
+ + + + ++ C ERP + + +
Sbjct: 226 YLSPDLSKVRSNCPKA--------MKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 7e-55
Identities = 61/296 (20%), Positives = 114/296 (38%), Gaps = 27/296 (9%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
K+D + ++G+G G V+K +G ++A K + ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLI-------------HLEIKPAIRN 49
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
QI E+ + + ++ + E M GSL +L +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQI 105
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
K+++ V GL YL +I+HRD+KP+N+L++ E ++ DFG++ + D+ +
Sbjct: 106 LGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-- 161
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
+ GT Y++PE Q ++ + DI+S G+ L + +GR P + + +
Sbjct: 162 --SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP---IPPPDAKELELMFG 216
Query: 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630
V T M +A F +D P K + S
Sbjct: 217 CQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-54
Identities = 73/312 (23%), Positives = 121/312 (38%), Gaps = 44/312 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E IG G GEV++ + G+ +A+K S+ R+ EI
Sbjct: 8 QESIGKGRFGEVWRGKW---RGEEVAVKIF-------------SSREERSWFREA--EIY 49
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL----LVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+RH N+L +A + + LV ++ ++GSL D LN R + K
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 104
Query: 458 IALGVACGLEYLHIS-----HNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQ-- 510
+AL A GL +LH+ P I HRDLK N+L+ + IAD GLA A
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 511 THITTSNVAGTVGYIAPEY------HQTLKFTDKCDIYSFGVLLAVLVMGRLPSD---DF 561
I ++ GT Y+APE + + + DIY+ G++ + D+
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYE-EQMLLVLKIACFCTVDSPRERPN 620
++ M + + + E + ++ KI C + R
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 621 SKDVRCMLSQIR 632
+ ++ LSQ+
Sbjct: 285 ALRIKKTLSQLS 296
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 6e-54
Identities = 65/314 (20%), Positives = 120/314 (38%), Gaps = 56/314 (17%)
Query: 342 LEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ IG G G V++A PG M+A+K + + +
Sbjct: 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-------------KEEASADMQADFQ 64
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILND--------------- 442
E + + + N++ LL A L++E+M G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 443 -----VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497
S G L + IA VA G+ YL + +HRDL N L+ ++M +I
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP 557
ADFGL++ + A + N A + ++ PE ++T + D++++GV+L + L
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 558 SDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRE 617
+ ++ ++R+ P E L + + C P +
Sbjct: 242 ---PYYGMAHEEVIYYVRDGNILACP-------------ENCPLELYNLMRLCWSKLPAD 285
Query: 618 RPNSKDVRCMLSQI 631
RP+ + +L ++
Sbjct: 286 RPSFCSIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-53
Identities = 65/287 (22%), Positives = 120/287 (41%), Gaps = 36/287 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L IG+G G K S+GK++ K++ + + + + + SE+N
Sbjct: 9 LYTIGTGSYGRCQKIRRK-SDGKILVWKEL------------DYGSMTEAEKQMLVSEVN 55
Query: 402 TVGQIRHRNLLPLL-AHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ +++H N++ + R + L +V E+ + G L ++ ++ R+ LD ++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 460 LGVACGLEYLH--ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSN 517
+ L+ H ++HRDLKPANV LD ++ DFGLA+ + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-- 173
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577
GT Y++PE + + +K DI+S G LL L P F + L +R
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAGKIREG 229
Query: 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
P R +L E ++ + RP+ +++
Sbjct: 230 KFRRIPYR-YSDELNE--------IITR----MLNLKDYHRPSVEEI 263
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-53
Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 40/290 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+E++G+G GEV+ G +A+K + K + +E N
Sbjct: 18 VERLGAGQFGEVWMGYYNG--HTKVAVKSL---------------KQGSMSPDAFLAEAN 60
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q++H+ L+ L A + + ++ + E+M+NGSL D L +L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQ 117
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+A G+ ++ IHRDL+ AN+L+ D + +IADFGLA+ + D +
Sbjct: 118 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFP 173
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
+ + APE FT K D++SFG+LL +V + +++ +
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI---PYPGMTNPEVIQNLERGYRMV 230
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
P + + ++ C + P +RP +R +L
Sbjct: 231 RPDNCPEE-------------LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 9e-53
Identities = 57/287 (19%), Positives = 113/287 (39%), Gaps = 43/287 (14%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+IG G VYK +A ++ +D KL + ++ + E
Sbjct: 15 IEIGRGSFKTVYKGLDTE-TTVEVAWCEL------------QDRKLTKSERQRFKEEAEM 61
Query: 403 VGQIRHRNLLPLLAHMA----RPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ ++H N++ C +LV E M +G+L+ L + + +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSW 117
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-DMEARIADFGLAKAMPDAQTHITTSN 517
+ GL++LH + P IIHRDLK N+ + +I D GLA +
Sbjct: 118 CRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----A 172
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577
V GT ++APE ++ K+ + D+Y+FG+ + + P + + + + + +
Sbjct: 173 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSG 228
Query: 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ + + ++ E ++ C + ER + KD+
Sbjct: 229 VKPASFDKVAIPEVKE--------IIEG----CIRQNKDERYSIKDL 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-52
Identities = 74/292 (25%), Positives = 115/292 (39%), Gaps = 46/292 (15%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ IG G G+V + G +A+K + + + +E +
Sbjct: 12 LQTIGKGEFGDVMLGDY---RGNKVAVKCIKN----------------DATAQAFLAEAS 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ Q+RH NL+ LL + L +V E+M GSL D L S+GR L K +L
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSL 110
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
V +EYL +HRDL NVL+ +D A+++DFGL K Q
Sbjct: 111 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKL 162
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580
V + APE + KF+ K D++SFG+LL + + +V +
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEKGYKM 219
Query: 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
+ P A V ++ C RP+ +R L I+
Sbjct: 220 DAPDGCPPA-------------VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 8e-52
Identities = 74/320 (23%), Positives = 121/320 (37%), Gaps = 38/320 (11%)
Query: 318 AIFSPLIKKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIK-KVIQPPK 376
A+ L++ + + + E IG G G VY L ++GK I K +
Sbjct: 8 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67
Query: 377 DAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPD-CHLLVYEFMKNGS 435
D E+ Q +E + H N+L LL R + L+V +MK+G
Sbjct: 68 DIGEV------------SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGD 115
Query: 436 LQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495
L++ + L VA G+ + + +HRDL N +LD+
Sbjct: 116 LRNFIR---NETHNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTV 169
Query: 496 RIADFGLAKAMPDAQTHITT--SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553
++ADFGLA+ M D + + V ++A E QT KFT K D++SFGVLL L+
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229
Query: 554 GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVD 613
P + + ++ P D + ++ C
Sbjct: 230 RGAP---PYPDVNTFDITVYLLQGRRLLQPEYCPDP-------------LYEVMLKCWHP 273
Query: 614 SPRERPNSKDVRCMLSQIRH 633
RP+ ++ +S I
Sbjct: 274 KAEMRPSFSELVSRISAIFS 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-51
Identities = 58/288 (20%), Positives = 111/288 (38%), Gaps = 43/288 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ ++G G G+VYKA+ + A K + +++ EI+
Sbjct: 17 IGELGDGAFGKVYKAQNK-ETSVLAAAKVI--------------DTKSEEELEDYMVEID 61
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ H N++ LL + ++ EF G++ ++ + R L +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQ 118
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
L YLH + +IIHRDLK N+L D + ++ADFG++ + GT
Sbjct: 119 TLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGT 173
Query: 522 VGYIAPEYHQTL-----KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
++APE + K D++S G+ L + P + ++ ++ +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-------LNPMRVLLK 226
Query: 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ SE PT A ++ N + + K C + R + +
Sbjct: 227 IAKSEPPTLAQPSRWSSNFKD----FLKK----CLEKNVDARWTTSQL 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-51
Identities = 62/291 (21%), Positives = 111/291 (38%), Gaps = 40/291 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+++IGSG G V+ N +AIK + + E
Sbjct: 10 VQEIGSGQFGLVHLGYWL--NKDKVAIKTI---------------REGAMSEEDFIEEAE 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H L+ L LV+EFM++G L D + R + L
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLD 109
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
V G+ YL +IHRDL N L+ ++ +++DFG+ + + D Q +T
Sbjct: 110 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFP 165
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
V + +PE +++ K D++SFGVL+ + +++ +V+ +
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTGFRLY 222
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
P A V +I C + P +RP + L++I
Sbjct: 223 KPRLASTH-------------VYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-51
Identities = 59/291 (20%), Positives = 112/291 (38%), Gaps = 42/291 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+++G+G G V + G +AIK + K + + E
Sbjct: 9 LKELGTGQFGVVKYGKWRG--QYDVAIKMI---------------KEGSMSEDEFIEEAK 51
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + H L+ L + ++ E+M NG L + L + R ++
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKD 108
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
V +EYL + + +HRDL N L++D +++DFGL++ + D + ++
Sbjct: 109 VCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFP 164
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580
V + PE KF+ K DI++FGVL+ + +G++P + F + + +R
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224
Query: 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
+ I C + ERP K + + +
Sbjct: 225 LASEKVYT-----------------IMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-51
Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 37/285 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++ +G G GEV A + +A+K V D K I+ EI
Sbjct: 10 VQTLGEGAYGEVQLAVNR-VTEEAVAVKIV-------------DMKRAVDCPENIKKEIC 55
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ H N++ H + L E+ G L D + + + +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQ 111
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ G+ YLH I HRD+KP N+LLD+ +I+DFGLA + + GT
Sbjct: 112 LMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 522 VGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580
+ Y+APE + +F + D++S G++L ++ G LP + Q ++ + T
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKTY 225
Query: 581 ENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625
NP + ID+ L L+ K V++P R D++
Sbjct: 226 LNPWKKIDSAPLA--------LLHK----ILVENPSARITIPDIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-51
Identities = 64/290 (22%), Positives = 111/290 (38%), Gaps = 40/290 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
K+G G GEV+ G +AIK + K E
Sbjct: 22 EVKLGQGCFGEVWMGTWNG--TTRVAIKTL---------------KPGTMSPEAFLQEAQ 64
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++RH L+ L A + + +V E+M GSL D + + L +A
Sbjct: 65 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDF--LKGETGKYLRLPQLVDMAAQ 121
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+A G+ Y+ +HRDL+ AN+L+ +++ ++ADFGLA+ + D +
Sbjct: 122 IASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFP 177
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
+ + APE +FT K D++SFG+LL L + ++ +
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVERGYRMP 234
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
P ++ + + C C P ERP + ++ L
Sbjct: 235 CPPECPES-------------LHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 4e-51
Identities = 66/296 (22%), Positives = 124/296 (41%), Gaps = 42/296 (14%)
Query: 342 LEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
+ IG+G GEV L PG +AIK + S K+ R SE
Sbjct: 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-------------KSGYTEKQRRDFLSE 77
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ +GQ H N++ L + + +++ EFM+NGSL + Q + + +
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQNDGQFTVIQLVGML 134
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVA 519
G+A G++YL + +HRDL N+L++ ++ +++DFGL++ + D + T ++
Sbjct: 135 RGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 520 G---TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575
G + + APE Q KFT D++S+G+++ ++ G P + ++ +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMTNQDVINAIE 247
Query: 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
P A + ++ C RP + L ++
Sbjct: 248 QDYRLPPPMDCPSA-------------LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 1e-50
Identities = 63/290 (21%), Positives = 115/290 (39%), Gaps = 38/290 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
K+G G GEVY+ +A+K + K ++ + E
Sbjct: 22 KHKLGGGQYGEVYEGVWKK-YSLTVAVKTL---------------KEDTMEVEEFLKEAA 65
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +I+H NL+ LL R ++ EFM G+L D L + R+E+ + +A
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQ 123
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
++ +EYL IHRDL N L+ ++ ++ADFGL++ M
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFP 179
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
+ + APE KF+ K D+++FGVLL + + + + + + + E
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLSQVYELLEKDYRME 236
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
P + V ++ C +P +RP+ ++ +
Sbjct: 237 RPEGCPEK-------------VYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-50
Identities = 67/283 (23%), Positives = 114/283 (40%), Gaps = 41/283 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+G G G VY A + ++A+K + A+L + Q+R E+
Sbjct: 11 GRPLGKGKFGNVYLAREK-QSKFILALKVL-----FKAQLEKAG------VEHQLRREVE 58
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+RH N+L L + L+ E+ G++ L Q + D
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITE 114
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+A L Y H + R+IHRD+KP N+LL E +IADFG + P ++ + GT
Sbjct: 115 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGT 167
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
+ Y+ PE + +K D++S GVL ++G+ P F+ K + V
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRISRV---- 219
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ + E L+ + +P +RP ++V
Sbjct: 220 ------EFTFPDFVTEGARDLISR----LLKHNPSQRPMLREV 252
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 6e-50
Identities = 67/296 (22%), Positives = 126/296 (42%), Gaps = 40/296 (13%)
Query: 341 SLEK-IGSGGCGEVYKAELPGSNGKM---IAIKKVIQPPKDAAELTEEDSKLLNKKMRQI 396
+ +K IG+G GEVYK L S+GK +AIK + + K+
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-------------KAGYTEKQRVDF 56
Query: 397 RSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
E +GQ H N++ L +++ +++ E+M+NG+L L + E L
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLV 113
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI-TT 515
+ G+A G++Y N +HRDL N+L++ ++ +++DFGL++ + D TT
Sbjct: 114 GMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575
S + + APE KFT D++SFG+++ ++ + ++K +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---PYWELSNHEVMKAIN 227
Query: 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
+ P + + ++ C RP D+ +L ++
Sbjct: 228 DGFRLPTP-------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 6e-50
Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 57/312 (18%)
Query: 342 LEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +GSG G+V A G + +A+K + K + + +
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-------------KEKADSSEREALM 88
Query: 398 SEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILN--------------- 441
SE+ + Q+ H N++ LL L++E+ G L + L
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 442 ----DVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARI 497
+ + L + A VA G+E+L +HRDL NVL+ +I
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI 205
Query: 498 ADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLV-MGRL 556
DFGLA+ + ++ N V ++APE +T K D++S+G+LL + +G
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 557 PSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPR 616
P + + + K ++N + P A + + I C R
Sbjct: 266 P---YPGIPVDANFYKLIQNGFKMDQPFYATEE-------------IYIIMQSCWAFDSR 309
Query: 617 ERPNSKDVRCML 628
+RP+ ++ L
Sbjct: 310 KRPSFPNLTSFL 321
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 2e-49
Identities = 69/287 (24%), Positives = 117/287 (40%), Gaps = 46/287 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +IG G G VY A N +++AIKK+ K N+K + I E+
Sbjct: 20 LREIGHGSFGAVYFARDV-RNSEVVAIKKM-----------SYSGKQSNEKWQDIIKEVR 67
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++RH N + R LV E+ + + ++ L + + G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE----VHKKPLQEVEIAAVTHG 123
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
GL YLH + +IHRD+K N+LL + ++ DFG A M A + + GT
Sbjct: 124 ALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GT 174
Query: 522 VGYIAPEYHQTL---KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578
++APE + ++ K D++S G+ L + P + MS + ++
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSA---LYHIA 227
Query: 579 TSENPTRAIDAKLLENGYEEQML-LVLKIACFCTVDSPRERPNSKDV 624
+E+P L + E V C P++RP S+ +
Sbjct: 228 QNESP------ALQSGHWSEYFRNFVDS----CLQKIPQDRPTSEVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 61/302 (20%), Positives = 120/302 (39%), Gaps = 38/302 (12%)
Query: 332 FLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNK 391
FL++++ L + ++G G G V + ++ KV++ + A+
Sbjct: 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT---------- 53
Query: 392 KMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELD 451
++ E + Q+ + ++ L+ +LV E G L L R E+
Sbjct: 54 --EEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL---VGKREEIP 107
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
++ V+ G++YL +HRDL NVLL + A+I+DFGL+KA+ +
Sbjct: 108 VSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164
Query: 512 HIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLA-VLVMGRLPSDDFFQHTEEMS 569
+ T S + + APE KF+ + D++S+GV + L G+ P ++ +
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPE 220
Query: 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629
++ ++ E P + + C + +RP+ V +
Sbjct: 221 VMAFIEQGKRMECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMR 267
Query: 630 QI 631
Sbjct: 268 AC 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-49
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 44/305 (14%)
Query: 332 FLEKEDGLASLE--KIGSGGCGEVYKAELPGSN-GKMIAIKKVIQPPKDAAELTEEDSKL 388
+L+++ L +LE ++GSG G V K K +A+K + D A
Sbjct: 2 YLDRK--LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL-------- 51
Query: 389 LNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRR 448
++ +E N + Q+ + ++ ++ + +LV E + G L L R
Sbjct: 52 ----KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NR 102
Query: 449 ELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPD 508
+ ++ V+ G++YL S+ +HRDL NVLL A+I+DFGL+KA+
Sbjct: 103 HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159
Query: 509 AQTHITTSN-VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQHTE 566
+ + V + APE KF+ K D++SFGVL+ G+ P ++ +
Sbjct: 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMK 215
Query: 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626
+ + P + + C RP V
Sbjct: 216 GSEVTAMLEKGERMGCPAGCPRE-------------MYDLMNLCWTYDVENRPGFAAVEL 262
Query: 627 MLSQI 631
L
Sbjct: 263 RLRNY 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-49
Identities = 64/309 (20%), Positives = 115/309 (37%), Gaps = 50/309 (16%)
Query: 342 LEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +G+G G+V +A G +A+K + K +A LTE + +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML----KPSAHLTERE---------ALM 74
Query: 398 SEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILND-------------- 442
SE+ + + H N++ LL L++ E+ G L + L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 443 VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502
+ LD + VA G+ +L + IHRDL N+LL +I DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562
A+ + + ++ N V ++APE +T + D++S+G+ L L +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--PYP 249
Query: 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK 622
+ K ++ +P A + I C P +RP K
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAE-------------MYDIMKTCWDADPLKRPTFK 296
Query: 623 DVRCMLSQI 631
+ ++ +
Sbjct: 297 QIVQLIEKQ 305
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-48
Identities = 66/306 (21%), Positives = 113/306 (36%), Gaps = 49/306 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
+ IG G G+V KA + +M AIK++ R E+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-------------KEYASKDDHRDFAGEL 61
Query: 401 NTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILND------------VSQGR 447
+ ++ H N++ LL L E+ +G+L D L +
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 448 RELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMP 507
L A VA G++YL + IHRDL N+L+ ++ A+IADFGL++
Sbjct: 122 STLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ- 177
Query: 508 DAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567
+ ++ + V ++A E +T D++S+GVLL +V +
Sbjct: 178 --EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGMTC 232
Query: 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCM 627
L + + E P D V + C + P ERP+ +
Sbjct: 233 AELYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVS 279
Query: 628 LSQIRH 633
L+++
Sbjct: 280 LNRMLE 285
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 71/309 (22%), Positives = 122/309 (39%), Gaps = 51/309 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSN------GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQ 395
+ +G G G+V AE G + +A+K + S K +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-------------KSDATEKDLSD 64
Query: 396 IRSEINTVGQI-RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDIL------------ND 442
+ SE+ + I +H+N++ LL + ++ E+ G+L++ L N
Sbjct: 65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 443 VSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGL 502
+L A VA G+EYL + + IHRDL NVL+ +D +IADFGL
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 503 AKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562
A+ + + T+N V ++APE +T + D++SFGVLL + +
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PY 238
Query: 563 QHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK 622
L K ++ + P+ + + + C P +RP K
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFK 285
Query: 623 DVRCMLSQI 631
+ L +I
Sbjct: 286 QLVEDLDRI 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 62/283 (21%), Positives = 114/283 (40%), Gaps = 40/283 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
EKIG G G VY A + G+ +AI+++ + K I +EI
Sbjct: 25 FEKIGQGASGTVYTAMDV-ATGQEVAIRQM--------------NLQQQPKKELIINEIL 69
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + ++ N++ L D +V E++ GSL D++ +D +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRE 124
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
LE+LH + ++IHRD+K N+LL D ++ DFG + Q+ +T + GT
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
++APE + K DI+S G++ ++ G P + +L N
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPLRALYLIATNGTPEL 236
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ A + + + C +R ++K++
Sbjct: 237 QNPEKLSAIFRD--------FLNR----CLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 9e-47
Identities = 52/302 (17%), Positives = 115/302 (38%), Gaps = 42/302 (13%)
Query: 342 LEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
++G G G VY+ G +AIK V + ++ +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------------NEAASMRERIEFL 71
Query: 398 SEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQG------RRELD 451
+E + + + +++ LL +++ L++ E M G L+ L +
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 452 WLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQT 511
++A +A G+ YL+ + +HRDL N ++ +D +I DFG+ + + +
Sbjct: 132 LSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 512 HITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571
+ V +++PE + FT D++SFGV+L + +Q ++
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNEQVL 245
Query: 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
+++ + P D + ++ C +P+ RP+ ++ + +
Sbjct: 246 RFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
Query: 632 RH 633
Sbjct: 293 ME 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-46
Identities = 77/294 (26%), Positives = 116/294 (39%), Gaps = 36/294 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIK-KVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
LEK+G G G V + E +GK +++ K ++P + + M E+
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP----------EAMDDFIREV 62
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
N + + HRNL+ L + P + V E GSL D L QG L L+R A+
Sbjct: 63 NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK-HQGHFLLGTLSR--YAV 118
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-TSNVA 519
VA G+ YL + R IHRDL N+LL +I DFGL +A+P H +
Sbjct: 119 QVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVM 578
+ APE +T F+ D + FGV L + G+ P + L K +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQILHKIDKEGE 232
Query: 579 TSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632
P + + C P +RP +R L + +
Sbjct: 233 RLPRPEDCPQD-------------IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-46
Identities = 59/292 (20%), Positives = 103/292 (35%), Gaps = 37/292 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ +G G V A + + AIK + E+ + K+ + E +
Sbjct: 13 GKILGEGSFSTVVLAREL-ATSREYAIKIL-----------EKRHIIKENKVPYVTRERD 60
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H + L + + KNG L + +
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-------FDETCTRFY 113
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
A + L H IIHRDLKP N+LL++DM +I DFG AK + ++ GT
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
Y++PE D+++ G ++ LV G P F+ E + + ++ E
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLI---FQKIIKLE 226
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
E + + LV K V +R +++ H
Sbjct: 227 YD-------FPEKFFPKARDLVEK----LLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 58/299 (19%), Positives = 108/299 (36%), Gaps = 33/299 (11%)
Query: 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMR 394
KE ++ +GSG G VYK G+ + I I+ ++A K +
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREATS---------PKANK 56
Query: 395 QIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLA 454
+I E + + + ++ LL L + + M G L L+ V + + +
Sbjct: 57 EILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL---LDYVREHKDNIGSQY 112
Query: 455 RHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT 514
+ +A G+ YL + R++HRDL NVL+ +I DFGLAK + +
Sbjct: 113 LLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
+ ++A E +T + D++S+GV + L+ + + +
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSIL 226
Query: 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633
P V I C + RP +++ S++
Sbjct: 227 EKGERLPQPPICTID-------------VYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-44
Identities = 61/308 (19%), Positives = 113/308 (36%), Gaps = 49/308 (15%)
Query: 342 LEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIR 397
+ +G G G+V +A+ G + + +A+K + + + R +
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-------------KEGATHSEHRALM 64
Query: 398 SEINTVGQIRHRNLLPLL--AHMARPDCHLLVYEFMKNGSLQDILND------------V 443
SE+ + I H + L A +++ EF K G+L L
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 444 SQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLA 503
+ L + VA G+E+L + + IHRDL N+LL + +I DFGLA
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 504 KAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQ 563
+ + ++ + + ++APE +T + D++SFGVLL +
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 237
Query: 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
+ + + + RA D E + + C P +RP +
Sbjct: 238 --PGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSE 286
Query: 624 VRCMLSQI 631
+ L +
Sbjct: 287 LVEHLGNL 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 9e-44
Identities = 59/292 (20%), Positives = 108/292 (36%), Gaps = 39/292 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIK-KVIQPPKDAAELTEEDSKLLNKKMRQIRSEI 400
IG G G+V++ +A+ K + + + E
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS------------DSVREKFLQEA 59
Query: 401 NTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
T+ Q H +++ L+ + + ++ E G L+ L + LD + A
Sbjct: 60 LTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAY 115
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
++ L YL + R +HRD+ NVL+ + ++ DFGL++ M D+ + +
Sbjct: 116 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-GKL 171
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLL-AVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
+ ++APE +FT D++ FGV + +L+ G P + + R M
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231
Query: 580 SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
P L+ K C P RP +++ LS I
Sbjct: 232 PNCPPTLYS-------------LMTK----CWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (394), Expect = 6e-43
Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 40/285 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E++G+G G V++ + G A K V+ P + E +R EI
Sbjct: 31 HEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKE--------------TVRKEIQ 75
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
T+ +RH L+ L + +++YEFM G L + + D ++ +
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQ 132
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLL--DDDMEARIADFGLAKAMPDAQTHITTSNVA 519
V GL ++ H +H DLKP N++ E ++ DFGL + Q+ T+
Sbjct: 133 VCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 186
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
GT + APE + D++S GVL +L+ G P F + ++ +++
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETLRNVKSCDW 242
Query: 580 SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
N + + + E+G + + K + P R
Sbjct: 243 --NMDDSAFSGISEDGKD----FIRK----LLLADPNTRMTIHQA 277
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 2e-42
Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 37/290 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E +G G V + K A+K + D ++ + + E++
Sbjct: 8 KEILGRGVSSVVRRCIHK-PTCKEYAVKII-----DVTGGGSFSAEEVQELREATLKEVD 61
Query: 402 TVGQIR-HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ ++ H N++ L LV++ MK G L D L + + L KI
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMR 117
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ + LH I+HRDLKP N+LLDDDM ++ DFG + + + V G
Sbjct: 118 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCG 171
Query: 521 TVGYIAPEYHQT------LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
T Y+APE + + + D++S GV++ L+ G P F H ++M + +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLM---L 224
Query: 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
R +M+ + ++ + LV + V P++R +++
Sbjct: 225 RMIMSGNYQ---FGSPEWDDYSDTVKDLVSR----FLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-41
Identities = 63/285 (22%), Positives = 108/285 (37%), Gaps = 41/285 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E +G G G V++ S+ K K V K+ ++ EI+
Sbjct: 10 AEDLGRGEFGIVHRCVET-SSKKTYMAKFV---------------KVKGTDQVLVKKEIS 53
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ RHRN+L L + ++++EF+ + + +N EL+
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQ 110
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLD--DDMEARIADFGLAKAMPDAQTHITTSNVA 519
V L++LH SHN I H D++P N++ +I +FG A+ +
Sbjct: 111 VCEALQFLH-SHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--- 164
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
Y APE HQ + D++S G L+ VL+ G P F + + N+M
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQQI---IENIMN 217
Query: 580 SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+E D + + E M V + V + R + +
Sbjct: 218 AEYT---FDEEAFKEISIEAMDFVDR----LLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 4e-41
Identities = 64/299 (21%), Positives = 108/299 (36%), Gaps = 43/299 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
KIGSG G++Y + G+ +AIK + K Q+ E
Sbjct: 12 GRKIGSGSFGDIYLGTDI-AAGEEVAIKLE----------------CVKTKHPQLHIESK 54
Query: 402 TVGQIRHRNLLPLL-AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
++ +P + A D +++V E + R+ +A
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLAD 110
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVL---LDDDMEARIADFGLAKAMPDAQTH----- 512
+ +EY+H + IHRD+KP N L I DFGLAK DA+TH
Sbjct: 111 QMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 513 ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572
N+ GT Y + H ++ + + D+ S G +L +G LP T+ +
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
Query: 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
M+ ++L GY + L C ++P+ +R + +
Sbjct: 228 ISEKKMS-------TPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 63/236 (26%), Positives = 98/236 (41%), Gaps = 26/236 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ +G G G+V+ AE + AIK + ++D L++ + E
Sbjct: 7 HKMLGKGSFGKVFLAEFK-KTNQFFAIKAL-----------KKDVVLMDDDVECTMVEKR 54
Query: 402 TVG-QIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIAL 460
+ H L + + V E++ G L + Q + D A
Sbjct: 55 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAA 110
Query: 461 GVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ GL++LH + I++RDLK N+LLD D +IADFG+ K T G
Sbjct: 111 EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCG 165
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
T YIAPE K+ D +SFGVLL +++G+ P F +E L +R
Sbjct: 166 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRM 217
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (377), Expect = 1e-40
Identities = 54/285 (18%), Positives = 106/285 (37%), Gaps = 40/285 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LE++GSG G V++ + G++ K + + +++EI+
Sbjct: 34 LEELGSGAFGVVHRCVEK-ATGRVFVAKFI--------------NTPYPLDKYTVKNEIS 78
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ Q+ H L+ L +L+ EF+ G L D + + ++
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQ 135
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLD--DDMEARIADFGLAKAMPDAQTHITTSNVA 519
GL+++ H I+H D+KP N++ + +I DFGLA + + T+
Sbjct: 136 ACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--- 189
Query: 520 GTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
T + APE D+++ GVL VL+ G P F +++ ++ ++
Sbjct: 190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLETLQNVKRC-- 243
Query: 580 SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ + + + PR+R D
Sbjct: 244 DWEFDEDAFSSVSPEAKD----FIKN----LLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (365), Expect = 8e-40
Identities = 63/298 (21%), Positives = 118/298 (39%), Gaps = 39/298 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E +G GG EV+ A + +A+K + D + R E
Sbjct: 12 GEILGFGGMSEVHLARDL-RLHRDVAVKVL-----------RADLARDPSFYLRFRREAQ 59
Query: 402 TVGQIRHRNLLPLLAHMARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+ H ++ + +V E++ +L+DI++ + +
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIE 115
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHIT-TS 516
+ L + H IIHRD+KPAN+++ ++ DFG+A+A+ D+ +T T+
Sbjct: 116 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
V GT Y++PE + + D+YS G +L ++ G P F +S+ ++
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSV--AYQH 226
Query: 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS-KDVRCMLSQIRH 633
V P A L + +VLK +P R + ++R L ++ +
Sbjct: 227 VREDPIPPSARHEGLSADLDA----VVLK----ALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 1e-39
Identities = 70/303 (23%), Positives = 120/303 (39%), Gaps = 46/303 (15%)
Query: 325 KKAEDLAFLEKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEE 384
K+AED+ D + +G+G EV AE K++AIK +
Sbjct: 2 KQAEDI-----RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCI------------- 42
Query: 385 DSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVS 444
K L K + +EI + +I+H N++ L L+ + + G L D + +
Sbjct: 43 AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-- 100
Query: 445 QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL---DDDMEARIADFG 501
+ ++ V ++YL H+ I+HRDLKP N+L D+D + I+DFG
Sbjct: 101 --KGFYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155
Query: 502 LAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561
L+K S GT GY+APE ++ D +S GV+ +L+ G P D
Sbjct: 156 LSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD- 211
Query: 562 FQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNS 621
+ K ++ +E D+ ++ + + P +R
Sbjct: 212 ------ENDAKLFEQILKAEYE---FDSPYWDDISDSAKDFIRH----LMEKDPEKRFTC 258
Query: 622 KDV 624
+
Sbjct: 259 EQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (365), Expect = 2e-39
Identities = 59/235 (25%), Positives = 100/235 (42%), Gaps = 28/235 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +G+G G V+ NG+ A+K + +++ + K++ E
Sbjct: 9 LRTLGTGSFGRVHLIRSR-HNGRYYAMKVL-----------KKEIVVRLKQVEHTNDERL 56
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + H ++ + ++ ++++ G L +L + A
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAE 112
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
V LEYLH + II+RDLKP N+LLD + +I DFG AK +PD + GT
Sbjct: 113 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GT 164
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
YIAPE T + D +SFG+L+ ++ G P F + M + + N
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEKILN 215
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (365), Expect = 7e-39
Identities = 67/243 (27%), Positives = 102/243 (41%), Gaps = 23/243 (9%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
IG GG GEVY GKM A+K + K ++ + ++ LN R ++
Sbjct: 9 HRIIGRGGFGEVYGCRKA-DTGKMYAMKCL---DKKRIKMKQGETLALN-----ERIMLS 59
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
V ++ + PD + + M G L L+ A
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAE 115
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ GLE++H N +++RDLKPAN+LLD+ RI+D GLA + H + GT
Sbjct: 116 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GT 168
Query: 522 VGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580
GY+APE Q + + D +S G +L L+ G P T++ + M M
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMAV 226
Query: 581 ENP 583
E P
Sbjct: 227 ELP 229
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 9e-39
Identities = 49/300 (16%), Positives = 105/300 (35%), Gaps = 43/300 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+IG G G +++ N + +AIK + Q+R E
Sbjct: 10 GRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPR----------------RSDAPQLRDEYR 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
T + +P + + + H ++ + SL+D+L+ R+ A
Sbjct: 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQ 109
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDME-----ARIADFGLAKAMPDAQTH---- 512
+ ++ +H +++RD+KP N L+ + DFG+ K D T
Sbjct: 110 MLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 513 -ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571
N++GT Y++ H + + + D+ + G + + G LP T +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226
Query: 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
+ + + L G+ E+ + + P+ ++ + S++
Sbjct: 227 RIGEKKQS-------TPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 65/298 (21%), Positives = 112/298 (37%), Gaps = 38/298 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ +G G VYKA + +++AIKK+ + A+ + R EI
Sbjct: 3 LDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAK---------DGINRTALREIK 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H N++ LL LV++FM+ I L L
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLM 108
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
GLEYLH I+HRDLKP N+LLD++ ++ADFGLAK+ T + T
Sbjct: 109 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVT 163
Query: 522 VGYIAPEYHQTLKFTD-KCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTS 580
Y APE + D+++ G +LA L++ ++ + + + +
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF----LPGDSDLDQLTRIFETLGT 219
Query: 581 ENPTRAIDAKLLENGYEEQMLLVLKIACF--------------CTVDSPRERPNSKDV 624
+ D L + + + + + +P R +
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-38
Identities = 58/301 (19%), Positives = 118/301 (39%), Gaps = 40/301 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ +IG G G+V+KA + G+ +A+K+V + + + +R++ +
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRV--------RVQTGEEGMPLSTIREVA-VLR 62
Query: 402 TVGQIRHRNLLPLL-----AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
+ H N++ L + R LV+E + + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIK 119
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
+ + GL++LH + R++HRDLKP N+L+ + ++ADFGLA+ +
Sbjct: 120 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-- 174
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK---- 572
V T+ Y APE + D++S G + A + + F+ + ++ +
Sbjct: 175 -VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKILD 229
Query: 573 ---------WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD 623
W R+V + A+ +E + L + C +P +R ++
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 624 V 624
Sbjct: 290 A 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 37/287 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
E++GSG V K S G A K + K + + I E++
Sbjct: 15 GEELGSGQFAVVKKCREK-STGLQYAAKFI---KKRRTKSSRRG-----VSREDIEREVS 65
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +I+H N++ L +L+ E + G L D E + L +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF-------LAEKESLTEEEATEF 118
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR----IADFGLAKAMPDAQTHITTSN 517
+ L ++ H+ +I H DLKP N++L D + I DFGLA + N
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKN 175
Query: 518 VAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577
+ GT ++APE + D++S GV+ +L+ G P F T++ +L
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---FLGDTKQETLANVSAVN 232
Query: 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
E+ + + L ++ + + V P++R +D
Sbjct: 233 YEFEDEYFSNTSALAKD-------FIRR----LLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 6e-36
Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 42/296 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ IG+G G VY+A+L +G+++AIKK + + R E+
Sbjct: 25 TKVIGNGSFGVVYQAKLC-DSGELVAIKK------------------VLQDKRFKNRELQ 65
Query: 402 TVGQIRHRNLLPLLAHMARPDCH------LLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ ++ H N++ L LV +++ + S+ ++ L +
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR-HYSRAKQTLPVIYV 124
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD-MEARIADFGLAKAMPDAQTHIT 514
+ L Y+H + I HRD+KP N+LLD D ++ DFG AK + + +++
Sbjct: 125 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 515 TSNVAGTVGYIAP-EYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573
+ Y AP +T D++S G +LA L++G+ F + LV+
Sbjct: 182 YIC---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI---FPGDSGVDQLVEI 235
Query: 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD-VRCML 628
++ + T PTR ++ N Y E +K + V PR P + +L
Sbjct: 236 IKVLGT---PTREQIREMNPN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 134 bits (337), Expect = 8e-36
Identities = 67/297 (22%), Positives = 115/297 (38%), Gaps = 39/297 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEKIG G G VYKA+ G+ A+KK+ +D EI+
Sbjct: 7 LEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDE------------GIPSTTIREIS 52
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +++H N++ L + +LV+E + + + L+ + L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLLQ 108
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ G+ Y H + R++HRDLKP N+L++ + E +IADFGLA+A T +
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-IVTL 164
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
+ K++ DI+S G + A +V G F +E L++ R + T
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL---FPGVSEADQLMRIFRILGTPN 221
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACF--------------CTVDSPRERPNSKDV 624
+ +L + + L F P +R +K
Sbjct: 222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 9e-36
Identities = 56/290 (19%), Positives = 105/290 (36%), Gaps = 46/290 (15%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G G+V + + A+K + + + R E+
Sbjct: 18 QVLGLGINGKVLQIFNK-RTQEKFALKML-------------------QDCPKARREVEL 57
Query: 403 VGQI-RHRNLLPLL----AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHK 457
+ + +++ ++ A C L+V E + G L + D +G + +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASE 115
Query: 458 IALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME---ARIADFGLAKAMPDAQTHIT 514
I + ++YLH + I HRD+KP N+L ++ DFG AK + T
Sbjct: 116 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
Query: 515 TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574
T Y+APE K+ CD++S GV++ +L+ G P F +++ M
Sbjct: 173 PCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGM 225
Query: 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDV 624
+ + EE +L+ P +R +
Sbjct: 226 KTRIRMGQYE--FPNPEWSEVSEEVKMLIRN----LLKTEPTQRMTITEF 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 57/261 (21%), Positives = 97/261 (37%), Gaps = 23/261 (8%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L IG G G V A N +AIKK+ ++ EI
Sbjct: 13 LSYIGEGAYGMVCSAYDN-VNKVRVAIKKI-------------SPFEHQTYCQRTLREIK 58
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + RH N++ + + P + ++ + L + + + L
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT-SNVAG 520
+ GL+Y+H + ++HRDLKP+N+LL+ + +I DFGLA+ H +
Sbjct: 118 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 521 TVGYIAPEY-HQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
T Y APE + +T DI+S G +LA ++ R F L + + +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI---FPGKHYLDQLNHILGILGS 231
Query: 580 SENPTRAIDAKLLENGYEEQM 600
L Y +
Sbjct: 232 PSQEDLNCIINLKARNYLLSL 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-35
Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 25/235 (10%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ +G G G+V + G+ A+K + ++ + ++ +E
Sbjct: 10 LKLLGKGTFGKVILVREK-ATGRYYAMKIL-----------RKEVIIAKDEVAHTVTESR 57
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ RH L L D V E+ G L L +
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFY 110
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
A + L H+ +++RD+K N++LD D +I DFGL K T GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGT 168
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
Y+APE + + D + GV++ ++ GRLP F + + L + +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFELILM 219
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-35
Identities = 62/288 (21%), Positives = 108/288 (37%), Gaps = 47/288 (16%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+GSGG G VY S+ +AIK V KD E ++ E+
Sbjct: 9 GPLLGSGGFGSVYSGIRV-SDNLPVAIKHV---EKDRISDWGEL-----PNGTRVPMEVV 59
Query: 402 TVGQIR--HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIA 459
+ ++ ++ LL RPD +L+ E + L D R L
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFF 116
Query: 460 LGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHITTSNV 518
V + + H ++HRD+K N+L+D + E ++ DFG + D +
Sbjct: 117 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DF 169
Query: 519 AGTVGYIAPEYHQTLKFTDK-CDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNV 577
GT Y PE+ + ++ + ++S G+LL +V G +P F+H EE+ +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEI---IRGQVF 222
Query: 578 MTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVR 625
+ L+ C P +RP ++++
Sbjct: 223 FRQRVSSECQH-------------LIRW----CLALRPSDRPTFEEIQ 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-35
Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 25/239 (10%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+EKIG G G VYKA G+++A+KK+ + EI+
Sbjct: 7 VEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTET------------EGVPSTAIREIS 53
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ ++ H N++ LL + + LV+EF+ + + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQ 110
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ GL + H + R++HRDLKP N+L++ + ++ADFGLA+A T T
Sbjct: 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVT 165
Query: 522 VGYIAPE-YHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579
+ Y APE ++ DI+S G + A +V R F +E L + R + T
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL---FPGDSEIDQLFRIFRTLGT 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 1e-34
Identities = 46/235 (19%), Positives = 90/235 (38%), Gaps = 28/235 (11%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
++ +G+G G V + +G A+K + ++ + K++ +E
Sbjct: 46 IKTLGTGSFGRVMLVKHK-ESGNHYAMKIL-----------DKQKVVKLKQIEHTLNEKR 93
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ + L+ L +V E++ G + L A
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQ 149
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ EYLH + +I+RDLKP N+L+D ++ DFG AK + + GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GT 201
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
+APE + + D ++ GVL+ + G P F + + + + + +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFADQPIQIYEKIVS 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 2e-33
Identities = 59/288 (20%), Positives = 110/288 (38%), Gaps = 28/288 (9%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
LEKIG G G V+KA+ +++A+K+V D EI
Sbjct: 7 LEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDD------------EGVPSSALREIC 53
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +++H+N++ L + LV+EF QD+ +LD
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ GL + H + ++HRDLKP N+L++ + E ++A+FGLA+A ++ V
Sbjct: 110 LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTL 165
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMTSE 581
++ D++S G + A L P F + +K + ++ +
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTP 222
Query: 582 NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD-VRCML 628
+ L + M P+ +D ++ +L
Sbjct: 223 TEEQWPSMTKLPDYKPYPM---YPATTSLVNVVPKLNATGRDLLQNLL 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 63/299 (21%), Positives = 115/299 (38%), Gaps = 36/299 (12%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L KIG G GEV+KA G+ +A+KKV+ EI
Sbjct: 15 LAKIGQGTFGEVFKARHR-KTGQKVALKKVLM------------ENEKEGFPITALREIK 61
Query: 402 TVGQIRHRNLLPLL--------AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWL 453
+ ++H N++ L+ + LV++F ++ + N +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLS 117
Query: 454 ARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHI 513
++ + GL Y+H +I+HRD+K ANVL+ D ++ADFGLA+A A+
Sbjct: 118 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 514 TT--SNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570
+N T+ Y PE + + D++ G ++A + Q E
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQ 230
Query: 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKD-VRCML 628
+ + + S P + E + +++ K + + P + D + +L
Sbjct: 231 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 54/237 (22%), Positives = 94/237 (39%), Gaps = 24/237 (10%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ +GSG G V A G +AIKK+ +P + ++ E+
Sbjct: 23 LQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQS------------ELFAKRAYRELR 69
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
+ +RH N++ LL + +F +L +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGT 521
+ GL Y+ H IIHRDLKP N+ +++D E +I DFGLA+ T V
Sbjct: 130 MLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTR 182
Query: 522 VGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVM 578
+++T DI+S G ++A ++ G+ F+ ++ + +K + V
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL----FKGSDHLDQLKEIMKVT 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (305), Expect = 4e-31
Identities = 60/297 (20%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ K+G G EV++A +N + + +K L K ++I+ EI
Sbjct: 40 VRKLGRGKYSEVFEAINI-TNNEKVVVKI-----------------LKPVKKKKIKREIK 81
Query: 402 TVGQIR-HRNLLPLLAHMARPDCHL--LVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ +R N++ L + P LV+E + N + + + L
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFY 134
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHITTSN 517
+ L+Y H I+HRD+KP NV++D + + R+ D+GLA+ Q + +
Sbjct: 135 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NV 188
Query: 518 VAGTVGYIAPEYHQTLKFTD-KCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
+ + PE + D D++S G +LA ++ + P FF + + +
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAK 245
Query: 577 VMTSENPTRAIDAKLLEN--GYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631
V+ +E+ ID +E + + + + V S + S + L ++
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 61/247 (24%), Positives = 106/247 (42%), Gaps = 26/247 (10%)
Query: 342 LEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSE 399
L+ +G+G G+V+ + GK+ A+K + A + ++ K R+E
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL-----KKATIVQKA-----KTTEHTRTE 78
Query: 400 INTVGQIRHRNLLPLLAHMARPDCHL-LVYEFMKNGSLQDILNDVSQGRRELDWLARHKI 458
+ IR L L + + + L L+ +++ G L L + + H++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-------SQRERFTEHEV 131
Query: 459 ALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNV 518
+ V + L H II+RD+K N+LLD + + DFGL+K +T
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191
Query: 519 AGTVGYIAPEYHQTLK--FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
GT+ Y+AP+ + D +S GVL+ L+ G P F E+ S + R
Sbjct: 192 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---FTVDGEKNSQAEISRR 247
Query: 577 VMTSENP 583
++ SE P
Sbjct: 248 ILKSEPP 254
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 36/248 (14%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L+ IGSG G V A + +AIKK+ +P ++ ++ E+
Sbjct: 22 LKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQN------------QTHAKRAYRELV 68
Query: 402 TVGQIRHRNLLPLLAHMARPDC------HLLVYEFMKNGSLQDILNDVSQGRRELDWLAR 455
+ + H+N++ LL LV E M Q I + ELD
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERM 121
Query: 456 HKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITT 515
+ + CG+++LH + IIHRDLKP+N+++ D +I DFGLA+ +
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MM 175
Query: 516 SNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575
+ T Y APE + + + DI+S G ++ +V ++ F + + +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKVI 231
Query: 576 NVMTSENP 583
+ + P
Sbjct: 232 EQLGTPCP 239
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 1e-27
Identities = 53/264 (20%), Positives = 106/264 (40%), Gaps = 9/264 (3%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
+ K+G G V+ A+ N +A+K +++ K E E++ KLL + ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDM-VNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 402 TVGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALG 461
++G LL H H+++ + +L ++ L ++ + I+
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQ 133
Query: 462 VACGLEYLHISHNPRIIHRDLKPANVLLD-DDMEARIADFGLAKAMPDAQTHITTSNVAG 520
+ GL+Y+H IIH D+KP NVL++ D + +A +N
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLP--SDDFFQHTEEMSLVKWMRNVM 578
T Y +PE + DI+S L+ L+ G D+ +T++ + + ++
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 579 TSENPTRAIDAKLLENGYEEQMLL 602
+ K + + LL
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLL 275
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-26
Identities = 55/247 (22%), Positives = 101/247 (40%), Gaps = 34/247 (13%)
Query: 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEIN 401
L +GSG G V A G +A+KK+ +P + ++ E+
Sbjct: 23 LSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIH------------AKRTYRELR 69
Query: 402 TVGQIRHRNLLPLLAHMARPDC-----HLLVYEFMKNGSLQDILNDVSQGRRELDWLARH 456
+ ++H N++ LL + + + L +I+ ++L
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQ 124
Query: 457 KIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTS 516
+ + GL+Y+H + IIHRDLKP+N+ +++D E +I DFGLA+ T
Sbjct: 125 FLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTG 177
Query: 517 NVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576
VA + + DI+S G ++A L+ GR F T+ + +K +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL----FPGTDHIDQLKLILR 233
Query: 577 VMTSENP 583
++ +
Sbjct: 234 LVGTPGA 240
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 1e-16
Identities = 29/211 (13%), Positives = 62/211 (29%), Gaps = 28/211 (13%)
Query: 343 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINT 402
+ +G G V+ +K + K +
Sbjct: 6 KLMGEGKESAVFNCYSE--KFGECVVKFH---KVGHTSFKKVKEKRDYGDLHFSV-LAIR 59
Query: 403 VGQIRHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGV 462
+ R L L + VY + N L ++++ R ++ + +
Sbjct: 60 SARNEFRALQKL-----QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMI 112
Query: 463 ACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAM--PDAQTHITTSNVAG 520
+ + + I+H DL NVL+ + I DF + + + +
Sbjct: 113 LEEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREI-----LER 163
Query: 521 TVGYIAPEYHQTLKFTDKCDIYSFGVLLAVL 551
V I + + + + DI S + +L
Sbjct: 164 DVRNIITYFSR--TYRTEKDINS--AIDRIL 190
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.5 bits (166), Expect = 6e-13
Identities = 27/132 (20%), Positives = 45/132 (34%), Gaps = 25/132 (18%)
Query: 92 PSIGRLSELRELSLANNSLVDLLP--------------------PQIVDCKKLEILNVQN 131
+ L++L EL L N + ++ P I + K L L +
Sbjct: 257 APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316
Query: 132 NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRT 191
N S P +SSL +L+ L + N S + L N+ LS N + P +
Sbjct: 317 NNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LAN 371
Query: 192 FRNLQFFDFSGN 203
+ +
Sbjct: 372 LTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 2e-12
Identities = 32/158 (20%), Positives = 56/158 (35%), Gaps = 28/158 (17%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
+ +L +L + ++ L+ L +L LANN + +L P + KL L + NQ
Sbjct: 220 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 275
Query: 135 SGTIPSDLSS--------------------LIRLRVLDLSGNSFSGNLGFLKYFPNLEHL 174
S P + L L L L N+ S + + L+ L
Sbjct: 276 SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD-ISPVSSLTKLQRL 334
Query: 175 SLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPV 212
A N + +S+ N+ + N + P+
Sbjct: 335 FFANNKVSD--VSSLANLTNINWLSAGHNQ-ISDLTPL 369
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 15/80 (18%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
+ K V +T +S + L ++ L + + + L +N NNQ
Sbjct: 23 EKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQL 78
Query: 135 SGTIPSDLSSLIRLRVLDLS 154
+ P L +L +L + ++
Sbjct: 79 TDITP--LKNLTKLVDILMN 96
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 10/80 (12%), Positives = 27/80 (33%), Gaps = 5/80 (6%)
Query: 122 KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLF 181
+ + + T+ + L ++ L ++ ++Y NL ++ + N
Sbjct: 22 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQL 78
Query: 182 TGKVPTSIRTFRNLQFFDFS 201
T P ++ L +
Sbjct: 79 TDITP--LKNLTKLVDILMN 96
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.5 bits (150), Expect = 4e-11
Identities = 18/66 (27%), Positives = 30/66 (45%)
Query: 121 CKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNL 180
K L L+++NN+ GT+P L+ L L L++S N+ G + + + A N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 181 FTGKVP 186
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 18/54 (33%), Positives = 22/54 (40%), Gaps = 1/54 (1%)
Query: 105 LANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSF 158
L NN + LP + K L LNV N G IP +L R V + N
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 12/54 (22%), Positives = 26/54 (48%), Gaps = 1/54 (1%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIP 139
+ G L + +L L L+++ N+L + PQ + ++ ++ NN+ P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 14/45 (31%), Positives = 19/45 (42%), Gaps = 1/45 (2%)
Query: 167 YFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211
NL L L N G +P + + L + S N+ L G IP
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN-LCGEIP 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.0 bits (131), Expect = 8e-09
Identities = 27/157 (17%), Positives = 48/157 (30%), Gaps = 2/157 (1%)
Query: 55 CSTPGVFC-ERRLSDNNTYVLK-ITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVD 112
C V C + L + L ++T + L L L L NN +
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 113 LLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLE 172
+ P KLE L + NQ +L LRV + ++ +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 173 HLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
L +G + + + L + + ++ P
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 24/127 (18%), Positives = 48/127 (37%), Gaps = 3/127 (2%)
Query: 79 LVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTI 138
L P + +G+ + + + +L + +A+ ++ + P + L L++ N+ +
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKITKVD 187
Query: 139 PSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFF 198
+ L L L L LS NS S N KVP + + +Q
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVV 247
Query: 199 DFSGNSL 205
N++
Sbjct: 248 YLHNNNI 254
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.5 bits (114), Expect = 1e-06
Identities = 23/123 (18%), Positives = 36/123 (29%), Gaps = 6/123 (4%)
Query: 95 GRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154
G L EL L N + + + L L + N S L++ LR L L+
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTG------KVPTSIRTFRNLQFFDFSGNSLLEG 208
N G L ++ + L N + P + N +
Sbjct: 228 NNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287
Query: 209 PIP 211
I
Sbjct: 288 EIQ 290
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 8e-09
Identities = 25/130 (19%), Positives = 45/130 (34%), Gaps = 2/130 (1%)
Query: 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQF 134
+T L ++ V + L L L L N + + P D +L L + N
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 135 SGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIR--TF 192
S L+ L L+ L L+ N + + + L+ + + +P +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL 273
Query: 193 RNLQFFDFSG 202
+ L D G
Sbjct: 274 KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 28/119 (23%), Positives = 38/119 (31%), Gaps = 1/119 (0%)
Query: 86 LTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
L V + L L L L L +L P L+ L +Q+N L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 146 IRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203
L L L GN S + +L+ L L +N P + R L N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 20/91 (21%), Positives = 34/91 (37%), Gaps = 8/91 (8%)
Query: 107 NNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLK 166
N+ + + LE LNV NN+ +P+ RL L S N + +
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA---EVPE 321
Query: 167 YFPNLEHLSLAKNLFTGKVPTSIRTFRNLQF 197
NL+ L + N + P + +L+
Sbjct: 322 LPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 6e-08
Identities = 19/80 (23%), Positives = 33/80 (41%), Gaps = 11/80 (13%)
Query: 97 LSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156
L EL+++NN L++ LP +LE L N + +P + L+ L + N
Sbjct: 283 PPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPELPQN---LKQLHVEYN 334
Query: 157 SFSGNLGFLKYFPNLEHLSL 176
F ++E L +
Sbjct: 335 PLR---EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.7 bits (101), Expect = 4e-05
Identities = 21/80 (26%), Positives = 27/80 (33%), Gaps = 7/80 (8%)
Query: 130 QNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSI 189
N S I S L L++S N P LE L + N +VP
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI---ELPALPPRLERLIASFNHLA-EVPELP 323
Query: 190 RTFRNLQFFDFSGNSLLEGP 209
+NL+ N L E P
Sbjct: 324 ---QNLKQLHVEYNPLREFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.001
Identities = 19/69 (27%), Positives = 25/69 (36%), Gaps = 5/69 (7%)
Query: 100 LRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFS 159
EL L N L LP LE L N + +P SL L V + + + S
Sbjct: 40 AHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 160 GNLGFLKYF 168
L+Y
Sbjct: 95 DLPPLLEYL 103
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 2e-08
Identities = 15/89 (16%), Positives = 35/89 (39%), Gaps = 11/89 (12%)
Query: 99 ELRELSLANNSLVDLLPPQIVDC-KKLEILNVQNNQFSGTIPSDLSSLIR----LRVLDL 153
+++ L + L D +++ ++ +++ + + + D+SS +R L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 154 SGNSFSGNL------GFLKYFPNLEHLSL 176
N G ++ LSL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.7 bits (124), Expect = 9e-08
Identities = 22/92 (23%), Positives = 33/92 (35%), Gaps = 14/92 (15%)
Query: 98 SELRELSLANNSLVDL----LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIR-----L 148
S LR L LA+ + D L ++ L L++ NN L +R L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 149 RVLDLSGNSFSGNL-----GFLKYFPNLEHLS 175
L L +S + K P+L +S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.7 bits (119), Expect = 4e-07
Identities = 13/72 (18%), Positives = 27/72 (37%), Gaps = 6/72 (8%)
Query: 124 LEILNVQNNQFSGTIPSDL-SSLIRLRVLDLSGNSFSGN-----LGFLKYFPNLEHLSLA 177
++ L++Q + S ++L L + +V+ L + L+ P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 178 KNLFTGKVPTSI 189
N +
Sbjct: 64 SNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 7e-07
Identities = 17/81 (20%), Positives = 32/81 (39%), Gaps = 10/81 (12%)
Query: 121 CKKLEILNVQNNQFSGT----IPSDLSSLIRLRVLDLSGNSFS--GNLGFLKYFPN---- 170
L +L + + S + + + L + LR LDLS N G L ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 171 LEHLSLAKNLFTGKVPTSIRT 191
LE L L ++ ++ ++
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 10/66 (15%), Positives = 21/66 (31%), Gaps = 6/66 (9%)
Query: 146 IRLRVLDLSGNSFS--GNLGFLKYFPNLEHLSLAKNLFTGK----VPTSIRTFRNLQFFD 199
+ ++ LD+ S L + + L T + +++R L +
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 200 FSGNSL 205
N L
Sbjct: 62 LRSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 3e-05
Identities = 9/76 (11%), Positives = 27/76 (35%), Gaps = 9/76 (11%)
Query: 90 LSPSIGRLSELRELSLANNSLVD----LLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSL 145
+ + L + + + L + L + + + L LN+++N+ +
Sbjct: 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78
Query: 146 I-----RLRVLDLSGN 156
+ +++ L L
Sbjct: 79 LQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 5e-05
Identities = 21/71 (29%), Positives = 34/71 (47%), Gaps = 9/71 (12%)
Query: 90 LSPSIGRLSELRELSLANNSLVDLLPPQIVD-----CKKLEILNVQNNQFSGTIPSDLSS 144
L+ ++ LREL L+NN L D Q+V+ LE L + + +S + L +
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448
Query: 145 LIR----LRVL 151
L + LRV+
Sbjct: 449 LEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 13/68 (19%), Positives = 20/68 (29%), Gaps = 10/68 (14%)
Query: 148 LRVLDLSGNSFSGN-----LGFLKYFPNLEHLSLAKNLFTGKVPTSI-RTFRN----LQF 197
LRVL L+ S + L +L L L+ N + + R L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 198 FDFSGNSL 205
Sbjct: 431 LVLYDIYW 438
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 5e-08
Identities = 16/102 (15%), Positives = 38/102 (37%), Gaps = 4/102 (3%)
Query: 101 RELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG 160
+ L L +L + +++ + + + + S R++ +DLS +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60
Query: 161 N--LGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDF 200
+ G L L++LSL + + ++ NL +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 102
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 1e-05
Identities = 19/94 (20%), Positives = 35/94 (37%), Gaps = 1/94 (1%)
Query: 82 VPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIV-DCKKLEILNVQNNQFSGTIPS 140
PR ++ + L+N+ + I+ C KL+ L+++ + S I +
Sbjct: 30 CPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVN 89
Query: 141 DLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHL 174
L+ L L+LSG S + L
Sbjct: 90 TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 17/88 (19%), Positives = 32/88 (36%), Gaps = 3/88 (3%)
Query: 112 DLLPPQIVDCKKLEILNVQN-NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPN 170
+ + L+ L++ +L + L+ L + G G L LK
Sbjct: 190 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK--EA 247
Query: 171 LEHLSLAKNLFTGKVPTSIRTFRNLQFF 198
L HL + + FT +I +N + +
Sbjct: 248 LPHLQINCSHFTTIARPTIGNKKNQEIW 275
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 1e-07
Identities = 27/106 (25%), Positives = 42/106 (39%), Gaps = 5/106 (4%)
Query: 101 RELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSG 160
R L LA+ L L + + L++ +N+ P+ L++L L VL S N+
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 161 NLGFLKYFPNLEHLSLAKNLFTG-KVPTSIRTFRNLQFFDFSGNSL 205
G P L+ L L N + + L + GNSL
Sbjct: 58 VDGV-ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 2e-07
Identities = 22/109 (20%), Positives = 40/109 (36%), Gaps = 26/109 (23%)
Query: 92 PSIGRLSELRELSLANNSLVDLLP---------------------PQIVDCKKLEILNVQ 130
+ +L + L L++N L L P + + +L+ L +
Sbjct: 14 CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLC 73
Query: 131 NNQFSGT-IPSDLSSLIRLRVLDLSGNSFSGNLGF----LKYFPNLEHL 174
NN+ + L S RL +L+L GNS G + P++ +
Sbjct: 74 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 6e-07
Identities = 17/62 (27%), Positives = 26/62 (41%), Gaps = 3/62 (4%)
Query: 115 PPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHL 174
+ + KL L +N+ S P L+SL L + L N S + L NL +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD-VSPLANTSNLFIV 222
Query: 175 SL 176
+L
Sbjct: 223 TL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 5e-04
Identities = 12/78 (15%), Positives = 28/78 (35%), Gaps = 4/78 (5%)
Query: 104 SLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG 163
S+ + ++++ P + + + T+ + L + L G + +
Sbjct: 2 SITQPTAINVIFP-DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE 57
Query: 164 FLKYFPNLEHLSLAKNLF 181
++Y NL L L N
Sbjct: 58 GVQYLNNLIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 11/40 (27%), Positives = 19/40 (47%), Gaps = 2/40 (5%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN 131
+ L L E+ L NN + D+ P + + L I+ + N
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 15/74 (20%), Positives = 26/74 (35%), Gaps = 3/74 (4%)
Query: 128 NVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPT 187
+ + + L++L +L L N S + L PNL + L N + P
Sbjct: 155 YLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP- 212
Query: 188 SIRTFRNLQFFDFS 201
+ NL +
Sbjct: 213 -LANTSNLFIVTLT 225
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 9e-07
Identities = 14/66 (21%), Positives = 26/66 (39%), Gaps = 3/66 (4%)
Query: 93 SIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152
+ +++ E++ +L L PP + K IL++ N + L RL L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTAL-PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 153 LSGNSF 158
L
Sbjct: 62 LDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.001
Identities = 39/180 (21%), Positives = 55/180 (30%), Gaps = 9/180 (5%)
Query: 11 SLFALLSLLFLSHARL---------NLDRSDYKALSVILRDLGGQQLFIPSDPCSTPGVF 61
L ++L LS L R L +P
Sbjct: 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHN 87
Query: 62 CERRLSDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDC 121
+ L + +T L LT + ++ L EL+EL L N L L P +
Sbjct: 88 QLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 122 KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLF 181
KLE L++ NN + L+ L L L L NS L L N +
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (104), Expect = 5e-06
Identities = 17/109 (15%), Positives = 34/109 (31%), Gaps = 2/109 (1%)
Query: 116 PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLS 175
Q + + L+++ + I + ++L + +D S N L L+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLL 69
Query: 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQYP 224
+ N + +L + NSL+E S
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.001
Identities = 10/72 (13%), Positives = 22/72 (30%), Gaps = 3/72 (4%)
Query: 91 SPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRV 150
+ REL L + + + + ++ +N+ L RL+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67
Query: 151 LDLSGNSFSGNL 162
L ++ N
Sbjct: 68 LLVNNNRICRIG 79
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 2e-05
Identities = 11/53 (20%), Positives = 16/53 (30%), Gaps = 9/53 (16%)
Query: 120 DCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLE 172
IL++ + L +L +LR LK P LE
Sbjct: 199 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---------LKKLPTLE 242
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 5e-05
Identities = 24/120 (20%), Positives = 46/120 (38%), Gaps = 6/120 (5%)
Query: 89 VLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRL 148
L + + + + +L L P +V +LN +++ + T+ ++ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRSD--PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 149 RVLDLSGNSFSGNLGF---LKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSL 205
L+LS N ++ PNL+ L+L+ N + L+ GNSL
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 1e-04
Identities = 29/118 (24%), Positives = 44/118 (37%), Gaps = 10/118 (8%)
Query: 67 SDNNTYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL--LPPQIVDCKKL 124
SD + I ++ + L + EL L+L+NN L L + + L
Sbjct: 34 SDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNL 93
Query: 125 EILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG--------FLKYFPNLEHL 174
+ILN+ N+ D ++L L L GNS S + FP L L
Sbjct: 94 KILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 17/66 (25%), Positives = 26/66 (39%), Gaps = 11/66 (16%)
Query: 105 LANNSLVDLLPPQIVDC------KKLEILNVQNNQFSGTIPSDLSSLI-----RLRVLDL 153
L + L +VD L+ L +Q N+ L ++I L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 154 SGNSFS 159
+GN FS
Sbjct: 310 NGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 10/63 (15%), Positives = 19/63 (30%), Gaps = 7/63 (11%)
Query: 97 LSELRELSLANNSLVDLLPPQIVD-----CKKLEILNVQNNQFS--GTIPSDLSSLIRLR 149
L+ L L N + + L L + N+FS + ++ + R
Sbjct: 272 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR 331
Query: 150 VLD 152
Sbjct: 332 GRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.003
Identities = 9/65 (13%), Positives = 23/65 (35%), Gaps = 6/65 (9%)
Query: 120 DCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLG-----FLKYFPNLEHL 174
+ K L++ + ++ + L ++ + LSGN+ + +LE
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 175 SLAKN 179
+
Sbjct: 65 EFSDI 69
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.004
Identities = 13/80 (16%), Positives = 24/80 (30%), Gaps = 13/80 (16%)
Query: 128 NVQNNQFSGTIPSDLS------SLIRLRVLDLSGNSFSGNL------GFLKYFPNLEHLS 175
+ + S + + I L+ L L N + + P+L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 176 LAKNLFTGKVPTSIRTFRNL 195
L N F + + R +
Sbjct: 309 LNGNRF-SEEDDVVDEIREV 327
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 4e-04
Identities = 18/116 (15%), Positives = 30/116 (25%), Gaps = 2/116 (1%)
Query: 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDL-SSLIRLRV 150
P L + +D + + L L ++N Q + L LR
Sbjct: 2 PDACCPHGSSGLRCTRDGALDS-LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 151 LDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206
L + + +F + +LQ SGN L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.001
Identities = 15/96 (15%), Positives = 26/96 (27%), Gaps = 3/96 (3%)
Query: 116 PQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL--GFLKYFPNLEH 173
P L + L L L + +L L+ L +
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 174 LSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209
L++ K+ P + L + S N+L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLS 96
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 13/79 (16%), Positives = 27/79 (34%), Gaps = 3/79 (3%)
Query: 122 KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLF 181
+ N++ + + + L + + + + G ++Y PN+ L L N
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKL 80
Query: 182 TGKVPTSIRTFRNLQFFDF 200
T P + F D
Sbjct: 81 TDIKPLANLKNLGWLFLDE 99
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 11/41 (26%), Positives = 18/41 (43%), Gaps = 2/41 (4%)
Query: 115 PPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSG 155
+ KL+ L + N S + + L+ L L VL+L
Sbjct: 171 IVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFS 209
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 16/45 (35%), Positives = 22/45 (48%), Gaps = 3/45 (6%)
Query: 130 QNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHL 174
+NQ + P L++L L LD+S N S + L NLE L
Sbjct: 158 SSNQVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.002
Identities = 8/62 (12%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 122 KKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLF 181
+ + + T+ + L ++ L ++ ++Y NL ++ + N
Sbjct: 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQL 74
Query: 182 TG 183
T
Sbjct: 75 TD 76
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 633 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.71 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.71 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.68 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.68 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.65 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.65 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.65 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.63 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.54 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.51 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.5 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.47 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.45 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.41 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.38 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.35 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.23 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.12 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.92 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.84 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.79 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.7 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.67 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.59 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.48 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.46 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.44 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.44 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.13 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.67 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.66 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.5 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.93 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.93 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.82 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=414.48 Aligned_cols=263 Identities=23% Similarity=0.398 Sum_probs=202.3
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||+||+|+++ ..||||+++....+.. ..+.|++|++++++++|||||++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~------------~~~~~~~E~~~l~~l~HpnIv~~ 69 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQ------------QLQAFKNEVGVLRKTRHVNILLF 69 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTT------------HHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHH------------HHHHHHHHHHHHHhCCCCCEeee
Confidence 4578999999999999999999863 3599999875543221 15678999999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+ +..++||||+++|+|.+++... +..+++..+..|+.||++||+|| |+++||||||||+|||++.++.
T Consensus 70 ~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~~~ 142 (276)
T d1uwha_ 70 MGYSTA-PQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLT 142 (276)
T ss_dssp EEEECS-SSCEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTSS
T ss_pred eEEEec-cEEEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEEEcCCCC
Confidence 998754 5689999999999999999752 35699999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+||+|||+|+...............||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.+... ...+.
T Consensus 143 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~---~~~~~ 219 (276)
T d1uwha_ 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN---RDQII 219 (276)
T ss_dssp EEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---HHHHH
T ss_pred EEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh---HHHHH
Confidence 99999999988765444333455689999999999864 3588999999999999999999999976432 11222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..+.......... .. .......+.+++.+||+.||++|||++|+++.|+.++
T Consensus 220 ~~~~~~~~~p~~~-----~~----~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 220 FMVGRGYLSPDLS-----KV----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp HHHHHTSCCCCGG-----GS----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCCcch-----hc----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2222111111110 11 1112234788899999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-52 Score=405.72 Aligned_cols=257 Identities=24% Similarity=0.340 Sum_probs=198.6
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..+.||+|+||+||+|++. +++.||||++...... .++|.+|++++++++|||||+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~---------------~~~~~~E~~~l~~l~HpnIv~~~g 67 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQLYG 67 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSSSC---------------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCcCc---------------HHHHHHHHHHHHhcCCCCcccccc
Confidence 57889999999999999999985 6789999998653321 346889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
+|..++..++||||+++|+|.+++.. ....+++..+..++.||++||+|| |+.+|+||||||+|||+++++.+|
T Consensus 68 ~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~K 141 (263)
T d1sm2a_ 68 VCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIK 141 (263)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCEE
T ss_pred eeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheeecCCCCeE
Confidence 99999999999999999999999875 245689999999999999999999 678899999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+|+..|+... .....+.+.+..
T Consensus 142 l~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~ 217 (263)
T d1sm2a_ 142 VSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDIST 217 (263)
T ss_dssp ECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHHHH
T ss_pred ecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC---CCHHHHHHHHHh
Confidence 99999998776543322 23457899999999999999999999999999999999965444321 122223232222
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhhC
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIRH 633 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~~ 633 (633)
...... + .. ....+.+++.+||+.||++||||+|+++.|++|++
T Consensus 218 ---~~~~~~---p----~~---~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 218 ---GFRLYK---P----RL---ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---TCCCCC---C----TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cCCCCC---c----cc---cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 211110 0 01 12347789999999999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4e-52 Score=413.04 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=212.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||+||+|++. .+++.||||++.....+ .++|.+|++++++++|||||++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~---------------~~~~~~E~~il~~l~HpnIv~~ 78 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTME---------------VEEFLKEAAVMKEIKHPNLVQL 78 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTTCSC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCccch---------------HHHHHHHHHHHHhCCCCCEecC
Confidence 4578999999999999999999875 46889999998654321 3568899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+++|.+++..++||||+++|+|.+++... ....+++..+..|+.||++||+|| |+++|+||||||+|||+++++.
T Consensus 79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~~~~~ 153 (287)
T d1opja_ 79 LGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHL 153 (287)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGC
T ss_pred CccEeeCCeeEEEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEECCCCc
Confidence 99999999999999999999999999753 346799999999999999999999 5679999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ....+.+.+
T Consensus 154 ~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~~~~~i 229 (287)
T d1opja_ 154 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELL 229 (287)
T ss_dssp EEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHH
T ss_pred EEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc---hHHHHHHHH
Confidence 999999999987654332 2344568999999999999999999999999999999999887764321 222222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.. ...+. .+......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 230 ~~---~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 230 EK---DYRME----------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HT---TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hc---CCCCC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22 11111 01111234788999999999999999999999998864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=407.83 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=202.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||+||+|++. .+|+.||||++...... +..+.+.+|++++++++|||||++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~-------------~~~~~~~~Ei~~l~~l~HpnIv~~~~ 70 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAV-------------DCPENIKKEICINKMLNHENVVKFYG 70 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC--------------------CHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcc-------------hHHHHHHHHHHHHHhCCCCCEeeEee
Confidence 57999999999999999999875 57899999998654211 11356889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..|+||||+++|+|.+++.. ...+++..+..++.||++||+|| |+++|+||||||+|||+++++.+|
T Consensus 71 ~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~K 143 (271)
T d1nvra_ 71 HRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNLK 143 (271)
T ss_dssp EEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEE
T ss_pred eeccCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEECCCCCEE
Confidence 99999999999999999999999864 45699999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+|+...............||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .......+.
T Consensus 144 L~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~~~~~- 220 (271)
T d1nvra_ 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWK- 220 (271)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST--TSHHHHHHH-
T ss_pred EccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh--HHHHHHHHh-
Confidence 999999998755433333345689999999999988776 5689999999999999999999975322 111111111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........ .......+.+++.+||+.||++|||++|+++
T Consensus 221 ---~~~~~~~~---------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 221 ---EKKTYLNP---------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---TTCTTSTT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cCCCCCCc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111100 0011123678899999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-51 Score=408.88 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=198.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCC--CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.+.|++.+.||+|+||+||+|++...+ ...||||++...... +..++|.+|++++++++|||||+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~ 91 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-------------KQRRDFLSEASIMGQFDHPNVIH 91 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH-------------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH-------------HHHHHHHHHHHHHHhCCCCCCcc
Confidence 467888999999999999999875332 236889987543321 11467899999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++|++.+++..++||||+++|+|.+++.. ....+++.++..++.||++||+|| |+++|+||||||+|||+++++
T Consensus 92 l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl~~~~ 165 (299)
T d1jpaa_ 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNL 165 (299)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTC
T ss_pred EEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEEECCCC
Confidence 99999999999999999999999998874 245699999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcc---eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccch
Q 006739 494 EARIADFGLAKAMPDAQTHI---TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMS 569 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~ 569 (633)
.+||+|||+|+......... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.. ...
T Consensus 166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~~ 241 (299)
T d1jpaa_ 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT----NQD 241 (299)
T ss_dssp CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHH
T ss_pred cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC----HHH
Confidence 99999999999876543222 1223457999999999999999999999999999999998 899987532 222
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+...+ .....+.. +......+.+++.+||+.||++|||++|+++.|+++
T Consensus 242 ~~~~i---~~~~~~~~----------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 242 VINAI---EQDYRLPP----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HHHHH---HTTCCCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHH---HcCCCCCC----------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 32222 22222211 111223478899999999999999999999999886
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=399.32 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=204.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+++.||+|++.+.... .....+.+.+|++++++++|||||++++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~-----------~~~~~~~~~~E~~il~~l~hpnIv~~~~ 73 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLE-----------KAGVEHQLRREVEIQSHLRHPNILRLYG 73 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHcc-----------ChHHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence 57999999999999999999875 57899999998532110 0112457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..++||||+++|+|.+++.. ...+++..+..++.||++||+|| |+++|+||||||+|||+++++.+|
T Consensus 74 ~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~k 146 (263)
T d2j4za1 74 YFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGELK 146 (263)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceecCCCCEe
Confidence 99999999999999999999999976 34599999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+|+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ...
T Consensus 147 l~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~---~~~ 215 (263)
T d2j4za1 147 IADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT----YQET---YKR 215 (263)
T ss_dssp ECCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS----HHHH---HHH
T ss_pred ecccceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC----HHHH---HHH
Confidence 999999987654322 34679999999999999999999999999999999999999996532 1222 222
Q ss_pred hhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..... ..++.+ ...+.+++.+||+.||++|||++|+++
T Consensus 216 i~~~~~~~p~~~------------s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 216 ISRVEFTFPDFV------------TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTTCCCCCTTS------------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCCCccC------------CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 22211 111111 123778899999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-52 Score=407.56 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=206.5
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+++ +++.||||++...... .++|.+|++++++++|||||++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~---------------~~~~~~E~~~l~~l~HpnIv~~ 73 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS---------------PDAFLAEANLMKQLQHQRLVRL 73 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCcCC---------------HHHHHHHHHHHHhCCCCCEeEE
Confidence 4578999999999999999999985 6789999998654321 3568999999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+ +..++||||+++|+|.+++.... ...+++..+..|+.||++||+|| |+++|+||||||+|||+++++.
T Consensus 74 ~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~~~~~ 147 (272)
T d1qpca_ 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLS 147 (272)
T ss_dssp EEEECS-SSCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSC
T ss_pred Eeeecc-CCeEEEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheeeecccc
Confidence 998754 56799999999999999876432 34589999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+|+...+.... ......||+.|+|||++.+..++.++|||||||++|||+||..|+.... ....+.+.+
T Consensus 148 ~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~~~~~~~i 223 (272)
T d1qpca_ 148 CKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNL 223 (272)
T ss_dssp EEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHH
T ss_pred eeeccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CHHHHHHHH
Confidence 999999999987654332 2244678999999999999899999999999999999999766654321 122222222
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.....+.. ... ....+.+++.+||+.||++||||+|+++.|+++
T Consensus 224 ---~~~~~~~~-------p~~---~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 224 ---ERGYRMVR-------PDN---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ---HTTCCCCC-------CTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HhcCCCCC-------ccc---ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 22221110 011 123478899999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=403.12 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=196.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||+||+|+.. .+|+.||+|++....... ...+.+.+|++++++++|||||+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~------------~~~~~~~~E~~il~~l~HpnIv~~~ 69 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTE------------AEKQMLVSEVNLLRELKHPNIVRYY 69 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCH------------HHHHHHHHHHHHTTSCCCTTBCCEE
T ss_pred chhCEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCH------------HHHHHHHHHHHHHHHCCCCCEeeEE
Confidence 367999999999999999999864 578999999987654321 1145788999999999999999999
Q ss_pred eeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCeEecC
Q 006739 416 AHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISH--NPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 416 ~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h--~~~ivH~Dikp~Nill~~ 491 (633)
+++.+ .+..|+||||+++|+|.+++.+.......+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.
T Consensus 70 ~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~ 149 (269)
T d2java1 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149 (269)
T ss_dssp EEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT
T ss_pred EEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC
Confidence 99865 45678999999999999999865555678999999999999999999997543 346999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
++.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .++.
T Consensus 150 ~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----~~~~ 223 (269)
T d2java1 150 KQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELA 223 (269)
T ss_dssp TSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH
T ss_pred CCcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----HHHH
Confidence 999999999999987654322 2346799999999999999999999999999999999999999975321 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+ ....... + .... ...+.+++.+||+.||++|||++|+++
T Consensus 224 ~~i---~~~~~~~------~-~~~~---s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 224 GKI---REGKFRR------I-PYRY---SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHH---HHTCCCC------C-CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH---HcCCCCC------C-Cccc---CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 222 2221110 0 0111 123778889999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=401.38 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=204.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|+..+.||+|+||+||+|+.. .+|+.||||++...... ..+.+.+|++++++++|||||+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~~~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~~~ 83 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQP--------------KKELIINEILVMRENKNPNIVNYL 83 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBT-TTCCEEEEEEEEGGGCS--------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEecccCh--------------HHHHHHHHHHHHHhCCCCCEeeEe
Confidence 457999999999999999999864 57999999998643211 035688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|| |+++|+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~v 155 (293)
T d1yhwa1 84 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSV 155 (293)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeEECCCCcE
Confidence 999999999999999999999998764 3589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+|+........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+... ...+....
T Consensus 156 kl~DFG~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~- 229 (293)
T d1yhwa1 156 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIA- 229 (293)
T ss_dssp EECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH-
T ss_pred eeccchhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHH-
Confidence 99999999987654322 2346799999999999999999999999999999999999999965321 11111111
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....+..... ......+.+++.+||+.||++|||++|+++
T Consensus 230 ---~~~~~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 230 ---TNGTPELQNP--------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---HHCSCCCSSG--------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---hCCCCCCCCc--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111110000 111233778999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=396.41 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=210.3
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+..++||+|+||+||+|+++ +++.||||+++..... .++|.+|+.++++++||||++++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~---------------~~~~~~Ev~~~~~l~HpnIv~~~g 66 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLVQLYG 66 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSSSC---------------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCcCC---------------HHHHHHHHHHHHhcCCCceeeEEE
Confidence 68899999999999999999985 7889999998765432 346889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
+|.+++..++||||+++|+|.+++... ...+++..+.+++.|+++||+|| |+.+|+||||||+||++++++.+|
T Consensus 67 ~~~~~~~~~iv~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~k 140 (258)
T d1k2pa_ 67 VCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVK 140 (258)
T ss_dssp EECCSSSEEEEEECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCEE
T ss_pred EEeeCCceEEEEEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEcCCCcEE
Confidence 999999999999999999999997642 35689999999999999999999 578999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .++.+
T Consensus 141 l~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~----~~~~~--- 212 (258)
T d1k2pa_ 141 VSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETAE--- 212 (258)
T ss_dssp ECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHHHH---
T ss_pred ECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH----HHHHH---
Confidence 9999999877654333 2234678999999999999999999999999999999998 8999876422 22222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+....... .+ .. ....+.+++.+||+.||++|||++|+++.|.+|
T Consensus 213 ~i~~~~~~~---~p----~~---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 213 HIAQGLRLY---RP----HL---ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHTTCCCC---CC----TT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHhCCCCC---Cc----cc---ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 222221111 01 11 123478899999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=410.46 Aligned_cols=203 Identities=27% Similarity=0.457 Sum_probs=177.5
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
+.++|++.+.||+|+||+||+|++. .+|+.||+|++....... ...++.+|+.++++++|||||++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~-------------~~~~~~~Ei~il~~l~HpnIv~l 69 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPA-------------IRNQIIRELQVLHECNSPYIVGF 69 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEET-TTTEEEEEEEEECCCCTT-------------HHHHHHHHGGGGGGCCCTTBCCE
T ss_pred CccCCEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEChhhCHH-------------HHHHHHHHHHHHHhCCCCCCCcE
Confidence 4678999999999999999999864 579999999987543211 14578899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
+++|.+++..|+||||+++|+|.+++.+. ..+++..+..++.|+++||+|||+ ..+|+||||||+|||+++++.
T Consensus 70 ~~~~~~~~~~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~ 143 (322)
T d1s9ja_ 70 YGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE 143 (322)
T ss_dssp EEEEECSSEEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCC
Confidence 99999999999999999999999999763 459999999999999999999962 348999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccc
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDF 561 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 561 (633)
+||+|||+|+...+.. ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus 144 vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 144 IKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp EEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred EEEeeCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999998764322 13468999999999999999999999999999999999999999753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=400.87 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=200.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCC---eEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNG---KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
.+.|+..++||+|+||.||+|.++..++ ..||||++...... +...+|.+|++++++++|||||
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~-------------~~~~~~~~E~~il~~l~H~nIv 72 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-------------KQRVDFLGEAGIMGQFSHHNII 72 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh-------------HHHHHHHHHHHHHHhcCCCCEe
Confidence 3568889999999999999998864333 47999998643321 1145789999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
+++|++.+.+..++||||+++|++.+++... ...+++..+..++.||++||+|| |+.+|+||||||+|||++.+
T Consensus 73 ~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~ 146 (283)
T d1mqba_ 73 RLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSN 146 (283)
T ss_dssp CEEEEECSSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTT
T ss_pred eeeEEEecCCceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhc---cccccccCccccceEEECCC
Confidence 9999999999999999999999999987652 45699999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ....+.
T Consensus 147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~~ 223 (283)
T d1mqba_ 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVM 223 (283)
T ss_dssp CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHH
T ss_pred CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC---CHHHHH
Confidence 99999999999987654322 22234568999999999999999999999999999999999776654321 122233
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
+.+. ....+.. +......+.+++.+||+.||++||||.|+++.|+++
T Consensus 224 ~~i~---~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 224 KAIN---DGFRLPT----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHH---TTCCCCC----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHh---ccCCCCC----------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 3222 2222111 111223478899999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=404.46 Aligned_cols=266 Identities=24% Similarity=0.320 Sum_probs=209.9
Q ss_pred hhhhhcCcccccccccccCeeEEEEEecCCC----CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-
Q 006739 332 FLEKEDGLASLEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI- 406 (633)
Q Consensus 332 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 406 (633)
|....++|++.+.||+|+||+||+|++.+.+ ...||+|.+...... .....+.+|+.++.++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~ 98 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-------------SEREALMSELKMMTQLG 98 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-------------HHHHHHHHHHHHHHHhc
Confidence 3345578999999999999999999875432 247999988543211 1145788999999998
Q ss_pred CCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHH
Q 006739 407 RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ-------------------GRRELDWLARHKIALGVACGLE 467 (633)
Q Consensus 407 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~ 467 (633)
+|||||++++++.+.+..++||||+++|+|.++++.... ....+++..++.++.||++||+
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 178 (325)
T d1rjba_ 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178 (325)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999975432 1245899999999999999999
Q ss_pred HHHhcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHH
Q 006739 468 YLHISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVL 547 (633)
Q Consensus 468 ~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~ 547 (633)
|| |+++|+||||||+||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||+
T Consensus 179 yL---H~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 179 FL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255 (325)
T ss_dssp HH---HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HH---HhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHH
Confidence 99 678999999999999999999999999999988766555444455678999999999999999999999999999
Q ss_pred HHHHHh-CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 548 LAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 548 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+|||+| |+.||.+... ...+.+.+... ..+. .+......+.+++.+||+.||++|||++|+++
T Consensus 256 l~emlt~g~~Pf~~~~~---~~~~~~~~~~~---~~~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPV---DANFYKLIQNG---FKMD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp HHHHTTTSCCSSTTCCC---SHHHHHHHHTT---CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCCH---HHHHHHHHhcC---CCCC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 8999875432 22223333221 1111 01111234788999999999999999999999
Q ss_pred HHH
Q 006739 627 MLS 629 (633)
Q Consensus 627 ~l~ 629 (633)
.|.
T Consensus 320 ~L~ 322 (325)
T d1rjba_ 320 FLG 322 (325)
T ss_dssp HHH
T ss_pred HHh
Confidence 984
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=400.59 Aligned_cols=252 Identities=22% Similarity=0.322 Sum_probs=201.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||+||+|+.. .+|+.||||++..... ......+.+.+|++++++++|||||++++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~-----------~~~~~~~~~~~E~~il~~l~HpnIv~l~~ 75 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHI-----------IKENKVPYVTRERDVMSRLDHPFFVKLYF 75 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHc-----------cCHHHHHHHHHHHHHHHHcCCCCeeEEEE
Confidence 57999999999999999999875 5789999999843211 01112467899999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|| |+.+|+||||||+|||+++++.+|
T Consensus 76 ~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~vk 148 (288)
T d1uu3a_ 76 TFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHIQ 148 (288)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCEE
T ss_pred EEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccccCCCceEE
Confidence 99999999999999999999999876 34699999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+|+.+.............||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...+ ...
T Consensus 149 l~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~---~~~ 221 (288)
T d1uu3a_ 149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLI---FQK 221 (288)
T ss_dssp ECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---HHH
T ss_pred ecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC----HHHH---HHH
Confidence 999999998765443333345679999999999999999999999999999999999999997532 1122 222
Q ss_pred hhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 577 VMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 577 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.... ..+.. . ...+.+++.+||+.||++|||++|+++
T Consensus 222 i~~~~~~~p~~--------~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 222 IIKLEYDFPEK--------F----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHTTCCCCCTT--------C----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHcCCCCCCcc--------C----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 22211 11111 1 123778999999999999999998743
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=399.82 Aligned_cols=254 Identities=24% Similarity=0.336 Sum_probs=203.0
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..+.|++.+.||+|+||.||+|++. .+|+.||||++....... .+.+.+|++++++++|||||++
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~l 74 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEE--------------LEDYMVEIDILASCDHPNIVKL 74 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSGG--------------GGGTHHHHHHHHHCCCTTBCCE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHHH--------------HHHHHHHHHHHHhCCCCCCCeE
Confidence 3467899999999999999999875 578999999986543211 3467889999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+++..++||||+++|+|.+++.+. ...+++..+..++.||++||+|| |+++|+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~lvmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~ 148 (288)
T d2jfla1 75 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGD 148 (288)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSC
T ss_pred EEEEeeCCeEEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhheeECCCCC
Confidence 99999999999999999999999997653 35699999999999999999999 6789999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccc-----cCCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQ-----TLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
+||+|||+|+....... ......||+.|+|||++. +..|+.++|||||||++|||++|+.||.+... ...
T Consensus 149 ~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~ 223 (288)
T d2jfla1 149 IKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRV 223 (288)
T ss_dssp EEECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGH
T ss_pred EEEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHH
Confidence 99999999976533211 123467999999999884 45689999999999999999999999976422 111
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+. .....+..... ......+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~i----~~~~~~~~~~~--------~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 224 LLKI----AKSEPPTLAQP--------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHH----HHSCCCCCSSG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHH----HcCCCCCCCcc--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1121 12211110000 111234778999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-50 Score=395.09 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=205.7
Q ss_pred hcCcccccc-cccccCeeEEEEEecC-CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEK-IGSGGCGEVYKAELPG-SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~-ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|.+.+. ||+|+||.||+|.++. .++..||||++...... ...++|.+|++++++++|||||+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~ 73 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------------ADTEEMMREAQIMHQLDNPYIVR 73 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-------------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-------------HHHHHHHHHHHHHHhCCCCCEee
Confidence 456777774 9999999999998743 34568999998654321 11467899999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++|++.+ +..|+||||+++|+|.+++.. .+..+++..+..++.||++||+|| |+++|+||||||+||+++.++
T Consensus 74 l~g~~~~-~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~~ 146 (285)
T d1u59a_ 74 LIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRH 146 (285)
T ss_dssp EEEEEES-SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEETT
T ss_pred Eeeeecc-CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhheeeccCC
Confidence 9999865 467999999999999998754 245699999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 494 EARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... .++.
T Consensus 147 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~~~ 222 (285)
T d1u59a_ 147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVM 222 (285)
T ss_dssp EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHH
T ss_pred ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 99999999999876543322 2234568999999999999999999999999999999998 9999976422 2222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
..+. ....+. . ++.....+.+++.+||+.||++|||+.++++.|+.+
T Consensus 223 ~~i~---~~~~~~------~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 223 AFIE---QGKRME------C----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHH---TTCCCC------C----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH---cCCCCC------C----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2222 222211 0 111123477899999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=389.94 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=194.7
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeee
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 419 (633)
+..++||+|+||+||+|++. .+++.||+|++...... ....+.+.+|++++++++|||||++++++.
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 78 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFYDSWE 78 (270)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCC------------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence 55678999999999999875 57889999998543211 111467899999999999999999999986
Q ss_pred c----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCeEec-CC
Q 006739 420 R----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPR--IIHRDLKPANVLLD-DD 492 (633)
Q Consensus 420 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~--ivH~Dikp~Nill~-~~ 492 (633)
+ ....++||||+++|+|.+++.+. ..+++..+..++.||++||+|| |+++ |+||||||+|||++ ++
T Consensus 79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDiKp~NILl~~~~ 151 (270)
T d1t4ha_ 79 STVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITGPT 151 (270)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESSTT
T ss_pred eccccCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCcChhhceeeCCC
Confidence 4 34578999999999999999763 4699999999999999999999 5555 99999999999997 57
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+|+...... .....||+.|+|||++.+ +++.++|||||||++|||++|+.||.+... ..+
T Consensus 152 ~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------~~~ 220 (270)
T d1t4ha_ 152 GSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQ 220 (270)
T ss_dssp SCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHH
T ss_pred CCEEEeecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc------HHH
Confidence 899999999998654432 234679999999999875 699999999999999999999999965321 112
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.......+.. .+ ....+ .+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~i~~~~~~~~-~~----~~~~~----~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 221 IYRRVTSGVKPAS-FD----KVAIP----EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHTTTCCCGG-GG----GCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCCcc-cC----ccCCH----HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2222222222211 11 11122 3778899999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=398.09 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=198.9
Q ss_pred cccccccCeeEEEEEecC-CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeecC
Q 006739 343 EKIGSGGCGEVYKAELPG-SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMARP 421 (633)
Q Consensus 343 ~~ig~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 421 (633)
++||+|+||+||+|.++. ..++.||||++.....+ ....++|.+|++++++++|||||+++++|..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~- 79 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------------PALKDELLAEANVMQQLDNPYIVRMIGICEA- 79 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC------------HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-
Confidence 579999999999998742 34678999998543221 1124679999999999999999999999865
Q ss_pred CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEcccc
Q 006739 422 DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADFG 501 (633)
Q Consensus 422 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG 501 (633)
+..++||||+++|+|.++++. ...+++..+..++.||++||+|| |+++|+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DFG 152 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFG 152 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCcccccchh
Confidence 457899999999999999875 45699999999999999999999 67889999999999999999999999999
Q ss_pred cccccCCCCCcc-eecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHHHHHHhhc
Q 006739 502 LAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVKWMRNVMT 579 (633)
Q Consensus 502 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 579 (633)
+|+......... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+... ..+...+. .
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i~---~ 225 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLE---K 225 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHH---T
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHHHH---c
Confidence 999876554332 2234578999999999999999999999999999999998 8999975321 22222222 2
Q ss_pred cCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 580 SENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 580 ~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
...+.. +......+.+++.+||+.||++|||++++++.|+.+
T Consensus 226 ~~~~~~----------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 226 GERMGC----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCCCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCC----------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 222110 011123477899999999999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-49 Score=397.61 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=201.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|+..+.||+|+||.||+|+.. .+|+.||||++....... ....+.+.+|++++++++|||||+++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~-----------~~~~~~~~~Ei~il~~l~HpnIv~~~ 81 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQYR 81 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCH-----------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccC-----------HHHHHHHHHHHHHHHHCCCCCEeeEE
Confidence 346999999999999999999864 579999999987544321 11256789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..|+||||+++|+|..++.. ...+++..+..++.||++||+|| |+++|+||||||+|||+++++.+
T Consensus 82 ~~~~~~~~~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~ 154 (309)
T d1u5ra_ 82 GCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLV 154 (309)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEE
T ss_pred EEEEECCEEEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEECCCCCE
Confidence 999999999999999999999876654 45699999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc---CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT---LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
||+|||+|+..... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+... ..
T Consensus 155 Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----~~--- 221 (309)
T d1u5ra_ 155 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MS--- 221 (309)
T ss_dssp EECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HH---
T ss_pred EEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----HH---
Confidence 99999999865432 23579999999999864 4589999999999999999999999865321 11
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+........+. .. ....+ ..+.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~i~~~~~~~-~~-----~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 222 ALYHIAQNESPA-LQ-----SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHSCCCC-CS-----CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHhCCCCC-CC-----CCCCC---HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 122222222111 00 11111 23778899999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-49 Score=397.40 Aligned_cols=266 Identities=24% Similarity=0.406 Sum_probs=213.3
Q ss_pred hhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|++.+.||+|+||+||+|++++ .+++.||||++...... ...++|.+|++++++++|||
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-------------~~~~~~~~E~~il~~l~h~n 77 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------------DMQADFQREAALMAEFDNPN 77 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------------HHHHHHHHHHHHHHTCCCTT
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-------------HHHHHHHHHHHHHHhcCCCC
Confidence 46789999999999999999998753 46689999998654321 11567899999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ--------------------GRRELDWLARHKIALGVACGLEYLH 470 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~L~~Lh 470 (633)
|++++++|.+.+..++||||+++|+|.+++..... ....+++..+..|+.|+++||+||
T Consensus 78 iv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl- 156 (301)
T d1lufa_ 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL- 156 (301)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH-
T ss_pred cccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc-
Confidence 99999999999999999999999999999975321 134589999999999999999999
Q ss_pred hcCCCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHH
Q 006739 471 ISHNPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAV 550 (633)
Q Consensus 471 ~~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~e 550 (633)
|+++||||||||+|||+|.++.+||+|||+|+...+.......+...||+.|+|||++.+..++.++|||||||++||
T Consensus 157 --H~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 157 --SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp --HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --ccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 688999999999999999999999999999987765544434445678999999999999999999999999999999
Q ss_pred HHhCC-CCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHH
Q 006739 551 LVMGR-LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLS 629 (633)
Q Consensus 551 lltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~ 629 (633)
|++|. .||... ....+...+ .....+.. + .. ....+.+++.+||+.||++||||.||+++|+
T Consensus 235 ll~~~~~p~~~~----~~~e~~~~v---~~~~~~~~--p----~~----~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 235 IFSYGLQPYYGM----AHEEVIYYV---RDGNILAC--P----EN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHTTTCCTTTTS----CHHHHHHHH---HTTCCCCC--C----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHccCCCCCCCC----CHHHHHHHH---HcCCCCCC--C----cc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99996 466542 222232222 22222110 0 11 1224788999999999999999999999999
Q ss_pred hhhC
Q 006739 630 QIRH 633 (633)
Q Consensus 630 ~~~~ 633 (633)
+|++
T Consensus 298 ~i~~ 301 (301)
T d1lufa_ 298 RMCE 301 (301)
T ss_dssp HTTC
T ss_pred HhcC
Confidence 9875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-49 Score=394.79 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=189.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||+||+|+.. .+|+.||||++...... .....+.+|+.++++++|||||+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l~ 73 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALE-------------GKEGSMENEIAVLHKIKHPNIVALD 73 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC-----------------------CHHHHHHHTCCCTTBCCEE
T ss_pred ccceEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhh-------------hHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 467999999999999999999865 57899999998654321 1135678999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec---CC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD---DD 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~---~~ 492 (633)
+++.+++..|+||||++||+|.+++.. ...+++..+..++.||+.||+|| |+++|+||||||+||++. ++
T Consensus 74 ~~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~~ 146 (307)
T d1a06a_ 74 DIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDED 146 (307)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTT
T ss_pred EEEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceeecccCCC
Confidence 999999999999999999999999975 45699999999999999999999 678999999999999995 57
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~ 572 (633)
+.+||+|||+|+........ ....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... .....
T Consensus 147 ~~vkl~DFG~a~~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~~~~ 219 (307)
T d1a06a_ 147 SKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AKLFE 219 (307)
T ss_dssp CCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHH
T ss_pred ceEEEeccceeEEccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HHHHH
Confidence 89999999999876544322 345799999999999999999999999999999999999999975321 22222
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
. +....... +...... ....+.+++.+||+.||++|||++|+++
T Consensus 220 ~---i~~~~~~~---~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 220 Q---ILKAEYEF---DSPYWDD----ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp H---HHTTCCCC---CTTTTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H---HhccCCCC---CCccccC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 2 22211111 0000011 1223778999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=390.02 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=200.5
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|++.+.||+|+||.||+|+++ +++.||||++...... .++|.+|+.++++++|||||++
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~~~---------------~~~~~~E~~~l~~l~h~nIv~~ 77 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQL 77 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcccCC---------------HHHHHHHHHHHHhcccCCEeEE
Confidence 3468999999999999999999885 6678999998654321 3568899999999999999999
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCc
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDME 494 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~ 494 (633)
++++.+ +..++||||+++|+|.+++.... ...++|.++..|+.||++||+|| |+.+|+||||||+|||+++++.
T Consensus 78 ~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~ 151 (285)
T d1fmka3 78 YAVVSE-EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLV 151 (285)
T ss_dssp EEEECS-SSCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEec-CCeEEEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHH---hhhheecccccceEEEECCCCc
Confidence 999854 56899999999999999887533 34699999999999999999999 6778999999999999999999
Q ss_pred eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHH
Q 006739 495 ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWM 574 (633)
Q Consensus 495 ~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 574 (633)
+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ....+...+
T Consensus 152 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~---~~~~~~~~i 227 (285)
T d1fmka3 152 CKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV 227 (285)
T ss_dssp EEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHH
T ss_pred EEEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC---CHHHHHHHH
Confidence 999999999877554332 2244678999999999999999999999999999999999777654321 222233333
Q ss_pred HHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 575 RNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 575 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.. ..... .. .. ....+.+++.+||+.||++|||+++|+++|+++
T Consensus 228 ~~---~~~~~--~~----~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 228 ER---GYRMP--CP----PE----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp HT---TCCCC--CC----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred Hh---cCCCC--CC----cc----cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 22 11111 01 11 123478899999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=387.00 Aligned_cols=252 Identities=29% Similarity=0.418 Sum_probs=198.4
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPL 414 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 414 (633)
..++|+..+.||+|+||.||+|++ .|+.||||+++.... .+++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~~~~----------------~~~~~~E~~~l~~l~HpnIv~~ 65 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKNDAT----------------AQAFLAEASVMTQLRHSNLVQL 65 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECcHHH----------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 346788999999999999999997 578999999864321 4568899999999999999999
Q ss_pred ceeeec-CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 415 LAHMAR-PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 415 ~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+|+|.+ .+..++||||+++|+|.+++.... ...+++..++.|+.||++||+|| |+.+|+||||||+||+++.++
T Consensus 66 ~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~~~ 140 (262)
T d1byga_ 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 140 (262)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTS
T ss_pred EEEEEecCCcEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhheecCCC
Confidence 999865 466899999999999999997532 24589999999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLVK 572 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 572 (633)
.+|++|||+++...... ....+|..|+|||++.+..++.++|||||||++|||+| |+.||... ...++.+
T Consensus 141 ~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~----~~~~~~~ 211 (262)
T d1byga_ 141 VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVP 211 (262)
T ss_dssp CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS----CGGGHHH
T ss_pred CEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC----CHHHHHH
Confidence 99999999998755432 23467999999999999999999999999999999998 67777643 2233434
Q ss_pred HHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 573 WMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 573 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
++.. ...+. ..... ...+.+++.+||+.||++|||+.|++++|++||
T Consensus 212 ~i~~---~~~~~------~~~~~----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 212 RVEK---GYKMD------APDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHTT---TCCCC------CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHc---CCCCC------CCccC----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 4322 11111 11111 134778999999999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=388.03 Aligned_cols=257 Identities=25% Similarity=0.319 Sum_probs=206.6
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||+||+|+.. .+|+.||||++.+.......... ..+.+.+|++++++++|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGV--------SREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSB--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhhhH--------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 467999999999999999999874 57999999998765432221110 145789999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC--
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM-- 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~-- 493 (633)
+++.+++..|+||||+++|+|.+++... ..+++..+..++.|++.||+|| |+.+|+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~ 152 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVP 152 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSS
T ss_pred EEEEECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEEecCCCc
Confidence 9999999999999999999999999763 4699999999999999999999 678999999999999999776
Q ss_pred --ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 494 --EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 --~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
.+|++|||+|+........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. .....
T Consensus 153 ~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~ 225 (293)
T d1jksa_ 153 KPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----KQETL 225 (293)
T ss_dssp SCCEEECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHH
T ss_pred ccceEecchhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC----HHHHH
Confidence 4999999999887654322 34578999999999999999999999999999999999999997532 12221
Q ss_pred HHHHHhhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.... ...... .... ...+.+++.+||+.||++|||++|+++
T Consensus 226 ---~~i~~~~~~~~~~~----~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 226 ---ANVSAVNYEFEDEY----FSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---HHHHTTCCCCCHHH----HTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHHhcCCCCCchh----cCCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2221111 111111 1111 123778999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-48 Score=394.77 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=204.8
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|+.. .+|+.||||++...... ..+.+.+|++++++++|||||+++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~~~ 89 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHES--------------DKETVRKEIQTMSVLRHPTLVNLH 89 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHH--------------HHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccchh--------------hHHHHHHHHHHHHhCCCCCCCcEE
Confidence 368999999999999999999864 57999999998654311 145688999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec--CCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD--DDM 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~--~~~ 493 (633)
+++.+++..|+|||||++|+|.+++... ...+++..+..++.||+.||+|| |+.+|+||||||+|||++ .++
T Consensus 90 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~ 163 (350)
T d1koaa2 90 DAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSN 163 (350)
T ss_dssp EEEEETTEEEEEECCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSC
T ss_pred EEEEECCEEEEEEEcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHeeeccCCCC
Confidence 9999999999999999999999998642 34699999999999999999999 678999999999999996 467
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+|+........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ....
T Consensus 164 ~vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~--- 233 (350)
T d1koaa2 164 ELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN----DDET--- 233 (350)
T ss_dssp CEEECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---
T ss_pred eEEEeecchheeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC----HHHH---
Confidence 8999999999987654432 34679999999999999999999999999999999999999996532 1222
Q ss_pred HHHhhccCC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSEN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+..+..... .... .... ....+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~i~~~~~~~~~~----~~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 234 LRNVKSCDWNMDDS----AFSG----ISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHHTCCCSCCG----GGGG----CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCcc----cccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222222111 1111 0011 1123778999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=395.91 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=201.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCe----EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNL 411 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 411 (633)
.++|+..++||+|+||+||+|.+.. +|+ +||+|++...... +..++|.+|++++++++||||
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnI 73 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSP-------------KANKEILDEAYVMASVDNPHV 73 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC-----------------CTHHHHHHHHHHHHHCCCTTB
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccCH-------------HHHHHHHHHHHHHHhCCCCCE
Confidence 3579999999999999999998753 343 6888887543211 114678999999999999999
Q ss_pred cccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 412 LPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 412 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
|+++|+|.++ ..++++||+.+|+|.+++.. ....+++..+..++.||++||+|| |+++|+||||||+|||++.
T Consensus 74 v~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~ 146 (317)
T d1xkka_ 74 CRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKT 146 (317)
T ss_dssp CCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEE
T ss_pred eeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhhcceeCC
Confidence 9999999865 56788999999999998875 256799999999999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 570 (633)
++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||+... ...+
T Consensus 147 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~----~~~~ 222 (317)
T d1xkka_ 147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEI 222 (317)
T ss_dssp TTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----GGGH
T ss_pred CCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC----HHHH
Confidence 99999999999998876554444445678999999999999999999999999999999998 788887532 2223
Q ss_pred HHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 571 VKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 571 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
.+.+... ..+.. ++.....+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 223 ~~~i~~~---~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 223 SSILEKG---ERLPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHHHHT---CCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcC---CCCCC----------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 3333221 11110 111123478899999999999999999999998876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-49 Score=388.04 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=196.9
Q ss_pred hhcCcccccccccccCeeEEEEEecCCC--CeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCccc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLL 412 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 412 (633)
..++|++.+.||+|+||.||+|++...+ +..||||.+.....+ ...+.+.+|++++++++|||||
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv 71 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-------------SVREKFLQEALTMRQFDHPHIV 71 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-------------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-------------HHHHHHHHHHHHHHhCCCCCEe
Confidence 4568999999999999999999875333 457888887543321 1256789999999999999999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++++. .+..++||||+++|+|.+++... ...+++..+..++.||++||+|| |+++|+||||||+||+++++
T Consensus 72 ~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~~~ 144 (273)
T d1mp8a_ 72 KLIGVIT-ENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSN 144 (273)
T ss_dssp CEEEEEC-SSSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEET
T ss_pred eEEEEEe-cCeEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhheeecCC
Confidence 9999986 46789999999999999987642 45689999999999999999999 67899999999999999999
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 145 ~~~Kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----~~~~ 219 (273)
T d1mp8a_ 145 DCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVI 219 (273)
T ss_dssp TEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHH
T ss_pred CcEEEccchhheeccCCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH----HHHH
Confidence 999999999998765543322 244578999999999999999999999999999999998 8899876432 2333
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
+.+.. ...+. .. .. ....+.+++.+||+.||++|||++|+++.|+++.
T Consensus 220 ~~i~~---~~~~~--~~----~~----~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 220 GRIEN---GERLP--MP----PN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHT---TCCCC--CC----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHc---CCCCC--CC----CC----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 32222 22111 01 11 1234788999999999999999999999998873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=384.02 Aligned_cols=263 Identities=27% Similarity=0.373 Sum_probs=198.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCC--eEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
.++|++.+.||+|+||.||+|++...++ ..||||++....... .+..++|.+|+.++++++|||||+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-----------~~~~~~~~~Ei~~l~~l~H~nIv~ 75 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----------PEAMDDFIREVNAMHSLDHRNLIR 75 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------CHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-----------HHHHHHHHHHHHHHHhCCCCCEEE
Confidence 3569999999999999999998764444 478999885433211 122567999999999999999999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
++|++.+ +..++||||+++|++.+.+... ...+++..+..++.||++||+|| |+++|+||||||+||+++.++
T Consensus 76 ~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~ 148 (273)
T d1u46a_ 76 LYGVVLT-PPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRD 148 (273)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETT
T ss_pred EEEEEee-cchheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhcccccc
Confidence 9999976 4678999999999999988753 34699999999999999999999 568999999999999999999
Q ss_pred ceEEcccccccccCCCCCcce-ecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-CCCCCcccccccccchHH
Q 006739 494 EARIADFGLAKAMPDAQTHIT-TSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM-GRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+++.......... .....||..|+|||.+.+..++.++|||||||++|||+| |+.||.+.. .....
T Consensus 149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~----~~~~~ 224 (273)
T d1u46a_ 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN----GSQIL 224 (273)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHH
T ss_pred ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC----HHHHH
Confidence 999999999998766544322 234567889999999999999999999999999999998 899987532 22222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.++ ......... .+.....+.+++.+||+.||++|||+.|+++.|++.+
T Consensus 225 ~~i---~~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 225 HKI---DKEGERLPR---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp HHH---HTSCCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHH---HhCCCCCCC---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 222 222111100 0111134778999999999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=387.87 Aligned_cols=266 Identities=23% Similarity=0.339 Sum_probs=199.8
Q ss_pred hhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCC
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHR 409 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 409 (633)
..++|++.+.||+|+||.||+|++.+ .+++.||||++...... ...+.+.+|..++.++ +|+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-------------~~~~~~~~e~~~l~~~~~h~ 77 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-------------SEHRALMSELKILIHIGHHL 77 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-------------HHHHHHHHHHHHHHHHCCCT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-------------HHHHHHHHHHHHHHhhcCCC
Confidence 45789999999999999999998743 24578999998543221 1145667777777776 689
Q ss_pred cccccceeeecC-CccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 006739 410 NLLPLLAHMARP-DCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHNPR 476 (633)
Q Consensus 410 niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ 476 (633)
|||.+++++... ...++||||+++|+|.++++.... ....+++..+..++.||++||+|| |+++
T Consensus 78 ~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl---H~~~ 154 (299)
T d1ywna1 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRK 154 (299)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH---HHTT
T ss_pred eEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH---HhCC
Confidence 999999988664 468999999999999999975432 134589999999999999999999 6789
Q ss_pred eeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCC-
Q 006739 477 IIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR- 555 (633)
Q Consensus 477 ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~- 555 (633)
|+||||||+|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||.
T Consensus 155 ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence 9999999999999999999999999999876655444445578999999999999999999999999999999999975
Q ss_pred CCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 556 LPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 556 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.||..... ...+.+.+... ..+. .... ....+.+++.+||+.||++|||++|+++.|+++-
T Consensus 235 ~p~~~~~~---~~~~~~~~~~~---~~~~------~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 235 SPYPGVKI---DEEFCRRLKEG---TRMR------APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CSSTTCCC---SHHHHHHHHHT---CCCC------CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCH---HHHHHHHHhcC---CCCC------CCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 56654322 22222222221 1111 0011 1223788999999999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.3e-48 Score=392.87 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=205.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|++.+.||+|+||.||+|+.. .+|+.||||++...... ....+.+|++++++++|||||+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIv~~~ 92 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPL--------------DKYTVKNEISIMNQLHHPKLINLH 92 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHH--------------HHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECCcchh--------------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 367999999999999999999864 57999999998654311 135678999999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec--CCC
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD--DDM 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~--~~~ 493 (633)
+++.+++..|+||||+++|+|.+++.. ....+++..++.|+.||+.||+|| |+.+|+||||||+|||++ .++
T Consensus 93 ~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~ 166 (352)
T d1koba_ 93 DAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKAS 166 (352)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCC
T ss_pred EEEEECCEEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccccccccccccCCC
Confidence 999999999999999999999987754 245699999999999999999999 678999999999999998 678
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+|+........ ....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.. .......
T Consensus 167 ~vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~ 239 (352)
T d1koba_ 167 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED----DLETLQN 239 (352)
T ss_dssp CEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS----HHHHHHH
T ss_pred eEEEeecccceecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHH
Confidence 9999999999987664332 33579999999999999999999999999999999999999997532 1222222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.... ..... .........+.+++.+||+.||++|||++|+++
T Consensus 240 i~~~~--~~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 240 VKRCD--WEFDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHCC--CCCCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhCC--CCCCc--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22111 11110 001111233778999999999999999999976
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-47 Score=385.49 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=203.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||+||+|+.. .+|+.||||++.+... ...+..+.+.+|+.++++++|||||++++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~-----------~~~~~~~~~~~E~~il~~l~HpnIv~~~~ 71 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIV-----------VRLKQVEHTNDERLMLSIVTHPFIIRMWG 71 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHc-----------cCHHHHHHHHHHHHHHHhccCcChhheee
Confidence 57999999999999999999864 5799999999843211 01112567889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..|+||||++||+|..++.. ...+++..+..++.||+.||+|| |+++|+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 72 TFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCEE
T ss_pred eEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCEE
Confidence 99999999999999999999999876 45688999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+|+...... ....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... . +....
T Consensus 145 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~---~~~~~ 212 (316)
T d1fota_ 145 ITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----M---KTYEK 212 (316)
T ss_dssp ECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----H---HHHHH
T ss_pred EecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH----H---HHHHH
Confidence 99999999875432 346799999999999999999999999999999999999999975321 1 12222
Q ss_pred hhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 577 VMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 577 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
+.... ..+..++ ..+.+++.+||+.||.+|| |++|+++
T Consensus 213 i~~~~~~~p~~~s------------~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 213 ILNAELRFPPFFN------------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHCCCCCCTTSC------------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcCCCCCCCCCC------------HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 22221 1111111 2377889999999999996 8998875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-47 Score=380.45 Aligned_cols=264 Identities=21% Similarity=0.324 Sum_probs=202.5
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||.||+|++. .+|+.||||++........ .....+.+|+++++.++|||||+++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~E~~~l~~~~hpniv~~~ 73 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL-RLHRDVAVKVLRADLARDP-----------SFYLRFRREAQNAAALNHPAIVAVY 73 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTTTCH-----------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEchhhccCH-----------HHHHHHHHHHHHHHhcCCCCCCccc
Confidence 367999999999999999999864 5799999999875432111 1245789999999999999999999
Q ss_pred eeeecCC----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 416 AHMARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 416 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++...+ ..|+||||++||+|.+++.. ...+++.++..++.||++||+|| |+.+|+||||||+|||++.
T Consensus 74 ~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISA 146 (277)
T ss_dssp EEEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEET
T ss_pred ceeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCcccccCc
Confidence 9987654 37899999999999998875 34699999999999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCc-ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 492 DMEARIADFGLAKAMPDAQTH-ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
++..+++|||.++........ .......||+.|+|||++.+..++.++||||+||++|||+||+.||..... .
T Consensus 147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~-- 220 (277)
T d1o6ya_ 147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----V-- 220 (277)
T ss_dssp TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----H--
T ss_pred cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH----H--
Confidence 999999999998766443221 223456799999999999999999999999999999999999999975321 1
Q ss_pred HHHHHHhhccCC-cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-CHHHHHHHHHhhhC
Q 006739 571 VKWMRNVMTSEN-PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-NSKDVRCMLSQIRH 633 (633)
Q Consensus 571 ~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-s~~ev~~~l~~~~~ 633 (633)
+.......... +..... .. ....+.+++.+||+.||++|| |++++++.|.+++.
T Consensus 221 -~~~~~~~~~~~~~~~~~~-----~~---~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 221 -SVAYQHVREDPIPPSARH-----EG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -HHHHHHHHCCCCCGGGTS-----SS---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -HHHHHHHhcCCCCCchhc-----cC---CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11222222221 111111 11 123477888999999999999 89999999988753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=387.77 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=204.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++++.||+|+||.||+|+.. .+|+.||||++.+... ......+++.+|+.++++++|||||++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~i~k~~~-----------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 72 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVI-----------IAKDEVAHTVTESRVLQNTRHPFLTALKY 72 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEchhhc-----------cCHHHHHHHHHHHHHHHhCCCCCEEEEEe
Confidence 67999999999999999999864 5899999999853211 01112567889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+.+..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|| |+++|+||||||+|||++++|.+|
T Consensus 73 ~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 73 AFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCEE
T ss_pred eeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEecCCCCEE
Confidence 99999999999999999999999886 34689999999999999999999 788999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+|+....... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.. ...+.+.+..
T Consensus 146 l~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~----~~~~~~~i~~ 219 (337)
T d1o6la_ 146 ITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HERLFELILM 219 (337)
T ss_dssp ECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHH
T ss_pred EeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----HHHHHHHHhc
Confidence 999999987654332 2234689999999999999999999999999999999999999987532 1222222211
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
.....+..+ ...+.+++.+||+.||++||+ ++|+++
T Consensus 220 --~~~~~p~~~------------s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 220 --EEIRFPRTL------------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCCCTTS------------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCCccC------------CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111111111 123678999999999999995 777764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=385.37 Aligned_cols=268 Identities=27% Similarity=0.345 Sum_probs=201.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.+|...+.||+|+||.||+|++ +|+.||||++..... . ...++.|+..+.+++|||||++++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~---------~------~~~~e~ei~~~~~~~HpnIv~~~~ 64 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE---------R------SWFREAEIYQTVMLRHENILGFIA 64 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGH---------H------HHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch---------h------HHHHHHHHHHHhhCCCCcCcceEE
Confidence 4577789999999999999987 689999999843210 0 122345677777889999999999
Q ss_pred eeecCC----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCe
Q 006739 417 HMARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHIS-----HNPRIIHRDLKPANV 487 (633)
Q Consensus 417 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----h~~~ivH~Dikp~Ni 487 (633)
++.+.+ ..++||||+++|+|.+++++ ..++|..+..++.|++.||+|+|.. |+++|+||||||+||
T Consensus 65 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NI 139 (303)
T d1vjya_ 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139 (303)
T ss_dssp EEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGE
T ss_pred EEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccce
Confidence 997654 57899999999999999975 3589999999999999999999853 578999999999999
Q ss_pred EecCCCceEEcccccccccCCCCCcc--eecccccCcccccccccccCC------CCCccchHHHHHHHHHHHhCCCCCc
Q 006739 488 LLDDDMEARIADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTLK------FTDKCDIYSFGVLLAVLVMGRLPSD 559 (633)
Q Consensus 488 ll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~elltg~~p~~ 559 (633)
|++.++.+||+|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||.
T Consensus 140 Ll~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred EEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 99999999999999998876543321 224567999999999987643 5678999999999999999998875
Q ss_pred ccccccc--------cchHHHHHHHhhccCCcchhhhhhhhhc-CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHh
Q 006739 560 DFFQHTE--------EMSLVKWMRNVMTSENPTRAIDAKLLEN-GYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQ 630 (633)
Q Consensus 560 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~ 630 (633)
....... ..... .+......... ++.+... ...+....+.+++.+||+.||++|||+.|+++.|++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 220 IHEDYQLPYYDLVPSDPSVE-EMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp BCCCCCCTTTTTSCSSCCHH-HHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccchhhcccccchHH-HHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 3221110 11111 12222111111 0111011 122345568899999999999999999999999998
Q ss_pred hh
Q 006739 631 IR 632 (633)
Q Consensus 631 ~~ 632 (633)
|+
T Consensus 295 i~ 296 (303)
T d1vjya_ 295 LS 296 (303)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=389.12 Aligned_cols=267 Identities=22% Similarity=0.312 Sum_probs=214.6
Q ss_pred hhhhcCcccccccccccCeeEEEEEec----CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-C
Q 006739 333 LEKEDGLASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-R 407 (633)
Q Consensus 333 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 407 (633)
....++|+..++||+|+||.||+|++. ..+++.||||+++..... ....++.+|+.++.++ +
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-------------~~~~~~~~E~~~~~~l~~ 85 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL-------------TEREALMSELKVLSYLGN 85 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHHCC
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-------------HHHHHHHHHHHHHHhccC
Confidence 345578999999999999999999863 356789999998654321 1145788999999999 6
Q ss_pred CCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 006739 408 HRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ--------------GRRELDWLARHKIALGVACGLEYLHISH 473 (633)
Q Consensus 408 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h 473 (633)
|||||+++++|.+.+..++||||+++|+|.++++.... ....+++..+..++.||++||+|| |
T Consensus 86 HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L---H 162 (311)
T d1t46a_ 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---A 162 (311)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---H
Confidence 99999999999999999999999999999999976432 234689999999999999999999 6
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM 553 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 553 (633)
+++|+||||||+||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 163 ~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt 242 (311)
T d1t46a_ 163 SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242 (311)
T ss_dssp HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh
Confidence 78999999999999999999999999999998876655555566789999999999999999999999999999999999
Q ss_pred CCCC-CcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 554 GRLP-SDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 554 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
++.| |.... ....+.+.+........+ +.....+.+++.+||+.||++||||++++++|+++
T Consensus 243 ~g~p~~~~~~---~~~~~~~~i~~~~~~~~~-------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 243 LGSSPYPGMP---VDSKFYKMIKEGFRMLSP-------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TTCCSSTTCC---SSHHHHHHHHHTCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCC---HHHHHHHHHhcCCCCCCc-------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5555 43322 112222333322111111 11123478899999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-47 Score=374.19 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=206.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~ 415 (633)
++|++.+.||+|+||+||+|+.. .+|+.||||++.+........ .......+.+.+|+.++++++ |||||+++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~-~~~~~~AvK~i~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSA-----EEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCH-----HHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred ccCEEceEEecCcCeEEEEEEEC-CCCCEEEEEEEecccccchhH-----HHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 68999999999999999999864 589999999997765432211 112333567899999999997 99999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..|+||||+++|+|.++++. ...+++..+..++.||++||+|| |+++|+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCE
T ss_pred eecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEEcCCCCe
Confidence 999999999999999999999999975 34699999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCccccccccccc------CCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT------LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
||+|||+++........ ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+... ..
T Consensus 150 kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~~ 222 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----ML 222 (277)
T ss_dssp EECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH
T ss_pred EEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----HH
Confidence 99999999987654322 34679999999998853 4578899999999999999999999975321 12
Q ss_pred HHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+.+.. .......... .... ..+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~i~~--~~~~~~~~~~----~~~s----~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 MLRMIMS--GNYQFGSPEW----DDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHH--TCCCCCTTTG----GGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHh--CCCCCCCccc----ccCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2111111 1111111000 1111 23778899999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=382.46 Aligned_cols=265 Identities=27% Similarity=0.379 Sum_probs=208.5
Q ss_pred hhhcCcccccccccccCeeEEEEEecCC------CCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGS------NGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI- 406 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 406 (633)
...++|++.+.||+|+||.||+|+..+. ++..||||+++....+ +...++.+|...+.++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-------------~~~~~~~~e~~~l~~~~ 76 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-------------KDLSDLISEMEMMKMIG 76 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-------------HHHHHHHHHHHHHHHHC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh-------------HHHHHHHHHHHHHHHhc
Confidence 3457899999999999999999987432 3458999998654421 1145678888888888
Q ss_pred CCCcccccceeeecCCccEEEEecccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 006739 407 RHRNLLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVSQ------------GRRELDWLARHKIALGVACGLEYLHISHN 474 (633)
Q Consensus 407 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~ 474 (633)
+|||||+++++|.+++..++||||+++|+|.+++..... ....+++.+++.++.||++||+|| |+
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl---H~ 153 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---AS 153 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH---HH
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh---hh
Confidence 799999999999999999999999999999999975432 135689999999999999999999 78
Q ss_pred CCeeeCCCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHh-
Q 006739 475 PRIIHRDLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVM- 553 (633)
Q Consensus 475 ~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt- 553 (633)
.+||||||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++
T Consensus 154 ~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 154 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 8999999999999999999999999999998766554444456679999999999999999999999999999999998
Q ss_pred CCCCCcccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 554 GRLPSDDFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 554 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
|..||.+.. ...+.+.+.. ...+.. .... ...+.+++.+||+.||++|||+.|+++.|++|
T Consensus 234 g~~p~~~~~----~~~~~~~i~~---~~~~~~-------p~~~---~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 234 GGSPYPGVP----VEELFKLLKE---GHRMDK-------PSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp SCCSSTTCC----HHHHHHHHHT---TCCCCC-------CSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCC----HHHHHHHHHc---CCCCCC-------Cccc---hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 688876432 2223233322 211110 0111 22478899999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=384.35 Aligned_cols=256 Identities=27% Similarity=0.381 Sum_probs=200.8
Q ss_pred ccccccccCeeEEEEEecCCCC--eEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeee
Q 006739 342 LEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMA 419 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 419 (633)
.++||+|+||+||+|++...++ ..||||++...... ...++|.+|++++++++|||||+++|++.
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 98 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-------------GEVSQFLTEGIIMKDFSHPNVLSLLGICL 98 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH-------------HHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH-------------HHHHHHHHHHHHHHhCCCCCEeEEeEEEE
Confidence 5789999999999999864333 36899998643211 11567999999999999999999999987
Q ss_pred c-CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEc
Q 006739 420 R-PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIA 498 (633)
Q Consensus 420 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~ 498 (633)
+ +...++||||+++|+|.+++.. ....+++..+..++.|+++||.|+ |+.+|+||||||+|||+++++.+||+
T Consensus 99 ~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL~ 172 (311)
T d1r0pa_ 99 RSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVA 172 (311)
T ss_dssp ETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeECCCCCEEEe
Confidence 5 4578999999999999999874 245678899999999999999999 67899999999999999999999999
Q ss_pred ccccccccCCCCCcc--eecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 499 DFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 499 DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|||+++......... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||..... ..++..++
T Consensus 173 DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~---~~~~~~~i-- 247 (311)
T d1r0pa_ 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYL-- 247 (311)
T ss_dssp SSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH--
T ss_pred cccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC---HHHHHHHH--
Confidence 999999876543221 22345789999999999999999999999999999999998888754321 12222222
Q ss_pred hhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 577 VMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 577 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
..+.++.. + ... ...+.+++.+||+.||++||||.||++.|++++
T Consensus 248 -~~g~~~~~---p----~~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 248 -LQGRRLLQ---P----EYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp -HTTCCCCC---C----TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HcCCCCCC---c----ccC---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22222211 0 111 234778999999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=382.85 Aligned_cols=265 Identities=20% Similarity=0.335 Sum_probs=212.2
Q ss_pred hhcCcccccccccccCeeEEEEEecC----CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRN 410 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 410 (633)
..++|+..+.||+|+||.||+|.+.+ .+++.||||++...... +....|.+|++++++++|||
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~-------------~~~~~~~~E~~il~~l~h~n 84 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-------------RERIEFLNEASVMKEFNCHH 84 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH-------------HHHHHHHHHHHHGGGCCCTT
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh-------------HHHHHHHHHHHHHHHcCCCC
Confidence 45789999999999999999998742 24678999998643321 11457899999999999999
Q ss_pred ccccceeeecCCccEEEEecccCCCHHHHHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 006739 411 LLPLLAHMARPDCHLLVYEFMKNGSLQDILNDVS------QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484 (633)
Q Consensus 411 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp 484 (633)
||++++++..++..++||||+++|+|.+++.... .....+++..+.+++.|+++||.|| |+.+|+||||||
T Consensus 85 Iv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHrDlk~ 161 (308)
T d1p4oa_ 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAA 161 (308)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCSG
T ss_pred EeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeeceEcC
Confidence 9999999999999999999999999999987532 1234579999999999999999999 677999999999
Q ss_pred CCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCC-CCCccccc
Q 006739 485 ANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGR-LPSDDFFQ 563 (633)
Q Consensus 485 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~-~p~~~~~~ 563 (633)
+|||+++++++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||+ .||....
T Consensus 162 ~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~- 240 (308)
T d1p4oa_ 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS- 240 (308)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-
T ss_pred CceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-
Confidence 99999999999999999998776554443444557899999999999999999999999999999999985 6665421
Q ss_pred ccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 564 HTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
. .++...+.....+.. ... ....+.+++.+||+.||++||||+++++.|++..
T Consensus 241 ---~---~~~~~~i~~~~~~~~------p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 241 ---N---EQVLRFVMEGGLLDK------PDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp ---H---HHHHHHHHTTCCCCC------CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ---H---HHHHHHHHhCCCCCC------ccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 222222222222211 011 1234888999999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6e-47 Score=387.78 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=198.7
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.+.||+|+||.||+|+.. .+|+.||||++.+..... . ..........+|+++++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~-~t~~~vAiK~i~~~~~~~-----~---~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKM-----K---QGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHH-----H---TCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEEC-CCCCEEEEEEEchHHcch-----h---hHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 67999999999999999999864 579999999984321100 0 00111223345678888889999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..|+||||+++|+|.+++.. ...+++..+..++.||+.||+|| |+++|+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~iK 147 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVR 147 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCEE
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEcCCCcEE
Confidence 99999999999999999999999976 34588999999999999999999 688999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||+|+....... ....||+.|+|||++.. ..|+.++||||+||++|||+||+.||..... .......+
T Consensus 148 l~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~ 219 (364)
T d1omwa3 148 ISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDR 219 (364)
T ss_dssp ECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHHHHH
T ss_pred EeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 999999997765432 34579999999999865 5689999999999999999999999976322 11222222
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
......... .... ...+.+++.+||+.||++||| ++|+++
T Consensus 220 ~~~~~~~~~--------~~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MTLTMAVEL--------PDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HSSSCCCCC--------CSSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hcccCCCCC--------CCCC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 221111100 0111 123778999999999999999 577764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=383.83 Aligned_cols=260 Identities=24% Similarity=0.331 Sum_probs=204.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCe--EEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcC-CCCccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGK--MIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQI-RHRNLL 412 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv 412 (633)
.++|++.++||+|+||.||+|+++. +|. .||||++...... +..+++.+|+++++++ +|||||
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~HpnIv 74 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASK-------------DDHRDFAGELEVLCKLGHHPNII 74 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTBC
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccCh-------------HHHHHHHHHHHHHHhccCCCCEe
Confidence 3788899999999999999999863 444 5778877433211 1145789999999998 799999
Q ss_pred ccceeeecCCccEEEEecccCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 006739 413 PLLAHMARPDCHLLVYEFMKNGSLQDILNDVS------------QGRRELDWLARHKIALGVACGLEYLHISHNPRIIHR 480 (633)
Q Consensus 413 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~ 480 (633)
+++++|.+++..++||||+++|+|.++++... .....+++..+..++.||++||.|+ |+++|+||
T Consensus 75 ~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHr 151 (309)
T d1fvra_ 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 151 (309)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECS
T ss_pred eEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcCCcccc
Confidence 99999999999999999999999999997531 2346799999999999999999999 67899999
Q ss_pred CCCCCCeEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCC-CCc
Q 006739 481 DLKPANVLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRL-PSD 559 (633)
Q Consensus 481 Dikp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~-p~~ 559 (633)
||||+|||++.++.+||+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||.
T Consensus 152 Dlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 152 DLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccccceEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999865443221 23468999999999999999999999999999999999765 554
Q ss_pred ccccccccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhhh
Q 006739 560 DFFQHTEEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQIR 632 (633)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~~ 632 (633)
.. .... .+..+.....+.. +......+.+++.+||+.||++||||+|+++.|+++.
T Consensus 229 ~~----~~~~---~~~~i~~~~~~~~----------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 229 GM----TCAE---LYEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp TC----CHHH---HHHHGGGTCCCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----CHHH---HHHHHHhcCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 32 1222 2233332222211 0111234788999999999999999999999998863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-47 Score=384.05 Aligned_cols=247 Identities=19% Similarity=0.275 Sum_probs=202.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++++.||+|+||.||+|++. .+|+.||||++.+... ......+.+.+|+++++.++|||||++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~-----------~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 108 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKV-----------VKLKQIEHTLNEKRILQAVNFPFLVKLEF 108 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHc-----------cCHHHHHHHHHHHHHHHHcCCCcEeeccc
Confidence 67999999999999999999874 5799999999843211 00112457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+....++||||+.+|+|.+++... ..+++..+..++.||+.||.|| |+.+|+||||||+|||++.++.+|
T Consensus 109 ~~~~~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~ik 181 (350)
T d1rdqe_ 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCEE
T ss_pred ccccccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccCCCCCEE
Confidence 999999999999999999999999763 4599999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRN 576 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 576 (633)
|+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.. ...+ ...
T Consensus 182 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~---~~~ 249 (350)
T d1rdqe_ 182 VTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQI---YEK 249 (350)
T ss_dssp ECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH---HHH
T ss_pred eeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC----HHHH---HHH
Confidence 99999999875432 34679999999999999999999999999999999999999996531 1222 222
Q ss_pred hhccC-CcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCC-----CHHHHHH
Q 006739 577 VMTSE-NPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERP-----NSKDVRC 626 (633)
Q Consensus 577 ~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RP-----s~~ev~~ 626 (633)
+.... .....+ ...+.+++.+||+.||.+|+ |++|+++
T Consensus 250 i~~~~~~~p~~~------------s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 250 IVSGKVRFPSHF------------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHCCCCCCTTC------------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HhcCCCCCCccC------------CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 22211 111111 12377899999999999994 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=379.22 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=203.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.+.||+|+||+||+|... .+|+.||||++.....+ ...+.+|++++++++|||||+++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-~~~~~~AiK~i~~~~~~---------------~~~~~~Ei~il~~l~HpnIv~~~ 67 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVKGTD---------------QVLVKKEISILNIARHRNILHLH 67 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCTHH---------------HHHHHHHHHHHHHSCCTTBCCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEcCCccc---------------HHHHHHHHHHHHhCCCCCCCeEE
Confidence 367999999999999999999864 57899999998654311 34578899999999999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC--C
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD--M 493 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~--~ 493 (633)
+++.+++..|+||||++||+|.+++.. .+..+++.++..++.||++||+|| |+.+|+||||||+|||++.+ .
T Consensus 68 ~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~ 141 (321)
T d1tkia_ 68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeecCCCce
Confidence 999999999999999999999999964 234699999999999999999999 67899999999999999854 4
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKW 573 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 573 (633)
.+||+|||+++........ ....||+.|+|||...+..++.++||||+||++|||++|+.||..... ..+
T Consensus 142 ~ikl~DFG~~~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~----~~~--- 211 (321)
T d1tkia_ 142 TIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----QQI--- 211 (321)
T ss_dssp CEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----HHH---
T ss_pred EEEEcccchhhccccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH----HHH---
Confidence 7999999999887554322 335789999999999999999999999999999999999999975321 222
Q ss_pred HHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 574 MRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 574 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+..+....... +....... ...+.+++.+||+.||++|||++|+++
T Consensus 212 ~~~i~~~~~~~---~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 212 IENIMNAEYTF---DEEAFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTCCCC---CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCC---ChhhccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222221110 11111111 123778999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=377.29 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=199.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhh-cCCCCcccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVG-QIRHRNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~ 415 (633)
++|++.+.||+|+||+||+|+.. .+|+.||||++.+... ......+.+..|..++. .++|||||+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~-----------~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~ 69 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVV-----------LMDDDVECTMVEKRVLSLAWEHPFLTHMF 69 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHH-----------HHTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CCeEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhc-----------cChHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 57999999999999999999875 5799999999853211 00111344556666654 68999999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
+++.+++..|+||||+++|+|.+++.. ...+++.++..++.||+.||+|| |+++|+||||||+|||+++++.+
T Consensus 70 ~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~~ 142 (320)
T d1xjda_ 70 CTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGHI 142 (320)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCE
T ss_pred EEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceeecCCCce
Confidence 999999999999999999999999986 34589999999999999999999 67899999999999999999999
Q ss_pred EEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
||+|||+++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.. ...+.+.+.
T Consensus 143 kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~~~i~ 216 (320)
T d1xjda_ 143 KIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD----EEELFHSIR 216 (320)
T ss_dssp EECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHH
T ss_pred eccccchhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC----HHHHHHHHH
Confidence 99999999876544332 234679999999999999999999999999999999999999997532 222222221
Q ss_pred HhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHH-HHH
Q 006739 576 NVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSK-DVR 625 (633)
Q Consensus 576 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~-ev~ 625 (633)
. .....+..+ ...+.+++.+||+.||++||++. |++
T Consensus 217 ~--~~~~~p~~~------------s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 217 M--DNPFYPRWL------------EKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp H--CCCCCCTTS------------CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred c--CCCCCCccC------------CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 1 111111111 12378899999999999999995 664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=383.00 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=195.6
Q ss_pred hcCccccc-ccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc-CCCCcccc
Q 006739 336 EDGLASLE-KIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ-IRHRNLLP 413 (633)
Q Consensus 336 ~~~~~~~~-~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~ 413 (633)
.++|.+.. .||+|+||.||+|++. .+++.||||++.. ...+.+|+.++.+ .+|||||+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~-------------------~~~~~~E~~~~~~~~~hpnIv~ 69 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIVR 69 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBCC
T ss_pred ccCEEEeeEEeeeccCeEEEEEEEC-CCCCEEEEEEECC-------------------cHHHHHHHHHHHHhcCCCCCCe
Confidence 46788875 5999999999999864 5789999999843 2345678888655 48999999
Q ss_pred cceeeec----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 414 LLAHMAR----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 414 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
+++++.+ ....|+|||||+||+|.+++... ....+++.++..++.||+.||+|| |+.+|+||||||+|||+
T Consensus 70 l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll 144 (335)
T d2ozaa1 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLY 144 (335)
T ss_dssp EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEE
T ss_pred EEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHH---HHcCCcccccccccccc
Confidence 9999865 45679999999999999999752 245799999999999999999999 68899999999999999
Q ss_pred cC---CCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 490 DD---DMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 490 ~~---~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
++ ++.+||+|||+|+........ ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+......
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred ccccccccccccccceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 85 567999999999887654332 346799999999999999999999999999999999999999976432111
Q ss_pred cchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+.......... .... ........+.+++.+||+.||++|||+.|+++
T Consensus 222 ----~~~~~~~i~~~~~~--~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 222 ----SPGMKTRIRMGQYE--FPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----------CCCSCSSS--CCTT----HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHHHHHHhcCCCC--CCCc----ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111111111100 0000 01112234788999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=377.31 Aligned_cols=263 Identities=25% Similarity=0.293 Sum_probs=195.0
Q ss_pred cccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccceeeec
Q 006739 341 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHMAR 420 (633)
Q Consensus 341 ~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 420 (633)
.+++||+|+||+||+|++. .+|+.||||++........ .....+.+.+|+.++++++|||||++++++.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~---------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~ 71 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEA---------KDGINRTALREIKLLQELSHPNIIGLLDAFGH 71 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-SCCSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cceEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhh---------hHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 3578999999999999864 5789999999865432111 01113568899999999999999999999999
Q ss_pred CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceEEccc
Q 006739 421 PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEARIADF 500 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~kl~Df 500 (633)
++..|+||||++++++..+... ...+++..+..++.||+.||+|| |+++|+||||||+|||+++++.+||+||
T Consensus 72 ~~~~~ivmE~~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~DF 144 (299)
T d1ua2a_ 72 KSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLADF 144 (299)
T ss_dssp TTCCEEEEECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCceeehhhhhcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCCccccccC
Confidence 9999999999998877766542 46688999999999999999999 6789999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHHHhhc
Q 006739 501 GLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMRNVMT 579 (633)
Q Consensus 501 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 579 (633)
|+|+........ .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ..+....+.....
T Consensus 145 G~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~----~~~~l~~i~~~~~ 218 (299)
T d1ua2a_ 145 GLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS----DLDQLTRIFETLG 218 (299)
T ss_dssp GGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHHHHHHHHC
T ss_pred ccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC----HHHHHHHHHHhcC
Confidence 999876654322 2345799999999988654 57999999999999999999999986532 2222222222211
Q ss_pred cCCcchhhhhh----------h----hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 580 SENPTRAIDAK----------L----LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 580 ~~~~~~~~d~~----------~----~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
........+.. . .....+.....+.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 11000000000 0 00000111234788999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=373.82 Aligned_cols=266 Identities=24% Similarity=0.329 Sum_probs=198.2
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++++.||+|+||+||+|++. .+|+.||||++....... ....++.+|++++++++|||||++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~------------~~~~~~~~Ei~il~~l~Hp~Iv~~~~ 68 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETE------------GVPSTAIREISLLKELNHPNIVKLLD 68 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------------------CCHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCEeccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcCh------------HHHHHHHHHHHHHHhCCCCcEEEecc
Confidence 58999999999999999999875 578999999985432110 11457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+++..|+||||+.++ +.+++.. .....+++..+..++.||+.||+|| |+++|+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~iv~e~~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~k 142 (298)
T d1gz8a_ 69 VIHTENKLYLVFEFLHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIK 142 (298)
T ss_dssp EEEETTEEEEEEECCSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEE
T ss_pred ccccccceeEEEeecCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeecccCcce
Confidence 999999999999999764 4444432 2245699999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||.|+........ .....||+.|+|||.+.... ++.++|+||+||++|||++|+.||..... ...+.+..+
T Consensus 143 l~DFG~a~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~ 217 (298)
T d1gz8a_ 143 LADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFR 217 (298)
T ss_dssp ECSTTHHHHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred eccCCcceeccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHH
Confidence 9999999887554322 23457999999999877765 57899999999999999999999975321 111212111
Q ss_pred HhhccCC-c-chhh-hhhh-------hhc----CCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSEN-P-TRAI-DAKL-------LEN----GYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~-~-~~~~-d~~~-------~~~----~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....... . .... .+.. ... ........+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1110000 0 0000 0000 000 00111235788999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=369.32 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=194.9
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--CCccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR--HRNLLPL 414 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l 414 (633)
++|++.+.||+|+||.||+|+.. .+|+.||||++.+........... ..++.+|+.++++++ |||||++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~--------~~~~~~E~~il~~l~~~h~nIv~~ 74 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPN--------GTRVPMEVVLLKKVSSGFSGVIRL 74 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTT--------CCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhhhhH--------HHHHHHHHHHHHHhccCCCCccEE
Confidence 57999999999999999999864 578999999986533211110000 224567999999886 8999999
Q ss_pred ceeeecCCccEEEEecccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC-C
Q 006739 415 LAHMARPDCHLLVYEFMKN-GSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD-D 492 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~-~ 492 (633)
++++.+++..++||||+.+ +++.+++.. ...+++..+..++.||++||+|| |+++|+||||||+|||++. +
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 75 LDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNR 147 (273)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEETTT
T ss_pred EEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccceEEecCC
Confidence 9999999999999999976 588888765 34699999999999999999999 6889999999999999985 4
Q ss_pred CceEEcccccccccCCCCCcceecccccCcccccccccccCCC-CCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 493 MEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKF-TDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
+.+||+|||+|+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .
T Consensus 148 ~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~-- 215 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E-- 215 (273)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H--
T ss_pred CeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------H--
Confidence 799999999998765432 234679999999999987765 567899999999999999999986521 1
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
..+ ....... .. ...+.+++.+||+.||++|||++|+++
T Consensus 216 -i~~---~~~~~~~---------~~---s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 -IIR---GQVFFRQ---------RV---SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -HHH---CCCCCSS---------CC---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -Hhh---cccCCCC---------CC---CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111 1111111 11 123778899999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-45 Score=364.65 Aligned_cols=263 Identities=25% Similarity=0.342 Sum_probs=198.4
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|++.++||+|+||+||+|+++ +|+.||||++.....+... .+++.+|+.++++++|||||++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~------------~~~~~~E~~il~~l~hpnIv~~~~ 67 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGI------------PSTTIREISILKELKHSNIVKLYD 67 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCC------------CHHHHHHHHGGGGCCCTTBCCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHH------------HHHHHHHHHHHHhCCCCcEEeeee
Confidence 57999999999999999999875 7899999998665432111 457889999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++..++..+++|||+.++.+..+... ...+++..+..++.||+.||+|| |+.+|+||||||+|||++.++.+|
T Consensus 68 ~~~~~~~~~i~~e~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~k 140 (286)
T d1ob3a_ 68 VIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGELK 140 (286)
T ss_dssp EEECSSCEEEEEECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCEE
T ss_pred ecccCCceeEEEEeehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEcCCCCEE
Confidence 99999999999999988777666543 46799999999999999999999 578999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
++|||.|......... .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.... ..+.+..
T Consensus 141 l~DfG~a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~---~~~~~i~- 214 (286)
T d1ob3a_ 141 IADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIF- 214 (286)
T ss_dssp ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH-
T ss_pred ecccccceecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH---HHHHHHH-
Confidence 9999999887654322 2335689999999998764 5689999999999999999999999754321 1111111
Q ss_pred HhhccCCcchhhhh--------hh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTRAIDA--------KL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~~~d~--------~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
............+. .. .....+.....+.+++.+||+.||++|||++|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111100000000 00 00011111234778999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=374.25 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=195.7
Q ss_pred hhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhc---CCCCcc
Q 006739 335 KEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQ---IRHRNL 411 (633)
Q Consensus 335 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~ni 411 (633)
..++|++++.||+|+||+||+|++...+++.||||++.....+... ..++.+|+.+++. .+||||
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~------------~~~~~~E~~~l~~l~~~~HpnI 72 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------------PLSTIREVAVLRHLETFEHPNV 72 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------------BCTHHHHHHHHHHHHHTCCTTB
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchH------------HHHHHHHHHHHHHHhhcCCCCc
Confidence 3578999999999999999999876556788999998654322111 1234456666555 489999
Q ss_pred cccceeeec-----CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 006739 412 LPLLAHMAR-----PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPAN 486 (633)
Q Consensus 412 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~N 486 (633)
++++++|.. ....+++|||++++++...... ....+++..+..++.|++.||+|| |+++|+||||||+|
T Consensus 73 v~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~N 146 (305)
T d1blxa_ 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQN 146 (305)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGG
T ss_pred ceeeeeecccccccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecCCCccE
Confidence 999999853 3467899999988776554432 356789999999999999999999 67899999999999
Q ss_pred eEecCCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccc
Q 006739 487 VLLDDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTE 566 (633)
Q Consensus 487 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~ 566 (633)
||+++++.+||+|||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.....
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--- 220 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--- 220 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred EEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---
Confidence 999999999999999988654332 22446799999999999999999999999999999999999999975322
Q ss_pred cchHHHHHHHhhccCCcchh----h--hhh-------hhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 567 EMSLVKWMRNVMTSENPTRA----I--DAK-------LLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~----~--d~~-------~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
...+...+ ........... . ... ............+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 221 VDQLGKIL-DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHHHH-HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHH-HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11122211 11111000000 0 000 000011112234778899999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-43 Score=353.70 Aligned_cols=261 Identities=25% Similarity=0.334 Sum_probs=197.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc-
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL- 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~- 415 (633)
+.|++.+.||+|+||.||+|++. .+|+.||||++..... ..++.+|+++++.++|+|++..+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~----------------~~~~~~E~~i~~~l~~~~~i~~~~ 69 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTIR 69 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCTT----------------SCCHHHHHHHHHHSTTSTTCCCEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhcc----------------CHHHHHHHHHHHHccCCCcccEEE
Confidence 56999999999999999999864 5789999998765432 23467899999999887766555
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC---C
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD---D 492 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~---~ 492 (633)
+++.+.+..++||||+ ++++.+.+.. ....+++..+..++.|+++||+|| |+++|+||||||+|||++. +
T Consensus 70 ~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~~ 142 (299)
T d1ckia_ 70 WCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKKG 142 (299)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGGT
T ss_pred EEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhhccccccCCC
Confidence 4556777888999999 5577666653 245799999999999999999999 6789999999999999864 5
Q ss_pred CceEEcccccccccCCCCCc-----ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccccc
Q 006739 493 MEARIADFGLAKAMPDAQTH-----ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE 567 (633)
Q Consensus 493 ~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 567 (633)
..+|++|||+|+...+.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp TCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred ceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 57999999999987654322 1224567999999999999999999999999999999999999999765443332
Q ss_pred chHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 568 MSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
....++........ .+.+....+ ..+.+++..||+.+|++||+++++.+.|+++
T Consensus 223 ~~~~~~~~~~~~~~------~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 223 QKYERISEKKMSTP------IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --HHHHHHHHHHSC------HHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhhcccCCCC------hhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 22222222111110 011111112 3377888899999999999999999988875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=357.51 Aligned_cols=269 Identities=24% Similarity=0.314 Sum_probs=195.9
Q ss_pred hhhcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccc
Q 006739 334 EKEDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLP 413 (633)
Q Consensus 334 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~ 413 (633)
+..++|+++++||+|+||+||+|++. .+|+.||||++........ ..+++.+|++++++++||||++
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~------------~~~~~~~E~~il~~l~h~nii~ 73 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEG------------FPITALREIKILQLLKHENVVN 73 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTS------------SCHHHHHHHHHHHHCCCTTBCC
T ss_pred CccCCEEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchH------------HHHHHHHHHHHHHHhcCCCccc
Confidence 44588999999999999999999874 5899999999865432111 1456789999999999999999
Q ss_pred cceeeec--------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 006739 414 LLAHMAR--------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPA 485 (633)
Q Consensus 414 l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~ 485 (633)
+++++.. ....++||||++++++..+.. ....++...++.++.|+++||+|| |+.+|+||||||+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~ 146 (318)
T d3blha1 74 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAA 146 (318)
T ss_dssp EEEEEEC----------CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGG
T ss_pred eEeeeecccccccccCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHh---ccCCEEecCcCch
Confidence 9998855 345789999998877665443 245689999999999999999999 6889999999999
Q ss_pred CeEecCCCceEEcccccccccCCCCCcc--eecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccc
Q 006739 486 NVLLDDDMEARIADFGLAKAMPDAQTHI--TTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFF 562 (633)
Q Consensus 486 Nill~~~~~~kl~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 562 (633)
|||++.++.+|++|||+++......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 147 NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 147 NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp GEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred heeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence 9999999999999999998776433211 12335799999999998764 68999999999999999999999997532
Q ss_pred cccccchHHHHHHHhhccCCcch--hh-----hhhh-----hhcCCHH------HHHHHHHHHhHhccCCCCCCCCHHHH
Q 006739 563 QHTEEMSLVKWMRNVMTSENPTR--AI-----DAKL-----LENGYEE------QMLLVLKIACFCTVDSPRERPNSKDV 624 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~--~~-----d~~~-----~~~~~~~------~~~~~~~l~~~cl~~dP~~RPs~~ev 624 (633)
. ......+........... .. .... ......+ ....+.+++.+||+.||++|||++|+
T Consensus 227 ~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el 302 (318)
T d3blha1 227 E----QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302 (318)
T ss_dssp H----HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred H----HHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 2 222222222221111000 00 0000 0000000 01246789999999999999999999
Q ss_pred HH
Q 006739 625 RC 626 (633)
Q Consensus 625 ~~ 626 (633)
++
T Consensus 303 L~ 304 (318)
T d3blha1 303 LN 304 (318)
T ss_dssp HH
T ss_pred Hc
Confidence 85
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.8e-43 Score=348.08 Aligned_cols=261 Identities=19% Similarity=0.244 Sum_probs=204.0
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC-Ccccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH-RNLLPLL 415 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~ 415 (633)
++|++.+.||+|+||.||+|++. .+|+.||||++..... ..++++|++.++.++| +|++.++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~~~ 67 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPNVY 67 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCCEE
T ss_pred CceEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEccccC----------------cHHHHHHHHHHHHhcCCCCCCEEE
Confidence 57999999999999999999865 5789999998754321 1245677888888865 8999999
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC----
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD---- 491 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~---- 491 (633)
+++......++||||+ +++|.+++... +..+++.++..++.|++.||+|| |+.+|+||||||+|||++.
T Consensus 68 ~~~~~~~~~~~vme~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~~ 140 (293)
T d1csna_ 68 YFGQEGLHNVLVIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNSK 140 (293)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSST
T ss_pred EEeecCCccEEEEEec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCcccc
Confidence 9999999999999999 78999988752 35699999999999999999999 7899999999999999974
Q ss_pred -CCceEEcccccccccCCCCCc-----ceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCccccccc
Q 006739 492 -DMEARIADFGLAKAMPDAQTH-----ITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHT 565 (633)
Q Consensus 492 -~~~~kl~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 565 (633)
++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred cCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 578999999999987543221 12234679999999999999999999999999999999999999997643322
Q ss_pred ccchHHHHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHHHHHhh
Q 006739 566 EEMSLVKWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRCMLSQI 631 (633)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~~l~~~ 631 (633)
......+ +......... +.+....+ ..+.+++..|++.+|++||+++.+.+.|+++
T Consensus 221 ~~~~~~~-i~~~~~~~~~-----~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 221 NKQKYER-IGEKKQSTPL-----RELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHH-HHHHHHHSCH-----HHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHH-HHhccCCCCh-----HHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 2222211 1111111111 11111222 2377788899999999999999999988775
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=363.95 Aligned_cols=260 Identities=23% Similarity=0.293 Sum_probs=192.8
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
.+|+..++||+|+||+||+|++. .+|+.||||++..... .+.+|++++++++||||+++++
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~------------------~~~~Ei~il~~l~h~niv~~~~ 80 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR------------------FKNRELQIMRKLDHCNIVRLRY 80 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS------------------SCCHHHHHHHHCCCTTBCCEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccch------------------HHHHHHHHHHhcCCCCCCcEEE
Confidence 36888999999999999999875 5799999999865431 2346899999999999999999
Q ss_pred eeecC------CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 417 HMARP------DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 417 ~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+|... ...++||||++++.+.. +.........+++..+..++.||+.||+|| |+++|+||||||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~lv~Ey~~~~~~~~-l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~ 156 (350)
T d1q5ka_ 81 FFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLD 156 (350)
T ss_dssp EEEEC--CCSCCEEEEEEECCSEEHHHH-HHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEEC
T ss_pred EEEecCccCCceEEEEEEeccCCccHHH-HHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEe
Confidence 98543 34689999997654444 433333467799999999999999999999 689999999999999999
Q ss_pred CCC-ceEEcccccccccCCCCCcceecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 491 DDM-EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 491 ~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
.++ .+||+|||+++........ ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ..
T Consensus 157 ~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~ 230 (350)
T d1q5ka_ 157 PDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VD 230 (350)
T ss_dssp TTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HH
T ss_pred cCCCceeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HH
Confidence 775 8999999999887654432 33579999999998765 5789999999999999999999999965322 11
Q ss_pred hHHHHHHHhhccCC---------------cchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSEN---------------PTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~---------------~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+.+..+ ...... ....................+.+++.+||+.||++|||++|+++
T Consensus 231 ~l~~i~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 231 QLVEIIK-VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHH-HHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHH-HhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 111000 00000000000011112234788899999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=356.66 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=192.2
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.|+++++||+|+||+||+|... .+|+.||||++....... ...+++.+|++++++++|||||+++
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~hpniv~l~ 83 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG-RTGAKVAIKKLYRPFQSE------------LFAKRAYRELRLLKHMRHENVIGLL 83 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET-TTCCEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEchhhcCh------------HHHHHHHHHHHHHHhcCCCCeeEEE
Confidence 478999999999999999999864 579999999996543211 1146788999999999999999999
Q ss_pred eeeecCC------ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEe
Q 006739 416 AHMARPD------CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLL 489 (633)
Q Consensus 416 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill 489 (633)
++|...+ ..|+||||+ +.+|..+.+. ..+++..+..++.||+.||+|| |+.+|+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL~ 154 (346)
T d1cm8a_ 84 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLAV 154 (346)
T ss_dssp EEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred EEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHH---HhCCCcccccCcchhhc
Confidence 9997654 469999999 6688887753 4599999999999999999999 67899999999999999
Q ss_pred cCCCceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccc
Q 006739 490 DDDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEM 568 (633)
Q Consensus 490 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 568 (633)
+.++.+|++|||+|+...... +...||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ..
T Consensus 155 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~ 226 (346)
T d1cm8a_ 155 NEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LD 226 (346)
T ss_dssp CTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH
T ss_pred ccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HH
Confidence 999999999999998765432 346799999999998764 568999999999999999999999975321 11
Q ss_pred hHHHHHHHhhccCCcchhhh-----------hhh-------hhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 569 SLVKWMRNVMTSENPTRAID-----------AKL-------LENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~d-----------~~~-------~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.+..... .... .+.+... ..+ ...........+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 227 QLKEIMK-VTGT-PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHH-HHCC-CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHh-ccCC-CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111111 1000 0000000 000 00000111224678999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-43 Score=356.01 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=194.0
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++++.||+|+||+||+|+.. .+|+.||||++.+.... ...+++.+|++++++++||||++++
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~-------------~~~~~~~~Ei~il~~l~hp~iv~~~ 72 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDN-VNKVRVAIKKISPFEHQ-------------TYCQRTLREIKILLRFRHENIIGIN 72 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEET-TTCSEEEEEEECCTTCH-------------HHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEEC-CCCcEEEEEEEehhcCh-------------HHHHHHHHHHHHHHHcCCCCCCcEE
Confidence 457999999999999999999864 57999999998653321 1145788999999999999999999
Q ss_pred eeeecCC----ccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecC
Q 006739 416 AHMARPD----CHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDD 491 (633)
Q Consensus 416 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~ 491 (633)
+++.... ..+++++|+.+|+|.+++.. ..+++..+..++.|+++||+|| |+++|+||||||+|||+++
T Consensus 73 ~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp EEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECT
T ss_pred EEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCcceEEECC
Confidence 9986643 23555667779999999964 3589999999999999999999 6789999999999999999
Q ss_pred CCceEEcccccccccCCCCCcc-eecccccCccccccccccc-CCCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 492 DMEARIADFGLAKAMPDAQTHI-TTSNVAGTVGYIAPEYHQT-LKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 492 ~~~~kl~DfG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
++.+||+|||+|+......... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... +
T Consensus 145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~----~ 220 (345)
T d1pmea_ 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL----D 220 (345)
T ss_dssp TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH----H
T ss_pred CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH----H
Confidence 9999999999998765432221 1234679999999999854 56788999999999999999999999753221 1
Q ss_pred HHHHHHHhhccCCcch---------------------hhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPTR---------------------AIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~~---------------------~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
................ ..-...... ....+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN----ADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111100000 000000001 1124778999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=350.61 Aligned_cols=265 Identities=23% Similarity=0.278 Sum_probs=204.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+++++||+|+||+||+|++. .+++.||||+++....... ...++.+|+.++++++||||+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~------------~~~~~~~E~~il~~l~h~niv~~~~ 68 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEG------------VPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTT------------HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCChH------------HHHHHHHHHHHHHhcCcCCEEeecc
Confidence 57999999999999999999875 5789999999865543211 1567899999999999999999999
Q ss_pred eeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCceE
Q 006739 417 HMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEAR 496 (633)
Q Consensus 417 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~k 496 (633)
++.+....++|+|++.+++|..++.. ...+++..+..++.|+++||+|| |+.+|+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~k 141 (292)
T d1unla_ 69 VLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEECSSEEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEE
T ss_pred ccccccceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccccCCcee
Confidence 99999999999999999999888764 45689999999999999999999 678999999999999999999999
Q ss_pred EcccccccccCCCCCcceecccccCcccccccccccCC-CCCccchHHHHHHHHHHHhCCCCCcccccccccchHHHHHH
Q 006739 497 IADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLK-FTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLVKWMR 575 (633)
Q Consensus 497 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 575 (633)
|+|||.++......... ....++..|+|||.+.+.. ++.++||||+||++|||++|+.||.... ...+....+.
T Consensus 142 l~DFG~a~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~---~~~~~~~~~~ 216 (292)
T d1unla_ 142 LANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIF 216 (292)
T ss_dssp ECCCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS---SHHHHHHHHH
T ss_pred eeecchhhcccCCCccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC---CHHHHHHHHH
Confidence 99999999876543322 2346788999999887665 6899999999999999999999974322 2222222222
Q ss_pred HhhccCCcch---hh---h---------hhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 576 NVMTSENPTR---AI---D---------AKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 576 ~~~~~~~~~~---~~---d---------~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
.......... .. + ..............+.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2211110000 00 0 00000011112234778899999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-43 Score=354.60 Aligned_cols=260 Identities=19% Similarity=0.296 Sum_probs=195.3
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.++|+++++||+|+||+||+|+.. .+|+.||||++.... .+++.+|++++++++ ||||+++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~-----------------~~~~~~Ei~il~~l~~hpnIv~~ 95 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKPVK-----------------KKKIKREIKILENLRGGPNIITL 95 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSSC-----------------HHHHHHHHHHHHHHTTSTTBCCE
T ss_pred CcCeEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEECHHH-----------------HHHHHHHHHHHHhccCCCCCcEE
Confidence 467999999999999999999864 579999999985432 346788999999995 9999999
Q ss_pred ceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCC
Q 006739 415 LAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDD 492 (633)
Q Consensus 415 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~ 492 (633)
++++.. ....++||||+++++|.++. +.+++..+..++.||+.||+|| |+++|+||||||+|||++.+
T Consensus 96 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~~ 165 (328)
T d3bqca1 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHE 165 (328)
T ss_dssp EEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETT
T ss_pred EEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHH---hhcccccccccccceEEcCC
Confidence 999874 45688999999999987653 3489999999999999999999 68899999999999999865
Q ss_pred C-ceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCccccccccc-ch
Q 006739 493 M-EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEE-MS 569 (633)
Q Consensus 493 ~-~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-~~ 569 (633)
+ .+||+|||+|+........ ....||+.|+|||.+.+. .++.++|+||+||++|||++|+.||......... ..
T Consensus 166 ~~~vkl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~ 242 (328)
T d3bqca1 166 HRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242 (328)
T ss_dssp TTEEEECCGGGCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred CCeeeecccccceeccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence 5 6899999999887654332 345789999999998765 4799999999999999999999998653321110 01
Q ss_pred HH---------HHHHHhhccCCcc----------hhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LV---------KWMRNVMTSENPT----------RAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~---------~~~~~~~~~~~~~----------~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
+. .+........... ..................+.+++.+||+.||++|||++|+++
T Consensus 243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1111000000000 000000000011111234788999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=354.68 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=200.2
Q ss_pred cCcccccccccccCeeEEEEEec--CCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCC-Ccccc
Q 006739 337 DGLASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRH-RNLLP 413 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~ 413 (633)
++|++.+.||+|+||+||+|+.. ..+|+.||||++.......... ..+.+.+|++++++++| |||++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~----------~~~~~~~E~~il~~l~h~pnIv~ 93 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK----------TTEHTRTERQVLEHIRQSPFLVT 93 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES----------SGGGCCCHHHHHHHHHTCTTBCC
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH----------HHHHHHHHHHHHHhccCCCeEEE
Confidence 67999999999999999999763 3468999999986543211100 03457889999999976 89999
Q ss_pred cceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCC
Q 006739 414 LLAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDM 493 (633)
Q Consensus 414 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~ 493 (633)
+++++.+....++||||+.+|+|.+++... ..++......++.|++.||+|+ |+.+|+||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 94 LHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSNG 166 (322)
T ss_dssp EEEEEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTS
T ss_pred eeeeeccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCccceeecCCC
Confidence 999999999999999999999999999763 3578889999999999999999 678999999999999999999
Q ss_pred ceEEcccccccccCCCCCcceecccccCcccccccccccC--CCCCccchHHHHHHHHHHHhCCCCCcccccccccchHH
Q 006739 494 EARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL--KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSLV 571 (633)
Q Consensus 494 ~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 571 (633)
.+||+|||+++.+........ ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...........+.
T Consensus 167 ~vkL~DFG~a~~~~~~~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~ 245 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245 (322)
T ss_dssp CEEESCSSEEEECCGGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred CEEEeeccchhhhcccccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999987755433222 345799999999998764 46789999999999999999999997654332222222
Q ss_pred HHHHHhhccCCcchhhhhhhhhcCCHHHHHHHHHHHhHhccCCCCCCCC-----HHHHHH
Q 006739 572 KWMRNVMTSENPTRAIDAKLLENGYEEQMLLVLKIACFCTVDSPRERPN-----SKDVRC 626 (633)
Q Consensus 572 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~l~~~cl~~dP~~RPs-----~~ev~~ 626 (633)
+........ .+......+.+++.+||+.||++||| ++|+++
T Consensus 246 ---~~~~~~~~~-----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 246 ---RRILKSEPP-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---HHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---HhcccCCCC-----------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 211111111 00111234778899999999999995 788865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=350.51 Aligned_cols=261 Identities=24% Similarity=0.316 Sum_probs=188.1
Q ss_pred cCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccce
Q 006739 337 DGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLLA 416 (633)
Q Consensus 337 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~ 416 (633)
++|+++++||+|+||+||+|++. .+|+.||||++....... ....++.+|+.++++++|||||++++
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~-~t~~~vAvK~i~~~~~~~------------~~~~~~~~Ei~il~~l~hpnIv~~~~ 83 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA-VLDRNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIISLLN 83 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET-TTTEEEEEEEEESTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred CCeEEEEEeecCcCeEEEEEEEC-CCCCEEEEEEEChhhcCH------------HHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 57999999999999999999864 579999999997654321 11457889999999999999999999
Q ss_pred eeec------CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 417 HMAR------PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 417 ~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
++.. ....|+||||+.++.+. .+. ..+++..++.++.||+.||+|| |+.+|+||||||+|||++
T Consensus 84 ~f~~~~~~~~~~~~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 84 VFTPQKTLEEFQDVYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp EECSCCSTTTCCEEEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEC
T ss_pred EEecccccccCceeEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHh---hhcccccccCCccccccc
Confidence 9864 35779999999765444 432 3489999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCCcccccccccchH
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMSL 570 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 570 (633)
.++.+|++|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....
T Consensus 154 ~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~ 227 (355)
T d2b1pa1 154 SDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQW 227 (355)
T ss_dssp TTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred cccceeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHH
Confidence 999999999999887654332 2345789999999999999999999999999999999999999864321 1111
Q ss_pred HHHHHHh------------------hccCC-c-----chhhhhhhhhcC---CHHHHHHHHHHHhHhccCCCCCCCCHHH
Q 006739 571 VKWMRNV------------------MTSEN-P-----TRAIDAKLLENG---YEEQMLLVLKIACFCTVDSPRERPNSKD 623 (633)
Q Consensus 571 ~~~~~~~------------------~~~~~-~-----~~~~d~~~~~~~---~~~~~~~~~~l~~~cl~~dP~~RPs~~e 623 (633)
.+.+... ..... . ............ .......+.+++.+||+.||++|||++|
T Consensus 228 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 1111110 00000 0 000111111111 1223446889999999999999999999
Q ss_pred HHH
Q 006739 624 VRC 626 (633)
Q Consensus 624 v~~ 626 (633)
+++
T Consensus 308 lL~ 310 (355)
T d2b1pa1 308 ALQ 310 (355)
T ss_dssp HHT
T ss_pred Hhc
Confidence 974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=347.64 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=193.1
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.++|++.++||+|+||+||+|+.. .+|+.||||++.....+.. ..+++.+|++++++++|||+|+++
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~------------~~~~~~~Ei~il~~l~h~~iv~~~ 83 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSII------------HAKRTYRELRLLKHMKHENVIGLL 83 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET-TTTEEEEEEECSCTTSSHH------------HHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEECchhcChH------------HHHHHHHHHHHHHhcCCCCeeeEE
Confidence 467999999999999999999864 5899999999875543211 145688999999999999999999
Q ss_pred eeeecC-----CccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEec
Q 006739 416 AHMARP-----DCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLD 490 (633)
Q Consensus 416 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~ 490 (633)
+++... ...+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|| |+++|+||||||+|||++
T Consensus 84 ~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi~ 155 (348)
T d2gfsa1 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAVN 155 (348)
T ss_dssp EEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEC
T ss_pred EEEeeccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHH---HhCCCcccccCCcccccc
Confidence 998643 344677788889999999853 4699999999999999999999 678999999999999999
Q ss_pred CCCceEEcccccccccCCCCCcceecccccCcccccccccccC-CCCCccchHHHHHHHHHHHhCCCCCcccccccccch
Q 006739 491 DDMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTL-KFTDKCDIYSFGVLLAVLVMGRLPSDDFFQHTEEMS 569 (633)
Q Consensus 491 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 569 (633)
.++.+|++|||.+...... .....||+.|+|||...+. .++.++||||+||++|+|++|+.||..... ..
T Consensus 156 ~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~----~~ 226 (348)
T d2gfsa1 156 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----ID 226 (348)
T ss_dssp TTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----HH
T ss_pred ccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH----HH
Confidence 9999999999998765432 2345789999999987665 468899999999999999999999965321 11
Q ss_pred HHHHHHHhhccCCcc-------hhhhh---hhh---h----cCCHHHHHHHHHHHhHhccCCCCCCCCHHHHHH
Q 006739 570 LVKWMRNVMTSENPT-------RAIDA---KLL---E----NGYEEQMLLVLKIACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 570 ~~~~~~~~~~~~~~~-------~~~d~---~~~---~----~~~~~~~~~~~~l~~~cl~~dP~~RPs~~ev~~ 626 (633)
....+.......... ..... ... . .........+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 111111111110000 00000 000 0 000011234778999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-37 Score=318.21 Aligned_cols=263 Identities=21% Similarity=0.236 Sum_probs=187.3
Q ss_pred CcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC----------
Q 006739 338 GLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR---------- 407 (633)
Q Consensus 338 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---------- 407 (633)
+|+++++||+|+||+||+|+.. .+|+.||||++++... ..+.+.+|+++++.++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~-~~g~~vAvKvi~~~~~---------------~~~~~~~Ei~~l~~l~~~~~~~~~~~ 77 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGDKV---------------YTEAAEDEIKLLQRVNDADNTKEDSM 77 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSCHH---------------HHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred cEEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEecccc---------------chHHHHHHHHHHHHhcchhhhhhhhc
Confidence 5999999999999999999864 5899999999864321 0234566776666654
Q ss_pred -CCcccccceeeec--CCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 006739 408 -HRNLLPLLAHMAR--PDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKP 484 (633)
Q Consensus 408 -h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp 484 (633)
|+||+++++++.. ....+++++++..+........ ......+++..+..++.||+.||+||| +..+|+||||||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlKp 154 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKP 154 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSG
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHh--hhcCcccccCCh
Confidence 6789999998854 3455666776655543333222 223567899999999999999999996 457999999999
Q ss_pred CCeEecCCCc------eEEcccccccccCCCCCcceecccccCcccccccccccCCCCCccchHHHHHHHHHHHhCCCCC
Q 006739 485 ANVLLDDDME------ARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVLLAVLVMGRLPS 558 (633)
Q Consensus 485 ~Nill~~~~~------~kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 558 (633)
+|||++.++. ++++|||.+....... ....||+.|+|||++....++.++|+||+||+++||++|+.||
T Consensus 155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 155 ENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred hHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 9999986653 8999999998654432 3457999999999999999999999999999999999999999
Q ss_pred ccccccccc---chHHHHHHHhhccCCcchhh---------------------------hhh--hhhcCCHHHHHHHHHH
Q 006739 559 DDFFQHTEE---MSLVKWMRNVMTSENPTRAI---------------------------DAK--LLENGYEEQMLLVLKI 606 (633)
Q Consensus 559 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~---------------------------d~~--~~~~~~~~~~~~~~~l 606 (633)
......... ..+...+.. .+. .+.... ... ............+.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-lg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIEL-LGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp ---------CHHHHHHHHHHH-HCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCccccccchhHHHHHHHHH-hCC-CCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 754322111 111111111 110 000000 000 0112345566779999
Q ss_pred HhHhccCCCCCCCCHHHHHH
Q 006739 607 ACFCTVDSPRERPNSKDVRC 626 (633)
Q Consensus 607 ~~~cl~~dP~~RPs~~ev~~ 626 (633)
+.+||+.||++|||++|+++
T Consensus 308 l~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999976
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.92 E-value=1.1e-25 Score=225.98 Aligned_cols=180 Identities=29% Similarity=0.461 Sum_probs=160.7
Q ss_pred CChhHHHHHHHHHHhcCCCC---CCC-CCCCC--CCCceeeCCCCCCCCcceeeeEEEEecCCCCccc--CCccccCCcc
Q 006739 28 LDRSDYKALSVILRDLGGQQ---LFI-PSDPC--STPGVFCERRLSDNNTYVLKITKLVFVPRELTGV--LSPSIGRLSE 99 (633)
Q Consensus 28 ~~~~~~~~l~~~~~~~~~~~---~w~-~~~~C--~~~gv~c~~~~~~~~~~~~~~~~L~l~~n~l~~~--~~~~~~~l~~ 99 (633)
|.++|++||++||+.+.++. .|. ..||| .|.||+|+.... ..+|+.|+|++|+++|. +|+.+++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~-----~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ-----TYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSS-----CCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCC-----cEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 89999999999999998743 374 55999 499999986422 23899999999999984 7899999999
Q ss_pred ccEEEccC-CCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCc
Q 006739 100 LRELSLAN-NSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLA 177 (633)
Q Consensus 100 L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~ 177 (633)
|++|+|++ |+++|.+|.+|++|++|++|+|++|+|++..|..+..+.+|+.+++++|++.+.. ..+..+++|+.++++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 99999996 8999999999999999999999999999999999999999999999999988766 679999999999999
Q ss_pred CCcCCccCCcccccCCCC-CeeccCCCCCCCCCccc
Q 006739 178 KNLFTGKVPTSIRTFRNL-QFFDFSGNSLLEGPIPV 212 (633)
Q Consensus 178 ~N~l~~~~p~~~~~~~~L-~~l~l~~N~l~~~~~~~ 212 (633)
+|.++|.+|..+..+.++ +.+++++|+++..++..
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~ 193 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG
T ss_pred cccccccccccccccccccccccccccccccccccc
Confidence 999999999999998887 89999999997665543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.9e-23 Score=193.02 Aligned_cols=176 Identities=15% Similarity=0.139 Sum_probs=121.5
Q ss_pred ccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhH----HHHHHHHHHHHHHHHHHHHhhcCCCCcccccc
Q 006739 340 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTE----EDSKLLNKKMRQIRSEINTVGQIRHRNLLPLL 415 (633)
Q Consensus 340 ~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 415 (633)
.+.++||+|+||.||+|+.. +|+.||||+++........... ............+.+|+..+.++.|.+++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46789999999999999874 7899999987643221111000 00011122245567889999999999999887
Q ss_pred eeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCeEecCCCce
Q 006739 416 AHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHISHNPRIIHRDLKPANVLLDDDMEA 495 (633)
Q Consensus 416 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~h~~~ivH~Dikp~Nill~~~~~~ 495 (633)
++. ..+++|||+++..+.+ ++......++.|++++++|| |+.+|+||||||+|||++++ .+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETT-EE
T ss_pred Eec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCC-CE
Confidence 653 2479999998755432 33344568999999999999 67899999999999999975 58
Q ss_pred EEcccccccccCCCCCcceecccccCcccccc------cccccCCCCCccchHHHHHH
Q 006739 496 RIADFGLAKAMPDAQTHITTSNVAGTVGYIAP------EYHQTLKFTDKCDIYSFGVL 547 (633)
Q Consensus 496 kl~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~s~G~~ 547 (633)
+|+|||.|......... .|... +.+ ..+|+.++|+||..--
T Consensus 142 ~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp EECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred EEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99999999765432211 11111 111 3467889999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=2.4e-18 Score=158.46 Aligned_cols=152 Identities=23% Similarity=0.282 Sum_probs=97.8
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccC-CccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccC
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVL-SPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN 131 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 131 (633)
|++..|.|....-... ..+.+++.|+|++|.|++.+ +..|.++++|+.|+|++|.+++..+..|..+++|++|+|++
T Consensus 8 C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 6677788876321111 12346777777777776644 44567777777777777777777777777777777777777
Q ss_pred ccCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCC
Q 006739 132 NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
|+|++..|..|.++++|++|+|++|+|++++ ..|..+++|++|+|++|.+.......+ -...++.+.+..|.+.+
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c 163 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARC 163 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBB
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEe
Confidence 7777666666777777777777777777766 456777777777777777764322111 11224444555555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=8.4e-18 Score=154.74 Aligned_cols=131 Identities=20% Similarity=0.218 Sum_probs=117.4
Q ss_pred eEEEEecCCCCcccCCccccCCccccEEEccCCCCCCC-CchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 76 ITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDL-LPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 76 ~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.+.++.++++++. +|..+. +++++|+|++|+|++. .+..|.++++|+.|+|++|++++..+..|..+++|+.|+|+
T Consensus 10 ~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 4578999999996 455552 6899999999999874 46678999999999999999998899999999999999999
Q ss_pred CCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 155 GNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 155 ~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|+|+..+ ..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++.+..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 99999987 57899999999999999999888889999999999999999997654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=3.9e-17 Score=158.59 Aligned_cols=172 Identities=22% Similarity=0.181 Sum_probs=136.7
Q ss_pred ceeeCCCC-CCCC-cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCC
Q 006739 59 GVFCERRL-SDNN-TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSG 136 (633)
Q Consensus 59 gv~c~~~~-~~~~-~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 136 (633)
-|.|.+.. ...+ ..+.+++.|+|++|+|+++.+..|.++++|++|+|++|+|+. +| .+..+++|++|+|++|+++
T Consensus 14 ~v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~- 90 (266)
T d1p9ag_ 14 EVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ- 90 (266)
T ss_dssp EEECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-
T ss_pred EEEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-
Confidence 37886632 2211 234579999999999999888899999999999999999987 55 4688999999999999999
Q ss_pred CCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccccc
Q 006739 137 TIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRR 215 (633)
Q Consensus 137 ~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 215 (633)
.++..+.++++|+.|++++|.+.+.. ..+..+.+|+.|++++|.+++..+..+..+++|+.+++++|+|+.+++.
T Consensus 91 ~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~---- 166 (266)
T d1p9ag_ 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG---- 166 (266)
T ss_dssp SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT----
T ss_pred ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc----
Confidence 67888999999999999999998876 5677888899999999998876677778888899999999988776653
Q ss_pred cCCCCccccccccccccccCCCCCCC
Q 006739 216 VGPSGFQYPKRYVLAETTTNGRSNGP 241 (633)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~p 241 (633)
.|..+.++..+....|.....|
T Consensus 167 ----~~~~l~~L~~L~Ls~N~L~~lp 188 (266)
T d1p9ag_ 167 ----LLNGLENLDTLLLQENSLYTIP 188 (266)
T ss_dssp ----TTTTCTTCCEEECCSSCCCCCC
T ss_pred ----ccccccccceeecccCCCcccC
Confidence 3344556666666666655433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.71 E-value=4.3e-18 Score=169.90 Aligned_cols=137 Identities=28% Similarity=0.423 Sum_probs=106.6
Q ss_pred CcceeeeEEEEecC-CCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCC
Q 006739 70 NTYVLKITKLVFVP-RELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRL 148 (633)
Q Consensus 70 ~~~~~~~~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 148 (633)
.....++++|+|++ |+++|.+|+.|++|++|++|+|++|+|++..|..+..+.+|+.+++++|++.+.+|..+.++++|
T Consensus 72 l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L 151 (313)
T d1ogqa_ 72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151 (313)
T ss_dssp GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred HhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccc
Confidence 33456899999987 89999999999999999999999999888766666666666666666666666666666666666
Q ss_pred CEEEccCCcCCC--------------------------------------------------------------------
Q 006739 149 RVLDLSGNSFSG-------------------------------------------------------------------- 160 (633)
Q Consensus 149 ~~L~l~~N~l~~-------------------------------------------------------------------- 160 (633)
+.+++++|.+++
T Consensus 152 ~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~ 231 (313)
T d1ogqa_ 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231 (313)
T ss_dssp CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred ceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 655555554432
Q ss_pred ----CCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCC
Q 006739 161 ----NLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 161 ----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
.++.+..+++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+
T Consensus 232 ~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~ 281 (313)
T d1ogqa_ 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp EECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred cccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccc
Confidence 2234556788999999999999999999999999999999999996
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.68 E-value=1.2e-16 Score=158.66 Aligned_cols=174 Identities=20% Similarity=0.229 Sum_probs=127.7
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCc
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNN 132 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 132 (633)
|.|.+|.|.+..-... ..+.+++.|+|++|+|+.+.+.+|.++++|+.|++++|.++...|..|.++++|+.|+|++|
T Consensus 10 c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred ecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 7899999987422211 23458999999999999988788999999999999999999988889999999999999999
Q ss_pred cCCCCCc------------------------------------------------ccccCCCCCCEEEccCCcCCC----
Q 006739 133 QFSGTIP------------------------------------------------SDLSSLIRLRVLDLSGNSFSG---- 160 (633)
Q Consensus 133 ~l~~~~p------------------------------------------------~~~~~l~~L~~L~l~~N~l~~---- 160 (633)
+|+ .+| ..+..+++|+.+++++|.++.
T Consensus 90 ~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~ 168 (305)
T d1xkua_ 90 QLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQG 168 (305)
T ss_dssp CCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSS
T ss_pred ccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcc
Confidence 987 333 122334555555555555433
Q ss_pred -----------------CC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccccccCCCCcc
Q 006739 161 -----------------NL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVMRRVGPSGFQ 222 (633)
Q Consensus 161 -----------------~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~ 222 (633)
.+ ..+..++.++.|++++|.+++..+..+..+++|++|+|++|+|+.+|.. +.
T Consensus 169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~---------l~ 239 (305)
T d1xkua_ 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGG---------LA 239 (305)
T ss_dssp CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTT---------TT
T ss_pred cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccc---------cc
Confidence 22 3456677888888888888877778888888888888888888776532 23
Q ss_pred ccccccccccccCCCC
Q 006739 223 YPKRYVLAETTTNGRS 238 (633)
Q Consensus 223 ~~~~~~~~~~~~~~~~ 238 (633)
.+.++..+....|...
T Consensus 240 ~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 240 DHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TCSSCCEEECCSSCCC
T ss_pred cccCCCEEECCCCccC
Confidence 3344555555555443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.6e-16 Score=154.15 Aligned_cols=138 Identities=30% Similarity=0.324 Sum_probs=119.1
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|+|+.+ +.++.+++|+.|+|++|++++ .+..+.++++|++|++++|.+.+..+..+..+.+|+.|+
T Consensus 54 l~~L~~L~L~~N~l~~l--~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~ 130 (266)
T d1p9ag_ 54 YTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130 (266)
T ss_dssp CTTCCEEECTTSCCCEE--ECCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred ccccccccccccccccc--ccccccccccccccccccccc-cccccccccccccccccccccceeecccccccccccccc
Confidence 34799999999999865 246789999999999999987 677889999999999999999977778888899999999
Q ss_pred ccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcccc
Q 006739 153 LSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIPVM 213 (633)
Q Consensus 153 l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~~~ 213 (633)
+++|.++..+ ..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+.+|...+
T Consensus 131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~ 192 (266)
T d1p9ag_ 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFF 192 (266)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHC
Confidence 9999999887 556788999999999999998777888899999999999999988876544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=6.5e-16 Score=151.46 Aligned_cols=151 Identities=20% Similarity=0.235 Sum_probs=94.3
Q ss_pred ceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEcc-CccCC
Q 006739 59 GVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQ-NNQFS 135 (633)
Q Consensus 59 gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~ 135 (633)
-|.|.+...... ..+..+++|+|++|+|+++.+.+|.++++|++|++++|+|..+.+..+..++.++.++.+ .|.++
T Consensus 15 ~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~ 94 (284)
T d1ozna_ 15 TTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94 (284)
T ss_dssp EEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred EEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccc
Confidence 477776322221 234578999999999999888899999999999999999877655555555555555443 34444
Q ss_pred CCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 136 GTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 136 ~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
...|..|.++++|+.|+|++|.+.... ..+..+++|+.+++++|+|++..+..|..+++|+.|++++|++..++
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~ 169 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccc
Confidence 344455555555555555555555443 33445555555555555555444445555555555555555554443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=3.2e-16 Score=132.30 Aligned_cols=116 Identities=23% Similarity=0.324 Sum_probs=72.5
Q ss_pred EEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCc
Q 006739 78 KLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNS 157 (633)
Q Consensus 78 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 157 (633)
.|+|++|+++.. + .+.++++|++|+|++|+|+. +|..|..+++|+.|++++|+|+ .+| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCCC-c-ccccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 466777777643 2 36667777777777777765 5666677777777777777776 444 36667777777777777
Q ss_pred CCCCC--ccCCCCCCCCeEeCcCCcCCcc---CCcccccCCCCCee
Q 006739 158 FSGNL--GFLKYFPNLEHLSLAKNLFTGK---VPTSIRTFRNLQFF 198 (633)
Q Consensus 158 l~~~~--~~~~~l~~L~~L~l~~N~l~~~---~p~~~~~~~~L~~l 198 (633)
|+..+ ..+..+++|+.|++++|.+++. ....+..+++|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 76554 3456666777777777766532 11223335555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.65 E-value=3e-16 Score=132.50 Aligned_cols=105 Identities=25% Similarity=0.346 Sum_probs=93.7
Q ss_pred cEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCc
Q 006739 101 RELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNL 180 (633)
Q Consensus 101 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~ 180 (633)
+.|+|++|+|+. ++ .+..+++|++|||++|+|+ .+|..++.+++|+.|++++|.|++.+ .+..+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccccC-ccccccccCeEECCCCc
Confidence 579999999987 55 5899999999999999999 78889999999999999999999875 58899999999999999
Q ss_pred CCccC-CcccccCCCCCeeccCCCCCCCCC
Q 006739 181 FTGKV-PTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 181 l~~~~-p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|+... ...+..+++|+.|++++|++...+
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 99543 256899999999999999997654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=4.3e-16 Score=152.81 Aligned_cols=132 Identities=20% Similarity=0.203 Sum_probs=66.2
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+++.|++++|.+....+..+..+.+|+.+++++|+|+++.+..|..+++|+.|+|++|+|++..+..|.++++|+.|+++
T Consensus 106 ~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~ 185 (284)
T d1ozna_ 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185 (284)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred cCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhh
Confidence 44555555555544444444445555555555555554434444455555555555555554444445555555555555
Q ss_pred CCcCCCCC-ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCC
Q 006739 155 GNSFSGNL-GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLL 206 (633)
Q Consensus 155 ~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~ 206 (633)
+|++++.. ..|..+++|++|++++|++++..|..|..+++|++|+|++|++.
T Consensus 186 ~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred hccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 55554443 34445555555555555555444444555555555555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=6.8e-16 Score=136.97 Aligned_cols=121 Identities=18% Similarity=0.158 Sum_probs=83.4
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+++.|+|++|+|+.+ +..+..+++|+.|||++|+|+. ++ .|..+++|++|+|++|+++...+..+..+++|+.|+|+
T Consensus 19 ~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 567777777777664 4455667777777777777776 33 46777777777777777774434445567777777777
Q ss_pred CCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCCc----ccccCCCCCeec
Q 006739 155 GNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPT----SIRTFRNLQFFD 199 (633)
Q Consensus 155 ~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~~~~L~~l~ 199 (633)
+|+|+... ..+..+++|++|++++|.++ ..|. .+..+++|++||
T Consensus 96 ~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 96 NNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp SCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred cccccccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 77777654 45667777777777777776 3442 356677777776
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=1.2e-15 Score=135.47 Aligned_cols=114 Identities=15% Similarity=0.209 Sum_probs=100.1
Q ss_pred ccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCcc-CCCCCC
Q 006739 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGF-LKYFPN 170 (633)
Q Consensus 92 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~ 170 (633)
+.+.++..|++|+|++|+|+. +|..+..+++|+.|||++|+|+ .++ .|..+++|++|+|++|+++..++. +..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 357788899999999999988 5777788999999999999999 564 589999999999999999988754 567999
Q ss_pred CCeEeCcCCcCCccCC--cccccCCCCCeeccCCCCCCCCC
Q 006739 171 LEHLSLAKNLFTGKVP--TSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 171 L~~L~l~~N~l~~~~p--~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|+.|++++|+|+. ++ ..+..+++|+.|++++|++...|
T Consensus 89 L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~ 128 (162)
T d1a9na_ 89 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKK 128 (162)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGST
T ss_pred cccceeccccccc-cccccccccccccchhhcCCCcccccc
Confidence 9999999999984 44 46889999999999999997765
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.54 E-value=2.1e-14 Score=132.38 Aligned_cols=127 Identities=25% Similarity=0.392 Sum_probs=81.8
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEc
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDL 153 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 153 (633)
.+++.|++++|++++..+ +.++++|+.|++++|.+.. ++ .+.++++|+.|++++|.+.. + ..+..+++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccccccccccc-c-cccchhhhhHHhhh
Confidence 466677777777666432 6666777777777776655 33 36666777777777766663 2 23566677777777
Q ss_pred cCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 154 SGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 154 ~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
++|++... +.+..+++|+.|++++|++++. + .++++++|+.|++++|+++.++
T Consensus 136 ~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~i~ 188 (199)
T d2omxa2 136 SSNTISDI-SALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSDIS 188 (199)
T ss_dssp CSSCCCCC-GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG
T ss_pred hhhhhccc-ccccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCCCc
Confidence 77776644 3456667777777777777642 2 3666777777777777776543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.51 E-value=4.5e-14 Score=131.31 Aligned_cols=128 Identities=28% Similarity=0.360 Sum_probs=94.8
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|++++|++++.. .++++++|+.|++++|+|++ +| .+.++++|+.|++++|.+. .++ .+..+++|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccccccccccc-ccc-cccccccccccc
Confidence 446778888888877743 36777788888888888876 44 5777788888888888776 333 567777888888
Q ss_pred ccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 153 LSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 153 l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+++|.+++.. .+..+++|+.+++++|++++ ++ .+.++++|+.|+|++|+|++++
T Consensus 141 ~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~l~ 194 (210)
T d1h6ta2 141 LGNNKITDIT-VLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISDLR 194 (210)
T ss_dssp CCSSCCCCCG-GGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCBCG
T ss_pred cccccccccc-cccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCCCh
Confidence 8888877543 45667888888888888885 33 3778888888888888887654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.50 E-value=1.1e-13 Score=127.33 Aligned_cols=126 Identities=26% Similarity=0.388 Sum_probs=110.7
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+++.|++++|+++.. +.+..+++|++|+|++|+|++. +. +.++++|++|++++|.+. .++ .+.++++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCCc--cccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence 789999999999875 4588999999999999999984 43 999999999999999998 565 48899999999999
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|.+.... .+..+++|+.|++++|++. .++ .+..+++|+.|++++|+++.++
T Consensus 115 ~~~~~~~~-~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~ 166 (199)
T d2omxa2 115 NNQITDID-PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK 166 (199)
T ss_dssp SSCCCCCG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG
T ss_pred cccccccc-ccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCCc
Confidence 99988654 5778999999999999998 344 6889999999999999998764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.47 E-value=1.1e-13 Score=136.69 Aligned_cols=130 Identities=17% Similarity=0.165 Sum_probs=76.5
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
.++.+++++|+++.. |..+ +++|+.|++++|.+++..+..|.+++.+++|++++|.+++..+..+.++++|++|+|+
T Consensus 151 ~L~~l~l~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~ 227 (305)
T d1xkua_ 151 KLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227 (305)
T ss_dssp TCCEEECCSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred ccCccccccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence 455666666665542 2222 4556666666666666556666666666666666666665555566666666666666
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcc------cccCCCCCeeccCCCCCCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTS------IRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~------~~~~~~L~~l~l~~N~l~~ 207 (633)
+|+|+..+..+..+++|++|+|++|+|+..-... +..+.+|+.|+|++|++..
T Consensus 228 ~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 228 NNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp SSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred cccccccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 6666666555666666666666666666321111 2334556666666666643
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.45 E-value=4.3e-13 Score=124.51 Aligned_cols=126 Identities=25% Similarity=0.348 Sum_probs=110.4
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
+++.|++++|+++... .+..+++|++|+|++|+|++ ++ .+..+++|++|++++|+|+ .+| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 6899999999998753 48899999999999999998 44 4789999999999999999 566 58899999999999
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
+|.+... +.+..+++|+.+++++|.+++ +..+..+++|+.+++++|++..++
T Consensus 121 ~~~~~~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~ 172 (210)
T d1h6ta2 121 HNGISDI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV 172 (210)
T ss_dssp TSCCCCC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG
T ss_pred ccccccc-ccccccccccccccccccccc--cccccccccccccccccccccccc
Confidence 9998754 457889999999999999984 345788999999999999997654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.42 E-value=5.3e-13 Score=125.62 Aligned_cols=128 Identities=20% Similarity=0.337 Sum_probs=67.2
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCc---------------
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIP--------------- 139 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------------- 139 (633)
+++.|++++|.+++..+ +..+++|+.|++++|.++. ++ .+..+++|+.|++++|.+.+..+
T Consensus 64 ~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~ 139 (227)
T d1h6ua2 64 NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139 (227)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSS
T ss_pred CCcEeecCCceeecccc--ccccccccccccccccccc-cc-cccccccccccccccccccccchhccccchhhhhchhh
Confidence 56666666666655432 5556666666666666554 22 45556666666666555542211
Q ss_pred -----ccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 140 -----SDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 140 -----~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
..+.++++|+.|++++|.+++.. .+.++++|+.|+|++|++++ ++ .+..+++|++|+|++|++++++
T Consensus 140 ~~~~~~~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~ 211 (227)
T d1h6ua2 140 QITNISPLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS 211 (227)
T ss_dssp CCCCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG
T ss_pred hhchhhhhccccccccccccccccccch-hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc
Confidence 11233444555555555554332 24555566666666665553 22 2555556666666666555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=4e-13 Score=117.98 Aligned_cols=104 Identities=19% Similarity=0.095 Sum_probs=64.7
Q ss_pred EEEecCCCCcccCCccccCCccccEEEccCC-CCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCC
Q 006739 78 KLVFVPRELTGVLSPSIGRLSELRELSLANN-SLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGN 156 (633)
Q Consensus 78 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (633)
.++.++++++. .|..+..+++|++|+|++| .|+.+-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 35666666654 3445666667777777544 466655556677777777777777777555666666777777777777
Q ss_pred cCCCCCccCCCCCCCCeEeCcCCcCC
Q 006739 157 SFSGNLGFLKYFPNLEHLSLAKNLFT 182 (633)
Q Consensus 157 ~l~~~~~~~~~l~~L~~L~l~~N~l~ 182 (633)
+|+..+.......+|+.|+|++|.|.
T Consensus 91 ~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 91 ALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCcccChhhhccccccccccCCCccc
Confidence 76665533333335666666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=5.9e-13 Score=126.66 Aligned_cols=157 Identities=13% Similarity=0.140 Sum_probs=117.6
Q ss_pred CCCCceeeCCCCCCCC--cceeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCC-chhccCCCCCcEEEccC
Q 006739 55 CSTPGVFCERRLSDNN--TYVLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLL-PPQIVDCKKLEILNVQN 131 (633)
Q Consensus 55 C~~~gv~c~~~~~~~~--~~~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~Ls~ 131 (633)
|+...|.|....-... ..+.++++|++++|.|+.+.+..|.++++|++|+|++|.+...+ +..|.++++++.|++.+
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 6777899986421211 22457999999999999877778999999999999999998744 45789999999998864
Q ss_pred -ccCCCCCcccccCCCCCCEEEccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCCcccccCC-CCCeeccCCCCCCC
Q 006739 132 -NQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFR-NLQFFDFSGNSLLE 207 (633)
Q Consensus 132 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~-~L~~l~l~~N~l~~ 207 (633)
|++....+..|.++++|+.|++++|+++..+ ..+..+..|..+..+++.+....+..|..++ .++.|++++|++..
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 7888778888999999999999999998654 2344455566666666666654455555443 56677777777766
Q ss_pred CCcc
Q 006739 208 GPIP 211 (633)
Q Consensus 208 ~~~~ 211 (633)
++..
T Consensus 168 i~~~ 171 (242)
T d1xwdc1 168 IHNC 171 (242)
T ss_dssp ECTT
T ss_pred cccc
Confidence 5543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=5.2e-13 Score=117.18 Aligned_cols=108 Identities=20% Similarity=0.194 Sum_probs=79.4
Q ss_pred ccccEEEccCCCCCCCCchhccCCCCCcEEEccCc-cCCCCCcccccCCCCCCEEEccCCcCCCCC-ccCCCCCCCCeEe
Q 006739 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNN-QFSGTIPSDLSSLIRLRVLDLSGNSFSGNL-GFLKYFPNLEHLS 175 (633)
Q Consensus 98 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~ 175 (633)
...+.++++++.+.. .|..+..+++|+.|+|++| .|+..-+..|.++++|+.|+|++|+|+.+. ..|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 345567888888776 6777888888888888765 477555566888888888888888888775 5677888888888
Q ss_pred CcCCcCCccCCcccccCCCCCeeccCCCCCCC
Q 006739 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 176 l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~ 207 (633)
|++|+|+ .+|.......+|+.|+|++|++.+
T Consensus 87 Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 87 LSFNALE-SLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp CCSSCCS-CCCSTTTCSCCCCEEECCSSCCCC
T ss_pred ccCCCCc-ccChhhhccccccccccCCCcccC
Confidence 8888888 444443334468888888888754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=4.9e-13 Score=136.45 Aligned_cols=130 Identities=25% Similarity=0.321 Sum_probs=99.0
Q ss_pred eeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCC---------------
Q 006739 74 LKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTI--------------- 138 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--------------- 138 (633)
.+++.|++++|.++.. +.+..+++|+.|++++|.+++. + .+..+++|+.|++++|++++..
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~-~-~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~ 294 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL-A-PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCS
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCC-C-cccccccCCEeeccCcccCCCCccccccccccccccc
Confidence 3567777777777653 3566677777777777777763 2 2666777777777777666322
Q ss_pred -----cccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 139 -----PSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 139 -----p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
...+..+++++.|++++|++++.+ .+..+++|+.|++++|+|++ ++ .+..+++|++|++++|+|+.+++
T Consensus 295 n~l~~~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 295 NQLEDISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp SCCSCCGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred cccccccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 134667789999999999999875 47889999999999999984 54 68999999999999999987753
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.35 E-value=5e-15 Score=136.07 Aligned_cols=111 Identities=20% Similarity=0.253 Sum_probs=64.0
Q ss_pred ccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCC
Q 006739 92 PSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNL 171 (633)
Q Consensus 92 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L 171 (633)
.++..|++|++|+|++|+|+. ++ .|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++.. +.+..+++|
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L 117 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNL 117 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHS
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccc
Confidence 345566666666666666655 33 3556666666666666665 4554444445566666666666543 234455666
Q ss_pred CeEeCcCCcCCccCC--cccccCCCCCeeccCCCCCCC
Q 006739 172 EHLSLAKNLFTGKVP--TSIRTFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 172 ~~L~l~~N~l~~~~p--~~~~~~~~L~~l~l~~N~l~~ 207 (633)
+.|++++|+|+. ++ ..+..+++|+.|+|++|++..
T Consensus 118 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 118 RVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccchhcc-ccccccccCCCccceeecCCCcccc
Confidence 666666666653 22 345566666666666666543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.34 E-value=1.8e-12 Score=132.24 Aligned_cols=148 Identities=24% Similarity=0.298 Sum_probs=116.2
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..++..+++++|.+++..| +..+++|+.|++++|+++. +| .+..+++|+.|++++|.+++.. .+..+++|+.|+
T Consensus 196 l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~ 269 (384)
T d2omza2 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELK 269 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred ccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-cc-hhhcccccchhccccCccCCCC--cccccccCCEee
Confidence 3468899999999998754 5667899999999999987 44 6889999999999999999543 378899999999
Q ss_pred ccCCcCCCCC---------------------ccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCCCCCCCCCcc
Q 006739 153 LSGNSFSGNL---------------------GFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPIP 211 (633)
Q Consensus 153 l~~N~l~~~~---------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~~ 211 (633)
+++|.+++.+ ..+..+++++.|++++|+|++.. .+..+++|+.|++++|+|+.++.
T Consensus 270 l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~~- 346 (384)
T d2omza2 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVSS- 346 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCGG-
T ss_pred ccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCChh-
Confidence 9999887643 12456789999999999999654 38889999999999999976541
Q ss_pred cccccCCCCccccccccccccccCCCC
Q 006739 212 VMRRVGPSGFQYPKRYVLAETTTNGRS 238 (633)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (633)
+..+.++..+....|...
T Consensus 347 ---------l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 347 ---------LANLTNINWLSAGHNQIS 364 (384)
T ss_dssp ---------GGGCTTCCEEECCSSCCC
T ss_pred ---------HcCCCCCCEEECCCCcCC
Confidence 223345555555555444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=7.6e-15 Score=134.83 Aligned_cols=122 Identities=25% Similarity=0.325 Sum_probs=104.1
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEE
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLD 152 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 152 (633)
..+++.|+|++|+|+.+ +.|.++++|+.|+|++|.|+. +|..+..+++|+.|++++|+|+ .++ .+..+++|+.|+
T Consensus 47 L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~ 121 (198)
T d1m9la_ 47 LKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEE
T ss_pred ccccceeECcccCCCCc--ccccCCccccChhhccccccc-cccccccccccccccccccccc-ccc-cccccccccccc
Confidence 44799999999999875 359999999999999999987 6766666789999999999999 454 588899999999
Q ss_pred ccCCcCCCCC--ccCCCCCCCCeEeCcCCcCCccCCcc----------cccCCCCCeec
Q 006739 153 LSGNSFSGNL--GFLKYFPNLEHLSLAKNLFTGKVPTS----------IRTFRNLQFFD 199 (633)
Q Consensus 153 l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~----------~~~~~~L~~l~ 199 (633)
|++|+++... ..+..+++|+.|+|++|.+....+.. +..+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 9999999875 56889999999999999998554432 56789999987
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.23 E-value=1.6e-11 Score=115.26 Aligned_cols=123 Identities=26% Similarity=0.398 Sum_probs=94.4
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCc--------------------hhccCCCCCcEEEccCc
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLP--------------------PQIVDCKKLEILNVQNN 132 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--------------------~~~~~l~~L~~L~Ls~N 132 (633)
..+++.+++++|.++.+ +.+.++++|+.|++++|.+.+..+ ..+.++++|+.|++++|
T Consensus 84 l~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n 161 (227)
T d1h6ua2 84 LTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA 161 (227)
T ss_dssp CCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccc--ccccccccccccccccccccccchhccccchhhhhchhhhhchhhhhcccccccccccccc
Confidence 34667777777776643 346666777777777666554311 23566788999999999
Q ss_pred cCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCcCCcCCccCCcccccCCCCCeeccCC
Q 006739 133 QFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLAKNLFTGKVPTSIRTFRNLQFFDFSG 202 (633)
Q Consensus 133 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~L~~l~l~~ 202 (633)
.+++ .+ .+.++++|+.|+|++|++++.+ .+..+++|++|+|++|+|++ ++ .++++++|+.|++++
T Consensus 162 ~~~~-~~-~l~~l~~L~~L~Ls~n~l~~l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 162 QVSD-LT-PLANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIVTLTN 226 (227)
T ss_dssp CCCC-CG-GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEEEEEE
T ss_pred cccc-ch-hhcccccceecccCCCccCCCh-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEEEeeC
Confidence 9984 33 3889999999999999999764 47889999999999999995 44 388999999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=1.1e-10 Score=110.45 Aligned_cols=139 Identities=15% Similarity=0.146 Sum_probs=96.9
Q ss_pred eeeeEEEEecCCCCcccCC-ccccCCccccEEEcc-CCCCCCCCchhccCCCCCcEEEccCccCCCCCc-----------
Q 006739 73 VLKITKLVFVPRELTGVLS-PSIGRLSELRELSLA-NNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIP----------- 139 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p----------- 139 (633)
..+++.|++++|.+...++ ..|.+++.++.|++. .|.+....+..|.++++|+.|++++|+++...+
T Consensus 52 l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~ 131 (242)
T d1xwdc1 52 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131 (242)
T ss_dssp CTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEE
T ss_pred cchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccc
Confidence 3478899999998877554 468888888888876 467777777788888999999998888873222
Q ss_pred --------------ccccCC-CCCCEEEccCCcCCCCCccCCCCCCCCeE-eCcCCcCCccCCcccccCCCCCeeccCCC
Q 006739 140 --------------SDLSSL-IRLRVLDLSGNSFSGNLGFLKYFPNLEHL-SLAKNLFTGKVPTSIRTFRNLQFFDFSGN 203 (633)
Q Consensus 140 --------------~~~~~l-~~L~~L~l~~N~l~~~~~~~~~l~~L~~L-~l~~N~l~~~~p~~~~~~~~L~~l~l~~N 203 (633)
..|.++ ..++.|++++|+++.........++++.+ ++++|+|+...+..|..+++|++|++++|
T Consensus 132 ~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N 211 (242)
T d1xwdc1 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211 (242)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTS
T ss_pred cccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCC
Confidence 112222 24566677777776665444445555444 56777787444456788888999999999
Q ss_pred CCCCCCcc
Q 006739 204 SLLEGPIP 211 (633)
Q Consensus 204 ~l~~~~~~ 211 (633)
+|+.+|..
T Consensus 212 ~l~~l~~~ 219 (242)
T d1xwdc1 212 RIHSLPSY 219 (242)
T ss_dssp CCCCCCSS
T ss_pred cCCccCHH
Confidence 88877653
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.92 E-value=3.2e-09 Score=105.98 Aligned_cols=96 Identities=23% Similarity=0.228 Sum_probs=73.2
Q ss_pred eeEEEEecCCCCcccCCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEcc
Q 006739 75 KITKLVFVPRELTGVLSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLS 154 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (633)
++++|+|++++++. +|+. +++|++|+|++|+|+. +|.. +.+|+.|++++|+++ .++.. .++|++|+|+
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCcc-cccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 57788999998876 4543 4678888999999886 6754 457888888888888 55532 2468899999
Q ss_pred CCcCCCCCccCCCCCCCCeEeCcCCcCCc
Q 006739 155 GNSFSGNLGFLKYFPNLEHLSLAKNLFTG 183 (633)
Q Consensus 155 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~ 183 (633)
+|.++..+. +..+++|+.|++++|.++.
T Consensus 107 ~n~l~~lp~-~~~l~~L~~L~l~~~~~~~ 134 (353)
T d1jl5a_ 107 NNQLEKLPE-LQNSSFLKIIDVDNNSLKK 134 (353)
T ss_dssp SSCCSSCCC-CTTCTTCCEEECCSSCCSC
T ss_pred ccccccccc-hhhhccceeeccccccccc
Confidence 998887664 5678889999998888873
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.84 E-value=6.4e-09 Score=103.67 Aligned_cols=100 Identities=28% Similarity=0.345 Sum_probs=84.1
Q ss_pred ccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCCccCCCCCCCCeEeCc
Q 006739 98 SELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNLGFLKYFPNLEHLSLA 177 (633)
Q Consensus 98 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~ 177 (633)
.+|+.|||++|.++. +|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++..... .+.|++|+++
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALSDL---PPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCCSC---CTTCCEEECC
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhhhh---cccccccccc
Confidence 468999999999987 7853 578999999999999 88875 45899999999999866531 2579999999
Q ss_pred CCcCCccCCcccccCCCCCeeccCCCCCCCCCc
Q 006739 178 KNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGPI 210 (633)
Q Consensus 178 ~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~~ 210 (633)
+|.|+ .+|. ++.+++|+.|++++|.+...+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccccc
Confidence 99999 5674 6789999999999999976654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=5.9e-10 Score=108.04 Aligned_cols=83 Identities=25% Similarity=0.274 Sum_probs=60.0
Q ss_pred eeeEEEEecCCCCccc-CCccccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccC-ccCCCC-CcccccCCCCCCE
Q 006739 74 LKITKLVFVPRELTGV-LSPSIGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQN-NQFSGT-IPSDLSSLIRLRV 150 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~-~p~~~~~l~~L~~ 150 (633)
.++++||++++.++.. +...+.++++|++|+|++|.+++..+..+..+++|++|+|++ +.++.. +..-+.++++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 3788888888877654 334567788888888888888777777888888888888888 456521 2222346778888
Q ss_pred EEccCC
Q 006739 151 LDLSGN 156 (633)
Q Consensus 151 L~l~~N 156 (633)
|+|+++
T Consensus 126 L~ls~c 131 (284)
T d2astb2 126 LNLSWC 131 (284)
T ss_dssp EECCCC
T ss_pred cccccc
Confidence 888874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=2.1e-09 Score=103.98 Aligned_cols=134 Identities=19% Similarity=0.343 Sum_probs=93.3
Q ss_pred eeeeEEEEecCCCCcccCCccccCCccccEEEccCC-CCCCC-CchhccCCCCCcEEEccCc-cCCCC-CcccccC-CCC
Q 006739 73 VLKITKLVFVPRELTGVLSPSIGRLSELRELSLANN-SLVDL-LPPQIVDCKKLEILNVQNN-QFSGT-IPSDLSS-LIR 147 (633)
Q Consensus 73 ~~~~~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~-l~~ 147 (633)
..++++|+|+++.+++.....++.+++|++|+|+++ .++.. +...+.++++|++|+|+++ .++.. +...+.. .++
T Consensus 70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 358999999999988877778889999999999994 66532 2333467899999999985 45421 2222333 467
Q ss_pred CCEEEccCC--cCCCCC--ccCCCCCCCCeEeCcCC-cCCccCCcccccCCCCCeeccCCC-CCC
Q 006739 148 LRVLDLSGN--SFSGNL--GFLKYFPNLEHLSLAKN-LFTGKVPTSIRTFRNLQFFDFSGN-SLL 206 (633)
Q Consensus 148 L~~L~l~~N--~l~~~~--~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~~~~L~~l~l~~N-~l~ 206 (633)
|+.|++++. .++... .....+++|+.|++++| .+++.....+.++++|++|+++++ .++
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~ 214 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII 214 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCC
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCC
Confidence 888888764 344321 23356788888888875 467666677778888888888874 443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=3.1e-10 Score=99.84 Aligned_cols=105 Identities=21% Similarity=0.139 Sum_probs=67.1
Q ss_pred ccCCccccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCC--CcccccCCCCCCEEEccCCcCCCCCc-cCCCCCC
Q 006739 94 IGRLSELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGT--IPSDLSSLIRLRVLDLSGNSFSGNLG-FLKYFPN 170 (633)
Q Consensus 94 ~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~ 170 (633)
+..+..+..|++.+|.+.. ++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+++...+ ......+
T Consensus 38 l~~~~~~~~l~~~~~~~~~-l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHHH-HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhhh-hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 3344444445555554433 455556678888888888888743 23446677888888888888887653 2223446
Q ss_pred CCeEeCcCCcCCccCCcc-------cccCCCCCeec
Q 006739 171 LEHLSLAKNLFTGKVPTS-------IRTFRNLQFFD 199 (633)
Q Consensus 171 L~~L~l~~N~l~~~~p~~-------~~~~~~L~~l~ 199 (633)
|+.|++++|.++...... +..+++|+.||
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 888888888887554422 55678888775
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.59 E-value=2.4e-09 Score=106.85 Aligned_cols=133 Identities=21% Similarity=0.291 Sum_probs=87.7
Q ss_pred eeEEEEecCCCCccc----CCccccCCccccEEEccCCCCCCC-----CchhccCCCCCcEEEccCccCCCC----Cccc
Q 006739 75 KITKLVFVPRELTGV----LSPSIGRLSELRELSLANNSLVDL-----LPPQIVDCKKLEILNVQNNQFSGT----IPSD 141 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 141 (633)
.++.|.+++|.+... +...+...+.|+.|+|++|+|+.. +...+..+++|+.|+|++|.|+.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 466677777766532 222355667788888888887642 233456678888888888887632 3455
Q ss_pred ccCCCCCCEEEccCCcCCCCC-----ccCC--CCCCCCeEeCcCCcCCcc----CCcccc-cCCCCCeeccCCCCCCC
Q 006739 142 LSSLIRLRVLDLSGNSFSGNL-----GFLK--YFPNLEHLSLAKNLFTGK----VPTSIR-TFRNLQFFDFSGNSLLE 207 (633)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~~-----~~~~--~l~~L~~L~l~~N~l~~~----~p~~~~-~~~~L~~l~l~~N~l~~ 207 (633)
+..+++|+.|+|++|.|++.. ..+. ..+.|+.|++++|+|+.. +...+. ++++|+.|+|++|++..
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 677788888888888887532 2232 235688888888887632 233332 56788888888888754
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=9.2e-09 Score=106.43 Aligned_cols=110 Identities=21% Similarity=0.310 Sum_probs=73.3
Q ss_pred eeeEEEEecCCCCcccC-CccccCCccccEEEccCCCCCC----CCchhccCCCCCcEEEccCccCCCC----Cccccc-
Q 006739 74 LKITKLVFVPRELTGVL-SPSIGRLSELRELSLANNSLVD----LLPPQIVDCKKLEILNVQNNQFSGT----IPSDLS- 143 (633)
Q Consensus 74 ~~~~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~- 143 (633)
.++++||++.|++++.. ..-+..+++++.|+|++|.|+. .+...+..+++|+.|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 37888888888887642 3345667788888888888763 2445567788888888888887521 122222
Q ss_pred CCCCCCEEEccCCcCCCCC-----ccCCCCCCCCeEeCcCCcCCc
Q 006739 144 SLIRLRVLDLSGNSFSGNL-----GFLKYFPNLEHLSLAKNLFTG 183 (633)
Q Consensus 144 ~l~~L~~L~l~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~ 183 (633)
...+|+.|+|++|.+++.. ..+..+++|++|+|++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 2246777888777776542 345667777777777777763
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.46 E-value=1e-08 Score=102.15 Aligned_cols=132 Identities=19% Similarity=0.230 Sum_probs=77.8
Q ss_pred eeEEEEecCCCCccc----CCccccCCccccEEEccCCCCCCCCc----h---------hccCCCCCcEEEccCccCCCC
Q 006739 75 KITKLVFVPRELTGV----LSPSIGRLSELRELSLANNSLVDLLP----P---------QIVDCKKLEILNVQNNQFSGT 137 (633)
Q Consensus 75 ~~~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p----~---------~~~~l~~L~~L~Ls~N~l~~~ 137 (633)
+++.|+|++|.+... +...+...++|+.|+|++|.+...-. . .....+.|+.|++++|.++..
T Consensus 94 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~ 173 (344)
T d2ca6a1 94 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 173 (344)
T ss_dssp TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred CcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccc
Confidence 566677777766553 22234455667777777776532100 0 112355667777777766522
Q ss_pred ----CcccccCCCCCCEEEccCCcCCCC------CccCCCCCCCCeEeCcCCcCCcc----CCcccccCCCCCeeccCCC
Q 006739 138 ----IPSDLSSLIRLRVLDLSGNSFSGN------LGFLKYFPNLEHLSLAKNLFTGK----VPTSIRTFRNLQFFDFSGN 203 (633)
Q Consensus 138 ----~p~~~~~l~~L~~L~l~~N~l~~~------~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~l~l~~N 203 (633)
+...+..++.|+.|+|++|.++.. ...+..+++|+.|+|++|.|+.. +...+..+++|+.|+|++|
T Consensus 174 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n 253 (344)
T d2ca6a1 174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 253 (344)
T ss_dssp GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTC
T ss_pred ccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcC
Confidence 223344566777777777777642 13456677777777777777532 3345566777777777777
Q ss_pred CCC
Q 006739 204 SLL 206 (633)
Q Consensus 204 ~l~ 206 (633)
.|.
T Consensus 254 ~i~ 256 (344)
T d2ca6a1 254 LLS 256 (344)
T ss_dssp CCC
T ss_pred ccC
Confidence 764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=5.6e-09 Score=91.56 Aligned_cols=106 Identities=22% Similarity=0.158 Sum_probs=78.3
Q ss_pred cccEEEccCCCCCCCCchhccCCCCCcEEEccCccCCCCCcccccCCCCCCEEEccCCcCCCCC---ccCCCCCCCCeEe
Q 006739 99 ELRELSLANNSLVDLLPPQIVDCKKLEILNVQNNQFSGTIPSDLSSLIRLRVLDLSGNSFSGNL---GFLKYFPNLEHLS 175 (633)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~---~~~~~l~~L~~L~ 175 (633)
..+.|+++++... ..+..+..+..|++.+|... .++..+..+++|++|+|++|+|+... ..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3556777766532 23555666667777777665 56666678999999999999999765 3466799999999
Q ss_pred CcCCcCCccCCcccccCCCCCeeccCCCCCCCCC
Q 006739 176 LAKNLFTGKVPTSIRTFRNLQFFDFSGNSLLEGP 209 (633)
Q Consensus 176 l~~N~l~~~~p~~~~~~~~L~~l~l~~N~l~~~~ 209 (633)
|++|+|+...+-.+....+|+.|++++|++....
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 9999999543334445568999999999996543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=1.4e-08 Score=104.91 Aligned_cols=111 Identities=21% Similarity=0.254 Sum_probs=88.0
Q ss_pred ccccEEEccCCCCCCC-CchhccCCCCCcEEEccCccCCC----CCcccccCCCCCCEEEccCCcCCCCC-----ccCC-
Q 006739 98 SELRELSLANNSLVDL-LPPQIVDCKKLEILNVQNNQFSG----TIPSDLSSLIRLRVLDLSGNSFSGNL-----GFLK- 166 (633)
Q Consensus 98 ~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~-----~~~~- 166 (633)
.+|+.||++.|++++. +...+..+++|++|+|++|.|+. .+...+..+++|+.|||++|.|+... ..+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 3689999999999873 24456778999999999999983 34556788999999999999986422 2232
Q ss_pred CCCCCCeEeCcCCcCCcc----CCcccccCCCCCeeccCCCCCCCC
Q 006739 167 YFPNLEHLSLAKNLFTGK----VPTSIRTFRNLQFFDFSGNSLLEG 208 (633)
Q Consensus 167 ~l~~L~~L~l~~N~l~~~----~p~~~~~~~~L~~l~l~~N~l~~~ 208 (633)
...+|+.|+|++|++++. ++..+..+++|+.|++++|++...
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~ 127 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 127 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhh
Confidence 345899999999999853 456678899999999999998643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=3.3e-07 Score=87.00 Aligned_cols=143 Identities=14% Similarity=0.087 Sum_probs=92.7
Q ss_pred hcCcccccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 336 EDGLASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 336 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
.+.|+..+..+-++.+.||+... +++.+++|+........ ...+.+|...+..+. +--+.++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~~~~--------------~~~~~~E~~~l~~l~~~vpvP~v 75 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGT--------------TYDVEREKDMMLWLEGKLPVPKV 75 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGGTTS--------------TTCHHHHHHHHHHHTTTSCCCCE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe---CCCeEEEEEcCCCcccc--------------hhhHHHHHHHHHHHhccCCCCcE
Confidence 35666666655555678999863 56678888764332111 123456777766654 4446778
Q ss_pred ceeeecCCccEEEEecccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------
Q 006739 415 LAHMARPDCHLLVYEFMKNGSLQDILNDVSQGRRELDWLARHKIALGVACGLEYLHI----------------------- 471 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~----------------------- 471 (633)
+.+...++..++||++++|.++.+.... ......++.++++.++.||.
T Consensus 76 l~~~~~~~~~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T d1j7la_ 76 LHFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEEEEETTEEEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEEecCCceEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence 8888888889999999999877654321 01122344455555555551
Q ss_pred ---------------------------------cCCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 472 ---------------------------------SHNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 472 ---------------------------------~h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
.....++|+|+.|.||++++++..-|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 012347899999999999987666799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=2e-06 Score=80.90 Aligned_cols=74 Identities=9% Similarity=0.132 Sum_probs=48.6
Q ss_pred ccccccC-eeEEEEEecCCCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC--CCcccccceeeec
Q 006739 344 KIGSGGC-GEVYKAELPGSNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR--HRNLLPLLAHMAR 420 (633)
Q Consensus 344 ~ig~G~~-g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~ 420 (633)
.+..|.. +.||+.... ++..+++|....... ..+..|...++.+. .-.+.+++.+..+
T Consensus 17 ~~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~~-----------------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~ 77 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGAL-----------------NELQDEAARLSWLATTGVPCAAVLDVVTE 77 (255)
T ss_dssp ECSCTTSSCEEEEEECT--TSCCEEEEEECSCTT-----------------SCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC--CCCEEEEEeCCccCH-----------------hHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence 4455554 678998753 677788897543321 12445555555553 2346677888888
Q ss_pred CCccEEEEecccCCCH
Q 006739 421 PDCHLLVYEFMKNGSL 436 (633)
Q Consensus 421 ~~~~~lv~e~~~~gsL 436 (633)
++..++||+|++|.++
T Consensus 78 ~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 78 AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SSCEEEEEECCSSEET
T ss_pred ccceEEEEEeeecccc
Confidence 8888999999988654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.13 E-value=5.4e-07 Score=78.94 Aligned_cols=110 Identities=16% Similarity=0.143 Sum_probs=77.0
Q ss_pred cCCccccEEEccCC-CCCCC----CchhccCCCCCcEEEccCccCCC----CCcccccCCCCCCEEEccCCcCCCCC---
Q 006739 95 GRLSELRELSLANN-SLVDL----LPPQIVDCKKLEILNVQNNQFSG----TIPSDLSSLIRLRVLDLSGNSFSGNL--- 162 (633)
Q Consensus 95 ~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~--- 162 (633)
.+.+.|++|+|+++ .++.. +-..+...+.|+.|+|++|.+.. .+...+...+.|+.|+|++|.++...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34577888888874 45432 23356667888889998888873 22334556678999999999887532
Q ss_pred --ccCCCCCCCCeEeCcCCcCCcc-------CCcccccCCCCCeeccCCCC
Q 006739 163 --GFLKYFPNLEHLSLAKNLFTGK-------VPTSIRTFRNLQFFDFSGNS 204 (633)
Q Consensus 163 --~~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~~~~L~~l~l~~N~ 204 (633)
..+...++|+.|+|++|.+... +...+...++|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 4577788899999998876521 33455667888999887764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.67 E-value=1.8e-06 Score=75.47 Aligned_cols=113 Identities=13% Similarity=0.134 Sum_probs=79.7
Q ss_pred cccCCccccEEEccC-CCCCCC----CchhccCCCCCcEEEccCccCCCC----CcccccCCCCCCEEEccCCcCCCCC-
Q 006739 93 SIGRLSELRELSLAN-NSLVDL----LPPQIVDCKKLEILNVQNNQFSGT----IPSDLSSLIRLRVLDLSGNSFSGNL- 162 (633)
Q Consensus 93 ~~~~l~~L~~L~l~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~- 162 (633)
...+.+.|++|+|++ |.++.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.++...
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~ 91 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 91 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence 345667888999987 456442 334456778899999999988743 2233556788999999999887532
Q ss_pred ----ccCCCCCCCCeEeC--cCCcCCc----cCCcccccCCCCCeeccCCCCC
Q 006739 163 ----GFLKYFPNLEHLSL--AKNLFTG----KVPTSIRTFRNLQFFDFSGNSL 205 (633)
Q Consensus 163 ----~~~~~l~~L~~L~l--~~N~l~~----~~p~~~~~~~~L~~l~l~~N~l 205 (633)
..+...++|+.++| ++|.+.. .+...+...++|+.|+++.|..
T Consensus 92 ~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 92 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 55677888887555 5677753 3445667889999999987754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.66 E-value=6.3e-06 Score=71.85 Aligned_cols=108 Identities=14% Similarity=0.087 Sum_probs=81.1
Q ss_pred eeEEEEecCC-CCccc----CCccccCCccccEEEccCCCCCC----CCchhccCCCCCcEEEccCccCCCC----Cccc
Q 006739 75 KITKLVFVPR-ELTGV----LSPSIGRLSELRELSLANNSLVD----LLPPQIVDCKKLEILNVQNNQFSGT----IPSD 141 (633)
Q Consensus 75 ~~~~L~l~~n-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 141 (633)
+++.|+|+++ .+... +...+...+.|+.|+|++|.+.. .+...+...+.|+.|+|++|.|+.. +-..
T Consensus 16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~a 95 (167)
T d1pgva_ 16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRS 95 (167)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHH
T ss_pred CCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHH
Confidence 7999999975 45432 23357777889999999999964 2444566679999999999999843 2334
Q ss_pred ccCCCCCCEEEccCCcCCCCC--------ccCCCCCCCCeEeCcCCcCC
Q 006739 142 LSSLIRLRVLDLSGNSFSGNL--------GFLKYFPNLEHLSLAKNLFT 182 (633)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~~--------~~~~~l~~L~~L~l~~N~l~ 182 (633)
+...++|+.|+|++|++.... ..+...++|+.|+++.+...
T Consensus 96 L~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~~ 144 (167)
T d1pgva_ 96 TLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 144 (167)
T ss_dssp TTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCch
Confidence 667789999999999876532 34556789999999887643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.50 E-value=0.00013 Score=72.88 Aligned_cols=83 Identities=14% Similarity=0.172 Sum_probs=45.3
Q ss_pred ccccccccCeeEEEEEecCCCCeEEEEEEccCCCcchh-hhhHHHHHHHHHHHHHHHHHHHHhhcCC-C--Cccccccee
Q 006739 342 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIQPPKDAA-ELTEEDSKLLNKKMRQIRSEINTVGQIR-H--RNLLPLLAH 417 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~ 417 (633)
.+.||.|....||++... .+++.++||.-........ ..... ..+...|.+.++.+. + ..+++++.
T Consensus 31 ~~eig~G~~N~vfrV~~~-~~~~svivKqa~p~~r~~g~~~~~~--------~~R~~~E~~~L~~~~~~~p~~vP~v~~- 100 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAKVVGESWPLT--------IDRARIESSALIRQGEHVPHLVPRVFY- 100 (392)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCC--------TTHHHHHHHHHHHHHTTCGGGSCCEEE-
T ss_pred EEEeCCCceEeEEEEEeC-CCCeEEEEecCCchhcccCCCCCCC--------HHHHHHHHHHHHHhhhhCCCCcceEEE-
Confidence 456899999999999754 3467899995422111000 00000 122345666665542 2 23445554
Q ss_pred eecCCccEEEEecccCCC
Q 006739 418 MARPDCHLLVYEFMKNGS 435 (633)
Q Consensus 418 ~~~~~~~~lv~e~~~~gs 435 (633)
.+++..++|||++++..
T Consensus 101 -~d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 101 -SDTEMAVTVMEDLSHLK 117 (392)
T ss_dssp -EETTTTEEEECCCTTSE
T ss_pred -EcCCCCEEEEeccCCcc
Confidence 35566789999997653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.93 E-value=0.0015 Score=62.98 Aligned_cols=30 Identities=23% Similarity=0.318 Sum_probs=24.3
Q ss_pred CCCeeeCCCCCCCeEecCCCceEEcccccccc
Q 006739 474 NPRIIHRDLKPANVLLDDDMEARIADFGLAKA 505 (633)
Q Consensus 474 ~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~~ 505 (633)
..++||+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4578999999999999754 45899997653
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.93 E-value=3.4e-05 Score=66.98 Aligned_cols=108 Identities=16% Similarity=0.176 Sum_probs=79.6
Q ss_pred eeEEEEecC-CCCccc----CCccccCCccccEEEccCCCCCCC----CchhccCCCCCcEEEccCccCCCC----Cccc
Q 006739 75 KITKLVFVP-RELTGV----LSPSIGRLSELRELSLANNSLVDL----LPPQIVDCKKLEILNVQNNQFSGT----IPSD 141 (633)
Q Consensus 75 ~~~~L~l~~-n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 141 (633)
.+++|+|++ +.++.. +...+...++|++|+|++|.++.. +-..+...++|+.|++++|.++.. +-..
T Consensus 18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~ 97 (166)
T d1io0a_ 18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEA 97 (166)
T ss_dssp TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHG
T ss_pred CCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHH
Confidence 789999997 456433 233466789999999999998763 334556679999999999998743 3355
Q ss_pred ccCCCCCCEEEc--cCCcCCCCC-----ccCCCCCCCCeEeCcCCcCC
Q 006739 142 LSSLIRLRVLDL--SGNSFSGNL-----GFLKYFPNLEHLSLAKNLFT 182 (633)
Q Consensus 142 ~~~l~~L~~L~l--~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~ 182 (633)
+...++|+.++| ++|.+.... ..+...++|+.|+++.|...
T Consensus 98 l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 98 LQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp GGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 677889997666 566775422 45667899999999888654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.38 E-value=0.0049 Score=61.03 Aligned_cols=75 Identities=11% Similarity=0.158 Sum_probs=46.1
Q ss_pred ccccccccCeeEEEEEecC------CCCeEEEEEEccCCCcchhhhhHHHHHHHHHHHHHHHHHHHHhhcCC-CCccccc
Q 006739 342 LEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIQPPKDAAELTEEDSKLLNKKMRQIRSEINTVGQIR-HRNLLPL 414 (633)
Q Consensus 342 ~~~ig~G~~g~Vy~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l 414 (633)
++.|+.|-.=.+|++.... ...+.|.+++.-.... .....+|..+++.+. +.-..++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~----------------~idr~~E~~i~~~ls~~gl~Pkl 110 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----------------ESHLVAESVIFTLLSERHLGPKL 110 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----------------HHHHHHHHHHHHHHHHTTSSSCE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch----------------hhHHHHHHHHHHHHHhCCCCCeE
Confidence 4678888889999998642 1235677776542211 112345666666664 3334577
Q ss_pred ceeeecCCccEEEEecccCCCH
Q 006739 415 LAHMARPDCHLLVYEFMKNGSL 436 (633)
Q Consensus 415 ~~~~~~~~~~~lv~e~~~~gsL 436 (633)
++++.+ .+|+||++|.++
T Consensus 111 l~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 111 YGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EEEETT----EEEECCCCEEEC
T ss_pred EEEcCC----ceEEEEeccccC
Confidence 777643 689999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.82 E-value=0.0062 Score=58.12 Aligned_cols=32 Identities=31% Similarity=0.340 Sum_probs=28.0
Q ss_pred CCCCeeeCCCCCCCeEecCCCceEEccccccc
Q 006739 473 HNPRIIHRDLKPANVLLDDDMEARIADFGLAK 504 (633)
Q Consensus 473 h~~~ivH~Dikp~Nill~~~~~~kl~DfG~a~ 504 (633)
...++||+|+.+.||+++++...-|+||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 46789999999999999988777899999764
|